Citrus Sinensis ID: 037224

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550--
Protein Sequence
MRNKSQCLSFSVLFFFFFFLFSYHQSQAQPSTTGYTCSANQTTYPCRTYAFYRASAPDFLDLASIADLFSVSRLMISEPSNISSPSSPLIQNQPLFVPITCSCNTLNASYTISFANLSYTIKSGDTFYLVSTNKYQNLTTYQSVEVVNPTFVPTKLEVGDVIIFPVFCKCPNQTQLRNRVNYLVSYVLQPSENLSSVASRFGIETQAIIDVNGNNIRPFDTLFVPVARLPELKQPAVAPSTPPSAETPSRKTERKGVIIGLSIGLGICGASLVLVAGMWIYREALLKKKREREIDEQKQKLQFNKGGRDLKDMEVNFMADVSDCLDKYRIFKIEELREATDNFSEGCLIQGSVYKGNIHGEVYAIKMMKWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYWREMKRGK
Secondary Structure (PSIPRED)
ccccccHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccEEEEEccccccccHHHHHHHHcccHHHHccccccccccccccccccEEEEEEcccccccccccEEEEEcEEEEccccccEEEHHHHcccccHHHHHHHHcccccccccccccEEEEEEEEcccccccccccccEEEEEEccccccHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHHHcHHHHHHHHHHHHcccccccccccccccccccccccccccEEEEHHHHHHHHHcccccccccccEEEEEEccEEEEEEEcccccHHHHHHHHHccccccccEEEEEEccccccEEEEEEEcccccccccccccccccccHHHHHHHHHHHHHHHHHHHccccccEEEcccccccccccccccEEccccccccccccccccEEccccccccccccccccccccccEEHHHHHHHHHHHcccccccccccccccHHHHHHHHHHcc
Secondary Structure Prediction (SSPRO)
cccHcHHHHHHHHHHHHHHHcccHHccccccccccEEccccccccccEEEEEEEcccccccEcEcccccccccccccccccccccccEccccccEEEEEccccccccccHHccccccEEEEcccccEEEEccccHccHHHHHHHHHccccccccccccccEEEEEEEcccccccHHHcccEEEEEEEEccccccccccccccccccEEEEccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccEEEEHHHHHHHHccccccccccEEEEEEEccccEEEHHHHHHHHHHHHHHHHHHHcHccEEEEEEEEccccccEEEEEEEcccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHHcccccccccccHHHEEEcccccEEEccccccccccccEEEEEEccccHccHHHHHHccccHHHHHHHHHHHHHHHHHcccccccccccccHHHHHHHHHHHccc
Coil and Loop (DISEMBL)
mrnksqclsfSVLFFFFFFLFsyhqsqaqpsttgytcsanqttypcrtyafyrasapdfldlasIADLFSVSRlmisepsnisspsspliqnqplfvpitcscntlnasyTISFANLSYTIKSGDTFYLVStnkyqnlttyqsvevvnptfvptklevgdviifpvfckcpnqtqlrnRVNYLVSYVLqpsenlssvaSRFGIETQAiidvngnnirpfdtlfvpvarlpelkqpavapstppsaetpsrkterkGVIIGLSIGLGICGASLVLVAGMWIYREALLKKKREREIDEQKQKLQfnkggrdlkDMEVNFMADVSDCLDKYRIFKIEELREAtdnfsegcliqgsvykgniHGEVYAIKMMKWNACEELKILQKvnhgnlvklegfcidpedanCYLIYEYIENGSLHSWLHEnknenlnwKTRLRIAIDVANGLqyihehtrprvvhkdikssnilldsnMRAKIANfglaksgcnaITMHIVgtqgyiapeyladgvvstkmDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYWREMKRGK
Flexible Loop (DISEMBL)
MRNKSQCLSFSVLFFFFFFLFSYHQSQAQPSTTGYTCSANQTTYPCRTYAFYRASAPDFLDLASIADLFSVSRLMISEPSNISSPSSPLIQNQPLFVPITCSCNTLNASYTISFANLSYTIKSGDTFYLVSTNKYQNLTTYQSVEVVNPTFVPTKLEVGDVIIFPVFCKCPNQTQLRNRVNYLVSYVLQPSENLSSVASRFGIETQAIIDVNGNNIRPFDTLFVPVARLPElkqpavapstppsaetpsrkterKGVIIGLSIGLGICGASLVLVAGMWIYREALLKkkrereideqkqklqfnkggrdlkdMEVNFMADVSDCLDKYRIFKIEELREATDNFSEGCLIQGSVYKGNIHGEVYAIKMMKWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIhehtrprvvhkdiKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISgkeaideegkfcgqklkgywremkrgk
Low Complexity Region (SEG)
MRNKSQClsfsvlfffffflfsYHQSQAQPSTTGYTCSANQTTYPCRTYAFYRASAPDFLDLASIADLFSVSRLMISEpsnisspsspliqnqplFVPITCSCNTLNASYTISFANLSYTIKSGDTFYLVSTNKYQNLTTYQSVEVVNPTFVPTKLEVGDVIIFPVFCKCPNQTQLRNRVNYLVSYVLQPSENLSSVASRFGIETQAIIDVNGNNIRPFDTLFVPVARLPELKQpavapstppsaetpsRKTERKGViiglsiglgicgaslVLVAGMWIYREALLKKKREREIDEQKQKLQFNKGGRDLKDMEVNFMADVSDCLDKYRIFKIEELREATDNFSEGCLIQGSVYKGNIHGEVYAIKMMKWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYWREMKRGK
Disordered region (IsUnstruct)
******CLSFSVLFFFFFFLFSYHQSQAQPSTTGYTCSANQTTYPCRTYAFYRASAPDFLDLASIADLFSVSRLMI*************IQNQPLFVPITCSCNTLNASYTISFANLSYTIKSGDTFYLVSTNKYQNLTTYQSVEVVNPTFVPTKLEVGDVIIFPVFCKCPNQTQLRNRVNYLVSYVLQPSENLSSVASRFGIETQAIIDVNGNNIRPFDTLFVPVARL**************************GVIIGLSIGLGICGASLVLVAGMWIYREALLK***********************KDMEVNFMADVSDCLDKYRIFKIEELREATDNFSEGCLIQGSVYKGNIHGEVYAIKMMKWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYWR******
Disordered Region (DISOPRED)
******C**FSVLFFFFFFLFSYHQSQAQPSTTGYTCSANQTTYPCRTYAFYRASAPDFLDLASIADLFSVSRLMISEPSNISSPSSPLIQNQPLFVPITCSCNTLNASYTISFANLSYTIKSGDTFYLVSTNKYQNLTTYQSVEVVNPTFVPTKLEVGDVIIFPVFCKCPNQTQLRNRVNYLVSYVLQPSENLSSVASRFGIETQAIIDVNGNNIRPFDTLFVPVARLPE****************************GLSIGLGICGASLVLVAGMWIYRE*********************************************RIFKIEELREATDNFSEGCLIQGSVYKGNIHGEVYAIKMMKWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAI*****FCGQKLKGYWREMKRG*
Disordered Region (DISEMBL)
MRNKSQCLSFSVLFFFFFFLFSYHQSQ*********CSANQTTYPCRTYAFYRASAPDFLDLASIADLFSVSRLMISEP********PLIQNQPLFVPITCSCNTLNASYTISFANLSYTIKSGDTFYLVSTNKYQNLTTYQSVEVVNPTFVPTKLEVGDVIIFPVFCKCPNQTQLRNRVNYLVSYVLQPSENLSSVASRFGIETQAIIDVNGNNIRPFDTLFVPVARLPELKQ*******************RKGVIIGLSIGLGICGASLVLVAGMWIYREALLKKKREREIDEQKQKLQFNKGGRDLKDMEVNFMADVSDCLDKYRIFKIEELREATDNFSEGCLIQGSVYKGNIHGEVYAIKMMKWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYWREMKRGK
Disordered Region (DISPRO)
****SQCLSFSVLFFFFFFLFSYHQSQAQPSTTGYTCSANQTTYPCRTYAFYRASAPDFLDLASIADLFSVSRLMISEPSNISSPSSPLIQNQPLFVPITCSCNTLNASYTISFANLSYTIKSGDTFYLVSTNKYQNLTTYQSVEVVNPTFVPTKLEVGDVIIFPVFCKCPNQTQLRNRVNYLVSYVLQPSENLSSVASRFGIETQAIIDVNGNNIRPFDTLFVPVARLP************************KGVIIGLSIGLGICGASLVLVAGMWIYREALLK***********************************DCLDKYRIFKIEELREATDNFSEGCLIQGSVYKGNIHGEVYAIKMMKWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYWREMKRG*
Transmembrane Helix (TMHMM)
iiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MRNKSQCLSFSVLFFFFFFLFSYHQSQAQPSTTGYTCSANQTTYPCRTYAFYRASAPDFLDLASIADLFSVSRLMISEPSNISSPSSPLIQNQPLFVPITCSCNTLNASYTISFANLSYTIKSGDTFYLVSTNKYQNLTTYQSVEVVNPTFVPTKLEVGDVIIFPVFCKCPNQTQLRNRVNYLVSYVLQPSENLSSVASRFGIETQAIIDVNGNNIRPFDTLFVPVARLPELKQPAVAPSTPPSAETPSRKTERKGVIIGLSIGLGICGASLVLVAGMWIYREALLKKKREREIDEQKQKLQFNKGGRDLKDMEVNFMADVSDCLDKYRIFKIEELREATDNFSEGCLIQGSVYKGNIHGEVYAIKMMKWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYWREMKRGK
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	552	2.2.26 [Sep-21-2011]
O64825	612	LysM domain receptor-like	yes	no	0.922	0.831	0.341	2e-75
O22808	664	Protein LYK5 OS=Arabidops	no	no	0.913	0.759	0.306	3e-64
A8R7E6	617	Chitin elicitor receptor	no	no	0.768	0.687	0.344	1e-57
D7UPN3	605	Chitin elicitor receptor	no	no	0.777	0.709	0.317	5e-52
Q9FX99	663	Probable receptor-like pr	no	no	0.543	0.452	0.364	2e-46
Q9SGI7	654	Protein LYK2 OS=Arabidops	no	no	0.820	0.692	0.295	7e-46
F4IB81	651	LysM domain receptor-like	no	no	0.369	0.313	0.454	2e-45
C0LGV0	895	Probable LRR receptor-lik	no	no	0.485	0.299	0.359	2e-45
C0LGH2	1032	Probable LRR receptor-lik	no	no	0.496	0.265	0.360	2e-43
Q1PEM5	513	Proline-rich receptor-lik	no	no	0.516	0.555	0.335	3e-43

>sp|O64825|LYK4_ARATH LysM domain receptor-like kinase 4 OS=Arabidopsis thaliana GN=LYK4 PE=1 SV=1

 Score =  283 bits (725), Expect = 2e-75,   Method: Compositional matrix adjust.
 Identities = 194/568 (34%), Positives = 311/568 (54%), Gaps = 59/568 (10%)

Query: 8   LSFSVLFFFFFFLFSYHQSQAQP----STT------------GYTCSANQTTYPCRTYAF 51
            SF +L F    L S+  +Q QP    STT            GY+C+    T  C+ Y  
Sbjct: 4   FSFHLLVFILLSLSSFATAQ-QPYVGISTTDCSVSDNTTSVFGYSCNGLNKT--CQAYVI 60

Query: 52  YRASAPDFLDLASIADLFSVSRLMISEPSNISSPSSPLIQNQPLFVPITCSCNTLNASYT 111
           +R S P F  + SI+ LFSV   ++S   N +SPS+     Q + +P+TCSC   ++   
Sbjct: 61  FR-STPSFSTVTSISSLFSVDPSLVSSL-NDASPSTSFPSGQQVIIPLTCSCTGDDSQ-- 116

Query: 112 ISFANLSYTIKSGDTFYLVSTNKYQNLTTYQSVEVVNPTFVPTKLEVGDVIIFPVFCKCP 171
              +N++YTI+  D+++ ++ +  Q L+T Q++   N       L  G  I+ P+ C CP
Sbjct: 117 ---SNITYTIQPNDSYFAIANDTLQGLSTCQALAKQN-NVSSQSLFPGMRIVVPIRCACP 172

Query: 172 NQTQL-RNRVNYLVSYVLQPSENLSSVASRFGIETQAIIDVN-----GNNIRPFDTLFVP 225
              Q+  + V YL+SY +   + ++ ++ RFG+ET   +  N      + + PF T+ +P
Sbjct: 173 TAKQINEDGVKYLMSYTVVFEDTIAIISDRFGVETSKTLKANEMSFENSEVFPFTTILIP 232

Query: 226 VARLPELKQPAVAPSTPPSAET--------PSRKTERKGVIIGLSIGLGICGASLVL-VA 276
           +   P      + P  PP  ++          RK+++K  +  L+   G+ G +LVL V 
Sbjct: 233 LVNPPANTNSLIPPPPPPPPQSVSPPPLSPDGRKSKKKTWVYALA---GVLGGALVLSVI 289

Query: 277 GMWIYREALLKKKREREIDEQKQKLQFNKGGRD-LKDMEVNFMADVSD-CLDKYRIFKIE 334
           G  I+   L KKK + +  E+   L    G +  + D E + +  +S   ++  +++K  
Sbjct: 290 GAAIF--CLSKKKTKTQTQEETGNLDSFMGKKPPMSDQEFDPLDGLSGMVVESLKVYKFH 347

Query: 335 ELREATDNFSEGCLIQGSVYKGNIHGEVYAIKMMKWNACEELKILQKVNHGNLVKLEGFC 394
           EL+ AT +F+    I GS Y G I+G+   IK ++ NA EE+ +L K+NH N+++L GFC
Sbjct: 348 ELQSATSDFTSSSSIGGSGYIGKINGDGAMIKKIEGNASEEVNLLSKLNHLNIIRLSGFC 407

Query: 395 IDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVV 454
               + + YL+YE+  NGSL  W+H  K+  L+   +L+IA+D+A GL Y+H    P  V
Sbjct: 408 F--HEGDWYLVYEHASNGSLSEWIHTTKSL-LSLTQKLQIALDIATGLNYLHNFADPPYV 464

Query: 455 HKDIKSSNILLDSNMRAKIANFGLAKSGCN--AITMHIVGTQGYIAPEYLADGVVSTKMD 512
           H+D+ S+N+ LD   RAKI + G A+S      +T H+ GT+GY+APEYL  G+VSTK+D
Sbjct: 465 HRDLNSNNVFLDLEFRAKIGSLGSARSTTEDFVLTKHVEGTRGYLAPEYLEHGLVSTKLD 524

Query: 513 VFSFGVVLLELISGKEAID-----EEGK 535
           V++FGVVLLE+++GKEA +     +EGK
Sbjct: 525 VYAFGVVLLEIVTGKEASELKKEIDEGK 552

Lysin motif (LysM) receptor kinase that functions as a cell surface receptor in chitin elicitor (chitooligosaccharides) signaling leading to innate immunity. Recognizes microbe-derived N-acetylglucosamine (NAG)-containing ligands. Involved in the resistance to the pathogenic fungus Alternaria brassicicola and to the bacterial pathogen the bacterial pathogen Pseudomonas syringae pv tomato DC3000, probably by sensing microbe-associated molecular pattern (MAMP) and pathogen-associated molecular patterns (PAMP). May play a role in detecting peptidoglycans (e.g. PGNs) during bacterial growth.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|O22808|LYK5_ARATH Protein LYK5 OS=Arabidopsis thaliana GN=LYK5 PE=1 SV=1

 Score =  246 bits (629), Expect = 3e-64,   Method: Compositional matrix adjust.
 Identities = 174/567 (30%), Positives = 295/567 (52%), Gaps = 63/567 (11%)

Query: 12  VLFFFFFFLFSYHQSQAQPS----------------TTGYTCSANQTTYPCRTYAFYRAS 55
            LF   FF  S  ++Q QP                 T G+TC+   +   CR+Y  +  S
Sbjct: 12  TLFLLLFFAVSPAKAQ-QPYVNNHQLACEVRVYDNITNGFTCNGPPS---CRSYLTFW-S 66

Query: 56  APDFLDLASIADLFSVSRLMISEPSNISSPSSPLIQNQPLFVPITCSCNTLNASYTISFA 115
            P +    SIA L +VS   I   +N+ + ++ +   + + +P  CSC++ +  +    A
Sbjct: 67  QPPYNTADSIAKLLNVSAAEIQSINNLPTATTRIPTRELVVIPANCSCSSSSGGFYQHNA 126

Query: 116 NLSYTIKSGD-TFYLVSTNKYQNLTTYQSVEVVNPTFVPTKLEVGDVIIFPVFCKCPNQT 174
             + +   GD T++ V+ + YQ L+T Q++   N  +   +L  G  ++ P+ C CP   
Sbjct: 127 TYNLSGNRGDETYFSVANDTYQALSTCQAMMSQN-RYGERQLTPGLNLLVPLRCACPTAK 185

Query: 175 QLRNRVNYLVSYVLQPSENLSSVASRFGIETQAIIDVN---GNNIRPFDTLFVPVARLPE 231
           Q      YL++Y++   +++S +A  F   + AI + N    +NI  F  + VP+   P 
Sbjct: 186 QTTAGFKYLLTYLVAMGDSISGIAEMFNSTSAAITEGNELTSDNIFFFTPVLVPLTTEPT 245

Query: 232 -------------LKQPAVAPSTPPSAETPSRKTERKGVIIGLSIGLGICGASLVLVAGM 278
                        +  P   P  PP + +  +        I + IG+G     L+ +  +
Sbjct: 246 KIVISPSPPPPPVVATPPQTPVDPPGSSSSHK-------WIYIGIGIGAGLLLLLSILAL 298

Query: 279 WIYREALLKKKREREIDEQKQKLQFNKGGRDLKDMEVNFMADVSD---------CLDKYR 329
             Y+    KK     + E+ +    +            +  D+S+          ++   
Sbjct: 299 CFYKRRSKKKSLPSSLPEENKLFDSSTKQSIPTTTTTQWSIDLSNSSEAFGLKSAIESLT 358

Query: 330 IFKIEELREATDNFSEGCLIQGSVYKGNIHGEVYAIKMMKWN-ACEELKILQKVNHGNLV 388
           +++  +L+ AT NFS+   I+GSVY+  I+G+  A+K++K + +  E+ +L+K+NH N++
Sbjct: 359 LYRFNDLQSATSNFSDENRIKGSVYRATINGDDAAVKVIKGDVSSSEINLLKKLNHSNII 418

Query: 389 KLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEH 448
           +L GFCI   +   YL++EY ENGS+  WLH +  ++L WK R+ IA DVA  L Y+H +
Sbjct: 419 RLSGFCI--REGTSYLVFEYSENGSISDWLHSSGKKSLTWKQRVEIARDVAEALDYLHNY 476

Query: 449 TRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-----ITMHIVGTQGYIAPEYLA 503
             P  +HK+++S+NILLDSN RAKIANFG+A+          +T H+ GTQGY+APEY+ 
Sbjct: 477 ITPPHIHKNLESTNILLDSNFRAKIANFGVARILDEGDLDLQLTRHVEGTQGYLAPEYVE 536

Query: 504 DGVVSTKMDVFSFGVVLLELISGKEAI 530
           +GV+++K+DVF+FGV +LEL+SG+EA+
Sbjct: 537 NGVITSKLDVFAFGVAVLELLSGREAV 563

May recognize microbe-derived N-acetylglucosamine (NAG)-containing ligands.

Arabidopsis thaliana (taxid: 3702)

>sp|A8R7E6|CERK1_ARATH Chitin elicitor receptor kinase 1 OS=Arabidopsis thaliana GN=CERK1 PE=1 SV=1

 Score =  224 bits (571), Expect = 1e-57,   Method: Compositional matrix adjust.
 Identities = 165/479 (34%), Positives = 242/479 (50%), Gaps = 55/479 (11%)

Query: 95  LFVPITCSCNTLNASYTISFANLSYTIKSGDTFYLVSTNKYQNLTTYQSVEVVNPTFVPT 154
           + VP  C C   +        N SY+++  DT+  V+ + Y NLTT +S++  NP F  T
Sbjct: 85  VLVPFPCECQPGD----FLGHNFSYSVRQEDTYERVAISNYANLTTMESLQARNP-FPAT 139

Query: 155 KLEVGDVIIFPVFCKCPNQTQLRNRVNYLVSYVLQPSENLSSVASRFGIETQAIIDVNGN 214
            + +   +   V C C +++  ++     V+Y L+P ++LSS+A   G+    +   N  
Sbjct: 140 NIPLSATLNVLVNCSCGDESVSKD-FGLFVTYPLRPEDSLSSIARSSGVSADILQRYN-- 196

Query: 215 NIRPFDTLFVPVARLPELKQPAVAPSTPPSAETPSRKTERK-----GVIIGLSIGLGICG 269
                     P             P   P+   P  K+ ++     GVI G+ IG+ I  
Sbjct: 197 ----------PGVNFNSGNGIVYVPGRDPNGAFPPFKSSKQDGVGAGVIAGIVIGV-IVA 245

Query: 270 ASLVLVAGMWIYREALLKKKREREI------DEQKQKLQFNKGGRDLKDMEVNFMADVSD 323
             L+L    + YR+   K              +         GG     +     A    
Sbjct: 246 LLLILFIVYYAYRKNKSKGDSFSSSIPLSTKADHASSTSLQSGGLGGAGVSPGIAAI--- 302

Query: 324 CLDKYRIFKIEELREATDNFSEGCLIQ----GSVYKGNIHGEVYAIKMMKWNACE----E 375
            +DK   F +EEL +ATDNF+    I     G+VY   + GE  AIK M   A +    E
Sbjct: 303 SVDKSVEFSLEELAKATDNFNLSFKIGQGGFGAVYYAELRGEKAAIKKMDMEASKQFLAE 362

Query: 376 LKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIA 435
           LK+L +V+H NLV+L G+C++    + +L+YEY+ENG+L   LH +  E L W  R++IA
Sbjct: 363 LKVLTRVHHVNLVRLIGYCVE---GSLFLVYEYVENGNLGQHLHGSGREPLPWTKRVQIA 419

Query: 436 IDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK---SGCNAITMHIVG 492
           +D A GL+YIHEHT P  VH+DIKS+NIL+D   RAK+A+FGL K    G +A T   +G
Sbjct: 420 LDSARGLEYIHEHTVPVYVHRDIKSANILIDQKFRAKVADFGLTKLTEVGGSA-TRGAMG 478

Query: 493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAI----DEEGKFCGQKLKGYWRE 547
           T GY+APE +  G VS K+DV++FGVVL ELIS K A+    +  G+F G  L G + E
Sbjct: 479 TFGYMAPETVY-GEVSAKVDVYAFGVVLYELISAKGAVVKMTEAVGEFRG--LVGVFEE 534

Lysin motif (LysM) receptor kinase that functions as a cell surface receptor in chitin elicitor (chitooligosaccharides) signaling leading to innate immunity toward both biotic and abiotic stresses (e.g. tolerance to salinity, heavy-metal stresses, and Botrytis cinerea infection). Recognizes microbe-derived N-acetylglucosamine (NAG)-containing ligands. Involved in the resistance to pathogenic fungi Alternaria brassicicola and Erysiphe cichoracearum, probably by sensing microbe-associated molecular patterns (MAMP) and pathogen-associated molecular patterns (PAMP). Plays an essential role in detecting peptidoglycans (e.g. PGNs) and restricting bacterial growth. Target of the bacterial type III effector E3-ligase protein hopAB2/avrPtoB of Pseudomonas syringae pv. tomato DC3000 that mediates ubiquitination and subsequent proteolysis, thus blocking all defense responses by suppressing PAMP-triggered immunity (PTI).

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|D7UPN3|CERK1_ORYSJ Chitin elicitor receptor kinase 1 OS=Oryza sativa subsp. japonica GN=CERK1 PE=1 SV=1

 Score =  206 bits (523), Expect = 5e-52,   Method: Compositional matrix adjust.
 Identities = 162/511 (31%), Positives = 250/511 (48%), Gaps = 82/511 (16%)

Query: 61  DLASIADLFSVS-----RLMISEPSNISSPSSPLIQNQPLFVPITCSCNTLNASYTISF- 114
           +L  IA +F++       L+   P+ I++P   ++    + VP  CSC  L A+   +F 
Sbjct: 44  NLTFIATIFAIGGGGYQALLPYNPA-ITNPDY-VVTGDRVLVPFPCSCLGLPAAPASTFL 101

Query: 115 -ANLSYTIK----SGDTFYLVSTNKYQNLTTYQSVEVVNPTFVPTKLEVGDVII-FPVFC 168
              + Y +      GDT+  V+ N Y +LTT   +E  N  + P ++  GD  +   + C
Sbjct: 102 AGAIPYPLPLPRGGGDTYDAVAAN-YADLTTAAWLEATN-AYPPGRIPGGDGRVNVTINC 159

Query: 169 KCPNQTQLRNRVNYLVSYVLQPSENLSSVASRFGIETQAIID-----------VNGNNIR 217
            C ++ ++  R    ++Y L   E L SVA+++G  + A ++           V+G  I 
Sbjct: 160 SCGDE-RVSPRYGLFLTYPLWDGETLESVAAQYGFSSPAEMELIRRYNPGMGGVSGKGI- 217

Query: 218 PFDTLFVPVARLPELKQPAVAPSTPPSAETPSRKTERKGVIIGLSIGLGICGASLVLVAG 277
               +F+PV               P  +  P +       + G +I   +     + +  
Sbjct: 218 ----VFIPV-------------KDPNGSYHPLKSGGMGNSLSGGAIAGIVIACIAIFIVA 260

Query: 278 MWI----YREALLKKKREREIDEQKQKLQFNKGGRDLKDMEVNFMADVSDCLDKYRIFKI 333
           +W+    YR    +K   R   E+   L        +K             +++   F  
Sbjct: 261 IWLIIMFYRWQKFRKATSRPSPEETSHLDDASQAEGIK-------------VERSIEFSY 307

Query: 334 EELREATDNFSEGCLIQ----GSVYKGNIHGEVYAIKMMKWNACEE----LKILQKVNHG 385
           EE+  AT  FS    I     GSVY   + GE  AIK M   A +E    LK+L  V+H 
Sbjct: 308 EEIFNATQGFSMEHKIGQGGFGSVYYAELRGEKTAIKKMGMQATQEFLAELKVLTHVHHL 367

Query: 386 NLVKLEGFCIDPEDANC-YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQY 444
           NLV+L G+C++    NC +L+YE+I+NG+L   L       L+W TR++IA+D A GL+Y
Sbjct: 368 NLVRLIGYCVE----NCLFLVYEFIDNGNLSQHLQRTGYAPLSWATRVQIALDSARGLEY 423

Query: 445 IHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK-----SGCNAITMHIVGTQGYIAP 499
           +HEH  P  VH+DIKS+NILLD + RAKIA+FGLAK     S   +++  + GT GY+ P
Sbjct: 424 LHEHVVPVYVHRDIKSANILLDKDFRAKIADFGLAKLTEVGSMSQSLSTRVAGTFGYMPP 483

Query: 500 EYLADGVVSTKMDVFSFGVVLLELISGKEAI 530
           E    G VS K+DV++FGVVL EL+S K+AI
Sbjct: 484 E-ARYGEVSPKVDVYAFGVVLYELLSAKQAI 513

Plays an essential role in detecting peptidoglycans (e.g. PGNs) and restricting bacterial growth. Recognizes microbe-derived N-acetylglucosamine (NAG)-containing ligands (By similarity). Lysin motif (LysM) receptor kinase required as a cell surface receptor for chitin elicitor (chitooligosaccharides) signaling leading to innate immunity in response to both biotic and abiotic stresses. Involved in the resistance to pathogenic fungi, probably by sensing microbe-associated molecular patterns (MAMP) and pathogen-associated molecular patterns (PAMP).

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FX99|Y1497_ARATH Probable receptor-like protein kinase At1g49730 OS=Arabidopsis thaliana GN=At1g49730 PE=1 SV=1

 Score =  187 bits (474), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 120/329 (36%), Positives = 185/329 (56%), Gaps = 29/329 (8%)

Query: 223 FVPVARLPELKQPAV---APSTPPSAETPSRKTERKGVIIGLSIGLGICGASLVLVAGMW 279
           F PVA  PE     V   +PS   S  T SR T    + +  +IG+ +   +L ++  + 
Sbjct: 214 FSPVAS-PEPSPSTVGGISPSNSDSQMTTSRSTNPYHLTMVPTIGIVVTAVALTMLVVLV 272

Query: 280 IYREALLKKKREREIDEQKQKLQFNKGGRDLKDMEVNFMADVSDCLDKYRIFKIEELREA 339
           I     L +++ RE+DE +   +  K  + +      F     D    +R F  +E+  A
Sbjct: 273 I-----LIRRKNRELDESESLDR--KSTKSVPSSLPVFKIHEDDSSSAFRKFSYKEMTNA 325

Query: 340 TDNFSE--GCLIQGSVYKGNIH-GEVYAIKMM-------KWNACEELKILQKVNHGNLVK 389
           T++F+   G    G+VYK   + G + A+K M       + + C E+ +L K++H NLV 
Sbjct: 326 TNDFNTVIGQGGFGTVYKAEFNDGLIAAVKKMNKVSEQAEQDFCREIGLLAKLHHRNLVA 385

Query: 390 LEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHT 449
           L+GFCI+ ++   +L+Y+Y++NGSL   LH       +W TR++IAIDVAN L+Y+H + 
Sbjct: 386 LKGFCINKKER--FLVYDYMKNGSLKDHLHAIGKPPPSWGTRMKIAIDVANALEYLHFYC 443

Query: 450 RPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA------ITMHIVGTQGYIAPEYLA 503
            P + H+DIKSSNILLD N  AK+++FGLA S  +       +   I GT GY+ PEY+ 
Sbjct: 444 DPPLCHRDIKSSNILLDENFVAKLSDFGLAHSSRDGSVCFEPVNTDIRGTPGYVDPEYVV 503

Query: 504 DGVVSTKMDVFSFGVVLLELISGKEAIDE 532
              ++ K DV+S+GVVLLELI+G+ A+DE
Sbjct: 504 TQELTEKSDVYSYGVVLLELITGRRAVDE 532

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SGI7|LYK2_ARATH Protein LYK2 OS=Arabidopsis thaliana GN=LYK2 PE=2 SV=1

 Score =  185 bits (470), Expect = 7e-46,   Method: Compositional matrix adjust.
 Identities = 161/544 (29%), Positives = 256/544 (47%), Gaps = 91/544 (16%)

Query: 25  QSQAQPSTTGYTCSANQTTYPCRTYAFYRASAPDFLDLASIADLFSVSRLMISEPSNISS 84
           + + + S+ GY C +N     C T+A  RA  P +    S++DL   SR +  +  +   
Sbjct: 38  EEEEEASSFGYVCHSN--LQKCHTFAILRAKPPFY----SLSDL---SRHLGLDADDEYV 88

Query: 85  PSSPLIQNQPLFVPITCSCNTLNASYTISFANLSYTIKSGDTFYLVSTNKYQNLTTYQSV 144
           P     + Q L +PI C CN      +I  A+L      GDTF  VS +  Q LTT  S+
Sbjct: 89  P-----KGQLLLIPIECRCNG-----SIYEASLIKNCVKGDTFRSVSQS-LQGLTTCLSI 137

Query: 145 EVVNPTFVPTKLEVGDVIIFPVFCKCPNQTQLRNRVNYLVSYVLQPSENLSSVASRFGIE 204
              NP     KL     +   + C CP Q  + N  ++LV+Y +   +++SS+A RF   
Sbjct: 138 REKNPHISEDKLGDNIKLRLAIRCSCP-QEGVSN-ASFLVTYPVGVRDSVSSLAVRFNTT 195

Query: 205 TQAIIDVNGNN-IRPFDTLFVPVARLPELKQPAVAPSTPPSAETPSRKTERK-GVIIGLS 262
             AI+  N  + + P     +P+   PE KQ +           PS+K   K  ++I +S
Sbjct: 196 EDAIVSANNKSGVVPLKPALIPLDHKPE-KQGS-------RKRNPSKKKRSKMKLMIAVS 247

Query: 263 IGL-GICGASLVLVAGMWIYREALLKKKREREIDEQKQKLQFNKGG---------RDLKD 312
             + G+CG   ++V G        L  K+E +I  Q QK   NK           R   D
Sbjct: 248 SAIAGVCGLVTLMVFGY-------LHWKKETQIQTQTQKWISNKDPETRQLSLSIRTTSD 300

Query: 313 MEVNFMADVS-DCLDKY-------------RIFKIEELREATDNFSEGCLIQGSVYKGNI 358
            +++F        LD +              I+  EEL +AT+NFS    I+GSVY G++
Sbjct: 301 KKISFEGSQDGSILDSHNTVGTTTPRKPVLEIYAFEELEKATENFSSSNHIKGSVYFGSL 360

Query: 359 HGEVYAIKMMKWNACE--ELKILQKVNH---GNLVKLEGFCIDPEDANCYLIYEYIENGS 413
            G+  AIK +  +  +  +  +L   +H    N++++ G C    D + YL++EY  NGS
Sbjct: 361 KGKDLAIKQVNADEMKRFDFGLLNDQSHYYNHNVIRVLGTCFREIDQDSYLVFEYARNGS 420

Query: 414 LHSWLHEN---KNE-------NLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI 463
           L  W+      KN+        L WK R++I  DVA  L+Y+H   R   VH +IKS NI
Sbjct: 421 LWDWIQNKLAIKNQFIESCYCFLAWKQRIKICHDVAIALKYMH---RINYVHGNIKSRNI 477

Query: 464 LLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLEL 523
            L+ ++R K+ NFG++K   N +             E L +  +S   D+F++G++++E+
Sbjct: 478 FLNEDLRGKVGNFGMSKCVTNELATE----------ENLIESSLSPASDIFAYGIIVMEV 527

Query: 524 ISGK 527
           +SG+
Sbjct: 528 LSGQ 531

May recognize microbe-derived N-acetylglucosamine (NAG)-containing ligands.

Arabidopsis thaliana (taxid: 3702)

>sp|F4IB81|LYK3_ARATH LysM domain receptor-like kinase 3 OS=Arabidopsis thaliana GN=LYK3 PE=2 SV=1

 Score =  184 bits (467), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 101/222 (45%), Positives = 148/222 (66%), Gaps = 18/222 (8%)

Query: 325 LDKYRIFKIEELREATDNFSEGCLIQ----GSVYKGNIHGEVYAIKMMKWNACEE----L 376
           ++K  +F  EE+R ATD FS+  L+     GSVY G +  +  A+K M     +E    +
Sbjct: 323 IEKPMVFTYEEIRAATDEFSDSNLLGHGNYGSVYFGLLREQEVAVKRMTATKTKEFAAEM 382

Query: 377 KILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENK---NENLNWKTRLR 433
           K+L KV+H NLV+L G+    ++   +++YEY+  G L S LH+ +   N  L+W  R +
Sbjct: 383 KVLCKVHHSNLVELIGYAATVDE--LFVVYEYVRKGMLKSHLHDPQSKGNTPLSWIMRNQ 440

Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLA----KSGCNAITM- 488
           IA+D A GL+YIHEHT+   VH+DIK+SNILLD   RAKI++FGLA    K+G   I++ 
Sbjct: 441 IALDAARGLEYIHEHTKTHYVHRDIKTSNILLDEAFRAKISDFGLAKLVEKTGEGEISVT 500

Query: 489 HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAI 530
            +VGT GY+APEYL+DG+ ++K D+++FGVVL E+ISG+EA+
Sbjct: 501 KVVGTYGYLAPEYLSDGLATSKSDIYAFGVVLFEIISGREAV 542

Putative Lysin motif (LysM) receptor kinase that may recognize microbe-derived N-acetylglucosamine (NAG)-containing ligands.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|C0LGV0|Y5487_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g48740 OS=Arabidopsis thaliana GN=At5g48740 PE=2 SV=1

 Score =  184 bits (466), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 111/309 (35%), Positives = 173/309 (55%), Gaps = 41/309 (13%)

Query: 243 PSAETPSRKTERKGVIIGLSIGLGICGASLVLVAGMWIYREALLKKKREREIDEQKQKLQ 302
           P    P  K +RK   I  +I LG+ G +L     ++++     +++R +E D  + +L+
Sbjct: 529 PQVTIPINKKQRKQNRI--AILLGVSGGALFATFLVFVFMSIFTRRQRNKERDITRAQLK 586

Query: 303 FNKGGRDLKDMEVNFMADVSDCLDKYRIFKIEELREATDNFSE--GCLIQGSVYKGNI-H 359
                        N+ A         RIF  +E++ AT NF E  G    G+VY+G +  
Sbjct: 587 MQ-----------NWNAS--------RIFSHKEIKSATRNFKEVIGRGSFGAVYRGKLPD 627

Query: 360 GEVYAIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN 411
           G+  A+K+ +++  +        E+ +L ++ H NLV  EGFC +P+     L+YEY+  
Sbjct: 628 GKQVAVKV-RFDRTQLGADSFINEVHLLSQIRHQNLVSFEGFCYEPKRQ--ILVYEYLSG 684

Query: 412 GSL--HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM 469
           GSL  H +   +K  +LNW +RL++A+D A GL Y+H  + PR++H+D+KSSNILLD +M
Sbjct: 685 GSLADHLYGPRSKRHSLNWVSRLKVAVDAAKGLDYLHNGSEPRIIHRDVKSSNILLDKDM 744

Query: 470 RAKIANFGLAKSGCNAITMHIV----GTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
            AK+++FGL+K    A   HI     GT GY+ PEY +   ++ K DV+SFGVVLLELI 
Sbjct: 745 NAKVSDFGLSKQFTKADASHITTVVKGTAGYLDPEYYSTLQLTEKSDVYSFGVVLLELIC 804

Query: 526 GKEAIDEEG 534
           G+E +   G
Sbjct: 805 GREPLSHSG 813

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2

 Score =  177 bits (449), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 119/330 (36%), Positives = 180/330 (54%), Gaps = 56/330 (16%)

Query: 230 PELKQPAVAPSTPPSA--ETPSRKTERKGVIIGLSIGLGICGASLVLVAGMWIYREALLK 287
           P +   +  P   P+   + PS+   R G I+G+ +G+G+    L ++AG+ ++    ++
Sbjct: 608 PLISAVSATPDFTPTVANKPPSKGKNRTGTIVGVIVGVGL----LSILAGVVMFT---IR 660

Query: 288 KKREREIDEQKQKLQFNKGGRDLKDMEVNFMADVSDCLDKYRIFKIEELREATDNF---- 343
           K+R+R  D++           +L  M+V           K  IF   EL+ AT +F    
Sbjct: 661 KRRKRYTDDE-----------ELLGMDV-----------KPYIFTYSELKSATQDFDPSN 698

Query: 344 --SEGCLIQGSVYKGNIH-GEVYAIKMM-------KWNACEELKILQKVNHGNLVKLEGF 393
              EG    G VYKGN++ G V A+K++       K     E+  +  V H NLVKL G 
Sbjct: 699 KLGEGGF--GPVYKGNLNDGRVVAVKLLSVGSRQGKGQFVAEIVAISSVLHRNLVKLYGC 756

Query: 394 CIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRV 453
           C + E  +  L+YEY+ NGSL   L  +K  +L+W TR  I + VA GL Y+HE    R+
Sbjct: 757 CFEGE--HRMLVYEYLPNGSLDQALFGDKTLHLDWSTRYEICLGVARGLVYLHEEASVRI 814

Query: 454 VHKDIKSSNILLDSNMRAKIANFGLAK---SGCNAITMHIVGTQGYIAPEYLADGVVSTK 510
           VH+D+K+SNILLDS +  +I++FGLAK        I+  + GT GY+APEY   G ++ K
Sbjct: 815 VHRDVKASNILLDSRLVPQISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEK 874

Query: 511 MDVFSFGVVLLELISGK----EAIDEEGKF 536
            DV++FGVV LEL+SG+    E ++EE K+
Sbjct: 875 TDVYAFGVVALELVSGRPNSDENLEEEKKY 904

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2

 Score =  176 bits (447), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 112/334 (33%), Positives = 174/334 (52%), Gaps = 49/334 (14%)

Query: 231 ELKQPAVAPSTPPSAETPSRKTERKGVIIGLSIGLGICGASLVLVAGMWIYREALLKKKR 290
           E   P + P    S  +PSR +   G ++G+SIG G+   +L+           L KKKR
Sbjct: 101 EPTTPTMTPGFSLSPPSPSRLS--TGAVVGISIGGGVFVLTLIFF---------LCKKKR 149

Query: 291 EREIDEQKQKLQFNKGGRDLKDMEVNFMADVSDCLDKYR-IFKIEELREATDNFSEGCLI 349
            R+                    +    A +   L  ++  F   EL  AT+ FSE  L+
Sbjct: 150 PRD--------------------DKALPAPIGLVLGIHQSTFTYGELARATNKFSEANLL 189

Query: 350 Q----GSVYKGNIH-GEVYAIKMMKWNACE-------ELKILQKVNHGNLVKLEGFCIDP 397
                G VYKG ++ G   A+K +K  + +       E+ I+ +++H NLV L G+CI  
Sbjct: 190 GEGGFGFVYKGILNNGNEVAVKQLKVGSAQGEKEFQAEVNIISQIHHRNLVSLVGYCI-- 247

Query: 398 EDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKD 457
             A   L+YE++ N +L   LH      + W  RL+IA+  + GL Y+HE+  P+++H+D
Sbjct: 248 AGAQRLLVYEFVPNNTLEFHLHGKGRPTMEWSLRLKIAVSSSKGLSYLHENCNPKIIHRD 307

Query: 458 IKSSNILLDSNMRAKIANFGLAKSGCNA---ITMHIVGTQGYIAPEYLADGVVSTKMDVF 514
           IK++NIL+D    AK+A+FGLAK   +    ++  ++GT GY+APEY A G ++ K DV+
Sbjct: 308 IKAANILIDFKFEAKVADFGLAKIALDTNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVY 367

Query: 515 SFGVVLLELISGKEAIDEEGKFCGQKLKGYWREM 548
           SFGVVLLELI+G+  +D    +    L  + R +
Sbjct: 368 SFGVVLLELITGRRPVDANNVYADDSLVDWARPL 401

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	552
255551969	615	serine-threonine protein kinase, plant-t	0.969	0.869	0.725	0.0
225432878	622	PREDICTED: probable LRR receptor-like se	0.931	0.826	0.714	0.0
297737149	595	unnamed protein product [Vitis vinifera]	0.882	0.818	0.692	0.0
449516043	631	PREDICTED: proline-rich receptor-like pr	0.918	0.803	0.672	0.0
147771926	591	hypothetical protein VITISV_032728 [Viti	0.873	0.815	0.657	0.0
224099871	524	predicted protein [Populus trichocarpa]	0.768	0.809	0.754	0.0
449433287	640	PREDICTED: proline-rich receptor-like pr	0.856	0.739	0.684	0.0
356499893	625	PREDICTED: probable receptor-like protei	0.936	0.827	0.662	0.0
357487233	660	Cysteine-rich receptor-like protein kina	0.927	0.775	0.603	1e-179
224111082	461	predicted protein [Populus trichocarpa]	0.733	0.878	0.636	1e-153

>gi|255551969|ref|XP_002517029.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223543664|gb|EEF45192.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  800 bits (2067), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 396/546 (72%), Positives = 457/546 (83%), Gaps = 11/546 (2%)

Query: 1   MRNKSQCLSFSVLFFFFFFL-FSYHQSQAQPSTTGYTCSANQTTYPCRTYAFYRASAPDF 59
           MR K+   S  + F F F+L    +  +AQPST G TC+ NQT+ PC+TYAFYRA AP+F
Sbjct: 1   MRAKT---SLILSFLFIFYLNHVLNHLRAQPSTDGITCTVNQTSNPCQTYAFYRAMAPNF 57

Query: 60  LDLASIADLFSVSRLMISEPSNISSPSSPLIQNQPLFVPITCSCNTLNASYTISFANLSY 119
           LDLAS+ DLFSVSRLMISEPSNISSPSSPLI NQ LFVPI+CSC  +N++  +S+ANLSY
Sbjct: 58  LDLASVGDLFSVSRLMISEPSNISSPSSPLIPNQSLFVPISCSCRAINSTTNLSYANLSY 117

Query: 120 TIKSGDTFYLVSTNKYQNLTTYQSVEVVNPTFVPTKLEVGDVIIFPVFCKCPNQTQLRNR 179
           TIK  DTFYLVST ++QNLTTYQ+V+VVNPT VPT LE+G  +IFPVFCKCPNQTQL+N+
Sbjct: 118 TIKKDDTFYLVSTTQFQNLTTYQAVQVVNPTLVPTLLEIGQEVIFPVFCKCPNQTQLQNQ 177

Query: 180 VNYLVSYVLQPSENLSSVASRFGIETQAIIDVNGNNIRPFDTLFVPVARLPELKQPAVAP 239
           VN+++SYV QPS+NLS VAS FG  TQ+I+DVNGNNI+PFDT+FVPV RLP+L QP V P
Sbjct: 178 VNFMISYVFQPSDNLSLVASSFGTNTQSIVDVNGNNIQPFDTIFVPVNRLPQLSQPVVVP 237

Query: 240 STPPSAETPSRKTERKGVIIGLSIGLGICGASLVLVAGMWIYREALLKKKREREIDEQKQ 299
           S P      + K ERKG+I GL++GLG+CG  L+L+ G W++RE  L +K+  E DE K+
Sbjct: 238 SVP------TEKKERKGLITGLAVGLGVCGFLLILIIGSWVFREGKLNRKKSEE-DEDKK 290

Query: 300 KLQFNKGGRDLKDMEVNFMADVSDCLDKYRIFKIEELREATDNFSEGCLIQGSVYKGNIH 359
           +L+F KG + L +ME   +ADVSDCLDKYR+FKI+EL+EATD F+E  LIQGSVYKG+I+
Sbjct: 291 RLRFYKGEKGLTEMETKLIADVSDCLDKYRVFKIDELKEATDGFNENFLIQGSVYKGSIN 350

Query: 360 GEVYAIKMMKWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLH 419
           G+ YAIK MKWNA EELKILQKVNHGNLVKLEGFCID ED +CYLIYEYIENGSLHSWLH
Sbjct: 351 GQDYAIKKMKWNAYEELKILQKVNHGNLVKLEGFCIDSEDGSCYLIYEYIENGSLHSWLH 410

Query: 420 ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLA 479
            NKNE LNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS MRAKIANFGLA
Sbjct: 411 INKNEKLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSTMRAKIANFGLA 470

Query: 480 KSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGKFCGQ 539
           KSGCNAITMHIVGTQGYIAPEYL DGVVST+MDVFSFGVVLLELISGKEAIDEEG+    
Sbjct: 471 KSGCNAITMHIVGTQGYIAPEYLTDGVVSTRMDVFSFGVVLLELISGKEAIDEEGRVLWA 530

Query: 540 KLKGYW 545
           K+ G W
Sbjct: 531 KVSGNW 536

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225432878|ref|XP_002280070.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At5g48740-like [Vitis vinifera]

 Score =  786 bits (2030), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 372/521 (71%), Positives = 436/521 (83%), Gaps = 7/521 (1%)

Query: 23  YHQSQAQPSTTGYTCSANQTTYPCRTYAFYRASAPDFLDLASIADLFSVSRLMISEPSNI 82
           Y Q+Q +P+ TGY CSAN ++YPC T+AFY A++P+FLDLASI DLF VSRLMISEPSNI
Sbjct: 26  YSQAQPEPNATGYPCSANLSSYPCHTFAFYTATSPNFLDLASIGDLFWVSRLMISEPSNI 85

Query: 83  SSPSSPLIQNQPLFVPITCSCNTLNASYTISFANLSYTIKSGDTFYLVSTNKYQNLTTYQ 142
           SSPS+PL+  Q LFVP+ CSCN++N +  IS+ANLSYTIKSGDTFYLVST  + NLTTY 
Sbjct: 86  SSPSNPLVAGQSLFVPLNCSCNSVNTTTAISYANLSYTIKSGDTFYLVSTFSFLNLTTYY 145

Query: 143 SVEVVNPTFVPTKLEVGDVIIFPVFCKCPNQTQLRNRVNYLVSYVLQPSENLSSVASRFG 202
           SVE+VNPT VPT L+VGD +IFP+FCKCPN+TQLRN VN+L+SYV QPS+NL+ VA+  G
Sbjct: 146 SVEIVNPTLVPTDLDVGDKVIFPIFCKCPNETQLRNGVNFLISYVFQPSDNLTGVAASLG 205

Query: 203 IETQAIIDVNGNNIRPFDTLFVPVARLPELKQPAVAPSTPPSAETPSRKTERKGVIIGLS 262
            +T +IIDVNG+NI+PF T+FVPV+RLP + QP V  S   S     RK ERKGVIIGL+
Sbjct: 206 SDTASIIDVNGDNIQPFQTIFVPVSRLPNISQPNVTASVATSV----RKVERKGVIIGLA 261

Query: 263 IGLGICGASLVLVAGMWIYREALLKKKREREIDEQKQKLQFNKGGRDLKDMEVNFMADVS 322
           IGLG+CG  LVL+ G+W+YR  +++K +E E D+++  +    G   LK  EVN MADVS
Sbjct: 262 IGLGVCGILLVLLIGVWVYRHVMVEKIKEIEGDKERPLVGRGTG---LKAEEVNLMADVS 318

Query: 323 DCLDKYRIFKIEELREATDNFSEGCLIQGSVYKGNIHGEVYAIKMMKWNACEELKILQKV 382
           DCLDKY+++ IEELR+AT  FSE  LIQGSVYKG+I GE+YAIK MKWNA EELKILQKV
Sbjct: 319 DCLDKYKVYGIEELRDATGGFSERSLIQGSVYKGSIDGELYAIKKMKWNAYEELKILQKV 378

Query: 383 NHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGL 442
           NHGNLV+LEGFCIDPEDA CYL+YE++ENGSL SWLH +++E LNWK RLRIAIDVANGL
Sbjct: 379 NHGNLVRLEGFCIDPEDATCYLVYEFVENGSLQSWLHGDRDEKLNWKNRLRIAIDVANGL 438

Query: 443 QYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYL 502
           QYIHEHTRPRVVHKDIKSSNILLD NMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYL
Sbjct: 439 QYIHEHTRPRVVHKDIKSSNILLDGNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYL 498

Query: 503 ADGVVSTKMDVFSFGVVLLELISGKEAIDEEGKFCGQKLKG 543
           ADGVVST+MDVFSFGVVLLELISGKEA+DEEG+      +G
Sbjct: 499 ADGVVSTRMDVFSFGVVLLELISGKEAVDEEGRVLWMSARG 539

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297737149|emb|CBI26350.3| unnamed protein product [Vitis vinifera]

 Score =  744 bits (1920), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 361/521 (69%), Positives = 416/521 (79%), Gaps = 34/521 (6%)

Query: 23  YHQSQAQPSTTGYTCSANQTTYPCRTYAFYRASAPDFLDLASIADLFSVSRLMISEPSNI 82
           Y Q+Q +P+ TGY CSAN ++YPC T+AFY A++P+FLDLASI DLF VSRLMISEPSNI
Sbjct: 26  YSQAQPEPNATGYPCSANLSSYPCHTFAFYTATSPNFLDLASIGDLFWVSRLMISEPSNI 85

Query: 83  SSPSSPLIQNQPLFVPITCSCNTLNASYTISFANLSYTIKSGDTFYLVSTNKYQNLTTYQ 142
           SSPS+PL+  Q LFVP+ CSCN++N +  IS+ANLSYTIKSGDTFYLVST  + NLTTY 
Sbjct: 86  SSPSNPLVAGQSLFVPLNCSCNSVNTTTAISYANLSYTIKSGDTFYLVSTFSFLNLTTYY 145

Query: 143 SVEVVNPTFVPTKLEVGDVIIFPVFCKCPNQTQLRNRVNYLVSYVLQPSENLSSVASRFG 202
           SVE+VNPT VPT L+VGD +IFP+FCKCPN+TQLRN VN+L+SYV QPS+NL+ VA+  G
Sbjct: 146 SVEIVNPTLVPTDLDVGDKVIFPIFCKCPNETQLRNGVNFLISYVFQPSDNLTGVAASLG 205

Query: 203 IETQAIIDVNGNNIRPFDTLFVPVARLPELKQPAVAPSTPPSAETPSRKTERKGVIIGLS 262
            +T +IIDVNG+NI+PF T+FVPV+RLP + QP V  S   S     RK ERKGVIIGL+
Sbjct: 206 SDTASIIDVNGDNIQPFQTIFVPVSRLPNISQPNVTASVATSV----RKVERKGVIIGLA 261

Query: 263 IGLGICGASLVLVAGMWIYREALLKKKREREIDEQKQKLQFNKGGRDLKDMEVNFMADVS 322
           IGLG                       +ER +  +         G  LK  EVN MADVS
Sbjct: 262 IGLG---------------------GDKERPLVGR---------GTGLKAEEVNLMADVS 291

Query: 323 DCLDKYRIFKIEELREATDNFSEGCLIQGSVYKGNIHGEVYAIKMMKWNACEELKILQKV 382
           DCLDKY+++ IEELR+AT  FSE  LIQGSVYKG+I GE+YAIK MKWNA EELKILQKV
Sbjct: 292 DCLDKYKVYGIEELRDATGGFSERSLIQGSVYKGSIDGELYAIKKMKWNAYEELKILQKV 351

Query: 383 NHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGL 442
           NHGNLV+LEGFCIDPEDA CYL+YE++ENGSL SWLH +++E LNWK RLRIAIDVANGL
Sbjct: 352 NHGNLVRLEGFCIDPEDATCYLVYEFVENGSLQSWLHGDRDEKLNWKNRLRIAIDVANGL 411

Query: 443 QYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYL 502
           QYIHEHTRPRVVHKDIKSSNILLD NMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYL
Sbjct: 412 QYIHEHTRPRVVHKDIKSSNILLDGNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYL 471

Query: 503 ADGVVSTKMDVFSFGVVLLELISGKEAIDEEGKFCGQKLKG 543
           ADGVVST+MDVFSFGVVLLELISGKEA+DEEG+      +G
Sbjct: 472 ADGVVSTRMDVFSFGVVLLELISGKEAVDEEGRVLWMSARG 512

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449516043|ref|XP_004165057.1| PREDICTED: proline-rich receptor-like protein kinase PERK8-like [Cucumis sativus]

 Score =  728 bits (1880), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 349/519 (67%), Positives = 426/519 (82%), Gaps = 12/519 (2%)

Query: 24  HQSQAQ-PSTTGYTCSANQTTYPCRTYAFYRASAPDFLDLASIADLFSVSRLMISEPSNI 82
           H S A+ P   GYTCSANQT  PC+ Y FYRA+ P+FL+LA+IADLF VSRL IS PSNI
Sbjct: 25  HYSAAEAPDADGYTCSANQTANPCQAYVFYRATPPNFLNLAAIADLFWVSRLQISRPSNI 84

Query: 83  SSPSS--PLIQNQPLFVPITCSCNTLNASYTISFANLSYTIKSGDTFYLVSTNKYQNLTT 140
           S  ++  PL+  QPLF+PITCSC+++NAS +IS+ANLSY I +GD F+LVST+K+QNLTT
Sbjct: 85  SDSNATFPLLSGQPLFIPITCSCHSVNASVSISYANLSYKINAGDNFWLVSTSKFQNLTT 144

Query: 141 YQSVEVVNPTFVPTKLEVGDVIIFPVFCKCPNQTQLRNRVNYLVSYVLQPSENLSSVASR 200
           +QSVE+ NPT + T L +G  ++FP+FCKCPN TQLRNRVN+++SYV+QP++ LSS+ASR
Sbjct: 145 FQSVEIANPTLIATNLSIGVDVVFPIFCKCPNPTQLRNRVNFMISYVIQPADTLSSIASR 204

Query: 201 FGIETQAIIDVNGNNIRPFDTLFVPVARLPELKQPAVAPSTPPSAETPSRKTERKGVIIG 260
           FG++T  I D N  N +PF+T+F+PV+RLP L QP V P +P  A  P R+ ++  V+ G
Sbjct: 205 FGVQTSEIRDANWPNPQPFETIFIPVSRLPNLTQPIVLPPSPEQAPAPVRE-DKNRVVTG 263

Query: 261 LSIGLGICGASLVLVAGMWIYREALLKKKREREIDE--QKQKLQFN---KGGRDLKDMEV 315
           L+IGLGI G  L+L  G+ ++     ++K ERE++E  +KQ++Q +   K  R  K+MEV
Sbjct: 264 LAIGLGIVGFLLILAVGLLVFGVGK-RRKNEREMEERFEKQRVQDDGIWKAKR--KEMEV 320

Query: 316 NFMADVSDCLDKYRIFKIEELREATDNFSEGCLIQGSVYKGNIHGEVYAIKMMKWNACEE 375
           + MADVSDCLDKYR+FKIEEL EAT+ FSE  LIQGSVYKG I G  +AIK MKWNA E+
Sbjct: 321 DLMADVSDCLDKYRVFKIEELNEATNGFSESSLIQGSVYKGTIGGVEFAIKKMKWNAYEQ 380

Query: 376 LKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIA 435
           LKILQKVNHGNLVKLEGFC+DPEDA CYLIYEY+ENGSL+SWLHE + + LNW+ RLRIA
Sbjct: 381 LKILQKVNHGNLVKLEGFCVDPEDATCYLIYEYVENGSLYSWLHETQKQKLNWRMRLRIA 440

Query: 436 IDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG 495
           IDVANGL YIHEHTRP+VVHKDIKSSNILLD+NMRAKIANFGLAKSGCNAITMHIVGTQG
Sbjct: 441 IDVANGLLYIHEHTRPQVVHKDIKSSNILLDANMRAKIANFGLAKSGCNAITMHIVGTQG 500

Query: 496 YIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG 534
           YIAPEY+ADG+VSTKMD+FSFGVVLLELISGKEAID++G
Sbjct: 501 YIAPEYIADGIVSTKMDIFSFGVVLLELISGKEAIDDQG 539

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147771926|emb|CAN66762.1| hypothetical protein VITISV_032728 [Vitis vinifera]

 Score =  706 bits (1822), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 343/522 (65%), Positives = 405/522 (77%), Gaps = 40/522 (7%)

Query: 24  HQSQAQP--STTGYTCSANQTTYPCRTYAFYRASAPDFLDLASIADLFSVSRLMISEPSN 81
           H SQAQP  + TGY CSAN ++YPC T+AFY A++P+FLDLASI DLF VSRLMISEPSN
Sbjct: 25  HYSQAQPEANATGYPCSANLSSYPCHTFAFYTATSPNFLDLASIGDLFWVSRLMISEPSN 84

Query: 82  ISSPSSPLIQNQPLFVPITCSCNTLNASYTISFANLSYTIKSGDTFYLVSTNKYQNLTTY 141
           ISSPS+PL+  Q LFVP+ CSCN++NA+  IS+ANL+YTIKSGDTFYLVST  + NLTTY
Sbjct: 85  ISSPSNPLVAGQSLFVPLNCSCNSVNATTAISYANLTYTIKSGDTFYLVSTFSFLNLTTY 144

Query: 142 QSVEVVNPTFVPTKLEVGDVIIFPVFCKCPNQTQLRNRVNYLVSYVLQPSENLSSVASRF 201
            SVE+VNPT VPT L+VGD +IFP+FCKCPN+TQLRN VN+L+SYV QPS+NL+ VA+  
Sbjct: 145 YSVEIVNPTLVPTDLDVGDKVIFPIFCKCPNETQLRNGVNFLISYVFQPSDNLTGVAASL 204

Query: 202 GIETQAIIDVNGNNIRPFDTLFVPVARLPELKQPAVAPSTPPSAETPSRKTERKGVIIGL 261
           G +T +IIDVNG+NI+PF T+FVPV+RLP + QP V  S   S     R+ ERKG IIGL
Sbjct: 205 GSDTASIIDVNGDNIQPFQTIFVPVSRLPNISQPNVTASPATSV----RRVERKGAIIGL 260

Query: 262 SIGLGICGASLVLVAGMWIYREALLKKKREREIDEQKQKLQFNKGGRDLKDMEVNFMADV 321
           SIGLG+CG  LVL+ G+W+YR  +++K +E E D+++  +    G   LK  EVN MADV
Sbjct: 261 SIGLGVCGILLVLLIGVWVYRHVMVEKIKEIEGDKERPLVGRGSG---LKAEEVNLMADV 317

Query: 322 SDCLDKYRIFKIEELREATDNFSEGCLIQGSVYKGNIHGEVYAIKMMKWNACEELKILQK 381
           SDCLDKY+++ IEELR+AT  FSE  LIQGSVYKG+I GE+YAIK MKWNA EELKILQK
Sbjct: 318 SDCLDKYKVYGIEELRDATGGFSERSLIQGSVYKGSIDGELYAIKKMKWNAYEELKILQK 377

Query: 382 VNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANG 441
           VNHGNLV+LEGFCIDPEDA CYL+YE++ENGSL SWLH +++E LNWK RLRIAIDVANG
Sbjct: 378 VNHGNLVRLEGFCIDPEDATCYLVYEFVENGSLQSWLHGDRDEKLNWKNRLRIAIDVANG 437

Query: 442 LQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEY 501
           LQYIHEHTRPRVVHKDIKSSNILLD NMRAKIANFGLAKSGCNAITMHIVGTQ       
Sbjct: 438 LQYIHEHTRPRVVHKDIKSSNILLDGNMRAKIANFGLAKSGCNAITMHIVGTQ------- 490

Query: 502 LADGVVSTKMDVFSFGVVLLELISGKEAIDEEGKFCGQKLKG 543
                                   GKEA+DEEG+      +G
Sbjct: 491 ------------------------GKEAVDEEGRVLWMSARG 508

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224099871|ref|XP_002311653.1| predicted protein [Populus trichocarpa] gi|222851473|gb|EEE89020.1| predicted protein [Populus trichocarpa]

 Score =  696 bits (1796), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 322/427 (75%), Positives = 382/427 (89%), Gaps = 3/427 (0%)

Query: 109 SYTISFANLSYTIKSGDTFYLVSTNKYQNLTTYQSVEVVNPTFVPTKLEVGDVIIFPVFC 168
           S +IS AN++YTI++G+TFY+VST  +QNLTTYQSVE+ NPT +P  L++G  +IFP+FC
Sbjct: 9   STSISSANITYTIEAGNTFYIVSTKYFQNLTTYQSVELFNPTLIPELLDIGVEVIFPIFC 68

Query: 169 KCPNQTQLRNRVNYLVSYVLQPSENLSSVASRFGIETQAIIDVNGNNIRPFDTLFVPVAR 228
           KCP+QTQL+N+VNYLVSYV QPS+NLSSVAS FG+ETQ+I+DVNGNNI+P+DT+FVPV +
Sbjct: 69  KCPHQTQLQNKVNYLVSYVFQPSDNLSSVASTFGVETQSIVDVNGNNIQPYDTIFVPVNQ 128

Query: 229 LPELKQPAVAPSTPPSAETPSRKTERKGVIIGLSIGLGICGASLVLVAGMWIYREALLKK 288
           LP+L QP V     PS   P  KTERKGVIIGL++GLGI G  LVLV+G+W YRE +LKK
Sbjct: 129 LPQLAQPTV---VVPSGAPPPEKTERKGVIIGLAVGLGIAGLLLVLVSGVWFYREGVLKK 185

Query: 289 KREREIDEQKQKLQFNKGGRDLKDMEVNFMADVSDCLDKYRIFKIEELREATDNFSEGCL 348
           +R+ E  E+K+++Q N G + LKD+EV+ MADVSDCLDKYR+FKI+EL+EAT+ FSE CL
Sbjct: 186 RRDVEKVEEKRRMQLNGGSKGLKDIEVSLMADVSDCLDKYRVFKIDELKEATNGFSENCL 245

Query: 349 IQGSVYKGNIHGEVYAIKMMKWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEY 408
           I+GSV+KG+I+GE YAIK MKWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYL+YE+
Sbjct: 246 IEGSVFKGSINGETYAIKKMKWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLVYEF 305

Query: 409 IENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN 468
           +++GSLHSWLH N+ E L+WKTRLR+AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS+
Sbjct: 306 VDSGSLHSWLHRNEKEKLSWKTRLRVAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSS 365

Query: 469 MRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKE 528
           MRAKIANFGLAK+GCNAITMHIVGTQGYIAPEYLADGVVST+MDVFSFGVVLLELISG+E
Sbjct: 366 MRAKIANFGLAKTGCNAITMHIVGTQGYIAPEYLADGVVSTRMDVFSFGVVLLELISGRE 425

Query: 529 AIDEEGK 535
           AIDEEGK
Sbjct: 426 AIDEEGK 432

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449433287|ref|XP_004134429.1| PREDICTED: proline-rich receptor-like protein kinase PERK8-like [Cucumis sativus]

 Score =  690 bits (1780), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 330/482 (68%), Positives = 401/482 (83%), Gaps = 9/482 (1%)

Query: 58  DFLDLASIADLFSVSRLMISEPSNISSPSSPLIQNQPLFVPITCSCNTLNASYTISFANL 117
           +FL+LA+IADLF VSRL IS PSNIS  S PL+  QPLF+PITCSC+++NAS +IS+ANL
Sbjct: 71  NFLNLAAIADLFWVSRLQISRPSNISDSSFPLLSGQPLFIPITCSCHSVNASVSISYANL 130

Query: 118 SYTIKSGDTFYLVSTNKYQNLTTYQSVEVVNPTFVPTKLEVGDVIIFPVFCKCPNQTQLR 177
           SY I +GD F+LVST+K+QNLTT+QSVE+ NPT + T L +G  ++FP+FCKCPN TQLR
Sbjct: 131 SYKINAGDNFWLVSTSKFQNLTTFQSVEIANPTLIATNLSIGVDVVFPIFCKCPNPTQLR 190

Query: 178 NRVNYLVSYVLQPSENLSSVASRFGIETQAIIDVNGNNIRPFDTLFVPVARLPELKQPAV 237
           NRVN+++SYV+QP++ LSS+ASRFG++T  I D N  N +PF+T+F+PV+RLP L QP V
Sbjct: 191 NRVNFMISYVIQPADTLSSIASRFGVQTSEIRDANWPNPQPFETIFIPVSRLPNLTQPIV 250

Query: 238 APSTPPSAETPSRKTERKGVIIGLSIGLGICGASLVLVAGMWIYREALLKKKREREIDE- 296
            P +P  A  P R+ ++  V+ GL+IGLGI G  L+L  G+ ++     ++K ERE++E 
Sbjct: 251 LPPSPEQAPAPVRE-DKNRVVTGLAIGLGIVGFLLILAVGLLVFGVGK-RRKNEREMEER 308

Query: 297 -QKQKLQFN---KGGRDLKDMEVNFMADVSDCLDKYRIFKIEELREATDNFSEGCLIQGS 352
            +KQ++Q +   K  R  K+MEV+ MADVSDCLDKYR+FKIEEL EAT+ FSE  LIQGS
Sbjct: 309 FEKQRVQDDGIWKAKR--KEMEVDLMADVSDCLDKYRVFKIEELNEATNGFSESSLIQGS 366

Query: 353 VYKGNIHGEVYAIKMMKWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG 412
           VYKG I G  +AIK MKWNA E+LKILQKVNHGNLVKLEGFC+DPEDA CYLIYEY+ENG
Sbjct: 367 VYKGTIGGVEFAIKKMKWNAYEQLKILQKVNHGNLVKLEGFCVDPEDATCYLIYEYVENG 426

Query: 413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAK 472
           SL+SWLHE + + LNW+ RLRIAIDVANGL YIHEHTRP+VVHKDIKSSNILLD+NMRAK
Sbjct: 427 SLYSWLHETQKQKLNWRMRLRIAIDVANGLLYIHEHTRPQVVHKDIKSSNILLDANMRAK 486

Query: 473 IANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDE 532
           IANFGLAKSGCNAITMHIVGTQGYIAPEY+ADGVVSTKMD+FSFGVVLLELISGKEAID+
Sbjct: 487 IANFGLAKSGCNAITMHIVGTQGYIAPEYIADGVVSTKMDIFSFGVVLLELISGKEAIDD 546

Query: 533 EG 534
           +G
Sbjct: 547 QG 548

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356499893|ref|XP_003518770.1| PREDICTED: probable receptor-like protein kinase At1g49730-like [Glycine max]

 Score =  657 bits (1694), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 353/533 (66%), Positives = 418/533 (78%), Gaps = 16/533 (3%)

Query: 10  FSVLFFFFFF-LFSYHQSQAQPSTTGYTCSANQTTYPCRTYAFYRASAPDFLDLASIADL 68
           FS +F F    L S  Q+  Q + TG+TC+  +T   C +YAFYRA+AP+F DLASI DL
Sbjct: 13  FSAVFLFLLLPLCSNAQTARQANNTGFTCNFTRT---CTSYAFYRATAPNFTDLASIGDL 69

Query: 69  FSVSRLMISEPSNISSP--SSPLIQNQPLFVPITCSCNTLNASY-TISFANLSYTIKSGD 125
           FSVSRLMIS PSNISS   ++PL+ N PLFVP+TCSCN +NAS+ ++S+AN+SYTI  GD
Sbjct: 70  FSVSRLMISTPSNISSSSLNTPLLPNTPLFVPLTCSCNPVNASFGSLSYANISYTINPGD 129

Query: 126 TFYLVSTNKYQNLTTYQSVEVVNPTFVPTKLEVGDVIIFPVFCKCPNQTQLRNRVNYLVS 185
           TF+LVST K+QNLTT+ SVEVVNPT + T L +G   IFP+FCKCP  +Q     NY++S
Sbjct: 130 TFFLVSTIKFQNLTTFPSVEVVNPTLLATNLSIGQDTIFPIFCKCPPNSQ---GTNYMIS 186

Query: 186 YVLQPSENLSSVASRFGIETQAIIDVNG--NNIRPFDTLFVPVARLPELKQPAVAPSTPP 243
           YV+QP +N+SS+AS FG E Q+IID NG    +  +DT+FVPVARLP L QPAV P  P 
Sbjct: 187 YVVQPEDNMSSIASTFGAEEQSIIDANGGETTLHDYDTIFVPVARLPALSQPAVVPHAP- 245

Query: 244 SAETPSRKTERKGVIIGLSIGLGICGASLVLVAGMWIYREALLKKKREREIDEQKQKLQF 303
                S   +R G + GL +GLGI G  L+LV+G+W+YRE ++ K   R+ +E+   L  
Sbjct: 246 PPVIGSNNDDRTGTVRGLGVGLGIVGLLLILVSGVWVYREVVVMKGVVRDDEEKNVYL-- 303

Query: 304 NKGGRDLKDMEVNFMADVSDCLDKYRIFKIEELREATDNFSEGCLIQGSVYKGNIHGEVY 363
             G  + K+++V  MA+VSDCLDKYR+F I+EL EATD F + CLIQGSVYKG I G V+
Sbjct: 304 -GGKAEGKNLDVKLMANVSDCLDKYRVFGIDELVEATDGFDQSCLIQGSVYKGEIDGHVF 362

Query: 364 AIKMMKWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKN 423
           AIK MKWNA EELKILQKVNHGNLVKLEGFCIDPE+ANCYL+YEY+ENGSL+SWLHE K 
Sbjct: 363 AIKKMKWNAYEELKILQKVNHGNLVKLEGFCIDPEEANCYLVYEYVENGSLYSWLHEGKK 422

Query: 424 ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC 483
           E L+WK RLRIAID+ANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG 
Sbjct: 423 EKLSWKIRLRIAIDIANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGM 482

Query: 484 NAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGKF 536
           NAITMHIVGTQGYIAPEYLADGVVSTKMDVF+FGVVLLELISGKE I+EEG  
Sbjct: 483 NAITMHIVGTQGYIAPEYLADGVVSTKMDVFAFGVVLLELISGKEVINEEGNL 535

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357487233|ref|XP_003613904.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] gi|355515239|gb|AES96862.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula]

 Score =  635 bits (1639), Expect = e-179,   Method: Compositional matrix adjust.
 Identities = 340/563 (60%), Positives = 420/563 (74%), Gaps = 51/563 (9%)

Query: 15  FFFFFLFSYHQSQA--QPSTTGYTC----SANQTTYPCRTYAFYRASAPDFLDLASIADL 68
           F F  LF + +SQ   Q + TGYTC    + N  TYPC+TY +Y+A+ P++LDLA+I+DL
Sbjct: 14  FIFILLFPFLKSQTARQQNNTGYTCPNNNNNNNNTYPCQTYVYYKATPPNYLDLATISDL 73

Query: 69  FSVSRLMISEPSNISSPSSPLIQNQPLFVPITCSCNTLNASY-TISFANLSYTIKSGDTF 127
           F +SRLMIS+PSNISSPSSPL+ NQPL +P+TCSCN +N ++ +IS++N++YTIK  DTF
Sbjct: 74  FQLSRLMISKPSNISSPSSPLLPNQPLLIPLTCSCNFINTTFGSISYSNITYTIKPNDTF 133

Query: 128 YLVSTNKYQNLTTYQSVEVVNPTFVPTKLEVGDVIIFPVFCKCPNQTQLRNRVNYLVSYV 187
           +LVST  +QNLTTY SV+VVNP  V T L +GD  +FP+FCKCP++T+  +  ++++SYV
Sbjct: 134 FLVSTINFQNLTTYPSVQVVNPNLVATNLSIGDNAVFPIFCKCPDKTKTNS--SFMISYV 191

Query: 188 LQPSENLSSVASRFGIETQAIIDVNGNNIRPFDTLFVPVARLPELKQPA-VAPSTPPSAE 246
           +QP +N+SS+AS FG   ++I+DVNG  +  +DT+FVPV  LP LKQP+ + PS  P   
Sbjct: 192 VQPHDNVSSIASMFGTSEKSIVDVNGERLYDYDTIFVPVTELPVLKQPSTIVPSPAPRGN 251

Query: 247 TPSRKTE--RKGVIIGLSIGLGICGASLVLVAGMWIYREALLKKKREREIDEQKQKLQFN 304
           +     +  + G++ GL+IGLGI G  L+LV   W YRE L KK++      + + L F 
Sbjct: 252 SDDGDDDDDKSGIVKGLAIGLGILGFLLILVIVFWFYREVLFKKEK------KGKGLYFG 305

Query: 305 KGG-----RDLKDMEVNFMADVSDCLDKYRIFKIEELREATDNFSEGCLIQGSVYKGNIH 359
             G        K M+VNFMA+VSDCLDKYR+F  +EL EATD F E  LIQGSVYKG I 
Sbjct: 306 DKGYKGNDEKKKKMDVNFMANVSDCLDKYRVFGFDELVEATDGFDERFLIQGSVYKGEID 365

Query: 360 GEVYAIKMMKWNACEELKILQ----------------------------KVNHGNLVKLE 391
           G+VYAIK MKWNA EELKILQ                            KVNHGNLVKLE
Sbjct: 366 GQVYAIKKMKWNAYEELKILQKKGIRQKKKKYLDIFQVHLNNNVSFFVLKVNHGNLVKLE 425

Query: 392 GFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRP 451
           GFCI+PE++NCYL+YEY+ENGSL+SWLHE+KNE LNW TRLRIA+D+ANGL YIHEHTRP
Sbjct: 426 GFCIEPEESNCYLVYEYVENGSLYSWLHEDKNEKLNWVTRLRIAVDIANGLLYIHEHTRP 485

Query: 452 RVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKM 511
           +VVHKDIKSSNILLDSNMRAKIANFGLAKSG NAITMHIVGTQGYI+PEYLADG+VSTKM
Sbjct: 486 KVVHKDIKSSNILLDSNMRAKIANFGLAKSGINAITMHIVGTQGYISPEYLADGIVSTKM 545

Query: 512 DVFSFGVVLLELISGKEAIDEEG 534
           DVFSFG+VLLELISGKE IDEEG
Sbjct: 546 DVFSFGIVLLELISGKEVIDEEG 568

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224111082|ref|XP_002315740.1| predicted protein [Populus trichocarpa] gi|222864780|gb|EEF01911.1| predicted protein [Populus trichocarpa]

 Score =  547 bits (1410), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 268/421 (63%), Positives = 340/421 (80%), Gaps = 16/421 (3%)

Query: 1   MRNKSQCLSFSVLFFFFFFLFSYHQSQAQPSTTGYTCSANQTTYPCRTYAFYRASAPDFL 60
           M +KS  L FS+LFF ++    +H  QAQPST G+TC+ANQ+++PC+TYAFYRA+AP+FL
Sbjct: 1   MTSKSH-LVFSLLFFIYYSTILHHL-QAQPSTQGFTCTANQSSFPCQTYAFYRATAPNFL 58

Query: 61  DLASIADLFSVSRLMISEPSNISSPSSPLIQNQPLFVPITCSCNTLNASYTISFANLSYT 120
           DL+SI DLFSVSRLMIS+PSNISSP+SPLI NQPLFVP++CSCNT+N + +ISFAN++YT
Sbjct: 59  DLSSIGDLFSVSRLMISKPSNISSPASPLIPNQPLFVPLSCSCNTMNGT-SISFANITYT 117

Query: 121 IKSGDTFYLVSTNKYQNLTTYQSVEVVNPTFVPTKLEVGDVIIFPVFCKCPNQTQLRNRV 180
           IK  DTFYLVST  + NLTTYQSV++VNPT +PT L++G  +IFP+FCKCPNQTQL+N+V
Sbjct: 118 IKPNDTFYLVSTEYFGNLTTYQSVQLVNPTLIPTLLQIGVEVIFPIFCKCPNQTQLQNKV 177

Query: 181 NYLVSYVLQPSENLSSVASRFGIETQAIIDVNGNNIRPFDTLFVPVARLPELKQPAVAPS 240
           NYLVSYV QPS+NLSSVAS FG+ETQ+I+D NGNNI+PFDT+F+PV +LP+L QP V PS
Sbjct: 178 NYLVSYVFQPSDNLSSVASTFGVETQSIVDANGNNIQPFDTIFIPVNQLPQLAQPTVFPS 237

Query: 241 TPPSAETPSRKTERKGVIIGLSIGLGICGASLVLVAGMWIYREALLKKKREREIDEQ-KQ 299
             PS      KT+RKG+IIGL++GLGI G  LVLV+G+  +R+ +LKK+R+ E D+Q KQ
Sbjct: 238 LAPSG-----KTQRKGLIIGLAVGLGIAGLLLVLVSGVCFFRDGVLKKRRDFERDDQEKQ 292

Query: 300 KLQFNKGGRDLKDMEVNFMADVSDCLDKYRIFKIEELREATDNFSEGCLIQGSVYKGNIH 359
           ++QFN G + LKD+EVN MADVSDCLDKYR+FKI+EL+EATD F E CLI+GSV+KG+I+
Sbjct: 293 RMQFNGGRKGLKDIEVNLMADVSDCLDKYRVFKIDELKEATDEFGENCLIEGSVFKGSIN 352

Query: 360 GEVYAIKMMKWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLH 419
           GE YAIK MKWNACEELKILQKV   +L+ +      P    C +  E + +G   + LH
Sbjct: 353 GETYAIKKMKWNACEELKILQKVRSFSLITV----YTPAFTVCLVSNEIVGSG---TQLH 405

Query: 420 E 420
           E
Sbjct: 406 E 406

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	552
TAIR|locus:2049029	612	LYK4 "LysM-containing receptor	0.884	0.797	0.318	3.8e-69
TAIR|locus:2050987	664	LYK5 "LysM-containing receptor	0.394	0.328	0.442	6.8e-69
TAIR|locus:2195814	651	LYK3 "LysM-containing receptor	0.369	0.313	0.454	1.1e-56
TAIR|locus:2089860	617	CERK1 "chitin elicitor recepto	0.391	0.350	0.470	1.1e-56
UNIPROTKB|D7UPN3	605	CERK1 "Chitin elicitor recepto	0.353	0.322	0.476	6.8e-51
TAIR|locus:2012191	693	AT1G49730 [Arabidopsis thalian	0.442	0.352	0.393	2.2e-43
TAIR|locus:2156549	895	AT5G48740 [Arabidopsis thalian	0.369	0.227	0.427	2.3e-42
TAIR|locus:2016377	788	AT1G19390 [Arabidopsis thalian	0.449	0.314	0.394	1.1e-41
TAIR|locus:2126316	786	AT4G31100 [Arabidopsis thalian	0.449	0.315	0.392	1.8e-41
TAIR|locus:2090634	663	AT3G19300 [Arabidopsis thalian	0.440	0.366	0.393	4.5e-41

TAIR|locus:2049029 LYK4 "LysM-containing receptor-like kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 701 (251.8 bits), Expect = 3.8e-69, P = 3.8e-69
 Identities = 168/528 (31%), Positives = 274/528 (51%)

Query:    31 STTGYTCSANQTTYPCRTYAFYRASAPDFLDLASIADLFSVSRLMISEXXXXXXXXXXXX 90
             S  GY+C+    T  C+ Y  +R S P F  + SI+ LFSV   ++S             
Sbjct:    42 SVFGYSCNGLNKT--CQAYVIFR-STPSFSTVTSISSLFSVDPSLVSSLNDASPSTSFPS 98

Query:    91 XXXXXFVPITCSCNTLNASYTISFANLSYTIKSGDTFYLVSTNKYQNLTTYQSVEVVNPT 150
                   +P+TCSC   ++      +N++YTI+  D+++ ++ +  Q L+T Q++   N  
Sbjct:    99 GQQV-IIPLTCSCTGDDSQ-----SNITYTIQPNDSYFAIANDTLQGLSTCQALAKQN-N 151

Query:   151 FVPTKLEVGDVIIFPVFCKCPNQTQLR-NRVNYLVSYVLQPSENLSSVASRFGIETQAII 209
                  L  G  I+ P+ C CP   Q+  + V YL+SY +   + ++ ++ RFG+ET   +
Sbjct:   152 VSSQSLFPGMRIVVPIRCACPTAKQINEDGVKYLMSYTVVFEDTIAIISDRFGVETSKTL 211

Query:   210 DVN-----GNNIRPFDTLFVPVARLPELKQXXX--------XXXXXXXXXXXXRKTERKG 256
               N      + + PF T+ +P+   P                           RK+++K 
Sbjct:   212 KANEMSFENSEVFPFTTILIPLVNPPANTNSLIPPPPPPPPQSVSPPPLSPDGRKSKKKT 271

Query:   257 VXXXXXXXXXXXXXXXVLVAGMWIYREALLKKKREREIDEQKQKLQFNKGGRD-LKDMEV 315
                             V+ A ++     L KKK + +  E+   L    G +  + D E 
Sbjct:   272 WVYALAGVLGGALVLSVIGAAIF----CLSKKKTKTQTQEETGNLDSFMGKKPPMSDQEF 327

Query:   316 NFMADVSDCL-DKYRIFKIEELREATDNFSEGCLIQGSVYKGNIHGEVYAIKMMKWNACE 374
             + +  +S  + +  +++K  EL+ AT +F+    I GS Y G I+G+   IK ++ NA E
Sbjct:   328 DPLDGLSGMVVESLKVYKFHELQSATSDFTSSSSIGGSGYIGKINGDGAMIKKIEGNASE 387

Query:   375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
             E+ +L K+NH N+++L GFC    + + YL+YE+  NGSL  W+H  K+  L+   +L+I
Sbjct:   388 EVNLLSKLNHLNIIRLSGFCF--HEGDWYLVYEHASNGSLSEWIHTTKSL-LSLTQKLQI 444

Query:   435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN--AITMHIVG 492
             A+D+A GL Y+H    P  VH+D+ S+N+ LD   RAKI + G A+S      +T H+ G
Sbjct:   445 ALDIATGLNYLHNFADPPYVHRDLNSNNVFLDLEFRAKIGSLGSARSTTEDFVLTKHVEG 504

Query:   493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID-----EEGK 535
             T+GY+APEYL  G+VSTK+DV++FGVVLLE+++GKEA +     +EGK
Sbjct:   505 TRGYLAPEYLEHGLVSTKLDVYAFGVVLLEIVTGKEASELKKEIDEGK 552

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=IDA

GO:0008061 "chitin binding" evidence=IDA

GO:0045087 "innate immune response" evidence=IMP

GO:0071219 "cellular response to molecule of bacterial origin" evidence=IEP

GO:0071323 "cellular response to chitin" evidence=IEP

TAIR|locus:2050987 LYK5 "LysM-containing receptor-like kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 535 (193.4 bits), Expect = 6.8e-69, Sum P(2) = 6.8e-69
 Identities = 100/226 (44%), Positives = 158/226 (69%)

Query:   321 VSDCLDKYRIFKIEELREATDNFSEGCLIQGSVYKGNIHGEVYAIKMMKWN-ACEELKIL 379
             +   ++   +++  +L+ AT NFS+   I+GSVY+  I+G+  A+K++K + +  E+ +L
Sbjct:   350 LKSAIESLTLYRFNDLQSATSNFSDENRIKGSVYRATINGDDAAVKVIKGDVSSSEINLL 409

Query:   380 QKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVA 439
             +K+NH N+++L GFCI   +   YL++EY ENGS+  WLH +  ++L WK R+ IA DVA
Sbjct:   410 KKLNHSNIIRLSGFCI--REGTSYLVFEYSENGSISDWLHSSGKKSLTWKQRVEIARDVA 467

Query:   440 NGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK---SGCN--AITMHIVGTQ 494
               L Y+H +  P  +HK+++S+NILLDSN RAKIANFG+A+    G     +T H+ GTQ
Sbjct:   468 EALDYLHNYITPPHIHKNLESTNILLDSNFRAKIANFGVARILDEGDLDLQLTRHVEGTQ 527

Query:   495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGKFCGQK 540
             GY+APEY+ +GV+++K+DVF+FGV +LEL+SG+EA+    K  G++
Sbjct:   528 GYLAPEYVENGVITSKLDVFAFGVAVLELLSGREAVTIHKKKEGEE 573

GO:0005576 "extracellular region" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=IDA

GO:0010200 "response to chitin" evidence=RCA

GO:0008061 "chitin binding" evidence=IDA

GO:0071323 "cellular response to chitin" evidence=IEP

TAIR|locus:2195814 LYK3 "LysM-containing receptor-like kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 466 (169.1 bits), Expect = 1.1e-56, Sum P(2) = 1.1e-56
 Identities = 101/222 (45%), Positives = 148/222 (66%)

Query:   325 LDKYRIFKIEELREATDNFSEGCLI----QGSVYKGNIHGEVYAIKMMKWNACEE----L 376
             ++K  +F  EE+R ATD FS+  L+     GSVY G +  +  A+K M     +E    +
Sbjct:   323 IEKPMVFTYEEIRAATDEFSDSNLLGHGNYGSVYFGLLREQEVAVKRMTATKTKEFAAEM 382

Query:   377 KILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENK---NENLNWKTRLR 433
             K+L KV+H NLV+L G+    ++   +++YEY+  G L S LH+ +   N  L+W  R +
Sbjct:   383 KVLCKVHHSNLVELIGYAATVDEL--FVVYEYVRKGMLKSHLHDPQSKGNTPLSWIMRNQ 440

Query:   434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAITM- 488
             IA+D A GL+YIHEHT+   VH+DIK+SNILLD   RAKI++FGLAK    +G   I++ 
Sbjct:   441 IALDAARGLEYIHEHTKTHYVHRDIKTSNILLDEAFRAKISDFGLAKLVEKTGEGEISVT 500

Query:   489 HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAI 530
              +VGT GY+APEYL+DG+ ++K D+++FGVVL E+ISG+EA+
Sbjct:   501 KVVGTYGYLAPEYLSDGLATSKSDIYAFGVVLFEIISGREAV 542

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016998 "cell wall macromolecule catabolic process" evidence=IEA

GO:0007020 "microtubule nucleation" evidence=RCA

TAIR|locus:2089860 CERK1 "chitin elicitor receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 464 (168.4 bits), Expect = 1.1e-56, Sum P(2) = 1.1e-56
 Identities = 112/238 (47%), Positives = 152/238 (63%)

Query:   325 LDKYRIFKIEELREATDNFSEGCLIQ----GSVYKGNIHGEVYAIKMMKWNACE----EL 376
             +DK   F +EEL +ATDNF+    I     G+VY   + GE  AIK M   A +    EL
Sbjct:   304 VDKSVEFSLEELAKATDNFNLSFKIGQGGFGAVYYAELRGEKAAIKKMDMEASKQFLAEL 363

Query:   377 KILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAI 436
             K+L +V+H NLV+L G+C++    + +L+YEY+ENG+L   LH +  E L W  R++IA+
Sbjct:   364 KVLTRVHHVNLVRLIGYCVE---GSLFLVYEYVENGNLGQHLHGSGREPLPWTKRVQIAL 420

Query:   437 DVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS---GCNAITMHIVGT 493
             D A GL+YIHEHT P  VH+DIKS+NIL+D   RAK+A+FGL K    G +A T   +GT
Sbjct:   421 DSARGLEYIHEHTVPVYVHRDIKSANILIDQKFRAKVADFGLTKLTEVGGSA-TRGAMGT 479

Query:   494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAI----DEEGKFCGQKLKGYWRE 547
              GY+APE +  G VS K+DV++FGVVL ELIS K A+    +  G+F G  L G + E
Sbjct:   480 FGYMAPETVY-GEVSAKVDVYAFGVVLYELISAKGAVVKMTEAVGEFRG--LVGVFEE 534

GO:0005576 "extracellular region" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=IMP;IDA

GO:0032491 "detection of molecule of fungal origin" evidence=IEP;IMP

GO:0035556 "intracellular signal transduction" evidence=RCA;IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009817 "defense response to fungus, incompatible interaction" evidence=IMP

GO:0010200 "response to chitin" evidence=RCA;IMP

GO:0005515 "protein binding" evidence=IPI

GO:0002752 "cell surface pattern recognition receptor signaling pathway" evidence=IDA

GO:0042742 "defense response to bacterium" evidence=IDA

GO:0008061 "chitin binding" evidence=IDA

GO:2001080 "chitosan binding" evidence=IDA

GO:0032499 "detection of peptidoglycan" evidence=IMP

GO:0045087 "innate immune response" evidence=IMP

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0042803 "protein homodimerization activity" evidence=IDA

GO:0071219 "cellular response to molecule of bacterial origin" evidence=IEP

GO:0071323 "cellular response to chitin" evidence=IEP

UNIPROTKB|D7UPN3 CERK1 "Chitin elicitor receptor kinase 1" [Oryza sativa Japonica Group (taxid:39947)]

 Score = 433 (157.5 bits), Expect = 6.8e-51, Sum P(2) = 6.8e-51
 Identities = 102/214 (47%), Positives = 137/214 (64%)

Query:   331 FKIEELREATDNFS-EGCLIQG---SVYKGNIHGEVYAIKMMKWNACEE----LKILQKV 382
             F  EE+  AT  FS E  + QG   SVY   + GE  AIK M   A +E    LK+L  V
Sbjct:   305 FSYEEIFNATQGFSMEHKIGQGGFGSVYYAELRGEKTAIKKMGMQATQEFLAELKVLTHV 364

Query:   383 NHGNLVKLEGFCIDPEDANC-YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANG 441
             +H NLV+L G+C++    NC +L+YE+I+NG+L   L       L+W TR++IA+D A G
Sbjct:   365 HHLNLVRLIGYCVE----NCLFLVYEFIDNGNLSQHLQRTGYAPLSWATRVQIALDSARG 420

Query:   442 LQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK-----SGCNAITMHIVGTQGY 496
             L+Y+HEH  P  VH+DIKS+NILLD + RAKIA+FGLAK     S   +++  + GT GY
Sbjct:   421 LEYLHEHVVPVYVHRDIKSANILLDKDFRAKIADFGLAKLTEVGSMSQSLSTRVAGTFGY 480

Query:   497 IAPEYLADGVVSTKMDVFSFGVVLLELISGKEAI 530
             + PE    G VS K+DV++FGVVL EL+S K+AI
Sbjct:   481 MPPE-ARYGEVSPKVDVYAFGVVLYELLSAKQAI 513

GO:0005515 "protein binding" evidence=IPI

GO:0008061 "chitin binding" evidence=IDA

GO:0010200 "response to chitin" evidence=IDA

GO:0043621 "protein self-association" evidence=IDA

TAIR|locus:2012191 AT1G49730 [Arabidopsis thaliana (taxid:3702)]

 Score = 443 (161.0 bits), Expect = 2.2e-43, Sum P(2) = 2.2e-43
 Identities = 104/264 (39%), Positives = 158/264 (59%)

Query:   285 LLKKKREREIDEQKQKLQFNKGGRDLKDMEVNFMADVSDCLDKYRIFKIEELREATDNFS 344
             +L +++ RE+DE  + L   K  + +      F     D    +R F  +E+  AT++F+
Sbjct:   303 ILIRRKNRELDES-ESLD-RKSTKSVPSSLPVFKIHEDDSSSAFRKFSYKEMTNATNDFN 360

Query:   345 E--GCLIQGSVYKGNIH-GEVYAIKMM-------KWNACEELKILQKVNHGNLVKLEGFC 394
                G    G+VYK   + G + A+K M       + + C E+ +L K++H NLV L+GFC
Sbjct:   361 TVIGQGGFGTVYKAEFNDGLIAAVKKMNKVSEQAEQDFCREIGLLAKLHHRNLVALKGFC 420

Query:   395 IDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVV 454
             I+ ++   +L+Y+Y++NGSL   LH       +W TR++IAIDVAN L+Y+H +  P + 
Sbjct:   421 INKKER--FLVYDYMKNGSLKDHLHAIGKPPPSWGTRMKIAIDVANALEYLHFYCDPPLC 478

Query:   455 HKDIKSSNILLDSNMRAKIANFGLAKSG-----C-NAITMHIVGTQGYIAPEYLADGVVS 508
             H+DIKSSNILLD N  AK+++FGLA S      C   +   I GT GY+ PEY+    ++
Sbjct:   479 HRDIKSSNILLDENFVAKLSDFGLAHSSRDGSVCFEPVNTDIRGTPGYVDPEYVVTQELT 538

Query:   509 TKMDVFSFGVVLLELISGKEAIDE 532
              K DV+S+GVVLLELI+G+ A+DE
Sbjct:   539 EKSDVYSYGVVLLELITGRRAVDE 562

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2156549 AT5G48740 [Arabidopsis thaliana (taxid:3702)]

 Score = 435 (158.2 bits), Expect = 2.3e-42, Sum P(2) = 2.3e-42
 Identities = 95/222 (42%), Positives = 138/222 (62%)

Query:   329 RIFKIEELREATDNFSE--GCLIQGSVYKGNI-HGEVYAIKMM----KWNA---CEELKI 378
             RIF  +E++ AT NF E  G    G+VY+G +  G+  A+K+     +  A     E+ +
Sbjct:   594 RIFSHKEIKSATRNFKEVIGRGSFGAVYRGKLPDGKQVAVKVRFDRTQLGADSFINEVHL 653

Query:   379 LQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLH--ENKNENLNWKTRLRIAI 436
             L ++ H NLV  EGFC +P+     L+YEY+  GSL   L+   +K  +LNW +RL++A+
Sbjct:   654 LSQIRHQNLVSFEGFCYEPKRQ--ILVYEYLSGGSLADHLYGPRSKRHSLNWVSRLKVAV 711

Query:   437 DVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIV----G 492
             D A GL Y+H  + PR++H+D+KSSNILLD +M AK+++FGL+K    A   HI     G
Sbjct:   712 DAAKGLDYLHNGSEPRIIHRDVKSSNILLDKDMNAKVSDFGLSKQFTKADASHITTVVKG 771

Query:   493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG 534
             T GY+ PEY +   ++ K DV+SFGVVLLELI G+E +   G
Sbjct:   772 TAGYLDPEYYSTLQLTEKSDVYSFGVVLLELICGREPLSHSG 813

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2016377 AT1G19390 [Arabidopsis thaliana (taxid:3702)]

 Score = 434 (157.8 bits), Expect = 1.1e-41, Sum P(2) = 1.1e-41
 Identities = 108/274 (39%), Positives = 161/274 (58%)

Query:   273 VLVAGMWIYREALLKKKREREIDEQKQKLQFNKGGRDLKDMEVNFMADVSDCLDKYRIFK 332
             VLV G+W  R+  LKK+R   + ++K+K  F + G  L   ++N   +  + ++K RIF 
Sbjct:   389 VLVVGIWWLRK-FLKKRR---MSKRKRKF-FKRNGGLLLQQQLN--TNKGN-VEKTRIFS 440

Query:   333 IEELREATDNFSEGCLI----QGSVYKGN-IHGEVYAIKMMKW---NACEE----LKILQ 380
               EL +ATDNFSE  ++    QG+VYKG  + G   A+K  K    +  EE    + IL 
Sbjct:   441 SRELEKATDNFSESRILGQGGQGTVYKGMLVDGRTVAVKKSKVVDEDKLEEFINEVVILS 500

Query:   381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNE-NLNWKTRLRIAIDVA 439
             ++NH ++VKL G C++ E     L+YE+I NG+L   +HE  ++    W  RLRIA+D+A
Sbjct:   501 QINHRHVVKLLGCCLETEVPT--LVYEFIPNGNLFQHIHEESDDYTKTWGMRLRIAVDIA 558

Query:   440 NGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC---NAITMHIVGTQGY 496
               L Y+H      + H+DIKS+NILLD   R K+++FG ++S        T  I GT GY
Sbjct:   559 GALSYLHSAASSPIYHRDIKSTNILLDEKYRTKVSDFGTSRSVTIDHTHWTTVISGTVGY 618

Query:   497 IAPEYLADGVVSTKMDVFSFGVVLLELISGKEAI 530
             + PEY      + K DV+SFGVVL+ELI+G++ +
Sbjct:   619 VDPEYYGSSQYTDKSDVYSFGVVLVELITGEKPV 652

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2126316 AT4G31100 [Arabidopsis thaliana (taxid:3702)]

 Score = 432 (157.1 bits), Expect = 1.8e-41, Sum P(2) = 1.8e-41
 Identities = 108/275 (39%), Positives = 158/275 (57%)

Query:   273 VLVAGMWIYREALLKKKREREIDEQKQKLQFNKGGRDLKDMEVNFMADVSDCLDKYRIFK 332
             VLV G+W  R+ L+K    R + ++K+K  F + G  L   E+N    V   ++K RIF 
Sbjct:   382 VLVGGVWWLRKFLVK----RRMAKRKKKF-FKRNGGLLLQQELNTRQGV---VEKARIFT 433

Query:   333 IEELREATDNFSEGCLI----QGSVYKGN-IHGEVYAIKMMK-------WNACEELKILQ 380
              +EL +AT+NFSE  ++    QG+VYKG  + G   A+K  K            E+ IL 
Sbjct:   434 SKELEKATENFSENRVLGHGGQGTVYKGMLVDGRTVAVKKSKVIDEDKLQEFINEVVILS 493

Query:   381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLN--WKTRLRIAIDV 438
             ++NH ++VKL G C++ E     L+YE+I NG+L   +HE + ++    W  RLRIA+D+
Sbjct:   494 QINHRHVVKLLGCCLETEVP--ILVYEFIINGNLFKHIHEEEADDYTMIWGMRLRIAVDI 551

Query:   439 ANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC---NAITMHIVGTQG 495
             A  L Y+H      + H+DIKS+NILLD   RAK+A+FG ++S        T  I GT G
Sbjct:   552 AGALSYLHSAASSPIYHRDIKSTNILLDEKYRAKVADFGTSRSVTIDQTHWTTVISGTVG 611

Query:   496 YIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAI 530
             Y+ PEY      + K DV+SFGV+L ELI+G + +
Sbjct:   612 YVDPEYYRSSQYTEKSDVYSFGVILAELITGDKPV 646

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2090634 AT3G19300 [Arabidopsis thaliana (taxid:3702)]

 Score = 439 (159.6 bits), Expect = 4.5e-41, P = 4.5e-41
 Identities = 104/264 (39%), Positives = 162/264 (61%)

Query:   285 LLKKKREREIDEQKQKLQFNKGGRDLKDMEVNFMADVSDCLDKYRIFKIEELREATDNFS 344
             +L ++++RE+D+ K  +  N   R         M    +    +R F  +E+R+AT++F+
Sbjct:   273 VLIQRKKRELDDSKS-IACNLT-RTSPSPRPRSMIHEGNSFG-FRKFSYKEIRKATEDFN 329

Query:   345 E--GCLIQGSVYKGNI-HGEVYAIKMMKWNA-------CEELKILQKVNHGNLVKLEGFC 394
                G    G+VYK    +G V A+K M  ++       C E+++L +++H +LV L+GFC
Sbjct:   330 AVIGRGGFGTVYKAEFSNGLVAAVKKMNKSSEQAEDEFCREIELLARLHHRHLVALKGFC 389

Query:   395 IDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVV 454
                 +   +L+YEY+ENGSL   LH  +   L+W++R++IAIDVAN L+Y+H +  P + 
Sbjct:   390 NKKNER--FLVYEYMENGSLKDHLHSTEKSPLSWESRMKIAIDVANALEYLHFYCDPPLC 447

Query:   455 HKDIKSSNILLDSNMRAKIANFGLA---KSG--C-NAITMHIVGTQGYIAPEYLADGVVS 508
             H+DIKSSNILLD +  AK+A+FGLA   + G  C   +   I GT GY+ PEY+    ++
Sbjct:   448 HRDIKSSNILLDEHFVAKLADFGLAHASRDGSICFEPVNTDIRGTPGYVDPEYVVTHELT 507

Query:   509 TKMDVFSFGVVLLELISGKEAIDE 532
              K DV+S+GVVLLE+I+GK A+DE
Sbjct:   508 EKSDVYSYGVVLLEIITGKRAVDE 531

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
O64825	LYK4_ARATH	2, ., 7, ., 1, 1, ., 1	0.3415	0.9221	0.8316	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	552
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-47
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	5e-44
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-43
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-43
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-43
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-42
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-41
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-37
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-31
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-28
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-28
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-28
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	5e-28
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	6e-28
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-27
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-26
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-26
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-25
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-25
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-24
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-24
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	5e-24
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	9e-24
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	6e-23
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-22
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	6e-22
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	8e-22
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-21
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-21
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-21
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-21
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	7e-21
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	7e-21
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-20
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-20
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-20
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-20
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-20
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	6e-20
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	7e-20
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	7e-20
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	8e-20
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-19
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-19
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-19
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-19
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	7e-19
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	9e-19
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-18
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-18
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-18
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-18
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-18
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-18
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	6e-18
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	8e-18
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	9e-18
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-17
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-17
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-17
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-17
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-17
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	5e-17
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-17
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	6e-17
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	6e-17
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-17
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	7e-17
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	7e-17
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	7e-17
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-16
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-16
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-16
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-16
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-16
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-16
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-16
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-16
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-16
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-16
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	6e-16
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	8e-16
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-15
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-15
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-15
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-15
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-15
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-15
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-15
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-15
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-15
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-15
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-15
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	5e-15
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	6e-15
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	7e-15
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	8e-15
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	8e-15
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	9e-15
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-14
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-14
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-14
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-14
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-14
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-14
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-14
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-14
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-14
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-14
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-14
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-14
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-14
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-14
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-14
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-14
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-14
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-14
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-14
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	6e-14
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	7e-14
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	7e-14
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	7e-14
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	7e-14
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	8e-14
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	9e-14
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-13
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-13
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-13
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-13
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-13
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-13
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-13
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-13
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-13
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-13
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-13
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-13
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-13
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-13
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-13
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-13
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-13
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-13
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-13
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-13
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-13
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-13
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	5e-13
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	6e-13
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	6e-13
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	6e-13
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	7e-13
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	7e-13
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	9e-13
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	9e-13
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-12
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-12
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-12
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-12
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-12
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-12
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-12
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-12
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-12
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	4e-12
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	4e-12
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	4e-12
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	5e-12
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	5e-12
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	5e-12
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	5e-12
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	6e-12
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	6e-12
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	7e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	7e-12
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-11
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-11
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-11
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-11
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-11
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-11
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-11
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-11
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-11
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-11
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-11
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	7e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	8e-11
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	9e-11
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	9e-11
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	9e-11
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	9e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-10
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-10
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-10
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-10
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-10
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-10
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-10
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-10
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-10
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-10
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-10
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-10
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-10
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-10
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-10
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-10
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-10
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-10
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	5e-10
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	5e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	6e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	6e-10
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	6e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	7e-10
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	8e-10
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	8e-10
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	8e-10
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	9e-10
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	9e-10
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-09
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-09
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-09
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-09
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-09
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-09
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-09
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-09
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-09
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-09
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-09
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-09
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-09
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-09
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	5e-09
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	6e-09
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-09
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	7e-09
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	7e-09
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	8e-09
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	9e-09
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-08
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-08
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-08
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-08
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-08
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-08
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-08
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-08
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-08
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-08
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-08
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-08
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	4e-08
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-08
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	5e-08
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	5e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	7e-08
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	7e-08
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	9e-08
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-07
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	1e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-07
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-07
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-07
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-07
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-07
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	4e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	5e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	7e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-06
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-06
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-06
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	5e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	6e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	7e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-05
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	5e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	6e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	8e-05
pfam01476	43	pfam01476, LysM, LysM domain	1e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	2e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	0.002
smart00257	44	smart00257, LysM, Lysin motif	0.002
cd00118	45	cd00118, LysM, Lysine Motif is a small domain invo	0.002
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  163 bits (416), Expect = 2e-47
 Identities = 75/195 (38%), Positives = 109/195 (55%), Gaps = 20/195 (10%)

Query: 351 GSVYKGNIH--GEVYAIKMMK--------WNACEELKILQKVNHGNLVKLEGFCIDPEDA 400
           G+VY       G+  AIK++K             E++IL+K+NH N+VKL G   D    
Sbjct: 7   GTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDEN-- 64

Query: 401 NCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
           + YL+ EY E GSL   L EN+ + L+    LRI + +  GL+Y+H +    ++H+D+K 
Sbjct: 65  HLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSN---GIIHRDLKP 120

Query: 461 SNILLDS-NMRAKIANFGLAKSGCNA--ITMHIVGTQGYIAPEYLADGV-VSTKMDVFSF 516
            NILLDS N + K+A+FGL+K   +   +   IVGT  Y+APE L      S K D++S 
Sbjct: 121 ENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSL 180

Query: 517 GVVLLELISGKEAID 531
           GV+L EL   K+ I 
Sbjct: 181 GVILYELPELKDLIR 195

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  156 bits (397), Expect = 5e-44
 Identities = 62/200 (31%), Positives = 107/200 (53%), Gaps = 31/200 (15%)

Query: 351 GSVYKGNIHGEVY-----AIKMMKWNA--------CEELKILQKVNHGNLVKLEGFCIDP 397
           G VYKG + G+       A+K +K +A         +E ++++K+ H N+V+L G C + 
Sbjct: 9   GEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEE 68

Query: 398 EDANCYLIYEYIENGSLHSWLHENKNE-------NLNWKTRLRIAIDVANGLQYIHEHTR 450
           E    YL+ EY+E G L  +L +++          L+ K  L  AI +A G++Y+     
Sbjct: 69  E--PLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK-- 124

Query: 451 PRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI-----APEYLADG 505
            + VH+D+ + N L+  ++  KI++FGL++        +   T G +     APE L DG
Sbjct: 125 -KFVHRDLAARNCLVGEDLVVKISDFGLSRDV-YDDDYYRKKTGGKLPIRWMAPESLKDG 182

Query: 506 VVSTKMDVFSFGVVLLELIS 525
           + ++K DV+SFGV+L E+ +
Sbjct: 183 IFTSKSDVWSFGVLLWEIFT 202

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  155 bits (393), Expect = 2e-43
 Identities = 60/193 (31%), Positives = 103/193 (53%), Gaps = 24/193 (12%)

Query: 351 GSVYKG-------NIHGEVYAIKMMKWNA--------CEELKILQKVNHGNLVKLEGFCI 395
           G VYKG           EV A+K +K +A          E +I++K++H N+VKL G C 
Sbjct: 13  GEVYKGTLKGKGDGKEVEV-AVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCT 71

Query: 396 DPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVH 455
           + E     ++ EY+  G L  +L +N+ + L+    L  A+ +A G++Y+        +H
Sbjct: 72  EEE--PLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIH 126

Query: 456 KDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI---APEYLADGVVSTKMD 512
           +D+ + N L+  N+  KI++FGL++   +     + G +  I   APE L +G  ++K D
Sbjct: 127 RDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSD 186

Query: 513 VFSFGVVLLELIS 525
           V+SFGV+L E+ +
Sbjct: 187 VWSFGVLLWEIFT 199

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  153 bits (390), Expect = 4e-43
 Identities = 62/188 (32%), Positives = 93/188 (49%), Gaps = 18/188 (9%)

Query: 351 GSVYKG--NIHGEVYAIKMMKW--------NACEELKILQKVNHGNLVKLEGFCIDPEDA 400
           G VY       G++ AIK++K             E+KIL+K+ H N+V+L     D +  
Sbjct: 13  GKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDED-- 70

Query: 401 NCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             YL+ EY E G L   L +     L+          + + L+Y+H      +VH+D+K 
Sbjct: 71  KLYLVMEYCEGGDLFDLLKKRGR--LSEDEARFYLRQILSALEYLHSK---GIVHRDLKP 125

Query: 461 SNILLDSNMRAKIANFGLAKS-GCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVV 519
            NILLD +   K+A+FGLA+           VGT  Y+APE L        +D++S GV+
Sbjct: 126 ENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVI 185

Query: 520 LLELISGK 527
           L EL++GK
Sbjct: 186 LYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  154 bits (391), Expect = 4e-43
 Identities = 70/192 (36%), Positives = 108/192 (56%), Gaps = 23/192 (11%)

Query: 351 GSVYKGNIH---GEVYAIKMMK---------WNACEELKILQKVNHGNLVKLEGFCIDPE 398
           G+VYK   H   G++ A+K++K           A  E++IL++++H N+V+L     D +
Sbjct: 13  GTVYKA-KHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKD 71

Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
             + YL+ EY E G L  +L       L+     +IA+ +  GL+Y+H +    ++H+D+
Sbjct: 72  --HLYLVMEYCEGGDLFDYLSRGGP--LSEDEAKKIALQILRGLEYLHSN---GIIHRDL 124

Query: 459 KSSNILLDSNMRAKIANFGLAK--SGCNAITMHIVGTQGYIAPEYLADG-VVSTKMDVFS 515
           K  NILLD N   KIA+FGLAK     ++     VGT  Y+APE L  G     K+DV+S
Sbjct: 125 KPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWS 184

Query: 516 FGVVLLELISGK 527
            GV+L EL++GK
Sbjct: 185 LGVILYELLTGK 196

Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  151 bits (385), Expect = 2e-42
 Identities = 61/192 (31%), Positives = 102/192 (53%), Gaps = 23/192 (11%)

Query: 351 GSVYKG------NIHGEVYAIKMMKWNA--------CEELKILQKVNHGNLVKLEGFCID 396
           G VYKG             A+K +K +A          E +I++K++H N+VKL G C +
Sbjct: 13  GEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTE 72

Query: 397 PEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHK 456
            E    Y++ EY+E G L S+L +N+   L+    L  A+ +A G++Y+        +H+
Sbjct: 73  EE--PLYIVMEYMEGGDLLSYLRKNR-PKLSLSDLLSFALQIARGMEYLESK---NFIHR 126

Query: 457 DIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI---APEYLADGVVSTKMDV 513
           D+ + N L+  N+  KI++FGL++   +       G +  I   APE L +G  ++K DV
Sbjct: 127 DLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDV 186

Query: 514 FSFGVVLLELIS 525
           +SFGV+L E+ +
Sbjct: 187 WSFGVLLWEIFT 198

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  149 bits (378), Expect = 2e-41
 Identities = 62/196 (31%), Positives = 100/196 (51%), Gaps = 28/196 (14%)

Query: 351 GSVYKG-------NIHGEVYAIKMMKWNA--------CEELKILQKVNHGNLVKLEGFCI 395
           G VYKG           +V A+K +K  A         EE  I++K++H N+V+L G C 
Sbjct: 13  GEVYKGTLKGDGEGTETKV-AVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCT 71

Query: 396 DPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVH 455
             E    Y++ EY+  G L  +L ++  E L  K  L++A+ +A G++Y+        VH
Sbjct: 72  QGEPL--YIVTEYMPGGDLLDFLRKHG-EKLTLKDLLQMALQIAKGMEYLESK---NFVH 125

Query: 456 KDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI-----APEYLADGVVSTK 510
           +D+ + N L+  N+  KI++FGL++              G +     APE L DG  ++K
Sbjct: 126 RDLAARNCLVTENLVVKISDFGLSRDIYEDDYYR-KRGGGKLPIKWMAPESLKDGKFTSK 184

Query: 511 MDVFSFGVVLLELISG 526
            DV+SFGV+L E+ + 
Sbjct: 185 SDVWSFGVLLWEIFTL 200

Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  137 bits (348), Expect = 4e-37
 Identities = 58/194 (29%), Positives = 93/194 (47%), Gaps = 24/194 (12%)

Query: 351 GSVYKGNIH--GEVYAIKMMKWNAC---------EELKILQKVNHGNLVKLEGFCIDPED 399
           GSVY       GE+ A+K ++ +            E++IL  + H N+V+  G   D E 
Sbjct: 14  GSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEK 73

Query: 400 ANCYLIYEYIENGSLHSWLHENK--NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKD 457
               +  EY+  GSL S L +     E +    R +    +  GL Y+H +    +VH+D
Sbjct: 74  NTLNIFLEYVSGGSLSSLLKKFGKLPEPV---IR-KYTRQILEGLAYLHSN---GIVHRD 126

Query: 458 IKSSNILLDSNMRAKIANFGLAK----SGCNAITMHIVGTQGYIAPEYLADGVVSTKMDV 513
           IK +NIL+DS+   K+A+FG AK          T  + GT  ++APE +         D+
Sbjct: 127 IKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADI 186

Query: 514 FSFGVVLLELISGK 527
           +S G  ++E+ +GK
Sbjct: 187 WSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  121 bits (305), Expect = 4e-31
 Identities = 58/187 (31%), Positives = 97/187 (51%), Gaps = 16/187 (8%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNACE-------ELKILQKVNHGNLVKLEGFCIDPEDAN 401
           G VYK      G+  AIK++K  + E       E++IL+K  H N+VK  G     +D  
Sbjct: 14  GEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYG-SYLKKD-E 71

Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSS 461
            +++ E+   GSL   L  + N+ L       +  ++  GL+Y+H +    ++H+DIK++
Sbjct: 72  LWIVMEFCSGGSLKDLLK-STNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAA 127

Query: 462 NILLDSNMRAKIANFGLAKSGCNA-ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVL 520
           NILL S+   K+ +FGL+    +      +VGT  ++APE +       K D++S G+  
Sbjct: 128 NILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITA 187

Query: 521 LELISGK 527
           +EL  GK
Sbjct: 188 IELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  114 bits (287), Expect = 1e-28
 Identities = 67/208 (32%), Positives = 103/208 (49%), Gaps = 34/208 (16%)

Query: 342 NFSEGCLI----QGSVYKG-NIH-GEVYAIKMMKWNAC---------EELKILQKVNHGN 386
           N+  G LI     G VYKG N+  G+  AIK +              +E+ +L+ + H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 387 LVKLEGFCIDPEDANCYLIYEYIENGSLHSWL--HENKNENLNWKTRLRIAIDVAN---G 441
           +VK  G        + Y+I EY ENGSL   +       E+L       +A+ V     G
Sbjct: 61  IVKYIGSI--ETSDSLYIILEYAENGSLRQIIKKFGPFPESL-------VAVYVYQVLQG 111

Query: 442 LQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLA-KSGCNAITMH-IVGTQGYIAP 499
           L Y+HE     V+H+DIK++NIL   +   K+A+FG+A K    +     +VGT  ++AP
Sbjct: 112 LAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAP 168

Query: 500 EYLADGVVSTKMDVFSFGVVLLELISGK 527
           E +     ST  D++S G  ++EL++G 
Sbjct: 169 EVIEMSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  114 bits (287), Expect = 1e-28
 Identities = 55/181 (30%), Positives = 94/181 (51%), Gaps = 12/181 (6%)

Query: 351 GSVYKGNIHGEVYAIKMMKWNA------CEELKILQKVNHGNLVKLEGFCIDPEDANCYL 404
           G V  G+  G+  A+K +K ++        E  ++  + H NLV+L G  +       Y+
Sbjct: 20  GDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ--GNPLYI 77

Query: 405 IYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNIL 464
           + EY+  GSL  +L       +    +L  A+DV  G++Y+ E      VH+D+ + N+L
Sbjct: 78  VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVL 134

Query: 465 LDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELI 524
           +  ++ AK+++FGLAK          +  + + APE L +   STK DV+SFG++L E+ 
Sbjct: 135 VSEDLVAKVSDFGLAKEASQGQDSGKLPVK-WTAPEALREKKFSTKSDVWSFGILLWEIY 193

Query: 525 S 525
           S
Sbjct: 194 S 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  113 bits (285), Expect = 2e-28
 Identities = 57/180 (31%), Positives = 92/180 (51%), Gaps = 19/180 (10%)

Query: 360 GEVYAIKMM------KWNACE----ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI 409
           G++YA+K++      K    E    E  IL ++NH  +VKL  +    E+   YL+ EY 
Sbjct: 18  GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH-YAFQTEE-KLYLVLEYA 75

Query: 410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM 469
             G L S  H +K    + +     A ++   L+Y+H      ++++D+K  NILLD++ 
Sbjct: 76  PGGELFS--HLSKEGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADG 130

Query: 470 RAKIANFGLAKSGCNAI--TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
             K+ +FGLAK   +    T    GT  Y+APE L        +D +S GV+L E+++GK
Sbjct: 131 HIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  112 bits (283), Expect = 5e-28
 Identities = 60/191 (31%), Positives = 90/191 (47%), Gaps = 20/191 (10%)

Query: 350 QGSVYKGNIH---GEVYAIK--------MMKWNACEELKILQKVNHGNLVKLEGFCIDPE 398
            G VYK   H   G++YA+K          +     ELK L+      +VK  G      
Sbjct: 14  SGVVYKV-RHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEG 72

Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
           +    ++ EY++ GSL   L   K   +       IA  +  GL Y+H   R  ++H+DI
Sbjct: 73  EI--SIVLEYMDGGSLADLL--KKVGKIPEPVLAYIARQILKGLDYLH-TKR-HIIHRDI 126

Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAITMHI--VGTQGYIAPEYLADGVVSTKMDVFSF 516
           K SN+L++S    KIA+FG++K   N +      VGT  Y++PE +     S   D++S 
Sbjct: 127 KPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSL 186

Query: 517 GVVLLELISGK 527
           G+ LLE   GK
Sbjct: 187 GLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  112 bits (283), Expect = 6e-28
 Identities = 60/192 (31%), Positives = 96/192 (50%), Gaps = 23/192 (11%)

Query: 351 GSVYKG-NIH-GEVYAIKMMKW---------NACEELKILQKVNHGNLVKLEGFCIDPED 399
           G VYK  +   GE+ A+K ++           A  E+ +L+++ H N+VKL         
Sbjct: 13  GVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER- 71

Query: 400 ANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIK 459
              YL++EY +   L  +L + +   L+      I   +  GL Y H H   R++H+D+K
Sbjct: 72  -KLYLVFEYCDM-DLKKYL-DKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLK 125

Query: 460 SSNILLDSNMRAKIANFGLAKSGC---NAITMHIVGTQGYIAPEYL-ADGVVSTKMDVFS 515
             NIL++ +   K+A+FGLA++        T H V T  Y APE L      ST +D++S
Sbjct: 126 PQNILINRDGVLKLADFGLARAFGIPLRTYT-HEVVTLWYRAPEILLGSKHYSTAVDIWS 184

Query: 516 FGVVLLELISGK 527
            G +  E+I+GK
Sbjct: 185 VGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  112 bits (281), Expect = 1e-27
 Identities = 61/194 (31%), Positives = 97/194 (50%), Gaps = 23/194 (11%)

Query: 351 GSVYK------GNIHGEVYAIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCID 396
           G V        G+  GE  A+K +  +  E        E++IL+ ++H N+VK +G C  
Sbjct: 18  GKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK 77

Query: 397 PEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHK 456
           P   +  LI EY+ +GSL  +L  +++  +N K  L  +  +  G+ Y+      R +H+
Sbjct: 78  PGGRSLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQ---RYIHR 133

Query: 457 DIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKM 511
           D+ + NIL++S    KI++FGLAK        + V   G     + APE L     S+  
Sbjct: 134 DLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSAS 193

Query: 512 DVFSFGVVLLELIS 525
           DV+SFGV L EL +
Sbjct: 194 DVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  109 bits (274), Expect = 1e-26
 Identities = 58/195 (29%), Positives = 96/195 (49%), Gaps = 26/195 (13%)

Query: 351 GSVYKG--NIHGEVYAIKMMK-WN--------ACEELKILQKVNHGNLVKLEGFCIDPED 399
           G VYK      GE+ A+K ++  N        A  E+K+LQK+ H N+V+L+        
Sbjct: 13  GQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGK 72

Query: 400 ANCYLIYEYIENGSLH--SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKD 457
            + Y+++EY++    H  + L ++                +  GLQY+H +    ++H+D
Sbjct: 73  GSIYMVFEYMD----HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRD 125

Query: 458 IKSSNILLDSNMRAKIANFGLA----KSGCNAITMHIVGTQGYIAPEYL-ADGVVSTKMD 512
           IK SNIL++++   K+A+FGLA    K      T  ++ T  Y  PE L        ++D
Sbjct: 126 IKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLGATRYGPEVD 184

Query: 513 VFSFGVVLLELISGK 527
           ++S G +L EL  GK
Sbjct: 185 MWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  107 bits (270), Expect = 3e-26
 Identities = 65/218 (29%), Positives = 104/218 (47%), Gaps = 46/218 (21%)

Query: 351 GSVYKG--NIHGEVYAIKMMKW---------NACEELKILQKVNHGNLVKL-EGFCIDPE 398
           G VY       G++Y +K +           +A  E+KIL+K+NH N++K  E F    E
Sbjct: 14  GKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESF----E 69

Query: 399 DANC-YLIYEYIENGSLHSWLHENKNEN--------LNWKTRLRIAIDVANGLQYIHEHT 449
           +     ++ EY + G L   + + K E         L+W  +L +A      L+Y+H   
Sbjct: 70  EKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA------LKYLHSR- 122

Query: 450 RPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAITMHIVGTQGYIAPEYLADG 505
             +++H+DIK  NI L SN   K+ +FG++K    +   A T+  VGT  Y++PE   + 
Sbjct: 123 --KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV--VGTPYYLSPELCQNK 178

Query: 506 VVSTKMDVFSFGVVLLELISGKEAIDEEGKFCGQKLKG 543
             + K D++S G VL EL + K        F G+ L  
Sbjct: 179 PYNYKSDIWSLGCVLYELCTLKHP------FEGENLLE 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  105 bits (265), Expect = 2e-25
 Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 21/215 (9%)

Query: 332 KIEELREATDNFSEGCLIQGSVYKGNIH--GEVYAIK--------MMKWNACEELKILQK 381
           KI EL        EG    GSV K  +   G ++A+K         ++     EL+I + 
Sbjct: 2   KIVELS----RLGEG--AGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKS 55

Query: 382 VNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNEN--LNWKTRLRIAIDVA 439
                +VK  G  +D   ++  +  EY E GSL S   + K     +  K   +IA  V 
Sbjct: 56  CKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVL 115

Query: 440 NGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAP 499
            GL Y+H     +++H+DIK SNILL    + K+ +FG++    N++     GT  Y+AP
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAP 172

Query: 500 EYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG 534
           E +     S   DV+S G+ LLE+   +     EG
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEG 207

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  107 bits (267), Expect = 3e-25
 Identities = 64/201 (31%), Positives = 98/201 (48%), Gaps = 30/201 (14%)

Query: 351 GSVYKGNIHGEVYAIKMMK----------WNACEELKILQKVNH-GNLVKLEGFCIDPED 399
           G VY      ++ A+K++                E++IL  +NH  N+VKL  F  D   
Sbjct: 14  GEVYLA-RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEG- 71

Query: 400 ANCYLIYEYIENGSLHSWLHENKNE-NLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
            + YL+ EY++ GSL   L +   +  L+    L I   + + L+Y+H      ++H+DI
Sbjct: 72  -SLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDI 127

Query: 459 KSSNILLDSN-MRAKIANFGLAK--------SGCNAITMHIVGTQGYIAPEYLADGV--- 506
           K  NILLD +    K+ +FGLAK        S   A+    VGT GY+APE L       
Sbjct: 128 KPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAY 187

Query: 507 VSTKMDVFSFGVVLLELISGK 527
            S+  D++S G+ L EL++G 
Sbjct: 188 ASSSSDIWSLGITLYELLTGL 208

Length = 384

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  103 bits (258), Expect = 1e-24
 Identities = 60/197 (30%), Positives = 93/197 (47%), Gaps = 27/197 (13%)

Query: 351 GSVYKG-NIH-GEVYAIKMMKW---------NACEELKILQKVNHGNLVKLEGFCIDPED 399
           G VY   N+  GE+ A+K ++             +E+K+L+ + H NLVK  G  ++   
Sbjct: 14  GKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG--VEVHR 71

Query: 400 ANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIK 459
              Y+  EY   G+L   L   +  + +   R    + +  GL Y+H H    +VH+DIK
Sbjct: 72  EKVYIFMEYCSGGTLEELLEHGRILDEH-VIR-VYTLQLLEGLAYLHSH---GIVHRDIK 126

Query: 460 SSNILLDSNMRAKIANFGLAKSGCNAITM------HIVGTQGYIAPEYLADGVVSTK--- 510
            +NI LD N   K+ +FG A    N  T        + GT  Y+APE +  G        
Sbjct: 127 PANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRA 186

Query: 511 MDVFSFGVVLLELISGK 527
            D++S G V+LE+ +GK
Sbjct: 187 ADIWSLGCVVLEMATGK 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  101 bits (253), Expect = 4e-24
 Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 28/201 (13%)

Query: 351 GSVYKG--NIHGEVYAIK---------MMKWNACEELKILQKVNHGNLVK-LEGFCIDPE 398
           G V+K        VYA+K           +  A +E ++L K++   +++  E F    +
Sbjct: 14  GVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL---D 70

Query: 399 DANCYLIYEYIENGSLHSWLHENKN----ENLNWKTRLRIAIDVANGLQYIHEHTRPRVV 454
                ++ EY ENG LH  L   +     E+  W+  ++I +    GL ++H     +++
Sbjct: 71  KGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL----GLAHLHSK---KIL 123

Query: 455 HKDIKSSNILLDSNMRAKIANFGLAK--SGCNAITMHIVGTQGYIAPEYLADGVVSTKMD 512
           H+DIKS N+ LD+    KI + G+AK  S        IVGT  Y++PE   D   + K D
Sbjct: 124 HRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSD 183

Query: 513 VFSFGVVLLELISGKEAIDEE 533
           V++ GVVL E  +GK   D  
Sbjct: 184 VWALGVVLYECCTGKHPFDAN 204

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  101 bits (254), Expect = 5e-24
 Identities = 61/178 (34%), Positives = 94/178 (52%), Gaps = 16/178 (8%)

Query: 360 GEVYAIKMMKWNACE-------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG 412
           GEV A+K ++ +  E       E++IL+ + H N+VK +G C      N  L+ EY+  G
Sbjct: 33  GEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYG 92

Query: 413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAK 472
           SL  +L +++ E L+ +  L  A  +  G++Y+      R VH+D+ + NIL++S  R K
Sbjct: 93  SLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVK 148

Query: 473 IANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           I +FGL K        + V   G     + APE L +   S   DV+SFGVVL EL +
Sbjct: 149 IGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  100 bits (251), Expect = 9e-24
 Identities = 56/186 (30%), Positives = 95/186 (51%), Gaps = 17/186 (9%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNAC------EELKILQKVNHGNLVKLEGFCIDPEDANC 402
           G V+ G  N   +V A+K +K          +E +I++K+ H  LV+L   C + E    
Sbjct: 20  GEVWMGTWNGTTKV-AVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPI-- 76

Query: 403 YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSN 462
           Y++ EY+  GSL  +L   + + L     + +A  +A G+ Y+        +H+D+ + N
Sbjct: 77  YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARN 133

Query: 463 ILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI---APEYLADGVVSTKMDVFSFGVV 519
           IL+  N+  KIA+FGLA+   +       G +  I   APE    G  + K DV+SFG++
Sbjct: 134 ILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGIL 193

Query: 520 LLELIS 525
           L E+++
Sbjct: 194 LTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 98.6 bits (246), Expect = 6e-23
 Identities = 64/217 (29%), Positives = 106/217 (48%), Gaps = 41/217 (18%)

Query: 350 QGSVYKG--NIHGEVYAIKMMKW---------NACEELKILQKVNHGNLVKL-EGFCIDP 397
            G VYK    + GE+ AIK +K           A  E+K+L+++NH N++KL + F    
Sbjct: 12  YGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVF---R 68

Query: 398 EDANCYLIYEYIENGSLH------SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRP 451
              + YL++E+++             L E+  ++  ++  L+       GL + H H   
Sbjct: 69  HKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQL-LQ-------GLAFCHSH--- 117

Query: 452 RVVHKDIKSSNILLDSNMRAKIANFGLAKS--GCNAITMHIVGTQGYIAPEYL-ADGVVS 508
            ++H+D+K  N+L+++    K+A+FGLA+S         H V T+ Y APE L  D   S
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYS 177

Query: 509 TKMDVFSFGVVLLELIS------GKEAIDEEGKFCGQ 539
           T +D++S G +  EL+S      GK  ID+  K    
Sbjct: 178 TPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRT 214

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 96.0 bits (239), Expect = 3e-22
 Identities = 54/182 (29%), Positives = 94/182 (51%), Gaps = 18/182 (9%)

Query: 354 YKGNIHGEVYAIKMMKWNAC------EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYE 407
           ++G I     AIKM++  A       EE K++ K++H NLV+L G C   +    +++ E
Sbjct: 25  WRGKID---VAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT--KQRPIFIVTE 79

Query: 408 YIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS 467
           Y+ NG L ++L E K   L  +  L +  DV   ++Y+  +     +H+D+ + N L+  
Sbjct: 80  YMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGE 135

Query: 468 NMRAKIANFGLAKSGCNAITMHIVGTQGYI---APEYLADGVVSTKMDVFSFGVVLLELI 524
           +   K+++FGLA+   +       GT+  +    PE       S+K DV+SFGV++ E+ 
Sbjct: 136 DNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVF 195

Query: 525 SG 526
           S 
Sbjct: 196 SE 197

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 95.3 bits (238), Expect = 6e-22
 Identities = 51/187 (27%), Positives = 86/187 (45%), Gaps = 31/187 (16%)

Query: 365 IKMMKWN-ACEELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENK 422
           IK  K      E ++L ++N H  ++KL  +    ++ N Y + EY  NG L    +  K
Sbjct: 40  IKEKKVKYVKIEKEVLTRLNGHPGIIKL--YYTFQDEENLYFVLEYAPNGEL--LQYIRK 95

Query: 423 NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK-- 480
             +L+ K     A ++   L+Y+H      ++H+D+K  NILLD +M  KI +FG AK  
Sbjct: 96  YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVL 152

Query: 481 -------SGCNAITMHI-------------VGTQGYIAPEYLADGVVSTKMDVFSFGVVL 520
                  S     T                VGT  Y++PE L +       D+++ G ++
Sbjct: 153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCII 212

Query: 521 LELISGK 527
            ++++GK
Sbjct: 213 YQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 95.0 bits (237), Expect = 8e-22
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 33/200 (16%)

Query: 351 GSVY--KGNIHGEVYAIK------MMKWNACEELK----ILQKVNHGNLVKLEGFCIDPE 398
           G V+  K    G++YAIK      M++ N  +++     IL +     +VKL  +     
Sbjct: 7   GRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL--YYSFQG 64

Query: 399 DANCYLIYEYIENGSLHSWLH--ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHK 456
             N YL+ EY+  G L S L    + +E++    R+ IA ++   L+Y+H +    ++H+
Sbjct: 65  KKNLYLVMEYLPGGDLASLLENVGSLDEDV---ARIYIA-EIVLALEYLHSN---GIIHR 117

Query: 457 DIKSSNILLDSNMRAKIANFGLAKSGC-------NAITMH---IVGTQGYIAPEYLADGV 506
           D+K  NIL+DSN   K+ +FGL+K G        N        IVGT  YIAPE +    
Sbjct: 118 DLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG 177

Query: 507 VSTKMDVFSFGVVLLELISG 526
            S  +D +S G +L E + G
Sbjct: 178 HSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 93.5 bits (233), Expect = 2e-21
 Identities = 51/153 (33%), Positives = 87/153 (56%), Gaps = 5/153 (3%)

Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           EL IL K N   +V   G   +  + +  +  EY++ GSL   L E +   +  +   +I
Sbjct: 49  ELDILHKCNSPYIVGFYGAFYN--NGDISICMEYMDGGSLDKILKEVQGR-IPERILGKI 105

Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
           A+ V  GL Y+HE  + +++H+D+K SNIL++S  + K+ +FG++    N++    VGT 
Sbjct: 106 AVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTS 163

Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
            Y+APE +     S K D++S G+ L+EL +G+
Sbjct: 164 SYMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 92.7 bits (230), Expect = 3e-21
 Identities = 54/180 (30%), Positives = 100/180 (55%), Gaps = 12/180 (6%)

Query: 351 GSVYKGNIHGEVYAIKMMKWNAC-----EELKILQKVNHGNLVKLEGFCIDPEDANCYLI 405
           G+V +G   G+  A+K +K +       EE  ++ K++H NLV+L G  +       Y++
Sbjct: 20  GAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH---NGLYIV 76

Query: 406 YEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL 465
            E +  G+L ++L       ++    L+ ++DVA G++Y+      ++VH+D+ + NIL+
Sbjct: 77  MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILV 133

Query: 466 DSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
             +  AK+++FGLA+ G   +    +  + + APE L     S+K DV+S+GV+L E+ S
Sbjct: 134 SEDGVAKVSDFGLARVGSMGVDNSKLPVK-WTAPEALKHKKFSSKSDVWSYGVLLWEVFS 192

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 93.1 bits (232), Expect = 4e-21
 Identities = 48/159 (30%), Positives = 78/159 (49%), Gaps = 6/159 (3%)

Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNEN--LNWKTRL 432
           E+ IL+++ H N+V+     ID  +   Y++ EY E G L   + + K E   +  +   
Sbjct: 49  EVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW 108

Query: 433 RIAIDVANGLQYIH--EHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS--GCNAITM 488
           RI   +   L   H        V+H+D+K +NI LD+N   K+ +FGLAK     ++   
Sbjct: 109 RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAK 168

Query: 489 HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
             VGT  Y++PE L       K D++S G ++ EL +  
Sbjct: 169 TYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 93.4 bits (233), Expect = 4e-21
 Identities = 74/228 (32%), Positives = 108/228 (47%), Gaps = 46/228 (20%)

Query: 351 GSVYKG-NIH-GEVYAIKMMK-----WNAC---EELKILQKVN-HGNLVKL-EGFCIDPE 398
           GSVY   N   GE+ AIK MK     W  C    E+K L+K+N H N+VKL E F    E
Sbjct: 13  GSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVF---RE 69

Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
           +   Y ++EY+E G+L+  + + K +  +      I   +  GL +IH+H      H+D+
Sbjct: 70  NDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDL 125

Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAITMHI---------VGTQGYIAPE-YLADGVVS 508
           K  N+L+      KIA+FGLA+         I         V T+ Y APE  L     S
Sbjct: 126 KPENLLVSGPEVVKIADFGLAR--------EIRSRPPYTDYVSTRWYRAPEILLRSTSYS 177

Query: 509 TKMDVFSFGVVLLELIS------GKEAIDEEGKFC---GQKLKGYWRE 547
           + +D+++ G ++ EL +      G   ID+  K C   G   K  W E
Sbjct: 178 SPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPE 225

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 92.0 bits (229), Expect = 7e-21
 Identities = 56/194 (28%), Positives = 101/194 (52%), Gaps = 27/194 (13%)

Query: 351 GSVYKG--NIHGEVY---AIKMMK--------WNACEELKILQKVNHGNLVKLEGFCIDP 397
           G V +G   + G+     AIK +K         +   E  I+ + +H N+++LEG     
Sbjct: 18  GEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS 77

Query: 398 EDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKD 457
                 +I EY+ENGSL  +L EN +        + +   +A+G++Y+ E      VH+D
Sbjct: 78  RPV--MIITEYMENGSLDKFLREN-DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRD 131

Query: 458 IKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG------YIAPEYLADGVVSTKM 511
           + + NIL++SN+  K+++FGL++   ++       T+G      + APE +A    ++  
Sbjct: 132 LAARNILVNSNLVCKVSDFGLSRRLEDSEA--TYTTKGGKIPIRWTAPEAIAYRKFTSAS 189

Query: 512 DVFSFGVVLLELIS 525
           DV+SFG+V+ E++S
Sbjct: 190 DVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 92.7 bits (230), Expect = 7e-21
 Identities = 56/197 (28%), Positives = 101/197 (51%), Gaps = 41/197 (20%)

Query: 364 AIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH 415
           A+KM+K NA          E  +L++VNH +++KL G C   +D    LI EY + GSL 
Sbjct: 34  AVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGAC--SQDGPLLLIVEYAKYGSLR 91

Query: 416 SWLHENKN----------------------ENLNWKTRLRIAIDVANGLQYIHEHTRPRV 453
           S+L E++                         L     +  A  ++ G+QY+ E    ++
Sbjct: 92  SFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KL 148

Query: 454 VHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVS 508
           VH+D+ + N+L+    + KI++FGL++      + ++  ++G     ++A E L D + +
Sbjct: 149 VHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS-YVKRSKGRIPVKWMAIESLFDHIYT 207

Query: 509 TKMDVFSFGVVLLELIS 525
           T+ DV+SFGV+L E+++
Sbjct: 208 TQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 91.9 bits (229), Expect = 1e-20
 Identities = 54/189 (28%), Positives = 92/189 (48%), Gaps = 20/189 (10%)

Query: 350 QGSVYKGN--IHGEVYAIKMMKWN------ACEELKILQKVNHGNLVKLEGFCIDPEDAN 401
            G VYK      G+  AIK M+           E+ I++   H N+V      +  ++  
Sbjct: 32  SGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDE-- 89

Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSS 461
            +++ EY++ GSL   + +N    +N      +  +V  GL+Y+H      V+H+DIKS 
Sbjct: 90  LWVVMEYMDGGSLTDIITQNFVR-MNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSD 145

Query: 462 NILLDSNMRAKIANFGLA----KSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFG 517
           NILL  +   K+A+FG A    K      ++  VGT  ++APE +       K+D++S G
Sbjct: 146 NILLSKDGSVKLADFGFAAQLTKEKSKRNSV--VGTPYWMAPEVIKRKDYGPKVDIWSLG 203

Query: 518 VVLLELISG 526
           ++ +E+  G
Sbjct: 204 IMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 91.5 bits (228), Expect = 2e-20
 Identities = 59/185 (31%), Positives = 93/185 (50%), Gaps = 32/185 (17%)

Query: 359 HGEVYAIKMM-KW---------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEY 408
            G+ YA+K++ K          +   E +ILQ + H  LV L G   D  D+N YL+ EY
Sbjct: 25  SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD--DSNLYLVMEY 82

Query: 409 IENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN 468
           +  G L S L ++         R   A  V   L+Y+H      +V++D+K  N+LLDS+
Sbjct: 83  VPGGELFSHLRKSGRFPEPV-ARFYAA-QVVLALEYLHSLD---IVYRDLKPENLLLDSD 137

Query: 469 MRAKIANFGLAK--SGCNAITMHIVGTQGYIAPEYLADGVVSTK-----MDVFSFGVVLL 521
              KI +FG AK   G    T  + GT     PEYLA  ++ +K     +D ++ G+++ 
Sbjct: 138 GYIKITDFGFAKRVKG---RTYTLCGT-----PEYLAPEIILSKGYGKAVDWWALGILIY 189

Query: 522 ELISG 526
           E+++G
Sbjct: 190 EMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 90.2 bits (224), Expect = 3e-20
 Identities = 56/195 (28%), Positives = 99/195 (50%), Gaps = 25/195 (12%)

Query: 345 EGCLIQGSVYKGNIHGEV-YAIKMMKWNAC-------EELKILQKVNHGNLVKLEGFCID 396
            G    G V++G     V  AIK++K +         +E++ L+++ H +L+ L   C  
Sbjct: 16  SGYF--GEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC-- 71

Query: 397 PEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHK 456
                 Y+I E +E GSL ++L   + + L   + + +A  VA G+ Y+ E      +H+
Sbjct: 72  SVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHR 128

Query: 457 DIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG------YIAPEYLADGVVSTK 510
           D+ + NIL+  ++  K+A+FGLA+     I   +  +        + APE  + G  STK
Sbjct: 129 DLAARNILVGEDLVCKVADFGLAR----LIKEDVYLSSDKKIPYKWTAPEAASHGTFSTK 184

Query: 511 MDVFSFGVVLLELIS 525
            DV+SFG++L E+ +
Sbjct: 185 SDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 90.3 bits (224), Expect = 3e-20
 Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 29/201 (14%)

Query: 351 GSVYKGNIHGEV-----YAIKMMKWNACEELKI---------LQKVNHGNLVKLEGFCID 396
           GSV +G +  +       A+K MK +     +I         ++  +H N++KL G C +
Sbjct: 13  GSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFE 72

Query: 397 PEDANCY----LIYEYIENGSLHSWLH----ENKNENLNWKTRLRIAIDVANGLQYIHEH 448
                      +I  ++++G LHS+L         E L  +T L+  +D+A G++Y+   
Sbjct: 73  ASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYL--- 129

Query: 449 TRPRVVHKDIKSSNILLDSNMRAKIANFGLAK---SGCNAITMHIVGTQ-GYIAPEYLAD 504
           +    +H+D+ + N +L  +M   +A+FGL+K   SG       I      +IA E LAD
Sbjct: 130 SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD 189

Query: 505 GVVSTKMDVFSFGVVLLELIS 525
            V ++K DV++FGV + E+ +
Sbjct: 190 RVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 90.4 bits (224), Expect = 4e-20
 Identities = 56/184 (30%), Positives = 97/184 (52%), Gaps = 17/184 (9%)

Query: 355 KGNIHGEVYAIKMMK--------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIY 406
           +G+  GE  A+K +K         +  +E++IL+ + H N+VK +G C +       LI 
Sbjct: 28  EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIM 87

Query: 407 EYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLD 466
           E++ +GSL  +L  NKN+ +N K +L+ A+ +  G+ Y+      + VH+D+ + N+L++
Sbjct: 88  EFLPSGSLKEYLPRNKNK-INLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVE 143

Query: 467 SNMRAKIANFGLAKS-----GCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLL 521
           S  + KI +FGL K+         +   +     + APE L         DV+SFGV L 
Sbjct: 144 SEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLY 203

Query: 522 ELIS 525
           EL++
Sbjct: 204 ELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 89.4 bits (222), Expect = 6e-20
 Identities = 56/175 (32%), Positives = 83/175 (47%), Gaps = 37/175 (21%)

Query: 373 CEELKILQKVNHGNLVKLEGFCID--PEDANCYLIYEYIENGSLHSWLHENKNE-----N 425
             E  I+ K NH N+V+L G   +  P     +++ E +  G L S+L EN+       +
Sbjct: 57  LMEALIMSKFNHQNIVRLIGVSFERLPR----FILLELMAGGDLKSFLRENRPRPERPSS 112

Query: 426 LNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS---NMRAKIANFGLAKSG 482
           L  K  L  A DVA G +Y+ E+     +H+DI + N LL        AKIA+FG+A+  
Sbjct: 113 LTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARD- 168

Query: 483 CNAITMHIVGTQGY------------IAPEYLADGVVSTKMDVFSFGVVLLELIS 525
                  I     Y            + PE   DG+ ++K DV+SFGV+L E+ S
Sbjct: 169 -------IYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 89.1 bits (221), Expect = 7e-20
 Identities = 52/184 (28%), Positives = 94/184 (51%), Gaps = 16/184 (8%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPEDANC 402
           G VY+G    +    A+K +K +  E      E  +++++ H NLV+L G C    +   
Sbjct: 20  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--REPPF 77

Query: 403 YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSN 462
           Y+I E++  G+L  +L E   + +N    L +A  +++ ++Y+    +   +H+D+ + N
Sbjct: 78  YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARN 134

Query: 463 ILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFSFGVV 519
            L+  N   K+A+FGL++           G +    + APE LA    S K DV++FGV+
Sbjct: 135 CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 194

Query: 520 LLEL 523
           L E+
Sbjct: 195 LWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 89.4 bits (222), Expect = 7e-20
 Identities = 47/164 (28%), Positives = 84/164 (51%), Gaps = 15/164 (9%)

Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL-------HENKNENLN 427
           EL + +K++H N+V+L G C + E    Y+I EY + G L  +L        + K   L+
Sbjct: 58  ELDMFRKLSHKNVVRLLGLCREAEPH--YMILEYTDLGDLKQFLRATKSKDEKLKPPPLS 115

Query: 428 WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT 487
            K ++ +   +A G+ ++      R VH+D+ + N L+ S    K++   L+K   N+  
Sbjct: 116 TKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEY 172

Query: 488 MHIVGTQG---YIAPEYLADGVVSTKMDVFSFGVVLLELISGKE 528
             +        ++APE + +   STK DV+SFGV++ E+ +  E
Sbjct: 173 YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGE 216

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 88.9 bits (221), Expect = 8e-20
 Identities = 51/182 (28%), Positives = 81/182 (44%), Gaps = 24/182 (13%)

Query: 360 GEVYAIKMMKWNAC----------EELKILQKVNHGNLVKL-EGFCIDPEDANCYLIYEY 408
            +++A+K M    C           E +ILQ++NH  LV L   F    ++ N YL+ + 
Sbjct: 25  KKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQ---DEENMYLVVDL 81

Query: 409 IENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN 468
           +  G L    H ++    + +       ++   L+Y+H      ++H+DIK  NILLD  
Sbjct: 82  LLGGDLR--YHLSQKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQ 136

Query: 469 MRAKIANFGLA---KSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
               I +F +A          +    GT GY+APE L     S  +D +S GV   E + 
Sbjct: 137 GHVHITDFNIATKVTPDTLTTST--SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLR 194

Query: 526 GK 527
           GK
Sbjct: 195 GK 196

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 89.1 bits (221), Expect = 3e-19
 Identities = 67/204 (32%), Positives = 104/204 (50%), Gaps = 48/204 (23%)

Query: 351 GSVYKGNIH---GEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPED 399
           G+VYK  IH   G +YA+K++  N         C E++IL+ VNH N+VK    C D  D
Sbjct: 88  GTVYKV-IHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK----CHDMFD 142

Query: 400 AN--CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKD 457
            N    ++ E+++ GSL    H    + L       +A  + +G+ Y+H   R  +VH+D
Sbjct: 143 HNGEIQVLLEFMDGGSLEG-THIADEQFLA-----DVARQILSGIAYLH---RRHIVHRD 193

Query: 458 IKSSNILLDSNMRAKIANFGLAK------SGCNAITMHIVGTQGYIAPEYLA-------- 503
           IK SN+L++S    KIA+FG+++        CN+     VGT  Y++PE +         
Sbjct: 194 IKPSNLLINSAKNVKIADFGVSRILAQTMDPCNS----SVGTIAYMSPERINTDLNHGAY 249

Query: 504 DGVVSTKMDVFSFGVVLLELISGK 527
           DG      D++S GV +LE   G+
Sbjct: 250 DGYAG---DIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 87.7 bits (218), Expect = 3e-19
 Identities = 58/192 (30%), Positives = 94/192 (48%), Gaps = 24/192 (12%)

Query: 351 GSVYKGN--IHGEVYAIKMMKWNACEE------------LKILQKVNHGNLVKLEGFCID 396
           G+VYK      G   A+K ++    EE            LK L+   H N+V+L   C  
Sbjct: 13  GTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHG 72

Query: 397 PEDANC---YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRV 453
           P         L++E+++   L ++L +     L  +T   +   +  G+ ++H H   R+
Sbjct: 73  PRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RI 128

Query: 454 VHKDIKSSNILLDSNMRAKIANFGLAKSGCN--AITMHIVGTQGYIAPEYLADGVVSTKM 511
           VH+D+K  NIL+ S+ + KIA+FGLA+      A+T  +V T  Y APE L     +T +
Sbjct: 129 VHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTS-VVVTLWYRAPEVLLQSSYATPV 187

Query: 512 DVFSFGVVLLEL 523
           D++S G +  EL
Sbjct: 188 DMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 86.6 bits (215), Expect = 5e-19
 Identities = 56/187 (29%), Positives = 102/187 (54%), Gaps = 17/187 (9%)

Query: 351 GSVYKGNIH---GEVYAIKMMKWNAC-----EELKILQKVNHGNLVKLEGFCIDPEDANC 402
           GSVYK  IH   G+V AIK++          +E+ IL++ +   +VK  G     ++ + 
Sbjct: 17  GSVYKA-IHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYF--KNTDL 73

Query: 403 YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSN 462
           +++ EY   GS+ S + +  N+ L  +    I      GL+Y+H +   + +H+DIK+ N
Sbjct: 74  WIVMEYCGAGSV-SDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGN 129

Query: 463 ILLDSNMRAKIANFGLAK--SGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVL 520
           ILL+   +AK+A+FG++   +   A    ++GT  ++APE + +   + K D++S G+  
Sbjct: 130 ILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITA 189

Query: 521 LELISGK 527
           +E+  GK
Sbjct: 190 IEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 86.5 bits (214), Expect = 5e-19
 Identities = 52/185 (28%), Positives = 97/185 (52%), Gaps = 16/185 (8%)

Query: 351 GSVYKGN-IHGEVYAIKMMKWNAC------EELKILQKVNHGNLVKLEGFCIDPEDANCY 403
           G V+ G  +     AIK ++  A       EE +++ K++H  LV+L G C   E +   
Sbjct: 18  GLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT--ERSPIC 75

Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI 463
           L++E++E+G L  +L   + +  + +T L + +DV  G+ Y+       V+H+D+ + N 
Sbjct: 76  LVFEFMEHGCLSDYLRAQRGK-FSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNC 131

Query: 464 LLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFSFGVVL 520
           L+  N   K+++FG+ +   +       GT+    + +PE  +    S+K DV+SFGV++
Sbjct: 132 LVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLM 191

Query: 521 LELIS 525
            E+ S
Sbjct: 192 WEVFS 196

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 86.3 bits (214), Expect = 7e-19
 Identities = 52/184 (28%), Positives = 85/184 (46%), Gaps = 21/184 (11%)

Query: 360 GEVYAIKMMKWNAC--------EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN 411
            E  AIK +    C        +E++ + + NH N+VK   +         +L+  Y+  
Sbjct: 26  NEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY--YTSFVVGDELWLVMPYLSG 83

Query: 412 GSLHSWL-HENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR 470
           GSL   +        L+      +  +V  GL+Y+H + +   +H+DIK+ NILL  +  
Sbjct: 84  GSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGS 140

Query: 471 AKIANFG----LAKSGCNAITMH--IVGTQGYIAPEYLADGVVST-KMDVFSFGVVLLEL 523
            KIA+FG    LA  G     +    VGT  ++APE +        K D++SFG+  +EL
Sbjct: 141 VKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIEL 200

Query: 524 ISGK 527
            +G 
Sbjct: 201 ATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 85.6 bits (212), Expect = 9e-19
 Identities = 58/190 (30%), Positives = 100/190 (52%), Gaps = 21/190 (11%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNACEELK--------ILQKVNHGNLVKLEGFCIDPEDA 400
           G VYKG    + EV A+K  +     +LK        IL++ +H N+VKL G C+  +  
Sbjct: 9   GDVYKGVLKGNTEV-AVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPI 67

Query: 401 NCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             Y++ E +  GSL ++L + KN  L  K  L++++D A G++Y+        +H+D+ +
Sbjct: 68  --YIVMELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAA 121

Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ----GYIAPEYLADGVVSTKMDVFSF 516
            N L+  N   KI++FG+++     I     G +     + APE L  G  +++ DV+S+
Sbjct: 122 RNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSY 181

Query: 517 GVVLLELISG 526
           G++L E  S 
Sbjct: 182 GILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 85.7 bits (212), Expect = 1e-18
 Identities = 58/181 (32%), Positives = 90/181 (49%), Gaps = 23/181 (12%)

Query: 360 GEVYAIKMMK----------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI 409
           GE+ A+K +K          W   +E+ IL+ + H N+VK +G C +       LI EY+
Sbjct: 33  GEMVAVKTLKRECGQQNTSGWK--KEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYV 90

Query: 410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM 469
             GSL  +L ++    LN    L  A  +  G+ Y+H       +H+D+ + N+LLD++ 
Sbjct: 91  PLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDR 144

Query: 470 RAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELI 524
             KI +FGLAK+       + V   G     + A E L +   S   DV+SFGV L EL+
Sbjct: 145 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204

Query: 525 S 525
           +
Sbjct: 205 T 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 85.0 bits (210), Expect = 2e-18
 Identities = 54/180 (30%), Positives = 94/180 (52%), Gaps = 10/180 (5%)

Query: 351 GSVYKGNIHGEVYAIKMMKWNACE-----ELKILQKVNHGNLVKLEGFCIDPEDANCYLI 405
           G V  G+  G   A+K +K +A       E  ++ ++ H NLV+L G  ++ E    Y++
Sbjct: 20  GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE-EKGGLYIV 78

Query: 406 YEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL 465
            EY+  GSL  +L       L     L+ ++DV   ++Y+  +     VH+D+ + N+L+
Sbjct: 79  TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLV 135

Query: 466 DSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
             +  AK+++FGL K   +      +  + + APE L +   STK DV+SFG++L E+ S
Sbjct: 136 SEDNVAKVSDFGLTKEASSTQDTGKLPVK-WTAPEALREKKFSTKSDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 84.8 bits (210), Expect = 2e-18
 Identities = 61/196 (31%), Positives = 94/196 (47%), Gaps = 30/196 (15%)

Query: 351 GSVYKG--NIHGEVYAIKMM---------KWNACEELKILQKVNHGNLVKL-EGFCIDPE 398
           GSVYK       + YA+K +         + +A  E++IL  VNH N++   E F     
Sbjct: 14  GSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFL---- 69

Query: 399 DAN-CYLIYEYIENGSLHSWLHENKN------ENLNWKTRLRIAIDVANGLQYIHEHTRP 451
           D N   ++ EY   G L   + + K       E   W    RI I +  GLQ +HE    
Sbjct: 70  DGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW----RIFIQLLRGLQALHEQ--- 122

Query: 452 RVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKM 511
           +++H+D+KS+NILL +N   KI + G++K     +    +GT  Y+APE       S K 
Sbjct: 123 KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKS 182

Query: 512 DVFSFGVVLLELISGK 527
           D++S G +L E+ +  
Sbjct: 183 DIWSLGCLLYEMATFA 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 84.8 bits (210), Expect = 3e-18
 Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 38/208 (18%)

Query: 351 GSVYKGNIHG-------EVYAIKMMKWNAC--------EELKILQKVNHGNLVKLEGFCI 395
           G VYKG + G          AIK +K NA         +E +++  + H N+V L G C 
Sbjct: 19  GKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT 78

Query: 396 DPEDANCYLIYEYIENGSLHSWL--------------HENKNENLNWKTRLRIAIDVANG 441
             E   C +++EY+ +G LH +L               E    +L+    L IAI +A G
Sbjct: 79  K-EQPTC-MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAG 136

Query: 442 LQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ----GYI 497
           ++Y+  H     VH+D+ + N L+   +  KI++FGL++   +A    +         ++
Sbjct: 137 MEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWM 193

Query: 498 APEYLADGVVSTKMDVFSFGVVLLELIS 525
            PE +  G  +T+ D++SFGVVL E+ S
Sbjct: 194 PPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 88.4 bits (219), Expect = 3e-18
 Identities = 58/189 (30%), Positives = 96/189 (50%), Gaps = 15/189 (7%)

Query: 350 QGSVYKG-NIHGEVYAI--KMMKWNACEELKI--LQKVNHGNLVKLEGFCIDPEDANCYL 404
           +G+ YKG +I   +  +  ++   N+    +I  + K+ H N+VKL G C   + A  YL
Sbjct: 703 KGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGA--YL 760

Query: 405 IYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNIL 464
           I+EYIE  +L   L      NL+W+ R +IAI +A  L+++H    P VV  ++    I+
Sbjct: 761 IHEYIEGKNLSEVL-----RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKII 815

Query: 465 LDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELI 524
           +D      +    L    C      I  +  Y+APE      ++ K D++ FG++L+EL+
Sbjct: 816 IDGKDEPHLR-LSLPGLLCTDTKCFI--SSAYVAPETRETKDITEKSDIYGFGLILIELL 872

Query: 525 SGKEAIDEE 533
           +GK   D E
Sbjct: 873 TGKSPADAE 881

Length = 968

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 83.8 bits (207), Expect = 4e-18
 Identities = 53/167 (31%), Positives = 88/167 (52%), Gaps = 13/167 (7%)

Query: 372 ACEELKILQKVNHGNLVK-LEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           A  E ++L+ ++H N+++  E F    ED    ++ EY   G+L  ++ +  N  L+  T
Sbjct: 46  AQNECQVLKLLSHPNIIEYYENFL---EDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDT 102

Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN-MRAKIANFGLAK---SGCNAI 486
            L   + +   L ++H      ++H+D+K+ NILLD + M  KI +FG++K   S   A 
Sbjct: 103 ILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY 159

Query: 487 TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE 533
           T  +VGT  YI+PE       + K D+++ G VL EL S K A +  
Sbjct: 160 T--VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 84.0 bits (208), Expect = 6e-18
 Identities = 58/221 (26%), Positives = 106/221 (47%), Gaps = 40/221 (18%)

Query: 329 RIFKIEELRE----ATDNFSEGCLIQGSVYKG-------NIHGEVYAIKMMKWN----AC 373
           RI K  EL +     +  F       G+VYKG        +   V AIK+++      A 
Sbjct: 2   RILKETELEKIKVLGSGAF-------GTVYKGVWIPEGEKVKIPV-AIKVLREETSPKAN 53

Query: 374 EEL----KILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWK 429
           +E+     ++  V+H ++V+L G C+  +     LI + +  G L  ++  +K+ N+  +
Sbjct: 54  KEILDEAYVMASVDHPHVVRLLGICLSSQVQ---LITQLMPLGCLLDYVRNHKD-NIGSQ 109

Query: 430 TRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH 489
             L   + +A G+ Y+ E    R+VH+D+ + N+L+ +    KI +FGLAK   +     
Sbjct: 110 YLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL-LDVDEKE 165

Query: 490 IVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
                G     ++A E +   + + K DV+S+GV + EL++
Sbjct: 166 YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 83.4 bits (206), Expect = 8e-18
 Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 37/206 (17%)

Query: 351 GSVYKGNI-------HGEV-YAIKMMKWNACEELKI--------LQKVNHGNLVKLEGFC 394
           G VY+G          G +  A+K ++  A ++ K         +   NH N+VKL G C
Sbjct: 9   GEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVC 68

Query: 395 IDPEDANCYLIYEYIENGSLHSWLHENKNEN-----LNWKTRLRIAIDVANGLQYIHEHT 449
           +  E    Y+I E +E G L S+L + + E      L  K  L I +DVA G  Y+    
Sbjct: 69  LLNEPQ--YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE--- 123

Query: 450 RPRVVHKDIKSSNILL-----DSNMRAKIANFGLAKSGCNAITMHIVGTQG-----YIAP 499
           +   +H+D+ + N L+     D++   KI +FGLA+    +      G +G     ++AP
Sbjct: 124 QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEG-EGLLPVRWMAP 182

Query: 500 EYLADGVVSTKMDVFSFGVVLLELIS 525
           E L DG  +T+ DV+SFGV++ E+++
Sbjct: 183 ESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 82.9 bits (205), Expect = 9e-18
 Identities = 58/196 (29%), Positives = 96/196 (48%), Gaps = 29/196 (14%)

Query: 351 GSVYKG--NIHGEVYAIKMM-------KWNAC-----EELKILQKVNHGNLVKLEGFCID 396
           GSVY+G     G+ +A+K +                 +E+ +L K+ H N+V+  G   +
Sbjct: 14  GSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLG--TE 71

Query: 397 PEDANCYLIYEYIENGSLHSWLHEN---KNENLNWKTRLRIAIDVANGLQYIHEHTRPRV 453
            E+ N Y+  E +  GSL   L +        +   TR      +  GL+Y+H+      
Sbjct: 72  REEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-----QILLGLEYLHDR---NT 123

Query: 454 VHKDIKSSNILLDSNMRAKIANFGLAK-SGCNAITMHIVGTQGYIAPEYLAD-GVVSTKM 511
           VH+DIK +NIL+D+N   K+A+FG+AK     +      G+  ++APE +A  G      
Sbjct: 124 VHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAA 183

Query: 512 DVFSFGVVLLELISGK 527
           D++S G  +LE+ +GK
Sbjct: 184 DIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 82.9 bits (205), Expect = 1e-17
 Identities = 54/186 (29%), Positives = 91/186 (48%), Gaps = 17/186 (9%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPEDANC 402
           G V++G  N    V A+K +K    +      E +I++K+ H  L++L   C   E    
Sbjct: 20  GEVWEGLWNNTTPV-AVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPI-- 76

Query: 403 YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSN 462
           Y++ E ++ GSL  +L       L     + +A  VA+G+ Y+        +H+D+ + N
Sbjct: 77  YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARN 133

Query: 463 ILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI---APEYLADGVVSTKMDVFSFGVV 519
           +L+  N   K+A+FGLA+     I     G +  I   APE       S K DV+SFG++
Sbjct: 134 VLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGIL 193

Query: 520 LLELIS 525
           L E+++
Sbjct: 194 LTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 82.7 bits (205), Expect = 1e-17
 Identities = 53/197 (26%), Positives = 88/197 (44%), Gaps = 34/197 (17%)

Query: 351 GSVYKGNI--HGEVYAIKMMKW---------NACEELKILQKVNHGNLVKLEGFCID--P 397
           G V+K      GE  A+K +            A  E+K LQ   H  +VKL    +D  P
Sbjct: 14  GIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKL----LDVFP 69

Query: 398 EDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKD 457
             +   L+ EY+    L   L + +      + +      +  G+ Y+H +    ++H+D
Sbjct: 70  HGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVK-SYMRMLLKGVAYMHAN---GIMHRD 124

Query: 458 IKSSNILLDSNMRAKIANFGLA---KSGCNAITMHIVGTQGYIAPEYL-----ADGVVST 509
           +K +N+L+ ++   KIA+FGLA         +  H V T+ Y APE L      D  V  
Sbjct: 125 LKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGV-- 182

Query: 510 KMDVFSFGVVLLELISG 526
             D+++ G +  EL++G
Sbjct: 183 --DLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 81.2 bits (200), Expect = 4e-17
 Identities = 61/189 (32%), Positives = 98/189 (51%), Gaps = 24/189 (12%)

Query: 351 GSVYKGNIHGEV-YAIKMMKWNA------CEELKILQKVNHGNLVKLEGFCIDPEDANCY 403
           G V+ G  +G    A+K +K          EE +I++K+ H  LV+L  + +  E+   Y
Sbjct: 20  GEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQL--YAVVSEEP-IY 76

Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI 463
           ++ EY+  GSL  +L + +   L     + +A  VA G+ YI    R   +H+D++S+NI
Sbjct: 77  IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANI 133

Query: 464 LLDSNMRAKIANFGLAK-SGCNAITMHIVGTQG------YIAPEYLADGVVSTKMDVFSF 516
           L+   +  KIA+FGLA+    N  T      QG      + APE    G  + K DV+SF
Sbjct: 134 LVGDGLVCKIADFGLARLIEDNEYT----ARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 189

Query: 517 GVVLLELIS 525
           G++L EL++
Sbjct: 190 GILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 81.6 bits (202), Expect = 4e-17
 Identities = 67/229 (29%), Positives = 97/229 (42%), Gaps = 51/229 (22%)

Query: 336 LREATDNFSEGCLI----QGSVYKGNIH---GEVYAIKMMKWNACE------ELKILQKV 382
           L + T  F    +I     G VYK   H   G++ AIK+M     E      E  IL+K 
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKA-RHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKY 59

Query: 383 -NHGNLVKLEGFCIDPEDANC----YLIYEYIENGS----LHSWLHENKNENLNWKTRLR 433
            NH N+    G  I           +L+ E    GS    +     + K     W     
Sbjct: 60  SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW----- 114

Query: 434 IAI---DVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLA---KSGCNAIT 487
           IA    +   GL Y+HE+   +V+H+DIK  NILL  N   K+ +FG++    S     T
Sbjct: 115 IAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS-----T 166

Query: 488 MH----IVGTQGYIAPEYLA-----DGVVSTKMDVFSFGVVLLELISGK 527
           +      +GT  ++APE +A     D     + DV+S G+  +EL  GK
Sbjct: 167 LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 82.0 bits (203), Expect = 5e-17
 Identities = 57/195 (29%), Positives = 94/195 (48%), Gaps = 27/195 (13%)

Query: 360 GEVYAIKMMK-----------WNACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYE 407
            E+YA+K++K               E+ ++L     H  L +L   C   +D   + + E
Sbjct: 20  DELYAVKVLKKDVILQDDDVECTMTEK-RVLALAGKHPFLTQLHS-CFQTKD-RLFFVME 76

Query: 408 YIENGSLHSWLHENKNENLNWKTRLRI-AIDVANGLQYIHEHTRPRVVHKDIKSSNILLD 466
           Y+  G L   +  +   +     R R  A ++  GLQ++HE     ++++D+K  N+LLD
Sbjct: 77  YVNGGDLMFHIQRSGRFDEP---RARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLD 130

Query: 467 SNMRAKIANFGLAKSGC--NAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELI 524
           S    KIA+FG+ K G      T    GT  YIAPE L+       +D ++ GV+L E++
Sbjct: 131 SEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEML 190

Query: 525 SGK---EAIDEEGKF 536
           +G+   E  DE+  F
Sbjct: 191 AGQSPFEGDDEDELF 205

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 81.6 bits (201), Expect = 5e-17
 Identities = 60/190 (31%), Positives = 99/190 (52%), Gaps = 37/190 (19%)

Query: 364 AIKMMKWNACE--------ELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           AIKM+K  A E        EL++L K+ +H N++ L G C        Y+  EY   G+L
Sbjct: 33  AIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGAC--ENRGYLYIAIEYAPYGNL 90

Query: 415 HSWLHENK--------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             +L +++                 L  +  L+ A DVA G+QY+ E    + +H+D+ +
Sbjct: 91  LDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAA 147

Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFS 515
            N+L+  N+ +KIA+FGL++       +++  T G     ++A E L   V +TK DV+S
Sbjct: 148 RNVLVGENLASKIADFGLSRGE----EVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWS 203

Query: 516 FGVVLLELIS 525
           FGV+L E++S
Sbjct: 204 FGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 80.4 bits (198), Expect = 6e-17
 Identities = 58/193 (30%), Positives = 98/193 (50%), Gaps = 30/193 (15%)

Query: 351 GSVYKGNIHGEV-YAIKMMKWNACEELKI--------LQKVNHGNLVKLEGFCIDPEDAN 401
           G V+KG +  +   A+K  K +  +ELKI        L++ +H N+VKL G C   +   
Sbjct: 9   GEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPI- 67

Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSS 461
            Y++ E +  G   S+L + K+E L  K  ++ A+D A G+ Y+        +H+D+ + 
Sbjct: 68  -YIVMELVPGGDFLSFLRKKKDE-LKTKQLVKFALDAAAGMAYLESKN---CIHRDLAAR 122

Query: 462 NILLDSNMRAKIANFGLAK---------SGCNAITMHIVGTQGYIAPEYLADGVVSTKMD 512
           N L+  N   KI++FG+++         SG   I +       + APE L  G  S++ D
Sbjct: 123 NCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK------WTAPEALNYGRYSSESD 176

Query: 513 VFSFGVVLLELIS 525
           V+S+G++L E  S
Sbjct: 177 VWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 80.9 bits (199), Expect = 6e-17
 Identities = 58/190 (30%), Positives = 96/190 (50%), Gaps = 37/190 (19%)

Query: 364 AIKMMKWNACE--------ELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           AIK MK  A +        EL++L K+ +H N++ L G C        YL  EY  +G+L
Sbjct: 26  AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC--EHRGYLYLAIEYAPHGNL 83

Query: 415 HSWLHENK--------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             +L +++                 L+ +  L  A DVA G+ Y+ +    + +H+D+ +
Sbjct: 84  LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAA 140

Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFS 515
            NIL+  N  AKIA+FGL++       +++  T G     ++A E L   V +T  DV+S
Sbjct: 141 RNILVGENYVAKIADFGLSRGQ----EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWS 196

Query: 516 FGVVLLELIS 525
           +GV+L E++S
Sbjct: 197 YGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 80.7 bits (199), Expect = 6e-17
 Identities = 57/187 (30%), Positives = 98/187 (52%), Gaps = 20/187 (10%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNACE------ELKILQKVNHGNLVKLEGFCI-DPEDAN 401
           G V+ G  N H +V AIK +K  +        E  +++++ H  LV+L      +P    
Sbjct: 20  GEVWMGYYNGHTKV-AIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQEP---- 74

Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSS 461
            Y+I EY+ENGSL  +L   +   L     + +A  +A G+ +I    R   +H+D++++
Sbjct: 75  IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAA 131

Query: 462 NILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFSFGV 518
           NIL+   +  KIA+FGLA+   +       G +    + APE +  G  + K DV+SFG+
Sbjct: 132 NILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGI 191

Query: 519 VLLELIS 525
           +L E+++
Sbjct: 192 LLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 80.5 bits (198), Expect = 6e-17
 Identities = 63/197 (31%), Positives = 102/197 (51%), Gaps = 26/197 (13%)

Query: 343 FSEGCLIQGSVYKGNIHGEV-YAIK------MMKWNACEELKILQKVNHGNLVKLEGFCI 395
             +GC   G V+ G  +G    AIK      MM     +E +I++K+ H  LV L  + +
Sbjct: 14  LGQGCF--GEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPL--YAV 69

Query: 396 DPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVH 455
             E+   Y++ E++  GSL  +L E   + L     + +A  +A+G+ YI    R   +H
Sbjct: 70  VSEEP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIH 125

Query: 456 KDIKSSNILLDSNMRAKIANFGLAK-SGCNAITMHIVGTQG------YIAPEYLADGVVS 508
           +D++++NIL+  N+  KIA+FGLA+    N  T      QG      + APE    G  +
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYT----ARQGAKFPIKWTAPEAALYGRFT 181

Query: 509 TKMDVFSFGVVLLELIS 525
            K DV+SFG++L EL++
Sbjct: 182 IKSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 81.4 bits (201), Expect = 7e-17
 Identities = 62/188 (32%), Positives = 92/188 (48%), Gaps = 24/188 (12%)

Query: 351 GSVY--KGNIHGEVYAIKMM---------KWN-ACEELKILQKVNHGNLVKLEGFCIDPE 398
           G+VY  +     EV AIK M         KW    +E++ LQ++ H N ++ +G  +   
Sbjct: 29  GAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL--R 86

Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
           +   +L+ EY   GS    L  +K + L       I      GL Y+H H R   +H+DI
Sbjct: 87  EHTAWLVMEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHER---IHRDI 141

Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEY-LA--DGVVSTKMDVFS 515
           K+ NILL      K+A+FG A     A +   VGT  ++APE  LA  +G    K+DV+S
Sbjct: 142 KAGNILLTEPGTVKLADFGSASLVSPANSF--VGTPYWMAPEVILAMDEGQYDGKVDVWS 199

Query: 516 FGVVLLEL 523
            G+  +EL
Sbjct: 200 LGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 80.5 bits (198), Expect = 7e-17
 Identities = 57/202 (28%), Positives = 104/202 (51%), Gaps = 36/202 (17%)

Query: 351 GSVYKGNIHGEVY----AIKMMKWNAC---------EELKILQKVNHGNLVKLEGFCIDP 397
           GSV +G ++ +      A+K MK   C          E   +++ +H N+++L G C+  
Sbjct: 13  GSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQT 72

Query: 398 EDANCY----LIYEYIENGSLHSWLHENKNEN----LNWKTRLRIAIDVANGLQYIHEHT 449
            ++  Y    +I  ++++G LHS+L  ++  +    L  +  ++   D+A+G++Y+   +
Sbjct: 73  VESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYL---S 129

Query: 450 RPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG--------YIAPEY 501
               +H+D+ + N +L+ NM   +A+FGL+K   N         QG        +IA E 
Sbjct: 130 SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYR----QGRIAKMPVKWIAIES 185

Query: 502 LADGVVSTKMDVFSFGVVLLEL 523
           LAD V +TK DV+SFGV + E+
Sbjct: 186 LADRVYTTKSDVWSFGVTMWEI 207

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 80.9 bits (200), Expect = 7e-17
 Identities = 52/198 (26%), Positives = 94/198 (47%), Gaps = 23/198 (11%)

Query: 340 TDNFSEGCLIQGSVYKGNIHGEVYAIKMMKWNACEELK----------ILQKVNHGNLVK 389
           T  F    L+     +  I    YA+K+M       LK          +L++V+H  +++
Sbjct: 11  TGTFGRVHLV-----RDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIR 65

Query: 390 LEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHT 449
           L  F  + +    Y++ EY+  G L S+L  +     +  T L  A ++   L+Y+H   
Sbjct: 66  L--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGR--FSNSTGLFYASEIVCALEYLHSK- 120

Query: 450 RPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVST 509
              +V++D+K  NILLD     K+ +FG AK   +  T  + GT  Y+APE +     + 
Sbjct: 121 --EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-TWTLCGTPEYLAPEVIQSKGHNK 177

Query: 510 KMDVFSFGVVLLELISGK 527
            +D ++ G+++ E++ G 
Sbjct: 178 AVDWWALGILIYEMLVGY 195

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 80.2 bits (198), Expect = 1e-16
 Identities = 59/193 (30%), Positives = 98/193 (50%), Gaps = 21/193 (10%)

Query: 350 QGSVYKGNIHGEVYAIKMMK--WNACE--------ELKILQKVNHGNLVKLEGFCIDPED 399
           Q S+YKG  + +   I+  K      +        E+K L++++  N++K+ GF ID  D
Sbjct: 33  QNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92

Query: 400 ANCY--LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHT-RPRVVHK 456
                 LI EY   G L   L  +K ++L++KT+L +AID   GL  ++++T +P   +K
Sbjct: 93  DLPRLSLILEYCTRGYLREVL--DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP---YK 147

Query: 457 DIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLAD--GVVSTKMDVF 514
           ++ S + L+  N + KI   GL K   +      V    Y + + L D     + K D++
Sbjct: 148 NLTSVSFLVTENYKLKIICHGLEKILSSP-PFKNVNFMVYFSYKMLNDIFSEYTIKDDIY 206

Query: 515 SFGVVLLELISGK 527
           S GVVL E+ +GK
Sbjct: 207 SLGVVLWEIFTGK 219

Length = 283

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 55/195 (28%), Positives = 90/195 (46%), Gaps = 30/195 (15%)

Query: 351 GSVY--KGNIHGEVYAIKMMK------WNACE----ELKILQKVNHGNLVKLEGFCIDPE 398
           G V   K       +A+K +K          E    E +IL++ NH  +VKL  +    +
Sbjct: 7   GRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL--YRTFKD 64

Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
               Y++ EY   G L + L +    +  +  R  IA  V    +Y+H      ++++D+
Sbjct: 65  KKYIYMLMEYCLGGELWTILRDRGLFD-EYTARFYIAC-VVLAFEYLHNRG---IIYRDL 119

Query: 459 KSSNILLDSNMRAKIANFGLAKS-GCNAITMHIVGTQGYIAPEYLADGVVSTK-----MD 512
           K  N+LLDSN   K+ +FG AK       T    GT  Y+APE     ++  K     +D
Sbjct: 120 KPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPE-----IILNKGYDFSVD 174

Query: 513 VFSFGVVLLELISGK 527
            +S G++L EL++G+
Sbjct: 175 YWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 79.2 bits (195), Expect = 1e-16
 Identities = 53/174 (30%), Positives = 92/174 (52%), Gaps = 16/174 (9%)

Query: 364 AIKMMKWNAC------EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSW 417
           AIKM+K  +       EE K++ K++H  LV+L G C   +    Y++ EY+ NG L ++
Sbjct: 32  AIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC--TKQRPIYIVTEYMSNGCLLNY 89

Query: 418 LHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFG 477
           L E+  +       L +  DV  G+ Y+      + +H+D+ + N L+D     K+++FG
Sbjct: 90  LREHG-KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFG 145

Query: 478 LAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GK 527
           L++   +      VG++    +  PE L     S+K DV++FGV++ E+ S GK
Sbjct: 146 LSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGK 199

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 79.8 bits (197), Expect = 2e-16
 Identities = 72/231 (31%), Positives = 115/231 (49%), Gaps = 47/231 (20%)

Query: 324 CLDKYRIFKIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWN---------A 372
           C+DK+ I  I ++ E T          G VYK      GE+ A+K ++ +         A
Sbjct: 5   CVDKFDI--IGQIGEGT---------YGQVYKARDKDTGELVALKKVRLDNEKEGFPITA 53

Query: 373 CEELKILQKVNHGNLVKLEGFCIDPEDA--------NCYLIYEYIEN---GSLHSWL-HE 420
             E+KIL+++NH N+V L+    D +DA          YL++EY+++   G L S L H 
Sbjct: 54  IREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHF 113

Query: 421 NKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK 480
           +++   ++  +L        GL Y H+      +H+DIK SNILL++  + K+A+FGLA+
Sbjct: 114 SEDHIKSFMKQL------LEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLAR 164

Query: 481 ---SGCNAITMHIVGTQGYIAPE-YLADGVVSTKMDVFSFGVVLLELISGK 527
              S  +    + V T  Y  PE  L +      +DV+S G +L EL + K
Sbjct: 165 LYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 79.4 bits (196), Expect = 2e-16
 Identities = 59/216 (27%), Positives = 103/216 (47%), Gaps = 43/216 (19%)

Query: 345 EGCLIQGSVYKGNIHG-------EVYAIKMMKWNACE--------ELKILQKV-NHGNLV 388
           EG    G V K    G          A+KM+K +A E        E+++++ +  H N++
Sbjct: 22  EGAF--GQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 389 KLEGFCIDPEDANCYLIYEYIENGSLHSWLHENK--------------NENLNWKTRLRI 434
            L G C   ++   Y++ EY  +G+L  +L   +               E L  K  +  
Sbjct: 80  NLLGVCT--QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137

Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
           A  VA G++++      + +H+D+ + N+L+  +   KIA+FGLA+   + I  +   T 
Sbjct: 138 AYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLAR-DIHHIDYYRKTTN 193

Query: 495 G-----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           G     ++APE L D V + + DV+SFGV+L E+ +
Sbjct: 194 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 79.1 bits (195), Expect = 2e-16
 Identities = 44/163 (26%), Positives = 87/163 (53%), Gaps = 18/163 (11%)

Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENK--NENLNWKTR 431
           +E++++ ++NH +++++ G     ED++  L  E++  GS+   L +     E +     
Sbjct: 52  KEIRLMARLNHPHIIRMLGATC--EDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI---- 105

Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN-MRAKIANFGLAK------SGCN 484
           +     +  GL Y+HE+   +++H+D+K +N+L+DS   R +IA+FG A       +G  
Sbjct: 106 INYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAG 162

Query: 485 AITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
                ++GT  ++APE L         DV+S G V++E+ + K
Sbjct: 163 EFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 79.5 bits (196), Expect = 3e-16
 Identities = 51/175 (29%), Positives = 84/175 (48%), Gaps = 18/175 (10%)

Query: 364 AIKMMKWNA--------CEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K  A          ELKI+  + NH N+V L G C         +I EY   G L
Sbjct: 69  AVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT--IGGPILVITEYCCYGDL 126

Query: 415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIA 474
            ++L   +   L  +  L  +  VA G+ ++        +H+D+ + N+LL      KI 
Sbjct: 127 LNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKIC 183

Query: 475 NFGLAKSGCNAITMHIVGTQ----GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           +FGLA+   N     + G       ++APE + + V + + DV+S+G++L E+ S
Sbjct: 184 DFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 79.3 bits (195), Expect = 3e-16
 Identities = 55/190 (28%), Positives = 97/190 (51%), Gaps = 34/190 (17%)

Query: 364 AIKMMKWNACE--------ELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K +A E        E+++++ +  H N++ L G C   +D   Y+I EY   G+L
Sbjct: 51  AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNL 108

Query: 415 HSWLHENK--------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             +L   +              +E + +K  +     VA G++Y+      + +H+D+ +
Sbjct: 109 REYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAA 165

Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFS 515
            N+L+  N   KIA+FGLA+   N I  +   T G     ++APE L D V + + DV+S
Sbjct: 166 RNVLVTENNVMKIADFGLARD-VNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 224

Query: 516 FGVVLLELIS 525
           FGV++ E+ +
Sbjct: 225 FGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 79.2 bits (195), Expect = 4e-16
 Identities = 60/218 (27%), Positives = 107/218 (49%), Gaps = 45/218 (20%)

Query: 345 EGCLIQGSVYKGNIHG---------EVYAIKMMKWNACE--------ELKILQKVN-HGN 386
           EGC   G V +   +G            A+KM+K NA +        E+++++ +  H N
Sbjct: 22  EGCF--GQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 387 LVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENK--------------NENLNWKTRL 432
           ++ L G C   ++   Y+I EY   G+L  +L   +               E L++K  +
Sbjct: 80  IINLLGVCT--QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137

Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVG 492
             A  VA G++Y+      R +H+D+ + N+L+  +   KIA+FGLA+ G + I  +   
Sbjct: 138 SCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLAR-GVHDIDYYKKT 193

Query: 493 TQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           + G     ++APE L D V + + DV+SFG+++ E+ +
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 78.9 bits (194), Expect = 5e-16
 Identities = 55/190 (28%), Positives = 98/190 (51%), Gaps = 34/190 (17%)

Query: 364 AIKMMKWNACE--------ELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K +A E        E+++++ +  H N++ L G C   +D   Y+I EY   G+L
Sbjct: 54  AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNL 111

Query: 415 HSWLH--------------ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             +L               +   E L++K  +  A  VA G++Y+      + +H+D+ +
Sbjct: 112 REYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 168

Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFS 515
            N+L+  +   KIA+FGLA+   + I  +   T G     ++APE L D + + + DV+S
Sbjct: 169 RNVLVTEDNVMKIADFGLARD-IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 227

Query: 516 FGVVLLELIS 525
           FGV+L E+ +
Sbjct: 228 FGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 77.8 bits (192), Expect = 6e-16
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 36/204 (17%)

Query: 351 GSVYKGNIHG--------EVYAIKMMKWNAC--------EELKILQKVNHGNLVKLEGFC 394
           G VY+G   G         V AIK +  NA          E  ++++ N  ++V+L G  
Sbjct: 20  GMVYEGLAKGVVKGEPETRV-AIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVV 78

Query: 395 IDPEDANCYLIYEYIENGSLHSWLHENKNENLNWK-----TRLRI---AIDVANGLQYIH 446
              +     ++ E +  G L S+L   + E  N       T  +    A ++A+G+ Y+ 
Sbjct: 79  STGQPT--LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA 136

Query: 447 EHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEY 501
                + VH+D+ + N ++  ++  KI +FG+ +        +  G +G     ++APE 
Sbjct: 137 AK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRD-IYETDYYRKGGKGLLPVRWMAPES 192

Query: 502 LADGVVSTKMDVFSFGVVLLELIS 525
           L DGV +TK DV+SFGVVL E+ +
Sbjct: 193 LKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 77.3 bits (191), Expect = 8e-16
 Identities = 55/191 (28%), Positives = 85/191 (44%), Gaps = 24/191 (12%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCIDPEDA 400
           G VYK       +V AIK++     E        E++ L +     + K  G  +    +
Sbjct: 15  GEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK--GS 72

Query: 401 NCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             ++I EY   GS    L   K   L+      I  +V  GL+Y+HE      +H+DIK+
Sbjct: 73  KLWIIMEYCGGGSCLDLLKPGK---LDETYIAFILREVLLGLEYLHEE---GKIHRDIKA 126

Query: 461 SNILLDSNMRAKIANFG----LAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSF 516
           +NILL      K+A+FG    L  +     T   VGT  ++APE +       K D++S 
Sbjct: 127 ANILLSEEGDVKLADFGVSGQLTSTMSKRNTF--VGTPFWMAPEVIKQSGYDEKADIWSL 184

Query: 517 GVVLLELISGK 527
           G+  +EL  G+
Sbjct: 185 GITAIELAKGE 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 60/195 (30%), Positives = 101/195 (51%), Gaps = 26/195 (13%)

Query: 345 EGCLIQGSVYKGNIHGEV-YAIKMMKWNA------CEELKILQKVNHGNLVKLEGFCIDP 397
           +GC   G V+ G  +G    AIK +K          +E ++++K+ H  LV+L  + +  
Sbjct: 16  QGCF--GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVS 71

Query: 398 EDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKD 457
           E+   Y++ EY+  GSL  +L     + L     + +A  +A+G+ Y+    R   VH+D
Sbjct: 72  EEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 127

Query: 458 IKSSNILLDSNMRAKIANFGLAK-SGCNAITMHIVGTQG------YIAPEYLADGVVSTK 510
           ++++NIL+  N+  K+A+FGLA+    N  T      QG      + APE    G  + K
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYT----ARQGAKFPIKWTAPEAALYGRFTIK 183

Query: 511 MDVFSFGVVLLELIS 525
            DV+SFG++L EL +
Sbjct: 184 SDVWSFGILLTELTT 198

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 76.7 bits (189), Expect = 1e-15
 Identities = 44/156 (28%), Positives = 75/156 (48%), Gaps = 11/156 (7%)

Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  I+  ++H NL++L G  +        ++ E    GSL   L ++   +    T    
Sbjct: 46  EAAIMHSLDHENLIRLYGVVLTHP---LMMVTELAPLGSLLDRLRKDALGHFLISTLCDY 102

Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-----GCNAITMH 489
           A+ +ANG++Y+      R +H+D+ + NILL S+ + KI +FGL ++         +  H
Sbjct: 103 AVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH 159

Query: 490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           +     + APE L     S   DV+ FGV L E+ +
Sbjct: 160 LKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 77.1 bits (189), Expect = 1e-15
 Identities = 56/196 (28%), Positives = 92/196 (46%), Gaps = 23/196 (11%)

Query: 351 GSVYKGN--IHGEVYAIKMMKWNACEELKILQKVN-------HGNLVKLEGFCIDPE--- 398
           G VYKG     G++ AIK+M     EE +I Q++N       H N+    G  I      
Sbjct: 20  GQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79

Query: 399 -DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKD 457
            D   +L+ E+   GS+   +   K   L  +    I  ++  GL ++H+H   +V+H+D
Sbjct: 80  MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRD 136

Query: 458 IKSSNILLDSNMRAKIANFGLAKSGCNAITMH--IVGTQGYIAPEYLA-----DGVVSTK 510
           IK  N+LL  N   K+ +FG++      +      +GT  ++APE +A     D     K
Sbjct: 137 IKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFK 196

Query: 511 MDVFSFGVVLLELISG 526
            D++S G+  +E+  G
Sbjct: 197 SDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 60/208 (28%), Positives = 104/208 (50%), Gaps = 38/208 (18%)

Query: 351 GSVYKGNI------HGEVYAIKMMK-------WNACE-ELKILQKVNHGNLVKLEGFCID 396
           G +YKG++      H ++ AIK +K       W   + E  ++ +++H N+V L G  + 
Sbjct: 19  GKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLG-VVT 77

Query: 397 PEDANCYLIYEYIENGSLHSWL-----HEN----KNENLNWKTRL------RIAIDVANG 441
            E   C +++EY+  G LH +L     H +     +E+   K+ L       IAI +A G
Sbjct: 78  QEQPVC-MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAG 136

Query: 442 LQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ----GYI 497
           ++Y+  H     VHKD+ + NIL+   +  KI++ GL++   +A    +         ++
Sbjct: 137 MEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWM 193

Query: 498 APEYLADGVVSTKMDVFSFGVVLLELIS 525
            PE +  G  S+  D++SFGVVL E+ S
Sbjct: 194 PPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 77.0 bits (190), Expect = 2e-15
 Identities = 52/184 (28%), Positives = 86/184 (46%), Gaps = 28/184 (15%)

Query: 360 GEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE 410
           GE+ AIK  K +         A  E+K+L+++ H N+V L+           YL++EY+E
Sbjct: 26  GEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFR--RKGRLYLVFEYVE 83

Query: 411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR 470
             +L   L  +    L           +   + Y H H    ++H+DIK  NIL+  +  
Sbjct: 84  R-TLLELLEASPG-GLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGV 138

Query: 471 AKIANFGLAK----SGCNAITMHIVGTQGYIAPEYLADGVVSTK----MDVFSFGVVLLE 522
            K+ +FG A+       + +T + V T+ Y APE L   V  T     +DV++ G ++ E
Sbjct: 139 LKLCDFGFARALRARPASPLTDY-VATRWYRAPELL---VGDTNYGKPVDVWAIGCIMAE 194

Query: 523 LISG 526
           L+ G
Sbjct: 195 LLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 54/199 (27%), Positives = 88/199 (44%), Gaps = 38/199 (19%)

Query: 351 GSVYKGNIHGEVY----------AIKMMKWNA--------CEELKILQKVNHGNLVKLEG 392
           GSV KG     VY          A+K +K             E  ++ +++H  +V+L G
Sbjct: 9   GSVVKG-----VYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIG 63

Query: 393 FCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPR 452
            C         L+ E    G L  +L   K   +       +A  VA G+ Y+       
Sbjct: 64  VCKGEP---LMLVMELAPLGPLLKYLK--KRREIPVSDLKELAHQVAMGMAYLESK---H 115

Query: 453 VVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG------YIAPEYLADGV 506
            VH+D+ + N+LL +  +AKI++FG++++   A + +   T        + APE +  G 
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSRA-LGAGSDYYRATTAGRWPLKWYAPECINYGK 174

Query: 507 VSTKMDVFSFGVVLLELIS 525
            S+K DV+S+GV L E  S
Sbjct: 175 FSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 38/96 (39%), Positives = 61/96 (63%), Gaps = 4/96 (4%)

Query: 433 RIAIDVANGLQYIH-EHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIV 491
           +IA+ V  GL Y++  H   R++H+DIK SNIL++S  + K+ +FG++    N+I    V
Sbjct: 107 KIAVAVVEGLTYLYNVH---RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV 163

Query: 492 GTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
           GT  Y++PE +  G  + K DV+S G+ ++EL  GK
Sbjct: 164 GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 52/194 (26%), Positives = 94/194 (48%), Gaps = 28/194 (14%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNACE--------ELKILQKVNHG---NLVKLEGFCIDP 397
           G+VY+G     G V A+K++  +  +        E+ +L ++      N+ K  G  +  
Sbjct: 15  GAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK- 73

Query: 398 EDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKD 457
                ++I EY E GS+ + +             +R   +V   L+YIH+     V+H+D
Sbjct: 74  -GPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIR---EVLVALKYIHKVG---VIHRD 126

Query: 458 IKSSNILLDSNMRAKIANFG----LAKSGCNAITMHIVGTQGYIAPEYLADGVV-STKMD 512
           IK++NIL+ +    K+ +FG    L ++     T   VGT  ++APE + +G    TK D
Sbjct: 127 IKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF--VGTPYWMAPEVITEGKYYDTKAD 184

Query: 513 VFSFGVVLLELISG 526
           ++S G+ + E+ +G
Sbjct: 185 IWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 75.8 bits (186), Expect = 4e-15
 Identities = 55/206 (26%), Positives = 107/206 (51%), Gaps = 38/206 (18%)

Query: 364 AIKMMKWNA--------CEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH 415
           A+KM++ +          +E+KI+ ++ + N+++L G C+  +D  C +I EY+ENG L+
Sbjct: 48  AVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVS-DDPLC-MITEYMENGDLN 105

Query: 416 SWL----------HENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL 465
            +L          H N   +++    L +A+ +A+G++Y+        VH+D+ + N L+
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLV 162

Query: 466 DSNMRAKIANFGLAKSGCNAITMHIVGTQ----GYIAPEYLADGVVSTKMDVFSFGVVLL 521
            ++   KIA+FG++++  +     I G       ++A E +  G  +T  DV++FGV L 
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLW 222

Query: 522 E-----------LISGKEAIDEEGKF 536
           E           L+S ++ I+  G+F
Sbjct: 223 EMFTLCKEQPYSLLSDEQVIENTGEF 248

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 76.2 bits (187), Expect = 4e-15
 Identities = 55/190 (28%), Positives = 97/190 (51%), Gaps = 34/190 (17%)

Query: 364 AIKMMKWNACE--------ELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K +A +        E+++++ +  H N++ L G C   +D   Y++ EY   G+L
Sbjct: 48  AVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT--QDGPLYVLVEYASKGNL 105

Query: 415 HSWLHENK--------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             +L   +               E L +K  +  A  VA G++Y+      + +H+D+ +
Sbjct: 106 REYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAA 162

Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFS 515
            N+L+  +   KIA+FGLA+   N I  +   T G     ++APE L D V + + DV+S
Sbjct: 163 RNVLVTEDNVMKIADFGLARDVHN-IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 221

Query: 516 FGVVLLELIS 525
           FGV+L E+ +
Sbjct: 222 FGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 76.2 bits (187), Expect = 4e-15
 Identities = 50/157 (31%), Positives = 88/157 (56%), Gaps = 8/157 (5%)

Query: 375 ELKILQKVNHGNLVKLEG-FCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           EL++L + N   +V   G F  D E + C    E+++ GSL   L E K   +  +   +
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICM---EHMDGGSLDQVLKEAKR--IPEEILGK 107

Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT 493
           ++I V  GL Y+ E  + +++H+D+K SNIL++S    K+ +FG++    +++    VGT
Sbjct: 108 VSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGT 165

Query: 494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAI 530
           + Y++PE L     S + D++S G+ L+EL  G+  I
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 74.8 bits (184), Expect = 5e-15
 Identities = 57/190 (30%), Positives = 90/190 (47%), Gaps = 24/190 (12%)

Query: 351 GSVY--KGNIHGEVYAIKMMK----------WNACEELKILQKVNHG-NLVKLEGFCIDP 397
           GSVY  K    G+ +AIK++K           N   E  I+        + KL  +    
Sbjct: 10  GSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY-YSFQS 68

Query: 398 EDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKD 457
           +D   YL+ EY+  G   S +        +W  +  IA +V  G++ +H+     ++H+D
Sbjct: 69  KD-YLYLVMEYLNGGDCASLIKTLGGLPEDW-AKQYIA-EVVLGVEDLHQRG---IIHRD 122

Query: 458 IKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKM-DVFSF 516
           IK  N+L+D     K+ +FGL+++G        VGT  Y+APE +  GV   KM D +S 
Sbjct: 123 IKPENLLIDQTGHLKLTDFGLSRNG--LENKKFVGTPDYLAPETI-LGVGDDKMSDWWSL 179

Query: 517 GVVLLELISG 526
           G V+ E + G
Sbjct: 180 GCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 75.3 bits (186), Expect = 6e-15
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 52/208 (25%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWN------------ACEELKILQKVNHGNLVKLEGFCID 396
             VYK      G + AIK +K              A  E+K+LQ++ H N++ L    +D
Sbjct: 14  AVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL----LD 69

Query: 397 --PEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVA-------NGLQYIHE 447
                +N  L++E++E   L   + ++K+        L  A D+         GL+Y+H 
Sbjct: 70  VFGHKSNINLVFEFME-TDLEK-VIKDKS------IVLTPA-DIKSYMLMTLRGLEYLHS 120

Query: 448 HTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS--GCNAITMHIVGTQGYIAPEYL--- 502
           +    ++H+D+K +N+L+ S+   K+A+FGLA+S    N    H V T+ Y APE L   
Sbjct: 121 NW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGA 177

Query: 503 ---ADGVVSTKMDVFSFGVVLLELISGK 527
                GV     D++S G +  EL+   
Sbjct: 178 RHYGVGV-----DMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 75.7 bits (186), Expect = 7e-15
 Identities = 56/193 (29%), Positives = 93/193 (48%), Gaps = 25/193 (12%)

Query: 361 EVYAIKMMKWNA-----------CEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI 409
           EVYAIK++K +             E+  +     H  L  L   C   +D   + + EY+
Sbjct: 21  EVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHC-CFQTKD-RLFFVMEYV 78

Query: 410 ENGSLHSWLHENKNENLNWKTRLRI-AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN 468
             G L   +  ++  +   + R R  A +V   L ++H H    V+++D+K  NILLD+ 
Sbjct: 79  NGGDLMFQIQRSRKFD---EPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAE 132

Query: 469 MRAKIANFGLAKSGC--NAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
              K+A+FG+ K G      T    GT  YIAPE L +      +D ++ GV++ E+++G
Sbjct: 133 GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAG 192

Query: 527 K---EAIDEEGKF 536
           +   EA +E+  F
Sbjct: 193 QPPFEADNEDDLF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 74.8 bits (184), Expect = 8e-15
 Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 39/216 (18%)

Query: 345 EGCLIQGSVYKGNI-HG------EVYAIKMMKWNACEELK--------ILQKVNHGNLVK 389
           EG    G V+ G   H       E+ A+K +K  A  + +        +L    H N+VK
Sbjct: 15  EGAF--GKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 390 LEGFCIDPEDANCYLIYEYIENGSLHSWLHEN------------KNENLNWKTRLRIAID 437
             G C   E     +++EY+E+G L+ +L  +                L     L+IA+ 
Sbjct: 73  FYGVCT--EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ--- 494
           +A+G+ Y+        VH+D+ + N L+  ++  KI +FG+++         + G     
Sbjct: 131 IASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP 187

Query: 495 -GYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKE 528
             ++ PE +     +T+ DV+SFGVVL E+ + GK+
Sbjct: 188 IRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQ 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 75.0 bits (185), Expect = 8e-15
 Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 38/220 (17%)

Query: 345 EGCLIQGS---VYKG----NIHGEVYAIKMMKWN----------ACEELKILQKVNHGNL 387
           EGC+ +G+   VYK        G+ YAIK  K +          AC E+ +L+++ H N+
Sbjct: 5   EGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENV 64

Query: 388 VKLEGFCIDPEDANCYLIYEYIENGSLH--SWLHENKNENLNWKTRLRIAIDVANGLQYI 445
           V L    ++  D + YL+++Y E+       +  + K  ++       +   + NG+ Y+
Sbjct: 65  VSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124

Query: 446 HEHTRPRVVHKDIKSSNILLDSNM----RAKIANFGLAKSGCNAITM-----HIVGTQGY 496
           H +    V+H+D+K +NIL+          KI + GLA+     +        +V T  Y
Sbjct: 125 HSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWY 181

Query: 497 IAPEYLADGVVSTK-MDVFSFGVVLLELIS------GKEA 529
            APE L      TK +D+++ G +  EL++      G+EA
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 74.3 bits (183), Expect = 9e-15
 Identities = 61/222 (27%), Positives = 105/222 (47%), Gaps = 37/222 (16%)

Query: 332 KIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWN---------ACEELKILQ 380
           K+E++ E T          G VYK    + GE+ A+K ++           A  E+ +L+
Sbjct: 3   KVEKIGEGT---------YGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLK 53

Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
           ++NH N+V+L    +   +   YL++E++ +  L  ++  +    L+          +  
Sbjct: 54  ELNHPNIVRL--LDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQ 110

Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS---GCNAITMHIVGTQGYI 497
           G+ Y H H   RV+H+D+K  N+L+D     K+A+FGLA++        T H V T  Y 
Sbjct: 111 GIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYT-HEVVTLWYR 166

Query: 498 APEYLADG-VVSTKMDVFSFGVVLLELI------SGKEAIDE 532
           APE L      ST +D++S G +  E++       G   ID+
Sbjct: 167 APEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ 208

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 74.1 bits (182), Expect = 1e-14
 Identities = 52/190 (27%), Positives = 88/190 (46%), Gaps = 27/190 (14%)

Query: 360 GEVYAIKMM---KWNACEEL------------------KILQKVNHGNLVKLEGFCIDPE 398
           GEV A ++    K  AC++L                  KIL+KV+   +V L  +  + +
Sbjct: 7   GEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-AYAFETK 65

Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
           D  C L+   +  G L   ++            +  A  +  GL+++H+    R+V++D+
Sbjct: 66  DDLC-LVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDL 121

Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAITMH-IVGTQGYIAPEYLADGVVSTKMDVFSFG 517
           K  N+LLD +   +I++ GLA        +    GT GY+APE L   V    +D F+ G
Sbjct: 122 KPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALG 181

Query: 518 VVLLELISGK 527
             L E+I+G+
Sbjct: 182 CTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 51/160 (31%), Positives = 83/160 (51%), Gaps = 9/160 (5%)

Query: 371 NACEELKILQKVNHGNLVKL-EGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWK 429
           ++ +E  +L K+ H N+V   E F     D + Y++ EY + G L   +   + +     
Sbjct: 44  DSRKEAVLLAKMKHPNIVAFKESF---EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPED 100

Query: 430 TRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK--SGCNAIT 487
           T L+  + +  G+Q+IHE    RV+H+DIKS NI L  N + K+ +FG A+  +   A  
Sbjct: 101 TILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA 157

Query: 488 MHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
              VGT  Y+ PE   +   + K D++S G +L EL + K
Sbjct: 158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLK 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 74.1 bits (182), Expect = 1e-14
 Identities = 59/210 (28%), Positives = 105/210 (50%), Gaps = 29/210 (13%)

Query: 332 KIEELREATDNFSEGCLIQGSVYKGN--IHGEVYAIKMMKWN---------ACEELKILQ 380
           K+E++ E T          G VYK    + GEV A+K ++ +         A  E+ +L+
Sbjct: 4   KVEKIGEGT---------YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 54

Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
           ++NH N+VKL    +   +   YL++E++ +  L  ++  +    +           +  
Sbjct: 55  ELNHPNIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQ 111

Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAIT-MHIVGTQGYIA 498
           GL + H H   RV+H+D+K  N+L+++    K+A+FGLA++ G    T  H V T  Y A
Sbjct: 112 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 168

Query: 499 PE-YLADGVVSTKMDVFSFGVVLLELISGK 527
           PE  L     ST +D++S G +  E+++ +
Sbjct: 169 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 73.7 bits (181), Expect = 1e-14
 Identities = 47/167 (28%), Positives = 83/167 (49%), Gaps = 21/167 (12%)

Query: 371 NACE-ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL--HENKNENLN 427
           NA E E+++L+ + H  +V+  G     +D    +  EY+  GS+   L  +    E + 
Sbjct: 49  NALECEIQLLKNLQHERIVQYYG--CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVT 106

Query: 428 WK-TRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI 486
            K TR      +  G++Y+H +    +VH+DIK +NIL DS    K+ +FG +K     I
Sbjct: 107 RKYTR-----QILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR-LQTI 157

Query: 487 TMH------IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
                    + GT  +++PE ++      K DV+S G  ++E+++ K
Sbjct: 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 43/155 (27%), Positives = 85/155 (54%), Gaps = 8/155 (5%)

Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           EE  +++ + H  LV+L  + +  ++   Y+I EY+  GSL  +L  ++   +     + 
Sbjct: 50  EEANLMKTLQHDKLVRL--YAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLID 107

Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT 493
            +  +A G+ YI    R   +H+D++++N+L+  ++  KIA+FGLA+   +       G 
Sbjct: 108 FSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGA 164

Query: 494 Q---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           +    + APE +  G  + K DV+SFG++L E+++
Sbjct: 165 KFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 41/156 (26%), Positives = 82/156 (52%), Gaps = 10/156 (6%)

Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E +IL++ +H N+V+L G C   +    Y++ E ++ G   ++L   +   L  K  ++
Sbjct: 42  QEARILKQYSHPNIVRLIGVCTQKQP--IYIVMELVQGGDFLTFL-RTEGPRLKVKELIQ 98

Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT 493
           +  + A G++Y+        +H+D+ + N L+      KI++FG+++   + +     G 
Sbjct: 99  MVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155

Query: 494 Q----GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           +     + APE L  G  S++ DV+SFG++L E  S
Sbjct: 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 74.9 bits (184), Expect = 2e-14
 Identities = 42/162 (25%), Positives = 83/162 (51%), Gaps = 12/162 (7%)

Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  +LQ VNH ++++++   +      C ++  Y  +  L+++L   ++  L     L I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGA-ITCMVLPHY--SSDLYTYL-TKRSRPLPIDQALII 162

Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
              +  GL+Y+H     R++H+D+K+ NI ++   +  I + G A+     +    +G  
Sbjct: 163 EKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQ--FPVVAPAFLGLA 217

Query: 495 GYI---APEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE 533
           G +   APE LA    ++K D++S G+VL E+++    I E+
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFED 259

Length = 357

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 30/211 (14%)

Query: 332 KIEELREATDNFSEGCLIQGSVYKGN--IHGEVYAIKMMKW---------NACEELKILQ 380
           KIE++ E T          G VYKG     G++ A+K ++           A  E+ +L+
Sbjct: 4   KIEKIGEGT---------YGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLK 54

Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHE-NKNENLNWKTRLRIAIDVA 439
           ++ H N+V L+   +  +++  YLI+E++    L  +L    K + ++ +        + 
Sbjct: 55  ELQHPNIVCLQDVLM--QESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQIL 111

Query: 440 NGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM--HIVGTQGYI 497
            G+ + H     RV+H+D+K  N+L+D+    K+A+FGLA++    + +  H V T  Y 
Sbjct: 112 QGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYR 168

Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE L      ST +D++S G +  E+ + K
Sbjct: 169 APEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 40/210 (19%)

Query: 351 GSVYKG--NIHGEVYAIK--MMK-------WNACEELKILQKVNHGNLVKLEGFCIDPED 399
           G VYK      G V A+K  +M          A  E+KIL+K+ H N+V L    ++  D
Sbjct: 22  GEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPD 81

Query: 400 A-----NC-YLIYEYIENGSLH--SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRP 451
                    Y++  Y++    H  S L EN +  L         + +  G+ Y+HE+   
Sbjct: 82  KSKRKRGSVYMVTPYMD----HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN--- 134

Query: 452 RVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM-------------HIVGTQGYIA 498
            ++H+DIK++NIL+D+    KIA+FGLA+                     ++V T+ Y  
Sbjct: 135 HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRP 194

Query: 499 PEYLA-DGVVSTKMDVFSFGVVLLELISGK 527
           PE L  +   +T +D++  G V  E+ + +
Sbjct: 195 PELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 73.7 bits (181), Expect = 2e-14
 Identities = 68/231 (29%), Positives = 112/231 (48%), Gaps = 42/231 (18%)

Query: 325 LDKYRIFKIEELREATDNFSEGCLIQGSVYKGN--IHGEVYAIKMMKW---------NAC 373
           +D+Y   K+E++ E T          G VYK    +  E  A+K ++           A 
Sbjct: 1   MDQYE--KVEKIGEGT---------YGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI 49

Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRL- 432
            E+ +L+++ HGN+V+L+   +   +   YL++EY++   L    H + + +     RL 
Sbjct: 50  REISLLKEMQHGNIVRLQD--VVHSEKRLYLVFEYLD---LDLKKHMDSSPDFAKNPRLI 104

Query: 433 -RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRA-KIANFGLAKS-GCNAITM- 488
                 +  G+ Y H H   RV+H+D+K  N+L+D    A K+A+FGLA++ G    T  
Sbjct: 105 KTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161

Query: 489 HIVGTQGYIAPE-YLADGVVSTKMDVFSFGVVLLELIS------GKEAIDE 532
           H V T  Y APE  L     ST +D++S G +  E+++      G   IDE
Sbjct: 162 HEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE 212

Length = 294

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 73.8 bits (181), Expect = 2e-14
 Identities = 49/149 (32%), Positives = 74/149 (49%), Gaps = 10/149 (6%)

Query: 393 FCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPR 452
           +C      N + + EY+  G L    H       +       A ++  GLQ++H      
Sbjct: 62  YCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--- 116

Query: 453 VVHKDIKSSNILLDSNMRAKIANFGLAKSGC--NAITMHIVGTQGYIAPEYLADGVVSTK 510
           +V++D+K  NILLD++   KIA+FG+ K     +A T    GT  YIAPE L     +T 
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTS 176

Query: 511 MDVFSFGVVLLELISGK---EAIDEEGKF 536
           +D +SFGV+L E++ G+      DEE  F
Sbjct: 177 VDWWSFGVLLYEMLIGQSPFHGHDEEELF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 47/157 (29%), Positives = 86/157 (54%), Gaps = 8/157 (5%)

Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E+ +L K+ H N+V    F    E+   +++ EY + G L   ++  +    +    L 
Sbjct: 48  KEVILLAKMKHPNIVTF--FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILS 105

Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN-MRAKIANFGLAKSGCNAITMH--I 490
             + ++ GL++IH+    +++H+DIKS NI L  N M AK+ +FG+A+   +++ +    
Sbjct: 106 WFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC 162

Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
           VGT  Y++PE   +   + K D++S G VL EL + K
Sbjct: 163 VGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 59/198 (29%), Positives = 103/198 (52%), Gaps = 28/198 (14%)

Query: 351 GSVYKGNI----HGEV-YAIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCIDP 397
           G V++G +      EV  AIK +K    E        E  I+ + +H N+++LEG     
Sbjct: 19  GEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF 78

Query: 398 EDANCYLIYEYIENGSLHSWLHENKNE--NLNWKTRLRIAIDVANGLQYIHEHTRPRVVH 455
           + A   +I EY+ENG+L  +L ++  E  +      LR    +A G++Y+ +      VH
Sbjct: 79  KPA--MIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYLSDMN---YVH 130

Query: 456 KDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI-----APEYLADGVVSTK 510
           +D+ + NIL++SN+  K+++FGL++   +        + G I     APE +A    ++ 
Sbjct: 131 RDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSA 190

Query: 511 MDVFSFGVVLLELISGKE 528
            DV+SFG+V+ E++S  E
Sbjct: 191 SDVWSFGIVMWEVMSFGE 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 47/156 (30%), Positives = 84/156 (53%), Gaps = 13/156 (8%)

Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  ++Q++++  +V++ G C   E  +  L+ E  E G L+ +L +NK+  +  K    +
Sbjct: 46  EANVMQQLDNPYIVRMIGIC---EAESWMLVMELAELGPLNKFLQKNKH--VTEKNITEL 100

Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
              V+ G++Y+ E      VH+D+ + N+LL +   AKI++FGL+K+       +   T 
Sbjct: 101 VHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157

Query: 495 G-----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           G     + APE +     S+K DV+SFGV++ E  S
Sbjct: 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 48/187 (25%), Positives = 96/187 (51%), Gaps = 37/187 (19%)

Query: 360 GEVYAIKMM---KWNACE----ELKILQKVNHGNLVKLEG-FCIDPEDANCYLIYEYIEN 411
           G   A+K M   K    E    E+ I++   H N+V++   + +  E    +++ E++E 
Sbjct: 44  GRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDE---LWVVMEFLEG 100

Query: 412 GSL-----HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLD 466
           G+L     H+ ++E +           + + V   L ++H      V+H+DIKS +ILL 
Sbjct: 101 GALTDIVTHTRMNEEQIAT--------VCLAVLKALSFLHAQ---GVIHRDIKSDSILLT 149

Query: 467 SNMRAKIANFGLAKSGCNAITMHI------VGTQGYIAPEYLADGVVSTKMDVFSFGVVL 520
           S+ R K+++FG     C  ++  +      VGT  ++APE ++     T++D++S G+++
Sbjct: 150 SDGRVKLSDFGF----CAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMV 205

Query: 521 LELISGK 527
           +E++ G+
Sbjct: 206 IEMVDGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 25/197 (12%)

Query: 351 GSVYKGNIH---GEVYAIKMMKWNACEELKILQKVN-------HGNLVKLEGFCIDP--- 397
           G VYKG  H   G++ AIK+M     EE +I  ++N       H N+    G  I     
Sbjct: 30  GQVYKGR-HVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88

Query: 398 -EDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHK 456
             D   +L+ E+   GS+   +   K   L       I  ++  GL ++H H   +V+H+
Sbjct: 89  GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHR 145

Query: 457 DIKSSNILLDSNMRAKIANFGLAKSGCNAITMH--IVGTQGYIAPEYLA-----DGVVST 509
           DIK  N+LL  N   K+ +FG++      +      +GT  ++APE +A     D     
Sbjct: 146 DIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDY 205

Query: 510 KMDVFSFGVVLLELISG 526
           + D++S G+  +E+  G
Sbjct: 206 RSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 72.7 bits (179), Expect = 4e-14
 Identities = 50/178 (28%), Positives = 88/178 (49%), Gaps = 19/178 (10%)

Query: 360 GEVYAIKMMKW--------NACEELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIE 410
           G+ YAIK MK         N   E++ L++++ H N+++L     D +     L++E ++
Sbjct: 24  GKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD 83

Query: 411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR 470
             +L+  L + +   L  K        +   L ++H +    + H+DIK  NIL+  +  
Sbjct: 84  -MNLYE-LIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKDD-I 137

Query: 471 AKIANFGLAKSGCN--AITMHIVGTQGYIAPE-YLADGVVSTKMDVFSFGVVLLELIS 525
            K+A+FG  +   +    T +I  T+ Y APE  L DG    KMD+++ G V  E++S
Sbjct: 138 LKLADFGSCRGIYSKPPYTEYI-STRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 72.2 bits (177), Expect = 4e-14
 Identities = 44/158 (27%), Positives = 83/158 (52%), Gaps = 15/158 (9%)

Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           EE K++ K++H  LV+L G C   +    Y++ E++ENG L ++L + + + L+    L 
Sbjct: 48  EEAKVMMKLSHPKLVQLYGVCT--QQKPLYIVTEFMENGCLLNYLRQRQGK-LSKDMLLS 104

Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT 493
           +  DV  G++Y+    R   +H+D+ + N L+ S    K+++FG+ +     +      +
Sbjct: 105 MCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRY---VLDDEYTSS 158

Query: 494 QG------YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
            G      +  PE       S+K DV+SFGV++ E+ +
Sbjct: 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFT 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 72.6 bits (178), Expect = 5e-14
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 49/200 (24%)

Query: 364 AIKMMKWNACEELK--------ILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH 415
           A+KM+K  A  +++        ++ + +H N+VKL G C   +   C L++EY+  G L+
Sbjct: 39  AVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM-C-LLFEYMAYGDLN 96

Query: 416 SWLHENKNEN--------------------LNWKTRLRIAIDVANGLQYIHEHTRPRVVH 455
            +L                           L+   +L IA  VA G+ Y+ E    + VH
Sbjct: 97  EFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVH 153

Query: 456 KDIKSSNILLDSNMRAKIANFGLAK----------SGCNAITMHIVGTQGYIAPEYLADG 505
           +D+ + N L+  NM  KIA+FGL++          S  +AI +       ++ PE +   
Sbjct: 154 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIR------WMPPESIFYN 207

Query: 506 VVSTKMDVFSFGVVLLELIS 525
             +T+ DV+++GVVL E+ S
Sbjct: 208 RYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 71.6 bits (175), Expect = 6e-14
 Identities = 49/179 (27%), Positives = 93/179 (51%), Gaps = 18/179 (10%)

Query: 357 NIHGEVYAIKMMKWNA------CEELKILQKVNHGNLVKLEGFCI-DPEDANCYLIYEYI 409
           N H +V A+K MK  +        E  +++ + H  LVKL      +P     Y+I E++
Sbjct: 28  NKHTKV-AVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEP----IYIITEFM 82

Query: 410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM 469
             GSL  +L  ++         +  +  +A G+ +I +      +H+D++++NIL+ +++
Sbjct: 83  AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASL 139

Query: 470 RAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
             KIA+FGLA+   +       G +    + APE +  G  + K DV+SFG++L+E+++
Sbjct: 140 VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 72.4 bits (178), Expect = 7e-14
 Identities = 65/202 (32%), Positives = 98/202 (48%), Gaps = 30/202 (14%)

Query: 354 YKGNIHGEVYAIKMMKWN-----------ACEELKILQKVN---HGNLVKLEGFCIDPED 399
           YK    GE+YAIK +K              CE+ +I +  N   H  LV L   C   ED
Sbjct: 20  YKKT--GELYAIKALKKGDIIARDEVESLMCEK-RIFETANSERHPFLVNLFA-CFQTED 75

Query: 400 ANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIK 459
             C+++ EY   G L   +H +     +    +  A  V  GLQY+HE+   ++V++D+K
Sbjct: 76  HVCFVM-EYAAGGDLMMHIHTDV---FSEPRAVFYAACVVLGLQYLHEN---KIVYRDLK 128

Query: 460 SSNILLDSNMRAKIANFGLAKSGC--NAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFG 517
             N+LLD+    KIA+FGL K G      T    GT  ++APE L +   +  +D +  G
Sbjct: 129 LDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLG 188

Query: 518 VVLLELISGKEAI---DEEGKF 536
           V++ E++ G+      DEE  F
Sbjct: 189 VLIYEMLVGESPFPGDDEEEVF 210

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 71.6 bits (175), Expect = 7e-14
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 22/206 (10%)

Query: 334 EELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWNACE--------ELKILQKVN 383
           EEL    +   +G    G V+KG  N   +V AIK++     E        E+ +L + +
Sbjct: 3   EELFTKLEKIGKGSF--GEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60

Query: 384 HGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQ 443
              + K  G  +  +D   ++I EY+  GS    L     +     T LR   ++  GL 
Sbjct: 61  SPYVTKYYGSYL--KDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR---EILKGLD 115

Query: 444 YIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH--IVGTQGYIAPEY 501
           Y+H   +   +H+DIK++N+LL  +   K+A+FG+A    +        VGT  ++APE 
Sbjct: 116 YLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172

Query: 502 LADGVVSTKMDVFSFGVVLLELISGK 527
           +      +K D++S G+  +EL  G+
Sbjct: 173 IKQSAYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 71.6 bits (176), Expect = 7e-14
 Identities = 56/190 (29%), Positives = 90/190 (47%), Gaps = 26/190 (13%)

Query: 351 GSVYKG-NIH-GEVYAIKMMKWNACEELKILQK-------VNHGNLVKLEGFCIDPEDAN 401
           G VYK  +I  GE+ AIK++K    ++ +I+Q+         H N+V   G  +      
Sbjct: 17  GDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL--RRDK 74

Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAI---DVANGLQYIHEHTRPRVVHKDI 458
            +++ EY   GSL           L   + L+IA    +   GL Y+HE      +H+DI
Sbjct: 75  LWIVMEYCGGGSLQDIYQVT-RGPL---SELQIAYVCRETLKGLAYLHET---GKIHRDI 127

Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAITMH--IVGTQGYIAPEYLA---DGVVSTKMDV 513
           K +NILL  +   K+A+FG++      I      +GT  ++APE  A    G    K D+
Sbjct: 128 KGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDI 187

Query: 514 FSFGVVLLEL 523
           ++ G+  +EL
Sbjct: 188 WALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 72.4 bits (177), Expect = 7e-14
 Identities = 48/157 (30%), Positives = 87/157 (55%), Gaps = 8/157 (5%)

Query: 375 ELKILQKVNHGNLVKLEG-FCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           EL++L + N   +V   G F  D E + C    E+++ GSL   L   K   +  +   +
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICM---EHMDGGSLDQVL--KKAGRIPEQILGK 107

Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT 493
           ++I V  GL Y+ E  + +++H+D+K SNIL++S    K+ +FG++    +++    VGT
Sbjct: 108 VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGT 165

Query: 494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAI 530
           + Y++PE L     S + D++S G+ L+E+  G+  I
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 72.6 bits (179), Expect = 8e-14
 Identities = 58/165 (35%), Positives = 93/165 (56%), Gaps = 22/165 (13%)

Query: 375 ELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           E+  LQ++ +H N+VKL        D + YL++EY+E   LH+ +  N  E+++   +  
Sbjct: 56  EIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRANILEDVH---KRY 111

Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC-------NAI 486
           I   +   L+YIH      V+H+D+K SNILL+S+ R K+A+FGLA+S         N +
Sbjct: 112 IMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPV 168

Query: 487 TMHIVGTQGYIAPEYLADGVVSTK----MDVFSFGVVLLELISGK 527
               V T+ Y APE L   + ST+    +D++S G +L E++ GK
Sbjct: 169 LTDYVATRWYRAPEIL---LGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 71.6 bits (175), Expect = 9e-14
 Identities = 49/170 (28%), Positives = 84/170 (49%), Gaps = 14/170 (8%)

Query: 376 LKILQKVNHGNLVKLEGFCI---DPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRL 432
           L+ L+   H N+V+L   C       +    L++E+++   L ++L +     +  +T  
Sbjct: 55  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK 113

Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK-SGCNAITMHIV 491
            +   +  GL ++H H   RVVH+D+K  NIL+ S+ + K+A+FGLA+          +V
Sbjct: 114 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV 170

Query: 492 GTQGYIAPEYLADGVVSTKMDVFSFGVVLLE------LISGKEAIDEEGK 535
            T  Y APE L     +T +D++S G +  E      L  G   +D+ GK
Sbjct: 171 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK 220

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 72.0 bits (176), Expect = 1e-13
 Identities = 53/181 (29%), Positives = 94/181 (51%), Gaps = 21/181 (11%)

Query: 360 GEVYAIKMMK----------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI 409
           G+ YA+K++K           +   E ++L+   H  L  L+ +    +D  C+++ EY+
Sbjct: 20  GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK-YSFQTKDRLCFVM-EYV 77

Query: 410 ENGSLHSWLHENKNENLNWKTRLRI-AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN 468
             G L  + H ++ E +  + R R    ++ + L Y+H     ++V++D+K  N++LD +
Sbjct: 78  NGGEL--FFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKD 131

Query: 469 MRAKIANFGLAKSG-CNAITMH-IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
              KI +FGL K G  +A TM    GT  Y+APE L D      +D +  GVV+ E++ G
Sbjct: 132 GHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191

Query: 527 K 527
           +
Sbjct: 192 R 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 71.4 bits (175), Expect = 1e-13
 Identities = 62/219 (28%), Positives = 102/219 (46%), Gaps = 27/219 (12%)

Query: 343 FSEGCLIQGSVYKGNIHGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEG 392
           F E C  Q         G++YA K ++            A  E +IL+KVN   +V L  
Sbjct: 13  FGEVCACQV-----RATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66

Query: 393 FCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPR 452
           +  + +DA C L+   +  G L   ++   N   + +  +  A ++  GL+ +H   R R
Sbjct: 67  YAYETKDALC-LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RER 122

Query: 453 VVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH-IVGTQGYIAPEYLADGVVSTKM 511
           +V++D+K  NILLD     +I++ GLA       T+   VGT GY+APE + +   +   
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSP 182

Query: 512 DVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYWREMKR 550
           D +  G ++ E+I GK        F  +K K    E++R
Sbjct: 183 DWWGLGCLIYEMIEGKSP------FRQRKEKVKREEVER 215

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 22/206 (10%)

Query: 334 EELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWNACE--------ELKILQKVN 383
           EEL    +   +G    G VYKG  N   EV AIK++     E        E+ +L + +
Sbjct: 3   EELFTKLERIGKGSF--GEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60

Query: 384 HGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQ 443
              + +  G  +  +    ++I EY+  GS    L     E     T LR   ++  GL 
Sbjct: 61  SPYITRYYGSYL--KGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR---EILKGLD 115

Query: 444 YIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH--IVGTQGYIAPEY 501
           Y+H     R +H+DIK++N+LL      K+A+FG+A    +        VGT  ++APE 
Sbjct: 116 YLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172

Query: 502 LADGVVSTKMDVFSFGVVLLELISGK 527
           +       K D++S G+  +EL  G+
Sbjct: 173 IKQSAYDFKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 71.3 bits (175), Expect = 2e-13
 Identities = 51/159 (32%), Positives = 88/159 (55%), Gaps = 12/159 (7%)

Query: 375 ELKILQKVNHGNLVKLEG-FCIDPEDANCYLIYEYIENGSLHSWLHENKN--ENLNWKTR 431
           ELK+L + N   +V   G F  D E + C    E+++ GSL   L +     EN+  K  
Sbjct: 49  ELKVLHECNSPYIVGFYGAFYSDGEISICM---EHMDGGSLDQVLKKAGRIPENILGK-- 103

Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIV 491
             I+I V  GL Y+ E  + +++H+D+K SNIL++S    K+ +FG++    +++    V
Sbjct: 104 --ISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 159

Query: 492 GTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAI 530
           GT+ Y++PE L     + + D++S G+ L+E+  G+  I
Sbjct: 160 GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 71.4 bits (175), Expect = 2e-13
 Identities = 53/181 (29%), Positives = 89/181 (49%), Gaps = 21/181 (11%)

Query: 360 GEVYAIKMMK----------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI 409
           G+ YA+K++K           +   E ++LQ   H  L  L+ +     D  C+++ EY 
Sbjct: 20  GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK-YSFQTHDRLCFVM-EYA 77

Query: 410 ENGSLHSWLHENKNENLNWKTRLRI-AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN 468
             G L  + H ++ E +  + R R    ++ + L Y+H      VV++D+K  N++LD +
Sbjct: 78  NGGEL--FFHLSR-ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKD 131

Query: 469 MRAKIANFGLAKSGCN--AITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
              KI +FGL K G +  A      GT  Y+APE L D      +D +  GVV+ E++ G
Sbjct: 132 GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191

Query: 527 K 527
           +
Sbjct: 192 R 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 47/173 (27%), Positives = 88/173 (50%), Gaps = 23/173 (13%)

Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIY-EYIENGSLHSWLH------ENKNENL 426
           EE+ +   + H N+V+  G   +      + I+ E +  GSL + L       ++  + +
Sbjct: 54  EEIALHSYLKHRNIVQYLGSDSE---NGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTI 110

Query: 427 NWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS-NMRAKIANFGLAK--SGC 483
            + T+      +  GL+Y+H++   ++VH+DIK  N+L+++ +   KI++FG +K  +G 
Sbjct: 111 IFYTK-----QILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162

Query: 484 NAITMHIVGTQGYIAPEYLADGV--VSTKMDVFSFGVVLLELISGKEAIDEEG 534
           N  T    GT  Y+APE +  G        D++S G  ++E+ +GK    E G
Sbjct: 163 NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG 215

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 57/204 (27%), Positives = 101/204 (49%), Gaps = 36/204 (17%)

Query: 351 GSVYKG-NIH-GEVYAIKMMKWNACE-----------------ELKILQKVNHGNLVKLE 391
           G VY   N+  GE+ A+K ++  A                   E++ L+ ++H N+V+  
Sbjct: 15  GRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYL 74

Query: 392 GFCIDPEDANCYLIYEYIENGSLHSWL--HENKNENLNWKTRLRIAIDVANGLQYIHEHT 449
           GF    E  + +L  EY+  GS+ S L  +    E L    R      V  GL Y+H   
Sbjct: 75  GFETTEEYLSIFL--EYVPGGSIGSCLRTYGRFEEQL---VRF-FTEQVLEGLAYLHSKG 128

Query: 450 RPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI----TMHIVGTQGYIAPE--YLA 503
              ++H+D+K+ N+L+D++   KI++FG++K   +       M + G+  ++APE  +  
Sbjct: 129 ---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185

Query: 504 DGVVSTKMDVFSFGVVLLELISGK 527
               S K+D++S G V+LE+ +G+
Sbjct: 186 SQGYSAKVDIWSLGCVVLEMFAGR 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 50/184 (27%), Positives = 92/184 (50%), Gaps = 29/184 (15%)

Query: 360 GEVYAIK---------MMKWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE 410
           G++ AIK         M+K  A  E+++L+++ H NLV L            YL++E+++
Sbjct: 26  GQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF--RRKKRLYLVFEFVD 83

Query: 411 NGSLHSWLHE-NKNEN-LNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN 468
               H+ L +  K  N L+     +    +  G+++ H H    ++H+DIK  NIL+  +
Sbjct: 84  ----HTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQS 136

Query: 469 MRAKIANFGLAK--SGCNAITMHIVGTQGYIAPEYLADGVVSTK----MDVFSFGVVLLE 522
              K+ +FG A+  +    +    V T+ Y APE L   V  TK    +D+++ G ++ E
Sbjct: 137 GVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELL---VGDTKYGRAVDIWAVGCLVTE 193

Query: 523 LISG 526
           +++G
Sbjct: 194 MLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 70.5 bits (172), Expect = 2e-13
 Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 22/206 (10%)

Query: 334 EELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWNACE--------ELKILQKVN 383
           EEL    +   +G    G V+KG  N   +V AIK++     E        E+ +L + +
Sbjct: 3   EELFTKLERIGKGSF--GEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60

Query: 384 HGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQ 443
              + K  G  +  +    ++I EY+  GS    L     +     T L+   ++  GL 
Sbjct: 61  SPYVTKYYGSYL--KGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKGLD 115

Query: 444 YIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH--IVGTQGYIAPEY 501
           Y+H   +   +H+DIK++N+LL      K+A+FG+A    +        VGT  ++APE 
Sbjct: 116 YLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172

Query: 502 LADGVVSTKMDVFSFGVVLLELISGK 527
           +      +K D++S G+  +EL  G+
Sbjct: 173 IQQSAYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 55/192 (28%), Positives = 96/192 (50%), Gaps = 21/192 (10%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPED 399
           G VY+      GE+ A+K ++ +         +  E+ +L  + H N+V+L+   +    
Sbjct: 21  GIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHL 80

Query: 400 ANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIK 459
            + +L+ EY E   L S L          + +  + + +  GLQY+HE+    ++H+D+K
Sbjct: 81  DSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKC-LMLQLLRGLQYLHENF---IIHRDLK 135

Query: 460 SSNILLDSNMRAKIANFGLAK---SGCNAITMHIVGTQGYIAPEYL-ADGVVSTKMDVFS 515
            SN+LL      KIA+FGLA+        +T  +V T  Y APE L      +T +D+++
Sbjct: 136 VSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPELLLGCTTYTTAIDMWA 194

Query: 516 FGVVLLELISGK 527
            G +L EL++ K
Sbjct: 195 VGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 70.7 bits (173), Expect = 2e-13
 Identities = 51/189 (26%), Positives = 93/189 (49%), Gaps = 25/189 (13%)

Query: 351 GSVYKGNIH---GEVYAIKMMKWNAC--------EELKILQKVNHGNLVKLEG-FCIDPE 398
           G+VYK   H     + A+K++  +           EL+IL K +   ++   G F ++  
Sbjct: 15  GTVYKA-YHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENR 73

Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
            + C    E+++ GSL  +        +      RIA+ V  GL Y+      +++H+D+
Sbjct: 74  ISICT---EFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSL---KILHRDV 121

Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGV 518
           K SN+L+++  + K+ +FG++    N+I    VGT  Y+APE ++        DV+S G+
Sbjct: 122 KPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGI 181

Query: 519 VLLELISGK 527
             +EL  G+
Sbjct: 182 SFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 54/181 (29%), Positives = 90/181 (49%), Gaps = 21/181 (11%)

Query: 360 GEVYAIKMMK----------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI 409
           G  YA+K+++           +   E ++LQ   H  L  L+ +     D  C+++ EY 
Sbjct: 20  GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK-YAFQTHDRLCFVM-EYA 77

Query: 410 ENGSLHSWLHENKNENLNWKTRLRI-AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN 468
             G L  + H ++ E +  + R R    ++ + L+Y+H      VV++DIK  N++LD +
Sbjct: 78  NGGEL--FFHLSR-ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKD 131

Query: 469 MRAKIANFGLAKSG-CNAITMH-IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
              KI +FGL K G  +  TM    GT  Y+APE L D      +D +  GVV+ E++ G
Sbjct: 132 GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191

Query: 527 K 527
           +
Sbjct: 192 R 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 54/192 (28%), Positives = 92/192 (47%), Gaps = 28/192 (14%)

Query: 351 GSVYKGN--IHGEVYAIKMMKWNACEELK-------ILQKVNHGNLVKL-EGFCIDPEDA 400
           G VYK      G   A K+++  + EEL+       IL +  H N+V L E +  +    
Sbjct: 19  GKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN--- 75

Query: 401 NCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             +++ E+ + G+L S +       L       +   +   L ++H H   +V+H+D+K+
Sbjct: 76  KLWILIEFCDGGALDS-IMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKA 131

Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMH----IVGTQGYIAPEYLA-----DGVVSTKM 511
            NILL  +   K+A+FG+  S  N  T+      +GT  ++APE +A     D     K 
Sbjct: 132 GNILLTLDGDVKLADFGV--SAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKA 189

Query: 512 DVFSFGVVLLEL 523
           D++S G+ L+EL
Sbjct: 190 DIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 50/183 (27%), Positives = 85/183 (46%), Gaps = 20/183 (10%)

Query: 362 VYAIKMMK-----------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE 410
           +YA+K++K           W   E+    Q  NH  LV L   C   E +  + + EY+ 
Sbjct: 22  IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHS-CFQTE-SRLFFVIEYVN 79

Query: 411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR 470
            G L    H  +   L  +     + +++  L Y+HE     ++++D+K  N+LLDS   
Sbjct: 80  GGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGH 134

Query: 471 AKIANFGLAKSGCNA--ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKE 528
            K+ ++G+ K G      T    GT  YIAPE L        +D ++ GV++ E+++G+ 
Sbjct: 135 IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 194

Query: 529 AID 531
             D
Sbjct: 195 PFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 70.7 bits (173), Expect = 2e-13
 Identities = 59/206 (28%), Positives = 109/206 (52%), Gaps = 42/206 (20%)

Query: 352 SVYKGNIHGEVYAIKMMKWNA--------CEELKILQKVNHGNLVKLEGFCIDPEDANCY 403
           +V KG     + A+K+++ +A         +E+KIL ++   N+++L G C+D ED  C 
Sbjct: 40  NVRKG--RPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVD-EDPLC- 95

Query: 404 LIYEYIENGSLHSWLH----ENKNEN-------------LNWKTRLRIAIDVANGLQYIH 446
           +I EY+ENG L+ +L     ++K EN             +++ + L +A+ +A+G++Y+ 
Sbjct: 96  MITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL- 154

Query: 447 EHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-------YIAP 499
             +    VH+D+ + N L+  N+  KIA+FG+++   N         QG       ++A 
Sbjct: 155 --SSLNFVHRDLATRNCLVGENLTIKIADFGMSR---NLYAGDYYRIQGRAVLPIRWMAW 209

Query: 500 EYLADGVVSTKMDVFSFGVVLLELIS 525
           E +  G  +T  DV++FGV L E++ 
Sbjct: 210 ECILMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 69.5 bits (170), Expect = 3e-13
 Identities = 45/166 (27%), Positives = 88/166 (53%), Gaps = 21/166 (12%)

Query: 375 ELKILQKVNHGNLVKL-EGFCIDPEDANCYLIYEYIENGSLHSWLHENK------NENLN 427
           E+ +L  + H N+V+  E F    E+ N Y++ +Y E G L+  ++  +      ++ L+
Sbjct: 49  EVAVLSNMKHPNIVQYQESF---EENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILD 105

Query: 428 WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT 487
           W  ++ +A+         H H R +++H+DIKS NI L  +   K+ +FG+A+   + + 
Sbjct: 106 WFVQICLALK--------HVHDR-KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156

Query: 488 MH--IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
           +    +GT  Y++PE   +   + K D+++ G VL E+ + K A +
Sbjct: 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 70.3 bits (172), Expect = 3e-13
 Identities = 50/187 (26%), Positives = 88/187 (47%), Gaps = 20/187 (10%)

Query: 360 GEVYAIKMMKWNAC----------EELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEY 408
           G +YA+K++K +             E +IL    NH  L +L  +C        + + E+
Sbjct: 20  GRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL--YCCFQTPDRLFFVMEF 77

Query: 409 IENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN 468
           +  G L    H  K+   +       A ++ + L ++H+     ++++D+K  N+LLD  
Sbjct: 78  VNGGDL--MFHIQKSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHE 132

Query: 469 MRAKIANFGLAKSG-CNAITMH-IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
              K+A+FG+ K G  N  T     GT  YIAPE L + +    +D ++ GV+L E++ G
Sbjct: 133 GHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192

Query: 527 KEAIDEE 533
               + E
Sbjct: 193 HAPFEAE 199

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 70.3 bits (173), Expect = 4e-13
 Identities = 49/164 (29%), Positives = 81/164 (49%), Gaps = 19/164 (11%)

Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANC----YLIYEYIENGSLHSWLHENKNENLNWKT 430
           E+K+L+ + H N++ L    + P         Y++ E +E   LH  +     + L    
Sbjct: 49  EIKLLRHLRHENIIGLLDI-LRPPSPEDFNDVYIVTELMET-DLHKVIK--SPQPLTDDH 104

Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC------N 484
                  +  GL+Y+H      V+H+D+K SNIL++SN   KI +FGLA+          
Sbjct: 105 IQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKG 161

Query: 485 AITMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELISGK 527
            +T ++V T+ Y APE L      TK +D++S G +  EL++ K
Sbjct: 162 FLTEYVV-TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 69.2 bits (169), Expect = 4e-13
 Identities = 52/180 (28%), Positives = 94/180 (52%), Gaps = 23/180 (12%)

Query: 364 AIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH 415
           AIK +K    E        E  I+ + +H N++ LEG     +     ++ EY+ENGSL 
Sbjct: 36  AIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV--MIVTEYMENGSLD 93

Query: 416 SWL--HENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKI 473
           ++L  H+ +   +     LR    +A+G++Y+ +      VH+D+ + NIL++SN+  K+
Sbjct: 94  AFLRKHDGQFTVIQLVGMLR---GIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKV 147

Query: 474 ANFGLAKSGCNAITMHIVGTQGYI-----APEYLADGVVSTKMDVFSFGVVLLELISGKE 528
           ++FGL++   +          G I     APE +A    ++  DV+S+G+V+ E++S  E
Sbjct: 148 SDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE 207

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 69.7 bits (171), Expect = 4e-13
 Identities = 53/183 (28%), Positives = 96/183 (52%), Gaps = 26/183 (14%)

Query: 364 AIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH 415
           A+K+++ +A +        E+KIL +++  N+ +L G C    D    +I EY+ENG L+
Sbjct: 50  AVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVC--TVDPPLCMIMEYMENGDLN 107

Query: 416 SWLH----ENKNENLNWK-----TRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLD 466
            +L     E      N K     T L +A  +A+G++Y+        VH+D+ + N L+ 
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVG 164

Query: 467 SNMRAKIANFGLAKSGCNAITMHIVGTQ----GYIAPEYLADGVVSTKMDVFSFGVVLLE 522
            N   KIA+FG++++  ++    + G       ++A E +  G  +TK DV++FGV L E
Sbjct: 165 KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWE 224

Query: 523 LIS 525
           +++
Sbjct: 225 ILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 69.6 bits (171), Expect = 4e-13
 Identities = 54/191 (28%), Positives = 96/191 (50%), Gaps = 19/191 (9%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPED 399
           G VY+      GE+ A+K +K           +  E+ IL K+ H N+V ++   +    
Sbjct: 19  GVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNL 78

Query: 400 ANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIK 459
              Y++ EY+E+  L S L E   +         + + + +G+ ++H++    ++H+D+K
Sbjct: 79  DKIYMVMEYVEH-DLKS-LMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLK 133

Query: 460 SSNILLDSNMRAKIANFGLA-KSGCNAITM-HIVGTQGYIAPE-YLADGVVSTKMDVFSF 516
           +SN+LL++    KI +FGLA + G        +V T  Y APE  L     ST +D++S 
Sbjct: 134 TSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSV 193

Query: 517 GVVLLELISGK 527
           G +  EL++ K
Sbjct: 194 GCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 69.4 bits (170), Expect = 5e-13
 Identities = 58/211 (27%), Positives = 108/211 (51%), Gaps = 31/211 (14%)

Query: 332 KIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWNACE--------ELKILQK 381
           ++E+L E T           +VYKG     GE+ A+K +  +A E        E+ ++++
Sbjct: 4   QLEKLGEGT---------YATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKE 54

Query: 382 VNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNEN-LNWKTRLRIAIDVAN 440
           + H N+V+L    I  E+    L++EY++   L  ++  +     L+  T       +  
Sbjct: 55  LKHENIVRLHD-VIHTEN-KLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLK 111

Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS---GCNAITMHIVGTQGYI 497
           G+ + HE+   RV+H+D+K  N+L++     K+A+FGLA++     N  +  +V T  Y 
Sbjct: 112 GIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYR 167

Query: 498 APEYL-ADGVVSTKMDVFSFGVVLLELISGK 527
           AP+ L      ST +D++S G ++ E+I+G+
Sbjct: 168 APDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 69.7 bits (170), Expect = 5e-13
 Identities = 62/195 (31%), Positives = 96/195 (49%), Gaps = 24/195 (12%)

Query: 351 GSVY-KGNIH-GEVYAIKMM---------KW-NACEELKILQKVNHGNLVKLEGFCIDPE 398
           G+VY   N H  EV A+K M         KW +  +E+K LQ++ H N ++ +G  +  +
Sbjct: 35  GAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL--K 92

Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
           +   +L+ EY   GS    L  +K + L       I      GL Y+H H     +H+DI
Sbjct: 93  EHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNM---IHRDI 147

Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEY---LADGVVSTKMDVFS 515
           K+ NILL    + K+A+FG A     A +   VGT  ++APE    + +G    K+DV+S
Sbjct: 148 KAGNILLTEPGQVKLADFGSASKSSPANSF--VGTPYWMAPEVILAMDEGQYDGKVDVWS 205

Query: 516 FGVVLLELISGKEAI 530
            G+  +EL   K  +
Sbjct: 206 LGITCIELAERKPPL 220

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 69.1 bits (169), Expect = 5e-13
 Identities = 55/204 (26%), Positives = 104/204 (50%), Gaps = 35/204 (17%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNACE----------------ELKILQKVNHGNLVKLEG 392
           GSVY G     GE+ A+K ++  +                  E+ +L+++ H N+V+  G
Sbjct: 14  GSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLG 73

Query: 393 FCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAI-DVANGLQYIHEHTRP 451
             +D +  N +L  EY+  GS+ + L+   N     +T +R  +  +  GL Y+H     
Sbjct: 74  SSLDADHLNIFL--EYVPGGSVAALLN---NYGAFEETLVRNFVRQILKGLNYLHNR--- 125

Query: 452 RVVHKDIKSSNILLDSNMRAKIANFGLAK--------SGCNAITMHIVGTQGYIAPEYLA 503
            ++H+DIK +NIL+D+    KI++FG++K        +  N     + G+  ++APE + 
Sbjct: 126 GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVK 185

Query: 504 DGVVSTKMDVFSFGVVLLELISGK 527
               + K D++S G +++E+++GK
Sbjct: 186 QTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 69.3 bits (170), Expect = 6e-13
 Identities = 52/183 (28%), Positives = 89/183 (48%), Gaps = 27/183 (14%)

Query: 360 GEVYAIK---------MMKWNACEELKILQKVNHGNLVKL-EGFCIDPEDANCYLIYEYI 409
           G++ AIK         ++K  A  E+++L+++ H NLV L E F         +L++EY 
Sbjct: 26  GQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVF---RRKRKLHLVFEYC 82

Query: 410 ENGSLHSWLHE-NKNEN-LNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS 467
           +    H+ L+E  KN   +      +I       + + H+H     +H+D+K  NIL+  
Sbjct: 83  D----HTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITK 135

Query: 468 NMRAKIANFGLAK---SGCNAITMHIVGTQGYIAPEYL-ADGVVSTKMDVFSFGVVLLEL 523
             + K+ +FG A+      +  T + V T+ Y APE L  D      +DV++ G V  EL
Sbjct: 136 QGQIKLCDFGFARILTGPGDDYTDY-VATRWYRAPELLVGDTQYGPPVDVWAIGCVFAEL 194

Query: 524 ISG 526
           ++G
Sbjct: 195 LTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 68.9 bits (168), Expect = 6e-13
 Identities = 46/166 (27%), Positives = 84/166 (50%), Gaps = 14/166 (8%)

Query: 372 ACEELKILQKVNHGNLV----KLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLN 427
           A +E ++L ++ H N+V      EG     ED   Y++  + E G L+  L E K + L 
Sbjct: 46  AEQEAQLLSQLKHPNIVAYRESWEG-----EDGLLYIVMGFCEGGDLYHKLKEQKGKLLP 100

Query: 428 WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT 487
               +   + +A  LQY+HE     ++H+D+K+ N+ L      K+ + G+A+   N   
Sbjct: 101 ENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157

Query: 488 MH--IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
           M   ++GT  Y++PE  ++   + K DV++ G  + E+ + K A +
Sbjct: 158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 69.7 bits (171), Expect = 6e-13
 Identities = 58/208 (27%), Positives = 83/208 (39%), Gaps = 34/208 (16%)

Query: 360 GEVYAIKMMK----WNACE------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI 409
           GE+ A+K MK    +   E      E  IL       LVKL     D E    YL  EY+
Sbjct: 26  GEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE--YLYLAMEYV 83

Query: 410 ENGSLHSWLHENKNENLNWKTRLRI-----AIDVANGLQYIHEHTRPRVVHKDIKSSNIL 464
             G   + L+ N         R  +     A+D  + L YIH         +D+K  N L
Sbjct: 84  PGGDFRTLLN-NLGVLSEDHARFYMAEMFEAVDALHELGYIH---------RDLKPENFL 133

Query: 465 LDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELI 524
           +D++   K+ +FGL+K         +VG+  Y+APE L        +D +S G +L E +
Sbjct: 134 IDASGHIKLTDFGLSKGIVT-YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFL 192

Query: 525 SGKEAIDEEGKFCGQKLKGYWREMKRGK 552
            G         F G      W  +K  K
Sbjct: 193 CGFPP------FSGSTPNETWENLKYWK 214

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 68.7 bits (168), Expect = 7e-13
 Identities = 56/200 (28%), Positives = 104/200 (52%), Gaps = 30/200 (15%)

Query: 351 GSVYKGNI----HGEVY-AIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCIDP 397
           G V +G +      E++ AIK +K    E        E  I+ + +H N++ LEG  +  
Sbjct: 18  GEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEG--VVT 75

Query: 398 EDANCYLIYEYIENGSLHSWLHENKNE--NLNWKTRLRIAIDVANGLQYIHEHTRPRVVH 455
           +     +I E++ENG+L S+L +N  +   +     LR    +A G++Y+ E      VH
Sbjct: 76  KSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYLSEMN---YVH 129

Query: 456 KDIKSSNILLDSNMRAKIANFGLAK----SGCNAITMHIVGTQ---GYIAPEYLADGVVS 508
           +D+ + NIL++SN+  K+++FGL++       +      +G +    + APE +A    +
Sbjct: 130 RDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFT 189

Query: 509 TKMDVFSFGVVLLELISGKE 528
           +  DV+S+G+V+ E++S  E
Sbjct: 190 SASDVWSYGIVMWEVMSYGE 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 69.3 bits (170), Expect = 7e-13
 Identities = 47/169 (27%), Positives = 89/169 (52%), Gaps = 27/169 (15%)

Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDA---NCYLIYEYIENGSLHSWLHENK---NENLNW 428
           ELKIL+   H N++ +    + P  A   + Y++ + +E+  LH  +H ++    E++ +
Sbjct: 54  ELKILRHFKHDNIIAIRDI-LRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRY 111

Query: 429 --KTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI 486
                LR       GL+YIH      V+H+D+K SN+L++ +   +I +FG+A+   ++ 
Sbjct: 112 FLYQLLR-------GLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161

Query: 487 TMH------IVGTQGYIAPE-YLADGVVSTKMDVFSFGVVLLELISGKE 528
           T H       V T+ Y APE  L+    +T +D++S G +  E++  ++
Sbjct: 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ 210

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 68.9 bits (168), Expect = 9e-13
 Identities = 42/156 (26%), Positives = 86/156 (55%), Gaps = 12/156 (7%)

Query: 375 ELKILQKVNHGNLVKL-EGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           E+ I++  +H N+V +   + +  E    +++ E++E G+L   +   +   +N +    
Sbjct: 69  EVVIMRDYHHENVVDMYNSYLVGDE---LWVVMEFLEGGALTDIVTHTR---MNEEQIAT 122

Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH--IV 491
           + + V   L Y+H      V+H+DIKS +ILL S+ R K+++FG        +     +V
Sbjct: 123 VCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV 179

Query: 492 GTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
           GT  ++APE ++     T++D++S G++++E+I G+
Sbjct: 180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 69.0 bits (168), Expect = 9e-13
 Identities = 58/180 (32%), Positives = 88/180 (48%), Gaps = 22/180 (12%)

Query: 361 EVYAIKMM---------KW-NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE 410
           EV AIK M         KW +  +E+K LQ++ H N ++ +G  +    A  +L+ EY  
Sbjct: 51  EVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTA--WLVMEYCL 108

Query: 411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR 470
             +  S L E   + L       I      GL Y+H H    ++H+DIK+ NILL    +
Sbjct: 109 GSA--SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQ 163

Query: 471 AKIANFGLAKSGCNAITMHIVGTQGYIAPEY---LADGVVSTKMDVFSFGVVLLELISGK 527
            K+A+FG A     A +   VGT  ++APE    + +G    K+DV+S G+  +EL   K
Sbjct: 164 VKLADFGSASIASPANSF--VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 221

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 47/181 (25%), Positives = 94/181 (51%), Gaps = 25/181 (13%)

Query: 360 GEVYAIKMMKWNACE-------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG 412
           G   A+KMM     +       E+ I++   H N+V++    +  E+   +++ E+++ G
Sbjct: 46  GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEE--LWVLMEFLQGG 103

Query: 413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAK 472
           +L   + + +   LN +    +   V   L Y+H      V+H+DIKS +ILL  + R K
Sbjct: 104 ALTDIVSQTR---LNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVK 157

Query: 473 IANFGLAKSGCNAITMHI------VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           +++FG     C  I+  +      VGT  ++APE ++     T++D++S G++++E++ G
Sbjct: 158 LSDFGF----CAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213

Query: 527 K 527
           +
Sbjct: 214 E 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 51/180 (28%), Positives = 86/180 (47%), Gaps = 18/180 (10%)

Query: 360 GEVYAIKMMK----------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI 409
           G  YA+K++K           +   E ++LQ   H  L  L+ +     D  C+++ EY 
Sbjct: 20  GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVM-EYA 77

Query: 410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM 469
             G L  + H ++    +         ++ + L Y+H  +   VV++D+K  N++LD + 
Sbjct: 78  NGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDG 133

Query: 470 RAKIANFGLAKSGC-NAITMH-IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
             KI +FGL K G  +  TM    GT  Y+APE L D      +D +  GVV+ E++ G+
Sbjct: 134 HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 58/190 (30%), Positives = 96/190 (50%), Gaps = 37/190 (19%)

Query: 364 AIKMMKWNACE--------ELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           AIK MK  A +        EL++L K+  H N++ L G C        YL  EY  +G+L
Sbjct: 38  AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC--EHRGYLYLAIEYAPHGNL 95

Query: 415 HSWLHENK--------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             +L +++                 L+ +  L  A DVA G+ Y+   ++ + +H+D+ +
Sbjct: 96  LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAA 152

Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFS 515
            NIL+  N  AKIA+FGL++       +++  T G     ++A E L   V +T  DV+S
Sbjct: 153 RNILVGENYVAKIADFGLSRGQ----EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWS 208

Query: 516 FGVVLLELIS 525
           +GV+L E++S
Sbjct: 209 YGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 50/165 (30%), Positives = 82/165 (49%), Gaps = 13/165 (7%)

Query: 372 ACEELKILQKVNHGNLVK-LEGFCIDPEDANCYLI-YEYIENGSLHSWLHENKNENLNWK 429
           A  E+ IL  + H N++     F     D N  LI  EY   G+L+  +   K +    +
Sbjct: 46  ALNEIVILSLLQHPNIIAYYNHF----MDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEE 101

Query: 430 TRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM- 488
             L     + + + YIH+     ++H+DIK+ NI L      K+ +FG++K   +  +M 
Sbjct: 102 MVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA 158

Query: 489 -HIVGTQGYIAPEYLADGV-VSTKMDVFSFGVVLLELISGKEAID 531
             +VGT  Y++PE L  GV  + K D+++ G VL EL++ K   D
Sbjct: 159 ETVVGTPYYMSPE-LCQGVKYNFKSDIWALGCVLYELLTLKRTFD 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 28/206 (13%)

Query: 351 GSVYKG-NIH-GEVYAIKMMKWNACEE------------LKILQKVNHGNLVKLEGFCID 396
           G+VYK  + H G   A+K ++    E+            LK L+  +H N+V+L   C  
Sbjct: 14  GTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCAT 73

Query: 397 P---EDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRV 453
                +    L++E+++   L ++L +     L  +T   +      GL ++H +    +
Sbjct: 74  SRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CI 129

Query: 454 VHKDIKSSNILLDSNMRAKIANFGLAK-SGCNAITMHIVGTQGYIAPEYLADGVVSTKMD 512
           VH+D+K  NIL+ S  + K+A+FGLA+   C      +V T  Y APE L     +T +D
Sbjct: 130 VHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVD 189

Query: 513 VFSFGVVLLELISGKEAIDEEGKFCG 538
           ++S G +  E+   K        FCG
Sbjct: 190 MWSVGCIFAEMFRRKPL------FCG 209

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 68.6 bits (168), Expect = 1e-12
 Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 35/200 (17%)

Query: 351 GSVYKGN--IHGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPED 399
           G V+K       ++ A+K +            A  E+KILQ + H N+V L   C     
Sbjct: 26  GEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAT 85

Query: 400 ------ANCYLIYEYIENGSLH--SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRP 451
                  + YL++E+ E    H  + L  NKN         ++   + NGL YIH   R 
Sbjct: 86  PYNRYKGSFYLVFEFCE----HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RN 138

Query: 452 RVVHKDIKSSNILLDSNMRAKIANFGLAK-------SGCNAITMHIVGTQGYIAPE-YLA 503
           +++H+D+K++NIL+  +   K+A+FGLA+       S  N  T  +V T  Y  PE  L 
Sbjct: 139 KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-TLWYRPPELLLG 197

Query: 504 DGVVSTKMDVFSFGVVLLEL 523
           +      +D++  G ++ E+
Sbjct: 198 ERDYGPPIDMWGAGCIMAEM 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 69.1 bits (169), Expect = 2e-12
 Identities = 36/92 (39%), Positives = 53/92 (57%), Gaps = 5/92 (5%)

Query: 446 HEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI----VGTQGYIAPEY 501
           H H++  ++H+DIKS+NILL SN   K+ +FG +K     ++  +     GT  Y+APE 
Sbjct: 158 HVHSK-HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEI 216

Query: 502 LADGVVSTKMDVFSFGVVLLELISGKEAIDEE 533
                 S K D+FS GV+L EL++ K   D E
Sbjct: 217 WRRKPYSKKADMFSLGVLLYELLTLKRPFDGE 248

Length = 496

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 68.0 bits (166), Expect = 2e-12
 Identities = 41/131 (31%), Positives = 71/131 (54%), Gaps = 8/131 (6%)

Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
           D++ YL+ +Y+  G L  W  + +      + +  IA ++   L+++H++    +V++D+
Sbjct: 68  DSDLYLVTDYMSGGELF-WHLQKEGRFSEDRAKFYIA-ELVLALEHLHKYD---IVYRDL 122

Query: 459 KSSNILLDSNMRAKIANFGLAKSGC--NAITMHIVGTQGYIAPEYLADGVVSTKM-DVFS 515
           K  NILLD+     + +FGL+K+    N  T    GT  Y+APE L D    TK  D +S
Sbjct: 123 KPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWS 182

Query: 516 FGVVLLELISG 526
            GV++ E+  G
Sbjct: 183 LGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 67.4 bits (164), Expect = 2e-12
 Identities = 48/165 (29%), Positives = 84/165 (50%), Gaps = 6/165 (3%)

Query: 372 ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTR 431
           A  E +IL+KVN   +V L  +  + +DA C L+   +  G L   ++            
Sbjct: 47  ALNEKQILEKVNSRFVVSL-AYAYETKDALC-LVLTLMNGGDLKFHIYHMGEAGFEEGRA 104

Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH-I 490
           +  A ++  GL+ +H   + R+V++D+K  NILLD +   +I++ GLA       T+   
Sbjct: 105 VFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR 161

Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK 535
           VGT GY+APE + +   +   D ++ G +L E+I+G+    +  K
Sbjct: 162 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK 206

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 66.5 bits (162), Expect = 3e-12
 Identities = 44/162 (27%), Positives = 82/162 (50%), Gaps = 15/162 (9%)

Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           EE+ +L+ + H N+V+  G C+D    + ++  E++  GS+ S L  N+   L      +
Sbjct: 51  EEVDLLKSLKHVNIVQYLGTCLDDNTISIFM--EFVPGGSISSIL--NRFGPLPEPVFCK 106

Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-------- 485
               + +G+ Y+H +    VVH+DIK +N++L  N   K+ +FG A+             
Sbjct: 107 YTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSN 163

Query: 486 ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
           +   + GT  ++APE + +     K D++S G  + E+ +GK
Sbjct: 164 MLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 67.0 bits (163), Expect = 4e-12
 Identities = 44/173 (25%), Positives = 86/173 (49%), Gaps = 24/173 (13%)

Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHEN------------- 421
           E ++L  + H ++VK  G C D +     +++EY+++G L+ +L  +             
Sbjct: 57  EAELLTNLQHEHIVKFYGVCGDGDP--LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPR 114

Query: 422 -KNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK 480
                L     L IA  +A+G+ Y+        VH+D+ + N L+ +N+  KI +FG+++
Sbjct: 115 QAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSR 171

Query: 481 ----SGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKE 528
               +    +  H +    ++ PE +     +T+ DV+SFGV+L E+ + GK+
Sbjct: 172 DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 66.1 bits (161), Expect = 4e-12
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 48/210 (22%)

Query: 348 LIQGSVYKGNIHGEVYAIKMMKWNACEELKILQ-----------------------KVNH 384
           ++Q  + KG+  G VY +K  K  A E LK+L+                       K++H
Sbjct: 3   ILQQRLGKGSF-GTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61

Query: 385 GNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENK--------NENLNWKTRLRIAI 436
             +VK     ++  DA C +I EY E   L   L E K        N+   W  +L +  
Sbjct: 62  PAIVKFHASFLE-RDAFC-IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL-- 117

Query: 437 DVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK---SGCNAITMHIVGT 493
               G+ Y+H+    R++H+D+K+ NI L +N+  KI +FG+++     C+  T    GT
Sbjct: 118 ----GVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT-FTGT 168

Query: 494 QGYIAPEYLADGVVSTKMDVFSFGVVLLEL 523
             Y++PE L      +K D++S G +L E+
Sbjct: 169 PYYMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 67.2 bits (164), Expect = 4e-12
 Identities = 51/155 (32%), Positives = 79/155 (50%), Gaps = 12/155 (7%)

Query: 375 ELKILQKVNHGNLVKLEGFCIDP-EDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           ELK+L+ + H N++ L    I P ED   Y + E +    LH  L    +  L  +    
Sbjct: 59  ELKLLKHLRHENIISLSDIFISPLEDI--YFVTELLGT-DLHRLL---TSRPLEKQFIQY 112

Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT 493
               +  GL+Y+H      VVH+D+K SNIL++ N   KI +FGLA+     +T + V T
Sbjct: 113 FLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGY-VST 168

Query: 494 QGYIAPE-YLADGVVSTKMDVFSFGVVLLELISGK 527
           + Y APE  L       ++D++S G +  E++ GK
Sbjct: 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 66.6 bits (162), Expect = 5e-12
 Identities = 45/160 (28%), Positives = 85/160 (53%), Gaps = 19/160 (11%)

Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E  I+  ++H +LV+L G C+ P      L+ + + +G L  ++HE+K +N+  +  L 
Sbjct: 58  DEALIMASMDHPHLVRLLGVCLSP---TIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLN 113

Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK--------SGCNA 485
             + +A G+ Y+ E    R+VH+D+ + N+L+ S    KI +FGLA+           + 
Sbjct: 114 WCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADG 170

Query: 486 ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
             M I     ++A E +     + + DV+S+GV + EL++
Sbjct: 171 GKMPI----KWMALECIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 66.5 bits (162), Expect = 5e-12
 Identities = 51/183 (27%), Positives = 99/183 (54%), Gaps = 26/183 (14%)

Query: 364 AIKMMKWNA--------CEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH 415
           A+KM++ +A         +E+KI+ ++   N+++L   CI   D  C +I EY+ENG L+
Sbjct: 50  AVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCIT-SDPLC-MITEYMENGDLN 107

Query: 416 SWL--HENKNE-------NLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLD 466
            +L  HE +          +++ T + +A  +A+G++Y+   +    VH+D+ + N L+ 
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVG 164

Query: 467 SNMRAKIANFGLAKSGCNAITMHIVGTQ----GYIAPEYLADGVVSTKMDVFSFGVVLLE 522
            N   KIA+FG++++  +     I G       +++ E +  G  +T  DV++FGV L E
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWE 224

Query: 523 LIS 525
           +++
Sbjct: 225 ILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 66.7 bits (163), Expect = 5e-12
 Identities = 42/138 (30%), Positives = 70/138 (50%), Gaps = 9/138 (6%)

Query: 393 FCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI-AIDVANGLQYIHEHTRP 451
           FC      + + + EY+  G L   +  +   +     R R  A ++  GLQ++H+    
Sbjct: 62  FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDE---ARARFYAAEIICGLQFLHKKG-- 116

Query: 452 RVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM--HIVGTQGYIAPEYLADGVVST 509
            ++++D+K  N+LLD +   KIA+FG+ K   N         GT  YIAPE L     + 
Sbjct: 117 -IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNE 175

Query: 510 KMDVFSFGVVLLELISGK 527
            +D +SFGV+L E++ G+
Sbjct: 176 SVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 66.0 bits (161), Expect = 5e-12
 Identities = 41/153 (26%), Positives = 78/153 (50%), Gaps = 8/153 (5%)

Query: 375 ELKIL-QKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL--HSWLHENKNENLNWKTR 431
           E+ I+ +++ H N+V+   +    E+   Y++ + IE   L  H    + K +    +  
Sbjct: 58  EVTIIKEQLRHPNIVRY--YKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI 115

Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAITMHI 490
             I + +   L+Y+H+  R  +VH+D+  +NI+L  + +  I +FGLAK     +    +
Sbjct: 116 WNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSV 173

Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLEL 523
           VGT  Y  PE + +     K DV++FG +L ++
Sbjct: 174 VGTILYSCPEIVKNEPYGEKADVWAFGCILYQM 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 65.8 bits (160), Expect = 6e-12
 Identities = 44/163 (26%), Positives = 82/163 (50%), Gaps = 11/163 (6%)

Query: 371 NACE-ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWK 429
           NA E E+++L+ + H  +V+  G   DP +    +  E++  GS+   L       L   
Sbjct: 49  NALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA--LTEN 106

Query: 430 TRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK---SGCNAI 486
              +    +  G+ Y+H +    +VH+DIK +NIL DS    K+ +FG +K   + C + 
Sbjct: 107 VTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSG 163

Query: 487 T--MHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
           T    + GT  +++PE ++      K D++S G  ++E+++ K
Sbjct: 164 TGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 66.1 bits (161), Expect = 6e-12
 Identities = 35/93 (37%), Positives = 53/93 (56%), Gaps = 4/93 (4%)

Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
           A ++  GL+++H      VV++D+K +NILLD +   +I++ GLA           VGT 
Sbjct: 103 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH 159

Query: 495 GYIAPEYLADGVV-STKMDVFSFGVVLLELISG 526
           GY+APE L  GV   +  D FS G +L +L+ G
Sbjct: 160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 65.8 bits (160), Expect = 7e-12
 Identities = 51/180 (28%), Positives = 88/180 (48%), Gaps = 12/180 (6%)

Query: 372 ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTR 431
           A  E +IL+KVN   +V L  +  + +DA C L+   +  G L   ++   N   + +  
Sbjct: 47  ALNEKRILEKVNSRFVVSL-AYAYETKDALC-LVLTIMNGGDLKFHIYNMGNPGFDEQRA 104

Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH-I 490
           +  A ++  GL+ +    R R+V++D+K  NILLD     +I++ GLA       T+   
Sbjct: 105 IFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR 161

Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYWREMKR 550
           VGT GY+APE + +   +   D +  G ++ E+I G      +  F  +K +    E+ R
Sbjct: 162 VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQG------QSPFRKRKERVKREEVDR 215

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 66.6 bits (163), Expect = 7e-12
 Identities = 51/174 (29%), Positives = 86/174 (49%), Gaps = 40/174 (22%)

Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDA----NCYLIYEYIENGSLHSWLHENKNENLN--- 427
           E+KIL++  H N++ +    I P       + Y++ E +E   L+  +   K ++L+   
Sbjct: 53  EIKILRRFKHENIIGILDI-IRPPSFESFNDVYIVQELMET-DLYKLI---KTQHLSNDH 107

Query: 428 -----WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG 482
                ++  LR       GL+YIH      V+H+D+K SN+LL++N   KI +FGLA+  
Sbjct: 108 IQYFLYQI-LR-------GLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARI- 155

Query: 483 CNAITMHI--------VGTQGYIAPE-YLADGVVSTKMDVFSFGVVLLELISGK 527
             A   H         V T+ Y APE  L     +  +D++S G +L E++S +
Sbjct: 156 --ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 47/188 (25%), Positives = 94/188 (50%), Gaps = 21/188 (11%)

Query: 352 SVYKG--NIHGEVYAIK------MMKWNA---C-EELKILQKVNHGNLVKLEGFCIDPED 399
            VYK    + G V A+K      MM   A   C +E+ +L++++H N++K     I+  +
Sbjct: 17  VVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNE 76

Query: 400 ANCYLIYEYIENGSLHSWLHENKNEN--LNWKTRLRIAIDVANGLQYIHEHTRPRVVHKD 457
            N  ++ E  + G L   +   K +   +  +T  +  + + + L+++H     R++H+D
Sbjct: 77  LN--IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRD 131

Query: 458 IKSSNILLDSNMRAKIANFGLAK--SGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFS 515
           IK +N+ + +    K+ + GL +  S        +VGT  Y++PE + +   + K D++S
Sbjct: 132 IKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWS 191

Query: 516 FGVVLLEL 523
            G +L E+
Sbjct: 192 LGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 38/216 (17%)

Query: 341 DNFSEGCLIQ----GSVYKGNIHGEVYA------IKMMKWNACE--------ELKILQKV 382
           D  +   L+Q    G ++ G +  E         +K +K +A E        E  +L  +
Sbjct: 6   DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65

Query: 383 NHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR------IAI 436
           +H N++ +   CI+  +   +++Y Y+  G+L  +L + +    N    L       +AI
Sbjct: 66  SHQNILPILHVCIEDGEPP-FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAI 124

Query: 437 DVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM--HIVGTQ 494
            +A G+ Y+H+     V+HKDI + N ++D  ++ KI +  L++   +   M  H +G  
Sbjct: 125 QIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSR---DLFPMDYHCLGDN 178

Query: 495 GY-----IAPEYLADGVVSTKMDVFSFGVVLLELIS 525
                  +A E L +   S+  DV+SFGV+L EL++
Sbjct: 179 ENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 47/167 (28%), Positives = 82/167 (49%), Gaps = 19/167 (11%)

Query: 371 NACE-ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWK 429
           NA E E+++L+ + H  +V+  G   DPE+    +  EY+  GS+   L       L   
Sbjct: 49  NALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTEN 106

Query: 430 TRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK--------- 480
              R    +  G+ Y+H +    +VH+DIK +NIL DS    K+ +FG +K         
Sbjct: 107 VTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSG 163

Query: 481 SGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
           +G  ++T    GT  +++PE ++      K DV+S    ++E+++ K
Sbjct: 164 TGIKSVT----GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 51/186 (27%), Positives = 87/186 (46%), Gaps = 18/186 (9%)

Query: 360 GEVYAIKMMKWNA--------CE--ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI 409
            E+YAIK++K +         C   E ++L   +    +     C    D   Y + EY+
Sbjct: 25  DELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD-RLYFVMEYV 83

Query: 410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM 469
             G L    H  +         +  A +++ GL ++H   R  ++++D+K  N++LDS  
Sbjct: 84  NGGDL--MYHIQQVGKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEG 138

Query: 470 RAKIANFGLAKSGC--NAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
             KIA+FG+ K        T    GT  YIAPE +A       +D +++GV+L E+++G+
Sbjct: 139 HIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198

Query: 528 EAIDEE 533
              D E
Sbjct: 199 PPFDGE 204

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 56/184 (30%), Positives = 87/184 (47%), Gaps = 16/184 (8%)

Query: 368 MKWNACEELKILQKVNHGNLVKL-EGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENL 426
           +K     ELK+L+ +   N+V+L E F         YL++EY+E   L   L E  N   
Sbjct: 43  VKETTLRELKMLRTLKQENIVELKEAF---RRRGKLYLVFEYVEKNMLE-LLEEMPNGVP 98

Query: 427 NWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS---GC 483
             K R  I   +   + + H++    +VH+DIK  N+L+  N   K+ +FG A++   G 
Sbjct: 99  PEKVRSYI-YQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154

Query: 484 NAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK----FCGQ 539
           NA     V T+ Y +PE L        +D++S G +L EL  G+     E +    F  Q
Sbjct: 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQ 214

Query: 540 KLKG 543
           K+ G
Sbjct: 215 KVLG 218

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 50/188 (26%), Positives = 97/188 (51%), Gaps = 34/188 (18%)

Query: 364 AIKMMKWNA---------CEELKILQKVNHGNLVKLEGFCIDPEDAN----CYLIYEYIE 410
           A+KM+K +            E   +++ +H N++KL G  +            +I  +++
Sbjct: 31  AVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMK 90

Query: 411 NGSLHSWLHENK----NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLD 466
           +G LH++L  ++       L  +T +R  ID+A+G++Y+   +    +H+D+ + N +L+
Sbjct: 91  HGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYL---SSKNFIHRDLAARNCMLN 147

Query: 467 SNMRAKIANFGLAK---------SGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFG 517
            NM   +A+FGL+K          GC A  + +     ++A E LAD V +T  DV++FG
Sbjct: 148 ENMTVCVADFGLSKKIYSGDYYRQGC-ASKLPV----KWLALESLADNVYTTHSDVWAFG 202

Query: 518 VVLLELIS 525
           V + E+++
Sbjct: 203 VTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 35/107 (32%), Positives = 60/107 (56%), Gaps = 8/107 (7%)

Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN--AITMHIVG 492
           A ++A GL ++H      ++++D+K  N++LD+    KIA+FG+ K        T    G
Sbjct: 107 AAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCG 163

Query: 493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK---EAIDEEGKF 536
           T  YIAPE +A       +D ++FGV+L E+++G+   +  DE+  F
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF 210

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 65.1 bits (158), Expect = 2e-11
 Identities = 47/184 (25%), Positives = 86/184 (46%), Gaps = 20/184 (10%)

Query: 361 EVYAIKMMK-----------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI 409
           ++YA+K++K           W   E+    Q  ++  LV L   C     +  +L+ EY+
Sbjct: 21  QIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHS-CFQTT-SRLFLVIEYV 78

Query: 410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM 469
             G L    H  +   L  +     A ++   L ++HE     ++++D+K  N+LLD++ 
Sbjct: 79  NGGDL--MFHMQRQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADG 133

Query: 470 RAKIANFGLAKSGCNA--ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
             K+ ++G+ K G      T    GT  YIAPE L        +D ++ GV++ E+++G+
Sbjct: 134 HIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGR 193

Query: 528 EAID 531
              D
Sbjct: 194 SPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 54/176 (30%), Positives = 83/176 (47%), Gaps = 22/176 (12%)

Query: 361 EVYAIKMM---------KW-NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE 410
           EV AIK M         KW +  +E++ LQK+ H N ++  G  +    A  +L+ EY  
Sbjct: 41  EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA--WLVMEYCL 98

Query: 411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR 470
             +  S L E   + L       +      GL Y+H H    ++H+D+K+ NILL     
Sbjct: 99  GSA--SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGL 153

Query: 471 AKIANFGLAKSGCNAITMHIVGTQGYIAPEY---LADGVVSTKMDVFSFGVVLLEL 523
            K+ +FG A     A     VGT  ++APE    + +G    K+DV+S G+  +EL
Sbjct: 154 VKLGDFGSASIMAPANXF--VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 47/226 (20%)

Query: 333 IEELREATDNFSEGCLIQGSVYKGNIHG-------EVYAIKMMKWNA----CEELK---- 377
           +EEL E  D F       G VYKG++ G       +  AIK +K  A     EE K    
Sbjct: 10  MEELGE--DRF-------GKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60

Query: 378 ILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL-----HENKNENLNWKTR- 431
           +  ++ H N+V L G  +  ++    +I+ Y  +  LH +L     H +     + KT  
Sbjct: 61  MRSRLQHPNIVCLLG--VVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 432 --------LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC 483
                   + I   +A G++++  H    VVHKD+ + N+L+   +  KI++ GL +   
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175

Query: 484 NAITMHIVGTQ----GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
            A    ++G       +++PE +  G  S   D++S+GVVL E+ S
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 64.2 bits (156), Expect = 3e-11
 Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 6/157 (3%)

Query: 372 ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTR 431
           A  E +IL+KVN   +V L  +  + +DA C L+   +  G L   ++   N     +  
Sbjct: 47  ALNEKQILEKVNSQFVVNL-AYAYETKDALC-LVLTIMNGGDLKFHIYNMGNPGFEEERA 104

Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLA-KSGCNAITMHI 490
           L  A ++  GL+ +H   R   V++D+K  NILLD     +I++ GLA K          
Sbjct: 105 LFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR 161

Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
           VGT GY+APE L +   +   D +  G ++ E+I G+
Sbjct: 162 VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 64.5 bits (157), Expect = 3e-11
 Identities = 52/190 (27%), Positives = 87/190 (45%), Gaps = 44/190 (23%)

Query: 360 GEVYAIKMMK----------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI 409
           GE YAIK +K           +  +E  IL +++H  +V +   C   ++   Y + E++
Sbjct: 43  GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNM--MCSFQDENRVYFLLEFV 100

Query: 410 ENGSLHSWLHENKNENLNWKTRLRIAIDVAN--------GLQYIHEHTRPRVVHKDIKSS 461
             G L + L          +   R   DVA           +Y+H      ++++D+K  
Sbjct: 101 VGGELFTHL----------RKAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPE 147

Query: 462 NILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTK-----MDVFSF 516
           N+LLD+    K+ +FG AK   +  T  + GT     PEYLA  V+ +K     +D ++ 
Sbjct: 148 NLLLDNKGHVKVTDFGFAKKVPDR-TFTLCGT-----PEYLAPEVIQSKGHGKAVDWWTM 201

Query: 517 GVVLLELISG 526
           GV+L E I+G
Sbjct: 202 GVLLYEFIAG 211

Length = 329

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 63.5 bits (154), Expect = 4e-11
 Identities = 42/129 (32%), Positives = 67/129 (51%), Gaps = 7/129 (5%)

Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
           D  C+ I + +  G LH   H +++   + K     A ++  GL+++H      VV++D+
Sbjct: 70  DKLCF-ILDLMNGGDLH--YHLSQHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDL 123

Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVV-STKMDVFSFG 517
           K +NILLD +   +I++ GLA           VGT GY+APE L  G    +  D FS G
Sbjct: 124 KPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLG 183

Query: 518 VVLLELISG 526
            +L +L+ G
Sbjct: 184 CMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 63.4 bits (154), Expect = 4e-11
 Identities = 44/168 (26%), Positives = 80/168 (47%), Gaps = 15/168 (8%)

Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E +IL+KVN   +V L  +  + +   C L+   +  G L   ++      L  +  +  
Sbjct: 43  EKEILEKVNSPFIVNL-AYAFESKTHLC-LVMSLMNGGDLKYHIYNVGERGLEMERVIHY 100

Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLA--KSGCNAITMHIVG 492
           +  +  G+ ++H      +V++D+K  N+LLD     ++++ GLA        IT    G
Sbjct: 101 SAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR-AG 156

Query: 493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG-------KEAIDEE 533
           T GY+APE L +   S  +D F+ G  + E+++G       KE + +E
Sbjct: 157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE 204

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 63.1 bits (153), Expect = 7e-11
 Identities = 42/152 (27%), Positives = 81/152 (53%), Gaps = 19/152 (12%)

Query: 382 VNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANG 441
           ++H  +V+L G C     A+  L+ +    GSL   + ++++ +L+ +  L   + +A G
Sbjct: 66  LDHAYIVRLLGIC---PGASLQLVTQLSPLGSLLDHVRQHRD-SLDPQRLLNWCVQIAKG 121

Query: 442 LQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLA--------KSGCNAITMHIVGT 493
           + Y+ EH   R+VH+++ + NILL S+   +IA+FG+A        K   +     I   
Sbjct: 122 MYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPI--- 175

Query: 494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
             ++A E +  G  + + DV+S+GV + E++S
Sbjct: 176 -KWMALESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 62.4 bits (151), Expect = 8e-11
 Identities = 56/190 (29%), Positives = 92/190 (48%), Gaps = 27/190 (14%)

Query: 351 GSVYKG-NIH-GEVYAIKMMKWNACEELKILQK-------VNHGNLVKLEGFCIDPEDAN 401
           G VYK  N+H GE+ A+K++K    ++  ++Q+         H N+V   G  +  E   
Sbjct: 23  GDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE--K 80

Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAI---DVANGLQYIHEHTRPRVVHKDI 458
            ++  EY   GSL    H          + L+IA    +   GL Y+H   +   +H+DI
Sbjct: 81  LWICMEYCGGGSLQDIYHVTGP-----LSELQIAYVCRETLQGLAYLHSKGK---MHRDI 132

Query: 459 KSSNILLDSNMRAKIANFGLAK--SGCNAITMHIVGTQGYIAPEYLA---DGVVSTKMDV 513
           K +NILL  N   K+A+FG+A   +   A     +GT  ++APE  A   +G  +   D+
Sbjct: 133 KGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDI 192

Query: 514 FSFGVVLLEL 523
           ++ G+  +EL
Sbjct: 193 WAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 62.8 bits (152), Expect = 9e-11
 Identities = 45/170 (26%), Positives = 84/170 (49%), Gaps = 21/170 (12%)

Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHE-----------NKN 423
           E ++L  + H ++VK  G C+  E     +++EY+++G L+ +L             N+ 
Sbjct: 57  EAELLTNLQHEHIVKFYGVCV--EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRP 114

Query: 424 ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC 483
             L     L IA  +A G+ Y+        VH+D+ + N L+  N+  KI +FG+++   
Sbjct: 115 AELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVY 171

Query: 484 NA----ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKE 528
           +     +  H +    ++ PE +     +T+ DV+S GVVL E+ + GK+
Sbjct: 172 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 221

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 62.1 bits (151), Expect = 9e-11
 Identities = 43/154 (27%), Positives = 83/154 (53%), Gaps = 11/154 (7%)

Query: 378 ILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAID 437
           I++  +H N++ L G C+  E +   ++  Y+++G L +++  ++  N   K  +   + 
Sbjct: 49  IMKDFSHPNVLSLLGICLPSEGSP-LVVLPYMKHGDLRNFI-RSETHNPTVKDLIGFGLQ 106

Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-- 495
           VA G++Y+      + VH+D+ + N +LD +   K+A+FGLA+   +     +    G  
Sbjct: 107 VAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAK 163

Query: 496 ----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
               ++A E L     +TK DV+SFGV+L EL++
Sbjct: 164 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 62.6 bits (152), Expect = 9e-11
 Identities = 44/161 (27%), Positives = 80/161 (49%), Gaps = 13/161 (8%)

Query: 375 ELKILQKVNHGNLVKLEG-FCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRL- 432
           EL IL K     +V   G F I+      Y+  EY++ GSL              +  L 
Sbjct: 49  ELDILHKAVSPYIVDFYGAFFIE---GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLR 105

Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVG 492
           RI   V  GL+++ E     ++H+D+K +N+L++ N + K+ +FG++ +   ++    +G
Sbjct: 106 RITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIG 163

Query: 493 TQGYIAPEYL------ADGVVSTKMDVFSFGVVLLELISGK 527
            Q Y+APE +       +   + + DV+S G+ +LE+  G+
Sbjct: 164 CQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 62.7 bits (152), Expect = 9e-11
 Identities = 38/156 (24%), Positives = 83/156 (53%), Gaps = 12/156 (7%)

Query: 375 ELKILQKVNHGNLVKL-EGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           E+ I++   H N+V++   + +  E    +++ E++E G+L   +   +   +N +    
Sbjct: 67  EVVIMRDYQHENVVEMYNSYLVGDE---LWVVMEFLEGGALTDIVTHTR---MNEEQIAA 120

Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH--IV 491
           + + V   L  +H      V+H+DIKS +ILL  + R K+++FG        +     +V
Sbjct: 121 VCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV 177

Query: 492 GTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
           GT  ++APE ++      ++D++S G++++E++ G+
Sbjct: 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 55/192 (28%), Positives = 86/192 (44%), Gaps = 24/192 (12%)

Query: 351 GSVY--KGNIHGEVYAIKMMKWNA-----------CEELKILQKVNHGNLVKLEGFCIDP 397
           G V   K    G+ YA+K+++  A            E   +L+ V H  LV L  +    
Sbjct: 9   GKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH-YSFQT 67

Query: 398 EDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI-AIDVANGLQYIHEHTRPRVVHK 456
            D   Y + +Y+  G L   L   ++     + R R  A ++A+ L Y+H      ++++
Sbjct: 68  AD-KLYFVLDYVNGGELFFHLQRERSFP---EPRARFYAAEIASALGYLHSL---NIIYR 120

Query: 457 DIKSSNILLDSNMRAKIANFGLAKSGC--NAITMHIVGTQGYIAPEYLADGVVSTKMDVF 514
           D+K  NILLDS     + +FGL K G   +  T    GT  Y+APE L        +D +
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWW 180

Query: 515 SFGVVLLELISG 526
             G VL E++ G
Sbjct: 181 CLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 62.2 bits (151), Expect = 1e-10
 Identities = 31/90 (34%), Positives = 54/90 (60%), Gaps = 7/90 (7%)

Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLA---KSGCNAITMHIVGTQGYI 497
           GL+++H+    R++++D+K  N+LLD++   +I++ GLA   K G +  T    GT G++
Sbjct: 109 GLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFM 164

Query: 498 APEYLADGVVSTKMDVFSFGVVLLELISGK 527
           APE L        +D F+ GV L E+I+ +
Sbjct: 165 APELLQGEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 41/154 (26%), Positives = 82/154 (53%), Gaps = 9/154 (5%)

Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNEN--LNWKTR 431
           +E+ +L+++NH N++K     I+  + N  ++ E  + G L   +   K +   +  KT 
Sbjct: 51  KEIDLLKQLNHPNVIKYYASFIEDNELN--IVLELADAGDLSRMIKHFKKQKRLIPEKTV 108

Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK--SGCNAITMH 489
            +  + + + L+  H H+R RV+H+DIK +N+ + +    K+ + GL +  S        
Sbjct: 109 WKYFVQLCSALE--HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS 165

Query: 490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLEL 523
           +VGT  Y++PE + +   + K D++S G +L E+
Sbjct: 166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 39/133 (29%), Positives = 66/133 (49%), Gaps = 7/133 (5%)

Query: 403 YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSN 462
           Y + EY+  G L       +         +  A ++A GL ++H      ++++D+K  N
Sbjct: 77  YFVMEYVNGGDL--MYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDN 131

Query: 463 ILLDSNMRAKIANFGLAKSGC--NAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVL 520
           ++LDS    KIA+FG+ K        T    GT  YIAPE +A       +D ++FGV+L
Sbjct: 132 VMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLL 191

Query: 521 LELISGKEAIDEE 533
            E+++G+   + E
Sbjct: 192 YEMLAGQAPFEGE 204

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 52/180 (28%), Positives = 91/180 (50%), Gaps = 26/180 (14%)

Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDAN----CYLIYEYIENGSLHSWLHENK---NENLN 427
           E+K+L+ ++H N++ ++   + P         Y++YE ++   LH  +  ++   +++  
Sbjct: 54  EIKLLRHLDHENVIAIKD-IMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQ 111

Query: 428 W--KTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA 485
           +     LR       GL+YIH      V+H+D+K SN+LL++N   KI +FGLA++    
Sbjct: 112 YFLYQLLR-------GLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161

Query: 486 --ITMHIVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEGKFCGQKLK 542
                  V T+ Y APE L +    +T +DV+S G +  EL+  K      GK    +LK
Sbjct: 162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLF--PGKDYVHQLK 219

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 32/93 (34%), Positives = 53/93 (56%), Gaps = 11/93 (11%)

Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK-----SGCNAITMHIVGTQG 495
           GL+Y+H      ++H+DIK  N+L++SN   KI +FGLA+        + +T  +V TQ 
Sbjct: 115 GLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKH-MTQEVV-TQY 169

Query: 496 YIAPEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           Y APE L      ++ +D++S G +  EL+  +
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 63.2 bits (153), Expect = 2e-10
 Identities = 50/180 (27%), Positives = 91/180 (50%), Gaps = 23/180 (12%)

Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLI---YEYIENGSLHSWLHEN----KNENLN 427
           E+  L ++NH N++K+E        AN Y+I   Y++     L+S++++     K+  L 
Sbjct: 213 EILALGRLNHENILKIEEILRSE--ANTYMITQKYDF----DLYSFMYDEAFDWKDRPLL 266

Query: 428 WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN--- 484
            +TR  I   +   ++YIH+    +++H+DIK  NI L+ + +  + +FG A        
Sbjct: 267 KQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE 322

Query: 485 AITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKE--AIDEEGKFCGQKLK 542
           A     VGT    +PE LA        D++S G++LL+++S  +   I + G   G++L 
Sbjct: 323 AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS-HDFCPIGDGGGKPGKQLL 381

Length = 501

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 62.0 bits (150), Expect = 2e-10
 Identities = 55/178 (30%), Positives = 81/178 (45%), Gaps = 22/178 (12%)

Query: 363 YAIKMMKWNACEELK-----------ILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN 411
           YA+K+++  A  + K           +L+ V H  LV L  F     D   Y + +YI  
Sbjct: 23  YAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTAD-KLYFVLDYING 80

Query: 412 GSLHSWLHENKNENLNWKTRLRI-AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR 470
           G L   L   + E    + R R  A ++A+ L Y+H      +V++D+K  NILLDS   
Sbjct: 81  GELFYHL---QRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGH 134

Query: 471 AKIANFGLAKSGC--NAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
             + +FGL K     N  T    GT  Y+APE L        +D +  G VL E++ G
Sbjct: 135 IVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 48/176 (27%), Positives = 89/176 (50%), Gaps = 17/176 (9%)

Query: 364 AIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH 415
           AI  ++    +        E   L + +H N+V+LEG  +        ++ EY+ NG+L 
Sbjct: 37  AIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEG--VITRGNTMMIVTEYMSNGALD 94

Query: 416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIAN 475
           S+L +++ + L     + +   +A+G++Y+ E      VHK + +  +L++S++  KI+ 
Sbjct: 95  SFLRKHEGQ-LVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISG 150

Query: 476 FG-LAKSGCNAI--TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKE 528
           F  L +    AI  TM       + APE +     S+  DV+SFG+V+ E++S  E
Sbjct: 151 FRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGE 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 52/193 (26%), Positives = 98/193 (50%), Gaps = 25/193 (12%)

Query: 351 GSVYKG--NIHGE----VYAIKMMK--------WNACEELKILQKVNHGNLVKLEGFCID 396
           G+VYKG     GE      AIK ++            +E  ++  V++ ++ +L G C+ 
Sbjct: 21  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 80

Query: 397 PEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHK 456
              +   LI + +  G L  ++ E+K +N+  +  L   + +A G+ Y+ E    R+VH+
Sbjct: 81  ---STVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEER---RLVHR 133

Query: 457 DIKSSNILLDSNMRAKIANFGLAK-SGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMD 512
           D+ + N+L+ +    KI +FGLAK  G +    H  G +    ++A E +   + + + D
Sbjct: 134 DLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSD 193

Query: 513 VFSFGVVLLELIS 525
           V+S+GV + EL++
Sbjct: 194 VWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 61.8 bits (150), Expect = 2e-10
 Identities = 46/184 (25%), Positives = 84/184 (45%), Gaps = 20/184 (10%)

Query: 361 EVYAIKMMK-----------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI 409
            +YA+K++K           W   E+       NH  LV L   C   E +  + + E++
Sbjct: 21  RIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHS-CFQTE-SRLFFVIEFV 78

Query: 410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM 469
             G L    H  +   L  +     + +++  L ++HE     ++++D+K  N+LLD+  
Sbjct: 79  SGGDL--MFHMQRQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEG 133

Query: 470 RAKIANFGLAKSGCNA--ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
             K+ ++G+ K G      T    GT  YIAPE L        +D ++ GV++ E+++G+
Sbjct: 134 HIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193

Query: 528 EAID 531
              D
Sbjct: 194 SPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 52/182 (28%), Positives = 90/182 (49%), Gaps = 26/182 (14%)

Query: 360 GEVYAIKMMKWNACE---------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE 410
           G++YA+K++K    +         E  IL +VNH  +VKL  +    E    YLI +++ 
Sbjct: 24  GQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLH-YAFQTE-GKLYLILDFLR 81

Query: 411 NGSLHSWLHEN---KNENLN-WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLD 466
            G L + L +      E++  +   L +A+D        H H+   ++++D+K  NILLD
Sbjct: 82  GGDLFTRLSKEVMFTEEDVKFYLAELALALD--------HLHSLG-IIYRDLKPENILLD 132

Query: 467 SNMRAKIANFGLAKSGCNAI--TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELI 524
                K+ +FGL+K   +         GT  Y+APE +     +   D +SFGV++ E++
Sbjct: 133 EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEML 192

Query: 525 SG 526
           +G
Sbjct: 193 TG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 61.7 bits (150), Expect = 3e-10
 Identities = 71/249 (28%), Positives = 110/249 (44%), Gaps = 51/249 (20%)

Query: 308 RDLKDMEVNFMADVSDCLDKYR--IFKIEELREATDNFSEGCLI-QGSVYKGNIH----- 359
           R  K+++ NF++       +Y     KI +LR   ++F    +I +G+   G +      
Sbjct: 16  RKNKNID-NFLS-------RYEKAAEKITKLRMKAEDFDVIKVIGRGAF--GEVQLVRHK 65

Query: 360 --GEVYAIK------MMK-------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYL 404
              +VYA+K      M+K       W   EE  I+   N   +V+L       +D   Y+
Sbjct: 66  SSKQVYAMKLLSKFEMIKRSDSAFFW---EERDIMAHANSEWIVQL--HYAFQDDKYLYM 120

Query: 405 IYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNIL 464
           + EY+  G L + L  N +    W  R   A +V   L  IH       +H+D+K  N+L
Sbjct: 121 VMEYMPGGDLVN-LMSNYDIPEKW-ARFYTA-EVVLALDAIHSMG---FIHRDVKPDNML 174

Query: 465 LDSNMRAKIANFGLA-KSGCNAITM--HIVGTQGYIAPEYL----ADGVVSTKMDVFSFG 517
           LD +   K+A+FG   K   N +      VGT  YI+PE L     DG    + D +S G
Sbjct: 175 LDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 234

Query: 518 VVLLELISG 526
           V L E++ G
Sbjct: 235 VFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 60.7 bits (147), Expect = 3e-10
 Identities = 52/197 (26%), Positives = 96/197 (48%), Gaps = 23/197 (11%)

Query: 342 NFSEGCLIQGSVYKGNIHGEVYAIKMMKWNA--------CEELKILQKVNHGNLVKLEGF 393
           NF  GC+ +G VYK        AIK++K             E +I+ ++++  +V++ G 
Sbjct: 7   NF--GCVKKG-VYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGV 63

Query: 394 CIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRV 453
           C   E     L+ E    G L+ +L   K+E +     + +   V+ G++Y+        
Sbjct: 64  C---EAEALMLVMEMASGGPLNKFLSGKKDE-ITVSNVVELMHQVSMGMKYLEGKN---F 116

Query: 454 VHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVS 508
           VH+D+ + N+LL +   AKI++FGL+K+     + +   + G     + APE +     S
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176

Query: 509 TKMDVFSFGVVLLELIS 525
           ++ DV+S+G+ + E  S
Sbjct: 177 SRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 61.1 bits (148), Expect = 3e-10
 Identities = 48/192 (25%), Positives = 90/192 (46%), Gaps = 22/192 (11%)

Query: 352 SVYKG--NIHGEVYAIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCIDPEDAN 401
           +VYKG   I+G++ A+K++     E        E  +L+ + H N+V L       E   
Sbjct: 20  TVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLT 79

Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSS 461
              ++EY+    L  ++ ++      +  RL     +  GL YIH      ++H+D+K  
Sbjct: 80  --FVFEYMHT-DLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIH---GQHILHRDLKPQ 132

Query: 462 NILLDSNMRAKIANFGLAKSG---CNAITMHIVGTQGYIAPEYLADGV-VSTKMDVFSFG 517
           N+L+      K+A+FGLA++        +  +V T  Y  P+ L      S+ +D++  G
Sbjct: 133 NLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATDYSSALDIWGAG 191

Query: 518 VVLLELISGKEA 529
            + +E++ G+ A
Sbjct: 192 CIFIEMLQGQPA 203

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 60.5 bits (146), Expect = 3e-10
 Identities = 45/162 (27%), Positives = 81/162 (50%), Gaps = 18/162 (11%)

Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL--HENKNENLNWK-TR 431
           E+++L+ + H  +V+  G   D  +    +  EY+  GS+   L  +    E++  K TR
Sbjct: 54  EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR 113

Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM--- 488
                 +  G+ Y+H +    +VH+DIK +NIL DS    K+ +FG +K     I M   
Sbjct: 114 -----QILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR-LQTICMSGT 164

Query: 489 ---HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
               + GT  +++PE ++      K DV+S G  ++E+++ K
Sbjct: 165 GIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 60.8 bits (147), Expect = 4e-10
 Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 34/206 (16%)

Query: 351 GSVYKGNIHGEV-------YAIKMMKWNAC--------EELKILQKVNHGNLVKLEGFCI 395
           G VY+G   G V        AIK +   A          E  ++++ N  ++V+L G  +
Sbjct: 20  GMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG--V 77

Query: 396 DPEDANCYLIYEYIENGSLHSWLHENKNENLN--------WKTRLRIAIDVANGLQYIHE 447
             +     +I E +  G L S+L   + E  N         K  +++A ++A+G+ Y++ 
Sbjct: 78  VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA 137

Query: 448 HTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYL 502
           +   + VH+D+ + N ++  +   KI +FG+ +        +  G +G     +++PE L
Sbjct: 138 N---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD-IYETDYYRKGGKGLLPVRWMSPESL 193

Query: 503 ADGVVSTKMDVFSFGVVLLELISGKE 528
            DGV +T  DV+SFGVVL E+ +  E
Sbjct: 194 KDGVFTTYSDVWSFGVVLWEIATLAE 219

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 61.1 bits (148), Expect = 4e-10
 Identities = 39/128 (30%), Positives = 68/128 (53%), Gaps = 9/128 (7%)

Query: 403 YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSN 462
           + + E++  G L   + +    +L   T    A ++  GLQ++H      ++++D+K  N
Sbjct: 72  FFVMEFLNGGDLMFHIQDKGRFDLYRATFY--AAEIVCGLQFLHSKG---IIYRDLKLDN 126

Query: 463 ILLDSNMRAKIANFGLAKS---GCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVV 519
           ++LD +   KIA+FG+ K    G N  +    GT  YIAPE L     +  +D +SFGV+
Sbjct: 127 VMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQGLKYTFSVDWWSFGVL 185

Query: 520 LLELISGK 527
           L E++ G+
Sbjct: 186 LYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 60.7 bits (147), Expect = 4e-10
 Identities = 43/160 (26%), Positives = 82/160 (51%), Gaps = 20/160 (12%)

Query: 375 ELKILQKVNHGNLVK-LEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           E+ ++++  H N+V  L+ + +  E    +++ EY+  GSL   + E   +        R
Sbjct: 66  EILVMRENKHPNIVNYLDSYLVGDE---LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR 122

Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH---- 489
              +    L+++H +   +V+H+DIKS NILL  +   K+ +FG     C  IT      
Sbjct: 123 ---ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF----CAQITPEQSKR 172

Query: 490 --IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
             +VGT  ++APE +       K+D++S G++ +E++ G+
Sbjct: 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 60.5 bits (147), Expect = 5e-10
 Identities = 35/119 (29%), Positives = 63/119 (52%), Gaps = 8/119 (6%)

Query: 414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKI 473
            + +++E     +  +   +IA+     L Y+ E  +  ++H+D+K SNILLD N   K+
Sbjct: 92  FYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKL 149

Query: 474 ANFGLAKSGCNAIT-MHIVGTQGYIAPEYLA----DGVVSTKMDVFSFGVVLLELISGK 527
            +FG++    ++I      G + Y+APE +     DG    + DV+S G+ L E+ +GK
Sbjct: 150 CDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDG-YDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 60.8 bits (148), Expect = 5e-10
 Identities = 32/93 (34%), Positives = 54/93 (58%), Gaps = 15/93 (16%)

Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPE 500
           GL+YIH      ++H+D+K SNI ++ +   KI +FGLA+   + +T + V T+ Y APE
Sbjct: 130 GLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGY-VATRWYRAPE 185

Query: 501 YLADGVVSTKM------DVFSFGVVLLELISGK 527
                ++   M      D++S G ++ EL++GK
Sbjct: 186 -----IMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 61.8 bits (150), Expect = 6e-10
 Identities = 45/192 (23%), Positives = 83/192 (43%), Gaps = 34/192 (17%)

Query: 364 AIKMMKWNACE----------ELKILQKVNHGNLVKL--EGFCIDPEDANCYLIYEYIEN 411
           AIK+++ +A E          E  +  ++ H N+V L   G          + ++EY+  
Sbjct: 7   AIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA---PPGLLFAVFEYVPG 63

Query: 412 GSLHSWLHENKNEN-LNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL---DS 467
            +L   L     +  L      R+ + V + L   H      +VH+D+K  NI++     
Sbjct: 64  RTLREVL---AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGV 117

Query: 468 NMRAKIANFGLAK--SGCNAI-------TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGV 518
              AK+ +FG+     G           T  ++GT  Y APE L    V+   D++++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177

Query: 519 VLLELISGKEAI 530
           + LE ++G+  +
Sbjct: 178 IFLECLTGQRVV 189

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 60.4 bits (146), Expect = 6e-10
 Identities = 46/152 (30%), Positives = 71/152 (46%), Gaps = 11/152 (7%)

Query: 378 ILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI-AI 436
           +L+ + H  LV L       E    Y + +Y+  G L  + H  + E    + R R  A 
Sbjct: 49  LLKNLKHPFLVGLHYSFQTAE--KLYFVLDYVNGGEL--FFHLQR-ERCFLEPRARFYAA 103

Query: 437 DVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC--NAITMHIVGTQ 494
           +VA+ + Y+H      ++++D+K  NILLDS     + +FGL K G      T    GT 
Sbjct: 104 EVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTP 160

Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            Y+APE L        +D +  G VL E++ G
Sbjct: 161 EYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 60.5 bits (147), Expect = 6e-10
 Identities = 51/178 (28%), Positives = 91/178 (51%), Gaps = 20/178 (11%)

Query: 362 VYAIKMMKWNACEELKILQKV-NHGNLVKLEGFCI-DPEDANCYLIYEYIENGSLHSWLH 419
           V++ K++   A  ELK+L+    H N+  L    I  P + N   +YE +    LH  + 
Sbjct: 38  VFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIR 97

Query: 420 ENKN-ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGL 478
             +   + ++++ +     +  GL+YIH      V+H+D+K  N+L++++   KI +FGL
Sbjct: 98  SGQPLTDAHFQSFI---YQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGL 151

Query: 479 AKSGCNA--------ITMHIVGTQGYIAPE-YLADGVVSTKMDVFSFGVVLLELISGK 527
           A+ G +         +T + V T+ Y APE  L+    +  +DV+S G +L EL+  K
Sbjct: 152 AR-GFSENPGENAGFMTEY-VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 59.8 bits (145), Expect = 7e-10
 Identities = 53/212 (25%), Positives = 102/212 (48%), Gaps = 36/212 (16%)

Query: 332 KIEELREATDNFSEGCLIQGSVYKGNIH--GEVYAIKMMKW---------NACEELKILQ 380
           K+E++ E T          G+V+K       E+ A+K ++          +A  E+ +L+
Sbjct: 4   KLEKIGEGT---------YGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLK 54

Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
           ++ H N+V+L  + +   D    L++EY +   L  +  ++ N +++ +        +  
Sbjct: 55  ELKHKNIVRL--YDVLHSDKKLTLVFEYCDQ-DLKKYF-DSCNGDIDPEIVKSFMFQLLK 110

Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-----GCNAITMHIVGTQG 495
           GL + H H    V+H+D+K  N+L++ N   K+A+FGLA++      C +     V T  
Sbjct: 111 GLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS---AEVVTLW 164

Query: 496 YIAPEYLADG-VVSTKMDVFSFGVVLLELISG 526
           Y  P+ L    + ST +D++S G +  EL + 
Sbjct: 165 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 59.7 bits (145), Expect = 8e-10
 Identities = 47/195 (24%), Positives = 89/195 (45%), Gaps = 31/195 (15%)

Query: 351 GSVYKGNIH---GEV--YAIKMMKWNA--------CEELKILQKVNHGNLVKLEGFCIDP 397
           G VY+G       E    A+K  K            +E  I+++ +H ++VKL G     
Sbjct: 20  GDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVI--- 76

Query: 398 EDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKD 457
            +   +++ E    G L S+L  NK  +L+  + +  +  ++  L Y+      R VH+D
Sbjct: 77  TENPVWIVMELAPLGELRSYLQVNKY-SLDLASLILYSYQLSTALAYLESK---RFVHRD 132

Query: 458 IKSSNILLDSNMRAKIANFGLAKSGCNAITMHIV--GTQG-----YIAPEYLADGVVSTK 510
           I + N+L+ S    K+ +FGL++     +        ++G     ++APE +     ++ 
Sbjct: 133 IAARNVLVSSPDCVKLGDFGLSR----YLEDESYYKASKGKLPIKWMAPESINFRRFTSA 188

Query: 511 MDVFSFGVVLLELIS 525
            DV+ FGV + E++ 
Sbjct: 189 SDVWMFGVCMWEILM 203

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 59.4 bits (144), Expect = 8e-10
 Identities = 49/173 (28%), Positives = 84/173 (48%), Gaps = 34/173 (19%)

Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNE-NLNWKTRL 432
           E   ++ +++H +LVKL G C+  E+    ++ EY++ G L  +LH  KN  +L+WK  L
Sbjct: 50  ETASLMSQLSHKHLVKLYGVCVRDENI---MVEEYVKFGPLDVFLHREKNNVSLHWK--L 104

Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL---DSNMR----AKIANFGLAKSGCNA 485
            +A  +A+ L Y+ +     +VH ++   NIL+     N       K+++ G+  +    
Sbjct: 105 DVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT---- 157

Query: 486 ITMHIVGTQGY-------IAPEYLADGVVSTK--MDVFSFGVVLLELISGKEA 529
                V ++         IAPE + +G  S     D +SFG  LLE+ S  E 
Sbjct: 158 -----VLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEE 205

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 59.5 bits (144), Expect = 8e-10
 Identities = 52/207 (25%), Positives = 95/207 (45%), Gaps = 42/207 (20%)

Query: 346 GCLIQGSVYKGNIHGEVYAIKMMKWNAC--EELKILQKV------NHGNLVKLEGFCIDP 397
           G ++ G  ++G     V  +K ++ +A   E+L  LQ+V      NH N+++  G CI  
Sbjct: 9   GKVLLGEAHRGMSKARV-VVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI-- 65

Query: 398 EDANCYLIYEYIENGSLHSWLHENK---NENLNWKTRLRIAIDVANGLQYIHEHTRPRVV 454
           E     L+ E+   G L ++L  N+    +        R+A +VA+GL ++H   +   +
Sbjct: 66  ESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFI 122

Query: 455 HKDIKSSNILLDSNMRAKIANFGLAKS----------GCNAITMHIVGTQGYIAPEYLAD 504
           H D+   N  L +++  KI ++GLA             C+A+ +       ++APE L +
Sbjct: 123 HSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR------WLAPE-LVE 175

Query: 505 GV--------VSTKMDVFSFGVVLLEL 523
                      + K +++S GV + EL
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 59.7 bits (145), Expect = 9e-10
 Identities = 30/100 (30%), Positives = 60/100 (60%), Gaps = 7/100 (7%)

Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI-V 491
           +IA+ +   L+Y+H   +  V+H+D+K SN+L++ N + K+ +FG++    +++   I  
Sbjct: 107 KIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA 164

Query: 492 GTQGYIAPEYL-ADGVVS---TKMDVFSFGVVLLELISGK 527
           G + Y+APE +  +        K DV+S G+ ++EL +G+
Sbjct: 165 GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 60.2 bits (146), Expect = 9e-10
 Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 35/197 (17%)

Query: 360 GEVYAIKMMKWNAC----------EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI 409
           G++YA+K+MK +            EE  IL   N   + +L+    D +  N YL+ EY 
Sbjct: 26  GDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD--NLYLVMEYQ 83

Query: 410 ENGSLHSWL--HENK-NENLN--WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNIL 464
             G L S L  +E++ +E++   +   L +AI   + + Y         VH+DIK  N+L
Sbjct: 84  PGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGY---------VHRDIKPENVL 134

Query: 465 LDSNMRAKIANFG-LAKSGCNAITMHI--VGTQGYIAPEYL------ADGVVSTKMDVFS 515
           +D     K+A+FG  A+   N +      VGT  YIAPE L        G    + D +S
Sbjct: 135 IDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWS 194

Query: 516 FGVVLLELISGKEAIDE 532
            GV+  E+I G+    E
Sbjct: 195 LGVIAYEMIYGRSPFHE 211

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 59.4 bits (143), Expect = 1e-09
 Identities = 42/160 (26%), Positives = 83/160 (51%), Gaps = 20/160 (12%)

Query: 375 ELKILQKVNHGNLVK-LEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           E+ +++++ + N+V  L+ F +  E    +++ EY+  GSL   + E   +        R
Sbjct: 66  EILVMKELKNPNIVNFLDSFLVGDE---LFVVMEYLAGGSLTDVVTETCMDEAQIAAVCR 122

Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH---- 489
              +    L+++H +   +V+H+DIKS N+LL  +   K+ +FG     C  IT      
Sbjct: 123 ---ECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGF----CAQITPEQSKR 172

Query: 490 --IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
             +VGT  ++APE +       K+D++S G++ +E++ G+
Sbjct: 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 59.8 bits (145), Expect = 1e-09
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 20/165 (12%)

Query: 375 ELKILQKVNHGNLVKLEGFCIDP---EDANCYLIYEYIENGSLHSWLHE--NKNENLNWK 429
           E+K+L+ + H ++V+++   + P   E  + Y+++E +E     S LH+    N++L  +
Sbjct: 49  EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-----SDLHQVIKANDDLTPE 103

Query: 430 TRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH 489
                   +   L+YIH      V H+D+K  NIL +++ + KI +FGLA+   N     
Sbjct: 104 HHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 160

Query: 490 I-----VGTQGYIAPEYLAD--GVVSTKMDVFSFGVVLLELISGK 527
           I     V T+ Y APE         +  +D++S G +  E+++GK
Sbjct: 161 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 59.0 bits (142), Expect = 1e-09
 Identities = 43/160 (26%), Positives = 82/160 (51%), Gaps = 20/160 (12%)

Query: 375 ELKILQKVNHGNLVK-LEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           E+ ++++  + N+V  L+ + +  E    +++ EY+  GSL   + E   +        R
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDE---LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR 123

Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT------ 487
              +    L+++H +   +V+H+DIKS NILL  +   K+ +FG     C  IT      
Sbjct: 124 ---ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF----CAQITPEQSKR 173

Query: 488 MHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
             +VGT  ++APE +       K+D++S G++ +E+I G+
Sbjct: 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 41/155 (26%), Positives = 83/155 (53%), Gaps = 11/155 (7%)

Query: 374 EELKILQKVNHGNLVK-LEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNEN--LNWKT 430
           +E+ +L+++NH N++K L+ F    ED    ++ E  + G L   +   K +   +  +T
Sbjct: 51  KEIDLLKQLNHPNVIKYLDSFI---EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERT 107

Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK--SGCNAITM 488
             +  + + + ++  H H+R RV+H+DIK +N+ + +    K+ + GL +  S       
Sbjct: 108 VWKYFVQLCSAVE--HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH 164

Query: 489 HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLEL 523
            +VGT  Y++PE + +   + K D++S G +L E+
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 44/161 (27%), Positives = 82/161 (50%), Gaps = 15/161 (9%)

Query: 372 ACEELKILQKVNHGNLVKLEGFCIDPEDA-----NCYLIYEYIENGSLHSWLHENKNENL 426
           A  EL +L+ VNH N++ L      P+ +     + YL+ E ++         E  +E +
Sbjct: 67  AYRELVLLKCVNHKNIISLLN-VFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERM 125

Query: 427 NWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI 486
           ++     +   +  G++++H      ++H+D+K SNI++ S+   KI +FGLA++ C   
Sbjct: 126 SY-----LLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF 177

Query: 487 TMH-IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            M   V T+ Y APE +        +D++S G ++ EL+ G
Sbjct: 178 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 59.2 bits (144), Expect = 2e-09
 Identities = 56/215 (26%), Positives = 88/215 (40%), Gaps = 62/215 (28%)

Query: 360 GEVYAIKMM-KW---------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI 409
           G+VYA+K++ K          +   E  IL   +   +VKL  +    ++ + YL+ EY+
Sbjct: 26  GQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL--YYSFQDEEHLYLVMEYM 83

Query: 410 ENGSLHSWL--HENKNENLNWKTRLRI-----AIDVANGLQYIHEHTRPRVVHKDIKSSN 462
             G L + L   +   E      R  I     A+D  + L +IH         +DIK  N
Sbjct: 84  PGGDLMNLLIRKDVFPEET---ARFYIAELVLALDSVHKLGFIH---------RDIKPDN 131

Query: 463 ILLDSNMRAKIANFGLAKSG------------------CNAITMH-------------IV 491
           IL+D++   K+A+FGL K                     + + +               V
Sbjct: 132 ILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTV 191

Query: 492 GTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           GT  YIAPE L       + D +S GV+L E++ G
Sbjct: 192 GTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 59.6 bits (144), Expect = 2e-09
 Identities = 66/236 (27%), Positives = 103/236 (43%), Gaps = 40/236 (16%)

Query: 316 NFMADVSDCLDKYRIFKIE-ELREATDNFSEGCLIQGSVYKGNIHGEVYAIKMMK----- 369
           NF+    D ++K R  +++ E  E       G   +  + +     +VYA+K++      
Sbjct: 23  NFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI 82

Query: 370 --------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHEN 421
                   W   EE  I+   N   +V+L  F    +D   Y++ EY+  G L + L  N
Sbjct: 83  KRSDSAFFW---EERDIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVN-LMSN 136

Query: 422 KNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFG---- 477
            +    W  R   A +V   L  IH       +H+D+K  N+LLD +   K+A+FG    
Sbjct: 137 YDVPEKW-ARFYTA-EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK 191

Query: 478 LAKSG---CNAITMHIVGTQGYIAPEYL----ADGVVSTKMDVFSFGVVLLELISG 526
           + K G   C+      VGT  YI+PE L     DG    + D +S GV L E++ G
Sbjct: 192 MNKEGMVRCDT----AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 58.3 bits (142), Expect = 2e-09
 Identities = 50/175 (28%), Positives = 81/175 (46%), Gaps = 16/175 (9%)

Query: 365 IKMMKWNACE-ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKN 423
           IK   +NA E  +  L K ++ N +KL  + +     +  LI +YI++G L   L   K 
Sbjct: 49  IKAKNFNAIEPMVHQLMK-DNPNFIKLY-YSVTTLKGH-VLIMDYIKDGDLFDLLK--KE 103

Query: 424 ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM-RAKIANFGLAKSG 482
             L+     +I   +   L  +H+H    ++H DIK  N+L D    R  + ++GL K  
Sbjct: 104 GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKI- 159

Query: 483 CNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG----KEAIDEE 533
               + +  GT  Y +PE +         D ++ GV+  EL++G    KE  DEE
Sbjct: 160 IGTPSCY-DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213

Length = 267

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 55/186 (29%), Positives = 84/186 (45%), Gaps = 31/186 (16%)

Query: 361 EVYAIKMMK-------------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYE 407
           +VYA+K++              W   EE  I+   N   +V+L  FC   +D   Y++ E
Sbjct: 69  KVYAMKLLSKFEMIKRSDSAFFW---EERDIMAFANSPWVVQL--FCAFQDDKYLYMVME 123

Query: 408 YIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS 467
           Y+  G L + L  N +    W  +   A +V   L  IH      ++H+D+K  N+LLD 
Sbjct: 124 YMPGGDLVN-LMSNYDVPEKW-AKFYTA-EVVLALDAIHSMG---LIHRDVKPDNMLLDK 177

Query: 468 NMRAKIANFGLAKSGCNAITMHI---VGTQGYIAPEYL----ADGVVSTKMDVFSFGVVL 520
           +   K+A+FG          +     VGT  YI+PE L     DG    + D +S GV L
Sbjct: 178 HGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 237

Query: 521 LELISG 526
            E++ G
Sbjct: 238 FEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 58/224 (25%), Positives = 97/224 (43%), Gaps = 39/224 (17%)

Query: 326 DKYRIFKIEELREATDNFSEGCLIQGSVYKGN--IHGEVYAIKMMKWN---------ACE 374
           D Y   K+E++ E T          G VYK      G++ A+K  +           A  
Sbjct: 1   DAYE--KLEKIGEGT---------YGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR 49

Query: 375 ELKILQKVNHGN----LVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNEN---LN 427
           E+ +LQ ++       L+ +E         + YL++EY+++  L  ++  N       L 
Sbjct: 50  EISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLP 108

Query: 428 WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLD-SNMRAKIANFGLAKS---GC 483
            KT       +  G+ + H+H    V+H+D+K  N+L+D      KIA+ GL ++     
Sbjct: 109 AKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPV 165

Query: 484 NAITMHIVGTQGYIAPEYLADGV-VSTKMDVFSFGVVLLELISG 526
            + T  IV T  Y APE L      ST +D++S G +  E+   
Sbjct: 166 KSYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 52/187 (27%), Positives = 90/187 (48%), Gaps = 21/187 (11%)

Query: 351 GSVYKG-NIH-GEVYAIKMMKWNACEELKILQK-------VNHGNLVKLEGFCIDPEDAN 401
           G VYK  N++ GE+ AIK++K    E+  ++Q+         H N+V   G  +  +   
Sbjct: 23  GDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD--K 80

Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSS 461
            ++  E+   GSL    H      L+      ++ +   GL Y+H   +   +H+DIK +
Sbjct: 81  LWICMEFCGGGSLQDIYHVTGP--LSESQIAYVSRETLQGLYYLHSKGK---MHRDIKGA 135

Query: 462 NILLDSNMRAKIANFGLAK--SGCNAITMHIVGTQGYIAPEYLA---DGVVSTKMDVFSF 516
           NILL  N   K+A+FG++   +   A     +GT  ++APE  A    G  +   D+++ 
Sbjct: 136 NILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAV 195

Query: 517 GVVLLEL 523
           G+  +EL
Sbjct: 196 GITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 48/157 (30%), Positives = 76/157 (48%), Gaps = 18/157 (11%)

Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E KIL  +NH   V L G   D  ++  YL+ E++  G   ++L  NK          R 
Sbjct: 81  ERKILNYINHPFCVNLYGSFKD--ESYLYLVLEFVIGGEFFTFLRRNK----------RF 128

Query: 435 AIDV----ANGLQYIHEHTRP-RVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH 489
             DV    A  +  I E+ +   +V++D+K  N+LLD +   K+ +FG AK   +  T  
Sbjct: 129 PNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-VDTRTYT 187

Query: 490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           + GT  YIAPE L +       D ++ G+ + E++ G
Sbjct: 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 50/185 (27%), Positives = 83/185 (44%), Gaps = 20/185 (10%)

Query: 355 KGNIHGEVYAIKMMK----WNACEELKI-------LQKVNHGNLVKLEGFCIDPEDANCY 403
           K  + G+ YA+K+++     N  E+  I       L+ V H  LV L  +     +   Y
Sbjct: 15  KRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH-YSFQTTE-KLY 72

Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI 463
            + +++  G L  + H  +  +         A ++A+ L Y+H      +V++D+K  NI
Sbjct: 73  FVLDFVNGGEL--FFHLQRERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENI 127

Query: 464 LLDSNMRAKIANFGLAKSGCNA--ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLL 521
           LLDS     + +FGL K G      T    GT  Y+APE +        +D +  G VL 
Sbjct: 128 LLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLY 187

Query: 522 ELISG 526
           E++ G
Sbjct: 188 EMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 57.4 bits (138), Expect = 4e-09
 Identities = 47/182 (25%), Positives = 87/182 (47%), Gaps = 27/182 (14%)

Query: 360 GEVYAIKMMKWNA-------CEELKILQKVNHGNLVK-LEGFCIDPEDANCYLIYEYIEN 411
           G+  AIK M             E+ ++++  + N+V  L+ + +  E    +++ EY+  
Sbjct: 44  GQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDE---LWVVMEYLAG 100

Query: 412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRA 471
           GSL   + E   +        R   +    L ++H +   +V+H+DIKS NILL  +   
Sbjct: 101 GSLTDVVTETCMDEGQIAAVCR---ECLQALDFLHSN---QVIHRDIKSDNILLGMDGSV 154

Query: 472 KIANFGLAKSGCNAITMH------IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           K+ +FG     C  IT        +VGT  ++APE +       K+D++S G++ +E++ 
Sbjct: 155 KLTDFGF----CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVE 210

Query: 526 GK 527
           G+
Sbjct: 211 GE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 57.3 bits (138), Expect = 5e-09
 Identities = 39/138 (28%), Positives = 73/138 (52%), Gaps = 17/138 (12%)

Query: 404 LIYEYIENGSLHSWLHENKNENLN--------WKTRLRIAIDVANGLQYIHEHTRPRVVH 455
           ++ E + +G L S+L   + E  N         +  +++A ++A+G+ Y++     + VH
Sbjct: 86  VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVH 142

Query: 456 KDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTK 510
           +D+ + N ++  +   KI +FG+ +        +  G +G     ++APE L DGV +T 
Sbjct: 143 RDLAARNCMVAHDFTVKIGDFGMTRD-IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTS 201

Query: 511 MDVFSFGVVLLELISGKE 528
            D++SFGVVL E+ S  E
Sbjct: 202 SDMWSFGVVLWEITSLAE 219

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 57.1 bits (138), Expect = 5e-09
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 10/133 (7%)

Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
           D   +LI +Y+  G L + L++ ++   + + R+ IA ++   L ++H+     ++++DI
Sbjct: 77  DTKLHLILDYVNGGELFTHLYQREHFTES-EVRVYIA-EIVLALDHLHQL---GIIYRDI 131

Query: 459 KSSNILLDSNMRAKIANFGLAK---SGCNAITMHIVGTQGYIAPEYL--ADGVVSTKMDV 513
           K  NILLDS     + +FGL+K   +          GT  Y+APE +    G     +D 
Sbjct: 132 KLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDW 191

Query: 514 FSFGVVLLELISG 526
           +S GV+  EL++G
Sbjct: 192 WSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 57.6 bits (139), Expect = 6e-09
 Identities = 41/161 (25%), Positives = 83/161 (51%), Gaps = 14/161 (8%)

Query: 372 ACEELKILQKVNHGNLVKL-EGFCIDP---EDANCYLIYEYIENGSLHSWLHENKNENLN 427
           A  EL +L+ + H N++ L + F       E  + YL+  Y++        H    + + 
Sbjct: 61  AYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQ 120

Query: 428 WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT 487
           +     +   +  GL+YIH      ++H+D+K  N+ ++ +   KI +FGLA+     +T
Sbjct: 121 Y-----LVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMT 172

Query: 488 MHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELISGK 527
            ++V T+ Y APE + + +   + +D++S G ++ E+++GK
Sbjct: 173 GYVV-TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 57.0 bits (137), Expect = 6e-09
 Identities = 53/207 (25%), Positives = 98/207 (47%), Gaps = 26/207 (12%)

Query: 338 EATDNFSEGCLIQGSVYKGN--IHGEVYAIKMMK--------WNACEELKILQKVNHGNL 387
           E  +   EG     +VYKG   ++G++ A+K+++        + A  E  +L+ + H N+
Sbjct: 8   EKLEKLGEGSY--ATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65

Query: 388 VKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHE 447
           V L       E     L++EY+    L  ++ ++    L+ +        +  GL YIH+
Sbjct: 66  VLLHDIIHTKETLT--LVFEYVHT-DLCQYMDKHPG-GLHPENVKLFLFQLLRGLSYIHQ 121

Query: 448 HTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI----VGTQGYIAPEYLA 503
                ++H+D+K  N+L+      K+A+FGLA++   ++  H     V T  Y  P+ L 
Sbjct: 122 RY---ILHRDLKPQNLLISDTGELKLADFGLARA--KSVPSHTYSNEVVTLWYRPPDVLL 176

Query: 504 DGV-VSTKMDVFSFGVVLLELISGKEA 529
                ST +D++  G + +E+I G  A
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGVAA 203

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 57.0 bits (137), Expect = 7e-09
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 26/207 (12%)

Query: 334 EELREATDNFSEGCLIQGSVYKGNIH--GEVYAIKMMKWNACEELK-------ILQKVNH 384
           EE  E      +G    G VYK      G + A K++   + EEL+       IL   +H
Sbjct: 4   EEFWEIIGELGDGAF--GKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDH 61

Query: 385 GNLVKL-EGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQ 443
            N+VKL + F  +    N +++ E+   G++ + + E +      + R+ +       L 
Sbjct: 62  PNIVKLLDAFYYE---NNLWILIEFCAGGAVDAVMLELERPLTEPQIRV-VCKQTLEALN 117

Query: 444 YIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH--IVGTQGYIAPEY 501
           Y+HE+   +++H+D+K+ NIL   +   K+A+FG++      I      +GT  ++APE 
Sbjct: 118 YLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEV 174

Query: 502 L-----ADGVVSTKMDVFSFGVVLLEL 523
           +      D     K DV+S G+ L+E+
Sbjct: 175 VMCETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 56.9 bits (137), Expect = 7e-09
 Identities = 50/200 (25%), Positives = 92/200 (46%), Gaps = 30/200 (15%)

Query: 356 GNIHGEVYAIKMMKWNACEELKILQKVNHGNLVKLEGFCID---------------PEDA 400
           G+  G++YA+K++K     +  I+QK       + E   ++                 D 
Sbjct: 24  GHDSGKLYAMKVLK-----KATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDT 78

Query: 401 NCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             +LI +YI  G L +  H ++ E    +     + ++   L+++H   +  ++++DIK 
Sbjct: 79  KLHLILDYINGGELFT--HLSQRERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKL 133

Query: 461 SNILLDSNMRAKIANFGLAK---SGCNAITMHIVGTQGYIAPEYLA--DGVVSTKMDVFS 515
            NILLDSN    + +FGL+K              GT  Y+AP+ +   DG     +D +S
Sbjct: 134 ENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWS 193

Query: 516 FGVVLLELISGKEAIDEEGK 535
            GV++ EL++G      +G+
Sbjct: 194 MGVLMYELLTGASPFTVDGE 213

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 57.0 bits (137), Expect = 8e-09
 Identities = 55/213 (25%), Positives = 102/213 (47%), Gaps = 34/213 (15%)

Query: 345 EGCLI----QGSVYK-----GNIHGEVYAIKMMK-----WNACEELKILQKVNHGNLVKL 390
           EGC +     G VYK     G    E YA+K ++      +AC E+ +L+++ H N++ L
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGKDEKE-YALKQIEGTGISMSACREIALLRELKHPNVIAL 63

Query: 391 EGFCIDPEDANCYLIYEYIENG-----SLHSWLHENKNENLNWKTRLR-IAIDVANGLQY 444
           +   +   D   +L+++Y E+        H     NK      ++ ++ +   + +G+ Y
Sbjct: 64  QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123

Query: 445 IHEHTRPRVVHKDIKSSNILL----DSNMRAKIANFGLAKSGCNAITM-----HIVGTQG 495
           +H +    V+H+D+K +NIL+        R KIA+ G A+   + +        +V T  
Sbjct: 124 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 496 YIAPEYLADGVVSTK-MDVFSFGVVLLELISGK 527
           Y APE L      TK +D+++ G +  EL++ +
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 56.5 bits (136), Expect = 9e-09
 Identities = 44/185 (23%), Positives = 86/185 (46%), Gaps = 34/185 (18%)

Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNE---------- 424
           E ++L  + H ++V+  G C +       +++EY+ +G L+ +L  +  +          
Sbjct: 57  EAELLTVLQHQHIVRFYGVCTEGRP--LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDV 114

Query: 425 ---NLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS 481
               L     L IA  +A+G+ Y+        VH+D+ + N L+   +  KI +FG+++ 
Sbjct: 115 APGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD 171

Query: 482 GCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLEL----------ISG 526
              +   + VG +      ++ PE +     +T+ D++SFGVVL E+          +S 
Sbjct: 172 -IYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN 230

Query: 527 KEAID 531
            EAI+
Sbjct: 231 TEAIE 235

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 40/121 (33%), Positives = 64/121 (52%), Gaps = 28/121 (23%)

Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----------SGCNAIT 487
           VA G++++      + +H+D+ + NILL  N   KI +FGLA+           G   + 
Sbjct: 182 VARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238

Query: 488 MHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEA------IDEEGKFCGQKL 541
           +       ++APE + D V +T+ DV+SFGV+L E+ S   +      IDEE  FC ++L
Sbjct: 239 LK------WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FC-RRL 289

Query: 542 K 542
           K
Sbjct: 290 K 290

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 56.0 bits (135), Expect = 1e-08
 Identities = 41/161 (25%), Positives = 82/161 (50%), Gaps = 15/161 (9%)

Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNE-NLNWKTRL 432
           E   ++ +++H +LV   G C+  +++   ++ EY++ GSL ++L +NKN  N++WK  L
Sbjct: 48  EAASMMSQLSHKHLVLNYGVCVCGDES--IMVQEYVKFGSLDTYLKKNKNLINISWK--L 103

Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVG 492
            +A  +A  L ++ +     + H ++ + N+LL      K  N    K     I++ ++ 
Sbjct: 104 EVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP 160

Query: 493 TQ------GYIAPEYLADG-VVSTKMDVFSFGVVLLELISG 526
            +       ++ PE + +   +S   D +SFG  L E+ SG
Sbjct: 161 KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 43/137 (31%), Positives = 70/137 (51%), Gaps = 34/137 (24%)

Query: 428 WKTRLRI------AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK- 480
           WK+ L +      +  VA G++++      + +H+D+ + NILL  N   KI +FGLA+ 
Sbjct: 167 WKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARD 223

Query: 481 ---------SGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEA-- 529
                     G   + +       ++APE + D V +T+ DV+SFGV+L E+ S   +  
Sbjct: 224 IYKDPDYVRKGSARLPLK------WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 277

Query: 530 ----IDEEGKFCGQKLK 542
               I+EE  FC Q+LK
Sbjct: 278 PGVQINEE--FC-QRLK 291

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 54/200 (27%), Positives = 95/200 (47%), Gaps = 22/200 (11%)

Query: 341 DNFSEGCLIQGSVYKG--NIHGEVYAIKMMKW--------NACEELKILQKVNHGNLVKL 390
           D   EG     +VYKG   +   + A+K ++          A  E+ +L+ + H N+V L
Sbjct: 12  DKLGEGTY--ATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL 69

Query: 391 EGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTR 450
               I   + +  L++EY++   L  +L +  N ++N          +  GL Y H   R
Sbjct: 70  HD--IIHTEKSLTLVFEYLDK-DLKQYLDDCGN-SINMHNVKLFLFQLLRGLNYCH---R 122

Query: 451 PRVVHKDIKSSNILLDSNMRAKIANFGL--AKSGCNAITMHIVGTQGYIAPEYLADGV-V 507
            +V+H+D+K  N+L++     K+A+FGL  AKS       + V T  Y  P+ L      
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDY 182

Query: 508 STKMDVFSFGVVLLELISGK 527
           ST++D++  G +  E+ +G+
Sbjct: 183 STQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 57.4 bits (138), Expect = 1e-08
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 35/205 (17%)

Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+ +++++ H N+V+     ++  +   Y++ E+ + G L   +   K   +  K     
Sbjct: 62  EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQ--KCYKMFGKIEEHA 119

Query: 435 AIDVA----NGLQYIHE----HTRPRVVHKDIKSSNILLDSNMR---------------- 470
            +D+     + L Y H         RV+H+D+K  NI L + +R                
Sbjct: 120 IVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRP 179

Query: 471 -AKIANFGLAKS-GCNAITMHIVGTQGYIAPEYLADGVVS--TKMDVFSFGVVLLELISG 526
            AKI +FGL+K+ G  ++    VGT  Y +PE L     S   K D+++ G ++ EL SG
Sbjct: 180 IAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239

Query: 527 KEAIDEEGKFCGQKLKGYWREMKRG 551
           K    +   F  Q +     E+KRG
Sbjct: 240 KTPFHKANNF-SQLIS----ELKRG 259

Length = 1021

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 40/221 (18%)

Query: 329 RIFKIEELREATDNFSEGCLIQGSVYKG-------NIHGEVYAIKMMKWNAC-------- 373
           RI K  EL++       G    G+VYKG       N+   V AIK+++ N          
Sbjct: 2   RILKETELKKVK-VLGSGAF--GTVYKGIWIPDGENVKIPV-AIKVLRENTSPKANKEIL 57

Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKN-----ENLNW 428
           +E  ++  V    + +L G C+    +   L+ + +  G L  ++ ENK+     + LNW
Sbjct: 58  DEAYVMAGVGSPYVCRLLGICLT---STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNW 114

Query: 429 KTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK-SGCNAIT 487
                  + +A G+ Y+ E    R+VH+D+ + N+L+ S    KI +FGLA+    +   
Sbjct: 115 ------CVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE 165

Query: 488 MHIVGTQ---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
            H  G +    ++A E +     + + DV+S+GV + EL++
Sbjct: 166 YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 45/159 (28%), Positives = 80/159 (50%), Gaps = 10/159 (6%)

Query: 372 ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTR 431
           A  E+ +L+ + H N+V L    I   D +  L++EY++   L  ++ +  N       +
Sbjct: 51  AIREVSLLKDLKHANIVTLHD--IVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVK 107

Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGL--AKSGCNAITMH 489
           + +   +  GL Y H   R +V+H+D+K  N+L++     K+A+FGL  AKS       +
Sbjct: 108 IFL-YQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSN 163

Query: 490 IVGTQGYIAPE-YLADGVVSTKMDVFSFGVVLLELISGK 527
            V T  Y  P+  L     ST++D++  G +  E+ SG+
Sbjct: 164 EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 56.5 bits (136), Expect = 2e-08
 Identities = 44/162 (27%), Positives = 79/162 (48%), Gaps = 11/162 (6%)

Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  IL+ +NH ++++L+G         C ++  Y     L+ +L   +N  +     L I
Sbjct: 133 EAHILRAINHPSIIQLKG-TFTYNKFTCLILPRY--KTDLYCYLAAKRN--IAICDILAI 187

Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
              V   +QY+HE+   R++H+DIK+ NI ++      + +FG A    +       G  
Sbjct: 188 ERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA 244

Query: 495 GYIA---PEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE 533
           G IA   PE LA       +D++S G+VL E+ +  +++ E+
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEK 286

Length = 391

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 56.1 bits (135), Expect = 2e-08
 Identities = 41/142 (28%), Positives = 74/142 (52%), Gaps = 11/142 (7%)

Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAI-DVANGLQYIHEHTRPRVVHKD 457
           +A  +LI +Y+  G + + L++  N +   +  +R    ++   L+++H   +  +V++D
Sbjct: 77  EAKLHLILDYVSGGEMFTHLYQRDNFS---EDEVRFYSGEIILALEHLH---KLGIVYRD 130

Query: 458 IKSSNILLDSNMRAKIANFGLAK---SGCNAITMHIVGTQGYIAPEYL-ADGVVSTKMDV 513
           IK  NILLDS     + +FGL+K   S     T    GT  Y+APE +   G     +D 
Sbjct: 131 IKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDW 190

Query: 514 FSFGVVLLELISGKEAIDEEGK 535
           +S G+++ EL++G      EG+
Sbjct: 191 WSLGILIFELLTGASPFTLEGE 212

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 57/192 (29%), Positives = 89/192 (46%), Gaps = 36/192 (18%)

Query: 360 GEVYAIKMM-KWN-------AC--EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI 409
           G+VYA+K++ KW        AC  EE  +L   +   +  L  +    E+ N YL+ +Y 
Sbjct: 26  GQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLH-YAFQDEN-NLYLVMDYY 83

Query: 410 ENG---SLHSWLHENKNENLN--WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNIL 464
             G   +L S   +   E++   +   + +AID  + L Y         VH+DIK  N+L
Sbjct: 84  VGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGY---------VHRDIKPDNVL 134

Query: 465 LDSNMRAKIANFG----LAKSGCNAITMHIVGTQGYIAPEYL-----ADGVVSTKMDVFS 515
           LD N   ++A+FG    L   G     +  VGT  YI+PE L       G    + D +S
Sbjct: 135 LDKNGHIRLADFGSCLRLLADGTVQSNV-AVGTPDYISPEILQAMEDGKGRYGPECDWWS 193

Query: 516 FGVVLLELISGK 527
            GV + E++ G+
Sbjct: 194 LGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 56.6 bits (136), Expect = 2e-08
 Identities = 47/167 (28%), Positives = 82/167 (49%), Gaps = 25/167 (14%)

Query: 372 ACEELKILQKVNHGNLVK-LEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           A  EL  L   +H  +VK  + F     D    LI EY   G L+  + +   E+L ++ 
Sbjct: 112 ARSELHCLAACDHFGIVKHFDDF---KSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQE 168

Query: 431 --------RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG 482
                   ++ +A+D          H+R +++H+D+KS+NI L      K+ +FG +K  
Sbjct: 169 YEVGLLFYQIVLALD--------EVHSR-KMMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219

Query: 483 CNAITMHI----VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
            +++++ +     GT  Y+APE       S K D++S GV+L EL++
Sbjct: 220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 32/212 (15%)

Query: 345 EGCLI----QGSVYKGNIHG----EVYAIKMMK-----WNACEELKILQKVNHGNLVKLE 391
           EGC +     G VYK           YA+K ++      +AC E+ +L+++ H N++ L+
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQ 64

Query: 392 GFCIDPEDANCYLIYEYIENG-----SLHSWLHENKNE-NLNWKTRLRIAIDVANGLQYI 445
              +   D   +L+++Y E+        H     NK    L       +   + +G+ Y+
Sbjct: 65  KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124

Query: 446 HEHTRPRVVHKDIKSSNILL----DSNMRAKIANFGLAKSGCNAITM-----HIVGTQGY 496
           H +    V+H+D+K +NIL+        R KIA+ G A+   + +        +V T  Y
Sbjct: 125 HANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181

Query: 497 IAPEYLADGVVSTK-MDVFSFGVVLLELISGK 527
            APE L      TK +D+++ G +  EL++ +
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 44/144 (30%), Positives = 72/144 (50%), Gaps = 24/144 (16%)

Query: 398 EDANCYLIYEYIENGSLHSWLHENKN---ENLN--WKTRLRIAIDVANGLQYIHEHTRPR 452
           ++ N YL+ +Y   G L + L + ++   E++   +   + IAID  + L Y        
Sbjct: 72  DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY-------- 123

Query: 453 VVHKDIKSSNILLDSNMRAKIANFG----LAKSGCNAITMHIVGTQGYIAPEYL-----A 503
            VH+DIK  NIL+D N   ++A+FG    L + G    ++  VGT  YI+PE L      
Sbjct: 124 -VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-AVGTPDYISPEILQAMEDG 181

Query: 504 DGVVSTKMDVFSFGVVLLELISGK 527
            G    + D +S GV + E++ G+
Sbjct: 182 KGKYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 53/191 (27%), Positives = 92/191 (48%), Gaps = 26/191 (13%)

Query: 351 GSVYKGNIH--GEVYAIKMMKWNACEELK-------ILQKVNHGNLVKLEGFCIDPEDAN 401
           G VYK      G + A K+++  + EEL+       IL   NH  +VKL G      D  
Sbjct: 26  GKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY--WDGK 83

Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSS 461
            +++ E+   G++ + + E  +  L       I   +   LQY+H     +++H+D+K+ 
Sbjct: 84  LWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAG 139

Query: 462 NILLDSNMRAKIANFGLAKSGCNAITMH----IVGTQGYIAPEY-----LADGVVSTKMD 512
           N+LL  +   K+A+FG+  S  N  T+      +GT  ++APE      + D     K D
Sbjct: 140 NVLLTLDGDIKLADFGV--SAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKAD 197

Query: 513 VFSFGVVLLEL 523
           ++S G+ L+E+
Sbjct: 198 IWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 55.3 bits (133), Expect = 3e-08
 Identities = 46/165 (27%), Positives = 92/165 (55%), Gaps = 21/165 (12%)

Query: 372 ACEELKILQKVNHGNLVKL-EGFCID---PEDANCYLIYEYI--ENGSL--HSWLHENKN 423
           A  EL++L+ + H N++ L + F  D       + YL+  ++  + G L  H  L E++ 
Sbjct: 61  AYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRI 120

Query: 424 ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC 483
           + L ++        +  GL+YIH      ++H+D+K  N+ ++ +   KI +FGLA+   
Sbjct: 121 QFLVYQ--------MLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169

Query: 484 NAITMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELISGK 527
           + +T ++V T+ Y APE + + +  T+ +D++S G ++ E+++GK
Sbjct: 170 SEMTGYVV-TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 55.4 bits (134), Expect = 3e-08
 Identities = 54/220 (24%), Positives = 88/220 (40%), Gaps = 63/220 (28%)

Query: 360 GEVYAIKMMKWNACEELK------------ILQKVNHGNLVKLEGFCIDPEDANCYLIYE 407
           G +YA+K ++    E L+            IL + ++  +VKL  +    ++   YLI E
Sbjct: 26  GHIYAMKKLR--KSEMLEKEQVAHVRAERDILAEADNPWVVKL--YYSFQDENYLYLIME 81

Query: 408 YIENGSLHSWLHENKNENLNWK-TRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLD 466
           Y+  G + + L   K +    + TR  IA +    +  IH+      +H+DIK  N+LLD
Sbjct: 82  YLPGGDMMTLLM--KKDTFTEEETRFYIA-ETILAIDSIHKLG---YIHRDIKPDNLLLD 135

Query: 467 SNMRAKIANFGLAK-------------------------------SGCNAITMH------ 489
           +    K+++FGL                                 S   A T        
Sbjct: 136 AKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRAL 195

Query: 490 ---IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
               VGT  YIAPE       + + D +S GV++ E++ G
Sbjct: 196 AYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 45/160 (28%), Positives = 82/160 (51%), Gaps = 12/160 (7%)

Query: 372 ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTR 431
           A  E+ +L+ + H N+V L    I   +    L++EY+++  L  +L  +   NL     
Sbjct: 50  AIREVSLLKNLKHANIVTLHD--IIHTERCLTLVFEYLDS-DLKQYL--DNCGNLMSMHN 104

Query: 432 LRIAI-DVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGL--AKSGCNAITM 488
           ++I +  +  GL Y H+    +++H+D+K  N+L++     K+A+FGL  AKS       
Sbjct: 105 VKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYS 161

Query: 489 HIVGTQGYIAPEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           + V T  Y  P+ L      ST +D++  G +L E+ +G+
Sbjct: 162 NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 55.0 bits (132), Expect = 4e-08
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)

Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 129 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY-VATRWYR 184

Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 55.1 bits (132), Expect = 4e-08
 Identities = 45/180 (25%), Positives = 89/180 (49%), Gaps = 21/180 (11%)

Query: 372 ACEELKILQKVNHGNLVKLEGFCIDPEDA-----NCYLIYEYIENGSLHSWLHENKNENL 426
           A  EL +++ VNH N++ L      P+ +     + YL+ E ++         E  +E +
Sbjct: 63  AYRELVLMKCVNHKNIISLLN-VFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERM 121

Query: 427 NWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI 486
           ++     +   +  G++++H      ++H+D+K SNI++ S+   KI +FGLA++   + 
Sbjct: 122 SY-----LLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173

Query: 487 TMH-IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS------GKEAIDEEGKFCGQ 539
            M   V T+ Y APE +        +D++S G ++ E++       G++ ID+  K   Q
Sbjct: 174 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 54.7 bits (132), Expect = 5e-08
 Identities = 43/162 (26%), Positives = 81/162 (50%), Gaps = 15/162 (9%)

Query: 372 ACEELKILQKVNHGNLVKLEGFCIDP-----EDANCYLIYEYIENGSLHSWLHENKNENL 426
           A  EL +++ VNH N++ L      P     E  + YL+ E ++       L +    +L
Sbjct: 62  AYRELVLMKLVNHKNIIGLLN-VFTPQKSLEEFQDVYLVMELMDAN-----LCQVIQMDL 115

Query: 427 NWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI 486
           + +    +   +  G++++H      ++H+D+K SNI++ S+   KI +FGLA++   + 
Sbjct: 116 DHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 172

Query: 487 TMH-IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
            M   V T+ Y APE +        +D++S G ++ E+I G 
Sbjct: 173 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 54.7 bits (131), Expect = 5e-08
 Identities = 41/162 (25%), Positives = 82/162 (50%), Gaps = 15/162 (9%)

Query: 372 ACEELKILQKVNHGNLVKLEGFCIDPEDA-----NCYLIYEYIENGSLHSWLHENKNENL 426
           A  EL +++ VNH N++ L      P+ +     + Y++ E ++         E  +E +
Sbjct: 70  AYRELVLMKCVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 128

Query: 427 NWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI 486
           ++     +   +  G++++H      ++H+D+K SNI++ S+   KI +FGLA++   + 
Sbjct: 129 SY-----LLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 180

Query: 487 TMH-IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
            M   V T+ Y APE +        +D++S G ++ E+I G 
Sbjct: 181 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 55.2 bits (133), Expect = 7e-08
 Identities = 48/181 (26%), Positives = 74/181 (40%), Gaps = 36/181 (19%)

Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHS-----WLHENKNENLNWK 429
           E KI   + H  +V +   C D +    Y    YIE  +L S     W  E+ ++ L  K
Sbjct: 52  EAKIAADLIHPGIVPVYSICSDGDPV--YYTMPYIEGYTLKSLLKSVWQKESLSKELAEK 109

Query: 430 TR----LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA 485
           T     L I   +   ++Y+H      V+H+D+K  NILL       I ++G A      
Sbjct: 110 TSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIF-KKL 165

Query: 486 ---------------------ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELI 524
                                I   IVGT  Y+APE L     S   D+++ GV+L +++
Sbjct: 166 EEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225

Query: 525 S 525
           +
Sbjct: 226 T 226

Length = 932

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 53.9 bits (130), Expect = 7e-08
 Identities = 33/110 (30%), Positives = 57/110 (51%), Gaps = 27/110 (24%)

Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGL--------AKS--- 481
           ++ + +   L Y+ E  +  V+H+D+K SNILLD++   K+ +FG+        AK+   
Sbjct: 118 KMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA 175

Query: 482 GCNAITMHIVGTQGYIAPEYL----ADGVVSTKMDVFSFGVVLLELISGK 527
           GC A          Y+APE +     +     + DV+S G+ L+EL +G+
Sbjct: 176 GCAA----------YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 53.5 bits (129), Expect = 9e-08
 Identities = 47/199 (23%), Positives = 84/199 (42%), Gaps = 31/199 (15%)

Query: 351 GSVYKGNIHGEVYAIKMMKWNAC--EELKILQK-------VNHGNLVKLEGFCIDPEDAN 401
             + K      + A+K +  ++C  E+LK+LQ+       + H N++      I   D+ 
Sbjct: 16  VHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV--DSE 73

Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAI---DVANGLQYIHEHTRPRVVHKDI 458
            Y++   +  GS    L  +  E L     L IA    DV N L YIH       +H+ +
Sbjct: 74  LYVVSPLMAYGSCEDLLKTHFPEGLP---ELAIAFILKDVLNALDYIH---SKGFIHRSV 127

Query: 459 KSSNILLDSNMRAKIANF---------GLAKSGCNAITMHIVGTQGYIAPEYLADGV--V 507
           K+S+ILL  + +  ++           G  +   +      V    +++PE L   +   
Sbjct: 128 KASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGY 187

Query: 508 STKMDVFSFGVVLLELISG 526
           + K D++S G+   EL +G
Sbjct: 188 NEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 56/224 (25%), Positives = 96/224 (42%), Gaps = 38/224 (16%)

Query: 333 IEELREATDNFSEGCLIQGSVYKGNIHGEVYAIKMMKWNACEELKILQKV---------- 382
           +E L + TD +     I  ++ KG  +G+VY +   K  +   +KIL  +          
Sbjct: 14  LESLGDPTDTWE----IIETIGKGT-YGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAE 68

Query: 383 --------NHGNLVKLEGFCIDPED---ANCYLIYEYIENGSLHSWLHE--NKNENLNWK 429
                   NH N+VK  G     +       +L+ E    GS+   +       + L+  
Sbjct: 69  YNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEA 128

Query: 430 TRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH 489
               I      GLQ++H +   R++H+D+K +NILL +    K+ +FG++    +     
Sbjct: 129 MISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 185

Query: 490 --IVGTQGYIAPEYLA-----DGVVSTKMDVFSFGVVLLELISG 526
              VGT  ++APE +A     D     + DV+S G+  +EL  G
Sbjct: 186 NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 46/172 (26%), Positives = 78/172 (45%), Gaps = 32/172 (18%)

Query: 374 EELKILQKVNHGNLVKLEGFCI-DPEDANCYLIYEYIENGSLHSWLHENKNE-NLNWKTR 431
           E   ++ +V+H +L  + G C+   E+    ++ E++E+G L   L + K    + WK  
Sbjct: 65  ETASLMSQVSHIHLAFVHGVCVRGSENI---MVEEFVEHGPLDVCLRKEKGRVPVAWK-- 119

Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIV 491
           + +A  +A+ L Y+ +     +VH ++ + NILL        A  GLA+     I +   
Sbjct: 120 ITVAQQLASALSYLEDKN---LVHGNVCAKNILL--------ARLGLAEGTSPFIKLSDP 168

Query: 492 GTQ-------------GYIAPEYLADGV-VSTKMDVFSFGVVLLELISGKEA 529
           G                +IAPE +  G  +ST  D +SFG  LLE+    E 
Sbjct: 169 GVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEV 220

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 29/88 (32%), Positives = 55/88 (62%), Gaps = 5/88 (5%)

Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPE 500
           GL+YIH      ++H+D+K SN+ ++ +   +I +FGLA+   + +T + V T+ Y APE
Sbjct: 130 GLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGY-VATRWYRAPE 185

Query: 501 YLADGV-VSTKMDVFSFGVVLLELISGK 527
            + + +  +  +D++S G ++ EL+ GK
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 47/176 (26%), Positives = 88/176 (50%), Gaps = 28/176 (15%)

Query: 372 ACEELKILQKVNHGNLVKL-----EGFCIDPED-------ANCYLIYEYIENGSLHSWLH 419
           A  E+KI+++++H N+VK+            ED        + Y++ EY+E   L + L 
Sbjct: 49  ALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVL- 106

Query: 420 ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS-NMRAKIANFGL 478
             +        RL     +  GL+YIH      V+H+D+K +N+ +++ ++  KI +FGL
Sbjct: 107 -EQGPLSEEHARL-FMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGL 161

Query: 479 AK------SGCNAITMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELISGK 527
           A+      S    ++  +V T+ Y +P  L      TK +D+++ G +  E+++GK
Sbjct: 162 ARIVDPHYSHKGYLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 48/177 (27%), Positives = 82/177 (46%), Gaps = 19/177 (10%)

Query: 362 VYAIKMMK----------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN 411
           +YA+K ++           +   E  +L +VN   +V L+     PE    YL+  +I  
Sbjct: 20  IYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPE--KLYLVLAFING 77

Query: 412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRA 471
           G L   L      +L  + R   A ++   L+ +H+     V+++D+K  NILLD     
Sbjct: 78  GELFHHLQREGRFDL-SRARFYTA-ELLCALENLHKFN---VIYRDLKPENILLDYQGHI 132

Query: 472 KIANFGLAKSGC--NAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            + +FGL K     +  T    GT  Y+APE L     +  +D ++ GV+L E+++G
Sbjct: 133 ALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 45/167 (26%), Positives = 78/167 (46%), Gaps = 20/167 (11%)

Query: 375 ELKILQKV-NHGNLVKLEGFCIDPEDAN---CYLIYEYIENGSLHSWLHE--NKNENLNW 428
           E  IL+ + +H N+VK  G     +  N    +L+ E    GS+   +     + E +  
Sbjct: 64  EYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEE 123

Query: 429 KTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM 488
                I  +   GLQ++H +   + +H+D+K +NILL +    K+ +FG++    +  T 
Sbjct: 124 PIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS--TR 178

Query: 489 H----IVGTQGYIAPEYLA-----DGVVSTKMDVFSFGVVLLELISG 526
                 VGT  ++APE +A     D     + DV+S G+  +EL  G
Sbjct: 179 LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 37/113 (32%), Positives = 58/113 (51%), Gaps = 15/113 (13%)

Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
           +  VA G++++      + +H+D+ + NILL  N   KI +FGLA+           G  
Sbjct: 185 SFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241

Query: 495 ----GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEA------IDEEGKFC 537
                ++APE + D V + + DV+SFGV+L E+ S   +      IDEE  FC
Sbjct: 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FC 292

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 52.1 bits (125), Expect = 3e-07
 Identities = 47/181 (25%), Positives = 85/181 (46%), Gaps = 22/181 (12%)

Query: 360 GEVYAIKMMKWNAC-----------EELKILQKVNHGNLVKLE-GFCIDPEDANCYLIYE 407
           G+++A+K++K                E  IL+ V H  +V L   F         YLI E
Sbjct: 24  GKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAF---QTGGKLYLILE 80

Query: 408 YIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS 467
           Y+  G L   L E +   +       ++ +++  L+++H+     ++++D+K  NILLD+
Sbjct: 81  YLSGGELFMHL-EREGIFMEDTACFYLS-EISLALEHLHQQG---IIYRDLKPENILLDA 135

Query: 468 NMRAKIANFGLAKSGC--NAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
               K+ +FGL K       +T    GT  Y+APE L        +D +S G ++ ++++
Sbjct: 136 QGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLT 195

Query: 526 G 526
           G
Sbjct: 196 G 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 51.9 bits (125), Expect = 3e-07
 Identities = 51/221 (23%), Positives = 91/221 (41%), Gaps = 52/221 (23%)

Query: 351 GSVY----KGNIHGEVYAIK------MMKWN----ACEELKILQKVNHGNLVKLEGFCID 396
           G V+    KG   G+++A+K      M+K N       E +IL  ++H  L  L      
Sbjct: 15  GRVFLVRLKGT--GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA-SFQ 71

Query: 397 PEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHK 456
            E   C ++ +Y   G L   L     + L+ +     A +V   L+Y+H      +V++
Sbjct: 72  TETYLCLVM-DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYR 127

Query: 457 DIKSSNILLDSNMRAKIANFGLAKSG-------------------------------CNA 485
           D+K  NILL  +    +++F L+K                                  + 
Sbjct: 128 DLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSF 187

Query: 486 ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            +   VGT+ YIAPE ++     + +D ++ G++L E++ G
Sbjct: 188 RSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 51.9 bits (124), Expect = 4e-07
 Identities = 56/186 (30%), Positives = 91/186 (48%), Gaps = 28/186 (15%)

Query: 362 VYAIKMM-KW-------NAC--EELKILQKVNHGNLVKLEGFCIDPEDAN-CYLIYEYIE 410
           +YA+K++ KW        AC  EE  +L  VN G+   +       +D N  YL+ +Y  
Sbjct: 28  IYAMKILNKWEMLKRAETACFREERNVL--VN-GDCQWITTLHYAFQDENYLYLVMDYYV 84

Query: 411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR 470
            G L + L + ++       R  IA ++   +  IH+      VH+DIK  N+LLD N  
Sbjct: 85  GGDLLTLLSKFEDRLPEDMARFYIA-EMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGH 140

Query: 471 AKIANFG----LAKSGCNAITMHIVGTQGYIAPEYLA---DGV--VSTKMDVFSFGVVLL 521
            ++A+FG    + + G    ++  VGT  YI+PE L    DG+     + D +S GV + 
Sbjct: 141 IRLADFGSCLKMNQDGTVQSSV-AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMY 199

Query: 522 ELISGK 527
           E++ G+
Sbjct: 200 EMLYGE 205

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 51.8 bits (124), Expect = 4e-07
 Identities = 31/98 (31%), Positives = 53/98 (54%), Gaps = 7/98 (7%)

Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIV 491
           LR +  VA G+ ++        +H+D+ + N+LL     AKI +FGLA+   N     + 
Sbjct: 215 LRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271

Query: 492 GTQ----GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           G       ++APE + D V + + DV+S+G++L E+ S
Sbjct: 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 51.9 bits (124), Expect = 5e-07
 Identities = 33/124 (26%), Positives = 62/124 (50%), Gaps = 7/124 (5%)

Query: 406 YEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL 465
           Y+   +  + + L ++ +E L     L     VA G++++        VH+D+ + N+LL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLL 270

Query: 466 DSNMRAKIANFGLAKSGCNAITMHIVGTQ----GYIAPEYLADGVVSTKMDVFSFGVVLL 521
                 KI +FGLA+   +       G+      ++APE + D + +T  DV+S+G++L 
Sbjct: 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLW 330

Query: 522 ELIS 525
           E+ S
Sbjct: 331 EIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 51.4 bits (123), Expect = 7e-07
 Identities = 40/164 (24%), Positives = 69/164 (42%), Gaps = 34/164 (20%)

Query: 375 ELKILQKVNHGNLVKL-------EGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLN 427
           E+ IL+ ++H  ++ L          C+      C L + Y++           ++  L 
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDL-FTYVD-----------RSGPLP 183

Query: 428 WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT 487
            +  + I   +   L Y+H      ++H+D+K+ NI LD    A + +FG A   C  + 
Sbjct: 184 LEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAA---CK-LD 236

Query: 488 MHI--------VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLEL 523
            H          GT    +PE LA      K D++S G+VL E+
Sbjct: 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 46/177 (25%), Positives = 89/177 (50%), Gaps = 25/177 (14%)

Query: 375 ELKILQKVNHGNLVKLEGF----CIDPEDANCYL--IYEYIENGSLHSWL--HENKNENL 426
           EL I++ +NH N++ L+ +    C    + N +L  + E+I   ++H ++  +   N  L
Sbjct: 109 ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHAL 167

Query: 427 NWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRA-KIANFGLAKS---G 482
                   +  +   L YIH      + H+D+K  N+L+D N    K+ +FG AK+   G
Sbjct: 168 PLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG 224

Query: 483 CNAITMHIVGTQGYIAPE-YLADGVVSTKMDVFSFGVVLLELI------SGKEAIDE 532
             +++   + ++ Y APE  L     +T +D++S G ++ E+I      SG+ ++D+
Sbjct: 225 QRSVSY--ICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ 279

Length = 440

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 50.1 bits (120), Expect = 1e-06
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 31/216 (14%)

Query: 324 CLDKYRIFKIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWNACE------- 374
            L+ Y+  K+++L E +           +VYKG   + G++ A+K ++    E       
Sbjct: 3   KLETYK--KLDKLGEGS---------YATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI 51

Query: 375 -ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
            E  +L+ + H N+V L    I        L++EY++   L  ++ ++    L+      
Sbjct: 52  REASLLKDLKHANIVTLHD--IIHTKKTLTLVFEYLDT-DLKQYM-DDCGGGLSMHNVRL 107

Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGL--AKSGCNAITMHIV 491
               +  GL Y H   + RV+H+D+K  N+L+      K+A+FGL  AKS  +    + V
Sbjct: 108 FLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEV 164

Query: 492 GTQGYIAPEYLADGV-VSTKMDVFSFGVVLLELISG 526
            T  Y  P+ L      ST +D++  G +  E+ +G
Sbjct: 165 VTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 54/203 (26%), Positives = 93/203 (45%), Gaps = 34/203 (16%)

Query: 346 GCLIQGSVYKGNIHGEVYAIKMMKWNAC--EELKILQKVN------HGNLVKLEGFCIDP 397
           G +I G V  G    +V  +K ++ +A   E++K L++        H NL++  G C   
Sbjct: 9   GKVILGEVNSGYTPAQV-VVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCT-- 65

Query: 398 EDANCYLIYEYIENGSLHSWLHE-NKNENL--NWKTRLRIAIDVANGLQYIHEHTRPRVV 454
           E     L+ E+   G L  +L    K E +  +  T  R+A ++A GL ++H++     +
Sbjct: 66  EVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FI 122

Query: 455 HKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG------YIAPEYLADGV-- 506
           H D+   N LL +++  KI ++GL+         + V          +IAPE L D V  
Sbjct: 123 HSDLALRNCLLTADLTVKIGDYGLSH--NKYKEDYYVTPDQLWVPLRWIAPE-LVDEVHG 179

Query: 507 ------VSTKMDVFSFGVVLLEL 523
                  + + +V+S GV + EL
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 43/177 (24%), Positives = 67/177 (37%), Gaps = 54/177 (30%)

Query: 398 EDANCYLIYEYIENGSLHSWL--HENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVH 455
           +  N Y + +YI  G + S L       E+L    R  IA ++   ++ +H   +   +H
Sbjct: 72  DKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL---ARFYIA-ELTCAIESVH---KMGFIH 124

Query: 456 KDIKSSNILLDSNMRAKIANFGL-------------------------------AKSGCN 484
           +DIK  NIL+D +   K+ +FGL                                   C 
Sbjct: 125 RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCR 184

Query: 485 A-------------ITMH-IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
                            H +VGT  YIAPE L     +   D +S GV+L E++ G+
Sbjct: 185 LKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 48.6 bits (116), Expect = 5e-06
 Identities = 57/241 (23%), Positives = 98/241 (40%), Gaps = 74/241 (30%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNA---------------------CEELKILQKVNHGNL 387
           G V K    + G++ AIK +K                          ELKI+ ++ H N+
Sbjct: 23  GKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENI 82

Query: 388 VKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR------IAIDVANG 441
           + L    ++ +  N  L+ +          +  +  + ++ K RL       I + + NG
Sbjct: 83  MGLVDVYVEGDFIN--LVMDI---------MASDLKKVVDRKIRLTESQVKCILLQILNG 131

Query: 442 LQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAI-------------- 486
           L  +H+      +H+D+  +NI ++S    KIA+FGLA+  G                  
Sbjct: 132 LNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188

Query: 487 --TMHIVGTQGYIAPEYLADGVVSTK----MDVFSFGVVLLELISGK------EAIDEEG 534
             T  +V T  Y APE L     + K    +D++S G +  EL++GK        ID+ G
Sbjct: 189 EMTSKVV-TLWYRAPELLMG---AEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244

Query: 535 K 535
           +
Sbjct: 245 R 245

Length = 335

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 48.2 bits (115), Expect = 5e-06
 Identities = 29/102 (28%), Positives = 50/102 (49%), Gaps = 20/102 (19%)

Query: 442 LQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM------------- 488
           L+Y+H +    +VH+D+K  N+L+ S    K+ +FGL+K G  ++T              
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170

Query: 489 ----HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
                + GT  YIAPE +        +D ++ G++L E + G
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 48.7 bits (116), Expect = 6e-06
 Identities = 25/80 (31%), Positives = 44/80 (55%), Gaps = 5/80 (6%)

Query: 401 NCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
           N YL+ EY+  G + S LH       + +  ++   +VA  L Y+H H    ++H+D+K 
Sbjct: 78  NVYLVMEYLIGGDVKSLLHIYGY--FDEEMAVKYISEVALALDYLHRHG---IIHRDLKP 132

Query: 461 SNILLDSNMRAKIANFGLAK 480
            N+L+ +    K+ +FGL+K
Sbjct: 133 DNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 47.6 bits (113), Expect = 7e-06
 Identities = 43/163 (26%), Positives = 81/163 (49%), Gaps = 21/163 (12%)

Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRL- 432
           +  +ILQ   H N+++  G C+  E     L++EY E G L S+L + +    N +  L 
Sbjct: 47  DPYRILQ---HPNILQCLGQCV--EAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLL 101

Query: 433 -RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC--NAITMH 489
            R+A ++A G+ ++H+H     +H D+   N  L S++  K+ ++G+  S    + I   
Sbjct: 102 QRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158

Query: 490 --IVGTQGYIAPEYLA---DGVVSTKM----DVFSFGVVLLEL 523
                   ++APE +     G+++ +     +V++ GV L EL
Sbjct: 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 46.8 bits (111), Expect = 2e-05
 Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 7/98 (7%)

Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIV 491
           L  +  VA G+ ++        +H+D+ + NILL      KI +FGLA+   N     + 
Sbjct: 217 LSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK 273

Query: 492 GTQ----GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           G       ++APE + + V + + DV+S+G++L E+ S
Sbjct: 274 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 38/146 (26%), Positives = 66/146 (45%), Gaps = 16/146 (10%)

Query: 386 NLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYI 445
           N+V L  + +  ED+  +L+ ++ E G L  W H +K  N+  +   R A ++   L  +
Sbjct: 46  NMVCLHKYIVS-EDS-VFLVLQHAEGGKL--WSHISKFLNIPEECVKRWAAEMVVALDAL 101

Query: 446 HEHTRPRVVHKDIKSSNILLDSNMRAKIANFG----LAKSGCNAITMHIVGTQGYIAPEY 501
           H      +V +D+  +NILLD     ++  F     +  S       ++     Y APE 
Sbjct: 102 HREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCAPEV 153

Query: 502 LADGVVSTKMDVFSFGVVLLELISGK 527
                 +   D +S G +L EL++GK
Sbjct: 154 GGISEETEACDWWSLGAILFELLTGK 179

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 46.6 bits (110), Expect = 2e-05
 Identities = 51/218 (23%), Positives = 85/218 (38%), Gaps = 62/218 (28%)

Query: 360 GEVYAIKMM-KWNACE---------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI 409
           G +YA+K++ K +  E         E  IL + +   +VK+  F    +  N YLI E++
Sbjct: 26  GHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM--FYSFQDKRNLYLIMEFL 83

Query: 410 ENGSLHSWLHE----NKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL 465
             G + + L +    ++     +     +AID  + L +IH         +DIK  N+LL
Sbjct: 84  PGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIH---------RDIKPDNLLL 134

Query: 466 DSNMRAKIANFGLA-------------------------------------KSGCNAITM 488
           D+    K+++FGL                                      K     +  
Sbjct: 135 DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAY 194

Query: 489 HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
             VGT  YIAPE       +   D +S GV++ E++ G
Sbjct: 195 STVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 46.2 bits (109), Expect = 3e-05
 Identities = 55/214 (25%), Positives = 87/214 (40%), Gaps = 54/214 (25%)

Query: 360 GEVYAIKMM-KWNACE---------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI 409
           G VYA+K++ K +  E         E  IL + +   +VK+  F    +  N YLI E++
Sbjct: 26  GHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM--FYSFQDKLNLYLIMEFL 83

Query: 410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM 469
             G + + L + K+     +T+  IA  V   +  IH+      +H+DIK  N+LLDS  
Sbjct: 84  PGGDMMTLLMK-KDTLTEEETQFYIAETVL-AIDSIHQLG---FIHRDIKPDNLLLDSKG 138

Query: 470 RAKIANFGLA-------------------------------------KSGCNAITMHIVG 492
             K+++FGL                                      K     +    VG
Sbjct: 139 HVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVG 198

Query: 493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           T  YIAPE       +   D +S GV++ E++ G
Sbjct: 199 TPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 46.4 bits (110), Expect = 3e-05
 Identities = 27/85 (31%), Positives = 44/85 (51%), Gaps = 7/85 (8%)

Query: 442 LQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLA--KSGCNAITMH--IVGTQGYI 497
           + YIH      ++H+DIK+ N+L++      + +FG A    G  +   H  I GT    
Sbjct: 273 IDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTN 329

Query: 498 APEYLADGVVSTKMDVFSFGVVLLE 522
           APE LA    +  +D++S G+V+ E
Sbjct: 330 APEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 44.9 bits (106), Expect = 5e-05
 Identities = 42/159 (26%), Positives = 77/159 (48%), Gaps = 18/159 (11%)

Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           E   ++++V+H ++V L G C+   D    ++ E++E G L  ++H  K++ L    + +
Sbjct: 53  ETASMMRQVSHKHIVLLYGVCV--RDVENIMVEEFVEFGPLDLFMHR-KSDVLTTPWKFK 109

Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFG--LAKSGCNAITMHIV 491
           +A  +A+ L Y+ +     +VH ++ + NILL    R  I        K     I + ++
Sbjct: 110 VAKQLASALSYLEDK---DLVHGNVCTKNILL---AREGIDGECGPFIKLSDPGIPITVL 163

Query: 492 GTQG------YIAPEYLADG-VVSTKMDVFSFGVVLLEL 523
             Q       +IAPE + D   +S   D +SFG  L E+
Sbjct: 164 SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 43.2 bits (102), Expect = 6e-05
 Identities = 26/108 (24%), Positives = 45/108 (41%), Gaps = 9/108 (8%)

Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+ ILQ +    L   +       D   YL+ E+IE  +L         + ++ + +  I
Sbjct: 41  EVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL---------DEVSEEEKEDI 91

Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG 482
           A  +A  L  +H+     + H D+   NIL+D      I ++  A  G
Sbjct: 92  AEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 45.0 bits (106), Expect = 8e-05
 Identities = 31/117 (26%), Positives = 58/117 (49%), Gaps = 23/117 (19%)

Query: 421 NKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK 480
           N++  L++   +  +  VANG++++        VH+D+ + N+L+      KI +FGLA+
Sbjct: 231 NESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLAR 287

Query: 481 SGCNAITMHIVGTQGYI------------APEYLADGVVSTKMDVFSFGVVLLELIS 525
                    I+    YI            APE + + + +T  DV+SFG++L E+ +
Sbjct: 288 D--------IMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|144899 pfam01476, LysM, LysM domain

 Score = 39.3 bits (93), Expect = 1e-04
 Identities = 13/43 (30%), Positives = 24/43 (55%), Gaps = 3/43 (6%)

Query: 186 YVLQPSENLSSVASRFGIETQAIIDVNG---NNIRPFDTLFVP 225
           Y ++  + LSS+A R+GI  + + ++NG    N+     L +P
Sbjct: 1   YTVKKGDTLSSIAKRYGITVEELAELNGLSSPNLYVGQKLKIP 43

The LysM (lysin motif) domain is about 40 residues long. It is found in a variety of enzymes involved in bacterial cell wall degradation. This domain may have a general peptidoglycan binding function. The structure of this domain is known. Length = 43

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 30/84 (35%), Positives = 40/84 (47%), Gaps = 13/84 (15%)

Query: 402 CYLIYEYIENGSLHSWLHENKNENL------NWKTRLRIAIDVANGLQYIHEHTRPRVVH 455
           C + Y +I    L   L EN  E        N K    I  D+   L+YIHEH    + H
Sbjct: 97  CRMYYRFI----LLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISH 149

Query: 456 KDIKSSNILLDSNMRAKIANFGLA 479
            DIK  NI++D N R  I ++G+A
Sbjct: 150 GDIKPENIMVDGNNRGYIIDYGIA 173

Length = 294

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 40.8 bits (95), Expect = 0.002
 Identities = 53/206 (25%), Positives = 79/206 (38%), Gaps = 64/206 (31%)

Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL--HENKNENLN--WKT 430
           E  IL + ++  +VKL     D +  N Y + +YI  G + S L   E   E L   +  
Sbjct: 51  ERDILAEADNEWVVKLYYSFQDKD--NLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA 108

Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK---------- 480
            L +AI+  + + +IH         +DIK  NIL+D +   K+ +FGL            
Sbjct: 109 ELTLAIESVHKMGFIH---------RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159

Query: 481 ---------------------SGC-----------NAITMH-------IVGTQGYIAPEY 501
                                S C            A   H       +VGT  YIAPE 
Sbjct: 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEV 219

Query: 502 LADGVVSTKMDVFSFGVVLLELISGK 527
           L     +   D +S GV+L E++ G+
Sbjct: 220 LLRKGYTQLCDWWSVGVILFEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|197609 smart00257, LysM, Lysin motif

 Score = 35.9 bits (84), Expect = 0.002
 Identities = 11/43 (25%), Positives = 24/43 (55%), Gaps = 4/43 (9%)

Query: 186 YVLQPSENLSSVASRFGIETQAIIDVNG----NNIRPFDTLFV 224
           Y ++  + LSS+A R+GI    ++++N     +N++    L +
Sbjct: 2   YTVKKGDTLSSIARRYGISVSDLLELNNILDPDNLQVGQKLKI 44

Length = 44

>gnl|CDD|212030 cd00118, LysM, Lysine Motif is a small domain involved in binding peptidoglycan

 Score = 35.9 bits (84), Expect = 0.002
 Identities = 10/45 (22%), Positives = 22/45 (48%), Gaps = 4/45 (8%)

Query: 184 VSYVLQPSENLSSVASRFGIETQAIIDVNG----NNIRPFDTLFV 224
            +Y ++P + L S+A ++G+  + +   N     + I P   L +
Sbjct: 1   KTYTVKPGDTLWSIAKKYGVTVEELAAANPLINPDCIYPGQKLKI 45

LysM, a small globular domain with approximately 40 amino acids, is a widespread protein module involved in binding peptidoglycan in bacteria and chitin in eukaryotes. The domain was originally identified in enzymes that degrade bacterial cell walls, but proteins involved in many other biological functions also contain this domain. It has been reported that the LysM domain functions as a signal for specific plant-bacteria recognition in bacterial pathogenesis. Many of these enzymes are modular and are composed of catalytic units linked to one or several repeats of LysM domains. LysM domains are found in bacteria and eukaryotes. Length = 45

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 39.2 bits (91), Expect = 0.004
 Identities = 42/178 (23%), Positives = 67/178 (37%), Gaps = 58/178 (32%)

Query: 401 NCYLIYEYIENGSLHSWLHENK--NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
           N Y + +YI  G + S L       E+L    R  IA ++   ++ +H+      +H+DI
Sbjct: 75  NLYFVMDYIPGGDMMSLLIRMGIFPEDL---ARFYIA-ELTCAVESVHKMG---FIHRDI 127

Query: 459 KSSNILLDSNMRAKIANFGL---------------------------------------- 478
           K  NIL+D +   K+ +FGL                                        
Sbjct: 128 KPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGD 187

Query: 479 ---------AKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
                    A+     +   +VGT  YIAPE L     +   D +S GV+L E++ G+
Sbjct: 188 RLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	552
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.98
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.98
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.98
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.98
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.98
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.98
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.98
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.98
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.98
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.98
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.98
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.98
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.98
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.98
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.98
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.98
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.98
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.98
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.97
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.97
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.97
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.97
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.97
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.97
KOG0589	426	consensus Serine/threonine protein kinase [General	99.97
KOG0584	632	consensus Serine/threonine protein kinase [General	99.97
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.97
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.97
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.97
PTZ00267	478	NIMA-related protein kinase; Provisional	99.97
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.97
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.97
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.97
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.97
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.97
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.97
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.97
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.97
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.97
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.97
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.97
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.97
PHA03212	391	serine/threonine kinase US3; Provisional	99.97
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.97
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.97
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.97
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.97
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.97
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.97
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.97
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.97
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.97
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.97
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.97
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.97
PTZ00283	496	serine/threonine protein kinase; Provisional	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.97
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.97
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.97
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.97
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.97
PTZ00036	440	glycogen synthase kinase; Provisional	99.97
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.97
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.97
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.97
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.97
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.97
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.97
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.97
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.97
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.97
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.97
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.97
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.97
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.97
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.97
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.97
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.97
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.97
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.97
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.97
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.97
PHA03207	392	serine/threonine kinase US3; Provisional	99.97
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.97
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.97
PHA03211	461	serine/threonine kinase US3; Provisional	99.97
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.97
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.97
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.97
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.97
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.97
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.97
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.97
PHA03209	357	serine/threonine kinase US3; Provisional	99.97
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.97
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.97
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.97
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.96
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.96
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.96
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.96
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.96
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.96
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.96
PTZ00284	467	protein kinase; Provisional	99.96
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.96
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.96
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.96
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.96
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.96
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.96
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.96
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.96
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.96
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.96
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.96
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.96
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.96
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.96
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.96
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.96
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.96
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.96
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.96
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.96
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.96
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.96
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.96
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.96
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.96
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.96
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.96
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.96
KOG0586	596	consensus Serine/threonine protein kinase [General	99.96
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.96
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.96
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.96
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.96
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.96
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.96
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.96
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.96
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.96
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.96
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.96
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.96
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.96
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.96
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.96
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.96
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.96
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.96
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.96
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.96
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.96
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.96
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.96
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.96
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.96
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.96
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.96
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.96
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.96
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.96
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.96
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.96
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.96
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.96
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.96
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.96
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.96
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.96
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.96
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.96
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.96
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.96
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.96
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.96
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.96
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.96
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.96
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.96
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.96
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.96
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.96
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.96
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.96
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.96
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.96
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.96
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.96
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.96
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.96
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.96
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.96
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.96
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.96
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.96
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.96
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.96
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.96
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.96
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.96
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.96
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.96
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.96
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.96
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.96
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.96
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.96
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.96
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.96
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.96
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.96
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.96
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.96
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.96
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.96
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.96
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.96
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.96
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.96
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.96
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.96
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.96
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.96
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.96
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.96
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.96
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.96
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.96
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.96
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.96
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.96
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.96
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.96
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.96
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.95
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.95
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.95
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.95
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.95
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.95
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.95
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.95
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.95
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.95
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.95
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.95
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.95
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.95
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.95
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.95
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.95
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.95
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.95
PLN00009	294	cyclin-dependent kinase A; Provisional	99.95
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.95
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.95
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.95
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.95
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.95
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.95
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.95
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.95
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.95
PHA02882	294	putative serine/threonine kinase; Provisional	99.95
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.95
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.95
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.95
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.95
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.95
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.95
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.95
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.95
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.95
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.95
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.95
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.95
PHA03210	501	serine/threonine kinase US3; Provisional	99.95
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.95
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.95
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.95
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.95
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.95
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.95
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.95
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.95
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.95
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.95
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.95
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.95
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.95
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.95
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.95
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.95
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.94
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.94
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.94
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.94
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.94
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.94
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.94
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.94
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.94
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.94
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.94
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.94
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.94
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.94
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.94
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.94
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.93
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.93
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.93
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.93
PRK06347	592	autolysin; Reviewed	99.93
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.93
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.92
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.92
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.92
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.92
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.92
PRK06347	592	autolysin; Reviewed	99.92
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.91
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.91
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.9
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.89
PRK10783	456	mltD membrane-bound lytic murein transglycosylase	99.86
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.86
PLN00181	793	protein SPA1-RELATED; Provisional	99.84
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.84
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.82
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.82
PRK09188	365	serine/threonine protein kinase; Provisional	99.82
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.81
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.8
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.78
PRK12274	218	serine/threonine protein kinase; Provisional	99.78
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.77
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.77
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.75
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.75
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.7
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.69
PRK10345	210	hypothetical protein; Provisional	99.67
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.66
PRK14879	211	serine/threonine protein kinase; Provisional	99.66
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.65
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.65
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.65
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.62
PRK10783	456	mltD membrane-bound lytic murein transglycosylase	99.62
smart00090	237	RIO RIO-like kinase.	99.61
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.58
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.57
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.57
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.54
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.52
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.52
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.51
PRK13914	481	invasion associated secreted endopeptidase; Provis	99.51
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.48
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.32
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.25
KOG1243	690	consensus Protein kinase [General function predict	99.18
KOG3087	229	consensus Serine/threonine protein kinase [General	99.18
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.16
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.15
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.08
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.07
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.07
PF01476	44	LysM: LysM domain; InterPro: IPR018392 This domain	99.02
PF01476	44	LysM: LysM domain; InterPro: IPR018392 This domain	99.01
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.0
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.99
COG1388	124	LytE FOG: LysM repeat [Cell envelope biogenesis, o	98.98
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.96
COG1388	124	LytE FOG: LysM repeat [Cell envelope biogenesis, o	98.91
PRK14125	103	cell division suppressor protein YneA; Provisional	98.87
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.85
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.75
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.75
PRK14125	103	cell division suppressor protein YneA; Provisional	98.73
PRK09902	216	hypothetical protein; Provisional	98.71
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.71
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.7
COG4248	637	Uncharacterized protein with protein kinase and he	98.65
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.56
TIGR02899	44	spore_safA spore coat assembly protein SafA. in wh	98.47
TIGR02899	44	spore_safA spore coat assembly protein SafA. in wh	98.47
COG3858	423	Predicted glycosyl hydrolase [General function pre	98.46
cd00118	46	LysM Lysin domain, found in a variety of enzymes i	98.45
COG3858	423	Predicted glycosyl hydrolase [General function pre	98.43
PRK10871	319	nlpD lipoprotein NlpD; Provisional	98.42
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.42
cd00118	46	LysM Lysin domain, found in a variety of enzymes i	98.38
PRK10871	319	nlpD lipoprotein NlpD; Provisional	98.27
TIGR02907	338	spore_VI_D stage VI sporulation protein D. SpoVID,	98.27
PRK11198	147	LysM domain/BON superfamily protein; Provisional	98.26
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.26
TIGR02907	338	spore_VI_D stage VI sporulation protein D. SpoVID,	98.25
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.21
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.21
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.19
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.14
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.13
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.07
PRK13914	481	invasion associated secreted endopeptidase; Provis	98.02
smart00257	44	LysM Lysin motif.	97.98
smart00257	44	LysM Lysin motif.	97.98
PF01636	239	APH: Phosphotransferase enzyme family This family	97.88
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.84
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.71
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.68
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.67
PRK10593	297	hypothetical protein; Provisional	97.67
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.64
PLN02876	822	acyl-CoA dehydrogenase	97.61
PRK11198	147	LysM domain/BON superfamily protein; Provisional	97.42
COG1652	269	XkdP Uncharacterized protein containing LysM domai	97.32
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.31
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.22
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.2
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.06

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-42  Score=347.33  Aligned_cols=217  Identities=47%  Similarity=0.802  Sum_probs=187.9

Q ss_pred             ccccccHHHHHHHhhccCC----CceEEEEEEEEee-cCcEEEEEEecc-------ChHHHHHHHHHcCCCCccceeeee
Q 037224          327 KYRIFKIEELREATDNFSE----GCLIQGSVYKGNI-HGEVYAIKMMKW-------NACEELKILQKVNHGNLVKLEGFC  394 (552)
Q Consensus       327 ~~~~~~~~~l~~~t~~~~~----G~g~~G~Vy~~~~-~g~~vAvK~~~~-------~~~~E~~~l~~l~h~niv~l~~~~  394 (552)
                      ..+.|++.|+..+|++|+.    |.|+||.||+|.+ +|..||||+++.       ++.+|++++.+++|||+++++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            5678999999999999995    8899999999999 458999998743       366899999999999999999999


Q ss_pred             ecCCCCeeEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEe
Q 037224          395 IDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIA  474 (552)
Q Consensus       395 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~  474 (552)
                      .+.++ ..+||||||++|+|.++|+......++|..+++|+.++|+||+|||+...++|+|||||++|||+|+++++||+
T Consensus       141 ~e~~~-~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGE-HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCc-eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            98332 58999999999999999987654368999999999999999999999988889999999999999999999999


Q ss_pred             eccCCccCCC-Ccccc-c-cccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccCcccccchHHH
Q 037224          475 NFGLAKSGCN-AITMH-I-VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGY  544 (552)
Q Consensus       475 Dfg~a~~~~~-~~~~~-~-~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~~~~~~~~~~  544 (552)
                      |||+++.... ..... . .||.+|++||+...+..+.++||||||++|+||+||+.|.+...+.....+..|
T Consensus       220 DFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w  292 (361)
T KOG1187|consen  220 DFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEW  292 (361)
T ss_pred             CccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHH
Confidence            9999976553 22211 2 799999999999999999999999999999999999999986543222334444

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3e-41  Score=328.06  Aligned_cols=184  Identities=32%  Similarity=0.512  Sum_probs=166.0

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccCh---------HHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWNA---------CEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~~---------~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      .|.|.|+.||+|+.  ++..||||.+....         ..|+.+|+.++|||||.+++++.+  ++.+|||||||+||+
T Consensus        18 iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~--~~~i~lVMEyC~gGD   95 (429)
T KOG0595|consen   18 IGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED--DDFIYLVMEYCNGGD   95 (429)
T ss_pred             ccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec--CCeEEEEEEeCCCCC
Confidence            58888899999988  78999999986542         369999999999999999999988  779999999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCC------CcEEEeeccCCccCCCC-c
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN------MRAKIANFGLAKSGCNA-I  486 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~------~~~kL~Dfg~a~~~~~~-~  486 (552)
                      |.++++..+  .+++..++.++.|++.||++||+++   ||||||||+|||++..      -.+||+|||+|+...+. .
T Consensus        96 Ls~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~  170 (429)
T KOG0595|consen   96 LSDYIRRRG--RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSM  170 (429)
T ss_pred             HHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhH
Confidence            999999876  4999999999999999999999999   9999999999999764      46899999999976543 3


Q ss_pred             cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          487 TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       487 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      ....+|++-|||||++..++|+.|+|+||+|+++|+|++|+.||+....
T Consensus       171 a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~  219 (429)
T KOG0595|consen  171 AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP  219 (429)
T ss_pred             HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence            3457999999999999999999999999999999999999999996553

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-39  Score=312.43  Aligned_cols=194  Identities=28%  Similarity=0.462  Sum_probs=170.4

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccCh----------HHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWNA----------CEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~~----------~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|.|+||.||.++.  .++.+|+|++++..          .+|..+|.+++||+|+++.-.|.+  ...+|+|+||+.||
T Consensus        33 iGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt--~~kLylVld~~~GG  110 (357)
T KOG0598|consen   33 IGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQT--EEKLYLVLDYLNGG  110 (357)
T ss_pred             eeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc--CCeEEEEEeccCCc
Confidence            38888899999977  78999999996542          369999999999999999988877  77899999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC--CCccccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC--NAITMHI  490 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~--~~~~~~~  490 (552)
                      .|..+|.+..  .+++..+..++.+|+.||.|||++|   |+||||||+|||+|.+|+++|+|||+++...  ...+...
T Consensus       111 eLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~tf  185 (357)
T KOG0598|consen  111 ELFYHLQREG--RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDATRTF  185 (357)
T ss_pred             cHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccCCCccccc
Confidence            9999998655  4999999999999999999999999   9999999999999999999999999998433  2345557


Q ss_pred             cccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccCcccccchHHHHHHHhcC
Q 037224          491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYWREMKRG  551 (552)
Q Consensus       491 ~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~g  551 (552)
                      +||+.|||||++.+..++..+|+||||+++|||++|.+||...+.      .++.+.+.++
T Consensus       186 cGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~------~~~~~~I~~~  240 (357)
T KOG0598|consen  186 CGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV------KKMYDKILKG  240 (357)
T ss_pred             cCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH------HHHHHHHhcC
Confidence            999999999999999999999999999999999999999997663      4444444444

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-39  Score=310.55  Aligned_cols=194  Identities=31%  Similarity=0.500  Sum_probs=170.3

Q ss_pred             ccHHHHHHHhhccCCCceEEEEEEEEee--cCcEEEEEEecc--------ChHHHHHHHHHcCCCCccceeeeeecCCCC
Q 037224          331 FKIEELREATDNFSEGCLIQGSVYKGNI--HGEVYAIKMMKW--------NACEELKILQKVNHGNLVKLEGFCIDPEDA  400 (552)
Q Consensus       331 ~~~~~l~~~t~~~~~G~g~~G~Vy~~~~--~g~~vAvK~~~~--------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  400 (552)
                      .+..|+.. .+.++.|+|  |+||+++.  +++.+|+|.+..        +..+|++++++++||+||.++|.|..... 
T Consensus        76 i~~~dle~-~~~lG~G~g--G~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-  151 (364)
T KOG0581|consen   76 ISLSDLER-LGVLGSGNG--GTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-  151 (364)
T ss_pred             cCHHHhhh-hhhcccCCC--cEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-
Confidence            45556533 344555555  99999988  689999999832        23589999999999999999999998433 


Q ss_pred             eeEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEECCCCcEEEeeccCC
Q 037224          401 NCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHE-HTRPRVVHKDIKSSNILLDSNMRAKIANFGLA  479 (552)
Q Consensus       401 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  479 (552)
                      ...++||||++|+|++++...+  ++++...-+++.++++||.|||+ ++   |+||||||+|||++..|++||+|||.+
T Consensus       152 ~isI~mEYMDgGSLd~~~k~~g--~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS  226 (364)
T KOG0581|consen  152 EISICMEYMDGGSLDDILKRVG--RIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVS  226 (364)
T ss_pred             eEEeehhhcCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEecccccc
Confidence            6899999999999999987653  59999999999999999999996 66   999999999999999999999999999


Q ss_pred             ccCCCCccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          480 KSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       480 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      ....+......+||..|||||.+.+..|+.++||||||+.++||.+|+.||...
T Consensus       227 ~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~  280 (364)
T KOG0581|consen  227 GILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP  280 (364)
T ss_pred             HHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence            877666777899999999999999999999999999999999999999999875

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-38  Score=320.95  Aligned_cols=188  Identities=36%  Similarity=0.625  Sum_probs=167.8

Q ss_pred             CCceEEEEEEEEeecCcE-EEEEEecc---------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          345 EGCLIQGSVYKGNIHGEV-YAIKMMKW---------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~g~~-vAvK~~~~---------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      .|.|.+|+||+|.+.|+. ||+|++..         .+.+|+.+|.+++||||++++|+|.++.. .+.+||||+++|+|
T Consensus        49 iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~-~~~iVtEy~~~GsL  127 (362)
T KOG0192|consen   49 LGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG-SLCIVTEYMPGGSL  127 (362)
T ss_pred             cccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC-ceEEEEEeCCCCcH
Confidence            578888999999999998 99999975         56789999999999999999999987322 67899999999999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCC-cEEEeeccCCccCCC--Ccccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM-RAKIANFGLAKSGCN--AITMHIV  491 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~~~~--~~~~~~~  491 (552)
                      .++++......+++..++.|+.||++|++|||+++.  ||||||||+|||++.++ .+||+|||+++....  .......
T Consensus       128 ~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~  205 (362)
T KOG0192|consen  128 SVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVA  205 (362)
T ss_pred             HHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeeccccccccCCC
Confidence            999988544569999999999999999999999973  99999999999999998 999999999986554  3334478


Q ss_pred             ccccccCccccC--CCCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          492 GTQGYIAPEYLA--DGVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       492 gt~~y~aPE~~~--~~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      ||..|||||++.  ...++.++||||||++||||+||+.||.+...
T Consensus       206 GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~  251 (362)
T KOG0192|consen  206 GTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP  251 (362)
T ss_pred             CCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence            999999999999  56899999999999999999999999997653

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-38  Score=294.57  Aligned_cols=194  Identities=29%  Similarity=0.484  Sum_probs=175.1

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccCh----------HHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWNA----------CEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~~----------~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|.|.||+|...+.  +|..+|+|+++++.          .+|..+|+.+.||+++++.+.|.+  ....|+||||.+||
T Consensus        52 lGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d--~~~lymvmeyv~GG  129 (355)
T KOG0616|consen   52 LGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD--NSNLYMVMEYVPGG  129 (355)
T ss_pred             eccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc--CCeEEEEEeccCCc
Confidence            58888899999987  78999999997642          369999999999999999999887  78899999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccccccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVG  492 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~g  492 (552)
                      .|..++++..  ++++..++.++.||+.||+|||+.+   |++||+||+|||+|.+|.+||+|||+|+..... +...+|
T Consensus       130 ElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-T~TlCG  203 (355)
T KOG0616|consen  130 ELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-TWTLCG  203 (355)
T ss_pred             cHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc-EEEecC
Confidence            9999998754  4999999999999999999999999   999999999999999999999999999876554 677999


Q ss_pred             cccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccCcccccchHHHHHHHhcCC
Q 037224          493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYWREMKRGK  552 (552)
Q Consensus       493 t~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~g~  552 (552)
                      ||.|+|||.+....++.++|.||||+++|||+.|.+||.++++      ....+++.+||
T Consensus       204 TPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~------~~iY~KI~~~~  257 (355)
T KOG0616|consen  204 TPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP------IQIYEKILEGK  257 (355)
T ss_pred             CccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh------HHHHHHHHhCc
Confidence            9999999999999999999999999999999999999998876      44566665554

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-37  Score=317.25  Aligned_cols=183  Identities=30%  Similarity=0.487  Sum_probs=167.3

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|.|+|.++|+++.  .|+.||+|++.+.          ..+|+++.+.|+|||||+++++|.+  .++.|+|+|+|+.+
T Consensus        26 LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED--s~nVYivLELC~~~  103 (592)
T KOG0575|consen   26 LGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED--SNNVYIVLELCHRG  103 (592)
T ss_pred             eccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec--CCceEEEEEecCCc
Confidence            58888999999998  7999999998642          2379999999999999999999998  77899999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC--CCccccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC--NAITMHI  490 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~--~~~~~~~  490 (552)
                      +|.+++.+.+  .+++.+++.+++||+.||.|||+++   |+|||||..|+|++++.++||+|||+|....  .......
T Consensus       104 sL~el~Krrk--~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~Tl  178 (592)
T KOG0575|consen  104 SLMELLKRRK--PLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKTL  178 (592)
T ss_pred             cHHHHHHhcC--CCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCccccccee
Confidence            9999888544  5999999999999999999999999   9999999999999999999999999998544  2455678


Q ss_pred             cccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       491 ~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +|||.|+|||++....++..+||||+||+||-||.|++||+.++
T Consensus       179 CGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~  222 (592)
T KOG0575|consen  179 CGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT  222 (592)
T ss_pred             cCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch
Confidence            99999999999999999999999999999999999999999764

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-38  Score=307.88  Aligned_cols=183  Identities=32%  Similarity=0.500  Sum_probs=160.4

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC--------------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEee
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN--------------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEY  408 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~  408 (552)
                      .|+|+||.|-+|..  +|+.||||++.++              ..+|+++|++|+||||+++.++|..  ....|+||||
T Consensus       180 LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~--~ds~YmVlE~  257 (475)
T KOG0615|consen  180 LGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV--PDSSYMVLEY  257 (475)
T ss_pred             ecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec--CCceEEEEEE
Confidence            48899999999976  8999999998543              1379999999999999999999987  5667999999


Q ss_pred             ccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCC---CcEEEeeccCCccCCC-
Q 037224          409 IENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN---MRAKIANFGLAKSGCN-  484 (552)
Q Consensus       409 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~---~~~kL~Dfg~a~~~~~-  484 (552)
                      ++||.|.+.+-.++.  +.+..-..+++|++.|+.|||++|   |+||||||+|||+..+   -.+||+|||+|+...+ 
T Consensus       258 v~GGeLfd~vv~nk~--l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~  332 (475)
T KOG0615|consen  258 VEGGELFDKVVANKY--LREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEG  332 (475)
T ss_pred             ecCccHHHHHHhccc--cccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchhhccccc
Confidence            999999999987764  788888999999999999999999   9999999999999765   6799999999997653 


Q ss_pred             CccccccccccccCccccCCCC--CC-ChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          485 AITMHIVGTQGYIAPEYLADGV--VS-TKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       485 ~~~~~~~gt~~y~aPE~~~~~~--~s-~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..+...+||+.|.|||++....  +. .+.|+||+||+||-+++|.+||.+.-
T Consensus       333 sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~  385 (475)
T KOG0615|consen  333 SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEY  385 (475)
T ss_pred             eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccccc
Confidence            3456689999999999997654  23 47899999999999999999998754

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.1e-39  Score=295.80  Aligned_cols=188  Identities=26%  Similarity=0.437  Sum_probs=163.4

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|.||+||++..  +|..+|.|.+.-+         ...|+.+|++|+||||++++++....+...+++||||++.|+|
T Consensus        28 G~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDL  107 (375)
T KOG0591|consen   28 GRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDL  107 (375)
T ss_pred             cCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCH
Confidence            6666799999976  8999999988532         2369999999999999999985554444458999999999999


Q ss_pred             hhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCc--eEecCCCCCcEEECCCCcEEEeeccCCccCCCCc--cc
Q 037224          415 HSWLHENK--NENLNWKTRLRIAIDVANGLQYIHEHTRPR--VVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI--TM  488 (552)
Q Consensus       415 ~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~--ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~--~~  488 (552)
                      .+++...+  .+.+++..+++++.|++.||.++|++- ++  +.||||||.||+++.+|.+||+|||+++...+..  ..
T Consensus       108 sqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~  186 (375)
T KOG0591|consen  108 SQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAH  186 (375)
T ss_pred             HHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhHhcchhHHHH
Confidence            99987544  356999999999999999999999842 33  9999999999999999999999999999765443  33


Q ss_pred             cccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          489 HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       489 ~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..+|||.||+||.+....|+.++||||+||++|||+.-+.||.+++
T Consensus       187 S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n  232 (375)
T KOG0591|consen  187 SLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN  232 (375)
T ss_pred             hhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc
Confidence            5799999999999999999999999999999999999999999875

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-37  Score=309.04  Aligned_cols=196  Identities=32%  Similarity=0.506  Sum_probs=171.1

Q ss_pred             CCceEEEEEEEEeecCc-EEEEEEecc------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhh
Q 037224          345 EGCLIQGSVYKGNIHGE-VYAIKMMKW------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSW  417 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~g~-~vAvK~~~~------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~  417 (552)
                      .|.|-||.||.|.+++. .||+|.++.      ++.+|+.+|++|+|+||++++++|..  ++.++||||||+.|+|.++
T Consensus       214 LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~--~~piyIVtE~m~~GsLl~y  291 (468)
T KOG0197|consen  214 LGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTK--QEPIYIVTEYMPKGSLLDY  291 (468)
T ss_pred             hcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEec--CCceEEEEEecccCcHHHH
Confidence            36666799999999877 899999864      35689999999999999999999987  5578999999999999999


Q ss_pred             hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcccccc---ccc
Q 037224          418 LHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIV---GTQ  494 (552)
Q Consensus       418 l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~---gt~  494 (552)
                      |+......+...+.+.++.|||+|++||++++   +|||||.++||||+++..+||+|||+|+...+.......   -..
T Consensus       292 Lr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPI  368 (468)
T KOG0197|consen  292 LRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPI  368 (468)
T ss_pred             hhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCc
Confidence            99866677999999999999999999999999   999999999999999999999999999965544333222   245


Q ss_pred             cccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccCcccccchHHHHHHHhcC
Q 037224          495 GYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEGKFCGQKLKGYWREMKRG  551 (552)
Q Consensus       495 ~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~g  551 (552)
                      .|.|||.+..+.++.++||||||++||||+| |+.|+.+...      .+..+.+.+|
T Consensus       369 kWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn------~ev~~~le~G  420 (468)
T KOG0197|consen  369 KWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN------EEVLELLERG  420 (468)
T ss_pred             eecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH------HHHHHHHhcc
Confidence            7999999999999999999999999999998 9999987764      5566666665

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-36  Score=302.21  Aligned_cols=186  Identities=33%  Similarity=0.497  Sum_probs=164.2

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|.+|.||+++.  +|+.||+|+++.+         ..+|+.+|++|+||||++|.+...+...+.+|||+|||+. +|
T Consensus       126 GeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL  204 (560)
T KOG0600|consen  126 GEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DL  204 (560)
T ss_pred             cCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-hh
Confidence            6677799999998  8999999998644         2489999999999999999999988656789999999987 88


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC---cccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA---ITMHIV  491 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~---~~~~~~  491 (552)
                      .-++... .-.|++.++..++.|++.||+|||++|   |.|||||.+|||||.+|.+||+|||+|++....   ..+..+
T Consensus       205 ~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rV  280 (560)
T KOG0600|consen  205 SGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRV  280 (560)
T ss_pred             hhhhcCC-CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCCCCcccccce
Confidence            8877654 334999999999999999999999999   999999999999999999999999999954322   345567


Q ss_pred             ccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccCcc
Q 037224          492 GTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEGKF  536 (552)
Q Consensus       492 gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~~~  536 (552)
                      -|.+|.|||.+.+ ..|+.+.|+||.||||.||++|++.|.+..+.
T Consensus       281 vTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv  326 (560)
T KOG0600|consen  281 VTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEV  326 (560)
T ss_pred             EEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHH
Confidence            8999999999876 56999999999999999999999999988764

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=6.2e-36  Score=283.23  Aligned_cols=205  Identities=28%  Similarity=0.446  Sum_probs=174.0

Q ss_pred             cHHHHHHHhhccCCCceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCC
Q 037224          332 KIEELREATDNFSEGCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDA  400 (552)
Q Consensus       332 ~~~~l~~~t~~~~~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~  400 (552)
                      +++|. +..+.++  .|.+|.||+|++  +++.||+|+++.+         ..+|+.+|.+++||||+.+-.+....+-+
T Consensus        74 sv~ef-e~lnrI~--EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d  150 (419)
T KOG0663|consen   74 SVEEF-EKLNRIE--EGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMD  150 (419)
T ss_pred             cHHHH-HHHhhcc--cCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccc
Confidence            34443 3334444  445599999998  7899999999754         35899999999999999999999887777


Q ss_pred             eeEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCc
Q 037224          401 NCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK  480 (552)
Q Consensus       401 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  480 (552)
                      .+|+||||++. +|..++...+ ++|...++..++.|+++|++|||.+.   |+|||||++|+|+++.|.+||+|||+|+
T Consensus       151 ~iy~VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR  225 (419)
T KOG0663|consen  151 KIYIVMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAR  225 (419)
T ss_pred             eeeeeHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhh
Confidence            89999999987 9999887765 56999999999999999999999999   9999999999999999999999999999


Q ss_pred             cCCCC--ccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccCcccccchHHHHH
Q 037224          481 SGCNA--ITMHIVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYWR  546 (552)
Q Consensus       481 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~~~~~~~~~~~~~  546 (552)
                      ...+.  ..+..+-|.+|.|||.+.+ ..|+...|+||+|||+.||+++++.|.+.++.  +.++.+++
T Consensus       226 ~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~--dQl~~If~  292 (419)
T KOG0663|consen  226 EYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI--DQLDKIFK  292 (419)
T ss_pred             hhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchH--HHHHHHHH
Confidence            76554  3445677999999999876 55899999999999999999999999988763  44555444

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-36  Score=300.25  Aligned_cols=183  Identities=27%  Similarity=0.459  Sum_probs=164.0

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccCh----------HHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWNA----------CEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~~----------~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      |.|.+++|++|+.  .++.||||++.+..          .+|-+.|.+| .||.|++|+-.|.|  +..+|+|+||+++|
T Consensus        82 GeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD--~~sLYFvLe~A~nG  159 (604)
T KOG0592|consen   82 GEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD--EESLYFVLEYAPNG  159 (604)
T ss_pred             ccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec--ccceEEEEEecCCC
Confidence            7777899999987  78999999996553          2688899999 89999999988887  77899999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC--------
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN--------  484 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~--------  484 (552)
                      +|.++|.+.+  .|++...+.++.||+.||+|||++|   ||||||||+|||+|.+++++|+|||.|+....        
T Consensus       160 dll~~i~K~G--sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~  234 (604)
T KOG0592|consen  160 DLLDLIKKYG--SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENP  234 (604)
T ss_pred             cHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChhhccccCc
Confidence            9999998775  4999999999999999999999999   99999999999999999999999999873321        


Q ss_pred             ---C----ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          485 ---A----ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       485 ---~----~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                         .    .....+||..|.+||++.+...++.+|+|+|||+||+|+.|++||.+.++
T Consensus       235 ~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne  292 (604)
T KOG0592|consen  235 VDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE  292 (604)
T ss_pred             cCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH
Confidence               1    11347899999999999999999999999999999999999999998765

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=5.7e-36  Score=300.22  Aligned_cols=183  Identities=29%  Similarity=0.401  Sum_probs=161.8

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccCh----------HHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWNA----------CEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~~----------~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|+||.||.++.  .|+.+|+|++++..          ..|-++|...++++||+++-.|.+  ...+||||||++||+
T Consensus       150 gkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD--~~~LYLiMEylPGGD  227 (550)
T KOG0605|consen  150 GKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD--KEYLYLIMEYLPGGD  227 (550)
T ss_pred             ccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC--CCeeEEEEEecCCcc
Confidence            8899999999976  89999999997643          258888989999999999988877  778999999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC----------
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC----------  483 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~----------  483 (552)
                      +..+|....  .|++..+..++.+++.|++.||+.|   ++||||||+|+|||..|++||+|||++....          
T Consensus       228 ~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~  302 (550)
T KOG0605|consen  228 MMTLLMRKD--TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRL  302 (550)
T ss_pred             HHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcc
Confidence            999998765  4999999999999999999999999   9999999999999999999999999984100          


Q ss_pred             -------------CC-c-------------------------cccccccccccCccccCCCCCCChhhHHHHHHHHHHHH
Q 037224          484 -------------NA-I-------------------------TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELI  524 (552)
Q Consensus       484 -------------~~-~-------------------------~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ell  524 (552)
                                   .. .                         ....+|||.|+|||++.+..|+..+|+|||||||||||
T Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmL  382 (550)
T KOG0605|consen  303 DEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEML  382 (550)
T ss_pred             hhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHH
Confidence                         00 0                         00136999999999999999999999999999999999


Q ss_pred             cCCCCCCccCc
Q 037224          525 SGKEAIDEEGK  535 (552)
Q Consensus       525 tG~~pf~~~~~  535 (552)
                      .|.+||..+++
T Consensus       383 vGyPPF~s~tp  393 (550)
T KOG0605|consen  383 VGYPPFCSETP  393 (550)
T ss_pred             hCCCCCCCCCH
Confidence            99999998876

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.9e-36  Score=281.89  Aligned_cols=183  Identities=26%  Similarity=0.400  Sum_probs=160.8

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|.+|.||+.+.  .|+.||||++...         ..||+++|++++|+|+|.++++|..  ....+||+||++. ++
T Consensus        11 GEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr--krklhLVFE~~dh-Tv   87 (396)
T KOG0593|consen   11 GEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR--KRKLHLVFEYCDH-TV   87 (396)
T ss_pred             ccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh--cceeEEEeeecch-HH
Confidence            6666799999987  8999999998432         4589999999999999999999977  6788999999988 55


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC--CCccccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC--NAITMHIVG  492 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~--~~~~~~~~g  492 (552)
                      .+-|...+. .++.+.+.+++.|++.|+.|+|+++   ++||||||+|||++.+|.+||||||+|+...  ....+..+.
T Consensus        88 L~eLe~~p~-G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDYVA  163 (396)
T KOG0593|consen   88 LHELERYPN-GVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDYVA  163 (396)
T ss_pred             HHHHHhccC-CCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhhhh
Confidence            555665554 4899999999999999999999999   9999999999999999999999999999654  334455788


Q ss_pred             cccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          493 TQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       493 t~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      |.+|.|||.+.+ .+|+..+||||+||++.||++|.+.|.+..+
T Consensus       164 TRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD  207 (396)
T KOG0593|consen  164 TRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSD  207 (396)
T ss_pred             hhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcch
Confidence            999999999876 8899999999999999999999999988764

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-35  Score=298.12  Aligned_cols=183  Identities=28%  Similarity=0.484  Sum_probs=162.9

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC------------hHHHHHHHHHcC-CCCccceeeeeecCCCCeeEEEEeec
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN------------ACEELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYI  409 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~------------~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~lv~e~~  409 (552)
                      .|.|.+|.|+.|..  +++.||+|+++..            ..+|+.++++++ ||||+++++++..  ...+++||||+
T Consensus        25 lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t--~~~~~ivmEy~  102 (370)
T KOG0583|consen   25 LGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT--PTKIYIVMEYC  102 (370)
T ss_pred             ecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec--CCeEEEEEEec
Confidence            37777899999977  7899999976542            126999999998 9999999999988  55699999999


Q ss_pred             cCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCC-CcEEEeeccCCccC--CCCc
Q 037224          410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN-MRAKIANFGLAKSG--CNAI  486 (552)
Q Consensus       410 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kL~Dfg~a~~~--~~~~  486 (552)
                      .+|+|.+++...  .++.+.++..++.|++.|++|||++|   |+||||||+|||++.+ +++||+|||++...  ....
T Consensus       103 ~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~  177 (370)
T KOG0583|consen  103 SGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDGL  177 (370)
T ss_pred             CCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccccCCCCCc
Confidence            999999999883  35899999999999999999999999   9999999999999999 99999999999866  3445


Q ss_pred             cccccccccccCccccCCCC-CC-ChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          487 TMHIVGTQGYIAPEYLADGV-VS-TKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       487 ~~~~~gt~~y~aPE~~~~~~-~s-~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ....+||+.|+|||++.+.. |+ .++||||+|++||.|++|+.||++.+
T Consensus       178 l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~  227 (370)
T KOG0583|consen  178 LKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN  227 (370)
T ss_pred             ccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc
Confidence            56689999999999998876 75 78999999999999999999999854

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-35  Score=302.97  Aligned_cols=182  Identities=30%  Similarity=0.486  Sum_probs=162.9

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccCh----------HHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWNA----------CEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~~----------~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      |.|.||.|+++..  +++.+|||+++++.          ..|..++... +||.++.++..|.+  ..++|+||||+.||
T Consensus       377 GkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT--~~~l~fvmey~~Gg  454 (694)
T KOG0694|consen  377 GRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT--KEHLFFVMEYVAGG  454 (694)
T ss_pred             ccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc--CCeEEEEEEecCCC
Confidence            7777899999998  67899999998753          3577777777 59999999999987  77899999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccC--CCCccccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG--CNAITMHI  490 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~--~~~~~~~~  490 (552)
                      ++..+.+..   .|++..+..++..++.||.|||+++   |||||||.+|||+|.+|.+||+|||+++..  ....+...
T Consensus       455 dm~~~~~~~---~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~TsTf  528 (694)
T KOG0694|consen  455 DLMHHIHTD---VFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRTSTF  528 (694)
T ss_pred             cEEEEEecc---cccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCCCCCccccc
Confidence            966555433   4999999999999999999999999   999999999999999999999999999843  34566779


Q ss_pred             cccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       491 ~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      +||+.|||||++.+..|+.++|+|||||+|||||.|+.||.++++
T Consensus       529 CGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE  573 (694)
T KOG0694|consen  529 CGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE  573 (694)
T ss_pred             cCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH
Confidence            999999999999999999999999999999999999999998776

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-36  Score=294.27  Aligned_cols=197  Identities=30%  Similarity=0.466  Sum_probs=172.8

Q ss_pred             ccHHHHHHHhhccCCCceEEEEEEEEee--cCcEEEEEEeccCh--------HHHHHHHHHcC-CCCccceeeeeecCCC
Q 037224          331 FKIEELREATDNFSEGCLIQGSVYKGNI--HGEVYAIKMMKWNA--------CEELKILQKVN-HGNLVKLEGFCIDPED  399 (552)
Q Consensus       331 ~~~~~l~~~t~~~~~G~g~~G~Vy~~~~--~g~~vAvK~~~~~~--------~~E~~~l~~l~-h~niv~l~~~~~~~~~  399 (552)
                      ..+.+-+...+++|.|.+  |.||+|+.  .|+.||||.++..+        .||+..|++|+ ||||+++.+++.+.+.
T Consensus         6 ~~~m~RY~~i~klGDGTf--GsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~   83 (538)
T KOG0661|consen    6 VIFMDRYTVIRKLGDGTF--GSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR   83 (538)
T ss_pred             hhHHHHHHHHHHhcCCcc--eeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence            345666777777755555  99999987  89999999998654        38999999998 9999999999988433


Q ss_pred             CeeEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCC
Q 037224          400 ANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLA  479 (552)
Q Consensus       400 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  479 (552)
                       .+++|||||+. +|.+++..+ ...|++.+++.|+.||++||+|+|.+|   +.|||+||+|||+.....+||+|||+|
T Consensus        84 -~L~fVfE~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLA  157 (538)
T KOG0661|consen   84 -ILYFVFEFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLA  157 (538)
T ss_pred             -eEeeeHHhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccc
Confidence             89999999987 999999877 667999999999999999999999999   999999999999998889999999999


Q ss_pred             ccCCC-CccccccccccccCcccc-CCCCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          480 KSGCN-AITMHIVGTQGYIAPEYL-ADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       480 ~~~~~-~~~~~~~gt~~y~aPE~~-~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      |...+ ...+..+.|.+|.|||++ +.+.|+.+.|+||+|||++|+.+=++.|.+.++
T Consensus       158 Rev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE  215 (538)
T KOG0661|consen  158 REVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE  215 (538)
T ss_pred             cccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH
Confidence            96554 344557899999999986 467799999999999999999999999998765

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-36  Score=300.06  Aligned_cols=183  Identities=30%  Similarity=0.551  Sum_probs=168.7

Q ss_pred             CCceEEEEEEEEeecCcEEEEEEeccChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhhhhhcCCC
Q 037224          345 EGCLIQGSVYKGNIHGEVYAIKMMKWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNE  424 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~g~~vAvK~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~  424 (552)
                      .|+|.+|.||+|++.++.||||+++.-...+++-|++|+|+||+.+.|+|..  ...+++|||||..|.|.+.|+...  
T Consensus       132 lGSGaQGAVF~Grl~netVAVKKV~elkETdIKHLRkLkH~NII~FkGVCtq--sPcyCIiMEfCa~GqL~~VLka~~--  207 (904)
T KOG4721|consen  132 LGSGAQGAVFLGRLHNETVAVKKVRELKETDIKHLRKLKHPNIITFKGVCTQ--SPCYCIIMEFCAQGQLYEVLKAGR--  207 (904)
T ss_pred             hccCcccceeeeeccCceehhHHHhhhhhhhHHHHHhccCcceeeEeeeecC--CceeEEeeeccccccHHHHHhccC--
Confidence            4899999999999999999999999888889999999999999999999987  668899999999999999998765  


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-ccccccccccccCccccC
Q 037224          425 NLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-ITMHIVGTQGYIAPEYLA  503 (552)
Q Consensus       425 ~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-~~~~~~gt~~y~aPE~~~  503 (552)
                      .++......|..+||.|+.|||.+.   |||||||.-||||..+..+||+|||-++...+. ..+.+.||..|||||++.
T Consensus       208 ~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIr  284 (904)
T KOG4721|consen  208 PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIR  284 (904)
T ss_pred             ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhh
Confidence            4899999999999999999999998   999999999999999999999999999854433 344689999999999999


Q ss_pred             CCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          504 DGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       504 ~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +...+.|+|||||||+||||+||..||.+-+
T Consensus       285 nePcsEKVDIwSfGVVLWEmLT~EiPYkdVd  315 (904)
T KOG4721|consen  285 NEPCSEKVDIWSFGVVLWEMLTGEIPYKDVD  315 (904)
T ss_pred             cCCcccccceehhHHHHHHHHhcCCCccccc
Confidence            9999999999999999999999999998654

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-34  Score=284.70  Aligned_cols=184  Identities=31%  Similarity=0.501  Sum_probs=152.0

Q ss_pred             CCceEEEEEEEEeecCcEEEEEEecc----ChHHHHHHHH--HcCCCCccceeeeeecCC--CCeeEEEEeeccCCCchh
Q 037224          345 EGCLIQGSVYKGNIHGEVYAIKMMKW----NACEELKILQ--KVNHGNLVKLEGFCIDPE--DANCYLIYEYIENGSLHS  416 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~g~~vAvK~~~~----~~~~E~~~l~--~l~h~niv~l~~~~~~~~--~~~~~lv~e~~~~gsL~~  416 (552)
                      .|.|.||.||+|.++++.||||++..    .+..|-++++  .++|+||+++++.-....  ...++||+||.+.|+|.+
T Consensus       218 i~~Grfg~V~KaqL~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~d  297 (534)
T KOG3653|consen  218 IGRGRFGCVWKAQLDNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCD  297 (534)
T ss_pred             hhcCccceeehhhccCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHH
Confidence            37888899999999999999999954    3455666655  468999999988765422  347899999999999999


Q ss_pred             hhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC----Cc
Q 037224          417 WLHENKNENLNWKTRLRIAIDVANGLQYIHEH------TRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN----AI  486 (552)
Q Consensus       417 ~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~------~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~----~~  486 (552)
                      ||..+-   ++|.+..+++..+++||+|||+.      .+|+|+|||||++||||.+|+.+.|+|||+|.....    ..
T Consensus       298 yL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d  374 (534)
T KOG3653|consen  298 YLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGD  374 (534)
T ss_pred             HHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcc
Confidence            998875   99999999999999999999954      357899999999999999999999999999974332    12


Q ss_pred             cccccccccccCccccCCCCC------CChhhHHHHHHHHHHHHcCCCCCC
Q 037224          487 TMHIVGTQGYIAPEYLADGVV------STKMDVFSFGVVLLELISGKEAID  531 (552)
Q Consensus       487 ~~~~~gt~~y~aPE~~~~~~~------s~~~Dv~slG~il~elltG~~pf~  531 (552)
                      .-..+||.+|||||++.+...      -.+.||||+|.+||||+++-..++
T Consensus       375 ~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~  425 (534)
T KOG3653|consen  375 THGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDAD  425 (534)
T ss_pred             hhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhccccc
Confidence            223689999999999865332      236899999999999998765553

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.7e-35  Score=295.16  Aligned_cols=180  Identities=30%  Similarity=0.478  Sum_probs=162.3

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|.+|+||||+.  +.+.||+|.+.+.         ..+|++++++++||||+.++++|..  ..++|+|.||+.| +|
T Consensus        11 G~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt--~~~~~vVte~a~g-~L   87 (808)
T KOG0597|consen   11 GEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET--SAHLWVVTEYAVG-DL   87 (808)
T ss_pred             cCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc--cceEEEEehhhhh-hH
Confidence            6677799999987  6789999998542         3479999999999999999999987  7789999999987 99


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--ccccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIVG  492 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~g  492 (552)
                      ..++.....  ++++.+..++.++..||.|||+.+   |.|||+||.|||++..|.+|++|||+++.....  ......|
T Consensus        88 ~~il~~d~~--lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsikG  162 (808)
T KOG0597|consen   88 FTILEQDGK--LPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSIKG  162 (808)
T ss_pred             HHHHHhccC--CCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCceeeeeccC
Confidence            999987654  999999999999999999999998   999999999999999999999999999965533  3345789


Q ss_pred             cccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       493 t~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      ||-|||||.+.++.|+..+|+||+||++|||++|++||...
T Consensus       163 tPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~  203 (808)
T KOG0597|consen  163 TPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR  203 (808)
T ss_pred             cccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH
Confidence            99999999999999999999999999999999999999754

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.6e-35  Score=298.04  Aligned_cols=196  Identities=27%  Similarity=0.468  Sum_probs=174.0

Q ss_pred             CCCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          344 SEGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       344 ~~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      ..|.|..|.|-.|+.  +|+.+|||++.+.          ..+|+-+|+.+.|||++++++++.+  ..++|+|.||+++
T Consensus        19 TLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~--~~~lylvlEyv~g   96 (786)
T KOG0588|consen   19 TLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN--KQHLYLVLEYVPG   96 (786)
T ss_pred             cccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc--CceEEEEEEecCC
Confidence            457888899999988  8999999999654          3489999999999999999999987  7789999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC-Cccccc
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN-AITMHI  490 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~-~~~~~~  490 (552)
                      |-|.+++-.++.  +.+.++.+++.||+.|+.|+|..+   |+|||+||+|+|+|..+++||+|||+|..... .....-
T Consensus        97 GELFdylv~kG~--l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeTS  171 (786)
T KOG0588|consen   97 GELFDYLVRKGP--LPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLETS  171 (786)
T ss_pred             chhHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCCcccccc
Confidence            999999987654  999999999999999999999999   99999999999999999999999999975443 334457


Q ss_pred             cccccccCccccCCCCC-CChhhHHHHHHHHHHHHcCCCCCCccCcccccchHHHHHHHhcCC
Q 037224          491 VGTQGYIAPEYLADGVV-STKMDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYWREMKRGK  552 (552)
Q Consensus       491 ~gt~~y~aPE~~~~~~~-s~~~Dv~slG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~g~  552 (552)
                      +|++.|.+||++.+..| +.++||||.|||||.||||+.||++++      ++..+.++++|+
T Consensus       172 CGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN------ir~LLlKV~~G~  228 (786)
T KOG0588|consen  172 CGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN------IRVLLLKVQRGV  228 (786)
T ss_pred             CCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc------HHHHHHHHHcCc
Confidence            99999999999999887 568999999999999999999999655      477888888875

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.8e-34  Score=265.59  Aligned_cols=184  Identities=29%  Similarity=0.420  Sum_probs=161.9

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEecc---------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKW---------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~---------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      .|.|.+|.||+|+.  .|+.||||+++.         ...||++.|+.++|+||+.++++|..  .+.+-+|+||++. +
T Consensus        10 lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~--~~~l~lVfEfm~t-d   86 (318)
T KOG0659|consen   10 LGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH--KSNLSLVFEFMPT-D   86 (318)
T ss_pred             hcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC--CCceEEEEEeccc-c
Confidence            37777899999998  799999999853         24589999999999999999999977  6778999999986 9


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--cccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIV  491 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~  491 (552)
                      |+..++... ..++..++..++.++++||+|||++.   |.||||||.|+|++++|.+||+|||+++.....  ...+.+
T Consensus        87 Le~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~V  162 (318)
T KOG0659|consen   87 LEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQV  162 (318)
T ss_pred             HHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCcccccce
Confidence            998887644 46999999999999999999999999   999999999999999999999999999965533  223347


Q ss_pred             ccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          492 GTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       492 gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      -|.+|.|||.+.+ +.|+...|+||.|||+.||+-|.+-|.++++
T Consensus       163 ~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD  207 (318)
T KOG0659|consen  163 VTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD  207 (318)
T ss_pred             eeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch
Confidence            7999999998876 5699999999999999999999998988765

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-36  Score=310.09  Aligned_cols=184  Identities=30%  Similarity=0.516  Sum_probs=162.3

Q ss_pred             CceEEEEEEEEee--cC---cEEEEEEecc--------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          346 GCLIQGSVYKGNI--HG---EVYAIKMMKW--------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g---~~vAvK~~~~--------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      |.|-||.||+|++  .|   ..||||.+|.        +|..|+.||.+++||||++|.|+...  ....++|.|||++|
T Consensus       638 GaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk--s~PvMIiTEyMENG  715 (996)
T KOG0196|consen  638 GAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK--SKPVMIITEYMENG  715 (996)
T ss_pred             ecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec--CceeEEEhhhhhCC
Confidence            8888899999998  34   4799999963        46689999999999999999999876  67889999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccc---c
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM---H  489 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~---~  489 (552)
                      +|+.||+.+.++ |++.+...++++|+.|+.||.+.+   +|||||..+|||++.+..+|++|||+++...+....   .
T Consensus       716 sLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt  791 (996)
T KOG0196|consen  716 SLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTT  791 (996)
T ss_pred             cHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCCCccccc
Confidence            999999998865 999999999999999999999999   999999999999999999999999999966543311   1


Q ss_pred             ccc--cccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccCc
Q 037224          490 IVG--TQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEGK  535 (552)
Q Consensus       490 ~~g--t~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~~  535 (552)
                      ..|  ..+|.|||.+..+.++.++||||||++|||.++ |..||-+...
T Consensus       792 ~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN  840 (996)
T KOG0196|consen  792 LGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN  840 (996)
T ss_pred             cCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch
Confidence            222  358999999999999999999999999999876 9999876653

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-35  Score=286.76  Aligned_cols=184  Identities=33%  Similarity=0.524  Sum_probs=161.1

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      .|.|.+|+||++..  +|+..|||.+...       ..+|+.+|.+++|||||+++|.....++..+++.|||+++|+|.
T Consensus        25 lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~  104 (313)
T KOG0198|consen   25 LGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLS  104 (313)
T ss_pred             ccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHH
Confidence            47788899999998  4799999998765       46899999999999999999975442223689999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECC-CCcEEEeeccCCccCC-----CCcccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS-NMRAKIANFGLAKSGC-----NAITMH  489 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kL~Dfg~a~~~~-----~~~~~~  489 (552)
                      +++....+ .+++..++.+..|+++||+|||++|   ++||||||+|||++. ++.+||+|||++....     ......
T Consensus       105 ~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~  180 (313)
T KOG0198|consen  105 DLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELS  180 (313)
T ss_pred             HHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccccccccccccc
Confidence            99998776 6999999999999999999999999   999999999999999 7999999999987544     223445


Q ss_pred             ccccccccCccccCCCC-CCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          490 IVGTQGYIAPEYLADGV-VSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~~~-~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                      ..||+.|||||++.++. ..+++|||||||++.||+||+.||.+
T Consensus       181 ~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~  224 (313)
T KOG0198|consen  181 VQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE  224 (313)
T ss_pred             ccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence            78999999999998643 44599999999999999999999987

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-34  Score=292.87  Aligned_cols=183  Identities=26%  Similarity=0.461  Sum_probs=164.6

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      .|.|..|.||.+..  .++.||+|++...       ..+|+.+|+..+|+|||.+++.|..  .+.+|+||||+++|+|.
T Consensus       281 igqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv--~deLWVVMEym~ggsLT  358 (550)
T KOG0578|consen  281 IGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLV--GDELWVVMEYMEGGSLT  358 (550)
T ss_pred             hccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcc--cceeEEEEeecCCCchh
Confidence            37777799999987  7889999998533       3489999999999999999998877  57889999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--cccccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIVGT  493 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~gt  493 (552)
                      |.+....   +++.++..|+++++.||+|||.++   |+|||||.+|||++.+|.+||+|||++......  .....+||
T Consensus       359 DvVt~~~---~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmVGT  432 (550)
T KOG0578|consen  359 DVVTKTR---MTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMVGT  432 (550)
T ss_pred             hhhhccc---ccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccCccccccCC
Confidence            9987765   999999999999999999999999   999999999999999999999999999755433  34457999


Q ss_pred             ccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       494 ~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      +.|||||++....|+++.||||||++++||+-|++||-++++
T Consensus       433 PYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P  474 (550)
T KOG0578|consen  433 PYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP  474 (550)
T ss_pred             CCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh
Confidence            999999999999999999999999999999999999986553

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-34  Score=263.24  Aligned_cols=198  Identities=27%  Similarity=0.428  Sum_probs=176.4

Q ss_pred             ccccHHHHHHHhhccCCCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeec
Q 037224          329 RIFKIEELREATDNFSEGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCID  396 (552)
Q Consensus       329 ~~~~~~~l~~~t~~~~~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~  396 (552)
                      +.++++++ +..+.+  |.|-||.||.|+.  ++-.||+|++.+.          ..+|+++.+.|+||||++++++|.+
T Consensus        17 ~~~~l~df-eigr~L--gkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd   93 (281)
T KOG0580|consen   17 KTWTLDDF-EIGRPL--GKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD   93 (281)
T ss_pred             cccchhhc-cccccc--cCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec
Confidence            45666665 223333  5566699999988  6779999998433          3479999999999999999999998


Q ss_pred             CCCCeeEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeec
Q 037224          397 PEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANF  476 (552)
Q Consensus       397 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Df  476 (552)
                        +...||++||...|.|...|...+...+++.....++.|++.||.|+|..+   ++||||||+|+|++.++.+||+||
T Consensus        94 --~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdf  168 (281)
T KOG0580|consen   94 --SKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADF  168 (281)
T ss_pred             --cceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCC
Confidence              778899999999999999999888888999999999999999999999998   999999999999999999999999


Q ss_pred             cCCccCCCCccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          477 GLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       477 g~a~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      |.+...........+||..|.+||...+..++..+|+|++|++.||++.|.+||+...
T Consensus       169 GwsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~  226 (281)
T KOG0580|consen  169 GWSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS  226 (281)
T ss_pred             CceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence            9998776777778899999999999999999999999999999999999999999765

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.7e-34  Score=276.64  Aligned_cols=199  Identities=27%  Similarity=0.454  Sum_probs=175.4

Q ss_pred             HHhhccCCCceEEEEEEEEee--cCcEEEEEEeccCh----------HHHHHHHHHcCCCCccceeeeeecCCCCeeEEE
Q 037224          338 EATDNFSEGCLIQGSVYKGNI--HGEVYAIKMMKWNA----------CEELKILQKVNHGNLVKLEGFCIDPEDANCYLI  405 (552)
Q Consensus       338 ~~t~~~~~G~g~~G~Vy~~~~--~g~~vAvK~~~~~~----------~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  405 (552)
                      +.++.+  |.|.+|.|-++..  .|+.||||.++++.          .+|+++|+.|+||||+.++.+|..  .+...+|
T Consensus        56 E~~etL--GkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN--kdKIviv  131 (668)
T KOG0611|consen   56 EITETL--GKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN--KDKIVIV  131 (668)
T ss_pred             HHHHHh--cCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC--CceEEEE
Confidence            344444  6677799999976  79999999987653          379999999999999999999987  6788999


Q ss_pred             EeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC-
Q 037224          406 YEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN-  484 (552)
Q Consensus       406 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~-  484 (552)
                      |||..+|.|.||+.+...  +++.+++.+++||..|+.|+|.++   ++|||||.+|||+|.++++||+|||++..... 
T Consensus       132 MEYaS~GeLYDYiSer~~--LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~  206 (668)
T KOG0611|consen  132 MEYASGGELYDYISERGS--LSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK  206 (668)
T ss_pred             EEecCCccHHHHHHHhcc--ccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence            999999999999988764  999999999999999999999998   99999999999999999999999999975543 


Q ss_pred             CccccccccccccCccccCCCCC-CChhhHHHHHHHHHHHHcCCCCCCccCcccccchHHHHHHHhcC
Q 037224          485 AITMHIVGTQGYIAPEYLADGVV-STKMDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYWREMKRG  551 (552)
Q Consensus       485 ~~~~~~~gt~~y~aPE~~~~~~~-s~~~Dv~slG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~g  551 (552)
                      .....++|++-|.+||++.+..| ++..|-||||++||.|+.|..||++.+.      +.+.+++.+|
T Consensus       207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh------k~lvrQIs~G  268 (668)
T KOG0611|consen  207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH------KRLVRQISRG  268 (668)
T ss_pred             cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH------HHHHHHhhcc
Confidence            34556899999999999998886 6789999999999999999999998765      6777888776

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.7e-33  Score=271.63  Aligned_cols=186  Identities=26%  Similarity=0.469  Sum_probs=162.5

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCC-ccceeeeeecCC----CCeeEEEEeec
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGN-LVKLEGFCIDPE----DANCYLIYEYI  409 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~n-iv~l~~~~~~~~----~~~~~lv~e~~  409 (552)
                      |.|.+|.||+|+.  +|+.||+|+++-+         ..+|+.++++++|+| |+++++++.+.+    ....++|+||+
T Consensus        20 GeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~   99 (323)
T KOG0594|consen   20 GEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFL   99 (323)
T ss_pred             CCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEee
Confidence            6777799999987  8899999998543         258999999999999 999999998733    23788999999


Q ss_pred             cCCCchhhhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC--CC
Q 037224          410 ENGSLHSWLHENKN--ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC--NA  485 (552)
Q Consensus       410 ~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~--~~  485 (552)
                      +. +|.+++.....  ..++...+..++.||++||+|||+++   |+||||||.|||++++|.+||+|||+|+...  ..
T Consensus       100 d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~  175 (323)
T KOG0594|consen  100 DR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMR  175 (323)
T ss_pred             cc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchHHHhcCCcc
Confidence            76 99999987653  35788899999999999999999999   9999999999999999999999999998443  22


Q ss_pred             ccccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          486 ITMHIVGTQGYIAPEYLADG-VVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       486 ~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      ...+.+.|.+|.|||++.+. .|+...||||+|||+.||++++..|.++.+
T Consensus       176 ~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se  226 (323)
T KOG0594|consen  176 TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE  226 (323)
T ss_pred             cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH
Confidence            34567889999999998876 699999999999999999999999998876

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-34  Score=279.99  Aligned_cols=184  Identities=32%  Similarity=0.488  Sum_probs=157.4

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC---------------------hHHHHHHHHHcCCCCccceeeeeecCCCCe
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN---------------------ACEELKILQKVNHGNLVKLEGFCIDPEDAN  401 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------------------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  401 (552)
                      .|+|.+|.|-+|..  +++.||||++.+.                     ..+|+.+|++++|+|||+|+.+.-++....
T Consensus       105 iG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~  184 (576)
T KOG0585|consen  105 IGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPESDK  184 (576)
T ss_pred             hcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcccCc
Confidence            47788899999987  8899999998432                     237999999999999999999999988999


Q ss_pred             eEEEEeeccCCCchhhhhhcCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCc
Q 037224          402 CYLIYEYIENGSLHSWLHENKNEN-LNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK  480 (552)
Q Consensus       402 ~~lv~e~~~~gsL~~~l~~~~~~~-l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  480 (552)
                      +|||+|||..|.+...-   .... +++.+++++++++..||+|||.+|   |+||||||+|+|++++|++||+|||.+.
T Consensus       185 ~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKIsDFGVs~  258 (576)
T KOG0585|consen  185 LYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKISDFGVSN  258 (576)
T ss_pred             eEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEeeccceee
Confidence            99999999988875432   2233 999999999999999999999999   9999999999999999999999999987


Q ss_pred             cC-------CCCccccccccccccCccccCCCC----CCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          481 SG-------CNAITMHIVGTQGYIAPEYLADGV----VSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       481 ~~-------~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..       .+.......||+.|+|||....+.    .+.+.||||+||.||.|+.|+.||.++.
T Consensus       259 ~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~  323 (576)
T KOG0585|consen  259 EFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF  323 (576)
T ss_pred             ecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence            43       112223368999999999887633    4568899999999999999999998764

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=7.4e-34  Score=300.04  Aligned_cols=195  Identities=29%  Similarity=0.525  Sum_probs=166.1

Q ss_pred             CceEEEEEEEEeecC-------cEEEEEEecc--------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          346 GCLIQGSVYKGNIHG-------EVYAIKMMKW--------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       346 G~g~~G~Vy~~~~~g-------~~vAvK~~~~--------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      |.|.||+||+|+..|       ..||||.++.        +|.+|++++..++|||||+++|+|..  ++..++|+|||.
T Consensus       495 GegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~--~~P~~MvFEYm~  572 (774)
T KOG1026|consen  495 GEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE--GDPLCMVFEYMD  572 (774)
T ss_pred             cCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc--CCeeEEEEEecc
Confidence            777779999998733       4699999964        36689999999999999999999988  778899999999


Q ss_pred             CCCchhhhhhcCC--------C----CCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccC
Q 037224          411 NGSLHSWLHENKN--------E----NLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGL  478 (552)
Q Consensus       411 ~gsL~~~l~~~~~--------~----~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~  478 (552)
                      .|+|.+||..+..        .    +++..+.+.|+.|||.|++||-++.   +|||||..+|+||.++..+||+|||+
T Consensus       573 ~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VKIsDfGL  649 (774)
T KOG1026|consen  573 HGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVKISDFGL  649 (774)
T ss_pred             cccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEEeccccc
Confidence            9999999975432        2    2889999999999999999999998   99999999999999999999999999


Q ss_pred             CccCCCCccccc----cccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccCcccccchHHHHHHHhcC
Q 037224          479 AKSGCNAITMHI----VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEGKFCGQKLKGYWREMKRG  551 (552)
Q Consensus       479 a~~~~~~~~~~~----~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~g  551 (552)
                      ++..-.......    .-..+||+||.+..++++.++|||||||+|||+++ |+.||.+-..      .+.++.++.|
T Consensus       650 sRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn------~EVIe~i~~g  721 (774)
T KOG1026|consen  650 SRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN------QEVIECIRAG  721 (774)
T ss_pred             chhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch------HHHHHHHHcC
Confidence            985543333222    23568999999999999999999999999999998 9999987654      3445555444

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.3e-34  Score=278.82  Aligned_cols=187  Identities=28%  Similarity=0.435  Sum_probs=158.6

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC---hHHHHHHHHHcCCCCccceeeeeecCCCC---eeEEEEeeccCCCchh
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN---ACEELKILQKVNHGNLVKLEGFCIDPEDA---NCYLIYEYIENGSLHS  416 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---~~~E~~~l~~l~h~niv~l~~~~~~~~~~---~~~lv~e~~~~gsL~~  416 (552)
                      .|+|.||.||+|+.  +++.||||+.-.+   ..+|+.+|++++||||+++.-+|....+.   ..-+||||++. +|.+
T Consensus        32 iG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~  110 (364)
T KOG0658|consen   32 IGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYR  110 (364)
T ss_pred             EeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHH
Confidence            38888899999998  6789999998443   34899999999999999999888754444   44589999987 9998


Q ss_pred             hhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCC-CcEEEeeccCCccCC-CCccccccc
Q 037224          417 WLHEN--KNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN-MRAKIANFGLAKSGC-NAITMHIVG  492 (552)
Q Consensus       417 ~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kL~Dfg~a~~~~-~~~~~~~~g  492 (552)
                      .++..  .+..++..++.-+..||++||.|||+.+   |+||||||.|+|+|.+ |.+||||||.|+... .........
T Consensus       111 ~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epniSYic  187 (364)
T KOG0658|consen  111 VIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNISYIC  187 (364)
T ss_pred             HHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeeccCCCceeEEE
Confidence            88742  2345888899999999999999999998   9999999999999976 999999999998543 333345677


Q ss_pred             cccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          493 TQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       493 t~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      |..|.|||.+.+ ..|+.+.||||.||++.||+-|++.|.+++.
T Consensus       188 SRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~  231 (364)
T KOG0658|consen  188 SRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS  231 (364)
T ss_pred             eccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH
Confidence            899999998876 5699999999999999999999999998653

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.8e-33  Score=290.55  Aligned_cols=182  Identities=29%  Similarity=0.407  Sum_probs=159.4

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|.+|+||++..  +++.||+|+++..          ..+|+.++.+++|+||+++++.+.+  ....++||||+++|+
T Consensus        10 G~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~--~~~~~lv~E~~~gg~   87 (363)
T cd05628          10 GRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD--KLNLYLIMEFLPGGD   87 (363)
T ss_pred             EeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCeEEEEEcCCCCCc
Confidence            7778899999987  6889999998642          2368899999999999999999887  678899999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--------
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--------  485 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--------  485 (552)
                      |.+++....  .+++.++..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....        
T Consensus        88 L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~  162 (363)
T cd05628          88 MMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRN  162 (363)
T ss_pred             HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccccccccccc
Confidence            999987654  4899999999999999999999999   999999999999999999999999998632210        


Q ss_pred             -----------------------------ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          486 -----------------------------ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       486 -----------------------------~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                                                   ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.+..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~  240 (363)
T cd05628         163 LNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET  240 (363)
T ss_pred             ccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCC
Confidence                                         0123478999999999999999999999999999999999999998654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.6e-33  Score=271.82  Aligned_cols=186  Identities=27%  Similarity=0.420  Sum_probs=164.8

Q ss_pred             CCceEEEEEEEEeecC--cEEEEEEeccCh----------HHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNIHG--EVYAIKMMKWNA----------CEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~g--~~vAvK~~~~~~----------~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|+|.-|+||.+++.+  ..+|+|++.++.          ..|-+||+.++||.++.|+..+..  +...+++||||+||
T Consensus        85 LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet--~~~~cl~meyCpGG  162 (459)
T KOG0610|consen   85 LGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET--DKYSCLVMEYCPGG  162 (459)
T ss_pred             cCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec--cceeEEEEecCCCc
Confidence            4777779999999954  799999997653          248899999999999999999987  78889999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccC----------
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG----------  482 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~----------  482 (552)
                      +|..++++...+.++++.++.++.+++-||+|||..|   ||+|||||+||||.++|++-|+||.++...          
T Consensus       163 dL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~  239 (459)
T KOG0610|consen  163 DLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSS  239 (459)
T ss_pred             cHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccC
Confidence            9999999998899999999999999999999999999   999999999999999999999999986300          


Q ss_pred             -------------------------C-C----------------------CccccccccccccCccccCCCCCCChhhHH
Q 037224          483 -------------------------C-N----------------------AITMHIVGTQGYIAPEYLADGVVSTKMDVF  514 (552)
Q Consensus       483 -------------------------~-~----------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~  514 (552)
                                               . .                      ......+||..|+|||++.+...+.++|+|
T Consensus       240 ~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWW  319 (459)
T KOG0610|consen  240 SPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWW  319 (459)
T ss_pred             CCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHH
Confidence                                     0 0                      011124689999999999999999999999


Q ss_pred             HHHHHHHHHHcCCCCCCccCc
Q 037224          515 SFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       515 slG~il~elltG~~pf~~~~~  535 (552)
                      +||+++|||+.|..||.+.+.
T Consensus       320 tfGIflYEmLyG~TPFKG~~~  340 (459)
T KOG0610|consen  320 TFGIFLYEMLYGTTPFKGSNN  340 (459)
T ss_pred             HHHHHHHHHHhCCCCcCCCCc
Confidence            999999999999999998763

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.4e-33  Score=283.88  Aligned_cols=183  Identities=28%  Similarity=0.425  Sum_probs=160.4

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|.|.+|.||+++.  +|+.||+|+++..          ..+|+.++++++||||+++++++.+  +...++||||++++
T Consensus         3 lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~~~   80 (323)
T cd05571           3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT--HDRLCFVMEYANGG   80 (323)
T ss_pred             eeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc--CCEEEEEEeCCCCC
Confidence            37788899999987  7889999998642          2358899999999999999998877  67889999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC--CCccccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC--NAITMHI  490 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~--~~~~~~~  490 (552)
                      +|.+++....  .+++.++..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...  .......
T Consensus        81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  155 (323)
T cd05571          81 ELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF  155 (323)
T ss_pred             cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccce
Confidence            9999887654  4899999999999999999999999   9999999999999999999999999987432  2223345


Q ss_pred             cccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       491 ~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .||+.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~  199 (323)
T cd05571         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD  199 (323)
T ss_pred             ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC
Confidence            78999999999999999999999999999999999999997644

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3.1e-33  Score=284.82  Aligned_cols=182  Identities=26%  Similarity=0.444  Sum_probs=161.3

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|.|.+|.||+++.  +++.||+|+++..          ..+|+.++++++||||+++++++.+  ++..+++|||++++
T Consensus        26 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~~  103 (329)
T PTZ00263         26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD--ENRVYFLLEFVVGG  103 (329)
T ss_pred             EEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc--CCEEEEEEcCCCCC
Confidence            37777899999988  6789999998532          3469999999999999999999987  67889999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccccccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVG  492 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~g  492 (552)
                      +|.+++....  .+++..+..++.|++.||+|||+++   ++||||||+|||++.++.+||+|||+++..... .....|
T Consensus       104 ~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~g  177 (329)
T PTZ00263        104 ELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-TFTLCG  177 (329)
T ss_pred             hHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC-cceecC
Confidence            9999987654  4899999999999999999999999   999999999999999999999999999755432 234578


Q ss_pred             cccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       493 t~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ++.|+|||.+.+..++.++|||||||++|||++|+.||.+..
T Consensus       178 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~  219 (329)
T PTZ00263        178 TPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT  219 (329)
T ss_pred             ChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC
Confidence            999999999999999999999999999999999999997654

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-33  Score=281.28  Aligned_cols=182  Identities=26%  Similarity=0.400  Sum_probs=159.8

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|++|.||+++.  +++.||+|+++..          ..+|+.++++++||||+++++++.+  ....++||||+++++
T Consensus         2 g~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g~   79 (312)
T cd05585           2 GKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS--PEKLYLVLAFINGGE   79 (312)
T ss_pred             CcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec--CCeEEEEEcCCCCCc
Confidence            6788899999988  6789999998532          2368999999999999999998876  678899999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC--Ccccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN--AITMHIV  491 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~--~~~~~~~  491 (552)
                      |.+++....  .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++....  .......
T Consensus        80 L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  154 (312)
T cd05585          80 LFHHLQREG--RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC  154 (312)
T ss_pred             HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccccc
Confidence            999987643  4899999999999999999999999   99999999999999999999999999874322  2223457


Q ss_pred             ccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          492 GTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       492 gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ||+.|+|||.+.+..++.++|||||||++|||++|+.||.+.+
T Consensus       155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~  197 (312)
T cd05585         155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN  197 (312)
T ss_pred             CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC
Confidence            8999999999999999999999999999999999999997643

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-33  Score=279.01  Aligned_cols=181  Identities=28%  Similarity=0.451  Sum_probs=160.2

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|.+|.||++..  +++.||+|+++..          ..+|+.++++++||||+++++++.+  +...++||||+++++
T Consensus        10 g~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~~~   87 (291)
T cd05612          10 GTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD--QRFLYMLMEYVPGGE   87 (291)
T ss_pred             ecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc--CCeEEEEEeCCCCCC
Confidence            7777899999988  5899999998532          3469999999999999999988876  678899999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcccccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT  493 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~gt  493 (552)
                      |.+++....  .+++..+..++.|++.||+|||+++   ++||||||+|||++.++.+||+|||++...... .....|+
T Consensus        88 L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-~~~~~gt  161 (291)
T cd05612          88 LFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-TWTLCGT  161 (291)
T ss_pred             HHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC-cccccCC
Confidence            999987654  4899999999999999999999999   999999999999999999999999998754332 2335789


Q ss_pred             ccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       494 ~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       162 ~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  202 (291)
T cd05612         162 PEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN  202 (291)
T ss_pred             hhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999998889999999999999999999999998654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-34  Score=278.14  Aligned_cols=177  Identities=31%  Similarity=0.509  Sum_probs=149.0

Q ss_pred             CceEEEEEEEEeecCcEEEEEEeccC----hHHHHHHHHH--cCCCCccceeeeeecCCC--CeeEEEEeeccCCCchhh
Q 037224          346 GCLIQGSVYKGNIHGEVYAIKMMKWN----ACEELKILQK--VNHGNLVKLEGFCIDPED--ANCYLIYEYIENGSLHSW  417 (552)
Q Consensus       346 G~g~~G~Vy~~~~~g~~vAvK~~~~~----~~~E~~~l~~--l~h~niv~l~~~~~~~~~--~~~~lv~e~~~~gsL~~~  417 (552)
                      |.|.||.||+|.|.|+.||||++...    ..+|.++++.  |+|+||+.+++.-....+  .++|||.+|.+.|||.||
T Consensus       220 GkGRyGEVwrG~wrGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~Dy  299 (513)
T KOG2052|consen  220 GKGRFGEVWRGRWRGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDY  299 (513)
T ss_pred             cCccccceeeccccCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHH
Confidence            88888999999999999999999543    3467777775  599999999987654333  268999999999999999


Q ss_pred             hhhcCCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC------CCc
Q 037224          418 LHENKNENLNWKTRLRIAIDVANGLQYIH-----EHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC------NAI  486 (552)
Q Consensus       418 l~~~~~~~l~~~~~~~i~~qi~~aL~~LH-----~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~------~~~  486 (552)
                      |.++.   ++.+..++++..++.||++||     .+|+|.|.|||||+.|||+..++.+.|+|+|+|....      +..
T Consensus       300 L~r~t---v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~  376 (513)
T KOG2052|consen  300 LNRNT---VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIP  376 (513)
T ss_pred             Hhhcc---CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCC
Confidence            98854   999999999999999999999     5688999999999999999999999999999996322      223


Q ss_pred             cccccccccccCccccCCCCC------CChhhHHHHHHHHHHHHc
Q 037224          487 TMHIVGTQGYIAPEYLADGVV------STKMDVFSFGVVLLELIS  525 (552)
Q Consensus       487 ~~~~~gt~~y~aPE~~~~~~~------s~~~Dv~slG~il~ellt  525 (552)
                      ....+||.+|||||++.....      -..+||||||.++||+..
T Consensus       377 ~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar  421 (513)
T KOG2052|consen  377 PNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR  421 (513)
T ss_pred             CCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence            345789999999999865331      235899999999999874

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=7.6e-33  Score=281.24  Aligned_cols=183  Identities=28%  Similarity=0.439  Sum_probs=159.8

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|.|++|.||+++.  +|+.||+|+++..          ..+|+.++++++||||+++++.+..  +...++||||++++
T Consensus         3 lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~E~~~~~   80 (323)
T cd05595           3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLCFVMEYANGG   80 (323)
T ss_pred             eeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCEEEEEEeCCCCC
Confidence            37788899999987  7899999998643          2368999999999999999999877  66889999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC--Cccccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN--AITMHI  490 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~--~~~~~~  490 (552)
                      +|.+++....  .+++..++.++.|++.||+|||+++   ++||||||+|||++.++.+||+|||++.....  ......
T Consensus        81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~  155 (323)
T cd05595          81 ELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF  155 (323)
T ss_pred             cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccc
Confidence            9998886544  4899999999999999999999999   99999999999999999999999999874221  222335


Q ss_pred             cccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       491 ~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .|++.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~  199 (323)
T cd05595         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD  199 (323)
T ss_pred             cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC
Confidence            78999999999999999999999999999999999999997654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=8.8e-33  Score=275.76  Aligned_cols=184  Identities=26%  Similarity=0.378  Sum_probs=161.3

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|++|.||++..  +|+.||+|.++..          ..+|+.++++++|+|++++++++.+  ++..+++|||+++|+
T Consensus         9 g~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~--~~~~~lv~e~~~~g~   86 (285)
T cd05631           9 GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET--KDALCLVLTIMNGGD   86 (285)
T ss_pred             ecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc--CCeEEEEEEecCCCc
Confidence            7777899999987  7899999987532          2368999999999999999998876  668899999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-ccccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-ITMHIVG  492 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-~~~~~~g  492 (552)
                      |.+++.......+++..+..++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||++...... ......|
T Consensus        87 L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~g  163 (285)
T cd05631          87 LKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVG  163 (285)
T ss_pred             HHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecCCCC
Confidence            998886655456899999999999999999999999   999999999999999999999999999754322 2234578


Q ss_pred             cccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       493 t~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +..|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus       164 ~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~  205 (285)
T cd05631         164 TVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK  205 (285)
T ss_pred             CCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999999999999999999998654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-33  Score=271.65  Aligned_cols=185  Identities=27%  Similarity=0.447  Sum_probs=161.9

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      |.|..+.||+|..  .++.||||++.-+        ..+|+..++.++||||++++..|..  +..+|+||.||.+|++.
T Consensus        35 G~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv--~~~LWvVmpfMa~GS~l  112 (516)
T KOG0582|consen   35 GVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV--DSELWVVMPFMAGGSLL  112 (516)
T ss_pred             eccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe--cceeEEeehhhcCCcHH
Confidence            6666699999988  7899999999543        2479999999999999999999988  78899999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-----cc-cc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-----IT-MH  489 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-----~~-~~  489 (552)
                      +++...-...+++..+..|++++++||.|||.+|   .||||||+.||||+++|.+||+|||.+......     .. ..
T Consensus       113 dIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~t  189 (516)
T KOG0582|consen  113 DIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNT  189 (516)
T ss_pred             HHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeecc
Confidence            9998877677999999999999999999999999   999999999999999999999999987532211     11 34


Q ss_pred             ccccccccCccccCC--CCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          490 IVGTQGYIAPEYLAD--GVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~--~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      .+||+.|||||++..  ..|+.|+||||||+...||.+|+.||....+
T Consensus       190 fvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP  237 (516)
T KOG0582|consen  190 FVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP  237 (516)
T ss_pred             ccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh
Confidence            689999999999644  4588999999999999999999999997654

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-33  Score=282.67  Aligned_cols=181  Identities=28%  Similarity=0.400  Sum_probs=160.9

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|.+|.||+++.  +++.||+|+++..          ..+|++++..++|+||+++++++.+  ....++||||+++++
T Consensus        10 g~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~~lv~e~~~g~~   87 (333)
T cd05600          10 GQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD--DEYLYLAMEYVPGGD   87 (333)
T ss_pred             eecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc--CCEEEEEEeCCCCCC
Confidence            7777899999988  5889999998643          2368999999999999999999877  678899999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcccccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT  493 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~gt  493 (552)
                      |.+++....  .+++.++..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++..... ......|+
T Consensus        88 L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-~~~~~~gt  161 (333)
T cd05600          88 FRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-YANSVVGS  161 (333)
T ss_pred             HHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-ccCCcccC
Confidence            999997644  4899999999999999999999999   99999999999999999999999999975433 23346789


Q ss_pred             ccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       494 ~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus       162 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~  202 (333)
T cd05600         162 PDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST  202 (333)
T ss_pred             ccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC
Confidence            99999999998899999999999999999999999997654

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.2e-32  Score=280.38  Aligned_cols=183  Identities=27%  Similarity=0.434  Sum_probs=159.9

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|.|.+|.||++..  +|+.||+|+++..          ..+|+.+++.++||||+++++++.+  +...++||||++++
T Consensus         3 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~Ey~~~g   80 (328)
T cd05593           3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT--KDRLCFVMEYVNGG   80 (328)
T ss_pred             eeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCEEEEEEeCCCCC
Confidence            36778899999987  6889999998643          2368899999999999999998876  67889999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC--CCccccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC--NAITMHI  490 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~--~~~~~~~  490 (552)
                      +|.+++....  .+++.+++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++...  .......
T Consensus        81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~  155 (328)
T cd05593          81 ELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF  155 (328)
T ss_pred             CHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccc
Confidence            9998886543  4899999999999999999999999   9999999999999999999999999987432  1222345


Q ss_pred             cccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       491 ~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .||+.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~  199 (328)
T cd05593         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD  199 (328)
T ss_pred             cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC
Confidence            78999999999998899999999999999999999999997654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.1e-32  Score=281.83  Aligned_cols=182  Identities=27%  Similarity=0.378  Sum_probs=160.0

Q ss_pred             CCceEEEEEEEEeec---CcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNIH---GEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~---g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|++|.||++.+.   +..||+|+++..          ..+|+.+++.++||||+++++++.+  +...++||||+++
T Consensus        38 ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~~lv~Ey~~~  115 (340)
T PTZ00426         38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD--ESYLYLVLEFVIG  115 (340)
T ss_pred             EeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe--CCEEEEEEeCCCC
Confidence            377788999999862   358999998532          2369999999999999999999987  6788999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcccccc
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIV  491 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~  491 (552)
                      |+|.+++....  .+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++...... .....
T Consensus       116 g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-~~~~~  189 (340)
T PTZ00426        116 GEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-TYTLC  189 (340)
T ss_pred             CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCC-cceec
Confidence            99999997654  4899999999999999999999999   999999999999999999999999999754332 23467


Q ss_pred             ccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          492 GTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       492 gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       190 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~  232 (340)
T PTZ00426        190 GTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE  232 (340)
T ss_pred             CChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC
Confidence            8999999999988889999999999999999999999998654

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.3e-32  Score=274.18  Aligned_cols=201  Identities=28%  Similarity=0.400  Sum_probs=167.5

Q ss_pred             ccccccHHHHHHHhhccCCCceEEEEEEEEeecCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeec
Q 037224          327 KYRIFKIEELREATDNFSEGCLIQGSVYKGNIHGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCID  396 (552)
Q Consensus       327 ~~~~~~~~~l~~~t~~~~~G~g~~G~Vy~~~~~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~  396 (552)
                      ..+.++.+++. ..+....|.|++|.||+|+++|+.||+|.++..          +.+|+.++++++||||+++++++.+
T Consensus        11 ~~~~i~~~~i~-~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~   89 (283)
T PHA02988         11 DIKCIESDDID-KYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIID   89 (283)
T ss_pred             cceecCHHHcC-CCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEe
Confidence            34445566662 222234577788999999999999999998642          2379999999999999999999876


Q ss_pred             --CCCCeeEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEECCCCcEEE
Q 037224          397 --PEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEH-TRPRVVHKDIKSSNILLDSNMRAKI  473 (552)
Q Consensus       397 --~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~ivH~Dikp~NIll~~~~~~kL  473 (552)
                        ......+++|||+++|+|.+++....  .+++...+.++.|++.||.|||+. +   ++||||||+||++++++.+||
T Consensus        90 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl  164 (283)
T PHA02988         90 IVDDLPRLSLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKI  164 (283)
T ss_pred             cccCCCceEEEEEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEE
Confidence              33456799999999999999997654  489999999999999999999985 6   889999999999999999999


Q ss_pred             eeccCCccCCCCccccccccccccCccccCC--CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          474 ANFGLAKSGCNAITMHIVGTQGYIAPEYLAD--GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       474 ~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +|||+++..... .....++..|+|||.+.+  ..++.++||||||+++|||++|+.||.+.+
T Consensus       165 ~dfg~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~  226 (283)
T PHA02988        165 ICHGLEKILSSP-PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT  226 (283)
T ss_pred             cccchHhhhccc-cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC
Confidence            999998754322 223567899999999876  678999999999999999999999998654

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.6e-32  Score=278.94  Aligned_cols=183  Identities=27%  Similarity=0.432  Sum_probs=158.8

Q ss_pred             CCceEEEEEEEEee-----cCcEEEEEEeccC-----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEee
Q 037224          345 EGCLIQGSVYKGNI-----HGEVYAIKMMKWN-----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEY  408 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-----~g~~vAvK~~~~~-----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~  408 (552)
                      .|.|++|.||+++.     .++.||+|+++..           ..+|+.+++.++||||+++++.+.+  ++..+++|||
T Consensus         4 lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~lv~e~   81 (323)
T cd05584           4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT--GGKLYLILEY   81 (323)
T ss_pred             eeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec--CCeEEEEEeC
Confidence            37778899999875     5789999998632           2368999999999999999999877  6688999999


Q ss_pred             ccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC--CCc
Q 037224          409 IENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC--NAI  486 (552)
Q Consensus       409 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~--~~~  486 (552)
                      +++++|.+++....  .+.+..+..++.|++.||+|||+++   ++||||||+|||++.++.+||+|||+++...  ...
T Consensus        82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  156 (323)
T cd05584          82 LSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV  156 (323)
T ss_pred             CCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCc
Confidence            99999999887654  4888999999999999999999999   9999999999999999999999999986322  222


Q ss_pred             cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          487 TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       487 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .....|++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~  204 (323)
T cd05584         157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN  204 (323)
T ss_pred             ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC
Confidence            233578999999999998889999999999999999999999998654

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-32  Score=284.95  Aligned_cols=183  Identities=27%  Similarity=0.401  Sum_probs=159.6

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|.|++|.||+++.  +++.||+|+++..          ..+|+.++..++|+||+++++++.+  +...++||||+++|
T Consensus         9 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~lv~E~~~~g   86 (364)
T cd05599           9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD--ENYLYLIMEYLPGG   86 (364)
T ss_pred             EEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCeEEEEECCCCCc
Confidence            37778899999988  6889999998642          2369999999999999999999987  67889999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-------
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-------  485 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-------  485 (552)
                      +|.+++....  .+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||++......       
T Consensus        87 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  161 (364)
T cd05599          87 DMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYR  161 (364)
T ss_pred             HHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccccccccccc
Confidence            9999987654  4899999999999999999999999   999999999999999999999999998632110       


Q ss_pred             ---------------------------------ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          486 ---------------------------------ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       486 ---------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                                                       ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~  241 (364)
T cd05599         162 ILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCS  241 (364)
T ss_pred             cccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCC
Confidence                                             01123689999999999999999999999999999999999999976


Q ss_pred             cC
Q 037224          533 EG  534 (552)
Q Consensus       533 ~~  534 (552)
                      .+
T Consensus       242 ~~  243 (364)
T cd05599         242 DN  243 (364)
T ss_pred             CC
Confidence            54

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.9e-32  Score=278.18  Aligned_cols=183  Identities=29%  Similarity=0.485  Sum_probs=158.5

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|++|.||+++.  .++.||+|+++..          ...|.+++..+ +||||+++++++.+  ....++||||+++
T Consensus         3 lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~--~~~~~lv~E~~~~   80 (321)
T cd05591           3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT--KDRLFFVMEYVNG   80 (321)
T ss_pred             cccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCeEEEEEeCCCC
Confidence            47788899999988  5789999998643          23577888766 89999999999987  6678999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC--CCcccc
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC--NAITMH  489 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~--~~~~~~  489 (552)
                      ++|.+++....  .+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++....  ......
T Consensus        81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (321)
T cd05591          81 GDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT  155 (321)
T ss_pred             CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCccccc
Confidence            99998887654  4899999999999999999999999   9999999999999999999999999987432  222334


Q ss_pred             ccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..|++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~  200 (321)
T cd05591         156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN  200 (321)
T ss_pred             cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC
Confidence            568999999999998899999999999999999999999998655

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-33  Score=284.15  Aligned_cols=181  Identities=30%  Similarity=0.565  Sum_probs=158.4

Q ss_pred             CCceEEEEEEEEeecCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          345 EGCLIQGSVYKGNIHGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      .|+|.||+||+|+|.|. ||||++..+         |.+|+..+++-+|.||+-++|+|..  +.. .+|+.||+|.+|.
T Consensus       400 IGsGsFGtV~Rg~whGd-VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~--p~~-AIiTqwCeGsSLY  475 (678)
T KOG0193|consen  400 IGSGSFGTVYRGRWHGD-VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN--PPL-AIITQWCEGSSLY  475 (678)
T ss_pred             eccccccceeecccccc-eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC--Cce-eeeehhccCchhh
Confidence            48888899999999995 699999643         5689999999999999999999987  333 8999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccC----CCCcccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG----CNAITMHIV  491 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~----~~~~~~~~~  491 (552)
                      .+++..+. .|+....+.|++|++.|+.|||.++   |+|||||..|||+.+++.+||+|||++...    .........
T Consensus       476 ~hlHv~et-kfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~  551 (678)
T KOG0193|consen  476 THLHVQET-KFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPH  551 (678)
T ss_pred             hhccchhh-hhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCc
Confidence            99987663 4999999999999999999999999   999999999999999999999999998632    223333456


Q ss_pred             ccccccCccccCC---CCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          492 GTQGYIAPEYLAD---GVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       492 gt~~y~aPE~~~~---~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      |...|||||++..   .++++++||||||+++|||+||..||...
T Consensus       552 gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~  596 (678)
T KOG0193|consen  552 GSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ  596 (678)
T ss_pred             cchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC
Confidence            7889999998853   56899999999999999999999999843

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-33  Score=268.19  Aligned_cols=185  Identities=30%  Similarity=0.470  Sum_probs=162.2

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeec---CCCCeeEEEEeecc
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCID---PEDANCYLIYEYIE  410 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~---~~~~~~~lv~e~~~  410 (552)
                      .|.|++|.|+.+..  +|+.||+|.+...         ..+|+.+|+.++|+||+.+.+++..   .+-...|+|+|+|+
T Consensus        30 iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMe  109 (359)
T KOG0660|consen   30 IGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELME  109 (359)
T ss_pred             ccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHHh
Confidence            38888899999987  7899999998633         3489999999999999999999875   23457899999996


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC----CCc
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC----NAI  486 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~----~~~  486 (552)
                      . +|.+.++....  ++...+..++.|+++||.|+|+.+   ++|||+||+|++++.+..+||+|||+|+...    ...
T Consensus       110 t-DL~~iik~~~~--L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~  183 (359)
T KOG0660|consen  110 T-DLHQIIKSQQD--LTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGF  183 (359)
T ss_pred             h-HHHHHHHcCcc--ccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeeccccCcccc
Confidence            5 99998877653  999999999999999999999999   9999999999999999999999999999764    344


Q ss_pred             cccccccccccCccccC-CCCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          487 TMHIVGTQGYIAPEYLA-DGVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       487 ~~~~~gt~~y~aPE~~~-~~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      .+..+.|.+|.|||.+. ...|+.+.||||.|||+.||++|++.|.+.+.
T Consensus       184 mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~  233 (359)
T KOG0660|consen  184 MTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY  233 (359)
T ss_pred             hhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch
Confidence            45568899999999875 46799999999999999999999999998764

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-32  Score=285.89  Aligned_cols=182  Identities=25%  Similarity=0.360  Sum_probs=157.6

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|.+|.||++..  +++.||+|++...          ..+|++++++++|+||+++++++.+  ....|+||||+++|+
T Consensus        10 G~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~lv~E~~~gg~   87 (377)
T cd05629          10 GKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD--AQYLYLIMEFLPGGD   87 (377)
T ss_pred             eecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCeeEEEEeCCCCCc
Confidence            7777899999987  7889999998532          2368999999999999999999987  678899999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--------
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--------  485 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--------  485 (552)
                      |.+++....  .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....        
T Consensus        88 L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  162 (377)
T cd05629          88 LMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQK  162 (377)
T ss_pred             HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccccccccccc
Confidence            999987643  4899999999999999999999999   999999999999999999999999998521100        


Q ss_pred             -----------------------------------------ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHH
Q 037224          486 -----------------------------------------ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELI  524 (552)
Q Consensus       486 -----------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ell  524 (552)
                                                               ......||+.|+|||++.+..++.++|||||||++|||+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell  242 (377)
T cd05629         163 LLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECL  242 (377)
T ss_pred             cccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhh
Confidence                                                     000246899999999999889999999999999999999


Q ss_pred             cCCCCCCccC
Q 037224          525 SGKEAIDEEG  534 (552)
Q Consensus       525 tG~~pf~~~~  534 (552)
                      +|+.||....
T Consensus       243 tG~~Pf~~~~  252 (377)
T cd05629         243 IGWPPFCSEN  252 (377)
T ss_pred             cCCCCCCCCC
Confidence            9999997654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.8e-32  Score=276.71  Aligned_cols=183  Identities=27%  Similarity=0.490  Sum_probs=158.3

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|.+|.||+++.  +++.||+|+++..          ..+|..++..+ +|+||+++++++.+  ....++||||+++
T Consensus         3 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~--~~~~~iv~Ey~~~   80 (320)
T cd05590           3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT--PDRLFFVMEFVNG   80 (320)
T ss_pred             eeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc--CCEEEEEEcCCCC
Confidence            37788899999987  6789999998642          12577777776 79999999999877  6788999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC--CCcccc
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC--NAITMH  489 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~--~~~~~~  489 (552)
                      ++|.+++....  .+++..+..++.|++.||+|||+++   ++||||||+|||++.++.+||+|||+++...  ......
T Consensus        81 g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (320)
T cd05590          81 GDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST  155 (320)
T ss_pred             chHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccc
Confidence            99999887654  4899999999999999999999999   9999999999999999999999999987432  222334


Q ss_pred             ccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~  200 (320)
T cd05590         156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN  200 (320)
T ss_pred             cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence            578999999999998899999999999999999999999998654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.9e-32  Score=277.07  Aligned_cols=183  Identities=28%  Similarity=0.450  Sum_probs=156.7

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccCh----------HHHHH-HHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWNA----------CEELK-ILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~~----------~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|++|.||+++.  +|+.||+|++....          .+|.. +++.++||||+++++.+.+  ....++||||+++
T Consensus         3 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~   80 (323)
T cd05575           3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--ADKLYFVLDYVNG   80 (323)
T ss_pred             eeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe--CCEEEEEEcCCCC
Confidence            37778899999988  78999999986421          12333 4577899999999998876  6788999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC--CCcccc
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC--NAITMH  489 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~--~~~~~~  489 (552)
                      ++|.+++....  .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++....  ......
T Consensus        81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (323)
T cd05575          81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST  155 (323)
T ss_pred             CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccc
Confidence            99999887644  4899999999999999999999999   9999999999999999999999999987432  222334


Q ss_pred             ccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~  200 (323)
T cd05575         156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD  200 (323)
T ss_pred             ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC
Confidence            578999999999999999999999999999999999999997654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.7e-32  Score=283.52  Aligned_cols=181  Identities=28%  Similarity=0.370  Sum_probs=157.2

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|++|.||+++.  +++.+|+|+++..          ..+|+.+++.++||||+++++++.+  +...++||||+++|+
T Consensus        52 G~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--~~~~~lv~Ey~~gg~  129 (370)
T cd05621          52 GRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD--DKYLYMVMEYMPGGD  129 (370)
T ss_pred             EecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEEEEEcCCCCCc
Confidence            7788899999988  6789999998531          2368999999999999999999877  678899999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC---ccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA---ITMHI  490 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~---~~~~~  490 (552)
                      |.+++...   .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++......   .....
T Consensus       130 L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~  203 (370)
T cd05621         130 LVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA  203 (370)
T ss_pred             HHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccCCceecccC
Confidence            99998654   3889999999999999999999999   999999999999999999999999999754322   12245


Q ss_pred             cccccccCccccCCC----CCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          491 VGTQGYIAPEYLADG----VVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       491 ~gt~~y~aPE~~~~~----~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .||+.|+|||.+...    .++.++|||||||++|||++|+.||...+
T Consensus       204 ~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~  251 (370)
T cd05621         204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS  251 (370)
T ss_pred             CCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC
Confidence            789999999998653    37889999999999999999999998654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.9e-32  Score=274.48  Aligned_cols=183  Identities=28%  Similarity=0.450  Sum_probs=156.7

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccCh----------HHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWNA----------CEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~~----------~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|++|.||+++.  +++.||+|+++...          ..|..++..+ +||||+++++++..  ....++||||+++
T Consensus         3 lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~~~g   80 (316)
T cd05592           3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT--KEHLFFVMEYLNG   80 (316)
T ss_pred             eeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCCCC
Confidence            37788899999987  57889999986432          2355566544 89999999999876  6688999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC--CCcccc
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC--NAITMH  489 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~--~~~~~~  489 (552)
                      ++|.+++....  .+++.++..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++....  ......
T Consensus        81 g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  155 (316)
T cd05592          81 GDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST  155 (316)
T ss_pred             CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccc
Confidence            99999887644  4899999999999999999999998   9999999999999999999999999987432  222334


Q ss_pred             ccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~  200 (316)
T cd05592         156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED  200 (316)
T ss_pred             ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC
Confidence            578999999999998889999999999999999999999998654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.8e-32  Score=284.94  Aligned_cols=183  Identities=27%  Similarity=0.365  Sum_probs=158.6

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|.|++|.||+++.  +++.||+|+++..          ..+|+.++++++|+||+++++++.+  ...+++||||+++|
T Consensus         9 LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~~~~~lv~E~~~gg   86 (381)
T cd05626           9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYFVMDYIPGG   86 (381)
T ss_pred             EeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec--CCEEEEEEecCCCC
Confidence            37888899999987  7789999998532          2368999999999999999999987  67889999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC--------
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN--------  484 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~--------  484 (552)
                      +|.+++....  .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.....        
T Consensus        87 ~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~  161 (381)
T cd05626          87 DMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ  161 (381)
T ss_pred             cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence            9999987654  4899999999999999999999998   99999999999999999999999998742110        


Q ss_pred             -----------------------------------------CccccccccccccCccccCCCCCCChhhHHHHHHHHHHH
Q 037224          485 -----------------------------------------AITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLEL  523 (552)
Q Consensus       485 -----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~el  523 (552)
                                                               .......||+.|+|||.+.+..++.++|||||||++|||
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~el  241 (381)
T cd05626         162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM  241 (381)
T ss_pred             ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHH
Confidence                                                     001124689999999999988899999999999999999


Q ss_pred             HcCCCCCCccC
Q 037224          524 ISGKEAIDEEG  534 (552)
Q Consensus       524 ltG~~pf~~~~  534 (552)
                      ++|+.||...+
T Consensus       242 ltG~~Pf~~~~  252 (381)
T cd05626         242 LVGQPPFLAPT  252 (381)
T ss_pred             HhCCCCCcCCC
Confidence            99999997654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.7e-32  Score=285.35  Aligned_cols=183  Identities=26%  Similarity=0.372  Sum_probs=158.5

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|.|.+|.||+++.  +++.||+|++...          ..+|+.++++++|+||+++++.+.+  +...++||||+++|
T Consensus         9 LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~--~~~~~lv~E~~~gg   86 (382)
T cd05625           9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD--KDNLYFVMDYIPGG   86 (382)
T ss_pred             EEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe--CCEEEEEEeCCCCC
Confidence            37788899999987  6789999998542          3369999999999999999999987  67889999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC--------
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN--------  484 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~--------  484 (552)
                      +|.+++....  .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++.....        
T Consensus        87 ~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~  161 (382)
T cd05625          87 DMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ  161 (382)
T ss_pred             cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence            9999987653  4889999999999999999999999   99999999999999999999999998742110        


Q ss_pred             -----------------------------------------CccccccccccccCccccCCCCCCChhhHHHHHHHHHHH
Q 037224          485 -----------------------------------------AITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLEL  523 (552)
Q Consensus       485 -----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~el  523 (552)
                                                               .......||+.|+|||++.+..++.++|||||||++|||
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~el  241 (382)
T cd05625         162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM  241 (382)
T ss_pred             cccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHH
Confidence                                                     001124689999999999999999999999999999999


Q ss_pred             HcCCCCCCccC
Q 037224          524 ISGKEAIDEEG  534 (552)
Q Consensus       524 ltG~~pf~~~~  534 (552)
                      ++|+.||...+
T Consensus       242 ltG~~Pf~~~~  252 (382)
T cd05625         242 LVGQPPFLAQT  252 (382)
T ss_pred             HhCCCCCCCCC
Confidence            99999998654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=5.7e-32  Score=273.95  Aligned_cols=183  Identities=26%  Similarity=0.443  Sum_probs=157.9

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccCh----------HHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWNA----------CEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~~----------~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|++|.||+++.  +|+.||+|+++...          ..|..++... +|+||+++++++.+  ++..++||||+.+
T Consensus         3 lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~E~~~~   80 (316)
T cd05620           3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT--KEHLFFVMEFLNG   80 (316)
T ss_pred             eeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe--CCEEEEEECCCCC
Confidence            37778899999988  67899999986431          2466677654 89999999999877  6788999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccC--CCCcccc
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG--CNAITMH  489 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~--~~~~~~~  489 (552)
                      ++|.+++....  .+++.++..++.|+++||+|||+++   ++||||||+|||++.++.+||+|||+++..  .......
T Consensus        81 g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (316)
T cd05620          81 GDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST  155 (316)
T ss_pred             CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceec
Confidence            99999887643  4899999999999999999999999   999999999999999999999999998642  1223334


Q ss_pred             ccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..|++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~  200 (316)
T cd05620         156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD  200 (316)
T ss_pred             cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence            678999999999999999999999999999999999999998654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2e-32  Score=282.08  Aligned_cols=184  Identities=27%  Similarity=0.412  Sum_probs=165.2

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccCh------HHHHHHHHHcC-C-----CCccceeeeeecCCCCeeEEEEeecc
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWNA------CEELKILQKVN-H-----GNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~~------~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      .|.|.||.|.++..  +++.||||+++...      ..|+.+|..|+ |     -|+|+++++|..  .++.+||+|.++
T Consensus       194 LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f--r~HlciVfELL~  271 (586)
T KOG0667|consen  194 LGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF--RNHLCIVFELLS  271 (586)
T ss_pred             ecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc--ccceeeeehhhh
Confidence            47788899999988  78999999998763      36999999996 3     389999999988  789999999996


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCC--CcEEEeeccCCccCCCCccc
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN--MRAKIANFGLAKSGCNAITM  488 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~--~~~kL~Dfg~a~~~~~~~~~  488 (552)
                      . +|.+++..+...+++...++.++.||+.||.+||+.+   |||+||||+||||.+.  ..+||+|||.|+....... 
T Consensus       272 ~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy-  346 (586)
T KOG0667|consen  272 T-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY-  346 (586)
T ss_pred             h-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccccCCcce-
Confidence            5 9999999999889999999999999999999999999   9999999999999653  3699999999987665544 


Q ss_pred             cccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          489 HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       489 ~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      ...-+..|.|||++.+.+|+.+.||||||||+.||++|.+.|.++++
T Consensus       347 tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne  393 (586)
T KOG0667|consen  347 TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE  393 (586)
T ss_pred             eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence            56678899999999999999999999999999999999999988876

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.9e-32  Score=284.40  Aligned_cols=183  Identities=27%  Similarity=0.372  Sum_probs=158.4

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|.|++|.||+++.  .++.||+|+++..          ..+|++++++++|+||+++++.+.+  ++.+++||||+++|
T Consensus         9 lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~lv~E~~~~g   86 (376)
T cd05598           9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYFVMDYIPGG   86 (376)
T ss_pred             EEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCEEEEEEeCCCCC
Confidence            37777899999987  6889999998532          2369999999999999999999987  67889999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC--------
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN--------  484 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~--------  484 (552)
                      +|.+++....  .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++.....        
T Consensus        87 ~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~  161 (376)
T cd05598          87 DMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ  161 (376)
T ss_pred             cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccc
Confidence            9999987654  4889999999999999999999999   99999999999999999999999998742100        


Q ss_pred             -------------------------------------CccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCC
Q 037224          485 -------------------------------------AITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK  527 (552)
Q Consensus       485 -------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~  527 (552)
                                                           .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~  241 (376)
T cd05598         162 KGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ  241 (376)
T ss_pred             cccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCC
Confidence                                                 0011246899999999999999999999999999999999999


Q ss_pred             CCCCccC
Q 037224          528 EAIDEEG  534 (552)
Q Consensus       528 ~pf~~~~  534 (552)
                      .||....
T Consensus       242 ~Pf~~~~  248 (376)
T cd05598         242 PPFLADT  248 (376)
T ss_pred             CCCCCCC
Confidence            9998655

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.3e-32  Score=278.00  Aligned_cols=183  Identities=28%  Similarity=0.429  Sum_probs=158.8

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|.|.+|.||++..  +|+.||+|+++..          ..+|+.+++.++|+||+++++++.+  +...++||||++++
T Consensus         3 lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~--~~~~~lv~E~~~~~   80 (325)
T cd05594           3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRLCFVMEYANGG   80 (325)
T ss_pred             eeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc--CCEEEEEEeCCCCC
Confidence            37788899999986  7889999998643          2358889999999999999998877  67889999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC--CCcccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHE-HTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC--NAITMH  489 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~--~~~~~~  489 (552)
                      +|.+++....  .+++..+..++.|++.||+|||+ .+   ++||||||+|||++.++.+||+|||+++...  ......
T Consensus        81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (325)
T cd05594          81 ELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT  155 (325)
T ss_pred             cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccc
Confidence            9998886544  48999999999999999999997 67   9999999999999999999999999986422  222233


Q ss_pred             ccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..|++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~  200 (325)
T cd05594         156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD  200 (325)
T ss_pred             ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC
Confidence            568999999999999999999999999999999999999997654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=7.1e-32  Score=273.21  Aligned_cols=183  Identities=30%  Similarity=0.480  Sum_probs=157.7

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|++|.||++..  .++.||+|+++..          ...|..++... +||||+++++++.+  ....++||||+++
T Consensus         3 lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~ey~~~   80 (316)
T cd05619           3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT--KENLFFVMEYLNG   80 (316)
T ss_pred             eeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe--CCEEEEEEeCCCC
Confidence            37788899999987  5789999998643          22466777764 89999999999887  6688999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccC--CCCcccc
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG--CNAITMH  489 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~--~~~~~~~  489 (552)
                      |+|.+++....  .+++.++..++.|++.||+|||+++   ++||||||+|||++.++.+||+|||++...  .......
T Consensus        81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (316)
T cd05619          81 GDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT  155 (316)
T ss_pred             CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceee
Confidence            99999887643  4899999999999999999999998   999999999999999999999999998642  2222334


Q ss_pred             ccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~  200 (316)
T cd05619         156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD  200 (316)
T ss_pred             ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC
Confidence            578999999999998899999999999999999999999997654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.98  E-value=4.6e-32  Score=275.84  Aligned_cols=183  Identities=29%  Similarity=0.417  Sum_probs=155.9

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccCh----------HHH-HHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWNA----------CEE-LKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~~----------~~E-~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|++|.||+++.  +++.||+|+++...          .+| ..+++.++|+||+++++++.+  .+..++||||+++
T Consensus         3 lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~--~~~~~lv~e~~~~   80 (325)
T cd05602           3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADKLYFVLDYING   80 (325)
T ss_pred             eeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc--CCeEEEEEeCCCC
Confidence            47788899999988  67889999986421          122 234677899999999999877  6788999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC--CCcccc
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC--NAITMH  489 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~--~~~~~~  489 (552)
                      ++|.+++....  .+.+..+..++.|+++||+|||+++   ++||||||+|||++.++.+||+|||+++...  ......
T Consensus        81 ~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~  155 (325)
T cd05602          81 GELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST  155 (325)
T ss_pred             CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccc
Confidence            99999887643  4888899999999999999999999   9999999999999999999999999987432  222334


Q ss_pred             ccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  200 (325)
T cd05602         156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN  200 (325)
T ss_pred             ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC
Confidence            578999999999999999999999999999999999999997654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.98  E-value=4.7e-32  Score=275.25  Aligned_cols=183  Identities=27%  Similarity=0.430  Sum_probs=156.1

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccCh----------HHHH-HHHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWNA----------CEEL-KILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~~----------~~E~-~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|++|.||+++.  +++.||+|++....          .+|. .+++.++|+||+++++++.+  .+..++||||+++
T Consensus         3 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~--~~~~~lv~e~~~~   80 (321)
T cd05603           3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT--AEKLYFVLDYVNG   80 (321)
T ss_pred             eeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCEEEEEEcCCCC
Confidence            37788899999988  68899999985321          1233 35778899999999998877  6688999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC--CCcccc
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC--NAITMH  489 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~--~~~~~~  489 (552)
                      ++|.+++....  .+++.++..++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||+++...  ......
T Consensus        81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (321)
T cd05603          81 GELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST  155 (321)
T ss_pred             CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccc
Confidence            99988886543  4889999999999999999999998   9999999999999999999999999987432  222234


Q ss_pred             ccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..|++.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  200 (321)
T cd05603         156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD  200 (321)
T ss_pred             ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC
Confidence            568999999999998889999999999999999999999997654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.98  E-value=3.5e-32  Score=276.67  Aligned_cols=183  Identities=27%  Similarity=0.434  Sum_probs=156.7

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccCh----------HHHHH-HHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWNA----------CEELK-ILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~~----------~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|++|.||+++.  +|+.+|+|+++...          .+|.. +++.++||||+++++.+..  ++..++||||+++
T Consensus         3 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~--~~~~~lv~e~~~~   80 (325)
T cd05604           3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--TEKLYFVLDFVNG   80 (325)
T ss_pred             eeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec--CCEEEEEEcCCCC
Confidence            37788899999987  78999999985431          12333 4677899999999998877  6788999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC--CCcccc
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC--NAITMH  489 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~--~~~~~~  489 (552)
                      ++|.+++....  .+++.++..++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||+++...  ......
T Consensus        81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (325)
T cd05604          81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT  155 (325)
T ss_pred             CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccc
Confidence            99998886543  4899999999999999999999999   9999999999999999999999999987432  222334


Q ss_pred             ccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..|++.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~  200 (325)
T cd05604         156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD  200 (325)
T ss_pred             ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC
Confidence            578999999999999999999999999999999999999998654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.98  E-value=2.4e-32  Score=281.95  Aligned_cols=183  Identities=28%  Similarity=0.404  Sum_probs=159.1

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|.|++|.||++..  .++.||+|+++..          ..+|+.++..++|+||+++++.+.+  +...++||||+++|
T Consensus         9 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--~~~~~lv~E~~~gg   86 (360)
T cd05627           9 IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD--KRNLYLIMEFLPGG   86 (360)
T ss_pred             EeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEEEEEeCCCCc
Confidence            37778899999987  6889999998532          2358899999999999999999877  67889999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-------
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-------  485 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-------  485 (552)
                      +|.+++....  .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++......       
T Consensus        87 ~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~  161 (360)
T cd05627          87 DMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYR  161 (360)
T ss_pred             cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccccccccccc
Confidence            9999987654  4899999999999999999999999   999999999999999999999999998632110       


Q ss_pred             ------------------------------ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          486 ------------------------------ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       486 ------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                                                    ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~  240 (360)
T cd05627         162 NLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET  240 (360)
T ss_pred             ccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence                                          0113468999999999999999999999999999999999999998654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.98  E-value=4.4e-32  Score=280.72  Aligned_cols=181  Identities=28%  Similarity=0.375  Sum_probs=156.6

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|.+|.||+++.  +++.||+|+++..          +.+|+.+++.++|+||+++++++.+  +...++||||+++|+
T Consensus        52 g~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~--~~~~~lv~Ey~~gg~  129 (370)
T cd05596          52 GRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD--DKYLYMVMEYMPGGD  129 (370)
T ss_pred             eeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec--CCEEEEEEcCCCCCc
Confidence            7777899999987  6889999998532          2368999999999999999998876  678899999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC---ccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA---ITMHI  490 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~---~~~~~  490 (552)
                      |.+++...   .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++......   .....
T Consensus       130 L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~  203 (370)
T cd05596         130 LVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA  203 (370)
T ss_pred             HHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccCCCC
Confidence            99988654   3888999999999999999999998   999999999999999999999999998754322   12235


Q ss_pred             cccccccCccccCCC----CCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          491 VGTQGYIAPEYLADG----VVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       491 ~gt~~y~aPE~~~~~----~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .||+.|+|||.+.+.    .++.++|||||||++|||++|+.||...+
T Consensus       204 ~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~  251 (370)
T cd05596         204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS  251 (370)
T ss_pred             CCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC
Confidence            789999999988643    47889999999999999999999998654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.98  E-value=7e-32  Score=274.88  Aligned_cols=181  Identities=24%  Similarity=0.449  Sum_probs=157.9

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|.+|.||+++.  +++.||+|+++..          ..+|..++.++ +||||+++++++.+  +...++||||+++
T Consensus         3 lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~--~~~~~lv~e~~~~   80 (329)
T cd05588           3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT--ESRLFFVIEFVSG   80 (329)
T ss_pred             EeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc--CCEEEEEEeCCCC
Confidence            36778899999987  6889999999643          23578888888 79999999999877  6788999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccC--CCCcccc
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG--CNAITMH  489 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~--~~~~~~~  489 (552)
                      ++|.+++....  .+++..++.++.|++.||+|||+++   ++||||||+|||++.++.+||+|||++...  .......
T Consensus        81 g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (329)
T cd05588          81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST  155 (329)
T ss_pred             CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCCcccc
Confidence            99998886543  4999999999999999999999999   999999999999999999999999998642  1222334


Q ss_pred             ccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                      ..||+.|+|||.+.+..++.++|+||||+++|||++|+.||+.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~  198 (329)
T cd05588         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  198 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence            5789999999999999999999999999999999999999963

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.98  E-value=7.3e-32  Score=274.23  Aligned_cols=181  Identities=31%  Similarity=0.469  Sum_probs=154.5

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccCh----------HHHHHH---HHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWNA----------CEELKI---LQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~~----------~~E~~~---l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      |.|.+|.||++..  +++.||+|+++...          .+|..+   ++.++||||+++++++.+  ....++||||++
T Consensus         8 g~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~--~~~~~lv~E~~~   85 (324)
T cd05589           8 GRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT--EDHVCFVMEYAA   85 (324)
T ss_pred             eecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc--CCEEEEEEcCCC
Confidence            6777799999987  68899999986431          134444   356689999999999877  678899999999


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC--CCccc
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC--NAITM  488 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~--~~~~~  488 (552)
                      +++|..++...   .+++.+++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++....  .....
T Consensus        86 ~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (324)
T cd05589          86 GGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS  159 (324)
T ss_pred             CCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCccc
Confidence            99998887643   4999999999999999999999999   9999999999999999999999999986432  22223


Q ss_pred             cccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          489 HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       489 ~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ...|++.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus       160 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~  205 (324)
T cd05589         160 TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD  205 (324)
T ss_pred             ccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Confidence            4578999999999999999999999999999999999999998654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.98  E-value=8.6e-32  Score=273.58  Aligned_cols=183  Identities=28%  Similarity=0.452  Sum_probs=156.7

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccCh----------HHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWNA----------CEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~~----------~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|++|.||++..  +++.||+|+++...          ..|..++..+ +|++|+++++++.+  .+..++||||+++
T Consensus         8 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~E~~~~   85 (323)
T cd05616           8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT--MDRLYFVMEYVNG   85 (323)
T ss_pred             EeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec--CCEEEEEEcCCCC
Confidence            37777899999987  56799999986432          2466677776 58889999988876  6688999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC--CCcccc
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC--NAITMH  489 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~--~~~~~~  489 (552)
                      |+|.+++....  .+++.+++.++.|++.||+|||+++   ++||||||+|||++.++.+||+|||+++...  ......
T Consensus        86 g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~  160 (323)
T cd05616          86 GDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT  160 (323)
T ss_pred             CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcccc
Confidence            99998887654  4899999999999999999999998   9999999999999999999999999987432  222334


Q ss_pred             ccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus       161 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~  205 (323)
T cd05616         161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED  205 (323)
T ss_pred             CCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC
Confidence            578999999999999999999999999999999999999998654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.98  E-value=1.2e-31  Score=272.51  Aligned_cols=182  Identities=29%  Similarity=0.463  Sum_probs=155.8

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCC-CccceeeeeecCCCCeeEEEEeeccCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHG-NLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      |.|++|.||+++.  .++.||+|+++..          ...|..++..++|+ +|+.+++++.+  .+..|+||||++++
T Consensus         9 g~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~E~~~~g   86 (324)
T cd05587           9 GKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRLYFVMEYVNGG   86 (324)
T ss_pred             eeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc--CCEEEEEEcCCCCC
Confidence            7788899999988  5679999998642          23578888888765 57788888776  66789999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccC--CCCccccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG--CNAITMHI  490 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~--~~~~~~~~  490 (552)
                      +|.+++....  .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++...  ........
T Consensus        87 ~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~  161 (324)
T cd05587          87 DLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTF  161 (324)
T ss_pred             cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceeee
Confidence            9999887644  4899999999999999999999998   999999999999999999999999998642  22223345


Q ss_pred             cccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       491 ~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .||+.|+|||++.+..++.++|||||||++|||+||+.||...+
T Consensus       162 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~  205 (324)
T cd05587         162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED  205 (324)
T ss_pred             cCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence            78999999999999999999999999999999999999997654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.98  E-value=9.3e-32  Score=273.95  Aligned_cols=180  Identities=26%  Similarity=0.473  Sum_probs=156.9

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|++|.||+++.  +++.||+|+++..          ..+|..++.++ +||||+++++++.+  +...++||||+++
T Consensus         3 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~~~~   80 (329)
T cd05618           3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFFVIEYVNG   80 (329)
T ss_pred             eeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe--CCEEEEEEeCCCC
Confidence            47788899999987  6789999998643          23577777776 89999999999877  6788999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC--CCcccc
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC--NAITMH  489 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~--~~~~~~  489 (552)
                      ++|.+++....  .+++..++.++.|++.||+|||+++   ++||||||+||+++.++.+||+|||+++...  ......
T Consensus        81 ~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (329)
T cd05618          81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST  155 (329)
T ss_pred             CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccc
Confidence            99998886543  4899999999999999999999999   9999999999999999999999999987432  222334


Q ss_pred             ccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCC
Q 037224          490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID  531 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~  531 (552)
                      ..||..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~  197 (329)
T cd05618         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD  197 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence            578999999999999999999999999999999999999996

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.98  E-value=6.8e-32  Score=279.30  Aligned_cols=181  Identities=28%  Similarity=0.359  Sum_probs=156.8

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|++|.||+++.  .++.+|+|+++..          ..+|+.+++.++||||+++++.+.+  +...++||||+++|+
T Consensus        52 G~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--~~~~~lv~Ey~~gg~  129 (371)
T cd05622          52 GRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD--DRYLYMVMEYMPGGD  129 (371)
T ss_pred             eecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--CCEEEEEEcCCCCCc
Confidence            7778899999988  6789999998531          2368899999999999999999876  678899999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC---ccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA---ITMHI  490 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~---~~~~~  490 (552)
                      |.+++...   .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++......   .....
T Consensus       130 L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~  203 (371)
T cd05622         130 LVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA  203 (371)
T ss_pred             HHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccccCc
Confidence            99988654   3889999999999999999999999   999999999999999999999999998754322   12245


Q ss_pred             cccccccCccccCCC----CCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          491 VGTQGYIAPEYLADG----VVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       491 ~gt~~y~aPE~~~~~----~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .||+.|+|||++...    .++.++|||||||++|||++|+.||...+
T Consensus       204 ~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~  251 (371)
T cd05622         204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS  251 (371)
T ss_pred             ccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC
Confidence            789999999998653    37889999999999999999999998654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.98  E-value=1.1e-31  Score=267.11  Aligned_cols=184  Identities=26%  Similarity=0.396  Sum_probs=158.7

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|++|+||++..  +++.+|+|.+...          ...|+.++++++|+||+++.+++..  +...+++|||+++|+
T Consensus         2 g~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~g~   79 (280)
T cd05608           2 GKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT--KTDLCLVMTIMNGGD   79 (280)
T ss_pred             CCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC--CCeEEEEEeCCCCCC
Confidence            6788899999987  6889999998532          2358999999999999999988876  667899999999999


Q ss_pred             chhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--cccc
Q 037224          414 LHSWLHEN--KNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMH  489 (552)
Q Consensus       414 L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~  489 (552)
                      |.+++...  ....+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++......  ....
T Consensus        80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~  156 (280)
T cd05608          80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG  156 (280)
T ss_pred             HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccc
Confidence            98877542  2345899999999999999999999998   999999999999999999999999998743322  2223


Q ss_pred             ccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..|++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  201 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG  201 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence            578999999999999999999999999999999999999997643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.98  E-value=1.1e-31  Score=273.18  Aligned_cols=181  Identities=25%  Similarity=0.456  Sum_probs=157.7

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|.+|.||+++.  +++.||+|+++..          ..+|..++.++ +|+||+++++++.+  ...+++||||+++
T Consensus         3 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~   80 (327)
T cd05617           3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT--TSRLFLVIEYVNG   80 (327)
T ss_pred             eeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe--CCEEEEEEeCCCC
Confidence            47778899999987  6789999999743          23578888888 69999999998876  6688999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC--CCcccc
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC--NAITMH  489 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~--~~~~~~  489 (552)
                      ++|.+++....  .+++..++.++.|++.||+|||+++   ++||||||+|||++.++.+||+|||++....  ......
T Consensus        81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (327)
T cd05617          81 GDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST  155 (327)
T ss_pred             CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceec
Confidence            99998886543  4999999999999999999999999   9999999999999999999999999987422  222334


Q ss_pred             ccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                      ..||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~  198 (327)
T cd05617         156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI  198 (327)
T ss_pred             ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence            6789999999999999999999999999999999999999964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.98  E-value=1.4e-32  Score=283.99  Aligned_cols=188  Identities=31%  Similarity=0.458  Sum_probs=163.0

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCC----CCeeEEEEeecc
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPE----DANCYLIYEYIE  410 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~~~lv~e~~~  410 (552)
                      .|.|++|.||+|+.  .|+.||||.++..        ..+|+++|++++|+|||+++++-.+..    .....++||||.
T Consensus        21 LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~  100 (732)
T KOG4250|consen   21 LGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCS  100 (732)
T ss_pred             hcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecC
Confidence            48889999999986  8999999998653        347999999999999999998766544    456789999999


Q ss_pred             CCCchhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEC--CCC--cEEEeeccCCccCCC-
Q 037224          411 NGSLHSWLHENKN-ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLD--SNM--RAKIANFGLAKSGCN-  484 (552)
Q Consensus       411 ~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~--~~~--~~kL~Dfg~a~~~~~-  484 (552)
                      +|+|...+....+ ..+++.+.+.++.++..||.|||+++   |+||||||.||++-  .+|  ..||+|||.|+...+ 
T Consensus       101 gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~  177 (732)
T KOG4250|consen  101 GGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDN  177 (732)
T ss_pred             CCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccccccCCCC
Confidence            9999999987654 56999999999999999999999999   99999999999983  334  489999999996543 


Q ss_pred             CccccccccccccCccccC-CCCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          485 AITMHIVGTQGYIAPEYLA-DGVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       485 ~~~~~~~gt~~y~aPE~~~-~~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      .......||..|++||.+. ++.++..+|.|||||++||+.||..||.....
T Consensus       178 s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~  229 (732)
T KOG4250|consen  178 SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG  229 (732)
T ss_pred             CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence            3455689999999999998 48899999999999999999999999986543

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.98  E-value=1.9e-31  Score=264.97  Aligned_cols=183  Identities=25%  Similarity=0.405  Sum_probs=160.3

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|++|.||++..  +|+.||+|.++..          ...|++++++++||||+++++++.+  +...+++|||+++++
T Consensus         2 g~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~g~~   79 (277)
T cd05607           2 GKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES--KTHLCLVMSLMNGGD   79 (277)
T ss_pred             CCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec--CCeEEEEEecCCCCC
Confidence            7788899999987  6899999998532          2358999999999999999998876  678899999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-ccccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-ITMHIVG  492 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-~~~~~~g  492 (552)
                      |.+++.......+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++...... ......+
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05607          80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAG  156 (277)
T ss_pred             HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCC
Confidence            998887665556899999999999999999999999   999999999999999999999999998754332 2223568


Q ss_pred             cccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       493 t~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      +..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       157 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~  197 (277)
T cd05607         157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH  197 (277)
T ss_pred             CCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence            89999999998888999999999999999999999999754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.98  E-value=2.1e-31  Score=271.58  Aligned_cols=182  Identities=30%  Similarity=0.470  Sum_probs=160.6

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      |.|.+|.||+++.  .+..+|+|.++..        +.+|++++++++|+||+++++++.+  ++..++||||+++++|.
T Consensus        14 g~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~   91 (331)
T cd06649          14 GAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLD   91 (331)
T ss_pred             cCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEEEEEeecCCCCcHH
Confidence            6777799999988  5889999988542        4479999999999999999999987  67889999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcccccccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG  495 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~gt~~  495 (552)
                      +++....  .+++..+..++.|++.||.|||+.+  .++||||||+|||++.++.+||+|||++............++..
T Consensus        92 ~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~g~~~  167 (331)
T cd06649          92 QVLKEAK--RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS  167 (331)
T ss_pred             HHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccccccCCCCcC
Confidence            9987654  4899999999999999999999853  39999999999999999999999999987554444445678999


Q ss_pred             ccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          496 YIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       496 y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      |+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       168 y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~  205 (331)
T cd06649         168 YMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP  205 (331)
T ss_pred             cCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999889999999999999999999999999754

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.98  E-value=1.7e-31  Score=270.73  Aligned_cols=183  Identities=28%  Similarity=0.492  Sum_probs=158.4

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|++|.||++..  +++.||+|+++..          ..+|..++..+ +|+||+++++++.+  ....++||||+++
T Consensus         3 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~   80 (318)
T cd05570           3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT--KDRLFFVMEYVNG   80 (318)
T ss_pred             eeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCCCC
Confidence            37778899999988  5789999998643          23577788877 79999999999877  6688999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC--CCcccc
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC--NAITMH  489 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~--~~~~~~  489 (552)
                      ++|.+++....  .+++.++..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++...  ......
T Consensus        81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (318)
T cd05570          81 GDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST  155 (318)
T ss_pred             CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccc
Confidence            99998887653  4999999999999999999999999   9999999999999999999999999986421  222233


Q ss_pred             ccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..|++.|+|||.+.+..++.++|+|||||++|||++|+.||...+
T Consensus       156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~  200 (318)
T cd05570         156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD  200 (318)
T ss_pred             eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC
Confidence            568999999999999999999999999999999999999997654

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.98  E-value=1.4e-31  Score=273.86  Aligned_cols=185  Identities=31%  Similarity=0.486  Sum_probs=154.8

Q ss_pred             CCceEEEEEEEEee-------cCcEEEEEEeccC--------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEee
Q 037224          345 EGCLIQGSVYKGNI-------HGEVYAIKMMKWN--------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEY  408 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-------~g~~vAvK~~~~~--------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~  408 (552)
                      .|.|++|.||++.+       .++.||+|+++..        +.+|+.++.++ +||||++++++|... ...++++|||
T Consensus        15 lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-~~~~~lv~ey   93 (338)
T cd05102          15 LGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP-NGPLMVIVEF   93 (338)
T ss_pred             eccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-CCceEEEEec
Confidence            37888899999974       3468999998632        34699999999 899999999988653 3467899999


Q ss_pred             ccCCCchhhhhhcC------------------------------------------------------------CCCCCH
Q 037224          409 IENGSLHSWLHENK------------------------------------------------------------NENLNW  428 (552)
Q Consensus       409 ~~~gsL~~~l~~~~------------------------------------------------------------~~~l~~  428 (552)
                      +++|+|.+++....                                                            ...+++
T Consensus        94 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  173 (338)
T cd05102          94 CKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTM  173 (338)
T ss_pred             CCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCCH
Confidence            99999999886532                                                            124788


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc----cccccccccccCccccCC
Q 037224          429 KTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI----TMHIVGTQGYIAPEYLAD  504 (552)
Q Consensus       429 ~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~  504 (552)
                      .+++.++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++......    .....++..|+|||.+.+
T Consensus       174 ~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  250 (338)
T cd05102         174 EDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFD  250 (338)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhc
Confidence            899999999999999999998   9999999999999999999999999997532211    112345678999999998


Q ss_pred             CCCCChhhHHHHHHHHHHHHc-CCCCCCcc
Q 037224          505 GVVSTKMDVFSFGVVLLELIS-GKEAIDEE  533 (552)
Q Consensus       505 ~~~s~~~Dv~slG~il~ellt-G~~pf~~~  533 (552)
                      ..++.++||||||+++|||++ |+.||...
T Consensus       251 ~~~~~~sDiwslG~il~el~~~g~~pf~~~  280 (338)
T cd05102         251 KVYTTQSDVWSFGVLLWEIFSLGASPYPGV  280 (338)
T ss_pred             CCCCcccCHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999997 99999764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.97  E-value=1.8e-31  Score=271.21  Aligned_cols=182  Identities=28%  Similarity=0.462  Sum_probs=155.9

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcC-CCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      |.|.+|.||++..  +|+.||+|+++..          ...|..++..+. |++|+++.+++.+  ++..++||||+++|
T Consensus         9 g~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~Ey~~~g   86 (323)
T cd05615           9 GKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT--VDRLYFVMEYVNGG   86 (323)
T ss_pred             EecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec--CCEEEEEEcCCCCC
Confidence            7788899999987  6889999998642          235777888775 5677788888776  56789999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC--CCccccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC--NAITMHI  490 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~--~~~~~~~  490 (552)
                      +|.+++....  .+++.+++.++.|++.||+|||+++   ++||||||+|||++.++.+||+|||+++...  .......
T Consensus        87 ~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~~  161 (323)
T cd05615          87 DLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTF  161 (323)
T ss_pred             cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCCccccCc
Confidence            9999887643  4999999999999999999999999   9999999999999999999999999987432  1122345


Q ss_pred             cccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       491 ~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       162 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~  205 (323)
T cd05615         162 CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED  205 (323)
T ss_pred             cCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC
Confidence            68999999999998889999999999999999999999998654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=5.8e-32  Score=254.54  Aligned_cols=194  Identities=27%  Similarity=0.464  Sum_probs=164.3

Q ss_pred             cHHHHHHHhhccCCCceEEEEEEEEee--cCcEEEEEEeccC-------hHHHHHHHHHc-CCCCccceeeeeecCCCCe
Q 037224          332 KIEELREATDNFSEGCLIQGSVYKGNI--HGEVYAIKMMKWN-------ACEELKILQKV-NHGNLVKLEGFCIDPEDAN  401 (552)
Q Consensus       332 ~~~~l~~~t~~~~~G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  401 (552)
                      +++|+++.|++. .|.|++++|-..+.  +|.+||||++.+.       ..+|++++.++ .|+||++++++|.+  +..
T Consensus        74 ~F~d~YkLt~e~-LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd--d~~  150 (463)
T KOG0607|consen   74 KFEDMYKLTSEL-LGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED--DTR  150 (463)
T ss_pred             hHHHHHHhHHHH-hcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc--cce
Confidence            578888888774 67788888877655  8999999999654       34899999999 69999999999988  788


Q ss_pred             eEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCC---cEEEeeccC
Q 037224          402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM---RAKIANFGL  478 (552)
Q Consensus       402 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~---~~kL~Dfg~  478 (552)
                      +|||||-|.||+|..++++++.  |++.++.++.++|+.||.|||.+|   |.|||+||+|||-.+..   -+||+||.+
T Consensus       151 FYLVfEKm~GGplLshI~~~~~--F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDL  225 (463)
T KOG0607|consen  151 FYLVFEKMRGGPLLSHIQKRKH--FNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDL  225 (463)
T ss_pred             EEEEEecccCchHHHHHHHhhh--ccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecccc
Confidence            9999999999999999988764  999999999999999999999999   99999999999996554   489999998


Q ss_pred             CccCC---------CCccccccccccccCccccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          479 AKSGC---------NAITMHIVGTQGYIAPEYLA-----DGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       479 a~~~~---------~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      .....         .......+|+..|||||+..     ...|+.+.|.||||+|+|-|++|.+||.+.
T Consensus       226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~  294 (463)
T KOG0607|consen  226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH  294 (463)
T ss_pred             ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence            75211         12223467888999999753     345888999999999999999999999853

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=5.4e-32  Score=278.11  Aligned_cols=183  Identities=31%  Similarity=0.426  Sum_probs=161.4

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|.|++|.||+++.  +|+.||+|+++..          +.+|++++..++|+||+++++++.+  +...++||||++++
T Consensus         9 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~   86 (350)
T cd05573           9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD--EEHLYLVMEYMPGG   86 (350)
T ss_pred             EEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec--CCeEEEEEcCCCCC
Confidence            37778899999998  5899999998642          3468999999999999999998877  67889999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc------
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI------  486 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~------  486 (552)
                      +|.+++...  ..+++..++.++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||++.......      
T Consensus        87 ~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~  161 (350)
T cd05573          87 DLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYL  161 (350)
T ss_pred             CHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccc
Confidence            999999765  35899999999999999999999998   9999999999999999999999999987443221      


Q ss_pred             -------------------------cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          487 -------------------------TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       487 -------------------------~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                                               .....||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         162 NDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             cccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence                                     223568999999999999999999999999999999999999998654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.97  E-value=4.5e-32  Score=275.05  Aligned_cols=183  Identities=28%  Similarity=0.430  Sum_probs=159.6

Q ss_pred             CCceEEEEEEEEee-----cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          345 EGCLIQGSVYKGNI-----HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-----~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      .|.|++|.||+++.     .|+.+|+|+++..         ..+|++++++++|+||+++++++.+  +...++||||++
T Consensus         4 lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~   81 (318)
T cd05582           4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT--EGKLYLILDFLR   81 (318)
T ss_pred             eeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCEEEEEEcCCC
Confidence            36777899998864     5789999998642         2358999999999999999999887  678899999999


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--ccc
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITM  488 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~  488 (552)
                      +++|.+++....  .+++.+++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++......  ...
T Consensus        82 ~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~  156 (318)
T cd05582          82 GGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY  156 (318)
T ss_pred             CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCcee
Confidence            999999886543  4899999999999999999999999   999999999999999999999999998754322  233


Q ss_pred             cccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          489 HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       489 ~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ...|++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~  202 (318)
T cd05582         157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD  202 (318)
T ss_pred             cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC
Confidence            4578999999999988889999999999999999999999998654

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.97  E-value=7.1e-32  Score=271.60  Aligned_cols=185  Identities=28%  Similarity=0.474  Sum_probs=161.6

Q ss_pred             CceEEEEEEEEeecC-cEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchh
Q 037224          346 GCLIQGSVYKGNIHG-EVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHS  416 (552)
Q Consensus       346 G~g~~G~Vy~~~~~g-~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~  416 (552)
                      |.|-||.|.....+| ..||||.++.+        +.+|+++|.+|+||||++++|+|..  ++.+++++|||++|+|.+
T Consensus       547 GeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~--DePicmI~EYmEnGDLnq  624 (807)
T KOG1094|consen  547 GEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ--DDPLCMITEYMENGDLNQ  624 (807)
T ss_pred             cCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec--CCchHHHHHHHhcCcHHH
Confidence            666779999999976 89999999643        5589999999999999999999998  778899999999999999


Q ss_pred             hhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccccc----cc
Q 037224          417 WLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI----VG  492 (552)
Q Consensus       417 ~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~----~g  492 (552)
                      ++..+..+.+.-....+|+.||+.|++||.+.+   +|||||.++|+|+|.++++||+|||+++..-.......    +-
T Consensus       625 Fl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vl  701 (807)
T KOG1094|consen  625 FLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVL  701 (807)
T ss_pred             HHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCceeeecceee
Confidence            999886554566677889999999999999998   99999999999999999999999999985444333333    34


Q ss_pred             cccccCccccCCCCCCChhhHHHHHHHHHHH--HcCCCCCCccCc
Q 037224          493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLEL--ISGKEAIDEEGK  535 (552)
Q Consensus       493 t~~y~aPE~~~~~~~s~~~Dv~slG~il~el--ltG~~pf~~~~~  535 (552)
                      ..+|||+|.+..++++.++|||+||+.+||+  ++...||++..+
T Consensus       702 piRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~  746 (807)
T KOG1094|consen  702 PIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD  746 (807)
T ss_pred             eeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH
Confidence            6799999999999999999999999999997  468999986543

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.6e-31  Score=265.15  Aligned_cols=184  Identities=27%  Similarity=0.383  Sum_probs=160.9

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|.+|.||++..  +++.||+|.++..          ..+|+.++++++|+||+++++.+.+  +...+++|||+++++
T Consensus         9 g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~   86 (285)
T cd05605           9 GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KDALCLVLTLMNGGD   86 (285)
T ss_pred             ecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC--CCeEEEEEeccCCCc
Confidence            6777799999987  6889999998532          2369999999999999999998876  567899999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-ccccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-ITMHIVG  492 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-~~~~~~g  492 (552)
                      |.+++.......+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++...... ......|
T Consensus        87 L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  163 (285)
T cd05605          87 LKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVG  163 (285)
T ss_pred             HHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCccccccC
Confidence            998887654456999999999999999999999999   999999999999999999999999998754322 2233578


Q ss_pred             cccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       493 t~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ++.|+|||.+.+..++.++||||+|+++|||++|+.||.+.+
T Consensus       164 ~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~  205 (285)
T cd05605         164 TVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK  205 (285)
T ss_pred             CCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCc
Confidence            899999999998889999999999999999999999998654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=3.4e-32  Score=273.72  Aligned_cols=184  Identities=29%  Similarity=0.466  Sum_probs=164.8

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCe-eEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDAN-CYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~-~~lv~e~~~~gs  413 (552)
                      |.|.||.++..+.  ++..+++|.+.-.         ...|+.++++++||||+.+.+.|..  ++. .++||+|++||+
T Consensus        13 G~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~--~~~~l~Ivm~Y~eGg~   90 (426)
T KOG0589|consen   13 GRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE--DGQLLCIVMEYCEGGD   90 (426)
T ss_pred             CccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhc--CCceEEEEEeecCCCC
Confidence            6666677766554  7889999998432         3579999999999999999999987  555 899999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--cccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIV  491 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~  491 (552)
                      |.+.+...++..++++.++.|+.|++.|+.|||++.   |+|||||+.|||++.++.+||+|||+|+.....  ......
T Consensus        91 l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvv  167 (426)
T KOG0589|consen   91 LAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLASTVV  167 (426)
T ss_pred             HHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCchhhhheec
Confidence            999998888777999999999999999999999888   999999999999999999999999999976654  455689


Q ss_pred             ccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          492 GTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       492 gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ||+.||+||.+.+..|..|+|||||||++|||++=+++|...+
T Consensus       168 GTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~  210 (426)
T KOG0589|consen  168 GTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN  210 (426)
T ss_pred             CCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc
Confidence            9999999999999999999999999999999999999998765

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=2.8e-32  Score=278.42  Aligned_cols=185  Identities=24%  Similarity=0.442  Sum_probs=162.6

Q ss_pred             CCceEEEEEEEEee--cCcEEE---EEE---ec-----cChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYA---IKM---MK-----WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vA---vK~---~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|.+-+||+|.+  .|-.||   ||.   .+     ..+..|+.+|+.|+|+||++++.++.+......-+|+|.+..
T Consensus        48 LGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TS  127 (632)
T KOG0584|consen   48 LGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTS  127 (632)
T ss_pred             cccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccC
Confidence            48888899999988  555554   222   11     224579999999999999999999998777778899999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECC-CCcEEEeeccCCccCCCCccccc
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS-NMRAKIANFGLAKSGCNAITMHI  490 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kL~Dfg~a~~~~~~~~~~~  490 (552)
                      |+|..|+.+.+.  ++...+..|++||++||.|||++. |||+|||||.+||||+. .|.+||+|+|+|...........
T Consensus       128 GtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~aksv  204 (632)
T KOG0584|consen  128 GTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAKSV  204 (632)
T ss_pred             CcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcccccee
Confidence            999999988764  899999999999999999999995 67999999999999975 58999999999998777777779


Q ss_pred             cccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       491 ~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      .|||.|||||.+. ..|+..+||||||++|+||+|+..||.+-
T Consensus       205 IGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC  246 (632)
T KOG0584|consen  205 IGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC  246 (632)
T ss_pred             ccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh
Confidence            9999999999886 88999999999999999999999999864

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.97  E-value=2.6e-31  Score=265.53  Aligned_cols=182  Identities=25%  Similarity=0.453  Sum_probs=155.6

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      |.|.+|.||++..  +++.||+|.++..        ..+|+.++++++|+||+++++++.+  +...++||||+++ +|.
T Consensus        14 g~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~-~l~   90 (288)
T cd07871          14 GEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHT--ERCLTLVFEYLDS-DLK   90 (288)
T ss_pred             ecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcC--CCeEEEEEeCCCc-CHH
Confidence            6777799999987  6889999988532        3479999999999999999999876  5678999999985 898


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--cccccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIVGT  493 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~gt  493 (552)
                      +++.... ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....  ......++
T Consensus        91 ~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~  166 (288)
T cd07871          91 QYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVT  166 (288)
T ss_pred             HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccCceec
Confidence            8886543 34789999999999999999999999   999999999999999999999999998743221  22235678


Q ss_pred             ccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          494 QGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       494 ~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +.|+|||.+.+ ..++.++||||+|+++|||++|+.||...+
T Consensus       167 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~  208 (288)
T cd07871         167 LWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST  208 (288)
T ss_pred             ccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999998865 568999999999999999999999997654

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.9e-31  Score=270.62  Aligned_cols=183  Identities=28%  Similarity=0.394  Sum_probs=156.7

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|.+|.||+++.  +++.||+|+++..          +.+|..++..++|+||+++++++.+  +...++||||+++++
T Consensus        10 G~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~g~~   87 (331)
T cd05597          10 GRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD--ENNLYLVMDYYVGGD   87 (331)
T ss_pred             EecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec--CCeEEEEEecCCCCc
Confidence            7778899999987  6889999998531          3468889999999999999999887  678899999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC---ccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA---ITMHI  490 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~---~~~~~  490 (552)
                      |.+++.... ..+++..+..++.|++.||+|||+++   ++||||||+|||++.++.+||+|||++......   .....
T Consensus        88 L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  163 (331)
T cd05597          88 LLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA  163 (331)
T ss_pred             HHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccccce
Confidence            999987532 34899999999999999999999999   999999999999999999999999998643221   11224


Q ss_pred             cccccccCccccCC-----CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          491 VGTQGYIAPEYLAD-----GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       491 ~gt~~y~aPE~~~~-----~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .||+.|+|||++..     ..++.++|||||||++|||++|+.||....
T Consensus       164 ~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~  212 (331)
T cd05597         164 VGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES  212 (331)
T ss_pred             eccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC
Confidence            68999999999863     457889999999999999999999997643

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-32  Score=268.09  Aligned_cols=186  Identities=28%  Similarity=0.393  Sum_probs=165.1

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|.|+||.||-...  +|+.+|.|.+.+.          ..+|-.+|.+++.+.||.+--.|.+  .+.+++|+..|.||
T Consensus       193 lGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT--kd~LClVLtlMNGG  270 (591)
T KOG0986|consen  193 LGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET--KDALCLVLTLMNGG  270 (591)
T ss_pred             EecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC--CCceEEEEEeecCC
Confidence            38999999998765  8999999987432          2469999999999999998666655  66789999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc-ccccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI-TMHIV  491 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-~~~~~  491 (552)
                      +|.-+|.+.....|+++.++.++.+|+.||++||...   ||+||+||+|||+|+.|+++|+|+|+|....... ....+
T Consensus       271 DLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~~rv  347 (591)
T KOG0986|consen  271 DLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIRGRV  347 (591)
T ss_pred             ceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCCCcccccc
Confidence            9999999888778999999999999999999999998   9999999999999999999999999998655443 33459


Q ss_pred             ccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          492 GTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       492 gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      ||.+|||||++.+..|+...|.|||||++|||+.|+.||....+
T Consensus       348 GT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke  391 (591)
T KOG0986|consen  348 GTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE  391 (591)
T ss_pred             CcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh
Confidence            99999999999999999999999999999999999999986543

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.97  E-value=5.1e-31  Score=281.54  Aligned_cols=184  Identities=25%  Similarity=0.337  Sum_probs=158.4

Q ss_pred             CceEEEEEEEEee--c-CcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          346 GCLIQGSVYKGNI--H-GEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~-g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      |.|++|.||++..  + ++.||+|.+...       ..+|+.+++.++||||+++++++..  ++..++||||+++|+|.
T Consensus        76 g~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~--~~~~~lv~E~~~gg~L~  153 (478)
T PTZ00267         76 GRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKS--DDKLLLIMEYGSGGDLN  153 (478)
T ss_pred             EeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE--CCEEEEEEECCCCCCHH
Confidence            6677799999976  3 678888876322       3469999999999999999999987  67899999999999999


Q ss_pred             hhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc----ccc
Q 037224          416 SWLHEN--KNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI----TMH  489 (552)
Q Consensus       416 ~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~----~~~  489 (552)
                      +++...  ....+++.++..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++......    ...
T Consensus       154 ~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~  230 (478)
T PTZ00267        154 KQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS  230 (478)
T ss_pred             HHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccc
Confidence            988643  2235899999999999999999999998   9999999999999999999999999997543221    233


Q ss_pred             ccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       231 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~  275 (478)
T PTZ00267        231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS  275 (478)
T ss_pred             cCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            568999999999999999999999999999999999999997654

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.1e-31  Score=273.70  Aligned_cols=182  Identities=27%  Similarity=0.422  Sum_probs=154.2

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccCh----------HHHHHHHHHc---CCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWNA----------CEELKILQKV---NHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~~----------~~E~~~l~~l---~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      |.|++|.||+++.  +++.||+|++....          ..|..++.+.   +||||+++++.+.+  ....++||||++
T Consensus         2 G~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~--~~~~~lv~e~~~   79 (330)
T cd05586           2 GKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT--DSDLYLVTDYMS   79 (330)
T ss_pred             CCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec--CCeEEEEEcCCC
Confidence            7788899999987  68999999985321          1355566555   69999999998877  668899999999


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC--CCccc
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC--NAITM  488 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~--~~~~~  488 (552)
                      +++|.+++....  .+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+||+|||++....  .....
T Consensus        80 ~g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~  154 (330)
T cd05586          80 GGELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN  154 (330)
T ss_pred             CChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCcc
Confidence            999998887543  4899999999999999999999999   9999999999999999999999999987432  22233


Q ss_pred             cccccccccCccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          489 HIVGTQGYIAPEYLADG-VVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       489 ~~~gt~~y~aPE~~~~~-~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ...||..|+|||.+.+. .++.++|||||||++|||++|+.||...+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~  201 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED  201 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC
Confidence            45789999999998654 47899999999999999999999997654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.97  E-value=4.6e-31  Score=265.70  Aligned_cols=181  Identities=27%  Similarity=0.464  Sum_probs=154.6

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      |.|.+|.||+++.  +++.||+|+++..        ..+|+.+++.++|+||+++++++.+  +...++||||++ ++|.
T Consensus        14 g~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~-~~l~   90 (303)
T cd07869          14 GEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT--KETLTLVFEYVH-TDLC   90 (303)
T ss_pred             EecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec--CCeEEEEEECCC-cCHH
Confidence            6777799999988  6889999998532        3479999999999999999999987  667899999996 5888


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC--Ccccccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN--AITMHIVGT  493 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~--~~~~~~~gt  493 (552)
                      +++.... ..+++..+..++.|++.||+|||+++   ++||||||+|||++.++.+||+|||++.....  .......++
T Consensus        91 ~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  166 (303)
T cd07869          91 QYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVT  166 (303)
T ss_pred             HHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCCCccc
Confidence            8776543 34899999999999999999999999   99999999999999999999999999864321  122235678


Q ss_pred             ccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          494 QGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       494 ~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      +.|+|||.+.+ ..++.++|||||||++|||++|+.||.+.
T Consensus       167 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  207 (303)
T cd07869         167 LWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM  207 (303)
T ss_pred             CCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999998765 45788999999999999999999999764

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.97  E-value=3.2e-31  Score=270.46  Aligned_cols=181  Identities=28%  Similarity=0.410  Sum_probs=155.4

Q ss_pred             CceEEEEEEEEee-----cCcEEEEEEeccC-----------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEee
Q 037224          346 GCLIQGSVYKGNI-----HGEVYAIKMMKWN-----------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEY  408 (552)
Q Consensus       346 G~g~~G~Vy~~~~-----~g~~vAvK~~~~~-----------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~  408 (552)
                      |.|++|.||+++.     .++.||+|+++..           ..+|+.++.++ +|+||+++++++..  +...+++|||
T Consensus         9 g~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~~~~lv~e~   86 (332)
T cd05614           9 GTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT--EAKLHLILDY   86 (332)
T ss_pred             eecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec--CCEEEEEEeC
Confidence            7778899999875     5789999998532           23588999999 59999999988876  6788999999


Q ss_pred             ccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC---C
Q 037224          409 IENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN---A  485 (552)
Q Consensus       409 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~---~  485 (552)
                      +++|+|.+++....  .+++.++..++.|++.||+|||+++   ++||||||+|||++.++.+||+|||+++....   .
T Consensus        87 ~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~  161 (332)
T cd05614          87 VSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE  161 (332)
T ss_pred             CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccccccCCC
Confidence            99999999987654  4899999999999999999999999   99999999999999999999999999874321   1


Q ss_pred             ccccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          486 ITMHIVGTQGYIAPEYLADG-VVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       486 ~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus       162 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~  210 (332)
T cd05614         162 RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE  210 (332)
T ss_pred             ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence            22345789999999998765 4788999999999999999999999754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1e-31  Score=293.78  Aligned_cols=187  Identities=35%  Similarity=0.575  Sum_probs=162.0

Q ss_pred             CCCceEEEEEEEEee---cCc----EEEEEEecc--------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEee
Q 037224          344 SEGCLIQGSVYKGNI---HGE----VYAIKMMKW--------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEY  408 (552)
Q Consensus       344 ~~G~g~~G~Vy~~~~---~g~----~vAvK~~~~--------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~  408 (552)
                      ..|.|.||.||+|..   +|.    .||+|.+++        ++.+|..+|++++||||++++|+|.+  ....++++||
T Consensus       699 ~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~--~~~~~i~ley  776 (1025)
T KOG1095|consen  699 VLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD--SGPPLILLEY  776 (1025)
T ss_pred             eeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC--CCCcEEEehh
Confidence            358999999999988   343    489998864        35689999999999999999999998  6677999999


Q ss_pred             ccCCCchhhhhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC
Q 037224          409 IENGSLHSWLHENK-----NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC  483 (552)
Q Consensus       409 ~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  483 (552)
                      |++|+|..+|++.+     ...++..+.+.++.|+|+|+.||++++   +|||||..+|+|++....+||+|||+|+...
T Consensus       777 M~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy  853 (1025)
T KOG1095|consen  777 MEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLARDIY  853 (1025)
T ss_pred             cccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchhHhhh
Confidence            99999999998763     235899999999999999999999998   9999999999999999999999999999443


Q ss_pred             CCcccccc----ccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccCc
Q 037224          484 NAITMHIV----GTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEGK  535 (552)
Q Consensus       484 ~~~~~~~~----gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~~  535 (552)
                      ........    -...|||||.+..+.++.|+|||||||+|||++| |..||.+.+.
T Consensus       854 ~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n  910 (1025)
T KOG1095|consen  854 DKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN  910 (1025)
T ss_pred             hchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch
Confidence            33222222    2358999999999999999999999999999998 9999987664

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.97  E-value=3.5e-32  Score=250.93  Aligned_cols=182  Identities=29%  Similarity=0.510  Sum_probs=156.2

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEe
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYE  407 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e  407 (552)
                      |.|+.+.|-+...  .|+.+|+|++...               ..+|+.+|+++ .||+|+.+.+++..  +..+++|+|
T Consensus        26 grgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes--~sF~FlVFd  103 (411)
T KOG0599|consen   26 GRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES--DAFVFLVFD  103 (411)
T ss_pred             cccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC--cchhhhhhh
Confidence            6666566666654  7888999988421               23689999998 79999999999987  778899999


Q ss_pred             eccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC-Cc
Q 037224          408 YIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN-AI  486 (552)
Q Consensus       408 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~-~~  486 (552)
                      .|+.|.|.|+|...-.  +++.+.++|++|+.+|++|||.++   ||||||||+|||+|++.++||+|||++..... ..
T Consensus       104 l~prGELFDyLts~Vt--lSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~l~~Gek  178 (411)
T KOG0599|consen  104 LMPRGELFDYLTSKVT--LSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQLEPGEK  178 (411)
T ss_pred             hcccchHHHHhhhhee--ecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeeccCCchh
Confidence            9999999999987653  999999999999999999999999   99999999999999999999999999986543 34


Q ss_pred             cccccccccccCccccC------CCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          487 TMHIVGTQGYIAPEYLA------DGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       487 ~~~~~gt~~y~aPE~~~------~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ....+|||+|+|||.+.      ...|+...|+|++|+|||.|+.|.+||-...
T Consensus       179 LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk  232 (411)
T KOG0599|consen  179 LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK  232 (411)
T ss_pred             HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH
Confidence            45689999999999874      2447889999999999999999999997544

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5e-32  Score=277.60  Aligned_cols=185  Identities=33%  Similarity=0.542  Sum_probs=160.5

Q ss_pred             CCceEEEEEEEEee--c-C--cE-EEEEEecc----------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEee
Q 037224          345 EGCLIQGSVYKGNI--H-G--EV-YAIKMMKW----------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEY  408 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~-g--~~-vAvK~~~~----------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~  408 (552)
                      .|.|+||.||+|++  . +  .. ||+|..+.          ++.+|++++++++||||++++|++..  +..+++|||+
T Consensus       165 LGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~--~~Pl~ivmEl  242 (474)
T KOG0194|consen  165 LGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL--EEPLMLVMEL  242 (474)
T ss_pred             eecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC--CCccEEEEEe
Confidence            47888899999998  2 2  23 89999874          23579999999999999999999988  7788999999


Q ss_pred             ccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccc
Q 037224          409 IENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM  488 (552)
Q Consensus       409 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  488 (552)
                      |.||+|.++|...+. .++..+.+.++.+.+.||+|||+++   ++||||..+|+|++.++.+||+|||+++........
T Consensus       243 ~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~  318 (474)
T KOG0194|consen  243 CNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMK  318 (474)
T ss_pred             cCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCCcceeec
Confidence            999999999998765 5999999999999999999999999   999999999999999999999999999865422111


Q ss_pred             --cccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccCc
Q 037224          489 --HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEGK  535 (552)
Q Consensus       489 --~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~~  535 (552)
                        ...-...|+|||.+..+.+++++|||||||++||+++ |..||.+...
T Consensus       319 ~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~  368 (474)
T KOG0194|consen  319 KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN  368 (474)
T ss_pred             cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH
Confidence              1123568999999999999999999999999999998 8999987653

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.97  E-value=1.8e-30  Score=301.23  Aligned_cols=192  Identities=29%  Similarity=0.535  Sum_probs=157.9

Q ss_pred             ccHHHHHHHhhc-cCCCceEEEEEEEEee--cCcEEEEEEeccC---hHHHHHHHHHcCCCCccceeeeeecCCCCeeEE
Q 037224          331 FKIEELREATDN-FSEGCLIQGSVYKGNI--HGEVYAIKMMKWN---ACEELKILQKVNHGNLVKLEGFCIDPEDANCYL  404 (552)
Q Consensus       331 ~~~~~l~~~t~~-~~~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  404 (552)
                      ++++++...... -..|.|.+|.||+|+.  ++..||+|.++..   ..+|++.+++++||||++++++|.+  +...++
T Consensus       683 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~--~~~~~l  760 (968)
T PLN00113        683 ITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRS--EKGAYL  760 (968)
T ss_pred             hhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEc--CCCCEE
Confidence            445554443222 2248888899999986  7889999998643   3468999999999999999999987  566799


Q ss_pred             EEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC
Q 037224          405 IYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN  484 (552)
Q Consensus       405 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  484 (552)
                      ||||+++|+|.++++.     ++|.++..++.|+++||+|||+...++++||||||+||+++.++..++. |+.......
T Consensus       761 v~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~  834 (968)
T PLN00113        761 IHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT  834 (968)
T ss_pred             EEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence            9999999999999853     8999999999999999999996544459999999999999999888775 665543221


Q ss_pred             CccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          485 AITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       485 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                        .....++..|+|||++.+..++.++|||||||++|||+||+.||+.
T Consensus       835 --~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~  880 (968)
T PLN00113        835 --DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA  880 (968)
T ss_pred             --CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence              1224678999999999999999999999999999999999999964

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.97  E-value=7.5e-31  Score=267.74  Aligned_cols=181  Identities=28%  Similarity=0.472  Sum_probs=159.2

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      |.|.+|.||++..  ++..+|+|.++..        +.+|++++++++|+||++++++|.+  ++..++||||+++++|.
T Consensus        14 g~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~   91 (333)
T cd06650          14 GAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLD   91 (333)
T ss_pred             cCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE--CCEEEEEEecCCCCcHH
Confidence            6677799999988  5789999987532        3479999999999999999999987  67889999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccccccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEH-TRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ  494 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~gt~  494 (552)
                      +++....  .+++..+..++.|++.||.|||+. +   ++|+||||+|||++.++.+||+|||++............++.
T Consensus        92 ~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~  166 (333)
T cd06650          92 QVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR  166 (333)
T ss_pred             HHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhhccccCCCCc
Confidence            9987644  488999999999999999999975 5   999999999999999999999999998754433334457899


Q ss_pred             cccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       495 ~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      .|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       167 ~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         167 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             cccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            999999999888999999999999999999999999754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.97  E-value=2.6e-31  Score=270.98  Aligned_cols=183  Identities=27%  Similarity=0.367  Sum_probs=157.2

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|++|.||+++.  .++.||+|+++..          +.+|..++..++|+||+++++++.+  ++..|+||||+++|+
T Consensus        10 G~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~--~~~~~lv~Ey~~gg~   87 (331)
T cd05624          10 GRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD--ENYLYLVMDYYVGGD   87 (331)
T ss_pred             eeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEEEEEeCCCCCc
Confidence            7788899999987  6789999998542          2357888999999999999999877  678899999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc---cccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI---TMHI  490 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~---~~~~  490 (552)
                      |.+++.... ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++.......   ....
T Consensus        88 L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~  163 (331)
T cd05624          88 LLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA  163 (331)
T ss_pred             HHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCceeeccc
Confidence            999997643 24899999999999999999999999   9999999999999999999999999987443221   1234


Q ss_pred             cccccccCccccCC-----CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          491 VGTQGYIAPEYLAD-----GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       491 ~gt~~y~aPE~~~~-----~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .|++.|+|||++.+     +.++.++||||||+++|||++|+.||...+
T Consensus       164 ~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~  212 (331)
T cd05624         164 VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES  212 (331)
T ss_pred             cCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC
Confidence            68999999998865     467889999999999999999999997543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.97  E-value=4.9e-31  Score=263.20  Aligned_cols=182  Identities=27%  Similarity=0.396  Sum_probs=156.0

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|.+|.||+++.  +++.||+|+++..         ..+|+.++++++|+||+++++++..  ++..++||||++++.+
T Consensus        10 g~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~l   87 (287)
T cd07848          10 GEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR--RGKLYLVFEYVEKNML   87 (287)
T ss_pred             cccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec--CCEEEEEEecCCCCHH
Confidence            6777899999988  5789999998532         3479999999999999999999876  6788999999998766


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC---cccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA---ITMHIV  491 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~---~~~~~~  491 (552)
                      ..+....  ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++......   ......
T Consensus        88 ~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  162 (287)
T cd07848          88 ELLEEMP--NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYV  162 (287)
T ss_pred             HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccccc
Confidence            6544322  34899999999999999999999998   999999999999999999999999999754321   122346


Q ss_pred             ccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          492 GTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       492 gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +++.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus       163 ~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~  205 (287)
T cd07848         163 ATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES  205 (287)
T ss_pred             cccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCC
Confidence            8899999999988889999999999999999999999998653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.97  E-value=1.5e-31  Score=272.60  Aligned_cols=183  Identities=31%  Similarity=0.421  Sum_probs=158.1

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|.+|.||+++.  +|+.||+|+++..          ..+|+.+++.++|+||+++++++.+  ....++||||+++++
T Consensus        10 g~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~   87 (330)
T cd05601          10 GRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD--KDNLYLVMEYQPGGD   87 (330)
T ss_pred             EeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCeEEEEECCCCCCC
Confidence            7778899999987  7889999998643          2368889999999999999998876  667899999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc---cccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI---TMHI  490 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~---~~~~  490 (552)
                      |.+++.... ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.......   ....
T Consensus        88 L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~  163 (330)
T cd05601          88 LLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLP  163 (330)
T ss_pred             HHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCceeeecc
Confidence            999997653 24899999999999999999999999   9999999999999999999999999997543221   2234


Q ss_pred             cccccccCccccC------CCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          491 VGTQGYIAPEYLA------DGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       491 ~gt~~y~aPE~~~------~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .||+.|+|||.+.      ...++.++||||||+++|||++|+.||....
T Consensus       164 ~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~  213 (330)
T cd05601         164 VGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT  213 (330)
T ss_pred             cCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC
Confidence            6899999999986      4567889999999999999999999997654

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.97  E-value=3.9e-31  Score=269.77  Aligned_cols=183  Identities=27%  Similarity=0.382  Sum_probs=156.6

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|++|.||+++.  .++.+|+|++...          +.+|+.++..++|+||+++++.+.+  ....++||||+++|+
T Consensus        10 G~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ey~~~g~   87 (332)
T cd05623          10 GRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD--ENNLYLVMDYYVGGD   87 (332)
T ss_pred             EeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec--CCEEEEEEeccCCCc
Confidence            7778899999988  5788999998532          3468888999999999999998877  678899999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC---ccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA---ITMHI  490 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~---~~~~~  490 (552)
                      |.+++.... ..+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||++......   .....
T Consensus        88 L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~  163 (332)
T cd05623          88 LLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA  163 (332)
T ss_pred             HHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCcceeccc
Confidence            999997643 24899999999999999999999999   999999999999999999999999998643211   12235


Q ss_pred             cccccccCccccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          491 VGTQGYIAPEYLA-----DGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       491 ~gt~~y~aPE~~~-----~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .||+.|+|||++.     ...++.++|||||||++|||++|+.||...+
T Consensus       164 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~  212 (332)
T cd05623         164 VGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES  212 (332)
T ss_pred             ccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC
Confidence            7899999999885     3457889999999999999999999997654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=7.2e-31  Score=273.06  Aligned_cols=179  Identities=26%  Similarity=0.353  Sum_probs=156.1

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEecc-ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhhhhhcC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKW-NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENK  422 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~-~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~  422 (552)
                      |.|++|.||++..  .++.||+|.... ...+|+.++++++||||+++++++..  ....++++|++. ++|.+++....
T Consensus       101 g~G~~g~V~~~~d~~~~~~vaiK~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~lv~e~~~-~~L~~~l~~~~  177 (391)
T PHA03212        101 TPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTY--NKFTCLILPRYK-TDLYCYLAAKR  177 (391)
T ss_pred             cCCCCeEEEEEEECCCCCEEEEechhhhhhHHHHHHHHhCCCCCCCCEeEEEEE--CCeeEEEEecCC-CCHHHHHHhcC
Confidence            6777899999987  688999998754 35689999999999999999999877  567899999986 58888876543


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC---CccccccccccccCc
Q 037224          423 NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN---AITMHIVGTQGYIAP  499 (552)
Q Consensus       423 ~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~---~~~~~~~gt~~y~aP  499 (552)
                        .+++.+++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++....   .......||+.|+||
T Consensus       178 --~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aP  252 (391)
T PHA03212        178 --NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAP  252 (391)
T ss_pred             --CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccccCccCCCCh
Confidence              4899999999999999999999998   99999999999999999999999999864321   222345789999999


Q ss_pred             cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          500 EYLADGVVSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       500 E~~~~~~~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                      |++.+..++.++|||||||++|||++|+.||..
T Consensus       253 E~~~~~~~~~~~DiwSlGvil~elltg~~p~~~  285 (391)
T PHA03212        253 ELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE  285 (391)
T ss_pred             hhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence            999988999999999999999999999988754

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=5.2e-31  Score=269.39  Aligned_cols=183  Identities=28%  Similarity=0.471  Sum_probs=154.8

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCC---CeeEEEEeeccC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPED---ANCYLIYEYIEN  411 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~~~lv~e~~~~  411 (552)
                      |.|.+|.||++..  +|+.||+|+++..         ..+|+.++++++||||+++++++.....   ...++||||+. 
T Consensus         9 g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-   87 (338)
T cd07859           9 GKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-   87 (338)
T ss_pred             eecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-
Confidence            6677799999987  6889999988532         3479999999999999999998865322   35799999996 


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-----c
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-----I  486 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-----~  486 (552)
                      ++|.+++....  .+++..+..++.|+++||.|||+++   ++||||||+|||++.++.+||+|||+++.....     .
T Consensus        88 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  162 (338)
T cd07859          88 SDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF  162 (338)
T ss_pred             CCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccccccCcccc
Confidence            58988887544  4899999999999999999999999   999999999999999999999999998743211     1


Q ss_pred             cccccccccccCccccCC--CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          487 TMHIVGTQGYIAPEYLAD--GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       487 ~~~~~gt~~y~aPE~~~~--~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .....+++.|+|||++.+  ..++.++|||||||++|||++|+.||.+.+
T Consensus       163 ~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~  212 (338)
T cd07859         163 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN  212 (338)
T ss_pred             ccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence            123568999999999865  678999999999999999999999997654

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.97  E-value=7.5e-31  Score=262.29  Aligned_cols=186  Identities=27%  Similarity=0.445  Sum_probs=156.6

Q ss_pred             CCceEEEEEEEEee---cCcEEEEEEeccC---------hHHHHHHHHHc---CCCCccceeeeeecC---CCCeeEEEE
Q 037224          345 EGCLIQGSVYKGNI---HGEVYAIKMMKWN---------ACEELKILQKV---NHGNLVKLEGFCIDP---EDANCYLIY  406 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~---~g~~vAvK~~~~~---------~~~E~~~l~~l---~h~niv~l~~~~~~~---~~~~~~lv~  406 (552)
                      .|.|.+|.||+++.   .++.||+|.++..         ..+|+.+++.+   +||||++++++|...   .....+++|
T Consensus         9 lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~   88 (290)
T cd07862           9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVF   88 (290)
T ss_pred             eccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEE
Confidence            37777899999986   4678999988532         33577777766   699999999988632   245689999


Q ss_pred             eeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-
Q 037224          407 EYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-  485 (552)
Q Consensus       407 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-  485 (552)
                      ||++ ++|.+++.......+++.+++.++.|++.||.|||+++   ++||||||+|||++.++.+||+|||+++..... 
T Consensus        89 e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  164 (290)
T cd07862          89 EHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM  164 (290)
T ss_pred             ccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccceEeccCCc
Confidence            9997 58999987765556899999999999999999999999   999999999999999999999999998754322 


Q ss_pred             ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          486 ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       486 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ......+++.|+|||.+.+..++.++||||||+++|||++|+.||.+..
T Consensus       165 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  213 (290)
T cd07862         165 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS  213 (290)
T ss_pred             ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence            2334568999999999988889999999999999999999999998654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.97  E-value=1e-30  Score=266.60  Aligned_cols=182  Identities=33%  Similarity=0.459  Sum_probs=163.1

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcC-CCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      |.|.||.||+++.  +|+.+|+|.+++.          ..+|+.+|+++. ||||+.+.+.+.+  ....++|||+++||
T Consensus        44 G~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~--~~~~~lvmEL~~GG  121 (382)
T KOG0032|consen   44 GRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED--PDSVYLVMELCEGG  121 (382)
T ss_pred             CCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc--CCeEEEEEEecCCc
Confidence            6777799999988  6899999998543          347999999998 9999999999988  66889999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECC----CCcEEEeeccCCccCCC-Ccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS----NMRAKIANFGLAKSGCN-AIT  487 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~----~~~~kL~Dfg~a~~~~~-~~~  487 (552)
                      .|.+.+...   .+++.++..++.|++.++.|||+.|   ++||||||+|+|+..    ++.+|++|||++..... ...
T Consensus       122 eLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~  195 (382)
T KOG0032|consen  122 ELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERL  195 (382)
T ss_pred             hHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceE
Confidence            999999876   2999999999999999999999999   999999999999954    35799999999986554 345


Q ss_pred             ccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          488 MHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       488 ~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      ...+||+.|+|||++....++..+||||+|+++|.|++|..||....+
T Consensus       196 ~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~  243 (382)
T KOG0032|consen  196 HTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETE  243 (382)
T ss_pred             eeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCCh
Confidence            568999999999999999999999999999999999999999998764

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=9.5e-32  Score=279.68  Aligned_cols=194  Identities=28%  Similarity=0.418  Sum_probs=165.0

Q ss_pred             HHHHHhhccCCCceEEEEEEEEee--cCc----EEEEEEecc--------ChHHHHHHHHHcCCCCccceeeeeecCCCC
Q 037224          335 ELREATDNFSEGCLIQGSVYKGNI--HGE----VYAIKMMKW--------NACEELKILQKVNHGNLVKLEGFCIDPEDA  400 (552)
Q Consensus       335 ~l~~~t~~~~~G~g~~G~Vy~~~~--~g~----~vAvK~~~~--------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  400 (552)
                      +-.+..+.+..|+|+||+||+|.|  +|+    +||+|++..        +..+|+..|.+++|+|+++++++|..+   
T Consensus       694 kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s---  770 (1177)
T KOG1025|consen  694 KETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS---  770 (1177)
T ss_pred             hhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc---
Confidence            333445667889999999999998  443    689998843        345899999999999999999999863   


Q ss_pred             eeEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCc
Q 037224          401 NCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK  480 (552)
Q Consensus       401 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  480 (552)
                      ...||++|++.|+|.++++.++. .+-.+..+.|..||++|+.|||++.   ++||||..+||||..-..+||.|||+++
T Consensus       771 ~~qlvtq~mP~G~LlDyvr~hr~-~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~  846 (1177)
T KOG1025|consen  771 TLQLVTQLMPLGCLLDYVREHRD-NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAK  846 (1177)
T ss_pred             hHHHHHHhcccchHHHHHHHhhc-cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhh
Confidence            36899999999999999998775 4888999999999999999999998   9999999999999999999999999998


Q ss_pred             cCCCCc-cc---cccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccCc
Q 037224          481 SGCNAI-TM---HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEGK  535 (552)
Q Consensus       481 ~~~~~~-~~---~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~~  535 (552)
                      ...... ..   ...-.+.|||-|.+....++.++|||||||.+||++| |..|+++...
T Consensus       847 ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~  906 (1177)
T KOG1025|consen  847 LLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA  906 (1177)
T ss_pred             ccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH
Confidence            543221 11   1223567999999999999999999999999999998 9999997653

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.97  E-value=1.7e-30  Score=259.23  Aligned_cols=185  Identities=28%  Similarity=0.368  Sum_probs=161.4

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|.|++|+||++..  +++.+|+|.++..          ..+|++++++++|+|++.+.+.+..  ++..+++|||++++
T Consensus         8 lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~   85 (285)
T cd05632           8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET--KDALCLVLTIMNGG   85 (285)
T ss_pred             EecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec--CCEEEEEEEeccCc
Confidence            37778899999988  6889999988532          2469999999999999999988876  66889999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-cccccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-ITMHIV  491 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-~~~~~~  491 (552)
                      +|.+++.......+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++...... ......
T Consensus        86 ~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~  162 (285)
T cd05632          86 DLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV  162 (285)
T ss_pred             cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccCCC
Confidence            9998887655556999999999999999999999999   999999999999999999999999998643322 223457


Q ss_pred             ccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          492 GTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       492 gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      |+..|+|||.+.+..++.++|+||||+++|||++|+.||....
T Consensus       163 g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~  205 (285)
T cd05632         163 GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK  205 (285)
T ss_pred             CCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence            8999999999988899999999999999999999999998654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=2.9e-31  Score=281.71  Aligned_cols=188  Identities=26%  Similarity=0.387  Sum_probs=157.1

Q ss_pred             CceEEEEEEEEee-cC-cEEEEEEeccC-------hHHHHHHHHHcC-CCCccceeeee-ecC---C-CCeeEEEEeecc
Q 037224          346 GCLIQGSVYKGNI-HG-EVYAIKMMKWN-------ACEELKILQKVN-HGNLVKLEGFC-IDP---E-DANCYLIYEYIE  410 (552)
Q Consensus       346 G~g~~G~Vy~~~~-~g-~~vAvK~~~~~-------~~~E~~~l~~l~-h~niv~l~~~~-~~~---~-~~~~~lv~e~~~  410 (552)
                      ..|+|+.||.+.. .+ ..||+|++-..       ..+|+++|++|. |+|||.+++.. ...   . .-.++|.||||.
T Consensus        46 AEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~  125 (738)
T KOG1989|consen   46 AEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCK  125 (738)
T ss_pred             ccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhcc
Confidence            4566799999998 34 89999997321       347999999995 99999999933 221   1 236789999999


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc----
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI----  486 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~----  486 (552)
                      +|.|-|++..+...+|++.++++|+.|+++|+++||... ++|||||||-+||||..++.+||||||.+.......    
T Consensus       126 gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~  204 (738)
T KOG1989|consen  126 GGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQ  204 (738)
T ss_pred             CCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHH
Confidence            999999998777777999999999999999999999985 679999999999999999999999999986322111    


Q ss_pred             -------cccccccccccCcccc---CCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          487 -------TMHIVGTQGYIAPEYL---ADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       487 -------~~~~~gt~~y~aPE~~---~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                             .-....|+.|.|||.+   .+..+++|+|||||||+||-|+....||++.+
T Consensus       205 e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg  262 (738)
T KOG1989|consen  205 EVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG  262 (738)
T ss_pred             HHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc
Confidence                   1113579999999975   57789999999999999999999999999773

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.97  E-value=1.6e-30  Score=263.35  Aligned_cols=186  Identities=26%  Similarity=0.450  Sum_probs=155.5

Q ss_pred             CCceEEEEEEEEee----cCcEEEEEEeccC-----hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          345 EGCLIQGSVYKGNI----HGEVYAIKMMKWN-----ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~----~g~~vAvK~~~~~-----~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      .|.|++|.||+++.    .++.+|+|.++..     ..+|+.++++++||||+++++++....+...+++|||+.+ +|.
T Consensus         9 lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~   87 (317)
T cd07868           9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLW   87 (317)
T ss_pred             cccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-CHH
Confidence            48888899999985    4578999998643     4589999999999999999999877666788999999865 887


Q ss_pred             hhhhhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE----CCCCcEEEeeccCCccCCC
Q 037224          416 SWLHENK-------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL----DSNMRAKIANFGLAKSGCN  484 (552)
Q Consensus       416 ~~l~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll----~~~~~~kL~Dfg~a~~~~~  484 (552)
                      +++....       ...+++..+..++.|++.||.|||+++   |+||||||+|||+    +.++.+||+|||+++....
T Consensus        88 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~  164 (317)
T cd07868          88 HIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS  164 (317)
T ss_pred             HHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCC
Confidence            7765321       124899999999999999999999999   9999999999999    4567899999999975432


Q ss_pred             C-----ccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          485 A-----ITMHIVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       485 ~-----~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .     ......+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||....
T Consensus       165 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             CCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            2     1223577999999999876 458899999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.97  E-value=1.4e-30  Score=268.07  Aligned_cols=177  Identities=31%  Similarity=0.506  Sum_probs=150.0

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      .|.|.+|.||+++.  +++.||+|++...        +.+|++++++++|+||+++++++.+  ++..+++|||+++++|
T Consensus        82 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L  159 (353)
T PLN00034         82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH--NGEIQVLLEFMDGGSL  159 (353)
T ss_pred             ccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEecc--CCeEEEEEecCCCCcc
Confidence            46777799999987  6899999998532        3479999999999999999999876  6788999999999998


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--ccccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIVG  492 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~g  492 (552)
                      .+..      ...+..+..++.|++.||+|||+++   ++||||||+|||+++++.+||+|||+++.....  ......|
T Consensus       160 ~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g  230 (353)
T PLN00034        160 EGTH------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVG  230 (353)
T ss_pred             cccc------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccccccccccc
Confidence            6532      2567788899999999999999999   999999999999999999999999998754322  1234578


Q ss_pred             cccccCccccCC-----CCCCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          493 TQGYIAPEYLAD-----GVVSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       493 t~~y~aPE~~~~-----~~~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                      +..|+|||.+..     ...+.++|||||||++|||++|+.||..
T Consensus       231 t~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~  275 (353)
T PLN00034        231 TIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV  275 (353)
T ss_pred             CccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence            999999998743     2345689999999999999999999974

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.7e-32  Score=265.91  Aligned_cols=183  Identities=30%  Similarity=0.440  Sum_probs=162.6

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      .|.|.||.||+|..  .++.||+|++.-+        ..+|+.+|.+++++||.++++.+..  +..+|++|||+.+|++
T Consensus        21 IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~--g~~LwiiMey~~gGsv   98 (467)
T KOG0201|consen   21 IGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLK--GTKLWIIMEYCGGGSV   98 (467)
T ss_pred             ccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheee--cccHHHHHHHhcCcch
Confidence            37777899999988  7899999999643        3469999999999999999999988  7788999999999999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--ccccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIVG  492 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~g  492 (552)
                      .+.+....  .+++.++.-++++++.||.|||.++   .+|||||+.|||+..+|.+||+|||.+......  .....+|
T Consensus        99 ~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfvG  173 (467)
T KOG0201|consen   99 LDLLKSGN--ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTFVG  173 (467)
T ss_pred             hhhhccCC--CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhccccccc
Confidence            99987654  2588888899999999999999999   999999999999999999999999998754432  2356899


Q ss_pred             cccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       493 t~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      |+.|||||++....|+.++||||||++.+||.+|.+|+....
T Consensus       174 TPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~h  215 (467)
T KOG0201|consen  174 TPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLH  215 (467)
T ss_pred             cccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccC
Confidence            999999999998899999999999999999999999998654

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.97  E-value=2.5e-30  Score=255.36  Aligned_cols=184  Identities=26%  Similarity=0.400  Sum_probs=155.9

Q ss_pred             CCceEEEEEEEEee-----cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI-----HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-----~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|++|.||+|.+     .+..||+|.++..        +.+|+.++++++||||+++++++..  +...++||||+++
T Consensus        13 ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~   90 (266)
T cd05064          13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR--GNTMMIVTEYMSN   90 (266)
T ss_pred             ecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec--CCCcEEEEEeCCC
Confidence            47778899999975     3568999998643        3469999999999999999999876  6678999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc---cc
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI---TM  488 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~---~~  488 (552)
                      ++|.+++.... ..+++.+++.++.|++.||+|||+++   ++||||||+||+++.++.++++|||.+.......   ..
T Consensus        91 ~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~  166 (266)
T cd05064          91 GALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTM  166 (266)
T ss_pred             CcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccccchhccc
Confidence            99999987643 35899999999999999999999998   9999999999999999999999999876432211   11


Q ss_pred             cccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          489 HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       489 ~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      ...++..|+|||.+.+..++.++||||||+++||+++ |+.||.+..
T Consensus       167 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~  213 (266)
T cd05064         167 SGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS  213 (266)
T ss_pred             CCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence            2234578999999999999999999999999999875 999997644

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.97  E-value=2.2e-30  Score=258.49  Aligned_cols=184  Identities=27%  Similarity=0.385  Sum_probs=160.9

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|++|.||++..  +++.||+|.+...          ..+|+.++++++|++++.+++.+.+  +...+++|||+++++
T Consensus         9 g~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~g~~   86 (285)
T cd05630           9 GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET--KDALCLVLTLMNGGD   86 (285)
T ss_pred             ecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec--CCEEEEEEEecCCCc
Confidence            7777899999988  6889999987532          2368999999999999999998876  668899999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-ccccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-ITMHIVG  492 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-~~~~~~g  492 (552)
                      |.+++.......+++.++..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++...... ......|
T Consensus        87 L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~g  163 (285)
T cd05630          87 LKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVG  163 (285)
T ss_pred             HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccCCCC
Confidence            999887655556999999999999999999999998   999999999999999999999999998754322 2223578


Q ss_pred             cccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       493 t~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       164 ~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~  205 (285)
T cd05630         164 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK  205 (285)
T ss_pred             CccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999999999999999999998643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.97  E-value=7.5e-31  Score=258.07  Aligned_cols=184  Identities=37%  Similarity=0.632  Sum_probs=155.3

Q ss_pred             CceEEEEEEEEeec------CcEEEEEEecc--------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          346 GCLIQGSVYKGNIH------GEVYAIKMMKW--------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       346 G~g~~G~Vy~~~~~------g~~vAvK~~~~--------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      |.|.||.||+|.+.      +..|+||.++.        .+.+|++.+++++||||++++|++..  ....++|+||+++
T Consensus         8 g~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~--~~~~~lv~e~~~~   85 (259)
T PF07714_consen    8 GEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE--NEPLFLVMEYCPG   85 (259)
T ss_dssp             EEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES--SSSEEEEEE--TT
T ss_pred             ccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccc--ccccccccccccc
Confidence            77778999999997      67899999953        23478999999999999999999995  5568999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC----cc
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA----IT  487 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~----~~  487 (552)
                      |+|.+++.......+++.++..|+.|+++||.|||+++   ++|+||+++||+++.++.+||+|||++......    ..
T Consensus        86 g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~  162 (259)
T PF07714_consen   86 GSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKND  162 (259)
T ss_dssp             EBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEES
T ss_pred             cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence            99999999875556999999999999999999999998   999999999999999999999999998755211    11


Q ss_pred             ccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          488 MHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       488 ~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      ........|+|||.+.+..++.++||||||+++||+++ |+.||.+..
T Consensus       163 ~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~  210 (259)
T PF07714_consen  163 SSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD  210 (259)
T ss_dssp             TTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            22346678999999988889999999999999999999 789987653

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.97  E-value=6.1e-30  Score=252.03  Aligned_cols=184  Identities=28%  Similarity=0.455  Sum_probs=159.1

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchh
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHS  416 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~  416 (552)
                      .|.|.+|.||++.+  .++.+|+|.++.+      +.+|++++++++|+|++++++++..  +...+++|||+++++|.+
T Consensus        14 ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~   91 (263)
T cd05052          14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYIITEFMTYGNLLD   91 (263)
T ss_pred             cCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcC--CCCcEEEEEeCCCCcHHH
Confidence            37777899999987  5789999998654      3479999999999999999999876  667899999999999999


Q ss_pred             hhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccc---ccccc
Q 037224          417 WLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM---HIVGT  493 (552)
Q Consensus       417 ~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~---~~~gt  493 (552)
                      ++.......+++..++.++.|+++||+|||+.+   ++||||||+||++++++.+||+|||++.........   ....+
T Consensus        92 ~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~  168 (263)
T cd05052          92 YLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP  168 (263)
T ss_pred             HHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceeeccCCCCCc
Confidence            997665556899999999999999999999998   999999999999999999999999998754432211   12235


Q ss_pred             ccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCcc
Q 037224          494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEE  533 (552)
Q Consensus       494 ~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~  533 (552)
                      ..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus       169 ~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~  209 (263)
T cd05052         169 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI  209 (263)
T ss_pred             cccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence            67999999988999999999999999999998 99999754

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.97  E-value=2.9e-30  Score=276.09  Aligned_cols=187  Identities=29%  Similarity=0.391  Sum_probs=158.4

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCC------CeeEEEEe
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPED------ANCYLIYE  407 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~~~lv~e  407 (552)
                      .|.|++|.||+++.  +|+.||||+++..         ..+|+.++..++|+|++++...+.....      ...++|||
T Consensus        40 LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~E  119 (496)
T PTZ00283         40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLD  119 (496)
T ss_pred             EecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEe
Confidence            47788899999987  7899999998532         3368889999999999999877654221      13679999


Q ss_pred             eccCCCchhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC-
Q 037224          408 YIENGSLHSWLHENK--NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN-  484 (552)
Q Consensus       408 ~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~-  484 (552)
                      |+++|+|.+++....  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.... 
T Consensus       120 y~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~  196 (496)
T PTZ00283        120 YANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGFSKMYAAT  196 (496)
T ss_pred             CCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEecccCeecccc
Confidence            999999999986532  245899999999999999999999998   99999999999999999999999999874332 


Q ss_pred             ---CccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          485 ---AITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       485 ---~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                         .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       197 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~  249 (496)
T PTZ00283        197 VSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN  249 (496)
T ss_pred             ccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence               12234578999999999999999999999999999999999999997643

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-31  Score=250.97  Aligned_cols=183  Identities=28%  Similarity=0.432  Sum_probs=161.5

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccCh----------HHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWNA----------CEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~~----------~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|.||.|...+.  .++.+|+|+++++.          ..|-++|+..+||.+..+--.|..  ...+++||||..||.
T Consensus       177 GkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt--~drlCFVMeyanGGe  254 (516)
T KOG0690|consen  177 GKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT--QDRLCFVMEYANGGE  254 (516)
T ss_pred             cCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc--CceEEEEEEEccCce
Confidence            6777799988876  79999999998753          247889999999999888666665  678899999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccC--CCCcccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG--CNAITMHIV  491 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~--~~~~~~~~~  491 (552)
                      |.-+|.+.+  .+++...+.+...|..||.|||+++   ||.||+|.+|.|+|.+|++||.|||+++..  ....+...+
T Consensus       255 Lf~HLsrer--~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFC  329 (516)
T KOG0690|consen  255 LFFHLSRER--VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFC  329 (516)
T ss_pred             Eeeehhhhh--cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcccccceecccc
Confidence            988887644  4899999999999999999999998   999999999999999999999999999843  233455689


Q ss_pred             ccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          492 GTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       492 gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      |||.|+|||++....|+.+.|+|.+|++||||++|+.||.+.+.
T Consensus       330 GTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh  373 (516)
T KOG0690|consen  330 GTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH  373 (516)
T ss_pred             CChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch
Confidence            99999999999999999999999999999999999999997764

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.97  E-value=4.1e-30  Score=260.36  Aligned_cols=186  Identities=26%  Similarity=0.465  Sum_probs=154.6

Q ss_pred             CCceEEEEEEEEee----cCcEEEEEEeccC-----hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          345 EGCLIQGSVYKGNI----HGEVYAIKMMKWN-----ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~----~g~~vAvK~~~~~-----~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      .|.|++|.||+++.    .+..||+|.++..     ..+|+.++++++|+||+++++++....+...++++||+++ +|.
T Consensus         9 lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~   87 (317)
T cd07867           9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLW   87 (317)
T ss_pred             eccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-cHH
Confidence            47788899999986    3468999998643     4579999999999999999999977667788999999875 777


Q ss_pred             hhhhhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE----CCCCcEEEeeccCCccCCC
Q 037224          416 SWLHENK-------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL----DSNMRAKIANFGLAKSGCN  484 (552)
Q Consensus       416 ~~l~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll----~~~~~~kL~Dfg~a~~~~~  484 (552)
                      +++....       ...+++..++.++.|++.||.|||+.+   ++||||||+|||+    +.++.+||+|||+++....
T Consensus        88 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~  164 (317)
T cd07867          88 HIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS  164 (317)
T ss_pred             HHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCC
Confidence            7764321       234889999999999999999999998   9999999999999    5667899999999975432


Q ss_pred             Cc-----cccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          485 AI-----TMHIVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       485 ~~-----~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..     .....+|+.|+|||.+.+ ..++.++||||||+++|||+||+.||....
T Consensus       165 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             CcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence            21     223467899999998876 457899999999999999999999997544

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.97  E-value=3.7e-30  Score=265.52  Aligned_cols=182  Identities=27%  Similarity=0.427  Sum_probs=154.3

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCC----CeeEEEEeec
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPED----ANCYLIYEYI  409 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~~~lv~e~~  409 (552)
                      .|.|++|.||++..  .|+.||+|.++..         ..+|+.+++.++|+||+++++++.....    ...+++|||+
T Consensus        29 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~  108 (359)
T cd07876          29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM  108 (359)
T ss_pred             eecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCC
Confidence            37777899999987  6889999998532         2368999999999999999998864321    3579999999


Q ss_pred             cCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC-Cccc
Q 037224          410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN-AITM  488 (552)
Q Consensus       410 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~-~~~~  488 (552)
                      ++ +|.+.+..    .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.... ....
T Consensus       109 ~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~  180 (359)
T cd07876         109 DA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMT  180 (359)
T ss_pred             Cc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCccccccCccCC
Confidence            76 56665542    3888999999999999999999999   99999999999999999999999999975432 2223


Q ss_pred             cccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          489 HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       489 ~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ...+|+.|+|||.+.+..++.++||||||+++|||++|+.||.+.+
T Consensus       181 ~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~  226 (359)
T cd07876         181 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD  226 (359)
T ss_pred             CCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence            4578999999999999999999999999999999999999998654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.97  E-value=6e-32  Score=245.88  Aligned_cols=205  Identities=25%  Similarity=0.406  Sum_probs=167.9

Q ss_pred             HHHHHHHhhccCCCceEEEEEEEEee--cCcEEEEEEecc---------ChHHHHHHHHHcCCCCccceeeeeecCCCCe
Q 037224          333 IEELREATDNFSEGCLIQGSVYKGNI--HGEVYAIKMMKW---------NACEELKILQKVNHGNLVKLEGFCIDPEDAN  401 (552)
Q Consensus       333 ~~~l~~~t~~~~~G~g~~G~Vy~~~~--~g~~vAvK~~~~---------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  401 (552)
                      ++|.++..+.+  |.|.|+.||+...  .|+.+|+|++..         +..+|+.+-+.|+||||+++.+....  +..
T Consensus         9 f~d~y~l~e~i--gkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~--~~~   84 (355)
T KOG0033|consen    9 FSDNYDVKEEL--GKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESF   84 (355)
T ss_pred             cchhhhHHHHH--ccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcc--cce
Confidence            34444555554  5666688988765  788888887732         23479999999999999999988766  778


Q ss_pred             eEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECC---CCcEEEeeccC
Q 037224          402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS---NMRAKIANFGL  478 (552)
Q Consensus       402 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kL~Dfg~  478 (552)
                      .|+|+|+++|++|..-+-..  .-+++..+-..++||+++|.|+|.++   |||||+||.|+++-+   .--+||+|||+
T Consensus        85 ~ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGv  159 (355)
T KOG0033|consen   85 HYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGL  159 (355)
T ss_pred             eEEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccce
Confidence            89999999999997555433  23788899999999999999999999   999999999999943   34599999999


Q ss_pred             CccCCCCc-cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccCcccccchHHHHHHHhcCC
Q 037224          479 AKSGCNAI-TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYWREMKRGK  552 (552)
Q Consensus       479 a~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~g~  552 (552)
                      +....... .....|||+|||||++...+++..+|||+.|++||-|+.|.+||.+.+.      .+.+++++.|+
T Consensus       160 Ai~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~------~rlye~I~~g~  228 (355)
T KOG0033|consen  160 AIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ------HRLYEQIKAGA  228 (355)
T ss_pred             EEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH------HHHHHHHhccc
Confidence            98555332 3357899999999999999999999999999999999999999987554      66777777764

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=6.3e-30  Score=251.53  Aligned_cols=184  Identities=28%  Similarity=0.433  Sum_probs=158.5

Q ss_pred             CceEEEEEEEEee-cCcEEEEEEeccC------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhhh
Q 037224          346 GCLIQGSVYKGNI-HGEVYAIKMMKWN------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL  418 (552)
Q Consensus       346 G~g~~G~Vy~~~~-~g~~vAvK~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l  418 (552)
                      |.|++|.||++.. .++.||+|.++..      +.+|+.++++++|+|++++++++..  .+..+++|||+++++|.+++
T Consensus        15 g~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~   92 (261)
T cd05068          15 GAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL--EEPIYIVTELMKYGSLLEYL   92 (261)
T ss_pred             cccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEec--CCCeeeeeecccCCcHHHHH
Confidence            6777799999987 5678999998642      4579999999999999999998876  56789999999999999999


Q ss_pred             hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcccccc---cccc
Q 037224          419 HENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIV---GTQG  495 (552)
Q Consensus       419 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~---gt~~  495 (552)
                      .......+++.++..++.|++.||.+||+.+   ++||||||+||++++++.++|+|||++............   .+..
T Consensus        93 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~  169 (261)
T cd05068          93 QGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIK  169 (261)
T ss_pred             hccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCCcCcee
Confidence            7765556899999999999999999999998   999999999999999999999999998754422221122   2357


Q ss_pred             ccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          496 YIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       496 y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      |+|||.+.+..++.++|+||||+++|||++ |+.||.+..
T Consensus       170 y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  209 (261)
T cd05068         170 WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT  209 (261)
T ss_pred             ccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence            999999988899999999999999999999 999997644

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.97  E-value=3.2e-30  Score=259.68  Aligned_cols=184  Identities=28%  Similarity=0.486  Sum_probs=153.7

Q ss_pred             CCceEEEEEEEEee------------------cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCC
Q 037224          345 EGCLIQGSVYKGNI------------------HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPE  398 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~------------------~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~  398 (552)
                      .|.|++|.||++.+                  .+..||+|.++..        +.+|+.++.+++|+||+++++++.+  
T Consensus        13 lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--   90 (304)
T cd05096          13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVD--   90 (304)
T ss_pred             ecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEec--
Confidence            37888899999975                  2336999998642        4479999999999999999999987  


Q ss_pred             CCeeEEEEeeccCCCchhhhhhcC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCC
Q 037224          399 DANCYLIYEYIENGSLHSWLHENK-----------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSS  461 (552)
Q Consensus       399 ~~~~~lv~e~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~  461 (552)
                      ....+++|||+++++|.+++....                 ...+++.+++.++.|++.||.|||+.+   ++||||||+
T Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH~dlkp~  167 (304)
T cd05096          91 EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLATR  167 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccccCcchh
Confidence            567899999999999999886432                 124788899999999999999999999   999999999


Q ss_pred             cEEECCCCcEEEeeccCCccCCCCc----cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc--CCCCCCcc
Q 037224          462 NILLDSNMRAKIANFGLAKSGCNAI----TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS--GKEAIDEE  533 (552)
Q Consensus       462 NIll~~~~~~kL~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt--G~~pf~~~  533 (552)
                      |||++.++.+||+|||+++......    .....++..|+|||.+....++.++||||||+++|||++  +..||.+.
T Consensus       168 Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~  245 (304)
T cd05096         168 NCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGEL  245 (304)
T ss_pred             heEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcC
Confidence            9999999999999999987443221    112345778999999988899999999999999999986  66788754

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.97  E-value=3.3e-30  Score=272.25  Aligned_cols=185  Identities=25%  Similarity=0.415  Sum_probs=152.6

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---hHHHHHHHHHcCCCCccceeeeeecC------CCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---ACEELKILQKVNHGNLVKLEGFCIDP------EDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~~~lv~e~~~~gsL  414 (552)
                      |.|++|.||+|..  .++.||||++...   ..+|+.++++++|+||+++++++...      ....+++||||+++ +|
T Consensus        75 G~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l  153 (440)
T PTZ00036         75 GNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TV  153 (440)
T ss_pred             EeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cH
Confidence            7788899999987  6789999988543   34799999999999999998877532      12246799999985 77


Q ss_pred             hhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCC-cEEEeeccCCccCCC-Cccccc
Q 037224          415 HSWLHEN--KNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM-RAKIANFGLAKSGCN-AITMHI  490 (552)
Q Consensus       415 ~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~~~~-~~~~~~  490 (552)
                      .+++...  ....+++..++.++.|++.||+|||+.+   |+||||||+|||++.++ .+||+|||+++.... ......
T Consensus       154 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~  230 (440)
T PTZ00036        154 HKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY  230 (440)
T ss_pred             HHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccccchhccCCCCcccC
Confidence            7766532  2345899999999999999999999999   99999999999998665 699999999975432 222345


Q ss_pred             cccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          491 VGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       491 ~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .+|+.|+|||++.+ ..++.++|||||||++|||++|++||.+..
T Consensus       231 ~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~  275 (440)
T PTZ00036        231 ICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQS  275 (440)
T ss_pred             CCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            78999999998765 468999999999999999999999998654

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.97  E-value=6.8e-30  Score=250.18  Aligned_cols=184  Identities=32%  Similarity=0.495  Sum_probs=160.8

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|.+|.||++..  +++.|++|.++..         ..+|++++++++|+|++++++++.+  +...+++|||+++++|
T Consensus         9 ~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L   86 (256)
T cd08529           9 GKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD--KGKLNIVMEYAENGDL   86 (256)
T ss_pred             cCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc--CCEEEEEEEeCCCCcH
Confidence            6677799999987  6889999987532         2368999999999999999999887  6788999999999999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--ccccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIVG  492 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~g  492 (552)
                      .+++.......+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......  ......+
T Consensus        87 ~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~  163 (256)
T cd08529          87 HKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVG  163 (256)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccchhhcccc
Confidence            99998765556999999999999999999999998   999999999999999999999999998754322  1223467


Q ss_pred             cccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       493 t~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ++.|+|||++.+..++.++|+||||+++|||++|+.||...+
T Consensus       164 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  205 (256)
T cd08529         164 TPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN  205 (256)
T ss_pred             CccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence            889999999999889999999999999999999999997654

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.97  E-value=6.6e-30  Score=250.72  Aligned_cols=184  Identities=30%  Similarity=0.455  Sum_probs=156.6

Q ss_pred             CCceEEEEEEEEee-cCcEEEEEEecc------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhh
Q 037224          345 EGCLIQGSVYKGNI-HGEVYAIKMMKW------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSW  417 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-~g~~vAvK~~~~------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~  417 (552)
                      .|.|.+|.||++.+ .+..+|+|.++.      .+.+|++++++++|+||+++++++.+  ....+++|||+++++|.++
T Consensus        12 lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~   89 (256)
T cd05059          12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK--QRPIFIVTEYMANGCLLNY   89 (256)
T ss_pred             hccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcC--CCceEEEEecCCCCCHHHH
Confidence            36777799999988 456899999864      24579999999999999999998876  5678999999999999999


Q ss_pred             hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccccc---cccc
Q 037224          418 LHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI---VGTQ  494 (552)
Q Consensus       418 l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~---~gt~  494 (552)
                      +..... .+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++...+......   .++.
T Consensus        90 l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  165 (256)
T cd05059          90 LRERKG-KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPV  165 (256)
T ss_pred             HHhccc-CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccccCCCCCCc
Confidence            876543 5899999999999999999999999   99999999999999999999999999875433222112   2345


Q ss_pred             cccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          495 GYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       495 ~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      .|+|||.+.+..++.++|+||||+++|||++ |+.||...+
T Consensus       166 ~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~  206 (256)
T cd05059         166 KWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS  206 (256)
T ss_pred             cccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCC
Confidence            7999999998899999999999999999999 899997543

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.7e-31  Score=256.43  Aligned_cols=192  Identities=28%  Similarity=0.443  Sum_probs=165.4

Q ss_pred             CCceEEEEEEEEeec--CcEEEEEEeccCh----------HHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNIH--GEVYAIKMMKWNA----------CEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~--g~~vAvK~~~~~~----------~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|.||.|..+...  .+.+|||+++++.          +.|-++|... +-|.+++++.+|..  -+.+|+||||+.|
T Consensus       357 lGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT--mDRLyFVMEyvnG  434 (683)
T KOG0696|consen  357 LGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT--MDRLYFVMEYVNG  434 (683)
T ss_pred             eccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh--hhheeeEEEEecC
Confidence            378888999999884  4689999998763          2466666665 56788899888876  5678999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCcc--CCCCcccc
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS--GCNAITMH  489 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~--~~~~~~~~  489 (552)
                      |+|.-.+++-.  .+.+..+..++.+|+-||-+||++|   |+.||||.+|||+|.+|.+||.|||+++.  .....+..
T Consensus       435 GDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TTkT  509 (683)
T KOG0696|consen  435 GDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTTKT  509 (683)
T ss_pred             chhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccccCCcceee
Confidence            99998887655  3889999999999999999999999   99999999999999999999999999974  33445667


Q ss_pred             ccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccCcccccchHHHHHHHh
Q 037224          490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYWREMK  549 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  549 (552)
                      .+||+.|+|||++....|+.++|+||+|++||||+.|+.||+++++      .+.++.++
T Consensus       510 FCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE------~elF~aI~  563 (683)
T KOG0696|consen  510 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE------DELFQAIM  563 (683)
T ss_pred             ecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHH
Confidence            8999999999999999999999999999999999999999998876      44555554

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.97  E-value=9.9e-30  Score=249.41  Aligned_cols=184  Identities=28%  Similarity=0.458  Sum_probs=157.1

Q ss_pred             CCceEEEEEEEEee-cCcEEEEEEecc------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhh
Q 037224          345 EGCLIQGSVYKGNI-HGEVYAIKMMKW------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSW  417 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-~g~~vAvK~~~~------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~  417 (552)
                      .|.|++|.||++.+ ++..+|+|.++.      ++.+|+.++++++|+||+++++++.+  +...+++|||+++++|.++
T Consensus        12 lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~iv~e~~~~~~L~~~   89 (256)
T cd05114          12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ--QKPLYIVTEFMENGCLLNY   89 (256)
T ss_pred             ecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEcc--CCCEEEEEEcCCCCcHHHH
Confidence            37777899999988 556899998753      23579999999999999999999876  5678999999999999999


Q ss_pred             hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcc---ccccccc
Q 037224          418 LHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT---MHIVGTQ  494 (552)
Q Consensus       418 l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~---~~~~gt~  494 (552)
                      +..... .+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||.++.......   ....++.
T Consensus        90 ~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~  165 (256)
T cd05114          90 LRQRQG-KLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPV  165 (256)
T ss_pred             HHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCCCch
Confidence            875443 4899999999999999999999999   99999999999999999999999999875432211   1223456


Q ss_pred             cccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          495 GYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       495 ~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      .|+|||.+.+..++.++|+||||+++|||++ |+.||...+
T Consensus       166 ~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~  206 (256)
T cd05114         166 KWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS  206 (256)
T ss_pred             hhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence            8999999988889999999999999999999 999997654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.97  E-value=7.4e-30  Score=250.98  Aligned_cols=184  Identities=27%  Similarity=0.467  Sum_probs=158.4

Q ss_pred             CceEEEEEEEEee-cCcEEEEEEeccC------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhhh
Q 037224          346 GCLIQGSVYKGNI-HGEVYAIKMMKWN------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL  418 (552)
Q Consensus       346 G~g~~G~Vy~~~~-~g~~vAvK~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l  418 (552)
                      |.|++|.||+|.. ++..||+|.++..      +.+|+.++++++|+||+++++.+.+  ....+++|||+++++|.+++
T Consensus        15 g~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l   92 (261)
T cd05072          15 GAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK--EEPIYIITEYMAKGSLLDFL   92 (261)
T ss_pred             CCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcC--CCCcEEEEecCCCCcHHHHH
Confidence            6777799999987 5678999987643      3469999999999999999998876  56789999999999999999


Q ss_pred             hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcc---cccccccc
Q 037224          419 HENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT---MHIVGTQG  495 (552)
Q Consensus       419 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~---~~~~gt~~  495 (552)
                      .......+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++........   ....++..
T Consensus        93 ~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~  169 (261)
T cd05072          93 KSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK  169 (261)
T ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCceeccCCCcccee
Confidence            7765556899999999999999999999998   99999999999999999999999999975433221   12335668


Q ss_pred             ccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          496 YIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       496 y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      |+|||.+....++.++||||||+++|||++ |+.||....
T Consensus       170 y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~  209 (261)
T cd05072         170 WTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS  209 (261)
T ss_pred             cCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC
Confidence            999999988889999999999999999998 999997543

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.97  E-value=6.1e-30  Score=265.18  Aligned_cols=184  Identities=29%  Similarity=0.444  Sum_probs=154.5

Q ss_pred             CCceEEEEEEEEee-------cCcEEEEEEeccC--------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEee
Q 037224          345 EGCLIQGSVYKGNI-------HGEVYAIKMMKWN--------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEY  408 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-------~g~~vAvK~~~~~--------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~  408 (552)
                      .|.|+||.||++++       .+..||||+++..        ..+|+.++..+ +||||++++++|.+  ....++||||
T Consensus        43 LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~--~~~~~lv~E~  120 (375)
T cd05104          43 LGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV--GGPTLVITEY  120 (375)
T ss_pred             ecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc--CCcceeeehh
Confidence            37778899999974       3458999998642        34799999999 89999999999977  5678999999


Q ss_pred             ccCCCchhhhhhcC------------------------------------------------------------------
Q 037224          409 IENGSLHSWLHENK------------------------------------------------------------------  422 (552)
Q Consensus       409 ~~~gsL~~~l~~~~------------------------------------------------------------------  422 (552)
                      +++|+|.+++....                                                                  
T Consensus       121 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (375)
T cd05104         121 CCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVT  200 (375)
T ss_pred             ccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccH
Confidence            99999999886432                                                                  


Q ss_pred             -------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccc----ccc
Q 037224          423 -------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM----HIV  491 (552)
Q Consensus       423 -------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~----~~~  491 (552)
                             ...+++..++.++.|+++||+|||+.+   ++||||||+|||++.++.+||+|||+++........    ...
T Consensus       201 ~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~  277 (375)
T cd05104         201 SEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNAR  277 (375)
T ss_pred             HHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCC
Confidence                   124788999999999999999999998   999999999999999999999999998754322211    123


Q ss_pred             ccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCcc
Q 037224          492 GTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEE  533 (552)
Q Consensus       492 gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~  533 (552)
                      ++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus       278 ~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~  320 (375)
T cd05104         278 LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM  320 (375)
T ss_pred             CCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCC
Confidence            4567999999999999999999999999999998 89999754

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.97  E-value=9.4e-30  Score=256.92  Aligned_cols=183  Identities=25%  Similarity=0.459  Sum_probs=155.4

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      .|.|++|.||+++.  .++.||+|.++..        ..+|+.++++++|+||+++++++..  +...++||||+++ +|
T Consensus        14 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~-~l   90 (309)
T cd07872          14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT--DKSLTLVFEYLDK-DL   90 (309)
T ss_pred             ecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEee--CCeEEEEEeCCCC-CH
Confidence            37777899999987  6789999998532        3479999999999999999999987  6678999999985 88


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--ccccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIVG  492 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~g  492 (552)
                      .+++.... ..+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++......  ......+
T Consensus        91 ~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  166 (309)
T cd07872          91 KQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV  166 (309)
T ss_pred             HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCccccccccc
Confidence            88776543 34889999999999999999999998   999999999999999999999999998743221  1223467


Q ss_pred             cccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          493 TQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       493 t~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ++.|+|||.+.+ ..++.++||||||+++|||+||+.||...+
T Consensus       167 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~  209 (309)
T cd07872         167 TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGST  209 (309)
T ss_pred             cccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            889999998764 568899999999999999999999998654

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.97  E-value=9.7e-30  Score=253.22  Aligned_cols=185  Identities=32%  Similarity=0.569  Sum_probs=156.4

Q ss_pred             CCceEEEEEEEEeecC-------cEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeec
Q 037224          345 EGCLIQGSVYKGNIHG-------EVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI  409 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~g-------~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~  409 (552)
                      .|.|++|.||+|...+       ..||+|.++..        +.+|+.++.+++|+||+++++++.+  ....+++|||+
T Consensus        13 lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~~~~~~~~e~~   90 (283)
T cd05048          13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK--EQPTCMLFEYL   90 (283)
T ss_pred             ccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC--CCceEEEEecC
Confidence            3677779999998732       56999998642        3479999999999999999999876  56789999999


Q ss_pred             cCCCchhhhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEee
Q 037224          410 ENGSLHSWLHENKN--------------ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIAN  475 (552)
Q Consensus       410 ~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~D  475 (552)
                      ++++|.+++.....              ..+++.+++.++.|++.||.|||+.+   ++|+||||+||++++++.++|+|
T Consensus        91 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~L~d  167 (283)
T cd05048          91 AHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISD  167 (283)
T ss_pred             CCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCcEEECC
Confidence            99999999875421              35889999999999999999999999   99999999999999999999999


Q ss_pred             ccCCccCCCC----ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          476 FGLAKSGCNA----ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       476 fg~a~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      ||+++.....    ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.+..
T Consensus       168 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~  231 (283)
T cd05048         168 FGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS  231 (283)
T ss_pred             CcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            9998743221    1223455788999999988899999999999999999998 999997643

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.97  E-value=5.8e-30  Score=281.90  Aligned_cols=183  Identities=28%  Similarity=0.365  Sum_probs=157.1

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|++|.||+|..  .|+.||+|+++.+          +.+|++++++++||||+++++++.+  ++..+++|||+++++
T Consensus        11 GkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d--~~~lyLVMEY~eGGS   88 (932)
T PRK13184         11 GKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD--GDPVYYTMPYIEGYT   88 (932)
T ss_pred             ecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee--CCEEEEEEEcCCCCC
Confidence            7778899999987  6889999998532          3479999999999999999999877  668899999999999


Q ss_pred             chhhhhhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC
Q 037224          414 LHSWLHENK---------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN  484 (552)
Q Consensus       414 L~~~l~~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  484 (552)
                      |.+++....         ...+++..++.++.|+++||+|||+++   |+||||||+||+++.++.++|+|||++.....
T Consensus        89 L~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~  165 (932)
T PRK13184         89 LKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKL  165 (932)
T ss_pred             HHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCcceeccc
Confidence            999886421         123667788999999999999999998   99999999999999999999999999874310


Q ss_pred             C--------------------ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          485 A--------------------ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       485 ~--------------------~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      .                    ......||+.|+|||.+.+..++.++|||||||++|||+||+.||...
T Consensus       166 ~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~  234 (932)
T PRK13184        166 EEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK  234 (932)
T ss_pred             ccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence            0                    011246899999999999999999999999999999999999999754

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=5.3e-31  Score=247.32  Aligned_cols=186  Identities=29%  Similarity=0.471  Sum_probs=159.0

Q ss_pred             CCceEEEEEEEEee----c--CcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeec
Q 037224          345 EGCLIQGSVYKGNI----H--GEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI  409 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~----~--g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~  409 (552)
                      .|.|.+|.||++..    +  ...+|+|.++.+         ..+|+.+++.++|+|++.+..++... +...|+++||.
T Consensus        32 Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d~~v~l~fdYA  110 (438)
T KOG0666|consen   32 IGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH-DKKVWLLFDYA  110 (438)
T ss_pred             ecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-CceEEEEehhh
Confidence            47788899999965    2  237999998755         45999999999999999999998765 77899999999


Q ss_pred             cCCCchhhhhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCC----CcEEEeeccCCccC
Q 037224          410 ENGSLHSWLHENKN---ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN----MRAKIANFGLAKSG  482 (552)
Q Consensus       410 ~~gsL~~~l~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~----~~~kL~Dfg~a~~~  482 (552)
                      +. +|.+.++.+..   ..++...+..|+.||+.|+.|||++.   |.||||||.|||+..+    |++||+|||+++..
T Consensus       111 Eh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~  186 (438)
T KOG0666|consen  111 EH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADLGLARLF  186 (438)
T ss_pred             hh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeecccHHHHh
Confidence            87 89988865442   45889999999999999999999999   9999999999999777    89999999999865


Q ss_pred             CCCc-----cccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          483 CNAI-----TMHIVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       483 ~~~~-----~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      .+..     ....+-|.+|.|||.+.+ ..|+++.||||.|||+.||+|-++.|.++++
T Consensus       187 ~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~  245 (438)
T KOG0666|consen  187 NNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREE  245 (438)
T ss_pred             hccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhh
Confidence            5432     223567899999999877 5589999999999999999999999986653

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.97  E-value=4.5e-30  Score=265.97  Aligned_cols=185  Identities=31%  Similarity=0.465  Sum_probs=154.8

Q ss_pred             CCceEEEEEEEEee-------cCcEEEEEEeccC--------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEee
Q 037224          345 EGCLIQGSVYKGNI-------HGEVYAIKMMKWN--------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEY  408 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-------~g~~vAvK~~~~~--------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~  408 (552)
                      .|.|++|.||++..       ++..||+|+++..        ..+|+.+++.+ +|+||+++++.|.+  ....++||||
T Consensus        46 LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~--~~~~~lv~ey  123 (374)
T cd05106          46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH--GGPVLVITEY  123 (374)
T ss_pred             ecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC--CCCeEEeHhh
Confidence            37777899999875       2347999998642        34799999999 89999999999977  5678999999


Q ss_pred             ccCCCchhhhhhcC------------------------------------------------------------------
Q 037224          409 IENGSLHSWLHENK------------------------------------------------------------------  422 (552)
Q Consensus       409 ~~~gsL~~~l~~~~------------------------------------------------------------------  422 (552)
                      +++|+|.+++....                                                                  
T Consensus       124 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  203 (374)
T cd05106         124 CCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDT  203 (374)
T ss_pred             ccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchhcc
Confidence            99999999885421                                                                  


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccc----cccccccc
Q 037224          423 --NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM----HIVGTQGY  496 (552)
Q Consensus       423 --~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~----~~~gt~~y  496 (552)
                        ..++++.++++++.|+++||+|||+++   ++||||||+|||+++++.+||+|||+++........    ...++..|
T Consensus       204 ~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y  280 (374)
T cd05106         204 EDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKW  280 (374)
T ss_pred             CCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccce
Confidence              124788999999999999999999998   999999999999999999999999998754322111    12345679


Q ss_pred             cCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          497 IAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       497 ~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      +|||++.+..++.++||||||+++|||++ |+.||....
T Consensus       281 ~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~  319 (374)
T cd05106         281 MAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL  319 (374)
T ss_pred             eCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccc
Confidence            99999998999999999999999999997 999997543

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.97  E-value=6.5e-30  Score=255.14  Aligned_cols=186  Identities=27%  Similarity=0.466  Sum_probs=156.4

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHc---CCCCccceeeeeecCC---CCeeEEEEe
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKV---NHGNLVKLEGFCIDPE---DANCYLIYE  407 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l---~h~niv~l~~~~~~~~---~~~~~lv~e  407 (552)
                      .|.|++|.||++..  +++.||+|.++..         ..+|+.+++.+   +|+||+++++++....   ....+++||
T Consensus         8 lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e   87 (288)
T cd07863           8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFE   87 (288)
T ss_pred             EeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEc
Confidence            37778899999987  6889999988532         23577777665   7999999999886422   345789999


Q ss_pred             eccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-c
Q 037224          408 YIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-I  486 (552)
Q Consensus       408 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-~  486 (552)
                      |+.+ +|.+++.......+++.++..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++...... .
T Consensus        88 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~  163 (288)
T cd07863          88 HVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA  163 (288)
T ss_pred             cccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccccccCccc
Confidence            9985 8988887655556899999999999999999999999   999999999999999999999999998754322 2


Q ss_pred             cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          487 TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       487 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .....++..|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~  211 (288)
T cd07863         164 LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS  211 (288)
T ss_pred             CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCC
Confidence            233567899999999988889999999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.97  E-value=1e-29  Score=248.69  Aligned_cols=184  Identities=26%  Similarity=0.457  Sum_probs=156.0

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      .|.|.+|.||+++.  +++.+|+|..+..        +.+|++++++++|+||+++++++.+  ....++||||+++++|
T Consensus         3 lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L   80 (252)
T cd05084           3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPIYIVMELVQGGDF   80 (252)
T ss_pred             cCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCCeEEEEeeccCCcH
Confidence            36777899999987  7889999987532        4579999999999999999999977  5678999999999999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcccc----c
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH----I  490 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~----~  490 (552)
                      .+++.... ..+++.+++.++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++..........    .
T Consensus        81 ~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  156 (252)
T cd05084          81 LTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK  156 (252)
T ss_pred             HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence            99986543 34899999999999999999999998   9999999999999999999999999987533221111    1


Q ss_pred             cccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       491 ~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      ..+..|+|||.+.++.++.++||||||+++|||++ |..||....
T Consensus       157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~  201 (252)
T cd05084         157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS  201 (252)
T ss_pred             CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccC
Confidence            22456999999988889999999999999999997 999986543

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.97  E-value=1.2e-29  Score=256.12  Aligned_cols=181  Identities=29%  Similarity=0.463  Sum_probs=159.1

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      |.|.+|.||++..  ++..+|+|.++.+        ..+|++++++++|+||+++++++.+  ++..+++|||+++++|.
T Consensus        10 g~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ey~~~~~L~   87 (308)
T cd06615          10 GAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLD   87 (308)
T ss_pred             cCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCEEEEEeeccCCCcHH
Confidence            6777799999987  6788999987533        3479999999999999999999987  67889999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccccccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHE-HTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ  494 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~gt~  494 (552)
                      +++....  .+++..+..++.|+++||.|||+ .+   ++|+||||+||+++.++.+||+|||++............++.
T Consensus        88 ~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  162 (308)
T cd06615          88 QVLKKAG--RIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR  162 (308)
T ss_pred             HHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccccccCCCCc
Confidence            9997653  48999999999999999999997 46   999999999999999999999999998755443344467889


Q ss_pred             cccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       495 ~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      .|+|||.+.+..++.++|+||||+++|||++|+.||...
T Consensus       163 ~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~  201 (308)
T cd06615         163 SYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPP  201 (308)
T ss_pred             CccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCc
Confidence            999999998888999999999999999999999999643

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.97  E-value=1.6e-29  Score=252.88  Aligned_cols=181  Identities=31%  Similarity=0.484  Sum_probs=160.0

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|++|.||++..  +++.+|+|.++..          ..+|++++++++|+||+++++++.+  +...+++|||+++++
T Consensus        10 g~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~~   87 (290)
T cd05580          10 GTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD--DSNLYLVMEYVPGGE   87 (290)
T ss_pred             ecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCeEEEEEecCCCCC
Confidence            6677799999988  6799999998532          2368999999999999999999877  678899999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcccccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT  493 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~gt  493 (552)
                      |.+++....  .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++...... .....++
T Consensus        88 L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~  161 (290)
T cd05580          88 LFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-TYTLCGT  161 (290)
T ss_pred             HHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC-CCCCCCC
Confidence            999987653  4899999999999999999999998   999999999999999999999999998765443 3345688


Q ss_pred             ccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       494 ~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +.|+|||.+.+...+.++|+||||+++|+|++|+.||...+
T Consensus       162 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  202 (290)
T cd05580         162 PEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN  202 (290)
T ss_pred             ccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999988888999999999999999999999997654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.97  E-value=9.3e-30  Score=259.11  Aligned_cols=187  Identities=21%  Similarity=0.295  Sum_probs=157.5

Q ss_pred             ccCCCceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          342 NFSEGCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       342 ~~~~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      .++.|.+.+|+||++..  +|+.||+|+++.+         ..+|+.+++.++||||+++++++..  +...++||||++
T Consensus         5 ~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e~~~   82 (327)
T cd08227           5 VIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DNELWVVTSFMA   82 (327)
T ss_pred             hccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE--CCEEEEEEeccC
Confidence            45667668899999987  7899999998643         2368999999999999999999987  678899999999


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC------
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN------  484 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~------  484 (552)
                      +++|.+++..+....+++..++.++.|++.||+|||+++   ++||||||+||+++.++.++++||+.......      
T Consensus        83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~  159 (327)
T cd08227          83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR  159 (327)
T ss_pred             CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence            999999997655455899999999999999999999999   99999999999999999999999986532111      


Q ss_pred             ---CccccccccccccCccccCC--CCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          485 ---AITMHIVGTQGYIAPEYLAD--GVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       485 ---~~~~~~~gt~~y~aPE~~~~--~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                         .......++..|+|||.+.+  ..++.++|||||||++|||++|+.||...
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  213 (327)
T cd08227         160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM  213 (327)
T ss_pred             ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence               01112345678999999875  45889999999999999999999999753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.97  E-value=4.5e-31  Score=246.71  Aligned_cols=186  Identities=23%  Similarity=0.361  Sum_probs=162.1

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC--hHHHHHHHHHc-CCCCccceeeeeecCC--CCeeEEEEeeccCCCchhh
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN--ACEELKILQKV-NHGNLVKLEGFCIDPE--DANCYLIYEYIENGSLHSW  417 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~--~~~E~~~l~~l-~h~niv~l~~~~~~~~--~~~~~lv~e~~~~gsL~~~  417 (552)
                      .|-|..|.|.....  .++.+|+|++...  ..+|+++--.. .|+|||.+++++...-  ...+.+|||+|+||.|.+.
T Consensus        70 LG~GinGkV~~C~~k~T~ekfALKvL~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsr  149 (400)
T KOG0604|consen   70 LGAGINGKVVQCVHKRTQEKFALKVLLDSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSR  149 (400)
T ss_pred             hccccCCceEEEEeccchhhhHHHHHhcCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHH
Confidence            47778899887765  8999999999644  56788876666 7999999999986532  3567899999999999999


Q ss_pred             hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECC---CCcEEEeeccCCccCC-CCcccccccc
Q 037224          418 LHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS---NMRAKIANFGLAKSGC-NAITMHIVGT  493 (552)
Q Consensus       418 l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kL~Dfg~a~~~~-~~~~~~~~gt  493 (552)
                      +..++...+++.++-.|+.||..|+.|||+.+   |.||||||+|+|...   +-.+||+|||+++... .......+.|
T Consensus       150 iq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~T  226 (400)
T KOG0604|consen  150 IQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFT  226 (400)
T ss_pred             HHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccccccccCCCccccCCccc
Confidence            99998888999999999999999999999999   999999999999964   4569999999998655 3344567889


Q ss_pred             ccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       494 ~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      +.|.|||++....|+...|+||+||++|-|++|.+||...
T Consensus       227 PyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~  266 (400)
T KOG0604|consen  227 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN  266 (400)
T ss_pred             ccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccccc
Confidence            9999999999999999999999999999999999999854

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.97  E-value=1.4e-29  Score=248.42  Aligned_cols=184  Identities=30%  Similarity=0.465  Sum_probs=157.0

Q ss_pred             CCceEEEEEEEEeecC-cEEEEEEeccC------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhh
Q 037224          345 EGCLIQGSVYKGNIHG-EVYAIKMMKWN------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSW  417 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~g-~~vAvK~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~  417 (552)
                      .|.|.+|.||.+.+.+ ..+|+|.++..      +.+|+.++++++||||+++++++.+  ....+++|||+.+++|.++
T Consensus        12 lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~l~~~   89 (256)
T cd05113          12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK--QRPIYIVTEYMSNGCLLNY   89 (256)
T ss_pred             ecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEcc--CCCcEEEEEcCCCCcHHHH
Confidence            4778889999998844 46999988643      3579999999999999999999876  5567999999999999999


Q ss_pred             hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccc---cccccc
Q 037224          418 LHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM---HIVGTQ  494 (552)
Q Consensus       418 l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~---~~~gt~  494 (552)
                      +..... .+++.+++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||.++........   ...++.
T Consensus        90 i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~  165 (256)
T cd05113          90 LREHGK-RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPV  165 (256)
T ss_pred             HHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCccCh
Confidence            876443 5899999999999999999999998   999999999999999999999999998744322211   123456


Q ss_pred             cccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          495 GYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       495 ~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      .|++||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       166 ~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~  206 (256)
T cd05113         166 RWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN  206 (256)
T ss_pred             hhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence            7999999988889999999999999999998 999997543

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.97  E-value=1.5e-29  Score=248.20  Aligned_cols=184  Identities=29%  Similarity=0.485  Sum_probs=159.2

Q ss_pred             CCceEEEEEEEEeecCcEEEEEEeccC-----hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhhhh
Q 037224          345 EGCLIQGSVYKGNIHGEVYAIKMMKWN-----ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLH  419 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~g~~vAvK~~~~~-----~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~  419 (552)
                      .|.|++|.||++...|..+|+|..+.+     +.+|+.++++++|+|++++++++... +...++++||+++++|.+++.
T Consensus        14 lg~g~~~~v~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~   92 (256)
T cd05082          14 IGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVTEYMAKGSLVDYLR   92 (256)
T ss_pred             ecccCCCeEEEEEEcCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcC-CCceEEEEECCCCCcHHHHHH
Confidence            367777999999999999999998754     34799999999999999999977542 456799999999999999998


Q ss_pred             hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccccccccccccCc
Q 037224          420 ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAP  499 (552)
Q Consensus       420 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~gt~~y~aP  499 (552)
                      ......+++..++.++.|++.||+|||+++   ++||||||+||++++++.+||+|||++....... .....+..|+||
T Consensus        93 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~y~aP  168 (256)
T cd05082          93 SRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPVKWTAP  168 (256)
T ss_pred             hcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC-CCCccceeecCH
Confidence            766556899999999999999999999998   9999999999999999999999999987543222 223445689999


Q ss_pred             cccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCcc
Q 037224          500 EYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEE  533 (552)
Q Consensus       500 E~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~  533 (552)
                      |.+....++.++||||||+++|||++ |+.||...
T Consensus       169 E~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~  203 (256)
T cd05082         169 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI  203 (256)
T ss_pred             HHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            99988889999999999999999997 99998754

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.97  E-value=9.5e-30  Score=262.97  Aligned_cols=183  Identities=25%  Similarity=0.374  Sum_probs=155.4

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCC----CCeeEEEEeec
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPE----DANCYLIYEYI  409 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~~~lv~e~~  409 (552)
                      .|.|++|.||++..  .++.||||+++..         ..+|+.+++.++|+||+++++++....    ....++||||+
T Consensus        32 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~  111 (364)
T cd07875          32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM  111 (364)
T ss_pred             eecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCC
Confidence            37777899999987  6889999998632         236899999999999999999875422    23579999999


Q ss_pred             cCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-ccc
Q 037224          410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-ITM  488 (552)
Q Consensus       410 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-~~~  488 (552)
                      ++ +|.+++..    .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++..... ...
T Consensus       112 ~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~  183 (364)
T cd07875         112 DA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT  183 (364)
T ss_pred             CC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCccccCCCCccc
Confidence            76 77776643    3888999999999999999999998   999999999999999999999999999754332 223


Q ss_pred             cccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          489 HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       489 ~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      ...++..|+|||.+.+..++.++|||||||++|||++|+.||...+.
T Consensus       184 ~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  230 (364)
T cd07875         184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH  230 (364)
T ss_pred             CCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH
Confidence            45789999999999999999999999999999999999999986553

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.97  E-value=2.2e-29  Score=247.30  Aligned_cols=183  Identities=26%  Similarity=0.397  Sum_probs=153.4

Q ss_pred             CCceEEEEEEEEee----cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI----HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~----~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|.|++|.||+|.+    .+..||+|+++..        +.+|+.++++++|+||+++++++..   ...++||||++++
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~lv~e~~~~~   79 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA---EALMLVMEMASGG   79 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC---CCeEEEEEeCCCC
Confidence            57788899999976    3457999988543        3478999999999999999998753   4679999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc-----c
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI-----T  487 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-----~  487 (552)
                      +|.+++.... ..+++.+++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++.......     .
T Consensus        80 ~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          80 PLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            9999987543 35899999999999999999999998   9999999999999999999999999987432211     1


Q ss_pred             ccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          488 MHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       488 ~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      ....++..|+|||.+....++.++||||||+++|||++ |+.||.+..
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  203 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK  203 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC
Confidence            11223568999999988889999999999999999996 999997543

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.97  E-value=1.3e-29  Score=256.83  Aligned_cols=183  Identities=28%  Similarity=0.461  Sum_probs=154.0

Q ss_pred             CCceEEEEEEEEee--cCc----EEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          345 EGCLIQGSVYKGNI--HGE----VYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~----~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      .|.|.+|.||+|++  +++    .||+|.++..        +.+|+.+++.++|+||++++++|..   ...++++||++
T Consensus        15 lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~---~~~~~v~e~~~   91 (316)
T cd05108          15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---STVQLITQLMP   91 (316)
T ss_pred             eecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC---CCceeeeecCC
Confidence            47777899999986  344    3899998532        3468899999999999999999875   24579999999


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcc---
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT---  487 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~---  487 (552)
                      +|+|.+++.... ..+++..++.++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||+++.......   
T Consensus        92 ~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  167 (316)
T cd05108          92 FGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYH  167 (316)
T ss_pred             CCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccCCCccee
Confidence            999999987654 34889999999999999999999998   99999999999999999999999999985432211   


Q ss_pred             -ccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          488 -MHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       488 -~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                       .....+..|+|||.+.+..++.++||||||+++|||++ |+.||++..
T Consensus       168 ~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~  216 (316)
T cd05108         168 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP  216 (316)
T ss_pred             ccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence             11233568999999999999999999999999999998 999997643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.97  E-value=1.9e-29  Score=250.80  Aligned_cols=177  Identities=28%  Similarity=0.478  Sum_probs=155.9

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      .|.|.+|.||++..  +++.||+|....+        +.+|++++++++|+|++++++++..  +...+++|||+++++|
T Consensus         9 lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~l   86 (279)
T cd06619           9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV--ENRISICTEFMDGGSL   86 (279)
T ss_pred             eccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE--CCEEEEEEecCCCCCh
Confidence            36777799999987  7889999998533        3469999999999999999999987  6678999999999998


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccccccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ  494 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~gt~  494 (552)
                      ..+.      .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++............++.
T Consensus        87 ~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  157 (279)
T cd06619          87 DVYR------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTN  157 (279)
T ss_pred             HHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCCCCCh
Confidence            6542      3788899999999999999999999   999999999999999999999999999765444444567899


Q ss_pred             cccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       495 ~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                      .|+|||.+.+..++.++|+||||+++|||++|+.||..
T Consensus       158 ~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~  195 (279)
T cd06619         158 AYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ  195 (279)
T ss_pred             hhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence            99999999988999999999999999999999999975

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.97  E-value=8.9e-30  Score=263.93  Aligned_cols=185  Identities=27%  Similarity=0.386  Sum_probs=155.1

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCC---CeeEEEEeecc
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPED---ANCYLIYEYIE  410 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~~~lv~e~~~  410 (552)
                      .|.|++|.||++..  +|+.||+|.+...         ..+|+.+++.++|+||+++++++.....   ...++|+||+.
T Consensus         8 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~   87 (372)
T cd07853           8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ   87 (372)
T ss_pred             eeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc
Confidence            37788899999986  7899999988532         3479999999999999999999876321   26799999997


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC---cc
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA---IT  487 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~---~~  487 (552)
                       ++|.+++....  .+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++.....   ..
T Consensus        88 -~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~  161 (372)
T cd07853          88 -SDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHM  161 (372)
T ss_pred             -cCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecccCccccC
Confidence             47887775443  4899999999999999999999999   999999999999999999999999998743321   12


Q ss_pred             ccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          488 MHIVGTQGYIAPEYLADG-VVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       488 ~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      ....+++.|+|||.+.+. .++.++|||||||++|||++|+.||...+.
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~  210 (372)
T cd07853         162 TQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP  210 (372)
T ss_pred             CCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH
Confidence            234678899999998764 478999999999999999999999986653

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=1e-29  Score=265.12  Aligned_cols=181  Identities=21%  Similarity=0.293  Sum_probs=156.0

Q ss_pred             CceEEEEEEEEee----cCcEEEEEEeccC--hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhhhh
Q 037224          346 GCLIQGSVYKGNI----HGEVYAIKMMKWN--ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLH  419 (552)
Q Consensus       346 G~g~~G~Vy~~~~----~g~~vAvK~~~~~--~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~  419 (552)
                      |.|.+|.||++..    .+..|++|.+...  ..+|++++++++|+||+++++++..  +...+++||++. ++|.+++.
T Consensus       101 g~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~-~~l~~~l~  177 (392)
T PHA03207        101 TPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRW--KSTVCMVMPKYK-CDLFTYVD  177 (392)
T ss_pred             cCCCCeEEEEEEEcCCccceeEEEEeccccccHHHHHHHHHhcCCCCccceeeeEee--CCEEEEEehhcC-CCHHHHHH
Confidence            6777799999875    3468999998643  4589999999999999999998876  667899999986 58888884


Q ss_pred             hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC----cccccccccc
Q 037224          420 ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA----ITMHIVGTQG  495 (552)
Q Consensus       420 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~----~~~~~~gt~~  495 (552)
                      ..  ..+++.+++.++.|++.||.|||+++   |+||||||+|||++.++.++|+|||++......    ......||+.
T Consensus       178 ~~--~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~  252 (392)
T PHA03207        178 RS--GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLE  252 (392)
T ss_pred             hc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccC
Confidence            33  35999999999999999999999999   999999999999999999999999998743322    1223578999


Q ss_pred             ccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          496 YIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       496 y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      |+|||++....++.++|||||||++|||++|+.||.+..
T Consensus       253 y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~  291 (392)
T PHA03207        253 TNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ  291 (392)
T ss_pred             ccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence            999999998999999999999999999999999997654

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.97  E-value=2.3e-29  Score=247.05  Aligned_cols=181  Identities=30%  Similarity=0.454  Sum_probs=153.6

Q ss_pred             CCceEEEEEEEEee----cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI----HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~----~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|++|.||+|.+    ++..+|+|+++..         +.+|+.++++++|+||+++++++..   ...+++|||+++
T Consensus         3 lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~lv~e~~~~   79 (257)
T cd05116           3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA---ESWMLVMELAEL   79 (257)
T ss_pred             CCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCcEEEEecCCC
Confidence            47777899999965    5688999998532         3468999999999999999998753   456899999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcc----
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT----  487 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~----  487 (552)
                      ++|.+++....  .+++..++.++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++........    
T Consensus        80 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          80 GPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            99999987543  4899999999999999999999999   99999999999999999999999999875432211    


Q ss_pred             -ccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCcc
Q 037224          488 -MHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEE  533 (552)
Q Consensus       488 -~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~  533 (552)
                       ....++..|+|||.+....++.++|+||||+++|||++ |+.||...
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  202 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM  202 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence             11233578999999988889999999999999999998 99999754

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.97  E-value=1.3e-29  Score=248.55  Aligned_cols=181  Identities=36%  Similarity=0.601  Sum_probs=160.5

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccCh---------HHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWNA---------CEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~~---------~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|++|+||+++.  +++.+|+|++....         .+|+.++++++|+||+++++++.+  ....+++|||+++++|
T Consensus         8 g~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~v~~~~~~~~L   85 (260)
T PF00069_consen    8 GSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD--DNYLYIVMEYCPGGSL   85 (260)
T ss_dssp             EEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE--SSEEEEEEEEETTEBH
T ss_pred             EeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc--cccccccccccccccc
Confidence            7788899999998  56789999996542         248899999999999999999988  7788999999999999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCcc--CCCCccccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS--GCNAITMHIVG  492 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~--~~~~~~~~~~g  492 (552)
                      .+++....  .+++.+++.++.|+++||++||+.+   ++|+||||+||+++.++.++|+|||.+..  ..........+
T Consensus        86 ~~~l~~~~--~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~  160 (260)
T PF00069_consen   86 QDYLQKNK--PLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFVG  160 (260)
T ss_dssp             HHHHHHHS--SBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSSS
T ss_pred             cccccccc--ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccccc
Confidence            99998333  4899999999999999999999999   99999999999999999999999999874  23334445678


Q ss_pred             cccccCccccC-CCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          493 TQGYIAPEYLA-DGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       493 t~~y~aPE~~~-~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      +..|+|||.+. ....+.++|+||+|+++|+|++|..||.+.
T Consensus       161 ~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~  202 (260)
T PF00069_consen  161 TPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES  202 (260)
T ss_dssp             SGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999998 888999999999999999999999999976

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=2.1e-29  Score=265.60  Aligned_cols=180  Identities=21%  Similarity=0.304  Sum_probs=154.9

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEec-cChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhhhhhcC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMK-WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENK  422 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~  422 (552)
                      |.|.+|.||++..  .++.||||... ....+|++++++++|+||+++++++..  ++..+++||++. ++|.+++....
T Consensus       178 g~G~~G~Vy~a~~~~~~~~vavK~~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~--~~~~~lv~e~~~-~~L~~~l~~~~  254 (461)
T PHA03211        178 TPGSEGCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVV--GGLTCLVLPKYR-SDLYTYLGARL  254 (461)
T ss_pred             ccCCCeEEEEEEECCCCCEEEEecccccCHHHHHHHHHHCCCCCCCcEEEEEEE--CCEEEEEEEccC-CCHHHHHHhcC
Confidence            6778899999998  57889999753 345689999999999999999999877  667899999995 58888876543


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC----ccccccccccccC
Q 037224          423 NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA----ITMHIVGTQGYIA  498 (552)
Q Consensus       423 ~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~----~~~~~~gt~~y~a  498 (552)
                       ..+++.+++.|+.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.....    ......||..|+|
T Consensus       255 -~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~A  330 (461)
T PHA03211        255 -RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNA  330 (461)
T ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcC
Confidence             25999999999999999999999999   999999999999999999999999998753221    1123568999999


Q ss_pred             ccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          499 PEYLADGVVSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       499 PE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                      ||++.+..++.++|||||||++|||++|..|+..
T Consensus       331 PE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~  364 (461)
T PHA03211        331 PEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFS  364 (461)
T ss_pred             HHHHcCCCCCchHHHHHHHHHHHHHHHcCCCccc
Confidence            9999999999999999999999999998876543

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=3.1e-29  Score=245.81  Aligned_cols=184  Identities=31%  Similarity=0.514  Sum_probs=161.2

Q ss_pred             CCceEEEEEEEEeecCcEEEEEEeccCh------HHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhhh
Q 037224          345 EGCLIQGSVYKGNIHGEVYAIKMMKWNA------CEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL  418 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~g~~vAvK~~~~~~------~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l  418 (552)
                      .|.|.+|.||++...|+.||+|.++...      .+|+.++++++|+|++++++++.+  ....+++|||+++++|.+++
T Consensus        14 ig~g~~g~v~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~   91 (256)
T cd05039          14 IGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ--GNPLYIVTEYMAKGSLVDYL   91 (256)
T ss_pred             eecCCCceEEEEEecCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcC--CCCeEEEEEecCCCcHHHHH
Confidence            3777789999999999999999996543      369999999999999999999887  66789999999999999999


Q ss_pred             hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccccccccccccC
Q 037224          419 HENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIA  498 (552)
Q Consensus       419 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~gt~~y~a  498 (552)
                      .......+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||.++....... ....+..|+|
T Consensus        92 ~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~a  167 (256)
T cd05039          92 RSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-SGKLPVKWTA  167 (256)
T ss_pred             HhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-cCCCcccccC
Confidence            7765446999999999999999999999999   99999999999999999999999999976533222 2344567999


Q ss_pred             ccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          499 PEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       499 PE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      ||.+....++.++|+||||+++|||++ |+.||....
T Consensus       168 pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~  204 (256)
T cd05039         168 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP  204 (256)
T ss_pred             chhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC
Confidence            999988889999999999999999997 999987553

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4e-30  Score=255.28  Aligned_cols=184  Identities=24%  Similarity=0.404  Sum_probs=158.2

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccCh---------HHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWNA---------CEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~~---------~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|-|..|-.++.  .|+.||||++.+..         .+|+..|+.++||||++++++.-.  ...+|||+|.-++|+|
T Consensus        27 G~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT--QTKlyLiLELGD~GDl  104 (864)
T KOG4717|consen   27 GRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT--QTKLYLILELGDGGDL  104 (864)
T ss_pred             cCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc--cceEEEEEEecCCchH
Confidence            5555566766654  99999999996543         379999999999999999988755  6788999999999999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE-CCCCcEEEeeccCCccCC-CCccccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL-DSNMRAKIANFGLAKSGC-NAITMHIVG  492 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll-~~~~~~kL~Dfg~a~~~~-~~~~~~~~g  492 (552)
                      .+|+..+.. .+.+..+.+++.||+.|+.|+|+.+   +|||||||+|+.+ ..-|-+||.|||++.... .......+|
T Consensus       105 ~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~TsCG  180 (864)
T KOG4717|consen  105 FDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTSCG  180 (864)
T ss_pred             HHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcchhhcccc
Confidence            999987754 4999999999999999999999998   9999999999977 567889999999997443 334456799


Q ss_pred             cccccCccccCCCCCC-ChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          493 TQGYIAPEYLADGVVS-TKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       493 t~~y~aPE~~~~~~~s-~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      +..|-|||++.+..|+ ++.||||||||||-|++|+.||...++
T Consensus       181 SLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND  224 (864)
T KOG4717|consen  181 SLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND  224 (864)
T ss_pred             hhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc
Confidence            9999999999988875 688999999999999999999997553

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.97  E-value=1.9e-29  Score=248.77  Aligned_cols=183  Identities=26%  Similarity=0.400  Sum_probs=157.1

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC------------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN------------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~------------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      |.|.+|.||++..  +++.||+|.++..            ..+|+.++++++|+||+++++++.+.....++++|||+++
T Consensus        11 ~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~   90 (265)
T cd06652          11 GQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPG   90 (265)
T ss_pred             ecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCC
Confidence            6677799999987  6889999987421            2358999999999999999998876555678899999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC-----Cc
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN-----AI  486 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~-----~~  486 (552)
                      ++|.+++....  .+++..++.++.|++.+|+|||+.+   ++|+||+|+||+++.++.++|+|||++.....     ..
T Consensus        91 ~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  165 (265)
T cd06652          91 GSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTG  165 (265)
T ss_pred             CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccccccccccccc
Confidence            99999987643  3889999999999999999999999   99999999999999999999999999874321     11


Q ss_pred             cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          487 TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       487 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      .....++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       166 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~  212 (265)
T cd06652         166 MKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF  212 (265)
T ss_pred             cccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence            22346788999999998888999999999999999999999999754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.97  E-value=1.9e-29  Score=251.21  Aligned_cols=183  Identities=32%  Similarity=0.458  Sum_probs=155.9

Q ss_pred             CCceEEEEEEEEee------cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          345 EGCLIQGSVYKGNI------HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~------~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      .|.|++|.||++..      +++.||+|.++..        +.+|++++++++|+||+++++++........+++|||++
T Consensus        12 lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~   91 (283)
T cd05080          12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVP   91 (283)
T ss_pred             cccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCC
Confidence            37777899987653      5778999998642        246999999999999999999987755567899999999


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcc---
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT---  487 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~---  487 (552)
                      +++|.+++....   +++.+++.++.|++.||.|||+++   ++||||||+||++++++.++|+|||++........   
T Consensus        92 ~~~l~~~~~~~~---l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~  165 (283)
T cd05080          92 LGSLRDYLPKHK---LNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR  165 (283)
T ss_pred             CCCHHHHHHHcC---CCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCCcchhhc
Confidence            999999987643   999999999999999999999998   99999999999999999999999999875432211   


Q ss_pred             --ccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          488 --MHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       488 --~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                        ....++..|+|||.+.+..++.++||||||+++|||++|..||...
T Consensus       166 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~  213 (283)
T cd05080         166 VREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP  213 (283)
T ss_pred             cCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence              1223456799999998888999999999999999999999998643

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.97  E-value=2.2e-29  Score=250.13  Aligned_cols=185  Identities=29%  Similarity=0.491  Sum_probs=156.8

Q ss_pred             CCceEEEEEEEEeec-------CcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeec
Q 037224          345 EGCLIQGSVYKGNIH-------GEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI  409 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~-------g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~  409 (552)
                      .|.|++|.||+|...       ++.||+|.++..        +.+|++++++++|+|++++++++..  ....+++|||+
T Consensus        13 lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~   90 (280)
T cd05049          13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE--GDPPIMVFEYM   90 (280)
T ss_pred             ccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec--CCCeEEEEecC
Confidence            366777999999762       368999998542        3469999999999999999999987  56789999999


Q ss_pred             cCCCchhhhhhcC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeecc
Q 037224          410 ENGSLHSWLHENK------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFG  477 (552)
Q Consensus       410 ~~gsL~~~l~~~~------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg  477 (552)
                      ++++|.+++....            ...+++.++..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||
T Consensus        91 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~kl~d~g  167 (280)
T cd05049          91 EHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFG  167 (280)
T ss_pred             CCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeEEECCcc
Confidence            9999999987542            234789999999999999999999998   9999999999999999999999999


Q ss_pred             CCccCCCCc----cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          478 LAKSGCNAI----TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       478 ~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      ++.......    .....++..|+|||.+.+..+++++||||||+++|||++ |+.||...+
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~  229 (280)
T cd05049         168 MSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS  229 (280)
T ss_pred             cceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence            987432211    122345678999999999999999999999999999998 999997543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.97  E-value=1.9e-29  Score=278.98  Aligned_cols=189  Identities=25%  Similarity=0.428  Sum_probs=157.0

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|.||.||+++.  .++.+|+|.++..         +.+|+.++++++||||++++++|.+.....+|+||||+++++|
T Consensus        22 G~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL  101 (1021)
T PTZ00266         22 GNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDL  101 (1021)
T ss_pred             ecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcH
Confidence            7777899999988  6788999988532         3469999999999999999999877666788999999999999


Q ss_pred             hhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCC----CceEecCCCCCcEEECC-----------------CCcE
Q 037224          415 HSWLHENK--NENLNWKTRLRIAIDVANGLQYIHEHTR----PRVVHKDIKSSNILLDS-----------------NMRA  471 (552)
Q Consensus       415 ~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~----~~ivH~Dikp~NIll~~-----------------~~~~  471 (552)
                      .+++....  ...+++..++.|+.||+.||.|||+.+.    .+|+||||||+||||+.                 .+.+
T Consensus       102 ~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iV  181 (1021)
T PTZ00266        102 SRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA  181 (1021)
T ss_pred             HHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCce
Confidence            99987532  2359999999999999999999998542    23999999999999964                 2358


Q ss_pred             EEeeccCCccCCCC-ccccccccccccCccccCC--CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          472 KIANFGLAKSGCNA-ITMHIVGTQGYIAPEYLAD--GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       472 kL~Dfg~a~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ||+|||++...... ......||+.|+|||++..  ..++.++|||||||+||||+||+.||....
T Consensus       182 KLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        182 KIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             EEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence            99999999754322 2234578999999998854  458899999999999999999999997543

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.97  E-value=2.5e-29  Score=251.50  Aligned_cols=185  Identities=27%  Similarity=0.467  Sum_probs=156.7

Q ss_pred             CCceEEEEEEEEee-------cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          345 EGCLIQGSVYKGNI-------HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-------~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      .|.|++|.||+++.       ++..+++|.++..       +.+|+.++++++|+||+++++++.+  ....++||||++
T Consensus        13 lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~   90 (291)
T cd05094          13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGD--GDPLIMVFEYMK   90 (291)
T ss_pred             ecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc--CCceEEEEecCC
Confidence            36677899999975       3456899998643       4478999999999999999999976  567899999999


Q ss_pred             CCCchhhhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeec
Q 037224          411 NGSLHSWLHENKN--------------ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANF  476 (552)
Q Consensus       411 ~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Df  476 (552)
                      +++|.+++.....              ..+++..++.++.|++.||+|||+++   ++||||||+||+++.++.++|+||
T Consensus        91 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df  167 (291)
T cd05094          91 HGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDF  167 (291)
T ss_pred             CCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEECCC
Confidence            9999999875431              34899999999999999999999999   999999999999999999999999


Q ss_pred             cCCccCCCCc----cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          477 GLAKSGCNAI----TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       477 g~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      |++.......    .....++..|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus       168 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  230 (291)
T cd05094         168 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS  230 (291)
T ss_pred             CcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9987443221    122445778999999998999999999999999999999 999986543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=2.5e-29  Score=258.95  Aligned_cols=180  Identities=24%  Similarity=0.377  Sum_probs=154.5

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEecc-ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhhhhhcC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKW-NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENK  422 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~-~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~  422 (552)
                      |.|.+|.||+++.  .++.||+|+... ....|+.++++++|+||+++++++..  ....++|+|++. ++|.+++....
T Consensus        75 g~G~~g~Vy~~~~~~~~~~valK~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~-~~l~~~l~~~~  151 (357)
T PHA03209         75 TPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVS--GAITCMVLPHYS-SDLYTYLTKRS  151 (357)
T ss_pred             cCCCCeEEEEEEECCCCceEEEEeCCccccHHHHHHHHhCCCCCCcChhheEEe--CCeeEEEEEccC-CcHHHHHHhcc
Confidence            7778899999998  567899998643 34679999999999999999999987  567899999996 58888876543


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC-CccccccccccccCccc
Q 037224          423 NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN-AITMHIVGTQGYIAPEY  501 (552)
Q Consensus       423 ~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~-~~~~~~~gt~~y~aPE~  501 (552)
                       ..+++.+++.|+.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.... .......||..|+|||+
T Consensus       152 -~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~  227 (357)
T PHA03209        152 -RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEV  227 (357)
T ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCcccccccccccccCCee
Confidence             35899999999999999999999999   99999999999999999999999999974322 22234578999999999


Q ss_pred             cCCCCCCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          502 LADGVVSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       502 ~~~~~~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                      +.+..++.++|||||||++|||+++..|+..
T Consensus       228 ~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~  258 (357)
T PHA03209        228 LARDKYNSKADIWSAGIVLFEMLAYPSTIFE  258 (357)
T ss_pred             cCCCCCCchhhHHHHHHHHHHHHHcCCcccc
Confidence            9999999999999999999999986666543

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.97  E-value=1.1e-29  Score=261.54  Aligned_cols=182  Identities=25%  Similarity=0.372  Sum_probs=154.6

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCC----CCeeEEEEeec
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPE----DANCYLIYEYI  409 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~~~lv~e~~  409 (552)
                      .|.|++|.||++..  .++.||+|.++..         ..+|+.+++.++|+||+++++++....    ....+++|||+
T Consensus        25 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~  104 (355)
T cd07874          25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM  104 (355)
T ss_pred             eeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhh
Confidence            37788899999986  6889999998632         236899999999999999999886432    23579999999


Q ss_pred             cCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-ccc
Q 037224          410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-ITM  488 (552)
Q Consensus       410 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-~~~  488 (552)
                      ++ +|.+.+..    .+++..+..++.|+++||.|||+++   ++||||||+|||++.++.+||+|||+++..... ...
T Consensus       105 ~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  176 (355)
T cd07874         105 DA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT  176 (355)
T ss_pred             cc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccCCCccccC
Confidence            76 66666643    3889999999999999999999999   999999999999999999999999999754332 223


Q ss_pred             cccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          489 HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       489 ~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ...+|..|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus       177 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  222 (355)
T cd07874         177 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD  222 (355)
T ss_pred             CccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            4578999999999998899999999999999999999999998654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.97  E-value=2.1e-29  Score=250.53  Aligned_cols=182  Identities=27%  Similarity=0.385  Sum_probs=152.1

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccCh----------HHHHHHHH---HcCCCCccceeeeeecCCCCeeEEEEeec
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWNA----------CEELKILQ---KVNHGNLVKLEGFCIDPEDANCYLIYEYI  409 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~~----------~~E~~~l~---~l~h~niv~l~~~~~~~~~~~~~lv~e~~  409 (552)
                      .|.|.+|.||++..  +++.+|+|.++...          .+|..+++   ..+|+|++.+++.+..  ++..++||||+
T Consensus         2 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~   79 (279)
T cd05633           2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT--PDKLCFILDLM   79 (279)
T ss_pred             cccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec--CCeEEEEEecC
Confidence            37788899999987  67899999885321          23333333   3479999999988876  56789999999


Q ss_pred             cCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcccc
Q 037224          410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH  489 (552)
Q Consensus       410 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  489 (552)
                      ++++|.+++....  .+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||++..........
T Consensus        80 ~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~  154 (279)
T cd05633          80 NGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA  154 (279)
T ss_pred             CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccCccC
Confidence            9999999887654  4999999999999999999999999   9999999999999999999999999987544333334


Q ss_pred             ccccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          490 IVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      ..++..|+|||.+.. ..++.++|+||+|+++|||++|+.||...
T Consensus       155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  199 (279)
T cd05633         155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQH  199 (279)
T ss_pred             cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCC
Confidence            578999999998864 55789999999999999999999999754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3e-29  Score=246.76  Aligned_cols=182  Identities=27%  Similarity=0.423  Sum_probs=157.2

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC------------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN------------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~------------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      .|.|.+|.||++..  +++.+|+|.+...            ..+|+.++++++|+||+++++++.+  +...++++||++
T Consensus        10 lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~~~   87 (263)
T cd06625          10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD--DETLSIFMEYMP   87 (263)
T ss_pred             ecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc--CCeEEEEEEECC
Confidence            36777799999976  6899999987421            3368999999999999999999987  568899999999


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcc---
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT---  487 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~---  487 (552)
                      +++|.+++....  .+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++........   
T Consensus        88 ~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~  162 (263)
T cd06625          88 GGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGT  162 (263)
T ss_pred             CCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccccccccc
Confidence            999999887654  4889999999999999999999999   99999999999999999999999999864322111   


Q ss_pred             --ccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          488 --MHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       488 --~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                        ....++..|+|||.+.+..++.++||||||+++|||++|+.||.+.
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  210 (263)
T cd06625         163 GMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF  210 (263)
T ss_pred             cccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc
Confidence              2245778999999999888999999999999999999999999754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.96  E-value=3.2e-31  Score=247.47  Aligned_cols=193  Identities=29%  Similarity=0.478  Sum_probs=168.5

Q ss_pred             HHHHHHHhhccCCCceEEEEEEEEee--cCcEEEEEEeccC-----hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEE
Q 037224          333 IEELREATDNFSEGCLIQGSVYKGNI--HGEVYAIKMMKWN-----ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLI  405 (552)
Q Consensus       333 ~~~l~~~t~~~~~G~g~~G~Vy~~~~--~g~~vAvK~~~~~-----~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  405 (552)
                      .+|.....+++++|+.  |.||++..  .|+.+|+|.+.-+     ...|+.++++++.+++++++|.+..  ...+|+|
T Consensus        31 PEEVFDi~~KLGEGSY--GSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK--~sDLWIV  106 (502)
T KOG0574|consen   31 PEEVFDIVGKLGEGSY--GSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFK--HSDLWIV  106 (502)
T ss_pred             hHHHHHHHHHhcCCcc--hHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhcc--CCceEee
Confidence            4666677777766554  99999976  8999999998643     3479999999999999999998876  5678999


Q ss_pred             EeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC
Q 037224          406 YEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA  485 (552)
Q Consensus       406 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~  485 (552)
                      ||||..|+..+.++.+. +++++.++..+++..++||+|||...   -+|||||..|||++.+|.+||.|||.+....+.
T Consensus       107 MEYCGAGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT  182 (502)
T KOG0574|consen  107 MEYCGAGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT  182 (502)
T ss_pred             hhhcCCCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh
Confidence            99999999999887643 46999999999999999999999887   899999999999999999999999999754432


Q ss_pred             --ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          486 --ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       486 --~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                        ......||+.|||||++..-.|+.++||||||+...||..|++||.+-
T Consensus       183 MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDI  232 (502)
T KOG0574|consen  183 MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDI  232 (502)
T ss_pred             HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccc
Confidence              334578999999999999999999999999999999999999999854

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.96  E-value=4.4e-29  Score=249.37  Aligned_cols=185  Identities=26%  Similarity=0.468  Sum_probs=156.2

Q ss_pred             CCceEEEEEEEEee-------cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          345 EGCLIQGSVYKGNI-------HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-------~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      .|.|++|.||++..       ++..+|+|.++..       +.+|++++++++|+|++++++++..  ....+++|||++
T Consensus        13 lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~   90 (288)
T cd05093          13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE--GDPLIMVFEYMK   90 (288)
T ss_pred             cCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCccEEEEEcCC
Confidence            37777899999974       2456899998542       4479999999999999999999976  667899999999


Q ss_pred             CCCchhhhhhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCC
Q 037224          411 NGSLHSWLHENK-----------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLA  479 (552)
Q Consensus       411 ~gsL~~~l~~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  479 (552)
                      +++|.+++....           ...+++.+++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++
T Consensus        91 ~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~  167 (288)
T cd05093          91 HGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMS  167 (288)
T ss_pred             CCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEeccCCcc
Confidence            999999987543           124899999999999999999999998   999999999999999999999999998


Q ss_pred             ccCCCCc----cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          480 KSGCNAI----TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       480 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      +......    .....++..|+|||.+.+..++.++|+||||+++|||++ |+.||....
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~  227 (288)
T cd05093         168 RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS  227 (288)
T ss_pred             ccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            7443221    112334678999999998899999999999999999998 999987543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1e-30  Score=263.31  Aligned_cols=180  Identities=31%  Similarity=0.477  Sum_probs=158.5

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEecc----------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKW----------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~----------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|.||.||-+..  +.+.||||.+.-          +...|+.+|++++|||++.+-|+|..  +...|||||||-| +
T Consensus        35 GHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr--e~TaWLVMEYClG-S  111 (948)
T KOG0577|consen   35 GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR--EHTAWLVMEYCLG-S  111 (948)
T ss_pred             cCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec--cchHHHHHHHHhc-c
Confidence            6667799999987  788999999852          23479999999999999999999987  6678999999965 8


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcccccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT  493 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~gt  493 (552)
                      -.|++.-++. ++.+-++..|+.+.+.||+|||+.+   .||||||..|||+++.|.+||+|||.+.....  ...++||
T Consensus       112 AsDlleVhkK-plqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--AnsFvGT  185 (948)
T KOG0577|consen  112 ASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP--ANSFVGT  185 (948)
T ss_pred             HHHHHHHHhc-cchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc--hhcccCC
Confidence            8888876553 5899999999999999999999999   99999999999999999999999999876543  3458999


Q ss_pred             ccccCccccC---CCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          494 QGYIAPEYLA---DGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       494 ~~y~aPE~~~---~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      |.|||||++.   .+.|+-++||||||+...||...++|+.+.+
T Consensus       186 PywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN  229 (948)
T KOG0577|consen  186 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN  229 (948)
T ss_pred             ccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch
Confidence            9999999864   5889999999999999999999999987654

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.96  E-value=2.8e-29  Score=261.44  Aligned_cols=184  Identities=32%  Similarity=0.478  Sum_probs=154.4

Q ss_pred             CCceEEEEEEEEeec-------CcEEEEEEeccC--------hHHHHHHHHHcC-CCCccceeeeeecCCCCeeEEEEee
Q 037224          345 EGCLIQGSVYKGNIH-------GEVYAIKMMKWN--------ACEELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEY  408 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~-------g~~vAvK~~~~~--------~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~lv~e~  408 (552)
                      .|.|++|.||+|+..       +..||||+++..        +.+|+.+++++. ||||++++++|.+  ....++||||
T Consensus        45 LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~--~~~~~lv~Ey  122 (400)
T cd05105          45 LGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK--SGPIYIITEY  122 (400)
T ss_pred             ecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc--CCceEEEEEe
Confidence            477888999999862       246999998632        346999999996 9999999999976  6678999999


Q ss_pred             ccCCCchhhhhhcC------------------------------------------------------------------
Q 037224          409 IENGSLHSWLHENK------------------------------------------------------------------  422 (552)
Q Consensus       409 ~~~gsL~~~l~~~~------------------------------------------------------------------  422 (552)
                      +++|+|.+++....                                                                  
T Consensus       123 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  202 (400)
T cd05105         123 CFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSD  202 (400)
T ss_pred             cCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhh
Confidence            99999999886431                                                                  


Q ss_pred             ----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEe
Q 037224          423 ----------------------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIA  474 (552)
Q Consensus       423 ----------------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~  474 (552)
                                                  ...+++.+++.++.|+++||+|||+.+   ++||||||+|||++.++.+||+
T Consensus       203 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~~~~~kL~  279 (400)
T cd05105         203 IQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQGKIVKIC  279 (400)
T ss_pred             cccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeCCCEEEEE
Confidence                                        124788889999999999999999998   9999999999999999999999


Q ss_pred             eccCCccCCCC----ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCcc
Q 037224          475 NFGLAKSGCNA----ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEE  533 (552)
Q Consensus       475 Dfg~a~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~  533 (552)
                      |||+++.....    ......++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus       280 DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~  343 (400)
T cd05105         280 DFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM  343 (400)
T ss_pred             eCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence            99998743221    1122346678999999988889999999999999999997 99998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.96  E-value=3.1e-29  Score=249.00  Aligned_cols=184  Identities=27%  Similarity=0.392  Sum_probs=159.7

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|++|+||++..  +|+.+|+|.+...          +.+|++++++++|+|++++++.+..  .+..++||||+++++
T Consensus         2 g~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~   79 (277)
T cd05577           2 GKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET--KDDLCLVMTLMNGGD   79 (277)
T ss_pred             CCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec--CCeEEEEEecCCCCc
Confidence            6778899999976  6889999988532          2368999999999999999998876  667899999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC-Cccccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN-AITMHIVG  492 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~-~~~~~~~g  492 (552)
                      |.+++.......+++.+++.++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||.+..... .......+
T Consensus        80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05577          80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAG  156 (277)
T ss_pred             HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccC
Confidence            999998766556999999999999999999999999   99999999999999999999999999875432 12223457


Q ss_pred             cccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       493 t~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +..|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus       157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  198 (277)
T cd05577         157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK  198 (277)
T ss_pred             CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCc
Confidence            789999999988889999999999999999999999997543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.96  E-value=3.1e-29  Score=249.78  Aligned_cols=184  Identities=31%  Similarity=0.540  Sum_probs=155.0

Q ss_pred             CceEEEEEEEEee------cCcEEEEEEecc--------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          346 GCLIQGSVYKGNI------HGEVYAIKMMKW--------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       346 G~g~~G~Vy~~~~------~g~~vAvK~~~~--------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      |.|++|.||+|.+      .+..+++|.++.        .+.+|+.++++++|+||+++++++..  +...+++|||+++
T Consensus        14 g~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~   91 (283)
T cd05090          14 GECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ--EQPVCMLFEYLNQ   91 (283)
T ss_pred             cccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec--CCceEEEEEcCCC
Confidence            6777799999975      457899999863        24579999999999999999999877  5678999999999


Q ss_pred             CCchhhhhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeec
Q 037224          412 GSLHSWLHENK---------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANF  476 (552)
Q Consensus       412 gsL~~~l~~~~---------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Df  476 (552)
                      ++|.+++....               ...+++.+++.++.|++.||+|||+++   ++||||||+||++++++.+||+||
T Consensus        92 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~~~kl~df  168 (283)
T cd05090          92 GDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDL  168 (283)
T ss_pred             CcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCCcEEeccc
Confidence            99999985332               124788999999999999999999998   999999999999999999999999


Q ss_pred             cCCccCCCCc----cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          477 GLAKSGCNAI----TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       477 g~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      |++.......    .....++..|+|||.+.+..++.++||||||+++|||++ |..||.+..
T Consensus       169 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~  231 (283)
T cd05090         169 GLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS  231 (283)
T ss_pred             cccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence            9997432211    122344667999999988889999999999999999998 999996543

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.96  E-value=2.2e-29  Score=252.69  Aligned_cols=181  Identities=25%  Similarity=0.449  Sum_probs=157.8

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchh
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHS  416 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~  416 (552)
                      |.|.+|.||++..  +++.+++|.+...       ..+|+.+++.++|+|++++++.+..  +...++||||+++++|.+
T Consensus        29 g~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~--~~~~~lv~e~~~~~~L~~  106 (296)
T cd06654          29 GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVVMEYLAGGSLTD  106 (296)
T ss_pred             cCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe--CCEEEEeecccCCCCHHH
Confidence            6777799999986  6889999988532       3468999999999999999999887  668899999999999999


Q ss_pred             hhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--ccccccccc
Q 037224          417 WLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIVGTQ  494 (552)
Q Consensus       417 ~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~gt~  494 (552)
                      ++...   .+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++......  ......+++
T Consensus       107 ~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  180 (296)
T cd06654         107 VVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP  180 (296)
T ss_pred             HHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccccccCcccCCc
Confidence            88654   3899999999999999999999999   999999999999999999999999998743221  122346788


Q ss_pred             cccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       495 ~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       181 ~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~  220 (296)
T cd06654         181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN  220 (296)
T ss_pred             cccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999988889999999999999999999999997654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PTZ00284 protein kinase; Provisional

Probab=99.96  E-value=1.6e-29  Score=269.69  Aligned_cols=182  Identities=23%  Similarity=0.356  Sum_probs=151.2

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC------hHHHHHHHHHcCCC------CccceeeeeecCCCCeeEEEEeecc
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN------ACEELKILQKVNHG------NLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~------~~~E~~~l~~l~h~------niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      .|.|.+|+||++..  .++.||||+++..      ...|+.+++.++|.      +++.+++++... ....++|||++ 
T Consensus       137 lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~-~~~~~iv~~~~-  214 (467)
T PTZ00284        137 LGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE-TGHMCIVMPKY-  214 (467)
T ss_pred             EEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC-CceEEEEEecc-
Confidence            37888899999987  6789999998642      34588888887654      478888887653 45788999988 


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEECCCC----------------cEEE
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHE-HTRPRVVHKDIKSSNILLDSNM----------------RAKI  473 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~Dikp~NIll~~~~----------------~~kL  473 (552)
                      +++|.+++....  .+++.++..++.|++.||+|||+ .+   |+||||||+|||++.++                .+||
T Consensus       215 g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl  289 (467)
T PTZ00284        215 GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRI  289 (467)
T ss_pred             CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccccccCCCCceEEE
Confidence            668888887653  49999999999999999999998 47   99999999999998765                4999


Q ss_pred             eeccCCccCCCCccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          474 ANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       474 ~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       290 ~DfG~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~  349 (467)
T PTZ00284        290 CDLGGCCDERH-SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD  349 (467)
T ss_pred             CCCCccccCcc-ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99998764322 2334678999999999999999999999999999999999999998654

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.96  E-value=4e-29  Score=245.07  Aligned_cols=185  Identities=32%  Similarity=0.581  Sum_probs=160.9

Q ss_pred             CCceEEEEEEEEeec-----CcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNIH-----GEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~-----g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|.+|.||++...     +..+++|.++..        ..+|+++++.++|+|++++++++.+  +...+++|||+++
T Consensus         3 ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~   80 (262)
T cd00192           3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVLEYMEG   80 (262)
T ss_pred             cccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEEEeccC
Confidence            367788999999984     779999998643        2368999999999999999999887  6788999999999


Q ss_pred             CCchhhhhhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC
Q 037224          412 GSLHSWLHENK-------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN  484 (552)
Q Consensus       412 gsL~~~l~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  484 (552)
                      ++|.+++....       ...+++.+++.++.|++.||+|||+++   ++|+||+|+||+++.++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            99999998752       245999999999999999999999998   99999999999999999999999999985543


Q ss_pred             C----ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          485 A----ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       485 ~----~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      .    ......++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~  212 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS  212 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC
Confidence            2    1333567889999999988889999999999999999999 699998653

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.96  E-value=3.1e-29  Score=245.66  Aligned_cols=184  Identities=28%  Similarity=0.420  Sum_probs=160.3

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      |.|.+|.||++..  +++.+|+|.++..        ..+|+.++++++|+|++++++.+.+  +...+++|||+++++|.
T Consensus         9 g~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~l~   86 (255)
T cd08219           9 GEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA--DGHLYIVMEYCDGGDLM   86 (255)
T ss_pred             eccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEE--CCEEEEEEeeCCCCcHH
Confidence            6677799999987  6889999987432        3468899999999999999999877  67889999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--cccccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIVGT  493 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~gt  493 (552)
                      +++.......+++..++.++.|++.||.|||+++   ++|+||||+||++++++.++|+|||.+......  ......++
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  163 (255)
T cd08219          87 QKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGT  163 (255)
T ss_pred             HHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccccccccccCC
Confidence            9887655556899999999999999999999999   999999999999999999999999998744322  12235678


Q ss_pred             ccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       494 ~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..|+|||.+.+..++.++|+||||+++|+|++|+.||...+
T Consensus       164 ~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~  204 (255)
T cd08219         164 PYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS  204 (255)
T ss_pred             ccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC
Confidence            89999999988889999999999999999999999998654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.96  E-value=3.2e-29  Score=246.31  Aligned_cols=184  Identities=30%  Similarity=0.497  Sum_probs=159.2

Q ss_pred             CceEEEEEEEEee-cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhh
Q 037224          346 GCLIQGSVYKGNI-HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSW  417 (552)
Q Consensus       346 G~g~~G~Vy~~~~-~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~  417 (552)
                      |.|++|.||+|.. ++..+++|.++..       ..+|+.+++.++|+|++++++++.+  ....+++|||+++++|.++
T Consensus        15 g~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~   92 (261)
T cd05148          15 GSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV--GEPVYIITELMEKGSLLAF   92 (261)
T ss_pred             ccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEec--CCCeEEEEeecccCCHHHH
Confidence            6777799999988 6788999998643       3468999999999999999999877  5678999999999999999


Q ss_pred             hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc--ccccccccc
Q 037224          418 LHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI--TMHIVGTQG  495 (552)
Q Consensus       418 l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~--~~~~~gt~~  495 (552)
                      +.......+++.+++.++.|++.||.|||+++   ++|+||+|+||++++++.+||+|||.+.......  .....++..
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~  169 (261)
T cd05148          93 LRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK  169 (261)
T ss_pred             HhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccccccCCCCceE
Confidence            98766666899999999999999999999998   9999999999999999999999999987543221  112345668


Q ss_pred             ccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          496 YIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       496 y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      |++||.+....++.++||||||+++|+|++ |+.||....
T Consensus       170 ~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~  209 (261)
T cd05148         170 WTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN  209 (261)
T ss_pred             ecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC
Confidence            999999988889999999999999999998 899997644

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.96  E-value=2.4e-29  Score=248.77  Aligned_cols=185  Identities=30%  Similarity=0.505  Sum_probs=157.2

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC------hHHHHHHHHHc-CCCCccceeeeeecCC----CCeeEEEEeeccCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN------ACEELKILQKV-NHGNLVKLEGFCIDPE----DANCYLIYEYIENG  412 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~------~~~E~~~l~~l-~h~niv~l~~~~~~~~----~~~~~lv~e~~~~g  412 (552)
                      |.|.+|.||+|..  .++.+|+|+++..      ..+|+.++.++ +|+|++++++++....    +..++++|||+.++
T Consensus        15 g~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~   94 (272)
T cd06637          15 GNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAG   94 (272)
T ss_pred             eecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCC
Confidence            6667799999987  6789999998532      34688899998 7999999999987532    24689999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC--Cccccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN--AITMHI  490 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~--~~~~~~  490 (552)
                      +|.+++.......+++..+..++.|++.||+|||+++   ++|+||+|+||++++++.++|+|||++.....  ......
T Consensus        95 ~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~  171 (272)
T cd06637          95 SVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF  171 (272)
T ss_pred             cHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCceecccccccCCcc
Confidence            9999998765556899999999999999999999998   99999999999999999999999999875432  122335


Q ss_pred             cccccccCccccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          491 VGTQGYIAPEYLA-----DGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       491 ~gt~~y~aPE~~~-----~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      .|+..|+|||++.     +..++.++||||||+++|||++|+.||...
T Consensus       172 ~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~  219 (272)
T cd06637         172 IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM  219 (272)
T ss_pred             cccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence            6888999999885     345788999999999999999999999753

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.96  E-value=3.9e-29  Score=246.69  Aligned_cols=184  Identities=26%  Similarity=0.407  Sum_probs=158.2

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC------------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN------------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~------------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      |.|.+|.||++..  .+..|++|.++..            ..+|+.++++++|+||+++++++.+..+...++++||+++
T Consensus        11 g~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~   90 (266)
T cd06651          11 GQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPG   90 (266)
T ss_pred             cCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCC
Confidence            6777799999987  6889999987522            3368999999999999999998876556778999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-----c
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-----I  486 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-----~  486 (552)
                      ++|.+++....  .+++...+.++.|++.||+|||+.+   ++||||+|+||+++.++.+||+|||++......     .
T Consensus        91 ~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  165 (266)
T cd06651          91 GSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTG  165 (266)
T ss_pred             CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCc
Confidence            99999987644  3899999999999999999999998   999999999999999999999999998743221     1


Q ss_pred             cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          487 TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       487 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .....++..|+|||.+.+..++.++|+||||+++|||++|+.||....
T Consensus       166 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~  213 (266)
T cd06651         166 IRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE  213 (266)
T ss_pred             cccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc
Confidence            122457889999999988889999999999999999999999997543

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-30  Score=259.17  Aligned_cols=198  Identities=25%  Similarity=0.403  Sum_probs=168.5

Q ss_pred             cHHHHHHHhhccCCCceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCC
Q 037224          332 KIEELREATDNFSEGCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDA  400 (552)
Q Consensus       332 ~~~~l~~~t~~~~~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~  400 (552)
                      .+..+++.-.+-..|+|-||+||-|+.  +|+.||||++++.         ..+|+.+|+++.||.|+.+.-.|..  .+
T Consensus       559 d~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET--~e  636 (888)
T KOG4236|consen  559 DISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET--PE  636 (888)
T ss_pred             hHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC--Cc
Confidence            344444444444568888999999987  8999999998542         2479999999999999999888877  66


Q ss_pred             eeEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCC---CcEEEeecc
Q 037224          401 NCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN---MRAKIANFG  477 (552)
Q Consensus       401 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~---~~~kL~Dfg  477 (552)
                      ..++|||-+.| +..+++-.....++++..-..++.||+.||.|||.++   |+|+||||+|||+.+.   -++||||||
T Consensus       637 rvFVVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFG  712 (888)
T KOG4236|consen  637 RVFVVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFG  712 (888)
T ss_pred             eEEEEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeecccc
Confidence            78999999965 7777776666667999999999999999999999999   9999999999999543   479999999


Q ss_pred             CCccCCCC-ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          478 LAKSGCNA-ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       478 ~a~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      +++...+. .....+||+.|+|||++.+..|...-|+||.|+|+|--++|..||+++++
T Consensus       713 fARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd  771 (888)
T KOG4236|consen  713 FARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED  771 (888)
T ss_pred             ceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc
Confidence            99976543 45568999999999999999999999999999999999999999997754

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.2e-30  Score=264.81  Aligned_cols=188  Identities=30%  Similarity=0.441  Sum_probs=161.7

Q ss_pred             hccCCCceEEEEEEEEee--cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          341 DNFSEGCLIQGSVYKGNI--HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       341 ~~~~~G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      +..-.|.|.+|+||-|++  +...+|||.+...       ..+|+.+-++++|.||++++|.|..  ++.+-+.||.++|
T Consensus       579 ervVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~se--nGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  579 ERVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSE--NGFFKIFMEQVPG  656 (1226)
T ss_pred             ceEEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCC--CCeEEEEeecCCC
Confidence            344569999999999998  4457899988543       3479999999999999999999866  7788899999999


Q ss_pred             CCchhhhhhcCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEC-CCCcEEEeeccCCccCC--CCc
Q 037224          412 GSLHSWLHENKNENL--NWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLD-SNMRAKIANFGLAKSGC--NAI  486 (552)
Q Consensus       412 gsL~~~l~~~~~~~l--~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~-~~~~~kL~Dfg~a~~~~--~~~  486 (552)
                      |+|.++++..-+ ++  ++..+-.+.+||++||.|||++.   |||||||-+|+|++ ..|.+||+|||-++...  +..
T Consensus       657 GSLSsLLrskWG-PlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~  732 (1226)
T KOG4279|consen  657 GSLSSLLRSKWG-PLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC  732 (1226)
T ss_pred             CcHHHHHHhccC-CCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence            999999987554 35  78888999999999999999998   99999999999994 68999999999987432  344


Q ss_pred             cccccccccccCccccCCCC--CCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          487 TMHIVGTQGYIAPEYLADGV--VSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       487 ~~~~~gt~~y~aPE~~~~~~--~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +....||..|||||++..+.  |+.++|||||||.+.||.||++||.+.+
T Consensus       733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elg  782 (1226)
T KOG4279|consen  733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELG  782 (1226)
T ss_pred             ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecC
Confidence            55678999999999997654  8899999999999999999999998755

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.96  E-value=5.3e-29  Score=244.91  Aligned_cols=184  Identities=30%  Similarity=0.447  Sum_probs=156.2

Q ss_pred             CCceEEEEEEEEee-cCcEEEEEEeccC------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhh
Q 037224          345 EGCLIQGSVYKGNI-HGEVYAIKMMKWN------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSW  417 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-~g~~vAvK~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~  417 (552)
                      .|.|++|.||++.+ .+..+|+|.+...      +.+|+.++++++|+|++++++++.   ....+++|||+++++|.++
T Consensus        14 ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~~~v~e~~~~~~L~~~   90 (260)
T cd05069          14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS---EEPIYIVTEFMGKGSLLDF   90 (260)
T ss_pred             ecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc---CCCcEEEEEcCCCCCHHHH
Confidence            37777899999988 4457999987642      357999999999999999998874   3457899999999999999


Q ss_pred             hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcc---ccccccc
Q 037224          418 LHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT---MHIVGTQ  494 (552)
Q Consensus       418 l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~---~~~~gt~  494 (552)
                      +.......+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++........   ....++.
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~  167 (260)
T cd05069          91 LKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPI  167 (260)
T ss_pred             HhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCCccch
Confidence            98765556899999999999999999999998   99999999999999999999999999875432211   1234567


Q ss_pred             cccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          495 GYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       495 ~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      .|+|||...+...+.++|+||||+++|||++ |+.||.+..
T Consensus       168 ~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  208 (260)
T cd05069         168 KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV  208 (260)
T ss_pred             hhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            8999999988889999999999999999999 999997653

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=7.8e-31  Score=260.16  Aligned_cols=196  Identities=23%  Similarity=0.372  Sum_probs=172.5

Q ss_pred             ccHHHHHHHhhccCCCceEEEEEEEEeecCcE--EEEEEeccCh----------HHHHHHHHHcCCCCccceeeeeecCC
Q 037224          331 FKIEELREATDNFSEGCLIQGSVYKGNIHGEV--YAIKMMKWNA----------CEELKILQKVNHGNLVKLEGFCIDPE  398 (552)
Q Consensus       331 ~~~~~l~~~t~~~~~G~g~~G~Vy~~~~~g~~--vAvK~~~~~~----------~~E~~~l~~l~h~niv~l~~~~~~~~  398 (552)
                      ..+.++....   ..|.|+||+|=..+.+++.  +|+|++++..          ..|-.+|..++.+.|++++..|.+  
T Consensus       417 v~l~dl~~ia---TLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd--  491 (732)
T KOG0614|consen  417 VKLSDLKRIA---TLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD--  491 (732)
T ss_pred             cchhhhhhhh---hcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc--
Confidence            3455554322   4589999999999887665  8999986542          258899999999999999998887  


Q ss_pred             CCeeEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccC
Q 037224          399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGL  478 (552)
Q Consensus       399 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~  478 (552)
                      +...|++||-|-||.|+..++....  |+......++..+++|++|||+++   ||+|||||+|.++|.+|-+||.|||+
T Consensus       492 ~kyvYmLmEaClGGElWTiLrdRg~--Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGF  566 (732)
T KOG0614|consen  492 SKYVYMLMEACLGGELWTILRDRGS--FDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGF  566 (732)
T ss_pred             chhhhhhHHhhcCchhhhhhhhcCC--cccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhh
Confidence            7788999999999999999987664  999999999999999999999999   99999999999999999999999999


Q ss_pred             CccCC-CCccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccCcc
Q 037224          479 AKSGC-NAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGKF  536 (552)
Q Consensus       479 a~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~~  536 (552)
                      |+... ...+...+||+.|.|||++.+...+.++|.||||+++|||++|.+||.+.+++
T Consensus       567 AKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm  625 (732)
T KOG0614|consen  567 AKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM  625 (732)
T ss_pred             HHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH
Confidence            98554 45677799999999999999999999999999999999999999999988764

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.96  E-value=2e-29  Score=258.32  Aligned_cols=181  Identities=24%  Similarity=0.408  Sum_probs=153.4

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCC----CCeeEEEEeecc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPE----DANCYLIYEYIE  410 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~~~lv~e~~~  410 (552)
                      |.|.+|.||++..  +++.||+|.++..         ..+|+.++++++|+||+++++++....    ....++++|++ 
T Consensus        24 g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-  102 (343)
T cd07878          24 GSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-  102 (343)
T ss_pred             ccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-
Confidence            6777799999986  6789999998642         236999999999999999998875421    23568999988 


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccccc
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI  490 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  490 (552)
                      +++|.+++...   .+++.++..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++..... ....
T Consensus       103 ~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~  175 (343)
T cd07878         103 GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDE-MTGY  175 (343)
T ss_pred             CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceecCCC-cCCc
Confidence            66898877543   4999999999999999999999999   999999999999999999999999999765432 2345


Q ss_pred             cccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          491 VGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       491 ~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...+
T Consensus       176 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  220 (343)
T cd07878         176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND  220 (343)
T ss_pred             cccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence            78999999999876 568899999999999999999999997543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.96  E-value=7.2e-29  Score=242.23  Aligned_cols=184  Identities=30%  Similarity=0.475  Sum_probs=156.6

Q ss_pred             CCceEEEEEEEEee-cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          345 EGCLIQGSVYKGNI-HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      .|.|++|.||++.. ++..+|+|.++..        +.+|++++++++|+||+++++++..  ....+++|||+++++|.
T Consensus         3 ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ--RQPIYIVMELVPGGDFL   80 (250)
T ss_pred             cCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec--CCccEEEEECCCCCcHH
Confidence            37788899999987 6788999997543        3468999999999999999999977  56789999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcc---ccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT---MHIVG  492 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~---~~~~g  492 (552)
                      +++.... ..+++..++.++.|++.+|.|||+++   ++||||+|+||+++.++.+||+|||++........   ....+
T Consensus        81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (250)
T cd05085          81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI  156 (250)
T ss_pred             HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence            9886543 34899999999999999999999998   99999999999999999999999999864332211   11234


Q ss_pred             cccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       493 t~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      +..|+|||++....++.++||||||+++||+++ |..||....
T Consensus       157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~  199 (250)
T cd05085         157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT  199 (250)
T ss_pred             cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC
Confidence            567999999988889999999999999999998 999997543

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.96  E-value=4.2e-29  Score=248.31  Aligned_cols=182  Identities=27%  Similarity=0.396  Sum_probs=152.6

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHH---HHHHHcCCCCccceeeeeecCCCCeeEEEEeec
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEEL---KILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI  409 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~---~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~  409 (552)
                      .|.|.+|.||++..  .++.||+|.+...          ...|.   ..++...|++++.+++.+.+  ....++||||+
T Consensus         2 ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e~~   79 (278)
T cd05606           2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDKLSFILDLM   79 (278)
T ss_pred             cccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCEEEEEEecC
Confidence            36777899999987  6789999987532          11233   33444579999999998876  56789999999


Q ss_pred             cCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcccc
Q 037224          410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH  489 (552)
Q Consensus       410 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  489 (552)
                      .+++|.+++....  .+++.+++.++.|+++||+|||+.+   ++||||||+||+++.++.++|+|||++..........
T Consensus        80 ~g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~  154 (278)
T cd05606          80 NGGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA  154 (278)
T ss_pred             CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcC
Confidence            9999998886543  5999999999999999999999998   9999999999999999999999999987544333334


Q ss_pred             ccccccccCccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          490 IVGTQGYIAPEYLADG-VVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~~-~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      ..|+..|+|||.+.++ .++.++|+||+|+++|||++|+.||.+.
T Consensus       155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~  199 (278)
T cd05606         155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH  199 (278)
T ss_pred             cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence            5789999999998754 5889999999999999999999999765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.96  E-value=6e-29  Score=244.40  Aligned_cols=184  Identities=29%  Similarity=0.481  Sum_probs=158.5

Q ss_pred             CceEEEEEEEEee-cCcEEEEEEeccC------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhhh
Q 037224          346 GCLIQGSVYKGNI-HGEVYAIKMMKWN------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL  418 (552)
Q Consensus       346 G~g~~G~Vy~~~~-~g~~vAvK~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l  418 (552)
                      |.|++|.||++.. ++..+|+|.++..      ..+|+.++++++|+|++++++++.+  +...+++|||+++++|.+++
T Consensus        15 g~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~i   92 (261)
T cd05034          15 GAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE--EEPIYIVTEYMSKGSLLDFL   92 (261)
T ss_pred             ccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeec--CCceEEEEeccCCCCHHHHH
Confidence            6777799999987 5578999998643      4579999999999999999998876  56789999999999999999


Q ss_pred             hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcc---cccccccc
Q 037224          419 HENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT---MHIVGTQG  495 (552)
Q Consensus       419 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~---~~~~gt~~  495 (552)
                      .......+++.++..++.|++.||.|||+++   ++|+||+|+||++++++.+||+|||++........   .....+..
T Consensus        93 ~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~  169 (261)
T cd05034          93 KSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIK  169 (261)
T ss_pred             hccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhhhhhccCCCcc
Confidence            8766566999999999999999999999998   99999999999999999999999999875432111   11234568


Q ss_pred             ccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          496 YIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       496 y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      |+|||.+.+...+.++|+||||+++|||++ |+.||.+..
T Consensus       170 y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~  209 (261)
T cd05034         170 WTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT  209 (261)
T ss_pred             ccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            999999998889999999999999999998 999997543

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.96  E-value=1e-28  Score=245.84  Aligned_cols=194  Identities=27%  Similarity=0.410  Sum_probs=160.7

Q ss_pred             HHHHHHHhhccCCCceEEEEEEEEee--cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeE
Q 037224          333 IEELREATDNFSEGCLIQGSVYKGNI--HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCY  403 (552)
Q Consensus       333 ~~~l~~~t~~~~~G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  403 (552)
                      .+|.++..+.+  |.|.+|.||++..  .+..+++|.+...       +.+|+++++.++|+|++++++++..  +...+
T Consensus         3 ~~~~~~i~~~l--g~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~   78 (282)
T cd06643           3 PEEFWEIIGEL--GDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLW   78 (282)
T ss_pred             HHHHHHHHhhc--ccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee--CCEEE
Confidence            35555665555  5555699999988  5678899988542       3468999999999999999999887  67889


Q ss_pred             EEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC
Q 037224          404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC  483 (552)
Q Consensus       404 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  483 (552)
                      +++||+++++|.+++.... ..+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        79 ~v~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  154 (282)
T cd06643          79 ILIEFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT  154 (282)
T ss_pred             EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccc
Confidence            9999999999988876532 35899999999999999999999998   9999999999999999999999999986433


Q ss_pred             CC--ccccccccccccCccccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          484 NA--ITMHIVGTQGYIAPEYLA-----DGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       484 ~~--~~~~~~gt~~y~aPE~~~-----~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..  ......++..|+|||.+.     +..++.++|+|||||++|||++|+.||...+
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~  212 (282)
T cd06643         155 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN  212 (282)
T ss_pred             ccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC
Confidence            21  122356888999999873     4557789999999999999999999997543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.96  E-value=5.3e-29  Score=245.26  Aligned_cols=183  Identities=29%  Similarity=0.438  Sum_probs=155.4

Q ss_pred             CceEEEEEEEEee-cCcEEEEEEeccC------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhhh
Q 037224          346 GCLIQGSVYKGNI-HGEVYAIKMMKWN------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL  418 (552)
Q Consensus       346 G~g~~G~Vy~~~~-~g~~vAvK~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l  418 (552)
                      |.|++|.||+|++ +...||+|+++..      +.+|+.++++++|+||+++++++.   +...+++|||+++++|.+++
T Consensus        15 g~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~---~~~~~lv~e~~~~~~L~~~~   91 (262)
T cd05071          15 GQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS---EEPIYIVTEYMSKGSLLDFL   91 (262)
T ss_pred             CCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC---CCCcEEEEEcCCCCcHHHHH
Confidence            6677799999988 4457999998642      357999999999999999998764   34568999999999999999


Q ss_pred             hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcc---cccccccc
Q 037224          419 HENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT---MHIVGTQG  495 (552)
Q Consensus       419 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~---~~~~gt~~  495 (552)
                      .......+++..++.++.|+++||+|||+.+   ++|+||||+||++++++.++|+|||.++.......   ....++..
T Consensus        92 ~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~  168 (262)
T cd05071          92 KGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK  168 (262)
T ss_pred             hhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccccccCCcccce
Confidence            8655556899999999999999999999998   99999999999999999999999999874432211   12345668


Q ss_pred             ccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          496 YIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       496 y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      |+|||...+..++.++||||||+++|||++ |+.||.+..
T Consensus       169 y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~  208 (262)
T cd05071         169 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV  208 (262)
T ss_pred             ecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            999999988889999999999999999999 888997653

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.96  E-value=5.3e-29  Score=250.42  Aligned_cols=182  Identities=26%  Similarity=0.470  Sum_probs=154.9

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      |.|.+|.||+++.  +++.||+|.++..        ..+|+.++++++|+||+++++++.+  +...++||||++ ++|.
T Consensus        15 g~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~--~~~~~lv~e~~~-~~l~   91 (301)
T cd07873          15 GEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT--EKSLTLVFEYLD-KDLK   91 (301)
T ss_pred             ccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEec--CCeEEEEEeccc-cCHH
Confidence            7777899999987  6789999998532        3479999999999999999999976  668899999997 4898


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--cccccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIVGT  493 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~gt  493 (552)
                      +++.... ..+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||++......  ......++
T Consensus        92 ~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  167 (301)
T cd07873          92 QYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVT  167 (301)
T ss_pred             HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCccccccee
Confidence            8886543 34899999999999999999999998   999999999999999999999999998743221  12234568


Q ss_pred             ccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          494 QGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       494 ~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +.|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus       168 ~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~  209 (301)
T cd07873         168 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST  209 (301)
T ss_pred             ecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            89999998765 457889999999999999999999998654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.96  E-value=8.7e-29  Score=242.59  Aligned_cols=185  Identities=27%  Similarity=0.439  Sum_probs=158.5

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|.+|.||++..  +++.+|+|.++..         ..+|++++++++|+|++++++.+.. .+...+++|||+++++|
T Consensus         9 g~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~lv~e~~~~~~l   87 (257)
T cd08223           9 GKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG-EDGLLYIVMGFCEGGDL   87 (257)
T ss_pred             cCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC-CCCEEEEEecccCCCcH
Confidence            5667799999987  6789999998532         3468899999999999999887653 24567899999999999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--ccccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIVG  492 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~g  492 (552)
                      .+++.......+++.+++.++.|++.+|++||+.+   ++||||+|+||+++.++.++|+|||++......  ......+
T Consensus        88 ~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  164 (257)
T cd08223          88 YHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIG  164 (257)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccCCccccccC
Confidence            99998765556899999999999999999999999   999999999999999999999999998744321  2223467


Q ss_pred             cccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       493 t~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ++.|+|||.+.+..++.++|+||||+++|||++|+.||...+
T Consensus       165 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~  206 (257)
T cd08223         165 TPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD  206 (257)
T ss_pred             CcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence            889999999999999999999999999999999999997544

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.96  E-value=4.3e-29  Score=246.42  Aligned_cols=181  Identities=28%  Similarity=0.443  Sum_probs=155.3

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchh
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHS  416 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~  416 (552)
                      |.|.+|.||+|+.  +++.||+|+++..       ..+|+.++++++|+||+++++.+..  +...++||||+++++|.+
T Consensus        18 g~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~--~~~~~iv~e~~~~~~L~~   95 (267)
T cd06646          18 GSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLS--REKLWICMEYCGGGSLQD   95 (267)
T ss_pred             ecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEe--CCEEEEEEeCCCCCcHHH
Confidence            6777799999987  7889999998532       3469999999999999999999977  668899999999999999


Q ss_pred             hhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--ccccccccc
Q 037224          417 WLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIVGTQ  494 (552)
Q Consensus       417 ~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~gt~  494 (552)
                      ++....  .+++.++..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++......  ......++.
T Consensus        96 ~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  170 (267)
T cd06646          96 IYHVTG--PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTP  170 (267)
T ss_pred             HHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccccccCccccCc
Confidence            886543  4899999999999999999999998   999999999999999999999999998744322  122346788


Q ss_pred             cccCccccC---CCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          495 GYIAPEYLA---DGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       495 ~y~aPE~~~---~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      .|+|||.+.   ...++.++|+||||+++|||++|+.||...
T Consensus       171 ~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~  212 (267)
T cd06646         171 YWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDL  212 (267)
T ss_pred             cccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence            999999874   345778999999999999999999998643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.96  E-value=5e-29  Score=248.26  Aligned_cols=183  Identities=28%  Similarity=0.483  Sum_probs=155.0

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|.+|.||+|+.  +++.||+|.++..         ..+|+.++++++|+|++++++++.+  +...++||||++ ++|
T Consensus         9 ~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~-~~l   85 (285)
T cd07861           9 GEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ--ESRLYLIFEFLS-MDL   85 (285)
T ss_pred             cccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee--CCeEEEEEecCC-CCH
Confidence            6677799999987  6889999987532         3479999999999999999999987  678899999997 588


Q ss_pred             hhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--cccccc
Q 037224          415 HSWLHENKN-ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIV  491 (552)
Q Consensus       415 ~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~  491 (552)
                      .+++..... ..+++.+++.++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||++......  ......
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  162 (285)
T cd07861          86 KKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEV  162 (285)
T ss_pred             HHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcccccCCc
Confidence            888765432 46899999999999999999999998   999999999999999999999999998643221  112235


Q ss_pred             ccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          492 GTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       492 gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +++.|+|||.+.+ ..++.++||||||+++|||+||+.||....
T Consensus       163 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~  206 (285)
T cd07861         163 VTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDS  206 (285)
T ss_pred             ccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            6889999998765 447889999999999999999999998654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.96  E-value=6.7e-29  Score=244.10  Aligned_cols=184  Identities=29%  Similarity=0.459  Sum_probs=158.1

Q ss_pred             CCceEEEEEEEEee-cCcEEEEEEeccC------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhh
Q 037224          345 EGCLIQGSVYKGNI-HGEVYAIKMMKWN------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSW  417 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-~g~~vAvK~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~  417 (552)
                      .|.|++|.||++.. +++.||+|.++..      +.+|+.++++++|+|++++++++.   +...+++|||+++++|.++
T Consensus        14 ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~~~v~e~~~~~~L~~~   90 (260)
T cd05067          14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT---QEPIYIITEYMENGSLVDF   90 (260)
T ss_pred             eccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc---cCCcEEEEEcCCCCCHHHH
Confidence            37778899999988 7789999988642      457999999999999999998764   3467999999999999999


Q ss_pred             hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc---cccccccc
Q 037224          418 LHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI---TMHIVGTQ  494 (552)
Q Consensus       418 l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~---~~~~~gt~  494 (552)
                      +.......+++.++..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++.......   .....++.
T Consensus        91 ~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~  167 (260)
T cd05067          91 LKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPI  167 (260)
T ss_pred             HHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCCcccc
Confidence            87766566899999999999999999999998   9999999999999999999999999987543211   11234567


Q ss_pred             cccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          495 GYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       495 ~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      .|+|||.+....++.++||||||+++|||++ |+.||.+.+
T Consensus       168 ~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  208 (260)
T cd05067         168 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT  208 (260)
T ss_pred             cccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence            8999999988889999999999999999999 999997543

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.96  E-value=4.6e-29  Score=246.55  Aligned_cols=185  Identities=23%  Similarity=0.385  Sum_probs=150.9

Q ss_pred             CCceEEEEEEEEee----cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI----HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~----~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|.|.+|.||+|..    ....+++|.++..        +.+|+..++.++|+||+++++.+.+  ....+++|||+++|
T Consensus         3 lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~--~~~~~lv~e~~~~g   80 (269)
T cd05042           3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE--SIPYLLVLEFCPLG   80 (269)
T ss_pred             CCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECC--CCceEEEEEeCCCC
Confidence            47778899999975    2347888977532        3468899999999999999999876  56789999999999


Q ss_pred             CchhhhhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc---
Q 037224          413 SLHSWLHENKN---ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI---  486 (552)
Q Consensus       413 sL~~~l~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~---  486 (552)
                      +|.+++.....   ...++..++.++.|++.||+|||+++   ++||||||+|||++.++.+||+|||++.......   
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99999976543   23567888999999999999999998   9999999999999999999999999986432211   


Q ss_pred             -cccccccccccCccccC-------CCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          487 -TMHIVGTQGYIAPEYLA-------DGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       487 -~~~~~gt~~y~aPE~~~-------~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                       .....++..|+|||++.       ...++.++||||||+++|||++ |+.||....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~  214 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS  214 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence             12234567799999864       2456789999999999999999 788887543

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.96  E-value=7.9e-29  Score=242.82  Aligned_cols=184  Identities=25%  Similarity=0.369  Sum_probs=159.0

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|.+|.||.++.  +++.+++|.+...         +.+|+.++++++|+||+++++++.+  ....+++|||+++++|
T Consensus         9 g~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~~~e~~~~~~L   86 (256)
T cd08221           9 GKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD--DNTLLIEMEYANGGTL   86 (256)
T ss_pred             cccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec--CCeEEEEEEecCCCcH
Confidence            6666687777665  7889999987532         3479999999999999999999987  6788999999999999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc--cccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI--TMHIVG  492 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~--~~~~~g  492 (552)
                      .+++.......+++.++..++.|++.+|.|||+.+   ++|+||+|+||++++++.+||+|||++.......  .....+
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~  163 (256)
T cd08221          87 YDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVG  163 (256)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccccccccCC
Confidence            99998765556899999999999999999999998   9999999999999999999999999987443221  233568


Q ss_pred             cccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       493 t~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ++.|+|||.+.+..++.++|+||||+++|||++|+.||....
T Consensus       164 ~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~  205 (256)
T cd08221         164 TPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN  205 (256)
T ss_pred             CccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC
Confidence            899999999988888999999999999999999999997643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.96  E-value=9.7e-29  Score=244.47  Aligned_cols=186  Identities=30%  Similarity=0.456  Sum_probs=152.8

Q ss_pred             CCceEEEEEEEEeec--Cc--EEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCC----CCeeEEEEe
Q 037224          345 EGCLIQGSVYKGNIH--GE--VYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPE----DANCYLIYE  407 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~--g~--~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~~~lv~e  407 (552)
                      .|.|++|.||+|.+.  +.  .+|+|.++..         +.+|+.+++.++|+||+++++++....    ....+++||
T Consensus         7 ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e   86 (272)
T cd05075           7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILP   86 (272)
T ss_pred             cCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEE
Confidence            377888999999873  32  6899987532         346889999999999999999875422    235689999


Q ss_pred             eccCCCchhhhhhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC
Q 037224          408 YIENGSLHSWLHEN----KNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC  483 (552)
Q Consensus       408 ~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  483 (552)
                      |+++++|.+++...    ....+++..+..++.|++.||+|||+++   ++||||||+|||+++++.+||+|||+++...
T Consensus        87 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  163 (272)
T cd05075          87 FMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIY  163 (272)
T ss_pred             eCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCcccccC
Confidence            99999999887432    1234899999999999999999999998   9999999999999999999999999987543


Q ss_pred             CCc----cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCcc
Q 037224          484 NAI----TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEE  533 (552)
Q Consensus       484 ~~~----~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~  533 (552)
                      ...    .....+++.|++||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       164 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  218 (272)
T cd05075         164 NGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV  218 (272)
T ss_pred             cccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            221    112245678999999999999999999999999999999 89999754

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.96  E-value=4.5e-29  Score=248.51  Aligned_cols=184  Identities=28%  Similarity=0.429  Sum_probs=154.0

Q ss_pred             CceEEEEEEEEeec-------CcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          346 GCLIQGSVYKGNIH-------GEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       346 G~g~~G~Vy~~~~~-------g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      |.|++|.||+|...       +..||+|+++..        +.+|+.++.+++|+||+++++++.+  ....++++||+.
T Consensus        14 g~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~~~~~e~~~   91 (283)
T cd05091          14 GEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK--EQPLSMIFSYCS   91 (283)
T ss_pred             CCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CCceEEEEEcCC
Confidence            66777999999862       468999998643        3468889999999999999999977  556799999999


Q ss_pred             CCCchhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeec
Q 037224          411 NGSLHSWLHENK--------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANF  476 (552)
Q Consensus       411 ~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Df  476 (552)
                      +++|.+++....              ...+++..++.++.|++.||.|||+++   ++||||||+||++++++.+||+||
T Consensus        92 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~kl~Df  168 (283)
T cd05091          92 HSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDL  168 (283)
T ss_pred             CCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCceEeccc
Confidence            999999885321              134888999999999999999999999   999999999999999999999999


Q ss_pred             cCCccCCCCc----cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          477 GLAKSGCNAI----TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       477 g~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      |+++......    .....+++.|+|||.+.+..++.++||||||+++|||++ |..||.+..
T Consensus       169 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~  231 (283)
T cd05091         169 GLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS  231 (283)
T ss_pred             ccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            9987543221    112345678999999988889999999999999999998 888987543

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.96  E-value=5.9e-29  Score=243.63  Aligned_cols=183  Identities=31%  Similarity=0.513  Sum_probs=158.4

Q ss_pred             CCceEEEEEEEEeecCcEEEEEEeccC-----hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhhhh
Q 037224          345 EGCLIQGSVYKGNIHGEVYAIKMMKWN-----ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLH  419 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~g~~vAvK~~~~~-----~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~  419 (552)
                      .|.|++|.||++...++.+|+|..+..     +.+|+.++++++|+|++++++++..   ...+++|||+.+++|.+++.
T Consensus        14 lg~g~~g~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~~~v~e~~~~~~L~~~l~   90 (254)
T cd05083          14 IGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH---NGLYIVMELMSKGNLVNFLR   90 (254)
T ss_pred             eccCCCCceEecccCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcC---CCcEEEEECCCCCCHHHHHH
Confidence            477888999999999999999998654     3579999999999999999998864   34689999999999999998


Q ss_pred             hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccccccccccccCc
Q 037224          420 ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAP  499 (552)
Q Consensus       420 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~gt~~y~aP  499 (552)
                      ......+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++....... .....+..|+||
T Consensus        91 ~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~y~~p  166 (254)
T cd05083          91 TRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-DNSKLPVKWTAP  166 (254)
T ss_pred             hcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC-CCCCCCceecCH
Confidence            765556899999999999999999999998   9999999999999999999999999987543221 123345679999


Q ss_pred             cccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          500 EYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       500 E~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      |.+.+..++.++|+||||+++|||++ |+.||....
T Consensus       167 e~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~  202 (254)
T cd05083         167 EALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS  202 (254)
T ss_pred             HHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC
Confidence            99988899999999999999999997 999997654

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1e-28  Score=250.07  Aligned_cols=185  Identities=25%  Similarity=0.387  Sum_probs=159.5

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|.|.+|.||++..  +++.+|+|.+...          ..+|++++++++|+||+++++.+.+  +...+++|||+.++
T Consensus         9 ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~   86 (316)
T cd05574           9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT--ETYLCLVMDYCPGG   86 (316)
T ss_pred             ecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec--CCEEEEEEEecCCC
Confidence            36777799999988  5799999998542          2368999999999999999999876  67889999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-------
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-------  485 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-------  485 (552)
                      +|.+++.......+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++......       
T Consensus        87 ~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~  163 (316)
T cd05574          87 ELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKA  163 (316)
T ss_pred             CHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccccccccccc
Confidence            9999988665566999999999999999999999998   999999999999999999999999987632211       


Q ss_pred             ------------------------ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          486 ------------------------ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       486 ------------------------~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                                              ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         164 LRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             cccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence                                    0112357888999999998889999999999999999999999997554

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.96  E-value=8.4e-29  Score=244.24  Aligned_cols=182  Identities=31%  Similarity=0.486  Sum_probs=155.4

Q ss_pred             CceEEEEEEEEeec-----CcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          346 GCLIQGSVYKGNIH-----GEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       346 G~g~~G~Vy~~~~~-----g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      |.|++|.||+|.+.     ...||+|.++..        +.+|+.++++++|+||+++++++.+  ....+++|||++++
T Consensus        13 g~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~iv~e~~~~~   90 (266)
T cd05033          13 GGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK--SRPVMIITEYMENG   90 (266)
T ss_pred             cCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec--CCceEEEEEcCCCC
Confidence            77888999999873     347999998643        3468999999999999999999876  56789999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC--Cc--cc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN--AI--TM  488 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~--~~--~~  488 (552)
                      +|.+++..... .+++.+++.++.|++.||+|||+++   ++|+||||+||++++++.++|+|||++.....  ..  ..
T Consensus        91 ~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~  166 (266)
T cd05033          91 SLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK  166 (266)
T ss_pred             CHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccccccceecc
Confidence            99999876543 5899999999999999999999998   99999999999999999999999999975431  11  11


Q ss_pred             cccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCcc
Q 037224          489 HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEE  533 (552)
Q Consensus       489 ~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~  533 (552)
                      ...++..|+|||.+.+..++.++||||||+++|||++ |..||.+.
T Consensus       167 ~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~  212 (266)
T cd05033         167 GGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM  212 (266)
T ss_pred             CCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC
Confidence            1234568999999998899999999999999999998 99999654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.96  E-value=5.4e-29  Score=248.19  Aligned_cols=182  Identities=31%  Similarity=0.487  Sum_probs=158.4

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      |.|.+|.||++..  +++.||+|++...        +.+|+++++.++|+||+++++++.+  ...+++||||+++++|.
T Consensus        14 g~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~   91 (284)
T cd06620          14 GAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN--ENNICMCMEFMDCGSLD   91 (284)
T ss_pred             CCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec--CCEEEEEEecCCCCCHH
Confidence            6666799999988  5889999987432        3479999999999999999999987  57889999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccccccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHE-HTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ  494 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~gt~  494 (552)
                      +++....  .+++..+..++.+++.+|.|||+ .+   ++||||+|+||++++++.++|+|||++............++.
T Consensus        92 ~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~~~~~~~  166 (284)
T cd06620          92 RIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTS  166 (284)
T ss_pred             HHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhccCccccCc
Confidence            9887643  48999999999999999999997 46   999999999999999999999999998654333334457899


Q ss_pred             cccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       495 ~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .|+|||.+.+..++.++|+|||||++|||++|+.||....
T Consensus       167 ~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~  206 (284)
T cd06620         167 TYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSN  206 (284)
T ss_pred             ccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence            9999999988889999999999999999999999998543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.96  E-value=6.9e-29  Score=245.56  Aligned_cols=184  Identities=34%  Similarity=0.472  Sum_probs=152.9

Q ss_pred             CCceEEEEEEEEee--cCc--EEEEEEeccC--------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI--HGE--VYAIKMMKWN--------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~--~vAvK~~~~~--------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|++|.||++.+  ++.  .+++|.++..        +.+|+.+++++ +||||+++++++..  .+..+++|||+++
T Consensus         3 lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~~~~   80 (270)
T cd05047           3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLYLAIEYAPH   80 (270)
T ss_pred             CCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec--CCCceEEEEeCCC
Confidence            47788899999987  333  5788887632        23689999999 89999999999977  5678999999999


Q ss_pred             CCchhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeecc
Q 037224          412 GSLHSWLHENK--------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFG  477 (552)
Q Consensus       412 gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg  477 (552)
                      ++|.+++....              ...+++.+++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            99999987543              124789999999999999999999998   9999999999999999999999999


Q ss_pred             CCccCCCCc-cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCcc
Q 037224          478 LAKSGCNAI-TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEE  533 (552)
Q Consensus       478 ~a~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~  533 (552)
                      ++....... ......+..|+|||++....++.++||||||+++|||++ |+.||...
T Consensus       158 l~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~  215 (270)
T cd05047         158 LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM  215 (270)
T ss_pred             CccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence            986322111 111233567999999988889999999999999999997 99999654

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.96  E-value=5.5e-29  Score=248.03  Aligned_cols=184  Identities=33%  Similarity=0.484  Sum_probs=155.2

Q ss_pred             CCceEEEEEEEEee------cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI------HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~------~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|++|.||++..      +++.||+|.++..       +.+|++++++++|+|++++++++...+....++++||+++
T Consensus        12 lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~   91 (284)
T cd05081          12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPY   91 (284)
T ss_pred             ccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCC
Confidence            37777899999874      4789999998543       3479999999999999999998876556678999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccc---
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM---  488 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~---  488 (552)
                      ++|.+++..... .+++..++.++.|++.||+|||+++   ++||||||+||++++++.+||+|||++.........   
T Consensus        92 ~~L~~~l~~~~~-~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~  167 (284)
T cd05081          92 GSLRDYLQKHRE-RLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKV  167 (284)
T ss_pred             CCHHHHHHhcCc-CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccccCCCcceee
Confidence            999999875432 4899999999999999999999999   999999999999999999999999998754322111   


Q ss_pred             --cccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          489 --HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       489 --~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                        ...++..|+|||.+.+..++.++|+||||+++|||++|..|+..
T Consensus       168 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~  213 (284)
T cd05081         168 REPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCS  213 (284)
T ss_pred             cCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCC
Confidence              11234469999999888899999999999999999999877653

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.96  E-value=9.3e-30  Score=259.75  Aligned_cols=182  Identities=30%  Similarity=0.471  Sum_probs=162.3

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccCh---------HHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWNA---------CEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~~---------~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |+|-|+.|..++.  .+..||+|.+++..         .+|+++|+.++||||++++.+...  ...+|+||||+.+|.+
T Consensus        65 g~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t--~~~lylV~eya~~ge~  142 (596)
T KOG0586|consen   65 GKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET--EATLYLVMEYASGGEL  142 (596)
T ss_pred             ccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee--cceeEEEEEeccCchh
Confidence            6677799999987  89999999986542         479999999999999999999887  7789999999999999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC-CCcccccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC-NAITMHIVGT  493 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~-~~~~~~~~gt  493 (552)
                      .+++..+..  ..+.++..++.|+.+|++|||+++   |+|||||++|||++.+..+||+|||++.... .......+|+
T Consensus       143 ~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt~cgs  217 (596)
T KOG0586|consen  143 FDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQTFCGS  217 (596)
T ss_pred             HHHHHhccc--chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecccccccccCCC
Confidence            999987764  677899999999999999999999   9999999999999999999999999998544 3344567999


Q ss_pred             ccccCccccCCCCC-CChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          494 QGYIAPEYLADGVV-STKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       494 ~~y~aPE~~~~~~~-s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +.|.|||++.+..+ ++++|+||+|+++|-|+.|..||++..
T Consensus       218 ppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~  259 (596)
T KOG0586|consen  218 PPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN  259 (596)
T ss_pred             CCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc
Confidence            99999999988665 689999999999999999999999654

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.96  E-value=4.1e-29  Score=246.24  Aligned_cols=183  Identities=28%  Similarity=0.494  Sum_probs=158.4

Q ss_pred             CCceEEEEEEEEee-cCcEEEEEEeccC-------------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          345 EGCLIQGSVYKGNI-HGEVYAIKMMKWN-------------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-~g~~vAvK~~~~~-------------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      .|.|.+|.||+|.. +++.+|+|.++..             ..+|++++++++|+||+++++++.+  ....++++||++
T Consensus         8 ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~   85 (265)
T cd06631           8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD--DNTISIFMEFVP   85 (265)
T ss_pred             EeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec--CCeEEEEEecCC
Confidence            37778899999987 7889999987532             3469999999999999999999987  578899999999


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC-------
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC-------  483 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~-------  483 (552)
                      +++|.+++....  .+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++....       
T Consensus        86 ~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  160 (265)
T cd06631          86 GGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGT  160 (265)
T ss_pred             CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhcccccc
Confidence            999999997643  4889999999999999999999998   9999999999999999999999999886421       


Q ss_pred             -CCccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          484 -NAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       484 -~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                       ........++..|+|||.+.+..++.++|+||||+++|||++|+.||...+
T Consensus       161 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~  212 (265)
T cd06631         161 HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD  212 (265)
T ss_pred             ccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCC
Confidence             111223467889999999988889999999999999999999999997543

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.8e-30  Score=277.62  Aligned_cols=182  Identities=28%  Similarity=0.362  Sum_probs=161.1

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|+||.|...+.  .++.||+|++.+.          |.+|-++|..-+.+.|+.++-.|.+  +.++|+|||||+||+
T Consensus        84 GrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD--~~~LYlVMdY~pGGD  161 (1317)
T KOG0612|consen   84 GRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD--ERYLYLVMDYMPGGD  161 (1317)
T ss_pred             cccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC--ccceEEEEecccCch
Confidence            8888899999887  7889999998642          4578899999999999999888877  789999999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC---CCccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC---NAITMHI  490 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~---~~~~~~~  490 (552)
                      |..++....  ++++..++.++..|.-||.-||+.|   +|||||||+|||+|..|++||+|||.+-...   .......
T Consensus       162 lltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~a  236 (1317)
T KOG0612|consen  162 LLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVA  236 (1317)
T ss_pred             HHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEeccc
Confidence            999998765  5999999999999999999999999   9999999999999999999999999886433   2334457


Q ss_pred             cccccccCccccC----C-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          491 VGTQGYIAPEYLA----D-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       491 ~gt~~y~aPE~~~----~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +|||.|++||++.    + +.|++.+|+||+||++|||+.|..||..+.
T Consensus       237 VGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads  285 (1317)
T KOG0612|consen  237 VGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS  285 (1317)
T ss_pred             cCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH
Confidence            9999999999884    3 679999999999999999999999998654

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.96  E-value=8.6e-29  Score=245.74  Aligned_cols=184  Identities=26%  Similarity=0.426  Sum_probs=153.6

Q ss_pred             CceEEEEEEEEeec-------CcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          346 GCLIQGSVYKGNIH-------GEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       346 G~g~~G~Vy~~~~~-------g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      |.|++|.||+|.+.       +..||+|.++..        +.+|+.+++.++|+||+++++++.+  ....+++|||++
T Consensus        15 g~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--~~~~~lv~e~~~   92 (277)
T cd05062          15 GQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--GQPTLVIMELMT   92 (277)
T ss_pred             ccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC--CCCeEEEEecCC
Confidence            77778999998753       357999987532        3468999999999999999999876  567899999999


Q ss_pred             CCCchhhhhhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccC
Q 037224          411 NGSLHSWLHENKN--------ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG  482 (552)
Q Consensus       411 ~gsL~~~l~~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  482 (552)
                      +++|.+++.....        ..+++..++.++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||+++..
T Consensus        93 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~  169 (277)
T cd05062          93 RGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDI  169 (277)
T ss_pred             CCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEECCCCCcccc
Confidence            9999999865321        23678899999999999999999998   999999999999999999999999998743


Q ss_pred             CCCcc----ccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          483 CNAIT----MHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       483 ~~~~~----~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      .....    ....++..|+|||.+.+..++.++||||||+++|||++ |..||.+..
T Consensus       170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~  226 (277)
T cd05062         170 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS  226 (277)
T ss_pred             CCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            32211    11344678999999998899999999999999999999 788987543

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=7.6e-29  Score=244.36  Aligned_cols=183  Identities=27%  Similarity=0.426  Sum_probs=158.0

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEecc------------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKW------------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~------------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      |.|.+|.||++..  +++.+|+|.+..            .+.+|+.++++++|+||+++++++.+.....+++++||+++
T Consensus        11 g~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~   90 (264)
T cd06653          11 GRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPG   90 (264)
T ss_pred             ccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCC
Confidence            6777799999987  688999998732            12368999999999999999999877656678899999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC-----Cc
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN-----AI  486 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~-----~~  486 (552)
                      ++|.+++....  .+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||+++....     ..
T Consensus        91 ~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~  165 (264)
T cd06653          91 GSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTG  165 (264)
T ss_pred             CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccccccccccCcc
Confidence            99999887643  3889999999999999999999999   99999999999999999999999999874322     11


Q ss_pred             cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          487 TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       487 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      .....++..|+|||.+.+...+.++|+||||+++|||++|+.||.+.
T Consensus       166 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  212 (264)
T cd06653         166 IKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY  212 (264)
T ss_pred             ccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence            12346788999999998888999999999999999999999999754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.96  E-value=6.3e-29  Score=245.22  Aligned_cols=181  Identities=28%  Similarity=0.444  Sum_probs=156.2

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchh
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHS  416 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~  416 (552)
                      |.|++|.||++..  +++.||+|.++..       ..+|+.+++.++|+||+++++.+.+  +...+++|||+++++|.+
T Consensus        18 g~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~--~~~~~lv~e~~~~~~L~~   95 (267)
T cd06645          18 GSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR--RDKLWICMEFCGGGSLQD   95 (267)
T ss_pred             CCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CCEEEEEEeccCCCcHHH
Confidence            6777799999987  6889999998643       2468999999999999999999877  678899999999999999


Q ss_pred             hhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--ccccccccc
Q 037224          417 WLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIVGTQ  494 (552)
Q Consensus       417 ~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~gt~  494 (552)
                      ++....  .+++.+++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++......  ......|+.
T Consensus        96 ~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  170 (267)
T cd06645          96 IYHVTG--PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTP  170 (267)
T ss_pred             HHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcccccccccCcc
Confidence            886544  4899999999999999999999999   999999999999999999999999998643221  122356889


Q ss_pred             cccCccccC---CCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          495 GYIAPEYLA---DGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       495 ~y~aPE~~~---~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      .|+|||.+.   ...++.++|+|||||++|||++|+.||...
T Consensus       171 ~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~  212 (267)
T cd06645         171 YWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDL  212 (267)
T ss_pred             cccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccc
Confidence            999999874   455788999999999999999999998643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.96  E-value=7e-29  Score=247.54  Aligned_cols=183  Identities=29%  Similarity=0.491  Sum_probs=156.6

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      |.|.+|.||++..  .+..||+|.++..        +.+|+.++++++|+||+++++.+..  ++..+++|||+++++|.
T Consensus        10 g~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~l~   87 (286)
T cd06622          10 GKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI--EGAVYMCMEYMDAGSLD   87 (286)
T ss_pred             cccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec--CCeEEEEEeecCCCCHH
Confidence            6677799999988  5889999987532        3469999999999999999998877  67889999999999999


Q ss_pred             hhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcccccccc
Q 037224          416 SWLHENK-NENLNWKTRLRIAIDVANGLQYIHEH-TRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT  493 (552)
Q Consensus       416 ~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~gt  493 (552)
                      +++.... ...+++..+..++.|++.||.|||+. +   ++|+||||+||+++.++.++|+|||++............++
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  164 (286)
T cd06622          88 KLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGC  164 (286)
T ss_pred             HHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCccccCCCc
Confidence            8887642 23589999999999999999999974 6   99999999999999999999999999875544444445678


Q ss_pred             ccccCccccCCC------CCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          494 QGYIAPEYLADG------VVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       494 ~~y~aPE~~~~~------~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      ..|+|||.+.+.      .++.++|+||||+++|||++|+.||...
T Consensus       165 ~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  210 (286)
T cd06622         165 QSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE  210 (286)
T ss_pred             cCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc
Confidence            899999988544      3478999999999999999999999653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.96  E-value=6e-29  Score=254.06  Aligned_cols=185  Identities=32%  Similarity=0.490  Sum_probs=154.3

Q ss_pred             CCceEEEEEEEEee-------cCcEEEEEEeccC--------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEee
Q 037224          345 EGCLIQGSVYKGNI-------HGEVYAIKMMKWN--------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEY  408 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-------~g~~vAvK~~~~~--------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~  408 (552)
                      .|.|++|.||+|..       .++.||+|+++..        ..+|+.++.++ +|+||++++++|... +...+++|||
T Consensus        15 lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~-~~~~~~v~ey   93 (337)
T cd05054          15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP-GGPLMVIVEY   93 (337)
T ss_pred             cccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-CCCEEEEEec
Confidence            37777799999965       2468999998632        23689999999 899999999988753 4567899999


Q ss_pred             ccCCCchhhhhhcCC-----------------------------------------------------------CCCCHH
Q 037224          409 IENGSLHSWLHENKN-----------------------------------------------------------ENLNWK  429 (552)
Q Consensus       409 ~~~gsL~~~l~~~~~-----------------------------------------------------------~~l~~~  429 (552)
                      +++++|.+++.....                                                           ..+++.
T Consensus        94 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  173 (337)
T cd05054          94 CKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLE  173 (337)
T ss_pred             CCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHH
Confidence            999999998864321                                                           258999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc----cccccccccccCccccCCC
Q 037224          430 TRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI----TMHIVGTQGYIAPEYLADG  505 (552)
Q Consensus       430 ~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~  505 (552)
                      .+..++.|++.||+|||+.+   |+||||||+|||++.++.++|+|||++.......    .....++..|+|||.+.+.
T Consensus       174 ~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  250 (337)
T cd05054         174 DLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDK  250 (337)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCC
Confidence            99999999999999999998   9999999999999999999999999997542211    1123456789999999999


Q ss_pred             CCCChhhHHHHHHHHHHHHc-CCCCCCcc
Q 037224          506 VVSTKMDVFSFGVVLLELIS-GKEAIDEE  533 (552)
Q Consensus       506 ~~s~~~Dv~slG~il~ellt-G~~pf~~~  533 (552)
                      .++.++|||||||++|||++ |+.||...
T Consensus       251 ~~~~~~Di~SlGv~l~el~t~g~~p~~~~  279 (337)
T cd05054         251 VYTTQSDVWSFGVLLWEIFSLGASPYPGV  279 (337)
T ss_pred             CCCccccHHHHHHHHHHHHHcCCCCCCCC
Confidence            99999999999999999998 99999753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.96  E-value=1e-28  Score=242.41  Aligned_cols=182  Identities=29%  Similarity=0.415  Sum_probs=153.7

Q ss_pred             CCceEEEEEEEEee--cC---cEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI--HG---EVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g---~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|++|.||+|.+  .+   ..+|+|.++..        ..+|+.++++++|+|++++++++..   ...+++|||+++
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~~~~   79 (257)
T cd05060           3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG---EPLMLVMELAPL   79 (257)
T ss_pred             cCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC---CceEEEEEeCCC
Confidence            37788899999986  22   68999998643        2368999999999999999998753   457999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcc----
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT----  487 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~----  487 (552)
                      ++|.+++....  .+++..++.++.|++.+|+|||+.+   ++|+||||+||+++.++.+||+|||+++.......    
T Consensus        80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~  154 (257)
T cd05060          80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA  154 (257)
T ss_pred             CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence            99999998655  4899999999999999999999998   99999999999999999999999999874422211    


Q ss_pred             -ccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          488 -MHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       488 -~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                       ....++..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~  203 (257)
T cd05060         155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK  203 (257)
T ss_pred             ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC
Confidence             11123457999999988899999999999999999998 999997643

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.96  E-value=5.6e-29  Score=249.70  Aligned_cols=182  Identities=24%  Similarity=0.443  Sum_probs=158.4

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      .|.|.+|.||++..  +++.|++|.+...       ..+|+.+++.++|+|++++++++..  ....++|+||+++++|.
T Consensus        27 lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~  104 (296)
T cd06655          27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLV--GDELFVVMEYLAGGSLT  104 (296)
T ss_pred             EecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEec--CceEEEEEEecCCCcHH
Confidence            36777799999986  7899999988532       3468999999999999999999977  66889999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--cccccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIVGT  493 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~gt  493 (552)
                      +++...   .+++.++..++.|++.||+|||+.+   ++||||+|+||+++.++.+||+|||++......  ......++
T Consensus       105 ~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  178 (296)
T cd06655         105 DVVTET---CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT  178 (296)
T ss_pred             HHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCcCCC
Confidence            988654   3899999999999999999999999   999999999999999999999999998743322  12234678


Q ss_pred             ccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       494 ~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..|+|||.+.+..++.++|+||||+++|+|++|+.||...+
T Consensus       179 ~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~  219 (296)
T cd06655         179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN  219 (296)
T ss_pred             ccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            89999999988889999999999999999999999997654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.96  E-value=8.9e-29  Score=243.43  Aligned_cols=182  Identities=29%  Similarity=0.428  Sum_probs=159.8

Q ss_pred             CceEEEEEEEEeec--CcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNIH--GEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~~--g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|.+|.||+++..  ++.+++|++...          ..+|+.++++++|+||+++++.+.+  +...++++||+++++
T Consensus         2 g~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~   79 (262)
T cd05572           2 GVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD--KKYIYMLMEYCLGGE   79 (262)
T ss_pred             CCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc--CCccEEEEecCCCCc
Confidence            67778999999984  889999998532          3368999999999999999999876  667899999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-ccccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-ITMHIVG  492 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-~~~~~~g  492 (552)
                      |.+++....  .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++...... ......+
T Consensus        80 L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~  154 (262)
T cd05572          80 LWTILRDRG--LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCG  154 (262)
T ss_pred             HHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccC
Confidence            999997654  3899999999999999999999998   999999999999999999999999998755432 2233567


Q ss_pred             cccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       493 t~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +..|++||.+.+..++.++|+||||+++|||++|+.||....
T Consensus       155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  196 (262)
T cd05572         155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD  196 (262)
T ss_pred             CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence            889999999988889999999999999999999999998665

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.96  E-value=7.4e-29  Score=243.78  Aligned_cols=184  Identities=30%  Similarity=0.463  Sum_probs=156.4

Q ss_pred             CCceEEEEEEEEee-cCcEEEEEEecc------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhh
Q 037224          345 EGCLIQGSVYKGNI-HGEVYAIKMMKW------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSW  417 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-~g~~vAvK~~~~------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~  417 (552)
                      .|.|++|.||++.. .+..+|+|.++.      .+.+|+.++++++|+|++++++++.   +...+++|||+++++|.++
T Consensus        14 ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~---~~~~~lv~e~~~~~~L~~~   90 (260)
T cd05070          14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS---EEPIYIVTEYMSKGSLLDF   90 (260)
T ss_pred             eccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC---CCCcEEEEEecCCCcHHHH
Confidence            36677799999987 567899999864      2457999999999999999998874   3456899999999999999


Q ss_pred             hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcc---ccccccc
Q 037224          418 LHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT---MHIVGTQ  494 (552)
Q Consensus       418 l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~---~~~~gt~  494 (552)
                      +.......+++.+++.++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++........   ....++.
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~  167 (260)
T cd05070          91 LKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPI  167 (260)
T ss_pred             HHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCCCCCc
Confidence            98765556899999999999999999999998   99999999999999999999999999875432211   1123456


Q ss_pred             cccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          495 GYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       495 ~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      .|+|||.+.+..++.++|+||||+++|||++ |+.||.+.+
T Consensus       168 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~  208 (260)
T cd05070         168 KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN  208 (260)
T ss_pred             cccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence            7999999988889999999999999999999 899997643

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.96  E-value=5.5e-29  Score=245.51  Aligned_cols=181  Identities=28%  Similarity=0.499  Sum_probs=156.5

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEe
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYE  407 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  407 (552)
                      |.|.+|.||+|..  +++.+|+|.+...                ..+|+.++++++|+||+++++++.+  ....++++|
T Consensus         9 g~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e   86 (267)
T cd06628           9 GSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--ADHLNIFLE   86 (267)
T ss_pred             ecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CCccEEEEE
Confidence            6677799999987  6789999987421                3468999999999999999999877  567899999


Q ss_pred             eccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--
Q 037224          408 YIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--  485 (552)
Q Consensus       408 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--  485 (552)
                      |+++++|.+++....  .+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.++|+|||.++.....  
T Consensus        87 ~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06628          87 YVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSL  161 (267)
T ss_pred             ecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcccccccc
Confidence            999999999997653  4889999999999999999999998   999999999999999999999999998744311  


Q ss_pred             ------ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          486 ------ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       486 ------~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                            ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus       162 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  215 (267)
T cd06628         162 STKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC  215 (267)
T ss_pred             cCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc
Confidence                  111235788999999998888999999999999999999999999754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.96  E-value=5.9e-29  Score=245.31  Aligned_cols=183  Identities=22%  Similarity=0.394  Sum_probs=157.1

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEecc----------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKW----------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~----------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|.+|.||+++.  +++.||+|.++.          .+.+|+.+++.++|||++++++++.+  .+..++++||+++++
T Consensus        11 ~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~~   88 (267)
T cd08228          11 GRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE--DNELNIVLELADAGD   88 (267)
T ss_pred             ccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE--CCeEEEEEEecCCCc
Confidence            6677799999987  789999997642          13469999999999999999999887  567899999999999


Q ss_pred             chhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc--ccc
Q 037224          414 LHSWLHENK--NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI--TMH  489 (552)
Q Consensus       414 L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~--~~~  489 (552)
                      |.+++....  ...+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.......  ...
T Consensus        89 L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~  165 (267)
T cd08228          89 LSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS  165 (267)
T ss_pred             HHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccchhHHHhc
Confidence            998886432  234889999999999999999999998   9999999999999999999999999987543221  123


Q ss_pred             ccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      ..++..|+|||.+.+..++.++|+||||+++|||++|+.||...
T Consensus       166 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~  209 (267)
T cd08228         166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             CCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence            46788999999998888999999999999999999999999654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.96  E-value=6.4e-29  Score=245.07  Aligned_cols=183  Identities=23%  Similarity=0.410  Sum_probs=157.7

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEecc----------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKW----------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~----------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|.+|.||++..  +++.+++|.++.          ++.+|+.+++.++|+||+++++++.+  ++..+++|||+++++
T Consensus        11 g~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~v~e~~~~~~   88 (267)
T cd08229          11 GRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--DNELNIVLELADAGD   88 (267)
T ss_pred             cccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe--CCeEEEEEEecCCCC
Confidence            6677799999986  789999997742          23468999999999999999999887  668899999999999


Q ss_pred             chhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--cccc
Q 037224          414 LHSWLHENK--NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMH  489 (552)
Q Consensus       414 L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~  489 (552)
                      |.+++....  ...+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++......  ....
T Consensus        89 L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~  165 (267)
T cd08229          89 LSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS  165 (267)
T ss_pred             HHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccCCccccc
Confidence            999886422  245899999999999999999999999   999999999999999999999999998754322  1223


Q ss_pred             ccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      ..++..|+|||.+.+..++.++|+||||+++|||++|..||...
T Consensus       166 ~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  209 (267)
T cd08229         166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             ccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccc
Confidence            46788999999998888999999999999999999999999754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.96  E-value=1e-28  Score=247.86  Aligned_cols=185  Identities=34%  Similarity=0.491  Sum_probs=153.4

Q ss_pred             CCceEEEEEEEEee--cCc--EEEEEEecc--------ChHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI--HGE--VYAIKMMKW--------NACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~--~vAvK~~~~--------~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|++|.||++..  ++.  .+++|.++.        .+.+|+.++.++ +||||+++++++.+  ....++++||+++
T Consensus        10 lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~~lv~e~~~~   87 (297)
T cd05089          10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN--RGYLYIAIEYAPY   87 (297)
T ss_pred             ecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc--CCcceEEEEecCC
Confidence            47788899999987  333  478888763        234699999999 79999999999876  5678999999999


Q ss_pred             CCchhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeecc
Q 037224          412 GSLHSWLHENK--------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFG  477 (552)
Q Consensus       412 gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg  477 (552)
                      ++|.+++....              ...+++..++.++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||
T Consensus        88 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg  164 (297)
T cd05089          88 GNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFG  164 (297)
T ss_pred             CcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeEEECCcC
Confidence            99999986532              124889999999999999999999998   9999999999999999999999999


Q ss_pred             CCccCCCCcc-ccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          478 LAKSGCNAIT-MHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       478 ~a~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      ++........ .....+..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~  223 (297)
T cd05089         165 LSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT  223 (297)
T ss_pred             CCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            9864322111 11223457999999988889999999999999999997 999997543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.96  E-value=1.3e-28  Score=244.71  Aligned_cols=183  Identities=28%  Similarity=0.446  Sum_probs=153.3

Q ss_pred             CCceEEEEEEEEee--cCc----EEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          345 EGCLIQGSVYKGNI--HGE----VYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~----~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      .|.|++|.||+|++  +++    .||+|.++..        ..+|+.+++.++|+||+++++++..   ...++++||++
T Consensus        15 lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~~l~~~~~~   91 (279)
T cd05109          15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT---STVQLVTQLMP   91 (279)
T ss_pred             cCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC---CCcEEEEEcCC
Confidence            37777899999986  444    4899998532        2368889999999999999999875   34579999999


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcc---
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT---  487 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~---  487 (552)
                      +|+|.+++.... ..+++.+++.++.|++.||+|||+++   ++||||||+||++++++.+||+|||+++.......   
T Consensus        92 ~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~  167 (279)
T cd05109          92 YGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH  167 (279)
T ss_pred             CCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecccccceee
Confidence            999999987643 34899999999999999999999998   99999999999999999999999999875432211   


Q ss_pred             -ccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          488 -MHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       488 -~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                       ....++..|+|||...+..++.++||||||+++|||++ |+.||+...
T Consensus       168 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  216 (279)
T cd05109         168 ADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP  216 (279)
T ss_pred             cCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence             11234568999999988899999999999999999998 999997543

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.96  E-value=7.5e-29  Score=245.07  Aligned_cols=184  Identities=24%  Similarity=0.387  Sum_probs=151.6

Q ss_pred             CCceEEEEEEEEeec----CcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNIH----GEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~----g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|.|++|.||+|++.    +..+|+|.++..        +.+|+.++++++|+||+++++++.+  ....++||||++++
T Consensus         3 lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g   80 (269)
T cd05087           3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE--VTPYLLVMEFCPLG   80 (269)
T ss_pred             ccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CCCcEEEEECCCCC
Confidence            477888999999863    357999988542        3468999999999999999999876  56679999999999


Q ss_pred             CchhhhhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc---
Q 037224          413 SLHSWLHENKN---ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI---  486 (552)
Q Consensus       413 sL~~~l~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~---  486 (552)
                      +|.+++.....   ...++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++.......   
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            99999875432   24677888899999999999999998   9999999999999999999999999986433221   


Q ss_pred             -cccccccccccCccccCCC-------CCCChhhHHHHHHHHHHHHc-CCCCCCcc
Q 037224          487 -TMHIVGTQGYIAPEYLADG-------VVSTKMDVFSFGVVLLELIS-GKEAIDEE  533 (552)
Q Consensus       487 -~~~~~gt~~y~aPE~~~~~-------~~s~~~Dv~slG~il~ellt-G~~pf~~~  533 (552)
                       .....++..|+|||.+.+.       .++.++|+||||+++|||++ |+.||...
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~  213 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL  213 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCC
Confidence             1123567789999987542       35789999999999999996 99999754

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=8.1e-29  Score=245.47  Aligned_cols=181  Identities=29%  Similarity=0.436  Sum_probs=159.6

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      |.|++|.||+++.  +++.+|+|.++..        ..+|+.+++.++|+|++++++++.+  +...++++||+++++|.
T Consensus        10 g~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~   87 (274)
T cd06609          10 GKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK--GSKLWIIMEYCGGGSCL   87 (274)
T ss_pred             cCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE--CCeEEEEEEeeCCCcHH
Confidence            6777899999987  6889999998543        3468999999999999999999887  57889999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--cccccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIVGT  493 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~gt  493 (552)
                      +++...   .+++..++.++.|++.||.|||+++   ++|+||+|+||++++++.++|+|||+++.....  ......++
T Consensus        88 ~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  161 (274)
T cd06609          88 DLLKPG---KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGT  161 (274)
T ss_pred             HHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccccccccccCC
Confidence            998765   4899999999999999999999998   999999999999999999999999998754432  22335678


Q ss_pred             ccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       494 ~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..|+|||.+.+..++.++||||||+++|||+||+.||...+
T Consensus       162 ~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~  202 (274)
T cd06609         162 PFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH  202 (274)
T ss_pred             ccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc
Confidence            88999999998889999999999999999999999997543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.96  E-value=1e-28  Score=246.99  Aligned_cols=185  Identities=32%  Similarity=0.485  Sum_probs=154.6

Q ss_pred             CCceEEEEEEEEeec-------CcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeec
Q 037224          345 EGCLIQGSVYKGNIH-------GEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI  409 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~-------g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~  409 (552)
                      .|.|++|.||+|...       ...+++|.++..        +.+|+.+++.++||||+++++.+..  +...++++||+
T Consensus         8 lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~   85 (290)
T cd05045           8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ--DGPLLLIVEYA   85 (290)
T ss_pred             ccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec--CCCcEEEEEec
Confidence            377888999999862       257899987532        3469999999999999999999876  56779999999


Q ss_pred             cCCCchhhhhhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECC
Q 037224          410 ENGSLHSWLHENK----------------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS  467 (552)
Q Consensus       410 ~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~  467 (552)
                      .+++|.+++....                      ...+++..++.++.|++.||+|||+.+   ++||||||+||++++
T Consensus        86 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~nill~~  162 (290)
T cd05045          86 KYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAE  162 (290)
T ss_pred             CCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhheEEEcC
Confidence            9999999876431                      134789999999999999999999998   999999999999999


Q ss_pred             CCcEEEeeccCCccCCCCc----cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          468 NMRAKIANFGLAKSGCNAI----TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       468 ~~~~kL~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      ++.+||+|||+++......    .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.+..
T Consensus       163 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  234 (290)
T cd05045         163 GRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA  234 (290)
T ss_pred             CCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence            9999999999987432211    112345678999999988889999999999999999998 999997644

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.96  E-value=1.2e-28  Score=241.42  Aligned_cols=184  Identities=28%  Similarity=0.491  Sum_probs=157.3

Q ss_pred             CCceEEEEEEEEee-cCcEEEEEEeccC------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhh
Q 037224          345 EGCLIQGSVYKGNI-HGEVYAIKMMKWN------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSW  417 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-~g~~vAvK~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~  417 (552)
                      .|.|++|.||++.+ +++.+|+|.++..      +.+|++++++++|+|++++++++..  ....+++|||+++++|.++
T Consensus        12 ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~   89 (256)
T cd05112          12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE--RSPICLVFEFMEHGCLSDY   89 (256)
T ss_pred             ecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEcc--CCceEEEEEcCCCCcHHHH
Confidence            37777899999988 4789999988643      4579999999999999999998876  5678999999999999999


Q ss_pred             hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccc---cccccc
Q 037224          418 LHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM---HIVGTQ  494 (552)
Q Consensus       418 l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~---~~~gt~  494 (552)
                      +..... .++++.++.++.|++.+|+|||+.+   ++|+||||+||+++.++.++|+|||++.........   ...++.
T Consensus        90 ~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~  165 (256)
T cd05112          90 LRAQRG-KFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPV  165 (256)
T ss_pred             HHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccccCCCccch
Confidence            876443 4889999999999999999999998   999999999999999999999999998744322111   223456


Q ss_pred             cccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          495 GYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       495 ~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      .|+|||.+.++.++.++||||||+++|||++ |+.||....
T Consensus       166 ~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~  206 (256)
T cd05112         166 KWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS  206 (256)
T ss_pred             hhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence            8999999988889999999999999999998 999997543

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.96  E-value=9.4e-29  Score=245.48  Aligned_cols=180  Identities=28%  Similarity=0.461  Sum_probs=156.4

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      |.|.+|.||+|..  .++.||+|.++..        ..+|+.++++++|+||+++++++..  +...++||||+++++|.
T Consensus        13 ~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~   90 (277)
T cd06642          13 GKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLK--GTKLWIIMEYLGGGSAL   90 (277)
T ss_pred             cCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccccc--CCceEEEEEccCCCcHH
Confidence            5666799999987  6789999998632        3479999999999999999999876  66789999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc--ccccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI--TMHIVGT  493 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~--~~~~~gt  493 (552)
                      +++...   .+++..+..++.|+++||.|||+++   ++|+||+|+||++++++.++|+|||++.......  .....++
T Consensus        91 ~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  164 (277)
T cd06642          91 DLLKPG---PLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGT  164 (277)
T ss_pred             HHhhcC---CCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcchhhhcccCc
Confidence            988653   4899999999999999999999998   9999999999999999999999999987543221  1224578


Q ss_pred             ccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       494 ~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      ..|+|||.+.+..++.++|+||||+++|||++|+.||.+.
T Consensus       165 ~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~  204 (277)
T cd06642         165 PFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL  204 (277)
T ss_pred             ccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCccc
Confidence            8999999999888999999999999999999999999754

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.96  E-value=6.6e-29  Score=250.07  Aligned_cols=185  Identities=34%  Similarity=0.458  Sum_probs=153.3

Q ss_pred             CCceEEEEEEEEee--cCc--EEEEEEeccC--------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI--HGE--VYAIKMMKWN--------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~--~vAvK~~~~~--------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|++|.||++.+  ++.  .+++|.++..        +.+|++++.++ +|+||+++++++.+  ++..+++|||+++
T Consensus        15 lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~~~~   92 (303)
T cd05088          15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLYLAIEYAPH   92 (303)
T ss_pred             ecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC--CCCceEEEEeCCC
Confidence            47778899999986  444  4688876532        33699999999 89999999999876  6678999999999


Q ss_pred             CCchhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeecc
Q 037224          412 GSLHSWLHENK--------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFG  477 (552)
Q Consensus       412 gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg  477 (552)
                      ++|.+++....              ...+++.+++.++.|++.||+|||+++   ++||||||+|||++.++.+||+|||
T Consensus        93 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~kl~dfg  169 (303)
T cd05088          93 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  169 (303)
T ss_pred             CcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcEEeCccc
Confidence            99999987542              135889999999999999999999998   9999999999999999999999999


Q ss_pred             CCccCCCC-ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          478 LAKSGCNA-ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       478 ~a~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      ++...... .......+..|+|||.+.+..++.++||||||+++|||+| |..||...+
T Consensus       170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  228 (303)
T cd05088         170 LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT  228 (303)
T ss_pred             cCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC
Confidence            98633211 1111233567999999988889999999999999999998 999997543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.96  E-value=7.8e-29  Score=248.81  Aligned_cols=182  Identities=25%  Similarity=0.438  Sum_probs=158.3

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      .|.|.+|.||++..  +++.||+|.+...       ..+|+.+++.++|+|++++++++..  +...++||||+++++|.
T Consensus        27 lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~  104 (297)
T cd06656          27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVVMEYLAGGSLT  104 (297)
T ss_pred             eccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCEEEEeecccCCCCHH
Confidence            37777799999986  7899999998532       3468899999999999999999987  66889999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--cccccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIVGT  493 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~gt  493 (552)
                      +++...   .+++.++..++.|++.+|.|||+.+   ++||||||+||+++.++.++|+|||++......  ......++
T Consensus       105 ~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  178 (297)
T cd06656         105 DVVTET---CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT  178 (297)
T ss_pred             HHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCcccCC
Confidence            988653   3899999999999999999999998   999999999999999999999999998743322  12234678


Q ss_pred             ccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       494 ~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +.|+|||.+.+..++.++|+||||+++|+|++|+.||...+
T Consensus       179 ~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~  219 (297)
T cd06656         179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN  219 (297)
T ss_pred             ccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            89999999998889999999999999999999999997543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.96  E-value=6.9e-29  Score=243.38  Aligned_cols=183  Identities=29%  Similarity=0.438  Sum_probs=156.5

Q ss_pred             CCceEEEEEEEEeec---C--cEEEEEEeccCh--------HHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNIH---G--EVYAIKMMKWNA--------CEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~---g--~~vAvK~~~~~~--------~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|++|.||++.+.   +  ..+|+|.++...        .+|+.++++++|+||+++++++.+   ...++++||+++
T Consensus         3 ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~~~~   79 (257)
T cd05040           3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVTELAPL   79 (257)
T ss_pred             CCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEEEecCC
Confidence            367778999999872   2  368999986542        369999999999999999999875   677999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-----c
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-----I  486 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-----~  486 (552)
                      ++|.+++.......+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||++......     .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999997765345899999999999999999999998   999999999999999999999999998754321     1


Q ss_pred             cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCcc
Q 037224          487 TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEE  533 (552)
Q Consensus       487 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~  533 (552)
                      .....++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  204 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL  204 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            112456778999999988899999999999999999998 99999643

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.96  E-value=9.7e-29  Score=245.15  Aligned_cols=185  Identities=26%  Similarity=0.438  Sum_probs=155.9

Q ss_pred             CCceEEEEEEEEeec-------CcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeec
Q 037224          345 EGCLIQGSVYKGNIH-------GEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI  409 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~-------g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~  409 (552)
                      .|.|++|.||++...       +..||+|.+...        +.+|+.+++.++|+||+++++++..  ....+++|||+
T Consensus        14 lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~e~~   91 (277)
T cd05032          14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST--GQPTLVVMELM   91 (277)
T ss_pred             ecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC--CCCcEEEEecC
Confidence            377788999999873       267999998533        3468999999999999999999877  56789999999


Q ss_pred             cCCCchhhhhhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCcc
Q 037224          410 ENGSLHSWLHENKN--------ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS  481 (552)
Q Consensus       410 ~~gsL~~~l~~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  481 (552)
                      ++++|.+++.....        ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.
T Consensus        92 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~dfg~~~~  168 (277)
T cd05032          92 AKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRD  168 (277)
T ss_pred             CCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEECCcccchh
Confidence            99999999865321        23788999999999999999999998   99999999999999999999999999874


Q ss_pred             CCCCc----cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          482 GCNAI----TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       482 ~~~~~----~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      .....    .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus       169 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  226 (277)
T cd05032         169 IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS  226 (277)
T ss_pred             hccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC
Confidence            33221    122345778999999988889999999999999999998 999997543

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.96  E-value=1.4e-28  Score=244.70  Aligned_cols=184  Identities=25%  Similarity=0.446  Sum_probs=155.5

Q ss_pred             CCceEEEEEEEEee-------cCcEEEEEEecc-------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          345 EGCLIQGSVYKGNI-------HGEVYAIKMMKW-------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-------~g~~vAvK~~~~-------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      .|.|++|.||++..       ++..+|+|.++.       .+.+|+++++.++|+||+++++++.+  ....+++|||++
T Consensus        13 lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~   90 (280)
T cd05092          13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTE--GRPLLMVFEYMR   90 (280)
T ss_pred             cCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEec--CCceEEEEecCC
Confidence            47788899999964       356899998764       24578999999999999999999877  567899999999


Q ss_pred             CCCchhhhhhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeecc
Q 037224          411 NGSLHSWLHENKN-------------ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFG  477 (552)
Q Consensus       411 ~gsL~~~l~~~~~-------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg  477 (552)
                      +++|.+++.....             ..+++..++.++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||
T Consensus        91 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~kL~dfg  167 (280)
T cd05092          91 HGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFG  167 (280)
T ss_pred             CCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCEEECCCC
Confidence            9999999876432             24889999999999999999999999   9999999999999999999999999


Q ss_pred             CCccCCCCc----cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCcc
Q 037224          478 LAKSGCNAI----TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEE  533 (552)
Q Consensus       478 ~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~  533 (552)
                      ++.......    .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  228 (280)
T cd05092         168 MSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL  228 (280)
T ss_pred             ceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccC
Confidence            986432211    112234678999999998999999999999999999998 99999654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.96  E-value=1.2e-28  Score=248.07  Aligned_cols=184  Identities=29%  Similarity=0.440  Sum_probs=156.6

Q ss_pred             CceEEEEEEEEee-------cCcEEEEEEeccC--------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeec
Q 037224          346 GCLIQGSVYKGNI-------HGEVYAIKMMKWN--------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYI  409 (552)
Q Consensus       346 G~g~~G~Vy~~~~-------~g~~vAvK~~~~~--------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~  409 (552)
                      |.|++|.||++..       .+..+|+|+++..        +.+|+.+++++ +|+||+++++++..  .+..+++|||+
T Consensus        44 g~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~~  121 (302)
T cd05055          44 GAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI--GGPILVITEYC  121 (302)
T ss_pred             eccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec--CCceEEEEEcC
Confidence            7777899999974       3457999988642        34699999999 79999999999877  56789999999


Q ss_pred             cCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc---
Q 037224          410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI---  486 (552)
Q Consensus       410 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~---  486 (552)
                      .+++|.+++.......+++.+++.++.|++.||+|||+++   ++|+||||+||+++.++.++|+|||++.......   
T Consensus       122 ~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~  198 (302)
T cd05055         122 CYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV  198 (302)
T ss_pred             CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccccccCCCcee
Confidence            9999999997655445899999999999999999999998   9999999999999999999999999987443221   


Q ss_pred             -cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          487 -TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       487 -~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                       .....++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       199 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~  248 (302)
T cd05055         199 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMP  248 (302)
T ss_pred             ecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCC
Confidence             112345678999999988889999999999999999998 999987543

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.96  E-value=1.5e-28  Score=244.48  Aligned_cols=183  Identities=27%  Similarity=0.434  Sum_probs=152.2

Q ss_pred             CCceEEEEEEEEee--cCc----EEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          345 EGCLIQGSVYKGNI--HGE----VYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~----~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      .|.|++|.||+|.+  +++    .+++|.+...        ...|+..+++++|+||+++++++..   ...++++||++
T Consensus        15 lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~---~~~~~i~e~~~   91 (279)
T cd05111          15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG---ASLQLVTQLSP   91 (279)
T ss_pred             cCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC---CccEEEEEeCC
Confidence            47777899999988  454    4778877432        2246667888999999999998753   34689999999


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC----c
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA----I  486 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~----~  486 (552)
                      +|+|.+++.... ..+++..++.++.|++.||+|||+++   ++||||||+||++++++.+||+|||+++.....    .
T Consensus        92 ~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~  167 (279)
T cd05111          92 LGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYF  167 (279)
T ss_pred             CCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccCCCcccc
Confidence            999999997643 34899999999999999999999998   999999999999999999999999999743221    1


Q ss_pred             cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          487 TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       487 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      .....++..|++||.+.+..++.++||||||+++|||++ |+.||.+..
T Consensus       168 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~  216 (279)
T cd05111         168 YSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR  216 (279)
T ss_pred             cCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            122346678999999988899999999999999999998 999997654

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.96  E-value=8.4e-29  Score=247.96  Aligned_cols=182  Identities=27%  Similarity=0.463  Sum_probs=157.6

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      .|.|.+|.||++..  ++..||+|.++..       ..+|+.++++++|+|++++++.+..  .+..+++|||+++++|.
T Consensus        30 lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~lv~e~~~~~~L~  107 (292)
T cd06658          30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLV--GDELWVVMEFLEGGALT  107 (292)
T ss_pred             ccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheec--CCeEEEEEeCCCCCcHH
Confidence            36777799999987  6889999998542       3478999999999999999999877  66789999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--cccccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIVGT  493 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~gt  493 (552)
                      +++...   .+++.+++.++.|++.||+|||+++   ++||||||+||++++++.++|+|||++......  ......++
T Consensus       108 ~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~  181 (292)
T cd06658         108 DIVTHT---RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGT  181 (292)
T ss_pred             HHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeecC
Confidence            988543   3899999999999999999999998   999999999999999999999999998643221  12234678


Q ss_pred             ccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       494 ~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..|+|||.+.+..++.++|+||||+++|||++|+.||...+
T Consensus       182 ~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~  222 (292)
T cd06658         182 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP  222 (292)
T ss_pred             ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            89999999988889999999999999999999999997544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.96  E-value=2.1e-28  Score=244.41  Aligned_cols=185  Identities=31%  Similarity=0.462  Sum_probs=160.8

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      |.|.+|.||++..  .++.+|+|.+...        ..+|++++++++|+||++++++|.+.....++++|||+++++|.
T Consensus        10 g~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~   89 (287)
T cd06621          10 GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLD   89 (287)
T ss_pred             ccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHH
Confidence            6777799999998  6789999998632        34799999999999999999999776566789999999999999


Q ss_pred             hhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcccccccc
Q 037224          416 SWLHEN--KNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT  493 (552)
Q Consensus       416 ~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~gt  493 (552)
                      +++...  ....+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++............++
T Consensus        90 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  166 (287)
T cd06621          90 SIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGT  166 (287)
T ss_pred             HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccccccccccCC
Confidence            887542  2345899999999999999999999998   99999999999999999999999999875443333345678


Q ss_pred             ccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       494 ~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      ..|++||.+.+..++.++||||||+++|||++|+.||...
T Consensus       167 ~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  206 (287)
T cd06621         167 SFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE  206 (287)
T ss_pred             ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence            8999999998889999999999999999999999999865

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.96  E-value=5.5e-29  Score=249.88  Aligned_cols=182  Identities=26%  Similarity=0.452  Sum_probs=157.7

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      .|.|++|.||++..  +++.||+|.++..       ..+|+.++..++|+|++++++++..  +...++++||+++++|.
T Consensus        29 ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~iv~e~~~~~~L~  106 (297)
T cd06659          29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLV--GEELWVLMEFLQGGALT  106 (297)
T ss_pred             cCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheee--CCeEEEEEecCCCCCHH
Confidence            47778899999987  6899999998532       3468999999999999999999877  67789999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--cccccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIVGT  493 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~gt  493 (552)
                      +++...   .+++.+++.++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||++......  ......++
T Consensus       107 ~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~  180 (297)
T cd06659         107 DIVSQT---RLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGT  180 (297)
T ss_pred             HHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceecC
Confidence            877553   3899999999999999999999999   999999999999999999999999998643222  12235688


Q ss_pred             ccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       494 ~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       181 ~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  221 (297)
T cd06659         181 PYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS  221 (297)
T ss_pred             ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999988889999999999999999999999997543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.96  E-value=1.4e-28  Score=248.06  Aligned_cols=184  Identities=30%  Similarity=0.495  Sum_probs=154.0

Q ss_pred             CceEEEEEEEEeec---------CcEEEEEEeccC--------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEe
Q 037224          346 GCLIQGSVYKGNIH---------GEVYAIKMMKWN--------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYE  407 (552)
Q Consensus       346 G~g~~G~Vy~~~~~---------g~~vAvK~~~~~--------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e  407 (552)
                      |.|++|.||+++..         ...+|+|.++.+        ..+|+.+++++ +|+||+++++++..  +...+++||
T Consensus        27 g~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~--~~~~~lv~e  104 (307)
T cd05098          27 GEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ--DGPLYVIVE  104 (307)
T ss_pred             ccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec--CCceEEEEe
Confidence            77778999999752         246999998643        23689999999 79999999999977  567899999


Q ss_pred             eccCCCchhhhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEE
Q 037224          408 YIENGSLHSWLHENKN--------------ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKI  473 (552)
Q Consensus       408 ~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL  473 (552)
                      |+++++|.+++.....              ..+++.+++.++.|++.||+|||+.+   ++||||||+||+++.++.+||
T Consensus       105 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~kL  181 (307)
T cd05098         105 YASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKI  181 (307)
T ss_pred             cCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEcCCCcEEE
Confidence            9999999999976432              24889999999999999999999998   999999999999999999999


Q ss_pred             eeccCCccCCCCc----cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          474 ANFGLAKSGCNAI----TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       474 ~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      +|||.++......    .....++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       182 ~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~  247 (307)
T cd05098         182 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  247 (307)
T ss_pred             CCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence            9999987443211    111233468999999988889999999999999999998 888987543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.96  E-value=2e-28  Score=243.17  Aligned_cols=180  Identities=27%  Similarity=0.455  Sum_probs=156.7

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      |.|.+|.||+|..  .++.||+|.++..        ..+|+.++++++|+|++++++++.+  +...++||||+++++|.
T Consensus        13 g~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~   90 (277)
T cd06640          13 GKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--GTKLWIIMEYLGGGSAL   90 (277)
T ss_pred             ccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCEEEEEEecCCCCcHH
Confidence            6666699999987  6789999998632        3468999999999999999999987  67889999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--cccccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIVGT  493 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~gt  493 (552)
                      +++...   .+++.++..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++......  ......++
T Consensus        91 ~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  164 (277)
T cd06640          91 DLLRAG---PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGT  164 (277)
T ss_pred             HHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccccCc
Confidence            988653   3899999999999999999999998   999999999999999999999999998643321  12234578


Q ss_pred             ccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       494 ~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      ..|+|||.+.+...+.++|+||||+++|||++|+.||...
T Consensus       165 ~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~  204 (277)
T cd06640         165 PFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM  204 (277)
T ss_pred             ccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            8899999998888999999999999999999999999754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.96  E-value=1.5e-28  Score=242.75  Aligned_cols=184  Identities=28%  Similarity=0.438  Sum_probs=154.9

Q ss_pred             CCceEEEEEEEEee--c---CcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI--H---GEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~---g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|.+|.||+|..  .   +..+|+|.++..        +.+|+.++++++||||+++++++.+  ++..+++|||+++
T Consensus        12 lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~   89 (267)
T cd05066          12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK--SKPVMIVTEYMEN   89 (267)
T ss_pred             ecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCccEEEEEcCCC
Confidence            37777899999986  2   237999988642        3468999999999999999999876  5678999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcc----
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT----  487 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~----  487 (552)
                      ++|.+++.... ..+++.+++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++........    
T Consensus        90 ~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~  165 (267)
T cd05066          90 GSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT  165 (267)
T ss_pred             CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccccceeee
Confidence            99999997654 34899999999999999999999999   99999999999999999999999999875432211    


Q ss_pred             -ccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          488 -MHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       488 -~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                       ....++..|++||.+.+..++.++|+||||+++||+++ |+.||.+..
T Consensus       166 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~  214 (267)
T cd05066         166 TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS  214 (267)
T ss_pred             cCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC
Confidence             11123457999999998889999999999999999886 999997543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.8e-28  Score=241.03  Aligned_cols=181  Identities=27%  Similarity=0.401  Sum_probs=153.3

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccCh----------HHHHHH-HHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWNA----------CEELKI-LQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~~----------~~E~~~-l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|.+|.||++..  +++.||+|.++...          ..|..+ ....+|+|++++++++..  +...++++||+++
T Consensus         4 l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~   81 (260)
T cd05611           4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS--KDYLYLVMEYLNG   81 (260)
T ss_pred             CCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEEEEEeccCC
Confidence            36677799999987  68899999986431          123333 334489999999999976  6788999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcccccc
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIV  491 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~  491 (552)
                      ++|.+++....  .+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++.....  .....
T Consensus        82 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--~~~~~  154 (260)
T cd05611          82 GDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE--NKKFV  154 (260)
T ss_pred             CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc--cccCC
Confidence            99999987654  4899999999999999999999998   99999999999999999999999999875432  22346


Q ss_pred             ccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          492 GTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       492 gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ++..|++||.+.+..++.++||||||+++|||++|..||...+
T Consensus       155 ~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  197 (260)
T cd05611         155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET  197 (260)
T ss_pred             CCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC
Confidence            7889999999988888999999999999999999999997543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.96  E-value=2.5e-28  Score=244.46  Aligned_cols=191  Identities=27%  Similarity=0.422  Sum_probs=158.5

Q ss_pred             HHHHHhhccCCCceEEEEEEEEee--cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEE
Q 037224          335 ELREATDNFSEGCLIQGSVYKGNI--HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLI  405 (552)
Q Consensus       335 ~l~~~t~~~~~G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  405 (552)
                      +.++..+.+  |.|.+|.||+++.  +++.+++|.++..       +.+|+.++++++|+|++++++.+..  +..+++|
T Consensus        12 ~~y~i~~~l--g~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv   87 (292)
T cd06644          12 EVWEIIGEL--GDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYW--DGKLWIM   87 (292)
T ss_pred             hhhhhhhee--cCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe--CCeEEEE
Confidence            444444444  5666799999987  5789999998643       3368899999999999999999877  6688999


Q ss_pred             EeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC
Q 037224          406 YEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA  485 (552)
Q Consensus       406 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~  485 (552)
                      |||+++++|..++.... ..+++..++.++.|++.+|.|||+.+   ++||||||+||+++.++.++|+|||++......
T Consensus        88 ~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  163 (292)
T cd06644          88 IEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT  163 (292)
T ss_pred             EecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence            99999999988776543 34899999999999999999999998   999999999999999999999999988643221


Q ss_pred             --ccccccccccccCccccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          486 --ITMHIVGTQGYIAPEYLA-----DGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       486 --~~~~~~gt~~y~aPE~~~-----~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                        ......++..|+|||.+.     ...++.++|+||||+++|||++|+.||...
T Consensus       164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~  218 (292)
T cd06644         164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL  218 (292)
T ss_pred             ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc
Confidence              122346788999999874     345678999999999999999999999754

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.96  E-value=1.7e-28  Score=247.20  Aligned_cols=184  Identities=30%  Similarity=0.510  Sum_probs=154.2

Q ss_pred             CCceEEEEEEEEee---------cCcEEEEEEeccC--------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEE
Q 037224          345 EGCLIQGSVYKGNI---------HGEVYAIKMMKWN--------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIY  406 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~---------~g~~vAvK~~~~~--------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~  406 (552)
                      .|.|++|.||+++.         ++..+|+|.++..        ..+|+.+++.+ +|+||+++++++..  +...+++|
T Consensus        23 lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~lv~  100 (304)
T cd05101          23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ--DGPLYVIV  100 (304)
T ss_pred             eeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec--CCceEEEE
Confidence            37777899999974         2347999998642        33689999999 89999999999877  56789999


Q ss_pred             eeccCCCchhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEE
Q 037224          407 EYIENGSLHSWLHENK--------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAK  472 (552)
Q Consensus       407 e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~k  472 (552)
                      ||+++++|.+++....              ...+++.+++.++.|+++||.|||+++   ++||||||+||+++.++.+|
T Consensus       101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili~~~~~~k  177 (304)
T cd05101         101 EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLVTENNVMK  177 (304)
T ss_pred             ecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEEcCCCcEE
Confidence            9999999999987642              134788999999999999999999999   99999999999999999999


Q ss_pred             EeeccCCccCCCCc----cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCcc
Q 037224          473 IANFGLAKSGCNAI----TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEE  533 (552)
Q Consensus       473 L~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~  533 (552)
                      |+|||+++......    .....++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus       178 l~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~  243 (304)
T cd05101         178 IADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI  243 (304)
T ss_pred             ECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence            99999987543211    112344678999999988889999999999999999998 88888654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.96  E-value=2.2e-28  Score=241.06  Aligned_cols=184  Identities=22%  Similarity=0.401  Sum_probs=158.5

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEecc----------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKW----------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~----------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|.+|.||++..  +|+.||+|.++.          ...+|++++++++|+|++++++.+.+  +...+++|||+++++
T Consensus        11 g~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~   88 (267)
T cd08224          11 GKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE--NNELNIVLELADAGD   88 (267)
T ss_pred             ccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeEEEEEecCCCCC
Confidence            6777799999988  689999998742          13479999999999999999999987  567899999999999


Q ss_pred             chhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--cccc
Q 037224          414 LHSWLHENK--NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMH  489 (552)
Q Consensus       414 L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~  489 (552)
                      |.+++....  ...+++.+++.++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++......  ....
T Consensus        89 L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~  165 (267)
T cd08224          89 LSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS  165 (267)
T ss_pred             HHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccCCCcccce
Confidence            999886532  245899999999999999999999999   999999999999999999999999998743321  1223


Q ss_pred             ccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..++..|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus       166 ~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  210 (267)
T cd08224         166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK  210 (267)
T ss_pred             ecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC
Confidence            467889999999988889999999999999999999999996543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.96  E-value=1.9e-28  Score=241.92  Aligned_cols=184  Identities=28%  Similarity=0.465  Sum_probs=154.4

Q ss_pred             CCceEEEEEEEEee--cCc---EEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI--HGE---VYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~---~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|++|.||+++.  +++   .+++|..+..        +.+|+.++++++|+|++++.+++.+  .+..+++|||+++
T Consensus        13 lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~   90 (268)
T cd05063          13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK--FKPAMIITEYMEN   90 (268)
T ss_pred             ecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc--CCCcEEEEEcCCC
Confidence            47777899999987  333   7999998643        2468999999999999999999876  5678999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccc---
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM---  488 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~---  488 (552)
                      ++|.+++.... ..+++.++..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++.........   
T Consensus        91 ~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~  166 (268)
T cd05063          91 GALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYT  166 (268)
T ss_pred             CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccccccccee
Confidence            99999987643 34899999999999999999999998   999999999999999999999999998744322111   


Q ss_pred             --cccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          489 --HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       489 --~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                        ....+..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus       167 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~  215 (268)
T cd05063         167 TSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS  215 (268)
T ss_pred             ccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence              1123457999999988889999999999999999997 999996543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.96  E-value=2.1e-28  Score=240.49  Aligned_cols=187  Identities=29%  Similarity=0.427  Sum_probs=160.8

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      .|.|++|.||++..  +++.+|+|.++..         ..+|+.++++++|+|++++++++....+...+++|||+++++
T Consensus         8 lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~   87 (265)
T cd08217           8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGD   87 (265)
T ss_pred             eccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCC
Confidence            37778899999987  7789999988532         235889999999999999999887655677899999999999


Q ss_pred             chhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc
Q 037224          414 LHSWLHENK--NENLNWKTRLRIAIDVANGLQYIH-----EHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI  486 (552)
Q Consensus       414 L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH-----~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~  486 (552)
                      |.+++....  ...+++.+++.++.|++.||.|||     +.+   ++|+||+|+||+++.++.+||+|||++.......
T Consensus        88 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~  164 (265)
T cd08217          88 LAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS  164 (265)
T ss_pred             HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEecccccccccCCc
Confidence            999986542  345899999999999999999999     666   9999999999999999999999999987544322


Q ss_pred             --cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          487 --TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       487 --~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                        .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+
T Consensus       165 ~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  214 (265)
T cd08217         165 SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN  214 (265)
T ss_pred             ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC
Confidence              233568899999999988889999999999999999999999998653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.96  E-value=1.4e-28  Score=243.02  Aligned_cols=183  Identities=28%  Similarity=0.420  Sum_probs=154.3

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      .|.|.+|.||+|..  ++..|++|.++..       ..+|+.++++++|+||+++++++..  +...++++||+++++|.
T Consensus        16 lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~   93 (268)
T cd06624          16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE--NGFFKIFMEQVPGGSLS   93 (268)
T ss_pred             EecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc--CCEEEEEEecCCCCCHH
Confidence            37888899999987  5678999987543       3478999999999999999999877  67889999999999999


Q ss_pred             hhhhhcCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECC-CCcEEEeeccCCccCCC--Cccccc
Q 037224          416 SWLHENKNENL--NWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS-NMRAKIANFGLAKSGCN--AITMHI  490 (552)
Q Consensus       416 ~~l~~~~~~~l--~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kL~Dfg~a~~~~~--~~~~~~  490 (552)
                      +++..... .+  ++..+..++.|++.||+|||+.+   ++||||||+||+++. ++.++|+|||++.....  ......
T Consensus        94 ~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~  169 (268)
T cd06624          94 ALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF  169 (268)
T ss_pred             HHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccC
Confidence            99876432 24  78889999999999999999998   999999999999976 67999999999864322  112234


Q ss_pred             cccccccCccccCCCC--CCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          491 VGTQGYIAPEYLADGV--VSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       491 ~gt~~y~aPE~~~~~~--~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      .++..|+|||.+....  ++.++|+||||+++|+|++|+.||...
T Consensus       170 ~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~  214 (268)
T cd06624         170 TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL  214 (268)
T ss_pred             CCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccc
Confidence            5788999999986543  788999999999999999999999753

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.96  E-value=1.3e-28  Score=246.12  Aligned_cols=182  Identities=26%  Similarity=0.465  Sum_probs=154.8

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      |.|.+|.||++..  +++.||+|.++..        ..+|++++++++|+||+++++++.+  +...++||||+.+ +|.
T Consensus        14 g~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~-~L~   90 (291)
T cd07844          14 GEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHT--KKTLTLVFEYLDT-DLK   90 (291)
T ss_pred             eecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEec--CCeEEEEEecCCC-CHH
Confidence            6677799999987  6889999998532        3469999999999999999999876  6788999999985 999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--cccccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIVGT  493 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~gt  493 (552)
                      +++..... .+++..++.++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||+++.....  ......++
T Consensus        91 ~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  166 (291)
T cd07844          91 QYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVT  166 (291)
T ss_pred             HHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCccccccccc
Confidence            98876543 5899999999999999999999998   999999999999999999999999998643221  11123467


Q ss_pred             ccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          494 QGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       494 ~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..|+|||.+.+ ..++.++||||+|+++|||++|+.||....
T Consensus       167 ~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~  208 (291)
T cd07844         167 LWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST  208 (291)
T ss_pred             cccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence            88999998865 457889999999999999999999997554

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.96  E-value=1.3e-28  Score=242.56  Aligned_cols=182  Identities=24%  Similarity=0.425  Sum_probs=150.4

Q ss_pred             CCceEEEEEEEEeec--------------CcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeE
Q 037224          345 EGCLIQGSVYKGNIH--------------GEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCY  403 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~--------------g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  403 (552)
                      .|.|.+|.||+|++.              ...+++|.++..       +.+|+.+++.++||||+++++++.+  +...+
T Consensus         3 lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~--~~~~~   80 (262)
T cd05077           3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVR--DVENI   80 (262)
T ss_pred             cccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCCCE
Confidence            377888999999862              125889987532       3467889999999999999999987  55679


Q ss_pred             EEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCc-------EEEeec
Q 037224          404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR-------AKIANF  476 (552)
Q Consensus       404 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~-------~kL~Df  476 (552)
                      ++|||+++++|..++.... ..+++..++.++.|+++||+|||+++   ++||||||+|||++.++.       ++++||
T Consensus        81 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             EEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            9999999999988876543 34899999999999999999999998   999999999999987664       899999


Q ss_pred             cCCccCCCCccccccccccccCccccC-CCCCCChhhHHHHHHHHHHHH-cCCCCCCccC
Q 037224          477 GLAKSGCNAITMHIVGTQGYIAPEYLA-DGVVSTKMDVFSFGVVLLELI-SGKEAIDEEG  534 (552)
Q Consensus       477 g~a~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~Dv~slG~il~ell-tG~~pf~~~~  534 (552)
                      |++......  ....++..|+|||.+. +..++.++||||||+++|||+ +|+.||....
T Consensus       157 g~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~  214 (262)
T cd05077         157 GIPITVLSR--QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT  214 (262)
T ss_pred             CCCccccCc--ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc
Confidence            998644322  2345788899999886 466889999999999999997 6888887543

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.9e-28  Score=243.60  Aligned_cols=183  Identities=28%  Similarity=0.437  Sum_probs=156.1

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchh
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHS  416 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~  416 (552)
                      |.|.+|.||++..  ++..+|+|..+..       +.+|++++++++|+|++++++.+..  +...++||||+++++|.+
T Consensus        14 ~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~   91 (280)
T cd06611          14 GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFY--ENKLWILIEFCDGGALDS   91 (280)
T ss_pred             cCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEec--CCeEEEEeeccCCCcHHH
Confidence            5666799999987  5789999998533       3469999999999999999999987  668899999999999999


Q ss_pred             hhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--ccccccccc
Q 037224          417 WLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIVGTQ  494 (552)
Q Consensus       417 ~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~gt~  494 (552)
                      ++.... ..+++.+++.++.|++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||++......  ......++.
T Consensus        92 ~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  167 (280)
T cd06611          92 IMLELE-RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTP  167 (280)
T ss_pred             HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccccccceeecch
Confidence            887643 34899999999999999999999999   999999999999999999999999988643221  222346788


Q ss_pred             cccCccccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          495 GYIAPEYLA-----DGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       495 ~y~aPE~~~-----~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .|++||.+.     ...++.++|+||||+++|||++|+.||...+
T Consensus       168 ~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~  212 (280)
T cd06611         168 YWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN  212 (280)
T ss_pred             hhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC
Confidence            999999874     3446779999999999999999999997643

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-29  Score=230.96  Aligned_cols=186  Identities=26%  Similarity=0.358  Sum_probs=154.6

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCC---CCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPE---DANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~---~~~~~lv~e~~~~gs  413 (552)
                      |.|+|..||.++.  +++.+|+|++.-.       ..+|++..++++|||+++++++.....   ....|++++|...|+
T Consensus        30 geGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gs  109 (302)
T KOG2345|consen   30 GEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGS  109 (302)
T ss_pred             cCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhcccc
Confidence            5666677888875  8899999998432       357999999999999999999886432   235899999999999


Q ss_pred             chhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc-----
Q 037224          414 LHSWLHENK--NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI-----  486 (552)
Q Consensus       414 L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-----  486 (552)
                      |.+.+...+  +..+++.+++.|+.++++||++||+.. +++.||||||.|||+.+++.++|.|||.+....-..     
T Consensus       110 l~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~  188 (302)
T KOG2345|consen  110 LLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQ  188 (302)
T ss_pred             HHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccccceEeechHH
Confidence            999987654  345999999999999999999999986 569999999999999999999999999986432111     


Q ss_pred             ------cccccccccccCccccC---CCCCCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          487 ------TMHIVGTQGYIAPEYLA---DGVVSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       487 ------~~~~~gt~~y~aPE~~~---~~~~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                            ......|..|.|||.+.   +...++++|||||||+||+|+.|..||+.
T Consensus       189 a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~  243 (302)
T KOG2345|consen  189 ALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER  243 (302)
T ss_pred             HHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence                  11135788999999875   45678999999999999999999999983

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.96  E-value=1.5e-28  Score=242.06  Aligned_cols=182  Identities=33%  Similarity=0.538  Sum_probs=159.6

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      |.|.+|.||++..  +++.+++|.+...        ..+|++++++++|+||+++++.+..  +...++++||+++++|.
T Consensus        10 g~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~   87 (265)
T cd06605          10 GAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN--NGDISICMEYMDGGSLD   87 (265)
T ss_pred             cCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec--CCEEEEEEEecCCCcHH
Confidence            6667799999988  5889999988543        3468999999999999999999987  57889999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccccccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHE-HTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ  494 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~gt~  494 (552)
                      +++.... ..+++..+..++.|++.+|+|||+ .+   ++|+||+|+||++++++.++|+|||.+............++.
T Consensus        88 ~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  163 (265)
T cd06605          88 KILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTS  163 (265)
T ss_pred             HHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhcccCCh
Confidence            9987653 458999999999999999999999 88   999999999999999999999999998754333222367888


Q ss_pred             cccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       495 ~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      .|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus       164 ~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  202 (265)
T cd06605         164 SYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE  202 (265)
T ss_pred             hccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence            999999998889999999999999999999999999765

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.96  E-value=1.6e-28  Score=241.25  Aligned_cols=182  Identities=32%  Similarity=0.487  Sum_probs=158.0

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|.+|.||+++.  +|+.+++|.++..          ..+|++++++++|+|++++++.+..  +...++++||+++++
T Consensus         2 g~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~   79 (265)
T cd05579           2 SKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG--KKNLYLVMEYLPGGD   79 (265)
T ss_pred             CCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec--CcEEEEEEecCCCCc
Confidence            6677899999998  4899999998543          2368899999999999999988876  678899999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--------
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--------  485 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--------  485 (552)
                      |.+++....  .+++..+..++.|+++||+|||+.+   ++|+||+|+||++++++.++|+|||++......        
T Consensus        80 L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          80 LASLLENVG--SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            999987654  4899999999999999999999998   999999999999999999999999998743322        


Q ss_pred             --ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          486 --ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       486 --~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                        ......++..|++||.......+.++|+||||+++|||++|+.||....
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~  205 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET  205 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence              1223467789999999988889999999999999999999999997543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.96  E-value=2.6e-28  Score=245.94  Aligned_cols=182  Identities=24%  Similarity=0.351  Sum_probs=155.4

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|.+|.||++..  .++.|++|.++..          ..+|+++++.++|+||+++++.+..  +...+++|||+++++
T Consensus        10 ~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~g~~   87 (305)
T cd05609          10 SNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET--KRHLCMVMEYVEGGD   87 (305)
T ss_pred             ecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec--CCEEEEEEecCCCCc
Confidence            5666699999987  6789999988543          2368899999999999999998876  668899999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--------
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--------  485 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--------  485 (552)
                      |.+++....  .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||+++.....        
T Consensus        88 L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~  162 (305)
T cd05609          88 CATLLKNIG--ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEG  162 (305)
T ss_pred             HHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccccc
Confidence            999997654  4899999999999999999999998   999999999999999999999999988631100        


Q ss_pred             ---------ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          486 ---------ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       486 ---------~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                               ......++..|+|||.+.+..++.++|+||||+++|||++|+.||.+..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~  220 (305)
T cd05609         163 HIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT  220 (305)
T ss_pred             ccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                     0112356788999999988889999999999999999999999997543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.96  E-value=2.1e-28  Score=240.74  Aligned_cols=183  Identities=27%  Similarity=0.468  Sum_probs=150.2

Q ss_pred             CCceEEEEEEEEee-----cCcEEEEEEecc--------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI-----HGEVYAIKMMKW--------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-----~g~~vAvK~~~~--------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|++|.||+|.+     .+..+|+|.+..        .+.+|+.+++.++|+|++++++++... +...++++||+.+
T Consensus         3 lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~lv~e~~~~   81 (262)
T cd05058           3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS-EGSPLVVLPYMKH   81 (262)
T ss_pred             ccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC-CCCcEEEEecCCC
Confidence            37778899999986     235799998843        123688899999999999999987643 3457899999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc-----
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI-----  486 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-----  486 (552)
                      ++|.+++..... .+++..++.++.|+++||.|||+.+   ++||||||+|||+++++.+||+|||+++......     
T Consensus        82 ~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          82 GDLRNFIRSETH-NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            999999876432 3678888999999999999999998   9999999999999999999999999987432211     


Q ss_pred             -cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcC-CCCCCc
Q 037224          487 -TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG-KEAIDE  532 (552)
Q Consensus       487 -~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG-~~pf~~  532 (552)
                       .....++..|+|||.+.+..++.++||||||+++|||++| ..||..
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~  205 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD  205 (262)
T ss_pred             ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC
Confidence             1123456789999999888999999999999999999995 556654

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.96  E-value=2e-28  Score=243.10  Aligned_cols=184  Identities=34%  Similarity=0.499  Sum_probs=153.5

Q ss_pred             CceEEEEEEEEeec-------CcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          346 GCLIQGSVYKGNIH-------GEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       346 G~g~~G~Vy~~~~~-------g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      |.|++|.||++.+.       +..|++|..+..        +.+|+.++++++|+||+++++++.+  ....+++|||++
T Consensus        15 g~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~   92 (277)
T cd05036          15 GHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE--RLPRFILLELMA   92 (277)
T ss_pred             CCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc--CCCcEEEEecCC
Confidence            77777999999883       367899987532        3468899999999999999998876  556799999999


Q ss_pred             CCCchhhhhhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCC---cEEEeeccCCccC
Q 037224          411 NGSLHSWLHENKN-----ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM---RAKIANFGLAKSG  482 (552)
Q Consensus       411 ~gsL~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~---~~kL~Dfg~a~~~  482 (552)
                      +++|.+++.....     ..+++.+++.++.|++.||+|||+++   ++||||||+||+++.++   .+||+|||+++..
T Consensus        93 g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~  169 (277)
T cd05036          93 GGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDI  169 (277)
T ss_pred             CCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEeccCcccccc
Confidence            9999999876532     25899999999999999999999998   99999999999998765   5999999998754


Q ss_pred             CCCccc----cccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          483 CNAITM----HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       483 ~~~~~~----~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      ......    ....+..|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus       170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~  226 (277)
T cd05036         170 YRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT  226 (277)
T ss_pred             CCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            322111    1223467999999998999999999999999999997 999998654

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.96  E-value=2.3e-28  Score=241.66  Aligned_cols=187  Identities=29%  Similarity=0.475  Sum_probs=154.5

Q ss_pred             CCceEEEEEEEEeec-----CcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCC----CeeEEEE
Q 037224          345 EGCLIQGSVYKGNIH-----GEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPED----ANCYLIY  406 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~-----g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~~~lv~  406 (552)
                      .|.|++|.||+|...     +..||+|.++.+         +.+|+.+++.++|+|++++++++.....    ...++++
T Consensus         7 lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~   86 (273)
T cd05035           7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVIL   86 (273)
T ss_pred             cCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEE
Confidence            377888999999872     367999998643         3468999999999999999998865322    2478999


Q ss_pred             eeccCCCchhhhhhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccC
Q 037224          407 EYIENGSLHSWLHENK----NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG  482 (552)
Q Consensus       407 e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  482 (552)
                      ||+++++|.+++....    ...+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++..
T Consensus        87 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  163 (273)
T cd05035          87 PFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKI  163 (273)
T ss_pred             eccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCccceeec
Confidence            9999999998885432    235899999999999999999999998   999999999999999999999999998754


Q ss_pred             CCCcc----ccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          483 CNAIT----MHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       483 ~~~~~----~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      .....    .....+..|+|||.+....++.++||||||+++|||++ |..||.+..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~  220 (273)
T cd05035         164 YSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE  220 (273)
T ss_pred             cccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence            32211    11234568999999988889999999999999999999 899987543

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.96  E-value=2.5e-28  Score=240.04  Aligned_cols=183  Identities=26%  Similarity=0.457  Sum_probs=156.4

Q ss_pred             CceEEEEEEEEee-cCcEEEEEEeccC------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhhh
Q 037224          346 GCLIQGSVYKGNI-HGEVYAIKMMKWN------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL  418 (552)
Q Consensus       346 G~g~~G~Vy~~~~-~g~~vAvK~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l  418 (552)
                      |.|++|.||++.. .+..+++|.++..      +.+|+.++++++|+|++++.+++.+   ...+++|||+++++|.+++
T Consensus        15 g~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~v~e~~~~~~L~~~~   91 (260)
T cd05073          15 GAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYIITEFMAKGSLLDFL   91 (260)
T ss_pred             cCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCeEEEEEeCCCCcHHHHH
Confidence            6777899999987 5678999988643      3479999999999999999988765   4679999999999999999


Q ss_pred             hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc---ccccccccc
Q 037224          419 HENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI---TMHIVGTQG  495 (552)
Q Consensus       419 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~---~~~~~gt~~  495 (552)
                      .......+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||.+.......   .....++..
T Consensus        92 ~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  168 (260)
T cd05073          92 KSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK  168 (260)
T ss_pred             HhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCCccccc
Confidence            8765556899999999999999999999998   9999999999999999999999999987443221   112234567


Q ss_pred             ccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          496 YIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       496 y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      |+|||.+....++.++|+||||+++|++++ |+.||...+
T Consensus       169 y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~  208 (260)
T cd05073         169 WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS  208 (260)
T ss_pred             ccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC
Confidence            999999988889999999999999999998 999997643

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.96  E-value=1.6e-28  Score=244.68  Aligned_cols=182  Identities=26%  Similarity=0.406  Sum_probs=155.3

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|.+|.||+++.  +|+.||+|++...         +.+|+.++++++|+|++++++++..  ....+++|||+++++|
T Consensus        10 ~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~v~e~~~~~~l   87 (286)
T cd07847          10 GEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR--KRKLHLVFEYCDHTVL   87 (286)
T ss_pred             cccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee--CCEEEEEEeccCccHH
Confidence            6777799999988  5889999987421         3479999999999999999999987  6678999999999888


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc--cccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI--TMHIVG  492 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~--~~~~~g  492 (552)
                      ..++....  .+++.+++.++.|++.+|+|||+.+   ++|+||||+||+++.++.++|+|||++.......  .....+
T Consensus        88 ~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  162 (286)
T cd07847          88 NELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA  162 (286)
T ss_pred             HHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcccccCccc
Confidence            87765433  4899999999999999999999998   9999999999999999999999999987543322  223456


Q ss_pred             cccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          493 TQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       493 t~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +..|+|||.+.+ ..++.++|+||||+++|||++|+.||.+..
T Consensus       163 ~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~  205 (286)
T cd07847         163 TRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKS  205 (286)
T ss_pred             ccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            789999998865 557889999999999999999999997654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.96  E-value=1.5e-28  Score=246.07  Aligned_cols=184  Identities=29%  Similarity=0.486  Sum_probs=155.3

Q ss_pred             CceEEEEEEEEeec-------CcEEEEEEeccC--------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeec
Q 037224          346 GCLIQGSVYKGNIH-------GEVYAIKMMKWN--------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYI  409 (552)
Q Consensus       346 G~g~~G~Vy~~~~~-------g~~vAvK~~~~~--------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~  409 (552)
                      |.|++|.||++...       ...+|+|.++..        ..+|+.++.++ +|+||+++++++..  ++..+++|||+
T Consensus        21 g~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~li~e~~   98 (293)
T cd05053          21 GEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ--EGPLYVVVEYA   98 (293)
T ss_pred             cccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC--CCCeEEEEEeC
Confidence            77788999999863       257999998643        34689999999 89999999999876  66789999999


Q ss_pred             cCCCchhhhhhc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEee
Q 037224          410 ENGSLHSWLHEN--------------KNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIAN  475 (552)
Q Consensus       410 ~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~D  475 (552)
                      ++++|.+++...              ....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|
T Consensus        99 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~~~~~kL~D  175 (293)
T cd05053          99 AHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIAD  175 (293)
T ss_pred             CCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcCCCeEEeCc
Confidence            999999998652              2345899999999999999999999998   99999999999999999999999


Q ss_pred             ccCCccCCCCcc----ccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          476 FGLAKSGCNAIT----MHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       476 fg~a~~~~~~~~----~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      ||+++.......    ....++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus       176 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  239 (293)
T cd05053         176 FGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP  239 (293)
T ss_pred             cccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC
Confidence            999975432211    11234567999999988899999999999999999997 999987543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.96  E-value=2.1e-28  Score=239.80  Aligned_cols=184  Identities=24%  Similarity=0.429  Sum_probs=159.6

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEecc---------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKW---------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~---------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|.+|.+|+++.  +|+.||+|.+..         +..+|+.++++++|+||+++++++.+  ....++++||+.+++|
T Consensus         9 g~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~l   86 (256)
T cd08218           9 GEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE--NGNLYIVMDYCEGGDL   86 (256)
T ss_pred             ccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC--CCeEEEEEecCCCCcH
Confidence            6777799999887  788999998742         23479999999999999999999876  6788999999999999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc--cccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI--TMHIVG  492 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~--~~~~~g  492 (552)
                      .+++.......+++.+++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......  .....+
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~  163 (256)
T cd08218          87 YKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIG  163 (256)
T ss_pred             HHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhhccC
Confidence            99987655556899999999999999999999998   9999999999999999999999999987543321  123457


Q ss_pred             cccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       493 t~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ++.|+|||.+.+...+.++|+||||+++|+|++|+.||...+
T Consensus       164 ~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~  205 (256)
T cd08218         164 TPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN  205 (256)
T ss_pred             CccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC
Confidence            889999999988889999999999999999999999997543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=2.3e-28  Score=240.17  Aligned_cols=183  Identities=28%  Similarity=0.438  Sum_probs=158.1

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchh
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHS  416 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~  416 (552)
                      |.|.+|.||++..  +++.+++|.+...       ..+|+.++++++|+|++++++++.+  ....+++|||+++++|.+
T Consensus        12 ~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~l~~e~~~~~~l~~   89 (262)
T cd06613          12 GSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLR--RDKLWIVMEYCGGGSLQD   89 (262)
T ss_pred             cCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEe--CCEEEEEEeCCCCCcHHH
Confidence            6677799999987  5788999998643       3478999999999999999999877  678899999999999999


Q ss_pred             hhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--ccccccccc
Q 037224          417 WLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIVGTQ  494 (552)
Q Consensus       417 ~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~gt~  494 (552)
                      ++.... ..+++.++..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||.+......  ......++.
T Consensus        90 ~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  165 (262)
T cd06613          90 IYQVTR-GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTP  165 (262)
T ss_pred             HHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhhccccccCCc
Confidence            887652 24899999999999999999999998   999999999999999999999999998754322  122346788


Q ss_pred             cccCccccCCC---CCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          495 GYIAPEYLADG---VVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       495 ~y~aPE~~~~~---~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .|+|||.+...   .++.++|+||||+++|||++|+.||.+..
T Consensus       166 ~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~  208 (262)
T cd06613         166 YWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH  208 (262)
T ss_pred             cccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            99999998776   78899999999999999999999997643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.96  E-value=2.3e-28  Score=241.48  Aligned_cols=184  Identities=29%  Similarity=0.476  Sum_probs=154.0

Q ss_pred             CCceEEEEEEEEee--cC---cEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI--HG---EVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g---~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|++|.||+|.+  ++   ..||+|.++..        +.+|+.++++++||||+++++++.+  +...+++|||+++
T Consensus        12 lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~lv~e~~~~   89 (269)
T cd05065          12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK--SRPVMIITEFMEN   89 (269)
T ss_pred             ecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC--CCceEEEEecCCC
Confidence            37788899999987  23   36999998642        3468999999999999999999876  6678999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccc---
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM---  488 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~---  488 (552)
                      ++|.+++.... ..+++.+++.++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||++.........   
T Consensus        90 ~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  165 (269)
T cd05065          90 GALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY  165 (269)
T ss_pred             CcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCcccccc
Confidence            99999987643 34899999999999999999999998   999999999999999999999999998643321111   


Q ss_pred             --ccc--ccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          489 --HIV--GTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       489 --~~~--gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                        ...  .+..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus       166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~  216 (269)
T cd05065         166 TSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS  216 (269)
T ss_pred             ccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC
Confidence              111  1347999999998999999999999999999886 999997543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.96  E-value=2.3e-28  Score=239.33  Aligned_cols=182  Identities=29%  Similarity=0.480  Sum_probs=159.2

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC-----hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhhh
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN-----ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL  418 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~-----~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l  418 (552)
                      |.|.+|.||++..  +++.+++|.++..     +.+|++++++++|+|++++++++.+  +...++++||+++++|.+++
T Consensus        12 ~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l~~e~~~~~~L~~~l   89 (256)
T cd06612          12 GEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK--NTDLWIVMEYCGAGSVSDIM   89 (256)
T ss_pred             cCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCcEEEEEecCCCCcHHHHH
Confidence            6667799999998  4789999998643     4579999999999999999999987  57889999999999999998


Q ss_pred             hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--ccccccccccc
Q 037224          419 HENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIVGTQGY  496 (552)
Q Consensus       419 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~gt~~y  496 (552)
                      .... ..+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||++......  ......++..|
T Consensus        90 ~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y  165 (256)
T cd06612          90 KITN-KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFW  165 (256)
T ss_pred             HhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCccccccccCCccc
Confidence            6543 35899999999999999999999998   999999999999999999999999998754332  22234578899


Q ss_pred             cCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          497 IAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       497 ~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      +|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       166 ~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~  202 (256)
T cd06612         166 MAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI  202 (256)
T ss_pred             cCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence            9999998889999999999999999999999999754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.96  E-value=3.2e-28  Score=241.98  Aligned_cols=186  Identities=26%  Similarity=0.406  Sum_probs=156.9

Q ss_pred             CCceEEEEEEEEeec------CcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          345 EGCLIQGSVYKGNIH------GEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~------g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      .|.|.+|.||+|...      +..|++|.++..        ..+|+.++++++|+|++++++++... +...++++||++
T Consensus        14 i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~~~~~~~~~~~   92 (280)
T cd05043          14 LQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-GEPPFVLYPYMN   92 (280)
T ss_pred             ecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CCCCEEEEEcCC
Confidence            377788999999873      578999988643        34689999999999999999988753 456789999999


Q ss_pred             CCCchhhhhhcCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC
Q 037224          411 NGSLHSWLHENKN------ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN  484 (552)
Q Consensus       411 ~gsL~~~l~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  484 (552)
                      +++|.+++.....      ..+++.+++.++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||+++....
T Consensus        93 ~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~  169 (280)
T cd05043          93 WGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFP  169 (280)
T ss_pred             CCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCCCCcccccC
Confidence            9999999866432      35899999999999999999999998   99999999999999999999999999974322


Q ss_pred             Cc----cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          485 AI----TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       485 ~~----~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      ..    .....++..|+|||.+.+..++.++||||||+++||+++ |+.||...+
T Consensus       170 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  224 (280)
T cd05043         170 MDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID  224 (280)
T ss_pred             CceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC
Confidence            11    112345678999999988889999999999999999999 999997643

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.96  E-value=2.8e-28  Score=253.91  Aligned_cols=184  Identities=31%  Similarity=0.499  Sum_probs=154.8

Q ss_pred             CCceEEEEEEEEeec-------CcEEEEEEeccC--------hHHHHHHHHHcC-CCCccceeeeeecCCCCeeEEEEee
Q 037224          345 EGCLIQGSVYKGNIH-------GEVYAIKMMKWN--------ACEELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEY  408 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~-------g~~vAvK~~~~~--------~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~lv~e~  408 (552)
                      .|.|++|.||++++.       +..||+|+++..        ..+|+.++.++. |+||++++++|..  ....++||||
T Consensus        45 lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~--~~~~~iv~E~  122 (401)
T cd05107          45 LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK--GGPIYIITEY  122 (401)
T ss_pred             ccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc--CCCcEEEEec
Confidence            477788999999863       358999999643        336999999997 9999999999977  5678999999


Q ss_pred             ccCCCchhhhhhcCC-----------------------------------------------------------------
Q 037224          409 IENGSLHSWLHENKN-----------------------------------------------------------------  423 (552)
Q Consensus       409 ~~~gsL~~~l~~~~~-----------------------------------------------------------------  423 (552)
                      +++|+|.++++....                                                                 
T Consensus       123 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  202 (401)
T cd05107         123 CRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYA  202 (401)
T ss_pred             cCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhh
Confidence            999999999865321                                                                 


Q ss_pred             -------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEE
Q 037224          424 -------------------------------ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAK  472 (552)
Q Consensus       424 -------------------------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~k  472 (552)
                                                     ..+++.+++.++.|++.||+|||+.+   ++||||||+|||+++++.+|
T Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~~~~~~k  279 (401)
T cd05107         203 DIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLICEGKLVK  279 (401)
T ss_pred             hhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEeCCCEEE
Confidence                                           23677888999999999999999998   99999999999999999999


Q ss_pred             EeeccCCccCCCC----ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCcc
Q 037224          473 IANFGLAKSGCNA----ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEE  533 (552)
Q Consensus       473 L~Dfg~a~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~  533 (552)
                      |+|||+++.....    ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       280 L~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~  345 (401)
T cd05107         280 ICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL  345 (401)
T ss_pred             EEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence            9999998743211    1122356788999999988889999999999999999998 89998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.96  E-value=1.3e-28  Score=245.35  Aligned_cols=183  Identities=31%  Similarity=0.490  Sum_probs=155.2

Q ss_pred             CCceEEEEEEEEee------cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          345 EGCLIQGSVYKGNI------HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~------~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      .|.|++|.||++++      .+..||+|.++..        +.+|+.++++++|+|++++.+++.+......+++|||++
T Consensus        12 lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~   91 (284)
T cd05079          12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP   91 (284)
T ss_pred             cCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccC
Confidence            36677799999874      4778999998632        346999999999999999999988754567899999999


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc----
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI----  486 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~----  486 (552)
                      +++|.+++.... ..+++.+++.++.|++.||+|||+++   ++||||||+||+++.++.++|+|||+++......    
T Consensus        92 g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~  167 (284)
T cd05079          92 SGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT  167 (284)
T ss_pred             CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccccccCcccee
Confidence            999999986543 24899999999999999999999999   9999999999999999999999999987543221    


Q ss_pred             -cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCC
Q 037224          487 -TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID  531 (552)
Q Consensus       487 -~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~  531 (552)
                       .....++..|+|||.+.+..++.++||||||+++|||++++.|+.
T Consensus       168 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~  213 (284)
T cd05079         168 VKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSES  213 (284)
T ss_pred             ecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCc
Confidence             112456678999999988889999999999999999999877653

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.96  E-value=1.8e-28  Score=245.18  Aligned_cols=186  Identities=28%  Similarity=0.405  Sum_probs=155.3

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC------hHHHHHHHHHc-CCCCccceeeeeecCC---CCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN------ACEELKILQKV-NHGNLVKLEGFCIDPE---DANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~------~~~E~~~l~~l-~h~niv~l~~~~~~~~---~~~~~lv~e~~~~gs  413 (552)
                      |.|.+|.||++..  +++.+|+|.++..      ..+|+.+++++ +|+|++++++++...+   ....++|+||+++++
T Consensus        31 ~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~s  110 (291)
T cd06639          31 GKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGS  110 (291)
T ss_pred             ecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCc
Confidence            6777899999987  6889999998532      23688899998 8999999999987533   246899999999999


Q ss_pred             chhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--cccc
Q 037224          414 LHSWLHEN--KNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMH  489 (552)
Q Consensus       414 L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~  489 (552)
                      |.+++...  ....+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++......  ....
T Consensus       111 L~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  187 (291)
T cd06639         111 VTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT  187 (291)
T ss_pred             HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEeecccchhcccccccccC
Confidence            99988642  2345899999999999999999999998   999999999999999999999999998753321  1223


Q ss_pred             ccccccccCccccCCC-----CCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          490 IVGTQGYIAPEYLADG-----VVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~~-----~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..++..|+|||.+...     .++.++||||||+++|||++|+.||....
T Consensus       188 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~  237 (291)
T cd06639         188 SVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH  237 (291)
T ss_pred             ccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc
Confidence            4678899999987543     36789999999999999999999997653

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.96  E-value=1.7e-28  Score=244.34  Aligned_cols=183  Identities=29%  Similarity=0.489  Sum_probs=156.0

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|.+|.||+++.  +|+.||+|.++.+         +.+|++++++++|+||+++++++.+  +...+++|||+. ++|
T Consensus         9 ~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~-~~l   85 (284)
T cd07860           9 GEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYLVFEFLH-QDL   85 (284)
T ss_pred             cCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc--CCcEEEEeeccc-cCH
Confidence            6677799999987  6889999988532         3479999999999999999999876  667899999996 589


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--ccccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIVG  492 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~g  492 (552)
                      .+++.......+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||++......  ......+
T Consensus        86 ~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  162 (284)
T cd07860          86 KKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV  162 (284)
T ss_pred             HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCccccccccc
Confidence            88887665566899999999999999999999998   999999999999999999999999998743322  1222356


Q ss_pred             cccccCccccCCCC-CCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          493 TQGYIAPEYLADGV-VSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       493 t~~y~aPE~~~~~~-~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +..|+|||.+.+.. ++.++||||||+++|||+||+.||..++
T Consensus       163 ~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~  205 (284)
T cd07860         163 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS  205 (284)
T ss_pred             cccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            78899999876544 6889999999999999999999997654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.96  E-value=1.3e-28  Score=245.35  Aligned_cols=180  Identities=27%  Similarity=0.437  Sum_probs=152.3

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEecc---------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKW---------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~---------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|.+|.||++..  +|+.+|+|.++.         ...+|+.++++++|+|++++++++.+  ....++++||+++ +|
T Consensus         9 ~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~-~l   85 (284)
T cd07839           9 GEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS--DKKLTLVFEYCDQ-DL   85 (284)
T ss_pred             cccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc--CCceEEEEecCCC-CH
Confidence            6677799999988  688999999853         23479999999999999999999876  6678999999975 88


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--ccccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIVG  492 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~g  492 (552)
                      .+++.... ..+++..++.++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||+++.....  ......+
T Consensus        86 ~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  161 (284)
T cd07839          86 KKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV  161 (284)
T ss_pred             HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCCcc
Confidence            88776543 34899999999999999999999998   999999999999999999999999998743321  1123456


Q ss_pred             cccccCccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          493 TQGYIAPEYLADG-VVSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       493 t~~y~aPE~~~~~-~~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                      +..|+|||.+.+. .++.++||||||+++|||+||..||..
T Consensus       162 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~  202 (284)
T cd07839         162 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  202 (284)
T ss_pred             ccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence            8899999988664 468999999999999999999998653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.96  E-value=2.2e-28  Score=241.67  Aligned_cols=180  Identities=25%  Similarity=0.343  Sum_probs=154.7

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccChH--HHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccCCCchhhhh
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWNAC--EELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLH  419 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~~~--~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~  419 (552)
                      .|.|.+|.||++..  ++..+|+|..+....  .|......+ +|+|++++++.+..  ++..++||||+++++|.+++.
T Consensus        24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~~~~h~~iv~~~~~~~~--~~~~~iv~e~~~~~~L~~~l~  101 (267)
T PHA03390         24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTT--LKGHVLIMDYIKDGDLFDLLK  101 (267)
T ss_pred             ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHHhhcCCCEEEEEEEEec--CCeeEEEEEcCCCCcHHHHHH
Confidence            58888899999987  788999999875432  244433333 79999999999987  568899999999999999997


Q ss_pred             hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCC-cEEEeeccCCccCCCCccccccccccccC
Q 037224          420 ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM-RAKIANFGLAKSGCNAITMHIVGTQGYIA  498 (552)
Q Consensus       420 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~~~~~~~~~~~gt~~y~a  498 (552)
                      ...  .+++.+++.++.|+++||.|||+.+   ++||||+|+||+++.++ .++|+|||++......  ....++..|+|
T Consensus       102 ~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~y~a  174 (267)
T PHA03390        102 KEG--KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--SCYDGTLDYFS  174 (267)
T ss_pred             hcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--ccCCCCCcccC
Confidence            654  5999999999999999999999999   99999999999999988 9999999998754322  23467889999


Q ss_pred             ccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          499 PEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       499 PE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      ||.+.+..++.++||||||+++|||++|+.||...
T Consensus       175 PE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  209 (267)
T PHA03390        175 PEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKED  209 (267)
T ss_pred             hhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            99999888999999999999999999999999754

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=4.4e-29  Score=250.59  Aligned_cols=181  Identities=28%  Similarity=0.438  Sum_probs=151.9

Q ss_pred             CCceEEEEEEEEee-cCcEEEEEEecc---------ChHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          345 EGCLIQGSVYKGNI-HGEVYAIKMMKW---------NACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-~g~~vAvK~~~~---------~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      .|+|+...||++.. +.+.+|+|++..         .+.+|+..|.+| .|.+|+++++|-..  ++.+|+||||-+. +
T Consensus       369 iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~--d~~lYmvmE~Gd~-D  445 (677)
T KOG0596|consen  369 IGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT--DGYLYMVMECGDI-D  445 (677)
T ss_pred             hcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc--CceEEEEeecccc-c
Confidence            48888899999988 567888887642         245899999999 69999999999887  8899999998765 9


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc----ccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI----TMH  489 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~----~~~  489 (552)
                      |..+|.........| .++.+..||+.++.++|++|   |||.||||.|+|+ -.|.+||+|||.|.......    ...
T Consensus       446 L~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTTsI~kds  520 (677)
T KOG0596|consen  446 LNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTTSIVKDS  520 (677)
T ss_pred             HHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEE-EeeeEEeeeechhcccCccccceeecc
Confidence            999998876543334 78889999999999999999   9999999999998 56789999999998554332    234


Q ss_pred             ccccccccCccccCCCC-----------CCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          490 IVGTQGYIAPEYLADGV-----------VSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~~~-----------~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      .+||+.||+||.+....           .++++||||||||||+|+.|+.||..-
T Consensus       521 QvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~  575 (677)
T KOG0596|consen  521 QVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI  575 (677)
T ss_pred             ccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH
Confidence            68999999999875322           567899999999999999999999753

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.96  E-value=1.6e-28  Score=240.84  Aligned_cols=180  Identities=28%  Similarity=0.480  Sum_probs=151.9

Q ss_pred             CCceEEEEEEEEeecCc------------EEEEEEeccC------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEE
Q 037224          345 EGCLIQGSVYKGNIHGE------------VYAIKMMKWN------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIY  406 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~g~------------~vAvK~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  406 (552)
                      .|.|++|.||+|.+.+.            .+++|.++..      +.+|+.++++++|+||+++++++..   ...+++|
T Consensus         3 lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~lv~   79 (259)
T cd05037           3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR---DENIMVE   79 (259)
T ss_pred             ccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec---CCcEEEE
Confidence            37778899999998322            4788876533      3478999999999999999999876   3458999


Q ss_pred             eeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCC-------cEEEeeccCC
Q 037224          407 EYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM-------RAKIANFGLA  479 (552)
Q Consensus       407 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~-------~~kL~Dfg~a  479 (552)
                      ||+++++|.+++..... .+++..++.++.|++.||+|||+++   ++||||||+||+++.++       .+||+|||++
T Consensus        80 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          80 EYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            99999999999876543 5899999999999999999999998   99999999999999887       7999999998


Q ss_pred             ccCCCCccccccccccccCccccCCC--CCCChhhHHHHHHHHHHHHc-CCCCCCcc
Q 037224          480 KSGCNAITMHIVGTQGYIAPEYLADG--VVSTKMDVFSFGVVLLELIS-GKEAIDEE  533 (552)
Q Consensus       480 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~Dv~slG~il~ellt-G~~pf~~~  533 (552)
                      .....  .....++..|+|||++...  .++.++||||||+++|||++ |..||...
T Consensus       156 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~  210 (259)
T cd05037         156 ITVLS--REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL  210 (259)
T ss_pred             ccccc--ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccC
Confidence            75433  2234567789999998776  78999999999999999999 57788655

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.96  E-value=3.6e-28  Score=245.94  Aligned_cols=185  Identities=29%  Similarity=0.507  Sum_probs=154.2

Q ss_pred             CCceEEEEEEEEee---------cCcEEEEEEeccC--------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEE
Q 037224          345 EGCLIQGSVYKGNI---------HGEVYAIKMMKWN--------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIY  406 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~---------~g~~vAvK~~~~~--------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~  406 (552)
                      .|.|++|.||+++.         ....+|+|.++..        +.+|+.+++++ +|+||+++++++.+  +...+++|
T Consensus        20 lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~   97 (314)
T cd05099          20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ--EGPLYVIV   97 (314)
T ss_pred             ecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc--CCceEEEE
Confidence            47778899999974         2457999998642        23689999999 69999999999876  56789999


Q ss_pred             eeccCCCchhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEE
Q 037224          407 EYIENGSLHSWLHENK--------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAK  472 (552)
Q Consensus       407 e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~k  472 (552)
                      ||+++++|.+++....              ...+++.++..++.|++.||.|||+++   ++||||||+||+++.++.+|
T Consensus        98 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~k  174 (314)
T cd05099          98 EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMK  174 (314)
T ss_pred             ecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEcCCCcEE
Confidence            9999999999986532              134889999999999999999999998   99999999999999999999


Q ss_pred             EeeccCCccCCCCc----cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          473 IANFGLAKSGCNAI----TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       473 L~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      |+|||+++......    .....++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus       175 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~  241 (314)
T cd05099         175 IADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP  241 (314)
T ss_pred             EccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence            99999997543211    111233457999999988889999999999999999999 899987543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.96  E-value=1.8e-28  Score=243.19  Aligned_cols=182  Identities=24%  Similarity=0.421  Sum_probs=149.9

Q ss_pred             CCceEEEEEEEEeec--------------------------CcEEEEEEeccC-------hHHHHHHHHHcCCCCcccee
Q 037224          345 EGCLIQGSVYKGNIH--------------------------GEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLE  391 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~--------------------------g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~  391 (552)
                      .|.|.+|.||+|.+.                          ...|++|+++..       +.+|+.+++.++|+||++++
T Consensus         3 lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~~   82 (274)
T cd05076           3 LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVH   82 (274)
T ss_pred             cCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeEE
Confidence            478888999999751                          125889988542       34678899999999999999


Q ss_pred             eeeecCCCCeeEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCC--
Q 037224          392 GFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM--  469 (552)
Q Consensus       392 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~--  469 (552)
                      ++|.+  +...++||||+++++|.+++.... ..+++..+..++.|+++||+|||+++   ++||||||+||+++..+  
T Consensus        83 ~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          83 GVCVR--GSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEe--CCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence            99987  567799999999999999886543 35899999999999999999999998   99999999999997643  


Q ss_pred             -----cEEEeeccCCccCCCCccccccccccccCccccCC-CCCCChhhHHHHHHHHHHH-HcCCCCCCccC
Q 037224          470 -----RAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLEL-ISGKEAIDEEG  534 (552)
Q Consensus       470 -----~~kL~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~el-ltG~~pf~~~~  534 (552)
                           .+|++|||.+......  ....++..|+|||.+.+ ..++.++||||||+++||| ++|+.||....
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~  226 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR--EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT  226 (274)
T ss_pred             cCccceeeecCCccccccccc--cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence                 4899999987643221  22456788999998865 5689999999999999998 57999997643

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.96  E-value=4.2e-28  Score=242.63  Aligned_cols=182  Identities=25%  Similarity=0.428  Sum_probs=152.8

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      |.|.+|.||++..  +|+.||+|+++..        ..+|+.+++.++|+||+++++++.+  +...++++||+. ++|.
T Consensus        14 g~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~lv~e~~~-~~l~   90 (291)
T cd07870          14 GEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT--KETLTFVFEYMH-TDLA   90 (291)
T ss_pred             EecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec--CCeEEEEEeccc-CCHH
Confidence            6777899999976  6889999998532        3479999999999999999999876  567899999996 5777


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--cccccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIVGT  493 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~gt  493 (552)
                      +++.... ..+.+.++..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++.....  ......++
T Consensus        91 ~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  166 (291)
T cd07870          91 QYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVT  166 (291)
T ss_pred             HHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCCcccc
Confidence            7765443 34788899999999999999999998   999999999999999999999999998743221  12234568


Q ss_pred             ccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          494 QGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       494 ~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus       167 ~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~  208 (291)
T cd07870         167 LWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS  208 (291)
T ss_pred             ccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence            89999998865 357889999999999999999999997644

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.96  E-value=2.7e-28  Score=242.98  Aligned_cols=182  Identities=29%  Similarity=0.420  Sum_probs=156.5

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|.+|.||++..  +|+.|++|+++..         ..+|+.++++++|+|++++++++.+  +...++|+||+ +++|
T Consensus         9 ~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~e~~-~~~L   85 (286)
T cd07832           9 GEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH--GSGFVLVMEYM-PSDL   85 (286)
T ss_pred             ccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec--CCeeEEEeccc-CCCH
Confidence            6677799999987  6889999998532         3478999999999999999999987  67889999999 9999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc---ccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI---TMHIV  491 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~---~~~~~  491 (552)
                      .+++.... ..+++.+++.++.|++++|+|||+.+   ++|+||+|+||+++.++.++|+|||++.......   .....
T Consensus        86 ~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  161 (286)
T cd07832          86 SEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV  161 (286)
T ss_pred             HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcccccc
Confidence            99886544 45999999999999999999999998   9999999999999999999999999987543322   23456


Q ss_pred             ccccccCccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          492 GTQGYIAPEYLADG-VVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       492 gt~~y~aPE~~~~~-~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ++..|+|||.+.+. .++.++||||+|+++|||++|++||....
T Consensus       162 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~  205 (286)
T cd07832         162 ATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN  205 (286)
T ss_pred             CcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC
Confidence            88899999988654 46889999999999999999988886554

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.96  E-value=5.4e-28  Score=240.28  Aligned_cols=183  Identities=28%  Similarity=0.473  Sum_probs=154.4

Q ss_pred             CCceEEEEEEEEee--cCc----EEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          345 EGCLIQGSVYKGNI--HGE----VYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~----~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      .|.|++|.||+|.+  +|+    .+|+|..+..        +.+|+.++++++|+|++++++++..   ...++++||++
T Consensus        15 ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~v~e~~~   91 (279)
T cd05057          15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS---SQVQLITQLMP   91 (279)
T ss_pred             ecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec---CceEEEEecCC
Confidence            37777899999986  333    5899987543        2368999999999999999999875   46789999999


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcc---
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT---  487 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~---  487 (552)
                      +++|.+++..... .+++..++.++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||.++.......   
T Consensus        92 ~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  167 (279)
T cd05057          92 LGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYH  167 (279)
T ss_pred             CCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccCccccee
Confidence            9999999876543 3899999999999999999999998   99999999999999999999999999975432211   


Q ss_pred             -ccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          488 -MHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       488 -~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                       ....++..|+|||.+....++.++|+||||+++||+++ |+.||+...
T Consensus       168 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  216 (279)
T cd05057         168 AEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP  216 (279)
T ss_pred             cCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC
Confidence             11223567999999988889999999999999999998 999998654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.96  E-value=5.6e-28  Score=236.56  Aligned_cols=184  Identities=28%  Similarity=0.436  Sum_probs=158.6

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|.+|.||++..  +++.+|+|.+...         ..+|+.++++++|+|++++++.+..  +...++||||+++++|
T Consensus         9 g~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L   86 (256)
T cd08220           9 GRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE--DKALMIVMEYAPGGTL   86 (256)
T ss_pred             cccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec--CCEEEEEEecCCCCCH
Confidence            6677799999877  7889999988532         3468999999999999999998876  6788999999999999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCC-CcEEEeeccCCccCCCC-ccccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN-MRAKIANFGLAKSGCNA-ITMHIVG  492 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kL~Dfg~a~~~~~~-~~~~~~g  492 (552)
                      .+++.......+++..+..++.|++.+|+|||+++   ++|+||+|+||+++++ +.+||+|||.+...... ......+
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~  163 (256)
T cd08220          87 AEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVG  163 (256)
T ss_pred             HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcccccccc
Confidence            99998765556899999999999999999999998   9999999999999865 45899999998754332 2223567


Q ss_pred             cccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       493 t~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +..|+|||.+.+...+.++||||||+++|+|++|+.||...+
T Consensus       164 ~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  205 (256)
T cd08220         164 TPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN  205 (256)
T ss_pred             CCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc
Confidence            889999999988889999999999999999999999997643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.96  E-value=1.6e-28  Score=242.47  Aligned_cols=184  Identities=32%  Similarity=0.513  Sum_probs=154.3

Q ss_pred             CCceEEEEEEEEeecC--------cEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEee
Q 037224          345 EGCLIQGSVYKGNIHG--------EVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEY  408 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~g--------~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~  408 (552)
                      .|.|.+|.||+++...        +.+|+|.+...        +.+|+.+++.++|+||+++++++.+  ....+++|||
T Consensus         3 lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~   80 (269)
T cd05044           3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL--NEPQYIIMEL   80 (269)
T ss_pred             cccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC--CCCeEEEEec
Confidence            4788889999998732        57899987532        3478999999999999999999876  5678999999


Q ss_pred             ccCCCchhhhhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCC-----cEEEeeccC
Q 037224          409 IENGSLHSWLHENK-----NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM-----RAKIANFGL  478 (552)
Q Consensus       409 ~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~-----~~kL~Dfg~  478 (552)
                      +++++|.+++....     ...+++.+++.++.|++.||.|||+.+   ++|+||+|+||+++.++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999987532     234789999999999999999999998   99999999999999877     899999999


Q ss_pred             CccCCCCc----cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCcc
Q 037224          479 AKSGCNAI----TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEE  533 (552)
Q Consensus       479 a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~  533 (552)
                      +.......    .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~  217 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL  217 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc
Confidence            86432211    112344678999999999999999999999999999998 99999754

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.96  E-value=4.1e-28  Score=245.43  Aligned_cols=187  Identities=28%  Similarity=0.463  Sum_probs=156.6

Q ss_pred             CCceEEEEEEEEee----cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          345 EGCLIQGSVYKGNI----HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~----~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      .|.|.+|.||+|..    .++.||+|.++..          ..+|+.++++++||||+++++++.+......++||||++
T Consensus         8 ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~   87 (316)
T cd07842           8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAE   87 (316)
T ss_pred             eccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCC
Confidence            36777899999998    4689999998762          347999999999999999999998865578999999997


Q ss_pred             CCCchhhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECC----CCcEEEeeccCCccCC
Q 037224          411 NGSLHSWLHENK---NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS----NMRAKIANFGLAKSGC  483 (552)
Q Consensus       411 ~gsL~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~----~~~~kL~Dfg~a~~~~  483 (552)
                      + +|.+++....   ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.    ++.+||+|||++....
T Consensus        88 ~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~  163 (316)
T cd07842          88 H-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN  163 (316)
T ss_pred             c-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCccccccC
Confidence            5 6776664332   135899999999999999999999999   999999999999999    9999999999987543


Q ss_pred             CCc-----cccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          484 NAI-----TMHIVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       484 ~~~-----~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      ...     .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.....
T Consensus       164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~  221 (316)
T cd07842         164 APLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA  221 (316)
T ss_pred             CCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence            221     123467888999998765 4578999999999999999999999986654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.96  E-value=4e-28  Score=242.39  Aligned_cols=184  Identities=30%  Similarity=0.461  Sum_probs=154.2

Q ss_pred             CCceEEEEEEEEee-------cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeec
Q 037224          345 EGCLIQGSVYKGNI-------HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI  409 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-------~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~  409 (552)
                      .|.|++|.||++..       ++..+|+|.++..        +.+|+.++++++|+|++++++++.+  +...++++||+
T Consensus        13 lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~   90 (288)
T cd05050          13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV--GKPMCLLFEYM   90 (288)
T ss_pred             ccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC--CCccEEEEecC
Confidence            37788899999986       3578999998543        3468999999999999999999876  56789999999


Q ss_pred             cCCCchhhhhhcCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCC
Q 037224          410 ENGSLHSWLHENKN--------------------ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM  469 (552)
Q Consensus       410 ~~gsL~~~l~~~~~--------------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~  469 (552)
                      ++++|.+++.....                    ..+++.+++.++.|++.||+|||+++   ++||||||+||+++.++
T Consensus        91 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~nil~~~~~  167 (288)
T cd05050          91 AYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENM  167 (288)
T ss_pred             CCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhheEecCCC
Confidence            99999999874321                    24788899999999999999999998   99999999999999999


Q ss_pred             cEEEeeccCCccCCCCc----cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCcc
Q 037224          470 RAKIANFGLAKSGCNAI----TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEE  533 (552)
Q Consensus       470 ~~kL~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~  533 (552)
                      .++|+|||++.......    ......+..|+|||.+.+..++.++||||||+++|||++ |..||.+.
T Consensus       168 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~  236 (288)
T cd05050         168 VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM  236 (288)
T ss_pred             ceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999986432111    112234567999999988899999999999999999997 88898643

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=3.3e-29  Score=254.08  Aligned_cols=196  Identities=27%  Similarity=0.363  Sum_probs=163.4

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|-|+||.|.++..  ....||+|.+++.          ...|-+||...+.+.||+|+-.|.+  .+.+|+||||++||
T Consensus       637 iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD--kdnLYFVMdYIPGG  714 (1034)
T KOG0608|consen  637 IGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD--KDNLYFVMDYIPGG  714 (1034)
T ss_pred             ecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc--CCceEEEEeccCCc
Confidence            48888899999876  5668999988643          2258999999999999999988877  77899999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC---------
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC---------  483 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~---------  483 (552)
                      ++..+|-+.+  .|.+..++.++.++.+|+++.|..|   +|||||||+|||||.+|.+||.|||++.-..         
T Consensus       715 DmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq  789 (1034)
T KOG0608|consen  715 DMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ  789 (1034)
T ss_pred             cHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecccccccc
Confidence            9999887654  4899999999999999999999999   9999999999999999999999999984100         


Q ss_pred             -------C----------------------------CccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCC
Q 037224          484 -------N----------------------------AITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKE  528 (552)
Q Consensus       484 -------~----------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~  528 (552)
                             +                            ......+||+.|+|||++....++..+|+||.|||||||+.|+.
T Consensus       790 ~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~  869 (1034)
T KOG0608|consen  790 EGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQP  869 (1034)
T ss_pred             CCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCC
Confidence                   0                            00011368999999999999999999999999999999999999


Q ss_pred             CCCccCcccccchHHHHHH
Q 037224          529 AIDEEGKFCGQKLKGYWRE  547 (552)
Q Consensus       529 pf~~~~~~~~~~~~~~~~~  547 (552)
                      ||..+.+...+--..-|+.
T Consensus       870 pf~~~tp~~tq~kv~nw~~  888 (1034)
T KOG0608|consen  870 PFLADTPGETQYKVINWRN  888 (1034)
T ss_pred             CccCCCCCcceeeeeehhh
Confidence            9998776443333333443

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.96  E-value=5.8e-28  Score=238.70  Aligned_cols=184  Identities=23%  Similarity=0.391  Sum_probs=147.9

Q ss_pred             CCceEEEEEEEEee-cC---cEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI-HG---EVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-~g---~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|.|.+|.||+++. ++   ..+++|.++..        +.+|+.+++.++||||+++++.|.+  ....+++|||++++
T Consensus         3 lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~   80 (268)
T cd05086           3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE--AIPYLLVFEYCELG   80 (268)
T ss_pred             CCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecC--CCccEEEEecCCCC
Confidence            47778899999976 22   34667766432        3468888999999999999999987  56789999999999


Q ss_pred             CchhhhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC----c
Q 037224          413 SLHSWLHENKN--ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA----I  486 (552)
Q Consensus       413 sL~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~----~  486 (552)
                      +|.+++.....  ..+++..++.++.|++.||+|||+.+   ++||||||+|||++.++.++|+|||++......    .
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            99999976432  34677788899999999999999998   999999999999999999999999997632211    1


Q ss_pred             cccccccccccCccccCC-------CCCCChhhHHHHHHHHHHHHc-CCCCCCcc
Q 037224          487 TMHIVGTQGYIAPEYLAD-------GVVSTKMDVFSFGVVLLELIS-GKEAIDEE  533 (552)
Q Consensus       487 ~~~~~gt~~y~aPE~~~~-------~~~s~~~Dv~slG~il~ellt-G~~pf~~~  533 (552)
                      .....++..|+|||++..       ..++.++||||||+++|||++ |..||...
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~  212 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL  212 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Confidence            123467889999998743       235778999999999999996 57788644

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.96  E-value=1.4e-28  Score=241.50  Aligned_cols=182  Identities=30%  Similarity=0.422  Sum_probs=159.6

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|++|.||+++.  .++.+|+|.+...          ..+|++++++++||||+++++.+.+  ....++++||+.+++
T Consensus         9 ~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~   86 (258)
T cd05578           9 GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD--EENMYLVVDLLLGGD   86 (258)
T ss_pred             ccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC--CCeEEEEEeCCCCCC
Confidence            6677799999988  5899999988532          2468999999999999999998876  668899999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-ccccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-ITMHIVG  492 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-~~~~~~g  492 (552)
                      |.+++...  ..+++.++..++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||.+...... ......+
T Consensus        87 L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~  161 (258)
T cd05578          87 LRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSG  161 (258)
T ss_pred             HHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCccccccCC
Confidence            99998765  34899999999999999999999998   999999999999999999999999998754332 2233567


Q ss_pred             cccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       493 t~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +..|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus       162 ~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  203 (258)
T cd05578         162 TPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS  203 (258)
T ss_pred             ChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence            889999999988889999999999999999999999998655

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.96  E-value=5.1e-28  Score=236.91  Aligned_cols=184  Identities=32%  Similarity=0.572  Sum_probs=157.8

Q ss_pred             CCceEEEEEEEEeecC------cEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          345 EGCLIQGSVYKGNIHG------EVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~g------~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      .|.|.+|.||++....      ..+|+|.++..        ..+|+.+++.++|+|++++++++.+  .+..+++|||++
T Consensus         7 lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~i~e~~~   84 (258)
T smart00219        7 LGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE--EEPLMIVMEYME   84 (258)
T ss_pred             eccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC--CCeeEEEEeccC
Confidence            3777889999999843      88999998643        2368999999999999999999987  567899999999


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccc--
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM--  488 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~--  488 (552)
                      +++|.+++.......+++.++..++.|++.||++||+.+   ++|+||+|+||++++++.++|+|||++.........  
T Consensus        85 ~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  161 (258)
T smart00219       85 GGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKK  161 (258)
T ss_pred             CCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccccccc
Confidence            999999997655434899999999999999999999998   999999999999999999999999998754332111  


Q ss_pred             -cccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCcc
Q 037224          489 -HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEE  533 (552)
Q Consensus       489 -~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~  533 (552)
                       ...++..|+|||.+.+..++.++|+||||+++|||++ |+.||...
T Consensus       162 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~  208 (258)
T smart00219      162 KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM  208 (258)
T ss_pred             ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence             1236688999999988889999999999999999998 88888754

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.96  E-value=3.5e-28  Score=238.19  Aligned_cols=183  Identities=30%  Similarity=0.474  Sum_probs=158.4

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC------------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN------------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~------------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      .|.|++|.||+|..  +++.|++|.+...            ..+|+.++++++|+|++++++++.+  +..+++++||++
T Consensus         8 ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~   85 (258)
T cd06632           8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE--EDNLYIFLELVP   85 (258)
T ss_pred             eeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec--CCeEEEEEEecC
Confidence            37777899999988  6889999987431            3368999999999999999999876  667899999999


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc-ccc
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI-TMH  489 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-~~~  489 (552)
                      +++|.+++....  .+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||++....... ...
T Consensus        86 ~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~  160 (258)
T cd06632          86 GGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS  160 (258)
T ss_pred             CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccccccc
Confidence            999999987654  4899999999999999999999999   9999999999999999999999999987543322 234


Q ss_pred             ccccccccCccccCCCC-CCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          490 IVGTQGYIAPEYLADGV-VSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~~~-~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..++..|++||.+.... ++.++|+||||+++|+|++|+.||....
T Consensus       161 ~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~  206 (258)
T cd06632         161 FKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE  206 (258)
T ss_pred             cCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence            56788999999987766 8999999999999999999999997643

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.96  E-value=2.5e-28  Score=245.08  Aligned_cols=183  Identities=28%  Similarity=0.410  Sum_probs=155.8

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC------------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN------------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~------------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      .|.|.+|.||+|..  +++.||+|.++..            ..+|++++++++|+|++++++++.+  ....++||||+ 
T Consensus         8 lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~-   84 (298)
T cd07841           8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH--KSNINLVFEFM-   84 (298)
T ss_pred             eeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec--CCEEEEEEccc-
Confidence            36777899999987  6889999998543            1358999999999999999999987  67889999999 


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--ccc
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITM  488 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~  488 (552)
                      +++|.+++.... ..+++.+++.++.|+++||.|||+++   ++|+||+|+||+++.++.++|+|||++......  ...
T Consensus        85 ~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~  160 (298)
T cd07841          85 ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMT  160 (298)
T ss_pred             CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCCcccc
Confidence            889999987654 35999999999999999999999999   999999999999999999999999998754332  122


Q ss_pred             cccccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          489 HIVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       489 ~~~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ...++..|+|||.+.+ ..++.++|+||||+++|||++|..||....
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~  207 (298)
T cd07841         161 HQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS  207 (298)
T ss_pred             ccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc
Confidence            2356778999998754 457889999999999999999988887544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=3.6e-30  Score=280.14  Aligned_cols=183  Identities=36%  Similarity=0.505  Sum_probs=157.0

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEecc---------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKW---------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~---------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      .|.|.||.||-+..  +|+..|+|.++-         ...+|+.++..++|||+++++|+-.+  ++..++.||||++|+
T Consensus      1243 Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH--Rekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1243 IGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH--REKVYIFMEYCEGGS 1320 (1509)
T ss_pred             cCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec--HHHHHHHHHHhccCc
Confidence            37788899999987  788999997742         23589999999999999999998877  667799999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc------c
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI------T  487 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~------~  487 (552)
                      |.+.+...+.  .++.....+..|++.|+.|||++|   ||||||||.||+++.+|.+|++|||.|....+..      .
T Consensus      1321 La~ll~~gri--~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el 1395 (1509)
T KOG4645|consen 1321 LASLLEHGRI--EDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGEL 1395 (1509)
T ss_pred             HHHHHHhcch--hhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHH
Confidence            9999877653  566666778899999999999999   9999999999999999999999999997544332      2


Q ss_pred             ccccccccccCccccCCCC---CCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          488 MHIVGTQGYIAPEYLADGV---VSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       488 ~~~~gt~~y~aPE~~~~~~---~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ....||+.|||||++.+..   ...+.|||||||++.||+||+.||.+.+
T Consensus      1396 ~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d 1445 (1509)
T KOG4645|consen 1396 QSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD 1445 (1509)
T ss_pred             HhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc
Confidence            2468999999999986533   5668999999999999999999998755

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.96  E-value=4.3e-28  Score=236.92  Aligned_cols=184  Identities=30%  Similarity=0.502  Sum_probs=156.3

Q ss_pred             CCceEEEEEEEEee-cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          345 EGCLIQGSVYKGNI-HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      .|.|++|.||++.. +++.|++|..+..        +.+|++++++++|+||+++++++.+  ....+++|||+++++|.
T Consensus         3 lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ--KQPIYIVMELVPGGSLL   80 (251)
T ss_pred             cccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEec--CCCeEEEEEcCCCCcHH
Confidence            36777899999988 4899999987542        3469999999999999999999877  66789999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcc----cccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT----MHIV  491 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~----~~~~  491 (552)
                      +++..... .+++..++.++.+++.+|+|||+++   ++||||+|+||+++.++.+||+|||++........    ....
T Consensus        81 ~~l~~~~~-~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (251)
T cd05041          81 TFLRKKKN-RLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ  156 (251)
T ss_pred             HHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence            99876433 4889999999999999999999998   99999999999999999999999999875432111    1122


Q ss_pred             ccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          492 GTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       492 gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      .+..|+|||.+.++.++.++|+||||+++|||+| |..||....
T Consensus       157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~  200 (251)
T cd05041         157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS  200 (251)
T ss_pred             ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC
Confidence            3567999999988889999999999999999999 888987543

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.96  E-value=3.4e-28  Score=239.90  Aligned_cols=182  Identities=26%  Similarity=0.493  Sum_probs=156.9

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC-------------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeec
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN-------------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI  409 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~  409 (552)
                      .|.|.+|.||++..  +++.+|+|.++..             ..+|+.++++++|+|++++++++.+  .+..++++||+
T Consensus         8 lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~~v~e~~   85 (268)
T cd06630           8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE--DSHFNLFVEWM   85 (268)
T ss_pred             ecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc--CCeEEEEEecc
Confidence            37788899999986  7889999998532             3469999999999999999999976  66789999999


Q ss_pred             cCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCC-cEEEeeccCCccCCCC---
Q 037224          410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM-RAKIANFGLAKSGCNA---  485 (552)
Q Consensus       410 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~~~~~---  485 (552)
                      ++++|.+++....  .+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++ .++|+|||.+......   
T Consensus        86 ~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~  160 (268)
T cd06630          86 AGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG  160 (268)
T ss_pred             CCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence            9999999987644  4899999999999999999999999   99999999999998776 5999999998644322   


Q ss_pred             ---ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          486 ---ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       486 ---~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                         ......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...
T Consensus       161 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  211 (268)
T cd06630         161 AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAE  211 (268)
T ss_pred             CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence               112245788999999998888999999999999999999999999744

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.96  E-value=2.3e-28  Score=243.68  Aligned_cols=187  Identities=26%  Similarity=0.384  Sum_probs=155.3

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC------hHHHHHHHHHc-CCCCccceeeeeec---CCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN------ACEELKILQKV-NHGNLVKLEGFCID---PEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~------~~~E~~~l~~l-~h~niv~l~~~~~~---~~~~~~~lv~e~~~~g  412 (552)
                      .|.|.+|.||++..  .++.+|+|+.+..      ..+|+.+++++ +|+|++++++++..   ..+...+++|||++++
T Consensus        26 lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~  105 (286)
T cd06638          26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGG  105 (286)
T ss_pred             eccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCC
Confidence            37777899999987  6789999987542      34688999999 79999999998853   2245789999999999


Q ss_pred             Cchhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--ccc
Q 037224          413 SLHSWLHEN--KNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITM  488 (552)
Q Consensus       413 sL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~  488 (552)
                      +|.+++...  ....+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++......  ...
T Consensus       106 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~  182 (286)
T cd06638         106 SVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN  182 (286)
T ss_pred             CHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCCceeecccCCCccc
Confidence            999987642  2245889999999999999999999998   999999999999999999999999998754321  222


Q ss_pred             cccccccccCccccCC-----CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          489 HIVGTQGYIAPEYLAD-----GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       489 ~~~gt~~y~aPE~~~~-----~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ...++..|+|||.+..     ..++.++||||||+++|||++|+.||....
T Consensus       183 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~  233 (286)
T cd06638         183 TSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH  233 (286)
T ss_pred             cccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc
Confidence            3468899999998753     447889999999999999999999997543

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4.7e-29  Score=252.28  Aligned_cols=192  Identities=28%  Similarity=0.450  Sum_probs=168.1

Q ss_pred             HHhhccCCCceEEEEEEEEee--cCcEEEEEEeccC------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeec
Q 037224          338 EATDNFSEGCLIQGSVYKGNI--HGEVYAIKMMKWN------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI  409 (552)
Q Consensus       338 ~~t~~~~~G~g~~G~Vy~~~~--~g~~vAvK~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~  409 (552)
                      +.+-.-..|.|-+|.||.|.|  ..-.||||.++.+      |..|+.+|+.++|||+++++|+|..  +..+|+|+|||
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~--EpPFYIiTEfM  345 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH--EPPFYIITEFM  345 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhcc--CCCeEEEEecc
Confidence            344455568888899999999  4568999999875      4579999999999999999999987  77889999999


Q ss_pred             cCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcccc
Q 037224          410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH  489 (552)
Q Consensus       410 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  489 (552)
                      ..|+|.+||++.....++.-..+.++.||..|++||..++   +|||||..+|+|+.++..+|+.|||+++.+.....+.
T Consensus       346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA  422 (1157)
T KOG4278|consen  346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA  422 (1157)
T ss_pred             cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCceec
Confidence            9999999998876666787888899999999999999998   9999999999999999999999999999876554444


Q ss_pred             ccc---cccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          490 IVG---TQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       490 ~~g---t~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      ..|   ...|.|||.+....++.++|||+|||+|||+.| |-.||.+-+
T Consensus       423 HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid  471 (1157)
T KOG4278|consen  423 HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID  471 (1157)
T ss_pred             ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc
Confidence            333   457999999999999999999999999999987 888887654

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.96  E-value=4e-28  Score=241.56  Aligned_cols=185  Identities=29%  Similarity=0.490  Sum_probs=156.3

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC------hHHHHHHHHHc-CCCCccceeeeeecC----CCCeeEEEEeeccCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN------ACEELKILQKV-NHGNLVKLEGFCIDP----EDANCYLIYEYIENG  412 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~------~~~E~~~l~~l-~h~niv~l~~~~~~~----~~~~~~lv~e~~~~g  412 (552)
                      |.|.+|.||++..  .++.+|+|+....      ...|+.+++++ +|+|++++++++...    .....+++|||++++
T Consensus        25 g~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~  104 (282)
T cd06636          25 GNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAG  104 (282)
T ss_pred             ccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCC
Confidence            6677899999988  6789999988543      23578888888 799999999998642    245789999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC--Cccccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN--AITMHI  490 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~--~~~~~~  490 (552)
                      +|.+++.......+++..++.++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||++.....  ......
T Consensus       105 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~  181 (282)
T cd06636         105 SVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF  181 (282)
T ss_pred             cHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcchhhhhccccCCCcc
Confidence            9999998766666889999999999999999999998   99999999999999999999999999874322  122335


Q ss_pred             cccccccCccccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          491 VGTQGYIAPEYLA-----DGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       491 ~gt~~y~aPE~~~-----~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      .++..|+|||.+.     ...++.++|+||||+++|||++|+.||...
T Consensus       182 ~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~  229 (282)
T cd06636         182 IGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM  229 (282)
T ss_pred             cccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence            6888999999875     345788999999999999999999999754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.96  E-value=5e-28  Score=244.27  Aligned_cols=184  Identities=30%  Similarity=0.458  Sum_probs=155.8

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|.+|.||++..  +|+.||+|.++..         ..+|+.++++++|+|++++++++.+......++||||+++ +|
T Consensus        16 g~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l   94 (309)
T cd07845          16 GEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DL   94 (309)
T ss_pred             eecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCCC-CH
Confidence            6777799999988  6899999998532         2479999999999999999999887555678999999975 88


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--ccccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIVG  492 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~g  492 (552)
                      .+++.... ..+++.+++.++.|++.||+|||+.+   ++||||+|+||++++++.+||+|||++......  ......+
T Consensus        95 ~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~  170 (309)
T cd07845          95 ASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV  170 (309)
T ss_pred             HHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCccCCCCcccc
Confidence            88876543 35899999999999999999999999   999999999999999999999999998754322  1222345


Q ss_pred             cccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          493 TQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       493 t~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +..|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus       171 ~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~  213 (309)
T cd07845         171 TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS  213 (309)
T ss_pred             cccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            778999998865 557899999999999999999999997554

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.96  E-value=7.2e-28  Score=236.82  Aligned_cols=182  Identities=32%  Similarity=0.498  Sum_probs=159.5

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      |.|++|.||+++.  +++.|++|++...        +.+|+..+.+++|+|++++++++..  ....++++||+++++|.
T Consensus        10 ~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~   87 (264)
T cd06623          10 GQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYK--EGEISIVLEYMDGGSLA   87 (264)
T ss_pred             eecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc--CCeEEEEEEecCCCcHH
Confidence            5666799999988  5899999997543        3468999999999999999999887  57889999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcc--ccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHE-HTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT--MHIVG  492 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~--~~~~g  492 (552)
                      +++...  ..+++..++.++.|++++|+|||+ .+   ++|+||+|+||+++.++.++|+|||.+........  ....+
T Consensus        88 ~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  162 (264)
T cd06623          88 DLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVG  162 (264)
T ss_pred             HHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCcccceee
Confidence            999765  348999999999999999999999 88   99999999999999999999999999875432222  13467


Q ss_pred             cccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       493 t~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +..|+|||.+....++.++|+||||+++|||++|+.||...+
T Consensus       163 ~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~  204 (264)
T cd06623         163 TVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG  204 (264)
T ss_pred             cccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence            889999999998889999999999999999999999997764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.96  E-value=4.8e-28  Score=239.59  Aligned_cols=182  Identities=29%  Similarity=0.485  Sum_probs=156.0

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEecc-----------------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEE
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKW-----------------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLI  405 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~-----------------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  405 (552)
                      .|.|.+|.||+|..  +|+.+|+|.++.                 ...+|+.++++++|+|++++++++..  ....++|
T Consensus         9 lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv   86 (272)
T cd06629           9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT--EEYLSIF   86 (272)
T ss_pred             ecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--CCceEEE
Confidence            47777899999976  688999998742                 12368899999999999999999876  5678999


Q ss_pred             EeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC
Q 037224          406 YEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA  485 (552)
Q Consensus       406 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~  485 (552)
                      |||+++++|.+++....  .+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++......
T Consensus        87 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  161 (272)
T cd06629          87 LEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDI  161 (272)
T ss_pred             EecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence            99999999999987653  4899999999999999999999998   999999999999999999999999998754321


Q ss_pred             ----ccccccccccccCccccCCCC--CCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          486 ----ITMHIVGTQGYIAPEYLADGV--VSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       486 ----~~~~~~gt~~y~aPE~~~~~~--~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                          ......++..|+|||.+....  ++.++|+||||+++|||++|+.||...
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  215 (272)
T cd06629         162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE  215 (272)
T ss_pred             ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCc
Confidence                122346788999999987654  788999999999999999999999643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.96  E-value=5.4e-28  Score=242.05  Aligned_cols=184  Identities=28%  Similarity=0.450  Sum_probs=156.5

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|.+|.||+|+.  +++.+++|.++..         ..+|+.++.+++|+||+++++++.+.+....++++||+++ +|
T Consensus        14 g~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L   92 (293)
T cd07843          14 EEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DL   92 (293)
T ss_pred             cCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcCc-CH
Confidence            6677799999998  5789999998532         2469999999999999999999887544789999999975 89


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--ccccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIVG  492 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~g  492 (552)
                      .+++..... .+++.+++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++......  ......+
T Consensus        93 ~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  168 (293)
T cd07843          93 KSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV  168 (293)
T ss_pred             HHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCccccccccc
Confidence            888876443 5899999999999999999999999   999999999999999999999999998754332  1223456


Q ss_pred             cccccCccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          493 TQGYIAPEYLADG-VVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       493 t~~y~aPE~~~~~-~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +..|+|||.+.+. ..+.++|+||||+++|||++|+.||....
T Consensus       169 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~  211 (293)
T cd07843         169 TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKS  211 (293)
T ss_pred             cccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            7889999988654 46889999999999999999999998654

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.96  E-value=3.3e-28  Score=247.81  Aligned_cols=188  Identities=19%  Similarity=0.293  Sum_probs=156.5

Q ss_pred             ccCCCceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          342 NFSEGCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       342 ~~~~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      .++.|.|.+|+||+++.  .|+.||+|+++..         ..+|+.+++.++|+||++++++|..  +...++++||+.
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~~~v~e~~~   82 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT--GSWLWVISPFMA   82 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec--CCceEEEEeccc
Confidence            45667788899999987  7899999998532         2368888888999999999999987  667899999999


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-----
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-----  485 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-----  485 (552)
                      +++|.+++.......+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++++||+.+......     
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            999999988765556899999999999999999999998   999999999999999999999999754321110     


Q ss_pred             ----ccccccccccccCccccCCC--CCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          486 ----ITMHIVGTQGYIAPEYLADG--VVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       486 ----~~~~~~gt~~y~aPE~~~~~--~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                          ......++..|+|||++.+.  .++.++||||||+++|||++|+.||....
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~  214 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML  214 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence                00112345679999998763  47889999999999999999999997643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.96  E-value=9.5e-28  Score=239.44  Aligned_cols=182  Identities=26%  Similarity=0.453  Sum_probs=157.2

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      .|.|.+|.||++..  +++.+++|.++..       ..+|+.+++.++|+|++++++++..  ....++++||+++++|.
T Consensus        27 lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~--~~~~~~v~e~~~~~~L~  104 (285)
T cd06648          27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV--GDELWVVMEFLEGGALT  104 (285)
T ss_pred             eccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEc--CCeEEEEEeccCCCCHH
Confidence            36677899999986  6789999987532       3468999999999999999998876  66789999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--cccccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIVGT  493 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~gt  493 (552)
                      +++...   .+++.++..++.|++.||+|||+++   ++||||+|+||+++.++.++|+|||.+......  ......++
T Consensus       105 ~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  178 (285)
T cd06648         105 DIVTHT---RMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGT  178 (285)
T ss_pred             HHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccCC
Confidence            998763   4899999999999999999999999   999999999999999999999999987643221  12234578


Q ss_pred             ccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       494 ~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       179 ~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~  219 (285)
T cd06648         179 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP  219 (285)
T ss_pred             ccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC
Confidence            89999999988889999999999999999999999997543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.96  E-value=6.9e-28  Score=239.29  Aligned_cols=190  Identities=29%  Similarity=0.471  Sum_probs=160.4

Q ss_pred             HHHHHHhhccCCCceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeE
Q 037224          334 EELREATDNFSEGCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCY  403 (552)
Q Consensus       334 ~~l~~~t~~~~~G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  403 (552)
                      +++....+.+  |.|++|.||++..  +++.+|+|..+..        +.+|+.++.+++|+|++++++++.+  +...+
T Consensus         3 ~~~~~~~~~i--g~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~   78 (277)
T cd06641           3 EELFTKLEKI--GKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DTKLW   78 (277)
T ss_pred             HHhhhhheeE--eecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe--CCeEE
Confidence            3444444433  6677799999976  6789999987532        3468999999999999999999987  66789


Q ss_pred             EEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC
Q 037224          404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC  483 (552)
Q Consensus       404 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  483 (552)
                      +||||+++++|.+++...   .+++..+..++.|++.++.+||+.+   ++|+||+|+||+++.++.++|+|||++....
T Consensus        79 lv~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06641          79 IIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLT  152 (277)
T ss_pred             EEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecc
Confidence            999999999999988653   3899999999999999999999998   9999999999999999999999999986443


Q ss_pred             CC--ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          484 NA--ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       484 ~~--~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      ..  ......++..|+|||.+.+...+.++|+||||+++|+|++|..||...
T Consensus       153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  204 (277)
T cd06641         153 DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL  204 (277)
T ss_pred             cchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence            22  122245788999999998888899999999999999999999999754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-28  Score=249.84  Aligned_cols=181  Identities=29%  Similarity=0.472  Sum_probs=157.3

Q ss_pred             CceEEEEEEEEeec----Cc--EEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          346 GCLIQGSVYKGNIH----GE--VYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       346 G~g~~G~Vy~~~~~----g~--~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      |.|-||.||+|.+.    |+  .||||..|.+        +..|..++++++||||++++|+|.+   ...|+|||.++-
T Consensus       398 G~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e---~P~WivmEL~~~  474 (974)
T KOG4257|consen  398 GEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE---QPMWIVMELAPL  474 (974)
T ss_pred             cCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec---cceeEEEecccc
Confidence            66666999999883    32  5899988753        5679999999999999999999975   567999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcccc--
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH--  489 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~--  489 (552)
                      |.|..+|..++. .++......++.||+.||+|||+..   +|||||..+|||+.+...+||+|||+++...+.....  
T Consensus       475 GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS  550 (974)
T KOG4257|consen  475 GELREYLQQNKD-SLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKAS  550 (974)
T ss_pred             hhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccccchhhcc
Confidence            999999988765 4899999999999999999999998   9999999999999999999999999999765543332  


Q ss_pred             -ccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCcc
Q 037224          490 -IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEE  533 (552)
Q Consensus       490 -~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~  533 (552)
                       ..-...|||||.+..++++.++|||-|||+|||++. |..||.+-
T Consensus       551 ~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgv  596 (974)
T KOG4257|consen  551 RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGV  596 (974)
T ss_pred             ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccc
Confidence             223457999999999999999999999999999865 99999853

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.96  E-value=6.7e-28  Score=247.07  Aligned_cols=185  Identities=30%  Similarity=0.472  Sum_probs=153.1

Q ss_pred             CCceEEEEEEEEee-------cCcEEEEEEeccC--------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEee
Q 037224          345 EGCLIQGSVYKGNI-------HGEVYAIKMMKWN--------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEY  408 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-------~g~~vAvK~~~~~--------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~  408 (552)
                      .|.|++|.||++.+       .++.||||+++..        ..+|+.++.++ +|+||+++++++... +...+++|||
T Consensus        15 lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-~~~~~lv~ey   93 (343)
T cd05103          15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-GGPLMVIVEF   93 (343)
T ss_pred             ccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC-CCceEEEEec
Confidence            37888899999973       4678999998642        33699999999 789999999988653 4567899999


Q ss_pred             ccCCCchhhhhhcCC-----------------------------------------------------------------
Q 037224          409 IENGSLHSWLHENKN-----------------------------------------------------------------  423 (552)
Q Consensus       409 ~~~gsL~~~l~~~~~-----------------------------------------------------------------  423 (552)
                      +++|+|.+++.....                                                                 
T Consensus        94 ~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (343)
T cd05103          94 CKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYK  173 (343)
T ss_pred             cCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhh
Confidence            999999998864321                                                                 


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcc----ccccccccccCc
Q 037224          424 ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT----MHIVGTQGYIAP  499 (552)
Q Consensus       424 ~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~----~~~~gt~~y~aP  499 (552)
                      ..+++.++..++.|+++||+|||+++   ++||||||+||+++.++.+||+|||++........    ....++..|+||
T Consensus       174 ~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  250 (343)
T cd05103         174 KVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  250 (343)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECc
Confidence            23688889999999999999999998   99999999999999999999999999875322111    112345679999


Q ss_pred             cccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCcc
Q 037224          500 EYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEE  533 (552)
Q Consensus       500 E~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~  533 (552)
                      |.+.+..++.++||||||+++|||++ |..||...
T Consensus       251 E~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~  285 (343)
T cd05103         251 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  285 (343)
T ss_pred             HHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence            99988889999999999999999996 99998653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-28  Score=214.70  Aligned_cols=193  Identities=27%  Similarity=0.455  Sum_probs=159.4

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|.+|+||+++.  .++.||+|+++-+         ..+|+-+++.++|+||++++++...  +....+|+|||+. +|
T Consensus        11 gegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs--dkkltlvfe~cdq-dl   87 (292)
T KOG0662|consen   11 GEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLVFEFCDQ-DL   87 (292)
T ss_pred             cCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc--CceeEEeHHHhhH-HH
Confidence            6667799999987  6789999998532         4589999999999999999998876  7788999999975 88


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc--cccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI--TMHIVG  492 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~--~~~~~g  492 (552)
                      ..+...-. ..++.+.+..++.|+++||.|+|+++   +.|||+||.|.|++.+|++||.|||+++...-..  ....+-
T Consensus        88 kkyfdsln-g~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvrcysaevv  163 (292)
T KOG0662|consen   88 KKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV  163 (292)
T ss_pred             HHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceEeeeceee
Confidence            88776543 34899999999999999999999999   9999999999999999999999999998543221  223466


Q ss_pred             cccccCccccCCC-CCCChhhHHHHHHHHHHHHc-CCCCCCccCcccccchHHHHHH
Q 037224          493 TQGYIAPEYLADG-VVSTKMDVFSFGVVLLELIS-GKEAIDEEGKFCGQKLKGYWRE  547 (552)
Q Consensus       493 t~~y~aPE~~~~~-~~s~~~Dv~slG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~  547 (552)
                      |.+|.+|.++.+. -|+...|+||-||++.|+.. |++.|.+.+.  .+.++++++.
T Consensus       164 tlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv--ddqlkrif~~  218 (292)
T KOG0662|consen  164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRL  218 (292)
T ss_pred             eeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH--HHHHHHHHHH
Confidence            8899999998764 48889999999999999986 6666665543  3555555543

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.96  E-value=6.5e-28  Score=240.08  Aligned_cols=183  Identities=29%  Similarity=0.486  Sum_probs=155.7

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|.+|.||++..  +|..||+|+++..         +.+|++++++++|+|++++++++.+  +...+++|||++ ++|
T Consensus         8 ~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~--~~~~~iv~e~~~-~~l   84 (283)
T cd07835           8 GEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS--ENKLYLVFEFLD-LDL   84 (283)
T ss_pred             cCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc--CCeEEEEEeccC-cCH
Confidence            5666799999987  7899999988532         3479999999999999999999976  678899999995 589


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--ccccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIVG  492 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~g  492 (552)
                      .+++.......+++..++.++.|+++||+|||+++   ++||||+|+||+++.++.++|+|||++......  ......+
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  161 (283)
T cd07835          85 KKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV  161 (283)
T ss_pred             HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCcccc
Confidence            99887765456899999999999999999999998   999999999999999999999999998743221  1122356


Q ss_pred             cccccCccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          493 TQGYIAPEYLADG-VVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       493 t~~y~aPE~~~~~-~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +..|+|||.+.+. .++.++|+||||+++|||++|+.||...+
T Consensus       162 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  204 (283)
T cd07835         162 TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDS  204 (283)
T ss_pred             ccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            7889999987654 57889999999999999999999997654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.96  E-value=5.4e-28  Score=242.22  Aligned_cols=181  Identities=26%  Similarity=0.454  Sum_probs=156.5

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchh
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHS  416 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~  416 (552)
                      |.|.+|.||++..  +++.|++|.++..       +.+|+.++++++|||++++++.+..  ....++|+||+++++|.+
T Consensus        28 g~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~  105 (293)
T cd06647          28 GQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV--GDELWVVMEYLAGGSLTD  105 (293)
T ss_pred             cCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeee--CCcEEEEEecCCCCcHHH
Confidence            6677799999976  6789999998532       3468899999999999999999987  567899999999999999


Q ss_pred             hhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--ccccccccc
Q 037224          417 WLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIVGTQ  494 (552)
Q Consensus       417 ~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~gt~  494 (552)
                      ++....   +++.++..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++......  ......+++
T Consensus       106 ~~~~~~---l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~  179 (293)
T cd06647         106 VVTETC---MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP  179 (293)
T ss_pred             HHhhcC---CCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccccccccccCCh
Confidence            987543   889999999999999999999999   999999999999999999999999987643221  122345788


Q ss_pred             cccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       495 ~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .|++||.+....++.++|+||||+++|||++|+.||...+
T Consensus       180 ~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~  219 (293)
T cd06647         180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN  219 (293)
T ss_pred             hhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            8999999988889999999999999999999999997543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.96  E-value=9.8e-28  Score=239.65  Aligned_cols=184  Identities=25%  Similarity=0.427  Sum_probs=152.1

Q ss_pred             CCceEEEEEEEEeec-------CcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeec
Q 037224          345 EGCLIQGSVYKGNIH-------GEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI  409 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~-------g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~  409 (552)
                      .|.|++|.||+|...       +..||+|.++..        +.+|+.+++.++|+||+++++++.+  ....+++|||+
T Consensus        14 lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~   91 (288)
T cd05061          14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK--GQPTLVVMELM   91 (288)
T ss_pred             ecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC--CCCcEEEEeCC
Confidence            377777999998652       347999987532        2368889999999999999999876  55779999999


Q ss_pred             cCCCchhhhhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCcc
Q 037224          410 ENGSLHSWLHENK--------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS  481 (552)
Q Consensus       410 ~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  481 (552)
                      ++|+|.+++....        ...+++..+..++.|++.||.|||+++   ++||||||+||++++++.++|+|||+++.
T Consensus        92 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L~Dfg~~~~  168 (288)
T cd05061          92 AHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRD  168 (288)
T ss_pred             CCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEECcCCcccc
Confidence            9999999997532        123567889999999999999999998   99999999999999999999999999874


Q ss_pred             CCCCcc----ccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCcc
Q 037224          482 GCNAIT----MHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEE  533 (552)
Q Consensus       482 ~~~~~~----~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~  533 (552)
                      ......    ....++..|+|||.+.+..++.++|+||||+++|||++ |+.||...
T Consensus       169 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~  225 (288)
T cd05061         169 IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL  225 (288)
T ss_pred             ccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            322111    11234667999999988899999999999999999998 78898653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.96  E-value=6.3e-28  Score=244.02  Aligned_cols=184  Identities=22%  Similarity=0.305  Sum_probs=154.6

Q ss_pred             CceEEEEEEEEeecCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchh
Q 037224          346 GCLIQGSVYKGNIHGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHS  416 (552)
Q Consensus       346 G~g~~G~Vy~~~~~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~  416 (552)
                      |.|+++.||+++.+++.||+|+++..         ..+|+.+++.++|+||+++++++.+  +...+++|||+++++|.+
T Consensus        11 ~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~--~~~~~~~~e~~~~~~l~~   88 (314)
T cd08216          11 EDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV--DSELYVVSPLMAYGSCED   88 (314)
T ss_pred             cCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec--CCeEEEEEeccCCCCHHH
Confidence            44455667777778999999998543         3479999999999999999999877  667899999999999999


Q ss_pred             hhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC---------cc
Q 037224          417 WLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA---------IT  487 (552)
Q Consensus       417 ~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~---------~~  487 (552)
                      ++.......+++..+..++.|+++||+|||+++   |+||||||+||+++.++.+||+|||.+......         ..
T Consensus        89 ~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~  165 (314)
T cd08216          89 LLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP  165 (314)
T ss_pred             HHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccccccc
Confidence            998765556899999999999999999999998   999999999999999999999999987632211         11


Q ss_pred             ccccccccccCccccCC--CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          488 MHIVGTQGYIAPEYLAD--GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       488 ~~~~gt~~y~aPE~~~~--~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ....++..|+|||.+..  ..++.++|+||||+++|||++|+.||....
T Consensus       166 ~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~  214 (314)
T cd08216         166 KSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMP  214 (314)
T ss_pred             ccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence            22356778999999865  357889999999999999999999998543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.96  E-value=1.2e-27  Score=236.67  Aligned_cols=183  Identities=25%  Similarity=0.368  Sum_probs=153.1

Q ss_pred             CCceEEEEEEEEeecC-----cEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNIHG-----EVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~g-----~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|++|.||+|.+..     ..+++|.....        +.+|+.++++++|+|++++++++.+   ...+++|||+++
T Consensus        14 lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~---~~~~lv~e~~~~   90 (270)
T cd05056          14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE---NPVWIVMELAPL   90 (270)
T ss_pred             eCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC---CCcEEEEEcCCC
Confidence            3778889999998732     36899987543        3469999999999999999998864   346899999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcc---c
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT---M  488 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~---~  488 (552)
                      ++|.+++.... ..+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||+++.......   .
T Consensus        91 ~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  166 (270)
T cd05056          91 GELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKAS  166 (270)
T ss_pred             CcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecccccceecC
Confidence            99999997643 24899999999999999999999998   99999999999999999999999999875432211   1


Q ss_pred             cccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          489 HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       489 ~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      ...++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus       167 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~  213 (270)
T cd05056         167 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK  213 (270)
T ss_pred             CCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            1233467999999988889999999999999999986 999997654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.96  E-value=5.2e-28  Score=238.22  Aligned_cols=184  Identities=28%  Similarity=0.447  Sum_probs=158.3

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      |.|++|.||++..  ++..+++|+++..        ..+|+.+++.++|+|++++++.+..  +...++++|++++++|.
T Consensus        10 g~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv~e~~~~~~l~   87 (267)
T cd06610          10 GVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV--GDELWLVMPYLSGGSLL   87 (267)
T ss_pred             cCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEee--CCEEEEEEeccCCCcHH
Confidence            6777899999987  6789999998532        3478999999999999999998877  67889999999999999


Q ss_pred             hhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC------ccc
Q 037224          416 SWLHENKN-ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA------ITM  488 (552)
Q Consensus       416 ~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~------~~~  488 (552)
                      +++..... ..+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++......      ...
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  164 (267)
T cd06610          88 DIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRK  164 (267)
T ss_pred             HHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccc
Confidence            99976433 45899999999999999999999999   999999999999999999999999998643321      112


Q ss_pred             cccccccccCccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          489 HIVGTQGYIAPEYLADG-VVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       489 ~~~gt~~y~aPE~~~~~-~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ...++..|++||.+... ..+.++|+||||+++|||++|+.||....
T Consensus       165 ~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~  211 (267)
T cd06610         165 TFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP  211 (267)
T ss_pred             cccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccC
Confidence            34678899999998776 78899999999999999999999997653

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.5e-29  Score=254.67  Aligned_cols=199  Identities=23%  Similarity=0.355  Sum_probs=165.6

Q ss_pred             ccccHHHHHHHhhccCCCceEEEEEEEEee--cCcEEEEEEecc-------ChHHHHHHHHHcCCCCccceeeeeecCCC
Q 037224          329 RIFKIEELREATDNFSEGCLIQGSVYKGNI--HGEVYAIKMMKW-------NACEELKILQKVNHGNLVKLEGFCIDPED  399 (552)
Q Consensus       329 ~~~~~~~l~~~t~~~~~G~g~~G~Vy~~~~--~g~~vAvK~~~~-------~~~~E~~~l~~l~h~niv~l~~~~~~~~~  399 (552)
                      +-+...|..+...++  |-|+||.||++..  .+-..|-|++..       ++.-|++||..++||+|+++++.|+.  +
T Consensus        26 rdlnP~d~WeIiGEL--GDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~--e  101 (1187)
T KOG0579|consen   26 RDLNPRDHWEIIGEL--GDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYF--E  101 (1187)
T ss_pred             ccCCHHHHHHHHhhh--cCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhc--c
Confidence            334566777777766  5566699999987  344556677743       34468999999999999999998887  7


Q ss_pred             CeeEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCC
Q 037224          400 ANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLA  479 (552)
Q Consensus       400 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  479 (552)
                      +.+|++.|||.||.....+-... ..+++.++..+++|++.||.|||++.   |+|||||..|||++-+|.++|+|||.+
T Consensus       102 nkLwiliEFC~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVS  177 (1187)
T KOG0579|consen  102 NKLWILIEFCGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVS  177 (1187)
T ss_pred             CceEEEEeecCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeeccccc
Confidence            78899999999999988776543 45999999999999999999999998   999999999999999999999999998


Q ss_pred             ccCCC--CccccccccccccCcccc-----CCCCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          480 KSGCN--AITMHIVGTQGYIAPEYL-----ADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       480 ~~~~~--~~~~~~~gt~~y~aPE~~-----~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      .....  .....+.|||.|||||+.     ...+|+.++||||||+.|.||..+.+|..+-++
T Consensus       178 AKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp  240 (1187)
T KOG0579|consen  178 AKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP  240 (1187)
T ss_pred             ccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch
Confidence            64322  223457899999999986     467899999999999999999999999986553

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.95  E-value=6.5e-28  Score=241.79  Aligned_cols=184  Identities=27%  Similarity=0.458  Sum_probs=152.5

Q ss_pred             CCceEEEEEEEEeecC----------------cEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCC
Q 037224          345 EGCLIQGSVYKGNIHG----------------EVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDA  400 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~g----------------~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~  400 (552)
                      .|.|++|.||++...+                ..||+|.++..        +.+|++++++++|+|++++++++..  +.
T Consensus        13 lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~~   90 (295)
T cd05097          13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVS--DD   90 (295)
T ss_pred             cCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcC--CC
Confidence            3677779999987522                25899998643        3469999999999999999999976  66


Q ss_pred             eeEEEEeeccCCCchhhhhhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCc
Q 037224          401 NCYLIYEYIENGSLHSWLHENKN----------ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR  470 (552)
Q Consensus       401 ~~~lv~e~~~~gsL~~~l~~~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~  470 (552)
                      ..+++|||+++++|.+++.....          ..+++..++.++.|++.||+|||+.+   ++|+||||+||++++++.
T Consensus        91 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nill~~~~~  167 (295)
T cd05097          91 PLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYT  167 (295)
T ss_pred             ccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEEEcCCCc
Confidence            78999999999999999865321          23788999999999999999999999   999999999999999999


Q ss_pred             EEEeeccCCccCCCCcc----ccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc--CCCCCCcc
Q 037224          471 AKIANFGLAKSGCNAIT----MHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS--GKEAIDEE  533 (552)
Q Consensus       471 ~kL~Dfg~a~~~~~~~~----~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt--G~~pf~~~  533 (552)
                      +||+|||++........    ....++..|+|||.+.+..++.++|+||||+++|||++  |..||...
T Consensus       168 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~  236 (295)
T cd05097         168 IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL  236 (295)
T ss_pred             EEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence            99999999874332211    12234678999999988889999999999999999988  67788653

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.95  E-value=8.4e-28  Score=247.39  Aligned_cols=181  Identities=27%  Similarity=0.406  Sum_probs=154.4

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCC----CCeeEEEEeecc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPE----DANCYLIYEYIE  410 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~~~lv~e~~~  410 (552)
                      |.|++|.||++..  +|+.||+|.++..         ..+|+.++++++|+||+++++++....    ....++||||+.
T Consensus        25 g~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~  104 (353)
T cd07850          25 GSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD  104 (353)
T ss_pred             ccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC
Confidence            7777899999987  7899999998532         236999999999999999999886432    235799999996


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc-ccc
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI-TMH  489 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-~~~  489 (552)
                      + +|.+.+...    +++.++..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++...... ...
T Consensus       105 ~-~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~  176 (353)
T cd07850         105 A-NLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP  176 (353)
T ss_pred             C-CHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeCCCCCCCCC
Confidence            5 888777542    889999999999999999999998   9999999999999999999999999997544322 223


Q ss_pred             ccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..++..|+|||.+.+..++.++||||||+++|+|++|+.||...+
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~  221 (353)
T cd07850         177 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD  221 (353)
T ss_pred             CcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence            467889999999999999999999999999999999999997654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.95  E-value=9.7e-28  Score=237.79  Aligned_cols=183  Identities=27%  Similarity=0.447  Sum_probs=155.3

Q ss_pred             CCceEEEEEEEEee-------cCcEEEEEEecc--------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeec
Q 037224          345 EGCLIQGSVYKGNI-------HGEVYAIKMMKW--------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI  409 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-------~g~~vAvK~~~~--------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~  409 (552)
                      .|.|++|.||+++.       ..+.+++|.+..        .+.+|++++++++|+|++++++++.+  ....+++|||+
T Consensus        13 lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~   90 (275)
T cd05046          13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE--AEPHYMILEYT   90 (275)
T ss_pred             ecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECC--CCcceEEEEec
Confidence            47888899999986       246799998843        24579999999999999999999876  56779999999


Q ss_pred             cCCCchhhhhhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccC
Q 037224          410 ENGSLHSWLHENKN-------ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG  482 (552)
Q Consensus       410 ~~gsL~~~l~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  482 (552)
                      ++++|.+++.....       ..+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++...
T Consensus        91 ~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~~~~~~~  167 (275)
T cd05046          91 DLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDV  167 (275)
T ss_pred             CCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccccccccc
Confidence            99999999976552       15899999999999999999999999   999999999999999999999999998643


Q ss_pred             CCC---ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCc
Q 037224          483 CNA---ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDE  532 (552)
Q Consensus       483 ~~~---~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~  532 (552)
                      ...   ......++..|+|||.+.+...+.++||||||+++|+|++ |..||..
T Consensus       168 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~  221 (275)
T cd05046         168 YNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG  221 (275)
T ss_pred             CcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            211   1122355678999999988888999999999999999998 8889864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.95  E-value=8.2e-28  Score=240.38  Aligned_cols=181  Identities=28%  Similarity=0.432  Sum_probs=153.9

Q ss_pred             CceEEEEEEEEee-----cCcEEEEEEeccC-----------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEee
Q 037224          346 GCLIQGSVYKGNI-----HGEVYAIKMMKWN-----------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEY  408 (552)
Q Consensus       346 G~g~~G~Vy~~~~-----~g~~vAvK~~~~~-----------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~  408 (552)
                      |.|.+|.||++..     +|+.||+|+++..           ..+|+.+++++ +|+||+++++.+..  +...++|+||
T Consensus         9 g~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~~~~lv~e~   86 (290)
T cd05613           9 GTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--DTKLHLILDY   86 (290)
T ss_pred             ccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec--CCeEEEEEec
Confidence            6777799999876     6789999998632           23589999999 69999999988876  6678999999


Q ss_pred             ccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC---
Q 037224          409 IENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA---  485 (552)
Q Consensus       409 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~---  485 (552)
                      +++++|.+++....  .+++..+..++.|+++||.|||+.+   ++||||+|+||+++.++.+||+|||++......   
T Consensus        87 ~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  161 (290)
T cd05613          87 INGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE  161 (290)
T ss_pred             CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceeccccccc
Confidence            99999999987654  4889999999999999999999998   999999999999999999999999998754321   


Q ss_pred             ccccccccccccCccccCCC--CCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          486 ITMHIVGTQGYIAPEYLADG--VVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       486 ~~~~~~gt~~y~aPE~~~~~--~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      ......++..|+|||.+...  .++.++||||||+++|+|++|+.||...
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~  211 (290)
T cd05613         162 RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD  211 (290)
T ss_pred             ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcC
Confidence            12234678899999998653  4678999999999999999999999743

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.95  E-value=8.7e-28  Score=245.35  Aligned_cols=185  Identities=30%  Similarity=0.497  Sum_probs=154.1

Q ss_pred             CCceEEEEEEEEeec---------CcEEEEEEeccC--------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEE
Q 037224          345 EGCLIQGSVYKGNIH---------GEVYAIKMMKWN--------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIY  406 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~---------g~~vAvK~~~~~--------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~  406 (552)
                      .|.|++|.||++...         +..||+|.++..        +.+|+.+++++ +|+||++++++|..  +...++++
T Consensus        20 ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~   97 (334)
T cd05100          20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ--DGPLYVLV   97 (334)
T ss_pred             eccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc--CCceEEEE
Confidence            377778999999752         236899988642        34689999999 89999999999976  56789999


Q ss_pred             eeccCCCchhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEE
Q 037224          407 EYIENGSLHSWLHENK--------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAK  472 (552)
Q Consensus       407 e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~k  472 (552)
                      ||+++++|.+++....              ...+++.+++.++.|++.||.|||+++   ++||||||+||+++.++.+|
T Consensus        98 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~~~~~~k  174 (334)
T cd05100          98 EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVTEDNVMK  174 (334)
T ss_pred             ecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEE
Confidence            9999999999987532              234788999999999999999999998   99999999999999999999


Q ss_pred             EeeccCCccCCCCc----cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          473 IANFGLAKSGCNAI----TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       473 L~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      |+|||+++......    .....++..|+|||.+.+..++.++||||||+++|||++ |..||...+
T Consensus       175 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  241 (334)
T cd05100         175 IADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP  241 (334)
T ss_pred             ECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence            99999987543221    111233567999999999999999999999999999998 889987543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=8e-28  Score=237.84  Aligned_cols=185  Identities=32%  Similarity=0.486  Sum_probs=155.5

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC------hHHHHHHHHHc-CCCCccceeeeeecCC----CCeeEEEEeeccCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN------ACEELKILQKV-NHGNLVKLEGFCIDPE----DANCYLIYEYIENG  412 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~------~~~E~~~l~~l-~h~niv~l~~~~~~~~----~~~~~lv~e~~~~g  412 (552)
                      |.|.+|.||++..  +++.+++|+++..      +.+|+.+++++ +|+||+++++++.+..    ....+++|||++++
T Consensus        15 ~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~   94 (275)
T cd06608          15 GEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGG   94 (275)
T ss_pred             cCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCC
Confidence            6667799999998  6789999998643      44799999999 7999999999997633    34689999999999


Q ss_pred             CchhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--ccc
Q 037224          413 SLHSWLHENK--NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITM  488 (552)
Q Consensus       413 sL~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~  488 (552)
                      +|.+++....  ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......  ...
T Consensus        95 ~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~  171 (275)
T cd06608          95 SVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRN  171 (275)
T ss_pred             cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCccceecccchhhhc
Confidence            9999886543  356899999999999999999999998   999999999999999999999999998643322  122


Q ss_pred             cccccccccCccccCC-----CCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          489 HIVGTQGYIAPEYLAD-----GVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       489 ~~~gt~~y~aPE~~~~-----~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      ...++..|+|||.+..     ..++.++||||||+++|+|++|+.||...
T Consensus       172 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  221 (275)
T cd06608         172 TFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM  221 (275)
T ss_pred             CccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc
Confidence            3567889999998753     34678899999999999999999999754

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.95  E-value=1.3e-27  Score=238.41  Aligned_cols=183  Identities=30%  Similarity=0.489  Sum_probs=159.2

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhh
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSW  417 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~  417 (552)
                      |.|.+|.||++..  +++.+++|+++..      ..+|++++++++|+|++++++.+..  ....++++||+++++|.++
T Consensus        28 ~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~  105 (286)
T cd06614          28 GEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLV--GDELWVVMEYMDGGSLTDI  105 (286)
T ss_pred             cCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEE--CCEEEEEEeccCCCcHHHH
Confidence            6666799999998  4889999998643      3479999999999999999999987  5788999999999999999


Q ss_pred             hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--cccccccccc
Q 037224          418 LHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIVGTQG  495 (552)
Q Consensus       418 l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~gt~~  495 (552)
                      +.... ..+++.++..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......  ......++..
T Consensus       106 l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~  181 (286)
T cd06614         106 ITQNF-VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPY  181 (286)
T ss_pred             HHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccccCCcc
Confidence            98764 35999999999999999999999998   999999999999999999999999987643221  1123457789


Q ss_pred             ccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          496 YIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       496 y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      |++||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus       182 y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~  220 (286)
T cd06614         182 WMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP  220 (286)
T ss_pred             cCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence            999999988889999999999999999999999998644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.95  E-value=1e-27  Score=240.25  Aligned_cols=183  Identities=29%  Similarity=0.479  Sum_probs=154.6

Q ss_pred             CceEEEEEEEEeecC------------------cEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCC
Q 037224          346 GCLIQGSVYKGNIHG------------------EVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPED  399 (552)
Q Consensus       346 G~g~~G~Vy~~~~~g------------------~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~  399 (552)
                      |.|++|.||++....                  ..||+|.+...        +.+|++++++++|+|++++++++..  +
T Consensus        14 g~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~   91 (296)
T cd05051          14 GEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTV--D   91 (296)
T ss_pred             cCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEec--C
Confidence            777789999987632                  45899998643        2368999999999999999999977  5


Q ss_pred             CeeEEEEeeccCCCchhhhhhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCc
Q 037224          400 ANCYLIYEYIENGSLHSWLHENKN---------ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR  470 (552)
Q Consensus       400 ~~~~lv~e~~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~  470 (552)
                      ...++++||+++++|.+++.....         ..+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.
T Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Nili~~~~~  168 (296)
T cd05051          92 PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGKNYT  168 (296)
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhceeecCCCc
Confidence            678999999999999999876541         25899999999999999999999998   999999999999999999


Q ss_pred             EEEeeccCCccCCCCc----cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc--CCCCCCcc
Q 037224          471 AKIANFGLAKSGCNAI----TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS--GKEAIDEE  533 (552)
Q Consensus       471 ~kL~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt--G~~pf~~~  533 (552)
                      ++|+|||+++......    .....++..|+|||.+.+..++.++||||||+++|||++  |..||...
T Consensus       169 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~  237 (296)
T cd05051         169 IKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL  237 (296)
T ss_pred             eEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence            9999999987432221    122345678999999988889999999999999999998  77888754

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.95  E-value=2.8e-28  Score=239.47  Aligned_cols=181  Identities=23%  Similarity=0.387  Sum_probs=150.3

Q ss_pred             CCceEEEEEEEEeec---------CcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEee
Q 037224          345 EGCLIQGSVYKGNIH---------GEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEY  408 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~---------g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~  408 (552)
                      .|.|++|.||+|...         ...+++|.+...       +.+|+.+++.++|+|++++++++..  +...++||||
T Consensus         3 lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~~lv~e~   80 (258)
T cd05078           3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVC--GDESIMVQEY   80 (258)
T ss_pred             CCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEe--CCCcEEEEec
Confidence            478888999999762         234888887532       3468889999999999999999987  5567999999


Q ss_pred             ccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCc--------EEEeeccCCc
Q 037224          409 IENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR--------AKIANFGLAK  480 (552)
Q Consensus       409 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~--------~kL~Dfg~a~  480 (552)
                      +++|+|.+++..... .+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.        ++++|||.+.
T Consensus        81 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          81 VKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             CCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            999999999876543 4899999999999999999999998   999999999999987765        6999999986


Q ss_pred             cCCCCccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCC-CCCCcc
Q 037224          481 SGCNAITMHIVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGK-EAIDEE  533 (552)
Q Consensus       481 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~-~pf~~~  533 (552)
                      .....  ....++..|+|||.+.+ ..++.++||||||+++|||++|. .||...
T Consensus       157 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~  209 (258)
T cd05078         157 TVLPK--EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL  209 (258)
T ss_pred             ccCCc--hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhc
Confidence            54322  23467889999999876 45789999999999999999995 566543

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.95  E-value=1.1e-27  Score=241.12  Aligned_cols=183  Identities=30%  Similarity=0.478  Sum_probs=153.2

Q ss_pred             CCceEEEEEEEEee--cCc----EEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          345 EGCLIQGSVYKGNI--HGE----VYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~----~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      .|.|++|.||++.+  +|+    .+|+|.+...        +.+|+.++++++|+||++++++|..   ...++++||++
T Consensus        15 lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~---~~~~~v~e~~~   91 (303)
T cd05110          15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS---PTIQLVTQLMP   91 (303)
T ss_pred             cccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC---CCceeeehhcC
Confidence            47788899999987  454    5788987643        3468899999999999999999865   23579999999


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc----
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI----  486 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~----  486 (552)
                      +|+|.+++..... .+++..++.++.|++.||+|||+++   ++|+||||+||+++.++.+||+|||+++......    
T Consensus        92 ~g~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~  167 (303)
T cd05110          92 HGCLLDYVHEHKD-NIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN  167 (303)
T ss_pred             CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccCcccccc
Confidence            9999999876532 4899999999999999999999998   9999999999999999999999999997533211    


Q ss_pred             cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          487 TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       487 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.+..
T Consensus       168 ~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~  216 (303)
T cd05110         168 ADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP  216 (303)
T ss_pred             cCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            112334678999999988899999999999999999997 999997643

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.95  E-value=1e-27  Score=241.81  Aligned_cols=180  Identities=33%  Similarity=0.485  Sum_probs=152.9

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEecc----------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKW----------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~----------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|.|.+|.||+++.  +++.||+|.+..          +..+|+++++.++|+|++++.++|.+  +...++|+||++ |
T Consensus        23 lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~-g   99 (307)
T cd06607          23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR--EHTAWLVMEYCL-G   99 (307)
T ss_pred             ecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe--CCeEEEEHHhhC-C
Confidence            46667799999987  689999998752          13478999999999999999999987  667899999997 4


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccccccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVG  492 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~g  492 (552)
                      +|.+++.... ..+++.++..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++......  ....+
T Consensus       100 ~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--~~~~~  173 (307)
T cd06607         100 SASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--NSFVG  173 (307)
T ss_pred             CHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC--CCccC
Confidence            7777765433 34899999999999999999999998   999999999999999999999999998754322  23467


Q ss_pred             cccccCccccC---CCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          493 TQGYIAPEYLA---DGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       493 t~~y~aPE~~~---~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      +..|+|||.+.   ...++.++||||||+++|||++|+.||...
T Consensus       174 ~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~  217 (307)
T cd06607         174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM  217 (307)
T ss_pred             CccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc
Confidence            88999999874   456888999999999999999999999754

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.95  E-value=8.5e-28  Score=239.07  Aligned_cols=184  Identities=31%  Similarity=0.480  Sum_probs=157.5

Q ss_pred             CceEEEEEEEEeec------CcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          346 GCLIQGSVYKGNIH------GEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       346 G~g~~G~Vy~~~~~------g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      |.|++|.||+++++      +..+|+|.++..        +.+|++++++++|+||+++++++........+++|||+++
T Consensus        13 g~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~   92 (284)
T cd05038          13 GEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPS   92 (284)
T ss_pred             ccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCC
Confidence            66777999999863      678999998633        3478999999999999999999877556678999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccc---
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM---  488 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~---  488 (552)
                      ++|.+++..... .+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||.+.........   
T Consensus        93 ~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  168 (284)
T cd05038          93 GSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYV  168 (284)
T ss_pred             CCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccccccCCcceec
Confidence            999999976543 4899999999999999999999998   999999999999999999999999999755422111   


Q ss_pred             --cccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          489 --HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       489 --~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                        ...++..|++||.+.+..++.++||||||+++|||++|+.|+...
T Consensus       169 ~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~  215 (284)
T cd05038         169 KEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP  215 (284)
T ss_pred             cCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence              123455799999998888999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.95  E-value=1e-27  Score=240.12  Aligned_cols=182  Identities=25%  Similarity=0.464  Sum_probs=157.0

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      .|.|.+|.||++..  +++.||+|.+...       ..+|+.+++.++|+|++++++.+..  .+..+++|||+++++|.
T Consensus        28 lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVVMEFLEGGALT  105 (292)
T ss_pred             cCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEe--CCEEEEEEecCCCCcHH
Confidence            36777799999987  7889999987432       3468999999999999999999987  67889999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc--ccccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI--TMHIVGT  493 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~--~~~~~gt  493 (552)
                      +++...   .+++..+..++.|++.+|+|||+.+   ++|+||+|+||++++++.++|+|||++.......  .....++
T Consensus       106 ~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  179 (292)
T cd06657         106 DIVTHT---RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGT  179 (292)
T ss_pred             HHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccccccccccC
Confidence            987543   3899999999999999999999998   9999999999999999999999999886433221  2234678


Q ss_pred             ccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       494 ~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..|++||.+.+..++.++|+||+|+++|||++|+.||....
T Consensus       180 ~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~  220 (292)
T cd06657         180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP  220 (292)
T ss_pred             ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            89999999988888999999999999999999999997543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.95  E-value=4.9e-28  Score=241.27  Aligned_cols=183  Identities=25%  Similarity=0.448  Sum_probs=154.8

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      .|.|.+|.||++..  .++.||+|++...         ..+|+++++.++|+||+++++++.+  +...++++||+++++
T Consensus         9 lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~   86 (286)
T cd07846           9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR--KKRLYLVFEFVDHTV   86 (286)
T ss_pred             eccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc--CCeEEEEEecCCccH
Confidence            36777799999998  5789999987421         3479999999999999999999976  678899999999988


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--cccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIV  491 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~  491 (552)
                      |.++.....  .+++.+++.++.|++.+|.|||+.+   ++|+||+|+||++++++.++|+|||++......  ......
T Consensus        87 l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  161 (286)
T cd07846          87 LDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV  161 (286)
T ss_pred             HHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCccc
Confidence            887765432  3899999999999999999999998   999999999999999999999999998743322  112345


Q ss_pred             ccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          492 GTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       492 gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ++..|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus       162 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~  205 (286)
T cd07846         162 ATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS  205 (286)
T ss_pred             ceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc
Confidence            7889999998865 447789999999999999999999997544

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.95  E-value=1e-27  Score=235.81  Aligned_cols=181  Identities=34%  Similarity=0.558  Sum_probs=156.2

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|.+|.||++..  +++.+++|.++..         ..+|+.++++++|+||+++++++.+  ....++++||+++++|
T Consensus         9 g~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L   86 (264)
T cd06626           9 GGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH--REKVYIFMEYCSGGTL   86 (264)
T ss_pred             ecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec--CCEEEEEEecCCCCcH
Confidence            6677799999987  6789999998543         2369999999999999999998876  6788999999999999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcc------c
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT------M  488 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~------~  488 (552)
                      .+++....  .+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++........      .
T Consensus        87 ~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~  161 (264)
T cd06626          87 EELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQ  161 (264)
T ss_pred             HHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccccc
Confidence            99987653  3889999999999999999999999   99999999999999999999999999875432211      1


Q ss_pred             cccccccccCccccCCCC---CCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          489 HIVGTQGYIAPEYLADGV---VSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       489 ~~~gt~~y~aPE~~~~~~---~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      ...++..|+|||.+....   .+.++||||||+++|||++|+.||...
T Consensus       162 ~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~  209 (264)
T cd06626         162 SLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL  209 (264)
T ss_pred             CCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence            245678999999987766   888999999999999999999999754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=9.8e-28  Score=238.02  Aligned_cols=182  Identities=29%  Similarity=0.483  Sum_probs=155.7

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcC---CCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVN---HGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|.+|.||+|..  +++.+|+|.++..        ..+|+.++++++   |+|++++++++.+  +...+++|||+++
T Consensus         9 l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~--~~~~~lv~e~~~~   86 (277)
T cd06917           9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK--GPRLWIIMEYAEG   86 (277)
T ss_pred             eeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee--CCEEEEEEecCCC
Confidence            36777799999997  6889999987532        346888999986   9999999999876  6678999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--cccc
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMH  489 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~  489 (552)
                      ++|.+++...   .+++..++.++.|++.+|.|||+.+   ++|+||+|+||++++++.++|+|||++......  ....
T Consensus        87 ~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06917          87 GSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST  160 (277)
T ss_pred             CcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccccc
Confidence            9999988654   4899999999999999999999999   999999999999999999999999998744322  1223


Q ss_pred             ccccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          490 IVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||....
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~  206 (277)
T cd06917         161 FVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD  206 (277)
T ss_pred             ccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC
Confidence            467889999998765 446889999999999999999999997553

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.95  E-value=6.8e-28  Score=239.84  Aligned_cols=181  Identities=25%  Similarity=0.445  Sum_probs=149.7

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccCh--------HHHHHH-HHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWNA--------CEELKI-LQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~~--------~~E~~~-l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|.+|.||++..  +|+.||+|+++...        ..|+.. ++.++|+|++++++++..  +...+++|||++ ++|
T Consensus        10 g~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~--~~~~~lv~e~~~-~~l   86 (283)
T cd06617          10 GRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR--EGDVWICMEVMD-TSL   86 (283)
T ss_pred             cccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec--CCcEEEEhhhhc-ccH
Confidence            7777899999988  68999999986432        235444 555689999999999976  667899999997 588


Q ss_pred             hhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc-cccc
Q 037224          415 HSWLHEN--KNENLNWKTRLRIAIDVANGLQYIHEH-TRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI-TMHI  490 (552)
Q Consensus       415 ~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-~~~~  490 (552)
                      .+++...  ....+++..++.++.|++.||+|||++ +   ++||||||+||+++.++.+||+|||++....... ....
T Consensus        87 ~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  163 (283)
T cd06617          87 DKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID  163 (283)
T ss_pred             HHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence            8877543  224589999999999999999999987 7   9999999999999999999999999987543322 2235


Q ss_pred             cccccccCccccCC----CCCCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          491 VGTQGYIAPEYLAD----GVVSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       491 ~gt~~y~aPE~~~~----~~~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                      .++..|+|||.+.+    ..++.++|+||||+++|||++|+.||..
T Consensus       164 ~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  209 (283)
T cd06617         164 AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS  209 (283)
T ss_pred             cCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence            67889999998764    4468899999999999999999999974

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=3e-28  Score=249.79  Aligned_cols=183  Identities=27%  Similarity=0.400  Sum_probs=157.9

Q ss_pred             CceEEEEEEEEeec---Cc--EEEEEEecc--------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          346 GCLIQGSVYKGNIH---GE--VYAIKMMKW--------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       346 G~g~~G~Vy~~~~~---g~--~vAvK~~~~--------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      |.|.||.|++|.|+   |+  .||||+++.        ++.+|+.+|.+|+|+|+++|+|+..+   ....+|+|.++.|
T Consensus       119 G~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~---qp~mMV~ELaplG  195 (1039)
T KOG0199|consen  119 GEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD---QPAMMVFELAPLG  195 (1039)
T ss_pred             cCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc---chhhHHhhhcccc
Confidence            55556999999993   43  689999964        36789999999999999999999875   4568999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccccc--
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI--  490 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~--  490 (552)
                      +|.+.|+......|-......++.||+.|+.||.+++   +|||||..+|+|+-....+||+|||+.+..........  
T Consensus       196 SLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~  272 (1039)
T KOG0199|consen  196 SLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMA  272 (1039)
T ss_pred             hHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcceEec
Confidence            9999999855566888999999999999999999998   99999999999999988999999999986544332222  


Q ss_pred             ---cccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          491 ---VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       491 ---~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                         .-...|+|||.+..+.++.++|||+|||.+|||+| |+.||-+-.
T Consensus       273 p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~  320 (1039)
T KOG0199|consen  273 PQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR  320 (1039)
T ss_pred             CCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC
Confidence               22457999999999999999999999999999998 889998643

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.95  E-value=8.4e-28  Score=233.13  Aligned_cols=177  Identities=20%  Similarity=0.250  Sum_probs=151.7

Q ss_pred             eEEEEEEEEee--cCcEEEEEEeccC--hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhhhhhcCC
Q 037224          348 LIQGSVYKGNI--HGEVYAIKMMKWN--ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKN  423 (552)
Q Consensus       348 g~~G~Vy~~~~--~g~~vAvK~~~~~--~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~  423 (552)
                      |.+|.||++..  +++.+|+|.++..  ..+|...+....|||++++++++.+  ....+++|||+++++|.+++.... 
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~-   80 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVS--EDSVFLVLQHAEGGKLWSHISKFL-   80 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhhhhhHHHHHHhcCCCceeehhhheec--CCeEEEEEecCCCCCHHHHHHHhc-
Confidence            56699999988  7899999999764  3456666666689999999999876  668899999999999999987654 


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccccccccccccCccccC
Q 037224          424 ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLA  503 (552)
Q Consensus       424 ~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~  503 (552)
                       .+++..+..++.|+++||+|||+.+   ++||||||+||+++.++.++++|||.+....... ....++..|+|||...
T Consensus        81 -~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~y~aPE~~~  155 (237)
T cd05576          81 -NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-DGEAVENMYCAPEVGG  155 (237)
T ss_pred             -CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-ccCCcCccccCCcccC
Confidence             4899999999999999999999998   9999999999999999999999999876443321 2344567899999998


Q ss_pred             CCCCCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          504 DGVVSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       504 ~~~~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                      ...++.++|+||+|+++|||++|+.|+..
T Consensus       156 ~~~~~~~~DvwslG~il~el~~g~~~~~~  184 (237)
T cd05576         156 ISEETEACDWWSLGAILFELLTGKTLVEC  184 (237)
T ss_pred             CCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence            88889999999999999999999988764

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.95  E-value=1.3e-27  Score=239.41  Aligned_cols=183  Identities=30%  Similarity=0.477  Sum_probs=152.7

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEecc---------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKW---------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~---------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|.+|.||++..  +|+.||+|.++.         ...+|++++++++|+|++++++++.+  +...++||||++ ++|
T Consensus        11 ~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~-~~l   87 (294)
T PLN00009         11 GEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS--EKRLYLVFEYLD-LDL   87 (294)
T ss_pred             cCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec--CCeEEEEEeccc-ccH
Confidence            6667799999987  678999998753         23479999999999999999999987  678899999996 488


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECC-CCcEEEeeccCCccCCCC--cccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS-NMRAKIANFGLAKSGCNA--ITMHIV  491 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kL~Dfg~a~~~~~~--~~~~~~  491 (552)
                      .+++.......+++..+..++.|++.||+|||+++   ++|+||+|+||+++. ++.+||+|||++......  ......
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  164 (294)
T PLN00009         88 KKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEV  164 (294)
T ss_pred             HHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCccccccCc
Confidence            88776655445788899999999999999999998   999999999999985 567999999998743221  112345


Q ss_pred             ccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          492 GTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       492 gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +++.|+|||.+.+ ..++.++||||||+++|+|+||+.||...+
T Consensus       165 ~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~  208 (294)
T PLN00009        165 VTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS  208 (294)
T ss_pred             eeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            6789999998765 457889999999999999999999997654

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.95  E-value=9.4e-28  Score=239.37  Aligned_cols=182  Identities=29%  Similarity=0.431  Sum_probs=155.1

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEecc---------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKW---------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~---------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|.+|.||++..  +++.|++|.++.         ...+|++++++++|+||+++++++.+  ++..+++|||++++.+
T Consensus        10 ~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv~e~~~~~~l   87 (288)
T cd07833          10 GEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR--KGRLYLVFEYVERTLL   87 (288)
T ss_pred             cccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE--CCEEEEEEecCCCCHH
Confidence            6677799999988  578999998753         23579999999999999999999987  6778999999998766


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC---cccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA---ITMHIV  491 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~---~~~~~~  491 (552)
                      ..+....  ..+++.++..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++......   ......
T Consensus        88 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~  162 (288)
T cd07833          88 ELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV  162 (288)
T ss_pred             HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccCcc
Confidence            6555433  34899999999999999999999998   999999999999999999999999998754332   222346


Q ss_pred             ccccccCccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          492 GTQGYIAPEYLADG-VVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       492 gt~~y~aPE~~~~~-~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ++..|+|||.+... .++.++|+||||+++|+|++|+.||....
T Consensus       163 ~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~  206 (288)
T cd07833         163 ATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDS  206 (288)
T ss_pred             cccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            78889999999887 78999999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.95  E-value=1.4e-27  Score=233.95  Aligned_cols=183  Identities=27%  Similarity=0.461  Sum_probs=158.2

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|++|.||++..  +|..+|+|.+...         ..+|+.++++++|+|++++++.+.+  +...++++||+++++|
T Consensus         9 ~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L   86 (257)
T cd08225           9 GEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE--NGRLFIVMEYCDGGDL   86 (257)
T ss_pred             cCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc--CCeEEEEEecCCCCcH
Confidence            6677799999988  6789999998432         3479999999999999999999876  6788999999999999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCc-EEEeeccCCccCCCCc--ccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR-AKIANFGLAKSGCNAI--TMHIV  491 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~-~kL~Dfg~a~~~~~~~--~~~~~  491 (552)
                      .+++.......+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++. +||+|||.+.......  .....
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~  163 (257)
T cd08225          87 MKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV  163 (257)
T ss_pred             HHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCcccccccC
Confidence            99997765556899999999999999999999998   999999999999988864 6999999987543321  12346


Q ss_pred             ccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          492 GTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       492 gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      +++.|+|||.+.+..++.++|+||||+++|||++|+.||...
T Consensus       164 ~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  205 (257)
T cd08225         164 GTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN  205 (257)
T ss_pred             CCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence            788999999998888999999999999999999999999754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.9e-27  Score=231.93  Aligned_cols=182  Identities=32%  Similarity=0.475  Sum_probs=159.6

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|++|.||++..  +++.+++|.++..          ..+|+.++++++|+|++++++.+.+  +...+++|||+++++
T Consensus         2 g~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~~   79 (250)
T cd05123           2 GKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT--EEKLYLVLEYAPGGE   79 (250)
T ss_pred             CCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec--CCeeEEEEecCCCCc
Confidence            6788899999988  5889999998542          3468999999999999999998876  678899999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--cccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIV  491 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~  491 (552)
                      |.+++....  .+++.++..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......  ......
T Consensus        80 L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~  154 (250)
T cd05123          80 LFSHLSKEG--RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC  154 (250)
T ss_pred             HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCc
Confidence            999997654  4899999999999999999999998   999999999999999999999999998754332  233456


Q ss_pred             ccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          492 GTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       492 gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ++..|++||...+...+.++|+||||+++|||++|+.||...+
T Consensus       155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~  197 (250)
T cd05123         155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED  197 (250)
T ss_pred             CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence            7889999999988888999999999999999999999997554

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.95  E-value=1.4e-27  Score=237.74  Aligned_cols=183  Identities=27%  Similarity=0.494  Sum_probs=154.9

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      |.|.+|.||+|+.  +|+.||+|.++..        ..+|+.++++++|+|++++++++.+  .+..++||||+++ +|.
T Consensus         9 ~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~-~l~   85 (284)
T cd07836           9 GEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT--ENKLMLVFEYMDK-DLK   85 (284)
T ss_pred             ccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee--CCcEEEEEecCCc-cHH
Confidence            6667799999998  6889999988532        2469999999999999999999987  5678999999985 888


Q ss_pred             hhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--ccccccc
Q 037224          416 SWLHENK-NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIVG  492 (552)
Q Consensus       416 ~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~g  492 (552)
                      +++.... ...+++.++..++.|+++||.|||+.+   ++||||+|+||++++++.++|+|||++......  ......+
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  162 (284)
T cd07836          86 KYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV  162 (284)
T ss_pred             HHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccccccc
Confidence            8876543 245899999999999999999999998   999999999999999999999999998743221  1123456


Q ss_pred             cccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          493 TQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       493 t~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +..|++||.+.+ ..++.++|+||||+++|||++|+.||.+.+
T Consensus       163 ~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~  205 (284)
T cd07836         163 TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN  205 (284)
T ss_pred             cccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            889999998765 456889999999999999999999998654

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.95  E-value=1.3e-27  Score=237.92  Aligned_cols=184  Identities=31%  Similarity=0.491  Sum_probs=156.3

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|++|.||+++.  +++.+|+|.++..         ..+|++++++++|+|++++++++.+......++++||+++ +|
T Consensus         8 ~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l   86 (287)
T cd07840           8 GEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DL   86 (287)
T ss_pred             ccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc-cH
Confidence            6677899999988  5789999999643         3469999999999999999999987433788999999975 88


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc---ccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI---TMHIV  491 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~---~~~~~  491 (552)
                      .+++.... ..+++.+++.++.|+++||+|||+.+   ++|+||+|+||++++++.+||+|||++.......   .....
T Consensus        87 ~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  162 (287)
T cd07840          87 TGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRV  162 (287)
T ss_pred             HHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccccc
Confidence            88876543 35899999999999999999999998   9999999999999999999999999987543322   22345


Q ss_pred             ccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          492 GTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       492 gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus       163 ~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~  206 (287)
T cd07840         163 ITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST  206 (287)
T ss_pred             cccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            6788999997754 457899999999999999999999997654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.95  E-value=1.4e-27  Score=239.58  Aligned_cols=184  Identities=26%  Similarity=0.445  Sum_probs=153.1

Q ss_pred             CCceEEEEEEEEeec------------------CcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCC
Q 037224          345 EGCLIQGSVYKGNIH------------------GEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPE  398 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~------------------g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~  398 (552)
                      .|.|++|.||++...                  +..+|+|.++..        +.+|+.++++++|+||+++++++.+  
T Consensus        13 lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--   90 (296)
T cd05095          13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCIT--   90 (296)
T ss_pred             ccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--
Confidence            477778999998532                  346899998642        3479999999999999999999977  


Q ss_pred             CCeeEEEEeeccCCCchhhhhhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCC
Q 037224          399 DANCYLIYEYIENGSLHSWLHENKN---------ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM  469 (552)
Q Consensus       399 ~~~~~lv~e~~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~  469 (552)
                      +...+++|||+++++|.+++.....         ..+++.+++.++.|++.||+|||+.+   ++|+||||+||+++.++
T Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Nili~~~~  167 (296)
T cd05095          91 SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNY  167 (296)
T ss_pred             CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheEEEcCCC
Confidence            5678999999999999999876432         23778899999999999999999999   99999999999999999


Q ss_pred             cEEEeeccCCccCCCCc----cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc--CCCCCCcc
Q 037224          470 RAKIANFGLAKSGCNAI----TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS--GKEAIDEE  533 (552)
Q Consensus       470 ~~kL~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt--G~~pf~~~  533 (552)
                      .++|+|||++.......    .....++..|++||....+.++.++|+||||+++|||++  |..||...
T Consensus       168 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~  237 (296)
T cd05095         168 TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL  237 (296)
T ss_pred             CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence            99999999987433221    111233568999999888889999999999999999998  77888654

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.95  E-value=1.8e-27  Score=236.62  Aligned_cols=183  Identities=27%  Similarity=0.400  Sum_probs=153.2

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccCh--------HHHHHHHHHcC-CCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWNA--------CEELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~~--------~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|.+|.||++..  +++.+|+|.++...        .+|+.++.++. |+|++++++++.+...+..++|+||+++ +|
T Consensus         8 g~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l   86 (282)
T cd07831           8 GEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDM-NL   86 (282)
T ss_pred             cccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCCc-cH
Confidence            6677799999987  68899999986431        25888888885 9999999999987544788999999975 88


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc-ccccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI-TMHIVGT  493 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-~~~~~gt  493 (552)
                      .+++.... ..+++.+++.++.|++.||+|||+.+   ++||||+|+||+++. +.+||+|||++....... .....++
T Consensus        87 ~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~~~~~  161 (282)
T cd07831          87 YELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTEYIST  161 (282)
T ss_pred             HHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCCcCCCCCC
Confidence            88776543 35899999999999999999999998   999999999999999 999999999997543222 1234578


Q ss_pred             ccccCccccC-CCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          494 QGYIAPEYLA-DGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       494 ~~y~aPE~~~-~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..|+|||.+. +..++.++|||||||++|||++|+.||...+
T Consensus       162 ~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~  203 (282)
T cd07831         162 RWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN  203 (282)
T ss_pred             cccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC
Confidence            8999999764 4557889999999999999999999997654

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.95  E-value=1.8e-27  Score=238.31  Aligned_cols=185  Identities=28%  Similarity=0.411  Sum_probs=151.8

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcC-CCCccceeeeeecCCC---CeeEEEEeecc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVN-HGNLVKLEGFCIDPED---ANCYLIYEYIE  410 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~-h~niv~l~~~~~~~~~---~~~~lv~e~~~  410 (552)
                      |.|.+|.||++..  +++.||+|..+..         ..+|+.+++++. |+|++++++++...+.   ...+++|||++
T Consensus        10 g~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~   89 (295)
T cd07837          10 GEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLD   89 (295)
T ss_pred             cccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccC
Confidence            6677799999987  6889999987532         347999999995 6999999998875322   23799999998


Q ss_pred             CCCchhhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECC-CCcEEEeeccCCccCCCC-
Q 037224          411 NGSLHSWLHENK---NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS-NMRAKIANFGLAKSGCNA-  485 (552)
Q Consensus       411 ~gsL~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kL~Dfg~a~~~~~~-  485 (552)
                      + +|.+++....   ...+++..++.++.|++.||.|||+++   ++||||+|+||+++. ++.+||+|||++...... 
T Consensus        90 ~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~  165 (295)
T cd07837          90 S-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPV  165 (295)
T ss_pred             c-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecccceecCCCc
Confidence            6 8888876532   235899999999999999999999998   999999999999998 889999999998743221 


Q ss_pred             -ccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          486 -ITMHIVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       486 -~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                       ......+++.|+|||.+.+ ..++.++|+||||+++|||++|..||...+
T Consensus       166 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~  216 (295)
T cd07837         166 KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDS  216 (295)
T ss_pred             cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Confidence             1222356788999998765 457899999999999999999999997654

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.95  E-value=1.6e-27  Score=243.50  Aligned_cols=182  Identities=28%  Similarity=0.388  Sum_probs=154.2

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC---------------------hHHHHHHHHHcCCCCccceeeeeecCCCCe
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN---------------------ACEELKILQKVNHGNLVKLEGFCIDPEDAN  401 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------------------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  401 (552)
                      .|.|.+|.||++..  .++.||+|.++..                     ..+|++++++++|+||+++++++..  +..
T Consensus        17 ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~   94 (335)
T PTZ00024         17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVE--GDF   94 (335)
T ss_pred             ccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEec--CCc
Confidence            47788899999986  6889999987532                     3479999999999999999999876  668


Q ss_pred             eEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCcc
Q 037224          402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS  481 (552)
Q Consensus       402 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  481 (552)
                      .+++|||++ ++|.+++....  .+++.....++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..
T Consensus        95 ~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg~~~~  168 (335)
T PTZ00024         95 INLVMDIMA-SDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARR  168 (335)
T ss_pred             EEEEEeccc-cCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCccceee
Confidence            899999997 58998886543  4899999999999999999999998   99999999999999999999999999864


Q ss_pred             CC----------------CCccccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          482 GC----------------NAITMHIVGTQGYIAPEYLADG-VVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       482 ~~----------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..                ........++..|+|||.+.+. .++.++|+||||+++|||++|+.||...+
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~  238 (335)
T PTZ00024        169 YGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN  238 (335)
T ss_pred             cccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            33                1111123457789999988654 46889999999999999999999998654

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.95  E-value=1.4e-27  Score=239.27  Aligned_cols=184  Identities=24%  Similarity=0.257  Sum_probs=140.9

Q ss_pred             CCceEEEEEEEEeec-----CcEEEEEEeccC---hH---------------HHHHHHHHcCCCCccceeeeeecCCCC-
Q 037224          345 EGCLIQGSVYKGNIH-----GEVYAIKMMKWN---AC---------------EELKILQKVNHGNLVKLEGFCIDPEDA-  400 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~-----g~~vAvK~~~~~---~~---------------~E~~~l~~l~h~niv~l~~~~~~~~~~-  400 (552)
                      .|.|+||.||+|...     +..+|+|+....   ..               .+...+..++|++++++++++...... 
T Consensus        20 LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~   99 (294)
T PHA02882         20 IGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKRCRM   99 (294)
T ss_pred             EecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEecCCc
Confidence            488888999999873     346777764211   11               122334456899999999876543222 


Q ss_pred             -eeEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCC
Q 037224          401 -NCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLA  479 (552)
Q Consensus       401 -~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  479 (552)
                       ..++++|++.. ++.+.+....  ..++..+..++.|++.||+|||+.+   ++||||||+|||++.++.++|+|||++
T Consensus       100 ~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~~l~DFGla  173 (294)
T PHA02882        100 YYRFILLEKLVE-NTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIA  173 (294)
T ss_pred             eEEEEEEehhcc-CHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcEEEEEcCCc
Confidence             34677777643 6666555432  2678889999999999999999998   999999999999999999999999998


Q ss_pred             ccCCC---------CccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          480 KSGCN---------AITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       480 ~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +....         .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~  237 (294)
T PHA02882        174 SHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG  237 (294)
T ss_pred             eeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence            74321         11122468999999999999999999999999999999999999998663

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.95  E-value=1.7e-28  Score=218.29  Aligned_cols=184  Identities=24%  Similarity=0.402  Sum_probs=148.6

Q ss_pred             CceEEEE--EEEEeecCcEEEEEEeccC--------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGS--VYKGNIHGEVYAIKMMKWN--------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~--Vy~~~~~g~~vAvK~~~~~--------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |+|++|.  +|+...+|...|+|+++..        ..+|+++..+. ..|.++.++|...+  +...|+.||.|+. +|
T Consensus        55 GrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r--egdvwIcME~M~t-Sl  131 (282)
T KOG0984|consen   55 GRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR--EGDVWICMELMDT-SL  131 (282)
T ss_pred             cCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc--cccEEEeHHHhhh-hH
Confidence            5555554  5666669999999998643        22456555444 69999999998877  6788999999975 88


Q ss_pred             hhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcccc-cc
Q 037224          415 HSWLHEN--KNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH-IV  491 (552)
Q Consensus       415 ~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~-~~  491 (552)
                      ..+-.+.  .+..+++.-+-+|+..+.+||.|||++-  .++|||+||+|||++.+|++|+||||.+....+..... ..
T Consensus       132 dkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~da  209 (282)
T KOG0984|consen  132 DKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTMDA  209 (282)
T ss_pred             HHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhhHHHHhc
Confidence            7665432  2356889999999999999999999975  59999999999999999999999999997665554444 57


Q ss_pred             ccccccCccccC----CCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          492 GTQGYIAPEYLA----DGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       492 gt~~y~aPE~~~----~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      |...|||||.+.    +..|+-++||||||+.+.||.+++.||+...
T Consensus       210 GCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  210 GCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG  256 (282)
T ss_pred             CCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence            888999999874    3468889999999999999999999998654

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.95  E-value=4e-27  Score=230.30  Aligned_cols=184  Identities=30%  Similarity=0.491  Sum_probs=160.6

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|++|.||++..  +++.+++|++...         ..+|++++++++|+|++++.+.+..  ....++++||+++++|
T Consensus         9 ~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~--~~~~~lv~e~~~~~~L   86 (258)
T cd08215           9 GKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE--KGKLCIVMEYADGGDL   86 (258)
T ss_pred             ccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec--CCEEEEEEEecCCCcH
Confidence            6677799999998  4899999998643         3468999999999999999999877  5788999999999999


Q ss_pred             hhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--ccccc
Q 037224          415 HSWLHENK--NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHI  490 (552)
Q Consensus       415 ~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~  490 (552)
                      .+++....  ...+++.++..++.+++.||.|||+.+   ++|+||+|+||++++++.++|+|||.+......  .....
T Consensus        87 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~  163 (258)
T cd08215          87 SQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV  163 (258)
T ss_pred             HHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCcceecce
Confidence            99987653  356999999999999999999999998   999999999999999999999999998754332  22234


Q ss_pred             cccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       491 ~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||...+
T Consensus       164 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~  207 (258)
T cd08215         164 VGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN  207 (258)
T ss_pred             eeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc
Confidence            67889999999988889999999999999999999999997653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.95  E-value=2e-27  Score=232.61  Aligned_cols=184  Identities=31%  Similarity=0.470  Sum_probs=160.0

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|.+|.||+++.  +++.+++|.++..         ..+|+.++++++|+||+++.+++.+  ....++++||+++++|
T Consensus         9 ~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~~~~~~L   86 (256)
T cd08530           9 GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD--GNKLCIVMEYAPFGDL   86 (256)
T ss_pred             cCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc--CCEEEEEehhcCCCCH
Confidence            5566799999977  6789999998532         2368899999999999999999877  5788999999999999


Q ss_pred             hhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccccccc
Q 037224          415 HSWLHENK--NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVG  492 (552)
Q Consensus       415 ~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~g  492 (552)
                      .+++....  ...+++..++.++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++............+
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~  163 (256)
T cd08530          87 SKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIG  163 (256)
T ss_pred             HHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCCcccccC
Confidence            99986632  245899999999999999999999999   9999999999999999999999999997654444444567


Q ss_pred             cccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       493 t~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +..|++||.+.+..++.++|+||||+++|||++|+.||...+
T Consensus       164 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~  205 (256)
T cd08530         164 TPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS  205 (256)
T ss_pred             CccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            889999999998889999999999999999999999998654

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.95  E-value=2.8e-27  Score=230.35  Aligned_cols=183  Identities=31%  Similarity=0.513  Sum_probs=160.7

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      .|.|.+|.||++..  +++.+++|++...       ..+|+.++++++|+|++++++++..  +...++++||+++++|.
T Consensus         8 l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l~~e~~~~~~L~   85 (253)
T cd05122           8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLK--KDELWIVMEFCSGGSLK   85 (253)
T ss_pred             eccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CCeEEEEEecCCCCcHH
Confidence            36677799999998  5889999998543       3479999999999999999999877  57789999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc-cccccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI-TMHIVGTQ  494 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-~~~~~gt~  494 (552)
                      +++.... ..+++..+..++.|++.+|.+||+.+   ++||||+|+||++++++.++|+|||.+....... .....++.
T Consensus        86 ~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  161 (253)
T cd05122          86 DLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTP  161 (253)
T ss_pred             HHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeeccccccccccccccceecCC
Confidence            9987653 35899999999999999999999998   9999999999999999999999999987554332 33467888


Q ss_pred             cccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       495 ~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      .|++||.+.....+.++|+||||+++|+|++|+.||...
T Consensus       162 ~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  200 (253)
T cd05122         162 YWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL  200 (253)
T ss_pred             cccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence            999999998888999999999999999999999999865

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.95  E-value=1.7e-27  Score=237.70  Aligned_cols=183  Identities=26%  Similarity=0.415  Sum_probs=150.9

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcC-CCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      .|.|.+|.||++..  +++.+|+|.+...        ..+|+.++.++. |+||+++++++..  +...+++|||+.. +
T Consensus        12 lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~--~~~~~~~~e~~~~-~   88 (288)
T cd06616          12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR--EGDCWICMELMDI-S   88 (288)
T ss_pred             hCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec--CCcEEEEEecccC-C
Confidence            47777899999988  6789999988532        246888899995 9999999999876  5677999999864 5


Q ss_pred             chhhh---hhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-ccc
Q 037224          414 LHSWL---HENKNENLNWKTRLRIAIDVANGLQYIHEH-TRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-ITM  488 (552)
Q Consensus       414 L~~~l---~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-~~~  488 (552)
                      +.++.   .......+++..+..++.|++.||+|||+. +   ++||||||+||+++.++.++|+|||++...... ...
T Consensus        89 l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  165 (288)
T cd06616          89 LDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKT  165 (288)
T ss_pred             HHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhccCCccc
Confidence            55433   223335699999999999999999999975 7   999999999999999999999999998643322 223


Q ss_pred             cccccccccCccccCCC---CCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          489 HIVGTQGYIAPEYLADG---VVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       489 ~~~gt~~y~aPE~~~~~---~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      ...++..|+|||.+...   .++.++||||||+++|||++|+.||...
T Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  213 (288)
T cd06616         166 RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW  213 (288)
T ss_pred             cccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhc
Confidence            34678899999998766   6889999999999999999999999754

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.95  E-value=3.5e-27  Score=233.48  Aligned_cols=187  Identities=28%  Similarity=0.443  Sum_probs=153.3

Q ss_pred             CCceEEEEEEEEee-----cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCC----eeEEEE
Q 037224          345 EGCLIQGSVYKGNI-----HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDA----NCYLIY  406 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-----~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~----~~~lv~  406 (552)
                      .|.|++|.||+|.+     .++.+|+|+++.+         ..+|+.++++++|||++++++++......    ..++++
T Consensus         7 ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~   86 (273)
T cd05074           7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVIL   86 (273)
T ss_pred             ccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEE
Confidence            36777899999986     3678999988643         34789999999999999999988653322    347889


Q ss_pred             eeccCCCchhhhhhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccC
Q 037224          407 EYIENGSLHSWLHENK----NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG  482 (552)
Q Consensus       407 e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  482 (552)
                      ||+.+++|.+++....    ...+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++..
T Consensus        87 ~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg~~~~~  163 (273)
T cd05074          87 PFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKI  163 (273)
T ss_pred             ecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcccccccc
Confidence            9999999988875322    124789999999999999999999998   999999999999999999999999998754


Q ss_pred             CCCc----cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          483 CNAI----TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       483 ~~~~----~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      ....    .....++..|++||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~  220 (273)
T cd05074         164 YSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE  220 (273)
T ss_pred             cCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC
Confidence            3211    112334578999999988889999999999999999999 899987554

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.95  E-value=3.3e-27  Score=230.87  Aligned_cols=184  Identities=33%  Similarity=0.474  Sum_probs=161.5

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|++|.||+|..  +++.+++|+++..         ..+|+.++++++|+|++++++.+.+......++++||+++++|
T Consensus         9 ~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L   88 (260)
T cd06606           9 GRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSL   88 (260)
T ss_pred             eecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcH
Confidence            6677799999998  4889999998543         3469999999999999999999987433788999999999999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc----cccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI----TMHI  490 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~----~~~~  490 (552)
                      .+++....  .+++.+++.++.|++.+|+|||+.+   ++|+||+|+||+++.++.++|+|||.+.......    ....
T Consensus        89 ~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~  163 (260)
T cd06606          89 SSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSV  163 (260)
T ss_pred             HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCC
Confidence            99987765  5999999999999999999999998   9999999999999999999999999987554332    3345


Q ss_pred             cccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       491 ~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .++..|++||.+.....+.++||||||+++|+|++|+.||...+
T Consensus       164 ~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  207 (260)
T cd06606         164 RGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG  207 (260)
T ss_pred             CCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            78889999999988889999999999999999999999997654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.95  E-value=2.6e-27  Score=233.99  Aligned_cols=184  Identities=24%  Similarity=0.441  Sum_probs=155.1

Q ss_pred             CceEEEEEEEEeec---CcEEEEEEeccC-----------------hHHHHHHHHH-cCCCCccceeeeeecCCCCeeEE
Q 037224          346 GCLIQGSVYKGNIH---GEVYAIKMMKWN-----------------ACEELKILQK-VNHGNLVKLEGFCIDPEDANCYL  404 (552)
Q Consensus       346 G~g~~G~Vy~~~~~---g~~vAvK~~~~~-----------------~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~~~l  404 (552)
                      |.|.+|.||++...   ++.+|+|.+...                 ..+|+.++.+ ++|+|++++++++.+  ++..++
T Consensus         9 g~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~l   86 (269)
T cd08528           9 GSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE--NDRLYI   86 (269)
T ss_pred             cCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc--CCeEEE
Confidence            67778999999983   578999987421                 2357777765 699999999999977  678899


Q ss_pred             EEeeccCCCchhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEECCCCcEEEeeccCCcc
Q 037224          405 IYEYIENGSLHSWLHEN--KNENLNWKTRLRIAIDVANGLQYIHE-HTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS  481 (552)
Q Consensus       405 v~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  481 (552)
                      +|||+++++|.+++...  ....+++..++.++.|++.+|.|||+ .+   ++|+||+|+||+++.++.++|+|||.+..
T Consensus        87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~  163 (269)
T cd08528          87 VMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDFGLAKQ  163 (269)
T ss_pred             EEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEecccceee
Confidence            99999999999987542  23458999999999999999999996 56   99999999999999999999999999875


Q ss_pred             CCCC-ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          482 GCNA-ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       482 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .... ......++..|++||.+.+..++.++|+||||+++|||++|+.||....
T Consensus       164 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~  217 (269)
T cd08528         164 KQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN  217 (269)
T ss_pred             cccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC
Confidence            4433 2234567889999999998889999999999999999999999997543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.95  E-value=3.1e-27  Score=238.18  Aligned_cols=185  Identities=27%  Similarity=0.427  Sum_probs=152.6

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCC------CCeeEEEEe
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPE------DANCYLIYE  407 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~~~lv~e  407 (552)
                      .|.|.+|.||++..  +++.||+|.+...         ..+|+.++++++||||+++++++...+      ....+++||
T Consensus        20 lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e   99 (310)
T cd07865          20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFE   99 (310)
T ss_pred             eecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEc
Confidence            36677799999987  6889999987432         246999999999999999999987532      235699999


Q ss_pred             eccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc-
Q 037224          408 YIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI-  486 (552)
Q Consensus       408 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-  486 (552)
                      |+.+ +|.+++.... ..+++.+++.++.|+++||+|||+++   ++|+||||+||+++.++.+||+|||++....... 
T Consensus       100 ~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  174 (310)
T cd07865         100 FCEH-DLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKN  174 (310)
T ss_pred             CCCc-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCcccccCCcc
Confidence            9975 7887776543 34899999999999999999999998   9999999999999999999999999987432211 


Q ss_pred             -----cccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          487 -----TMHIVGTQGYIAPEYLADG-VVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       487 -----~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                           .....++..|+|||.+.+. .++.++|+||||+++|||++|+.||...+
T Consensus       175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~  228 (310)
T cd07865         175 SKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT  228 (310)
T ss_pred             cCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence                 1224567889999987654 46889999999999999999999997654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.95  E-value=2.5e-27  Score=242.32  Aligned_cols=182  Identities=35%  Similarity=0.501  Sum_probs=153.7

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|++|.||+|..  .|+.+|+|.+...         ..+|+.+++++ +|+||++++++|...+....++||||+++ +
T Consensus        16 g~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~   94 (337)
T cd07852          16 GKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-D   94 (337)
T ss_pred             cCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEeccccc-C
Confidence            6677799999987  6789999987432         33699999999 99999999999876555678999999974 8


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-------c
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-------I  486 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-------~  486 (552)
                      |.+++...   .+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||++......       .
T Consensus        95 L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~  168 (337)
T cd07852          95 LHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPV  168 (337)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcc
Confidence            98888654   4889999999999999999999998   999999999999999999999999998743221       1


Q ss_pred             cccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          487 TMHIVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       487 ~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .....++..|+|||.+.+ ..++.++|+||||+++|||++|+.||....
T Consensus       169 ~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~  217 (337)
T cd07852         169 LTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTS  217 (337)
T ss_pred             hhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCC
Confidence            223467889999998754 557889999999999999999999997543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.95  E-value=2.6e-27  Score=242.91  Aligned_cols=195  Identities=24%  Similarity=0.397  Sum_probs=158.1

Q ss_pred             cHHHHHHHhhccC----CCceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeec
Q 037224          332 KIEELREATDNFS----EGCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCID  396 (552)
Q Consensus       332 ~~~~l~~~t~~~~----~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~  396 (552)
                      ...++....+.|.    .|.|.+|.||++..  +++.||+|+++..         ..+|+.++++++|+||+++++++..
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            3344444545443    37888899999986  6889999998642         2369999999999999999998864


Q ss_pred             CC----CCeeEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEE
Q 037224          397 PE----DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAK  472 (552)
Q Consensus       397 ~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~k  472 (552)
                      ..    ....+++++++ +++|.+++...   .+++..++.++.|+++||+|||+.+   ++||||||+||++++++.+|
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence            22    23467888876 67898877643   3899999999999999999999999   99999999999999999999


Q ss_pred             EeeccCCccCCCCccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          473 IANFGLAKSGCNAITMHIVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       473 L~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      |+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus       161 l~dfg~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  222 (345)
T cd07877         161 ILDFGLARHTDDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD  222 (345)
T ss_pred             Eeccccccccccc-ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999998754332 233567889999998766 567889999999999999999999997543

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.95  E-value=1.2e-26  Score=235.05  Aligned_cols=180  Identities=32%  Similarity=0.494  Sum_probs=152.9

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|.|.+|.||+++.  ++..+|+|.+...          ..+|+.++++++|+|++++++++.+  +...++||||+.+ 
T Consensus        33 lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~g-  109 (317)
T cd06635          33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR--EHTAWLVMEYCLG-  109 (317)
T ss_pred             eccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--CCeEEEEEeCCCC-
Confidence            36667799999987  6889999998532          3468999999999999999999987  6678999999975 


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccccccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVG  492 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~g  492 (552)
                      +|.+++.... ..+++.++..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++.....  .....+
T Consensus       110 ~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--~~~~~~  183 (317)
T cd06635         110 SASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP--ANSFVG  183 (317)
T ss_pred             CHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC--cccccC
Confidence            7877775433 34899999999999999999999998   99999999999999999999999999865432  223567


Q ss_pred             cccccCccccC---CCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          493 TQGYIAPEYLA---DGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       493 t~~y~aPE~~~---~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      +..|+|||.+.   .+.++.++||||||+++|||++|+.||...
T Consensus       184 ~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~  227 (317)
T cd06635         184 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM  227 (317)
T ss_pred             CccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence            88999999873   466889999999999999999999998654

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=1.2e-27  Score=256.52  Aligned_cols=153  Identities=27%  Similarity=0.404  Sum_probs=128.6

Q ss_pred             hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhhhhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC
Q 037224          372 ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKN---ENLNWKTRLRIAIDVANGLQYIHEH  448 (552)
Q Consensus       372 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~  448 (552)
                      +.+|+.++++++|+||+++++++.+  ....|+++|++.+ +|.+++.....   ......+++.++.|++.||+|||++
T Consensus       210 ~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~  286 (501)
T PHA03210        210 LENEILALGRLNHENILKIEEILRS--EANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK  286 (501)
T ss_pred             HHHHHHHHHhCCCCCcCcEeEEEEE--CCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC
Confidence            3479999999999999999999987  5677999999864 77777654321   2234667888999999999999999


Q ss_pred             CCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC---ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc
Q 037224          449 TRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA---ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS  525 (552)
Q Consensus       449 ~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt  525 (552)
                      +   |+||||||+|||++.++.+||+|||+++.....   ......||..|+|||++.+..++.++|||||||++|||++
T Consensus       287 g---IiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~  363 (501)
T PHA03210        287 K---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS  363 (501)
T ss_pred             C---eecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHH
Confidence            9   999999999999999999999999999754322   1223578999999999999999999999999999999999


Q ss_pred             CCCCC
Q 037224          526 GKEAI  530 (552)
Q Consensus       526 G~~pf  530 (552)
                      |..++
T Consensus       364 ~~~~p  368 (501)
T PHA03210        364 HDFCP  368 (501)
T ss_pred             CCCCC
Confidence            88644

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.95  E-value=4.6e-27  Score=234.19  Aligned_cols=185  Identities=29%  Similarity=0.472  Sum_probs=155.1

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHc---CCCCccceeeeeecCCC---CeeEEEEee
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKV---NHGNLVKLEGFCIDPED---ANCYLIYEY  408 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l---~h~niv~l~~~~~~~~~---~~~~lv~e~  408 (552)
                      |.|.+|.||+++.  +++.+|+|+++..         ..+|+.+++++   +|+|++++++++.+.+.   ...+++|||
T Consensus         8 ~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~   87 (287)
T cd07838           8 GEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEH   87 (287)
T ss_pred             cccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehh
Confidence            6777899999998  4899999998632         23577777666   59999999999986332   238999999


Q ss_pred             ccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-cc
Q 037224          409 IENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-IT  487 (552)
Q Consensus       409 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-~~  487 (552)
                      +.+ +|.+++.......+++.+++.++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++...... ..
T Consensus        88 ~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~~  163 (287)
T cd07838          88 VDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL  163 (287)
T ss_pred             ccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcceeccCCccc
Confidence            975 8988887655446999999999999999999999998   999999999999999999999999998754322 12


Q ss_pred             ccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          488 MHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       488 ~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ....++..|+|||.+.+..++.++|+||||+++|||++|+.||....
T Consensus       164 ~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~  210 (287)
T cd07838         164 TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS  210 (287)
T ss_pred             ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence            23457888999999998889999999999999999999999997654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.95  E-value=2.7e-27  Score=241.91  Aligned_cols=181  Identities=28%  Similarity=0.437  Sum_probs=150.7

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCC---CCeeEEEEeeccCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPE---DANCYLIYEYIENG  412 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~---~~~~~lv~e~~~~g  412 (552)
                      |.|++|.||++..  +|+.||+|.++..        ..+|+.++++++|+||+++++++....   ....++++||+++ 
T Consensus        14 g~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-   92 (336)
T cd07849          14 GEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-   92 (336)
T ss_pred             EecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhccc-
Confidence            6677799999987  7889999998531        346999999999999999999876432   2357999999975 


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc-----c
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI-----T  487 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-----~  487 (552)
                      +|.+++...   .+++..+..++.|+++||+|||+.+   ++||||||+||+++.++.+||+|||++.......     .
T Consensus        93 ~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~  166 (336)
T cd07849          93 DLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFL  166 (336)
T ss_pred             CHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeeccccccccCCc
Confidence            787776543   4899999999999999999999999   9999999999999999999999999987432211     1


Q ss_pred             ccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          488 MHIVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       488 ~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.+.
T Consensus       167 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~  213 (336)
T cd07849         167 TEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK  213 (336)
T ss_pred             CCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            22467889999998654 56889999999999999999999999754

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.95  E-value=5.2e-27  Score=240.40  Aligned_cols=180  Identities=27%  Similarity=0.442  Sum_probs=150.6

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCC----CeeEEEEeecc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPED----ANCYLIYEYIE  410 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~~~lv~e~~~  410 (552)
                      |.|.+|.||+|..  +|+.||+|.++..         ..+|+.++++++|+||+++++++.....    ..+++++||+.
T Consensus        24 g~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~  103 (342)
T cd07879          24 GSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ  103 (342)
T ss_pred             eecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccc
Confidence            6677799999986  6899999998532         3479999999999999999998865321    35689999996


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccccc
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI  490 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  490 (552)
                      . +|.+++.    ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++..... ....
T Consensus       104 ~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~-~~~~  174 (342)
T cd07879         104 T-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAE-MTGY  174 (342)
T ss_pred             c-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC-CCCc
Confidence            4 6665542    24899999999999999999999998   999999999999999999999999998754322 2234


Q ss_pred             cccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          491 VGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       491 ~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus       175 ~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~  219 (342)
T cd07879         175 VVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD  219 (342)
T ss_pred             eeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            67889999998866 468889999999999999999999998654

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.95  E-value=9.6e-27  Score=235.43  Aligned_cols=192  Identities=31%  Similarity=0.482  Sum_probs=158.1

Q ss_pred             cHHHHHHHhhccCCCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCC
Q 037224          332 KIEELREATDNFSEGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPED  399 (552)
Q Consensus       332 ~~~~l~~~t~~~~~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~  399 (552)
                      ..+++....+.  .|.|.+|.||+|+.  .++.|++|.+...          ..+|++++++++|+|++++++++.+  +
T Consensus        18 ~~~~~~~~~~~--lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~   93 (313)
T cd06633          18 DPEEIFVGLHE--IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK--E   93 (313)
T ss_pred             CHHHHhhccee--eccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe--C
Confidence            44454443333  36667799999987  7889999998531          3468999999999999999999987  6


Q ss_pred             CeeEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCC
Q 037224          400 ANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLA  479 (552)
Q Consensus       400 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  479 (552)
                      ...+++|||+. ++|.+++.... ..+++.+++.++.|++.+|.|||+.+   ++|+||+|+||+++.++.+||+|||++
T Consensus        94 ~~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~  168 (313)
T cd06633          94 HTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSA  168 (313)
T ss_pred             CEEEEEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCC
Confidence            77899999996 47777775533 35899999999999999999999999   999999999999999999999999998


Q ss_pred             ccCCCCccccccccccccCccccC---CCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          480 KSGCNAITMHIVGTQGYIAPEYLA---DGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       480 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .....  .....++..|+|||.+.   ...++.++||||||+++|||++|+.||...+
T Consensus       169 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~  224 (313)
T cd06633         169 SKSSP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN  224 (313)
T ss_pred             cccCC--CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            64322  22356888999999874   4568889999999999999999999997543

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.95  E-value=3.2e-27  Score=234.27  Aligned_cols=183  Identities=28%  Similarity=0.470  Sum_probs=158.9

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcC-CCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|++|.||++..  +++.|++|++...          ..+|..++++++ |+||+++++++.+  +...+++|||+++
T Consensus         9 lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~lv~e~~~~   86 (280)
T cd05581           9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD--EENLYFVLEYAPN   86 (280)
T ss_pred             ecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC--CceEEEEEcCCCC
Confidence            37778899999988  7899999998642          246889999998 9999999998876  6688999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc-----
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI-----  486 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-----  486 (552)
                      ++|.+++....  .+++..++.++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||++.......     
T Consensus        87 ~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~  161 (280)
T cd05581          87 GELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESN  161 (280)
T ss_pred             CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCccccccC
Confidence            99999997654  4999999999999999999999999   9999999999999999999999999987433211     


Q ss_pred             -----------------cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          487 -----------------TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       487 -----------------~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                                       .....++..|+|||.......+.++|+||||++++++++|+.||...+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  226 (280)
T cd05581         162 KGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN  226 (280)
T ss_pred             CCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence                             112356789999999988889999999999999999999999998654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=8.1e-27  Score=227.85  Aligned_cols=181  Identities=33%  Similarity=0.497  Sum_probs=158.1

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|.+|.||++..  .++.+++|.+...         ..+|++++++++|+|++++++++.+  ....++++||+++++|
T Consensus         9 ~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~~~~~~L   86 (254)
T cd06627           9 GRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET--SDSLYIILEYAENGSL   86 (254)
T ss_pred             cccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe--CCEEEEEEecCCCCcH
Confidence            6667799999987  6789999998543         2479999999999999999999877  5788999999999999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcc--ccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT--MHIVG  492 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~--~~~~g  492 (552)
                      .+++...  ..+++..+..++.|++.+|.+||+.+   ++||||+|+||+++.++.++|+|||.+........  ....+
T Consensus        87 ~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~  161 (254)
T cd06627          87 RQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVG  161 (254)
T ss_pred             HHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccccccccc
Confidence            9998765  34899999999999999999999998   99999999999999999999999999875443222  23567


Q ss_pred             cccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       493 t~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      +..|+|||.......+.++|+||+|+++|+|++|+.||...
T Consensus       162 ~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~  202 (254)
T cd06627         162 TPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDL  202 (254)
T ss_pred             chhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCc
Confidence            88999999988877899999999999999999999999754

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=3.3e-28  Score=237.84  Aligned_cols=185  Identities=29%  Similarity=0.452  Sum_probs=157.7

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEecc--------------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEee
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKW--------------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEY  408 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~--------------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~  408 (552)
                      .|.|+|+.||++.+  ..+.||+|+-.-              ...+|.++-+.|+||.||+++++|.-. ...++-|+||
T Consensus       471 LGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD-tdsFCTVLEY  549 (775)
T KOG1151|consen  471 LGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD-TDSFCTVLEY  549 (775)
T ss_pred             hccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec-cccceeeeee
Confidence            38888899999987  788999998621              234799999999999999999999653 4567899999


Q ss_pred             ccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEC---CCCcEEEeeccCCccCCCC
Q 037224          409 IENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLD---SNMRAKIANFGLAKSGCNA  485 (552)
Q Consensus       409 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~---~~~~~kL~Dfg~a~~~~~~  485 (552)
                      |+|.+|.-+|..++.  +++.+++.|+.||..||.||.+.. ++|+|-||||.|||+.   ..|.+||.|||+++...+.
T Consensus       550 ceGNDLDFYLKQhkl--mSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMddd  626 (775)
T KOG1151|consen  550 CEGNDLDFYLKQHKL--MSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDD  626 (775)
T ss_pred             cCCCchhHHHHhhhh--hhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecchhhhccCC
Confidence            999999999988764  899999999999999999999985 6799999999999993   4688999999999855432


Q ss_pred             ---------ccccccccccccCccccCC----CCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          486 ---------ITMHIVGTQGYIAPEYLAD----GVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       486 ---------~~~~~~gt~~y~aPE~~~~----~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                               .+....||.+|++||.+.-    ...+.++||||+|||+|.++.|+.||..+
T Consensus       627 Sy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn  687 (775)
T KOG1151|consen  627 SYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN  687 (775)
T ss_pred             ccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence                     2334578999999998743    34788999999999999999999999865

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.95  E-value=4.8e-27  Score=233.75  Aligned_cols=183  Identities=32%  Similarity=0.481  Sum_probs=156.5

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcC-CCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|.+|.||+|+.  .++.|++|++...        ..+|+..+.+++ |+|++++++++.+  +...++||||+ +++|
T Consensus         8 g~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~e~~-~~~l   84 (283)
T cd07830           8 GDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFVFEYM-EGNL   84 (283)
T ss_pred             ccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEEEecC-CCCH
Confidence            6777899999998  5789999998543        135888999998 9999999999987  67889999999 7799


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-cccccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-ITMHIVGT  493 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-~~~~~~gt  493 (552)
                      .+++.......+++.+++.++.|++.+|.|||+++   ++|+||+|+||++++++.++|+|||++...... ......++
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~  161 (283)
T cd07830          85 YQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVST  161 (283)
T ss_pred             HHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCCCCc
Confidence            99887765456899999999999999999999998   999999999999999999999999998754332 22234678


Q ss_pred             ccccCccccC-CCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          494 QGYIAPEYLA-DGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       494 ~~y~aPE~~~-~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..|+|||.+. ...++.++|+||||+++|||++|+.||....
T Consensus       162 ~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~  203 (283)
T cd07830         162 RWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSS  203 (283)
T ss_pred             ccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCC
Confidence            8999999874 4557899999999999999999999997553

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.95  E-value=7e-27  Score=234.92  Aligned_cols=184  Identities=32%  Similarity=0.485  Sum_probs=152.6

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCC--------CCeeEEEE
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPE--------DANCYLIY  406 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~--------~~~~~lv~  406 (552)
                      |.|.+|.||+|..  +|+.||+|.++..         ..+|+.++++++|||++++++++.+..        ...+++++
T Consensus        16 g~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~   95 (302)
T cd07864          16 GEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVF   95 (302)
T ss_pred             cccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEE
Confidence            6667799999998  6889999998532         246999999999999999999887643        23789999


Q ss_pred             eeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc
Q 037224          407 EYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI  486 (552)
Q Consensus       407 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~  486 (552)
                      ||+++ ++.+.+... ...+++.+++.++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        96 e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  170 (302)
T cd07864          96 EYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE  170 (302)
T ss_pred             cccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCcccccccccCCc
Confidence            99986 777766654 235899999999999999999999998   9999999999999999999999999987543221


Q ss_pred             ---cccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          487 ---TMHIVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       487 ---~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                         .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus       171 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~  222 (302)
T cd07864         171 SRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ  222 (302)
T ss_pred             ccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence               112345778999998764 457889999999999999999999997544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.9e-27  Score=244.11  Aligned_cols=182  Identities=26%  Similarity=0.356  Sum_probs=155.3

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC---hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccCCCchhhh
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN---ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL  418 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l  418 (552)
                      .|.|.++.|-++..  +++..++|++...   ..+|+.++... +|+|++++.+.+.+  ..+.|+|||.+.++-|.+.+
T Consensus       330 ~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~--~~~~~~v~e~l~g~ell~ri  407 (612)
T KOG0603|consen  330 LGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYED--GKEIYLVMELLDGGELLRRI  407 (612)
T ss_pred             cCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecC--CceeeeeehhccccHHHHHH
Confidence            36666687877766  7889999999766   56788777766 89999999999987  77889999999998887777


Q ss_pred             hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE-CCCCcEEEeeccCCccCCCCcccccccccccc
Q 037224          419 HENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL-DSNMRAKIANFGLAKSGCNAITMHIVGTQGYI  497 (552)
Q Consensus       419 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll-~~~~~~kL~Dfg~a~~~~~~~~~~~~gt~~y~  497 (552)
                      ...+.  +. .++..|+.+|+.|+.|||++|   ++||||||+|||+ ++.+.++|+|||.++..... ....+-|..|.
T Consensus       408 ~~~~~--~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-~~tp~~t~~y~  480 (612)
T KOG0603|consen  408 RSKPE--FC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-CDTPALTLQYV  480 (612)
T ss_pred             Hhcch--hH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh-hcccchhhccc
Confidence            65542  33 788889999999999999999   9999999999999 68999999999999865544 33456788999


Q ss_pred             CccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          498 APEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       498 aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      |||++....+++++|+||||++||+|++|+.||.....
T Consensus       481 APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~  518 (612)
T KOG0603|consen  481 APEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPA  518 (612)
T ss_pred             ChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCc
Confidence            99999999999999999999999999999999986543

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.8e-27  Score=225.35  Aligned_cols=180  Identities=24%  Similarity=0.461  Sum_probs=157.6

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccChH----------HHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWNAC----------EELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~~~----------~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      |.|.+..|..+++  ..+.+|+|+++++..          .|-.+..+. +||.++-+..+|..  +..+++|.||++||
T Consensus       259 grgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt--esrlffvieyv~gg  336 (593)
T KOG0695|consen  259 GRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT--ESRLFFVIEYVNGG  336 (593)
T ss_pred             cCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc--cceEEEEEEEecCc
Confidence            7777788888877  678999999986543          355566555 79999999988877  77889999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccC--CCCccccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG--CNAITMHI  490 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~--~~~~~~~~  490 (552)
                      +|.-++++.+  .++++.++.+..+|.-||.|||++|   |+.||||.+|+|+|..|.+||.|+|+++..  ....+...
T Consensus       337 dlmfhmqrqr--klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~~gd~tstf  411 (593)
T KOG0695|consen  337 DLMFHMQRQR--KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTTSTF  411 (593)
T ss_pred             ceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCCCCcccccc
Confidence            9987776554  3999999999999999999999999   999999999999999999999999999743  33455678


Q ss_pred             cccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       491 ~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                      +||+.|+|||++.+..|....|+|+||++|+||+.|+.||+-
T Consensus       412 cgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi  453 (593)
T KOG0695|consen  412 CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI  453 (593)
T ss_pred             cCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence            999999999999999999999999999999999999999983

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.95  E-value=5.2e-27  Score=239.93  Aligned_cols=182  Identities=30%  Similarity=0.496  Sum_probs=153.2

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCC---CeeEEEEeeccC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPED---ANCYLIYEYIEN  411 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~~~lv~e~~~~  411 (552)
                      |.|++|.||++..  +++.||+|.++..         ..+|+.+++.++|+||+++++++.....   ...++++||+. 
T Consensus        14 g~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-   92 (337)
T cd07858          14 GRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-   92 (337)
T ss_pred             ccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-
Confidence            6677899999987  6889999987542         2369999999999999999998865322   35799999996 


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--cccc
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMH  489 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~  489 (552)
                      ++|.+++....  .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++......  ....
T Consensus        93 ~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~  167 (337)
T cd07858          93 TDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTE  167 (337)
T ss_pred             CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccCCCcccccc
Confidence            58888886543  4999999999999999999999998   999999999999999999999999998754322  1223


Q ss_pred             ccccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          490 IVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      ..++..|+|||.+.. ..++.++|+||||+++|+|++|+.||...
T Consensus       168 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  212 (337)
T cd07858         168 YVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK  212 (337)
T ss_pred             cccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence            457889999998764 46889999999999999999999999754

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.95  E-value=7.1e-27  Score=233.33  Aligned_cols=181  Identities=28%  Similarity=0.419  Sum_probs=153.3

Q ss_pred             CceEEEEEEEEee-----cCcEEEEEEeccC-----------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEee
Q 037224          346 GCLIQGSVYKGNI-----HGEVYAIKMMKWN-----------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEY  408 (552)
Q Consensus       346 G~g~~G~Vy~~~~-----~g~~vAvK~~~~~-----------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~  408 (552)
                      |.|++|.||+++.     +++.||+|.++..           ..+|+.++.++ +|+|++++++.+..  +...++||||
T Consensus         9 g~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~e~   86 (288)
T cd05583           9 GTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT--DTKLHLILDY   86 (288)
T ss_pred             ccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec--CCEEEEEEec
Confidence            6777799999875     4678999998632           23689999999 69999999988876  6678999999


Q ss_pred             ccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc--
Q 037224          409 IENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI--  486 (552)
Q Consensus       409 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~--  486 (552)
                      +++++|.+++....  .+++..+..++.|++++|.|||+.+   ++||||+|+||+++.++.++|+|||+++......  
T Consensus        87 ~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  161 (288)
T cd05583          87 VNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE  161 (288)
T ss_pred             CCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccccccccc
Confidence            99999999887543  4899999999999999999999998   9999999999999999999999999987432221  


Q ss_pred             -cccccccccccCccccCCCC--CCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          487 -TMHIVGTQGYIAPEYLADGV--VSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       487 -~~~~~gt~~y~aPE~~~~~~--~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                       .....++..|++||.+.+..  .+.++|+||||+++|||++|+.||...
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~  211 (288)
T cd05583         162 RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVD  211 (288)
T ss_pred             ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccC
Confidence             22245788999999987655  788999999999999999999999643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.95  E-value=9.2e-28  Score=221.95  Aligned_cols=182  Identities=24%  Similarity=0.434  Sum_probs=146.8

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccCh-H-------HHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWNA-C-------EELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~~-~-------~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |+|.-|.||+.+.  .|...|||.+.... .       ..++++.+. +.|+|++.+|+|..  +...++.||.|.. .+
T Consensus       101 GsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~--n~dV~IcMelMs~-C~  177 (391)
T KOG0983|consen  101 GSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT--NTDVFICMELMST-CA  177 (391)
T ss_pred             cCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee--CchHHHHHHHHHH-HH
Confidence            6666799999988  67999999996432 2       233333333 48999999999998  6667899999853 55


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC-Ccccccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN-AITMHIVGT  493 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~-~~~~~~~gt  493 (552)
                      +.++..- .+++++.-+-++...+.+||.||.+++  .|+|||+||+|||+|+.|++||||||.+....+ .......|.
T Consensus       178 ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtrsAGC  254 (391)
T KOG0983|consen  178 EKLLKRI-KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTRSAGC  254 (391)
T ss_pred             HHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccccccccCC
Confidence            5555443 345898888899999999999999875  599999999999999999999999999864433 333446788


Q ss_pred             ccccCccccCC---CCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          494 QGYIAPEYLAD---GVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       494 ~~y~aPE~~~~---~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      +.|||||.+.-   ..|+-++||||||+.++||.||+.||.+.
T Consensus       255 ~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c  297 (391)
T KOG0983|consen  255 AAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGC  297 (391)
T ss_pred             ccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCC
Confidence            99999999853   45788999999999999999999999873

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.95  E-value=8e-27  Score=235.33  Aligned_cols=184  Identities=29%  Similarity=0.488  Sum_probs=151.1

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEecc---------ChHHHHHHHHHcCCCCccceeeeeecCC------CCeeEEEEee
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKW---------NACEELKILQKVNHGNLVKLEGFCIDPE------DANCYLIYEY  408 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~---------~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~~~lv~e~  408 (552)
                      |.|.+|.||++..  +++.+|+|++..         ...+|++++++++|+||+++++++.+..      ...+++++||
T Consensus        17 g~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~   96 (311)
T cd07866          17 GEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPY   96 (311)
T ss_pred             ccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEec
Confidence            6777799999987  688999998732         2357999999999999999999876532      2357999999


Q ss_pred             ccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc--
Q 037224          409 IENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI--  486 (552)
Q Consensus       409 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~--  486 (552)
                      +++ +|.+.+.... ..+++.++..++.|+++||.|||+++   ++|+||||+||++++++.++|+|||+++......  
T Consensus        97 ~~~-~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  171 (311)
T cd07866          97 MDH-DLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPN  171 (311)
T ss_pred             CCc-CHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccchhccCCCcc
Confidence            975 6776665432 35999999999999999999999999   9999999999999999999999999987432211  


Q ss_pred             -----------cccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          487 -----------TMHIVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       487 -----------~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                                 .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||.+.+
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~  231 (311)
T cd07866         172 PKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS  231 (311)
T ss_pred             cccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCC
Confidence                       112345788999998765 457889999999999999999999997654

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.95  E-value=3.3e-27  Score=241.03  Aligned_cols=183  Identities=27%  Similarity=0.474  Sum_probs=153.4

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecC--CCCeeEEEEeeccCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDP--EDANCYLIYEYIENG  412 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~~~lv~e~~~~g  412 (552)
                      |.|++|.||++..  +|+.||+|+++..         ..+|+.++++++|+||+++++++...  .....++||||+. +
T Consensus        14 g~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~   92 (334)
T cd07855          14 GSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-S   92 (334)
T ss_pred             ecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-h
Confidence            6677799999987  6899999998543         23689999999999999999887642  2356899999996 5


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc------
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI------  486 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~------  486 (552)
                      +|.+++....  .+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++.......      
T Consensus        93 ~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  167 (334)
T cd07855          93 DLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYF  167 (334)
T ss_pred             hHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcc
Confidence            8988886543  3899999999999999999999998   9999999999999999999999999986432211      


Q ss_pred             cccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          487 TMHIVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       487 ~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.+.+
T Consensus       168 ~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~  216 (334)
T cd07855         168 MTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKN  216 (334)
T ss_pred             cccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCC
Confidence            123467889999998765 558899999999999999999999997654

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.94  E-value=5.7e-27  Score=238.81  Aligned_cols=184  Identities=29%  Similarity=0.419  Sum_probs=157.0

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCC---CCeeEEEEeecc
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPE---DANCYLIYEYIE  410 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~---~~~~~lv~e~~~  410 (552)
                      .|.|.+|.||+++.  .++.+|+|.+...         ..+|+.+++.++|+||+++++++....   ....+++|||++
T Consensus         8 ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~   87 (330)
T cd07834           8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME   87 (330)
T ss_pred             ecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh
Confidence            36777899999997  5789999988542         346999999999999999999987632   236799999998


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc----
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI----  486 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~----  486 (552)
                      + +|.+++....  .+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++.......    
T Consensus        88 ~-~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~  161 (330)
T cd07834          88 T-DLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKG  161 (330)
T ss_pred             h-hHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeecccccccc
Confidence            5 8888886544  5999999999999999999999999   9999999999999999999999999987543322    


Q ss_pred             -cccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          487 -TMHIVGTQGYIAPEYLADG-VVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       487 -~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                       .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~  211 (330)
T cd07834         162 FLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD  211 (330)
T ss_pred             cccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence             2234678899999999877 78999999999999999999999997654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.94  E-value=1.2e-26  Score=237.77  Aligned_cols=182  Identities=25%  Similarity=0.414  Sum_probs=153.3

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCC----CeeEEEEeec
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPED----ANCYLIYEYI  409 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~~~lv~e~~  409 (552)
                      .|.|.+|.||++..  +++.||+|+++..         ..+|+.++++++|+||+++++++.....    ..+++||||+
T Consensus        23 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~  102 (343)
T cd07880          23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM  102 (343)
T ss_pred             eeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC
Confidence            37777899999987  7899999998531         3369999999999999999998865322    2468999998


Q ss_pred             cCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcccc
Q 037224          410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH  489 (552)
Q Consensus       410 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  489 (552)
                       +++|.+++...   .+++..++.++.|+++||+|||+.+   ++||||||+||+++.++.++|+|||++...... ...
T Consensus       103 -~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~-~~~  174 (343)
T cd07880         103 -GTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-MTG  174 (343)
T ss_pred             -CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccccccccC-ccc
Confidence             66888877643   4899999999999999999999998   999999999999999999999999998754332 223


Q ss_pred             ccccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          490 IVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..+++.|++||.+.+ ..++.++|+||||+++|+|++|+.||...+
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  220 (343)
T cd07880         175 YVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD  220 (343)
T ss_pred             cccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            467889999998865 458889999999999999999999998654

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.94  E-value=7.8e-27  Score=232.03  Aligned_cols=182  Identities=31%  Similarity=0.511  Sum_probs=155.6

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|.+|.||++..  +++.+++|.++..         ..+|+.++++++|+|++++++++.+  ....++++||+++ +|
T Consensus         8 ~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~~~~-~l   84 (283)
T cd05118           8 GEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH--KGDLYLVFEFMDT-DL   84 (283)
T ss_pred             ecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc--CCCEEEEEeccCC-CH
Confidence            6667799999987  6889999988533         3468999999999999999999877  5788999999976 88


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc--cccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI--TMHIVG  492 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~--~~~~~g  492 (552)
                      .+++.... ..+++.+++.++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||.+.......  .....+
T Consensus        85 ~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (283)
T cd05118          85 YKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV  160 (283)
T ss_pred             HHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCccC
Confidence            88876643 35899999999999999999999999   9999999999999999999999999987543322  223457


Q ss_pred             cccccCccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          493 TQGYIAPEYLADG-VVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       493 t~~y~aPE~~~~~-~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+
T Consensus       161 ~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~  203 (283)
T cd05118         161 TRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS  203 (283)
T ss_pred             cccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            7889999998776 78999999999999999999999997654

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=7.7e-29  Score=226.48  Aligned_cols=186  Identities=27%  Similarity=0.451  Sum_probs=155.5

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEec---------cChHHHHHHHHHcCCCCccceeeeeecC------CCCeeEEEEe
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMK---------WNACEELKILQKVNHGNLVKLEGFCIDP------EDANCYLIYE  407 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~---------~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~~~lv~e  407 (552)
                      .|+|.||.||+++.  .|+.||+|+.-         ....+|+++|..++|+|++.++++|...      ....+|+|++
T Consensus        25 igqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~  104 (376)
T KOG0669|consen   25 IGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFD  104 (376)
T ss_pred             cCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHH
Confidence            37777899999987  67788988652         1245899999999999999999988642      2345899999


Q ss_pred             eccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC---
Q 037224          408 YIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN---  484 (552)
Q Consensus       408 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~---  484 (552)
                      +|+. +|.-++.... .+++..++.+++.++.+||.|+|...   |+|||+|+.|+|++.+|.+||+|||+++....   
T Consensus       105 ~ceh-DLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n  179 (376)
T KOG0669|consen  105 FCEH-DLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARAFSTSKN  179 (376)
T ss_pred             Hhhh-hHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccccceecccc
Confidence            9987 8888776543 45999999999999999999999998   99999999999999999999999999974321   


Q ss_pred             ---CccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          485 ---AITMHIVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       485 ---~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                         ...+..+-|.+|.+||.+.+ +.++++.|+|+.||++.||+||.+.+.++.+
T Consensus       180 ~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte  234 (376)
T KOG0669|consen  180 VVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE  234 (376)
T ss_pred             cCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH
Confidence               12233456899999998765 6799999999999999999999999998764

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.94  E-value=1.6e-26  Score=233.22  Aligned_cols=179  Identities=32%  Similarity=0.496  Sum_probs=151.8

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|.+|.||+|+.  +++.+++|.+...          ..+|+++++.++|+|++++++++..  ....++||||+. ++
T Consensus        24 g~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~-~~  100 (308)
T cd06634          24 GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWLVMEYCL-GS  100 (308)
T ss_pred             eeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCeeEEEEEccC-CC
Confidence            6667799999987  6789999987521          2368999999999999999999987  567899999997 58


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcccccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT  493 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~gt  493 (552)
                      |.+++.... ..+++.++..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++......  ....++
T Consensus       101 l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~  174 (308)
T cd06634         101 ASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--NXFVGT  174 (308)
T ss_pred             HHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc--ccccCC
Confidence            877765433 34899999999999999999999998   999999999999999999999999998754322  235678


Q ss_pred             ccccCccccC---CCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          494 QGYIAPEYLA---DGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       494 ~~y~aPE~~~---~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      ..|+|||.+.   ....+.++||||||+++|||++|+.||.+.
T Consensus       175 ~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  217 (308)
T cd06634         175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM  217 (308)
T ss_pred             ccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccc
Confidence            8999999874   356788999999999999999999998654

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.94  E-value=2.3e-26  Score=234.11  Aligned_cols=180  Identities=30%  Similarity=0.463  Sum_probs=151.6

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEecc---------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKW---------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~---------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|.+|.||++..  +++.||+|++..         ...+|+.++++++|||++++.+++... ....++++||+. ++|
T Consensus        19 g~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~~lv~e~~~-~~L   96 (328)
T cd07856          19 GMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP-LEDIYFVTELLG-TDL   96 (328)
T ss_pred             cccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC-CCcEEEEeehhc-cCH
Confidence            6777799999976  788999998742         234799999999999999999988653 346789999984 588


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccccccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ  494 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~gt~  494 (552)
                      .+++...   .+++..+..++.|+++||.|||+.+   ++||||+|+||++++++.++|+|||.+...... .....++.
T Consensus        97 ~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~  169 (328)
T cd07856          97 HRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQ-MTGYVSTR  169 (328)
T ss_pred             HHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCCC-cCCCcccc
Confidence            8877643   3788899999999999999999999   999999999999999999999999998754322 22345688


Q ss_pred             cccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          495 GYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       495 ~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .|+|||.+.+ ..++.++|+||||+++|||++|+.||....
T Consensus       170 ~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~  210 (328)
T cd07856         170 YYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD  210 (328)
T ss_pred             cccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            8999998765 568999999999999999999999997543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=2.2e-27  Score=239.18  Aligned_cols=180  Identities=27%  Similarity=0.364  Sum_probs=160.1

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccChH---------------HHHHHHHHcC---CCCccceeeeeecCCCCeeEEE
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWNAC---------------EELKILQKVN---HGNLVKLEGFCIDPEDANCYLI  405 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~~~---------------~E~~~l~~l~---h~niv~l~~~~~~~~~~~~~lv  405 (552)
                      |.|++|.|+.+..  +...|+||.+.++..               -|+.+|..++   |+||++++++|.+  ++.+||+
T Consensus       570 G~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd--dd~yyl~  647 (772)
T KOG1152|consen  570 GEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED--DDYYYLE  647 (772)
T ss_pred             cccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec--CCeeEEE
Confidence            8888999999988  567899999865432               4999999997   9999999999988  8889999


Q ss_pred             Eeecc-CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC
Q 037224          406 YEYIE-NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN  484 (552)
Q Consensus       406 ~e~~~-~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  484 (552)
                      ||-.. +.+|.+++..++.  +++.++..|++|++-|+++||++|   |+|||||-+|+.++.+|-+||+|||.+....+
T Consensus       648 te~hg~gIDLFd~IE~kp~--m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgsaa~~ks  722 (772)
T KOG1152|consen  648 TEVHGEGIDLFDFIEFKPR--MDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGSAAYTKS  722 (772)
T ss_pred             ecCCCCCcchhhhhhccCc--cchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccchhhhcC
Confidence            99764 4588999987664  999999999999999999999999   99999999999999999999999999987776


Q ss_pred             CccccccccccccCccccCCCCC-CChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          485 AITMHIVGTQGYIAPEYLADGVV-STKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       485 ~~~~~~~gt~~y~aPE~~~~~~~-s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                      ..-....||..|.|||++.+..| +..-|||++|++||.++....||.+
T Consensus       723 gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  723 GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            66667899999999999988776 5567999999999999999999864

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.94  E-value=2.5e-26  Score=234.42  Aligned_cols=183  Identities=30%  Similarity=0.408  Sum_probs=150.9

Q ss_pred             CceEEEEEEEEeec----CcEEEEEEeccC---------hHHHHHHHHHc-CCCCccceeeeeecC--CCCeeEEEEeec
Q 037224          346 GCLIQGSVYKGNIH----GEVYAIKMMKWN---------ACEELKILQKV-NHGNLVKLEGFCIDP--EDANCYLIYEYI  409 (552)
Q Consensus       346 G~g~~G~Vy~~~~~----g~~vAvK~~~~~---------~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~~~~lv~e~~  409 (552)
                      |.|.+|.||++...    +..||+|.++..         ..+|+.+++++ +|+||+++++.+...  .....++++||+
T Consensus         9 g~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~   88 (332)
T cd07857           9 GQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELM   88 (332)
T ss_pred             cccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEecc
Confidence            67778999999983    668999988632         34699999999 599999999876432  234578889988


Q ss_pred             cCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC----
Q 037224          410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA----  485 (552)
Q Consensus       410 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~----  485 (552)
                      . ++|.+++....  .+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++......    
T Consensus        89 ~-~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~  162 (332)
T cd07857          89 E-ADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGEN  162 (332)
T ss_pred             c-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceecccccccc
Confidence            6 58988886543  4899999999999999999999999   999999999999999999999999998743211    


Q ss_pred             --ccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          486 --ITMHIVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       486 --~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                        ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+
T Consensus       163 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~  214 (332)
T cd07857         163 AGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD  214 (332)
T ss_pred             cccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence              1123468899999998765 568899999999999999999999997644

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.94  E-value=3e-27  Score=256.37  Aligned_cols=177  Identities=33%  Similarity=0.518  Sum_probs=145.9

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecC-----------------
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDP-----------------  397 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~-----------------  397 (552)
                      .|.|+||.||+++.  +|+.||||++...        ..+|+..|.+|+|||+++++..+.+.                 
T Consensus       487 LGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~~~  566 (1351)
T KOG1035|consen  487 LGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSESR  566 (1351)
T ss_pred             hcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchhhh
Confidence            48999999999987  9999999998655        34799999999999999997543211                 


Q ss_pred             --------------------------------------------------------------------------------
Q 037224          398 --------------------------------------------------------------------------------  397 (552)
Q Consensus       398 --------------------------------------------------------------------------------  397 (552)
                                                                                                      
T Consensus       567 sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~~~  646 (1351)
T KOG1035|consen  567 SQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDDTS  646 (1351)
T ss_pred             cccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCcch
Confidence                                                                                            


Q ss_pred             ------------CC--------CeeEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecC
Q 037224          398 ------------ED--------ANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKD  457 (552)
Q Consensus       398 ------------~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~D  457 (552)
                                  .+        ..+|+-||||+..+|.+++..+... -.....++++++|++||.|+|++|   +||||
T Consensus       647 ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGLaYIH~~g---iIHRD  722 (1351)
T KOG1035|consen  647 ESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGLAYIHDQG---IIHRD  722 (1351)
T ss_pred             hhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHHHHHHhCc---eeecc
Confidence                        00        2467889999997888877766531 146788999999999999999999   99999


Q ss_pred             CCCCcEEECCCCcEEEeeccCCccC--------------------CCCccccccccccccCccccCCCC---CCChhhHH
Q 037224          458 IKSSNILLDSNMRAKIANFGLAKSG--------------------CNAITMHIVGTQGYIAPEYLADGV---VSTKMDVF  514 (552)
Q Consensus       458 ikp~NIll~~~~~~kL~Dfg~a~~~--------------------~~~~~~~~~gt~~y~aPE~~~~~~---~s~~~Dv~  514 (552)
                      |||.|||+|+++.+||+|||++...                    .....+..+||.-|+|||++.+..   |+.|+|+|
T Consensus       723 LKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmY  802 (1351)
T KOG1035|consen  723 LKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMY  802 (1351)
T ss_pred             CCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhH
Confidence            9999999999999999999998630                    011233468999999999987654   99999999


Q ss_pred             HHHHHHHHHHc
Q 037224          515 SFGVVLLELIS  525 (552)
Q Consensus       515 slG~il~ellt  525 (552)
                      |||++++||+.
T Consensus       803 SLGIVlFEM~y  813 (1351)
T KOG1035|consen  803 SLGIVLFEMLY  813 (1351)
T ss_pred             HHHHHHHHHhc
Confidence            99999999985

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.94  E-value=1.8e-26  Score=229.27  Aligned_cols=182  Identities=32%  Similarity=0.517  Sum_probs=156.2

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|.+|.||+++.  +++.+|+|.++..         ..+|+.++++++|+|++++++++.+  ....++++||+++ +|
T Consensus         8 g~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~e~~~~-~l   84 (282)
T cd07829           8 GEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT--ERKLYLVFEYCDM-DL   84 (282)
T ss_pred             cccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc--CCceEEEecCcCc-CH
Confidence            6677799999998  5899999998643         2468999999999999999999877  5778999999984 89


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc--cccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI--TMHIVG  492 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~--~~~~~g  492 (552)
                      .+++.... ..+++..++.++.|++.||.|||+++   ++||||+|+||++++++.++|+|||.+.......  .....+
T Consensus        85 ~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  160 (282)
T cd07829          85 KKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV  160 (282)
T ss_pred             HHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcccc
Confidence            99997753 24999999999999999999999998   9999999999999999999999999987543221  122345


Q ss_pred             cccccCccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          493 TQGYIAPEYLADG-VVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       493 t~~y~aPE~~~~~-~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +..|+|||.+.+. .++.++|+||||+++|||++|+.||....
T Consensus       161 ~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  203 (282)
T cd07829         161 TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS  203 (282)
T ss_pred             CcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence            6789999998766 78999999999999999999999997654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.94  E-value=3.1e-26  Score=229.78  Aligned_cols=180  Identities=28%  Similarity=0.492  Sum_probs=148.0

Q ss_pred             CceEEEEEEEEeec--CcEEEEEEeccC--------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNIH--GEVYAIKMMKWN--------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~~--g~~vAvK~~~~~--------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|.+|.||++...  ++.||||.++..        ..+|+.++.+. .|+||+++++++.+  +...+++|||+.+ +|
T Consensus        24 g~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e~~~~-~l  100 (296)
T cd06618          24 GSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT--DSDVFICMELMST-CL  100 (296)
T ss_pred             eccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec--CCeEEEEeeccCc-CH
Confidence            66677999999984  899999998642        12466666666 59999999999987  6678999999864 77


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-ccccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHE-HTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-ITMHIVG  492 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-~~~~~~g  492 (552)
                      .+++.... ..+++..+..++.|++.||+|||+ .+   ++||||+|+||++++++.+||+|||++...... ......+
T Consensus       101 ~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~  176 (296)
T cd06618         101 DKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAG  176 (296)
T ss_pred             HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCCCcccCCCC
Confidence            77665433 358999999999999999999997 47   999999999999999999999999998754322 2223457


Q ss_pred             cccccCccccCCCC----CCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          493 TQGYIAPEYLADGV----VSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       493 t~~y~aPE~~~~~~----~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                      +..|+|||.+....    ++.++|+||||+++|||++|+.||..
T Consensus       177 ~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  220 (296)
T cd06618         177 CAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN  220 (296)
T ss_pred             CccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence            78999999986554    78899999999999999999999975

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.94  E-value=2.8e-28  Score=224.56  Aligned_cols=185  Identities=25%  Similarity=0.397  Sum_probs=147.5

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccCh--------HHHHHHHHH-cCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWNA--------CEELKILQK-VNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~~--------~~E~~~l~~-l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      .|+|.||+|++-..  .|+..|||+++...        ..|.+...+ -+.|||++++|.+..  ++.+|+.||.|+- +
T Consensus        72 iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~--EGdcWiCMELMd~-S  148 (361)
T KOG1006|consen   72 IGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS--EGDCWICMELMDI-S  148 (361)
T ss_pred             hcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc--CCceeeeHHHHhh-h
Confidence            38888899999876  79999999996432        234443333 368999999999987  6778999999965 6


Q ss_pred             chhhh---hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-cccc
Q 037224          414 LHSWL---HENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-ITMH  489 (552)
Q Consensus       414 L~~~l---~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-~~~~  489 (552)
                      |..+.   ..-....+++.-.-.|......||.||-+.-  .|+|||+||+|||++..|.+||||||.+....+. ..+.
T Consensus       149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT~  226 (361)
T KOG1006|consen  149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKTV  226 (361)
T ss_pred             HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHHHhhh
Confidence            65543   2333445888888889999999999998764  5999999999999999999999999998644332 3334


Q ss_pred             ccccccccCccccCC--CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          490 IVGTQGYIAPEYLAD--GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~--~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..|...|||||.+..  ..++-++||||||+.|||+.||+.|+...+
T Consensus       227 daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~  273 (361)
T KOG1006|consen  227 DAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD  273 (361)
T ss_pred             ccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH
Confidence            578889999999864  347889999999999999999999997543

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.94  E-value=1.4e-26  Score=237.21  Aligned_cols=181  Identities=26%  Similarity=0.434  Sum_probs=152.4

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCC----CeeEEEEeecc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPED----ANCYLIYEYIE  410 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~~~lv~e~~~  410 (552)
                      |.|.+|.||+++.  +++.||+|++...         ..+|+.++++++|+|++++++++...+.    ...++|+||+ 
T Consensus        24 g~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-  102 (343)
T cd07851          24 GSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-  102 (343)
T ss_pred             ccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-
Confidence            6677799999988  6789999997532         2369999999999999999987765222    2479999998 


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccccc
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI  490 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  490 (552)
                      +++|.+++...   .+++.+++.++.|+++||.|||+.+   ++||||+|+||++++++.++|+|||++...... ....
T Consensus       103 ~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-~~~~  175 (343)
T cd07851         103 GADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-MTGY  175 (343)
T ss_pred             CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccccccccc-ccCC
Confidence            56998888653   4999999999999999999999998   999999999999999999999999998754332 2334


Q ss_pred             cccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          491 VGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       491 ~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~  220 (343)
T cd07851         176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSD  220 (343)
T ss_pred             cccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            67889999998765 467889999999999999999999997554

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.94  E-value=2.2e-26  Score=235.73  Aligned_cols=182  Identities=25%  Similarity=0.440  Sum_probs=148.6

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCC------------CeeEE
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPED------------ANCYL  404 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~------------~~~~l  404 (552)
                      |.|++|.||++..  +|+.||+|.+...       ..+|++++++++|+||+++++++.....            ...++
T Consensus        14 g~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l   93 (342)
T cd07854          14 GCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYI   93 (342)
T ss_pred             cCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEE
Confidence            6677799999987  6889999987432       3479999999999999999987654321            35689


Q ss_pred             EEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECC-CCcEEEeeccCCccCC
Q 037224          405 IYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS-NMRAKIANFGLAKSGC  483 (552)
Q Consensus       405 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kL~Dfg~a~~~~  483 (552)
                      +|||+++ +|.+++...   .+++..++.++.|+++||.|||+.+   ++||||||+||+++. ++.+||+|||.+....
T Consensus        94 v~e~~~~-~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~dfg~~~~~~  166 (342)
T cd07854          94 VQEYMET-DLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVD  166 (342)
T ss_pred             Eeecccc-cHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECCcccceecC
Confidence            9999974 888877543   3899999999999999999999999   999999999999974 5678999999987432


Q ss_pred             CC-----ccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          484 NA-----ITMHIVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       484 ~~-----~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..     ......++..|+|||.+.. ..++.++|||||||++|||++|+.||....
T Consensus       167 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~  223 (342)
T cd07854         167 PHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH  223 (342)
T ss_pred             CccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            21     1122356888999997654 567889999999999999999999997543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.94  E-value=7.2e-26  Score=250.43  Aligned_cols=128  Identities=29%  Similarity=0.458  Sum_probs=114.7

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|.+|.||++..  .++.||+|+++..          +.+|+.++..++|+||+++++++..  ....++||||+.+++
T Consensus        13 G~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~~lVmEy~~g~~   90 (669)
T cd05610          13 SRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS--ANNVYLVMEYLIGGD   90 (669)
T ss_pred             ecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE--CCEEEEEEeCCCCCC
Confidence            7777899999998  4899999998632          3468899999999999999988876  678899999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK  480 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  480 (552)
                      |.+++....  .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        91 L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          91 VKSLLHIYG--YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999987644  4889999999999999999999998   9999999999999999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=2.2e-28  Score=225.74  Aligned_cols=185  Identities=28%  Similarity=0.410  Sum_probs=156.0

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCC---eeEEEEeecc
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDA---NCYLIYEYIE  410 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~---~~~lv~e~~~  410 (552)
                      .|.|.||.||..++  +|+.||+|++..-         ..+|+++|..++|.|++..+++..-+.-+   ..|+++|.|.
T Consensus        61 IGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQ  140 (449)
T KOG0664|consen   61 IGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQ  140 (449)
T ss_pred             ccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHH
Confidence            48889999999988  8999999998543         34799999999999999998877543322   4578889886


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC---cc
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA---IT  487 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~---~~  487 (552)
                      . +|...+-..  +.++...+.-+.+||++||.|||+.+   |.||||||.|.|++++..+||+|||+++.....   ..
T Consensus       141 S-DLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hM  214 (449)
T KOG0664|consen  141 S-DLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNM  214 (449)
T ss_pred             h-hhhheeccC--CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhhhhhh
Confidence            5 888777543  34888999999999999999999999   999999999999999999999999999864422   33


Q ss_pred             ccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          488 MHIVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       488 ~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      +..+-|..|.|||.+.+ +.|+.+.||||.|||+.||+..+..|...++
T Consensus       215 TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P  263 (449)
T KOG0664|consen  215 THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP  263 (449)
T ss_pred             HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh
Confidence            34567889999999887 5589999999999999999999999987665

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.94  E-value=3.5e-26  Score=224.71  Aligned_cols=183  Identities=26%  Similarity=0.400  Sum_probs=151.0

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEecc------------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKW------------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~------------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      .|.|++|.||+++.  .+..+++|.++.            ...+|+.++++++|||++++++++.+  ....++++||++
T Consensus         8 ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~   85 (260)
T cd08222           8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE--RDAFCIITEYCE   85 (260)
T ss_pred             ecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc--CCceEEEEEeCC
Confidence            37778899999987  344566666532            12358889999999999999999876  557899999999


Q ss_pred             CCCchhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--c
Q 037224          411 NGSLHSWLHEN--KNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--I  486 (552)
Q Consensus       411 ~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~  486 (552)
                      +++|.+++...  ....+++.+++.++.|+++||.|||+.+   ++|+||+|+||++++ +.++|+|||.+......  .
T Consensus        86 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~~  161 (260)
T cd08222          86 GRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDL  161 (260)
T ss_pred             CCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecCCCccc
Confidence            99999988642  2345899999999999999999999998   999999999999975 56999999998744322  2


Q ss_pred             cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          487 TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       487 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus       162 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~  208 (260)
T cd08222         162 ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ  208 (260)
T ss_pred             ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence            22346788999999998888899999999999999999999999743

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.94  E-value=4.7e-26  Score=248.27  Aligned_cols=198  Identities=34%  Similarity=0.512  Sum_probs=163.6

Q ss_pred             CCCceEEEEEEEEeec---------CcEEEEEEeccC--------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEE
Q 037224          344 SEGCLIQGSVYKGNIH---------GEVYAIKMMKWN--------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLI  405 (552)
Q Consensus       344 ~~G~g~~G~Vy~~~~~---------g~~vAvK~~~~~--------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv  405 (552)
                      ..|.|.||.|++|...         ...||||.++..        ...|+++++.+ .|+|++.++|.|..  .+..++|
T Consensus       303 ~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~--~~~~~~v  380 (609)
T KOG0200|consen  303 YLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ--DGPLYVI  380 (609)
T ss_pred             eeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc--CCceEEE
Confidence            5688888999999862         346999998643        34799999999 69999999999987  7788999


Q ss_pred             EeeccCCCchhhhhhcC------------CC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcE
Q 037224          406 YEYIENGSLHSWLHENK------------NE--NLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRA  471 (552)
Q Consensus       406 ~e~~~~gsL~~~l~~~~------------~~--~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~  471 (552)
                      +||+..|+|.++++..+            ..  .++..+.+.++.||+.|++||++..   ++||||..+|||+..+..+
T Consensus       381 ~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~~~~~~  457 (609)
T KOG0200|consen  381 VEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLITKNKVI  457 (609)
T ss_pred             EEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEecCCCEE
Confidence            99999999999998776            01  2889999999999999999999998   9999999999999999999


Q ss_pred             EEeeccCCccCCCCcccc---cc--ccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccCcccccchHHHH
Q 037224          472 KIANFGLAKSGCNAITMH---IV--GTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEGKFCGQKLKGYW  545 (552)
Q Consensus       472 kL~Dfg~a~~~~~~~~~~---~~--gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~~~~~~~~~~~~  545 (552)
                      ||+|||+++.........   ..  -...|||||.+....++.++||||||++|||++| |..||.+-.     ...+++
T Consensus       458 kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~-----~~~~l~  532 (609)
T KOG0200|consen  458 KIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP-----PTEELL  532 (609)
T ss_pred             EEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC-----cHHHHH
Confidence            999999998543322222   12  2346999999999999999999999999999998 889997622     113345


Q ss_pred             HHHhcC
Q 037224          546 REMKRG  551 (552)
Q Consensus       546 ~~~~~g  551 (552)
                      +.++.|
T Consensus       533 ~~l~~G  538 (609)
T KOG0200|consen  533 EFLKEG  538 (609)
T ss_pred             HHHhcC
Confidence            555555

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.93  E-value=3.8e-26  Score=240.73  Aligned_cols=187  Identities=27%  Similarity=0.458  Sum_probs=156.5

Q ss_pred             cCCCceEEEEEEEE--eecCcEEEEEEeccC------hHHHHHHHHHc-CCCCccceeeeeec---CCCCeeEEEEeecc
Q 037224          343 FSEGCLIQGSVYKG--NIHGEVYAIKMMKWN------ACEELKILQKV-NHGNLVKLEGFCID---PEDANCYLIYEYIE  410 (552)
Q Consensus       343 ~~~G~g~~G~Vy~~--~~~g~~vAvK~~~~~------~~~E~~~l~~l-~h~niv~l~~~~~~---~~~~~~~lv~e~~~  410 (552)
                      .+.|.+  |.||++  +.+++..|+|++..+      ...|.++++.. .|||++.++|++.-   ..++.+|||||||.
T Consensus        27 ig~Gty--gkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~  104 (953)
T KOG0587|consen   27 IGNGTY--GKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCG  104 (953)
T ss_pred             Eeeccc--eeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccC
Confidence            344555  555555  558999999998543      23467778777 79999999998863   23568999999999


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC--Cccc
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN--AITM  488 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~--~~~~  488 (552)
                      +|+..|++....+.++.|+.+..|++.++.||.+||...   ++|||||-.|||++.++.+||+|||.+.....  ....
T Consensus       105 gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~grRn  181 (953)
T KOG0587|consen  105 GGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVGRRN  181 (953)
T ss_pred             CccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeeeeeeccccccc
Confidence            999999999888888999999999999999999999998   99999999999999999999999999874432  2344


Q ss_pred             cccccccccCccccCC-----CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          489 HIVGTQGYIAPEYLAD-----GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       489 ~~~gt~~y~aPE~~~~-----~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ...||+.|||||++..     ..|+..+|+||||++..||--|.+|+.+.-
T Consensus       182 T~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH  232 (953)
T KOG0587|consen  182 TFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH  232 (953)
T ss_pred             CcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc
Confidence            5789999999999853     346778999999999999999999998654

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.93  E-value=1.1e-25  Score=217.57  Aligned_cols=187  Identities=26%  Similarity=0.372  Sum_probs=152.7

Q ss_pred             CceEEEEEEEEeec-------CcEEEEEEeccCh--------HHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          346 GCLIQGSVYKGNIH-------GEVYAIKMMKWNA--------CEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       346 G~g~~G~Vy~~~~~-------g~~vAvK~~~~~~--------~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      -.|.||+||+|.|.       .+.|-+|.++...        ..|.-++..+.|||++.+.+++.+. ....++++.++.
T Consensus       293 qEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~-~~~P~V~y~~~~  371 (563)
T KOG1024|consen  293 QEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED-YATPFVLYPATG  371 (563)
T ss_pred             hcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec-cCcceEEEeccC
Confidence            34556999999762       2456777776543        2566677778999999999999863 456789999999


Q ss_pred             CCCchhhhhhcC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC
Q 037224          411 NGSLHSWLHENK------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN  484 (552)
Q Consensus       411 ~gsL~~~l~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  484 (552)
                      -|+|..++..-+      .+.++-.+...++.|++.|++|||+++   ++|.||..+|.++|+..++||+|-.+++....
T Consensus       372 ~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP  448 (563)
T KOG1024|consen  372 VGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDSALSRDLFP  448 (563)
T ss_pred             cchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccchhccccCc
Confidence            999999997221      245788889999999999999999999   99999999999999999999999999984332


Q ss_pred             Cc----cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccCcc
Q 037224          485 AI----TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEGKF  536 (552)
Q Consensus       485 ~~----~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~~~  536 (552)
                      ..    -........||+||.+.+..++.++||||||++||||+| |+.|+.+-+++
T Consensus       449 ~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf  505 (563)
T KOG1024|consen  449 GDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF  505 (563)
T ss_pred             ccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH
Confidence            11    111234568999999999999999999999999999998 99999987764

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.93  E-value=3.1e-25  Score=214.34  Aligned_cols=176  Identities=35%  Similarity=0.568  Sum_probs=155.7

Q ss_pred             EEEEEEEee--cCcEEEEEEecc--------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhhhh
Q 037224          350 QGSVYKGNI--HGEVYAIKMMKW--------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLH  419 (552)
Q Consensus       350 ~G~Vy~~~~--~g~~vAvK~~~~--------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~  419 (552)
                      +|.||+++.  +|+.+++|++..        .+.+|+..+++++|+|++++++++..  +...++++||+++++|.+++.
T Consensus         2 ~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l~~e~~~~~~L~~~~~   79 (244)
T smart00220        2 FGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED--EDKLYLVMEYCDGGDLFDLLK   79 (244)
T ss_pred             ceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee--CCEEEEEEeCCCCCCHHHHHH
Confidence            589999998  468999999853        33479999999999999999999987  577899999999999999987


Q ss_pred             hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-ccccccccccccC
Q 037224          420 ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-ITMHIVGTQGYIA  498 (552)
Q Consensus       420 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-~~~~~~gt~~y~a  498 (552)
                      ....  +++..++.++.+++.++.+||+.+   ++|+||+|+||++++++.++|+|||.+...... ......++..|++
T Consensus        80 ~~~~--~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  154 (244)
T smart00220       80 KRGR--LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMA  154 (244)
T ss_pred             hccC--CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCC
Confidence            6543  899999999999999999999998   999999999999999999999999998754432 3334567889999


Q ss_pred             ccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          499 PEYLADGVVSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       499 PE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                      ||.+.....+.++|+||||+++|+|++|..||..
T Consensus       155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~  188 (244)
T smart00220      155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG  188 (244)
T ss_pred             HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999888899999999999999999999999976

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.93  E-value=1e-24  Score=208.65  Aligned_cols=181  Identities=34%  Similarity=0.527  Sum_probs=156.0

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      |.|.+|.||++..  .++.+++|.+...        ..+|++.+++++|+|++++++++..  ....++++||+++++|.
T Consensus         8 ~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~   85 (225)
T smart00221        8 GEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED--PEPLYLVMEYCEGGDLF   85 (225)
T ss_pred             ecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec--CCceEEEEeccCCCCHH
Confidence            5666799999998  3689999998643        2368999999999999999999876  56789999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC---ccccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA---ITMHIVG  492 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~---~~~~~~g  492 (552)
                      +++...... +++..+..++.+++.++.+||+.+   ++|+||+|+||+++.++.++|+|||.+......   ......+
T Consensus        86 ~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  161 (225)
T smart00221       86 DYLRKKGGK-LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVKG  161 (225)
T ss_pred             HHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccceec
Confidence            998765422 789999999999999999999998   999999999999999999999999998754432   2233567


Q ss_pred             cccccCcccc-CCCCCCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          493 TQGYIAPEYL-ADGVVSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       493 t~~y~aPE~~-~~~~~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                      +..|++||.+ ....++.++|+|+||++++||++|+.||..
T Consensus       162 ~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      162 TPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            7889999998 667788899999999999999999999966

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PRK06347 autolysin; Reviewed

Probab=99.93  E-value=1.9e-25  Score=236.01  Aligned_cols=169  Identities=17%  Similarity=0.140  Sum_probs=132.2

Q ss_pred             eeEeeccCCCCCCHHHHHHHhCCChhhhcCcCCCCCCCCCccCCCcEEEeeecccccC--CC---------CCceeeeee
Q 037224           49 YAFYRASAPDFLDLASIADLFSVSRLMISEPSNISSPSSPLIQNQPLFVPITCSCNTL--NA---------SYTISFANL  117 (552)
Q Consensus        49 ~~~y~v~~~~g~tl~~Ia~~~~~~~~~l~~~N~~~~~~~~~~~g~~l~iP~~~~~~~~--~~---------~~~~~~~~~  117 (552)
                      ...|+|++  ||||+.||++||+++++|+++|++.  .+.|.+||.|.||....-...  ..         .........
T Consensus       405 ~~~ytVk~--GDTL~sIA~kygVSv~~L~~~N~l~--s~~L~~Gq~L~IP~~~~~~~~t~~~s~~~~~~k~~s~~~~~~~  480 (592)
T PRK06347        405 AKVYTVVK--GDSLWRIANNNKVTIANLKSWNNLK--SDFIYPGQKLKVSAGSTSNTNTSKPSTNTNTSKPSTNTNTNAK  480 (592)
T ss_pred             ceeEEecC--CCCHHHHHHHhCCCHHHHHHHhCCC--cceeccCcEEEEecCCcccccccccccccccccccccccccce
Confidence            45899999  9999999999999999999999987  457999999999964211000  00         000111234


Q ss_pred             EEEEecCCchhhhHHhhcCCcchHHHHHHhCCCCCCCCCCCCcEEEEeeeecCCCCcc-----ccCceeEEEEEecCCCC
Q 037224          118 SYTIKSGDTFYLVSTNKYQNLTTYQSVEVVNPTFVPTKLEVGDVIIFPVFCKCPNQTQ-----LRNRVNYLVSYVLQPSE  192 (552)
Q Consensus       118 ~y~v~~gdtl~~Ia~~~~~~~~~~~~l~~~N~~~~~~~l~~gq~l~ip~~~~~~~~~~-----~~~~~~~~~~y~v~~Gd  192 (552)
                      .|+|++|||||+|| ++|+  +++++|+++|++.+ +.|++||+|.||....-.....     ..........|+|++||
T Consensus       481 ~YtVk~GDTL~sIA-kkyg--VSv~~L~~~N~l~s-~~L~~GQ~L~Ip~~~~~s~~~t~~~s~~~~~~~~~~~Y~Vk~GD  556 (592)
T PRK06347        481 VYTVAKGDSLWRIA-NNNK--VTIANLKSWNNLKS-DFIYPGQKLKVSAGSTTNNTNTAKPSTNKPSNSTVKTYTVKKGD  556 (592)
T ss_pred             eeeecCCCCHHHHH-HHHC--CCHHHHHHhcCCCc-ccccCCcEEEEecCcccccccccCCccCCccCccceeeecCCCC
Confidence            69999999999999 8899  99999999999986 7899999999997543211000     00011123589999999


Q ss_pred             CHHHHHhHhCCChhhHhhhcCC---cccCCceeecc
Q 037224          193 NLSSVASRFGIETQAIIDVNGN---NIRPFDTLFVP  225 (552)
Q Consensus       193 tl~~ia~~~~~s~~~l~~~N~~---~~~~g~~l~ip  225 (552)
                      |||+||++||+++++|++||++   .|++||.|.|+
T Consensus       557 TL~sIA~KygvSv~~L~~~N~L~~~~L~~GQ~L~I~  592 (592)
T PRK06347        557 SLWAISRQYKTTVDNIKAWNKLTSNMIHVGQKLTIK  592 (592)
T ss_pred             cHHHHHHHhCCCHHHHHHhcCCCcccCCCCCEEecC
Confidence            9999999999999999999999   79999999874

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.93  E-value=2.7e-26  Score=221.88  Aligned_cols=188  Identities=26%  Similarity=0.348  Sum_probs=155.7

Q ss_pred             HhhccCCCceEEEEEEEEee--cCcEEEEEEeccC------hHHHHHHHHHcCCC------CccceeeeeecCCCCeeEE
Q 037224          339 ATDNFSEGCLIQGSVYKGNI--HGEVYAIKMMKWN------ACEELKILQKVNHG------NLVKLEGFCIDPEDANCYL  404 (552)
Q Consensus       339 ~t~~~~~G~g~~G~Vy~~~~--~g~~vAvK~~~~~------~~~E~~~l~~l~h~------niv~l~~~~~~~~~~~~~l  404 (552)
                      +.+.+++  |.||.|....+  .+..||||+++.-      ..-|+++|+++.+.      -++.+.++|..  .++.++
T Consensus        93 i~~~lGe--GtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy--rghiCi  168 (415)
T KOG0671|consen   93 IVDLLGE--GTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY--RGHICI  168 (415)
T ss_pred             hhhhhcC--CcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc--cCceEE
Confidence            3344544  45588888766  5789999998642      34589999999422      25666676755  678899


Q ss_pred             EEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECC-----------------
Q 037224          405 IYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS-----------------  467 (552)
Q Consensus       405 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~-----------------  467 (552)
                      |+|.+ |.|+.+++..+...+++...++.++.|+++++++||+.+   ++|-||||+|||+.+                 
T Consensus       169 vfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~~~r  244 (415)
T KOG0671|consen  169 VFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVCFIR  244 (415)
T ss_pred             EEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccceec
Confidence            99988 459999999988888999999999999999999999998   999999999999831                 


Q ss_pred             ---CCcEEEeeccCCccCCCCccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          468 ---NMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       468 ---~~~~kL~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                         +..++|+|||.|....... ...+.|..|.|||++.+-.++..+||||+||||+||.||...|...+.
T Consensus       245 ~~ks~~I~vIDFGsAtf~~e~h-s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen  314 (415)
T KOG0671|consen  245 PLKSTAIKVIDFGSATFDHEHH-STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN  314 (415)
T ss_pred             cCCCcceEEEecCCcceeccCc-ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence               2358999999998765443 557889999999999999999999999999999999999999987663

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.92  E-value=2.9e-25  Score=239.88  Aligned_cols=185  Identities=19%  Similarity=0.278  Sum_probs=135.1

Q ss_pred             CCceEEEEEEEEee--c----CcEEEEEEeccChHHHHHHHHHcCC---CCccceeeeee----cCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI--H----GEVYAIKMMKWNACEELKILQKVNH---GNLVKLEGFCI----DPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~----g~~vAvK~~~~~~~~E~~~l~~l~h---~niv~l~~~~~----~~~~~~~~lv~e~~~~  411 (552)
                      .|.|+||.||+|++  +    +..||+|+++.....|..+..++.+   .++..++..+.    ...+...++|+||+.+
T Consensus       140 LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~LV~ey~~~  219 (566)
T PLN03225        140 LGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGE  219 (566)
T ss_pred             EeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCceEEEEEecCC
Confidence            37888899999998  4    6899999987655555555554432   23333222211    1235678999999999


Q ss_pred             CCchhhhhhcCCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECC-CCcEE
Q 037224          412 GSLHSWLHENKNE------------------NLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS-NMRAK  472 (552)
Q Consensus       412 gsL~~~l~~~~~~------------------~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~-~~~~k  472 (552)
                      ++|.+++......                  ......+..++.|++.||+|||+++   |+||||||+|||++. ++.+|
T Consensus       220 gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~NILl~~~~~~~K  296 (566)
T PLN03225        220 STLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFK  296 (566)
T ss_pred             CcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHHHEEEeCCCCcEE
Confidence            9999988654210                  1123446689999999999999998   999999999999985 57999


Q ss_pred             EeeccCCccCCC---CccccccccccccCccccCCC----------------------CCCChhhHHHHHHHHHHHHcCC
Q 037224          473 IANFGLAKSGCN---AITMHIVGTQGYIAPEYLADG----------------------VVSTKMDVFSFGVVLLELISGK  527 (552)
Q Consensus       473 L~Dfg~a~~~~~---~~~~~~~gt~~y~aPE~~~~~----------------------~~s~~~Dv~slG~il~elltG~  527 (552)
                      |+|||+++....   .......+++.|+|||.+...                      .++.++|||||||+||||+++.
T Consensus       297 L~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~  376 (566)
T PLN03225        297 IIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPN  376 (566)
T ss_pred             EEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCc
Confidence            999999974321   223346788999999965322                      2334569999999999999988


Q ss_pred             CCCCc
Q 037224          528 EAIDE  532 (552)
Q Consensus       528 ~pf~~  532 (552)
                      .+++.
T Consensus       377 ~~~~~  381 (566)
T PLN03225        377 LRSDS  381 (566)
T ss_pred             CCCch
Confidence            77653

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.92  E-value=2.5e-26  Score=241.08  Aligned_cols=177  Identities=28%  Similarity=0.477  Sum_probs=146.4

Q ss_pred             EEEEEEeecCcEEEEEEeccC----hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccCCCchhhhhhc--CC
Q 037224          351 GSVYKGNIHGEVYAIKMMKWN----ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHEN--KN  423 (552)
Q Consensus       351 G~Vy~~~~~g~~vAvK~~~~~----~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~  423 (552)
                      +.||+|.+.|+.||||++-.+    ..+|+..|+.- +||||++++  |.+.++...|+..|.|.. +|.+++...  ..
T Consensus       524 t~Vf~G~ye~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyy--c~E~d~qF~YIalELC~~-sL~dlie~~~~d~  600 (903)
T KOG1027|consen  524 TVVFRGVYEGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYY--CSEQDRQFLYIALELCAC-SLQDLIESSGLDV  600 (903)
T ss_pred             cEEEEEeeCCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEE--eeccCCceEEEEehHhhh-hHHHHHhccccch
Confidence            569999999999999998654    34899999988 799999995  455558899999999976 999999874  11


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECC---C--CcEEEeeccCCccCCCC-----cccccccc
Q 037224          424 ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS---N--MRAKIANFGLAKSGCNA-----ITMHIVGT  493 (552)
Q Consensus       424 ~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~---~--~~~kL~Dfg~a~~~~~~-----~~~~~~gt  493 (552)
                      ........+.++.|+++||++||+.+   ||||||||.||||+.   +  .+++|+|||+++.....     ......||
T Consensus       601 ~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt  677 (903)
T KOG1027|consen  601 EMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGT  677 (903)
T ss_pred             hhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCc
Confidence            11222456788999999999999998   999999999999965   3  47999999999854322     12346789


Q ss_pred             ccccCccccCCCCCCChhhHHHHHHHHHHHHcC-CCCCCcc
Q 037224          494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISG-KEAIDEE  533 (552)
Q Consensus       494 ~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG-~~pf~~~  533 (552)
                      -+|+|||++.....+.++||||+||++|+.++| .+||.+.
T Consensus       678 ~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~  718 (903)
T KOG1027|consen  678 SGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS  718 (903)
T ss_pred             ccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch
Confidence            999999999998888899999999999999886 9999854

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.92  E-value=1.4e-24  Score=229.08  Aligned_cols=184  Identities=20%  Similarity=0.325  Sum_probs=139.5

Q ss_pred             CceEEEEEEEEee------------------cCcEEEEEEeccC---------------------hHHHHHHHHHcCCCC
Q 037224          346 GCLIQGSVYKGNI------------------HGEVYAIKMMKWN---------------------ACEELKILQKVNHGN  386 (552)
Q Consensus       346 G~g~~G~Vy~~~~------------------~g~~vAvK~~~~~---------------------~~~E~~~l~~l~h~n  386 (552)
                      |.|+||.||+|.+                  .++.||||+++..                     ...|+.++.+++|.+
T Consensus       154 G~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l~~~~  233 (507)
T PLN03224        154 GGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNP  233 (507)
T ss_pred             ecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHhhccc
Confidence            7888899999963                  3467999998532                     123677777887665


Q ss_pred             c-----cceeeeeecC------CCCeeEEEEeeccCCCchhhhhhcCC----------------------CCCCHHHHHH
Q 037224          387 L-----VKLEGFCIDP------EDANCYLIYEYIENGSLHSWLHENKN----------------------ENLNWKTRLR  433 (552)
Q Consensus       387 i-----v~l~~~~~~~------~~~~~~lv~e~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~  433 (552)
                      +     ++++++|...      ..+..|+||||+++++|.++++....                      ..+++..++.
T Consensus       234 l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~  313 (507)
T PLN03224        234 IAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKG  313 (507)
T ss_pred             chhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHH
Confidence            4     6677777532      13467999999999999998864211                      1246778899


Q ss_pred             HHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc---cccccccccccCccccCCCCC---
Q 037224          434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI---TMHIVGTQGYIAPEYLADGVV---  507 (552)
Q Consensus       434 i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~---~~~~~gt~~y~aPE~~~~~~~---  507 (552)
                      ++.|++++|.|||+.+   ++||||||+|||++.++.+||+|||++.......   .....+++.|+|||.+.....   
T Consensus       314 i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~  390 (507)
T PLN03224        314 VMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPR  390 (507)
T ss_pred             HHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCc
Confidence            9999999999999998   9999999999999999999999999986433211   111234789999998754321   


Q ss_pred             -------------------CChhhHHHHHHHHHHHHcCCC-CCCc
Q 037224          508 -------------------STKMDVFSFGVVLLELISGKE-AIDE  532 (552)
Q Consensus       508 -------------------s~~~Dv~slG~il~elltG~~-pf~~  532 (552)
                                         ..+.|+||+||++|||++|.. ||.+
T Consensus       391 ~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~  435 (507)
T PLN03224        391 APAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN  435 (507)
T ss_pred             cchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence                               124699999999999999985 7753

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.92  E-value=1.1e-25  Score=203.12  Aligned_cols=180  Identities=26%  Similarity=0.410  Sum_probs=153.8

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEecc----ChHHHHHHHHHcC-CCCccceeeeeecCCCCeeEEEEeeccCCCchhhh
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKW----NACEELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL  418 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~----~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l  418 (552)
                      |.|-++.||.|..  +++.++||+++.    ...+|+.+|+.|. |+||+.++++..++......|++||+++.+...+.
T Consensus        47 GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly  126 (338)
T KOG0668|consen   47 GRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY  126 (338)
T ss_pred             cCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHh
Confidence            6666699999985  889999999964    3458999999996 99999999999998888899999999987766543


Q ss_pred             hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCC-cEEEeeccCCccCCCCccc-cccccccc
Q 037224          419 HENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM-RAKIANFGLAKSGCNAITM-HIVGTQGY  496 (552)
Q Consensus       419 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~~~~~~~~-~~~gt~~y  496 (552)
                      .     .++..++...+.+++.||.|+|+.|   |.|||+||.|+++|... .++|+|+|+|.+....... -.+.+..|
T Consensus       127 ~-----tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyf  198 (338)
T KOG0668|consen  127 P-----TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYF  198 (338)
T ss_pred             h-----hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCCceeeeeeehhhc
Confidence            2     3888899999999999999999999   99999999999998754 5999999999866544433 34667788


Q ss_pred             cCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          497 IAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       497 ~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      --||.+-. ..++..-|+|||||++..|+..+.||...
T Consensus       199 KGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG  236 (338)
T KOG0668|consen  199 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG  236 (338)
T ss_pred             CCchheeechhccccHHHHHHHHHHHHHHhccCcccCC
Confidence            99998765 56888999999999999999999998643

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.92  E-value=1.5e-25  Score=223.43  Aligned_cols=203  Identities=25%  Similarity=0.307  Sum_probs=169.5

Q ss_pred             ccccccHHHHHHHhhcc--CCCceEEEEEEEEee--cCcEEEEEEeccCh------HHHHHHHHHcC------CCCccce
Q 037224          327 KYRIFKIEELREATDNF--SEGCLIQGSVYKGNI--HGEVYAIKMMKWNA------CEELKILQKVN------HGNLVKL  390 (552)
Q Consensus       327 ~~~~~~~~~l~~~t~~~--~~G~g~~G~Vy~~~~--~g~~vAvK~~~~~~------~~E~~~l~~l~------h~niv~l  390 (552)
                      .|-.+.+.|+....-..  -.|.|.|++|.+|..  .|..||||+++...      .+|+++|++|+      --|++++
T Consensus       420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl  499 (752)
T KOG0670|consen  420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRL  499 (752)
T ss_pred             ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence            34455666664433221  238999999999988  67899999997653      47999999994      3488999


Q ss_pred             eeeeecCCCCeeEEEEeeccCCCchhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCC-
Q 037224          391 EGFCIDPEDANCYLIYEYIENGSLHSWLHENK-NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN-  468 (552)
Q Consensus       391 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~-  468 (552)
                      +..|..  .++++||+|-+. .+|.+.|...+ .-.|....+..++.|++-||..|-..+   |+|.||||+|||+++. 
T Consensus       500 ~r~F~h--knHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k  573 (752)
T KOG0670|consen  500 FRHFKH--KNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESK  573 (752)
T ss_pred             HHHhhh--cceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCc
Confidence            888877  789999999885 49999987654 345889999999999999999999998   9999999999999875 


Q ss_pred             CcEEEeeccCCccCCCCccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          469 MRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       469 ~~~kL~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      ..+||||||.|.....+..++..-+..|.|||++.+..|+...|+||.||+||||.||+..|.+...
T Consensus       574 ~iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN  640 (752)
T KOG0670|consen  574 NILKLCDFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN  640 (752)
T ss_pred             ceeeeccCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence            5689999999987776666666667789999999999999999999999999999999999998764

>PRK06347 autolysin; Reviewed

Probab=99.92  E-value=2.2e-24  Score=228.01  Aligned_cols=173  Identities=17%  Similarity=0.119  Sum_probs=135.1

Q ss_pred             ceeEeeccCCCCCCHHHHHHHhCCChhhhcCcCCCCCCCCCccCCCcEEEeeeccccc---CCCC-C--------ceeee
Q 037224           48 TYAFYRASAPDFLDLASIADLFSVSRLMISEPSNISSPSSPLIQNQPLFVPITCSCNT---LNAS-Y--------TISFA  115 (552)
Q Consensus        48 ~~~~y~v~~~~g~tl~~Ia~~~~~~~~~l~~~N~~~~~~~~~~~g~~l~iP~~~~~~~---~~~~-~--------~~~~~  115 (552)
                      .+..|+|++  ||||+.||++||+++++|+++|++.  .+.|.+||.|+||....-..   .... .        .....
T Consensus       329 ~~~~Y~V~s--GDTL~~IA~rygvSv~eL~~~N~l~--~d~L~~Gq~L~VP~~~~~~~~~t~~~~~~~~~~~~~~~~~~~  404 (592)
T PRK06347        329 NAKIYTVVK--GDSLWRIANNHKVTVANLKAWNNLK--SDFIYPGQKLKVSAGSTTSDTNTSKPSTGTSTSKPSTGTSTN  404 (592)
T ss_pred             CceEEEeCC--CCCHHHHHHHhCCCHHHHHHHhCCC--ccccccCcEEEEeccccccccccccccccccccccccccccC
Confidence            577899999  9999999999999999999999987  56899999999996421100   0000 0        00112


Q ss_pred             eeEEEEecCCchhhhHHhhcCCcchHHHHHHhCCCCCCCCCCCCcEEEEeeeecCCCC------cc-----ccCceeEEE
Q 037224          116 NLSYTIKSGDTFYLVSTNKYQNLTTYQSVEVVNPTFVPTKLEVGDVIIFPVFCKCPNQ------TQ-----LRNRVNYLV  184 (552)
Q Consensus       116 ~~~y~v~~gdtl~~Ia~~~~~~~~~~~~l~~~N~~~~~~~l~~gq~l~ip~~~~~~~~------~~-----~~~~~~~~~  184 (552)
                      ...|+|++||||+.|| ++|+  +++++|+++|++.. +.|.+||.|.||....-...      ..     .........
T Consensus       405 ~~~ytVk~GDTL~sIA-~kyg--VSv~~L~~~N~l~s-~~L~~Gq~L~IP~~~~~~~~t~~~s~~~~~~k~~s~~~~~~~  480 (592)
T PRK06347        405 AKVYTVVKGDSLWRIA-NNNK--VTIANLKSWNNLKS-DFIYPGQKLKVSAGSTSNTNTSKPSTNTNTSKPSTNTNTNAK  480 (592)
T ss_pred             ceeEEecCCCCHHHHH-HHhC--CCHHHHHHHhCCCc-ceeccCcEEEEecCCcccccccccccccccccccccccccce
Confidence            3479999999999999 8999  99999999999876 78999999999964211000      00     000011235


Q ss_pred             EEecCCCCCHHHHHhHhCCChhhHhhhcCC---cccCCceeeccccC
Q 037224          185 SYVLQPSENLSSVASRFGIETQAIIDVNGN---NIRPFDTLFVPVAR  228 (552)
Q Consensus       185 ~y~v~~Gdtl~~ia~~~~~s~~~l~~~N~~---~~~~g~~l~ip~~~  228 (552)
                      .|+|++||||++||++||+++++|++||++   .|++||.|.||...
T Consensus       481 ~YtVk~GDTL~sIAkkygVSv~~L~~~N~l~s~~L~~GQ~L~Ip~~~  527 (592)
T PRK06347        481 VYTVAKGDSLWRIANNNKVTIANLKSWNNLKSDFIYPGQKLKVSAGS  527 (592)
T ss_pred             eeeecCCCCHHHHHHHHCCCHHHHHHhcCCCcccccCCcEEEEecCc
Confidence            899999999999999999999999999998   89999999999764

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.91  E-value=3.5e-25  Score=209.55  Aligned_cols=175  Identities=28%  Similarity=0.398  Sum_probs=149.1

Q ss_pred             EEEEEee--cCcEEEEEEecc---------ChHHHHHHHHHcCCCCccceeeeeecCC----CCeeEEEEeeccCCCchh
Q 037224          352 SVYKGNI--HGEVYAIKMMKW---------NACEELKILQKVNHGNLVKLEGFCIDPE----DANCYLIYEYIENGSLHS  416 (552)
Q Consensus       352 ~Vy~~~~--~g~~vAvK~~~~---------~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~~~lv~e~~~~gsL~~  416 (552)
                      .|..+-+  .++.||+|.+..         ...+|..++..++|+|+++++.+|.-.+    ....|+|||+|+. +|.+
T Consensus        31 ~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~~  109 (369)
T KOG0665|consen   31 IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDA-NLCQ  109 (369)
T ss_pred             eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhh-HHHH
Confidence            3444443  788999998743         2447999999999999999999886422    2357999999976 8888


Q ss_pred             hhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-cccccccccc
Q 037224          417 WLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-ITMHIVGTQG  495 (552)
Q Consensus       417 ~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-~~~~~~gt~~  495 (552)
                      .+..    .++-+.+..|..|++.|+.|||+.+   |+||||||+||++..+..+||.|||+++..... ..+..+.+..
T Consensus       110 vi~~----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRy  182 (369)
T KOG0665|consen  110 VILM----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDFMMTPYVVTRY  182 (369)
T ss_pred             HHHH----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccCcccccCchhheee
Confidence            8773    2788899999999999999999999   999999999999999999999999999865544 4556788999


Q ss_pred             ccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          496 YIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       496 y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      |.|||++.+..+.+.+||||+||++.||++|+..|.+.+
T Consensus       183 yrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d  221 (369)
T KOG0665|consen  183 YRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD  221 (369)
T ss_pred             ccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch
Confidence            999999988889999999999999999999999998654

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.3e-24  Score=201.04  Aligned_cols=194  Identities=18%  Similarity=0.352  Sum_probs=149.3

Q ss_pred             ccccHHHHHHHhhccCCCceEEEEEEEEee--cCcEEEEEEeccChH------HHHHHHHHc-CCCCccceeeeeecCCC
Q 037224          329 RIFKIEELREATDNFSEGCLIQGSVYKGNI--HGEVYAIKMMKWNAC------EELKILQKV-NHGNLVKLEGFCIDPED  399 (552)
Q Consensus       329 ~~~~~~~l~~~t~~~~~G~g~~G~Vy~~~~--~g~~vAvK~~~~~~~------~E~~~l~~l-~h~niv~l~~~~~~~~~  399 (552)
                      ...+++|.+...+.+++|++  |.+..++.  ....+++|.+.....      +|...--.| .|.||+.-++..... .
T Consensus        18 ~kv~l~d~y~I~k~lgeG~F--gkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt-~   94 (378)
T KOG1345|consen   18 KKVDLEDVYTINKQLGEGRF--GKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQT-S   94 (378)
T ss_pred             cccchhhhhhHHHHhcccce--eeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhc-C
Confidence            44567777777777766655  88888877  667899999876543      444333233 589999887765443 3


Q ss_pred             CeeEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEC--CCCcEEEeecc
Q 037224          400 ANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLD--SNMRAKIANFG  477 (552)
Q Consensus       400 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~--~~~~~kL~Dfg  477 (552)
                      +.+++++||++.|+|.+-+...+   +.+.....++.|+++|++|||+++   +||||||.+|||+-  +..++||||||
T Consensus        95 d~YvF~qE~aP~gdL~snv~~~G---igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG  168 (378)
T KOG1345|consen   95 DAYVFVQEFAPRGDLRSNVEAAG---IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFG  168 (378)
T ss_pred             ceEEEeeccCccchhhhhcCccc---ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecc
Confidence            47789999999999988776543   888889999999999999999999   99999999999992  34489999999


Q ss_pred             CCccCCCCccccccccccccCccccCC-----CCCCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          478 LAKSGCNAITMHIVGTQGYIAPEYLAD-----GVVSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       478 ~a~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                      .++...... ....-+..|.+||....     -...+.+|+|+||+++|.++||..||..
T Consensus       169 ~t~k~g~tV-~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk  227 (378)
T KOG1345|consen  169 LTRKVGTTV-KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK  227 (378)
T ss_pred             cccccCcee-hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh
Confidence            987544322 12334567899997542     2357789999999999999999999984

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.90  E-value=2e-22  Score=189.76  Aligned_cols=172  Identities=43%  Similarity=0.654  Sum_probs=150.3

Q ss_pred             CceEEEEEEEEeec--CcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          346 GCLIQGSVYKGNIH--GEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       346 G~g~~G~Vy~~~~~--g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      |.|.+|.||++...  ++.+++|++...        +.+|+..++.++|++++++++++..  ....++++||+++++|.
T Consensus         2 ~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~~~e~~~~~~l~   79 (215)
T cd00180           2 GEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED--ENHLYLVMEYCEGGSLK   79 (215)
T ss_pred             CcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec--CCeEEEEEecCCCCcHH
Confidence            56677999999995  899999998654        4579999999999999999999876  56789999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECC-CCcEEEeeccCCccCCCCc--cccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS-NMRAKIANFGLAKSGCNAI--TMHIVG  492 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kL~Dfg~a~~~~~~~--~~~~~g  492 (552)
                      +++.... ..+++..++.++.++++++.+||+.+   ++|+||+|.||+++. ++.++|+|||.+.......  .....+
T Consensus        80 ~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~  155 (215)
T cd00180          80 DLLKENE-GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVG  155 (215)
T ss_pred             HHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccC
Confidence            9987652 24899999999999999999999998   999999999999999 8999999999987554432  334567


Q ss_pred             cccccCccccCCC-CCCChhhHHHHHHHHHHH
Q 037224          493 TQGYIAPEYLADG-VVSTKMDVFSFGVVLLEL  523 (552)
Q Consensus       493 t~~y~aPE~~~~~-~~s~~~Dv~slG~il~el  523 (552)
                      ...|++||..... ..+.+.|+|++|+++++|
T Consensus       156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l  187 (215)
T cd00180         156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL  187 (215)
T ss_pred             CCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence            8899999998777 788999999999999998

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=2.2e-22  Score=199.90  Aligned_cols=118  Identities=25%  Similarity=0.381  Sum_probs=101.8

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC------hHHHHHHHHHcC-----C---CCccceeeeeec--CCCCeeEEEE
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN------ACEELKILQKVN-----H---GNLVKLEGFCID--PEDANCYLIY  406 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~------~~~E~~~l~~l~-----h---~niv~l~~~~~~--~~~~~~~lv~  406 (552)
                      .|.|-|++||++.+  ..+.||+|+.+..      ...|+++|++++     |   .+||+|++.|..  +++.+.++|+
T Consensus        86 LGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVf  165 (590)
T KOG1290|consen   86 LGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVF  165 (590)
T ss_pred             ccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEe
Confidence            37777899999987  6789999999754      357999999983     2   379999999964  4456899999


Q ss_pred             eeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE
Q 037224          407 EYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL  465 (552)
Q Consensus       407 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll  465 (552)
                      |++ |-+|..++.....+.++...+.+|++|++.||.|||...  +|+|-||||+|||+
T Consensus       166 EvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  166 EVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             hhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence            999 459999998887788999999999999999999999876  69999999999998

>PRK10783 mltD membrane-bound lytic murein transglycosylase D; Provisional

Probab=99.86  E-value=1.4e-21  Score=203.07  Aligned_cols=170  Identities=19%  Similarity=0.268  Sum_probs=128.8

Q ss_pred             EeeccCCCCCCHHHHHHHhCCChhhhcCcCCCCCCCCCccCC-CcEEEeeecccccC-----------CCCC---ceeee
Q 037224           51 FYRASAPDFLDLASIADLFSVSRLMISEPSNISSPSSPLIQN-QPLFVPITCSCNTL-----------NASY---TISFA  115 (552)
Q Consensus        51 ~y~v~~~~g~tl~~Ia~~~~~~~~~l~~~N~~~~~~~~~~~g-~~l~iP~~~~~~~~-----------~~~~---~~~~~  115 (552)
                      .++|..+.+.+|..||+++|+++++|+++|+...+....+.| +.|+||....-...           .+..   .....
T Consensus       263 ~~~V~v~~~i~L~~iA~~~gvs~~eL~~LNP~~kr~~t~p~g~~~llvP~~~~~~f~~~l~~~~~~~~~p~~~~~~~~~~  342 (456)
T PRK10783        263 LARVDLGQQIELAQAAEMAGMSLTKLKTFNAGYKRSTTAPSGPHYIMVPKKHADQLRESLASGEIAAVQSTLVADNTPLN  342 (456)
T ss_pred             eEEEecCCCcCHHHHHHHcCCCHHHHHHhCccccCCCcCCCCCeEEEecCchhhHHHHhhhhhhhhhcccccccccCcCC
Confidence            455555337799999999999999999999754323333345 68889975321100           0000   00112


Q ss_pred             eeEEEEecCCchhhhHHhhcCCcchHHHHHHhCCCCCCCCCCCCcEEEEeeeecCCCCccccCceeEEEEEecCCCCCHH
Q 037224          116 NLSYTIKSGDTFYLVSTNKYQNLTTYQSVEVVNPTFVPTKLEVGDVIIFPVFCKCPNQTQLRNRVNYLVSYVLQPSENLS  195 (552)
Q Consensus       116 ~~~y~v~~gdtl~~Ia~~~~~~~~~~~~l~~~N~~~~~~~l~~gq~l~ip~~~~~~~~~~~~~~~~~~~~y~v~~Gdtl~  195 (552)
                      ..+|+|++||||++|| ++|+  ++.++|+++|++.+ +.|.+||+|.||..+.+...    ......++|+|++||||+
T Consensus       343 ~~~y~Vk~GDTL~sIA-~r~g--vs~~~L~~~N~l~~-~~L~~Gq~L~Ip~~~~~~~~----~~~~~~~~Y~Vr~GDTL~  414 (456)
T PRK10783        343 SRSYKVRSGDTLSGIA-SRLN--VSTKDLQQWNNLRG-SKLKVGQTLTIGAGSSAQRL----ANNSDSITYRVRKGDSLS  414 (456)
T ss_pred             ceEEEECCCCcHHHHH-HHHC--cCHHHHHHHcCCCc-ccCCCCCEEEecCCcccccc----cccccceeEEeCCCCCHH
Confidence            3479999999999999 7888  99999999999987 88999999999976655321    112234689999999999


Q ss_pred             HHHhHhCCChhhHhhhcCC---cccCCceeeccccC
Q 037224          196 SVASRFGIETQAIIDVNGN---NIRPFDTLFVPVAR  228 (552)
Q Consensus       196 ~ia~~~~~s~~~l~~~N~~---~~~~g~~l~ip~~~  228 (552)
                      +||++||+++++|++||++   .|+|||+|.|++..
T Consensus       415 sIA~kygVtv~~L~~~N~l~~~~L~pGq~L~l~v~~  450 (456)
T PRK10783        415 SIAKRHGVNIKDVMRWNSDTAKNLQPGDKLTLFVKN  450 (456)
T ss_pred             HHHHHhCCCHHHHHHhcCCCCCcCCCCCEEEEecCC
Confidence            9999999999999999998   69999999887665

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.86  E-value=7.8e-23  Score=209.75  Aligned_cols=182  Identities=27%  Similarity=0.432  Sum_probs=156.7

Q ss_pred             CCCceEEEEEEEEee--cCcEEEEEEeccCh-------HHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          344 SEGCLIQGSVYKGNI--HGEVYAIKMMKWNA-------CEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       344 ~~G~g~~G~Vy~~~~--~g~~vAvK~~~~~~-------~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      ..|+|.+|.|||+++  .++..|+|+++-+.       .+|+-+++.++|+||+.+++.+..  +...|++||||.+|+|
T Consensus        22 rvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr--~dklwicMEycgggsl   99 (829)
T KOG0576|consen   22 RVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR--RDKLWICMEYCGGGSL   99 (829)
T ss_pred             eecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhh--hcCcEEEEEecCCCcc
Confidence            348888899999988  78999999997542       478899999999999999999877  6678999999999999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--ccccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIVG  492 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~g  492 (552)
                      ++.-+...  ++++.++...++..++||+|||+++   -+|||||-.||++++.|.+|+.|||.+......  ......|
T Consensus       100 Qdiy~~Tg--plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati~KrksfiG  174 (829)
T KOG0576|consen  100 QDIYHVTG--PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSFIG  174 (829)
T ss_pred             cceeeecc--cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhhhhhhcccC
Confidence            99766543  5999999999999999999999999   899999999999999999999999998654322  3345789


Q ss_pred             cccccCcccc---CCCCCCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          493 TQGYIAPEYL---ADGVVSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       493 t~~y~aPE~~---~~~~~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                      |+.|||||+-   ..+.|...+|||++|+...|+---++|..+
T Consensus       175 tpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfd  217 (829)
T KOG0576|consen  175 TPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFD  217 (829)
T ss_pred             CccccchhHHHHHhcccccccccccccccchhhhhhcCCcccc
Confidence            9999999975   456788999999999999998777777543

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.84  E-value=1.1e-21  Score=222.33  Aligned_cols=148  Identities=18%  Similarity=0.254  Sum_probs=113.7

Q ss_pred             HcCC-CCccceeeeeecC-----CCCeeEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceE
Q 037224          381 KVNH-GNLVKLEGFCIDP-----EDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVV  454 (552)
Q Consensus       381 ~l~h-~niv~l~~~~~~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iv  454 (552)
                      .++| .||.+++++|...     +...+++++||+ +++|.+++... ...+++.+++.++.||++||+|||+++   |+
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g---Iv  102 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQG---IV  102 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence            4455 5888888877211     124567888987 45999999753 245999999999999999999999999   99


Q ss_pred             ecCCCCCcEEECCCC-------------------cEEEeeccCCccCCCC------------------cccccccccccc
Q 037224          455 HKDIKSSNILLDSNM-------------------RAKIANFGLAKSGCNA------------------ITMHIVGTQGYI  497 (552)
Q Consensus       455 H~Dikp~NIll~~~~-------------------~~kL~Dfg~a~~~~~~------------------~~~~~~gt~~y~  497 (552)
                      ||||||+||||+..+                   .+|++|||+++.....                  ......||+.|+
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            999999999996544                   4556666665421100                  000135788899


Q ss_pred             CccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          498 APEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       498 aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      |||++.+..++.++|||||||+||||++|..|+...
T Consensus       183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~  218 (793)
T PLN00181        183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK  218 (793)
T ss_pred             ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH
Confidence            999999999999999999999999999999988643

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.84  E-value=2.6e-21  Score=190.02  Aligned_cols=185  Identities=26%  Similarity=0.406  Sum_probs=149.7

Q ss_pred             HhhccCCCceEEEEEEEEee-----cCcEEEEEEecc-----ChHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEe
Q 037224          339 ATDNFSEGCLIQGSVYKGNI-----HGEVYAIKMMKW-----NACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYE  407 (552)
Q Consensus       339 ~t~~~~~G~g~~G~Vy~~~~-----~g~~vAvK~~~~-----~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e  407 (552)
                      ..+.+  |.|.|++||++.+     ..+.||+|.+..     ...+|+++|..+ .+.||+++.+++..  ++...+|+|
T Consensus        40 ~v~ki--geGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rn--nd~v~ivlp  115 (418)
T KOG1167|consen   40 VVNKI--GEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRN--NDQVAIVLP  115 (418)
T ss_pred             hhccc--cccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhcc--CCeeEEEec
Confidence            33444  5555699999987     357899998843     245899999999 69999999998876  678899999


Q ss_pred             eccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECC-CCcEEEeeccCCcc-----
Q 037224          408 YIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS-NMRAKIANFGLAKS-----  481 (552)
Q Consensus       408 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kL~Dfg~a~~-----  481 (552)
                      |++.-...++...     ++..++..+++.++.||.++|.+|   |+||||||+|+|.+. .++-.|+|||++..     
T Consensus       116 ~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~  187 (418)
T KOG1167|consen  116 YFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ  187 (418)
T ss_pred             ccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence            9999888887654     778999999999999999999999   999999999999965 56789999999840     


Q ss_pred             ------C------CC------------------C-----------ccccccccccccCccccCC-CCCCChhhHHHHHHH
Q 037224          482 ------G------CN------------------A-----------ITMHIVGTQGYIAPEYLAD-GVVSTKMDVFSFGVV  519 (552)
Q Consensus       482 ------~------~~------------------~-----------~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slG~i  519 (552)
                            .      ..                  .           ......||++|.|||++.. ...++++||||.|+|
T Consensus       188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI  267 (418)
T KOG1167|consen  188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI  267 (418)
T ss_pred             hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence                  0      00                  0           0001358999999999865 557889999999999


Q ss_pred             HHHHHcCCCCCCccCc
Q 037224          520 LLELISGKEAIDEEGK  535 (552)
Q Consensus       520 l~elltG~~pf~~~~~  535 (552)
                      ++.+++++.||.....
T Consensus       268 ~Lslls~~~PFf~a~d  283 (418)
T KOG1167|consen  268 LLSLLSRRYPFFKAKD  283 (418)
T ss_pred             eehhhccccccccCcc
Confidence            9999999999975443

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.82  E-value=1.4e-19  Score=183.47  Aligned_cols=185  Identities=24%  Similarity=0.275  Sum_probs=151.8

Q ss_pred             CCceEEEEEEEEeecC---cEEEEEEeccC-------hHHHHHHHHHcCC----CCccceeeeeecCCCCeeEEEEeecc
Q 037224          345 EGCLIQGSVYKGNIHG---EVYAIKMMKWN-------ACEELKILQKVNH----GNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~g---~~vAvK~~~~~-------~~~E~~~l~~l~h----~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      .|.|+||.||.+....   ..+|+|.....       ...|..++..+..    +++..+++... ..+...++||+.+ 
T Consensus        26 iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~~~iVM~l~-  103 (322)
T KOG1164|consen   26 IGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDFNFIVMSLL-  103 (322)
T ss_pred             ccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCceeEEEEecc-
Confidence            4788889999999833   47899887542       4468899998863    58888887764 2256779999977 


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCC-----CcEEEeeccCCc--cCC
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN-----MRAKIANFGLAK--SGC  483 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~-----~~~kL~Dfg~a~--~~~  483 (552)
                      |.+|.++........++...++.++.|++.+|++||+.|   ++||||||+|+++...     ..+.|.|||+++  ...
T Consensus       104 G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~  180 (322)
T KOG1164|consen  104 GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYV  180 (322)
T ss_pred             CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCCcccccc
Confidence            669999887666667999999999999999999999999   9999999999999754     359999999998  211


Q ss_pred             ---C-----C-c-cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          484 ---N-----A-I-TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       484 ---~-----~-~-~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                         .     . . .....||..|++++...+.+.+++.|+||++.++.||+.|..||....
T Consensus       181 ~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~  241 (322)
T KOG1164|consen  181 GDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE  241 (322)
T ss_pred             CCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence               0     0 1 122459999999999999999999999999999999999999997544

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.82  E-value=4.1e-20  Score=168.58  Aligned_cols=184  Identities=23%  Similarity=0.291  Sum_probs=148.9

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC-----hHHHHHHHHHcCCC-CccceeeeeecCCCCeeEEEEeeccCCCchh
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN-----ACEELKILQKVNHG-NLVKLEGFCIDPEDANCYLIYEYIENGSLHS  416 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~-----~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~  416 (552)
                      .|+|.||.+|.|..  +|+.||||+-+..     ...|..+...|++- .|..+..+..+  ...-.+|||.+ |.+|++
T Consensus        23 iGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e--~~ynvlVMdLL-GPsLEd   99 (341)
T KOG1163|consen   23 IGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTE--KDYNVLVMDLL-GPSLED   99 (341)
T ss_pred             ecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccc--cccceeeeecc-CccHHH
Confidence            37888899999987  8999999998654     34699999999754 45555444443  45558999988 679998


Q ss_pred             hhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEC---CCCcEEEeeccCCccCCC---------
Q 037224          417 WLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLD---SNMRAKIANFGLAKSGCN---------  484 (552)
Q Consensus       417 ~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~---~~~~~kL~Dfg~a~~~~~---------  484 (552)
                      ++.- ....++..+++.++-|++.-++|+|.++   ++||||||+|+|+.   ....+.|+|||+++...+         
T Consensus       100 Lfnf-C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpy  175 (341)
T KOG1163|consen  100 LFNF-CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPY  175 (341)
T ss_pred             HHHH-HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhccccccccCcc
Confidence            7653 3345999999999999999999999999   99999999999994   345789999999973322         


Q ss_pred             CccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          485 AITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       485 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      .......||.+|.+-....+.+.+.+.|+-|+|.+|.++.-|..||.+-..
T Consensus       176 re~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka  226 (341)
T KOG1163|consen  176 REDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA  226 (341)
T ss_pred             ccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence            122335789999998888888889999999999999999999999997654

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=1.2e-19  Score=183.79  Aligned_cols=144  Identities=19%  Similarity=0.183  Sum_probs=111.3

Q ss_pred             CceEEEEEEEEee---cCcEEEEEEeccC------------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          346 GCLIQGSVYKGNI---HGEVYAIKMMKWN------------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       346 G~g~~G~Vy~~~~---~g~~vAvK~~~~~------------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      |.|+||.||+|..   +++.+|||+....            +.+|++++++++|+|+++.+..     .+..++||||++
T Consensus        27 G~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-----~~~~~LVmE~~~  101 (365)
T PRK09188         27 KRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-----TGKDGLVRGWTE  101 (365)
T ss_pred             eecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-----cCCcEEEEEccC
Confidence            8888899999976   5678899985321            4589999999999999863322     134699999999


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCC-CCCcEEECCCCcEEEeeccCCccCCCCc---
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI-KSSNILLDSNMRAKIANFGLAKSGCNAI---  486 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Di-kp~NIll~~~~~~kL~Dfg~a~~~~~~~---  486 (552)
                      +++|.. +.  .   ..   ...++.|++++|.|||++|   |+|||| ||+|||++.++.+||+|||+++......   
T Consensus       102 G~~L~~-~~--~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~  169 (365)
T PRK09188        102 GVPLHL-AR--P---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALY  169 (365)
T ss_pred             CCCHHH-hC--c---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccceecccCcchh
Confidence            999863 21  1   11   1467889999999999999   999999 9999999999999999999997432211   


Q ss_pred             -------cccccccccccCccccCCCC
Q 037224          487 -------TMHIVGTQGYIAPEYLADGV  506 (552)
Q Consensus       487 -------~~~~~gt~~y~aPE~~~~~~  506 (552)
                             .....+++.|+|||.+...+
T Consensus       170 ~~~~~~d~~~~~~~~~~~~pe~~~~~~  196 (365)
T PRK09188        170 RIAAYEDLRHLLKHKRTYAPDALTPRE  196 (365)
T ss_pred             hhhhhhhhhhhhccCccCCcccCChhh
Confidence                   12356788899999886433

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.81  E-value=2.7e-19  Score=170.32  Aligned_cols=183  Identities=20%  Similarity=0.262  Sum_probs=150.1

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC-----hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccCCCchh
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN-----ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHS  416 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~-----~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~  416 (552)
                      .|+|.||..+.|+.  +++.||||.-...     ...|...++.| ..+.|...+-  ...++.+-.||+|.+ |.+|+|
T Consensus        36 IGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYY--FGqeG~~NiLVidLL-GPSLED  112 (449)
T KOG1165|consen   36 IGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYY--FGQEGKYNILVIDLL-GPSLED  112 (449)
T ss_pred             cccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceee--eccccchhhhhhhhh-CcCHHH
Confidence            36777799999986  9999999986322     34688888888 5678888753  334455668999988 669998


Q ss_pred             hhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCC-----CcEEEeeccCCccCCCCc-----
Q 037224          417 WLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN-----MRAKIANFGLAKSGCNAI-----  486 (552)
Q Consensus       417 ~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~-----~~~kL~Dfg~a~~~~~~~-----  486 (552)
                      ++. ..+..|+...+..++.|++.-++|+|++.   +|.|||||+|+||...     ..+.++|||+++...+..     
T Consensus       113 LFD-~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHI  188 (449)
T KOG1165|consen  113 LFD-LCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHI  188 (449)
T ss_pred             HHH-HhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccC
Confidence            664 34556999999999999999999999999   9999999999999543     358999999997443322     


Q ss_pred             ----cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          487 ----TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       487 ----~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                          .....||.+||+-....+++.+.+.|+-|||.++++.+-|..||.+-.
T Consensus       189 PYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK  240 (449)
T KOG1165|consen  189 PYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK  240 (449)
T ss_pred             ccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence                223579999999999999999999999999999999999999999754

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.80  E-value=1.2e-19  Score=167.42  Aligned_cols=108  Identities=24%  Similarity=0.270  Sum_probs=94.5

Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcccccc
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIV  491 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~  491 (552)
                      |+|.+++.... ..+++.+++.++.|+++||.|||+++         ||+|||++.++.+|+  ||++.......   ..
T Consensus         1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---~~   65 (176)
T smart00750        1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---SR   65 (176)
T ss_pred             CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc---CC
Confidence            68899887543 35999999999999999999999886         999999999999999  99987543322   36


Q ss_pred             ccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          492 GTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       492 gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      |++.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus        66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~  108 (176)
T smart00750       66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEER  108 (176)
T ss_pred             CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccc
Confidence            7899999999999999999999999999999999999997543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.78  E-value=1.8e-18  Score=161.10  Aligned_cols=128  Identities=17%  Similarity=0.237  Sum_probs=101.8

Q ss_pred             CCceEEEEEEEEee-cCcEEEEEEeccCh---------------------------------HHHHHHHHHcCCCCccce
Q 037224          345 EGCLIQGSVYKGNI-HGEVYAIKMMKWNA---------------------------------CEELKILQKVNHGNLVKL  390 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-~g~~vAvK~~~~~~---------------------------------~~E~~~l~~l~h~niv~l  390 (552)
                      .|.|++|.||+|.. +|+.||+|+++...                                 .+|+..+.++.++++...
T Consensus         5 ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~~p   84 (190)
T cd05147           5 ISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIPCP   84 (190)
T ss_pred             cccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCCCC
Confidence            47888899999988 79999999985431                                 128899999988877544


Q ss_pred             eeeeecCCCCeeEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceEecCCCCCcEEECCCC
Q 037224          391 EGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYI-HEHTRPRVVHKDIKSSNILLDSNM  469 (552)
Q Consensus       391 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~L-H~~~~~~ivH~Dikp~NIll~~~~  469 (552)
                      ..+...  .  .++||||++++++.......  ..+++.++..++.|++.+|.++ |+.|   |+||||||+|||++ ++
T Consensus        85 ~~~~~~--~--~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~  154 (190)
T cd05147          85 EPILLK--S--HVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DG  154 (190)
T ss_pred             cEEEec--C--CEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CC
Confidence            333222  2  38999999987776543222  3489999999999999999999 6888   99999999999998 47


Q ss_pred             cEEEeeccCCccC
Q 037224          470 RAKIANFGLAKSG  482 (552)
Q Consensus       470 ~~kL~Dfg~a~~~  482 (552)
                      .++|+|||++...
T Consensus       155 ~v~LiDFG~a~~~  167 (190)
T cd05147         155 KLYIIDVSQSVEH  167 (190)
T ss_pred             cEEEEEccccccC
Confidence            8999999998643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=3.3e-18  Score=158.02  Aligned_cols=174  Identities=15%  Similarity=0.095  Sum_probs=132.5

Q ss_pred             CCceEEEEEEEEeecCcEEEEEEeccC-----------hHHHHHHHHHcC-CCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNIHGEVYAIKMMKWN-----------ACEELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~g~~vAvK~~~~~-----------~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .+.++||+||.+...+..++.+.++..           +.+|+++|+++. |+++++++++      ...+++|||++|.
T Consensus        10 l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~lvmeyI~G~   83 (218)
T PRK12274         10 LKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRHLDRSYLAGA   83 (218)
T ss_pred             ecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEEEEEeeecCc
Confidence            477888999988888889987776422           457999999995 5789999875      2348999999998


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCC-CCCcEEECCCCcEEEeeccCCccCCCCcc----
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI-KSSNILLDSNMRAKIANFGLAKSGCNAIT----  487 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Di-kp~NIll~~~~~~kL~Dfg~a~~~~~~~~----  487 (552)
                      +|.+.+..         ....++.|++.+|+++|++|   |+|||| ||+|||++.++.++|+|||++........    
T Consensus        84 ~L~~~~~~---------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~  151 (218)
T PRK12274         84 AMYQRPPR---------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL  151 (218)
T ss_pred             cHHhhhhh---------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence            88654321         11357789999999999999   999999 79999999999999999999974332221    


Q ss_pred             -----------ccccccccccCccccCC-CCCC-ChhhHHHHHHHHHHHHcCCCCCCccCcc
Q 037224          488 -----------MHIVGTQGYIAPEYLAD-GVVS-TKMDVFSFGVVLLELISGKEAIDEEGKF  536 (552)
Q Consensus       488 -----------~~~~gt~~y~aPE~~~~-~~~s-~~~Dv~slG~il~elltG~~pf~~~~~~  536 (552)
                                 .....++.|+.|+...- ...+ ...+.++.|.-+|.++|++.++-++++-
T Consensus       152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~~  213 (218)
T PRK12274        152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNEG  213 (218)
T ss_pred             HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCCC
Confidence                       01134667777764322 1223 5678999999999999999998877653

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.77  E-value=8.7e-19  Score=165.39  Aligned_cols=154  Identities=16%  Similarity=0.191  Sum_probs=119.4

Q ss_pred             CceEEEEEEEEeecCcEEEEEEeccC----------------hHHHHHHHHHcCCCCccceeeeeecCC------CCeeE
Q 037224          346 GCLIQGSVYKGNIHGEVYAIKMMKWN----------------ACEELKILQKVNHGNLVKLEGFCIDPE------DANCY  403 (552)
Q Consensus       346 G~g~~G~Vy~~~~~g~~vAvK~~~~~----------------~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~~~  403 (552)
                      |.|++|.||....++..+|+|.++..                +.+|+..+.++.|++|..+.+++....      ....+
T Consensus        40 ~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~  119 (232)
T PRK10359         40 RNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYI  119 (232)
T ss_pred             cCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeE
Confidence            67778999998778889999999532                247888999999999999988866432      23578


Q ss_pred             EEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC
Q 037224          404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC  483 (552)
Q Consensus       404 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  483 (552)
                      ++|||++|.+|.++..      ++.    ....+++.+|..||+.|   ++|||+||+||+++++| ++|+|||......
T Consensus       120 lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~liDfg~~~~~~  185 (232)
T PRK10359        120 MLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRIIDLSGKRCTA  185 (232)
T ss_pred             EEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEEECCCccccc
Confidence            9999999999987632      333    24569999999999999   99999999999999988 9999999876442


Q ss_pred             CCccccccccccccCccccCCCCCCChhhHHHHHHHHHHH
Q 037224          484 NAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLEL  523 (552)
Q Consensus       484 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~el  523 (552)
                      .....          ..+.....+..++|+|+||+.+..+
T Consensus       186 e~~a~----------d~~vler~y~~~~di~~lg~~~~~~  215 (232)
T PRK10359        186 QRKAK----------DRIDLERHYGIKNEIKDLGYYLLIY  215 (232)
T ss_pred             chhhH----------HHHHHHhHhcccccccceeEeehHH
Confidence            22111          0133445566789999999988754

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.77  E-value=1.2e-17  Score=168.07  Aligned_cols=183  Identities=35%  Similarity=0.562  Sum_probs=153.7

Q ss_pred             CceEEEEEEEEeecCcEEEEEEeccC----------hHHHHHHHHHcCCC-CccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNIHGEVYAIKMMKWN----------ACEELKILQKVNHG-NLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~~g~~vAvK~~~~~----------~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|.+|.||++... ..+++|.+...          +.+|+.++..+.|+ +++++.+.+..  ....+++++++.++++
T Consensus         9 ~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~~~~~~~~l   85 (384)
T COG0515           9 GEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD--EGSLYLVMEYVDGGSL   85 (384)
T ss_pred             cCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec--CCEEEEEEecCCCCcH
Confidence            45666999999988 88899988432          34688899999988 79999999855  4557999999999999


Q ss_pred             hhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCC-cEEEeeccCCccCCCC-------
Q 037224          415 HSWLHENKN-ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM-RAKIANFGLAKSGCNA-------  485 (552)
Q Consensus       415 ~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~~~~~-------  485 (552)
                      .+++..... ..+.......++.|++.++.|+|+.+   ++|||+||+||+++..+ .++++|||.++.....       
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~  162 (384)
T COG0515          86 EDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIP  162 (384)
T ss_pred             HHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcccccc
Confidence            976665432 14899999999999999999999999   99999999999999988 7999999998743322       


Q ss_pred             -ccccccccccccCccccCC---CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          486 -ITMHIVGTQGYIAPEYLAD---GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       486 -~~~~~~gt~~y~aPE~~~~---~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                       ......++..|++||.+..   ...+...|+|++|++++++++|..||....
T Consensus       163 ~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~  215 (384)
T COG0515         163 ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK  215 (384)
T ss_pred             ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence             2345689999999999987   578889999999999999999999977654

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.75  E-value=1.2e-17  Score=155.94  Aligned_cols=128  Identities=19%  Similarity=0.228  Sum_probs=103.0

Q ss_pred             CCceEEEEEEEEee-cCcEEEEEEeccCh---------------------------------HHHHHHHHHcCCCCccce
Q 037224          345 EGCLIQGSVYKGNI-HGEVYAIKMMKWNA---------------------------------CEELKILQKVNHGNLVKL  390 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-~g~~vAvK~~~~~~---------------------------------~~E~~~l~~l~h~niv~l  390 (552)
                      .|.|.+|.||+|.. +|+.||||+++...                                 .+|...+.++.|+++...
T Consensus         5 ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p   84 (190)
T cd05145           5 ISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVPVP   84 (190)
T ss_pred             eecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCCCc
Confidence            36777799999988 69999999986421                                 257888999999988655


Q ss_pred             eeeeecCCCCeeEEEEeeccCCCchhh-hhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEECCC
Q 037224          391 EGFCIDPEDANCYLIYEYIENGSLHSW-LHENKNENLNWKTRLRIAIDVANGLQYIHE-HTRPRVVHKDIKSSNILLDSN  468 (552)
Q Consensus       391 ~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~Dikp~NIll~~~  468 (552)
                      ..+...  .  .++||||++++++... +..   ..++..++..++.|++.++.+||+ .|   ++||||||+||+++ +
T Consensus        85 ~~~~~~--~--~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~  153 (190)
T cd05145          85 EPILLK--K--NVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-D  153 (190)
T ss_pred             eEEEec--C--CEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-C
Confidence            444332  2  3899999998765433 332   247888999999999999999999 88   99999999999998 8


Q ss_pred             CcEEEeeccCCccCC
Q 037224          469 MRAKIANFGLAKSGC  483 (552)
Q Consensus       469 ~~~kL~Dfg~a~~~~  483 (552)
                      +.++|+|||++....
T Consensus       154 ~~~~liDFG~a~~~~  168 (190)
T cd05145         154 GKPYIIDVSQAVELD  168 (190)
T ss_pred             CCEEEEEcccceecC
Confidence            899999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.75  E-value=5.5e-19  Score=163.75  Aligned_cols=179  Identities=23%  Similarity=0.413  Sum_probs=145.2

Q ss_pred             EEEEEEeecCcEEEEEEec---------cChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhhhhhc
Q 037224          351 GSVYKGNIHGEVYAIKMMK---------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHEN  421 (552)
Q Consensus       351 G~Vy~~~~~g~~vAvK~~~---------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~  421 (552)
                      |..|+|+|.|..++.|+++         .++.+|.-.|+-+.||||+.+++.|..  ...+.++..||+.|+|...+++.
T Consensus       204 gelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacns--ppnlv~isq~mp~gslynvlhe~  281 (448)
T KOG0195|consen  204 GELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNS--PPNLVIISQYMPFGSLYNVLHEQ  281 (448)
T ss_pred             cccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccC--CCCceEeeeeccchHHHHHHhcC
Confidence            8899999998888888763         456678888888999999999999987  46778999999999999999988


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccccccccccccCccc
Q 037224          422 KNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEY  501 (552)
Q Consensus       422 ~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~gt~~y~aPE~  501 (552)
                      .+-..+..++.+++.++++|++|||+.. +-|.---|.+..+++|++...+|.- +-+++.  -........+.||+||.
T Consensus       282 t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarism-ad~kfs--fqe~gr~y~pawmspea  357 (448)
T KOG0195|consen  282 TSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISM-ADTKFS--FQEVGRAYSPAWMSPEA  357 (448)
T ss_pred             ccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheec-ccceee--eeccccccCcccCCHHH
Confidence            7766888999999999999999999986 2244446899999999998877642 112111  11223455789999999


Q ss_pred             cCCCCCC---ChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          502 LADGVVS---TKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       502 ~~~~~~s---~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      ++..+-+   .++|+|||++++|||.|...||.+-.+
T Consensus       358 lqrkped~n~raadmwsfaillwel~trevpfadlsp  394 (448)
T KOG0195|consen  358 LQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSP  394 (448)
T ss_pred             HhcCchhcchhhhhHHHHHHHHHHhhccccccccCCc
Confidence            9765533   478999999999999999999997665

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.70  E-value=2.6e-18  Score=177.18  Aligned_cols=177  Identities=28%  Similarity=0.363  Sum_probs=146.9

Q ss_pred             CCceEEEEEEEEe-----ecCcEEEEEEeccC---------hHHHHHHHHHcC-CCCccceeeeeecCCCCeeEEEEeec
Q 037224          345 EGCLIQGSVYKGN-----IHGEVYAIKMMKWN---------ACEELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYI  409 (552)
Q Consensus       345 ~G~g~~G~Vy~~~-----~~g~~vAvK~~~~~---------~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~lv~e~~  409 (552)
                      .|.|.+|.|+..+     ..|..+|+|+.++.         ...|..++..++ |+.++++.-.+..  +...+++++|.
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt--~~kl~l~ld~~   79 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT--DGKLYLILDFL   79 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc--ccchhHhhhhc
Confidence            3556667776543     35677888877532         235888888886 9999999877766  66779999999


Q ss_pred             cCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcccc
Q 037224          410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH  489 (552)
Q Consensus       410 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  489 (552)
                      .+|.|...+.....  +++.....+...++-+++++|+.+   ++|||+|++||+++.+|.+++.|||+++..-....  
T Consensus        80 rgg~lft~l~~~~~--f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--  152 (612)
T KOG0603|consen   80 RGGDLFTRLSKEVM--FDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--  152 (612)
T ss_pred             ccchhhhccccCCc--hHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence            99999877765543  788888888999999999999999   99999999999999999999999999985443322  


Q ss_pred             ccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                      .+||..|||||++.  ......|.||||++++||+||..||..
T Consensus       153 ~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  153 ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence            28999999999987  667789999999999999999999987

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.69  E-value=4.2e-17  Score=179.63  Aligned_cols=178  Identities=19%  Similarity=0.238  Sum_probs=141.0

Q ss_pred             CceEEEEEEEEee-cCcEEEEEEeccChHHH----HHHHHHcC---CCCccceeeeeecCCCCeeEEEEeeccCCCchhh
Q 037224          346 GCLIQGSVYKGNI-HGEVYAIKMMKWNACEE----LKILQKVN---HGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSW  417 (552)
Q Consensus       346 G~g~~G~Vy~~~~-~g~~vAvK~~~~~~~~E----~~~l~~l~---h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~  417 (552)
                      |.|++|+||+|.. +|+.||||+-+....-|    .+++.+|+   -+-|..+...+..  .+..+||+||.+.|+|.++
T Consensus       707 G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~--~~~S~lv~ey~~~Gtlld~  784 (974)
T KOG1166|consen  707 GEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVF--QNASVLVSEYSPYGTLLDL  784 (974)
T ss_pred             ccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHcc--CCcceeeeeccccccHHHh
Confidence            8888899999987 89999999987654433    33444444   2233444333333  3445899999999999999


Q ss_pred             hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEC-------CCCcEEEeeccCCccC---CCC-c
Q 037224          418 LHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLD-------SNMRAKIANFGLAKSG---CNA-I  486 (552)
Q Consensus       418 l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~-------~~~~~kL~Dfg~a~~~---~~~-~  486 (552)
                      +...+  .++|.-...+..|+++.+++||..+   ||||||||+|+||.       +..-++|+|||.+-..   .+. .
T Consensus       785 ~N~~~--~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~  859 (974)
T KOG1166|consen  785 INTNK--VMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTK  859 (974)
T ss_pred             hccCC--CCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcE
Confidence            98444  5999999999999999999999999   99999999999993       2345999999998522   222 3


Q ss_pred             cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCC
Q 037224          487 TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAI  530 (552)
Q Consensus       487 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf  530 (552)
                      -...++|-.+-.+|...++.++.+.|.|.|+.+++-||.|+.--
T Consensus       860 F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q  903 (974)
T KOG1166|consen  860 FKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME  903 (974)
T ss_pred             EeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH
Confidence            33467888999999999999999999999999999999998543

>PRK10345 hypothetical protein; Provisional

Probab=99.67  E-value=4.9e-16  Score=146.24  Aligned_cols=126  Identities=13%  Similarity=0.164  Sum_probs=97.5

Q ss_pred             CCceEEEEEEEEeecCcEEEEEEeccC-------hHHHHHHHHHc-----CCCCccceeeeeecCCC-Ce-eEEEEee--
Q 037224          345 EGCLIQGSVYKGNIHGEVYAIKMMKWN-------ACEELKILQKV-----NHGNLVKLEGFCIDPED-AN-CYLIYEY--  408 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~g~~vAvK~~~~~-------~~~E~~~l~~l-----~h~niv~l~~~~~~~~~-~~-~~lv~e~--  408 (552)
                      .|.|.+|.||....++.. +||+....       ..+|+.+++.+     +||||++++|++.+..+ +. +.+|+||  
T Consensus        10 LG~G~~~~Vy~hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G   88 (210)
T PRK10345         10 LGTGRHRKCYAHPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDG   88 (210)
T ss_pred             ecCCCceEEEECCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCC
Confidence            478888999974445555 68887543       45899999999     67999999999987432 23 3478999  


Q ss_pred             ccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCceEecCCCCCcEEECC----CCcEEEeeccCC
Q 037224          409 IENGSLHSWLHENKNENLNWKTRLRIAIDVANGL-QYIHEHTRPRVVHKDIKSSNILLDS----NMRAKIANFGLA  479 (552)
Q Consensus       409 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL-~~LH~~~~~~ivH~Dikp~NIll~~----~~~~kL~Dfg~a  479 (552)
                      +.+++|.+++.+..   +++.  ..++.|++.++ +|||+++   |+||||||+|||++.    +++++|+||+.+
T Consensus        89 ~~~~tL~~~l~~~~---~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         89 KPSITLTEFAEQCR---YEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             CcchhHHHHHHccc---ccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            55799999996632   5555  35678888888 9999999   999999999999964    347999995444

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.66  E-value=3e-17  Score=177.24  Aligned_cols=151  Identities=25%  Similarity=0.348  Sum_probs=125.9

Q ss_pred             HHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceE
Q 037224          375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVV  454 (552)
Q Consensus       375 E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iv  454 (552)
                      |+-+-..+.|+|++..+..+.+.  ....-.|||++. +|..++....  .++..++..++.|++.|+.|||+.|   +.
T Consensus       371 E~~i~~~l~h~~~~e~l~~~~~~--~~~~~~mE~~~~-Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h~~G---ia  442 (601)
T KOG0590|consen  371 EFCIGSSLSHPNIIETLDIVQEI--DGILQSMEYCPY-DLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLHSMG---LA  442 (601)
T ss_pred             heeecccccCCchhhhHHHHhhc--ccchhhhhcccH-HHHHHHhccc--ccchhhhhHHHHHHHHHHHHHHhcC---ce
Confidence            45555667999998877766652  223344999999 9999887652  3888999999999999999999999   99


Q ss_pred             ecCCCCCcEEECCCCcEEEeeccCCccCCC------CccccccccccccCccccCCCCCCCh-hhHHHHHHHHHHHHcCC
Q 037224          455 HKDIKSSNILLDSNMRAKIANFGLAKSGCN------AITMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELISGK  527 (552)
Q Consensus       455 H~Dikp~NIll~~~~~~kL~Dfg~a~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~~-~Dv~slG~il~elltG~  527 (552)
                      |||+|++|++++.+|.+||+|||.+.....      .......|+..|+|||.+.+.+|.+. .||||.|+++..|.+|+
T Consensus       443 hrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~  522 (601)
T KOG0590|consen  443 HRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGR  522 (601)
T ss_pred             eccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCC
Confidence            999999999999999999999999864321      23345689999999999999998774 79999999999999999


Q ss_pred             CCCCcc
Q 037224          528 EAIDEE  533 (552)
Q Consensus       528 ~pf~~~  533 (552)
                      .||.-.
T Consensus       523 ~~Wk~a  528 (601)
T KOG0590|consen  523 FPWKVA  528 (601)
T ss_pred             Cccccc
Confidence            999743

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.66  E-value=1e-15  Score=145.56  Aligned_cols=125  Identities=21%  Similarity=0.361  Sum_probs=106.0

Q ss_pred             CceEEEEEEEEeecCcEEEEEEecc---------------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          346 GCLIQGSVYKGNIHGEVYAIKMMKW---------------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       346 G~g~~G~Vy~~~~~g~~vAvK~~~~---------------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      |.|.+|.||+|...|..+++|....               ...+|+.++..+.|+++.....++.+  ....+++|||++
T Consensus         5 ~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv~e~~~   82 (211)
T PRK14879          5 KRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD--PENFIIVMEYIE   82 (211)
T ss_pred             ccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe--CCCCEEEEEEeC
Confidence            6777799999999999999998542               12368899999999998877777665  445689999999


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccC
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG  482 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  482 (552)
                      |++|.+++....     + .+..++.+++.+|.+||+.+   ++|+|++|+|||++ ++.++|+|||.+...
T Consensus        83 G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~  144 (211)
T PRK14879         83 GEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEFS  144 (211)
T ss_pred             CcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence            999999886432     2 78899999999999999999   99999999999999 788999999998753

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.65  E-value=3.2e-17  Score=177.22  Aligned_cols=179  Identities=25%  Similarity=0.334  Sum_probs=138.2

Q ss_pred             CCCceEEEEEEEEeecCcEEEEEEeccC--------hH---HHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          344 SEGCLIQGSVYKGNIHGEVYAIKMMKWN--------AC---EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       344 ~~G~g~~G~Vy~~~~~g~~vAvK~~~~~--------~~---~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      ..|++.|=+|.+++.+...|+||++-+.        +.   +|++ ...++|||.+++.-+-..  +...|+|-+|..+ 
T Consensus        30 ~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t--~kAAylvRqyvkh-  105 (1431)
T KOG1240|consen   30 NLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVT--DKAAYLVRQYVKH-  105 (1431)
T ss_pred             ccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHh--hHHHHHHHHHHhh-
Confidence            3477777889999997667999998322        22   3444 556699999998766544  5666899999976 


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccC---C-CCccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG---C-NAITM  488 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~---~-~~~~~  488 (552)
                      +|.|.+..++.  +..-+.+.|+.|++.||..+|..|   |+|||||.+|||++.-.-+.|+||..-+..   . +....
T Consensus       106 nLyDRlSTRPF--L~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf  180 (1431)
T KOG1240|consen  106 NLYDRLSTRPF--LVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADF  180 (1431)
T ss_pred             hhhhhhccchH--HHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCcccc
Confidence            99998877664  788889999999999999999999   999999999999999999999999865421   1 11111


Q ss_pred             c-cc----ccccccCccccCC-----------CCCCChhhHHHHHHHHHHHHc-CCCCCC
Q 037224          489 H-IV----GTQGYIAPEYLAD-----------GVVSTKMDVFSFGVVLLELIS-GKEAID  531 (552)
Q Consensus       489 ~-~~----gt~~y~aPE~~~~-----------~~~s~~~Dv~slG~il~ellt-G~~pf~  531 (552)
                      . ..    .-..|+|||.+..           ...+++.||||+||++.||++ |++||+
T Consensus       181 ~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~  240 (1431)
T KOG1240|consen  181 TFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT  240 (1431)
T ss_pred             eEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence            1 11    1236999997643           126789999999999999987 688887

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.65  E-value=1.2e-15  Score=143.63  Aligned_cols=123  Identities=21%  Similarity=0.320  Sum_probs=100.8

Q ss_pred             CCceEEEEEEEEeecCcEEEEEEeccC---------------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeec
Q 037224          345 EGCLIQGSVYKGNIHGEVYAIKMMKWN---------------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI  409 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~g~~vAvK~~~~~---------------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~  409 (552)
                      .|.|.+|.||++.++|..+++|.....               ..+|++++..+.|+++.....++.+  ....+++|||+
T Consensus         2 ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv~e~~   79 (199)
T TIGR03724         2 IAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD--PDNKTIVMEYI   79 (199)
T ss_pred             CCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE--CCCCEEEEEEE
Confidence            367888999999999999999985321               2268999999998876655555554  44558999999


Q ss_pred             cCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccC
Q 037224          410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG  482 (552)
Q Consensus       410 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  482 (552)
                      ++++|.+++....   .      .++.+++.+|.+||+.+   ++|+|++|+||+++ ++.++++|||++...
T Consensus        80 ~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEGN---D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhcH---H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            9999998775432   1      78999999999999999   99999999999999 889999999998754

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.65  E-value=4.9e-16  Score=151.15  Aligned_cols=184  Identities=20%  Similarity=0.257  Sum_probs=114.5

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC--h--------HHHHHHHHHcC----------CCCccceeeeeecC------
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN--A--------CEELKILQKVN----------HGNLVKLEGFCIDP------  397 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~--~--------~~E~~~l~~l~----------h~niv~l~~~~~~~------  397 (552)
                      |.|.++.||.+++  .|+.+|||++...  .        .+|.-....+.          |-.++..++.....      
T Consensus        21 ~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~~~~  100 (288)
T PF14531_consen   21 GKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKPPFF  100 (288)
T ss_dssp             EEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-SEE
T ss_pred             ccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCCcce
Confidence            6666799999999  6799999997321  1        12221221111          21222222222211      


Q ss_pred             ---C-CC-----eeEEEEeeccCCCchhhhhh---cCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcE
Q 037224          398 ---E-DA-----NCYLIYEYIENGSLHSWLHE---NKN--ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI  463 (552)
Q Consensus       398 ---~-~~-----~~~lv~e~~~~gsL~~~l~~---~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NI  463 (552)
                         . ..     ..+++|+-+. ++|.+++..   ...  ..+....++.+..|+++.+++||+.|   ++|+||+|+|+
T Consensus       101 ~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi~~~nf  176 (288)
T PF14531_consen  101 ERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDIKPENF  176 (288)
T ss_dssp             EECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGE
T ss_pred             ecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecccceeeE
Confidence               0 11     2356777774 488877542   211  12444556777799999999999999   99999999999


Q ss_pred             EECCCCcEEEeeccCCccCCCCccccccccccccCccccCC--------CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          464 LLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLAD--------GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       464 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +++.+|.++|+||+........... ...+..|.+||....        -.++.+.|.|+||+++|.|++|+.||+...
T Consensus       177 ll~~~G~v~Lg~F~~~~r~g~~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~  254 (288)
T PF14531_consen  177 LLDQDGGVFLGDFSSLVRAGTRYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSS  254 (288)
T ss_dssp             EE-TTS-EEE--GGGEEETTEEEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCG
T ss_pred             EEcCCCCEEEcChHHHeecCceeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCC
Confidence            9999999999999877654433222 344577999997533        247889999999999999999999998543

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.62  E-value=1.1e-15  Score=149.01  Aligned_cols=146  Identities=25%  Similarity=0.429  Sum_probs=114.5

Q ss_pred             CCCCccceeeeeecC-------------------------CCCeeEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHH
Q 037224          383 NHGNLVKLEGFCIDP-------------------------EDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAID  437 (552)
Q Consensus       383 ~h~niv~l~~~~~~~-------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q  437 (552)
                      +||||+++.++|.++                         +....|+||.-.+. +|.+++..+.   .+.....-++.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~---~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH---RSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC---CchHHHHHHHHH
Confidence            689999988877642                         23567899988865 9999987654   677788889999


Q ss_pred             HHHHHHHHHhCCCCceEecCCCCCcEEE--CCCC--cEEEeeccCCccCCC--------CccccccccccccCccccCCC
Q 037224          438 VANGLQYIHEHTRPRVVHKDIKSSNILL--DSNM--RAKIANFGLAKSGCN--------AITMHIVGTQGYIAPEYLADG  505 (552)
Q Consensus       438 i~~aL~~LH~~~~~~ivH~Dikp~NIll--~~~~--~~kL~Dfg~a~~~~~--------~~~~~~~gt~~y~aPE~~~~~  505 (552)
                      +++|+.|||.+|   +.|||+|++|||+  |+|+  .+.|+|||++-....        .......|....||||+....
T Consensus       350 lLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~  426 (598)
T KOG4158|consen  350 LLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV  426 (598)
T ss_pred             HHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence            999999999999   9999999999998  4443  478999998753221        122234677789999987532


Q ss_pred             C------CCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          506 V------VSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       506 ~------~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      .      .-.++|.|+.|.+.||+++...||...++
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe  462 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE  462 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHhccCCcccccch
Confidence            2      23489999999999999999999988654

>PRK10783 mltD membrane-bound lytic murein transglycosylase D; Provisional

Probab=99.62  E-value=1.3e-15  Score=158.67  Aligned_cols=108  Identities=20%  Similarity=0.236  Sum_probs=92.1

Q ss_pred             eeEeeccCCCCCCHHHHHHHhCCChhhhcCcCCCCCCCCCccCCCcEEEeeecccccCCCCCceeeeeeEEEEecCCchh
Q 037224           49 YAFYRASAPDFLDLASIADLFSVSRLMISEPSNISSPSSPLIQNQPLFVPITCSCNTLNASYTISFANLSYTIKSGDTFY  128 (552)
Q Consensus        49 ~~~y~v~~~~g~tl~~Ia~~~~~~~~~l~~~N~~~~~~~~~~~g~~l~iP~~~~~~~~~~~~~~~~~~~~y~v~~gdtl~  128 (552)
                      ...|+|++  ||||++||++||+++.+|.++|++.+  ..+.+||.|.||.++.+.....    .....+|+|++||||+
T Consensus       343 ~~~y~Vk~--GDTL~sIA~r~gvs~~~L~~~N~l~~--~~L~~Gq~L~Ip~~~~~~~~~~----~~~~~~Y~Vr~GDTL~  414 (456)
T PRK10783        343 SRSYKVRS--GDTLSGIASRLNVSTKDLQQWNNLRG--SKLKVGQTLTIGAGSSAQRLAN----NSDSITYRVRKGDSLS  414 (456)
T ss_pred             ceEEEECC--CCcHHHHHHHHCcCHHHHHHHcCCCc--ccCCCCCEEEecCCcccccccc----cccceeEEeCCCCCHH
Confidence            55899999  99999999999999999999999873  6799999999998766542111    1223469999999999


Q ss_pred             hhHHhhcCCcchHHHHHHhCCCCCCCCCCCCcEEEEeeee
Q 037224          129 LVSTNKYQNLTTYQSVEVVNPTFVPTKLEVGDVIIFPVFC  168 (552)
Q Consensus       129 ~Ia~~~~~~~~~~~~l~~~N~~~~~~~l~~gq~l~ip~~~  168 (552)
                      +|| ++|+  ||+++|+++|++..+ .|++||+|+|++..
T Consensus       415 sIA-~kyg--Vtv~~L~~~N~l~~~-~L~pGq~L~l~v~~  450 (456)
T PRK10783        415 SIA-KRHG--VNIKDVMRWNSDTAK-NLQPGDKLTLFVKN  450 (456)
T ss_pred             HHH-HHhC--CCHHHHHHhcCCCCC-cCCCCCEEEEecCC
Confidence            999 8999  999999999998774 99999999998753

>smart00090 RIO RIO-like kinase

Probab=99.61  E-value=5.6e-15  Score=142.42  Aligned_cols=126  Identities=17%  Similarity=0.224  Sum_probs=98.3

Q ss_pred             CceEEEEEEEEe---ecCcEEEEEEeccC-------------------------------hHHHHHHHHHcCCCC--ccc
Q 037224          346 GCLIQGSVYKGN---IHGEVYAIKMMKWN-------------------------------ACEELKILQKVNHGN--LVK  389 (552)
Q Consensus       346 G~g~~G~Vy~~~---~~g~~vAvK~~~~~-------------------------------~~~E~~~l~~l~h~n--iv~  389 (552)
                      |.|.+|.||+|.   .+|+.||+|+++..                               ..+|+..+.++.+..  +.+
T Consensus        37 g~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i~~p~  116 (237)
T smart00090       37 STGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGVPVPK  116 (237)
T ss_pred             ccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCe
Confidence            677779999998   27899999988532                               136889999997533  334


Q ss_pred             eeeeeecCCCCeeEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCC
Q 037224          390 LEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM  469 (552)
Q Consensus       390 l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~  469 (552)
                      +++.      ...++||||+++.+|........  .+...+...++.|++.++.+||+.+  .++||||||+||+++ ++
T Consensus       117 ~~~~------~~~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIli~-~~  185 (237)
T smart00090      117 PIAW------RRNVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNILVH-DG  185 (237)
T ss_pred             eeEe------cCceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEEEE-CC
Confidence            4332      12389999999988876543222  3666777899999999999999886  499999999999999 88


Q ss_pred             cEEEeeccCCccC
Q 037224          470 RAKIANFGLAKSG  482 (552)
Q Consensus       470 ~~kL~Dfg~a~~~  482 (552)
                      .++|+|||.+...
T Consensus       186 ~i~LiDFg~a~~~  198 (237)
T smart00090      186 KVVIIDVSQSVEL  198 (237)
T ss_pred             CEEEEEChhhhcc
Confidence            9999999998643

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.58  E-value=1.6e-14  Score=135.96  Aligned_cols=121  Identities=19%  Similarity=0.230  Sum_probs=95.8

Q ss_pred             CCceEEEEEEEEee-cCcEEEEEEeccC-----------------------------hHHHHHHHHHcCCCC--ccceee
Q 037224          345 EGCLIQGSVYKGNI-HGEVYAIKMMKWN-----------------------------ACEELKILQKVNHGN--LVKLEG  392 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-~g~~vAvK~~~~~-----------------------------~~~E~~~l~~l~h~n--iv~l~~  392 (552)
                      .|.|.+|.||++.. +|+.||||+++..                             ..+|..++.++.|.+  ++..++
T Consensus        23 i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~~~~  102 (198)
T cd05144          23 IGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPKPID  102 (198)
T ss_pred             cccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCceee
Confidence            36777799999988 7999999985421                             235788888887774  444433


Q ss_pred             eeecCCCCeeEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEE
Q 037224          393 FCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAK  472 (552)
Q Consensus       393 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~k  472 (552)
                      .      ...+++|||+++++|.+....        .....++.+++.++.++|+.+   ++||||+|+||++++++.++
T Consensus       103 ~------~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~~~~  165 (198)
T cd05144         103 W------NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDEKIY  165 (198)
T ss_pred             c------CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCCcEE
Confidence            2      234899999999998765321        345678899999999999998   99999999999999999999


Q ss_pred             EeeccCCccC
Q 037224          473 IANFGLAKSG  482 (552)
Q Consensus       473 L~Dfg~a~~~  482 (552)
                      |+|||++...
T Consensus       166 liDfg~~~~~  175 (198)
T cd05144         166 IIDWPQMVST  175 (198)
T ss_pred             EEECCccccC
Confidence            9999998643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.57  E-value=1.2e-14  Score=157.55  Aligned_cols=122  Identities=21%  Similarity=0.297  Sum_probs=101.1

Q ss_pred             CCceEEEEEEEEeecCcEEEEEEec-c--------------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeec
Q 037224          345 EGCLIQGSVYKGNIHGEVYAIKMMK-W--------------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI  409 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~g~~vAvK~~~-~--------------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~  409 (552)
                      .|.|.+|.||++.+.+..+++|+.. .              ...+|++++++++|++++....++.+  ....++||||+
T Consensus       341 iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv~E~~  418 (535)
T PRK09605        341 IGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD--PEEKTIVMEYI  418 (535)
T ss_pred             eccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe--CCCCEEEEEec
Confidence            4788889999999977666665431 1              13469999999999999887777665  34568999999


Q ss_pred             cCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccC
Q 037224          410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG  482 (552)
Q Consensus       410 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  482 (552)
                      ++++|.+++.          ....++.|++++|.+||+.+   ++||||||+|||+ +++.++|+|||+++..
T Consensus       419 ~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        419 GGKDLKDVLE----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             CCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            9999998775          34678999999999999999   9999999999999 6778999999999754

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.57  E-value=5.7e-15  Score=152.69  Aligned_cols=151  Identities=30%  Similarity=0.490  Sum_probs=125.8

Q ss_pred             HHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCce-EecC
Q 037224          379 LQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRV-VHKD  457 (552)
Q Consensus       379 l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~i-vH~D  457 (552)
                      |+.+.|.|+.+++|.+.+  +...+.|.+|+..|+|.|.+.... ..+++.....++++++.||+|||+..   | .|+.
T Consensus         1 l~~l~h~n~~~f~g~~~~--~~~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~   74 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVD--GPEMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLHNSP---IGYHGA   74 (484)
T ss_pred             CcccchhhhhhheeeEec--CCceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHhcCc---ceeeee
Confidence            356899999999999998  477899999999999999998743 45899999999999999999999875   4 9999


Q ss_pred             CCCCcEEECCCCcEEEeeccCCccCCC----CccccccccccccCccccCCCC-------CCChhhHHHHHHHHHHHHcC
Q 037224          458 IKSSNILLDSNMRAKIANFGLAKSGCN----AITMHIVGTQGYIAPEYLADGV-------VSTKMDVFSFGVVLLELISG  526 (552)
Q Consensus       458 ikp~NIll~~~~~~kL~Dfg~a~~~~~----~~~~~~~gt~~y~aPE~~~~~~-------~s~~~Dv~slG~il~elltG  526 (552)
                      +++.|.++|....+||+|||+......    .......-..-|.|||.+....       .+.+.|+||||++++|+++.
T Consensus        75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r  154 (484)
T KOG1023|consen   75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR  154 (484)
T ss_pred             eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence            999999999999999999999876532    1111122345699999886531       46679999999999999999


Q ss_pred             CCCCCccCc
Q 037224          527 KEAIDEEGK  535 (552)
Q Consensus       527 ~~pf~~~~~  535 (552)
                      +.||+....
T Consensus       155 ~~~~~~~~~  163 (484)
T KOG1023|consen  155 SGPFDLRNL  163 (484)
T ss_pred             cCccccccc
Confidence            999997543

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.54  E-value=6e-14  Score=135.52  Aligned_cols=130  Identities=18%  Similarity=0.240  Sum_probs=100.3

Q ss_pred             cCCC-ceEEEEEEEEeecCcEEEEEEecc--------------------ChHHHHHHHHHcCCCCc--cceeeeeecCCC
Q 037224          343 FSEG-CLIQGSVYKGNIHGEVYAIKMMKW--------------------NACEELKILQKVNHGNL--VKLEGFCIDPED  399 (552)
Q Consensus       343 ~~~G-~g~~G~Vy~~~~~g~~vAvK~~~~--------------------~~~~E~~~l~~l~h~ni--v~l~~~~~~~~~  399 (552)
                      ...| .|+.|+||+....+..++||.++.                    ...+|+.++.+++|+++  +..+++......
T Consensus        37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~  116 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG  116 (239)
T ss_pred             ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence            3344 566689999999899999997732                    12369999999998875  666666543222


Q ss_pred             C--eeEEEEeeccC-CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeec
Q 037224          400 A--NCYLIYEYIEN-GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANF  476 (552)
Q Consensus       400 ~--~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Df  476 (552)
                      .  ..++|||++++ .+|.+++...   .++..    .+.+++.+|.+||+.|   |+|+||||+|||++.++.++|+||
T Consensus       117 ~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDf  186 (239)
T PRK01723        117 LFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDF  186 (239)
T ss_pred             cceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEEC
Confidence            1  23599999997 6888887543   25543    3568999999999999   999999999999999999999999


Q ss_pred             cCCccC
Q 037224          477 GLAKSG  482 (552)
Q Consensus       477 g~a~~~  482 (552)
                      |.+...
T Consensus       187 g~~~~~  192 (239)
T PRK01723        187 DRGELR  192 (239)
T ss_pred             CCcccC
Confidence            988643

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.52  E-value=7.9e-14  Score=124.31  Aligned_cols=125  Identities=24%  Similarity=0.248  Sum_probs=104.5

Q ss_pred             CceEEEEEEEEeecCcEEEEEEeccC-----hHHHHHHHHHcCC--CCccceeeeeecCCCCeeEEEEeeccCCCchhhh
Q 037224          346 GCLIQGSVYKGNIHGEVYAIKMMKWN-----ACEELKILQKVNH--GNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL  418 (552)
Q Consensus       346 G~g~~G~Vy~~~~~g~~vAvK~~~~~-----~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l  418 (552)
                      |.|.++.||++..++..+++|..+..     ..+|+..+..++|  .++++++.+...  .+..++++||++++.+..+ 
T Consensus         7 ~~g~~~~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~--~~~~~~v~e~~~g~~~~~~-   83 (155)
T cd05120           7 KGGLTNRVYLLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGES--DGWSYLLMEWIEGETLDEV-   83 (155)
T ss_pred             ccccccceEEEEecCCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCC--CCccEEEEEecCCeecccC-
Confidence            56667999999998899999998654     4689999999976  588888877655  4567999999998777653 


Q ss_pred             hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCcc
Q 037224          419 HENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS  481 (552)
Q Consensus       419 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  481 (552)
                              +......++.+++++|++||.....+++|+|++|+||++++.+.++++|||.+..
T Consensus        84 --------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          84 --------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             --------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence                    4566778899999999999986444599999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.52  E-value=7.4e-15  Score=159.08  Aligned_cols=153  Identities=27%  Similarity=0.454  Sum_probs=110.8

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhhhhhcCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKN  423 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~  423 (552)
                      -+|++|.||..+.  ..+.+|+|+-+...     ++     +||..+.        +..+.|      |+-...+...+.
T Consensus        92 sngAygavylvrh~~trqrfa~kiNkq~l-----il-----Rnilt~a--------~npfvv------gDc~tllk~~g~  147 (1205)
T KOG0606|consen   92 SNGAYGAVYLVRHKETRQRFAMKINKQNL-----IL-----RNILTFA--------GNPFVV------GDCATLLKNIGP  147 (1205)
T ss_pred             ccCCCCceeeeeccccccchhhcccccch-----hh-----hcccccc--------CCccee------chhhhhcccCCC
Confidence            3455599999976  47788886544321     11     1233221        122333      344444443332


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC-----------------CCc
Q 037224          424 ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC-----------------NAI  486 (552)
Q Consensus       424 ~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~-----------------~~~  486 (552)
                        ++.        +++.+++|||+.+   |+|||+||+|.+|+.-|++|+.|||+++...                 ...
T Consensus       148 --lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~  214 (1205)
T KOG0606|consen  148 --LPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQ  214 (1205)
T ss_pred             --Ccc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhh
Confidence              222        2378899999999   9999999999999999999999999986211                 112


Q ss_pred             cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          487 TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       487 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      ....+||+.|.|||++....|+..+|+|++|+|+||.+-|..||.++.+
T Consensus       215 dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp  263 (1205)
T KOG0606|consen  215 DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP  263 (1205)
T ss_pred             hccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH
Confidence            3346899999999999999999999999999999999999999998853

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.51  E-value=2.6e-15  Score=152.39  Aligned_cols=119  Identities=29%  Similarity=0.537  Sum_probs=104.5

Q ss_pred             eeEEEEeeccCCCchhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCC
Q 037224          401 NCYLIYEYIENGSLHSWLHENK-NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLA  479 (552)
Q Consensus       401 ~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  479 (552)
                      .+|+.|++++..+|.+|+...+ ....++...+.++.|++.+++|   ++   .+|+|+||.||++..+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence            5789999999999999997544 3567888999999999999999   77   999999999999999999999999998


Q ss_pred             ccCCCC--------ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc
Q 037224          480 KSGCNA--------ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS  525 (552)
Q Consensus       480 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt  525 (552)
                      ......        ......||..||+||.+.+..|+.++||||||++|+||+.
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            643322        2334579999999999999999999999999999999998

>PRK13914 invasion associated secreted endopeptidase; Provisional

Probab=99.51  E-value=8.8e-14  Score=141.99  Aligned_cols=171  Identities=15%  Similarity=0.128  Sum_probs=97.3

Q ss_pred             EeeccCCCCCCHHHHHHHhCCChhhhcCcCCCCCCCCCccCCCcEEEeeecccccC----CC------CCceeeeeeEEE
Q 037224           51 FYRASAPDFLDLASIADLFSVSRLMISEPSNISSPSSPLIQNQPLFVPITCSCNTL----NA------SYTISFANLSYT  120 (552)
Q Consensus        51 ~y~v~~~~g~tl~~Ia~~~~~~~~~l~~~N~~~~~~~~~~~g~~l~iP~~~~~~~~----~~------~~~~~~~~~~y~  120 (552)
                      .|+|++  |||||.||++||+++++|+++|++.  ++.|.+||.|+||....-...    ..      .+........-.
T Consensus        29 tytVq~--GDTLw~IA~~ygvtv~~I~~~N~l~--~~~I~~Gq~L~Ip~~~~~~~~~~~Vta~~LNVRsgps~s~~IIgs  104 (481)
T PRK13914         29 TVVVEA--GDTLWGIAQSKGTTVDAIKKANNLT--TDKIVPGQKLQVNEVAAAEKTEKSVSATWLNVRSGAGVDNSIITS  104 (481)
T ss_pred             eEEECC--CCCHHHHHHHHCCCHHHHHHHhCCC--cccccCCCEEEeCCCCcccccceeEecceEEEecCCCCCcceeee
Confidence            699999  9999999999999999999999987  568999999999954311000    00      000011112233


Q ss_pred             EecCCchhhhHHh---h----cC----CcchHHHHHHhCCCCCCCCCCCCcEEEE--------eee----------ec-C
Q 037224          121 IKSGDTFYLVSTN---K----YQ----NLTTYQSVEVVNPTFVPTKLEVGDVIIF--------PVF----------CK-C  170 (552)
Q Consensus       121 v~~gdtl~~Ia~~---~----~~----~~~~~~~l~~~N~~~~~~~l~~gq~l~i--------p~~----------~~-~  170 (552)
                      +.+||.+.-+...   .    |.    |.+.-+-|...-.+   ..+..-|+++=        |..          .. .
T Consensus       105 l~~G~~V~Vl~~~~ngW~kI~~~~GktGwV~~~YLs~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (481)
T PRK13914        105 IKGGTKVTVETTESNGWHKITYNDGKTGFVNGKYLTDKVTS---TPVAPTQEVKKETTTQQAAPAAETKTEVKQTTQATT  181 (481)
T ss_pred             ecCCCEEEEeecccCCeEEEEcCCCCEEEEecccccCCCcc---CccccchhhhhccccccccchhcccchhccCCcccC
Confidence            4555554333200   0    10    00111111100000   00100011100        000          00 0


Q ss_pred             CCCc--cccCc---eeEEEEEecCCCCCHHHHHhHhCCChhhHhhhcCC---cccCCceeeccccC
Q 037224          171 PNQT--QLRNR---VNYLVSYVLQPSENLSSVASRFGIETQAIIDVNGN---NIRPFDTLFVPVAR  228 (552)
Q Consensus       171 ~~~~--~~~~~---~~~~~~y~v~~Gdtl~~ia~~~~~s~~~l~~~N~~---~~~~g~~l~ip~~~  228 (552)
                      +...  .....   ..-...|+|++|||||.||++|++++++|.+||++   .|++||.|.||...
T Consensus       182 ~~~~~~~~~~~~~~~~~a~tytVq~GDTL~sIAkrYgVtv~eI~~~N~l~s~~L~pGQ~L~Ip~sa  247 (481)
T PRK13914        182 PAPKVAETKETPVVDQNATTHAVKSGDTIWALSVKYGVSVQDIMSWNNLSSSSIYVGQKLAIKQTA  247 (481)
T ss_pred             CcccccccccCccccCCCeEEEECCCCCHHHHHHHHCCCHHHHHHhcCCCccccCCCCEEEecCCC
Confidence            0000  00000   00125899999999999999999999999999998   79999999999765

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.48  E-value=2.6e-13  Score=126.39  Aligned_cols=124  Identities=19%  Similarity=0.232  Sum_probs=90.0

Q ss_pred             CCceEEEEEEEEee-cCcEEEEEEeccCh-------------------------------HHHHHHHHHcCCCC--ccce
Q 037224          345 EGCLIQGSVYKGNI-HGEVYAIKMMKWNA-------------------------------CEELKILQKVNHGN--LVKL  390 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-~g~~vAvK~~~~~~-------------------------------~~E~~~l~~l~h~n--iv~l  390 (552)
                      .|.|.+|.||++.. +|+.||||+++...                               ..|...+.++.+..  +.+.
T Consensus         5 lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~   84 (187)
T cd05119           5 IGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVPKP   84 (187)
T ss_pred             cccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCCce
Confidence            47788899999988 59999999875421                               13444555554332  3334


Q ss_pred             eeeeecCCCCeeEEEEeeccCCCchhh-hhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEECCC
Q 037224          391 EGFCIDPEDANCYLIYEYIENGSLHSW-LHENKNENLNWKTRLRIAIDVANGLQYIHE-HTRPRVVHKDIKSSNILLDSN  468 (552)
Q Consensus       391 ~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~Dikp~NIll~~~  468 (552)
                      +++      ...+++|||++++++... +....   .. .++..++.+++.++.++|. .+   ++|+||||+||+++ +
T Consensus        85 ~~~------~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~  150 (187)
T cd05119          85 IDL------NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-D  150 (187)
T ss_pred             Eec------CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-C
Confidence            332      234899999998654321 21111   11 5678899999999999999 88   99999999999999 8


Q ss_pred             CcEEEeeccCCccC
Q 037224          469 MRAKIANFGLAKSG  482 (552)
Q Consensus       469 ~~~kL~Dfg~a~~~  482 (552)
                      +.++|+|||.+...
T Consensus       151 ~~~~liDfg~a~~~  164 (187)
T cd05119         151 GKVYIIDVPQAVEI  164 (187)
T ss_pred             CcEEEEECcccccc
Confidence            89999999998643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.32  E-value=1.9e-11  Score=128.35  Aligned_cols=131  Identities=17%  Similarity=0.194  Sum_probs=91.1

Q ss_pred             CCceEEEEEEEEee-cCcEEEEEEeccChH-----------------------------------------------HHH
Q 037224          345 EGCLIQGSVYKGNI-HGEVYAIKMMKWNAC-----------------------------------------------EEL  376 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-~g~~vAvK~~~~~~~-----------------------------------------------~E~  376 (552)
                      .|+|..|.||+|++ +|+.||||+.+....                                               +|+
T Consensus       125 lasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~Ea  204 (437)
T TIGR01982       125 LAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRREA  204 (437)
T ss_pred             eeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHHHH
Confidence            47888899999998 899999999854311                                               233


Q ss_pred             HHHHHc----CCCCccceeeeeecCCCCeeEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHH-HHHHHHhCCCC
Q 037224          377 KILQKV----NHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN-GLQYIHEHTRP  451 (552)
Q Consensus       377 ~~l~~l----~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~-aL~~LH~~~~~  451 (552)
                      ..+.++    +|.+-+.+-.++.+. ....++||||++|++|.++...... ..   ....++.+++. .+..+|..|  
T Consensus       205 ~n~~~~~~~~~~~~~v~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~~~g--  277 (437)
T TIGR01982       205 ANASELGENFKNDPGVYVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVLRDG--  277 (437)
T ss_pred             HHHHHHHHhcCCCCCEEeCCEehhh-cCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHHhCC--
Confidence            333333    222223332233221 2345899999999999987653221 12   23456666666 467899998  


Q ss_pred             ceEecCCCCCcEEECCCCcEEEeeccCCccCC
Q 037224          452 RVVHKDIKSSNILLDSNMRAKIANFGLAKSGC  483 (552)
Q Consensus       452 ~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  483 (552)
                       ++|+|+||.||+++++++++++|||++....
T Consensus       278 -~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       278 -FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             -ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence             9999999999999999999999999986543

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.25  E-value=4.8e-11  Score=109.09  Aligned_cols=121  Identities=19%  Similarity=0.196  Sum_probs=90.7

Q ss_pred             CceEEEEEEEEeecCcEEEEEEeccC------hHHHHHHHHHcCCCCcc-ceeeeeecCCCCeeEEEEeeccCCCchhhh
Q 037224          346 GCLIQGSVYKGNIHGEVYAIKMMKWN------ACEELKILQKVNHGNLV-KLEGFCIDPEDANCYLIYEYIENGSLHSWL  418 (552)
Q Consensus       346 G~g~~G~Vy~~~~~g~~vAvK~~~~~------~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l  418 (552)
                      +.|..+.||+.+..++.+++|.....      ..+|+.+++.+.+.+++ +++.+..    ...++||||+++.++.+. 
T Consensus         7 ~~G~~~~vy~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~----~~~~lv~e~i~G~~l~~~-   81 (170)
T cd05151           7 KGGMTNKNYRVEVANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP----ETGVLITEFIEGSELLTE-   81 (170)
T ss_pred             CCcccCceEEEEECCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC----CCCeEEEEecCCCccccc-
Confidence            44556899999999999999997543      35799999998655544 4544332    234799999999887653 


Q ss_pred             hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEecCCCCCcEEECCCCcEEEeeccCCcc
Q 037224          419 HENKNENLNWKTRLRIAIDVANGLQYIHEHT--RPRVVHKDIKSSNILLDSNMRAKIANFGLAKS  481 (552)
Q Consensus       419 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  481 (552)
                         .   .   ....+..+++++|+.||+.+  ...++|+|++|.||+++ ++.++++||+.+..
T Consensus        82 ---~---~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          82 ---D---F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ---c---c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence               0   1   11245679999999999887  22359999999999998 66899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.18  E-value=1.7e-10  Score=120.99  Aligned_cols=155  Identities=16%  Similarity=0.285  Sum_probs=117.7

Q ss_pred             cCcEEEEEEeccCh-------HHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhhhhhcCCCCCCHHHH
Q 037224          359 HGEVYAIKMMKWNA-------CEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTR  431 (552)
Q Consensus       359 ~g~~vAvK~~~~~~-------~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~  431 (552)
                      ++.+|.|...+...       .+-++.|+.++||||+++++.+..  ++..|+|+|-+  ..|..++.+     +.....
T Consensus        36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~--~~~~ylvTErV--~Pl~~~lk~-----l~~~~v  106 (690)
T KOG1243|consen   36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEE--EGTLYLVTERV--RPLETVLKE-----LGKEEV  106 (690)
T ss_pred             cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcc--cCceEEEeecc--ccHHHHHHH-----hHHHHH
Confidence            67777777765432       256778999999999999998876  66889999988  478777765     445667


Q ss_pred             HHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcc--ccccccccccCccccCCCCCCC
Q 037224          432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT--MHIVGTQGYIAPEYLADGVVST  509 (552)
Q Consensus       432 ~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~  509 (552)
                      ..-+.||+.||.|||+.+  .++|++|..+.|+++..|+.||++|.++........  .....-..|..|+.+....  -
T Consensus       107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~  182 (690)
T KOG1243|consen  107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--W  182 (690)
T ss_pred             HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--c
Confidence            778899999999999765  499999999999999999999999998754322211  1112223466666543222  3


Q ss_pred             hhhHHHHHHHHHHHHcC
Q 037224          510 KMDVFSFGVVLLELISG  526 (552)
Q Consensus       510 ~~Dv~slG~il~elltG  526 (552)
                      ..|.|.||++++|++.|
T Consensus       183 s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  183 SIDSWGLGCLIEELFNG  199 (690)
T ss_pred             chhhhhHHHHHHHHhCc
Confidence            56999999999999999

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.18  E-value=3.1e-10  Score=100.97  Aligned_cols=131  Identities=20%  Similarity=0.303  Sum_probs=99.7

Q ss_pred             ceEEEEEEEEeecCcEEEEEEe-cc--------------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          347 CLIQGSVYKGNIHGEVYAIKMM-KW--------------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       347 ~g~~G~Vy~~~~~g~~vAvK~~-~~--------------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|+.++|+++.+.|+...||.- .+              ...+|++.|.++.--.|.-..-++.+...+  .++|||+++
T Consensus        17 QGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~--~i~ME~~~g   94 (229)
T KOG3087|consen   17 QGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGG--QIYMEFIDG   94 (229)
T ss_pred             ccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCC--eEEEEeccc
Confidence            4555899999999999888863 11              223699999998766665554466664444  789999987


Q ss_pred             -CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCC---cEEEeeccCCccC
Q 037224          412 -GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM---RAKIANFGLAKSG  482 (552)
Q Consensus       412 -gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~---~~kL~Dfg~a~~~  482 (552)
                       .++.+++..........+....++.++-+.+.-||..+   ++|+||..+||++.+++   .+.++|||++...
T Consensus        95 ~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   95 ASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             hhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhcc
Confidence             47888887665544444444788999999999999999   99999999999996654   3589999998644

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.16  E-value=4.7e-10  Score=103.87  Aligned_cols=124  Identities=17%  Similarity=0.178  Sum_probs=89.8

Q ss_pred             CceEEEEEEEEeec--------CcEEEEEEeccC---------------------------------hHHHHHHHHHcCC
Q 037224          346 GCLIQGSVYKGNIH--------GEVYAIKMMKWN---------------------------------ACEELKILQKVNH  384 (552)
Q Consensus       346 G~g~~G~Vy~~~~~--------g~~vAvK~~~~~---------------------------------~~~E~~~l~~l~h  384 (552)
                      |.|-.+.||.|...        +..+|||+.+..                                 ..+|...|+++..
T Consensus         6 ~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~rl~~   85 (197)
T cd05146           6 STGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKRMQK   85 (197)
T ss_pred             ccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHHHHH
Confidence            45555889999763        368999987310                                 1168999999854


Q ss_pred             --CCccceeeeeecCCCCeeEEEEeeccCCCchh-hhhhcCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceEecCCCC
Q 037224          385 --GNLVKLEGFCIDPEDANCYLIYEYIENGSLHS-WLHENKNENLNWKTRLRIAIDVANGLQYI-HEHTRPRVVHKDIKS  460 (552)
Q Consensus       385 --~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~qi~~aL~~L-H~~~~~~ivH~Dikp  460 (552)
                        -+++.++++  .    .-++||||+.+..+.. .+...   .++.++...+..+++.+|..| |..+   ++||||++
T Consensus        86 ~Gv~vP~pi~~--~----~~~lvME~Ig~~~~~~~~Lkd~---~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~  153 (197)
T cd05146          86 AGIPCPEVVVL--K----KHVLVMSFIGDDQVPAPKLKDA---KLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLSE  153 (197)
T ss_pred             cCCCCCeEEEe--c----CCEEEEEEcCCCCccchhhhcc---ccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCCH
Confidence              456666653  2    2289999998754422 22221   255567778889999999998 8888   99999999


Q ss_pred             CcEEECCCCcEEEeeccCCccC
Q 037224          461 SNILLDSNMRAKIANFGLAKSG  482 (552)
Q Consensus       461 ~NIll~~~~~~kL~Dfg~a~~~  482 (552)
                      .||+++ ++.++|+|||.+...
T Consensus       154 ~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         154 YNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             HHEEEE-CCcEEEEECCCceeC
Confidence            999996 467999999988643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.15  E-value=6.6e-12  Score=136.00  Aligned_cols=184  Identities=29%  Similarity=0.340  Sum_probs=140.7

Q ss_pred             CceEEEEEEEEee---cCcEEEEEEeccC---------hHHHHHHHHHcC-CCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          346 GCLIQGSVYKGNI---HGEVYAIKMMKWN---------ACEELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       346 G~g~~G~Vy~~~~---~g~~vAvK~~~~~---------~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      |.|.++.|-....   ....+|+|.....         ...|..+-..+. |+|++.+++...+  ....++.++|.+++
T Consensus        29 g~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~--~~~~~~~~~~s~g~  106 (601)
T KOG0590|consen   29 GKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS--PRSYLLSLSYSDGG  106 (601)
T ss_pred             cccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC--CcccccccCccccc
Confidence            4555555554443   2234555544221         113666777776 9999999988766  56779999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCceEecCCCCCcEEECCCC-cEEEeeccCCccCCC-----C
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIH-EHTRPRVVHKDIKSSNILLDSNM-RAKIANFGLAKSGCN-----A  485 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~~~~-----~  485 (552)
                      ++.+.+........+......++.|+..++.|+| ..+   +.|+|+||+|.+++..+ ..++.|||++.....     .
T Consensus       107 ~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~  183 (601)
T KOG0590|consen  107 SLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAER  183 (601)
T ss_pred             ccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccccccCCcce
Confidence            9988873222224677788889999999999999 888   99999999999999999 999999999974332     1


Q ss_pred             ccccccc-cccccCccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          486 ITMHIVG-TQGYIAPEYLADG-VVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       486 ~~~~~~g-t~~y~aPE~~~~~-~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .....+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++...
T Consensus       184 ~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~  234 (601)
T KOG0590|consen  184 SLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPS  234 (601)
T ss_pred             eeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccc
Confidence            2233577 9999999998774 55778999999999999999999998654

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.08  E-value=1.3e-10  Score=111.52  Aligned_cols=153  Identities=24%  Similarity=0.375  Sum_probs=118.2

Q ss_pred             HHHHHHcCCCCccceeeeeecCCC---CeeEEEEeeccCCCchhhhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 037224          376 LKILQKVNHGNLVKLEGFCIDPED---ANCYLIYEYIENGSLHSWLHENKN--ENLNWKTRLRIAIDVANGLQYIHEHTR  450 (552)
Q Consensus       376 ~~~l~~l~h~niv~l~~~~~~~~~---~~~~lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~  450 (552)
                      .+-|-++.|.||++++.|+.+...   ....++.|||..|+|.++|++.+.  ..+......+|+-||+.||.|||+.. 
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence            344566789999999998876332   356799999999999999986543  45788889999999999999999985 


Q ss_pred             CceEecCCCCCcEEECCCCcEEEeeccCCccC------CCCccccccccccccCccccCCCCCCChhhHHHHHHHHHHHH
Q 037224          451 PRVVHKDIKSSNILLDSNMRAKIANFGLAKSG------CNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELI  524 (552)
Q Consensus       451 ~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~------~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ell  524 (552)
                      |+|+|+++..+.|++..+|-+|+.--.-....      .........+-++|.+||.-.....+..+|||+||+..+||.
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            67999999999999999998887532211100      011111234567999999877777788999999999999998


Q ss_pred             cCCCC
Q 037224          525 SGKEA  529 (552)
Q Consensus       525 tG~~p  529 (552)
                      -+..-
T Consensus       277 ilEiq  281 (458)
T KOG1266|consen  277 ILEIQ  281 (458)
T ss_pred             Hheec
Confidence            77644

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.07  E-value=1.4e-09  Score=97.40  Aligned_cols=123  Identities=24%  Similarity=0.292  Sum_probs=93.8

Q ss_pred             CceEEEEEEEEeecCcEEEEEEec-c--------------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          346 GCLIQGSVYKGNIHGEVYAIKMMK-W--------------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       346 G~g~~G~Vy~~~~~g~~vAvK~~~-~--------------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      ..|+-..+|.+.+.|..+.+|.-. +              ...+|+.++.+++--.+...+=+..+  .....++|||++
T Consensus         5 ~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD--~~~~~I~me~I~   82 (204)
T COG3642           5 KQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD--PDNGLIVMEYIE   82 (204)
T ss_pred             hCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc--CCCCEEEEEEeC
Confidence            345567889988877777777541 1              12369999999976655555445555  334479999999


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC  483 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  483 (552)
                      |..|.+.+...         ...++..+-.-+.-||..|   |+|+||.++||++..++ +.++|||++....
T Consensus        83 G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s~  142 (204)
T COG3642          83 GELLKDALEEA---------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFSD  142 (204)
T ss_pred             ChhHHHHHHhc---------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccccc
Confidence            99998888765         2457778888889999999   99999999999997765 9999999997543

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.07  E-value=7e-10  Score=118.03  Aligned_cols=127  Identities=13%  Similarity=0.128  Sum_probs=81.2

Q ss_pred             CCceEEEEEEEEee-c-CcEEEEEEeccCh-----------------------------------------------HHH
Q 037224          345 EGCLIQGSVYKGNI-H-GEVYAIKMMKWNA-----------------------------------------------CEE  375 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-~-g~~vAvK~~~~~~-----------------------------------------------~~E  375 (552)
                      .|+|..|.||+|++ + |+.||||+.+...                                               .+|
T Consensus       127 lasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~~E  206 (537)
T PRK04750        127 LASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLMRE  206 (537)
T ss_pred             hcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHHHH
Confidence            37777799999998 4 8999999986431                                               123


Q ss_pred             HHHHHHc----CCCCccceeeeeecCCCCeeEEEEeeccCCCchhhh--hhcCC--CCCCHHHHHHHHHHHHHHHHHHHh
Q 037224          376 LKILQKV----NHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL--HENKN--ENLNWKTRLRIAIDVANGLQYIHE  447 (552)
Q Consensus       376 ~~~l~~l----~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l--~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~  447 (552)
                      +..+.++    .+.+.+.+-.++.+- ....++||||++|+++.++-  .....  ..+....+..++.|+       +.
T Consensus       207 a~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f~  278 (537)
T PRK04750        207 AANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------FR  278 (537)
T ss_pred             HHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------Hh
Confidence            3333333    133333332333221 23447999999999998742  22110  012333333333443       45


Q ss_pred             CCCCceEecCCCCCcEEECCCC----cEEEeeccCCccC
Q 037224          448 HTRPRVVHKDIKSSNILLDSNM----RAKIANFGLAKSG  482 (552)
Q Consensus       448 ~~~~~ivH~Dikp~NIll~~~~----~~kL~Dfg~a~~~  482 (552)
                      .|   ++|+|+||.||+++.++    +++++|||+....
T Consensus       279 ~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l  314 (537)
T PRK04750        279 DG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL  314 (537)
T ss_pred             CC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence            77   99999999999999888    9999999998644

>PF01476 LysM: LysM domain; InterPro: IPR018392 This domain is about 40 residues long and is found in a variety of enzymes involved in bacterial cell wall degradation []

Probab=99.02  E-value=2.5e-10  Score=79.03  Aligned_cols=40  Identities=35%  Similarity=0.751  Sum_probs=34.2

Q ss_pred             EecCCCCCHHHHHhHhCCChhhHhhhc-CC---cccCCceeecc
Q 037224          186 YVLQPSENLSSVASRFGIETQAIIDVN-GN---NIRPFDTLFVP  225 (552)
Q Consensus       186 y~v~~Gdtl~~ia~~~~~s~~~l~~~N-~~---~~~~g~~l~ip  225 (552)
                      |+|++|||+++||++||++.++|+++| ++   .|.+||.|.||
T Consensus         1 y~V~~gDtl~~IA~~~~~~~~~l~~~N~~~~~~~l~~G~~l~iP   44 (44)
T PF01476_consen    1 YTVQPGDTLWSIAKRYGISVDELMELNPNIDSDNLQPGQKLCIP   44 (44)
T ss_dssp             EEE-TT--HHHHHHHTTS-HHHHHHHCCTTHGGCGGTTEEEEEC
T ss_pred             CEECcCCcHHHHHhhhhhhHhHHHHhcCCCCcccCCCCCEEEeC
Confidence            899999999999999999999999999 55   89999999987

This domain may have a general peptidoglycan binding function.; GO: 0016998 cell wall macromolecule catabolic process; PDB: 2DJP_A 3ZQD_A 1Y7M_B 4A52_A 2L9Y_A 1E0G_A.

>PF01476 LysM: LysM domain; InterPro: IPR018392 This domain is about 40 residues long and is found in a variety of enzymes involved in bacterial cell wall degradation []

Probab=99.01  E-value=2e-10  Score=79.59  Aligned_cols=43  Identities=23%  Similarity=0.511  Sum_probs=35.3

Q ss_pred             EEEecCCchhhhHHhhcCCcchHHHHHHhC-CCCCCCCCCCCcEEEEe
Q 037224          119 YTIKSGDTFYLVSTNKYQNLTTYQSVEVVN-PTFVPTKLEVGDVIIFP  165 (552)
Q Consensus       119 y~v~~gdtl~~Ia~~~~~~~~~~~~l~~~N-~~~~~~~l~~gq~l~ip  165 (552)
                      |+|++|||+++|| ++|+  ++.++|+++| .+.. +.|.+||+|.||
T Consensus         1 y~V~~gDtl~~IA-~~~~--~~~~~l~~~N~~~~~-~~l~~G~~l~iP   44 (44)
T PF01476_consen    1 YTVQPGDTLWSIA-KRYG--ISVDELMELNPNIDS-DNLQPGQKLCIP   44 (44)
T ss_dssp             EEE-TT--HHHHH-HHTT--S-HHHHHHHCCTTHG-GCGGTTEEEEEC
T ss_pred             CEECcCCcHHHHH-hhhh--hhHhHHHHhcCCCCc-ccCCCCCEEEeC
Confidence            8999999999999 7888  9999999999 6655 569999999998

This domain may have a general peptidoglycan binding function.; GO: 0016998 cell wall macromolecule catabolic process; PDB: 2DJP_A 3ZQD_A 1Y7M_B 4A52_A 2L9Y_A 1E0G_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.00  E-value=3.7e-09  Score=103.39  Aligned_cols=128  Identities=14%  Similarity=0.193  Sum_probs=97.1

Q ss_pred             EEEEEEeecCcEEEEEEecc------------------ChHHHHHHHHHcCCCCcc--ceeeeeecCC---CCeeEEEEe
Q 037224          351 GSVYKGNIHGEVYAIKMMKW------------------NACEELKILQKVNHGNLV--KLEGFCIDPE---DANCYLIYE  407 (552)
Q Consensus       351 G~Vy~~~~~g~~vAvK~~~~------------------~~~~E~~~l~~l~h~niv--~l~~~~~~~~---~~~~~lv~e  407 (552)
                      ..|++..++|+.+.||....                  .+.+|...+.++...+|.  .++++.....   ....++|+|
T Consensus        36 rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte  115 (268)
T PRK15123         36 RRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE  115 (268)
T ss_pred             ceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence            45778888999999996521                  145898999888555443  3455543321   224689999


Q ss_pred             eccCC-CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECC-------CCcEEEeeccCC
Q 037224          408 YIENG-SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS-------NMRAKIANFGLA  479 (552)
Q Consensus       408 ~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~-------~~~~kL~Dfg~a  479 (552)
                      ++++. +|.+++........+......++.+++..+.-||..|   |+|+|++++|||++.       +..+.|+||+.+
T Consensus       116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~  192 (268)
T PRK15123        116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA  192 (268)
T ss_pred             eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence            99985 7888875432334566778899999999999999999   999999999999975       468999999988


Q ss_pred             cc
Q 037224          480 KS  481 (552)
Q Consensus       480 ~~  481 (552)
                      ..
T Consensus       193 ~~  194 (268)
T PRK15123        193 QI  194 (268)
T ss_pred             cc
Confidence            53

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.99  E-value=3.6e-09  Score=97.62  Aligned_cols=117  Identities=23%  Similarity=0.359  Sum_probs=79.5

Q ss_pred             EEEEEee-cCcEEEEEEeccC---------------------------------hHHHHHHHHHcCCC--Cccceeeeee
Q 037224          352 SVYKGNI-HGEVYAIKMMKWN---------------------------------ACEELKILQKVNHG--NLVKLEGFCI  395 (552)
Q Consensus       352 ~Vy~~~~-~g~~vAvK~~~~~---------------------------------~~~E~~~l~~l~h~--niv~l~~~~~  395 (552)
                      .||.|.. +|..+|||+.+..                                 ..+|.+.|.++..-  ++++++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            3899987 7889999987321                                 12699999999766  566666543 


Q ss_pred             cCCCCeeEEEEeecc--CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCceEecCCCCCcEEECCCCcEE
Q 037224          396 DPEDANCYLIYEYIE--NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQY-IHEHTRPRVVHKDIKSSNILLDSNMRAK  472 (552)
Q Consensus       396 ~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~-LH~~~~~~ivH~Dikp~NIll~~~~~~k  472 (552)
                         ..  .+||||++  |..+..+ ....   ++..+...++.+++..+.. +|..|   ++|||+.+.||+++++ .+.
T Consensus        80 ---~~--~ivME~I~~~G~~~~~l-~~~~---~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~  146 (188)
T PF01163_consen   80 ---RN--VIVMEYIGEDGVPLPRL-KDVD---LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVY  146 (188)
T ss_dssp             ---TT--EEEEE--EETTEEGGCH-HHCG---GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEE
T ss_pred             ---CC--EEEEEecCCCccchhhH-Hhcc---ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEE
Confidence               22  79999999  6555443 3322   2244566778888886655 57888   9999999999999887 899


Q ss_pred             EeeccCCccC
Q 037224          473 IANFGLAKSG  482 (552)
Q Consensus       473 L~Dfg~a~~~  482 (552)
                      |+|||.+...
T Consensus       147 iIDf~qav~~  156 (188)
T PF01163_consen  147 IIDFGQAVDS  156 (188)
T ss_dssp             E--GTTEEET
T ss_pred             EEecCcceec
Confidence            9999988644

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG1388 LytE FOG: LysM repeat [Cell envelope biogenesis, outer membrane]

Probab=98.98  E-value=6.5e-10  Score=96.03  Aligned_cols=98  Identities=26%  Similarity=0.365  Sum_probs=75.7

Q ss_pred             HHHHhCCChhhhcCcCCCCCCCCCccCCCcEEEeeeccccc--CCCCCceee------------eeeEEEEecCCchhhh
Q 037224           65 IADLFSVSRLMISEPSNISSPSSPLIQNQPLFVPITCSCNT--LNASYTISF------------ANLSYTIKSGDTFYLV  130 (552)
Q Consensus        65 Ia~~~~~~~~~l~~~N~~~~~~~~~~~g~~l~iP~~~~~~~--~~~~~~~~~------------~~~~y~v~~gdtl~~I  130 (552)
                      ||..|++++.+|+++|.+....+.+.+||.|.+|..-.-..  .........            ...+|+|++||||+.|
T Consensus         1 ia~~~~~~v~~l~~~n~~~~~s~~i~~gq~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~V~~gdtL~~I   80 (124)
T COG1388           1 IASKYGVSVKALKKANALTGKSDAIKPGQVLKIPGDISSTVNAGQTLSSLSNKVSDSSSASKAPPVVTYTVKKGDTLSKI   80 (124)
T ss_pred             CcccccccHHHHHHHhcccCCCCccccCceEEccCCcccccccccccccccceeeccccccccCCCceEEEecCCCHHHH
Confidence            67899999999999998774467889999999996311110  000000000            0247999999999999


Q ss_pred             HHhhcCCcchHHHHHHhCCCCCCCCCCCCcEEEEee
Q 037224          131 STNKYQNLTTYQSVEVVNPTFVPTKLEVGDVIIFPV  166 (552)
Q Consensus       131 a~~~~~~~~~~~~l~~~N~~~~~~~l~~gq~l~ip~  166 (552)
                      | +.|+  +++.+|+++|.+.+ +.+.+||.|.+|.
T Consensus        81 a-~~~~--~tv~~l~~~n~l~~-~~i~~gq~l~~~~  112 (124)
T COG1388          81 A-RKYG--VTVAELKQLNNLSS-DKIKVGQKLKLPV  112 (124)
T ss_pred             H-HHhC--CCHHHHHHHhccCC-CceecCcEEEEec
Confidence            9 7888  99999999999999 5999999999996

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.96  E-value=7.3e-09  Score=98.86  Aligned_cols=134  Identities=20%  Similarity=0.299  Sum_probs=100.8

Q ss_pred             CceEEEEEEEEeecC-cEEEEEEecc--------ChHHHHHHHHHcCCC--CccceeeeeecCC-CCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNIHG-EVYAIKMMKW--------NACEELKILQKVNHG--NLVKLEGFCIDPE-DANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~~g-~~vAvK~~~~--------~~~~E~~~l~~l~h~--niv~l~~~~~~~~-~~~~~lv~e~~~~gs  413 (552)
                      +.|..+.+|+....+ +.+++|....        ...+|..+++.+.+.  .+.+++.+..... .+..+++|||+++.+
T Consensus         7 ~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~   86 (223)
T cd05154           7 SGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRV   86 (223)
T ss_pred             CCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEe
Confidence            455568999998854 8999998753        235799999999764  4566776654321 125689999999988


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHT--------------------------------------------  449 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--------------------------------------------  449 (552)
                      +.+.+..   ..+++.+...++.++++.|..||+..                                            
T Consensus        87 l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (223)
T cd05154          87 LRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRW  163 (223)
T ss_pred             cCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHH
Confidence            8876532   23777888888889999999988421                                            


Q ss_pred             ---------CCceEecCCCCCcEEECC--CCcEEEeeccCCccC
Q 037224          450 ---------RPRVVHKDIKSSNILLDS--NMRAKIANFGLAKSG  482 (552)
Q Consensus       450 ---------~~~ivH~Dikp~NIll~~--~~~~kL~Dfg~a~~~  482 (552)
                               ...++|+|+++.||+++.  ++.+.|+||+.+...
T Consensus       164 ~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g  207 (223)
T cd05154         164 LEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG  207 (223)
T ss_pred             HHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence                     245799999999999998  566899999987543

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG1388 LytE FOG: LysM repeat [Cell envelope biogenesis, outer membrane]

Probab=98.91  E-value=2.9e-09  Score=91.95  Aligned_cols=94  Identities=18%  Similarity=0.310  Sum_probs=72.5

Q ss_pred             hHHhhcCCcchHHHHHHhCCCCC-CCCCCCCcEEEEeeeecCCC--Cc-cccCceeE-----------EEEEecCCCCCH
Q 037224          130 VSTNKYQNLTTYQSVEVVNPTFV-PTKLEVGDVIIFPVFCKCPN--QT-QLRNRVNY-----------LVSYVLQPSENL  194 (552)
Q Consensus       130 Ia~~~~~~~~~~~~l~~~N~~~~-~~~l~~gq~l~ip~~~~~~~--~~-~~~~~~~~-----------~~~y~v~~Gdtl  194 (552)
                      || .+|+  +++++|+++|.+.. .+.+.+||+|.+|....-..  .. ........           ..+|+|+.||+|
T Consensus         1 ia-~~~~--~~v~~l~~~n~~~~~s~~i~~gq~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~V~~gdtL   77 (124)
T COG1388           1 IA-SKYG--VSVKALKKANALTGKSDAIKPGQVLKIPGDISSTVNAGQTLSSLSNKVSDSSSASKAPPVVTYTVKKGDTL   77 (124)
T ss_pred             Cc-cccc--ccHHHHHHHhcccCCCCccccCceEEccCCcccccccccccccccceeeccccccccCCCceEEEecCCCH
Confidence            45 5677  89999999999883 48999999999996311111  01 11111111           248999999999


Q ss_pred             HHHHhHhCCChhhHhhhcCC---cccCCceeeccc
Q 037224          195 SSVASRFGIETQAIIDVNGN---NIRPFDTLFVPV  226 (552)
Q Consensus       195 ~~ia~~~~~s~~~l~~~N~~---~~~~g~~l~ip~  226 (552)
                      +.||++|++++.+|+++|++   .+++||.|.++.
T Consensus        78 ~~Ia~~~~~tv~~l~~~n~l~~~~i~~gq~l~~~~  112 (124)
T COG1388          78 SKIARKYGVTVAELKQLNNLSSDKIKVGQKLKLPV  112 (124)
T ss_pred             HHHHHHhCCCHHHHHHHhccCCCceecCcEEEEec
Confidence            99999999999999999998   899999998886

>PRK14125 cell division suppressor protein YneA; Provisional

Probab=98.87  E-value=3.6e-09  Score=86.66  Aligned_cols=52  Identities=17%  Similarity=0.206  Sum_probs=44.2

Q ss_pred             cceeEeeccCCCCCCHHHHHHHhCCC--------hhhhcCcCCCCCCCCCccCCCcEEEeeecc
Q 037224           47 RTYAFYRASAPDFLDLASIADLFSVS--------RLMISEPSNISSPSSPLIQNQPLFVPITCS  102 (552)
Q Consensus        47 ~~~~~y~v~~~~g~tl~~Ia~~~~~~--------~~~l~~~N~~~~~~~~~~~g~~l~iP~~~~  102 (552)
                      ..+..|+|++  |||||+||++|+.+        +..|++.|++.+  +.|.+||.|.||...+
T Consensus        34 ~~~~~~tV~~--GDTLW~IA~~y~~~~~l~~~~~v~~I~~~N~l~~--~~I~~Gq~L~IP~~~~   93 (103)
T PRK14125         34 NQYVEITVQE--GDTLWALADQYAGKHHMAKNEFIEWVEDVNNLPS--GHIKAGDKLVIPVLKS   93 (103)
T ss_pred             CCcEEEEECC--CCCHHHHHHHhCCCcCCCHHHHHHHHHHhcCCCC--CcCCCCCEEEEecCCC
Confidence            4578999999  99999999999875        467888999984  4799999999997543

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.85  E-value=1.8e-09  Score=112.21  Aligned_cols=180  Identities=27%  Similarity=0.336  Sum_probs=140.0

Q ss_pred             Cc--eEEEEEEEEee----cCcEEEEEEecc---------ChHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeec
Q 037224          346 GC--LIQGSVYKGNI----HGEVYAIKMMKW---------NACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYI  409 (552)
Q Consensus       346 G~--g~~G~Vy~~~~----~g~~vAvK~~~~---------~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~  409 (552)
                      |.  |.+|.||.+..    ++..+|+|.-+.         ...+|.....++ .|++.++....+.+  .+..++-+|++
T Consensus       123 g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~--~~~lfiqtE~~  200 (524)
T KOG0601|consen  123 GSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG--SGILFIQTELC  200 (524)
T ss_pred             ccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc--CCcceeeeccc
Confidence            55  77799999876    677899998532         234677777777 58899997776665  66778888988


Q ss_pred             cCCCchhhhhhcCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCceEecCCCCCcEEECCC-CcEEEeeccCCccCCC
Q 037224          410 ENGSLHSWLHENKNENLNWKTRLRIAIDVAN----GLQYIHEHTRPRVVHKDIKSSNILLDSN-MRAKIANFGLAKSGCN  484 (552)
Q Consensus       410 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~----aL~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kL~Dfg~a~~~~~  484 (552)
                      . .+|.++.+.... .++....+....+...    ||.++|+.+   ++|-|+||.||++..+ ..++++|||+.....+
T Consensus       201 ~-~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~  275 (524)
T KOG0601|consen  201 G-ESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGLVSKISD  275 (524)
T ss_pred             c-chhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcceeEEccC
Confidence            6 588777665432 3677777888888888    999999998   9999999999999999 8899999998864433


Q ss_pred             Cc-------cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          485 AI-------TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       485 ~~-------~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      ..       .....+...|++||.. ++.++...|+|++|.++.+..++..++...
T Consensus       276 ~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g  330 (524)
T KOG0601|consen  276 GNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVG  330 (524)
T ss_pred             CccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCC
Confidence            22       1122567789999976 566788999999999999999988777654

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.75  E-value=5.6e-09  Score=114.30  Aligned_cols=132  Identities=24%  Similarity=0.381  Sum_probs=108.8

Q ss_pred             CCeeEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccC
Q 037224          399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGL  478 (552)
Q Consensus       399 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~  478 (552)
                      ....+|+++|..+++|...++...  ..+.+-.......+..++++||...   +.|+|++|.|++...++..++.||+.
T Consensus       876 rsP~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t  950 (1205)
T KOG0606|consen  876 RSPLPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGT  950 (1205)
T ss_pred             CCCcchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccc
Confidence            456789999999999999887765  3566666677778889999999987   89999999999999999999999983


Q ss_pred             CccCC-------------------------------C--CccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc
Q 037224          479 AKSGC-------------------------------N--AITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS  525 (552)
Q Consensus       479 a~~~~-------------------------------~--~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt  525 (552)
                      .....                               .  .......+|+.|.+||.+.+......+|+|++|++++|.++
T Consensus       951 ~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~ 1030 (1205)
T KOG0606|consen  951 LSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLT 1030 (1205)
T ss_pred             ccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhc
Confidence            21000                               0  01122468999999999999999999999999999999999


Q ss_pred             CCCCCCccCc
Q 037224          526 GKEAIDEEGK  535 (552)
Q Consensus       526 G~~pf~~~~~  535 (552)
                      |..||+....
T Consensus      1031 g~pp~na~tp 1040 (1205)
T KOG0606|consen 1031 GIPPFNAETP 1040 (1205)
T ss_pred             CCCCCCCcch
Confidence            9999997664

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.75  E-value=2.5e-09  Score=111.20  Aligned_cols=179  Identities=25%  Similarity=0.256  Sum_probs=130.2

Q ss_pred             CceEEEEEEEEee---cCcEEEEEEeccCh---------HHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          346 GCLIQGSVYKGNI---HGEVYAIKMMKWNA---------CEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       346 G~g~~G~Vy~~~~---~g~~vAvK~~~~~~---------~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      |.+.++.|++...   ++..|++|.+.+..         ..|+.+...+ .|.+++.+...+..  ....|+-.||++++
T Consensus       274 ~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~--~r~~~ip~e~~~~~  351 (524)
T KOG0601|consen  274 SDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ--LRQGYIPLEFCEGG  351 (524)
T ss_pred             cCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc--cccccCchhhhcCc
Confidence            5555577777554   56788988875432         2566666666 58888887666654  44557889999998


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCC-CcEEEeeccCCccCCCCcccccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN-MRAKIANFGLAKSGCNAITMHIV  491 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kL~Dfg~a~~~~~~~~~~~~  491 (552)
                      ++.....  ....+++..++++..|++.++.++|+..   ++|+|++|+||++..+ +..++.|||+.....-.......
T Consensus       352 s~~l~~~--~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~~~~~  426 (524)
T KOG0601|consen  352 SSSLRSV--TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSGVFHH  426 (524)
T ss_pred             chhhhhH--HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccccceecccccc
Confidence            8876552  2234788889999999999999999998   9999999999999876 78899999988632111111122


Q ss_pred             ccccc-cCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCC
Q 037224          492 GTQGY-IAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID  531 (552)
Q Consensus       492 gt~~y-~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~  531 (552)
                      .+..| .+++......+..+.|+||||.-+.|..++...-.
T Consensus       427 ~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~  467 (524)
T KOG0601|consen  427 IDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE  467 (524)
T ss_pred             cccccccchhhccccccccccccccccccccccccCcccCc
Confidence            23334 35666677788899999999999999998875433

>PRK14125 cell division suppressor protein YneA; Provisional

Probab=98.73  E-value=1.6e-08  Score=82.88  Aligned_cols=50  Identities=26%  Similarity=0.470  Sum_probs=40.3

Q ss_pred             EEEEecCCchhhhHHhhcCCc--ch----HHHHHHhCCCCCCCCCCCCcEEEEeeeec
Q 037224          118 SYTIKSGDTFYLVSTNKYQNL--TT----YQSVEVVNPTFVPTKLEVGDVIIFPVFCK  169 (552)
Q Consensus       118 ~y~v~~gdtl~~Ia~~~~~~~--~~----~~~l~~~N~~~~~~~l~~gq~l~ip~~~~  169 (552)
                      +|+|++|||||+|| ++|..-  ++    +++|++.|.+.+ +.|++||+|.||...+
T Consensus        38 ~~tV~~GDTLW~IA-~~y~~~~~l~~~~~v~~I~~~N~l~~-~~I~~Gq~L~IP~~~~   93 (103)
T PRK14125         38 EITVQEGDTLWALA-DQYAGKHHMAKNEFIEWVEDVNNLPS-GHIKAGDKLVIPVLKS   93 (103)
T ss_pred             EEEECCCCCHHHHH-HHhCCCcCCCHHHHHHHHHHhcCCCC-CcCCCCCEEEEecCCC
Confidence            49999999999999 677521  11    577888999987 6899999999997543

>PRK09902 hypothetical protein; Provisional

Probab=98.71  E-value=2e-07  Score=86.54  Aligned_cols=133  Identities=14%  Similarity=0.140  Sum_probs=101.8

Q ss_pred             CCCceEEEEEEEEeecCcEEEEEEecc-------------ChHHHHHHHHHcCCCC--ccceeeeee---cCCCCeeEEE
Q 037224          344 SEGCLIQGSVYKGNIHGEVYAIKMMKW-------------NACEELKILQKVNHGN--LVKLEGFCI---DPEDANCYLI  405 (552)
Q Consensus       344 ~~G~g~~G~Vy~~~~~g~~vAvK~~~~-------------~~~~E~~~l~~l~h~n--iv~l~~~~~---~~~~~~~~lv  405 (552)
                      ..|.|+-+.|++-.++|+.+-+|.-..             .+.+|...|.++...+  ++++. ++.   .+..-..+||
T Consensus        25 N~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         25 NYRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             CcCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            346667788999998888999998741             2458999999985443  44444 332   1112345799


Q ss_pred             EeeccC-CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCc--EEEeeccCCc
Q 037224          406 YEYIEN-GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR--AKIANFGLAK  480 (552)
Q Consensus       406 ~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a~  480 (552)
                      +|-+++ .+|.+++....-.+.+..+...+..+++..+.-||+.|   +.|+|+.+.||+++.++.  ++++||.-++
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            997764 58888886654445678888899999999999999999   999999999999986667  9999998775

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.71  E-value=2e-07  Score=95.23  Aligned_cols=161  Identities=22%  Similarity=0.322  Sum_probs=122.9

Q ss_pred             EEEEEEee--cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeec--CCCCeeEEEEeeccC-CCchhhh
Q 037224          351 GSVYKGNI--HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCID--PEDANCYLIYEYIEN-GSLHSWL  418 (552)
Q Consensus       351 G~Vy~~~~--~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~~~lv~e~~~~-gsL~~~l  418 (552)
                      -+.|++..  +|..|.+|++..+       ...-+++++++.|.|++++.+++..  -.+..+.+||+|.++ ++|.++.
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~  369 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY  369 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence            57888876  8999999999322       1245889999999999999988862  235678999999986 4676654


Q ss_pred             hhcC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC
Q 037224          419 HENK-------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA  485 (552)
Q Consensus       419 ~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~  485 (552)
                      ....             +...++..+|.++.|+..||.++|+.|   +.-+-|.+.+|+++.+.+++|+..|........
T Consensus       370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            3322             123678899999999999999999999   999999999999999999998877766543332


Q ss_pred             ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCC
Q 037224          486 ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEA  529 (552)
Q Consensus       486 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~p  529 (552)
                      ..            |-+.   --.+-|.-.||.+++.|.||..-
T Consensus       447 ~~------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  447 PT------------EPLE---SQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CC------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence            20            1111   12367999999999999999654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.70  E-value=2e-07  Score=88.11  Aligned_cols=105  Identities=21%  Similarity=0.282  Sum_probs=81.9

Q ss_pred             hHHHHHHHHHcCCCC--ccceeeeeecCCC--CeeEEEEeeccC-CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q 037224          372 ACEELKILQKVNHGN--LVKLEGFCIDPED--ANCYLIYEYIEN-GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIH  446 (552)
Q Consensus       372 ~~~E~~~l~~l~h~n--iv~l~~~~~~~~~--~~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH  446 (552)
                      ..+|...+..+....  .+..+++......  ...++|+|++++ .+|.+++.....  .+......++.+++..+.-||
T Consensus        58 a~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~lH  135 (206)
T PF06293_consen   58 AKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAKLH  135 (206)
T ss_pred             HHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHHHH
Confidence            347888888885443  4555555544222  245899999987 478888876433  566778899999999999999


Q ss_pred             hCCCCceEecCCCCCcEEECCCC---cEEEeeccCCcc
Q 037224          447 EHTRPRVVHKDIKSSNILLDSNM---RAKIANFGLAKS  481 (552)
Q Consensus       447 ~~~~~~ivH~Dikp~NIll~~~~---~~kL~Dfg~a~~  481 (552)
                      +.|   ++|+|+++.|||++.++   .+.|+||+.++.
T Consensus       136 ~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  136 DAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999   99999999999998887   899999997764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.65  E-value=3.6e-07  Score=91.23  Aligned_cols=185  Identities=15%  Similarity=0.211  Sum_probs=121.0

Q ss_pred             CCceEEEEEEEEeecCcEEEEEEeccC----hHHHHHHHHHc-CCCCccc----eeeeeecCCCC-eeEEEEeeccCC-C
Q 037224          345 EGCLIQGSVYKGNIHGEVYAIKMMKWN----ACEELKILQKV-NHGNLVK----LEGFCIDPEDA-NCYLIYEYIENG-S  413 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~g~~vAvK~~~~~----~~~E~~~l~~l-~h~niv~----l~~~~~~~~~~-~~~lv~e~~~~g-s  413 (552)
                      .|.|+.+.+|---.-+..|| |+....    ..+.+..|... .||-+..    ........+.+ ...+.|..+.+. .
T Consensus        19 LgqGgea~ly~l~e~~d~VA-KIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~v~g~~p   97 (637)
T COG4248          19 LGQGGEADLYTLGEVRDQVA-KIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPKVSGKEP   97 (637)
T ss_pred             ccCCccceeeecchhhchhh-eeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecccCCCccc
Confidence            46776677776443333333 554321    12233344433 5554433    11112222233 366788877664 2


Q ss_pred             chhhhh----hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC-Cccc
Q 037224          414 LHSWLH----ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN-AITM  488 (552)
Q Consensus       414 L~~~l~----~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~-~~~~  488 (552)
                      ...++.    +......+|...++.++.++.+.+.||+.|   .+-+|++++|+|+.+++.+.|.|-+.-....+ ....
T Consensus        98 I~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng~~~~  174 (637)
T COG4248          98 IHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQINANGTLHL  174 (637)
T ss_pred             hhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeeccCCceEe
Confidence            222221    111234889999999999999999999999   89999999999999999999998654332222 2223


Q ss_pred             cccccccccCccccC-----CCCCCChhhHHHHHHHHHHHHcC-CCCCCcc
Q 037224          489 HIVGTQGYIAPEYLA-----DGVVSTKMDVFSFGVVLLELISG-KEAIDEE  533 (552)
Q Consensus       489 ~~~gt~~y~aPE~~~-----~~~~s~~~Dv~slG~il~elltG-~~pf~~~  533 (552)
                      ..+|...|.+||...     +-.-+...|-|.||+++++|+.| ++||.+-
T Consensus       175 cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI  225 (637)
T COG4248         175 CPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI  225 (637)
T ss_pred             cccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence            467899999999754     34456788999999999999876 9999853

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.56  E-value=3.7e-07  Score=86.87  Aligned_cols=119  Identities=21%  Similarity=0.245  Sum_probs=88.9

Q ss_pred             CceEEEEEEEEee-cCcEEEEEEecc-----------------------------ChHHHHHHHHHcCCC--Cccceeee
Q 037224          346 GCLIQGSVYKGNI-HGEVYAIKMMKW-----------------------------NACEELKILQKVNHG--NLVKLEGF  393 (552)
Q Consensus       346 G~g~~G~Vy~~~~-~g~~vAvK~~~~-----------------------------~~~~E~~~l~~l~h~--niv~l~~~  393 (552)
                      |-|--+.||.|.. +|.++|||.-+.                             ...+|.++|++|...  .+++.+++
T Consensus       100 GvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~P~~~  179 (304)
T COG0478         100 GVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPKPIAW  179 (304)
T ss_pred             ccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCCcccc
Confidence            5555599999998 699999997421                             123799999999765  77777664


Q ss_pred             eecCCCCeeEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEE
Q 037224          394 CIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKI  473 (552)
Q Consensus       394 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL  473 (552)
                            +...+||||++|-.|...-       ++.+..-.++..|++-+..+-..|   ++|+|+++=||+++++|.+.+
T Consensus       180 ------nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg~~~v  243 (304)
T COG0478         180 ------NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDGDIVV  243 (304)
T ss_pred             ------ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCCCEEE
Confidence                  2338999999997665432       223344455666666666666777   999999999999999999999


Q ss_pred             eeccCCc
Q 037224          474 ANFGLAK  480 (552)
Q Consensus       474 ~Dfg~a~  480 (552)
                      +||-.+.
T Consensus       244 IDwPQ~v  250 (304)
T COG0478         244 IDWPQAV  250 (304)
T ss_pred             EeCcccc
Confidence            9997654

>TIGR02899 spore_safA spore coat assembly protein SafA

Probab=98.47  E-value=1.3e-07  Score=65.14  Aligned_cols=42  Identities=26%  Similarity=0.502  Sum_probs=36.9

Q ss_pred             EecCCchhhhHHhhcCCcchHHHHHHhCC-CCCCCCCCCCcEEEEe
Q 037224          121 IKSGDTFYLVSTNKYQNLTTYQSVEVVNP-TFVPTKLEVGDVIIFP  165 (552)
Q Consensus       121 v~~gdtl~~Ia~~~~~~~~~~~~l~~~N~-~~~~~~l~~gq~l~ip  165 (552)
                      |++|||||+|| ++|+  ++.++|.++|+ +.+++.+.+||+|.||
T Consensus         1 v~~gdtl~~IA-~~~~--~~~~~l~~~N~~~~~~~~~~~g~~l~ip   43 (44)
T TIGR02899         1 VQKGDTLWKIA-KKYG--VDFDELIQANPQLSNPNLIYPGMKIKIP   43 (44)
T ss_pred             CCCCCCHHHHH-HHHC--cCHHHHHHHhhcCCCCCCcCCCCEEecC
Confidence            68999999999 7888  88999999997 4455689999999998

in which one of which is found in most examples of endospore-forming bacteria. Lysin motifs are repeated in many proteins.

>TIGR02899 spore_safA spore coat assembly protein SafA

Probab=98.47  E-value=1.4e-07  Score=64.98  Aligned_cols=38  Identities=24%  Similarity=0.461  Sum_probs=35.0

Q ss_pred             cCCCCCHHHHHhHhCCChhhHhhhcCC-----cccCCceeecc
Q 037224          188 LQPSENLSSVASRFGIETQAIIDVNGN-----NIRPFDTLFVP  225 (552)
Q Consensus       188 v~~Gdtl~~ia~~~~~s~~~l~~~N~~-----~~~~g~~l~ip  225 (552)
                      |++|||||+||++|+++.++|.++|+.     .+.+|+.|.||
T Consensus         1 v~~gdtl~~IA~~~~~~~~~l~~~N~~~~~~~~~~~g~~l~ip   43 (44)
T TIGR02899         1 VQKGDTLWKIAKKYGVDFDELIQANPQLSNPNLIYPGMKIKIP   43 (44)
T ss_pred             CCCCCCHHHHHHHHCcCHHHHHHHhhcCCCCCCcCCCCEEecC
Confidence            689999999999999999999999973     58999999887

in which one of which is found in most examples of endospore-forming bacteria. Lysin motifs are repeated in many proteins.

>COG3858 Predicted glycosyl hydrolase [General function prediction only]

Probab=98.46  E-value=1.9e-07  Score=93.05  Aligned_cols=95  Identities=20%  Similarity=0.237  Sum_probs=84.2

Q ss_pred             EeeccCCCCCCHHHHHHHhCCChhhhcCcCCCCCCCCCccCCCcEEEeeecccccCCCCCceeeeeeEEEEecCCchhhh
Q 037224           51 FYRASAPDFLDLASIADLFSVSRLMISEPSNISSPSSPLIQNQPLFVPITCSCNTLNASYTISFANLSYTIKSGDTFYLV  130 (552)
Q Consensus        51 ~y~v~~~~g~tl~~Ia~~~~~~~~~l~~~N~~~~~~~~~~~g~~l~iP~~~~~~~~~~~~~~~~~~~~y~v~~gdtl~~I  130 (552)
                      .|.|++  ||++..|+++|+.+..+|...|.+++  +.+.+||.+.||..               ...|.|++|||+++|
T Consensus         3 i~~~~p--g~~~~~i~~~~~~~~~~i~~~~~~~~--d~~~~~q~~~v~~~---------------~~~y~~~~~d~~~Si   63 (423)
T COG3858           3 IHLVGP--GDSRLIIAVYFPYTNNRIVNGNDYTN--DDLVDGQTFVVPPS---------------GHFYDVGPGDTLTSI   63 (423)
T ss_pred             EEEccC--Cceeeeehhhcccccccccccccccc--ccccCceeEEECCc---------------ceEEEecCCcchhhh
Confidence            578888  99999999999999999988888874  77899999999942               123999999999999


Q ss_pred             HHhhcCCcchHHHHHHhCCCCCCCCCCCCcEEEEeee
Q 037224          131 STNKYQNLTTYQSVEVVNPTFVPTKLEVGDVIIFPVF  167 (552)
Q Consensus       131 a~~~~~~~~~~~~l~~~N~~~~~~~l~~gq~l~ip~~  167 (552)
                      | ++++  ||.+.+...|....+..+.+|-.+.+|-.
T Consensus        64 a-~~~~--vt~~~~~~m~~~~~~~~l~~~~~l~~P~~   97 (423)
T COG3858          64 A-RTVG--VTQDSAAIMNFVICPGYLQYGLNLYIPSA   97 (423)
T ss_pred             h-hhhc--CCHHHHHhhcccccccceeeeeEEeccCC
Confidence            9 7888  99999999999888889999999999943

>cd00118 LysM Lysin domain, found in a variety of enzymes involved in bacterial cell wall degradation

Probab=98.45  E-value=2.7e-07  Score=63.63  Aligned_cols=45  Identities=29%  Similarity=0.541  Sum_probs=41.0

Q ss_pred             EEEEecCCchhhhHHhhcCCcchHHHHHHhCCCCCCCCCCCCcEEEEe
Q 037224          118 SYTIKSGDTFYLVSTNKYQNLTTYQSVEVVNPTFVPTKLEVGDVIIFP  165 (552)
Q Consensus       118 ~y~v~~gdtl~~Ia~~~~~~~~~~~~l~~~N~~~~~~~l~~gq~l~ip  165 (552)
                      .|+|++|||+++|| ..|+  ++.++|.++|+..+...+.+|+.|.||
T Consensus         2 ~~~v~~gdt~~~ia-~~~~--~~~~~~~~~N~~~~~~~~~~g~~l~ip   46 (46)
T cd00118           2 TYTVKKGDTLSSIA-QRYG--ISVEELLKLNGLSDPDNLQVGQKLKIP   46 (46)
T ss_pred             EEEECCCCCHHHHH-HHHC--cCHHHHHHHcCCCCccccCCCCEEecC
Confidence            49999999999999 7888  899999999999666789999999987

This domain may have a general peptidoglycan binding function.

>COG3858 Predicted glycosyl hydrolase [General function prediction only]

Probab=98.43  E-value=2e-07  Score=92.91  Aligned_cols=93  Identities=19%  Similarity=0.228  Sum_probs=80.6

Q ss_pred             EEEEecCCchhhhHHhhcCCcchHHHHHHhCCCCCCCCCCCCcEEEEeeeecCCCCccccCceeEEEEEecCCCCCHHHH
Q 037224          118 SYTIKSGDTFYLVSTNKYQNLTTYQSVEVVNPTFVPTKLEVGDVIIFPVFCKCPNQTQLRNRVNYLVSYVLQPSENLSSV  197 (552)
Q Consensus       118 ~y~v~~gdtl~~Ia~~~~~~~~~~~~l~~~N~~~~~~~l~~gq~l~ip~~~~~~~~~~~~~~~~~~~~y~v~~Gdtl~~i  197 (552)
                      .|.|++||+++.|+ ++|.  ++...|...|.+.+ +.|.+||.+.||...               -.|.|++|||+++|
T Consensus         3 i~~~~pg~~~~~i~-~~~~--~~~~~i~~~~~~~~-d~~~~~q~~~v~~~~---------------~~y~~~~~d~~~Si   63 (423)
T COG3858           3 IHLVGPGDSRLIIA-VYFP--YTNNRIVNGNDYTN-DDLVDGQTFVVPPSG---------------HFYDVGPGDTLTSI   63 (423)
T ss_pred             EEEccCCceeeeeh-hhcc--cccccccccccccc-ccccCceeEEECCcc---------------eEEEecCCcchhhh
Confidence            38999999999999 8999  88889988899988 899999999999521               17999999999999


Q ss_pred             HhHhCCChhhHhhhcCC----cccCCceeeccccCC
Q 037224          198 ASRFGIETQAIIDVNGN----NIRPFDTLFVPVARL  229 (552)
Q Consensus       198 a~~~~~s~~~l~~~N~~----~~~~g~~l~ip~~~~  229 (552)
                      |++|+++.+++..+|..    .+.+|=.+.+|....
T Consensus        64 a~~~~vt~~~~~~m~~~~~~~~l~~~~~l~~P~~~~   99 (423)
T COG3858          64 ARTVGVTQDSAAIMNFVICPGYLQYGLNLYIPSARK   99 (423)
T ss_pred             hhhhcCCHHHHHhhcccccccceeeeeEEeccCCCC
Confidence            99999999999999975    566777777775543

>PRK10871 nlpD lipoprotein NlpD; Provisional

Probab=98.42  E-value=1.9e-07  Score=91.77  Aligned_cols=47  Identities=23%  Similarity=0.405  Sum_probs=43.9

Q ss_pred             EEEEecCCchhhhHHhhcCCcchHHHHHHhCCCCCCCCCCCCcEEEEeee
Q 037224          118 SYTIKSGDTFYLVSTNKYQNLTTYQSVEVVNPTFVPTKLEVGDVIIFPVF  167 (552)
Q Consensus       118 ~y~v~~gdtl~~Ia~~~~~~~~~~~~l~~~N~~~~~~~l~~gq~l~ip~~  167 (552)
                      +|+|++|||||.|| ..|+  +++.+|.++|++.+|+.|++||+|.||..
T Consensus        62 ~y~Vk~GDTL~~IA-~~~g--~~~~~La~~N~l~~p~~I~~GQ~L~i~~~  108 (319)
T PRK10871         62 TYTVKKGDTLFYIA-WITG--NDFRDLAQRNNIQAPYSLNVGQTLQVGNA  108 (319)
T ss_pred             ceEECCCCHHHHHH-HHHC--cCHHHHHHhcCCCCCccccCCCEEEeCCC
Confidence            49999999999999 7888  99999999999999999999999999854

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.42  E-value=1.8e-06  Score=91.51  Aligned_cols=128  Identities=16%  Similarity=0.178  Sum_probs=82.2

Q ss_pred             CceEEEEEEEEee-cCcEEEEEEeccCh-----------------------------------------------HHHHH
Q 037224          346 GCLIQGSVYKGNI-HGEVYAIKMMKWNA-----------------------------------------------CEELK  377 (552)
Q Consensus       346 G~g~~G~Vy~~~~-~g~~vAvK~~~~~~-----------------------------------------------~~E~~  377 (552)
                      +++.-|.||+|++ +|+.||||+.+...                                               .+|..
T Consensus       134 AsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~EA~  213 (517)
T COG0661         134 ASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRREAA  213 (517)
T ss_pred             hhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHHHHH
Confidence            5666699999999 59999999985321                                               12444


Q ss_pred             HHHHc----C-CCCccceeeeeecCCCCeeEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHH-HHHHHhCCCC
Q 037224          378 ILQKV----N-HGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANG-LQYIHEHTRP  451 (552)
Q Consensus       378 ~l~~l----~-h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~a-L~~LH~~~~~  451 (552)
                      -+.++    + .+++ .+-.++.+- .....|+|||++|..+.+...... ..++...+.   ..++++ +..+-..|  
T Consensus       214 n~~~~~~nf~~~~~v-~VP~V~we~-t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia---~~~~~~f~~q~~~dg--  285 (517)
T COG0661         214 NAERFRENFKDDPDV-YVPKVYWEY-TTRRVLTMEWIDGIKISDIAALKS-AGIDRKELA---ELLVRAFLRQLLRDG--  285 (517)
T ss_pred             HHHHHHHHcCCCCCe-Eeceeehhc-cCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHH---HHHHHHHHHHHHhcC--
Confidence            44444    1 2222 222223211 234489999999999988743222 235543333   333322 22333356  


Q ss_pred             ceEecCCCCCcEEECCCCcEEEeeccCCccC
Q 037224          452 RVVHKDIKSSNILLDSNMRAKIANFGLAKSG  482 (552)
Q Consensus       452 ~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  482 (552)
                       +.|.|.+|.||+++.+|++.+.|||+....
T Consensus       286 -ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l  315 (517)
T COG0661         286 -FFHADPHPGNILVRSDGRIVLLDFGIVGRL  315 (517)
T ss_pred             -ccccCCCccceEEecCCcEEEEcCcceecC
Confidence             999999999999999999999999998643

>cd00118 LysM Lysin domain, found in a variety of enzymes involved in bacterial cell wall degradation

Probab=98.38  E-value=4.9e-07  Score=62.32  Aligned_cols=41  Identities=32%  Similarity=0.657  Sum_probs=38.2

Q ss_pred             EEecCCCCCHHHHHhHhCCChhhHhhhcCC----cccCCceeecc
Q 037224          185 SYVLQPSENLSSVASRFGIETQAIIDVNGN----NIRPFDTLFVP  225 (552)
Q Consensus       185 ~y~v~~Gdtl~~ia~~~~~s~~~l~~~N~~----~~~~g~~l~ip  225 (552)
                      .|+|++|||+++||++|+++..+|.++|+.    .+.+|+.+.||
T Consensus         2 ~~~v~~gdt~~~ia~~~~~~~~~~~~~N~~~~~~~~~~g~~l~ip   46 (46)
T cd00118           2 TYTVKKGDTLSSIAQRYGISVEELLKLNGLSDPDNLQVGQKLKIP   46 (46)
T ss_pred             EEEECCCCCHHHHHHHHCcCHHHHHHHcCCCCccccCCCCEEecC
Confidence            699999999999999999999999999996    78899988776

This domain may have a general peptidoglycan binding function.

>PRK10871 nlpD lipoprotein NlpD; Provisional

Probab=98.27  E-value=1.8e-06  Score=85.00  Aligned_cols=48  Identities=21%  Similarity=0.047  Sum_probs=44.5

Q ss_pred             eEeeccCCCCCCHHHHHHHhCCChhhhcCcCCCCCCCCCccCCCcEEEeee
Q 037224           50 AFYRASAPDFLDLASIADLFSVSRLMISEPSNISSPSSPLIQNQPLFVPIT  100 (552)
Q Consensus        50 ~~y~v~~~~g~tl~~Ia~~~~~~~~~l~~~N~~~~~~~~~~~g~~l~iP~~  100 (552)
                      .+|+|++  ||||+.||.+||+++.+|+++|+|.+ +..|.+||.|+||.+
T Consensus        61 ~~y~Vk~--GDTL~~IA~~~g~~~~~La~~N~l~~-p~~I~~GQ~L~i~~~  108 (319)
T PRK10871         61 STYTVKK--GDTLFYIAWITGNDFRDLAQRNNIQA-PYSLNVGQTLQVGNA  108 (319)
T ss_pred             CceEECC--CCHHHHHHHHHCcCHHHHHHhcCCCC-CccccCCCEEEeCCC
Confidence            4799999  99999999999999999999999986 788999999999853

>TIGR02907 spore_VI_D stage VI sporulation protein D

Probab=98.27  E-value=7.8e-07  Score=86.45  Aligned_cols=43  Identities=21%  Similarity=0.444  Sum_probs=40.8

Q ss_pred             EEEEecCCCCCHHHHHhHhCCChhhHhhhcCC---cccCCceeecc
Q 037224          183 LVSYVLQPSENLSSVASRFGIETQAIIDVNGN---NIRPFDTLFVP  225 (552)
Q Consensus       183 ~~~y~v~~Gdtl~~ia~~~~~s~~~l~~~N~~---~~~~g~~l~ip  225 (552)
                      ...|+|++|||||+||++||+++.+|+++|++   .|++|+.|+||
T Consensus       293 ~~~YiVq~GDTL~sIAkRYGVSV~~L~r~N~L~~~~L~~GQ~L~IP  338 (338)
T TIGR02907       293 LRMCIVQEGDTIETIAERYEISVSQLIRHNQLEDFEVNEGQILYIP  338 (338)
T ss_pred             cEEEEECCCCCHHHHHHHHCcCHHHHHHHhCCCccccCCCCEEEeC
Confidence            46899999999999999999999999999997   89999999987

SpoVID, the stage VI sporulation protein D, is restricted to endospore-forming members of the bacteria, all of which are found among the Firmicutes. It is widely distributed but not quite universal in this group. Between well-conserved N-terminal and C-terminal domains is a poorly conserved, low-complexity region of variable length, rich enough in glutamic acid to cause spurious BLAST search results unless a filter is used. The seed alignment for this model was trimmed, in effect, by choosing member sequences in which these regions are relatively short. SpoVID is involved in spore coat assembly by the mother cell compartment late in the process of sporulation.

>PRK11198 LysM domain/BON superfamily protein; Provisional

Probab=98.26  E-value=1.1e-06  Score=77.83  Aligned_cols=49  Identities=33%  Similarity=0.498  Sum_probs=42.7

Q ss_pred             eEEEEecCCchhhhHHhhcCCcchHHHHHHhCC--CCCCCCCCCCcEEEEe
Q 037224          117 LSYTIKSGDTFYLVSTNKYQNLTTYQSVEVVNP--TFVPTKLEVGDVIIFP  165 (552)
Q Consensus       117 ~~y~v~~gdtl~~Ia~~~~~~~~~~~~l~~~N~--~~~~~~l~~gq~l~ip  165 (552)
                      ..|+|++|||||+||+++|+....++.|.++|+  +.+++.|.+||+|.||
T Consensus        96 ~~y~Vk~GDTL~~IA~~~~g~~~~~~~I~~~N~~~l~~~~~I~pGq~L~IP  146 (147)
T PRK11198         96 QFYTVKSGDTLSAIAKKVYGNANKYNKIFEANKPMLKSPDKIYPGQVLRIP  146 (147)
T ss_pred             eEEEECCCCCHHHHHHHHcCChhhHHHHHHhhhhcCCCcCCcCcCCEEecC
Confidence            469999999999999666676567889999998  7777899999999998

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.26  E-value=6.5e-06  Score=76.90  Aligned_cols=115  Identities=18%  Similarity=0.219  Sum_probs=75.2

Q ss_pred             EEEEEeecCcEEEEEEeccCh----------------HHHHHHHHHcCCCCcc---ceeeeeecC---CCCeeEEEEeec
Q 037224          352 SVYKGNIHGEVYAIKMMKWNA----------------CEELKILQKVNHGNLV---KLEGFCIDP---EDANCYLIYEYI  409 (552)
Q Consensus       352 ~Vy~~~~~g~~vAvK~~~~~~----------------~~E~~~l~~l~h~niv---~l~~~~~~~---~~~~~~lv~e~~  409 (552)
                      .|.+-..+|+.+.+|..+...                .+++..+.+++...+.   .++-+....   -....+++|||+
T Consensus        46 ~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYI  125 (229)
T PF06176_consen   46 YVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEYI  125 (229)
T ss_pred             EEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEEEe
Confidence            344445588899999876432                1344444455333322   222222111   123456899999


Q ss_pred             cCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCc
Q 037224          410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK  480 (552)
Q Consensus       410 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  480 (552)
                      +|..|.++..      +++    .+...+.+++.-||+.|   ++|+|.+|.|+++++++ ++++||+..+
T Consensus       126 eG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i~iID~~~k~  182 (229)
T PF06176_consen  126 EGVELNDIED------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-IRIIDTQGKR  182 (229)
T ss_pred             cCeecccchh------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-EEEEECcccc
Confidence            9988876532      232    24566778899999999   99999999999998654 9999998764

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>TIGR02907 spore_VI_D stage VI sporulation protein D

Probab=98.25  E-value=9.9e-07  Score=85.72  Aligned_cols=46  Identities=15%  Similarity=0.286  Sum_probs=42.6

Q ss_pred             eeEEEEecCCchhhhHHhhcCCcchHHHHHHhCCCCCCCCCCCCcEEEEe
Q 037224          116 NLSYTIKSGDTFYLVSTNKYQNLTTYQSVEVVNPTFVPTKLEVGDVIIFP  165 (552)
Q Consensus       116 ~~~y~v~~gdtl~~Ia~~~~~~~~~~~~l~~~N~~~~~~~l~~gq~l~ip  165 (552)
                      ...|+|++|||||.|| ++|+  ++++.|+++|++. ++.|++||+|.||
T Consensus       293 ~~~YiVq~GDTL~sIA-kRYG--VSV~~L~r~N~L~-~~~L~~GQ~L~IP  338 (338)
T TIGR02907       293 LRMCIVQEGDTIETIA-ERYE--ISVSQLIRHNQLE-DFEVNEGQILYIP  338 (338)
T ss_pred             cEEEEECCCCCHHHHH-HHHC--cCHHHHHHHhCCC-ccccCCCCEEEeC
Confidence            3579999999999999 8999  9999999999997 4899999999998

SpoVID, the stage VI sporulation protein D, is restricted to endospore-forming members of the bacteria, all of which are found among the Firmicutes. It is widely distributed but not quite universal in this group. Between well-conserved N-terminal and C-terminal domains is a poorly conserved, low-complexity region of variable length, rich enough in glutamic acid to cause spurious BLAST search results unless a filter is used. The seed alignment for this model was trimmed, in effect, by choosing member sequences in which these regions are relatively short. SpoVID is involved in spore coat assembly by the mother cell compartment late in the process of sporulation.

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.21  E-value=7.9e-06  Score=75.71  Aligned_cols=99  Identities=22%  Similarity=0.300  Sum_probs=80.6

Q ss_pred             HHHHHHHHcCC-CCccceeeeeecCCCCeeEEEEeeccCCCchhh---hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 037224          374 EELKILQKVNH-GNLVKLEGFCIDPEDANCYLIYEYIENGSLHSW---LHENKNENLNWKTRLRIAIDVANGLQYIHEHT  449 (552)
Q Consensus       374 ~E~~~l~~l~h-~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~---l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  449 (552)
                      .|.-+++.+++ +++++++|+|-+      +++.||...+++...   +...  ...+|..+.+|+.++++.+++|++..
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~------~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~~~~   79 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR------FYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELDHGP   79 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC------EEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHhcCC
Confidence            58888999966 699999999954      789999987665421   1111  12689999999999999999999864


Q ss_pred             CCceEecCCCCCcEEECCCCcEEEeeccCCc
Q 037224          450 RPRVVHKDIKSSNILLDSNMRAKIANFGLAK  480 (552)
Q Consensus       450 ~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  480 (552)
                      ...+...|++++|+-+++++++|++|.+...
T Consensus        80 ~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~  110 (188)
T PF12260_consen   80 LGFFYLCDVSPDNFGVNDDGRLKLIDLDDVF  110 (188)
T ss_pred             CCcEEEeecchHHeEEeCCCcEEEEechhcc
Confidence            4458899999999999999999999998764

Proteins in this uncharacterised family are described as transmembrane proteins.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.21  E-value=2.4e-05  Score=73.90  Aligned_cols=124  Identities=19%  Similarity=0.244  Sum_probs=87.8

Q ss_pred             ceEEEEEEEEee-cCcEEEEEEeccCh-------------------------------HHHHHHHHHcC--CCCccceee
Q 037224          347 CLIQGSVYKGNI-HGEVYAIKMMKWNA-------------------------------CEELKILQKVN--HGNLVKLEG  392 (552)
Q Consensus       347 ~g~~G~Vy~~~~-~g~~vAvK~~~~~~-------------------------------~~E~~~l~~l~--h~niv~l~~  392 (552)
                      +|--..||+|.. ++..+|+|+++...                               .+|..-|.++.  +-.+++.++
T Consensus        58 tGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~  137 (268)
T COG1718          58 TGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIA  137 (268)
T ss_pred             CCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCcee
Confidence            344478999887 78999999985321                               14777777773  445566665


Q ss_pred             eeecCCCCeeEEEEeeccCCCc-hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEECCCCc
Q 037224          393 FCIDPEDANCYLIYEYIENGSL-HSWLHENKNENLNWKTRLRIAIDVANGLQYIHE-HTRPRVVHKDIKSSNILLDSNMR  470 (552)
Q Consensus       393 ~~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~Dikp~NIll~~~~~  470 (552)
                      +...      .|||||+..... .-.|..   -++...+...+..++++.+.-|-. .+   +||+||+.=|||+. ++.
T Consensus       138 ~~~n------VLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~~-~~~  204 (268)
T COG1718         138 FRNN------VLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILVH-DGE  204 (268)
T ss_pred             ecCC------eEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEEE-CCe
Confidence            5432      799999965311 111111   124444677888899999988877 66   99999999999998 889


Q ss_pred             EEEeeccCCccCC
Q 037224          471 AKIANFGLAKSGC  483 (552)
Q Consensus       471 ~kL~Dfg~a~~~~  483 (552)
                      +.++||+.+....
T Consensus       205 p~iID~~QaV~~~  217 (268)
T COG1718         205 PYIIDVSQAVTID  217 (268)
T ss_pred             EEEEECccccccC
Confidence            9999999886443

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.19  E-value=2.3e-05  Score=75.06  Aligned_cols=131  Identities=18%  Similarity=0.193  Sum_probs=76.7

Q ss_pred             CceEEEEEEEEeecCcEEEEEEecc-----ChHHHHHHHHHcCCCCc--cceeeeeecCCCCeeEEEEeeccCCC-chhh
Q 037224          346 GCLIQGSVYKGNIHGEVYAIKMMKW-----NACEELKILQKVNHGNL--VKLEGFCIDPEDANCYLIYEYIENGS-LHSW  417 (552)
Q Consensus       346 G~g~~G~Vy~~~~~g~~vAvK~~~~-----~~~~E~~~l~~l~h~ni--v~l~~~~~~~~~~~~~lv~e~~~~gs-L~~~  417 (552)
                      |.|..+.||+.  .|..+++|....     ...+|.++++.+..-.+  .+.+++..+  .+...++||+++|.+ +...
T Consensus        10 ~~G~t~~~y~~--~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~--~~~~glv~e~i~G~~~~~~~   85 (226)
T TIGR02172        10 GEGGNGESYTH--KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVED--GGRLGLIYELIVGKRSFSRI   85 (226)
T ss_pred             cCCCCcceeEe--cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEec--CCeeeeeeeecCCccchhhh
Confidence            56666889984  355678898754     24579999999864444  566666544  455688999999863 2111


Q ss_pred             h---------------------hhcCCCCCCHHHHHH-HHH----------HHHHH-HHHHHh-CCCCceEecCCCCCcE
Q 037224          418 L---------------------HENKNENLNWKTRLR-IAI----------DVANG-LQYIHE-HTRPRVVHKDIKSSNI  463 (552)
Q Consensus       418 l---------------------~~~~~~~l~~~~~~~-i~~----------qi~~a-L~~LH~-~~~~~ivH~Dikp~NI  463 (552)
                      +                     +.............. +..          .+.+. ..+|.. ...+.++|+|++|.||
T Consensus        86 ~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Ni  165 (226)
T TIGR02172        86 ISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNL  165 (226)
T ss_pred             hcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcE
Confidence            1                     111000111111100 000          01111 122221 1234579999999999


Q ss_pred             EECCCCcEEEeeccCCcc
Q 037224          464 LLDSNMRAKIANFGLAKS  481 (552)
Q Consensus       464 ll~~~~~~kL~Dfg~a~~  481 (552)
                      ++++++ +.++||+.+..
T Consensus       166 i~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       166 ITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             EEcCCC-cEEEechhcCc
Confidence            999888 99999998753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.14  E-value=2.4e-05  Score=82.92  Aligned_cols=128  Identities=16%  Similarity=0.146  Sum_probs=81.5

Q ss_pred             CceEEEEEEEEee-cCcEEEEEEeccCh--------------------------------------------HHHHHHHH
Q 037224          346 GCLIQGSVYKGNI-HGEVYAIKMMKWNA--------------------------------------------CEELKILQ  380 (552)
Q Consensus       346 G~g~~G~Vy~~~~-~g~~vAvK~~~~~~--------------------------------------------~~E~~~l~  380 (552)
                      +.-..|.||+|++ +|+.||||+-+...                                            .+|++-..
T Consensus       170 aaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae  249 (538)
T KOG1235|consen  170 AAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAE  249 (538)
T ss_pred             hhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHH
Confidence            5556699999999 88999999974321                                            12332222


Q ss_pred             H----cCCCC------ccceeeeeecCCCCeeEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 037224          381 K----VNHGN------LVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTR  450 (552)
Q Consensus       381 ~----l~h~n------iv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~  450 (552)
                      +    +.|-+      |++++-.+    .....|+|||++|..+.|.-.- ....++...+..-+.+...  +-+=..| 
T Consensus       250 ~~~~~f~~~~~~~~V~VP~Vy~~~----st~RVLtME~~~G~~i~Dl~~i-~~~gi~~~~i~~~l~~~~~--~qIf~~G-  321 (538)
T KOG1235|consen  250 RFRENFKDFSLLTYVLVPKVYWDL----STKRVLTMEYVDGIKINDLDAI-DKRGISPHDILNKLVEAYL--EQIFKTG-  321 (538)
T ss_pred             HHHHHHHhcccccceeCCeehhhc----CcceEEEEEecCCccCCCHHHH-HHcCCCHHHHHHHHHHHHH--HHHHhcC-
Confidence            2    33444      44443322    2345899999999888765322 1223666654443333322  2222345 


Q ss_pred             CceEecCCCCCcEEECC----CCcEEEeeccCCccCC
Q 037224          451 PRVVHKDIKSSNILLDS----NMRAKIANFGLAKSGC  483 (552)
Q Consensus       451 ~~ivH~Dikp~NIll~~----~~~~kL~Dfg~a~~~~  483 (552)
                        ++|+|-+|.||+++.    ++++.+-|||+.....
T Consensus       322 --ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  322 --FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             --CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence              999999999999983    6789999999986543

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.13  E-value=3.3e-05  Score=75.01  Aligned_cols=129  Identities=15%  Similarity=0.121  Sum_probs=80.3

Q ss_pred             EEEEEEeecCcEEEEEEeccC----hHHHHHHHHHcC-CCCccceeeeeecCCCCeeEEEEeeccCCCchhhh-------
Q 037224          351 GSVYKGNIHGEVYAIKMMKWN----ACEELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL-------  418 (552)
Q Consensus       351 G~Vy~~~~~g~~vAvK~~~~~----~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l-------  418 (552)
                      ..||+...++..+.+|+....    ..+|+++++.+. +--+.+++++...  .+..++|||+++|.+|.+..       
T Consensus        13 ~~v~~~~~~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~lv~e~i~G~~l~~~~~~~~~~~   90 (244)
T cd05150          13 ATVYRLDGKNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSD--DGRAWLLTSAVPGVPAAALWEELEPER   90 (244)
T ss_pred             CeEEEEcCCCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEec--CCccEEEEEeeCCccHhHhhcccCHHH
Confidence            679999887788999998753    678999999884 4445566666554  34568999999998776432       


Q ss_pred             ------------hhcCC--CCCCH--HHHHHHHH--------------------HHHHHHHHHHh----CCCCceEecCC
Q 037224          419 ------------HENKN--ENLNW--KTRLRIAI--------------------DVANGLQYIHE----HTRPRVVHKDI  458 (552)
Q Consensus       419 ------------~~~~~--~~l~~--~~~~~i~~--------------------qi~~aL~~LH~----~~~~~ivH~Di  458 (552)
                                  +....  ..+..  ........                    .+...+..|-.    ...+.++|+|+
T Consensus        91 ~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~  170 (244)
T cd05150          91 LVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLVVTHGDA  170 (244)
T ss_pred             HHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceEEECCCC
Confidence                        11100  01110  00000000                    01111222211    12345899999


Q ss_pred             CCCcEEECCCCcEEEeeccCCcc
Q 037224          459 KSSNILLDSNMRAKIANFGLAKS  481 (552)
Q Consensus       459 kp~NIll~~~~~~kL~Dfg~a~~  481 (552)
                      .|.|||+++++...|+||+.+..
T Consensus       171 ~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         171 CLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             CCccEEEeCCcEEEEEEcccccc
Confidence            99999999987788999998753

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.07  E-value=7.4e-07  Score=94.45  Aligned_cols=96  Identities=30%  Similarity=0.567  Sum_probs=75.8

Q ss_pred             HHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccc-----------cccccccccCccccCCC
Q 037224          437 DVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM-----------HIVGTQGYIAPEYLADG  505 (552)
Q Consensus       437 qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-----------~~~gt~~y~aPE~~~~~  505 (552)
                      +++.|+.|+|...  .+||++|.|++|.++..+..||+.|+.+.........           -......|.|||++...
T Consensus       107 ~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             cccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            4448999999765  5999999999999999999999999987533221110           12345679999999998


Q ss_pred             CCCChhhHHHHHHHHHHHH-cCCCCCCccC
Q 037224          506 VVSTKMDVFSFGVVLLELI-SGKEAIDEEG  534 (552)
Q Consensus       506 ~~s~~~Dv~slG~il~ell-tG~~pf~~~~  534 (552)
                      ..++++|+||+|+++|.+. .|+.-+...+
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~  214 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANG  214 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccC
Confidence            8999999999999999998 5666665543

>PRK13914 invasion associated secreted endopeptidase; Provisional

Probab=98.02  E-value=4.8e-06  Score=85.89  Aligned_cols=47  Identities=17%  Similarity=0.253  Sum_probs=42.9

Q ss_pred             eEEEEecCCchhhhHHhhcCCcchHHHHHHhCCCCCCCCCCCCcEEEEeee
Q 037224          117 LSYTIKSGDTFYLVSTNKYQNLTTYQSVEVVNPTFVPTKLEVGDVIIFPVF  167 (552)
Q Consensus       117 ~~y~v~~gdtl~~Ia~~~~~~~~~~~~l~~~N~~~~~~~l~~gq~l~ip~~  167 (552)
                      .+|+|++|||||.|| ++|+  +++++|+++|++.+ +.|.+||+|.||..
T Consensus        28 ~tytVq~GDTLw~IA-~~yg--vtv~~I~~~N~l~~-~~I~~Gq~L~Ip~~   74 (481)
T PRK13914         28 STVVVEAGDTLWGIA-QSKG--TTVDAIKKANNLTT-DKIVPGQKLQVNEV   74 (481)
T ss_pred             ceEEECCCCCHHHHH-HHHC--CCHHHHHHHhCCCc-ccccCCCEEEeCCC
Confidence            359999999999999 8898  99999999999876 79999999999954

>smart00257 LysM Lysin motif

Probab=97.98  E-value=9e-06  Score=55.13  Aligned_cols=43  Identities=28%  Similarity=0.530  Sum_probs=37.6

Q ss_pred             EEEecCCchhhhHHhhcCCcchHHHHHHhCCCCCCCCCCCCcEEEE
Q 037224          119 YTIKSGDTFYLVSTNKYQNLTTYQSVEVVNPTFVPTKLEVGDVIIF  164 (552)
Q Consensus       119 y~v~~gdtl~~Ia~~~~~~~~~~~~l~~~N~~~~~~~l~~gq~l~i  164 (552)
                      |+|++|||+++|| +.|+  ++.+++..+|+......+.+|+.|.|
T Consensus         2 ~~v~~gdt~~~ia-~~~~--~~~~~~~~~N~~~~~~~~~~g~~l~i   44 (44)
T smart00257        2 YTVKKGDTLSSIA-RRYG--ISVSDLLELNNILDPDNLQVGQKLKI   44 (44)
T ss_pred             eEeCCCCCHHHHH-HHhC--CCHHHHHHHcCCCCccccCCCCEEeC
Confidence            8999999999999 7888  78899999999655578999998864

>smart00257 LysM Lysin motif

Probab=97.98  E-value=8.3e-06  Score=55.31  Aligned_cols=39  Identities=28%  Similarity=0.548  Sum_probs=34.7

Q ss_pred             EEecCCCCCHHHHHhHhCCChhhHhhhcCC----cccCCceee
Q 037224          185 SYVLQPSENLSSVASRFGIETQAIIDVNGN----NIRPFDTLF  223 (552)
Q Consensus       185 ~y~v~~Gdtl~~ia~~~~~s~~~l~~~N~~----~~~~g~~l~  223 (552)
                      +|.|++|||+++||++|+++..+|.++|+.    .+.+|+.+.
T Consensus         1 ~~~v~~gdt~~~ia~~~~~~~~~~~~~N~~~~~~~~~~g~~l~   43 (44)
T smart00257        1 TYTVKKGDTLSSIARRYGISVSDLLELNNILDPDNLQVGQKLK   43 (44)
T ss_pred             CeEeCCCCCHHHHHHHhCCCHHHHHHHcCCCCccccCCCCEEe
Confidence            388999999999999999999999999994    677887664

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.88  E-value=7.5e-05  Score=71.52  Aligned_cols=132  Identities=23%  Similarity=0.291  Sum_probs=75.0

Q ss_pred             EEEEEEEEeecCcEEEEEEeccC-----hHHHHHHHHHcCCCC--ccceeeeeecCC-CCeeEEEEeeccCCCchh----
Q 037224          349 IQGSVYKGNIHGEVYAIKMMKWN-----ACEELKILQKVNHGN--LVKLEGFCIDPE-DANCYLIYEYIENGSLHS----  416 (552)
Q Consensus       349 ~~G~Vy~~~~~g~~vAvK~~~~~-----~~~E~~~l~~l~h~n--iv~l~~~~~~~~-~~~~~lv~e~~~~gsL~~----  416 (552)
                      ..+.||+...+++.+++|.....     ..+|..+++.+....  +.+++..+.... ....+++|+++++.++..    
T Consensus         9 ~~n~~~~v~~~~~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~~~~~   88 (239)
T PF01636_consen    9 FSNRVYRVTTDDGRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDDELSP   88 (239)
T ss_dssp             SSSEEEEEEETTSEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHHTSTH
T ss_pred             CeeeEEEEEECCcEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccccccc
Confidence            34789999997789999998654     346888888885443  556665443321 335689999999987776    


Q ss_pred             ------------hh---hhc--CCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh----CCCCce
Q 037224          417 ------------WL---HEN--KNENLNWKT---------RLRI------------AIDVAN-GLQYIHE----HTRPRV  453 (552)
Q Consensus       417 ------------~l---~~~--~~~~l~~~~---------~~~i------------~~qi~~-aL~~LH~----~~~~~i  453 (552)
                                  .+   +..  ....+....         ....            ...+.. .+..+++    .....+
T Consensus        89 ~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (239)
T PF01636_consen   89 EQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALLPKPLPPVL  168 (239)
T ss_dssp             HHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCSCEEE
T ss_pred             cccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhhccCCCcEE
Confidence                        11   111  001111110         0000            111222 2333332    133459


Q ss_pred             EecCCCCCcEEEC-CCCcEEEeeccCCc
Q 037224          454 VHKDIKSSNILLD-SNMRAKIANFGLAK  480 (552)
Q Consensus       454 vH~Dikp~NIll~-~~~~~kL~Dfg~a~  480 (552)
                      +|+|+.+.||+++ +++.+.|+||+.+.
T Consensus       169 ~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  169 IHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             E-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             EEeccccccceeeeccceeEEEecccce
Confidence            9999999999999 66667899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.84  E-value=0.00012  Score=65.67  Aligned_cols=118  Identities=19%  Similarity=0.208  Sum_probs=82.0

Q ss_pred             CceEEEEEEEEeecCcEEEEEEeccC-----hHHHHHHHHHcCCCCccc-eeeeeecCCCCeeEEEEeeccCCCchhhhh
Q 037224          346 GCLIQGSVYKGNIHGEVYAIKMMKWN-----ACEELKILQKVNHGNLVK-LEGFCIDPEDANCYLIYEYIENGSLHSWLH  419 (552)
Q Consensus       346 G~g~~G~Vy~~~~~g~~vAvK~~~~~-----~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~  419 (552)
                      +.|..|.||.+.+.|..+|+|+-+.+     ...|+++|..+.-.++.+ ++.+-.+      ++.|||++|.+|.++-.
T Consensus        31 ~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~------~i~me~i~G~~L~~~~~  104 (201)
T COG2112          31 AKGTTSVVYLGEWRGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGED------FIRMEYIDGRPLGKLEI  104 (201)
T ss_pred             hcccccEEEEeeccCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechh------hhhhhhhcCcchhhhhh
Confidence            56666999999999999999998655     346999999998776654 4333221      56699999988876543


Q ss_pred             hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCC-CCcEEECCCCcEEEeeccCCcc
Q 037224          420 ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIK-SSNILLDSNMRAKIANFGLAKS  481 (552)
Q Consensus       420 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik-p~NIll~~~~~~kL~Dfg~a~~  481 (552)
                      ..     +.+.    ...+++.---|-..|   |-|+.|+ |..+++..++.+.|+||..|..
T Consensus       105 ~~-----~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112         105 GG-----DRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             cc-----cHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            21     2223    334444444455666   8898886 4555555555999999998873

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.71  E-value=8.3e-06  Score=85.75  Aligned_cols=175  Identities=17%  Similarity=0.121  Sum_probs=121.3

Q ss_pred             ceEEEEEEEEeec-CcEEEEEEeccC--hHHHHHHHHHcCCCC-ccceeeeeecCCCCeeEEEEeeccCC-Cchhhhhhc
Q 037224          347 CLIQGSVYKGNIH-GEVYAIKMMKWN--ACEELKILQKVNHGN-LVKLEGFCIDPEDANCYLIYEYIENG-SLHSWLHEN  421 (552)
Q Consensus       347 ~g~~G~Vy~~~~~-g~~vAvK~~~~~--~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~  421 (552)
                      .+..+.++|.+.. .+....+.+...  ..-++++|.+++||| .+..++-+.  .+...++.++++.++ +-...... 
T Consensus       252 K~altknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~~~v~~~~d~~--~E~~~~i~~~i~s~~rs~~~~~~~-  328 (829)
T KOG0576|consen  252 KGALTKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPNPVVRYLEDYD--GEDYLWIPMRICSTGRSSALEMTV-  328 (829)
T ss_pred             HHHhcCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCCCcccccccCC--cccccchhhhhhcCCccccccCCh-
Confidence            3344888888763 223335555433  234899999999999 444444332  256778999999876 22221111 


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-ccccccccccccCcc
Q 037224          422 KNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-ITMHIVGTQGYIAPE  500 (552)
Q Consensus       422 ~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-~~~~~~gt~~y~aPE  500 (552)
                      ....+...+...+.+.-.++++++|+..   =+|+|    ||+..+ +..+..||+........ ......+++.++|||
T Consensus       329 se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pe  400 (829)
T KOG0576|consen  329 SEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPE  400 (829)
T ss_pred             hhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcccccccCCCCCCCCCch
Confidence            1122555566677888889999999874   58888    777655 67899999987644332 334567899999999


Q ss_pred             ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          501 YLADGVVSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       501 ~~~~~~~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                      ......+....|+|++|.--.++--|-+|-..
T Consensus       401 v~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~  432 (829)
T KOG0576|consen  401 VIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS  432 (829)
T ss_pred             hhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence            99999999999999999877777777776553

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.68  E-value=0.00045  Score=67.58  Aligned_cols=129  Identities=16%  Similarity=0.174  Sum_probs=76.6

Q ss_pred             ceEEEEEEEEeecCcEEEEEEecc-------ChHHHHHHHHHcCCCCc-cceeeeeecCCCCeeEEEEeeccCCCchhh-
Q 037224          347 CLIQGSVYKGNIHGEVYAIKMMKW-------NACEELKILQKVNHGNL-VKLEGFCIDPEDANCYLIYEYIENGSLHSW-  417 (552)
Q Consensus       347 ~g~~G~Vy~~~~~g~~vAvK~~~~-------~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~~~lv~e~~~~gsL~~~-  417 (552)
                      .|....+|+...+++.+++|....       +..+|..+++.+....+ .+++..+    .+  ++|+||++|..+... 
T Consensus         6 ~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~--~~v~e~i~G~~~~~~~   79 (256)
T TIGR02721         6 GGLTNRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EH--WLLVEWLEGEVITLDQ   79 (256)
T ss_pred             CcCcCCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CC--EEEEEeccCccccccc
Confidence            344578898888888899997532       34579999999965434 4444332    22  789999998766421 


Q ss_pred             ----------------hhhcC--CCCCCHHH-HHHHHHHH---------HHHHHHHHhC-----CCCceEecCCCCCcEE
Q 037224          418 ----------------LHENK--NENLNWKT-RLRIAIDV---------ANGLQYIHEH-----TRPRVVHKDIKSSNIL  464 (552)
Q Consensus       418 ----------------l~~~~--~~~l~~~~-~~~i~~qi---------~~aL~~LH~~-----~~~~ivH~Dikp~NIl  464 (552)
                                      ++...  ..+++... +..+..++         ...+..+-..     ....++|+|+.|.||+
T Consensus        80 ~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil  159 (256)
T TIGR02721        80 FVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLV  159 (256)
T ss_pred             ccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEE
Confidence                            11111  11122221 11111111         1112222211     1234899999999999


Q ss_pred             ECCCCcEEEeeccCCccC
Q 037224          465 LDSNMRAKIANFGLAKSG  482 (552)
Q Consensus       465 l~~~~~~kL~Dfg~a~~~  482 (552)
                      +++++ +.|+||+.+...
T Consensus       160 ~~~~~-~~lIDwE~a~~g  176 (256)
T TIGR02721       160 VTPQG-LKLIDWEYASDG  176 (256)
T ss_pred             EeCCC-CEEEeccccCcC
Confidence            99877 789999988644

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.67  E-value=0.00069  Score=65.25  Aligned_cols=130  Identities=20%  Similarity=0.250  Sum_probs=75.3

Q ss_pred             CceEEEEEEEEeec---CcEEEEEEeccC------hHHHHHHHHHcCCCCc-cceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          346 GCLIQGSVYKGNIH---GEVYAIKMMKWN------ACEELKILQKVNHGNL-VKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       346 G~g~~G~Vy~~~~~---g~~vAvK~~~~~------~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      ..|....+|+....   ++.|++|+....      ..+|+.+++.+....+ ++++..+    ++  .++|||++|.++.
T Consensus         7 ~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~----~~--~~l~e~i~G~~l~   80 (235)
T cd05157           7 TGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF----QN--GLIYEFIPGRTLE   80 (235)
T ss_pred             CCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe----CC--cEEEEeeCCCcCC
Confidence            34455789988764   578889987532      2479999999854444 4444322    12  4899999987763


Q ss_pred             hh-----------------hhhcCCC---------CCC-HHHHHHHHH----------------------HHHHHHHHH-
Q 037224          416 SW-----------------LHENKNE---------NLN-WKTRLRIAI----------------------DVANGLQYI-  445 (552)
Q Consensus       416 ~~-----------------l~~~~~~---------~l~-~~~~~~i~~----------------------qi~~aL~~L-  445 (552)
                      ..                 ++.....         ... ++.+..+..                      .+...+..| 
T Consensus        81 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~  160 (235)
T cd05157          81 PEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISWLK  160 (235)
T ss_pred             HHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHHHH
Confidence            21                 1111100         111 122222211                      111111122 


Q ss_pred             ---HhC-CCCceEecCCCCCcEEECC-CCcEEEeeccCCcc
Q 037224          446 ---HEH-TRPRVVHKDIKSSNILLDS-NMRAKIANFGLAKS  481 (552)
Q Consensus       446 ---H~~-~~~~ivH~Dikp~NIll~~-~~~~kL~Dfg~a~~  481 (552)
                         ... ....++|+|+++.|||++. ++.+.|+||..+..
T Consensus       161 ~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         161 ELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             HHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence               111 2345899999999999998 57899999988753

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK10593 hypothetical protein; Provisional

Probab=97.67  E-value=0.00097  Score=66.71  Aligned_cols=69  Identities=12%  Similarity=-0.036  Sum_probs=50.0

Q ss_pred             CceEEEEEEEEeecCcEEEEEEecc-----ChHHHHHHHHHcCC---CCccceeeeeecCC-CCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNIHGEVYAIKMMKW-----NACEELKILQKVNH---GNLVKLEGFCIDPE-DANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~~g~~vAvK~~~~-----~~~~E~~~l~~l~h---~niv~l~~~~~~~~-~~~~~lv~e~~~~gsL  414 (552)
                      |.|..+.||+-...+..+.+|..+.     .+..|...|+.+..   -.+++++++|.+.. .+..++|||++++.++
T Consensus        23 ~~G~~~~vy~~~~~~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~  100 (297)
T PRK10593         23 SEQPYAALWALYDSQGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSV  100 (297)
T ss_pred             CCccceeEEEEEcCCCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEec
Confidence            5666689999887555677777654     23579999999853   36788888775422 3457999999998765

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.64  E-value=0.00051  Score=66.26  Aligned_cols=32  Identities=25%  Similarity=0.488  Sum_probs=26.4

Q ss_pred             CceEecCCCCCcEEECCCCcEEEeeccCCccC
Q 037224          451 PRVVHKDIKSSNILLDSNMRAKIANFGLAKSG  482 (552)
Q Consensus       451 ~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  482 (552)
                      +.++|+|+++.||++++++..-|+||+.+...
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~g  195 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGVG  195 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccCcC
Confidence            44899999999999987765679999987543

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PLN02876 acyl-CoA dehydrogenase

Probab=97.61  E-value=0.00077  Score=77.14  Aligned_cols=69  Identities=17%  Similarity=0.330  Sum_probs=46.9

Q ss_pred             CceEEEEEEEEeecC----cEEEEEEecc--------ChHHHHHHHHHcC-CCCc--cceeeeeecCC-CCeeEEEEeec
Q 037224          346 GCLIQGSVYKGNIHG----EVYAIKMMKW--------NACEELKILQKVN-HGNL--VKLEGFCIDPE-DANCYLIYEYI  409 (552)
Q Consensus       346 G~g~~G~Vy~~~~~g----~~vAvK~~~~--------~~~~E~~~l~~l~-h~ni--v~l~~~~~~~~-~~~~~lv~e~~  409 (552)
                      +.|....+|+....+    ..+++|+...        ...+|.++++.+. |.++  ++++.+|.+.. .+..|+||||+
T Consensus        47 ~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v  126 (822)
T PLN02876         47 GHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYL  126 (822)
T ss_pred             CCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEec
Confidence            344457888876643    4677777532        2458999999995 6665  77777776532 24578999999


Q ss_pred             cCCCc
Q 037224          410 ENGSL  414 (552)
Q Consensus       410 ~~gsL  414 (552)
                      +|..+
T Consensus       127 ~G~~~  131 (822)
T PLN02876        127 EGRIF  131 (822)
T ss_pred             CCccc
Confidence            98654

>PRK11198 LysM domain/BON superfamily protein; Provisional

Probab=97.42  E-value=0.00011  Score=65.14  Aligned_cols=47  Identities=23%  Similarity=0.224  Sum_probs=40.0

Q ss_pred             eeEeeccCCCCCCHHHHHHHhCC---ChhhhcCcCC--CCCCCCCccCCCcEEEe
Q 037224           49 YAFYRASAPDFLDLASIADLFSV---SRLMISEPSN--ISSPSSPLIQNQPLFVP   98 (552)
Q Consensus        49 ~~~y~v~~~~g~tl~~Ia~~~~~---~~~~l~~~N~--~~~~~~~~~~g~~l~iP   98 (552)
                      ...|+|++  ||||++||++|..   ...+|.++|+  +.+ ++.|.+||.|.||
T Consensus        95 ~~~y~Vk~--GDTL~~IA~~~~g~~~~~~~I~~~N~~~l~~-~~~I~pGq~L~IP  146 (147)
T PRK11198         95 SQFYTVKS--GDTLSAIAKKVYGNANKYNKIFEANKPMLKS-PDKIYPGQVLRIP  146 (147)
T ss_pred             CeEEEECC--CCCHHHHHHHHcCChhhHHHHHHhhhhcCCC-cCCcCcCCEEecC
Confidence            45799999  9999999999853   4678999997  665 6779999999998

>COG1652 XkdP Uncharacterized protein containing LysM domain [Function unknown]

Probab=97.32  E-value=9.5e-05  Score=72.81  Aligned_cols=49  Identities=29%  Similarity=0.490  Sum_probs=46.0

Q ss_pred             EEEEecCCchhhhHHhhcCCcchHHHHHHhCC---CCCCCCCCCCcEEEEee
Q 037224          118 SYTIKSGDTFYLVSTNKYQNLTTYQSVEVVNP---TFVPTKLEVGDVIIFPV  166 (552)
Q Consensus       118 ~y~v~~gdtl~~Ia~~~~~~~~~~~~l~~~N~---~~~~~~l~~gq~l~ip~  166 (552)
                      +|+|++|||||.||++.|++.+.+..|..+|.   +.+|+.|.+||+|.||-
T Consensus       212 ~~~v~rgDTl~~is~~~Yg~~~~y~~I~~aNk~~~~~~p~~I~pGq~l~iP~  263 (269)
T COG1652         212 TNTVKRGDTLWQISKKVYGDGVEYRKIAEANKALVLDNPDKIKPGQVLRIPD  263 (269)
T ss_pred             EEEeccCCcccccchhhcCcceEEEeHhhhhhhhccCCCCcCCCcceeeCCC
Confidence            79999999999999999999998889999999   78889999999999994

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.31  E-value=0.0018  Score=64.98  Aligned_cols=129  Identities=23%  Similarity=0.279  Sum_probs=76.1

Q ss_pred             eEEEEEEEEeec--------CcEEEEEEeccC------hHHHHHHHHHcCCCCc-cceeeeeecCCCCeeEEEEeeccCC
Q 037224          348 LIQGSVYKGNIH--------GEVYAIKMMKWN------ACEELKILQKVNHGNL-VKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       348 g~~G~Vy~~~~~--------g~~vAvK~~~~~------~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      |....+|+....        ++.+++|+....      ..+|..++..+....+ .++++++.   +   .+|+||++|.
T Consensus         9 GltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~---~---~~v~e~i~G~   82 (302)
T cd05156           9 GLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP---N---GRIEEFIPSR   82 (302)
T ss_pred             cccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC---C---CchhheeCCC
Confidence            344678887764        478899997542      3478889988854333 44554442   1   4689999987


Q ss_pred             Cchhh-----------------hhhcCCC-------CCC--HHHHHHH--------------------------HHHHHH
Q 037224          413 SLHSW-----------------LHENKNE-------NLN--WKTRLRI--------------------------AIDVAN  440 (552)
Q Consensus       413 sL~~~-----------------l~~~~~~-------~l~--~~~~~~i--------------------------~~qi~~  440 (552)
                      ++...                 ++.....       ...  +..+..+                          ...+..
T Consensus        83 ~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (302)
T cd05156          83 TLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLEDEAK  162 (302)
T ss_pred             cCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHHHHH
Confidence            76431                 1111100       000  1111111                          112222


Q ss_pred             HHHHHHh------CCCCceEecCCCCCcEEECCC----CcEEEeeccCCccC
Q 037224          441 GLQYIHE------HTRPRVVHKDIKSSNILLDSN----MRAKIANFGLAKSG  482 (552)
Q Consensus       441 aL~~LH~------~~~~~ivH~Dikp~NIll~~~----~~~kL~Dfg~a~~~  482 (552)
                      -+.+|..      .....++|+|+.+.||+++++    +.++++||+.+...
T Consensus       163 ~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~  214 (302)
T cd05156         163 YLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN  214 (302)
T ss_pred             HHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence            2334432      133458999999999999885    88999999998643

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.22  E-value=0.0043  Score=57.83  Aligned_cols=117  Identities=19%  Similarity=0.272  Sum_probs=77.5

Q ss_pred             CceEEEEEEEEeecCcEEEEEEeccCh-----------------------HHHHHHHHHcC------CCCccceeeeeec
Q 037224          346 GCLIQGSVYKGNIHGEVYAIKMMKWNA-----------------------CEELKILQKVN------HGNLVKLEGFCID  396 (552)
Q Consensus       346 G~g~~G~Vy~~~~~g~~vAvK~~~~~~-----------------------~~E~~~l~~l~------h~niv~l~~~~~~  396 (552)
                      |.|..-.||..-.+ ....||+.+...                       .+|+.....+.      +.+|.+++|+..+
T Consensus        10 ~~G~~R~cy~HP~d-p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT   88 (199)
T PF10707_consen   10 AQGGERDCYQHPDD-PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVET   88 (199)
T ss_pred             ccCCCceEEECCCC-CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEEEec
Confidence            55555667765443 334667764333                       35777776666      8899999999987


Q ss_pred             CCCCeeEEEEeeccC------CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCC--
Q 037224          397 PEDANCYLIYEYIEN------GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN--  468 (552)
Q Consensus       397 ~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~--  468 (552)
                        +....+|+|.+.+      .+|.+++....   ++. ...+.+.   +-..||-+.+   |+.+|++|.||++...  
T Consensus        89 --~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl~~~NIv~~~~~~  156 (199)
T PF10707_consen   89 --NLGLGLVVELIRDADGNISPTLEDYLKEGG---LTE-ELRQALD---EFKRYLLDHH---IVIRDLNPHNIVVQRRDS  156 (199)
T ss_pred             --CCceEEEEEEEECCCCCcCccHHHHHHcCC---ccH-HHHHHHH---HHHHHHHHcC---CeecCCCcccEEEEecCC
Confidence              5566888888753      36777775433   555 3333333   3445667776   9999999999999432  


Q ss_pred             C--cEEEee
Q 037224          469 M--RAKIAN  475 (552)
Q Consensus       469 ~--~~kL~D  475 (552)
                      +  .+.|+|
T Consensus       157 ~~~~lvlID  165 (199)
T PF10707_consen  157 GEFRLVLID  165 (199)
T ss_pred             CceEEEEEe
Confidence            2  578888

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.20  E-value=0.0032  Score=58.41  Aligned_cols=111  Identities=22%  Similarity=0.397  Sum_probs=77.9

Q ss_pred             CceEE-EEEEEEeecCcEEEEEEecc----------------------------ChHHHHHHHHHcC---CCCc--ccee
Q 037224          346 GCLIQ-GSVYKGNIHGEVYAIKMMKW----------------------------NACEELKILQKVN---HGNL--VKLE  391 (552)
Q Consensus       346 G~g~~-G~Vy~~~~~g~~vAvK~~~~----------------------------~~~~E~~~l~~l~---h~ni--v~l~  391 (552)
                      |.|.. |.||+.+.+|+.+|||+++.                            .+..|.+...+|+   +.++  ++.+
T Consensus        46 g~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~~~Avkc~  125 (207)
T PF13095_consen   46 GHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREGLWAVKCH  125 (207)
T ss_pred             CCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccccCceEEEee
Confidence            77777 99999999999999999421                            1225777777764   4455  8888


Q ss_pred             eeeecCC----------------CCeeEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEe
Q 037224          392 GFCIDPE----------------DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVH  455 (552)
Q Consensus       392 ~~~~~~~----------------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH  455 (552)
                      |+..-..                .....+|.||.+...           .+...    -+.+|.+-+..+|..|   |+-
T Consensus       126 Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~----~~~~~~~dl~~~~k~g---I~~  187 (207)
T PF13095_consen  126 GYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIR----DIPQMLRDLKILHKLG---IVP  187 (207)
T ss_pred             EEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchh----HHHHHHHHHHHHHHCC---eee
Confidence            8874221                112356777765532           12332    3456777889999999   999


Q ss_pred             cCCCCCcEEECCCCcEEEeeccCC
Q 037224          456 KDIKSSNILLDSNMRAKIANFGLA  479 (552)
Q Consensus       456 ~Dikp~NIll~~~~~~kL~Dfg~a  479 (552)
                      +|+++.|..     .-||+|||.+
T Consensus       188 ~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  188 RDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             ccCcccccc-----CCEEEecccC
Confidence            999999986     4589999864

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.06  E-value=0.0094  Score=61.71  Aligned_cols=64  Identities=16%  Similarity=0.084  Sum_probs=42.4

Q ss_pred             CceEEEEEEEEeec-C-cEEEEEEec-------cC-------hHHHHHHHHHcC---CCCccceeeeeecCCCCeeEEEE
Q 037224          346 GCLIQGSVYKGNIH-G-EVYAIKMMK-------WN-------ACEELKILQKVN---HGNLVKLEGFCIDPEDANCYLIY  406 (552)
Q Consensus       346 G~g~~G~Vy~~~~~-g-~~vAvK~~~-------~~-------~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~~~lv~  406 (552)
                      |.|-...||+.... | +.+.||...       ..       ...|.+.|..+.   ..++++++.+  +  ....++||
T Consensus        35 ggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D--~~~~~lVM  110 (401)
T PRK09550         35 GDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--D--EELAVTVM  110 (401)
T ss_pred             CCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--C--CCCCEEEE
Confidence            55555899999884 4 489999742       11       235777777762   3456777655  3  34458999


Q ss_pred             eeccCCC
Q 037224          407 EYIENGS  413 (552)
Q Consensus       407 e~~~~gs  413 (552)
                      ||+++..
T Consensus       111 E~L~~~~  117 (401)
T PRK09550        111 EDLSDHK  117 (401)
T ss_pred             ecCCCcc
Confidence            9998643

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	552
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		6e-38
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		7e-37
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		5e-32
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		5e-32
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		8e-32
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-30
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		4e-29
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		5e-29
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-23
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-23
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-18
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-18
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		7e-18
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		8e-18
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		8e-18
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		8e-18
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		9e-18
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		9e-18
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		9e-18
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		9e-18
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		9e-18
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		9e-18
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-17
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-17
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-17
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-17
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-17
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-17
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-17
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-17
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-17
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-17
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-17
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-17
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-17
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-17
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-17
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-17
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-17
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-17
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-17
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-17
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		4e-17
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-17
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		5e-17
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-17
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		6e-17
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		7e-17
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		8e-17
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		9e-17
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-16
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-16
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-16
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-16
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-16
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-16
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-16
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-16
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-16
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		5e-16
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		5e-16
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		7e-16
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		9e-16
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		9e-16
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-15
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-15
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-15
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-15
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-15
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-15
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-15
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-15
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-15
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-15
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-15
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-15
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-15
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-15
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-15
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-15
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-15
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-15
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		5e-15
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		5e-15
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-15
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		5e-15
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-15
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		5e-15
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		5e-15
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		6e-15
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		6e-15
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		6e-15
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		7e-15
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		7e-15
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		7e-15
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		7e-15
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		7e-15
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		7e-15
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		7e-15
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		8e-15
2pl0_A	289	Lck Bound To Imatinib Length = 289		8e-15
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-15
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		8e-15
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-15
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		9e-15
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		9e-15
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-14
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-14
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-14
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-14
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-14
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-14
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-14
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-14
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-14
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-14
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-14
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-14
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-14
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-14
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-14
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-14
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-14
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-14
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-14
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-14
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-14
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-14
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-14
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-14
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-14
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-14
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-14
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-14
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-14
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-14
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-14
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-14
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-14
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-14
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-14
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-14
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-14
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-14
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-14
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-14
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-14
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-14
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-14
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-14
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-14
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-14
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-14
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-14
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-14
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-14
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-14
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-14
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-14
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-14
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-14
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-14
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		4e-14
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		4e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-14
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-14
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-14
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-14
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-14
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-14
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-14
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-14
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-14
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-14
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-14
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		4e-14
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-14
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-14
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-14
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-14
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-14
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-14
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-14
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		5e-14
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-14
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		5e-14
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-14
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		6e-14
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		6e-14
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-14
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		6e-14
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		6e-14
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		7e-14
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-14
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		7e-14
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		7e-14
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		7e-14
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		8e-14
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		8e-14
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		9e-14
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-13
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-13
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-13
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-13
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-13
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-13
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-13
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-13
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-13
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-13
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-13
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-13
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-13
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-13
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-13
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-13
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-13
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-13
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-13
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-13
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-13
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-13
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-13
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-13
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-13
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-13
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-13
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-13
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-13
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-13
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-13
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-13
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-13
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-13
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-13
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-13
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-13
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-13
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-13
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-13
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-13
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-13
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-13
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-13
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-13
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-13
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-13
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-13
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-13
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-13
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-13
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-13
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		4e-13
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-13
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		4e-13
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-13
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-13
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-13
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-13
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-13
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-13
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-13
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-13
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		5e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		5e-13
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		5e-13
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		5e-13
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-13
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		5e-13
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-13
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-13
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		5e-13
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-13
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		5e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-13
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-13
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-13
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		6e-13
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-13
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-13
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-13
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-13
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		6e-13
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-13
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		6e-13
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		6e-13
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-13
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		6e-13
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-13
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		7e-13
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		7e-13
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		7e-13
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		7e-13
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		7e-13
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		7e-13
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		8e-13
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		8e-13
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		8e-13
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		9e-13
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		9e-13
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		9e-13
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-12
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-12
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-12
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-12
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-12
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-12
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-12
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-12
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-12
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-12
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-12
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-12
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-12
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-12
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-12
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-12
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-12
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-12
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-12
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-12
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-12
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-12
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-12
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-12
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-12
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-12
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-12
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-12
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-12
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-12
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-12
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-12
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-12
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-12
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-12
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-12
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-12
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-12
1fvr_A	327	Tie2 Kinase Domain Length = 327		5e-12
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		5e-12
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		5e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-12
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-12
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		5e-12
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		7e-12
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		7e-12
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-12
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		7e-12
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		8e-12
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		8e-12
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		8e-12
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		8e-12
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		8e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		8e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		9e-12
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		9e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		9e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-11
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-11
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-11
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-11
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-11
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-11
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-11
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-11
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-11
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-11
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-11
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-11
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-11
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-11
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-11
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-11
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-11
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-11
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-11
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-11
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-11
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-11
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-11
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-11
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-11
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-11
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-11
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-11
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-11
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-11
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-11
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-11
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-11
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-11
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-11
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-11
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-11
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-11
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-11
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-11
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-11
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-11
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-11
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-11
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-11
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-11
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-11
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		4e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		5e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		5e-11
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		5e-11
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		5e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		5e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		5e-11
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		5e-11
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-11
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-11
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		5e-11
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		5e-11
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		5e-11
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		6e-11
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		6e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		6e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		6e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-11
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		6e-11
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		6e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		6e-11
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		7e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		7e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		7e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		7e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		7e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		7e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		7e-11
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		8e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		8e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		8e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		8e-11
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		8e-11
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		9e-11
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-10
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-10
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-10
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-10
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-10
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-10
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-10
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-10
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-10
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-10
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-10
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-10
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-10
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-10
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-10
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-10
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-10
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-10
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-10
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-10
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-10
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-10
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-10
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-10
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-10
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-10
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-10
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-10
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-10
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-10
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-10
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-10
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-10
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-10
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-10
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-10
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-10
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-10
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-10
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-10
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-10
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-10
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-10
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-10
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-10
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-10
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-10
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-10
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-10
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-10
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-10
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-10
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-10
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-10
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-10
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-10
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-10
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-10
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-10
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-10
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-10
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-10
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		4e-10
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		4e-10
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-10
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-10
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-10
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-10
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-10
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-10
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		4e-10
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		5e-10
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		5e-10
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-10
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		6e-10
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-10
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		6e-10
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		6e-10
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		6e-10
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-10
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		6e-10
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-10
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		6e-10
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-10
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		6e-10
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		6e-10
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		6e-10
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-10
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		6e-10
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		6e-10
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		6e-10
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		7e-10
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		7e-10
3g51_A	325	Structural Diversity Of The Active Conformation Of		7e-10
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-10
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		7e-10
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		7e-10
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		7e-10
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		7e-10
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		8e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		8e-10
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		8e-10
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		8e-10
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		8e-10
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		8e-10
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		8e-10
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		8e-10
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		9e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		9e-10
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		9e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		9e-10
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		9e-10
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		9e-10
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		9e-10
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		9e-10
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		9e-10
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-09
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-09
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-09
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-09
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-09
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-09
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-09
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-09
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-09
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-09
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-09
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-09
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-09
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-09
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-09
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-09
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-09
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-09
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-09
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-09
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-09
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-09
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-09
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-09
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-09
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-09
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-09
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-09
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-09
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-09
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-09
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-09
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-09
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-09
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-09
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-09
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-09
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-09
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-09
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-09
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-09
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-09
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-09
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-09
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-09
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-09
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-09
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-09
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-09
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-09
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-09
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-09
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-09
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-09
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-09
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-09
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-09
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-09
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-09
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-09
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-09
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-09
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-09
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-09
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-09
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-09
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		4e-09
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-09
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-09
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-09
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-09
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-09
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-09
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-09
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-09
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-09
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-09
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		5e-09
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-09
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		5e-09
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		6e-09
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		6e-09
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		6e-09
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		6e-09
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		6e-09
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		6e-09
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		7e-09
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		7e-09
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		7e-09
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-09
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		7e-09
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		7e-09
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-09
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		8e-09
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		8e-09
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		8e-09
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		8e-09
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		8e-09
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		8e-09
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		8e-09
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		9e-09
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-08
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-08
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-08
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-08
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-08
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-08
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-08
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-08
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-08
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-08
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-08
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-08
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-08
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-08
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-08
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-08
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-08
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-08
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-08
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-08
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-08
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-08
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-08
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-08
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-08
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-08
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-08
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-08
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-08
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-08
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-08
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-08
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-08
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-08
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-08
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-08
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-08
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-08
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-08
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-08
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-08
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-08
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-08
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-08
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		4e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-08
4exu_A	371	Mapk13, Inactive Form Length = 371		4e-08
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		4e-08
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		4e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		4e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		4e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-08
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		4e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-08
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		4e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		4e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		4e-08
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		5e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		5e-08
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-08
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		5e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		5e-08
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		5e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		5e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		5e-08
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-08
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-08
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		5e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		5e-08
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		5e-08
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-08
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		5e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		5e-08
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		5e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		6e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		6e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		6e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		6e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		6e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		6e-08
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		6e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		6e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		6e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		6e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		6e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		6e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		6e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		6e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		6e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-08
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		6e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		6e-08
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		7e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		7e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		7e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		7e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		7e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		7e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		7e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		7e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		7e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		7e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		7e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		7e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		7e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		7e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		7e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		7e-08
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		7e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		7e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		7e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		8e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		8e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		8e-08
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		8e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		8e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		8e-08
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		9e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		9e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		9e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		9e-08
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		9e-08
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		9e-08
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		9e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		9e-08
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-07
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-07
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-07
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-07
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-07
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-07
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-07
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-07
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-07
3soa_A	444	Full-Length Human Camkii Length = 444		2e-07
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-07
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-07
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-07
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-07
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		5e-07
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		5e-07
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		5e-07
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		6e-07
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		6e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		6e-07
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		6e-07
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-07
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		6e-07
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		6e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		6e-07
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		6e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		6e-07
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		7e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		7e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		7e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		7e-07
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		8e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-07
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-06
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-06
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-06
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-06
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-06
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-06
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-06
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-06
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-06
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-06
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-06
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-06
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-06
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-06
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-06
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-06
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-06
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-06
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-06
4eby_A	212	Crystal Structure Of The Ectodomain Of A Receptor L		2e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-06
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-06
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-06
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-06
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-06
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		4e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		4e-06
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		4e-06
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		5e-06
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-06
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		6e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		6e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		6e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		7e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		7e-06
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		8e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		9e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		9e-06
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-05
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-05
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-05
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-05
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		4e-05
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		4e-05
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		4e-05
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-05
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		5e-05
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		5e-05
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		6e-05
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		7e-05
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		8e-05
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		9e-05
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		9e-05
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-04
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		7e-04
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		8e-04
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-04
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		8e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  155 bits (392), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 88/225 (39%), Positives = 132/225 (58%), Gaps = 20/225 (8%)
Query: 325 LDKYRIFKIEELREATDNFSEGCLIQ----GSVYKGNI-HGEVYAIKMMKWNACE----- 374
           L + + F + EL+ A+DNFS   ++     G VYKG +  G + A+K +K    +     
Sbjct: 22  LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQ 81
Query: 375 ---ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNEN--LNWK 429
              E++++    H NL++L GFC+ P +    L+Y Y+ NGS+ S L E       L+W 
Sbjct: 82  FQTEVEMISMAVHRNLLRLRGFCMTPTER--LLVYPYMANGSVASCLRERPESQPPLDWP 139
Query: 430 TRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK---SGCNAI 486
            R RIA+  A GL Y+H+H  P+++H+D+K++NILLD    A + +FGLAK        +
Sbjct: 140 KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHV 199
Query: 487 TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
              + GT G+IAPEYL+ G  S K DVF +GV+LLELI+G+ A D
Sbjct: 200 XXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 244

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  151 bits (382), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 86/225 (38%), Positives = 130/225 (57%), Gaps = 20/225 (8%)
Query: 325 LDKYRIFKIEELREATDNFSEGCLIQ----GSVYKGNI-HGEVYAIKMMKWNACE----- 374
           L + + F + EL+ A+DNF    ++     G VYKG +  G + A+K +K    +     
Sbjct: 14  LGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQ 73
Query: 375 ---ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNEN--LNWK 429
              E++++    H NL++L GFC+ P +    L+Y Y+ NGS+ S L E       L+W 
Sbjct: 74  FQTEVEMISMAVHRNLLRLRGFCMTPTER--LLVYPYMANGSVASCLRERPESQPPLDWP 131
Query: 430 TRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK---SGCNAI 486
            R RIA+  A GL Y+H+H  P+++H+D+K++NILLD    A + +FGLAK        +
Sbjct: 132 KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHV 191
Query: 487 TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
              + G  G+IAPEYL+ G  S K DVF +GV+LLELI+G+ A D
Sbjct: 192 XXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  135 bits (341), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 91/239 (38%), Positives = 132/239 (55%), Gaps = 34/239 (14%)
Query: 320 DVSDCLDKYRIFKIEELREATDNFSEGCLIQGS----------VYKGNIHGEVYAIKMM- 368
           +VSD   ++  F   EL+  T+NF E  +  G           VYKG ++    A+K + 
Sbjct: 6   EVSDT--RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLA 63
Query: 369 ----------KWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL 418
                     K    +E+K++ K  H NLV+L GF  D +D  C L+Y Y+ NGSL   L
Sbjct: 64  AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDL-C-LVYVYMPNGSLLDRL 121
Query: 419 H-ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFG 477
              +    L+W  R +IA   ANG+ ++HE+     +H+DIKS+NILLD    AKI++FG
Sbjct: 122 SCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFG 178
Query: 478 LAKS----GCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDE 532
           LA++        +   IVGT  Y+APE L  G ++ K D++SFGVVLLE+I+G  A+DE
Sbjct: 179 LARASEKFAQTVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 236

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  135 bits (340), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 91/239 (38%), Positives = 132/239 (55%), Gaps = 34/239 (14%)
Query: 320 DVSDCLDKYRIFKIEELREATDNFSEGCLIQGS----------VYKGNIHGEVYAIKMM- 368
           +VSD   ++  F   EL+  T+NF E  +  G           VYKG ++    A+K + 
Sbjct: 6   EVSDT--RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLA 63
Query: 369 ----------KWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL 418
                     K    +E+K++ K  H NLV+L GF  D +D  C L+Y Y+ NGSL   L
Sbjct: 64  AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDL-C-LVYVYMPNGSLLDRL 121
Query: 419 H-ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFG 477
              +    L+W  R +IA   ANG+ ++HE+     +H+DIKS+NILLD    AKI++FG
Sbjct: 122 SCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFG 178
Query: 478 LAKS----GCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDE 532
           LA++        +   IVGT  Y+APE L  G ++ K D++SFGVVLLE+I+G  A+DE
Sbjct: 179 LARASEKFAQTVMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 236

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  135 bits (339), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 91/238 (38%), Positives = 131/238 (55%), Gaps = 34/238 (14%)
Query: 321 VSDCLDKYRIFKIEELREATDNFSEGCLIQGS----------VYKGNIHGEVYAIKMM-- 368
           VSD   ++  F   EL+  T+NF E  +  G           VYKG ++    A+K +  
Sbjct: 1   VSDT--RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAA 58
Query: 369 ---------KWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLH 419
                    K    +E+K++ K  H NLV+L GF  D +D  C L+Y Y+ NGSL   L 
Sbjct: 59  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDL-C-LVYVYMPNGSLLDRLS 116
Query: 420 -ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGL 478
             +    L+W  R +IA   ANG+ ++HE+     +H+DIKS+NILLD    AKI++FGL
Sbjct: 117 CLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGL 173
Query: 479 AKS----GCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDE 532
           A++        +   IVGT  Y+APE L  G ++ K D++SFGVVLLE+I+G  A+DE
Sbjct: 174 ARASEKFAQXVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 230

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  130 bits (326), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 88/232 (37%), Positives = 124/232 (53%), Gaps = 32/232 (13%)
Query: 327 KYRIFKIEELREATDNFSEGCLIQGS----------VYKGNIHGEVYAIKMM-------- 368
           ++  F   EL+  T+NF E  +  G           VYKG ++    A+K +        
Sbjct: 2   RFHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT 61
Query: 369 ---KWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLH-ENKNE 424
              K    +E+K+  K  H NLV+L GF  D +D  C L+Y Y  NGSL   L   +   
Sbjct: 62  EELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDL-C-LVYVYXPNGSLLDRLSCLDGTP 119
Query: 425 NLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS--- 481
            L+W  R +IA   ANG+ ++HE+     +H+DIKS+NILLD    AKI++FGLA++   
Sbjct: 120 PLSWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEK 176
Query: 482 -GCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDE 532
                    IVGT  Y APE L  G ++ K D++SFGVVLLE+I+G  A+DE
Sbjct: 177 FAQXVXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 227

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 87/224 (38%), Positives = 123/224 (54%), Gaps = 24/224 (10%)
Query: 325 LDKYRIFKIEELREATDNFSEGCLIQ----GSVYKGNIH-GEVYAIKMMKWNACE----- 374
            + YR+  + +L EAT+NF    LI     G VYKG +  G   A+K     + +     
Sbjct: 24  FESYRV-PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEF 82
Query: 375 --ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL--HSWLHENKNENLNWKT 430
             E++ L    H +LV L GFC   E     LIY+Y+ENG+L  H +  +    +++W+ 
Sbjct: 83  ETEIETLSFCRHPHLVSLIGFC--DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQ 140
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
           RL I I  A GL Y+H  TR  ++H+D+KS NILLD N   KI +FG++K G      H+
Sbjct: 141 RLEICIGAARGLHYLH--TRA-IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL 197
Query: 491 V----GTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAI 530
                GT GYI PEY   G ++ K DV+SFGVVL E++  + AI
Sbjct: 198 XXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI 241

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  125 bits (315), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 87/224 (38%), Positives = 123/224 (54%), Gaps = 24/224 (10%)
Query: 325 LDKYRIFKIEELREATDNFSEGCLIQ----GSVYKGNIH-GEVYAIKMMKWNACE----- 374
            + YR+  + +L EAT+NF    LI     G VYKG +  G   A+K     + +     
Sbjct: 24  FESYRV-PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEF 82
Query: 375 --ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL--HSWLHENKNENLNWKT 430
             E++ L    H +LV L GFC   E     LIY+Y+ENG+L  H +  +    +++W+ 
Sbjct: 83  ETEIETLSFCRHPHLVSLIGFC--DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQ 140
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
           RL I I  A GL Y+H  TR  ++H+D+KS NILLD N   KI +FG++K G      H+
Sbjct: 141 RLEICIGAARGLHYLH--TRA-IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHL 197
Query: 491 V----GTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAI 530
                GT GYI PEY   G ++ K DV+SFGVVL E++  + AI
Sbjct: 198 XXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI 241

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/187 (34%), Positives = 105/187 (56%), Gaps = 15/187 (8%)
Query: 351 GSVYKGNIHGEVYAIKMM---KWNA------CEELKILQKVNHGNLVKLEGFCIDPEDAN 401
           G+V++   HG   A+K++    ++A        E+ I++++ H N+V   G    P   N
Sbjct: 51  GTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP--PN 108
Query: 402 CYLIYEYIENGSLHSWLHEN-KNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             ++ EY+  GSL+  LH++   E L+ + RL +A DVA G+ Y+H    P +VH+D+KS
Sbjct: 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPP-IVHRDLKS 167
Query: 461 SNILLDSNMRAKIANFGLA--KSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGV 518
            N+L+D     K+ +FGL+  K+     +    GT  ++APE L D   + K DV+SFGV
Sbjct: 168 PNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGV 227
Query: 519 VLLELIS 525
           +L EL +
Sbjct: 228 ILWELAT 234

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 62/187 (33%), Positives = 105/187 (56%), Gaps = 15/187 (8%)
Query: 351 GSVYKGNIHGEVYAIKMM---KWNA------CEELKILQKVNHGNLVKLEGFCIDPEDAN 401
           G+V++   HG   A+K++    ++A        E+ I++++ H N+V   G    P   N
Sbjct: 51  GTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP--PN 108
Query: 402 CYLIYEYIENGSLHSWLHEN-KNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             ++ EY+  GSL+  LH++   E L+ + RL +A DVA G+ Y+H    P +VH+++KS
Sbjct: 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPP-IVHRNLKS 167
Query: 461 SNILLDSNMRAKIANFGLAKSGCNAI--TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGV 518
            N+L+D     K+ +FGL++   +    +    GT  ++APE L D   + K DV+SFGV
Sbjct: 168 PNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGV 227
Query: 519 VLLELIS 525
           +L EL +
Sbjct: 228 ILWELAT 234

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 59/167 (35%), Positives = 92/167 (55%), Gaps = 17/167 (10%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTR--- 431
           EL+ L +VNH N+VKL G C++P      L+ EY E GSL++ LH    E L + T    
Sbjct: 52  ELRQLSRVNHPNIVKLYGACLNP----VCLVMEYAEGGSLYNVLH--GAEPLPYYTAAHA 105
Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRA-KIANFGLAKSGCNAITMHI 490
           +   +  + G+ Y+H      ++H+D+K  N+LL +     KI +FG A   C+ I  H+
Sbjct: 106 MSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA---CD-IQTHM 161
Query: 491 V---GTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG 534
               G+  ++APE       S K DVFS+G++L E+I+ ++  DE G
Sbjct: 162 TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG 208

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 59/167 (35%), Positives = 92/167 (55%), Gaps = 17/167 (10%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTR--- 431
           EL+ L +VNH N+VKL G C++P      L+ EY E GSL++ LH    E L + T    
Sbjct: 51  ELRQLSRVNHPNIVKLYGACLNP----VCLVMEYAEGGSLYNVLH--GAEPLPYYTAAHA 104
Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRA-KIANFGLAKSGCNAITMHI 490
           +   +  + G+ Y+H      ++H+D+K  N+LL +     KI +FG A   C+ I  H+
Sbjct: 105 MSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA---CD-IQTHM 160
Query: 491 V---GTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG 534
               G+  ++APE       S K DVFS+G++L E+I+ ++  DE G
Sbjct: 161 TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG 207

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 59/178 (33%), Positives = 92/178 (51%), Gaps = 16/178 (8%)
Query: 360 GEVYAIKMMKWNACE-------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG 412
           GEV A+K ++ +  E       E++IL+ + H N+VK +G C      N  LI EY+  G
Sbjct: 70  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 129
Query: 413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAK 472
           SL  +L ++K E ++    L+    +  G++Y+      R +H+D+ + NIL+++  R K
Sbjct: 130 SLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 185
Query: 473 IANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           I +FGL K          V   G     + APE L +   S   DV+SFGVVL EL +
Sbjct: 186 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 59/178 (33%), Positives = 92/178 (51%), Gaps = 16/178 (8%)
Query: 360 GEVYAIKMMKWNACE-------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG 412
           GEV A+K ++ +  E       E++IL+ + H N+VK +G C      N  LI EY+  G
Sbjct: 39  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 98
Query: 413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAK 472
           SL  +L ++K E ++    L+    +  G++Y+      R +H+D+ + NIL+++  R K
Sbjct: 99  SLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 154
Query: 473 IANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           I +FGL K          V   G     + APE L +   S   DV+SFGVVL EL +
Sbjct: 155 IGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 59/178 (33%), Positives = 92/178 (51%), Gaps = 16/178 (8%)
Query: 360 GEVYAIKMMKWNACE-------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG 412
           GEV A+K ++ +  E       E++IL+ + H N+VK +G C      N  LI EY+  G
Sbjct: 44  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 103
Query: 413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAK 472
           SL  +L ++K E ++    L+    +  G++Y+      R +H+D+ + NIL+++  R K
Sbjct: 104 SLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 159
Query: 473 IANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           I +FGL K          V   G     + APE L +   S   DV+SFGVVL EL +
Sbjct: 160 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 30/199 (15%)
Query: 351 GSVYKGNIHGEVYAIKMMKW-----------NACEELKILQKVNHGNLVKLEGFCIDPED 399
           G VY+    G+  A+K  +            N  +E K+   + H N++ L G C+  ++
Sbjct: 21  GKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL--KE 78
Query: 400 ANCYLIYEYIENGSLHSWLHENK---NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHK 456
            N  L+ E+   G L+  L   +   +  +NW      A+ +A G+ Y+H+     ++H+
Sbjct: 79  PNLCLVMEFARGGPLNRVLSGKRIPPDILVNW------AVQIARGMNYLHDEAIVPIIHR 132
Query: 457 DIKSSNILLD--------SNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVS 508
           D+KSSNIL+         SN   KI +FGLA+       M   G   ++APE +   + S
Sbjct: 133 DLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFS 192
Query: 509 TKMDVFSFGVVLLELISGK 527
              DV+S+GV+L EL++G+
Sbjct: 193 KGSDVWSYGVLLWELLTGE 211

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 59/178 (33%), Positives = 92/178 (51%), Gaps = 16/178 (8%)
Query: 360 GEVYAIKMMKWNACE-------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG 412
           GEV A+K ++ +  E       E++IL+ + H N+VK +G C      N  LI EY+  G
Sbjct: 43  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 102
Query: 413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAK 472
           SL  +L ++K E ++    L+    +  G++Y+      R +H+D+ + NIL+++  R K
Sbjct: 103 SLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 158
Query: 473 IANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           I +FGL K          V   G     + APE L +   S   DV+SFGVVL EL +
Sbjct: 159 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 59/178 (33%), Positives = 92/178 (51%), Gaps = 16/178 (8%)
Query: 360 GEVYAIKMMKWNACE-------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG 412
           GEV A+K ++ +  E       E++IL+ + H N+VK +G C      N  LI EY+  G
Sbjct: 38  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 97
Query: 413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAK 472
           SL  +L ++K E ++    L+    +  G++Y+      R +H+D+ + NIL+++  R K
Sbjct: 98  SLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 153
Query: 473 IANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           I +FGL K          V   G     + APE L +   S   DV+SFGVVL EL +
Sbjct: 154 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 59/178 (33%), Positives = 92/178 (51%), Gaps = 16/178 (8%)
Query: 360 GEVYAIKMMKWNACE-------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG 412
           GEV A+K ++ +  E       E++IL+ + H N+VK +G C      N  LI EY+  G
Sbjct: 37  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 96
Query: 413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAK 472
           SL  +L ++K E ++    L+    +  G++Y+      R +H+D+ + NIL+++  R K
Sbjct: 97  SLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 152
Query: 473 IANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           I +FGL K          V   G     + APE L +   S   DV+SFGVVL EL +
Sbjct: 153 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 59/178 (33%), Positives = 92/178 (51%), Gaps = 16/178 (8%)
Query: 360 GEVYAIKMMKWNACE-------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG 412
           GEV A+K ++ +  E       E++IL+ + H N+VK +G C      N  LI EY+  G
Sbjct: 42  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 101
Query: 413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAK 472
           SL  +L ++K E ++    L+    +  G++Y+      R +H+D+ + NIL+++  R K
Sbjct: 102 SLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 157
Query: 473 IANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           I +FGL K          V   G     + APE L +   S   DV+SFGVVL EL +
Sbjct: 158 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 59/178 (33%), Positives = 92/178 (51%), Gaps = 16/178 (8%)
Query: 360 GEVYAIKMMKWNACE-------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG 412
           GEV A+K ++ +  E       E++IL+ + H N+VK +G C      N  LI EY+  G
Sbjct: 46  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 105
Query: 413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAK 472
           SL  +L ++K E ++    L+    +  G++Y+      R +H+D+ + NIL+++  R K
Sbjct: 106 SLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 161
Query: 473 IANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           I +FGL K          V   G     + APE L +   S   DV+SFGVVL EL +
Sbjct: 162 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 59/178 (33%), Positives = 92/178 (51%), Gaps = 16/178 (8%)
Query: 360 GEVYAIKMMKWNACE-------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG 412
           GEV A+K ++ +  E       E++IL+ + H N+VK +G C      N  LI EY+  G
Sbjct: 45  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 104
Query: 413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAK 472
           SL  +L ++K E ++    L+    +  G++Y+      R +H+D+ + NIL+++  R K
Sbjct: 105 SLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 160
Query: 473 IANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           I +FGL K          V   G     + APE L +   S   DV+SFGVVL EL +
Sbjct: 161 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/193 (31%), Positives = 102/193 (52%), Gaps = 24/193 (12%)
Query: 351 GSVYKGNIHGEVYAIKMMKWNAC---------EELKILQKVNHGNLVKLEGFCIDPEDAN 401
           G+VYKG  HG+V A+KM+   A           E+ +L+K  H N++   G+   P+ A 
Sbjct: 38  GTVYKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLA- 95
Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSS 461
             ++ ++ E  SL+  LH ++ +    K  + IA   A G+ Y+H  +   ++H+D+KS+
Sbjct: 96  --IVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSN 149
Query: 462 NILLDSNMRAKIANFGLAKSGCNAITMH----IVGTQGYIAPEYLA---DGVVSTKMDVF 514
           NI L  +   KI +FGLA         H    + G+  ++APE +        S + DV+
Sbjct: 150 NIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVY 209
Query: 515 SFGVVLLELISGK 527
           +FG+VL EL++G+
Sbjct: 210 AFGIVLYELMTGQ 222

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/178 (33%), Positives = 92/178 (51%), Gaps = 16/178 (8%)
Query: 360 GEVYAIKMMKWNACE-------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG 412
           GEV A+K ++ +  E       E++IL+ + H N+VK +G C      N  LI EY+  G
Sbjct: 39  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 98
Query: 413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAK 472
           SL  +L ++K E ++    L+    +  G++Y+      R +H+D+ + NIL+++  R K
Sbjct: 99  SLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 154
Query: 473 IANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           I +FGL K          V   G     + APE L +   S   DV+SFGVVL EL +
Sbjct: 155 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/178 (33%), Positives = 92/178 (51%), Gaps = 16/178 (8%)
Query: 360 GEVYAIKMMKWNACE-------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG 412
           GEV A+K ++ +  E       E++IL+ + H N+VK +G C      N  LI EY+  G
Sbjct: 39  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 98
Query: 413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAK 472
           SL  +L ++K E ++    L+    +  G++Y+      R +H+D+ + NIL+++  R K
Sbjct: 99  SLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 154
Query: 473 IANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           I +FGL K          V   G     + APE L +   S   DV+SFGVVL EL +
Sbjct: 155 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/193 (31%), Positives = 102/193 (52%), Gaps = 24/193 (12%)
Query: 351 GSVYKGNIHGEVYAIKMMKWNAC---------EELKILQKVNHGNLVKLEGFCIDPEDAN 401
           G+VYKG  HG+V A+KM+   A           E+ +L+K  H N++   G+   P+ A 
Sbjct: 38  GTVYKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLA- 95
Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSS 461
             ++ ++ E  SL+  LH ++ +    K  + IA   A G+ Y+H  +   ++H+D+KS+
Sbjct: 96  --IVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSN 149
Query: 462 NILLDSNMRAKIANFGLAKSGCNAITMH----IVGTQGYIAPEYLA---DGVVSTKMDVF 514
           NI L  +   KI +FGLA         H    + G+  ++APE +        S + DV+
Sbjct: 150 NIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVY 209
Query: 515 SFGVVLLELISGK 527
           +FG+VL EL++G+
Sbjct: 210 AFGIVLYELMTGQ 222

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/178 (33%), Positives = 92/178 (51%), Gaps = 16/178 (8%)
Query: 360 GEVYAIKMMKWNACE-------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG 412
           GEV A+K ++ +  E       E++IL+ + H N+VK +G C      N  LI EY+  G
Sbjct: 57  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 116
Query: 413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAK 472
           SL  +L ++K E ++    L+    +  G++Y+      R +H+D+ + NIL+++  R K
Sbjct: 117 SLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 172
Query: 473 IANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           I +FGL K          V   G     + APE L +   S   DV+SFGVVL EL +
Sbjct: 173 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/178 (33%), Positives = 92/178 (51%), Gaps = 16/178 (8%)
Query: 360 GEVYAIKMMKWNACE-------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG 412
           GEV A+K ++ +  E       E++IL+ + H N+VK +G C      N  LI EY+  G
Sbjct: 57  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 116
Query: 413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAK 472
           SL  +L ++K E ++    L+    +  G++Y+      R +H+D+ + NIL+++  R K
Sbjct: 117 SLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 172
Query: 473 IANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           I +FGL K          V   G     + APE L +   S   DV+SFGVVL EL +
Sbjct: 173 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 103/195 (52%), Gaps = 28/195 (14%)
Query: 351 GSVYKGNIHGEVYAIKMMKWNAC---------EELKILQKVNHGNLVKLEGFCIDPEDAN 401
           G+VYKG  HG+V A+KM+   A           E+ +L+K  H N++   G+   P+ A 
Sbjct: 42  GTVYKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLA- 99
Query: 402 CYLIYEYIENGSLHSWLH--ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIK 459
             ++ ++ E  SL+  LH  E K E +     + IA   A G+ Y+H  +   ++H+D+K
Sbjct: 100 --IVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLHAKS---IIHRDLK 151
Query: 460 SSNILLDSNMRAKIANFGLAKSGCNAITMH----IVGTQGYIAPEYLA---DGVVSTKMD 512
           S+NI L  ++  KI +FGLA         H    + G+  ++APE +        S + D
Sbjct: 152 SNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 211
Query: 513 VFSFGVVLLELISGK 527
           V++FG+VL EL++G+
Sbjct: 212 VYAFGIVLYELMTGQ 226

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/194 (31%), Positives = 104/194 (53%), Gaps = 26/194 (13%)
Query: 351 GSVYKGNIHGEVYAIKMMKWNAC---------EELKILQKVNHGNLVKLEGFCIDPEDAN 401
           G+VYKG  HG+V A+KM+   A           E+ +L+K  H N++   G+   P+ A 
Sbjct: 26  GTVYKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLA- 83
Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSS 461
             ++ ++ E  SL+  LH ++ +    K  + IA   A G+ Y+H  +   ++H+D+KS+
Sbjct: 84  --IVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSN 137
Query: 462 NILLDSNMRAKIANFGLAK-----SGCNAITMHIVGTQGYIAPEYLA---DGVVSTKMDV 513
           NI L  +   KI +FGLA      SG +     + G+  ++APE +        S + DV
Sbjct: 138 NIFLHEDNTVKIGDFGLATVKSRWSGSHQFE-QLSGSILWMAPEVIRMQDSNPYSFQSDV 196
Query: 514 FSFGVVLLELISGK 527
           ++FG+VL EL++G+
Sbjct: 197 YAFGIVLYELMTGQ 210

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 104/206 (50%), Gaps = 23/206 (11%)
Query: 351 GSVYKGN--IHGEVYAIKMMKWN---ACEELKILQKVNHGNLVKL----EGFCIDPEDAN 401
           G V+K    I G+ Y IK +K+N   A  E+K L K++H N+V      +GF  DPE ++
Sbjct: 25  GQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84
Query: 402 ---------CYLI-YEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRP 451
                    C  I  E+ + G+L  W+ + + E L+    L +   +  G+ YIH     
Sbjct: 85  KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---K 141
Query: 452 RVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN-AITMHIVGTQGYIAPEYLADGVVSTK 510
           +++++D+K SNI L    + KI +FGL  S  N        GT  Y++PE ++      +
Sbjct: 142 KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMSPEQISSQDYGKE 201
Query: 511 MDVFSFGVVLLELISGKEAIDEEGKF 536
           +D+++ G++L EL+   +   E  KF
Sbjct: 202 VDLYALGLILAELLHVCDTAFETSKF 227

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 103/195 (52%), Gaps = 28/195 (14%)
Query: 351 GSVYKGNIHGEVYAIKMMKWNAC---------EELKILQKVNHGNLVKLEGFCIDPEDAN 401
           G+VYKG  HG+V A+KM+   A           E+ +L+K  H N++   G+   P+ A 
Sbjct: 50  GTVYKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLA- 107
Query: 402 CYLIYEYIENGSLHSWLH--ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIK 459
             ++ ++ E  SL+  LH  E K E +     + IA   A G+ Y+H  +   ++H+D+K
Sbjct: 108 --IVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLHAKS---IIHRDLK 159
Query: 460 SSNILLDSNMRAKIANFGLAKSGCNAITMH----IVGTQGYIAPEYLA---DGVVSTKMD 512
           S+NI L  ++  KI +FGLA         H    + G+  ++APE +        S + D
Sbjct: 160 SNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 219
Query: 513 VFSFGVVLLELISGK 527
           V++FG+VL EL++G+
Sbjct: 220 VYAFGIVLYELMTGQ 234

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 103/195 (52%), Gaps = 28/195 (14%)
Query: 351 GSVYKGNIHGEVYAIKMMKWNAC---------EELKILQKVNHGNLVKLEGFCIDPEDAN 401
           G+VYKG  HG+V A+KM+   A           E+ +L+K  H N++   G+   P+ A 
Sbjct: 22  GTVYKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLA- 79
Query: 402 CYLIYEYIENGSLHSWLH--ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIK 459
             ++ ++ E  SL+  LH  E K E +     + IA   A G+ Y+H  +   ++H+D+K
Sbjct: 80  --IVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLHAKS---IIHRDLK 131
Query: 460 SSNILLDSNMRAKIANFGLAKSGCNAITMH----IVGTQGYIAPEYLA---DGVVSTKMD 512
           S+NI L  ++  KI +FGLA         H    + G+  ++APE +        S + D
Sbjct: 132 SNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 191
Query: 513 VFSFGVVLLELISGK 527
           V++FG+VL EL++G+
Sbjct: 192 VYAFGIVLYELMTGQ 206

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 94/180 (52%), Gaps = 10/180 (5%)
Query: 351 GSVYKGNIHGEVYAIKMMKWNACE-----ELKILQKVNHGNLVKLEGFCIDPEDANCYLI 405
           G V  G+  G   A+K +K +A       E  ++ ++ H NLV+L G  ++ E    Y++
Sbjct: 26  GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE-EKGGLYIV 84
Query: 406 YEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL 465
            EY+  GSL  +L       L     L+ ++DV   ++Y+  +     VH+D+ + N+L+
Sbjct: 85  TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLV 141
Query: 466 DSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
             +  AK+++FGL K   +      +  + + APE L +   STK DV+SFG++L E+ S
Sbjct: 142 SEDNVAKVSDFGLTKEASSTQDTGKLPVK-WTAPEALREAAFSTKSDVWSFGILLWEIYS 200

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/178 (32%), Positives = 93/178 (52%), Gaps = 16/178 (8%)
Query: 360 GEVYAIKMMKWNACE-------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG 412
           GEV A+K ++ +  E       E++IL+ + H N+VK +G C      N  LI EY+  G
Sbjct: 40  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 99
Query: 413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAK 472
           SL  +L ++K E ++    L+    +  G++Y+      R +H+++ + NIL+++  R K
Sbjct: 100 SLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYL---GTKRYIHRNLATRNILVENENRVK 155
Query: 473 IANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           I +FGL K        + V   G     + APE L +   S   DV+SFGVVL EL +
Sbjct: 156 IGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 105/196 (53%), Gaps = 30/196 (15%)
Query: 351 GSVYKGNIHGEVYAIKMMKWNAC---------EELKILQKVNHGNLVKLEGFCIDPEDAN 401
           G+VYKG  HG+V A+KM+   A           E+ +L+K  H N++   G+   P+ A 
Sbjct: 49  GTVYKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLA- 106
Query: 402 CYLIYEYIENGSLHSWLH--ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIK 459
             ++ ++ E  SL+  LH  E K E +     + IA   A G+ Y+H  +   ++H+D+K
Sbjct: 107 --IVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLHAKS---IIHRDLK 158
Query: 460 SSNILLDSNMRAKIANFGLAK-----SGCNAITMHIVGTQGYIAPEYLA---DGVVSTKM 511
           S+NI L  ++  KI +FGLA      SG +     + G+  ++APE +        S + 
Sbjct: 159 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE-QLSGSILWMAPEVIRMQDKNPYSFQS 217
Query: 512 DVFSFGVVLLELISGK 527
           DV++FG+VL EL++G+
Sbjct: 218 DVYAFGIVLYELMTGQ 233

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 105/196 (53%), Gaps = 30/196 (15%)
Query: 351 GSVYKGNIHGEVYAIKMMKWNAC---------EELKILQKVNHGNLVKLEGFCIDPEDAN 401
           G+VYKG  HG+V A+KM+   A           E+ +L+K  H N++   G+   P+ A 
Sbjct: 24  GTVYKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLA- 81
Query: 402 CYLIYEYIENGSLHSWLH--ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIK 459
             ++ ++ E  SL+  LH  E K E +     + IA   A G+ Y+H  +   ++H+D+K
Sbjct: 82  --IVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLHAKS---IIHRDLK 133
Query: 460 SSNILLDSNMRAKIANFGLAK-----SGCNAITMHIVGTQGYIAPEYLA---DGVVSTKM 511
           S+NI L  ++  KI +FGLA      SG +     + G+  ++APE +        S + 
Sbjct: 134 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE-QLSGSILWMAPEVIRMQDKNPYSFQS 192
Query: 512 DVFSFGVVLLELISGK 527
           DV++FG+VL EL++G+
Sbjct: 193 DVYAFGIVLYELMTGQ 208

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 105/196 (53%), Gaps = 30/196 (15%)
Query: 351 GSVYKGNIHGEVYAIKMMKWNAC---------EELKILQKVNHGNLVKLEGFCIDPEDAN 401
           G+VYKG  HG+V A+KM+   A           E+ +L+K  H N++   G+   P+ A 
Sbjct: 50  GTVYKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLA- 107
Query: 402 CYLIYEYIENGSLHSWLH--ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIK 459
             ++ ++ E  SL+  LH  E K E +     + IA   A G+ Y+H  +   ++H+D+K
Sbjct: 108 --IVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLHAKS---IIHRDLK 159
Query: 460 SSNILLDSNMRAKIANFGLAK-----SGCNAITMHIVGTQGYIAPEYLA---DGVVSTKM 511
           S+NI L  ++  KI +FGLA      SG +     + G+  ++APE +        S + 
Sbjct: 160 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE-QLSGSILWMAPEVIRMQDKNPYSFQS 218
Query: 512 DVFSFGVVLLELISGK 527
           DV++FG+VL EL++G+
Sbjct: 219 DVYAFGIVLYELMTGQ 234

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 105/196 (53%), Gaps = 30/196 (15%)
Query: 351 GSVYKGNIHGEVYAIKMMKWNAC---------EELKILQKVNHGNLVKLEGFCIDPEDAN 401
           G+VYKG  HG+V A+KM+   A           E+ +L+K  H N++   G+   P+ A 
Sbjct: 27  GTVYKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLA- 84
Query: 402 CYLIYEYIENGSLHSWLH--ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIK 459
             ++ ++ E  SL+  LH  E K E +     + IA   A G+ Y+H  +   ++H+D+K
Sbjct: 85  --IVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLHAKS---IIHRDLK 136
Query: 460 SSNILLDSNMRAKIANFGLAK-----SGCNAITMHIVGTQGYIAPEYLA---DGVVSTKM 511
           S+NI L  ++  KI +FGLA      SG +     + G+  ++APE +        S + 
Sbjct: 137 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE-QLSGSILWMAPEVIRMQDKNPYSFQS 195
Query: 512 DVFSFGVVLLELISGK 527
           DV++FG+VL EL++G+
Sbjct: 196 DVYAFGIVLYELMTGQ 211

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 105/196 (53%), Gaps = 30/196 (15%)
Query: 351 GSVYKGNIHGEVYAIKMMKWNAC---------EELKILQKVNHGNLVKLEGFCIDPEDAN 401
           G+VYKG  HG+V A+KM+   A           E+ +L+K  H N++   G+   P+ A 
Sbjct: 22  GTVYKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLA- 79
Query: 402 CYLIYEYIENGSLHSWLH--ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIK 459
             ++ ++ E  SL+  LH  E K E +     + IA   A G+ Y+H  +   ++H+D+K
Sbjct: 80  --IVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLHAKS---IIHRDLK 131
Query: 460 SSNILLDSNMRAKIANFGLAK-----SGCNAITMHIVGTQGYIAPEYLA---DGVVSTKM 511
           S+NI L  ++  KI +FGLA      SG +     + G+  ++APE +        S + 
Sbjct: 132 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE-QLSGSILWMAPEVIRMQDKNPYSFQS 190
Query: 512 DVFSFGVVLLELISGK 527
           DV++FG+VL EL++G+
Sbjct: 191 DVYAFGIVLYELMTGQ 206

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/178 (32%), Positives = 92/178 (51%), Gaps = 16/178 (8%)
Query: 360 GEVYAIKMMKWNACE-------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG 412
           GEV A+K ++ +  E       E++IL+ + H N+VK +G C      N  LI E++  G
Sbjct: 42  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYG 101
Query: 413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAK 472
           SL  +L ++K E ++    L+    +  G++Y+      R +H+D+ + NIL+++  R K
Sbjct: 102 SLREYLQKHK-ERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 157
Query: 473 IANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           I +FGL K          V   G     + APE L +   S   DV+SFGVVL EL +
Sbjct: 158 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 105/196 (53%), Gaps = 30/196 (15%)
Query: 351 GSVYKGNIHGEVYAIKMMKWNAC---------EELKILQKVNHGNLVKLEGFCIDPEDAN 401
           G+VYKG  HG+V A+KM+   A           E+ +L+K  H N++   G+   P+ A 
Sbjct: 27  GTVYKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLA- 84
Query: 402 CYLIYEYIENGSLHSWLH--ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIK 459
             ++ ++ E  SL+  LH  E K E +     + IA   A G+ Y+H  +   ++H+D+K
Sbjct: 85  --IVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLHAKS---IIHRDLK 136
Query: 460 SSNILLDSNMRAKIANFGLAK-----SGCNAITMHIVGTQGYIAPEYLA---DGVVSTKM 511
           S+NI L  ++  KI +FGLA      SG +     + G+  ++APE +        S + 
Sbjct: 137 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE-QLSGSILWMAPEVIRMQDKNPYSFQS 195
Query: 512 DVFSFGVVLLELISGK 527
           DV++FG+VL EL++G+
Sbjct: 196 DVYAFGIVLYELMTGQ 211

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 105/196 (53%), Gaps = 30/196 (15%)
Query: 351 GSVYKGNIHGEVYAIKMMKWNAC---------EELKILQKVNHGNLVKLEGFCIDPEDAN 401
           G+VYKG  HG+V A+KM+   A           E+ +L+K  H N++   G+   P+ A 
Sbjct: 22  GTVYKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLA- 79
Query: 402 CYLIYEYIENGSLHSWLH--ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIK 459
             ++ ++ E  SL+  LH  E K E +     + IA   A G+ Y+H  +   ++H+D+K
Sbjct: 80  --IVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLHAKS---IIHRDLK 131
Query: 460 SSNILLDSNMRAKIANFGLAK-----SGCNAITMHIVGTQGYIAPEYLA---DGVVSTKM 511
           S+NI L  ++  KI +FGLA      SG +     + G+  ++APE +        S + 
Sbjct: 132 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE-QLSGSILWMAPEVIRMQDKNPYSFQS 190
Query: 512 DVFSFGVVLLELISGK 527
           DV++FG+VL EL++G+
Sbjct: 191 DVYAFGIVLYELMTGQ 206

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 54/188 (28%), Positives = 106/188 (56%), Gaps = 15/188 (7%)
Query: 352 SVYKGNIHGEVYAIKMMKWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN 411
           S+  G+  GE   I+  +     E+ I+  +NH N+VKL G   +P      ++ E++  
Sbjct: 51  SLILGDSEGETEMIEKFQ-EFQREVFIMSNLNHPNIVKLYGLMHNPPR----MVMEFVPC 105
Query: 412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS---- 467
           G L+  L  +K   + W  +LR+ +D+A G++Y+ ++  P +VH+D++S NI L S    
Sbjct: 106 GDLYHRLL-DKAHPIKWSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDEN 163
Query: 468 -NMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLA--DGVVSTKMDVFSFGVVLLELI 524
             + AK+A+FGL++   ++++  ++G   ++APE +   +   + K D +SF ++L  ++
Sbjct: 164 APVCAKVADFGLSQQSVHSVS-GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTIL 222
Query: 525 SGKEAIDE 532
           +G+   DE
Sbjct: 223 TGEGPFDE 230

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 94/180 (52%), Gaps = 10/180 (5%)
Query: 351 GSVYKGNIHGEVYAIKMMKWNACE-----ELKILQKVNHGNLVKLEGFCIDPEDANCYLI 405
           G V  G+  G   A+K +K +A       E  ++ ++ H NLV+L G  ++ E    Y++
Sbjct: 207 GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE-EKGGLYIV 265
Query: 406 YEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL 465
            EY+  GSL  +L       L     L+ ++DV   ++Y+  +     VH+D+ + N+L+
Sbjct: 266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLV 322
Query: 466 DSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
             +  AK+++FGL K   +      +  + + APE L +   STK DV+SFG++L E+ S
Sbjct: 323 SEDNVAKVSDFGLTKEASSTQDTGKLPVK-WTAPEALREKKFSTKSDVWSFGILLWEIYS 381

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 94/180 (52%), Gaps = 10/180 (5%)
Query: 351 GSVYKGNIHGEVYAIKMMKWNACE-----ELKILQKVNHGNLVKLEGFCIDPEDANCYLI 405
           G V  G+  G   A+K +K +A       E  ++ ++ H NLV+L G  ++ E    Y++
Sbjct: 35  GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE-EKGGLYIV 93
Query: 406 YEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL 465
            EY+  GSL  +L       L     L+ ++DV   ++Y+  +     VH+D+ + N+L+
Sbjct: 94  TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLV 150
Query: 466 DSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
             +  AK+++FGL K   +      +  + + APE L +   STK DV+SFG++L E+ S
Sbjct: 151 SEDNVAKVSDFGLTKEASSTQDTGKLPVK-WTAPEALREKKFSTKSDVWSFGILLWEIYS 209

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 104/219 (47%), Gaps = 36/219 (16%)
Query: 351 GSVYKGN--IHGEVYAIKMMKWN---ACEELKILQKVNHGNLVKL----EGFCIDPEDAN 401
           G V+K    I G+ Y I+ +K+N   A  E+K L K++H N+V      +GF  DPE ++
Sbjct: 26  GQVFKAKHRIDGKTYVIRRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSD 85
Query: 402 ----------------------CYLI-YEYIENGSLHSWLHENKNENLNWKTRLRIAIDV 438
                                 C  I  E+ + G+L  W+ + + E L+    L +   +
Sbjct: 86  DSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQI 145
Query: 439 ANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN-AITMHIVGTQGYI 497
             G+ YIH     +++H+D+K SNI L    + KI +FGL  S  N        GT  Y+
Sbjct: 146 TKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYM 202
Query: 498 APEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGKF 536
           +PE ++      ++D+++ G++L EL+   +   E  KF
Sbjct: 203 SPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKF 241

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 94/180 (52%), Gaps = 10/180 (5%)
Query: 351 GSVYKGNIHGEVYAIKMMKWNACE-----ELKILQKVNHGNLVKLEGFCIDPEDANCYLI 405
           G V  G+  G   A+K +K +A       E  ++ ++ H NLV+L G  ++ E    Y++
Sbjct: 20  GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE-EKGGLYIV 78
Query: 406 YEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL 465
            EY+  GSL  +L       L     L+ ++DV   ++Y+  +     VH+D+ + N+L+
Sbjct: 79  TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLV 135
Query: 466 DSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
             +  AK+++FGL K   +      +  + + APE L +   STK DV+SFG++L E+ S
Sbjct: 136 SEDNVAKVSDFGLTKEASSTQDTGKLPVK-WTAPEALREKKFSTKSDVWSFGILLWEIYS 194

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 58/178 (32%), Positives = 90/178 (50%), Gaps = 16/178 (8%)
Query: 360 GEVYAIKMMKWNACE-------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG 412
           GEV A+K ++ +  E       E++IL+ + H N+VK +G C      N  LI EY+  G
Sbjct: 42  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 101
Query: 413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAK 472
           SL  +L  +  E ++    L+    +  G++Y+      R +H+D+ + NIL+++  R K
Sbjct: 102 SLRDYLQAHA-ERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVK 157
Query: 473 IANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           I +FGL K          V   G     + APE L +   S   DV+SFGVVL EL +
Sbjct: 158 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 97/184 (52%), Gaps = 17/184 (9%)
Query: 355 KGNIHGEVYAIKMMKWNAC--------EELKILQKVNHGNLVKLEGFCIDPEDANCYLIY 406
           +G+  GE  A+K +K  +         +E++IL+ + H N+VK +G C +       LI 
Sbjct: 45  EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIM 104
Query: 407 EYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLD 466
           E++ +GSL  +L +NKN+ +N K +L+ A+ +  G+ Y+      + VH+D+ + N+L++
Sbjct: 105 EFLPSGSLKEYLPKNKNK-INLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVE 160
Query: 467 SNMRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLL 521
           S  + KI +FGL K+         V         + APE L         DV+SFGV L 
Sbjct: 161 SEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLH 220
Query: 522 ELIS 525
           EL++
Sbjct: 221 ELLT 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 97/184 (52%), Gaps = 17/184 (9%)
Query: 355 KGNIHGEVYAIKMMKWNAC--------EELKILQKVNHGNLVKLEGFCIDPEDANCYLIY 406
           +G+  GE  A+K +K  +         +E++IL+ + H N+VK +G C +       LI 
Sbjct: 33  EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIM 92
Query: 407 EYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLD 466
           E++ +GSL  +L +NKN+ +N K +L+ A+ +  G+ Y+      + VH+D+ + N+L++
Sbjct: 93  EFLPSGSLKEYLPKNKNK-INLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVE 148
Query: 467 SNMRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLL 521
           S  + KI +FGL K+         V         + APE L         DV+SFGV L 
Sbjct: 149 SEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLH 208
Query: 522 ELIS 525
           EL++
Sbjct: 209 ELLT 212

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 103/205 (50%), Gaps = 27/205 (13%)
Query: 351 GSVYKGNIHGEVYAIKMM------KWNACEELKILQKVNHGNLVKLEGFCIDPE--DANC 402
           G V+K  +  E  A+K+        W    E+  L  + H N+++  G        D + 
Sbjct: 38  GCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97
Query: 403 YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHT-------RPRVVH 455
           +LI  + E GSL  +L  N    ++W     IA  +A GL Y+HE         +P + H
Sbjct: 98  WLITAFHEKGSLSDFLKANV---VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISH 154
Query: 456 KDIKSSNILLDSNMRAKIANFGLA---KSGCNAITMH-IVGTQGYIAPEYLADGV----- 506
           +DIKS N+LL +N+ A IA+FGLA   ++G +A   H  VGT+ Y+APE L   +     
Sbjct: 155 RDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRD 214
Query: 507 VSTKMDVFSFGVVLLELISGKEAID 531
              ++D+++ G+VL EL S   A D
Sbjct: 215 AFLRIDMYAMGLVLWELASRCTAAD 239

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 19/205 (9%)
Query: 341 DNFSEGCLIQGSVYKGNIHGEVYAIKMMKWNACEELKILQKVN----------HGNLVKL 390
           D    G   +  V K  + G   A+K++       L ++ K+           H +++KL
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 391 EGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTR 450
                 P D   +++ EY+  G L  ++   KN  L+ K   R+   + +G+ Y H H  
Sbjct: 82  YQVISTPSD--IFMVMEYVSGGELFDYI--CKNGRLDEKESRRLFQQILSGVDYCHRHM- 136
Query: 451 PRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI-VGTQGYIAPEYLADGVVS- 508
             VVH+D+K  N+LLD++M AKIA+FGL+    +   +    G+  Y APE ++  + + 
Sbjct: 137 --VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAG 194
Query: 509 TKMDVFSFGVVLLELISGKEAIDEE 533
            ++D++S GV+L  L+ G    D++
Sbjct: 195 PEVDIWSSGVILYALLCGTLPFDDD 219

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 105/188 (55%), Gaps = 15/188 (7%)
Query: 352 SVYKGNIHGEVYAIKMMKWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN 411
           S+  G+  GE   I+  +     E+ I+  +NH N+VKL G   +P      ++ E++  
Sbjct: 51  SLILGDSEGETEMIEKFQ-EFQREVFIMSNLNHPNIVKLYGLMHNPPR----MVMEFVPC 105
Query: 412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS---- 467
           G L+  L  +K   + W  +LR+ +D+A G++Y+ ++  P +VH+D++S NI L S    
Sbjct: 106 GDLYHRLL-DKAHPIKWSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDEN 163
Query: 468 -NMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLA--DGVVSTKMDVFSFGVVLLELI 524
             + AK+A+FG ++   ++++  ++G   ++APE +   +   + K D +SF ++L  ++
Sbjct: 164 APVCAKVADFGTSQQSVHSVS-GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTIL 222
Query: 525 SGKEAIDE 532
           +G+   DE
Sbjct: 223 TGEGPFDE 230

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 107/221 (48%), Gaps = 30/221 (13%)
Query: 328 YRIFKIEELREATDNFSEGCLIQGSVYKGNIHGEVYAIK-MMKWNA------CEELKILQ 380
           +RIF+  +L    +   +GC  Q         GEV  +K +++++        +E+K+++
Sbjct: 4   HRIFRPSDLIHG-EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMR 62
Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
            + H N++K  G     +D     I EYI+ G+L   + ++ +    W  R+  A D+A+
Sbjct: 63  CLEHPNVLKFIGVLY--KDKRLNFITEYIKGGTLRGII-KSMDSQYPWSQRVSFAKDIAS 119
Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH----------- 489
           G+ Y+H      ++H+D+ S N L+  N    +A+FGLA+   +  T             
Sbjct: 120 GMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDR 176
Query: 490 -----IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
                +VG   ++APE +       K+DVFSFG+VL E+I 
Sbjct: 177 KKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIG 217

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 105/188 (55%), Gaps = 15/188 (7%)
Query: 352 SVYKGNIHGEVYAIKMMKWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN 411
           S+  G+  GE   I+  +     E+ I+  +NH N+VKL G   +P      ++ E++  
Sbjct: 51  SLILGDSEGETEMIEKFQ-EFQREVFIMSNLNHPNIVKLYGLMHNPPR----MVMEFVPC 105
Query: 412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS---- 467
           G L+  L  +K   + W  +LR+ +D+A G++Y+ ++  P +VH+D++S NI L S    
Sbjct: 106 GDLYHRLL-DKAHPIKWSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDEN 163
Query: 468 -NMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLA--DGVVSTKMDVFSFGVVLLELI 524
             + AK+A+F L++   ++++  ++G   ++APE +   +   + K D +SF ++L  ++
Sbjct: 164 APVCAKVADFSLSQQSVHSVS-GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTIL 222
Query: 525 SGKEAIDE 532
           +G+   DE
Sbjct: 223 TGEGPFDE 230

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 95/182 (52%), Gaps = 16/182 (8%)
Query: 356 GNIHGEVYAIKMMKWNACE-------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEY 408
           G+  G + A+K ++ +  +       E++IL+ ++   +VK  G    P   +  L+ EY
Sbjct: 35  GDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEY 94
Query: 409 IENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN 468
           + +G L  +L  ++   L+    L  +  +  G++Y+      R VH+D+ + NIL++S 
Sbjct: 95  LPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESE 150
Query: 469 MRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLEL 523
              KIA+FGLAK        ++V   G     + APE L+D + S + DV+SFGVVL EL
Sbjct: 151 AHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 210
Query: 524 IS 525
            +
Sbjct: 211 FT 212

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 95/182 (52%), Gaps = 16/182 (8%)
Query: 356 GNIHGEVYAIKMMKWNACE-------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEY 408
           G+  G + A+K ++ +  +       E++IL+ ++   +VK  G    P   +  L+ EY
Sbjct: 48  GDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEY 107
Query: 409 IENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN 468
           + +G L  +L  ++   L+    L  +  +  G++Y+      R VH+D+ + NIL++S 
Sbjct: 108 LPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESE 163
Query: 469 MRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLEL 523
              KIA+FGLAK        ++V   G     + APE L+D + S + DV+SFGVVL EL
Sbjct: 164 AHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 223
Query: 524 IS 525
            +
Sbjct: 224 FT 225

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 95/182 (52%), Gaps = 16/182 (8%)
Query: 356 GNIHGEVYAIKMMKWNACE-------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEY 408
           G+  G + A+K ++ +  +       E++IL+ ++   +VK  G    P   +  L+ EY
Sbjct: 36  GDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEY 95
Query: 409 IENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN 468
           + +G L  +L  ++   L+    L  +  +  G++Y+      R VH+D+ + NIL++S 
Sbjct: 96  LPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESE 151
Query: 469 MRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLEL 523
              KIA+FGLAK        ++V   G     + APE L+D + S + DV+SFGVVL EL
Sbjct: 152 AHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 211
Query: 524 IS 525
            +
Sbjct: 212 FT 213

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 83/150 (55%), Gaps = 10/150 (6%)
Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
           +++H N+V +    +D ED   YL+ EYIE  +L  ++  +    L+  T +     + +
Sbjct: 67  QLSHQNIVSM--IDVDEEDDCYYLVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILD 122
Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI---TMHIVGTQGYI 497
           G+++ H+    R+VH+DIK  NIL+DSN   KI +FG+AK+        T H++GT  Y 
Sbjct: 123 GIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYF 179
Query: 498 APEYLADGVVSTKMDVFSFGVVLLELISGK 527
           +PE           D++S G+VL E++ G+
Sbjct: 180 SPEQAKGEATDECTDIYSIGIVLYEMLVGE 209

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 93/182 (51%), Gaps = 16/182 (8%)
Query: 356 GNIHGEVYAIKMMKWNACE-------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEY 408
           G+  G + A+K ++ +  +       E++IL+ ++   +VK  G    P      L+ EY
Sbjct: 32  GDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEY 91
Query: 409 IENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN 468
           + +G L  +L  ++   L+    L  +  +  G++Y+      R VH+D+ + NIL++S 
Sbjct: 92  LPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESE 147
Query: 469 MRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLEL 523
              KIA+FGLAK         +V   G     + APE L+D + S + DV+SFGVVL EL
Sbjct: 148 AHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 207
Query: 524 IS 525
            +
Sbjct: 208 FT 209

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 91/179 (50%), Gaps = 19/179 (10%)
Query: 360 GEVYAIKMMKWNAC--------EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN 411
           GE+ A+K +K +A         +E+ IL+ + H +++K +G C D   A+  L+ EY+  
Sbjct: 60  GEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPL 119
Query: 412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRA 471
           GSL  +L      ++     L  A  +  G+ Y+H       +H+D+ + N+LLD++   
Sbjct: 120 GSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLV 173
Query: 472 KIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           KI +FGLAK+       + V   G     + APE L +       DV+SFGV L EL++
Sbjct: 174 KIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/185 (32%), Positives = 95/185 (51%), Gaps = 25/185 (13%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL--HENKNENLNWKTRL 432
           E++I++ +NH N+VKL  F +   +   YLI EY   G +  +L  H    E    +++ 
Sbjct: 61  EVRIMKILNHPNIVKL--FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK-EARSKF 117
Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIV- 491
           R    + + +QY H+    R+VH+D+K+ N+LLD++M  KIA+FG +        +    
Sbjct: 118 R---QIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFC 171
Query: 492 GTQGYIAPEYLA----DGVVSTKMDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYWRE 547
           G+  Y APE       DG    ++DV+S GV+L  L+SG    D      GQ LK     
Sbjct: 172 GSPPYAAPELFQGKKYDG---PEVDVWSLGVILYTLVSGSLPFD------GQNLKELRER 222
Query: 548 MKRGK 552
           + RGK
Sbjct: 223 VLRGK 227

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 94/185 (50%), Gaps = 16/185 (8%)
Query: 351 GSVYKGNIHGEV-YAIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPEDANCY 403
           G V+ G  +G    A+K +K  +        E  +++++ H  LV+L            Y
Sbjct: 27  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIY 83
Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI 463
           +I EY+ENGSL  +L       L     L +A  +A G+ +I E      +H+D++++NI
Sbjct: 84  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANI 140
Query: 464 LLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFSFGVVL 520
           L+   +  KIA+FGLA+   +A      G +    + APE +  G  + K DV+SFG++L
Sbjct: 141 LVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 200
Query: 521 LELIS 525
            E+++
Sbjct: 201 TEIVT 205

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 59/185 (31%), Positives = 98/185 (52%), Gaps = 16/185 (8%)
Query: 351 GSVYKGNIHGEV-YAIKMMKWNA------CEELKILQKVNHGNLVKLEGFCIDPEDANCY 403
           G V+ G  +G    AIK +K          EE +I++K+ H  LV+L  + +  E+   Y
Sbjct: 23  GEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKLKHDKLVQL--YAVVSEEP-IY 79
Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI 463
           ++ EY+  GSL  +L + +   L     + +A  VA G+ YI    R   +H+D++S+NI
Sbjct: 80  IVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANI 136
Query: 464 LLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFSFGVVL 520
           L+ + +  KIA+FGLA+   +       G +    + APE    G  + K DV+SFG++L
Sbjct: 137 LVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 196
Query: 521 LELIS 525
            EL++
Sbjct: 197 TELVT 201

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/185 (32%), Positives = 94/185 (50%), Gaps = 25/185 (13%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL--HENKNENLNWKTRL 432
           E++I++ +NH N+VKL  F +   +   YLI EY   G +  +L  H    E    +++ 
Sbjct: 64  EVRIMKILNHPNIVKL--FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK-EARSKF 120
Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH-IV 491
           R    + + +QY H+    R+VH+D+K+ N+LLD++M  KIA+FG +        +    
Sbjct: 121 R---QIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC 174
Query: 492 GTQGYIAPEYLA----DGVVSTKMDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYWRE 547
           G   Y APE       DG    ++DV+S GV+L  L+SG    D      GQ LK     
Sbjct: 175 GAPPYAAPELFQGKKYDG---PEVDVWSLGVILYTLVSGSLPFD------GQNLKELRER 225
Query: 548 MKRGK 552
           + RGK
Sbjct: 226 VLRGK 230

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 108/217 (49%), Gaps = 43/217 (19%)
Query: 346 GCLIQGSVY--KGNIHGEVYAIKMMKWNAC--------EELKILQKVNHGNLVKLEGFCI 395
           G +++ + +  KG       A+KM+K NA          E  +L++VNH +++KL G C 
Sbjct: 37  GKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC- 95
Query: 396 DPEDANCYLIYEYIENGSLHSWLHENKN----------------------ENLNWKTRLR 433
             +D    LI EY + GSL  +L E++                         L     + 
Sbjct: 96  -SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLIS 154
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT 493
            A  ++ G+QY+ E    ++VH+D+ + NIL+    + KI++FGL++      + ++  +
Sbjct: 155 FAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS-YVKRS 210
Query: 494 QG-----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           QG     ++A E L D + +T+ DV+SFGV+L E+++
Sbjct: 211 QGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 91/178 (51%), Gaps = 18/178 (10%)
Query: 359 HGEVYAIKMMKWNACEELK----------ILQKVNHGNLVKLEGFCIDPEDANCYLIYEY 408
           +G  YA+K++K      LK          +L  V H  ++++ G   D +    ++I +Y
Sbjct: 30  NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ--QIFMIMDY 87
Query: 409 IENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN 468
           IE G L S L   K++          A +V   L+Y+H      ++++D+K  NILLD N
Sbjct: 88  IEGGELFSLLR--KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKN 142
Query: 469 MRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
              KI +FG AK     +T  + GT  YIAPE ++    +  +D +SFG+++ E+++G
Sbjct: 143 GHIKITDFGFAKY-VPDVTYXLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 103/194 (53%), Gaps = 26/194 (13%)
Query: 351 GSVYKGNIHGEVYAIKMMK--------WNACE-ELKILQKVNHGNLVKLEGFCIDPEDAN 401
           G+VYKG  HG+V A+K++K        + A   E+ +L+K  H N++   G+       N
Sbjct: 50  GTVYKGKWHGDV-AVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK---DN 105
Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSS 461
             ++ ++ E  SL+  LH  + +   ++  + IA   A G+ Y+H      ++H+D+KS+
Sbjct: 106 LAIVTQWCEGSSLYKHLHVQETKFQMFQL-IDIARQTAQGMDYLHAKN---IIHRDMKSN 161
Query: 462 NILLDSNMRAKIANFGLAK-----SGCNAITMHIVGTQGYIAPEYLA---DGVVSTKMDV 513
           NI L   +  KI +FGLA      SG   +     G+  ++APE +    +   S + DV
Sbjct: 162 NIFLHEGLTVKIGDFGLATVKSRWSGSQQVE-QPTGSVLWMAPEVIRMQDNNPFSFQSDV 220
Query: 514 FSFGVVLLELISGK 527
           +S+G+VL EL++G+
Sbjct: 221 YSYGIVLYELMTGE 234

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 107/217 (49%), Gaps = 43/217 (19%)
Query: 346 GCLIQGSVY--KGNIHGEVYAIKMMKWNAC--------EELKILQKVNHGNLVKLEGFCI 395
           G +++ + +  KG       A+KM+K NA          E  +L++VNH +++KL G C 
Sbjct: 37  GKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC- 95
Query: 396 DPEDANCYLIYEYIENGSLHSWLHENKN----------------------ENLNWKTRLR 433
             +D    LI EY + GSL  +L E++                         L     + 
Sbjct: 96  -SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLIS 154
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT 493
            A  ++ G+QY+ E    ++VH+D+ + NIL+    + KI++FGL++      +  +  +
Sbjct: 155 FAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSX-VKRS 210
Query: 494 QG-----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           QG     ++A E L D + +T+ DV+SFGV+L E+++
Sbjct: 211 QGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 107/217 (49%), Gaps = 43/217 (19%)
Query: 346 GCLIQGSVY--KGNIHGEVYAIKMMKWNAC--------EELKILQKVNHGNLVKLEGFCI 395
           G +++ + +  KG       A+KM+K NA          E  +L++VNH +++KL G C 
Sbjct: 37  GKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC- 95
Query: 396 DPEDANCYLIYEYIENGSLHSWLHENKN----------------------ENLNWKTRLR 433
             +D    LI EY + GSL  +L E++                         L     + 
Sbjct: 96  -SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLIS 154
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT 493
            A  ++ G+QY+ E +   +VH+D+ + NIL+    + KI++FGL++      +  +  +
Sbjct: 155 FAWQISQGMQYLAEMS---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSX-VKRS 210
Query: 494 QG-----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           QG     ++A E L D + +T+ DV+SFGV+L E+++
Sbjct: 211 QGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/186 (30%), Positives = 93/186 (50%), Gaps = 27/186 (14%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL------HSWLHENKNENLNW 428
           E++I++ +NH N+VKL  F +   +   YL+ EY   G +      H W+ E +      
Sbjct: 56  EVRIMKVLNHPNIVKL--FEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEA----- 108
Query: 429 KTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM 488
           + + R    + + +QY H+     +VH+D+K+ N+LLD++M  KIA+FG +        +
Sbjct: 109 RAKFR---QIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL 162
Query: 489 HIV-GTQGYIAPE-YLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYWR 546
               G+  Y APE +        ++DV+S GV+L  L+SG    D      GQ LK    
Sbjct: 163 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD------GQNLKELRE 216
Query: 547 EMKRGK 552
            + RGK
Sbjct: 217 RVLRGK 222

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 87/155 (56%), Gaps = 9/155 (5%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           EE +++ K++H  LV+L G C+  E A   L++E++E+G L  +L   +      +T L 
Sbjct: 51  EEAEVMMKLSHPKLVQLYGVCL--EQAPICLVFEFMEHGCLSDYLRTQRG-LFAAETLLG 107
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT 493
           + +DV  G+ Y+ E +   V+H+D+ + N L+  N   K+++FG+ +   +       GT
Sbjct: 108 MCLDVCEGMAYLEEAS---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 164
Query: 494 Q---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           +    + +PE  +    S+K DV+SFGV++ E+ S
Sbjct: 165 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 199

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 100/194 (51%), Gaps = 18/194 (9%)
Query: 342 NFSEGCLIQGSVYKGNIHGEV-YAIKMMKWNA------CEELKILQKVNHGNLVKLEGFC 394
              +GC   G V+ G  +G    AIK +K          +E ++++K+ H  LV+L  + 
Sbjct: 25  KLGQGCF--GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKIRHEKLVQL--YA 80
Query: 395 IDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVV 454
           +  E+   Y++ EY+  GSL  +L     + L     + +A  +A+G+ Y+    R   V
Sbjct: 81  VVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 455 HKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKM 511
           H+D++++NIL+  N+  K+A+FGLA+   +       G +    + APE    G  + K 
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 512 DVFSFGVVLLELIS 525
           DV+SFG++L EL +
Sbjct: 197 DVWSFGILLTELTT 210

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 100/194 (51%), Gaps = 18/194 (9%)
Query: 342 NFSEGCLIQGSVYKGNIHGEV-YAIKMMKWNA------CEELKILQKVNHGNLVKLEGFC 394
              +GC   G V+ G  +G    AIK +K          +E ++++K+ H  LV+L  + 
Sbjct: 25  KLGQGCF--GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YA 80
Query: 395 IDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVV 454
           +  E+   Y++ EY+  GSL  +L     + L     + +A  +A+G+ Y+    R   V
Sbjct: 81  VVSEEP-IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 455 HKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKM 511
           H+D++++NIL+  N+  K+A+FGLA+   +       G +    + APE    G  + K 
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 512 DVFSFGVVLLELIS 525
           DV+SFG++L EL +
Sbjct: 197 DVWSFGILLTELTT 210

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 100/194 (51%), Gaps = 18/194 (9%)
Query: 342 NFSEGCLIQGSVYKGNIHGEV-YAIKMMKWNA------CEELKILQKVNHGNLVKLEGFC 394
              +GC   G V+ G  +G    AIK +K          +E ++++K+ H  LV+L  + 
Sbjct: 18  KLGQGCF--GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YA 73
Query: 395 IDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVV 454
           +  E+   Y++ EY+  GSL  +L     + L     + +A  +A+G+ Y+    R   V
Sbjct: 74  VVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 129
Query: 455 HKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKM 511
           H+D++++NIL+  N+  K+A+FGLA+   +       G +    + APE    G  + K 
Sbjct: 130 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 189
Query: 512 DVFSFGVVLLELIS 525
           DV+SFG++L EL +
Sbjct: 190 DVWSFGILLTELTT 203

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 100/193 (51%), Gaps = 18/193 (9%)
Query: 343 FSEGCLIQGSVYKGNIHGEV-YAIKMMKWNA------CEELKILQKVNHGNLVKLEGFCI 395
             +GC   G V+ G  +G    AIK +K          +E ++++K+ H  LV+L  + +
Sbjct: 275 LGQGCF--GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 330
Query: 396 DPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVH 455
             E+   Y++ EY+  GSL  +L     + L     + +A  +A+G+ Y+    R   VH
Sbjct: 331 VSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 386
Query: 456 KDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMD 512
           +D++++NIL+  N+  K+A+FGLA+   +       G +    + APE    G  + K D
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446
Query: 513 VFSFGVVLLELIS 525
           V+SFG++L EL +
Sbjct: 447 VWSFGILLTELTT 459

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 100/193 (51%), Gaps = 18/193 (9%)
Query: 343 FSEGCLIQGSVYKGNIHGEV-YAIKMMKWNA------CEELKILQKVNHGNLVKLEGFCI 395
             +GC   G V+ G  +G    AIK +K          +E ++++K+ H  LV+L  + +
Sbjct: 192 LGQGCF--GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 247
Query: 396 DPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVH 455
             E+   Y++ EY+  GSL  +L     + L     + +A  +A+G+ Y+    R   VH
Sbjct: 248 VSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 456 KDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMD 512
           +D++++NIL+  N+  K+A+FGLA+   +       G +    + APE    G  + K D
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 513 VFSFGVVLLELIS 525
           V+SFG++L EL +
Sbjct: 364 VWSFGILLTELTT 376

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 100/193 (51%), Gaps = 18/193 (9%)
Query: 343 FSEGCLIQGSVYKGNIHGEV-YAIKMMKWNA------CEELKILQKVNHGNLVKLEGFCI 395
             +GC   G V+ G  +G    AIK +K          +E ++++K+ H  LV+L  + +
Sbjct: 192 LGQGCF--GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 247
Query: 396 DPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVH 455
             E+   Y++ EY+  GSL  +L     + L     + +A  +A+G+ Y+    R   VH
Sbjct: 248 VSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 456 KDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMD 512
           +D++++NIL+  N+  K+A+FGLA+   +       G +    + APE    G  + K D
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 513 VFSFGVVLLELIS 525
           V+SFG++L EL +
Sbjct: 364 VWSFGILLTELTT 376

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 93/185 (50%), Gaps = 16/185 (8%)
Query: 351 GSVYKGNIHGEV-YAIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPEDANCY 403
           G V+ G  +G    A+K +K  +        E  +++++ H  LV+L            Y
Sbjct: 33  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIY 89
Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI 463
           +I EY+ENGSL  +L       L     L +A  +A G+ +I E      +H+D++++NI
Sbjct: 90  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANI 146
Query: 464 LLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFSFGVVL 520
           L+   +  KIA+FGLA+   +       G +    + APE +  G  + K DV+SFG++L
Sbjct: 147 LVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 206
Query: 521 LELIS 525
            E+++
Sbjct: 207 TEIVT 211

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 93/185 (50%), Gaps = 16/185 (8%)
Query: 351 GSVYKGNIHGEV-YAIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPEDANCY 403
           G V+ G  +G    A+K +K  +        E  +++++ H  LV+L            Y
Sbjct: 36  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIY 92
Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI 463
           +I EY+ENGSL  +L       L     L +A  +A G+ +I E      +H+D++++NI
Sbjct: 93  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANI 149
Query: 464 LLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFSFGVVL 520
           L+   +  KIA+FGLA+   +       G +    + APE +  G  + K DV+SFG++L
Sbjct: 150 LVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 209
Query: 521 LELIS 525
            E+++
Sbjct: 210 TEIVT 214

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 93/185 (50%), Gaps = 16/185 (8%)
Query: 351 GSVYKGNIHGEV-YAIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPEDANCY 403
           G V+ G  +G    A+K +K  +        E  +++++ H  LV+L            Y
Sbjct: 35  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIY 91
Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI 463
           +I EY+ENGSL  +L       L     L +A  +A G+ +I E      +H+D++++NI
Sbjct: 92  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANI 148
Query: 464 LLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFSFGVVL 520
           L+   +  KIA+FGLA+   +       G +    + APE +  G  + K DV+SFG++L
Sbjct: 149 LVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 208
Query: 521 LELIS 525
            E+++
Sbjct: 209 TEIVT 213

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 86/155 (55%), Gaps = 9/155 (5%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           EE +++ K++H  LV+L G C+  E A   L++E++E+G L  +L   +      +T L 
Sbjct: 49  EEAEVMMKLSHPKLVQLYGVCL--EQAPICLVFEFMEHGCLSDYLRTQRG-LFAAETLLG 105
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT 493
           + +DV  G+ Y+ E     V+H+D+ + N L+  N   K+++FG+ +   +       GT
Sbjct: 106 MCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 162
Query: 494 Q---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           +    + +PE  +    S+K DV+SFGV++ E+ S
Sbjct: 163 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 197

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 86/155 (55%), Gaps = 9/155 (5%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           EE +++ K++H  LV+L G C+  E A   L++E++E+G L  +L   +      +T L 
Sbjct: 51  EEAEVMMKLSHPKLVQLYGVCL--EQAPICLVFEFMEHGCLSDYLRTQRG-LFAAETLLG 107
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT 493
           + +DV  G+ Y+ E     V+H+D+ + N L+  N   K+++FG+ +   +       GT
Sbjct: 108 MCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 164
Query: 494 Q---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           +    + +PE  +    S+K DV+SFGV++ E+ S
Sbjct: 165 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 199

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 100/194 (51%), Gaps = 18/194 (9%)
Query: 342 NFSEGCLIQGSVYKGNIHGEV-YAIKMMKWNA------CEELKILQKVNHGNLVKLEGFC 394
              +GC   G V+ G  +G    AIK +K          +E ++++K+ H  LV+L  + 
Sbjct: 14  KLGQGCF--GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YA 69
Query: 395 IDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVV 454
           +  E+   Y++ EY+  GSL  +L     + L     + +A  +A+G+ Y+    R   V
Sbjct: 70  VVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 125
Query: 455 HKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKM 511
           H+D++++NIL+  N+  K+A+FGLA+   +       G +    + APE    G  + K 
Sbjct: 126 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 185
Query: 512 DVFSFGVVLLELIS 525
           DV+SFG++L EL +
Sbjct: 186 DVWSFGILLTELTT 199

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 86/155 (55%), Gaps = 9/155 (5%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           EE +++ K++H  LV+L G C+  E A   L++E++E+G L  +L   +      +T L 
Sbjct: 54  EEAEVMMKLSHPKLVQLYGVCL--EQAPICLVFEFMEHGCLSDYLRTQRG-LFAAETLLG 110
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT 493
           + +DV  G+ Y+ E     V+H+D+ + N L+  N   K+++FG+ +   +       GT
Sbjct: 111 MCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 167
Query: 494 Q---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           +    + +PE  +    S+K DV+SFGV++ E+ S
Sbjct: 168 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 202

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 100/194 (51%), Gaps = 18/194 (9%)
Query: 342 NFSEGCLIQGSVYKGNIHGEV-YAIKMMKWNA------CEELKILQKVNHGNLVKLEGFC 394
              +GC   G V+ G  +G    AIK +K          +E ++++K+ H  LV+L  + 
Sbjct: 16  KLGQGCF--GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YA 71
Query: 395 IDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVV 454
           +  E+   Y++ EY+  GSL  +L     + L     + +A  +A+G+ Y+    R   V
Sbjct: 72  VVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 127
Query: 455 HKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKM 511
           H+D++++NIL+  N+  K+A+FGLA+   +       G +    + APE    G  + K 
Sbjct: 128 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 187
Query: 512 DVFSFGVVLLELIS 525
           DV+SFG++L EL +
Sbjct: 188 DVWSFGILLTELTT 201

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 100/193 (51%), Gaps = 18/193 (9%)
Query: 343 FSEGCLIQGSVYKGNIHGEV-YAIKMMKWNA------CEELKILQKVNHGNLVKLEGFCI 395
             +GC   G V+ G  +G    AIK +K          +E ++++K+ H  LV+L  + +
Sbjct: 192 LGQGCF--GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 247
Query: 396 DPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVH 455
             E+   Y++ EY+  GSL  +L     + L     + +A  +A+G+ Y+    R   VH
Sbjct: 248 VSEEP-IYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 456 KDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMD 512
           +D++++NIL+  N+  K+A+FGLA+   +       G +    + APE    G  + K D
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 513 VFSFGVVLLELIS 525
           V+SFG++L EL +
Sbjct: 364 VWSFGILLTELTT 376

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 93/185 (50%), Gaps = 16/185 (8%)
Query: 351 GSVYKGNIHGEV-YAIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPEDANCY 403
           G V+ G  +G    A+K +K  +        E  +++++ H  LV+L            Y
Sbjct: 27  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIY 83
Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI 463
           +I EY+ENGSL  +L       L     L +A  +A G+ +I E      +H+D++++NI
Sbjct: 84  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANI 140
Query: 464 LLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFSFGVVL 520
           L+   +  KIA+FGLA+   +       G +    + APE +  G  + K DV+SFG++L
Sbjct: 141 LVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 200
Query: 521 LELIS 525
            E+++
Sbjct: 201 TEIVT 205

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 100/194 (51%), Gaps = 18/194 (9%)
Query: 342 NFSEGCLIQGSVYKGNIHGEV-YAIKMMKWNA------CEELKILQKVNHGNLVKLEGFC 394
              +GC   G V+ G  +G    AIK +K          +E ++++K+ H  LV+L  + 
Sbjct: 25  KLGQGCF--GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YA 80
Query: 395 IDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVV 454
           +  E+   Y++ EY+  GSL  +L     + L     + +A  +A+G+ Y+    R   V
Sbjct: 81  VVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 455 HKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKM 511
           H+D++++NIL+  N+  K+A+FGLA+   +       G +    + APE    G  + K 
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 512 DVFSFGVVLLELIS 525
           DV+SFG++L EL +
Sbjct: 197 DVWSFGILLTELTT 210

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 100/194 (51%), Gaps = 18/194 (9%)
Query: 342 NFSEGCLIQGSVYKGNIHGEV-YAIKMMKWNA------CEELKILQKVNHGNLVKLEGFC 394
              +GC   G V+ G  +G    AIK +K          +E ++++K+ H  LV+L  + 
Sbjct: 25  KLGQGCF--GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YA 80
Query: 395 IDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVV 454
           +  E+   Y++ EY+  GSL  +L     + L     + +A  +A+G+ Y+    R   V
Sbjct: 81  VVSEEP-IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 455 HKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKM 511
           H+D++++NIL+  N+  K+A+FGLA+   +       G +    + APE    G  + K 
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 512 DVFSFGVVLLELIS 525
           DV+SFG++L EL +
Sbjct: 197 DVWSFGILLTELTT 210

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 94/169 (55%), Gaps = 11/169 (6%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E+ IL+K++H N+VKL     DP + + Y+++E +  G +   +     + L+      
Sbjct: 85  QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV---MEVPTLKPLSEDQARF 141
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS--GCNAITMHIV 491
              D+  G++Y+H     +++H+DIK SN+L+  +   KIA+FG++    G +A+  + V
Sbjct: 142 YFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV 198
Query: 492 GTQGYIAPEYLAD--GVVSTK-MDVFSFGVVLLELISGKEAIDEEGKFC 537
           GT  ++APE L++   + S K +DV++ GV L   + G+    +E   C
Sbjct: 199 GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 93/185 (50%), Gaps = 16/185 (8%)
Query: 351 GSVYKGNIHGEV-YAIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPEDANCY 403
           G V+ G  +G    A+K +K  +        E  +++++ H  LV+L            Y
Sbjct: 29  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIY 85
Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI 463
           +I EY+ENGSL  +L       L     L +A  +A G+ +I E      +H+D++++NI
Sbjct: 86  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANI 142
Query: 464 LLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFSFGVVL 520
           L+   +  KIA+FGLA+   +       G +    + APE +  G  + K DV+SFG++L
Sbjct: 143 LVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 202
Query: 521 LELIS 525
            E+++
Sbjct: 203 TEIVT 207

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 92/182 (50%), Gaps = 19/182 (10%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL--HENKNENLNWKTRL 432
           E++I++ +NH N+VKL  F +   +   YL+ EY   G +  +L  H    E    + + 
Sbjct: 63  EVRIMKVLNHPNIVKL--FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-EARAKF 119
Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM-HIV 491
           R    + + +QY H+     +VH+D+K+ N+LLD++M  KIA+FG +        +    
Sbjct: 120 R---QIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFC 173
Query: 492 GTQGYIAPE-YLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYWREMKR 550
           G+  Y APE +        ++DV+S GV+L  L+SG    D      GQ LK     + R
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD------GQNLKELRERVLR 227
Query: 551 GK 552
           GK
Sbjct: 228 GK 229

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 86/155 (55%), Gaps = 9/155 (5%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           EE +++ K++H  LV+L G C+  E A   L++E++E+G L  +L   +      +T L 
Sbjct: 71  EEAEVMMKLSHPKLVQLYGVCL--EQAPICLVFEFMEHGCLSDYLRTQRG-LFAAETLLG 127
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT 493
           + +DV  G+ Y+ E     V+H+D+ + N L+  N   K+++FG+ +   +       GT
Sbjct: 128 MCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 184
Query: 494 Q---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           +    + +PE  +    S+K DV+SFGV++ E+ S
Sbjct: 185 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 219

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 320 DVSDCLDKYRIFKIEELREATDNFSEGCLIQGSVYKGN--IHGEVYAIKMMKWNACEELK 377
           D+S   D   IF++ EL         G    G VYKG     G++ AIK+M     EE +
Sbjct: 15  DLSALRDPAGIFELVELV--------GNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEE 66
Query: 378 ILQKVN-------HGNLVKLEGFCI--DPE--DANCYLIYEYIENGSLHSWLHENKNENL 426
           I Q++N       H N+    G  I  +P   D   +L+ E+   GS+   +   K   L
Sbjct: 67  IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL 126
Query: 427 NWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI 486
             +    I  ++  GL ++H+H   +V+H+DIK  N+LL  N   K+ +FG++      +
Sbjct: 127 KEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 183
Query: 487 TMH--IVGTQGYIAPEYLA-----DGVVSTKMDVFSFGVVLLELISG 526
                 +GT  ++APE +A     D     K D++S G+  +E+  G
Sbjct: 184 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 93/185 (50%), Gaps = 16/185 (8%)
Query: 351 GSVYKGNIHGEV-YAIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPEDANCY 403
           G V+ G  +G    A+K +K  +        E  +++++ H  LV+L            Y
Sbjct: 33  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIY 89
Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI 463
           +I EY+ENGSL  +L       L     L +A  +A G+ +I E      +H+D++++NI
Sbjct: 90  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANI 146
Query: 464 LLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFSFGVVL 520
           L+   +  KIA+FGLA+   +       G +    + APE +  G  + K DV+SFG++L
Sbjct: 147 LVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 206
Query: 521 LELIS 525
            E+++
Sbjct: 207 TEIVT 211

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 93/185 (50%), Gaps = 16/185 (8%)
Query: 351 GSVYKGNIHGEV-YAIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPEDANCY 403
           G V+ G  +G    A+K +K  +        E  +++++ H  LV+L            Y
Sbjct: 28  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIY 84
Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI 463
           +I EY+ENGSL  +L       L     L +A  +A G+ +I E      +H+D++++NI
Sbjct: 85  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANI 141
Query: 464 LLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFSFGVVL 520
           L+   +  KIA+FGLA+   +       G +    + APE +  G  + K DV+SFG++L
Sbjct: 142 LVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 201
Query: 521 LELIS 525
            E+++
Sbjct: 202 TEIVT 206

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 93/185 (50%), Gaps = 16/185 (8%)
Query: 351 GSVYKGNIHGEV-YAIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPEDANCY 403
           G V+ G  +G    A+K +K  +        E  +++++ H  LV+L            Y
Sbjct: 27  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIY 83
Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI 463
           +I EY+ENGSL  +L       L     L +A  +A G+ +I E      +H+D++++NI
Sbjct: 84  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANI 140
Query: 464 LLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFSFGVVL 520
           L+   +  KIA+FGLA+   +       G +    + APE +  G  + K DV+SFG++L
Sbjct: 141 LVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 200
Query: 521 LELIS 525
            E+++
Sbjct: 201 TEIVT 205

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 93/185 (50%), Gaps = 16/185 (8%)
Query: 351 GSVYKGNIHGEV-YAIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPEDANCY 403
           G V+ G  +G    A+K +K  +        E  +++++ H  LV+L            Y
Sbjct: 32  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIY 88
Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI 463
           +I EY+ENGSL  +L       L     L +A  +A G+ +I E      +H+D++++NI
Sbjct: 89  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANI 145
Query: 464 LLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFSFGVVL 520
           L+   +  KIA+FGLA+   +       G +    + APE +  G  + K DV+SFG++L
Sbjct: 146 LVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 205
Query: 521 LELIS 525
            E+++
Sbjct: 206 TEIVT 210

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 100/194 (51%), Gaps = 18/194 (9%)
Query: 342 NFSEGCLIQGSVYKGNIHGEV-YAIKMMKWNA------CEELKILQKVNHGNLVKLEGFC 394
              +GC   G V+ G  +G    AIK +K          +E ++++K+ H  LV+L  + 
Sbjct: 25  KLGQGCF--GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YA 80
Query: 395 IDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVV 454
           +  E+   Y++ EY+  GSL  +L     + L     + +A  +A+G+ Y+    R   V
Sbjct: 81  VVSEEP-IYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 455 HKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKM 511
           H+D++++NIL+  N+  K+A+FGLA+   +       G +    + APE    G  + K 
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 512 DVFSFGVVLLELIS 525
           DV+SFG++L EL +
Sbjct: 197 DVWSFGILLTELTT 210

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 93/185 (50%), Gaps = 16/185 (8%)
Query: 351 GSVYKGNIHGEV-YAIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPEDANCY 403
           G V+ G  +G    A+K +K  +        E  +++++ H  LV+L            Y
Sbjct: 37  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIY 93
Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI 463
           +I EY+ENGSL  +L       L     L +A  +A G+ +I E      +H+D++++NI
Sbjct: 94  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANI 150
Query: 464 LLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFSFGVVL 520
           L+   +  KIA+FGLA+   +       G +    + APE +  G  + K DV+SFG++L
Sbjct: 151 LVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 210
Query: 521 LELIS 525
            E+++
Sbjct: 211 TEIVT 215

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 92/182 (50%), Gaps = 19/182 (10%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL--HENKNENLNWKTRL 432
           E++I++ +NH N+VKL  F +   +   YL+ EY   G +  +L  H    E    + + 
Sbjct: 63  EVRIMKVLNHPNIVKL--FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-EARAKF 119
Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIV- 491
           R    + + +QY H+     +VH+D+K+ N+LLD++M  KIA+FG +        +    
Sbjct: 120 R---QIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC 173
Query: 492 GTQGYIAPE-YLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYWREMKR 550
           G+  Y APE +        ++DV+S GV+L  L+SG    D      GQ LK     + R
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD------GQNLKELRERVLR 227
Query: 551 GK 552
           GK
Sbjct: 228 GK 229

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 92/182 (50%), Gaps = 19/182 (10%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL--HENKNENLNWKTRL 432
           E++I++ +NH N+VKL  F +   +   YL+ EY   G +  +L  H    E    + + 
Sbjct: 63  EVRIMKVLNHPNIVKL--FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-EARAKF 119
Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIV- 491
           R    + + +QY H+     +VH+D+K+ N+LLD++M  KIA+FG +        +    
Sbjct: 120 R---QIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC 173
Query: 492 GTQGYIAPE-YLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYWREMKR 550
           G+  Y APE +        ++DV+S GV+L  L+SG    D      GQ LK     + R
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD------GQNLKELRERVLR 227
Query: 551 GK 552
           GK
Sbjct: 228 GK 229

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 92/182 (50%), Gaps = 19/182 (10%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL--HENKNENLNWKTRL 432
           E++I++ +NH N+VKL  F +   +   YL+ EY   G +  +L  H    E    + + 
Sbjct: 63  EVRIMKVLNHPNIVKL--FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-EARAKF 119
Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIV- 491
           R    + + +QY H+     +VH+D+K+ N+LLD++M  KIA+FG +        +    
Sbjct: 120 R---QIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC 173
Query: 492 GTQGYIAPE-YLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYWREMKR 550
           G+  Y APE +        ++DV+S GV+L  L+SG    D      GQ LK     + R
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD------GQNLKELRERVLR 227
Query: 551 GK 552
           GK
Sbjct: 228 GK 229

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 93/185 (50%), Gaps = 16/185 (8%)
Query: 351 GSVYKGNIHGEV-YAIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPEDANCY 403
           G V+ G  +G    A+K +K  +        E  +++++ H  LV+L            Y
Sbjct: 22  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIY 78
Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI 463
           +I EY+ENGSL  +L       L     L +A  +A G+ +I E      +H+D++++NI
Sbjct: 79  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANI 135
Query: 464 LLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFSFGVVL 520
           L+   +  KIA+FGLA+   +       G +    + APE +  G  + K DV+SFG++L
Sbjct: 136 LVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 195
Query: 521 LELIS 525
            E+++
Sbjct: 196 TEIVT 200

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 100/194 (51%), Gaps = 18/194 (9%)
Query: 342 NFSEGCLIQGSVYKGNIHGEV-YAIKMMKWNA------CEELKILQKVNHGNLVKLEGFC 394
              +GC   G V+ G  +G    AIK +K          +E ++++K+ H  LV+L  + 
Sbjct: 22  KLGQGCF--GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YA 77
Query: 395 IDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVV 454
           +  E+   Y++ EY+  GSL  +L     + L     + ++  +A+G+ Y+    R   V
Sbjct: 78  VVSEEP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYV 133
Query: 455 HKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKM 511
           H+D++++NIL+  N+  K+A+FGLA+   +       G +    + APE    G  + K 
Sbjct: 134 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 193
Query: 512 DVFSFGVVLLELIS 525
           DV+SFG++L EL +
Sbjct: 194 DVWSFGILLTELTT 207

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 100/194 (51%), Gaps = 18/194 (9%)
Query: 342 NFSEGCLIQGSVYKGNIHGEV-YAIKMMKWNA------CEELKILQKVNHGNLVKLEGFC 394
              +GC   G V+ G  +G    AIK +K          +E ++++K+ H  LV+L  + 
Sbjct: 22  KLGQGCF--GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YA 77
Query: 395 IDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVV 454
           +  E+   Y++ EY+  GSL  +L     + L     + ++  +A+G+ Y+    R   V
Sbjct: 78  VVSEEP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYV 133
Query: 455 HKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKM 511
           H+D++++NIL+  N+  K+A+FGLA+   +       G +    + APE    G  + K 
Sbjct: 134 HRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKS 193
Query: 512 DVFSFGVVLLELIS 525
           DV+SFG++L EL +
Sbjct: 194 DVWSFGILLTELTT 207

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 95/190 (50%), Gaps = 25/190 (13%)
Query: 356 GNIHGEVY-----------AIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPE 398
           G  +GEVY           A+K +K +  E      E  +++++ H NLV+L G C    
Sbjct: 24  GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--R 81
Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
           +   Y+I E++  G+L  +L E   + +N    L +A  +++ ++Y+    +   +H+D+
Sbjct: 82  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDL 138
Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFS 515
            + N L+  N   K+A+FGL++           G +    + APE LA    S K DV++
Sbjct: 139 AARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWA 198
Query: 516 FGVVLLELIS 525
           FGV+L E+ +
Sbjct: 199 FGVLLWEIAT 208

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 93/185 (50%), Gaps = 16/185 (8%)
Query: 351 GSVYKGNIHGEV-YAIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPEDANCY 403
           G V+ G  +G    A+K +K  +        E  +++++ H  LV+L            Y
Sbjct: 27  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIY 83
Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI 463
           +I EY+ENGSL  +L       L     L +A  +A G+ +I E      +H+D++++NI
Sbjct: 84  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANI 140
Query: 464 LLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFSFGVVL 520
           L+   +  KIA+FGLA+   +       G +    + APE +  G  + K DV+SFG++L
Sbjct: 141 LVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 200
Query: 521 LELIS 525
            E+++
Sbjct: 201 TEIVT 205

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 95/190 (50%), Gaps = 25/190 (13%)
Query: 356 GNIHGEVY-----------AIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPE 398
           G  +GEVY           A+K +K +  E      E  +++++ H NLV+L G C    
Sbjct: 24  GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--R 81
Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
           +   Y+I E++  G+L  +L E   + +N    L +A  +++ ++Y+    +   +H+D+
Sbjct: 82  EPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDL 138
Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFS 515
            + N L+  N   K+A+FGL++           G +    + APE LA    S K DV++
Sbjct: 139 AARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 198
Query: 516 FGVVLLELIS 525
           FGV+L E+ +
Sbjct: 199 FGVLLWEIAT 208

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 95/190 (50%), Gaps = 25/190 (13%)
Query: 356 GNIHGEVY-----------AIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPE 398
           G  +GEVY           A+K +K +  E      E  +++++ H NLV+L G C    
Sbjct: 28  GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--R 85
Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
           +   Y+I E++  G+L  +L E   + +N    L +A  +++ ++Y+    +   +H+D+
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDL 142
Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFS 515
            + N L+  N   K+A+FGL++           G +    + APE LA    S K DV++
Sbjct: 143 AARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 202
Query: 516 FGVVLLELIS 525
           FGV+L E+ +
Sbjct: 203 FGVLLWEIAT 212

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 99/194 (51%), Gaps = 18/194 (9%)
Query: 342 NFSEGCLIQGSVYKGNIHGEV-YAIKMMKWNA------CEELKILQKVNHGNLVKLEGFC 394
              +GC   G V+ G  +G    AIK +K          +E ++++K+ H  LV+L  + 
Sbjct: 25  KLGQGCF--GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YA 80
Query: 395 IDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVV 454
           +  E+   Y++ EY+  GSL  +L     + L     + +A  +A+G+ Y+    R   V
Sbjct: 81  VVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 455 HKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKM 511
           H+D+ ++NIL+  N+  K+A+FGLA+   +       G +    + APE    G  + K 
Sbjct: 137 HRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 512 DVFSFGVVLLELIS 525
           DV+SFG++L EL +
Sbjct: 197 DVWSFGILLTELTT 210

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 90/181 (49%), Gaps = 23/181 (12%)
Query: 360 GEVYAIKMMK----------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI 409
           GE+ A+K +K          W   +E+ IL+ + H +++K +G C D  + +  L+ EY+
Sbjct: 43  GEMVAVKALKADCGPQHRSGWK--QEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYV 100
Query: 410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM 469
             GSL  +L      ++     L  A  +  G+ Y+H       +H+++ + N+LLD++ 
Sbjct: 101 PLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHSQ---HYIHRNLAARNVLLDNDR 154
Query: 470 RAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELI 524
             KI +FGLAK+       + V   G     + APE L +       DV+SFGV L EL+
Sbjct: 155 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 214
Query: 525 S 525
           +
Sbjct: 215 T 215

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 91/182 (50%), Gaps = 19/182 (10%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL--HENKNENLNWKTRL 432
           E++I++ +NH N+VKL  F +   +   YL+ EY   G +  +L  H    E    + + 
Sbjct: 63  EVRIMKVLNHPNIVKL--FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-EARAKF 119
Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH-IV 491
           R    + + +QY H+     +VH+D+K+ N+LLD++M  KIA+FG +        +    
Sbjct: 120 R---QIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFC 173
Query: 492 GTQGYIAPE-YLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYWREMKR 550
           G   Y APE +        ++DV+S GV+L  L+SG    D      GQ LK     + R
Sbjct: 174 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD------GQNLKELRERVLR 227
Query: 551 GK 552
           GK
Sbjct: 228 GK 229

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 79/157 (50%), Gaps = 7/157 (4%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E++I   + H N+++L G+  D      YLI EY   G+++  L   K    + +     
Sbjct: 60  EVEIQSHLRHPNILRLYGYFHDA--TRVYLILEYAPLGTVYREL--QKLSKFDEQRTATY 115
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
             ++AN L Y H     RV+H+DIK  N+LL S    KIANFG +    ++    + GT 
Sbjct: 116 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTL 172
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
            Y+ PE +   +   K+D++S GV+  E + GK   +
Sbjct: 173 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 209

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 97/190 (51%), Gaps = 34/190 (17%)
Query: 364 AIKMMKWNACE--------ELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K +A E        E+++++ +  H N++ L G C   +D   Y+I EY   G+L
Sbjct: 56  AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNL 113
Query: 415 HSWLH--------------ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             +L                N  E L+ K  +  A  VA G++Y+      + +H+D+ +
Sbjct: 114 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 170
Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFS 515
            N+L+  +   KIA+FGLA+   + I  +   T G     ++APE L D + + + DV+S
Sbjct: 171 RNVLVTEDNVMKIADFGLARD-IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 229
Query: 516 FGVVLLELIS 525
           FGV+L E+ +
Sbjct: 230 FGVLLWEIFT 239

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 95/190 (50%), Gaps = 25/190 (13%)
Query: 356 GNIHGEVY-----------AIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPE 398
           G  +GEVY           A+K +K +  E      E  +++++ H NLV+L G C    
Sbjct: 25  GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--R 82
Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
           +   Y+I E++  G+L  +L E   + +N    L +A  +++ ++Y+    +   +H+D+
Sbjct: 83  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDL 139
Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFS 515
            + N L+  N   K+A+FGL++           G +    + APE LA    S K DV++
Sbjct: 140 AARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWA 199
Query: 516 FGVVLLELIS 525
           FGV+L E+ +
Sbjct: 200 FGVLLWEIAT 209

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 97/190 (51%), Gaps = 34/190 (17%)
Query: 364 AIKMMKWNACE--------ELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K +A E        E+++++ +  H N++ L G C   +D   Y+I EY   G+L
Sbjct: 64  AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNL 121
Query: 415 HSWLH--------------ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             +L                N  E L+ K  +  A  VA G++Y+      + +H+D+ +
Sbjct: 122 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 178
Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFS 515
            N+L+  +   KIA+FGLA+   + I  +   T G     ++APE L D + + + DV+S
Sbjct: 179 RNVLVTEDNVMKIADFGLARD-IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 237
Query: 516 FGVVLLELIS 525
           FGV+L E+ +
Sbjct: 238 FGVLLWEIFT 247

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 97/190 (51%), Gaps = 34/190 (17%)
Query: 364 AIKMMKWNACE--------ELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K +A E        E+++++ +  H N++ L G C   +D   Y+I EY   G+L
Sbjct: 57  AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNL 114
Query: 415 HSWLH--------------ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             +L                N  E L+ K  +  A  VA G++Y+      + +H+D+ +
Sbjct: 115 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 171
Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFS 515
            N+L+  +   KIA+FGLA+   + I  +   T G     ++APE L D + + + DV+S
Sbjct: 172 RNVLVTEDNVMKIADFGLARD-IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 230
Query: 516 FGVVLLELIS 525
           FGV+L E+ +
Sbjct: 231 FGVLLWEIFT 240

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 95/190 (50%), Gaps = 25/190 (13%)
Query: 356 GNIHGEVY-----------AIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPE 398
           G  +GEVY           A+K +K +  E      E  +++++ H NLV+L G C    
Sbjct: 28  GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--R 85
Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
           +   Y+I E++  G+L  +L E   + +N    L +A  +++ ++Y+    +   +H+D+
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDL 142
Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFS 515
            + N L+  N   K+A+FGL++           G +    + APE LA    S K DV++
Sbjct: 143 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 202
Query: 516 FGVVLLELIS 525
           FGV+L E+ +
Sbjct: 203 FGVLLWEIAT 212

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 90/181 (49%), Gaps = 23/181 (12%)
Query: 360 GEVYAIKMMK----------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI 409
           GE+ A+K +K          W   +E+ IL+ + H +++K +G C D  + +  L+ EY+
Sbjct: 43  GEMVAVKALKADCGPQHRSGWK--QEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYV 100
Query: 410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM 469
             GSL  +L      ++     L  A  +  G+ Y+H       +H+++ + N+LLD++ 
Sbjct: 101 PLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRNLAARNVLLDNDR 154
Query: 470 RAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELI 524
             KI +FGLAK+       + V   G     + APE L +       DV+SFGV L EL+
Sbjct: 155 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 214
Query: 525 S 525
           +
Sbjct: 215 T 215

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 79/157 (50%), Gaps = 7/157 (4%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E++I   + H N+++L G+  D      YLI EY   G+++  L   K    + +     
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATY 116
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
             ++AN L Y H     RV+H+DIK  N+LL S    KIANFG +    ++    + GT 
Sbjct: 117 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTL 173
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
            Y+ PE +   +   K+D++S GV+  E + GK   +
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 97/190 (51%), Gaps = 34/190 (17%)
Query: 364 AIKMMKWNACE--------ELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K +A E        E+++++ +  H N++ L G C   +D   Y+I EY   G+L
Sbjct: 64  AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNL 121
Query: 415 HSWLH--------------ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             +L                N  E L+ K  +  A  VA G++Y+      + +H+D+ +
Sbjct: 122 REYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 178
Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFS 515
            N+L+  +   KIA+FGLA+   + I  +   T G     ++APE L D + + + DV+S
Sbjct: 179 RNVLVTEDNVMKIADFGLARD-IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 237
Query: 516 FGVVLLELIS 525
           FGV+L E+ +
Sbjct: 238 FGVLLWEIFT 247

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 96/190 (50%), Gaps = 34/190 (17%)
Query: 364 AIKMMKWNACE--------ELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K +A E        E+++++ +  H N++ L G C   +D   Y+I EY   G+L
Sbjct: 117 AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNL 174
Query: 415 HSWLHENK--------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             +L   +               E + +K  +     +A G++Y+      + +H+D+ +
Sbjct: 175 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 231
Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFS 515
            N+L+  N   KIA+FGLA+   N I  +   T G     ++APE L D V + + DV+S
Sbjct: 232 RNVLVTENNVMKIADFGLARD-INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 290
Query: 516 FGVVLLELIS 525
           FGV++ E+ +
Sbjct: 291 FGVLMWEIFT 300

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 97/190 (51%), Gaps = 34/190 (17%)
Query: 364 AIKMMKWNACE--------ELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K +A E        E+++++ +  H N++ L G C   +D   Y+I EY   G+L
Sbjct: 105 AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNL 162
Query: 415 HSWLH--------------ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             +L                N  E L+ K  +  A  VA G++Y+      + +H+D+ +
Sbjct: 163 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA 219
Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFS 515
            N+L+  +   KIA+FGLA+   + I  +   T G     ++APE L D + + + DV+S
Sbjct: 220 RNVLVTEDNVMKIADFGLARD-IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 278
Query: 516 FGVVLLELIS 525
           FGV+L E+ +
Sbjct: 279 FGVLLWEIFT 288

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 97/190 (51%), Gaps = 34/190 (17%)
Query: 364 AIKMMKWNACE--------ELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K +A E        E+++++ +  H N++ L G C   +D   Y+I EY   G+L
Sbjct: 53  AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNL 110
Query: 415 HSWLH--------------ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             +L                N  E L+ K  +  A  VA G++Y+      + +H+D+ +
Sbjct: 111 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 167
Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFS 515
            N+L+  +   KIA+FGLA+   + I  +   T G     ++APE L D + + + DV+S
Sbjct: 168 RNVLVTEDNVMKIADFGLARD-IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 226
Query: 516 FGVVLLELIS 525
           FGV+L E+ +
Sbjct: 227 FGVLLWEIFT 236

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 95/190 (50%), Gaps = 25/190 (13%)
Query: 356 GNIHGEVY-----------AIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPE 398
           G  +GEVY           A+K +K +  E      E  +++++ H NLV+L G C    
Sbjct: 28  GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--R 85
Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
           +   Y+I E++  G+L  +L E   + +N    L +A  +++ ++Y+    +   +H+D+
Sbjct: 86  EPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDL 142
Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFS 515
            + N L+  N   K+A+FGL++           G +    + APE LA    S K DV++
Sbjct: 143 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 202
Query: 516 FGVVLLELIS 525
           FGV+L E+ +
Sbjct: 203 FGVLLWEIAT 212

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 91/182 (50%), Gaps = 19/182 (10%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL--HENKNENLNWKTRL 432
           E++I++ +NH N+VKL  F +   +   YL+ EY   G +  +L  H    E    + + 
Sbjct: 64  EVRIMKILNHPNIVKL--FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-EARAKF 120
Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIV- 491
           R    + + +QY H+     +VH+D+K+ N+LLD +M  KIA+FG +        +    
Sbjct: 121 R---QIVSAVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFC 174
Query: 492 GTQGYIAPE-YLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYWREMKR 550
           G+  Y APE +        ++DV+S GV+L  L+SG    D      GQ LK     + R
Sbjct: 175 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD------GQNLKELRERVLR 228
Query: 551 GK 552
           GK
Sbjct: 229 GK 230

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 97/190 (51%), Gaps = 34/190 (17%)
Query: 364 AIKMMKWNACE--------ELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K +A E        E+++++ +  H N++ L G C   +D   Y+I EY   G+L
Sbjct: 64  AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNL 121
Query: 415 HSWLH--------------ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             +L                N  E L+ K  +  A  VA G++Y+      + +H+D+ +
Sbjct: 122 REYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 178
Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFS 515
            N+L+  +   KIA+FGLA+   + I  +   T G     ++APE L D + + + DV+S
Sbjct: 179 RNVLVTEDNVMKIADFGLARD-IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 237
Query: 516 FGVVLLELIS 525
           FGV+L E+ +
Sbjct: 238 FGVLLWEIFT 247

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 97/190 (51%), Gaps = 34/190 (17%)
Query: 364 AIKMMKWNACE--------ELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K +A E        E+++++ +  H N++ L G C   +D   Y+I EY   G+L
Sbjct: 49  AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNL 106
Query: 415 HSWLH--------------ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             +L                N  E L+ K  +  A  VA G++Y+      + +H+D+ +
Sbjct: 107 REYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 163
Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFS 515
            N+L+  +   KIA+FGLA+   + I  +   T G     ++APE L D + + + DV+S
Sbjct: 164 RNVLVTEDNVMKIADFGLARD-IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 222
Query: 516 FGVVLLELIS 525
           FGV+L E+ +
Sbjct: 223 FGVLLWEIFT 232

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 95/190 (50%), Gaps = 25/190 (13%)
Query: 356 GNIHGEVY-----------AIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPE 398
           G  +GEVY           A+K +K +  E      E  +++++ H NLV+L G C    
Sbjct: 27  GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--R 84
Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
           +   Y+I E++  G+L  +L E   + +N    L +A  +++ ++Y+    +   +H+D+
Sbjct: 85  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDL 141
Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFS 515
            + N L+  N   K+A+FGL++           G +    + APE LA    S K DV++
Sbjct: 142 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 201
Query: 516 FGVVLLELIS 525
           FGV+L E+ +
Sbjct: 202 FGVLLWEIAT 211

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 96/191 (50%), Gaps = 27/191 (14%)
Query: 356 GNIHGEVY-----------AIKMMKWNACE------ELKILQKVNHGNLVKLEGFC-IDP 397
           G  +GEVY           A+K +K +  E      E  +++++ H NLV+L G C ++P
Sbjct: 42  GGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTLEP 101
Query: 398 EDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKD 457
                Y++ EY+  G+L  +L E   E +     L +A  +++ ++Y+    +   +H+D
Sbjct: 102 P---FYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE---KKNFIHRD 155
Query: 458 IKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVF 514
           + + N L+  N   K+A+FGL++           G +    + APE LA    S K DV+
Sbjct: 156 LAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVW 215
Query: 515 SFGVVLLELIS 525
           +FGV+L E+ +
Sbjct: 216 AFGVLLWEIAT 226

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 95/190 (50%), Gaps = 25/190 (13%)
Query: 356 GNIHGEVY-----------AIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPE 398
           G  +GEVY           A+K +K +  E      E  +++++ H NLV+L G C    
Sbjct: 28  GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--R 85
Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
           +   Y+I E++  G+L  +L E   + +N    L +A  +++ ++Y+    +   +H+D+
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDL 142
Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFS 515
            + N L+  N   K+A+FGL++           G +    + APE LA    S K DV++
Sbjct: 143 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 202
Query: 516 FGVVLLELIS 525
           FGV+L E+ +
Sbjct: 203 FGVLLWEIAT 212

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 85/155 (54%), Gaps = 9/155 (5%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           EE +++ K++H  LV+L G C+  E A   L+ E++E+G L  +L   +      +T L 
Sbjct: 52  EEAEVMMKLSHPKLVQLYGVCL--EQAPICLVTEFMEHGCLSDYLRTQRG-LFAAETLLG 108
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT 493
           + +DV  G+ Y+ E     V+H+D+ + N L+  N   K+++FG+ +   +       GT
Sbjct: 109 MCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 165
Query: 494 Q---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           +    + +PE  +    S+K DV+SFGV++ E+ S
Sbjct: 166 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 200

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 95/190 (50%), Gaps = 25/190 (13%)
Query: 356 GNIHGEVY-----------AIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPE 398
           G  +GEVY           A+K +K +  E      E  +++++ H NLV+L G C    
Sbjct: 25  GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--R 82
Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
           +   Y+I E++  G+L  +L E   + +N    L +A  +++ ++Y+    +   +H+D+
Sbjct: 83  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDL 139
Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFS 515
            + N L+  N   K+A+FGL++           G +    + APE LA    S K DV++
Sbjct: 140 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 199
Query: 516 FGVVLLELIS 525
           FGV+L E+ +
Sbjct: 200 FGVLLWEIAT 209

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 95/190 (50%), Gaps = 25/190 (13%)
Query: 356 GNIHGEVY-----------AIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPE 398
           G  +GEVY           A+K +K +  E      E  +++++ H NLV+L G C    
Sbjct: 23  GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--R 80
Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
           +   Y+I E++  G+L  +L E   + +N    L +A  +++ ++Y+    +   +H+D+
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDL 137
Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFS 515
            + N L+  N   K+A+FGL++           G +    + APE LA    S K DV++
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 197
Query: 516 FGVVLLELIS 525
           FGV+L E+ +
Sbjct: 198 FGVLLWEIAT 207

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 78/157 (49%), Gaps = 7/157 (4%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E++I   + H N+++L G+  D      YLI EY   G ++  L   K    + +     
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDA--TRVYLILEYAPRGEVYKEL--QKLSKFDEQRTATY 118
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
             ++AN L Y H     RV+H+DIK  N+LL S    KIA+FG +    ++    + GT 
Sbjct: 119 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLXGTL 175
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
            Y+ PE +   +   K+D++S GV+  E + GK   +
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 95/190 (50%), Gaps = 25/190 (13%)
Query: 356 GNIHGEVY-----------AIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPE 398
           G  +GEVY           A+K +K +  E      E  +++++ H NLV+L G C    
Sbjct: 36  GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--R 93
Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
           +   Y+I E++  G+L  +L E   + +N    L +A  +++ ++Y+    +   +H+D+
Sbjct: 94  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDL 150
Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFS 515
            + N L+  N   K+A+FGL++           G +    + APE LA    S K DV++
Sbjct: 151 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 210
Query: 516 FGVVLLELIS 525
           FGV+L E+ +
Sbjct: 211 FGVLLWEIAT 220

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 95/190 (50%), Gaps = 25/190 (13%)
Query: 356 GNIHGEVY-----------AIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPE 398
           G  +GEVY           A+K +K +  E      E  +++++ H NLV+L G C    
Sbjct: 23  GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--R 80
Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
           +   Y+I E++  G+L  +L E   + +N    L +A  +++ ++Y+    +   +H+D+
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDL 137
Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFS 515
            + N L+  N   K+A+FGL++           G +    + APE LA    S K DV++
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 197
Query: 516 FGVVLLELIS 525
           FGV+L E+ +
Sbjct: 198 FGVLLWEIAT 207

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 99/194 (51%), Gaps = 18/194 (9%)
Query: 342 NFSEGCLIQGSVYKGNIHGEV-YAIKMMKWNA------CEELKILQKVNHGNLVKLEGFC 394
              +GC   G V+ G  +G    AIK +K          +E ++++K+ H  LV+L  + 
Sbjct: 25  KLGQGCF--GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YA 80
Query: 395 IDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVV 454
           +  E+   Y++ EY+  G L  +L     + L     + +A  +A+G+ Y+    R   V
Sbjct: 81  VVSEEP-IYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 455 HKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKM 511
           H+D++++NIL+  N+  K+A+FGLA+   +       G +    + APE    G  + K 
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 512 DVFSFGVVLLELIS 525
           DV+SFG++L EL +
Sbjct: 197 DVWSFGILLTELTT 210

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 96/190 (50%), Gaps = 34/190 (17%)
Query: 364 AIKMMKWNACE--------ELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K +A E        E+++++ +  H N++ L G C   +D   Y+I EY   G+L
Sbjct: 71  AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIITLLGACT--QDGPLYVIVEYASKGNL 128
Query: 415 HSWLHENK--------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             +L   +               E + +K  +     +A G++Y+      + +H+D+ +
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 185
Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFS 515
            N+L+  N   KIA+FGLA+   N I  +   T G     ++APE L D V + + DV+S
Sbjct: 186 RNVLVTENNVMKIADFGLARD-INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 244
Query: 516 FGVVLLELIS 525
           FGV++ E+ +
Sbjct: 245 FGVLMWEIFT 254

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 96/190 (50%), Gaps = 34/190 (17%)
Query: 364 AIKMMKWNACE--------ELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K +A E        E+++++ +  H N++ L G C   +D   Y+I EY   G+L
Sbjct: 58  AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNL 115
Query: 415 HSWLHENK--------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             +L   +               E + +K  +     +A G++Y+      + +H+D+ +
Sbjct: 116 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLTA 172
Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFS 515
            N+L+  N   KIA+FGLA+   N I  +   T G     ++APE L D V + + DV+S
Sbjct: 173 RNVLVTENNVMKIADFGLARD-INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 231
Query: 516 FGVVLLELIS 525
           FGV++ E+ +
Sbjct: 232 FGVLMWEIFT 241

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 7/157 (4%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E++I   + H N+++L G+  D      YLI EY   G+++  L   K    + +     
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATY 113
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
             ++AN L Y H     RV+H+DIK  N+LL S    KIA+FG +    ++    + GT 
Sbjct: 114 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELCGTL 170
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
            Y+ PE +   +   K+D++S GV+  E + GK   +
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 78/157 (49%), Gaps = 7/157 (4%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E++I   + H N+++L G+  D      YLI EY   G ++  L   K    + +     
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDA--TRVYLILEYAPRGEVYKEL--QKLSKFDEQRTATY 118
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
             ++AN L Y H     RV+H+DIK  N+LL S    KIA+FG +    ++    + GT 
Sbjct: 119 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL 175
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
            Y+ PE +   +   K+D++S GV+  E + GK   +
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 99/194 (51%), Gaps = 18/194 (9%)
Query: 342 NFSEGCLIQGSVYKGNIHGEV-YAIKMMKWNA------CEELKILQKVNHGNLVKLEGFC 394
              +GC   G V+ G  +G    AIK +K          +E ++++K+ H  LV+L  + 
Sbjct: 25  KLGQGCF--GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YA 80
Query: 395 IDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVV 454
           +  E+   Y++ EY+  G L  +L     + L     + +A  +A+G+ Y+    R   V
Sbjct: 81  VVSEEP-IYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 455 HKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKM 511
           H+D++++NIL+  N+  K+A+FGLA+   +       G +    + APE    G  + K 
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 512 DVFSFGVVLLELIS 525
           DV+SFG++L EL +
Sbjct: 197 DVWSFGILLTELTT 210

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 99/194 (51%), Gaps = 18/194 (9%)
Query: 342 NFSEGCLIQGSVYKGNIHGEV-YAIKMMKWNA------CEELKILQKVNHGNLVKLEGFC 394
              +GC   G V+ G  +G    AIK +K          +E ++++K+ H  LV+L  + 
Sbjct: 15  KLGQGCF--GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YA 70
Query: 395 IDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVV 454
           +  E+    ++ EY+  GSL  +L     + L     + +A  +A+G+ Y+    R   V
Sbjct: 71  VVSEEP-IXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 126
Query: 455 HKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKM 511
           H+D++++NIL+  N+  K+A+FGLA+   +       G +    + APE    G  + K 
Sbjct: 127 HRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKS 186
Query: 512 DVFSFGVVLLELIS 525
           DV+SFG++L EL +
Sbjct: 187 DVWSFGILLTELTT 200

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 95/190 (50%), Gaps = 25/190 (13%)
Query: 356 GNIHGEVY-----------AIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPE 398
           G  +GEVY           A+K +K +  E      E  +++++ H NLV+L G C    
Sbjct: 25  GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--R 82
Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
           +   Y+I E++  G+L  +L E   + +N    L +A  +++ ++Y+    +   +H+D+
Sbjct: 83  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDL 139
Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFS 515
            + N L+  N   K+A+FGL++           G +    + APE LA    S K DV++
Sbjct: 140 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 199
Query: 516 FGVVLLELIS 525
           FGV+L E+ +
Sbjct: 200 FGVLLWEIAT 209

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 96/190 (50%), Gaps = 34/190 (17%)
Query: 364 AIKMMKWNACE--------ELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K +A E        E+++++ +  H N++ L G C   +D   Y+I EY   G+L
Sbjct: 63  AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNL 120
Query: 415 HSWLHENK--------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             +L   +               E + +K  +     +A G++Y+      + +H+D+ +
Sbjct: 121 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 177
Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFS 515
            N+L+  N   KIA+FGLA+   N I  +   T G     ++APE L D V + + DV+S
Sbjct: 178 RNVLVTENNVMKIADFGLARD-INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 236
Query: 516 FGVVLLELIS 525
           FGV++ E+ +
Sbjct: 237 FGVLMWEIFT 246

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 96/190 (50%), Gaps = 34/190 (17%)
Query: 364 AIKMMKWNACEE--------LKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K +A EE        +++++ +  H N++ L G C   +D   Y+I EY   G+L
Sbjct: 71  AVKMLKDDATEEDLSDLVSEMEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNL 128
Query: 415 HSWLHENK--------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             +L   +               E + +K  +     +A G++Y+      + +H+D+ +
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 185
Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFS 515
            N+L+  N   KIA+FGLA+   N I  +   T G     ++APE L D V + + DV+S
Sbjct: 186 RNVLVTENNVMKIADFGLARD-INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 244
Query: 516 FGVVLLELIS 525
           FGV++ E+ +
Sbjct: 245 FGVLMWEIFT 254

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 99/193 (51%), Gaps = 18/193 (9%)
Query: 343 FSEGCLIQGSVYKGNIHGEV-YAIKMMKWNA------CEELKILQKVNHGNLVKLEGFCI 395
             +GC   G V+ G  +G    AIK +K          +E ++++K+ H  LV+L  + +
Sbjct: 193 LGQGCF--GEVWMGTWNGTTRVAIKTLKPGNMSPEAFLQEAQVMKKLRHEKLVQL--YAV 248
Query: 396 DPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVH 455
             E+   Y++ EY+  GSL  +L     + L     + +A  +A+G+ Y+    R   VH
Sbjct: 249 VSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 304
Query: 456 KDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMD 512
           +D++++NIL+  N+  K+A+FGL +   +       G +    + APE    G  + K D
Sbjct: 305 RDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 364
Query: 513 VFSFGVVLLELIS 525
           V+SFG++L EL +
Sbjct: 365 VWSFGILLTELTT 377

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 96/190 (50%), Gaps = 34/190 (17%)
Query: 364 AIKMMKWNACE--------ELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K +A E        E+++++ +  H N++ L G C   +D   Y+I EY   G+L
Sbjct: 60  AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNL 117
Query: 415 HSWLHENK--------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             +L   +               E + +K  +     +A G++Y+      + +H+D+ +
Sbjct: 118 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 174
Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFS 515
            N+L+  N   KIA+FGLA+   N I  +   T G     ++APE L D V + + DV+S
Sbjct: 175 RNVLVTENNVMKIADFGLARD-INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 233
Query: 516 FGVVLLELIS 525
           FGV++ E+ +
Sbjct: 234 FGVLMWEIFT 243

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 106/204 (51%), Gaps = 19/204 (9%)
Query: 334 EELREATDNFSEGCLIQGSVYKGNIH---GEVYAIKMMKWNA-----CEELKILQKVNHG 385
           EE+ +  +   EG    GSVYK  IH   G++ AIK +   +      +E+ I+Q+ +  
Sbjct: 28  EEVFDVLEKLGEGSY--GSVYKA-IHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSP 84
Query: 386 NLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYI 445
           ++VK  G     ++ + +++ EY   GS+   +   +N+ L       I      GL+Y+
Sbjct: 85  HVVKYYGSYF--KNTDLWIVMEYCGAGSVSDIIR-LRNKTLTEDEIATILQSTLKGLEYL 141
Query: 446 HEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH--IVGTQGYIAPEYLA 503
           H     R +H+DIK+ NILL++   AK+A+FG+A    + +     ++GT  ++APE + 
Sbjct: 142 HFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQ 198
Query: 504 DGVVSTKMDVFSFGVVLLELISGK 527
           +   +   D++S G+  +E+  GK
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEGK 222

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 96/190 (50%), Gaps = 34/190 (17%)
Query: 364 AIKMMKWNACE--------ELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K +A E        E+++++ +  H N++ L G C   +D   Y+I EY   G+L
Sbjct: 71  AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACT--QDGPLYVIVEYASKGNL 128
Query: 415 HSWLHENK--------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             +L   +               E + +K  +     +A G++Y+      + +H+D+ +
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 185
Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFS 515
            N+L+  N   KIA+FGLA+   N I  +   T G     ++APE L D V + + DV+S
Sbjct: 186 RNVLVTENNVMKIADFGLARD-INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 244
Query: 516 FGVVLLELIS 525
           FGV++ E+ +
Sbjct: 245 FGVLMWEIFT 254

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 7/157 (4%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E++I   + H N+++L G+  D      YLI EY   G+++  L   K    + +     
Sbjct: 84  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATY 139
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
             ++AN L Y H     RV+H+DIK  N+LL S    KIA+FG +    ++    + GT 
Sbjct: 140 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL 196
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
            Y+ PE +   +   K+D++S GV+  E + GK   +
Sbjct: 197 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 96/190 (50%), Gaps = 34/190 (17%)
Query: 364 AIKMMKWNACE--------ELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K +A E        E+++++ +  H N++ L G C   +D   Y+I EY   G+L
Sbjct: 64  AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNL 121
Query: 415 HSWLH--------------ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             +L                N  E L+ K  +  A  VA G++Y+      + +H+D+ +
Sbjct: 122 REYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 178
Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFS 515
            N+L+  +   KIA+FGLA+   + I      T G     ++APE L D + + + DV+S
Sbjct: 179 RNVLVTEDNVMKIADFGLARD-IHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 237
Query: 516 FGVVLLELIS 525
           FGV+L E+ +
Sbjct: 238 FGVLLWEIFT 247

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 32/208 (15%)
Query: 351 GSVYKGNIHGEVYAIKMM------KWNACEELKILQKVNHGNLVKLEGFCIDPEDANC-- 402
           G V+K  +  +  A+K+        W +  E+     + H NL++      +   +N   
Sbjct: 29  GCVWKAQLMNDFVAVKIFPLQDKQSWQSEREIFSTPGMKHENLLQF--IAAEKRGSNLEV 86
Query: 403 --YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHT--------RPR 452
             +LI  + + GSL  +L   K   + W     +A  ++ GL Y+HE          +P 
Sbjct: 87  ELWLITAFHDKGSLTDYL---KGNIITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPS 143
Query: 453 VVHKDIKSSNILLDSNMRAKIANFGLA---KSGCNAITMH-IVGTQGYIAPEYLADGV-- 506
           + H+D KS N+LL S++ A +A+FGLA   + G      H  VGT+ Y+APE L   +  
Sbjct: 144 IAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLEGAINF 203
Query: 507 ---VSTKMDVFSFGVVLLELISGKEAID 531
                 ++D+++ G+VL EL+S  +A D
Sbjct: 204 QRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 88/181 (48%), Gaps = 23/181 (12%)
Query: 360 GEVYAIKMMK----------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI 409
           GE+ A+K +K          W    E++IL+ + H ++VK +G C D  + +  L+ EY+
Sbjct: 37  GEMVAVKALKEGCGPQLRSGWQ--REIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYV 94
Query: 410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM 469
             GSL  +L       +     L  A  +  G+ Y+H       +H+ + + N+LLD++ 
Sbjct: 95  PLGSLRDYL---PRHCVGLAQLLLFAQQICEGMAYLHAQ---HYIHRALAARNVLLDNDR 148
Query: 470 RAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELI 524
             KI +FGLAK+       + V   G     + APE L +       DV+SFGV L EL+
Sbjct: 149 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELL 208
Query: 525 S 525
           +
Sbjct: 209 T 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 88/181 (48%), Gaps = 23/181 (12%)
Query: 360 GEVYAIKMMK----------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI 409
           GE+ A+K +K          W    E++IL+ + H ++VK +G C D  + +  L+ EY+
Sbjct: 38  GEMVAVKALKEGCGPQLRSGWQ--REIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYV 95
Query: 410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM 469
             GSL  +L       +     L  A  +  G+ Y+H       +H+ + + N+LLD++ 
Sbjct: 96  PLGSLRDYL---PRHCVGLAQLLLFAQQICEGMAYLHAQ---HYIHRALAARNVLLDNDR 149
Query: 470 RAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELI 524
             KI +FGLAK+       + V   G     + APE L +       DV+SFGV L EL+
Sbjct: 150 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELL 209
Query: 525 S 525
           +
Sbjct: 210 T 210

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 88/157 (56%), Gaps = 8/157 (5%)
Query: 375 ELKILQKVNHGNLVKLEG-FCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           EL++L + N   +V   G F  D E + C    E+++ GSL   L E K   +  +   +
Sbjct: 64  ELQVLHECNSPYIVGFYGAFYSDGEISICM---EHMDGGSLDQVLKEAKR--IPEEILGK 118
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT 493
           ++I V  GL Y+ E  + +++H+D+K SNIL++S    K+ +FG++    +++    VGT
Sbjct: 119 VSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGT 176
Query: 494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAI 530
           + Y+APE L     S + D++S G+ L+EL  G+  I
Sbjct: 177 RSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 7/157 (4%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E++I   + H N+++L G+  D      YLI EY   G+++  L   K    + +     
Sbjct: 60  EVEIQSHLRHPNILRLYGYFHDA--TRVYLILEYAPLGTVYREL--QKLSKFDEQRTATY 115
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
             ++AN L Y H     RV+H+DIK  N+LL S    KIA+FG +    ++    + GT 
Sbjct: 116 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTL 172
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
            Y+ PE +   +   K+D++S GV+  E + GK   +
Sbjct: 173 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 209

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 96/190 (50%), Gaps = 34/190 (17%)
Query: 364 AIKMMKWNACE--------ELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K +A E        E+++++ +  H N++ L G C   +D   Y+I EY   G+L
Sbjct: 71  AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNL 128
Query: 415 HSWLHENK--------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             +L   +               E + +K  +     +A G++Y+      + +H+D+ +
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 185
Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFS 515
            N+L+  N   KIA+FGLA+   N I  +   T G     ++APE L D V + + DV+S
Sbjct: 186 RNVLVTENNVMKIADFGLARD-INNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWS 244
Query: 516 FGVVLLELIS 525
           FGV++ E+ +
Sbjct: 245 FGVLMWEIFT 254

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 7/157 (4%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E++I   + H N+++L G+  D      YLI EY   G+++  L   K    + +     
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDA--TRVYLILEYAPLGTVYREL--QKLSKFDEQRTATY 113
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
             ++AN L Y H     RV+H+DIK  N+LL S    KIA+FG +    ++    + GT 
Sbjct: 114 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTL 170
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
            Y+ PE +   +   K+D++S GV+  E + GK   +
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 95/190 (50%), Gaps = 34/190 (17%)
Query: 364 AIKMMKWNACE--------ELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K +A E        E+++++ +  H N++ L G C   +D   Y+I EY   G+L
Sbjct: 71  AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNL 128
Query: 415 HSWLHENK--------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             +L   +               E + +K  +     +A G++Y+      + +H+D+ +
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 185
Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFS 515
            N+L+  N   KIA+FGLA+   N I      T G     ++APE L D V + + DV+S
Sbjct: 186 RNVLVTENNVMKIADFGLARD-INNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 244
Query: 516 FGVVLLELIS 525
           FGV++ E+ +
Sbjct: 245 FGVLMWEIFT 254

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 7/157 (4%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E++I   + H N+++L G+  D      YLI EY   G+++  L   K    + +     
Sbjct: 59  EVEIQSHLRHPNILRLYGYFHDA--TRVYLILEYAPLGTVYREL--QKLSKFDEQRTATY 114
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
             ++AN L Y H     RV+H+DIK  N+LL S    KIA+FG +    ++    + GT 
Sbjct: 115 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTL 171
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
            Y+ PE +   +   K+D++S GV+  E + GK   +
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 7/157 (4%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E++I   + H N+++L G+  D      YLI EY   G+++  L   K    + +     
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDA--TRVYLILEYAPLGTVYREL--QKLSKFDEQRTATY 116
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
             ++AN L Y H     RV+H+DIK  N+LL S    KIA+FG +    ++    + GT 
Sbjct: 117 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL 173
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
            Y+ PE +   +   K+D++S GV+  E + GK   +
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 7/157 (4%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E++I   + H N+++L G+  D      YLI EY   G+++  L   K    + +     
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATY 113
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
             ++AN L Y H     RV+H+DIK  N+LL S    KIA+FG +    ++    + GT 
Sbjct: 114 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL 170
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
            Y+ PE +   +   K+D++S GV+  E + GK   +
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 95/190 (50%), Gaps = 34/190 (17%)
Query: 364 AIKMMKWNACE--------ELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K +A E        E+++++ +  H N++ L G C   +D   Y+I EY   G+L
Sbjct: 71  AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNL 128
Query: 415 HSWLHENK--------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             +L   +               E + +K  +     +A G++Y+      + +H+D+ +
Sbjct: 129 REYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 185
Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFS 515
            N+L+  N   KIA+FGLA+   N I      T G     ++APE L D V + + DV+S
Sbjct: 186 RNVLVTENNVMKIADFGLARD-INNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 244
Query: 516 FGVVLLELIS 525
           FGV++ E+ +
Sbjct: 245 FGVLMWEIFT 254

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 100/198 (50%), Gaps = 28/198 (14%)
Query: 351 GSVYKGNIHGEVYAIKMMK------WNACEELKILQKVNHGNLVKLEGFCIDPEDANC-- 402
           G V++G  HGE  A+K+        W    E+     + H N++      +   +++   
Sbjct: 22  GEVWRGLWHGESVAVKIFSSRDEQSWFRETEIYNTVLLRHDNILGFIASDMTSRNSSTQL 81
Query: 403 YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIH-----EHTRPRVVHKD 457
           +LI  Y E+GSL+ +L   + + L     LR+A+  A GL ++H        +P + H+D
Sbjct: 82  WLITHYHEHGSLYDFL---QRQTLEPHLALRLAVSAACGLAHLHVEIFGTQGKPAIAHRD 138
Query: 458 IKSSNILLDSNMRAKIANFGLA---KSGCNAITM---HIVGTQGYIAPEYLADGVVS--- 508
            KS N+L+ SN++  IA+ GLA     G + + +     VGT+ Y+APE L + + +   
Sbjct: 139 FKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVLDEQIRTDCF 198
Query: 509 ---TKMDVFSFGVVLLEL 523
                 D+++FG+VL E+
Sbjct: 199 ESYKWTDIWAFGLVLWEI 216

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 7/157 (4%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E++I   + H N+++L G+  D      YLI EY   G+++  L   K    + +     
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDA--TRVYLILEYAPLGTVYREL--QKLSKFDEQRTATY 118
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
             ++AN L Y H     RV+H+DIK  N+LL S    KIA+FG +    ++    + GT 
Sbjct: 119 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTL 175
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
            Y+ PE +   +   K+D++S GV+  E + GK   +
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 78/152 (51%), Gaps = 7/152 (4%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E++I   + H N+++L G+  D      YLI EY   G+++  L   K    + +     
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHDA--TRVYLILEYAPLGTVYREL--QKLSRFDEQRTATY 117
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
             ++AN L Y H     RV+H+DIK  N+LL SN   KIA+FG +    ++    + GT 
Sbjct: 118 ITELANALSYCHSK---RVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTL 174
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            Y+ PE +   +   K+D++S GV+  E + G
Sbjct: 175 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 7/157 (4%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E++I   + H N+++L G+  D      YLI EY   G+++  L   K    + +     
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATY 113
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
             ++AN L Y H     RV+H+DIK  N+LL S    KIA+FG +    ++    + GT 
Sbjct: 114 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTL 170
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
            Y+ PE +   +   K+D++S GV+  E + GK   +
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 7/157 (4%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E++I   + H N+++L G+  D      YLI EY   G+++  L   K    + +     
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDA--TRVYLILEYAPLGTVYREL--QKLSKFDEQRTATY 113
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
             ++AN L Y H     RV+H+DIK  N+LL S    KIA+FG +    ++    + GT 
Sbjct: 114 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTL 170
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
            Y+ PE +   +   K+D++S GV+  E + GK   +
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 7/157 (4%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E++I   + H N+++L G+  D      YLI EY   G+++  L   K    + +     
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDA--TRVYLILEYAPLGTVYREL--QKLSKFDEQRTATY 118
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
             ++AN L Y H     RV+H+DIK  N+LL S    KIA+FG +    ++    + GT 
Sbjct: 119 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL 175
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
            Y+ PE +   +   K+D++S GV+  E + GK   +
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 93/185 (50%), Gaps = 16/185 (8%)
Query: 351 GSVYKGNIHGEV-YAIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPEDANCY 403
           G V+ G  +G    A+K +K  +        E  +++++ H  LV+L            Y
Sbjct: 23  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIY 79
Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI 463
           +I EY+ENGSL  +L       L     L +A  +A G+ +I E      +H++++++NI
Sbjct: 80  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRNLRAANI 136
Query: 464 LLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFSFGVVL 520
           L+   +  KIA+FGLA+   +       G +    + APE +  G  + K DV+SFG++L
Sbjct: 137 LVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 196
Query: 521 LELIS 525
            E+++
Sbjct: 197 TEIVT 201

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 7/157 (4%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E++I   + H N+++L G+  D      YLI EY   G+++  L   K    + +     
Sbjct: 75  EVEIQSHLRHPNILRLYGYFHDA--TRVYLILEYAPLGTVYREL--QKLSKFDEQRTATY 130
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
             ++AN L Y H     RV+H+DIK  N+LL S    KIA+FG +    ++    + GT 
Sbjct: 131 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL 187
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
            Y+ PE +   +   K+D++S GV+  E + GK   +
Sbjct: 188 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 224

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 7/157 (4%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E++I   + H N+++L G+  D      YLI EY   G+++  L   K    + +     
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDA--TRVYLILEYAPLGTVYREL--QKLSKFDEQRTATY 116
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
             ++AN L Y H     RV+H+DIK  N+LL S    KIA+FG +    ++    + GT 
Sbjct: 117 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL 173
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
            Y+ PE +   +   K+D++S GV+  E + GK   +
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 7/157 (4%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E++I   + H N+++L G+  D      YLI EY   G+++  L   K    + +     
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATY 113
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
             ++AN L Y H     RV+H+DIK  N+LL S    KIA+FG +    ++    + GT 
Sbjct: 114 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLCGTL 170
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
            Y+ PE +   +   K+D++S GV+  E + GK   +
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 95/190 (50%), Gaps = 25/190 (13%)
Query: 356 GNIHGEVY-----------AIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPE 398
           G  +GEVY           A+K +K +  E      E  +++++ H NLV+L G C    
Sbjct: 21  GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--R 78
Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
           +   Y+I E++  G+L  +L E   + ++    L +A  +++ ++Y+    +   +H+D+
Sbjct: 79  EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDL 135
Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFS 515
            + N L+  N   K+A+FGL++           G +    + APE LA    S K DV++
Sbjct: 136 AARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 195
Query: 516 FGVVLLELIS 525
           FGV+L E+ +
Sbjct: 196 FGVLLWEIAT 205

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 96/190 (50%), Gaps = 34/190 (17%)
Query: 364 AIKMMKWNACE--------ELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K +A E        E+++++ +  H N++ L G C   +D   Y+I EY   G+L
Sbjct: 71  AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNL 128
Query: 415 HSWLHENK--------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             +L   +               E + +K  +     +A G++Y+      + +H+D+ +
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 185
Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFS 515
            N+L+  N   +IA+FGLA+   N I  +   T G     ++APE L D V + + DV+S
Sbjct: 186 RNVLVTENNVMRIADFGLARD-INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 244
Query: 516 FGVVLLELIS 525
           FGV++ E+ +
Sbjct: 245 FGVLMWEIFT 254

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 94/178 (52%), Gaps = 16/178 (8%)
Query: 364 AIKMMKWNACEELKILQ------KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSW 417
           A+KM+K  +  E +  Q      K++H  LVK  G C   ++   Y++ EYI NG L ++
Sbjct: 36  AVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC--SKEYPIYIVTEYISNGCLLNY 93
Query: 418 LHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFG 477
           L  +  + L     L +  DV  G+ ++  H   + +H+D+ + N L+D ++  K+++FG
Sbjct: 94  LRSH-GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFG 149
Query: 478 LAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAID 531
           + +   +   +  VGT+    + APE       S+K DV++FG+++ E+ S GK   D
Sbjct: 150 MTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYD 207

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 7/157 (4%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E++I   + H N+++L G+  D      YLI EY   G+++  L   K    + +     
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDA--TRVYLILEYAPLGTVYREL--QKLSKFDEQRTATY 116
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
             ++AN L Y H     RV+H+DIK  N+LL S    KIA+FG +    ++    + GT 
Sbjct: 117 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTL 173
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
            Y+ PE +   +   K+D++S GV+  E + GK   +
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 7/157 (4%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E++I   + H N+++L G+  D      YLI EY   G+++  L   K    + +     
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATY 113
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
             ++AN L Y H     RV+H+DIK  N+LL S    KIA+FG +    ++    + GT 
Sbjct: 114 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTL 170
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
            Y+ PE +   +   K+D++S GV+  E + GK   +
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 7/157 (4%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E++I   + H N+++L G+  D      YLI EY   G+++  L   K    + +     
Sbjct: 84  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATY 139
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
             ++AN L Y H     RV+H+DIK  N+LL S    KIA+FG +    ++    + GT 
Sbjct: 140 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTL 196
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
            Y+ PE +   +   K+D++S GV+  E + GK   +
Sbjct: 197 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 7/157 (4%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E++I   + H N+++L G+  D      YLI EY   G+++  L   K    + +     
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDA--TRVYLILEYAPLGTVYREL--QKLSKFDEQRTATY 116
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
             ++AN L Y H     RV+H+DIK  N+LL S    KIA+FG +    ++    + GT 
Sbjct: 117 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTL 173
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
            Y+ PE +   +   K+D++S GV+  E + GK   +
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 7/157 (4%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E++I   + H N+++L G+  D      YLI EY   G+++  L   K    + +     
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATY 117
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
             ++AN L Y H     RV+H+DIK  N+LL S    KIA+FG +    ++    + GT 
Sbjct: 118 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL 174
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
            Y+ PE +   +   K+D++S GV+  E + GK   +
Sbjct: 175 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 211

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 7/157 (4%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E++I   + H N+++L G+  D      YLI EY   G+++  L   K    + +     
Sbjct: 57  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATY 112
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
             ++AN L Y H     RV+H+DIK  N+LL S    KIA+FG +    ++    + GT 
Sbjct: 113 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL 169
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
            Y+ PE +   +   K+D++S GV+  E + GK   +
Sbjct: 170 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 206

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/187 (33%), Positives = 98/187 (52%), Gaps = 25/187 (13%)
Query: 355 KGNIHGEVYAIKMMKWNACE---------ELKILQKVNHGNLVKLEGFCIDPEDANCYLI 405
           K  I  + YA+K++   + +         E+++L+K++H N++KL  F I  + ++ Y++
Sbjct: 42  KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL--FEILEDSSSFYIV 99
Query: 406 YEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL 465
            E    G L   + + K    +     RI   V +G+ Y+H+H    +VH+D+K  NILL
Sbjct: 100 GELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILL 154
Query: 466 DSNMR---AKIANFGLAKSGC---NAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVV 519
           +S  +    KI +FGL  S C   N      +GT  YIAPE L  G    K DV+S GV+
Sbjct: 155 ESKEKDCDIKIIDFGL--STCFQQNTKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVI 211
Query: 520 LLELISG 526
           L  L+SG
Sbjct: 212 LYILLSG 218

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 7/157 (4%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E++I   + H N+++L G+  D      YLI EY   G+++  L   K    + +     
Sbjct: 55  EVEIQSHLRHPNILRLYGYFHDA--TRVYLILEYAPLGTVYREL--QKLSKFDEQRTATY 110
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
             ++AN L Y H     RV+H+DIK  N+LL S    KIA+FG +    ++    + GT 
Sbjct: 111 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL 167
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
            Y+ PE +   +   K+D++S GV+  E + GK   +
Sbjct: 168 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 204

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 95/186 (51%), Gaps = 16/186 (8%)
Query: 351 GSVYKG--NIHGEVYAIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPEDANC 402
           G VY+G    +    A+K +K +  E      E  +++++ H NLV+L G C    +   
Sbjct: 25  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--REPPF 82
Query: 403 YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSN 462
           Y+I E++  G+L  +L E   + ++    L +A  +++ ++Y+    +   +H+D+ + N
Sbjct: 83  YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARN 139
Query: 463 ILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFSFGVV 519
            L+  N   K+A+FGL++           G +    + APE LA    S K DV++FGV+
Sbjct: 140 CLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 199
Query: 520 LLELIS 525
           L E+ +
Sbjct: 200 LWEIAT 205

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 95/190 (50%), Gaps = 25/190 (13%)
Query: 356 GNIHGEVY-----------AIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPE 398
           G  +GEVY           A+K +K +  E      E  +++++ H NLV+L G C    
Sbjct: 28  GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--R 85
Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
           +   Y+I E++  G+L  +L E   + ++    L +A  +++ ++Y+    +   +H+D+
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDL 142
Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFS 515
            + N L+  N   K+A+FGL++           G +    + APE LA    S K DV++
Sbjct: 143 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 202
Query: 516 FGVVLLELIS 525
           FGV+L E+ +
Sbjct: 203 FGVLLWEIAT 212

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 98/191 (51%), Gaps = 27/191 (14%)
Query: 356 GNIHGEVY-----------AIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPE 398
           G  +GEVY           A+K +K +  E      E  +++++ H NLV+L G C    
Sbjct: 21  GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--R 78
Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
           +   Y+I E++  G+L  +L E   + ++    L +A  +++ ++Y+    +   +H+D+
Sbjct: 79  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDL 135
Query: 459 KSSNILLDSNMRAKIANFGLAK-SGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVF 514
            + N L+  N   K+A+FGL++    +  T H  G +    + APE LA    S K DV+
Sbjct: 136 AARNCLVGENHLVKVADFGLSRLMTGDTFTAH-AGAKFPIKWTAPESLAYNKFSIKSDVW 194
Query: 515 SFGVVLLELIS 525
           +FGV+L E+ +
Sbjct: 195 AFGVLLWEIAT 205

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 89/175 (50%), Gaps = 20/175 (11%)
Query: 357 NIHGEVYAIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE 410
           N H +V A+K MK  +        E  +++ + H  LVKL            Y+I E++ 
Sbjct: 204 NKHTKV-AVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYIITEFMA 259
Query: 411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR 470
            GSL  +L  ++         +  +  +A G+ +I +      +H+D++++NIL+ +++ 
Sbjct: 260 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLV 316
Query: 471 AKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
            KIA+FGLA+ G             + APE +  G  + K DV+SFG++L+E+++
Sbjct: 317 CKIADFGLARVGAKFPI-------KWTAPEAINFGSFTIKSDVWSFGILLMEIVT 364

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 95/190 (50%), Gaps = 25/190 (13%)
Query: 356 GNIHGEVY-----------AIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPE 398
           G  +GEVY           A+K +K +  E      E  +++++ H NLV+L G C    
Sbjct: 23  GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--R 80
Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
           +   Y+I E++  G+L  +L E   + ++    L +A  +++ ++Y+    +   +H+D+
Sbjct: 81  EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDL 137
Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFS 515
            + N L+  N   K+A+FGL++           G +    + APE LA    S K DV++
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 197
Query: 516 FGVVLLELIS 525
           FGV+L E+ +
Sbjct: 198 FGVLLWEIAT 207

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 91/187 (48%), Gaps = 20/187 (10%)
Query: 360 GEVYAIKMMKWNAC----------EELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEY 408
           G++YA+K++K +             E +IL    NH  L +L  FC        + + E+
Sbjct: 48  GDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL--FCCFQTPDRLFFVMEF 105
Query: 409 IENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN 468
           +  G L    H  K+   +       A ++ + L ++H+     ++++D+K  N+LLD  
Sbjct: 106 VNGGDL--MFHIQKSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHE 160
Query: 469 MRAKIANFGLAKSG-CNAITMH-IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
              K+A+FG+ K G CN +T     GT  YIAPE L + +    +D ++ GV+L E++ G
Sbjct: 161 GHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220
Query: 527 KEAIDEE 533
               + E
Sbjct: 221 HAPFEAE 227

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 95/190 (50%), Gaps = 25/190 (13%)
Query: 356 GNIHGEVY-----------AIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPE 398
           G  +GEVY           A+K +K +  E      E  +++++ H NLV+L G C    
Sbjct: 23  GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--R 80
Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
           +   Y+I E++  G+L  +L E   + ++    L +A  +++ ++Y+    +   +H+D+
Sbjct: 81  EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDL 137
Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFS 515
            + N L+  N   K+A+FGL++           G +    + APE LA    S K DV++
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 197
Query: 516 FGVVLLELIS 525
           FGV+L E+ +
Sbjct: 198 FGVLLWEIAT 207

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 95/190 (50%), Gaps = 25/190 (13%)
Query: 356 GNIHGEVY-----------AIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPE 398
           G  +GEVY           A+K +K +  E      E  +++++ H NLV+L G C    
Sbjct: 23  GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--R 80
Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
           +   Y+I E++  G+L  +L E   + ++    L +A  +++ ++Y+    +   +H+D+
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDL 137
Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFS 515
            + N L+  N   K+A+FGL++           G +    + APE LA    S K DV++
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 197
Query: 516 FGVVLLELIS 525
           FGV+L E+ +
Sbjct: 198 FGVLLWEIAT 207

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 7/157 (4%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E++I   + H N+++L G+  D      YLI EY   G+++  L   K    + +     
Sbjct: 59  EVEIQSHLRHPNILRLYGYFHDA--TRVYLILEYAPLGTVYREL--QKLSKFDEQRTATY 114
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
             ++AN L Y H     RV+H+DIK  N+LL S    KIA+FG +    ++    + GT 
Sbjct: 115 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLSGTL 171
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
            Y+ PE +   +   K+D++S GV+  E + GK   +
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 32/206 (15%)
Query: 343 FSEGCLIQGSVYKGNIHGEVYAIKMMKWNAC-------EELKILQKVNHGNLVKLEGFCI 395
           FSE  L+     K  + G+++A+K +K +          E+ +L+K+ H N+V LE   I
Sbjct: 22  FSEVFLV-----KQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED--I 74
Query: 396 DPEDANCYLIYEYIENGSLHSWLHE-----NKNENLNWKTRLRIAIDVANGLQYIHEHTR 450
                + YL+ + +  G L   + E      K+ +L       +   V + ++Y+HE+  
Sbjct: 75  YESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL-------VIQQVLSAVKYLHENG- 126
Query: 451 PRVVHKDIKSSNILL---DSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVV 507
             +VH+D+K  N+L    + N +  I +FGL+K   N I     GT GY+APE LA    
Sbjct: 127 --IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPY 184
Query: 508 STKMDVFSFGVVLLELISGKEAIDEE 533
           S  +D +S GV+   L+ G     EE
Sbjct: 185 SKAVDCWSIGVITYILLCGYPPFYEE 210

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 95/190 (50%), Gaps = 25/190 (13%)
Query: 356 GNIHGEVY-----------AIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPE 398
           G  +GEVY           A+K +K +  E      E  +++++ H NLV+L G C    
Sbjct: 23  GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--R 80
Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
           +   Y+I E++  G+L  +L E   + ++    L +A  +++ ++Y+    +   +H+D+
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDL 137
Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFS 515
            + N L+  N   K+A+FGL++           G +    + APE LA    S K DV++
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 197
Query: 516 FGVVLLELIS 525
           FGV+L E+ +
Sbjct: 198 FGVLLWEIAT 207

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 78/157 (49%), Gaps = 7/157 (4%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E++I   + H N+++L G+  D      YLI EY   G+++  L   K    + +     
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDA--TRVYLILEYAPLGTVYREL--QKLSKFDEQRTATY 118
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
             ++AN L Y H     RV+H+DIK  N+LL S    KIA+FG +    ++    + GT 
Sbjct: 119 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL 175
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
            Y+ PE +       K+D++S GV+  E + GK   +
Sbjct: 176 DYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 78/152 (51%), Gaps = 7/152 (4%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E++I   + H N+++L G+  D      YLI EY   G+++  L   K    + +     
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHDA--TRVYLILEYAPLGTVYREL--QKLSRFDEQRTATY 117
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
             ++AN L Y H     RV+H+DIK  N+LL SN   KIA+FG +    ++    + GT 
Sbjct: 118 ITELANALSYCHSK---RVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLCGTL 174
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            Y+ PE +   +   K+D++S GV+  E + G
Sbjct: 175 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 7/157 (4%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E++I   + H N+++L G+  D      YLI EY   G+++  L   K    + +     
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDA--TRVYLILEYAPLGTVYREL--QKLSKFDEQRTATY 116
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
             ++AN L Y H     RV+H+DIK  N+LL S    KIA+FG +    ++    + GT 
Sbjct: 117 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTL 173
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
            Y+ PE +   +   K+D++S GV+  E + GK   +
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 7/157 (4%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E++I   + H N+++L G+  D      YLI EY   G+++  L   K    + +     
Sbjct: 59  EVEIQSHLRHPNILRLYGYFHDA--TRVYLILEYAPLGTVYREL--QKLSKFDEQRTATY 114
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
             ++AN L Y H     RV+H+DIK  N+LL S    KIA+FG +    ++    + GT 
Sbjct: 115 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCGTL 171
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
            Y+ PE +   +   K+D++S GV+  E + GK   +
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 93/177 (52%), Gaps = 23/177 (12%)
Query: 364 AIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH 415
           AIK +K    E        E  I+ + +H N+++LEG       A   ++ EY+ENGSL 
Sbjct: 81  AIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA--MIVTEYMENGSLD 138
Query: 416 SWL--HENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKI 473
           ++L  H+ +   +     LR    V  G++Y+ +      VH+D+ + N+L+DSN+  K+
Sbjct: 139 TFLRTHDGQFTIMQLVGMLR---GVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKV 192
Query: 474 ANFGLAKSGCNAITMHIVGTQGYI-----APEYLADGVVSTKMDVFSFGVVLLELIS 525
           ++FGL++   +        T G I     APE +A    S+  DV+SFGVV+ E+++
Sbjct: 193 SDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 94/180 (52%), Gaps = 23/180 (12%)
Query: 364 AIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH 415
           AIK +K    E        E  I+ + +H N+++LEG       A   ++ EY+ENGSL 
Sbjct: 81  AIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA--MIVTEYMENGSLD 138
Query: 416 SWL--HENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKI 473
           ++L  H+ +   +     LR    V  G++Y+ +      VH+D+ + N+L+DSN+  K+
Sbjct: 139 TFLRTHDGQFTIMQLVGMLR---GVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKV 192
Query: 474 ANFGLAKSGCNAITMHIVGTQGYI-----APEYLADGVVSTKMDVFSFGVVLLELISGKE 528
           ++FGL++   +        T G I     APE +A    S+  DV+SFGVV+ E+++  E
Sbjct: 193 SDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGE 252

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 79/157 (50%), Gaps = 7/157 (4%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E++I   + H N+++L G+  D      YLI EY   G+++  L   K    + +     
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHD--STRVYLILEYAPLGTVYREL--QKLSKFDEQRTATY 113
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
             ++AN L Y H     +V+H+DIK  N+LL S    KIA+FG +    ++    + GT 
Sbjct: 114 ITELANALSYCHSK---KVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTL 170
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
            Y+ PE +   +   K+D++S GV+  E + GK   +
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 84/155 (54%), Gaps = 8/155 (5%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           EE  +++ + H  LV+L  + +   +   Y+I EY+  GSL  +L  ++   +     + 
Sbjct: 57  EEANLMKTLQHDKLVRL--YAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLID 114
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT 493
            +  +A G+ YI    R   +H+D++++N+L+  ++  KIA+FGLA+   +       G 
Sbjct: 115 FSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGA 171
Query: 494 Q---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           +    + APE +  G  + K DV+SFG++L E+++
Sbjct: 172 KFPIKWTAPEAINFGCFTIKSDVWSFGILLYEIVT 206

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 95/190 (50%), Gaps = 34/190 (17%)
Query: 364 AIKMMKWNACE--------ELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K +A E        E+++++ +  H N++ L G C   +D   Y+I  Y   G+L
Sbjct: 71  AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--QDGPLYVIVAYASKGNL 128
Query: 415 HSWLHENK--------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             +L   +               E + +K  +     +A G++Y+      + +H+D+ +
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 185
Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFS 515
            N+L+  N   KIA+FGLA+   N I  +   T G     ++APE L D V + + DV+S
Sbjct: 186 RNVLVTENNVMKIADFGLARD-INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 244
Query: 516 FGVVLLELIS 525
           FGV++ E+ +
Sbjct: 245 FGVLMWEIFT 254

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 87/158 (55%), Gaps = 16/158 (10%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+++L+K++H N++KL  F I  + ++ Y++ E    G L   +   K +  +     RI
Sbjct: 71  EVELLKKLDHPNIMKL--FEILEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARI 126
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR---AKIANFGLAKSGC---NAITM 488
              V +G+ Y+H+H    +VH+D+K  NILL+S  +    KI +FGL  S C   N    
Sbjct: 127 IKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGL--STCFQQNTKMK 181
Query: 489 HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
             +GT  YIAPE L  G    K DV+S GV+L  L+SG
Sbjct: 182 DRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 87/158 (55%), Gaps = 16/158 (10%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+++L+K++H N++KL  F I  + ++ Y++ E    G L   +   K +  +     RI
Sbjct: 71  EVELLKKLDHPNIMKL--FEILEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARI 126
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR---AKIANFGLAKSGC---NAITM 488
              V +G+ Y+H+H    +VH+D+K  NILL+S  +    KI +FGL  S C   N    
Sbjct: 127 IKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGL--STCFQQNTKMK 181
Query: 489 HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
             +GT  YIAPE L  G    K DV+S GV+L  L+SG
Sbjct: 182 DRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 95/190 (50%), Gaps = 25/190 (13%)
Query: 356 GNIHGEVY-----------AIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPE 398
           G  +GEVY           A+K +K +  E      E  +++++ H NLV+L G C    
Sbjct: 269 GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--R 326
Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
           +   Y+I E++  G+L  +L E   + +N    L +A  +++ ++Y+    +   +H+++
Sbjct: 327 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRNL 383
Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFS 515
            + N L+  N   K+A+FGL++           G +    + APE LA    S K DV++
Sbjct: 384 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 443
Query: 516 FGVVLLELIS 525
           FGV+L E+ +
Sbjct: 444 FGVLLWEIAT 453

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 89/181 (49%), Gaps = 17/181 (9%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL-HENKNENLNWKTRLR 433
           E++I + +NH N+VKL  F +   +   YL+ EY   G +  +L    + +    + + R
Sbjct: 63  EVRIXKVLNHPNIVKL--FEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR 120
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH-IVG 492
               + + +QY H+     +VH+D+K+ N+LLD++   KIA+FG +        +    G
Sbjct: 121 ---QIVSAVQYCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCG 174
Query: 493 TQGYIAPE-YLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYWREMKRG 551
              Y APE +        ++DV+S GV+L  L+SG    D      GQ LK     + RG
Sbjct: 175 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD------GQNLKELRERVLRG 228
Query: 552 K 552
           K
Sbjct: 229 K 229

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 95/190 (50%), Gaps = 34/190 (17%)
Query: 364 AIKMMKWNACE--------ELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K +A E        E+++++ +  H N++ L G C   +D   Y+I  Y   G+L
Sbjct: 71  AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--QDGPLYVIVGYASKGNL 128
Query: 415 HSWLHENK--------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             +L   +               E + +K  +     +A G++Y+      + +H+D+ +
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 185
Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFS 515
            N+L+  N   KIA+FGLA+   N I  +   T G     ++APE L D V + + DV+S
Sbjct: 186 RNVLVTENNVMKIADFGLARD-INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 244
Query: 516 FGVVLLELIS 525
           FGV++ E+ +
Sbjct: 245 FGVLMWEIFT 254

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 100/222 (45%), Gaps = 22/222 (9%)
Query: 318 MADVSDCLDKYRIFKIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWNAC-- 373
           MA +    +++     EEL    D   +G    G VYKG  N   EV AIK++       
Sbjct: 2   MAHLRGFANQHSRVDPEELFTKLDRIGKGSF--GEVYKGIDNHTKEVVAIKIIDLEEAED 59
Query: 374 ------EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLN 427
                 +E+ +L + +   + +  G  +  +    ++I EY+  GS    L     E   
Sbjct: 60  EIEDIQQEITVLSQCDSPYITRYFGSYL--KSTKLWIIMEYLGGGSALDLLKPGPLEETY 117
Query: 428 WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT 487
             T LR   ++  GL Y+H     R +H+DIK++N+LL      K+A+FG+A    +   
Sbjct: 118 IATILR---EILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 171
Query: 488 MH--IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
                VGT  ++APE +       K D++S G+  +EL  G+
Sbjct: 172 KRNXFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGE 213

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 29/208 (13%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWN---------ACEELKILQ 380
           K+E++ E T          G VYK    + GEV A+K ++ +         A  E+ +L+
Sbjct: 14  KVEKIGEGT---------YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 64
Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
           ++NH N+VKL    I  E+   YL++E++    L  ++  +    +           +  
Sbjct: 65  ELNHPNIVKLLD-VIHTEN-KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 121
Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAIT-MHIVGTQGYIA 498
           GL + H H   RV+H+D+K  N+L+++    K+A+FGLA++ G    T  H V T  Y A
Sbjct: 122 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 178
Query: 499 PE-YLADGVVSTKMDVFSFGVVLLELIS 525
           PE  L     ST +D++S G +  E+++
Sbjct: 179 PEILLGXKYYSTAVDIWSLGCIFAEMVT 206

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 29/208 (13%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWN---------ACEELKILQ 380
           K+E++ E T          G VYK    + GEV A+K ++ +         A  E+ +L+
Sbjct: 10  KVEKIGEGT---------YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
           ++NH N+VKL    +   +   YL++E++    L +++  +    +           +  
Sbjct: 61  ELNHPNIVKL--LDVIHTENKLYLVFEFLHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQ 117
Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAIT-MHIVGTQGYIA 498
           GL + H H   RV+H+D+K  N+L+++    K+A+FGLA++ G    T  H V T  Y A
Sbjct: 118 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 499 PEYLAD-GVVSTKMDVFSFGVVLLELIS 525
           PE L      ST +D++S G +  E+++
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 95/189 (50%), Gaps = 20/189 (10%)
Query: 351 GSVYKGNIHGE--VYAIKM--------MKWNACEELKILQKVNHGNLVKLEGFCIDPEDA 400
           G V+ G +  +  + A+K         +K    +E +IL++ +H N+V+L G C   +  
Sbjct: 128 GEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT--QKQ 185
Query: 401 NCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             Y++ E ++ G   ++L   +   L  KT L++  D A G++Y+        +H+D+ +
Sbjct: 186 PIYIVMELVQGGDFLTFLR-TEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAA 241
Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ----GYIAPEYLADGVVSTKMDVFSF 516
            N L+      KI++FG+++   + +     G +     + APE L  G  S++ DV+SF
Sbjct: 242 RNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSESDVWSF 301
Query: 517 GVVLLELIS 525
           G++L E  S
Sbjct: 302 GILLWETFS 310

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 29/208 (13%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWN---------ACEELKILQ 380
           K+E++ E T          G VYK    + GEV A+K ++ +         A  E+ +L+
Sbjct: 7   KVEKIGEGT---------YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
           ++NH N+VKL    I  E+   YL++E++    L  ++  +    +           +  
Sbjct: 58  ELNHPNIVKLLD-VIHTEN-KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAIT-MHIVGTQGYIA 498
           GL + H H   RV+H+D+K  N+L+++    K+A+FGLA++ G    T  H V T  Y A
Sbjct: 115 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 171
Query: 499 PE-YLADGVVSTKMDVFSFGVVLLELIS 525
           PE  L     ST +D++S G +  E+++
Sbjct: 172 PEILLGXKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 89/181 (49%), Gaps = 21/181 (11%)
Query: 360 GEVYAIKMMK----------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI 409
           G  YA+K+++           +   E ++LQ   H  L  L+ +     D  C+++ EY 
Sbjct: 30  GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK-YAFQTHDRLCFVM-EYA 87
Query: 410 ENGSLHSWLHENKNENLNWKTRLRI-AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN 468
             G L  + H ++ E +  + R R    ++ + L+Y+H      VV++DIK  N++LD +
Sbjct: 88  NGGEL--FFHLSR-ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKD 141
Query: 469 MRAKIANFGLAKSGCN--AITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
              KI +FGL K G +  A      GT  Y+APE L D      +D +  GVV+ E++ G
Sbjct: 142 GHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201
Query: 527 K 527
           +
Sbjct: 202 R 202

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 85/183 (46%), Gaps = 20/183 (10%)
Query: 362 VYAIKMMK-----------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE 410
           +YA+K++K           W   E+    Q  NH  LV L   C   E +  + + EY+ 
Sbjct: 36  IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHS-CFQTE-SRLFFVIEYVN 93
Query: 411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR 470
            G L    H  +   L  +     + +++  L Y+HE     ++++D+K  N+LLDS   
Sbjct: 94  GGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGH 148
Query: 471 AKIANFGLAKSGCNA--ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKE 528
            K+ ++G+ K G      T    GT  YIAPE L        +D ++ GV++ E+++G+ 
Sbjct: 149 IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 208
Query: 529 AID 531
             D
Sbjct: 209 PFD 211

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 89/181 (49%), Gaps = 21/181 (11%)
Query: 360 GEVYAIKMMK----------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI 409
           G  YA+K+++           +   E ++LQ   H  L  L+ +     D  C+++ EY 
Sbjct: 33  GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK-YAFQTHDRLCFVM-EYA 90
Query: 410 ENGSLHSWLHENKNENLNWKTRLRI-AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN 468
             G L  + H ++ E +  + R R    ++ + L+Y+H      VV++DIK  N++LD +
Sbjct: 91  NGGEL--FFHLSR-ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKD 144
Query: 469 MRAKIANFGLAKSGCN--AITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
              KI +FGL K G +  A      GT  Y+APE L D      +D +  GVV+ E++ G
Sbjct: 145 GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 204
Query: 527 K 527
           +
Sbjct: 205 R 205

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 89/181 (49%), Gaps = 21/181 (11%)
Query: 360 GEVYAIKMMK----------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI 409
           G  YA+K+++           +   E ++LQ   H  L  L+ +     D  C+++ EY 
Sbjct: 30  GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK-YAFQTHDRLCFVM-EYA 87
Query: 410 ENGSLHSWLHENKNENLNWKTRLRI-AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN 468
             G L  + H ++ E +  + R R    ++ + L+Y+H      VV++DIK  N++LD +
Sbjct: 88  NGGEL--FFHLSR-ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKD 141
Query: 469 MRAKIANFGLAKSGCN--AITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
              KI +FGL K G +  A      GT  Y+APE L D      +D +  GVV+ E++ G
Sbjct: 142 GHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201
Query: 527 K 527
           +
Sbjct: 202 R 202

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 106/210 (50%), Gaps = 29/210 (13%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWN---------ACEELKILQ 380
           K+E++ E T          G VYK    + GEV A+K ++ +         A  E+ +L+
Sbjct: 6   KVEKIGEGT---------YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 56
Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
           ++NH N+VKL    I  E+   YL++E++    L +++  +    +           +  
Sbjct: 57  ELNHPNIVKLLD-VIHTEN-KLYLVFEHVHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAIT-MHIVGTQGYIA 498
           GL + H H   RV+H+D+K  N+L+++    K+A+FGLA++ G    T  H V T  Y A
Sbjct: 114 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 170
Query: 499 PEYLAD-GVVSTKMDVFSFGVVLLELISGK 527
           PE L      ST +D++S G +  E+++ +
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 85/183 (46%), Gaps = 20/183 (10%)
Query: 362 VYAIKMMK-----------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE 410
           +YA+K++K           W   E+    Q  NH  LV L   C   E +  + + EY+ 
Sbjct: 47  IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHS-CFQTE-SRLFFVIEYVN 104
Query: 411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR 470
            G L    H  +   L  +     + +++  L Y+HE     ++++D+K  N+LLDS   
Sbjct: 105 GGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGH 159
Query: 471 AKIANFGLAKSGCNA--ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKE 528
            K+ ++G+ K G      T    GT  YIAPE L        +D ++ GV++ E+++G+ 
Sbjct: 160 IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 219
Query: 529 AID 531
             D
Sbjct: 220 PFD 222

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 105/210 (50%), Gaps = 29/210 (13%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWN---------ACEELKILQ 380
           K+E++ E T          G VYK    + GEV A+K ++ +         A  E+ +L+
Sbjct: 7   KVEKIGEGT---------YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
           ++NH N+VKL    I  E+   YL++E++    L  ++  +    +           +  
Sbjct: 58  ELNHPNIVKLLD-VIHTEN-KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAIT-MHIVGTQGYIA 498
           GL + H H   RV+H+D+K  N+L+++    K+A+FGLA++ G    T  H V T  Y A
Sbjct: 115 GLSFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 171
Query: 499 PEYLAD-GVVSTKMDVFSFGVVLLELISGK 527
           PE L      ST +D++S G +  E+++ +
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 29/208 (13%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWN---------ACEELKILQ 380
           K+E++ E T          G VYK    + GEV A+K ++ +         A  E+ +L+
Sbjct: 10  KVEKIGEGT---------YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
           ++NH N+VKL    +   +   YL++E+++   L  ++  +    +           +  
Sbjct: 61  ELNHPNIVKL--LDVIHTENKLYLVFEHVDQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 117
Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAIT-MHIVGTQGYIA 498
           GL + H H   RV+H+D+K  N+L+++    K+A+FGLA++ G    T  H V T  Y A
Sbjct: 118 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 499 PEYLAD-GVVSTKMDVFSFGVVLLELIS 525
           PE L      ST +D++S G +  E+++
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 89/181 (49%), Gaps = 21/181 (11%)
Query: 360 GEVYAIKMMK----------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI 409
           G  YA+K+++           +   E ++LQ   H  L  L+ +     D  C+++ EY 
Sbjct: 30  GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK-YAFQTHDRLCFVM-EYA 87
Query: 410 ENGSLHSWLHENKNENLNWKTRLRI-AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN 468
             G L  + H ++ E +  + R R    ++ + L+Y+H      VV++DIK  N++LD +
Sbjct: 88  NGGEL--FFHLSR-ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKD 141
Query: 469 MRAKIANFGLAKSGCN--AITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
              KI +FGL K G +  A      GT  Y+APE L D      +D +  GVV+ E++ G
Sbjct: 142 GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201
Query: 527 K 527
           +
Sbjct: 202 R 202

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 85/183 (46%), Gaps = 20/183 (10%)
Query: 362 VYAIKMMK-----------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE 410
           +YA+K++K           W   E+    Q  NH  LV L   C   E +  + + EY+ 
Sbjct: 32  IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHS-CFQTE-SRLFFVIEYVN 89
Query: 411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR 470
            G L    H  +   L  +     + +++  L Y+HE     ++++D+K  N+LLDS   
Sbjct: 90  GGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGH 144
Query: 471 AKIANFGLAKSGCNA--ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKE 528
            K+ ++G+ K G      T    GT  YIAPE L        +D ++ GV++ E+++G+ 
Sbjct: 145 IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 204
Query: 529 AID 531
             D
Sbjct: 205 PFD 207

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 91/184 (49%), Gaps = 15/184 (8%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNEN--LNWKTRL 432
           E+ +L+++ H N+V+     ID  +   Y++ EY E G L S + +   E   L+ +  L
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 433 RIAIDVANGLQYIHE-----HTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK--SGCNA 485
           R+   +   L+  H      HT   V+H+D+K +N+ LD     K+ +FGLA+  +   +
Sbjct: 115 RVMTQLTLALKECHRRSDGGHT---VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS 171
Query: 486 ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYW 545
                VGT  Y++PE +     + K D++S G +L EL +    +     F  ++L G  
Sbjct: 172 FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA---LMPPFTAFSQKELAGKI 228
Query: 546 REMK 549
           RE K
Sbjct: 229 REGK 232

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 91/184 (49%), Gaps = 15/184 (8%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNEN--LNWKTRL 432
           E+ +L+++ H N+V+     ID  +   Y++ EY E G L S + +   E   L+ +  L
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 433 RIAIDVANGLQYIHE-----HTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK--SGCNA 485
           R+   +   L+  H      HT   V+H+D+K +N+ LD     K+ +FGLA+  +   +
Sbjct: 115 RVMTQLTLALKECHRRSDGGHT---VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS 171
Query: 486 ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYW 545
                VGT  Y++PE +     + K D++S G +L EL +    +     F  ++L G  
Sbjct: 172 FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA---LMPPFTAFSQKELAGKI 228
Query: 546 REMK 549
           RE K
Sbjct: 229 REGK 232

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 105/210 (50%), Gaps = 29/210 (13%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWN---------ACEELKILQ 380
           K+E++ E T          G VYK    + GEV A+K ++ +         A  E+ +L+
Sbjct: 6   KVEKIGEGT---------YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 56
Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
           ++NH N+VKL    I  E+   YL++E++    L  ++  +    +           +  
Sbjct: 57  ELNHPNIVKLLD-VIHTEN-KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAIT-MHIVGTQGYIA 498
           GL + H H   RV+H+D+K  N+L+++    K+A+FGLA++ G    T  H V T  Y A
Sbjct: 114 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 170
Query: 499 PEYLAD-GVVSTKMDVFSFGVVLLELISGK 527
           PE L      ST +D++S G +  E+++ +
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 87/157 (55%), Gaps = 8/157 (5%)
Query: 375 ELKILQKVNHGNLVKLEG-FCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           EL++L + N   +V   G F  D E + C    E+++ GSL   L   K   +  +   +
Sbjct: 116 ELQVLHECNSPYIVGFYGAFYSDGEISICM---EHMDGGSLDQVL--KKAGRIPEQILGK 170
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT 493
           ++I V  GL Y+ E  + +++H+D+K SNIL++S    K+ +FG++    +++    VGT
Sbjct: 171 VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGT 228
Query: 494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAI 530
           + Y++PE L     S + D++S G+ L+E+  G+  I
Sbjct: 229 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 29/208 (13%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWN---------ACEELKILQ 380
           K+E++ E T          G VYK    + GEV A+K ++ +         A  E+ +L+
Sbjct: 9   KVEKIGEGT---------YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 59
Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
           ++NH N+VKL    I  E+   YL++E++    L  ++  +    +           +  
Sbjct: 60  ELNHPNIVKLLD-VIHTEN-KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 116
Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAIT-MHIVGTQGYIA 498
           GL + H H   RV+H+D+K  N+L+++    K+A+FGLA++ G    T  H V T  Y A
Sbjct: 117 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 173
Query: 499 PEYLAD-GVVSTKMDVFSFGVVLLELIS 525
           PE L      ST +D++S G +  E+++
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 29/208 (13%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWN---------ACEELKILQ 380
           K+E++ E T          G VYK    + GEV A+K ++ +         A  E+ +L+
Sbjct: 6   KVEKIGEGT---------YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 56
Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
           ++NH N+VKL    I  E+   YL++E++    L  ++  +    +           +  
Sbjct: 57  ELNHPNIVKLLD-VIHTEN-KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAIT-MHIVGTQGYIA 498
           GL + H H   RV+H+D+K  N+L+++    K+A+FGLA++ G    T  H V T  Y A
Sbjct: 114 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 170
Query: 499 PEYLAD-GVVSTKMDVFSFGVVLLELIS 525
           PE L      ST +D++S G +  E+++
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 105/210 (50%), Gaps = 29/210 (13%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWN---------ACEELKILQ 380
           K+E++ E T          G VYK    + GEV A+K ++ +         A  E+ +L+
Sbjct: 7   KVEKIGEGT---------YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
           ++NH N+VKL    I  E+   YL++E++    L  ++  +    +           +  
Sbjct: 58  ELNHPNIVKLLD-VIHTEN-KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAIT-MHIVGTQGYIA 498
           GL + H H   RV+H+D+K  N+L+++    K+A+FGLA++ G    T  H V T  Y A
Sbjct: 115 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 171
Query: 499 PEYLAD-GVVSTKMDVFSFGVVLLELISGK 527
           PE L      ST +D++S G +  E+++ +
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 105/210 (50%), Gaps = 29/210 (13%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWN---------ACEELKILQ 380
           K+E++ E T          G VYK    + GEV A+K ++ +         A  E+ +L+
Sbjct: 7   KVEKIGEGT---------YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
           ++NH N+VKL    I  E+   YL++E++    L  ++  +    +           +  
Sbjct: 58  ELNHPNIVKLLD-VIHTEN-KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAIT-MHIVGTQGYIA 498
           GL + H H   RV+H+D+K  N+L+++    K+A+FGLA++ G    T  H V T  Y A
Sbjct: 115 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 171
Query: 499 PEYLAD-GVVSTKMDVFSFGVVLLELISGK 527
           PE L      ST +D++S G +  E+++ +
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 95/189 (50%), Gaps = 20/189 (10%)
Query: 351 GSVYKGNIHGE--VYAIKM--------MKWNACEELKILQKVNHGNLVKLEGFCIDPEDA 400
           G V+ G +  +  + A+K         +K    +E +IL++ +H N+V+L G C   +  
Sbjct: 128 GEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT--QKQ 185
Query: 401 NCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             Y++ E ++ G   ++L   +   L  KT L++  D A G++Y+        +H+D+ +
Sbjct: 186 PIYIVMELVQGGDFLTFLR-TEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAA 241
Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ----GYIAPEYLADGVVSTKMDVFSF 516
            N L+      KI++FG+++   + +     G +     + APE L  G  S++ DV+SF
Sbjct: 242 RNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSF 301
Query: 517 GVVLLELIS 525
           G++L E  S
Sbjct: 302 GILLWETFS 310

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 105/210 (50%), Gaps = 29/210 (13%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWN---------ACEELKILQ 380
           K+E++ E T          G VYK    + GEV A+K ++ +         A  E+ +L+
Sbjct: 6   KVEKIGEGT---------YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 56
Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
           ++NH N+VKL    I  E+   YL++E++    L  ++  +    +           +  
Sbjct: 57  ELNHPNIVKLLD-VIHTEN-KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAIT-MHIVGTQGYIA 498
           GL + H H   RV+H+D+K  N+L+++    K+A+FGLA++ G    T  H V T  Y A
Sbjct: 114 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 170
Query: 499 PEYLAD-GVVSTKMDVFSFGVVLLELISGK 527
           PE L      ST +D++S G +  E+++ +
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 29/208 (13%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWN---------ACEELKILQ 380
           K+E++ E T          G VYK    + GEV A+K ++ +         A  E+ +L+
Sbjct: 8   KVEKIGEGT---------YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 58
Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
           ++NH N+VKL    +   +   YL++E++    L  ++  +    +           +  
Sbjct: 59  ELNHPNIVKL--LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 115
Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAIT-MHIVGTQGYIA 498
           GL + H H   RV+H+D+K  N+L+++    K+A+FGLA++ G    T  H V T  Y A
Sbjct: 116 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 172
Query: 499 PEYLAD-GVVSTKMDVFSFGVVLLELIS 525
           PE L      ST +D++S G +  E+++
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 104/210 (49%), Gaps = 29/210 (13%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWN---------ACEELKILQ 380
           K+E++ E T          G VYK    + GEV A+K ++ +         A  E+ +L+
Sbjct: 7   KVEKIGEGT---------YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
           ++NH N+VKL    +   +   YL++E++    L  ++  +    +           +  
Sbjct: 58  ELNHPNIVKL--LDVIHTENKLYLVFEFLHQ-DLKDFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAIT-MHIVGTQGYIA 498
           GL + H H   RV+H+D+K  N+L+++    K+A+FGLA++ G    T  H V T  Y A
Sbjct: 115 GLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 171
Query: 499 PEYLAD-GVVSTKMDVFSFGVVLLELISGK 527
           PE L      ST +D++S G +  E+++ +
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 29/208 (13%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWN---------ACEELKILQ 380
           K+E++ E T          G VYK    + GEV A+K ++ +         A  E+ +L+
Sbjct: 10  KVEKIGEGT---------YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
           ++NH N+VKL    +   +   YL++E++    L  ++  +    +           +  
Sbjct: 61  ELNHPNIVKL--LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 117
Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAIT-MHIVGTQGYIA 498
           GL + H H   RV+H+D+K  N+L+++    K+A+FGLA++ G    T  H V T  Y A
Sbjct: 118 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 499 PEYLAD-GVVSTKMDVFSFGVVLLELIS 525
           PE L      ST +D++S G +  E+++
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 29/208 (13%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWN---------ACEELKILQ 380
           K+E++ E T          G VYK    + GEV A+K ++ +         A  E+ +L+
Sbjct: 9   KVEKIGEGT---------YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 59
Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
           ++NH N+VKL    +   +   YL++E++    L  ++  +    +           +  
Sbjct: 60  ELNHPNIVKL--LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 116
Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAIT-MHIVGTQGYIA 498
           GL + H H   RV+H+D+K  N+L+++    K+A+FGLA++ G    T  H V T  Y A
Sbjct: 117 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 173
Query: 499 PEYLAD-GVVSTKMDVFSFGVVLLELIS 525
           PE L      ST +D++S G +  E+++
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 29/208 (13%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWN---------ACEELKILQ 380
           K+E++ E T          G VYK    + GEV A+K ++ +         A  E+ +L+
Sbjct: 7   KVEKIGEGT---------YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
           ++NH N+VKL    I  E+   YL++E++    L  ++  +    +           +  
Sbjct: 58  ELNHPNIVKLLD-VIHTEN-KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAIT-MHIVGTQGYIA 498
           GL + H H   RV+H+D+K  N+L+++    K+A+FGLA++ G    T  H V T  Y A
Sbjct: 115 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 171
Query: 499 PEYLAD-GVVSTKMDVFSFGVVLLELIS 525
           PE L      ST +D++S G +  E+++
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 29/208 (13%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWN---------ACEELKILQ 380
           K+E++ E T          G VYK    + GEV A+K ++ +         A  E+ +L+
Sbjct: 10  KVEKIGEGT---------YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
           ++NH N+VKL    +   +   YL++E++    L  ++  +    +           +  
Sbjct: 61  ELNHPNIVKL--LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 117
Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAIT-MHIVGTQGYIA 498
           GL + H H   RV+H+D+K  N+L+++    K+A+FGLA++ G    T  H V T  Y A
Sbjct: 118 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 499 PEYLAD-GVVSTKMDVFSFGVVLLELIS 525
           PE L      ST +D++S G +  E+++
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 87/157 (55%), Gaps = 8/157 (5%)
Query: 375 ELKILQKVNHGNLVKLEG-FCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           EL++L + N   +V   G F  D E + C    E+++ GSL   L   K   +  +   +
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGEISICM---EHMDGGSLDQVL--KKAGRIPEQILGK 135
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT 493
           ++I V  GL Y+ E  + +++H+D+K SNIL++S    K+ +FG++    +++    VGT
Sbjct: 136 VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGT 193
Query: 494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAI 530
           + Y++PE L     S + D++S G+ L+E+  G+  I
Sbjct: 194 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 89/181 (49%), Gaps = 21/181 (11%)
Query: 360 GEVYAIKMMK----------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI 409
           G  YA+K+++           +   E ++LQ   H  L  L+ +     D  C+++ EY 
Sbjct: 30  GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK-YAFQTHDRLCFVM-EYA 87
Query: 410 ENGSLHSWLHENKNENLNWKTRLRI-AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN 468
             G L  + H ++ E +  + R R    ++ + L+Y+H      VV++DIK  N++LD +
Sbjct: 88  NGGEL--FFHLSR-ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKD 141
Query: 469 MRAKIANFGLAKSGCN--AITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
              KI +FGL K G +  A      GT  Y+APE L D      +D +  GVV+ E++ G
Sbjct: 142 GHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201
Query: 527 K 527
           +
Sbjct: 202 R 202

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 29/208 (13%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWN---------ACEELKILQ 380
           K+E++ E T          G VYK    + GEV A+K ++ +         A  E+ +L+
Sbjct: 8   KVEKIGEGT---------YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 58
Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
           ++NH N+VKL    +   +   YL++E++    L  ++  +    +           +  
Sbjct: 59  ELNHPNIVKL--LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 115
Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAIT-MHIVGTQGYIA 498
           GL + H H   RV+H+D+K  N+L+++    K+A+FGLA++ G    T  H V T  Y A
Sbjct: 116 GLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 172
Query: 499 PEYLAD-GVVSTKMDVFSFGVVLLELIS 525
           PE L      ST +D++S G +  E+++
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 29/208 (13%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWN---------ACEELKILQ 380
           K+E++ E T          G VYK    + GEV A+K ++ +         A  E+ +L+
Sbjct: 9   KVEKIGEGT---------YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 59
Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
           ++NH N+VKL    +   +   YL++E++    L  ++  +    +           +  
Sbjct: 60  ELNHPNIVKL--LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 116
Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAIT-MHIVGTQGYIA 498
           GL + H H   RV+H+D+K  N+L+++    K+A+FGLA++ G    T  H V T  Y A
Sbjct: 117 GLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 173
Query: 499 PEYLAD-GVVSTKMDVFSFGVVLLELIS 525
           PE L      ST +D++S G +  E+++
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 29/208 (13%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWN---------ACEELKILQ 380
           K+E++ E T          G VYK    + GEV A+K ++ +         A  E+ +L+
Sbjct: 7   KVEKIGEGT---------YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
           ++NH N+VKL    I  E+   YL++E++    L  ++  +    +           +  
Sbjct: 58  ELNHPNIVKLLD-VIHTEN-KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAIT-MHIVGTQGYIA 498
           GL + H H   RV+H+D+K  N+L+++    K+A+FGLA++ G    T  H V T  Y A
Sbjct: 115 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 171
Query: 499 PEYLAD-GVVSTKMDVFSFGVVLLELIS 525
           PE L      ST +D++S G +  E+++
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 29/208 (13%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWN---------ACEELKILQ 380
           K+E++ E T          G VYK    + GEV A+K ++ +         A  E+ +L+
Sbjct: 11  KVEKIGEGT---------YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 61
Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
           ++NH N+VKL    +   +   YL++E++    L  ++  +    +           +  
Sbjct: 62  ELNHPNIVKL--LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 118
Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAIT-MHIVGTQGYIA 498
           GL + H H   RV+H+D+K  N+L+++    K+A+FGLA++ G    T  H V T  Y A
Sbjct: 119 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 175
Query: 499 PEYLAD-GVVSTKMDVFSFGVVLLELIS 525
           PE L      ST +D++S G +  E+++
Sbjct: 176 PEILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 29/208 (13%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWN---------ACEELKILQ 380
           K+E++ E T          G VYK    + GEV A+K ++ +         A  E+ +L+
Sbjct: 14  KVEKIGEGT---------YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 64
Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
           ++NH N+VKL    I  E+   YL++E++    L  ++  +    +           +  
Sbjct: 65  ELNHPNIVKLLD-VIHTEN-KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 121
Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAIT-MHIVGTQGYIA 498
           GL + H H   RV+H+D+K  N+L+++    K+A+FGLA++ G    T  H V T  Y A
Sbjct: 122 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 178
Query: 499 PEYLAD-GVVSTKMDVFSFGVVLLELIS 525
           PE L      ST +D++S G +  E+++
Sbjct: 179 PEILLGCKYYSTAVDIWSLGCIFAEMVT 206

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 29/208 (13%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWN---------ACEELKILQ 380
           K+E++ E T          G VYK    + GEV A+K ++ +         A  E+ +L+
Sbjct: 6   KVEKIGEGT---------YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 56
Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
           ++NH N+VKL    I  E+   YL++E++    L  ++  +    +           +  
Sbjct: 57  ELNHPNIVKLLD-VIHTEN-KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAIT-MHIVGTQGYIA 498
           GL + H H   RV+H+D+K  N+L+++    K+A+FGLA++ G    T  H V T  Y A
Sbjct: 114 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 170
Query: 499 PEYLAD-GVVSTKMDVFSFGVVLLELIS 525
           PE L      ST +D++S G +  E+++
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 29/208 (13%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWN---------ACEELKILQ 380
           K+E++ E T          G VYK    + GEV A+K ++ +         A  E+ +L+
Sbjct: 8   KVEKIGEGT---------YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 58
Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
           ++NH N+VKL    +   +   YL++E++    L  ++  +    +           +  
Sbjct: 59  ELNHPNIVKL--LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 115
Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAIT-MHIVGTQGYIA 498
           GL + H H   RV+H+D+K  N+L+++    K+A+FGLA++ G    T  H V T  Y A
Sbjct: 116 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 172
Query: 499 PEYLAD-GVVSTKMDVFSFGVVLLELIS 525
           PE L      ST +D++S G +  E+++
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 29/208 (13%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWN---------ACEELKILQ 380
           K+E++ E T          G VYK    + GEV A+K ++ +         A  E+ +L+
Sbjct: 7   KVEKIGEGT---------YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
           ++NH N+VKL    I  E+   YL++E++    L  ++  +    +           +  
Sbjct: 58  ELNHPNIVKLLD-VIHTEN-KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAIT-MHIVGTQGYIA 498
           GL + H H   RV+H+D+K  N+L+++    K+A+FGLA++ G    T  H V T  Y A
Sbjct: 115 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 171
Query: 499 PEYLAD-GVVSTKMDVFSFGVVLLELIS 525
           PE L      ST +D++S G +  E+++
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 87/157 (55%), Gaps = 8/157 (5%)
Query: 375 ELKILQKVNHGNLVKLEG-FCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           EL++L + N   +V   G F  D E + C    E+++ GSL   L   K   +  +   +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICM---EHMDGGSLDQVL--KKAGRIPEQILGK 108
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT 493
           ++I V  GL Y+ E  + +++H+D+K SNIL++S    K+ +FG++    +++    VGT
Sbjct: 109 VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGT 166
Query: 494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAI 530
           + Y++PE L     S + D++S G+ L+E+  G+  I
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 89/181 (49%), Gaps = 21/181 (11%)
Query: 360 GEVYAIKMMK----------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI 409
           G  YA+K+++           +   E ++LQ   H  L  L+ +     D  C+++ EY 
Sbjct: 30  GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK-YAFQTHDRLCFVM-EYA 87
Query: 410 ENGSLHSWLHENKNENLNWKTRLRI-AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN 468
             G L  + H ++ E +  + R R    ++ + L+Y+H      VV++DIK  N++LD +
Sbjct: 88  NGGEL--FFHLSR-ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKD 141
Query: 469 MRAKIANFGLAKSGCN--AITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
              KI +FGL K G +  A      GT  Y+APE L D      +D +  GVV+ E++ G
Sbjct: 142 GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201
Query: 527 K 527
           +
Sbjct: 202 R 202

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 75/149 (50%), Gaps = 10/149 (6%)
Query: 393 FCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPR 452
           FC      N + + EY+  G L   +      +L+  T    A ++  GLQ++H      
Sbjct: 85  FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF--YAAEIILGLQFLHSKG--- 139
Query: 453 VVHKDIKSSNILLDSNMRAKIANFGLAKSGC--NAITMHIVGTQGYIAPEYLADGVVSTK 510
           +V++D+K  NILLD +   KIA+FG+ K     +A T    GT  YIAPE L     +  
Sbjct: 140 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQKYNHS 199
Query: 511 MDVFSFGVVLLELISGKEAI---DEEGKF 536
           +D +SFGV+L E++ G+      DEE  F
Sbjct: 200 VDWWSFGVLLYEMLIGQSPFHGQDEEELF 228

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 95/190 (50%), Gaps = 25/190 (13%)
Query: 356 GNIHGEVY-----------AIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPE 398
           G  +GEVY           A+K +K +  E      E  +++++ H NLV+L G C    
Sbjct: 230 GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--R 287
Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
           +   Y+I E++  G+L  +L E   + ++    L +A  +++ ++Y+    +   +H+++
Sbjct: 288 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNL 344
Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFS 515
            + N L+  N   K+A+FGL++           G +    + APE LA    S K DV++
Sbjct: 345 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 404
Query: 516 FGVVLLELIS 525
           FGV+L E+ +
Sbjct: 405 FGVLLWEIAT 414

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 44/208 (21%)
Query: 351 GSVYKGNIHGEV-------YAIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCI 395
           G VY+G + G          A+K +     E        E  I+ K+NH N+V+  G  +
Sbjct: 45  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSL 104
Query: 396 DPEDANCYLIYEYIENGSLHSWLHENKNE-----NLNWKTRLRIAIDVANGLQYIHEHTR 450
             +    +++ E +  G L S+L E +       +L     L +A D+A G QY+ E+  
Sbjct: 105 --QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-- 160
Query: 451 PRVVHKDIKSSNILL---DSNMRAKIANFGLA----------KSGCNAITMHIVGTQGYI 497
              +H+DI + N LL        AKI +FG+A          K GC  + +       ++
Sbjct: 161 -HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK------WM 213
Query: 498 APEYLADGVVSTKMDVFSFGVVLLELIS 525
            PE   +G+ ++K D +SFGV+L E+ S
Sbjct: 214 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 89/181 (49%), Gaps = 21/181 (11%)
Query: 360 GEVYAIKMMK----------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI 409
           G  YA+K+++           +   E ++LQ   H  L  L+ +     D  C+++ EY 
Sbjct: 35  GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK-YAFQTHDRLCFVM-EYA 92
Query: 410 ENGSLHSWLHENKNENLNWKTRLRI-AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN 468
             G L  + H ++ E +  + R R    ++ + L+Y+H      VV++DIK  N++LD +
Sbjct: 93  NGGEL--FFHLSR-ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKD 146
Query: 469 MRAKIANFGLAKSGCN--AITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
              KI +FGL K G +  A      GT  Y+APE L D      +D +  GVV+ E++ G
Sbjct: 147 GHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 206
Query: 527 K 527
           +
Sbjct: 207 R 207

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/255 (27%), Positives = 117/255 (45%), Gaps = 31/255 (12%)
Query: 286 LKKKREREIDEQKQKLQFNKGGRDLKDMEVNFMADVSDCLDKYRIFKIEELREATDNFSE 345
           LKK+ E E+D +      N G  ++         +VS    K+R+   E   E      +
Sbjct: 113 LKKQEEEEMDFRSGSPSDNSGAEEM---------EVSLAKPKHRVTMNE--FEYLKLLGK 161
Query: 346 GCLIQGSVYKGNIHGEVYAIKMMK----------WNACEELKILQKVNHGNLVKLEGFCI 395
           G   +  + K    G  YA+K++K           +   E ++LQ   H  L  L+ +  
Sbjct: 162 GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSF 220
Query: 396 DPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI-AIDVANGLQYIHEHTRPRVV 454
              D  C+++ EY   G L  + H ++ E +  + R R    ++ + L Y+H  +   VV
Sbjct: 221 QTHDRLCFVM-EYANGGEL--FFHLSR-ERVFSEDRARFYGAEIVSALDYLH--SEKNVV 274
Query: 455 HKDIKSSNILLDSNMRAKIANFGLAKSGC-NAITMHIV-GTQGYIAPEYLADGVVSTKMD 512
           ++D+K  N++LD +   KI +FGL K G  +  TM    GT  Y+APE L D      +D
Sbjct: 275 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 334
Query: 513 VFSFGVVLLELISGK 527
            +  GVV+ E++ G+
Sbjct: 335 WWGLGVVMYEMMCGR 349

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 87/157 (55%), Gaps = 8/157 (5%)
Query: 375 ELKILQKVNHGNLVKLEG-FCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           EL++L + N   +V   G F  D E + C    E+++ GSL   L   K   +  +   +
Sbjct: 73  ELQVLHECNSPYIVGFYGAFYSDGEISICM---EHMDGGSLDQVL--KKAGRIPEQILGK 127
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT 493
           ++I V  GL Y+ E  + +++H+D+K SNIL++S    K+ +FG++    +++    VGT
Sbjct: 128 VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGT 185
Query: 494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAI 530
           + Y++PE L     S + D++S G+ L+E+  G+  I
Sbjct: 186 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 222

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 104/210 (49%), Gaps = 29/210 (13%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWN---------ACEELKILQ 380
           K+E++ E T          G VYK    + GEV A+K ++ +         A  E+ +L+
Sbjct: 11  KVEKIGEGT---------YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 61
Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
           ++NH N+VKL    +   +   YL++E++    L  ++  +    +           +  
Sbjct: 62  ELNHPNIVKL--LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 118
Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAIT-MHIVGTQGYIA 498
           GL + H H   RV+H+D+K  N+L+++    K+A+FGLA++ G    T  H V T  Y A
Sbjct: 119 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 175
Query: 499 PEYLAD-GVVSTKMDVFSFGVVLLELISGK 527
           PE L      ST +D++S G +  E+++ +
Sbjct: 176 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 87/157 (55%), Gaps = 8/157 (5%)
Query: 375 ELKILQKVNHGNLVKLEG-FCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           EL++L + N   +V   G F  D E + C    E+++ GSL   L   K   +  +   +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICM---EHMDGGSLDQVL--KKAGRIPEQILGK 108
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT 493
           ++I V  GL Y+ E  + +++H+D+K SNIL++S    K+ +FG++    +++    VGT
Sbjct: 109 VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGT 166
Query: 494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAI 530
           + Y++PE L     S + D++S G+ L+E+  G+  I
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 44/208 (21%)
Query: 351 GSVYKGNIHGEV-------YAIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCI 395
           G VY+G + G          A+K +     E        E  I+ K+NH N+V+  G  +
Sbjct: 59  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSL 118
Query: 396 DPEDANCYLIYEYIENGSLHSWLHENKNE-----NLNWKTRLRIAIDVANGLQYIHEHTR 450
             +    +++ E +  G L S+L E +       +L     L +A D+A G QY+ E+  
Sbjct: 119 --QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-- 174
Query: 451 PRVVHKDIKSSNILL---DSNMRAKIANFGLA----------KSGCNAITMHIVGTQGYI 497
              +H+DI + N LL        AKI +FG+A          K GC  + +       ++
Sbjct: 175 -HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK------WM 227
Query: 498 APEYLADGVVSTKMDVFSFGVVLLELIS 525
            PE   +G+ ++K D +SFGV+L E+ S
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 87/157 (55%), Gaps = 8/157 (5%)
Query: 375 ELKILQKVNHGNLVKLEG-FCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           EL++L + N   +V   G F  D E + C    E+++ GSL   L   K   +  +   +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICM---EHMDGGSLDQVL--KKAGRIPEQILGK 108
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT 493
           ++I V  GL Y+ E  + +++H+D+K SNIL++S    K+ +FG++    +++    VGT
Sbjct: 109 VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGT 166
Query: 494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAI 530
           + Y++PE L     S + D++S G+ L+E+  G+  I
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 87/157 (55%), Gaps = 8/157 (5%)
Query: 375 ELKILQKVNHGNLVKLEG-FCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           EL++L + N   +V   G F  D E + C    E+++ GSL   L   K   +  +   +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICM---EHMDGGSLDQVL--KKAGRIPEQILGK 108
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT 493
           ++I V  GL Y+ E  + +++H+D+K SNIL++S    K+ +FG++    +++    VGT
Sbjct: 109 VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGT 166
Query: 494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAI 530
           + Y++PE L     S + D++S G+ L+E+  G+  I
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 87/157 (55%), Gaps = 8/157 (5%)
Query: 375 ELKILQKVNHGNLVKLEG-FCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           EL++L + N   +V   G F  D E + C    E+++ GSL   L   K   +  +   +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICM---EHMDGGSLDQVL--KKAGRIPEQILGK 108
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT 493
           ++I V  GL Y+ E  + +++H+D+K SNIL++S    K+ +FG++    +++    VGT
Sbjct: 109 VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGT 166
Query: 494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAI 530
           + Y++PE L     S + D++S G+ L+E+  G+  I
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 22/206 (10%)
Query: 334 EELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWNAC--------EELKILQKVN 383
           EEL    +   +G    G V+KG  N   +V AIK++             +E+ +L + +
Sbjct: 26  EELFTKLEKIGKGSF--GEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 83
Query: 384 HGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQ 443
              + K  G  +  +D   ++I EY+  GS    L     +     T LR   ++  GL 
Sbjct: 84  SPYVTKYYGSYL--KDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR---EILKGLD 138
Query: 444 YIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH--IVGTQGYIAPEY 501
           Y+H   +   +H+DIK++N+LL  +   K+A+FG+A    +        VGT  ++APE 
Sbjct: 139 YLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 195
Query: 502 LADGVVSTKMDVFSFGVVLLELISGK 527
           +      +K D++S G+  +EL  G+
Sbjct: 196 IKQSAYDSKADIWSLGITAIELARGE 221

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 29/208 (13%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWN---------ACEELKILQ 380
           K+E++ E T          G VYK    + GEV A+K ++ +         A  E+ +L+
Sbjct: 7   KVEKIGEGT---------YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
           ++NH N+VKL    I  E+   YL++E++    L  ++  +    +           +  
Sbjct: 58  ELNHPNIVKLLD-VIHTEN-KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAIT-MHIVGTQGYIA 498
           GL + H H   RV+H+D+K  N+L+++    K+A+FGLA++ G    T  H V T  Y A
Sbjct: 115 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 171
Query: 499 PEYLAD-GVVSTKMDVFSFGVVLLELIS 525
           PE L      ST +D++S G +  E+++
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 75/149 (50%), Gaps = 10/149 (6%)
Query: 393 FCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPR 452
           FC      N + + EY+  G L   +      +L+  T    A ++  GLQ++H      
Sbjct: 84  FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF--YAAEIILGLQFLHSKG--- 138
Query: 453 VVHKDIKSSNILLDSNMRAKIANFGLAKSGC--NAITMHIVGTQGYIAPEYLADGVVSTK 510
           +V++D+K  NILLD +   KIA+FG+ K     +A T    GT  YIAPE L     +  
Sbjct: 139 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQKYNHS 198
Query: 511 MDVFSFGVVLLELISGKEAI---DEEGKF 536
           +D +SFGV+L E++ G+      DEE  F
Sbjct: 199 VDWWSFGVLLYEMLIGQSPFHGQDEEELF 227

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 29/208 (13%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWN---------ACEELKILQ 380
           K+E++ E T          G VYK    + GEV A+K ++ +         A  E+ +L+
Sbjct: 8   KVEKIGEGT---------YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 58
Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
           ++NH N+VKL    I  E+   YL++E++    L  ++  +    +           +  
Sbjct: 59  ELNHPNIVKLLD-VIHTEN-KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 115
Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAIT-MHIVGTQGYIA 498
           GL + H H   RV+H+D+K  N+L+++    K+A+FGLA++ G    T  H V T  Y A
Sbjct: 116 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 172
Query: 499 PEYLAD-GVVSTKMDVFSFGVVLLELIS 525
           PE L      ST +D++S G +  E+++
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 90/184 (48%), Gaps = 15/184 (8%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNEN--LNWKTRL 432
           E+ +L+++ H N+V+     ID  +   Y++ EY E G L S + +   E   L+ +  L
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 433 RIAIDVANGLQYIHE-----HTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK--SGCNA 485
           R+   +   L+  H      HT   V+H+D+K +N+ LD     K+ +FGLA+  +    
Sbjct: 115 RVMTQLTLALKECHRRSDGGHT---VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDED 171
Query: 486 ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYW 545
                VGT  Y++PE +     + K D++S G +L EL +    +     F  ++L G  
Sbjct: 172 FAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA---LMPPFTAFSQKELAGKI 228
Query: 546 REMK 549
           RE K
Sbjct: 229 REGK 232

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 334 EELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWNAC--------EELKILQKVN 383
           EEL    +   +G    G V+KG  N   +V AIK++             +E+ +L + +
Sbjct: 21  EELFTKLEKIGKGSF--GEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 78
Query: 384 HGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQ 443
              + K  G  +  +D   ++I EY+  GS    L     +     T LR   ++  GL 
Sbjct: 79  SPYVTKYYGSYL--KDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR---EILKGLD 133
Query: 444 YIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH--IVGTQGYIAPEY 501
           Y+H   +   +H+DIK++N+LL  +   K+A+FG+A    +        VGT  ++APE 
Sbjct: 134 YLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEV 190
Query: 502 LADGVVSTKMDVFSFGVVLLELISGKEAIDE 532
           +      +K D++S G+  +EL  G+    E
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARGEPPHSE 221

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 341 DNFSEGCLIQGSVYKGNIHGEVYAIKMMKWNACEELKILQKVN----------HGNLVKL 390
           D    G   +  + +  + G   A+K++       L ++ K+           H +++KL
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 391 EGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTR 450
                 P D   +++ EY+  G L  ++   K+  +      R+   + + + Y H H  
Sbjct: 77  YQVISTPTD--FFMVMEYVSGGELFDYI--CKHGRVEEMEARRLFQQILSAVDYCHRHM- 131
Query: 451 PRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI-VGTQGYIAPEYLADGV-VS 508
             VVH+D+K  N+LLD++M AKIA+FGL+    +   +    G+  Y APE ++  +   
Sbjct: 132 --VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAG 189
Query: 509 TKMDVFSFGVVLLELISGKEAIDEE 533
            ++D++S GV+L  L+ G    D+E
Sbjct: 190 PEVDIWSCGVILYALLCGTLPFDDE 214

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 105/208 (50%), Gaps = 29/208 (13%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWN---------ACEELKILQ 380
           K+E++ E T          G VYK    + GEV A+K ++ +         A  E+ +L+
Sbjct: 10  KVEKIGEGT---------YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
           ++NH N+VKL    I  E+   YL++E++ +  L  ++  +    +           +  
Sbjct: 61  ELNHPNIVKLLD-VIHTEN-KLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQ 117
Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAIT-MHIVGTQGYIA 498
           GL + H H   RV+H+D+K  N+L+++    K+A+FGLA++ G    T  H V T  Y A
Sbjct: 118 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 499 PEYLAD-GVVSTKMDVFSFGVVLLELIS 525
           PE L      ST +D++S G +  E+++
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 22/206 (10%)
Query: 334 EELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWNAC--------EELKILQKVN 383
           EEL    +   +G    G V+KG  N   +V AIK++             +E+ +L + +
Sbjct: 6   EELFTKLEKIGKGSF--GEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 63
Query: 384 HGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQ 443
              + K  G  +  +D   ++I EY+  GS    L     +     T LR   ++  GL 
Sbjct: 64  SPYVTKYYGSYL--KDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR---EILKGLD 118
Query: 444 YIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH--IVGTQGYIAPEY 501
           Y+H   +   +H+DIK++N+LL  +   K+A+FG+A    +        VGT  ++APE 
Sbjct: 119 YLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEV 175
Query: 502 LADGVVSTKMDVFSFGVVLLELISGK 527
           +      +K D++S G+  +EL  G+
Sbjct: 176 IKQSAYDSKADIWSLGITAIELARGE 201

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 44/208 (21%)
Query: 351 GSVYKGNIHGEV-------YAIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCI 395
           G VY+G + G          A+K +     E        E  I+ K NH N+V+  G  +
Sbjct: 61  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 120
Query: 396 DPEDANCYLIYEYIENGSLHSWLHENKNE-----NLNWKTRLRIAIDVANGLQYIHEHTR 450
             +    +++ E +  G L S+L E +       +L     L +A D+A G QY+ E+  
Sbjct: 121 --QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-- 176
Query: 451 PRVVHKDIKSSNILL---DSNMRAKIANFGLA----------KSGCNAITMHIVGTQGYI 497
              +H+DI + N LL        AKI +FG+A          K GC  + +       ++
Sbjct: 177 -HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK------WM 229
Query: 498 APEYLADGVVSTKMDVFSFGVVLLELIS 525
            PE   +G+ ++K D +SFGV+L E+ S
Sbjct: 230 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 29/208 (13%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWN---------ACEELKILQ 380
           K+E++ E T          G VYK    + GEV A+K ++ +         A  E+ +L+
Sbjct: 10  KVEKIGEGT---------YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
           ++NH N+VKL    +   +   YL++E++ +  L  ++  +    +           +  
Sbjct: 61  ELNHPNIVKL--LDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQ 117
Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAIT-MHIVGTQGYIA 498
           GL + H H   RV+H+D+K  N+L+++    K+A+FGLA++ G    T  H V T  Y A
Sbjct: 118 GLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 499 PEYLAD-GVVSTKMDVFSFGVVLLELIS 525
           PE L      ST +D++S G +  E+++
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 46/209 (22%)
Query: 351 GSVYKGNIHG----------------EVYAIKMMKWNACEELKILQKVNHGNLVKLEGFC 394
           G VY+G + G                EVY+ +  + +   E  I+ K NH N+V+  G  
Sbjct: 59  GEVYEGQVSGMPNDPSPLQVAVKTLPEVYS-EQDELDFLMEALIISKFNHQNIVRCIGVS 117
Query: 395 IDPEDANCYLIYEYIENGSLHSWLHENKNE-----NLNWKTRLRIAIDVANGLQYIHEHT 449
           +  +    +++ E +  G L S+L E +       +L     L +A D+A G QY+ E+ 
Sbjct: 118 L--QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN- 174
Query: 450 RPRVVHKDIKSSNILL---DSNMRAKIANFGLA----------KSGCNAITMHIVGTQGY 496
               +H+DI + N LL        AKI +FG+A          K GC  + +       +
Sbjct: 175 --HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK------W 226
Query: 497 IAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           + PE   +G+ ++K D +SFGV+L E+ S
Sbjct: 227 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 22/206 (10%)
Query: 334 EELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWNAC--------EELKILQKVN 383
           EEL    +   +G    G V+KG  N   +V AIK++             +E+ +L + +
Sbjct: 6   EELFTKLEKIGKGSF--GEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 63
Query: 384 HGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQ 443
              + K  G  +  +D   ++I EY+  GS    L     +     T LR   ++  GL 
Sbjct: 64  SPYVTKYYGSYL--KDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR---EILKGLD 118
Query: 444 YIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH--IVGTQGYIAPEY 501
           Y+H   +   +H+DIK++N+LL  +   K+A+FG+A    +        VGT  ++APE 
Sbjct: 119 YLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 175
Query: 502 LADGVVSTKMDVFSFGVVLLELISGK 527
           +      +K D++S G+  +EL  G+
Sbjct: 176 IKQSAYDSKADIWSLGITAIELARGE 201

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 29/208 (13%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWN---------ACEELKILQ 380
           K+E++ E T          G VYK    + GEV A+K ++ +         A  E+ +L+
Sbjct: 9   KVEKIGEGT---------YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 59
Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
           ++NH N+VKL    +   +   YL++E++ +  L  ++  +    +           +  
Sbjct: 60  ELNHPNIVKL--LDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQ 116
Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAIT-MHIVGTQGYIA 498
           GL + H H   RV+H+D+K  N+L+++    K+A+FGLA++ G    T  H V T  Y A
Sbjct: 117 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 173
Query: 499 PEYLAD-GVVSTKMDVFSFGVVLLELIS 525
           PE L      ST +D++S G +  E+++
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 88/171 (51%), Gaps = 16/171 (9%)
Query: 376 LKILQKVNHGNLVKLEGFCI---DPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRL 432
           L+ L+   H N+V+L   C       +    L++E+++   L ++L +     +  +T  
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK 123
Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK--SGCNAITMHI 490
            +   +  GL ++H H   RVVH+D+K  NIL+ S+ + K+A+FGLA+  S   A+T  +
Sbjct: 124 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT-SV 179
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLE------LISGKEAIDEEGK 535
           V T  Y APE L     +T +D++S G +  E      L  G   +D+ GK
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK 230

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 44/208 (21%)
Query: 351 GSVYKGNIHGEV-------YAIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCI 395
           G VY+G + G          A+K +     E        E  I+ K NH N+V+  G  +
Sbjct: 45  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 104
Query: 396 DPEDANCYLIYEYIENGSLHSWLHENKNE-----NLNWKTRLRIAIDVANGLQYIHEHTR 450
             +    +++ E +  G L S+L E +       +L     L +A D+A G QY+ E+  
Sbjct: 105 --QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-- 160
Query: 451 PRVVHKDIKSSNILL---DSNMRAKIANFGLA----------KSGCNAITMHIVGTQGYI 497
              +H+DI + N LL        AKI +FG+A          K GC  + +       ++
Sbjct: 161 -HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVK------WM 213
Query: 498 APEYLADGVVSTKMDVFSFGVVLLELIS 525
            PE   +G+ ++K D +SFGV+L E+ S
Sbjct: 214 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 44/208 (21%)
Query: 351 GSVYKGNIHGEV-------YAIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCI 395
           G VY+G + G          A+K +     E        E  I+ K NH N+V+  G  +
Sbjct: 62  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 121
Query: 396 DPEDANCYLIYEYIENGSLHSWLHENKNE-----NLNWKTRLRIAIDVANGLQYIHEHTR 450
             +    +++ E +  G L S+L E +       +L     L +A D+A G QY+ E+  
Sbjct: 122 --QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-- 177
Query: 451 PRVVHKDIKSSNILL---DSNMRAKIANFGLA----------KSGCNAITMHIVGTQGYI 497
              +H+DI + N LL        AKI +FG+A          K GC  + +       ++
Sbjct: 178 -HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK------WM 230
Query: 498 APEYLADGVVSTKMDVFSFGVVLLELIS 525
            PE   +G+ ++K D +SFGV+L E+ S
Sbjct: 231 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 44/208 (21%)
Query: 351 GSVYKGNIHGEV-------YAIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCI 395
           G VY+G + G          A+K +     E        E  I+ K NH N+V+  G  +
Sbjct: 85  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 144
Query: 396 DPEDANCYLIYEYIENGSLHSWLHENKNE-----NLNWKTRLRIAIDVANGLQYIHEHTR 450
             +    +++ E +  G L S+L E +       +L     L +A D+A G QY+ E+  
Sbjct: 145 --QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-- 200
Query: 451 PRVVHKDIKSSNILL---DSNMRAKIANFGLA----------KSGCNAITMHIVGTQGYI 497
              +H+DI + N LL        AKI +FG+A          K GC  + +       ++
Sbjct: 201 -HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK------WM 253
Query: 498 APEYLADGVVSTKMDVFSFGVVLLELIS 525
            PE   +G+ ++K D +SFGV+L E+ S
Sbjct: 254 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 105/208 (50%), Gaps = 29/208 (13%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWN---------ACEELKILQ 380
           K+E++ E T          G VYK    + GEV A+K ++ +         A  E+ +L+
Sbjct: 8   KVEKIGEGT---------YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 58
Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
           ++NH N+VKL    I  E+   YL++E++ +  L  ++  +    +           +  
Sbjct: 59  ELNHPNIVKLLD-VIHTEN-KLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQ 115
Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAIT-MHIVGTQGYIA 498
           GL + H H   RV+H+D+K  N+L+++    K+A+FGLA++ G    T  H V T  Y A
Sbjct: 116 GLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 172
Query: 499 PEYLAD-GVVSTKMDVFSFGVVLLELIS 525
           PE L      ST +D++S G +  E+++
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 88/171 (51%), Gaps = 16/171 (9%)
Query: 376 LKILQKVNHGNLVKLEGFCI---DPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRL 432
           L+ L+   H N+V+L   C       +    L++E+++   L ++L +     +  +T  
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK 123
Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK--SGCNAITMHI 490
            +   +  GL ++H H   RVVH+D+K  NIL+ S+ + K+A+FGLA+  S   A+T  +
Sbjct: 124 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT-SV 179
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLE------LISGKEAIDEEGK 535
           V T  Y APE L     +T +D++S G +  E      L  G   +D+ GK
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK 230

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 87/168 (51%), Gaps = 16/168 (9%)
Query: 369 KWNACEELKILQKVNHGNLVKLEGFC-----IDPEDANCYLIYEYIENGSLHSWLHENKN 423
           +W  C E++I++K+NH N+V           + P D    L  EY E G L  +L++ +N
Sbjct: 59  RW--CLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP-LLAMEYCEGGDLRKYLNQFEN 115
Query: 424 ENLNWKTRLRIAI-DVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRA---KIANFGLA 479
                +  +R  + D+++ L+Y+HE+   R++H+D+K  NI+L    +    KI + G A
Sbjct: 116 CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 172
Query: 480 KS-GCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           K      +    VGT  Y+APE L     +  +D +SFG +  E I+G
Sbjct: 173 KELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 44/208 (21%)
Query: 351 GSVYKGNIHGEV-------YAIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCI 395
           G VY+G + G          A+K +     E        E  I+ K NH N+V+  G  +
Sbjct: 45  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 104
Query: 396 DPEDANCYLIYEYIENGSLHSWLHENKNE-----NLNWKTRLRIAIDVANGLQYIHEHTR 450
             +    +++ E +  G L S+L E +       +L     L +A D+A G QY+ E+  
Sbjct: 105 --QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-- 160
Query: 451 PRVVHKDIKSSNILL---DSNMRAKIANFGLA----------KSGCNAITMHIVGTQGYI 497
              +H+DI + N LL        AKI +FG+A          K GC  + +       ++
Sbjct: 161 -HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK------WM 213
Query: 498 APEYLADGVVSTKMDVFSFGVVLLELIS 525
            PE   +G+ ++K D +SFGV+L E+ S
Sbjct: 214 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 88/171 (51%), Gaps = 16/171 (9%)
Query: 376 LKILQKVNHGNLVKLEGFCI---DPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRL 432
           L+ L+   H N+V+L   C       +    L++E+++   L ++L +     +  +T  
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK 123
Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK--SGCNAITMHI 490
            +   +  GL ++H H   RVVH+D+K  NIL+ S+ + K+A+FGLA+  S   A+T  +
Sbjct: 124 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT-SV 179
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLE------LISGKEAIDEEGK 535
           V T  Y APE L     +T +D++S G +  E      L  G   +D+ GK
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK 230

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 87/168 (51%), Gaps = 16/168 (9%)
Query: 369 KWNACEELKILQKVNHGNLVKLEGFC-----IDPEDANCYLIYEYIENGSLHSWLHENKN 423
           +W  C E++I++K+NH N+V           + P D    L  EY E G L  +L++ +N
Sbjct: 58  RW--CLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP-LLAMEYCEGGDLRKYLNQFEN 114
Query: 424 ENLNWKTRLRIAI-DVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRA---KIANFGLA 479
                +  +R  + D+++ L+Y+HE+   R++H+D+K  NI+L    +    KI + G A
Sbjct: 115 CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171
Query: 480 KS-GCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           K      +    VGT  Y+APE L     +  +D +SFG +  E I+G
Sbjct: 172 KELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 44/208 (21%)
Query: 351 GSVYKGNIHGEV-------YAIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCI 395
           G VY+G + G          A+K +     E        E  I+ K NH N+V+  G  +
Sbjct: 51  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 110
Query: 396 DPEDANCYLIYEYIENGSLHSWLHENKNE-----NLNWKTRLRIAIDVANGLQYIHEHTR 450
             +    +++ E +  G L S+L E +       +L     L +A D+A G QY+ E+  
Sbjct: 111 --QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-- 166
Query: 451 PRVVHKDIKSSNILL---DSNMRAKIANFGLA----------KSGCNAITMHIVGTQGYI 497
              +H+DI + N LL        AKI +FG+A          K GC  + +       ++
Sbjct: 167 -HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK------WM 219
Query: 498 APEYLADGVVSTKMDVFSFGVVLLELIS 525
            PE   +G+ ++K D +SFGV+L E+ S
Sbjct: 220 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 44/208 (21%)
Query: 351 GSVYKGNIHGEV-------YAIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCI 395
           G VY+G + G          A+K +     E        E  I+ K NH N+V+  G  +
Sbjct: 36  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 95
Query: 396 DPEDANCYLIYEYIENGSLHSWLHENKNE-----NLNWKTRLRIAIDVANGLQYIHEHTR 450
             +    +++ E +  G L S+L E +       +L     L +A D+A G QY+ E+  
Sbjct: 96  --QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-- 151
Query: 451 PRVVHKDIKSSNILL---DSNMRAKIANFGLA----------KSGCNAITMHIVGTQGYI 497
              +H+DI + N LL        AKI +FG+A          K GC  + +       ++
Sbjct: 152 -HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK------WM 204
Query: 498 APEYLADGVVSTKMDVFSFGVVLLELIS 525
            PE   +G+ ++K D +SFGV+L E+ S
Sbjct: 205 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 44/208 (21%)
Query: 351 GSVYKGNIHGEV-------YAIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCI 395
           G VY+G + G          A+K +     E        E  I+ K NH N+V+  G  +
Sbjct: 71  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 130
Query: 396 DPEDANCYLIYEYIENGSLHSWLHENKNE-----NLNWKTRLRIAIDVANGLQYIHEHTR 450
             +    +++ E +  G L S+L E +       +L     L +A D+A G QY+ E+  
Sbjct: 131 --QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-- 186
Query: 451 PRVVHKDIKSSNILL---DSNMRAKIANFGLA----------KSGCNAITMHIVGTQGYI 497
              +H+DI + N LL        AKI +FG+A          K GC  + +       ++
Sbjct: 187 -HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK------WM 239
Query: 498 APEYLADGVVSTKMDVFSFGVVLLELIS 525
            PE   +G+ ++K D +SFGV+L E+ S
Sbjct: 240 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 85/183 (46%), Gaps = 20/183 (10%)
Query: 362 VYAIKMMK-----------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE 410
           +YA++++K           W   E+    Q  NH  LV L   C   E +  + + EY+ 
Sbjct: 79  IYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHS-CFQTE-SRLFFVIEYVN 136
Query: 411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR 470
            G L    H  +   L  +     + +++  L Y+HE     ++++D+K  N+LLDS   
Sbjct: 137 GGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGH 191
Query: 471 AKIANFGLAKSGCNA--ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKE 528
            K+ ++G+ K G      T    GT  YIAPE L        +D ++ GV++ E+++G+ 
Sbjct: 192 IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 251
Query: 529 AID 531
             D
Sbjct: 252 PFD 254

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 44/208 (21%)
Query: 351 GSVYKGNIHGEV-------YAIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCI 395
           G VY+G + G          A+K +     E        E  I+ K NH N+V+  G  +
Sbjct: 59  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 118
Query: 396 DPEDANCYLIYEYIENGSLHSWLHENKNE-----NLNWKTRLRIAIDVANGLQYIHEHTR 450
             +    +++ E +  G L S+L E +       +L     L +A D+A G QY+ E+  
Sbjct: 119 --QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-- 174
Query: 451 PRVVHKDIKSSNILL---DSNMRAKIANFGLA----------KSGCNAITMHIVGTQGYI 497
              +H+DI + N LL        AKI +FG+A          K GC  + +       ++
Sbjct: 175 -HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK------WM 227
Query: 498 APEYLADGVVSTKMDVFSFGVVLLELIS 525
            PE   +G+ ++K D +SFGV+L E+ S
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 44/208 (21%)
Query: 351 GSVYKGNIHGEV-------YAIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCI 395
           G VY+G + G          A+K +     E        E  I+ K NH N+V+  G  +
Sbjct: 44  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 103
Query: 396 DPEDANCYLIYEYIENGSLHSWLHENKNE-----NLNWKTRLRIAIDVANGLQYIHEHTR 450
             +    +++ E +  G L S+L E +       +L     L +A D+A G QY+ E+  
Sbjct: 104 --QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-- 159
Query: 451 PRVVHKDIKSSNILL---DSNMRAKIANFGLA----------KSGCNAITMHIVGTQGYI 497
              +H+DI + N LL        AKI +FG+A          K GC  + +       ++
Sbjct: 160 -HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK------WM 212
Query: 498 APEYLADGVVSTKMDVFSFGVVLLELIS 525
            PE   +G+ ++K D +SFGV+L E+ S
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 44/208 (21%)
Query: 351 GSVYKGNIHGEV-------YAIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCI 395
           G VY+G + G          A+K +     E        E  I+ K NH N+V+  G  +
Sbjct: 44  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 103
Query: 396 DPEDANCYLIYEYIENGSLHSWLHENKNE-----NLNWKTRLRIAIDVANGLQYIHEHTR 450
             +    +++ E +  G L S+L E +       +L     L +A D+A G QY+ E+  
Sbjct: 104 --QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-- 159
Query: 451 PRVVHKDIKSSNILL---DSNMRAKIANFGLA----------KSGCNAITMHIVGTQGYI 497
              +H+DI + N LL        AKI +FG+A          K GC  + +       ++
Sbjct: 160 -HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK------WM 212
Query: 498 APEYLADGVVSTKMDVFSFGVVLLELIS 525
            PE   +G+ ++K D +SFGV+L E+ S
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 338 EATDNFSEGCLIQGSVYKG-----NIH-GEVYAIKMMKWNAC----------EELKILQK 381
           E  ++F  G L+    + G     +IH G   AIKM+   A            E+KI  +
Sbjct: 8   EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQ 67
Query: 382 VNHGNLVKLEGFCIDPEDAN-CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
           + H ++++L  +    ED+N  YL+ E   NG ++ +L +N+ +  +          +  
Sbjct: 68  LKHPSILELYNYF---EDSNYVYLVLEMCHNGEMNRYL-KNRVKPFSENEARHFMHQIIT 123
Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH--IVGTQGYIA 498
           G+ Y+H H    ++H+D+  SN+LL  NM  KIA+FGLA         H  + GT  YI+
Sbjct: 124 GMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYIS 180
Query: 499 PEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE 533
           PE         + DV+S G +   L+ G+   D +
Sbjct: 181 PEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTD 215

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 28/200 (14%)
Query: 351 GSVYKGNIHGE-----VYAIKMMKWNACEELKI---------LQKVNHGNLVKLEGFCID 396
           GSV +GN+  E       A+K MK +   + +I         ++  +H N+++L G CI+
Sbjct: 48  GSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107
Query: 397 PEDANC---YLIYEYIENGSLHSWLH----ENKNENLNWKTRLRIAIDVANGLQYIHEHT 449
                     +I  +++ G LH++L     E   +++  +T L+  +D+A G++Y+    
Sbjct: 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN 167
Query: 450 RPRVVHKDIKSSNILLDSNMRAKIANFGLAK---SGCNAITMHIVGTQ-GYIAPEYLADG 505
               +H+D+ + N +L  +M   +A+FGL+K   SG       I      +IA E LAD 
Sbjct: 168 ---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR 224
Query: 506 VVSTKMDVFSFGVVLLELIS 525
           V ++K DV++FGV + E+ +
Sbjct: 225 VYTSKSDVWAFGVTMWEIAT 244

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 34/201 (16%)
Query: 351 GSVYKGNIHGEVYAIKMMK------WNACEELKILQKVNHGNLVKLEGFCIDP-----ED 399
           G V++G+  GE  A+K+        W    EL     + H N++   GF           
Sbjct: 22  GEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENIL---GFIASDMTSRHSS 78
Query: 400 ANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIH-----EHTRPRVV 454
              +LI  Y E GSL+ +L       L+  + LRI + +A+GL ++H        +P + 
Sbjct: 79  TQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIA 135
Query: 455 HKDIKSSNILLDSNMRAKIANFGLA---KSGCNAITM---HIVGTQGYIAPEYLADGV-- 506
           H+D+KS NIL+  N +  IA+ GLA       N + +     VGT+ Y+APE L + +  
Sbjct: 136 HRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQV 195
Query: 507 ----VSTKMDVFSFGVVLLEL 523
                  ++D+++FG+VL E+
Sbjct: 196 DCFDSYKRVDIWAFGLVLWEV 216

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 341 DNFSEGCLIQGSVYKGNIHGEVYAIKMMKWNACEELKILQKVN----------HGNLVKL 390
           D    G   +  + +  + G   A+K++       L ++ K+           H +++KL
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 391 EGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTR 450
                 P D   +++ EY+  G L  ++   K+  +      R+   + + + Y H H  
Sbjct: 77  YQVISTPTD--FFMVMEYVSGGELFDYI--CKHGRVEEMEARRLFQQILSAVDYCHRHM- 131
Query: 451 PRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH-IVGTQGYIAPEYLADGV-VS 508
             VVH+D+K  N+LLD++M AKIA+FGL+    +   +    G+  Y APE ++  +   
Sbjct: 132 --VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAG 189
Query: 509 TKMDVFSFGVVLLELISGKEAIDEE 533
            ++D++S GV+L  L+ G    D+E
Sbjct: 190 PEVDIWSCGVILYALLCGTLPFDDE 214

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 96/184 (52%), Gaps = 20/184 (10%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL-HSWLHENKNENLNWKTRL 432
           EE+ +L+ ++H N++KL  F  D    N YL+ E  + G L    +H  K   ++    +
Sbjct: 85  EEVAVLKLLDHPNIMKLYDFFEDKR--NYYLVMECYKGGELFDEIIHRMKFNEVDAAVII 142
Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR---AKIANFGLAKSGCNAITM- 488
           +    V +G+ Y+H+H    +VH+D+K  N+LL+S  +    KI +FGL+    N   M 
Sbjct: 143 K---QVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK 196
Query: 489 HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYWREM 548
             +GT  YIAPE L       K DV+S GV+L  L++G         F GQ  +   R++
Sbjct: 197 ERLGTAYYIAPEVLRKK-YDEKCDVWSIGVILFILLAGYPP------FGGQTDQEILRKV 249
Query: 549 KRGK 552
           ++GK
Sbjct: 250 EKGK 253

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 34/201 (16%)
Query: 351 GSVYKGNIHGEVYAIKMMK------WNACEELKILQKVNHGNLVKLEGFCIDP-----ED 399
           G V++G+  GE  A+K+        W    EL     + H N++   GF           
Sbjct: 22  GEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENIL---GFIASDMTSRHSS 78
Query: 400 ANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIH-----EHTRPRVV 454
              +LI  Y E GSL+ +L       L+  + LRI + +A+GL ++H        +P + 
Sbjct: 79  TQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIA 135
Query: 455 HKDIKSSNILLDSNMRAKIANFGLA---KSGCNAITM---HIVGTQGYIAPEYLADGV-- 506
           H+D+KS NIL+  N +  IA+ GLA       N + +     VGT+ Y+APE L + +  
Sbjct: 136 HRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQV 195
Query: 507 ----VSTKMDVFSFGVVLLEL 523
                  ++D+++FG+VL E+
Sbjct: 196 DCFDSYKRVDIWAFGLVLWEV 216

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 85/154 (55%), Gaps = 8/154 (5%)
Query: 375 ELKILQKVNHGNLVKLEG-FCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           EL++L + N   +V   G F  D E + C    E+++ GSL   L   K   +  +   +
Sbjct: 57  ELQVLHECNSPYIVGFYGAFYSDGEISICM---EHMDGGSLDQVL--KKAGRIPEQILGK 111
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT 493
           ++I V  GL Y+ E  + +++H+D+K SNIL++S    K+ +FG++    + +    VGT
Sbjct: 112 VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGT 169
Query: 494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
           + Y++PE L     S + D++S G+ L+E+  G+
Sbjct: 170 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 34/201 (16%)
Query: 351 GSVYKGNIHGEVYAIKMMK------WNACEELKILQKVNHGNLVKLEGFCIDP-----ED 399
           G V++G+  GE  A+K+        W    EL     + H N++   GF           
Sbjct: 51  GEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENIL---GFIASDMTSRHSS 107
Query: 400 ANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIH-----EHTRPRVV 454
              +LI  Y E GSL+ +L       L+  + LRI + +A+GL ++H        +P + 
Sbjct: 108 TQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIA 164
Query: 455 HKDIKSSNILLDSNMRAKIANFGLA---KSGCNAITMH---IVGTQGYIAPEYLADGV-- 506
           H+D+KS NIL+  N +  IA+ GLA       N + +     VGT+ Y+APE L + +  
Sbjct: 165 HRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQV 224
Query: 507 ----VSTKMDVFSFGVVLLEL 523
                  ++D+++FG+VL E+
Sbjct: 225 DCFDSYKRVDIWAFGLVLWEV 245

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 28/198 (14%)
Query: 351 GSVYKGNIHGEVYAIKMM----KWNACEELKILQKV--NHGNLVKLEGFCIDPEDA--NC 402
           G V+ G   GE  A+K+     + +   E +I Q V   H N++      I    +    
Sbjct: 51  GEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110
Query: 403 YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHT-----RPRVVHKD 457
           YLI +Y ENGSL+ +L   K+  L+ K+ L++A    +GL ++H        +P + H+D
Sbjct: 111 YLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRD 167
Query: 458 IKSSNILLDSNMRAKIANFGLAK---SGCNAITMHI---VGTQGYIAPEYLADGVVSTKM 511
           +KS NIL+  N    IA+ GLA    S  N + +     VGT+ Y+ PE L + +     
Sbjct: 168 LKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHF 227
Query: 512 ------DVFSFGVVLLEL 523
                 D++SFG++L E+
Sbjct: 228 QSYIMADMYSFGLILWEV 245

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 113/217 (52%), Gaps = 33/217 (15%)
Query: 325 LDKYRIFKIEELREATDNFSEGCLIQGSVYKG-NIHGEVYAIKMMKWNA---------CE 374
           ++KY+  K+E++ E T          G VYK  +  G + A+K ++ +A           
Sbjct: 20  MEKYQ--KLEKVGEGT---------YGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR 68
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCY-LIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           E+ +L++++H N+V L           C  L++E++E   L   L ENK    + + ++ 
Sbjct: 69  EISLLKELHHPNIVSLIDVI---HSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIY 124
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT--MHIV 491
           +   +  G+ + H+H   R++H+D+K  N+L++S+   K+A+FGLA++    +    H V
Sbjct: 125 L-YQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEV 180
Query: 492 GTQGYIAPEYL-ADGVVSTKMDVFSFGVVLLELISGK 527
            T  Y AP+ L      ST +D++S G +  E+I+GK
Sbjct: 181 VTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 113/217 (52%), Gaps = 33/217 (15%)
Query: 325 LDKYRIFKIEELREATDNFSEGCLIQGSVYKG-NIHGEVYAIKMMKWNA---------CE 374
           ++KY+  K+E++ E T          G VYK  +  G + A+K ++ +A           
Sbjct: 20  MEKYQ--KLEKVGEGT---------YGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR 68
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCY-LIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           E+ +L++++H N+V L           C  L++E++E   L   L ENK    + + ++ 
Sbjct: 69  EISLLKELHHPNIVSLIDVI---HSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIY 124
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT--MHIV 491
           +   +  G+ + H+H   R++H+D+K  N+L++S+   K+A+FGLA++    +    H V
Sbjct: 125 L-YQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEV 180
Query: 492 GTQGYIAPEYL-ADGVVSTKMDVFSFGVVLLELISGK 527
            T  Y AP+ L      ST +D++S G +  E+I+GK
Sbjct: 181 VTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 85/155 (54%), Gaps = 8/155 (5%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           EE  +++ + H  LV+L  + +  ++   Y+I E++  GSL  +L  ++   +     + 
Sbjct: 56  EEANLMKTLQHDKLVRL--YAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLID 113
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT 493
            +  +A G+ YI    R   +H+D++++N+L+  ++  KIA+FGLA+   +       G 
Sbjct: 114 FSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGA 170
Query: 494 Q---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           +    + APE +  G  + K +V+SFG++L E+++
Sbjct: 171 KFPIKWTAPEAINFGCFTIKSNVWSFGILLYEIVT 205

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 91/178 (51%), Gaps = 16/178 (8%)
Query: 357 NIHGEVYAIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE 410
           N H +V A+K MK  +        E  +++ + H  LVKL            Y+I E++ 
Sbjct: 210 NKHTKV-AVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYIITEFMA 265
Query: 411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR 470
            GSL  +L  ++         +  +  +A G+ +I +      +H+D++++NIL+ +++ 
Sbjct: 266 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLV 322
Query: 471 AKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
            KIA+FGLA+   +       G +    + APE +  G  + K DV+SFG++L+E+++
Sbjct: 323 CKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 93/187 (49%), Gaps = 16/187 (8%)
Query: 351 GSVYKGNIHGEVYAIKMMK---WNA------CEELKILQKVNHGNLVKLEGFCIDPEDAN 401
           G ++KG   G    +K++K   W+        EE   L+  +H N++ + G C  P   +
Sbjct: 24  GELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83
Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSS 461
             LI  ++  GSL++ LHE  N  ++    ++ A+D+A G+ ++H    P +    + S 
Sbjct: 84  PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSR 142
Query: 462 NILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVST---KMDVFSFGV 518
           ++++D +M A+I+   +  S  +   M+      ++APE L      T     D++SF V
Sbjct: 143 SVMIDEDMTARISMADVKFSFQSPGRMY---APAWVAPEALQKKPEDTNRRSADMWSFAV 199
Query: 519 VLLELIS 525
           +L EL++
Sbjct: 200 LLWELVT 206

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 34/201 (16%)
Query: 351 GSVYKGNIHGEVYAIKMMK------WNACEELKILQKVNHGNLVKLEGF-CIDPED---- 399
           G V++G   GE  A+K+        W    E+     + H N++   GF   D +D    
Sbjct: 56  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENIL---GFIAADNKDNGTW 112
Query: 400 ANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIH-----EHTRPRVV 454
              +L+ +Y E+GSL  +L+      +  +  +++A+  A+GL ++H        +P + 
Sbjct: 113 TQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 169
Query: 455 HKDIKSSNILLDSNMRAKIANFGLA---KSGCNAITM---HIVGTQGYIAPEYLADGV-- 506
           H+D+KS NIL+  N    IA+ GLA    S  + I +   H VGT+ Y+APE L D +  
Sbjct: 170 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 229
Query: 507 ----VSTKMDVFSFGVVLLEL 523
                  + D+++ G+V  E+
Sbjct: 230 KHFESFKRADIYAMGLVFWEI 250

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 91/178 (51%), Gaps = 16/178 (8%)
Query: 357 NIHGEVYAIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE 410
           N H +V A+K MK  +        E  +++ + H  LVKL            Y+I E++ 
Sbjct: 37  NKHTKV-AVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYIITEFMA 92
Query: 411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR 470
            GSL  +L  ++         +  +  +A G+ +I +      +H+D++++NIL+ +++ 
Sbjct: 93  KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLV 149
Query: 471 AKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
            KIA+FGLA+   +       G +    + APE +  G  + K DV+SFG++L+E+++
Sbjct: 150 CKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 207

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 29/210 (13%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWN---------ACEELKILQ 380
           K+E++ E T          G VYK    + GEV A+  ++ +         A  E+ +L+
Sbjct: 7   KVEKIGEGT---------YGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLK 57
Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
           ++NH N+VKL    I  E+   YL++E++    L  ++  +    +           +  
Sbjct: 58  ELNHPNIVKLLD-VIHTEN-KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAIT-MHIVGTQGYIA 498
           GL + H H   RV+H+D+K  N+L+++    K+A+FGLA++ G    T  H V T  Y A
Sbjct: 115 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 171
Query: 499 PEYLAD-GVVSTKMDVFSFGVVLLELISGK 527
           PE L      ST +D++S G +  E+++ +
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 29/210 (13%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWN---------ACEELKILQ 380
           K+E++ E T          G VYK    + GEV A+  ++ +         A  E+ +L+
Sbjct: 6   KVEKIGEGT---------YGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLK 56
Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
           ++NH N+VKL    I  E+   YL++E++    L  ++  +    +           +  
Sbjct: 57  ELNHPNIVKLLD-VIHTEN-KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAIT-MHIVGTQGYIA 498
           GL + H H   RV+H+D+K  N+L+++    K+A+FGLA++ G    T  H V T  Y A
Sbjct: 114 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 170
Query: 499 PEYLAD-GVVSTKMDVFSFGVVLLELISGK 527
           PE L      ST +D++S G +  E+++ +
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 88/181 (48%), Gaps = 20/181 (11%)
Query: 360 GEVYAIKMMK----------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI 409
           G  YA+K++K           +   E ++LQ   H  L  L+ +     D  C+++ EY 
Sbjct: 34  GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVM-EYA 91
Query: 410 ENGSLHSWLHENKNENLNWKTRLRI-AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN 468
             G L  + H ++ E +  + R R    ++ + L Y+H  +   VV++D+K  N++LD +
Sbjct: 92  NGGEL--FFHLSR-ERVFSEDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKD 146
Query: 469 MRAKIANFGLAKSGC--NAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
              KI +FGL K G    A      GT  Y+APE L D      +D +  GVV+ E++ G
Sbjct: 147 GHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 206
Query: 527 K 527
           +
Sbjct: 207 R 207

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 88/181 (48%), Gaps = 20/181 (11%)
Query: 360 GEVYAIKMMK----------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI 409
           G  YA+K++K           +   E ++LQ   H  L  L+ +     D  C+++ EY 
Sbjct: 35  GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVM-EYA 92
Query: 410 ENGSLHSWLHENKNENLNWKTRLRI-AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN 468
             G L  + H ++ E +  + R R    ++ + L Y+H  +   VV++D+K  N++LD +
Sbjct: 93  NGGEL--FFHLSR-ERVFSEDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKD 147
Query: 469 MRAKIANFGLAKSGC--NAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
              KI +FGL K G    A      GT  Y+APE L D      +D +  GVV+ E++ G
Sbjct: 148 GHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 207
Query: 527 K 527
           +
Sbjct: 208 R 208

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 88/158 (55%), Gaps = 15/158 (9%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL--HENKNENLNWKTRL 432
           E  I+ + +H N+++LEG     +     ++ EY+ENGSL S+L  H+ +   +     L
Sbjct: 96  EASIMGQFDHPNIIRLEGVVT--KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 153
Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVG 492
           R    +A+G++Y+ +      VH+D+ + NIL++SN+  K+++FGLA+   +        
Sbjct: 154 R---GIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTT 207
Query: 493 TQGYI-----APEYLADGVVSTKMDVFSFGVVLLELIS 525
             G I     +PE +A    ++  DV+S+G+VL E++S
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 22/206 (10%)
Query: 334 EELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWNAC--------EELKILQKVN 383
           EEL    +   +G    G V+KG  N   +V AIK++             +E+ +L + +
Sbjct: 22  EELFTKLERIGKGSF--GEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 79
Query: 384 HGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQ 443
              + K  G  +  + +  ++I EY+  GS    L     +     T L+   ++  GL 
Sbjct: 80  SSYVTKYYGSYL--KGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKGLD 134
Query: 444 YIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH--IVGTQGYIAPEY 501
           Y+H   +   +H+DIK++N+LL      K+A+FG+A    +        VGT  ++APE 
Sbjct: 135 YLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 191
Query: 502 LADGVVSTKMDVFSFGVVLLELISGK 527
           +      +K D++S G+  +EL  G+
Sbjct: 192 IQQSAYDSKADIWSLGITAIELAKGE 217

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 88/181 (48%), Gaps = 20/181 (11%)
Query: 360 GEVYAIKMMK----------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI 409
           G  YA+K++K           +   E ++LQ   H  L  L+ +     D  C+++ EY 
Sbjct: 33  GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVM-EYA 90
Query: 410 ENGSLHSWLHENKNENLNWKTRLRI-AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN 468
             G L  + H ++ E +  + R R    ++ + L Y+H  +   VV++D+K  N++LD +
Sbjct: 91  NGGEL--FFHLSR-ERVFSEDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKD 145
Query: 469 MRAKIANFGLAKSGC--NAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
              KI +FGL K G    A      GT  Y+APE L D      +D +  GVV+ E++ G
Sbjct: 146 GHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 205
Query: 527 K 527
           +
Sbjct: 206 R 206

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 34/201 (16%)
Query: 351 GSVYKGNIHGEVYAIKMMK------WNACEELKILQKVNHGNLVKLEGF-CIDPED---- 399
           G V++G   GE  A+K+        W    E+     + H N++   GF   D +D    
Sbjct: 43  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENIL---GFIAADNKDNGTW 99
Query: 400 ANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIH-----EHTRPRVV 454
              +L+ +Y E+GSL  +L+      +  +  +++A+  A+GL ++H        +P + 
Sbjct: 100 TQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 156
Query: 455 HKDIKSSNILLDSNMRAKIANFGLA---KSGCNAITM---HIVGTQGYIAPEYLADGV-- 506
           H+D+KS NIL+  N    IA+ GLA    S  + I +   H VGT+ Y+APE L D +  
Sbjct: 157 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 216
Query: 507 ----VSTKMDVFSFGVVLLEL 523
                  + D+++ G+V  E+
Sbjct: 217 KHFESFKRADIYAMGLVFWEI 237

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 34/201 (16%)
Query: 351 GSVYKGNIHGEVYAIKMMK------WNACEELKILQKVNHGNLVKLEGF-CIDPED---- 399
           G V++G   GE  A+K+        W    E+     + H N++   GF   D +D    
Sbjct: 18  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENIL---GFIAADNKDNGTW 74
Query: 400 ANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIH-----EHTRPRVV 454
              +L+ +Y E+GSL  +L+      +  +  +++A+  A+GL ++H        +P + 
Sbjct: 75  TQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 131
Query: 455 HKDIKSSNILLDSNMRAKIANFGLA---KSGCNAITM---HIVGTQGYIAPEYLADGV-- 506
           H+D+KS NIL+  N    IA+ GLA    S  + I +   H VGT+ Y+APE L D +  
Sbjct: 132 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 191
Query: 507 ----VSTKMDVFSFGVVLLEL 523
                  + D+++ G+V  E+
Sbjct: 192 KHFESFKRADIYAMGLVFWEI 212

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 34/201 (16%)
Query: 351 GSVYKGNIHGEVYAIKMMK------WNACEELKILQKVNHGNLVKLEGF-CIDPED---- 399
           G V++G   GE  A+K+        W    E+     + H N++   GF   D +D    
Sbjct: 23  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENIL---GFIAADNKDNGTW 79
Query: 400 ANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIH-----EHTRPRVV 454
              +L+ +Y E+GSL  +L+      +  +  +++A+  A+GL ++H        +P + 
Sbjct: 80  TQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 136
Query: 455 HKDIKSSNILLDSNMRAKIANFGLA---KSGCNAITM---HIVGTQGYIAPEYLADGV-- 506
           H+D+KS NIL+  N    IA+ GLA    S  + I +   H VGT+ Y+APE L D +  
Sbjct: 137 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 196
Query: 507 ----VSTKMDVFSFGVVLLEL 523
                  + D+++ G+V  E+
Sbjct: 197 KHFESFKRADIYAMGLVFWEI 217

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 100/212 (47%), Gaps = 38/212 (17%)
Query: 364 AIKMMKWNACE--------ELKILQKVNHG-NLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K  A          ELKIL  + H  N+V L G C  P      +I E+ + G+L
Sbjct: 62  AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-GGPLMVIVEFCKFGNL 120
Query: 415 HSWLHENKNENLNWKTRLRIAID-------------VANGLQYIHEHTRPRVVHKDIKSS 461
            ++L   +NE + +KT   +  D             VA G++++      + +H+D+ + 
Sbjct: 121 STYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAAR 177
Query: 462 NILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ----GYIAPEYLADGVVSTKMDVFSFG 517
           NILL      KI +FGLA+           G       ++APE + D V + + DV+SFG
Sbjct: 178 NILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 237
Query: 518 VVLLELISGKEA------IDEEGKFCGQKLKG 543
           V+L E+ S   +      IDEE  FC +  +G
Sbjct: 238 VLLWEIFSLGASPYPGVKIDEE--FCRRLKEG 267

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 108/214 (50%), Gaps = 28/214 (13%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKGNIHGEVYAIKMMKWNACE--------ELKILQKVN 383
           KIEE+  A + F E C  +G +          AIK +K    E        E  I+ +  
Sbjct: 17  KIEEVIGAGE-FGEVC--RGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFE 73
Query: 384 HGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNE--NLNWKTRLRIAIDVANG 441
           H N+++LEG   +       ++ E++ENG+L S+L  N  +   +     LR    +A+G
Sbjct: 74  HPNIIRLEGVVTN--SMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR---GIASG 128
Query: 442 LQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK-----SGCNAITMHIVGTQG- 495
           ++Y+ E +    VH+D+ + NIL++SN+  K+++FGL++     S     T  + G    
Sbjct: 129 MRYLAEMS---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPI 185
Query: 496 -YIAPEYLADGVVSTKMDVFSFGVVLLELISGKE 528
            + APE +A    ++  D +S+G+V+ E++S  E
Sbjct: 186 RWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGE 219

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 90/181 (49%), Gaps = 20/181 (11%)
Query: 360 GEVYAIKMMK----------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI 409
           G  YA+K++K           +   E ++LQ   H  L  L+ +     D  C+++ EY 
Sbjct: 173 GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVM-EYA 230
Query: 410 ENGSLHSWLHENKNENLNWKTRLRI-AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN 468
             G L  + H ++ E +  + R R    ++ + L Y+H  +   VV++D+K  N++LD +
Sbjct: 231 NGGEL--FFHLSR-ERVFSEDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKD 285
Query: 469 MRAKIANFGLAKSGC-NAITMH-IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
              KI +FGL K G  +  TM    GT  Y+APE L D      +D +  GVV+ E++ G
Sbjct: 286 GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 345
Query: 527 K 527
           +
Sbjct: 346 R 346

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 34/201 (16%)
Query: 351 GSVYKGNIHGEVYAIKMMK------WNACEELKILQKVNHGNLVKLEGF-CIDPED---- 399
           G V++G   GE  A+K+        W    E+     + H N++   GF   D +D    
Sbjct: 20  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENIL---GFIAADNKDNGTW 76
Query: 400 ANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIH-----EHTRPRVV 454
              +L+ +Y E+GSL  +L+      +  +  +++A+  A+GL ++H        +P + 
Sbjct: 77  TQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 133
Query: 455 HKDIKSSNILLDSNMRAKIANFGLA---KSGCNAITM---HIVGTQGYIAPEYLADGV-- 506
           H+D+KS NIL+  N    IA+ GLA    S  + I +   H VGT+ Y+APE L D +  
Sbjct: 134 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 193
Query: 507 ----VSTKMDVFSFGVVLLEL 523
                  + D+++ G+V  E+
Sbjct: 194 KHFESFKRADIYAMGLVFWEI 214

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 34/201 (16%)
Query: 351 GSVYKGNIHGEVYAIKMMK------WNACEELKILQKVNHGNLVKLEGF-CIDPED---- 399
           G V++G   GE  A+K+        W    E+     + H N++   GF   D +D    
Sbjct: 17  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENIL---GFIAADNKDNGTW 73
Query: 400 ANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIH-----EHTRPRVV 454
              +L+ +Y E+GSL  +L+      +  +  +++A+  A+GL ++H        +P + 
Sbjct: 74  TQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 130
Query: 455 HKDIKSSNILLDSNMRAKIANFGLA---KSGCNAITM---HIVGTQGYIAPEYLADGV-- 506
           H+D+KS NIL+  N    IA+ GLA    S  + I +   H VGT+ Y+APE L D +  
Sbjct: 131 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 190
Query: 507 ----VSTKMDVFSFGVVLLEL 523
                  + D+++ G+V  E+
Sbjct: 191 KHFESFKRADIYAMGLVFWEI 211

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 82/154 (53%), Gaps = 11/154 (7%)
Query: 378 ILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAID 437
           I++  +H N++ L G C+  E  +  ++  Y+++G L +++  N+  N   K  +   + 
Sbjct: 83  IMKDFSHPNVLSLLGICLRSE-GSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQ 140
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-- 495
           VA G++Y+      + VH+D+ + N +LD     K+A+FGLA+   +     +    G  
Sbjct: 141 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAK 197
Query: 496 ----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
               ++A E L     +TK DV+SFGV+L EL++
Sbjct: 198 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 109/214 (50%), Gaps = 28/214 (13%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKGNIHGEVYAIKMMKWNACE--------ELKILQKVN 383
           KIEE+  A + F E C  +G +          AIK +K    E        E  I+ +  
Sbjct: 19  KIEEVIGAGE-FGEVC--RGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFE 75
Query: 384 HGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNE--NLNWKTRLRIAIDVANG 441
           H N+++LEG   +       ++ E++ENG+L S+L  N  +   +     LR    +A+G
Sbjct: 76  HPNIIRLEGVVTN--SMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR---GIASG 130
Query: 442 LQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAITMHIVGTQ--- 494
           ++Y+ E +    VH+D+ + NIL++SN+  K+++FGL++    +  +      +G +   
Sbjct: 131 MRYLAEMS---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPI 187
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKE 528
            + APE +A    ++  D +S+G+V+ E++S  E
Sbjct: 188 RWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGE 221

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 86/156 (55%), Gaps = 12/156 (7%)
Query: 375 ELKILQKVNHGNLVKL-EGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           E+ I++  +H N+V +   + +  E    +++ E++E G+L   +   +   +N +    
Sbjct: 92  EVVIMRDYHHDNVVDMYSSYLVGDE---LWVVMEFLEGGALTDIVTHTR---MNEEQIAT 145
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH--IV 491
           + + V   L Y+H      V+H+DIKS +ILL S+ R K+++FG        +     +V
Sbjct: 146 VCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLV 202
Query: 492 GTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
           GT  ++APE ++     T++D++S G++++E+I G+
Sbjct: 203 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 238

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 88/158 (55%), Gaps = 15/158 (9%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL--HENKNENLNWKTRL 432
           E  I+ + +H N+++LEG     +     ++ EY+ENGSL S+L  H+ +   +     L
Sbjct: 96  EASIMGQFDHPNIIRLEGVVT--KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 153
Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVG 492
           R    +A+G++Y+ +      VH+D+ + NIL++SN+  K+++FGL++   +        
Sbjct: 154 R---GIASGMKYLSDMG---FVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
Query: 493 TQGYI-----APEYLADGVVSTKMDVFSFGVVLLELIS 525
             G I     +PE +A    ++  DV+S+G+VL E++S
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 86/165 (52%), Gaps = 10/165 (6%)
Query: 366 KMMKWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNEN 425
           KM+K  A  E+K+L+++ H NLV L   C   +    YL++E++++  L     E     
Sbjct: 65  KMVKKIAMREIKLLKQLRHENLVNLLEVC--KKKKRWYLVFEFVDHTILDDL--ELFPNG 120
Query: 426 LNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS--GC 483
           L+++   +    + NG+ + H H    ++H+DIK  NIL+  +   K+ +FG A++    
Sbjct: 121 LDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177
Query: 484 NAITMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELISGK 527
             +    V T+ Y APE L   V   K +DV++ G ++ E+  G+
Sbjct: 178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 88/158 (55%), Gaps = 15/158 (9%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL--HENKNENLNWKTRL 432
           E  I+ + +H N+++LEG     +     ++ EY+ENGSL S+L  H+ +   +     L
Sbjct: 67  EASIMGQFDHPNIIRLEGVVT--KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 124
Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVG 492
           R    +A+G++Y+ +      VH+D+ + NIL++SN+  K+++FGL++   +        
Sbjct: 125 R---GIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 178
Query: 493 TQGYI-----APEYLADGVVSTKMDVFSFGVVLLELIS 525
             G I     +PE +A    ++  DV+S+G+VL E++S
Sbjct: 179 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 88/158 (55%), Gaps = 15/158 (9%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL--HENKNENLNWKTRL 432
           E  I+ + +H N+++LEG     +     ++ EY+ENGSL S+L  H+ +   +     L
Sbjct: 84  EASIMGQFDHPNIIRLEGVVT--KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 141
Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVG 492
           R    +A+G++Y+ +      VH+D+ + NIL++SN+  K+++FGL++   +        
Sbjct: 142 R---GIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 195
Query: 493 TQGYI-----APEYLADGVVSTKMDVFSFGVVLLELIS 525
             G I     +PE +A    ++  DV+S+G+VL E++S
Sbjct: 196 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 233

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 37/211 (17%)
Query: 364 AIKMMKWNACE--------ELKILQKVNHG-NLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K  A          ELKIL  + H  N+V L G C  P      +I E+ + G+L
Sbjct: 63  AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-GGPLMVIVEFCKFGNL 121
Query: 415 HSWLHENKNENLNWKTR------------LRIAIDVANGLQYIHEHTRPRVVHKDIKSSN 462
            ++L   +NE + +K              +  +  VA G++++      + +H+D+ + N
Sbjct: 122 STYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASR---KXIHRDLAARN 178
Query: 463 ILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ----GYIAPEYLADGVVSTKMDVFSFGV 518
           ILL      KI +FGLA+           G       ++APE + D V + + DV+SFGV
Sbjct: 179 ILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 238
Query: 519 VLLELISGKEA------IDEEGKFCGQKLKG 543
           +L E+ S   +      IDEE  FC +  +G
Sbjct: 239 LLWEIFSLGASPYPGVKIDEE--FCRRLKEG 267

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 28/212 (13%)
Query: 330 IFKIEELRE--ATDNFSEGCLIQGSVYKGNIHGEVYAIKMMKWNACE--------ELKIL 379
           I KI E +E   T  FSE  L +         G+++A+K +   A +        E+ +L
Sbjct: 20  IKKIFEFKETLGTGAFSEVVLAEEKAT-----GKLFAVKCIPKKALKGKESSIENEIAVL 74
Query: 380 QKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENK-NENLNWKTRLRIAIDV 438
           +K+ H N+V LE     P   + YL+ + +  G L   + E       +  T +R  +D 
Sbjct: 75  RKIKHENIVALEDIYESPN--HLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLD- 131
Query: 439 ANGLQYIHEHTRPRVVHKDIKSSNILL---DSNMRAKIANFGLAK-SGCNAITMHIVGTQ 494
              + Y+H   R  +VH+D+K  N+L    D   +  I++FGL+K  G   +     GT 
Sbjct: 132 --AVYYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTP 186
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           GY+APE LA    S  +D +S GV+   L+ G
Sbjct: 187 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 88/158 (55%), Gaps = 15/158 (9%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL--HENKNENLNWKTRL 432
           E  I+ + +H N+++LEG     +     ++ EY+ENGSL S+L  H+ +   +     L
Sbjct: 96  EASIMGQFDHPNIIRLEGVVT--KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 153
Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVG 492
           R    +A+G++Y+ +      VH+D+ + NIL++SN+  K+++FGL++   +        
Sbjct: 154 R---GIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
Query: 493 TQGYI-----APEYLADGVVSTKMDVFSFGVVLLELIS 525
             G I     +PE +A    ++  DV+S+G+VL E++S
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 89/161 (55%), Gaps = 15/161 (9%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL--HENKNENLNWKTRL 432
           E  I+ + +H N+++LEG     +     ++ EY+ENGSL S+L  H+ +   +     L
Sbjct: 94  EASIMGQFDHPNIIRLEGVVT--KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 151
Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVG 492
           R    +A+G++Y+ +      VH+D+ + NIL++SN+  K+++FGL++   +        
Sbjct: 152 R---GIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 205
Query: 493 TQGYI-----APEYLADGVVSTKMDVFSFGVVLLELISGKE 528
             G I     +PE +A    ++  DV+S+G+VL E++S  E
Sbjct: 206 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE 246

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 88/158 (55%), Gaps = 15/158 (9%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL--HENKNENLNWKTRL 432
           E  I+ + +H N+++LEG     +     ++ EY+ENGSL S+L  H+ +   +     L
Sbjct: 96  EASIMGQFDHPNIIRLEGVVT--KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 153
Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVG 492
           R    +A+G++Y+ +      VH+D+ + NIL++SN+  K+++FGL++   +        
Sbjct: 154 R---GIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
Query: 493 TQGYI-----APEYLADGVVSTKMDVFSFGVVLLELIS 525
             G I     +PE +A    ++  DV+S+G+VL E++S
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 88/158 (55%), Gaps = 15/158 (9%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL--HENKNENLNWKTRL 432
           E  I+ + +H N+++LEG     +     ++ EY+ENGSL S+L  H+ +   +     L
Sbjct: 96  EASIMGQFDHPNIIRLEGVVT--KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 153
Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVG 492
           R    +A+G++Y+ +      VH+D+ + NIL++SN+  K+++FGL++   +        
Sbjct: 154 R---GIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
Query: 493 TQGYI-----APEYLADGVVSTKMDVFSFGVVLLELIS 525
             G I     +PE +A    ++  DV+S+G+VL E++S
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 88/158 (55%), Gaps = 15/158 (9%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL--HENKNENLNWKTRL 432
           E  I+ + +H N+++LEG     +     ++ EY+ENGSL S+L  H+ +   +     L
Sbjct: 96  EASIMGQFDHPNIIRLEGVVT--KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 153
Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVG 492
           R    +A+G++Y+ +      VH+D+ + NIL++SN+  K+++FGL++   +        
Sbjct: 154 R---GIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
Query: 493 TQGYI-----APEYLADGVVSTKMDVFSFGVVLLELIS 525
             G I     +PE +A    ++  DV+S+G+VL E++S
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 82/154 (53%), Gaps = 11/154 (7%)
Query: 378 ILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAID 437
           I++  +H N++ L G C+  E  +  ++  Y+++G L +++  N+  N   K  +   + 
Sbjct: 79  IMKDFSHPNVLSLLGICLRSE-GSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQ 136
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-- 495
           VA G++Y+      + VH+D+ + N +LD     K+A+FGLA+   +     +    G  
Sbjct: 137 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 193
Query: 496 ----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
               ++A E L     +TK DV+SFGV+L EL++
Sbjct: 194 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 82/154 (53%), Gaps = 11/154 (7%)
Query: 378 ILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAID 437
           I++  +H N++ L G C+  E  +  ++  Y+++G L +++  N+  N   K  +   + 
Sbjct: 76  IMKDFSHPNVLSLLGICLRSE-GSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQ 133
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-- 495
           VA G++Y+      + VH+D+ + N +LD     K+A+FGLA+   +     +    G  
Sbjct: 134 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 190
Query: 496 ----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
               ++A E L     +TK DV+SFGV+L EL++
Sbjct: 191 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 224

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 82/154 (53%), Gaps = 11/154 (7%)
Query: 378 ILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAID 437
           I++  +H N++ L G C+  E  +  ++  Y+++G L +++  N+  N   K  +   + 
Sbjct: 82  IMKDFSHPNVLSLLGICLRSE-GSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQ 139
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-- 495
           VA G++Y+      + VH+D+ + N +LD     K+A+FGLA+   +     +    G  
Sbjct: 140 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 196
Query: 496 ----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
               ++A E L     +TK DV+SFGV+L EL++
Sbjct: 197 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 82/154 (53%), Gaps = 11/154 (7%)
Query: 378 ILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAID 437
           I++  +H N++ L G C+  E  +  ++  Y+++G L +++  N+  N   K  +   + 
Sbjct: 84  IMKDFSHPNVLSLLGICLRSE-GSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQ 141
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-- 495
           VA G++Y+      + VH+D+ + N +LD     K+A+FGLA+   +     +    G  
Sbjct: 142 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 198
Query: 496 ----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
               ++A E L     +TK DV+SFGV+L EL++
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 82/154 (53%), Gaps = 11/154 (7%)
Query: 378 ILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAID 437
           I++  +H N++ L G C+  E  +  ++  Y+++G L +++  N+  N   K  +   + 
Sbjct: 83  IMKDFSHPNVLSLLGICLRSE-GSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQ 140
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-- 495
           VA G++Y+      + VH+D+ + N +LD     K+A+FGLA+   +     +    G  
Sbjct: 141 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 197
Query: 496 ----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
               ++A E L     +TK DV+SFGV+L EL++
Sbjct: 198 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 82/154 (53%), Gaps = 11/154 (7%)
Query: 378 ILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAID 437
           I++  +H N++ L G C+  E  +  ++  Y+++G L +++  N+  N   K  +   + 
Sbjct: 81  IMKDFSHPNVLSLLGICLRSE-GSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQ 138
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-- 495
           VA G++Y+      + VH+D+ + N +LD     K+A+FGLA+   +     +    G  
Sbjct: 139 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 195
Query: 496 ----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
               ++A E L     +TK DV+SFGV+L EL++
Sbjct: 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 229

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 87/158 (55%), Gaps = 15/158 (9%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL--HENKNENLNWKTRL 432
           E  I+ + +H N+++LEG     +     ++ EY+ENGSL S+L  H+ +   +     L
Sbjct: 96  EASIMGQFDHPNIIRLEGVVT--KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 153
Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVG 492
           R    +A+G++Y+ +      VH+D+ + NIL++SN+  K+++FGL +   +        
Sbjct: 154 R---GIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTT 207
Query: 493 TQGYI-----APEYLADGVVSTKMDVFSFGVVLLELIS 525
             G I     +PE +A    ++  DV+S+G+VL E++S
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 82/154 (53%), Gaps = 11/154 (7%)
Query: 378 ILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAID 437
           I++  +H N++ L G C+  E  +  ++  Y+++G L +++  N+  N   K  +   + 
Sbjct: 84  IMKDFSHPNVLSLLGICLRSE-GSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQ 141
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-- 495
           VA G++Y+      + VH+D+ + N +LD     K+A+FGLA+   +     +    G  
Sbjct: 142 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 198
Query: 496 ----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
               ++A E L     +TK DV+SFGV+L EL++
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 82/154 (53%), Gaps = 11/154 (7%)
Query: 378 ILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAID 437
           I++  +H N++ L G C+  E  +  ++  Y+++G L +++  N+  N   K  +   + 
Sbjct: 103 IMKDFSHPNVLSLLGICLRSE-GSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQ 160
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-- 495
           VA G++Y+      + VH+D+ + N +LD     K+A+FGLA+   +     +    G  
Sbjct: 161 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 217
Query: 496 ----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
               ++A E L     +TK DV+SFGV+L EL++
Sbjct: 218 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 251

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 84/165 (50%), Gaps = 6/165 (3%)
Query: 372 ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTR 431
           A  E +IL+KVN   +V L  +  + +DA C L+   +  G L   ++            
Sbjct: 231 ALNEKQILEKVNSRFVVSL-AYAYETKDALC-LVLTLMNGGDLKFHIYHMGQAGFPEARA 288
Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH-I 490
           +  A ++  GL+ +H   R R+V++D+K  NILLD +   +I++ GLA       T+   
Sbjct: 289 VFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR 345
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK 535
           VGT GY+APE + +   +   D ++ G +L E+I+G+    +  K
Sbjct: 346 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK 390

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 364 AIKMMKWNACE--------ELKILQKVNHG-NLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K  A          ELKIL  + H  N+V L G C  P      +I E+ + G+L
Sbjct: 61  AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-GGPLMVIVEFCKFGNL 119
Query: 415 HSWLHENKNENLNWKTRLR----------IAIDVANGLQYIHEHTRPRVVHKDIKSSNIL 464
            ++L   +NE + +K   +           +  VA G++++      + +H+D+ + NIL
Sbjct: 120 STYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFLASR---KXIHRDLAARNIL 176
Query: 465 LDSNMRAKIANFGLAKSGCNAITMHIVGTQ----GYIAPEYLADGVVSTKMDVFSFGVVL 520
           L      KI +FGLA+           G       ++APE + D V + + DV+SFGV+L
Sbjct: 177 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 236
Query: 521 LELISGKEA------IDEEGKFCGQKLKG 543
            E+ S   +      IDEE  FC +  +G
Sbjct: 237 WEIFSLGASPYPGVKIDEE--FCRRLKEG 263

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 84/165 (50%), Gaps = 6/165 (3%)
Query: 372 ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTR 431
           A  E +IL+KVN   +V L  +  + +DA C L+   +  G L   ++            
Sbjct: 231 ALNEKQILEKVNSRFVVSL-AYAYETKDALC-LVLTLMNGGDLKFHIYHMGQAGFPEARA 288
Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH-I 490
           +  A ++  GL+ +H   R R+V++D+K  NILLD +   +I++ GLA       T+   
Sbjct: 289 VFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR 345
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK 535
           VGT GY+APE + +   +   D ++ G +L E+I+G+    +  K
Sbjct: 346 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK 390

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 97/190 (51%), Gaps = 37/190 (19%)
Query: 364 AIKMMKWNACE--------ELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           AIK MK  A +        EL++L K+ +H N++ L G C        YL  EY  +G+L
Sbjct: 56  AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC--EHRGYLYLAIEYAPHGNL 113
Query: 415 HSWLHENK--------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             +L +++                 L+ +  L  A DVA G+ Y+   ++ + +H+D+ +
Sbjct: 114 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAA 170
Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFS 515
            NIL+  N  AKIA+FGL++       +++  T G     ++A E L   V +T  DV+S
Sbjct: 171 RNILVGENYVAKIADFGLSRGQ----EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWS 226
Query: 516 FGVVLLELIS 525
           +GV+L E++S
Sbjct: 227 YGVLLWEIVS 236

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 97/190 (51%), Gaps = 37/190 (19%)
Query: 364 AIKMMKWNACE--------ELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           AIK MK  A +        EL++L K+ +H N++ L G C        YL  EY  +G+L
Sbjct: 46  AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC--EHRGYLYLAIEYAPHGNL 103
Query: 415 HSWLHENK--------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             +L +++                 L+ +  L  A DVA G+ Y+   ++ + +H+D+ +
Sbjct: 104 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAA 160
Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFS 515
            NIL+  N  AKIA+FGL++       +++  T G     ++A E L   V +T  DV+S
Sbjct: 161 RNILVGENYVAKIADFGLSRGQ----EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWS 216
Query: 516 FGVVLLELIS 525
           +GV+L E++S
Sbjct: 217 YGVLLWEIVS 226

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 82/154 (53%), Gaps = 11/154 (7%)
Query: 378 ILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAID 437
           I++  +H N++ L G C+  E  +  ++  Y+++G L +++  N+  N   K  +   + 
Sbjct: 102 IMKDFSHPNVLSLLGICLRSE-GSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQ 159
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-- 495
           VA G++Y+      + VH+D+ + N +LD     K+A+FGLA+   +     +    G  
Sbjct: 160 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 216
Query: 496 ----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
               ++A E L     +TK DV+SFGV+L EL++
Sbjct: 217 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 250

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 79/153 (51%), Gaps = 12/153 (7%)
Query: 382 VNHGNLVKL--EGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVA 439
           +NH  +V +   G    P     Y++ EY++  +L   +H      +  K  + +  D  
Sbjct: 69  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADAC 126
Query: 440 NGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS---GCNAI--TMHIVGTQ 494
             L + H++    ++H+D+K +NIL+ +    K+ +FG+A++     N++  T  ++GT 
Sbjct: 127 QALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTA 183
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
            Y++PE      V  + DV+S G VL E+++G+
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 95/178 (53%), Gaps = 19/178 (10%)
Query: 360 GEVYAIKMMKWNACE-------ELKILQKVNHGNLVKL-EGFCIDPEDANCYLIYEYIEN 411
           G   A+KMM     +       E+ I++   H N+V++ + + +  E    +++ E+++ 
Sbjct: 70  GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEE---LWVLMEFLQG 126
Query: 412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRA 471
           G+L   + + +   LN +    +   V   L Y+H      V+H+DIKS +ILL  + R 
Sbjct: 127 GALTDIVSQVR---LNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRV 180
Query: 472 KIANFGLAKSGCNAITMH--IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
           K+++FG        +     +VGT  ++APE ++  + +T++D++S G++++E++ G+
Sbjct: 181 KLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 88/158 (55%), Gaps = 12/158 (7%)
Query: 371 NACEELKILQKVNHGNLVKL-EGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWK 429
            A  E+K+LQ+++H N++ L + F      +N  L+++++E   L   + +N        
Sbjct: 58  TALREIKLLQELSHPNIIGLLDAFG---HKSNISLVFDFMET-DLEVIIKDNSLVLTPSH 113
Query: 430 TRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS--GCNAIT 487
            +  + + +  GL+Y+H+H    ++H+D+K +N+LLD N   K+A+FGLAKS    N   
Sbjct: 114 IKAYMLMTL-QGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY 169
Query: 488 MHIVGTQGYIAPEYLADG-VVSTKMDVFSFGVVLLELI 524
            H V T+ Y APE L    +    +D+++ G +L EL+
Sbjct: 170 XHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 95/185 (51%), Gaps = 16/185 (8%)
Query: 351 GSVYKGNIHGEV-YAIKMMKWNA------CEELKILQKVNHGNLVKLEGFCIDPEDANCY 403
           G V  G   G+   AIKM+K  +       EE K++  ++H  LV+L G C   +    +
Sbjct: 18  GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT--KQRPIF 75
Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI 463
           +I EY+ NG L ++L E ++     +  L +  DV   ++Y+      + +H+D+ + N 
Sbjct: 76  IITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNC 131
Query: 464 LLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFSFGVVL 520
           L++     K+++FGL++   +      VG++    +  PE L     S+K D+++FGV++
Sbjct: 132 LVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLM 191
Query: 521 LELIS 525
            E+ S
Sbjct: 192 WEIYS 196

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 95/185 (51%), Gaps = 16/185 (8%)
Query: 351 GSVYKGNIHGEV-YAIKMMKWNA------CEELKILQKVNHGNLVKLEGFCIDPEDANCY 403
           G V  G   G+   AIKM+K  +       EE K++  ++H  LV+L G C   +    +
Sbjct: 38  GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT--KQRPIF 95
Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI 463
           +I EY+ NG L ++L E ++     +  L +  DV   ++Y+      + +H+D+ + N 
Sbjct: 96  IITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNC 151
Query: 464 LLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFSFGVVL 520
           L++     K+++FGL++   +      VG++    +  PE L     S+K D+++FGV++
Sbjct: 152 LVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLM 211
Query: 521 LELIS 525
            E+ S
Sbjct: 212 WEIYS 216

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 89/185 (48%), Gaps = 27/185 (14%)
Query: 364 AIKMMKWNACE--------ELKILQKVNHG-NLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K  A          ELKIL  + H  N+V L G C  P      +I E+ + G+L
Sbjct: 61  AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-GGPLMVIVEFCKFGNL 119
Query: 415 HSWLHENKNENLNWKTRLR----------IAIDVANGLQYIHEHTRPRVVHKDIKSSNIL 464
            ++L   +NE + +K   +           +  VA G++++      + +H+D+ + NIL
Sbjct: 120 STYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFLASR---KXIHRDLAARNIL 176
Query: 465 LDSNMRAKIANFGLAKSGCNAITMHIVGTQ----GYIAPEYLADGVVSTKMDVFSFGVVL 520
           L      KI +FGLA+           G       ++APE + D V + + DV+SFGV+L
Sbjct: 177 LSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 236
Query: 521 LELIS 525
            E+ S
Sbjct: 237 WEIFS 241

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 87/185 (47%), Gaps = 18/185 (9%)
Query: 361 EVYAIKMMKWNAC----------EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE 410
           E+YAIK++K +             E ++L  ++    +     C    D   Y + EY+ 
Sbjct: 45  ELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLHSCFQTVD-RLYFVMEYVN 103
Query: 411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR 470
            G L    H  +         +  A +++ GL ++H+     ++++D+K  N++LDS   
Sbjct: 104 GGDL--MYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRG---IIYRDLKLDNVMLDSEGH 158
Query: 471 AKIANFGLAKSGC--NAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKE 528
            KIA+FG+ K        T    GT  YIAPE +A       +D +++GV+L E+++G+ 
Sbjct: 159 IKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQP 218
Query: 529 AIDEE 533
             D E
Sbjct: 219 PFDGE 223

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 100/196 (51%), Gaps = 29/196 (14%)
Query: 351 GSVYKGNIHG-----EV-YAIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCID 396
           G VYKG +       EV  AIK +K    E        E  I+ + +H N+++LEG  + 
Sbjct: 58  GEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEG--VI 115
Query: 397 PEDANCYLIYEYIENGSLHSWLHENKNE--NLNWKTRLRIAIDVANGLQYIHEHTRPRVV 454
            +     +I EY+ENG+L  +L E   E   L     LR    +A G++Y+        V
Sbjct: 116 SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR---GIAAGMKYLANMN---YV 169
Query: 455 HKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI-----APEYLADGVVST 509
           H+D+ + NIL++SN+  K+++FGL++   +        + G I     APE ++    ++
Sbjct: 170 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTS 229
Query: 510 KMDVFSFGVVLLELIS 525
             DV+SFG+V+ E+++
Sbjct: 230 ASDVWSFGIVMWEVMT 245

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 99/191 (51%), Gaps = 24/191 (12%)
Query: 351 GSVYKG-NIHGEVYAIKMMKW---------NACEELKILQKVNHGNLVKLEGFCIDPEDA 400
           G VYK  N +GE +A+K ++              E+ IL+++ H N+VKL  + +     
Sbjct: 16  GVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL--YDVIHTKK 73
Query: 401 NCYLIYEYIENGSLHSWLH--ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
              L++E+++   L   L   E   E++  K+ L   + + NG+ Y H+    RV+H+D+
Sbjct: 74  RLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFL---LQLLNGIAYCHDR---RVLHRDL 126
Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAIT--MHIVGTQGYIAPEYL-ADGVVSTKMDVFS 515
           K  N+L++     KIA+FGLA++    +    H V T  Y AP+ L      ST +D++S
Sbjct: 127 KPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWS 186
Query: 516 FGVVLLELISG 526
            G +  E+++G
Sbjct: 187 VGCIFAEMVNG 197

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 99/191 (51%), Gaps = 24/191 (12%)
Query: 351 GSVYKG-NIHGEVYAIKMMKW---------NACEELKILQKVNHGNLVKLEGFCIDPEDA 400
           G VYK  N +GE +A+K ++              E+ IL+++ H N+VKL  + +     
Sbjct: 16  GVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL--YDVIHTKK 73
Query: 401 NCYLIYEYIENGSLHSWLH--ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
              L++E+++   L   L   E   E++  K+ L   + + NG+ Y H+    RV+H+D+
Sbjct: 74  RLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFL---LQLLNGIAYCHDR---RVLHRDL 126
Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAIT--MHIVGTQGYIAPEYL-ADGVVSTKMDVFS 515
           K  N+L++     KIA+FGLA++    +    H V T  Y AP+ L      ST +D++S
Sbjct: 127 KPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWS 186
Query: 516 FGVVLLELISG 526
            G +  E+++G
Sbjct: 187 VGCIFAEMVNG 197

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 84/169 (49%), Gaps = 17/169 (10%)
Query: 369 KWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNW 428
           K     E+ I + +++ ++V   GF  D  D   Y++ E     SL   LH+ +      
Sbjct: 86  KEKMSTEIAIHKSLDNPHVVGFHGFFED--DDFVYVVLEICRRRSLLE-LHKRRKAVTEP 142
Query: 429 KTR--LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SG 482
           + R  +R  I    G+QY+H +   RV+H+D+K  N+ L+ +M  KI +FGLA      G
Sbjct: 143 EARYFMRQTI---QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDG 196
Query: 483 CNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
               T+   GT  YIAPE L     S ++D++S G +L  L+ GK   +
Sbjct: 197 ERKKTL--CGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 95/185 (51%), Gaps = 16/185 (8%)
Query: 351 GSVYKGNIHGEV-YAIKMMKWNA------CEELKILQKVNHGNLVKLEGFCIDPEDANCY 403
           G V  G   G+   AIKM+K  +       EE K++  ++H  LV+L G C   +    +
Sbjct: 22  GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT--KQRPIF 79
Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI 463
           +I EY+ NG L ++L E ++     +  L +  DV   ++Y+      + +H+D+ + N 
Sbjct: 80  IITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNC 135
Query: 464 LLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFSFGVVL 520
           L++     K+++FGL++   +      VG++    +  PE L     S+K D+++FGV++
Sbjct: 136 LVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLM 195
Query: 521 LELIS 525
            E+ S
Sbjct: 196 WEIYS 200

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 80/156 (51%), Gaps = 11/156 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  ++ +++H   VKL  FC   +D   Y    Y +NG L  ++ +  + +    TR   
Sbjct: 87  ERDVMSRLDHPFFVKLY-FCFQ-DDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYT 143
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAITMHI 490
           A ++ + L+Y+H      ++H+D+K  NILL+ +M  +I +FG AK        A     
Sbjct: 144 A-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 199
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           VGT  Y++PE L +       D+++ G ++ +L++G
Sbjct: 200 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 95/199 (47%), Gaps = 18/199 (9%)
Query: 345 EGCLIQGSVYKGNIHGEVYAIKMM---------KWNACEELKILQKVNHGNLVKL-EGFC 394
           EG   +  + K    G  Y IK +         +  +  E+ +L  + H N+V+  E F 
Sbjct: 34  EGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESF- 92
Query: 395 IDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVV 454
              E+ + Y++ +Y E G L   ++  K         L   + +   L+++H+    +++
Sbjct: 93  --EENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KIL 147
Query: 455 HKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM--HIVGTQGYIAPEYLADGVVSTKMD 512
           H+DIKS NI L  +   ++ +FG+A+   + + +    +GT  Y++PE   +   + K D
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSD 207
Query: 513 VFSFGVVLLELISGKEAID 531
           +++ G VL EL + K A +
Sbjct: 208 IWALGCVLYELCTLKHAFE 226

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 95/185 (51%), Gaps = 16/185 (8%)
Query: 351 GSVYKGNIHGEV-YAIKMMKWNA------CEELKILQKVNHGNLVKLEGFCIDPEDANCY 403
           G V  G   G+   AIKM+K  +       EE K++  ++H  LV+L G C   +    +
Sbjct: 38  GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT--KQRPIF 95
Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI 463
           +I EY+ NG L ++L E ++     +  L +  DV   ++Y+      + +H+D+ + N 
Sbjct: 96  IITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNC 151
Query: 464 LLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFSFGVVL 520
           L++     K+++FGL++   +      VG++    +  PE L     S+K D+++FGV++
Sbjct: 152 LVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLM 211
Query: 521 LELIS 525
            E+ S
Sbjct: 212 WEIYS 216

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 79/153 (51%), Gaps = 12/153 (7%)
Query: 382 VNHGNLVKL--EGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVA 439
           +NH  +V +   G    P     Y++ EY++  +L   +H      +  K  + +  D  
Sbjct: 69  LNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADAC 126
Query: 440 NGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS---GCNAITM--HIVGTQ 494
             L + H++    ++H+D+K +NI++ +    K+ +FG+A++     N++T    ++GT 
Sbjct: 127 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
            Y++PE      V  + DV+S G VL E+++G+
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 79/153 (51%), Gaps = 12/153 (7%)
Query: 382 VNHGNLVKL--EGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVA 439
           +NH  +V +   G    P     Y++ EY++  +L   +H      +  K  + +  D  
Sbjct: 69  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADAC 126
Query: 440 NGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS---GCNAITM--HIVGTQ 494
             L + H++    ++H+D+K +NI++ +    K+ +FG+A++     N++T    ++GT 
Sbjct: 127 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
            Y++PE      V  + DV+S G VL E+++G+
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 95/185 (51%), Gaps = 16/185 (8%)
Query: 351 GSVYKGNIHGEV-YAIKMMKWNA------CEELKILQKVNHGNLVKLEGFCIDPEDANCY 403
           G V  G   G+   AIKM+K  +       EE K++  ++H  LV+L G C   +    +
Sbjct: 23  GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT--KQRPIF 80
Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI 463
           +I EY+ NG L ++L E ++     +  L +  DV   ++Y+      + +H+D+ + N 
Sbjct: 81  IITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNC 136
Query: 464 LLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFSFGVVL 520
           L++     K+++FGL++   +      VG++    +  PE L     S+K D+++FGV++
Sbjct: 137 LVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLM 196
Query: 521 LELIS 525
            E+ S
Sbjct: 197 WEIYS 201

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 95/185 (51%), Gaps = 16/185 (8%)
Query: 351 GSVYKGNIHGEV-YAIKMMKWNA------CEELKILQKVNHGNLVKLEGFCIDPEDANCY 403
           G V  G   G+   AIKM+K  +       EE K++  ++H  LV+L G C   +    +
Sbjct: 29  GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT--KQRPIF 86
Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI 463
           +I EY+ NG L ++L E ++     +  L +  DV   ++Y+      + +H+D+ + N 
Sbjct: 87  IITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNC 142
Query: 464 LLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFSFGVVL 520
           L++     K+++FGL++   +      VG++    +  PE L     S+K D+++FGV++
Sbjct: 143 LVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLM 202
Query: 521 LELIS 525
            E+ S
Sbjct: 203 WEIYS 207

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 79/153 (51%), Gaps = 12/153 (7%)
Query: 382 VNHGNLVKL--EGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVA 439
           +NH  +V +   G    P     Y++ EY++  +L   +H      +  K  + +  D  
Sbjct: 69  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADAC 126
Query: 440 NGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS---GCNAITM--HIVGTQ 494
             L + H++    ++H+D+K +NI++ +    K+ +FG+A++     N++T    ++GT 
Sbjct: 127 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
            Y++PE      V  + DV+S G VL E+++G+
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 79/153 (51%), Gaps = 12/153 (7%)
Query: 382 VNHGNLVKL--EGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVA 439
           +NH  +V +   G    P     Y++ EY++  +L   +H      +  K  + +  D  
Sbjct: 69  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADAC 126
Query: 440 NGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS---GCNAITM--HIVGTQ 494
             L + H++    ++H+D+K +NI++ +    K+ +FG+A++     N++T    ++GT 
Sbjct: 127 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
            Y++PE      V  + DV+S G VL E+++G+
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 79/156 (50%), Gaps = 11/156 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+ +L K+ H N+V L+   I     + YLI + +  G L   + E        +   R+
Sbjct: 66  EIAVLHKIKHPNIVALDD--IYESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRL 121
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNIL---LDSNMRAKIANFGLAK-SGCNAITMHI 490
              V + ++Y+H+     +VH+D+K  N+L   LD + +  I++FGL+K     ++    
Sbjct: 122 IFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA 178
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT GY+APE LA    S  +D +S GV+   L+ G
Sbjct: 179 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 99/191 (51%), Gaps = 24/191 (12%)
Query: 351 GSVYKG-NIHGEVYAIKMMKW---------NACEELKILQKVNHGNLVKLEGFCIDPEDA 400
           G VYK  N +GE +A+K ++              E+ IL+++ H N+VKL  + +     
Sbjct: 16  GVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL--YDVIHTKK 73
Query: 401 NCYLIYEYIENGSLHSWLH--ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
              L++E+++   L   L   E   E++  K+ L   + + NG+ Y H+    RV+H+D+
Sbjct: 74  RLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFL---LQLLNGIAYCHDR---RVLHRDL 126
Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAIT--MHIVGTQGYIAPEYL-ADGVVSTKMDVFS 515
           K  N+L++     KIA+FGLA++    +    H + T  Y AP+ L      ST +D++S
Sbjct: 127 KPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWS 186
Query: 516 FGVVLLELISG 526
            G +  E+++G
Sbjct: 187 VGCIFAEMVNG 197

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 79/156 (50%), Gaps = 11/156 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+ +L K+ H N+V L+   I     + YLI + +  G L   + E        +   R+
Sbjct: 66  EIAVLHKIKHPNIVALDD--IYESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRL 121
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNIL---LDSNMRAKIANFGLAK-SGCNAITMHI 490
              V + ++Y+H+     +VH+D+K  N+L   LD + +  I++FGL+K     ++    
Sbjct: 122 IFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA 178
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT GY+APE LA    S  +D +S GV+   L+ G
Sbjct: 179 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 79/156 (50%), Gaps = 11/156 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+ +L K+ H N+V L+   I     + YLI + +  G L   + E        +   R+
Sbjct: 66  EIAVLHKIKHPNIVALDD--IYESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRL 121
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNIL---LDSNMRAKIANFGLAK-SGCNAITMHI 490
              V + ++Y+H+     +VH+D+K  N+L   LD + +  I++FGL+K     ++    
Sbjct: 122 IFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA 178
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT GY+APE LA    S  +D +S GV+   L+ G
Sbjct: 179 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 79/156 (50%), Gaps = 11/156 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+ +L K+ H N+V L+   I     + YLI + +  G L   + E        +   R+
Sbjct: 66  EIAVLHKIKHPNIVALDD--IYESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRL 121
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNIL---LDSNMRAKIANFGLAK-SGCNAITMHI 490
              V + ++Y+H+     +VH+D+K  N+L   LD + +  I++FGL+K     ++    
Sbjct: 122 IFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA 178
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT GY+APE LA    S  +D +S GV+   L+ G
Sbjct: 179 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 39/213 (18%)
Query: 364 AIKMMKWNACE--------ELKILQKVNHG-NLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K  A          ELKIL  + H  N+V L G C  P      +I E+ + G+L
Sbjct: 61  AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-GGPLMVIVEFCKFGNL 119
Query: 415 HSWLHENKNENLNWKTR--------------LRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
            ++L   +NE + +K                +  +  VA G++++      + +H+D+ +
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 176
Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ----GYIAPEYLADGVVSTKMDVFSF 516
            NILL      KI +FGLA+           G       ++APE + D V + + DV+SF
Sbjct: 177 RNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 236
Query: 517 GVVLLELISGKEA------IDEEGKFCGQKLKG 543
           GV+L E+ S   +      IDEE  FC +  +G
Sbjct: 237 GVLLWEIFSLGASPYPGVKIDEE--FCRRLKEG 267

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 39/213 (18%)
Query: 364 AIKMMKWNACE--------ELKILQKVNHG-NLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K  A          ELKIL  + H  N+V L G C  P      +I E+ + G+L
Sbjct: 52  AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-GGPLMVIVEFCKFGNL 110
Query: 415 HSWLHENKNENLNWKTR--------------LRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
            ++L   +NE + +K                +  +  VA G++++      + +H+D+ +
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 167
Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ----GYIAPEYLADGVVSTKMDVFSF 516
            NILL      KI +FGLA+           G       ++APE + D V + + DV+SF
Sbjct: 168 RNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 227
Query: 517 GVVLLELISGKEA------IDEEGKFCGQKLKG 543
           GV+L E+ S   +      IDEE  FC +  +G
Sbjct: 228 GVLLWEIFSLGASPYPGVKIDEE--FCRRLKEG 258

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 39/213 (18%)
Query: 364 AIKMMKWNACE--------ELKILQKVNHG-NLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K  A          ELKIL  + H  N+V L G C  P      +I E+ + G+L
Sbjct: 52  AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-GGPLMVITEFCKFGNL 110
Query: 415 HSWLHENKNENLNWKTR--------------LRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
            ++L   +NE + +K                +  +  VA G++++      + +H+D+ +
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 167
Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ----GYIAPEYLADGVVSTKMDVFSF 516
            NILL      KI +FGLA+           G       ++APE + D V + + DV+SF
Sbjct: 168 RNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 227
Query: 517 GVVLLELISGKEA------IDEEGKFCGQKLKG 543
           GV+L E+ S   +      IDEE  FC +  +G
Sbjct: 228 GVLLWEIFSLGASPYPGVKIDEE--FCRRLKEG 258

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 82/154 (53%), Gaps = 11/154 (7%)
Query: 378 ILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAID 437
           I++  +H N++ L G C+  E  +  ++  Y+++G L +++  N+  N   K  +   + 
Sbjct: 85  IMKDFSHPNVLSLLGICLRSE-GSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQ 142
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-- 495
           VA G++++      + VH+D+ + N +LD     K+A+FGLA+   +     +    G  
Sbjct: 143 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAK 199
Query: 496 ----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
               ++A E L     +TK DV+SFGV+L EL++
Sbjct: 200 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 39/213 (18%)
Query: 364 AIKMMKWNACE--------ELKILQKVNHG-NLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K  A          ELKIL  + H  N+V L G C  P      +I E+ + G+L
Sbjct: 61  AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-GGPLMVIVEFCKFGNL 119
Query: 415 HSWLHENKNENLNWKTR--------------LRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
            ++L   +NE + +K                +  +  VA G++++      + +H+D+ +
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 176
Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ----GYIAPEYLADGVVSTKMDVFSF 516
            NILL      KI +FGLA+           G       ++APE + D V + + DV+SF
Sbjct: 177 RNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 236
Query: 517 GVVLLELISGKEA------IDEEGKFCGQKLKG 543
           GV+L E+ S   +      IDEE  FC +  +G
Sbjct: 237 GVLLWEIFSLGASPYPGVKIDEE--FCRRLKEG 267

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 86/156 (55%), Gaps = 11/156 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  I+ + +H N++ LEG     +     +I EY+ENGSL ++L +N +        + +
Sbjct: 80  EASIMGQFDHPNIIHLEGVVTKCKPV--MIITEYMENGSLDAFLRKN-DGRFTVIQLVGM 136
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
              + +G++Y+ + +    VH+D+ + NIL++SN+  K+++FG+++   +          
Sbjct: 137 LRGIGSGMKYLSDMS---AVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRG 193
Query: 495 GYI-----APEYLADGVVSTKMDVFSFGVVLLELIS 525
           G I     APE +A    ++  DV+S+G+V+ E++S
Sbjct: 194 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 229

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 108/221 (48%), Gaps = 36/221 (16%)
Query: 327 KYRIFKIEELREATDNFSEGCLIQGSVYKG--NIHGEVY----AIKMM------KWNA-- 372
           + RI K  EL+        G    G+VYKG     GE      AIK++      K N   
Sbjct: 31  QLRILKETELKR-VKVLGSGAF--GTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEF 87
Query: 373 CEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRL 432
            +E  I+  ++H +LV+L G C+ P      L+ + + +G L  ++HE+K+ N+  +  L
Sbjct: 88  MDEALIMASMDHPHLVRLLGVCLSP---TIQLVTQLMPHGCLLEYVHEHKD-NIGSQLLL 143
Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK--------SGCN 484
              + +A G+ Y+ E    R+VH+D+ + N+L+ S    KI +FGLA+           +
Sbjct: 144 NWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD 200
Query: 485 AITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
              M I     ++A E +     + + DV+S+GV + EL++
Sbjct: 201 GGKMPI----KWMALECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 39/213 (18%)
Query: 364 AIKMMKWNACE--------ELKILQKVNHG-NLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K  A          ELKIL  + H  N+V L G C  P      +I E+ + G+L
Sbjct: 98  AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-GGPLMVIVEFCKFGNL 156
Query: 415 HSWLHENKNENLNWKTR--------------LRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
            ++L   +NE + +K                +  +  VA G++++      + +H+D+ +
Sbjct: 157 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 213
Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ----GYIAPEYLADGVVSTKMDVFSF 516
            NILL      KI +FGLA+           G       ++APE + D V + + DV+SF
Sbjct: 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 273
Query: 517 GVVLLELISGKEA------IDEEGKFCGQKLKG 543
           GV+L E+ S   +      IDEE  FC +  +G
Sbjct: 274 GVLLWEIFSLGASPYPGVKIDEE--FCRRLKEG 304

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 79/153 (51%), Gaps = 12/153 (7%)
Query: 382 VNHGNLVKL--EGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVA 439
           +NH  +V +   G    P     Y++ EY++  +L   +H      +  K  + +  D  
Sbjct: 86  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADAC 143
Query: 440 NGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS---GCNAITM--HIVGTQ 494
             L + H++    ++H+D+K +NI++ +    K+ +FG+A++     N++T    ++GT 
Sbjct: 144 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 200
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
            Y++PE      V  + DV+S G VL E+++G+
Sbjct: 201 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 233

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 39/213 (18%)
Query: 364 AIKMMKWNACE--------ELKILQKVNHG-NLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K  A          ELKIL  + H  N+V L G C  P      +I E+ + G+L
Sbjct: 61  AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-GGPLMVIVEFCKFGNL 119
Query: 415 HSWLHENKNENLNWKTR--------------LRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
            ++L   +NE + +K                +  +  VA G++++      + +H+D+ +
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 176
Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ----GYIAPEYLADGVVSTKMDVFSF 516
            NILL      KI +FGLA+           G       ++APE + D V + + DV+SF
Sbjct: 177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 236
Query: 517 GVVLLELISGKEA------IDEEGKFCGQKLKG 543
           GV+L E+ S   +      IDEE  FC +  +G
Sbjct: 237 GVLLWEIFSLGASPYPGVKIDEE--FCRRLKEG 267

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 28/206 (13%)
Query: 351 GSVYKG-NIH-GEVYAIKMMKWNACEE------------LKILQKVNHGNLVKLEGFCID 396
           G+VYK  + H G   A+K ++    EE            L+ L+   H N+V+L   C  
Sbjct: 18  GTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 77
Query: 397 PE---DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRV 453
                +    L++E+++   L ++L +     L  +T   +      GL ++H +    +
Sbjct: 78  SRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---I 133
Query: 454 VHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH-IVGTQGYIAPEYLADGVVSTKMD 512
           VH+D+K  NIL+ S    K+A+FGLA+     + +  +V T  Y APE L     +T +D
Sbjct: 134 VHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEVLLQSTYATPVD 193
Query: 513 VFSFGVVLLELISGKEAIDEEGKFCG 538
           ++S G +  E+   K        FCG
Sbjct: 194 MWSVGCIFAEMFRRKPL------FCG 213

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 28/206 (13%)
Query: 351 GSVYKG-NIH-GEVYAIKMMKWNACEE------------LKILQKVNHGNLVKLEGFCID 396
           G+VYK  + H G   A+K ++    EE            L+ L+   H N+V+L   C  
Sbjct: 18  GTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 77
Query: 397 PE---DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRV 453
                +    L++E+++   L ++L +     L  +T   +      GL ++H +    +
Sbjct: 78  SRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---I 133
Query: 454 VHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH-IVGTQGYIAPEYLADGVVSTKMD 512
           VH+D+K  NIL+ S    K+A+FGLA+     + +  +V T  Y APE L     +T +D
Sbjct: 134 VHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEVLLQSTYATPVD 193
Query: 513 VFSFGVVLLELISGKEAIDEEGKFCG 538
           ++S G +  E+   K        FCG
Sbjct: 194 MWSVGCIFAEMFRRKPL------FCG 213

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 86/158 (54%), Gaps = 15/158 (9%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNE--NLNWKTRL 432
           E  I+ + +H N++ LEG     +     ++ EY+ENGSL ++L +N  +   +     L
Sbjct: 73  EASIMGQFDHPNIIHLEGVVT--KSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGML 130
Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVG 492
           R    ++ G++Y+ +      VH+D+ + NIL++SN+  K+++FGL++   +        
Sbjct: 131 R---GISAGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 184
Query: 493 TQGYI-----APEYLADGVVSTKMDVFSFGVVLLELIS 525
             G I     APE +A    ++  DV+S+G+V+ E++S
Sbjct: 185 RGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVS 222

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 87/158 (55%), Gaps = 15/158 (9%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL--HENKNENLNWKTRL 432
           E  I+ + +H N+++LEG     +     ++ E +ENGSL S+L  H+ +   +     L
Sbjct: 96  EASIMGQFDHPNIIRLEGVVT--KSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGML 153
Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVG 492
           R    +A+G++Y+ +      VH+D+ + NIL++SN+  K+++FGL++   +        
Sbjct: 154 R---GIASGMKYLSDMG---AVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
Query: 493 TQGYI-----APEYLADGVVSTKMDVFSFGVVLLELIS 525
             G I     +PE +A    ++  DV+S+G+VL E++S
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 39/213 (18%)
Query: 364 AIKMMKWNACE--------ELKILQKVNHG-NLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K  A          ELKIL  + H  N+V L G C  P      +I E+ + G+L
Sbjct: 52  AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-GGPLMVITEFCKFGNL 110
Query: 415 HSWLHENKNENLNWKTR--------------LRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
            ++L   +NE + +K                +  +  VA G++++      + +H+D+ +
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 167
Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ----GYIAPEYLADGVVSTKMDVFSF 516
            NILL      KI +FGLA+           G       ++APE + D V + + DV+SF
Sbjct: 168 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 227
Query: 517 GVVLLELISGKEA------IDEEGKFCGQKLKG 543
           GV+L E+ S   +      IDEE  FC +  +G
Sbjct: 228 GVLLWEIFSLGASPYPGVKIDEE--FCRRLKEG 258

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 80/156 (51%), Gaps = 11/156 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  ++ +++H   VKL  +    +D   Y    Y +NG L  ++ +  + +    TR   
Sbjct: 82  ERDVMSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETC-TRFYT 138
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAITMHI 490
           A ++ + L+Y+H      ++H+D+K  NILL+ +M  +I +FG AK        A     
Sbjct: 139 A-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 194
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           VGT  Y++PE L +   S   D+++ G ++ +L++G
Sbjct: 195 VGTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 28/206 (13%)
Query: 351 GSVYKG-NIH-GEVYAIKMMKWNACEE------------LKILQKVNHGNLVKLEGFCID 396
           G+VYK  + H G   A+K ++    EE            L+ L+   H N+V+L   C  
Sbjct: 18  GTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 77
Query: 397 PE---DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRV 453
                +    L++E+++   L ++L +     L  +T   +      GL ++H +    +
Sbjct: 78  SRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---I 133
Query: 454 VHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM-HIVGTQGYIAPEYLADGVVSTKMD 512
           VH+D+K  NIL+ S    K+A+FGLA+     + +  +V T  Y APE L     +T +D
Sbjct: 134 VHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEVLLQSTYATPVD 193
Query: 513 VFSFGVVLLELISGKEAIDEEGKFCG 538
           ++S G +  E+   K        FCG
Sbjct: 194 MWSVGCIFAEMFRRKPL------FCG 213

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 108/221 (48%), Gaps = 36/221 (16%)
Query: 327 KYRIFKIEELREATDNFSEGCLIQGSVYKG--NIHGEVY----AIKMM------KWNA-- 372
           + RI K  EL+        G    G+VYKG     GE      AIK++      K N   
Sbjct: 8   QLRILKETELKRVK-VLGSGAF--GTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEF 64
Query: 373 CEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRL 432
            +E  I+  ++H +LV+L G C+ P      L+ + + +G L  ++HE+K+ N+  +  L
Sbjct: 65  MDEALIMASMDHPHLVRLLGVCLSP---TIQLVTQLMPHGCLLEYVHEHKD-NIGSQLLL 120
Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK--------SGCN 484
              + +A G+ Y+ E    R+VH+D+ + N+L+ S    KI +FGLA+           +
Sbjct: 121 NWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD 177
Query: 485 AITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
              M I     ++A E +     + + DV+S+GV + EL++
Sbjct: 178 GGKMPI----KWMALECIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 39/213 (18%)
Query: 364 AIKMMKWNACE--------ELKILQKVNHG-NLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K  A          ELKIL  + H  N+V L G C  P      +I E+ + G+L
Sbjct: 52  AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-GGPLMVITEFCKFGNL 110
Query: 415 HSWLHENKNENLNWKTR--------------LRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
            ++L   +NE + +K                +  +  VA G++++      + +H+D+ +
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 167
Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ----GYIAPEYLADGVVSTKMDVFSF 516
            NILL      KI +FGLA+           G       ++APE + D V + + DV+SF
Sbjct: 168 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 227
Query: 517 GVVLLELISGKEA------IDEEGKFCGQKLKG 543
           GV+L E+ S   +      IDEE  FC +  +G
Sbjct: 228 GVLLWEIFSLGASPYPGVKIDEE--FCRRLKEG 258

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/165 (32%), Positives = 87/165 (52%), Gaps = 12/165 (7%)
Query: 366 KMMKWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNEN 425
           K  K +   E+++L++++H N++KL  F  D      YL+ E    G L   +   K   
Sbjct: 73  KTDKESLLREVQLLKQLDHPNIMKLYEFFEDK--GYFYLVGEVYTGGELFDEIISRKR-- 128
Query: 426 LNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR---AKIANFGLAKSG 482
            +     RI   V +G+ Y+H++   ++VH+D+K  N+LL+S  +    +I +FGL+   
Sbjct: 129 FSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 185
Query: 483 CNAITMH-IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
             +  M   +GT  YIAPE L  G    K DV+S GV+L  L+SG
Sbjct: 186 EASKKMKDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSG 229

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 82/154 (53%), Gaps = 11/154 (7%)
Query: 378 ILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAID 437
           I++  +H N++ L G C+  E  +  ++  Y+++G L +++  N+  N   K  +   + 
Sbjct: 84  IMKDFSHPNVLSLLGICLRSE-GSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQ 141
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-- 495
           VA G++++      + VH+D+ + N +LD     K+A+FGLA+   +     +    G  
Sbjct: 142 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 198
Query: 496 ----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
               ++A E L     +TK DV+SFGV+L EL++
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 82/167 (49%), Gaps = 13/167 (7%)
Query: 369 KWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNW 428
           K     E+ I + +++ ++V   GF  D  D   Y++ E     SL   LH+ +      
Sbjct: 70  KEKMSTEIAIHKSLDNPHVVGFHGFFED--DDFVYVVLEICRRRSLLE-LHKRRKAVTEP 126
Query: 429 KTR--LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK--SGCN 484
           + R  +R  I    G+QY+H +   RV+H+D+K  N+ L+ +M  KI +FGLA       
Sbjct: 127 EARYFMRQTI---QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDG 180
Query: 485 AITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
                + GT  YIAPE L     S ++D++S G +L  L+ GK   +
Sbjct: 181 ERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 227

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 82/154 (53%), Gaps = 11/154 (7%)
Query: 378 ILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAID 437
           I++  +H N++ L G C+  E  +  ++  Y+++G L +++  N+  N   K  +   + 
Sbjct: 82  IMKDFSHPNVLSLLGICLRSE-GSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQ 139
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-- 495
           VA G++++      + VH+D+ + N +LD     K+A+FGLA+   +     +    G  
Sbjct: 140 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 196
Query: 496 ----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
               ++A E L     +TK DV+SFGV+L EL++
Sbjct: 197 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 84/168 (50%), Gaps = 10/168 (5%)
Query: 368 MKWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLN 427
           M      E+  L+ + H +++KL      P D    ++ EY   G L  ++ E K    +
Sbjct: 52  MHMRVEREISYLKLLRHPHIIKLYDVITTPTD--IVMVIEY-AGGELFDYIVEKKRMTED 108
Query: 428 WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT 487
              R    I  A  ++Y H H   ++VH+D+K  N+LLD N+  KIA+FGL+    +   
Sbjct: 109 EGRRFFQQIICA--IEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163
Query: 488 MHI-VGTQGYIAPEYLADGVVS-TKMDVFSFGVVLLELISGKEAIDEE 533
           +    G+  Y APE +   + +  ++DV+S G+VL  ++ G+   D+E
Sbjct: 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 82/167 (49%), Gaps = 13/167 (7%)
Query: 369 KWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNW 428
           K     E+ I + +++ ++V   GF  D  D   Y++ E     SL   LH+ +      
Sbjct: 86  KEKMSTEIAIHKSLDNPHVVGFHGFFED--DDFVYVVLEICRRRSLLE-LHKRRKAVTEP 142
Query: 429 KTR--LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK--SGCN 484
           + R  +R  I    G+QY+H +   RV+H+D+K  N+ L+ +M  KI +FGLA       
Sbjct: 143 EARYFMRQTI---QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDG 196
Query: 485 AITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
                + GT  YIAPE L     S ++D++S G +L  L+ GK   +
Sbjct: 197 ERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/165 (32%), Positives = 87/165 (52%), Gaps = 12/165 (7%)
Query: 366 KMMKWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNEN 425
           K  K +   E+++L++++H N++KL  F  D      YL+ E    G L   +   K   
Sbjct: 67  KTDKESLLREVQLLKQLDHPNIMKLYEFFEDK--GYFYLVGEVYTGGELFDEIISRKR-- 122
Query: 426 LNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR---AKIANFGLAKSG 482
            +     RI   V +G+ Y+H++   ++VH+D+K  N+LL+S  +    +I +FGL+   
Sbjct: 123 FSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179
Query: 483 CNAITMH-IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
             +  M   +GT  YIAPE L  G    K DV+S GV+L  L+SG
Sbjct: 180 EASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 82/154 (53%), Gaps = 11/154 (7%)
Query: 378 ILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAID 437
           I++  +H N++ L G C+  E  +  ++  Y+++G L +++  N+  N   K  +   + 
Sbjct: 84  IMKDFSHPNVLSLLGICLRSE-GSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQ 141
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-- 495
           VA G++++      + VH+D+ + N +LD     K+A+FGLA+   +     +    G  
Sbjct: 142 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 198
Query: 496 ----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
               ++A E L     +TK DV+SFGV+L EL++
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 82/167 (49%), Gaps = 13/167 (7%)
Query: 369 KWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNW 428
           K     E+ I + +++ ++V   GF  D  D   Y++ E     SL   LH+ +      
Sbjct: 86  KEKMSTEIAIHKSLDNPHVVGFHGFFED--DDFVYVVLEICRRRSLLE-LHKRRKAVTEP 142
Query: 429 KTR--LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK--SGCN 484
           + R  +R  I    G+QY+H +   RV+H+D+K  N+ L+ +M  KI +FGLA       
Sbjct: 143 EARYFMRQTI---QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDG 196
Query: 485 AITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
                + GT  YIAPE L     S ++D++S G +L  L+ GK   +
Sbjct: 197 ERKKXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 97/190 (51%), Gaps = 37/190 (19%)
Query: 364 AIKMMKWNACE--------ELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           AIK MK  A +        EL++L K+ +H N++ L G C        YL  EY  +G+L
Sbjct: 53  AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC--EHRGYLYLAIEYAPHGNL 110
Query: 415 HSWLHENK--------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             +L +++                 L+ +  L  A DVA G+ Y+   ++ + +H+++ +
Sbjct: 111 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRNLAA 167
Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFS 515
            NIL+  N  AKIA+FGL++       +++  T G     ++A E L   V +T  DV+S
Sbjct: 168 RNILVGENYVAKIADFGLSRGQ----EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWS 223
Query: 516 FGVVLLELIS 525
           +GV+L E++S
Sbjct: 224 YGVLLWEIVS 233

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 82/154 (53%), Gaps = 11/154 (7%)
Query: 378 ILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAID 437
           I++  +H N++ L G C+  E  +  ++  Y+++G L +++  N+  N   K  +   + 
Sbjct: 85  IMKDFSHPNVLSLLGICLRSE-GSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQ 142
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-- 495
           VA G++++      + VH+D+ + N +LD     K+A+FGLA+   +     +    G  
Sbjct: 143 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 199
Query: 496 ----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
               ++A E L     +TK DV+SFGV+L EL++
Sbjct: 200 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 82/154 (53%), Gaps = 11/154 (7%)
Query: 378 ILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAID 437
           I++  +H N++ L G C+  E  +  ++  Y+++G L +++  N+  N   K  +   + 
Sbjct: 143 IMKDFSHPNVLSLLGICLRSE-GSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQ 200
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-- 495
           VA G++++      + VH+D+ + N +LD     K+A+FGLA+   +     +    G  
Sbjct: 201 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 257
Query: 496 ----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
               ++A E L     +TK DV+SFGV+L EL++
Sbjct: 258 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 82/154 (53%), Gaps = 11/154 (7%)
Query: 378 ILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAID 437
           I++  +H N++ L G C+  E  +  ++  Y+++G L +++  N+  N   K  +   + 
Sbjct: 89  IMKDFSHPNVLSLLGICLRSE-GSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQ 146
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG-- 495
           VA G++++      + VH+D+ + N +LD     K+A+FGLA+   +     +    G  
Sbjct: 147 VAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 203
Query: 496 ----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
               ++A E L     +TK DV+SFGV+L EL++
Sbjct: 204 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 237

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 39/213 (18%)
Query: 364 AIKMMKWNACE--------ELKILQKVNHG-NLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K  A          ELKIL  + H  N+V L G C  P      +I E+ + G+L
Sbjct: 63  AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-GGPLMVIVEFCKFGNL 121
Query: 415 HSWLHENKNENLNWKTR--------------LRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
            ++L   +NE + +K                +  +  VA G++++      + +H+D+ +
Sbjct: 122 STYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 178
Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ----GYIAPEYLADGVVSTKMDVFSF 516
            NILL      KI +FGLA+           G       ++APE + D V + + DV+SF
Sbjct: 179 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 238
Query: 517 GVVLLELISGKEA------IDEEGKFCGQKLKG 543
           GV+L E+ S   +      IDEE  FC +  +G
Sbjct: 239 GVLLWEIFSLGASPYPGVKIDEE--FCRRLKEG 269

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 87/158 (55%), Gaps = 15/158 (9%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL--HENKNENLNWKTRL 432
           E  I+ + +H N+++LEG     +     ++ E +ENGSL S+L  H+ +   +     L
Sbjct: 67  EASIMGQFDHPNIIRLEGVVT--KSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGML 124
Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVG 492
           R    +A+G++Y+ +      VH+D+ + NIL++SN+  K+++FGL++   +        
Sbjct: 125 R---GIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 178
Query: 493 TQGYI-----APEYLADGVVSTKMDVFSFGVVLLELIS 525
             G I     +PE +A    ++  DV+S+G+VL E++S
Sbjct: 179 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 78/156 (50%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY+  G + S  H  +    +   
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVPGGEMFS--HLRRIGRFSEPH 142
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+L+D     K+A+FG AK      T  +
Sbjct: 143 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAKR-VKGRTWXL 198
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 101/230 (43%), Gaps = 47/230 (20%)
Query: 336 LREATDNFSEGCLIQGSV-----YKGNIHGEVYAIKMMKWNA------CEELKILQKVNH 384
           LR A+D      L QG+       +  +    YAIK ++           E+ +L  +NH
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNH 61
Query: 385 GNLVKLEGFCIDPED-----------ANCYLIYEYIENGSLHSWLHENKNENLNWKTR-- 431
             +V+     ++  +           +  ++  EY ENG+L+  +H   +ENLN +    
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH---SENLNQQRDEY 118
Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS---------- 481
            R+   +   L YIH      ++H+D+K  NI +D +   KI +FGLAK+          
Sbjct: 119 WRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 482 ------GCNAITMHIVGTQGYIAPEYL-ADGVVSTKMDVFSFGVVLLELI 524
                 G +      +GT  Y+A E L   G  + K+D++S G++  E+I
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/165 (32%), Positives = 87/165 (52%), Gaps = 12/165 (7%)
Query: 366 KMMKWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNEN 425
           K  K +   E+++L++++H N++KL  F  D      YL+ E    G L   +   K   
Sbjct: 90  KTDKESLLREVQLLKQLDHPNIMKLYEFFEDK--GYFYLVGEVYTGGELFDEIISRKR-- 145
Query: 426 LNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR---AKIANFGLAKSG 482
            +     RI   V +G+ Y+H++   ++VH+D+K  N+LL+S  +    +I +FGL+   
Sbjct: 146 FSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 202
Query: 483 CNAITMH-IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
             +  M   +GT  YIAPE L  G    K DV+S GV+L  L+SG
Sbjct: 203 EASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 246

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 85/156 (54%), Gaps = 13/156 (8%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  ++Q++++  +V++ G C   E  +  L+ E  E G L+ +L +N++  +  K  + +
Sbjct: 78  EANVMQQLDNPYIVRMIGIC---EAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIEL 132
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
              V+ G++Y+ E      VH+D+ + N+LL +   AKI++FGL+K+       +   T 
Sbjct: 133 VHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 189
Query: 495 G-----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           G     + APE +     S+K DV+SFGV++ E  S
Sbjct: 190 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 85/156 (54%), Gaps = 13/156 (8%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  ++Q++++  +V++ G C   E  +  L+ E  E G L+ +L +N++  +  K  + +
Sbjct: 78  EANVMQQLDNPYIVRMIGIC---EAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIEL 132
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
              V+ G++Y+ E      VH+D+ + N+LL +   AKI++FGL+K+       +   T 
Sbjct: 133 VHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 189
Query: 495 G-----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           G     + APE +     S+K DV+SFGV++ E  S
Sbjct: 190 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 87/158 (55%), Gaps = 15/158 (9%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL--HENKNENLNWKTRL 432
           E  I+ + +H N+++LEG     +     ++ E +ENGSL S+L  H+ +   +     L
Sbjct: 96  EASIMGQFDHPNIIRLEGVVT--KSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGML 153
Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVG 492
           R    +A+G++Y+ +      VH+D+ + NIL++SN+  K+++FGL++   +        
Sbjct: 154 R---GIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
Query: 493 TQGYI-----APEYLADGVVSTKMDVFSFGVVLLELIS 525
             G I     +PE +A    ++  DV+S+G+VL E++S
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 87/161 (54%), Gaps = 13/161 (8%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  I+ + +H N++ LEG     +     +I E++ENGSL S+L +N  +       + +
Sbjct: 84  EASIMGQFDHPNVIHLEGVVT--KSTPVMIITEFMENGSLDSFLRQNDGQ-FTVIQLVGM 140
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAITMHI 490
              +A G++Y+ +      VH+D+ + NIL++SN+  K+++FGL++       +      
Sbjct: 141 LRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSA 197
Query: 491 VGTQ---GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKE 528
           +G +    + APE +     ++  DV+S+G+V+ E++S  E
Sbjct: 198 LGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 238

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/165 (32%), Positives = 87/165 (52%), Gaps = 12/165 (7%)
Query: 366 KMMKWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNEN 425
           K  K +   E+++L++++H N++KL  F  D      YL+ E    G L   +   K   
Sbjct: 91  KTDKESLLREVQLLKQLDHPNIMKLYEFFEDK--GYFYLVGEVYTGGELFDEIISRKR-- 146
Query: 426 LNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR---AKIANFGLAKSG 482
            +     RI   V +G+ Y+H++   ++VH+D+K  N+LL+S  +    +I +FGL+   
Sbjct: 147 FSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 203
Query: 483 CNAITMH-IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
             +  M   +GT  YIAPE L  G    K DV+S GV+L  L+SG
Sbjct: 204 EASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 247

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 86/156 (55%), Gaps = 11/156 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  I+ + +H N++ LEG     +     +I EY+ENGSL ++L +N +        + +
Sbjct: 65  EASIMGQFDHPNIIHLEGVVTKCKPV--MIITEYMENGSLDAFLRKN-DGRFTVIQLVGM 121
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
              + +G++Y+ + +    VH+D+ + NIL++SN+  K+++FG+++   +          
Sbjct: 122 LRGIGSGMKYLSDMS---YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRG 178
Query: 495 GYI-----APEYLADGVVSTKMDVFSFGVVLLELIS 525
           G I     APE +A    ++  DV+S+G+V+ E++S
Sbjct: 179 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 214

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 38/208 (18%)
Query: 351 GSVYKGNIHG-------EVYAIKMMKWNACEELK--------ILQKVNHGNLVKLEGFCI 395
           G VYKG++ G       +  AIK +K  A   L+        +  ++ H N+V L G   
Sbjct: 40  GKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT 99
Query: 396 DPEDANCYLIYEYIENGSLHSWL-----HEN---KNENLNWKTRL------RIAIDVANG 441
             +D    +I+ Y  +G LH +L     H +    +++   K+ L       +   +A G
Sbjct: 100 --KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAG 157
Query: 442 LQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ----GYI 497
           ++Y+  H    VVHKD+ + N+L+   +  KI++ GL +    A    ++G       ++
Sbjct: 158 MEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWM 214
Query: 498 APEYLADGVVSTKMDVFSFGVVLLELIS 525
           APE +  G  S   D++S+GVVL E+ S
Sbjct: 215 APEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 38/208 (18%)
Query: 351 GSVYKGNIHG-------EVYAIKMMKWNACEELK--------ILQKVNHGNLVKLEGFCI 395
           G VYKG++ G       +  AIK +K  A   L+        +  ++ H N+V L G   
Sbjct: 23  GKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT 82
Query: 396 DPEDANCYLIYEYIENGSLHSWL-----HEN---KNENLNWKTRL------RIAIDVANG 441
             +D    +I+ Y  +G LH +L     H +    +++   K+ L       +   +A G
Sbjct: 83  --KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAG 140
Query: 442 LQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ----GYI 497
           ++Y+  H    VVHKD+ + N+L+   +  KI++ GL +    A    ++G       ++
Sbjct: 141 MEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWM 197
Query: 498 APEYLADGVVSTKMDVFSFGVVLLELIS 525
           APE +  G  S   D++S+GVVL E+ S
Sbjct: 198 APEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 78/156 (50%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY+  G + S  H  +    +   
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYMPGGDMFS--HLRRIGRFSEPH 142
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+L+D     K+A+FG AK      T  +
Sbjct: 143 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAKR-VKGRTWXL 198
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 81/161 (50%), Gaps = 13/161 (8%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+ I + + H ++V   GF  D  +   +++ E     SL   LH+ +      + R  +
Sbjct: 67  EISIHRSLAHQHVVGFHGFFED--NDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYL 123
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAITMHI 490
              +  G QY+H   R RV+H+D+K  N+ L+ ++  KI +FGLA      G    T+  
Sbjct: 124 R-QIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL-- 177
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
            GT  YIAPE L+    S ++DV+S G ++  L+ GK   +
Sbjct: 178 CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 81/161 (50%), Gaps = 13/161 (8%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+ I + + H ++V   GF  D  +   +++ E     SL   LH+ +      + R  +
Sbjct: 71  EISIHRSLAHQHVVGFHGFFED--NDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYL 127
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAITMHI 490
              +  G QY+H   R RV+H+D+K  N+ L+ ++  KI +FGLA      G    T+  
Sbjct: 128 R-QIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL-- 181
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
            GT  YIAPE L+    S ++DV+S G ++  L+ GK   +
Sbjct: 182 CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 222

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 86/156 (55%), Gaps = 11/156 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  I+ + +H N++ LEG     +     +I EY+ENGSL ++L +N +        + +
Sbjct: 59  EASIMGQFDHPNIIHLEGVVTKCKPV--MIITEYMENGSLDAFLRKN-DGRFTVIQLVGM 115
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
              + +G++Y+ + +    VH+D+ + NIL++SN+  K+++FG+++   +          
Sbjct: 116 LRGIGSGMKYLSDMS---YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRG 172
Query: 495 GYI-----APEYLADGVVSTKMDVFSFGVVLLELIS 525
           G I     APE +A    ++  DV+S+G+V+ E++S
Sbjct: 173 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 208

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 79/156 (50%), Gaps = 11/156 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  ++ +++H   VKL  +    +D   Y    Y +NG L  ++ +  + +    TR   
Sbjct: 60  ERDVMSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYT 116
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAITMHI 490
           A ++ + L+Y+H      ++H+D+K  NILL+ +M  +I +FG AK        A     
Sbjct: 117 A-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 172
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           VGT  Y++PE L +       D+++ G ++ +L++G
Sbjct: 173 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 78/156 (50%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY+  G + S  H  +    +   
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYMPGGDMFS--HLRRIGRFSEPH 142
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+L+D     K+A+FG AK      T  +
Sbjct: 143 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAKR-VKGRTWXL 198
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 82/154 (53%), Gaps = 11/154 (7%)
Query: 378 ILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAID 437
           +++ +NH N++ L G  + PE    +++  Y+ +G L  ++  +   N   K  +   + 
Sbjct: 75  LMRGLNHPNVLALIGIMLPPEGLP-HVLLPYMCHGDLLQFI-RSPQRNPTVKDLISFGLQ 132
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN----AITMHIVG- 492
           VA G++Y+ E    + VH+D+ + N +LD +   K+A+FGLA+   +    ++  H    
Sbjct: 133 VARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHAR 189
Query: 493 -TQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
               + A E L     +TK DV+SFGV+L EL++
Sbjct: 190 LPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 79/156 (50%), Gaps = 11/156 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  ++ +++H   VKL  +    +D   Y    Y +NG L  ++ +  + +    TR   
Sbjct: 59  ERDVMSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYT 115
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAITMHI 490
           A ++ + L+Y+H      ++H+D+K  NILL+ +M  +I +FG AK        A     
Sbjct: 116 A-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 171
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           VGT  Y++PE L +       D+++ G ++ +L++G
Sbjct: 172 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 81/161 (50%), Gaps = 13/161 (8%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+ I + + H ++V   GF  D  +   +++ E     SL   LH+ +      + R  +
Sbjct: 67  EISIHRSLAHQHVVGFHGFFED--NDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYL 123
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAITMHI 490
              +  G QY+H   R RV+H+D+K  N+ L+ ++  KI +FGLA      G    T+  
Sbjct: 124 R-QIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL-- 177
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
            GT  YIAPE L+    S ++DV+S G ++  L+ GK   +
Sbjct: 178 CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 79/156 (50%), Gaps = 11/156 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  ++ +++H   VKL  +    +D   Y    Y +NG L  ++ +  + +    TR   
Sbjct: 58  ERDVMSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYT 114
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAITMHI 490
           A ++ + L+Y+H      ++H+D+K  NILL+ +M  +I +FG AK        A     
Sbjct: 115 A-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 170
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           VGT  Y++PE L +       D+++ G ++ +L++G
Sbjct: 171 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 85/156 (54%), Gaps = 13/156 (8%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  ++Q++++  +V++ G C   E  +  L+ E  E G L+ +L +N++  +  K  + +
Sbjct: 76  EANVMQQLDNPYIVRMIGIC---EAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIEL 130
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
              V+ G++Y+ E      VH+D+ + N+LL +   AKI++FGL+K+       +   T 
Sbjct: 131 VHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 187
Query: 495 G-----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           G     + APE +     S+K DV+SFGV++ E  S
Sbjct: 188 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 85/156 (54%), Gaps = 13/156 (8%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  ++Q++++  +V++ G C   E  +  L+ E  E G L+ +L +N++  +  K  + +
Sbjct: 420 EANVMQQLDNPYIVRMIGIC---EAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIEL 474
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
              V+ G++Y+ E      VH+D+ + N+LL +   AKI++FGL+K+       +   T 
Sbjct: 475 VHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 531
Query: 495 G-----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           G     + APE +     S+K DV+SFGV++ E  S
Sbjct: 532 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 79/156 (50%), Gaps = 11/156 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  ++ +++H   VKL  +    +D   Y    Y +NG L  ++ +  + +    TR   
Sbjct: 57  ERDVMSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYT 113
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAITMHI 490
           A ++ + L+Y+H      ++H+D+K  NILL+ +M  +I +FG AK        A     
Sbjct: 114 A-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 169
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           VGT  Y++PE L +       D+++ G ++ +L++G
Sbjct: 170 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 85/156 (54%), Gaps = 13/156 (8%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  ++Q++++  +V++ G C   E  +  L+ E  E G L+ +L +N++  +  K  + +
Sbjct: 421 EANVMQQLDNPYIVRMIGIC---EAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIEL 475
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
              V+ G++Y+ E      VH+D+ + N+LL +   AKI++FGL+K+       +   T 
Sbjct: 476 VHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 532
Query: 495 G-----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           G     + APE +     S+K DV+SFGV++ E  S
Sbjct: 533 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 85/156 (54%), Gaps = 13/156 (8%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  ++Q++++  +V++ G C   E  +  L+ E  E G L+ +L +N++  +  K  + +
Sbjct: 62  EANVMQQLDNPYIVRMIGIC---EAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIEL 116
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
              V+ G++Y+ E      VH+D+ + N+LL +   AKI++FGL+K+       +   T 
Sbjct: 117 VHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTH 173
Query: 495 G-----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           G     + APE +     S+K DV+SFGV++ E  S
Sbjct: 174 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 94/185 (50%), Gaps = 16/185 (8%)
Query: 351 GSVYKGNIHGEV-YAIKMMKWNA------CEELKILQKVNHGNLVKLEGFCIDPEDANCY 403
           G V  G   G+   AIKM+K  +       EE K++  ++H  LV+L G C   +    +
Sbjct: 23  GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT--KQRPIF 80
Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI 463
           +I EY+ NG L ++L E ++     +  L +  DV   ++Y+      + +H+D+ + N 
Sbjct: 81  IITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNC 136
Query: 464 LLDSNMRAKIANFGLAKSGCNAITMHIVGTQ---GYIAPEYLADGVVSTKMDVFSFGVVL 520
           L++     K+++FGL++   +       G++    +  PE L     S+K D+++FGV++
Sbjct: 137 LVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLM 196
Query: 521 LELIS 525
            E+ S
Sbjct: 197 WEIYS 201

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 85/156 (54%), Gaps = 13/156 (8%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  ++Q++++  +V++ G C   E  +  L+ E  E G L+ +L +N++  +  K  + +
Sbjct: 68  EANVMQQLDNPYIVRMIGIC---EAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIEL 122
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
              V+ G++Y+ E      VH+D+ + N+LL +   AKI++FGL+K+       +   T 
Sbjct: 123 VHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 179
Query: 495 G-----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           G     + APE +     S+K DV+SFGV++ E  S
Sbjct: 180 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 85/156 (54%), Gaps = 13/156 (8%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  ++Q++++  +V++ G C   E  +  L+ E  E G L+ +L +N++  +  K  + +
Sbjct: 58  EANVMQQLDNPYIVRMIGIC---EAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIEL 112
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
              V+ G++Y+ E      VH+D+ + N+LL +   AKI++FGL+K+       +   T 
Sbjct: 113 VHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 169
Query: 495 G-----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           G     + APE +     S+K DV+SFGV++ E  S
Sbjct: 170 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 86/169 (50%), Gaps = 15/169 (8%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           N   E++IL+K+NH  ++K++ F  D ED   Y++ E +E G L   +  NK   L   T
Sbjct: 186 NVETEIEILKKLNHPCIIKIKNF-FDAEDY--YIVLELMEGGELFDKVVGNKR--LKEAT 240
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS---NMRAKIANFGLAK-SGCNAI 486
                  +   +QY+HE+    ++H+D+K  N+LL S   +   KI +FG +K  G  ++
Sbjct: 241 CKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 297
Query: 487 TMHIVGTQGYIAPEYLAD---GVVSTKMDVFSFGVVLLELISGKEAIDE 532
              + GT  Y+APE L        +  +D +S GV+L   +SG     E
Sbjct: 298 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 346

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 39/196 (19%)
Query: 364 AIKMMKWNA--------CEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K  A          ELK++ ++ +H N+V L G C        YLI+EY   G L
Sbjct: 79  AVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT--LSGPIYLIFEYCCYGDL 136
Query: 415 HSWL-------------HENK-----NENLN---WKTRLRIAIDVANGLQYIHEHTRPRV 453
            ++L             +EN+      E+LN   ++  L  A  VA G++++   +    
Sbjct: 137 LNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---C 193
Query: 454 VHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ----GYIAPEYLADGVVST 509
           VH+D+ + N+L+      KI +FGLA+   +     + G       ++APE L +G+ + 
Sbjct: 194 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTI 253
Query: 510 KMDVFSFGVVLLELIS 525
           K DV+S+G++L E+ S
Sbjct: 254 KSDVWSYGILLWEIFS 269

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 85/156 (54%), Gaps = 13/156 (8%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  ++Q++++  +V++ G C   E  +  L+ E  E G L+ +L +N++  +  K  + +
Sbjct: 62  EANVMQQLDNPYIVRMIGIC---EAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIEL 116
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
              V+ G++Y+ E      VH+D+ + N+LL +   AKI++FGL+K+       +   T 
Sbjct: 117 VHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 173
Query: 495 G-----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           G     + APE +     S+K DV+SFGV++ E  S
Sbjct: 174 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 85/156 (54%), Gaps = 13/156 (8%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  ++Q++++  +V++ G C   E  +  L+ E  E G L+ +L +N++  +  K  + +
Sbjct: 56  EANVMQQLDNPYIVRMIGIC---EAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIEL 110
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
              V+ G++Y+ E      VH+D+ + N+LL +   AKI++FGL+K+       +   T 
Sbjct: 111 VHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 167
Query: 495 G-----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           G     + APE +     S+K DV+SFGV++ E  S
Sbjct: 168 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 79/156 (50%), Gaps = 11/156 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  ++ +++H   VKL  +    +D   Y    Y +NG L  ++ +  + +    TR   
Sbjct: 82  ERDVMSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYT 138
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAITMHI 490
           A ++ + L+Y+H      ++H+D+K  NILL+ +M  +I +FG AK        A     
Sbjct: 139 A-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           VGT  Y++PE L +       D+++ G ++ +L++G
Sbjct: 195 VGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/264 (23%), Positives = 121/264 (45%), Gaps = 33/264 (12%)
Query: 294 IDEQKQKLQ------FNKGGRDLKDMEVNFMADVSDCLDKYRIFKIEELREATDNFSEGC 347
           +DEQ Q +Q      F        DM  N +A+       +RI K     + ++ +   C
Sbjct: 1   MDEQSQGMQGPPVPQFQPQKALRPDMGYNTLAN-------FRIEKKIGRGQFSEVYRAAC 53
Query: 348 LIQG---SVYKGNIHGEVYAIKMMKWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYL 404
           L+ G   ++ K  I   + A    + +  +E+ +L+++NH N++K     I  ED    +
Sbjct: 54  LLDGVPVALKKVQIFDLMDA--KARADCIKEIDLLKQLNHPNVIKYYASFI--EDNELNI 109
Query: 405 IYEYIENGSLHSWLHENKNEN--LNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSN 462
           + E  + G L   +   K +   +  +T  +  + + + L+++H     RV+H+DIK +N
Sbjct: 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPAN 166
Query: 463 ILLDSNMRAKIANFGLAK--SGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVL 520
           + + +    K+ + GL +  S        +VGT  Y++PE + +   + K D++S G +L
Sbjct: 167 VFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLL 226
Query: 521 LELISGKEAIDEEGKFCGQKLKGY 544
            E+ +       +  F G K+  Y
Sbjct: 227 YEMAA------LQSPFYGDKMNLY 244

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 86/169 (50%), Gaps = 15/169 (8%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           N   E++IL+K+NH  ++K++ F  D ED   Y++ E +E G L   +  NK   L   T
Sbjct: 200 NVETEIEILKKLNHPCIIKIKNF-FDAEDY--YIVLELMEGGELFDKVVGNKR--LKEAT 254
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS---NMRAKIANFGLAK-SGCNAI 486
                  +   +QY+HE+    ++H+D+K  N+LL S   +   KI +FG +K  G  ++
Sbjct: 255 CKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 311
Query: 487 TMHIVGTQGYIAPEYLAD---GVVSTKMDVFSFGVVLLELISGKEAIDE 532
              + GT  Y+APE L        +  +D +S GV+L   +SG     E
Sbjct: 312 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 360

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 85/163 (52%), Gaps = 15/163 (9%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           N   E++IL+K+NH  ++K++ F  D ED   Y++ E +E G L   +  NK   L   T
Sbjct: 61  NVETEIEILKKLNHPCIIKIKNF-FDAEDY--YIVLELMEGGELFDKVVGNKR--LKEAT 115
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS---NMRAKIANFGLAK-SGCNAI 486
                  +   +QY+HE+    ++H+D+K  N+LL S   +   KI +FG +K  G  ++
Sbjct: 116 CKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172
Query: 487 TMHIVGTQGYIAPEYLAD---GVVSTKMDVFSFGVVLLELISG 526
              + GT  Y+APE L        +  +D +S GV+L   +SG
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 16/168 (9%)
Query: 376 LKILQKVNHGNLVKLEGFCIDPE---DANCYLIYEYIENGSLHSWLHENKNENLNWKTRL 432
           L+ L+   H N+V+L   C       +    L++E+++   L ++L +     L  +T  
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK 123
Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK--SGCNAITMHI 490
            +      GL ++H +    +VH+D+K  NIL+ S    K+A+FGLA+  S   A+T  +
Sbjct: 124 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALT-PV 179
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGKFCG 538
           V T  Y APE L     +T +D++S G +  E+   K        FCG
Sbjct: 180 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPL------FCG 221

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 85/163 (52%), Gaps = 15/163 (9%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           N   E++IL+K+NH  ++K++ F  D ED   Y++ E +E G L   +  NK   L   T
Sbjct: 61  NVETEIEILKKLNHPCIIKIKNF-FDAEDY--YIVLELMEGGELFDKVVGNKR--LKEAT 115
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS---NMRAKIANFGLAK-SGCNAI 486
                  +   +QY+HE+    ++H+D+K  N+LL S   +   KI +FG +K  G  ++
Sbjct: 116 CKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172
Query: 487 TMHIVGTQGYIAPEYLAD---GVVSTKMDVFSFGVVLLELISG 526
              + GT  Y+APE L        +  +D +S GV+L   +SG
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 84/163 (51%), Gaps = 15/163 (9%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           N   E++IL+K+NH  ++K++ F  D ED   Y++ E +E G L   +  NK   L   T
Sbjct: 60  NVETEIEILKKLNHPCIIKIKNF-FDAEDY--YIVLELMEGGELFDKVVGNKR--LKEAT 114
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR---AKIANFGLAK-SGCNAI 486
                  +   +QY+HE+    ++H+D+K  N+LL S       KI +FG +K  G  ++
Sbjct: 115 CKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 171
Query: 487 TMHIVGTQGYIAPEYLAD---GVVSTKMDVFSFGVVLLELISG 526
              + GT  Y+APE L        +  +D +S GV+L   +SG
Sbjct: 172 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 74/157 (47%), Gaps = 7/157 (4%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E++I   + H N++++  +  D      YL+ E+   G L+  L   K+   + +     
Sbjct: 64  EIEIQSHLRHPNILRMYNYFHD--RKRIYLMLEFAPRGELYKEL--QKHGRFDEQRSATF 119
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
             ++A+ L Y HE    +V+H+DIK  N+L+      KIA+FG +    +     + GT 
Sbjct: 120 MEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMCGTL 176
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
            Y+ PE +       K+D++  GV+  E + G    D
Sbjct: 177 DYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 84/163 (51%), Gaps = 15/163 (9%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           N   E++IL+K+NH  ++K++ F  D ED   Y++ E +E G L   +  NK   L   T
Sbjct: 61  NVETEIEILKKLNHPCIIKIKNF-FDAEDY--YIVLELMEGGELFDKVVGNKR--LKEAT 115
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR---AKIANFGLAK-SGCNAI 486
                  +   +QY+HE+    ++H+D+K  N+LL S       KI +FG +K  G  ++
Sbjct: 116 CKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172
Query: 487 TMHIVGTQGYIAPEYLAD---GVVSTKMDVFSFGVVLLELISG 526
              + GT  Y+APE L        +  +D +S GV+L   +SG
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 79/156 (50%), Gaps = 11/156 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  ++ +++H   VKL  +    +D   Y    Y +NG L  ++ +  + +    TR   
Sbjct: 80  ERDVMSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYT 136
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAITMHI 490
           A ++ + L+Y+H      ++H+D+K  NILL+ +M  +I +FG AK        A     
Sbjct: 137 A-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 192
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           VGT  Y++PE L +       D+++ G ++ +L++G
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 79/156 (50%), Gaps = 11/156 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  ++ +++H   VKL  +    +D   Y    Y +NG L  ++ +  + +    TR   
Sbjct: 83  ERDVMSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYT 139
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAITMHI 490
           A ++ + L+Y+H      ++H+D+K  NILL+ +M  +I +FG AK        A     
Sbjct: 140 A-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 195
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           VGT  Y++PE L +       D+++ G ++ +L++G
Sbjct: 196 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 79/156 (50%), Gaps = 11/156 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  ++ +++H   VKL  +    +D   Y    Y +NG L  ++ +  + +    TR   
Sbjct: 80  ERDVMSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYT 136
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAITMHI 490
           A ++ + L+Y+H      ++H+D+K  NILL+ +M  +I +FG AK        A     
Sbjct: 137 A-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 192
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           VGT  Y++PE L +       D+++ G ++ +L++G
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 79/156 (50%), Gaps = 11/156 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  ++ +++H   VKL  +    +D   Y    Y +NG L  ++ +  + +    TR   
Sbjct: 83  ERDVMSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYT 139
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAITMHI 490
           A ++ + L+Y+H      ++H+D+K  NILL+ +M  +I +FG AK        A     
Sbjct: 140 A-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 195
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           VGT  Y++PE L +       D+++ G ++ +L++G
Sbjct: 196 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 79/156 (50%), Gaps = 11/156 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  ++ +++H   VKL  +    +D   Y    Y +NG L  ++ +  + +    TR   
Sbjct: 82  ERDVMSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYT 138
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAITMHI 490
           A ++ + L+Y+H      ++H+D+K  NILL+ +M  +I +FG AK        A     
Sbjct: 139 A-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           VGT  Y++PE L +       D+++ G ++ +L++G
Sbjct: 195 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 79/156 (50%), Gaps = 11/156 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  ++ +++H   VKL  +    +D   Y    Y +NG L  ++ +  + +    TR   
Sbjct: 82  ERDVMSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYT 138
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAITMHI 490
           A ++ + L+Y+H      ++H+D+K  NILL+ +M  +I +FG AK        A     
Sbjct: 139 A-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           VGT  Y++PE L +       D+++ G ++ +L++G
Sbjct: 195 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 74/157 (47%), Gaps = 7/157 (4%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E++I   + H N++++  +  D      YL+ E+   G L+  L   K+   + +     
Sbjct: 65  EIEIQSHLRHPNILRMYNYFHD--RKRIYLMLEFAPRGELYKEL--QKHGRFDEQRSATF 120
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
             ++A+ L Y HE    +V+H+DIK  N+L+      KIA+FG +    +     + GT 
Sbjct: 121 MEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMCGTL 177
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
            Y+ PE +       K+D++  GV+  E + G    D
Sbjct: 178 DYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 87/189 (46%), Gaps = 32/189 (16%)
Query: 364 AIKMMKWNA--------CEELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K  A          ELKI+  +  H N+V L G C         +I EY   G L
Sbjct: 80  AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT--HGGPVLVITEYCCYGDL 137
Query: 415 HSWLH--------------ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
            ++L                N  E L+ +  L  +  VA G+ ++        +H+D+ +
Sbjct: 138 LNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFL---ASKNCIHRDVAA 194
Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ----GYIAPEYLADGVVSTKMDVFSF 516
            N+LL +   AKI +FGLA+   N     + G       ++APE + D V + + DV+S+
Sbjct: 195 RNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSY 254
Query: 517 GVVLLELIS 525
           G++L E+ S
Sbjct: 255 GILLWEIFS 263

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 79/156 (50%), Gaps = 11/156 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  ++ +++H   VKL  +    +D   Y    Y +NG L  ++ +  + +    TR   
Sbjct: 80  ERDVMSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYT 136
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAITMHI 490
           A ++ + L+Y+H      ++H+D+K  NILL+ +M  +I +FG AK        A     
Sbjct: 137 A-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 192
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           VGT  Y++PE L +       D+++ G ++ +L++G
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 79/156 (50%), Gaps = 11/156 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  ++ +++H   VKL  +    +D   Y    Y +NG L  ++ +  + +    TR   
Sbjct: 82  ERDVMSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYT 138
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAITMHI 490
           A ++ + L+Y+H      ++H+D+K  NILL+ +M  +I +FG AK        A     
Sbjct: 139 A-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           VGT  Y++PE L +       D+++ G ++ +L++G
Sbjct: 195 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 86/169 (50%), Gaps = 15/169 (8%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           N   E++IL+K+NH  ++K++ F  D ED   Y++ E +E G L   +  NK   L   T
Sbjct: 67  NVETEIEILKKLNHPCIIKIKNF-FDAEDY--YIVLELMEGGELFDKVVGNKR--LKEAT 121
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS---NMRAKIANFGLAK-SGCNAI 486
                  +   +QY+HE+    ++H+D+K  N+LL S   +   KI +FG +K  G  ++
Sbjct: 122 CKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 178
Query: 487 TMHIVGTQGYIAPEYLAD---GVVSTKMDVFSFGVVLLELISGKEAIDE 532
              + GT  Y+APE L        +  +D +S GV+L   +SG     E
Sbjct: 179 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 227

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 79/156 (50%), Gaps = 11/156 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  ++ +++H   VKL  +    +D   Y    Y +NG L  ++ +  + +    TR   
Sbjct: 80  ERDVMSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYT 136
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAITMHI 490
           A ++ + L+Y+H      ++H+D+K  NILL+ +M  +I +FG AK        A     
Sbjct: 137 A-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAF 192
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           VGT  Y++PE L +       D+++ G ++ +L++G
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 79/156 (50%), Gaps = 11/156 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  ++ +++H   VKL  +    +D   Y    Y +NG L  ++ +  + +    TR   
Sbjct: 79  ERDVMSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYT 135
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAITMHI 490
           A ++ + L+Y+H      ++H+D+K  NILL+ +M  +I +FG AK        A     
Sbjct: 136 A-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 191
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           VGT  Y++PE L +       D+++ G ++ +L++G
Sbjct: 192 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 79/156 (50%), Gaps = 11/156 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  ++ +++H   VKL  +    +D   Y    Y +NG L  ++ +  + +    TR   
Sbjct: 64  ERDVMSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYT 120
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAITMHI 490
           A ++ + L+Y+H      ++H+D+K  NILL+ +M  +I +FG AK        A     
Sbjct: 121 A-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 176
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           VGT  Y++PE L +       D+++ G ++ +L++G
Sbjct: 177 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 79/156 (50%), Gaps = 11/156 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  ++ +++H   VKL  +    +D   Y    Y +NG L  ++ +  + +    TR   
Sbjct: 85  ERDVMSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYT 141
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAITMHI 490
           A ++ + L+Y+H      ++H+D+K  NILL+ +M  +I +FG AK        A     
Sbjct: 142 A-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 197
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           VGT  Y++PE L +       D+++ G ++ +L++G
Sbjct: 198 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 79/156 (50%), Gaps = 11/156 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  ++ +++H   VKL  +    +D   Y    Y +NG L  ++ +  + +    TR   
Sbjct: 82  ERDVMSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYT 138
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAITMHI 490
           A ++ + L+Y+H      ++H+D+K  NILL+ +M  +I +FG AK        A     
Sbjct: 139 A-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           VGT  Y++PE L +       D+++ G ++ +L++G
Sbjct: 195 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 82/159 (51%), Gaps = 9/159 (5%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+ I + + H ++V   GF  D  +   +++ E     SL   LH+ +      + R  +
Sbjct: 65  EISIHRSLAHQHVVGFHGFFED--NDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYL 121
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLA-KSGCNAITMHIV-G 492
              +  G QY+H   R RV+H+D+K  N+ L+ ++  KI +FGLA K   +     ++ G
Sbjct: 122 R-QIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCG 177
Query: 493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
           T  YIAPE L+    S ++DV+S G ++  L+ GK   +
Sbjct: 178 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 216

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 72/244 (29%), Positives = 110/244 (45%), Gaps = 41/244 (16%)
Query: 306 GGR--DLKDMEVN--FMADVSDCLDKYRIFKIEELREATDNFSEGCLIQGSVY--KGNIH 359
           GGR   LKD +V   F  D     D  ++F   +LRE       G    G+VY  +   +
Sbjct: 32  GGRAGSLKDPDVAELFFKD-----DPEKLFS--DLRE----IGHGSF--GAVYFARDVRN 78
Query: 360 GEVYAIKMM---------KW-NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI 409
            EV AIK M         KW +  +E++ LQK+ H N ++  G  +   +   +L+ EY 
Sbjct: 79  SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL--REHTAWLVMEYC 136
Query: 410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM 469
              +  S L E   + L       +      GL Y+H H    ++H+D+K+ NILL    
Sbjct: 137 LGSA--SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPG 191
Query: 470 RAKIANFGLAKSGCNAITMHIVGTQGYIAPEY---LADGVVSTKMDVFSFGVVLLELISG 526
             K+ +FG A     A     VGT  ++APE    + +G    K+DV+S G+  +EL   
Sbjct: 192 LVKLGDFGSA--SIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249
Query: 527 KEAI 530
           K  +
Sbjct: 250 KPPL 253

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 79/156 (50%), Gaps = 11/156 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  ++ +++H   VKL  +    +D   Y    Y +NG L  ++ +  + +    TR   
Sbjct: 79  ERDVMSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYT 135
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAITMHI 490
           A ++ + L+Y+H      ++H+D+K  NILL+ +M  +I +FG AK        A     
Sbjct: 136 A-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 191
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           VGT  Y++PE L +       D+++ G ++ +L++G
Sbjct: 192 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 82/159 (51%), Gaps = 9/159 (5%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+ I + + H ++V   GF  D  +   +++ E     SL   LH+ +      + R  +
Sbjct: 89  EISIHRSLAHQHVVGFHGFFED--NDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYL 145
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLA-KSGCNAITMHIV-G 492
              +  G QY+H   R RV+H+D+K  N+ L+ ++  KI +FGLA K   +     ++ G
Sbjct: 146 R-QIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCG 201
Query: 493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
           T  YIAPE L+    S ++DV+S G ++  L+ GK   +
Sbjct: 202 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 240

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 82/159 (51%), Gaps = 9/159 (5%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+ I + + H ++V   GF  D  +   +++ E     SL   LH+ +      + R  +
Sbjct: 91  EISIHRSLAHQHVVGFHGFFED--NDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYL 147
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLA-KSGCNAITMHIV-G 492
              +  G QY+H   R RV+H+D+K  N+ L+ ++  KI +FGLA K   +     ++ G
Sbjct: 148 R-QIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCG 203
Query: 493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
           T  YIAPE L+    S ++DV+S G ++  L+ GK   +
Sbjct: 204 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 242

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 89/179 (49%), Gaps = 20/179 (11%)
Query: 360 GEVYAIKMMKWNACE---------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE 410
           G +YA+K++K    +         E  IL  VNH  +VKL  +    E    YLI +++ 
Sbjct: 56  GHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKLH-YAFQTE-GKLYLILDFLR 113
Query: 411 NGSLHSWLHENKNENLNWKTRLRIAI-DVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM 469
            G L + L     E +  +  ++  + ++A GL ++H      ++++D+K  NILLD   
Sbjct: 114 GGDLFTRL---SKEVMFTEEDVKFYLAELALGLDHLHSLG---IIYRDLKPENILLDEEG 167
Query: 470 RAKIANFGLAKSGCN--AITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
             K+ +FGL+K   +         GT  Y+APE +     S   D +S+GV++ E+++G
Sbjct: 168 HIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 82/178 (46%), Gaps = 22/178 (12%)
Query: 363 YAIKMMKWNACEELK-----------ILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN 411
           YA+K+++  A  + K           +L+ V H  LV L  F     D   Y + +YI  
Sbjct: 66  YAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTAD-KLYFVLDYING 123
Query: 412 GSLHSWLHENKNENLNWKTRLRI-AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR 470
           G L   L   + E    + R R  A ++A+ L Y+H      +V++D+K  NILLDS   
Sbjct: 124 GELFYHL---QRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGH 177
Query: 471 AKIANFGLAKSGC--NAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
             + +FGL K     N+ T    GT  Y+APE L        +D +  G VL E++ G
Sbjct: 178 IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 84/165 (50%), Gaps = 12/165 (7%)
Query: 366 KMMKWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNEN 425
           K  K +   E+++L++++H N+ KL  F  D      YL+ E    G L   +   K   
Sbjct: 67  KTDKESLLREVQLLKQLDHPNIXKLYEFFEDK--GYFYLVGEVYTGGELFDEIISRKR-- 122
Query: 426 LNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR---AKIANFGLAKS- 481
            +     RI   V +G+ Y H++   ++VH+D+K  N+LL+S  +    +I +FGL+   
Sbjct: 123 FSEVDAARIIRQVLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179
Query: 482 GCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
             +      +GT  YIAPE L  G    K DV+S GV+L  L+SG
Sbjct: 180 EASKKXKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/192 (22%), Positives = 94/192 (48%), Gaps = 19/192 (9%)
Query: 360 GEVYAIKMMKWNACE-------ELKILQKVNHGNLVKL-EGFCIDPEDANCYLIYEYIEN 411
           G++ A+K M     +       E+ I++   H N+V++   + +  E    +++ E++E 
Sbjct: 176 GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDE---LWVVMEFLEG 232
Query: 412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRA 471
           G+L   +   +   +N +    + + V   L  +H      V+H+DIKS +ILL  + R 
Sbjct: 233 GALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRV 286
Query: 472 KIANFGLAKSGCNAITMH--IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEA 529
           K+++FG        +     +VGT  ++APE ++      ++D++S G++++E++ G+  
Sbjct: 287 KLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 346
Query: 530 IDEEGKFCGQKL 541
              E      K+
Sbjct: 347 YFNEPPLKAMKM 358

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 85/158 (53%), Gaps = 15/158 (9%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL--HENKNENLNWKTRL 432
           E  I+ + +H N+V LEG           ++ E++ENG+L ++L  H+ +   +     L
Sbjct: 94  EASIMGQFDHPNVVHLEGVVT--RGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGML 151
Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVG 492
           R    +A G++Y+ +      VH+D+ + NIL++SN+  K+++FGL++   +        
Sbjct: 152 R---GIAAGMRYLADMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTT 205
Query: 493 TQGYI-----APEYLADGVVSTKMDVFSFGVVLLELIS 525
           T G I     APE +     ++  DV+S+G+V+ E++S
Sbjct: 206 TGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 243

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY+  G + S  H  +    +   
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGGEMFS--HLRRIGRFSEPH 142
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+L+D     ++ +FG AK      T  +
Sbjct: 143 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 199 AGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 91/195 (46%), Gaps = 24/195 (12%)
Query: 351 GSVY--KGNIHGEVYAIKMM---------KW-NACEELKILQKVNHGNLVKLEGFCIDPE 398
           G+VY  +   + EV AIK M         KW +  +E++ LQK+ H N ++  G  +   
Sbjct: 29  GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL--R 86
Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
           +   +L+ EY    +  S L E   + L       +      GL Y+H H    ++H+D+
Sbjct: 87  EHTAWLVMEYCLGSA--SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDV 141
Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEY---LADGVVSTKMDVFS 515
           K+ NILL      K+ +FG A     A     VGT  ++APE    + +G    K+DV+S
Sbjct: 142 KAGNILLSEPGLVKLGDFGSA--SIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWS 199
Query: 516 FGVVLLELISGKEAI 530
            G+  +EL   K  +
Sbjct: 200 LGITCIELAERKPPL 214

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 86/187 (45%), Gaps = 30/187 (16%)
Query: 364 AIKMMKWNA--------CEELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K  A          ELKI+  +  H N+V L G C         +I EY   G L
Sbjct: 80  AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT--HGGPVLVITEYCCYGDL 137
Query: 415 HSWLHENK------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSN 462
            ++L                N  L+ +  L  +  VA G+ ++        +H+D+ + N
Sbjct: 138 LNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARN 194
Query: 463 ILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ----GYIAPEYLADGVVSTKMDVFSFGV 518
           +LL +   AKI +FGLA+   N     + G       ++APE + D V + + DV+S+G+
Sbjct: 195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 254
Query: 519 VLLELIS 525
           +L E+ S
Sbjct: 255 LLWEIFS 261

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 66/133 (49%), Gaps = 7/133 (5%)
Query: 403 YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSN 462
           Y + EY+  G L    H  +         +  A ++A GL ++       ++++D+K  N
Sbjct: 418 YFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDN 472
Query: 463 ILLDSNMRAKIANFGLAKSGC--NAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVL 520
           ++LDS    KIA+FG+ K        T    GT  YIAPE +A       +D ++FGV+L
Sbjct: 473 VMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLL 532
Query: 521 LELISGKEAIDEE 533
            E+++G+   + E
Sbjct: 533 YEMLAGQAPFEGE 545

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 86/183 (46%), Gaps = 26/183 (14%)
Query: 364 AIKMMKWNA--------CEELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K  A          ELKI+  +  H N+V L G C         +I EY   G L
Sbjct: 80  AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT--HGGPVLVITEYCCYGDL 137
Query: 415 HSWLHENKNENLN--------WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLD 466
            ++L      +L+         +  L  +  VA G+ ++        +H+D+ + N+LL 
Sbjct: 138 LNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLT 194
Query: 467 SNMRAKIANFGLAKSGCNAITMHIVGTQ----GYIAPEYLADGVVSTKMDVFSFGVVLLE 522
           +   AKI +FGLA+   N     + G       ++APE + D V + + DV+S+G++L E
Sbjct: 195 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE 254
Query: 523 LIS 525
           + S
Sbjct: 255 IFS 257

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 101/213 (47%), Gaps = 30/213 (14%)
Query: 355 KGNIHGEVYAIKMMKWNAC----------EELKILQKVNHGNLVKLEGFCIDPEDANCYL 404
           K  + G   AIK++K ++           +E+ +L++++H N++KL  F  D    N YL
Sbjct: 41  KDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKR--NYYL 98
Query: 405 IYEYIENGSL-HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI 463
           + E    G L    +   K   ++    ++    V +G  Y+H+H    +VH+D+K  N+
Sbjct: 99  VMEVYRGGELFDEIILRQKFSEVDAAVIMK---QVLSGTTYLHKHN---IVHRDLKPENL 152
Query: 464 LLDSNMR---AKIANFGL-AKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVV 519
           LL+S  R    KI +FGL A           +GT  YIAPE L       K DV+S GV+
Sbjct: 153 LLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRKK-YDEKCDVWSCGVI 211
Query: 520 LLELISGKEAIDEEGKFCGQKLKGYWREMKRGK 552
           L  L+ G         F GQ  +   + +++GK
Sbjct: 212 LYILLCGYPP------FGGQTDQEILKRVEKGK 238

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 66/133 (49%), Gaps = 7/133 (5%)
Query: 403 YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSN 462
           Y + EY+  G L    H  +         +  A ++A GL ++       ++++D+K  N
Sbjct: 97  YFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDN 151
Query: 463 ILLDSNMRAKIANFGLAKSGC--NAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVL 520
           ++LDS    KIA+FG+ K        T    GT  YIAPE +A       +D ++FGV+L
Sbjct: 152 VMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLL 211
Query: 521 LELISGKEAIDEE 533
            E+++G+   + E
Sbjct: 212 YEMLAGQAPFEGE 224

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 86/183 (46%), Gaps = 26/183 (14%)
Query: 364 AIKMMKWNA--------CEELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K  A          ELKI+  +  H N+V L G C         +I EY   G L
Sbjct: 72  AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT--HGGPVLVITEYCCYGDL 129
Query: 415 HSWLHENKNENLN--------WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLD 466
            ++L      +L+         +  L  +  VA G+ ++        +H+D+ + N+LL 
Sbjct: 130 LNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLT 186
Query: 467 SNMRAKIANFGLAKSGCNAITMHIVGTQ----GYIAPEYLADGVVSTKMDVFSFGVVLLE 522
           +   AKI +FGLA+   N     + G       ++APE + D V + + DV+S+G++L E
Sbjct: 187 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE 246
Query: 523 LIS 525
           + S
Sbjct: 247 IFS 249

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY+  G + S  H  +    +   
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGGEMFS--HLRRIGRFSEPH 142
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+L+D     ++ +FG AK      T  +
Sbjct: 143 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 199 XGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 78/156 (50%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE F    +++N Y++ EY+  G + S  H  +    +   
Sbjct: 108 HTLNEKRILQAVNFPFLVKLE-FSFK-DNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPH 163
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+L+D     ++ +FG AK      T  +
Sbjct: 164 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGATWTL 219
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 220 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/192 (22%), Positives = 94/192 (48%), Gaps = 19/192 (9%)
Query: 360 GEVYAIKMMKWNACE-------ELKILQKVNHGNLVKL-EGFCIDPEDANCYLIYEYIEN 411
           G++ A+K M     +       E+ I++   H N+V++   + +  E    +++ E++E 
Sbjct: 54  GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDE---LWVVMEFLEG 110
Query: 412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRA 471
           G+L   +   +   +N +    + + V   L  +H      V+H+DIKS +ILL  + R 
Sbjct: 111 GALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRV 164
Query: 472 KIANFGLAKSGCNAITMH--IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEA 529
           K+++FG        +     +VGT  ++APE ++      ++D++S G++++E++ G+  
Sbjct: 165 KLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 224
Query: 530 IDEEGKFCGQKL 541
              E      K+
Sbjct: 225 YFNEPPLKAMKM 236

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY+  G + S  H  +    +   
Sbjct: 74  HTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGGEMFS--HLRRIGRFSEPH 129
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+L+D     ++ +FG AK      T  +
Sbjct: 130 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDEQGYIQVTDFGFAKR-VKGRTWXL 185
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 186 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 77/156 (49%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY   G + S  H  +    +   
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYAPGGEMFS--HLRRIGRFSEPH 142
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+++D     K+ +FGLAK      T  +
Sbjct: 143 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGLAKR-VKGRTWXL 198
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 66/125 (52%), Gaps = 8/125 (6%)
Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRI-AIDVANGLQYIHEHTRPRVVHKDIKSSN 462
            I + +  G LH  L ++    +  +  +R  A ++  GL+++H      VV++D+K +N
Sbjct: 269 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPAN 322
Query: 463 ILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVV-STKMDVFSFGVVLL 521
           ILLD +   +I++ GLA           VGT GY+APE L  GV   +  D FS G +L 
Sbjct: 323 ILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLF 382
Query: 522 ELISG 526
           +L+ G
Sbjct: 383 KLLRG 387

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY+  G + S  H  +    +   
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGGEMFS--HLRRIGRFSEPH 142
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+L+D     ++ +FG AK      T  +
Sbjct: 143 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 66/125 (52%), Gaps = 8/125 (6%)
Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRI-AIDVANGLQYIHEHTRPRVVHKDIKSSN 462
            I + +  G LH  L ++    +  +  +R  A ++  GL+++H      VV++D+K +N
Sbjct: 269 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPAN 322
Query: 463 ILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVV-STKMDVFSFGVVLL 521
           ILLD +   +I++ GLA           VGT GY+APE L  GV   +  D FS G +L 
Sbjct: 323 ILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLF 382
Query: 522 ELISG 526
           +L+ G
Sbjct: 383 KLLRG 387

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY+  G + S  H  +    +   
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGGEMFS--HLRRIGRFSEPH 142
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+L+D     ++ +FG AK      T  +
Sbjct: 143 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/192 (22%), Positives = 94/192 (48%), Gaps = 19/192 (9%)
Query: 360 GEVYAIKMMKWNACE-------ELKILQKVNHGNLVKL-EGFCIDPEDANCYLIYEYIEN 411
           G++ A+K M     +       E+ I++   H N+V++   + +  E    +++ E++E 
Sbjct: 99  GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDE---LWVVMEFLEG 155
Query: 412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRA 471
           G+L   +   +   +N +    + + V   L  +H      V+H+DIKS +ILL  + R 
Sbjct: 156 GALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRV 209
Query: 472 KIANFGLAKSGCNAITMH--IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEA 529
           K+++FG        +     +VGT  ++APE ++      ++D++S G++++E++ G+  
Sbjct: 210 KLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 269
Query: 530 IDEEGKFCGQKL 541
              E      K+
Sbjct: 270 YFNEPPLKAMKM 281

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY+  G + S  H  +    +   
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGGEMFS--HLRRIGRFSEPH 142
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+L+D     ++ +FG AK      T  +
Sbjct: 143 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/192 (22%), Positives = 94/192 (48%), Gaps = 19/192 (9%)
Query: 360 GEVYAIKMMKWNACE-------ELKILQKVNHGNLVKL-EGFCIDPEDANCYLIYEYIEN 411
           G++ A+K M     +       E+ I++   H N+V++   + +  E    +++ E++E 
Sbjct: 56  GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDE---LWVVMEFLEG 112
Query: 412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRA 471
           G+L   +   +   +N +    + + V   L  +H      V+H+DIKS +ILL  + R 
Sbjct: 113 GALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRV 166
Query: 472 KIANFGLAKSGCNAITMH--IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEA 529
           K+++FG        +     +VGT  ++APE ++      ++D++S G++++E++ G+  
Sbjct: 167 KLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 226
Query: 530 IDEEGKFCGQKL 541
              E      K+
Sbjct: 227 YFNEPPLKAMKM 238

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY+  G + S  H  +    +   
Sbjct: 80  HTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVPGGEMFS--HLRRIGRFSEPH 135
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+L+D     ++ +FG AK      T  +
Sbjct: 136 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 191
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 192 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY+  G + S  H  +    +   
Sbjct: 88  HTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGGEMFS--HLRRIGRFSEPH 143
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+L+D     ++ +FG AK      T  +
Sbjct: 144 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 199
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY+  G + S  H  +    +   
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGGEMFS--HLRRIGRFSEPH 142
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+L+D     ++ +FG AK      T  +
Sbjct: 143 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 107/225 (47%), Gaps = 40/225 (17%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKGN----IHGEV---YAIKMMKWNAC--------EEL 376
           KI  LRE      +G    G VY+GN    I GE     A+K +  +A          E 
Sbjct: 18  KITLLRE----LGQGSF--GMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEA 71
Query: 377 KILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTR----- 431
            +++     ++V+L G  +  +     ++ E + +G L S+L   + E  N   R     
Sbjct: 72  SVMKGFTCHHVVRLLG--VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 129
Query: 432 ---LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM 488
              +++A ++A+G+ Y++     + VH+D+ + N ++  +   KI +FG+ +        
Sbjct: 130 QEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRD-IYETAY 185
Query: 489 HIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELISGKE 528
           +  G +G     ++APE L DGV +T  D++SFGVVL E+ S  E
Sbjct: 186 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE 230

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 78/156 (50%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE F    +++N Y++ EY+  G + S  H  +    +   
Sbjct: 108 HTLNEKRILQAVNFPFLVKLE-FSFK-DNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPH 163
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+L+D     ++ +FG AK      T  +
Sbjct: 164 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 219
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 220 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY+  G + S  H  +    +   
Sbjct: 88  HTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVPGGEMFS--HLRRIGRFSEPH 143
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+L+D     ++ +FG AK      T  +
Sbjct: 144 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 199
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY+  G + S  H  +    +   
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVPGGEMFS--HLRRIGRFSEPH 142
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+L+D     ++ +FG AK      T  +
Sbjct: 143 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY+  G + S  H  +    +   
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGGEMFS--HLRRIGRFSEPH 142
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+L+D     ++ +FG AK      T  +
Sbjct: 143 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY+  G + S  H  +    +   
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEYSFKD--NSNLYMVMEYVPGGEMFS--HLRRIGRFSEPH 142
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+L+D     ++ +FG AK      T  +
Sbjct: 143 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY+  G + S  H  +    +   
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVPGGEMFS--HLRRIGRFSEPH 142
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+L+D     ++ +FG AK      T  +
Sbjct: 143 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY+  G + S  H  +    +   
Sbjct: 73  HTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVPGGEMFS--HLRRIGRFSEPH 128
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+L+D     ++ +FG AK      T  +
Sbjct: 129 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWTL 184
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 185 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY+  G + S  H  +    +   
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVPGGEMFS--HLRRIGRFSEPH 142
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+L+D     ++ +FG AK      T  +
Sbjct: 143 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY+  G + S  H  +    +   
Sbjct: 88  HTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVPGGEMFS--HLRRIGRFSEPH 143
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+L+D     ++ +FG AK      T  +
Sbjct: 144 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 199
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY+  G + S  H  +    +   
Sbjct: 88  HTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVPGGEMFS--HLRRIGRFSEPH 143
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+L+D     ++ +FG AK      T  +
Sbjct: 144 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 199
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 66/125 (52%), Gaps = 8/125 (6%)
Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRI-AIDVANGLQYIHEHTRPRVVHKDIKSSN 462
            I + +  G LH  L ++    +  +  +R  A ++  GL+++H      VV++D+K +N
Sbjct: 269 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPAN 322
Query: 463 ILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVV-STKMDVFSFGVVLL 521
           ILLD +   +I++ GLA           VGT GY+APE L  GV   +  D FS G +L 
Sbjct: 323 ILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLF 382
Query: 522 ELISG 526
           +L+ G
Sbjct: 383 KLLRG 387

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 87/173 (50%), Gaps = 24/173 (13%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNE---------- 424
           E ++L  + H ++VK  G C D +     +++EY+++G L+ +L  +  +          
Sbjct: 67  EAELLTNLQHEHIVKFYGVCGDGDP--LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPR 124
Query: 425 ----NLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK 480
                L     L IA  +A+G+ Y+        VH+D+ + N L+ +N+  KI +FG+++
Sbjct: 125 QAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSR 181
Query: 481 SGCNA----ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKE 528
              +     +  H +    ++ PE +     +T+ DV+SFGV+L E+ + GK+
Sbjct: 182 DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 234

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 66/125 (52%), Gaps = 8/125 (6%)
Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRI-AIDVANGLQYIHEHTRPRVVHKDIKSSN 462
            I + +  G LH  L ++    +  +  +R  A ++  GL+++H      VV++D+K +N
Sbjct: 268 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPAN 321
Query: 463 ILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVV-STKMDVFSFGVVLL 521
           ILLD +   +I++ GLA           VGT GY+APE L  GV   +  D FS G +L 
Sbjct: 322 ILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLF 381
Query: 522 ELISG 526
           +L+ G
Sbjct: 382 KLLRG 386

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY+  G + S  H  +    +   
Sbjct: 88  HTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVPGGEMFS--HLRRIGRFSEPH 143
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+L+D     ++ +FG AK      T  +
Sbjct: 144 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 199
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY+  G + S  H  +    +   
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEYSFKD--NSNLYMVMEYVPGGEMFS--HLRRIGRFSEPH 142
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+L+D     ++ +FG AK      T  +
Sbjct: 143 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY+  G + S  H  +    +   
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEYSFKD--NSNLYMVMEYVPGGEMFS--HLRRIGRFSEPH 142
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+L+D     ++ +FG AK      T  +
Sbjct: 143 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/192 (22%), Positives = 94/192 (48%), Gaps = 19/192 (9%)
Query: 360 GEVYAIKMMKWNACE-------ELKILQKVNHGNLVKL-EGFCIDPEDANCYLIYEYIEN 411
           G++ A+K M     +       E+ I++   H N+V++   + +  E    +++ E++E 
Sbjct: 45  GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDE---LWVVMEFLEG 101
Query: 412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRA 471
           G+L   +   +   +N +    + + V   L  +H      V+H+DIKS +ILL  + R 
Sbjct: 102 GALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRV 155
Query: 472 KIANFGLAKSGCNAITMH--IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEA 529
           K+++FG        +     +VGT  ++APE ++      ++D++S G++++E++ G+  
Sbjct: 156 KLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215
Query: 530 IDEEGKFCGQKL 541
              E      K+
Sbjct: 216 YFNEPPLKAMKM 227

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 76/156 (48%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY+  G + S  H  +        
Sbjct: 82  HTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGGEMFS--HLRRIGRFXEPH 137
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+L+D     ++ +FG AK      T  +
Sbjct: 138 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 193
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 194 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY+  G + S  H  +    +   
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGGEMFS--HLRRIGRFSEPH 142
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+L+D     ++ +FG AK      T  +
Sbjct: 143 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 100/230 (43%), Gaps = 47/230 (20%)
Query: 336 LREATDNFSEGCLIQGSV-----YKGNIHGEVYAIKMMKWNA------CEELKILQKVNH 384
           LR A+D      L QG+       +  +    YAIK ++           E+ +L  +NH
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNH 61
Query: 385 GNLVKLEGFCIDPED-----------ANCYLIYEYIENGSLHSWLHENKNENLNWKTR-- 431
             +V+     ++  +           +  ++  EY EN +L+  +H   +ENLN +    
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIH---SENLNQQRDEY 118
Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS---------- 481
            R+   +   L YIH      ++H+D+K  NI +D +   KI +FGLAK+          
Sbjct: 119 WRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 482 ------GCNAITMHIVGTQGYIAPEYL-ADGVVSTKMDVFSFGVVLLELI 524
                 G +      +GT  Y+A E L   G  + K+D++S G++  E+I
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 107/225 (47%), Gaps = 40/225 (17%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKGN----IHGEV---YAIKMMKWNAC--------EEL 376
           KI  LRE      +G    G VY+GN    I GE     A+K +  +A          E 
Sbjct: 18  KITLLRE----LGQGSF--GMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEA 71
Query: 377 KILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTR----- 431
            +++     ++V+L G  +  +     ++ E + +G L S+L   + E  N   R     
Sbjct: 72  SVMKGFTCHHVVRLLG--VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 129
Query: 432 ---LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM 488
              +++A ++A+G+ Y++     + VH+D+ + N ++  +   KI +FG+ +        
Sbjct: 130 QEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRD-IYETDY 185
Query: 489 HIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELISGKE 528
           +  G +G     ++APE L DGV +T  D++SFGVVL E+ S  E
Sbjct: 186 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE 230

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY+  G + S  H  +    +   
Sbjct: 88  HTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVPGGEMFS--HLRRIGRFSEPH 143
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+L+D     ++ +FG AK      T  +
Sbjct: 144 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWTL 199
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 106/225 (47%), Gaps = 40/225 (17%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKGN----IHGEV---YAIKMMKWNAC--------EEL 376
           KI  LRE      +G    G VY+GN    I GE     A+K +  +A          E 
Sbjct: 18  KITLLRE----LGQGSF--GMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEA 71
Query: 377 KILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTR----- 431
            +++     ++V+L G  +  +     ++ E + +G L S+L   + E  N   R     
Sbjct: 72  SVMKGFTCHHVVRLLG--VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 129
Query: 432 ---LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM 488
              +++A ++A+G+ Y++     + VH+D+ + N ++  +   KI +FG+ +        
Sbjct: 130 QEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRD-IXETDX 185
Query: 489 HIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELISGKE 528
              G +G     ++APE L DGV +T  D++SFGVVL E+ S  E
Sbjct: 186 XRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE 230

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 94/196 (47%), Gaps = 39/196 (19%)
Query: 364 AIKMMKWNACEELK--------ILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH 415
           A+KM+K  A  +++        ++ + ++ N+VKL G C   +   C L++EY+  G L+
Sbjct: 81  AVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM-C-LLFEYMAYGDLN 138
Query: 416 SWLHENKNENL------NWKTRLR----------------IAIDVANGLQYIHEHTRPRV 453
            +L       +      +  TR R                IA  VA G+ Y+ E    + 
Sbjct: 139 EFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 195
Query: 454 VHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG----YIAPEYLADGVVST 509
           VH+D+ + N L+  NM  KIA+FGL+++  +A      G       ++ PE +     +T
Sbjct: 196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTT 255
Query: 510 KMDVFSFGVVLLELIS 525
           + DV+++GVVL E+ S
Sbjct: 256 ESDVWAYGVVLWEIFS 271

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 28/212 (13%)
Query: 355 KGNIHGEVYAIKMMKWNAC----------EELKILQKVNHGNLVKLEGFCIDPEDANCYL 404
           K  + G   AIK++K ++           +E+ +L++++H N++KL  F  D    N YL
Sbjct: 24  KDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKR--NYYL 81
Query: 405 IYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNIL 464
           + E    G L   +     +  +      I   V +G  Y+H+H    +VH+D+K  N+L
Sbjct: 82  VMEVYRGGELFDEI--ILRQKFSEVDAAVIMKQVLSGTTYLHKHN---IVHRDLKPENLL 136
Query: 465 LDSNMR---AKIANFGL-AKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVL 520
           L+S  R    KI +FGL A           +GT  YIAPE L       K DV+S GV+L
Sbjct: 137 LESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRKK-YDEKCDVWSCGVIL 195
Query: 521 LELISGKEAIDEEGKFCGQKLKGYWREMKRGK 552
             L+ G         F GQ  +   + +++GK
Sbjct: 196 YILLCGYPP------FGGQTDQEILKRVEKGK 221

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 76/156 (48%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY+  G + S  H  +        
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGGEMFS--HLRRIGRFXEPH 142
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+L+D     ++ +FG AK      T  +
Sbjct: 143 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 76/156 (48%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY+  G + S  H  +        
Sbjct: 80  HTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVPGGEMFS--HLRRIGRFXEPH 135
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+L+D     ++ +FG AK      T  +
Sbjct: 136 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 191
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 192 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 75/152 (49%), Gaps = 8/152 (5%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E +ILQ VN   LVKLE    D  ++N Y++ EY+  G + S  H  +            
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGGEMFS--HLRRIGRFXEPHARFY 146
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
           A  +    +Y+H      ++++D+K  N+L+D     ++ +FG AK      T  + GT 
Sbjct: 147 AAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXLCGTP 202
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 106/225 (47%), Gaps = 40/225 (17%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKGN----IHGEV---YAIKMMKWNAC--------EEL 376
           KI  LRE      +G    G VY+GN    I GE     A+K +  +A          E 
Sbjct: 15  KITLLRE----LGQGSF--GMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEA 68
Query: 377 KILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTR----- 431
            +++     ++V+L G  +  +     ++ E + +G L S+L   + E  N   R     
Sbjct: 69  SVMKGFTCHHVVRLLG--VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 126
Query: 432 ---LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM 488
              +++A ++A+G+ Y++     + VH+D+ + N ++  +   KI +FG+ +        
Sbjct: 127 QEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRD-IXETDX 182
Query: 489 HIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELISGKE 528
              G +G     ++APE L DGV +T  D++SFGVVL E+ S  E
Sbjct: 183 XRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE 227

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 76/156 (48%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY+  G + S  H  +        
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGGEMFS--HLRRIGRFXEPH 142
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+L+D     ++ +FG AK      T  +
Sbjct: 143 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/192 (22%), Positives = 94/192 (48%), Gaps = 19/192 (9%)
Query: 360 GEVYAIKMMKWNACE-------ELKILQKVNHGNLVKL-EGFCIDPEDANCYLIYEYIEN 411
           G++ A+K M     +       E+ I++   H N+V++   + +  E    +++ E++E 
Sbjct: 49  GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDE---LWVVMEFLEG 105
Query: 412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRA 471
           G+L   +   +   +N +    + + V   L  +H      V+H+DIKS +ILL  + R 
Sbjct: 106 GALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRV 159
Query: 472 KIANFGLAKSGCNAITMH--IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEA 529
           K+++FG        +     +VGT  ++APE ++      ++D++S G++++E++ G+  
Sbjct: 160 KLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 219
Query: 530 IDEEGKFCGQKL 541
              E      K+
Sbjct: 220 YFNEPPLKAMKM 231

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 107/225 (47%), Gaps = 40/225 (17%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKGN----IHGEV---YAIKMMKWNAC--------EEL 376
           KI  LRE      +G    G VY+GN    I GE     A+K +  +A          E 
Sbjct: 17  KITLLRE----LGQGSF--GMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEA 70
Query: 377 KILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTR----- 431
            +++     ++V+L G  +  +     ++ E + +G L S+L   + E  N   R     
Sbjct: 71  SVMKGFTCHHVVRLLG--VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 128
Query: 432 ---LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM 488
              +++A ++A+G+ Y++     + VH+D+ + N ++  +   KI +FG+ +        
Sbjct: 129 QEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRD-IYETDY 184
Query: 489 HIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELISGKE 528
           +  G +G     ++APE L DGV +T  D++SFGVVL E+ S  E
Sbjct: 185 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE 229

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 76/156 (48%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY+  G + S  H  +        
Sbjct: 88  HTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVPGGEMFS--HLRRIGRFXEPH 143
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+L+D     ++ +FG AK      T  +
Sbjct: 144 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 199
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 76/156 (48%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY+  G + S  H  +        
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVPGGEMFS--HLRRIGRFXEPH 142
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+L+D     ++ +FG AK      T  +
Sbjct: 143 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 76/156 (48%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY+  G + S  H  +        
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVPGGEMFS--HLRRIGRFXEPH 142
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+L+D     ++ +FG AK      T  +
Sbjct: 143 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 106/225 (47%), Gaps = 40/225 (17%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKGN----IHGEV---YAIKMMKWNAC--------EEL 376
           KI  LRE      +G    G VY+GN    I GE     A+K +  +A          E 
Sbjct: 18  KITLLRE----LGQGSF--GMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEA 71
Query: 377 KILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTR----- 431
            +++     ++V+L G  +  +     ++ E + +G L S+L   + E  N   R     
Sbjct: 72  SVMKGFTCHHVVRLLG--VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 129
Query: 432 ---LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM 488
              +++A ++A+G+ Y++     + VH+D+ + N ++  +   KI +FG+ +        
Sbjct: 130 QEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRD-IXETDX 185
Query: 489 HIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELISGKE 528
              G +G     ++APE L DGV +T  D++SFGVVL E+ S  E
Sbjct: 186 XRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE 230

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 86/161 (53%), Gaps = 13/161 (8%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  I+ + +H N++ LEG     +     +I E++ENGSL S+L +N  +       + +
Sbjct: 58  EASIMGQFDHPNVIHLEGVVT--KSTPVMIITEFMENGSLDSFLRQNDGQ-FTVIQLVGM 114
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAITMHI 490
              +A G++Y+ +      VH+ + + NIL++SN+  K+++FGL++       +      
Sbjct: 115 LRGIAAGMKYLADMN---YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSA 171
Query: 491 VGTQ---GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKE 528
           +G +    + APE +     ++  DV+S+G+V+ E++S  E
Sbjct: 172 LGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 212

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 89/173 (51%), Gaps = 21/173 (12%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLH------ENKNENLN 427
           EE+ + + + H N+V+  G     E+    +  E +  GSL + L       ++  + + 
Sbjct: 68  EEIALHKHLKHKNIVQYLGSF--SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG 125
Query: 428 WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS-NMRAKIANFGLAK--SGCN 484
           + T+      +  GL+Y+H++   ++VH+DIK  N+L+++ +   KI++FG +K  +G N
Sbjct: 126 FYTK-----QILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177
Query: 485 AITMHIVGTQGYIAPEYLADGV--VSTKMDVFSFGVVLLELISGKEAIDEEGK 535
             T    GT  Y+APE +  G        D++S G  ++E+ +GK    E G+
Sbjct: 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE 230

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 83/170 (48%), Gaps = 21/170 (12%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHE-----------NKN 423
           E ++L  + H ++VK  G C+  E     +++EY+++G L+ +L             N  
Sbjct: 65  EAELLTNLQHEHIVKFYGVCV--EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPP 122
Query: 424 ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC 483
             L     L IA  +A G+ Y+        VH+D+ + N L+  N+  KI +FG+++   
Sbjct: 123 TELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVY 179
Query: 484 NA----ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKE 528
           +     +  H +    ++ PE +     +T+ DV+S GVVL E+ + GK+
Sbjct: 180 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 229

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 76/156 (48%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY+  G + S  H  +        
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGGEMFS--HLRRIGRFAEPH 142
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+L+D     ++ +FG AK      T  +
Sbjct: 143 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE F    +++N Y++ EY+  G + S  H  +        
Sbjct: 108 HTLNEKRILQAVNFPFLVKLE-FSFK-DNSNLYMVMEYVAGGEMFS--HLRRIGRFXEPH 163
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+L+D     ++ +FG AK      T  +
Sbjct: 164 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 219
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 220 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 89/167 (53%), Gaps = 21/167 (12%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDP-----EDANCYLIYEYIENGSLHSWLHENKNENLNWK 429
           ELKIL+   H N++ ++   + P     E  + Y++ + +E+  LH  +H ++   L   
Sbjct: 104 ELKILKHFKHDNIIAIKDI-LRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLE-- 159
Query: 430 TRLRIAI-DVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM 488
             +R  +  +  GL+Y+H     +V+H+D+K SN+L++ N   KI +FG+A+  C +   
Sbjct: 160 -HVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAE 215
Query: 489 H------IVGTQGYIAPE-YLADGVVSTKMDVFSFGVVLLELISGKE 528
           H       V T+ Y APE  L+    +  +D++S G +  E+++ ++
Sbjct: 216 HQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 76/156 (48%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +I Q VN   LVKLE    D  ++N Y++ EY   G + S  H  +    +   
Sbjct: 88  HTLNEKRIQQAVNFPFLVKLEFSFKD--NSNLYMVLEYAPGGEMFS--HLRRIGRFSEPH 143
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+L+D     K+A+FG AK      T  +
Sbjct: 144 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAKR-VKGRTWXL 199
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY+  G + S  H  +    +   
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGGEMFS--HLRRIGRFSEPH 142
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+++D     ++ +FG AK      T  +
Sbjct: 143 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLIIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 199 CGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 100/210 (47%), Gaps = 43/210 (20%)
Query: 351 GSVYKGNIHGEVYAIKMMKW----NACEELKI--LQKVNHGNLVKLEGFCIDPEDANC-- 402
           G+VYKG++     A+K+  +    N   E  I  +  + H N+ +   F +  E      
Sbjct: 27  GAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIAR---FIVGDERVTADG 83
Query: 403 ----YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIH------EHTRPR 452
                L+ EY  NGSL  +L  + +   +W +  R+A  V  GL Y+H      +H +P 
Sbjct: 84  RMEYLLVMEYYPNGSLXKYLSLHTS---DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA 140
Query: 453 VVHKDIKSSNILLDSNMRAKIANFGLAK--SGCNAI--------TMHIVGTQGYIAPEYL 502
           + H+D+ S N+L+ ++    I++FGL+   +G   +         +  VGT  Y+APE L
Sbjct: 141 ISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVL 200
Query: 503 ADGVVSTK--------MDVFSFGVVLLELI 524
            +G V+ +        +D+++ G++  E+ 
Sbjct: 201 -EGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 89/173 (51%), Gaps = 21/173 (12%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLH------ENKNENLN 427
           EE+ + + + H N+V+  G     E+    +  E +  GSL + L       ++  + + 
Sbjct: 54  EEIALHKHLKHKNIVQYLGSF--SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG 111
Query: 428 WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS-NMRAKIANFGLAK--SGCN 484
           + T+      +  GL+Y+H++   ++VH+DIK  N+L+++ +   KI++FG +K  +G N
Sbjct: 112 FYTK-----QILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 163
Query: 485 AITMHIVGTQGYIAPEYLADGV--VSTKMDVFSFGVVLLELISGKEAIDEEGK 535
             T    GT  Y+APE +  G        D++S G  ++E+ +GK    E G+
Sbjct: 164 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE 216

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 76/156 (48%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY   G + S  H  +    +   
Sbjct: 88  HTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYAPGGEMFS--HLRRIGRFSEPH 143
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+++D     K+ +FG AK      T  +
Sbjct: 144 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKR-VKGRTWXL 199
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 76/156 (48%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY   G + S  H  +    +   
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYAPGGEMFS--HLRRIGRFSEPH 142
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+++D     K+ +FG AK      T  +
Sbjct: 143 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKR-VKGRTWXL 198
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 87/166 (52%), Gaps = 19/166 (11%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDP-----EDANCYLIYEYIENGSLHSWLHENKNENLNWK 429
           ELKIL+   H N++ ++   + P     E  + Y++ + +E+  LH  +H   ++ L  +
Sbjct: 103 ELKILKHFKHDNIIAIKDI-LRPTVPYGEFKSVYVVLDLMES-DLHQIIH--SSQPLTLE 158
Query: 430 TRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH 489
                   +  GL+Y+H     +V+H+D+K SN+L++ N   KI +FG+A+  C +   H
Sbjct: 159 HVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEH 215
Query: 490 ------IVGTQGYIAPE-YLADGVVSTKMDVFSFGVVLLELISGKE 528
                  V T+ Y APE  L+    +  +D++S G +  E+++ ++
Sbjct: 216 QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY+  G + S  H  +    +   
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGGEMFS--HLRRIGRFSEPH 142
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+L+D     ++ +FG AK      T  +
Sbjct: 143 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ ++ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY   G + S  H  +    +   
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYAPGGEMFS--HLRRIGRFSEPH 142
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+++D     ++ +FGLAK      T  +
Sbjct: 143 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIQVTDFGLAKR-VKGRTWXL 198
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 93/186 (50%), Gaps = 25/186 (13%)
Query: 363 YAIKMMKWNACE-----ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSW 417
           YA+K++K    +     E+ +L +++H N++KL+     P + +  L+ E +  G L   
Sbjct: 81  YALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS--LVLELVTGGELFDR 138
Query: 418 LHENKNENLNWKTRLRIAID----VANGLQYIHEHTRPRVVHKDIKSSNILLDS---NMR 470
           + E    +       R A D    +   + Y+HE+    +VH+D+K  N+L  +   +  
Sbjct: 139 IVEKGYYSE------RDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAP 189
Query: 471 AKIANFGLAKSGCNAITMHIV-GTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEA 529
            KIA+FGL+K   + + M  V GT GY APE L       ++D++S G++   L+ G E 
Sbjct: 190 LKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249
Query: 530 I-DEEG 534
             DE G
Sbjct: 250 FYDERG 255

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 92/200 (46%), Gaps = 26/200 (13%)
Query: 342 NFSEGCLIQGSVYKGNIHGEVYAIKMMKWNAC----------EELKILQKVNHGNLVKLE 391
           +F + C++Q +  K     ++YA+K M    C          +EL+I+Q + H  LV L 
Sbjct: 27  SFGKVCIVQKNDTK-----KMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 392 GFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRP 451
               D ED   +++ + +  G L    H  +N +   +T      ++   L Y+      
Sbjct: 82  YSFQDEEDM--FMVVDLLLGGDLR--YHLQQNVHFKEETVKLFICELVMALDYLQNQ--- 134
Query: 452 RVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM-HIVGTQGYIAPEYLAD---GVV 507
           R++H+D+K  NILLD +    I +F +A        +  + GT+ Y+APE  +       
Sbjct: 135 RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGY 194
Query: 508 STKMDVFSFGVVLLELISGK 527
           S  +D +S GV   EL+ G+
Sbjct: 195 SFAVDWWSLGVTAYELLRGR 214

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 75/160 (46%), Gaps = 15/160 (9%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           EE  I+   N   +V+L  FC   +D   Y++ EY+  G L + L  N +    W     
Sbjct: 124 EERDIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYT 180
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH---I 490
             + +A  L  IH      ++H+D+K  N+LLD +   K+A+FG          +H    
Sbjct: 181 AEVVLA--LDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTA 235
Query: 491 VGTQGYIAPEYL----ADGVVSTKMDVFSFGVVLLELISG 526
           VGT  YI+PE L     DG    + D +S GV L E++ G
Sbjct: 236 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 79/157 (50%), Gaps = 12/157 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+ IL+++ H N++ L     +  D    LI E +  G L  +L E   E+L  +     
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTD--VILILELVAGGELFDFLAEK--ESLTEEEATEF 119
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNI-LLDSNM---RAKIANFGLA-KSGCNAITMH 489
              + NG+ Y+H     ++ H D+K  NI LLD N+   R KI +FGLA K        +
Sbjct: 120 LKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           I GT  ++APE +    +  + D++S GV+   L+SG
Sbjct: 177 IFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 83/170 (48%), Gaps = 11/170 (6%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
            A  E KIL KV+   +V L  +  + +   C L+   +  G +   ++    +N  ++ 
Sbjct: 231 GAMVEKKILAKVHSRFIVSL-AYAFETKTDLC-LVMTIMNGGDIRYHIYNVDEDNPGFQE 288
Query: 431 RLRI--AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLA---KSGCNA 485
              I     + +GL+++H+     ++++D+K  N+LLD +   +I++ GLA   K+G   
Sbjct: 289 PRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG-QT 344
Query: 486 ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK 535
            T    GT G++APE L        +D F+ GV L E+I+ +      G+
Sbjct: 345 KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 394

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 85/187 (45%), Gaps = 30/187 (16%)
Query: 364 AIKMMKWNA--------CEELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K  A          ELKI+  +  H N+V L G C         +I EY   G L
Sbjct: 80  AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT--HGGPVLVITEYCCYGDL 137
Query: 415 HSWLHENK------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSN 462
            ++L                N   + +  L  +  VA G+ ++        +H+D+ + N
Sbjct: 138 LNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARN 194
Query: 463 ILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ----GYIAPEYLADGVVSTKMDVFSFGV 518
           +LL +   AKI +FGLA+   N     + G       ++APE + D V + + DV+S+G+
Sbjct: 195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 254
Query: 519 VLLELIS 525
           +L E+ S
Sbjct: 255 LLWEIFS 261

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 84/156 (53%), Gaps = 11/156 (7%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E  ++  V++ ++ +L G C+    +   LI + +  G L  ++ E+K+ N+  +  L 
Sbjct: 67  DEAYVMASVDNPHVCRLLGICLT---STVQLIMQLMPFGXLLDYVREHKD-NIGSQYLLN 122
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK-SGCNAITMHIVG 492
             + +A G+ Y+ +    R+VH+D+ + N+L+ +    KI +FGLAK  G      H  G
Sbjct: 123 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 179
Query: 493 TQ---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
            +    ++A E +   + + + DV+S+GV + EL++
Sbjct: 180 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 75/156 (48%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY   G + S  H  +        
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYAPGGEMFS--HLRRIGRFXEPH 142
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+++D     K+ +FG AK      T  +
Sbjct: 143 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKR-VKGRTWXL 198
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 82/160 (51%), Gaps = 13/160 (8%)
Query: 372 ACEELKILQKVNHGNLVKLEGFCID----PEDANCYLIYEYIENGSLHSWLHENKNENLN 427
           A  EL +L+ VNH N++ L           E  + YL+ E ++         E  +E ++
Sbjct: 70  AYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMS 129
Query: 428 WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC-NAI 486
           +     +   +  G++++H      ++H+D+K SNI++ S+   KI +FGLA++ C N +
Sbjct: 130 Y-----LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM 181
Query: 487 TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
               V T+ Y APE +     +  +D++S G ++ EL+ G
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 84/156 (53%), Gaps = 11/156 (7%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E  ++  V++ ++ +L G C+    +   LI + +  G L  ++ E+K+ N+  +  L 
Sbjct: 70  DEAYVMASVDNPHVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKD-NIGSQYLLN 125
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK-SGCNAITMHIVG 492
             + +A G+ Y+ +    R+VH+D+ + N+L+ +    KI +FGLAK  G      H  G
Sbjct: 126 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 182
Query: 493 TQ---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
            +    ++A E +   + + + DV+S+GV + EL++
Sbjct: 183 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 84/156 (53%), Gaps = 11/156 (7%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E  ++  V++ ++ +L G C+    +   LI + +  G L  ++ E+K+ N+  +  L 
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKD-NIGSQYLLN 121
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK-SGCNAITMHIVG 492
             + +A G+ Y+ +    R+VH+D+ + N+L+ +    KI +FGLAK  G      H  G
Sbjct: 122 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178
Query: 493 TQ---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
            +    ++A E +   + + + DV+S+GV + EL++
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 83/170 (48%), Gaps = 11/170 (6%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
            A  E KIL KV+   +V L  +  + +   C L+   +  G +   ++    +N  ++ 
Sbjct: 231 GAMVEKKILAKVHSRFIVSL-AYAFETKTDLC-LVMTIMNGGDIRYHIYNVDEDNPGFQE 288
Query: 431 RLRI--AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLA---KSGCNA 485
              I     + +GL+++H+     ++++D+K  N+LLD +   +I++ GLA   K+G   
Sbjct: 289 PRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG-QT 344
Query: 486 ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK 535
            T    GT G++APE L        +D F+ GV L E+I+ +      G+
Sbjct: 345 KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 394

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 84/156 (53%), Gaps = 11/156 (7%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E  ++  V++ ++ +L G C+    +   LI + +  G L  ++ E+K+ N+  +  L 
Sbjct: 67  DEAYVMASVDNPHVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKD-NIGSQYLLN 122
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK-SGCNAITMHIVG 492
             + +A G+ Y+ +    R+VH+D+ + N+L+ +    KI +FGLAK  G      H  G
Sbjct: 123 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 179
Query: 493 TQ---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
            +    ++A E +   + + + DV+S+GV + EL++
Sbjct: 180 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 84/156 (53%), Gaps = 11/156 (7%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E  ++  V++ ++ +L G C+    +   LI + +  G L  ++ E+K+ N+  +  L 
Sbjct: 100 DEAYVMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKD-NIGSQYLLN 155
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK-SGCNAITMHIVG 492
             + +A G+ Y+ +    R+VH+D+ + N+L+ +    KI +FGLAK  G      H  G
Sbjct: 156 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 212
Query: 493 TQ---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
            +    ++A E +   + + + DV+S+GV + EL++
Sbjct: 213 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 83/170 (48%), Gaps = 11/170 (6%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
            A  E KIL KV+   +V L  +  + +   C L+   +  G +   ++    +N  ++ 
Sbjct: 231 GAMVEKKILAKVHSRFIVSL-AYAFETKTDLC-LVMTIMNGGDIRYHIYNVDEDNPGFQE 288
Query: 431 RLRI--AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLA---KSGCNA 485
              I     + +GL+++H+     ++++D+K  N+LLD +   +I++ GLA   K+G   
Sbjct: 289 PRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG-QT 344
Query: 486 ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK 535
            T    GT G++APE L        +D F+ GV L E+I+ +      G+
Sbjct: 345 KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 394

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 84/156 (53%), Gaps = 11/156 (7%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E  ++  V++ ++ +L G C+    +   LI + +  G L  ++ E+K+ N+  +  L 
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKD-NIGSQYLLN 123
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK-SGCNAITMHIVG 492
             + +A G+ Y+ +    R+VH+D+ + N+L+ +    KI +FGLAK  G      H  G
Sbjct: 124 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 180
Query: 493 TQ---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
            +    ++A E +   + + + DV+S+GV + EL++
Sbjct: 181 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 84/156 (53%), Gaps = 11/156 (7%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E  ++  V++ ++ +L G C+    +   LI + +  G L  ++ E+K+ N+  +  L 
Sbjct: 91  DEAYVMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKD-NIGSQYLLN 146
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK-SGCNAITMHIVG 492
             + +A G+ Y+ +    R+VH+D+ + N+L+ +    KI +FGLAK  G      H  G
Sbjct: 147 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 203
Query: 493 TQ---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
            +    ++A E +   + + + DV+S+GV + EL++
Sbjct: 204 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 93/189 (49%), Gaps = 29/189 (15%)
Query: 361 EVYAIKMMKWNACE--------ELKILQKVNHGNLVKL-EGFCIDPEDANCYLIYEYIEN 411
           E  AIK +    C+        E++ + + +H N+V     F +  E    +L+ + +  
Sbjct: 41  EKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE---LWLVMKLLSG 97
Query: 412 GSLHSWLH------ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL 465
           GS+   +       E+K+  L+  T   I  +V  GL+Y+H++ +   +H+D+K+ NILL
Sbjct: 98  GSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILL 154
Query: 466 DSNMRAKIANFG----LAKSGC---NAITMHIVGTQGYIAPEYLAD-GVVSTKMDVFSFG 517
             +   +IA+FG    LA  G    N +    VGT  ++APE +        K D++SFG
Sbjct: 155 GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFG 214
Query: 518 VVLLELISG 526
           +  +EL +G
Sbjct: 215 ITAIELATG 223

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 83/170 (48%), Gaps = 11/170 (6%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
            A  E KIL KV+   +V L  +  + +   C L+   +  G +   ++    +N  ++ 
Sbjct: 231 GAMVEKKILAKVHSRFIVSL-AYAFETKTDLC-LVMTIMNGGDIRYHIYNVDEDNPGFQE 288
Query: 431 RLRI--AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLA---KSGCNA 485
              I     + +GL+++H+     ++++D+K  N+LLD +   +I++ GLA   K+G   
Sbjct: 289 PRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG-QT 344
Query: 486 ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK 535
            T    GT G++APE L        +D F+ GV L E+I+ +      G+
Sbjct: 345 KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 394

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 84/156 (53%), Gaps = 11/156 (7%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E  ++  V++ ++ +L G C+    +   LI + +  G L  ++ E+K+ N+  +  L 
Sbjct: 69  DEAYVMASVDNPHVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKD-NIGSQYLLN 124
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK-SGCNAITMHIVG 492
             + +A G+ Y+ +    R+VH+D+ + N+L+ +    KI +FGLAK  G      H  G
Sbjct: 125 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 181
Query: 493 TQ---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
            +    ++A E +   + + + DV+S+GV + EL++
Sbjct: 182 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 84/156 (53%), Gaps = 11/156 (7%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E  ++  V++ ++ +L G C+    +   LI + +  G L  ++ E+K+ N+  +  L 
Sbjct: 73  DEAYVMASVDNPHVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKD-NIGSQYLLN 128
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK-SGCNAITMHIVG 492
             + +A G+ Y+ +    R+VH+D+ + N+L+ +    KI +FGLAK  G      H  G
Sbjct: 129 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 185
Query: 493 TQ---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
            +    ++A E +   + + + DV+S+GV + EL++
Sbjct: 186 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 12/157 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+ IL+++ H N++ L     +  D    LI E +  G L  +L E   E+L      + 
Sbjct: 65  EVNILREIRHPNIITLHDIFENKTD--VVLILELVSGGELFDFLAEK--ESLTEDEATQF 120
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNI-LLDSNM---RAKIANFGLA-KSGCNAITMH 489
              + +G+ Y+H     R+ H D+K  NI LLD N+   R K+ +FG+A K        +
Sbjct: 121 LKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN 177
Query: 490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           I GT  ++APE +    +  + D++S GV+   L+SG
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 93/189 (49%), Gaps = 29/189 (15%)
Query: 361 EVYAIKMMKWNACE--------ELKILQKVNHGNLVKL-EGFCIDPEDANCYLIYEYIEN 411
           E  AIK +    C+        E++ + + +H N+V     F +  E    +L+ + +  
Sbjct: 36  EKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE---LWLVMKLLSG 92
Query: 412 GSLHSWLH------ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL 465
           GS+   +       E+K+  L+  T   I  +V  GL+Y+H++ +   +H+D+K+ NILL
Sbjct: 93  GSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILL 149
Query: 466 DSNMRAKIANFG----LAKSGC---NAITMHIVGTQGYIAPEYLAD-GVVSTKMDVFSFG 517
             +   +IA+FG    LA  G    N +    VGT  ++APE +        K D++SFG
Sbjct: 150 GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFG 209
Query: 518 VVLLELISG 526
           +  +EL +G
Sbjct: 210 ITAIELATG 218

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 84/156 (53%), Gaps = 11/156 (7%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E  ++  V++ ++ +L G C+    +   LI + +  G L  ++ E+K+ N+  +  L 
Sbjct: 76  DEAYVMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKD-NIGSQYLLN 131
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK-SGCNAITMHIVG 492
             + +A G+ Y+ +    R+VH+D+ + N+L+ +    KI +FGLAK  G      H  G
Sbjct: 132 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 188
Query: 493 TQ---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
            +    ++A E +   + + + DV+S+GV + EL++
Sbjct: 189 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 88/181 (48%), Gaps = 26/181 (14%)
Query: 361 EVYAIKMMKWNACE---------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN 411
           ++YA+K++K    +         E  IL +VNH  +VKL  +    E    YLI +++  
Sbjct: 53  QLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLH-YAFQTE-GKLYLILDFLRG 110
Query: 412 GSLHSWLHEN---KNENLN-WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS 467
           G L + L +      E++  +   L +A+D  + L          ++++D+K  NILLD 
Sbjct: 111 GDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---------IIYRDLKPENILLDE 161
Query: 468 NMRAKIANFGLAKSGCN--AITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
               K+ +FGL+K   +         GT  Y+APE +     +   D +SFGV++ E+++
Sbjct: 162 EGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 221
Query: 526 G 526
           G
Sbjct: 222 G 222

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 84/156 (53%), Gaps = 11/156 (7%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E  ++  V++ ++ +L G C+    +   LI + +  G L  ++ E+K+ N+  +  L 
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLT---STVQLITQLMPFGXLLDYVREHKD-NIGSQYLLN 121
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK-SGCNAITMHIVG 492
             + +A G+ Y+ +    R+VH+D+ + N+L+ +    KI +FGLAK  G      H  G
Sbjct: 122 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178
Query: 493 TQ---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
            +    ++A E +   + + + DV+S+GV + EL++
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 84/156 (53%), Gaps = 11/156 (7%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E  ++  V++ ++ +L G C+    +   LI + +  G L  ++ E+K+ N+  +  L 
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKD-NIGSQYLLN 121
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK-SGCNAITMHIVG 492
             + +A G+ Y+ +    R+VH+D+ + N+L+ +    KI +FGLAK  G      H  G
Sbjct: 122 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178
Query: 493 TQ---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
            +    ++A E +   + + + DV+S+GV + EL++
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 84/156 (53%), Gaps = 11/156 (7%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E  ++  V++ ++ +L G C+    +   LI + +  G L  ++ E+K+ N+  +  L 
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKD-NIGSQYLLN 123
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK-SGCNAITMHIVG 492
             + +A G+ Y+ +    R+VH+D+ + N+L+ +    KI +FGLAK  G      H  G
Sbjct: 124 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 180
Query: 493 TQ---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
            +    ++A E +   + + + DV+S+GV + EL++
Sbjct: 181 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 12/157 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+ IL+++ H N++ L     +  D    LI E +  G L  +L E   E+L      + 
Sbjct: 58  EVNILREIRHPNIITLHDIFENKTD--VVLILELVSGGELFDFLAEK--ESLTEDEATQF 113
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNI-LLDSNM---RAKIANFGLA-KSGCNAITMH 489
              + +G+ Y+H     R+ H D+K  NI LLD N+   R K+ +FG+A K        +
Sbjct: 114 LKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN 170
Query: 490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           I GT  ++APE +    +  + D++S GV+   L+SG
Sbjct: 171 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 84/156 (53%), Gaps = 11/156 (7%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E  ++  V++ ++ +L G C+    +   LI + +  G L  ++ E+K+ N+  +  L 
Sbjct: 69  DEAYVMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKD-NIGSQYLLN 124
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK-SGCNAITMHIVG 492
             + +A G+ Y+ +    R+VH+D+ + N+L+ +    KI +FGLAK  G      H  G
Sbjct: 125 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 181
Query: 493 TQ---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
            +    ++A E +   + + + DV+S+GV + EL++
Sbjct: 182 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 86/187 (45%), Gaps = 16/187 (8%)
Query: 351 GSVYKGNIHGEVYAIKMMK---WNA------CEELKILQKVNHGNLVKLEGFCIDPEDAN 401
           G ++KG   G    +K++K   W+        EE   L+  +H N++ + G C  P   +
Sbjct: 24  GELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83
Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSS 461
             LI  +   GSL++ LHE  N  ++    ++ A+D A G  ++H    P +    + S 
Sbjct: 84  PTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLHT-LEPLIPRHALNSR 142
Query: 462 NILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVST---KMDVFSFGV 518
           ++ +D +  A+I+   +  S  +    +      ++APE L      T     D +SF V
Sbjct: 143 SVXIDEDXTARISXADVKFSFQSPGRXY---APAWVAPEALQKKPEDTNRRSADXWSFAV 199
Query: 519 VLLELIS 525
           +L EL++
Sbjct: 200 LLWELVT 206

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 84/156 (53%), Gaps = 11/156 (7%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E  ++  V++ ++ +L G C+    +   LI + +  G L  ++ E+K+ N+  +  L 
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKD-NIGSQYLLN 121
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK-SGCNAITMHIVG 492
             + +A G+ Y+ +    R+VH+D+ + N+L+ +    KI +FGLAK  G      H  G
Sbjct: 122 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178
Query: 493 TQ---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
            +    ++A E +   + + + DV+S+GV + EL++
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 84/156 (53%), Gaps = 11/156 (7%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E  ++  V++ ++ +L G C+    +   LI + +  G L  ++ E+K+ N+  +  L 
Sbjct: 73  DEAYVMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKD-NIGSQYLLN 128
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK-SGCNAITMHIVG 492
             + +A G+ Y+ +    R+VH+D+ + N+L+ +    KI +FGLAK  G      H  G
Sbjct: 129 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 185
Query: 493 TQ---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
            +    ++A E +   + + + DV+S+GV + EL++
Sbjct: 186 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 84/156 (53%), Gaps = 11/156 (7%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E  ++  V++ ++ +L G C+    +   LI + +  G L  ++ E+K+ N+  +  L 
Sbjct: 69  DEAYVMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKD-NIGSQYLLN 124
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK-SGCNAITMHIVG 492
             + +A G+ Y+ +    R+VH+D+ + N+L+ +    KI +FGLAK  G      H  G
Sbjct: 125 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 181
Query: 493 TQ---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
            +    ++A E +   + + + DV+S+GV + EL++
Sbjct: 182 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 84/156 (53%), Gaps = 11/156 (7%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E  ++  V++ ++ +L G C+    +   LI + +  G L  ++ E+K+ N+  +  L 
Sbjct: 69  DEAYVMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKD-NIGSQYLLN 124
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK-SGCNAITMHIVG 492
             + +A G+ Y+ +    R+VH+D+ + N+L+ +    KI +FGLAK  G      H  G
Sbjct: 125 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 181
Query: 493 TQ---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
            +    ++A E +   + + + DV+S+GV + EL++
Sbjct: 182 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 79/157 (50%), Gaps = 12/157 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+ IL+++ H N++ L     +  D    LI E +  G L  +L E   E+L  +     
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTD--VILILELVAGGELFDFLAEK--ESLTEEEATEF 119
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNI-LLDSNM---RAKIANFGLA-KSGCNAITMH 489
              + NG+ Y+H     ++ H D+K  NI LLD N+   R KI +FGLA K        +
Sbjct: 120 LKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           I GT  ++APE +    +  + D++S GV+   L+SG
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 12/157 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+ IL+++ H N++ L     +  D    LI E +  G L  +L E   E+L      + 
Sbjct: 79  EVNILREIRHPNIITLHDIFENKTD--VVLILELVSGGELFDFLAEK--ESLTEDEATQF 134
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNI-LLDSNM---RAKIANFGLA-KSGCNAITMH 489
              + +G+ Y+H     R+ H D+K  NI LLD N+   R K+ +FG+A K        +
Sbjct: 135 LKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN 191
Query: 490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           I GT  ++APE +    +  + D++S GV+   L+SG
Sbjct: 192 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 84/156 (53%), Gaps = 11/156 (7%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E  ++  V++ ++ +L G C+    +   LI + +  G L  ++ E+K+ N+  +  L 
Sbjct: 73  DEAYVMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKD-NIGSQYLLN 128
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK-SGCNAITMHIVG 492
             + +A G+ Y+ +    R+VH+D+ + N+L+ +    KI +FGLAK  G      H  G
Sbjct: 129 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 185
Query: 493 TQ---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
            +    ++A E +   + + + DV+S+GV + EL++
Sbjct: 186 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 96/183 (52%), Gaps = 20/183 (10%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL-HSWLHENKNENLNWKTRLR 433
           E+ +L+ ++H N++KL  F +  +    YL+ E+ E G L    ++ +K +  +    ++
Sbjct: 96  EISLLKSLDHPNIIKL--FDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMK 153
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLD---SNMRAKIANFGLAKSGCNAITMHI 490
               + +G+ Y+H+H    +VH+DIK  NILL+   S +  KI +FGL+        +  
Sbjct: 154 ---QILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD 207
Query: 491 -VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYWREMK 549
            +GT  YIAPE L     + K DV+S GV++  L+ G         F GQ  +   ++++
Sbjct: 208 RLGTAYYIAPEVLKKK-YNEKCDVWSCGVIMYILLCGYPP------FGGQNDQDIIKKVE 260
Query: 550 RGK 552
           +GK
Sbjct: 261 KGK 263

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 104/207 (50%), Gaps = 43/207 (20%)
Query: 351 GSVYKGNIH---GEVYAIKMMKWNA-------CEELK--------ILQKV-NHGNLVKLE 391
            SV +  +H   G  +A+K+M+  A        EE++        IL++V  H +++ L 
Sbjct: 107 SSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL- 165
Query: 392 GFCIDPEDANCY--LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHT 449
              ID  +++ +  L+++ +  G L  +L E     L+ K    I   +   + ++H + 
Sbjct: 166 ---IDSYESSSFMFLVFDLMRKGELFDYLTEKVA--LSEKETRSIMRSLLEAVSFLHANN 220
Query: 450 RPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN----AITMHIVGTQGYIAPEYLADG 505
              +VH+D+K  NILLD NM+ ++++FG +   C+         + GT GY+APE L   
Sbjct: 221 ---IVHRDLKPENILLDDNMQIRLSDFGFS---CHLEPGEKLRELCGTPGYLAPEILKCS 274
Query: 506 VVST------KMDVFSFGVVLLELISG 526
           +  T      ++D+++ GV+L  L++G
Sbjct: 275 MDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 84/156 (53%), Gaps = 11/156 (7%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E  ++  V++ ++ +L G C+    +   LI + +  G L  ++ E+K+ N+  +  L 
Sbjct: 63  DEAYVMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKD-NIGSQYLLN 118
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK-SGCNAITMHIVG 492
             + +A G+ Y+ +    R+VH+D+ + N+L+ +    KI +FGLAK  G      H  G
Sbjct: 119 WCVQIAEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 175
Query: 493 TQ---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
            +    ++A E +   + + + DV+S+GV + EL++
Sbjct: 176 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 84/156 (53%), Gaps = 11/156 (7%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E  ++  V++ ++ +L G C+    +   LI + +  G L  ++ E+K+ N+  +  L 
Sbjct: 60  DEAYVMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKD-NIGSQYLLN 115
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK-SGCNAITMHIVG 492
             + +A G+ Y+ +    R+VH+D+ + N+L+ +    KI +FGLAK  G      H  G
Sbjct: 116 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 172
Query: 493 TQ---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
            +    ++A E +   + + + DV+S+GV + EL++
Sbjct: 173 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 76/156 (48%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY   G + S  H  +    +   
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYAPGGEMFS--HLRRIGRFSEPH 142
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+++D     ++ +FG AK      T  +
Sbjct: 143 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 76/156 (48%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY+  G + S  H  +    +   
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGGEMFS--HLRRIGRFSEPH 142
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+L+D     ++ +FG AK      T  +
Sbjct: 143 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+AP  +     +  +D ++ GV++ E+ +G
Sbjct: 199 CGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 79/157 (50%), Gaps = 12/157 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+ IL+++ H N++ L     +  D    LI E +  G L  +L E   E+L  +     
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTD--VILILELVAGGELFDFLAEK--ESLTEEEATEF 119
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNI-LLDSNM---RAKIANFGLA-KSGCNAITMH 489
              + NG+ Y+H     ++ H D+K  NI LLD N+   R KI +FGLA K        +
Sbjct: 120 LKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           I GT  ++APE +    +  + D++S GV+   L+SG
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 79/157 (50%), Gaps = 12/157 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+ IL+++ H N++ L     +  D    LI E +  G L  +L E   E+L  +     
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTD--VILILELVAGGELFDFLAEK--ESLTEEEATEF 119
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNI-LLDSNM---RAKIANFGLA-KSGCNAITMH 489
              + NG+ Y+H     ++ H D+K  NI LLD N+   R KI +FGLA K        +
Sbjct: 120 LKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           I GT  ++APE +    +  + D++S GV+   L+SG
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 79/157 (50%), Gaps = 12/157 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+ IL+++ H N++ L     +  D    LI E +  G L  +L E   E+L  +     
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTD--VILILELVAGGELFDFLAEK--ESLTEEEATEF 119
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNI-LLDSNM---RAKIANFGLA-KSGCNAITMH 489
              + NG+ Y+H     ++ H D+K  NI LLD N+   R KI +FGLA K        +
Sbjct: 120 LKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           I GT  ++APE +    +  + D++S GV+   L+SG
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 79/157 (50%), Gaps = 12/157 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+ IL+++ H N++ L     +  D    LI E +  G L  +L E   E+L  +     
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTD--VILILELVAGGELFDFLAEK--ESLTEEEATEF 118
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNI-LLDSNM---RAKIANFGLA-KSGCNAITMH 489
              + NG+ Y+H     ++ H D+K  NI LLD N+   R KI +FGLA K        +
Sbjct: 119 LKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 175
Query: 490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           I GT  ++APE +    +  + D++S GV+   L+SG
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 84/156 (53%), Gaps = 11/156 (7%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E  ++  V++ ++ +L G C+    +   LI + +  G L  ++ E+K+ N+  +  L 
Sbjct: 72  DEAYVMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKD-NIGSQYLLN 127
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK-SGCNAITMHIVG 492
             + +A G+ Y+ +    R+VH+D+ + N+L+ +    KI +FGLAK  G      H  G
Sbjct: 128 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 184
Query: 493 TQ---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
            +    ++A E +   + + + DV+S+GV + EL++
Sbjct: 185 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 84/156 (53%), Gaps = 11/156 (7%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E  ++  V++ ++ +L G C+    +   LI + +  G L  ++ E+K+ N+  +  L 
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKD-NIGSQYLLN 121
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK-SGCNAITMHIVG 492
             + +A G+ Y+ +    R+VH+D+ + N+L+ +    KI +FGLAK  G      H  G
Sbjct: 122 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178
Query: 493 TQ---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
            +    ++A E +   + + + DV+S+GV + EL++
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 79/157 (50%), Gaps = 12/157 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+ IL+++ H N++ L     +  D    LI E +  G L  +L E   E+L  +     
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTD--VILILELVAGGELFDFLAEK--ESLTEEEATEF 119
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNI-LLDSNM---RAKIANFGLA-KSGCNAITMH 489
              + NG+ Y+H     ++ H D+K  NI LLD N+   R KI +FGLA K        +
Sbjct: 120 LKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           I GT  ++APE +    +  + D++S GV+   L+SG
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 79/157 (50%), Gaps = 12/157 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+ IL+++ H N++ L     +  D    LI E +  G L  +L E   E+L  +     
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTD--VILILELVAGGELFDFLAEK--ESLTEEEATEF 118
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNI-LLDSNM---RAKIANFGLA-KSGCNAITMH 489
              + NG+ Y+H     ++ H D+K  NI LLD N+   R KI +FGLA K        +
Sbjct: 119 LKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 175
Query: 490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           I GT  ++APE +    +  + D++S GV+   L+SG
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 79/157 (50%), Gaps = 12/157 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+ IL+++ H N++ L     +  D    LI E +  G L  +L E   E+L  +     
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTD--VILILELVAGGELFDFLAEK--ESLTEEEATEF 119
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNI-LLDSNM---RAKIANFGLA-KSGCNAITMH 489
              + NG+ Y+H     ++ H D+K  NI LLD N+   R KI +FGLA K        +
Sbjct: 120 LKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           I GT  ++APE +    +  + D++S GV+   L+SG
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 90/185 (48%), Gaps = 31/185 (16%)
Query: 360 GEVYAIK---------MMKWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE 410
           G++ AIK         ++K  A  E+++L+++ H NLV L    +       +L++EY +
Sbjct: 28  GQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNL--LEVFRRKRRLHLVFEYCD 85
Query: 411 NGSLHSW------LHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNIL 464
           +  LH        + E+  +++ W+T           + + H+H     +H+D+K  NIL
Sbjct: 86  HTVLHELDRYQRGVPEHLVKSITWQT--------LQAVNFCHKHN---CIHRDVKPENIL 134
Query: 465 LDSNMRAKIANFGLAK--SGCNAITMHIVGTQGYIAPEYL-ADGVVSTKMDVFSFGVVLL 521
           +  +   K+ +FG A+  +G +      V T+ Y +PE L  D      +DV++ G V  
Sbjct: 135 ITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFA 194
Query: 522 ELISG 526
           EL+SG
Sbjct: 195 ELLSG 199

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 79/157 (50%), Gaps = 12/157 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+ IL+++ H N++ L     +  D    LI E +  G L  +L E   E+L  +     
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTD--VILILELVAGGELFDFLAEK--ESLTEEEATEF 119
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNI-LLDSNM---RAKIANFGLA-KSGCNAITMH 489
              + NG+ Y+H     ++ H D+K  NI LLD N+   R KI +FGLA K        +
Sbjct: 120 LKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           I GT  ++APE +    +  + D++S GV+   L+SG
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 79/157 (50%), Gaps = 12/157 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+ IL+++ H N++ L     +  D    LI E +  G L  +L E   E+L  +     
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTD--VILILELVAGGELFDFLAEK--ESLTEEEATEF 119
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNI-LLDSNM---RAKIANFGLA-KSGCNAITMH 489
              + NG+ Y+H     ++ H D+K  NI LLD N+   R KI +FGLA K        +
Sbjct: 120 LKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           I GT  ++APE +    +  + D++S GV+   L+SG
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 79/157 (50%), Gaps = 12/157 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+ IL+++ H N++ L     +  D    LI E +  G L  +L E   E+L  +     
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTD--VILILELVAGGELFDFLAEK--ESLTEEEATEF 119
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNI-LLDSNM---RAKIANFGLA-KSGCNAITMH 489
              + NG+ Y+H     ++ H D+K  NI LLD N+   R KI +FGLA K        +
Sbjct: 120 LKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           I GT  ++APE +    +  + D++S GV+   L+SG
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 86/179 (48%), Gaps = 22/179 (12%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDP---EDANCYLIYEYIENGSLHSWLHENKNENLNWKTR 431
           E+KIL +  H N++ +      P   +  + Y++ + +E   L+  L   K ++L+    
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHI 126
Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG-----CNAI 486
                 +  GL+YIH      V+H+D+K SN+LL++    KI +FGLA+           
Sbjct: 127 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGF 183
Query: 487 TMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELIS------GKEAIDEEGKFCG 538
               V T+ Y APE + +    TK +D++S G +L E++S      GK  +D+     G
Sbjct: 184 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 242

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 99/195 (50%), Gaps = 25/195 (12%)
Query: 351 GSVYKG--NIHGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDA 400
            +VYKG     G   A+K +K +        A  E+ +++++ H N+V+L  + +   + 
Sbjct: 19  ATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRL--YDVIHTEN 76
Query: 401 NCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIA----IDVANGLQYIHEHTRPRVVHK 456
              L++E+++N  L  ++      N      L +       +  GL + HE+   +++H+
Sbjct: 77  KLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHR 132
Query: 457 DIKSSNILLDSNMRAKIANFGLAKS---GCNAITMHIVGTQGYIAPEYL-ADGVVSTKMD 512
           D+K  N+L++   + K+ +FGLA++     N  +  +V T  Y AP+ L      ST +D
Sbjct: 133 DLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAPDVLMGSRTYSTSID 191
Query: 513 VFSFGVVLLELISGK 527
           ++S G +L E+I+GK
Sbjct: 192 IWSCGCILAEMITGK 206

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 86/167 (51%), Gaps = 19/167 (11%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLN------- 427
           E  ++++ N  ++V+L G  +  +     +I E +  G L S+L   + E  N       
Sbjct: 72  EASVMKEFNCHHVVRLLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 129
Query: 428 -WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI 486
                +++A ++A+G+ Y++ +   + VH+D+ + N ++  +   KI +FG+ +      
Sbjct: 130 SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD-IYET 185
Query: 487 TMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELISGKE 528
             +  G +G     +++PE L DGV +T  DV+SFGVVL E+ +  E
Sbjct: 186 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 232

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 86/167 (51%), Gaps = 19/167 (11%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLN------- 427
           E  ++++ N  ++V+L G  +  +     +I E +  G L S+L   + E  N       
Sbjct: 69  EASVMKEFNCHHVVRLLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 126
Query: 428 -WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI 486
                +++A ++A+G+ Y++ +   + VH+D+ + N ++  +   KI +FG+ +      
Sbjct: 127 SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD-IYET 182
Query: 487 TMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELISGKE 528
             +  G +G     +++PE L DGV +T  DV+SFGVVL E+ +  E
Sbjct: 183 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 229

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 88/181 (48%), Gaps = 26/181 (14%)
Query: 361 EVYAIKMMKWNACE---------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN 411
           ++YA+K++K    +         E  IL +VNH  +VKL  +    E    YLI +++  
Sbjct: 53  QLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLH-YAFQTE-GKLYLILDFLRG 110
Query: 412 GSLHSWLHEN---KNENLN-WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS 467
           G L + L +      E++  +   L +A+D  + L          ++++D+K  NILLD 
Sbjct: 111 GDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---------IIYRDLKPENILLDE 161
Query: 468 NMRAKIANFGLAKSGCN--AITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
               K+ +FGL+K   +         GT  Y+APE +     +   D +SFGV++ E+++
Sbjct: 162 EGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 221
Query: 526 G 526
           G
Sbjct: 222 G 222

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 77/154 (50%), Gaps = 12/154 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           EL+I+  + +   +  EG   + ++   Y+IYEY+EN S+  +       + N+   + I
Sbjct: 93  ELQIITDIKNEYCLTCEGIITNYDEV--YIIYEYMENDSILKFDEYFFVLDKNYTCFIPI 150
Query: 435 AI------DVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM 488
            +       V N   YIH      + H+D+K SNIL+D N R K+++FG ++   +    
Sbjct: 151 QVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK 208
Query: 489 HIVGTQGYIAPEYLAD--GVVSTKMDVFSFGVVL 520
              GT  ++ PE+ ++       K+D++S G+ L
Sbjct: 209 GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 75/156 (48%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   L KLE    D  ++N Y++ EY   G + S  H  +    +   
Sbjct: 88  HTLNEKRILQAVNFPFLTKLEFSFKD--NSNLYMVMEYAPGGEMFS--HLRRIGRFSEPH 143
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+++D     K+ +FG AK      T  +
Sbjct: 144 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKR-VKGRTWXL 199
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 86/167 (51%), Gaps = 19/167 (11%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLN------- 427
           E  ++++ N  ++V+L G  +  +     +I E +  G L S+L   + E  N       
Sbjct: 65  EASVMKEFNCHHVVRLLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 122
Query: 428 -WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI 486
                +++A ++A+G+ Y++ +   + VH+D+ + N ++  +   KI +FG+ +      
Sbjct: 123 SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD-IYET 178
Query: 487 TMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELISGKE 528
             +  G +G     +++PE L DGV +T  DV+SFGVVL E+ +  E
Sbjct: 179 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 225

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 86/179 (48%), Gaps = 22/179 (12%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDP---EDANCYLIYEYIENGSLHSWLHENKNENLNWKTR 431
           E+KIL +  H N++ +      P   +  + Y++ + +E   L+  L   K ++L+    
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHI 126
Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG-----CNAI 486
                 +  GL+YIH      V+H+D+K SN+LL++    KI +FGLA+           
Sbjct: 127 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGF 183
Query: 487 TMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELIS------GKEAIDEEGKFCG 538
               V T+ Y APE + +    TK +D++S G +L E++S      GK  +D+     G
Sbjct: 184 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 242

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 75/156 (48%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   L KLE    D  ++N Y++ EY   G + S  H  +    +   
Sbjct: 88  HTLNEKRILQAVNFPFLTKLEFSFKD--NSNLYMVMEYAPGGEMFS--HLRRIGRFSEPH 143
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+++D     K+ +FG AK      T  +
Sbjct: 144 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKR-VKGRTWXL 199
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 86/167 (51%), Gaps = 19/167 (11%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLN------- 427
           E  ++++ N  ++V+L G  +  +     +I E +  G L S+L   + E  N       
Sbjct: 78  EASVMKEFNCHHVVRLLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 135
Query: 428 -WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI 486
                +++A ++A+G+ Y++ +   + VH+D+ + N ++  +   KI +FG+ +      
Sbjct: 136 SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD-IYET 191
Query: 487 TMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELISGKE 528
             +  G +G     +++PE L DGV +T  DV+SFGVVL E+ +  E
Sbjct: 192 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 238

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 114/238 (47%), Gaps = 46/238 (19%)
Query: 327 KYRIFKIEELREATDNF--SEGCLIQGS----VYKGNIHGEVYAIKMMKWNACE----EL 376
           K RI  I    ++  N   SE  L  GS    V++G+  G   A+K M  + C+    E+
Sbjct: 18  KSRIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEI 77
Query: 377 KIL-QKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKN---ENLNWKTR- 431
           K+L +  +H N+++   +C +  D   Y+  E   N +L   L E+KN   ENL  +   
Sbjct: 78  KLLTESDDHPNVIRY--YCSETTDRFLYIALELC-NLNLQD-LVESKNVSDENLKLQKEY 133
Query: 432 --LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS-------------NMRAKIANF 476
             + +   +A+G+ ++H     +++H+D+K  NIL+ +             N+R  I++F
Sbjct: 134 NPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 190
Query: 477 GLAK---SGCNAITMHI---VGTQGYIAPEYLADGV---VSTKMDVFSFGVVLLELIS 525
           GL K   SG      ++    GT G+ APE L +     ++  +D+FS G V   ++S
Sbjct: 191 GLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS 248

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 41/202 (20%)
Query: 360 GEVYAIKMM---------KWNACEELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYI 409
           GEV A+K +               E+ IL +++ H N+V L        D + YL+++Y+
Sbjct: 34  GEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM 93
Query: 410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM 469
           E   LH+ +  N  E ++ +  +   I V   ++Y+H      ++H+D+K SNILL++  
Sbjct: 94  ET-DLHAVIRANILEPVHKQYVVYQLIKV---IKYLHSGG---LLHRDMKPSNILLNAEC 146
Query: 470 RAKIANFGLAKSGCN-----------------------AITMHIVGTQGYIAPEYLADGV 506
             K+A+FGL++S  N                        I    V T+ Y APE L    
Sbjct: 147 HVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGST 206
Query: 507 VSTK-MDVFSFGVVLLELISGK 527
             TK +D++S G +L E++ GK
Sbjct: 207 KYTKGIDMWSLGCILGEILCGK 228

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 88/181 (48%), Gaps = 26/181 (14%)
Query: 361 EVYAIKMMKWNACE---------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN 411
           ++YA+K++K    +         E  IL +VNH  +VKL  +    E    YLI +++  
Sbjct: 54  QLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLH-YAFQTE-GKLYLILDFLRG 111
Query: 412 GSLHSWLHEN---KNENLN-WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS 467
           G L + L +      E++  +   L +A+D  + L          ++++D+K  NILLD 
Sbjct: 112 GDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---------IIYRDLKPENILLDE 162
Query: 468 NMRAKIANFGLAKSGCN--AITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
               K+ +FGL+K   +         GT  Y+APE +     +   D +SFGV++ E+++
Sbjct: 163 EGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 222
Query: 526 G 526
           G
Sbjct: 223 G 223

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 86/167 (51%), Gaps = 19/167 (11%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLN------- 427
           E  ++++ N  ++V+L G  +  +     +I E +  G L S+L   + E  N       
Sbjct: 71  EASVMKEFNCHHVVRLLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 128
Query: 428 -WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI 486
                +++A ++A+G+ Y++ +   + VH+D+ + N ++  +   KI +FG+ +      
Sbjct: 129 SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD-IYET 184
Query: 487 TMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELISGKE 528
             +  G +G     +++PE L DGV +T  DV+SFGVVL E+ +  E
Sbjct: 185 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 231

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 115/238 (48%), Gaps = 46/238 (19%)
Query: 327 KYRIFKIEELREATDNF--SEGCLIQGS----VYKGNIHGEVYAIKMMKWNACE----EL 376
           K RI  I    ++  N   SE  L  GS    V++G+  G   A+K M  + C+    E+
Sbjct: 18  KSRIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEI 77
Query: 377 KIL-QKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKN---ENLNWKTR- 431
           K+L +  +H N+++   +C +  D   Y+  E + N +L   L E+KN   ENL  +   
Sbjct: 78  KLLTESDDHPNVIRY--YCSETTDRFLYIALE-LCNLNLQD-LVESKNVSDENLKLQKEY 133
Query: 432 --LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS-------------NMRAKIANF 476
             + +   +A+G+ ++H     +++H+D+K  NIL+ +             N+R  I++F
Sbjct: 134 NPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 190
Query: 477 GLAK---SGCNAITMHI---VGTQGYIAPEYLADGV---VSTKMDVFSFGVVLLELIS 525
           GL K   SG      ++    GT G+ APE L +     ++  +D+FS G V   ++S
Sbjct: 191 GLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS 248

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 107/225 (47%), Gaps = 40/225 (17%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKGN----IHGEV---YAIKMMKWNAC--------EEL 376
           KI  LRE      +G    G VY+GN    I GE     A+K +  +A          E 
Sbjct: 18  KITLLRE----LGQGSF--GMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEA 71
Query: 377 KILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTR----- 431
            +++     ++V+L G  +  +     ++ E + +G L S+L   + E  N   R     
Sbjct: 72  SVMKGFTCHHVVRLLG--VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 129
Query: 432 ---LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM 488
              +++A ++A+G+ Y++     + VH+++ + N ++  +   KI +FG+ +        
Sbjct: 130 QEMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRD-IYETDY 185
Query: 489 HIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELISGKE 528
           +  G +G     ++APE L DGV +T  D++SFGVVL E+ S  E
Sbjct: 186 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE 230

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 107/225 (47%), Gaps = 40/225 (17%)
Query: 332 KIEELREATDNFSEGCLIQGSVYKGN----IHGEV---YAIKMMKWNAC--------EEL 376
           KI  LRE      +G    G VY+GN    I GE     A+K +  +A          E 
Sbjct: 19  KITLLRE----LGQGSF--GMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEA 72
Query: 377 KILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTR----- 431
            +++     ++V+L G  +  +     ++ E + +G L S+L   + E  N   R     
Sbjct: 73  SVMKGFTCHHVVRLLG--VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 130
Query: 432 ---LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM 488
              +++A ++A+G+ Y++     + VH+++ + N ++  +   KI +FG+ +        
Sbjct: 131 QEMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRD-IYETDY 186
Query: 489 HIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELISGKE 528
           +  G +G     ++APE L DGV +T  D++SFGVVL E+ S  E
Sbjct: 187 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE 231

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 85/167 (50%), Gaps = 19/167 (11%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLN------- 427
           E  ++++ N  ++V+L G  +  +     +I E +  G L S+L   + E  N       
Sbjct: 72  EASVMKEFNCHHVVRLLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 129
Query: 428 -WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI 486
                +++A ++A+G+ Y++ +   + VH+D+ + N ++  +   KI +FG+ +      
Sbjct: 130 SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD-IXET 185
Query: 487 TMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELISGKE 528
                G +G     +++PE L DGV +T  DV+SFGVVL E+ +  E
Sbjct: 186 DXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 232

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 86/179 (48%), Gaps = 22/179 (12%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDP---EDANCYLIYEYIENGSLHSWLHENKNENLNWKTR 431
           E+KIL +  H N++ +      P   +  + Y++ + +E   L+  L   K ++L+    
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHI 126
Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG-----CNAI 486
                 +  GL+YIH      V+H+D+K SN+LL++    KI +FGLA+           
Sbjct: 127 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGF 183
Query: 487 TMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELIS------GKEAIDEEGKFCG 538
               V T+ Y APE + +    TK +D++S G +L E++S      GK  +D+     G
Sbjct: 184 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 242

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 86/167 (51%), Gaps = 19/167 (11%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLN------- 427
           E  ++++ N  ++V+L G  +  +     +I E +  G L S+L   + E  N       
Sbjct: 71  EASVMKEFNCHHVVRLLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 128
Query: 428 -WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI 486
                +++A ++A+G+ Y++ +   + VH+D+ + N ++  +   KI +FG+ +      
Sbjct: 129 SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD-IYET 184
Query: 487 TMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELISGKE 528
             +  G +G     +++PE L DGV +T  DV+SFGVVL E+ +  E
Sbjct: 185 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 231

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 86/179 (48%), Gaps = 22/179 (12%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDP---EDANCYLIYEYIENGSLHSWLHENKNENLNWKTR 431
           E+KIL +  H N++ +      P   +  + Y++ + +E   L+  L   K ++L+    
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHI 130
Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG-----CNAI 486
                 +  GL+YIH      V+H+D+K SN+LL++    KI +FGLA+           
Sbjct: 131 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGF 187
Query: 487 TMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELIS------GKEAIDEEGKFCG 538
               V T+ Y APE + +    TK +D++S G +L E++S      GK  +D+     G
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 246

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 86/179 (48%), Gaps = 22/179 (12%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDP---EDANCYLIYEYIENGSLHSWLHENKNENLNWKTR 431
           E+KIL +  H N++ +      P   +  + Y++ + +E   L+  L   K ++L+    
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHI 130
Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG-----CNAI 486
                 +  GL+YIH      V+H+D+K SN+LL++    KI +FGLA+           
Sbjct: 131 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGF 187
Query: 487 TMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELIS------GKEAIDEEGKFCG 538
               V T+ Y APE + +    TK +D++S G +L E++S      GK  +D+     G
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 246

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 104/236 (44%), Gaps = 40/236 (16%)
Query: 316 NFMADVSDCLDKYRIFKIE-ELREATDNFSEGCLIQGSVYKGNIHGEVYAIKMMK----- 369
           NF++   D ++K R  +++ E  E       G   +  + +     +VYA+K++      
Sbjct: 54  NFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI 113
Query: 370 --------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHEN 421
                   W   EE  I+   N   +V+L  F    +D   Y++ EY+  G L + L  N
Sbjct: 114 KRSDSAFFW---EERDIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVN-LMSN 167
Query: 422 KNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFG---- 477
            +    W  R   A +V   L  IH       +H+D+K  N+LLD +   K+A+FG    
Sbjct: 168 YDVPEKW-ARFYTA-EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK 222
Query: 478 LAKSG---CNAITMHIVGTQGYIAPEYL----ADGVVSTKMDVFSFGVVLLELISG 526
           + K G   C+      VGT  YI+PE L     DG    + D +S GV L E++ G
Sbjct: 223 MNKEGMVRCDT----AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 104/236 (44%), Gaps = 40/236 (16%)
Query: 316 NFMADVSDCLDKYRIFKIE-ELREATDNFSEGCLIQGSVYKGNIHGEVYAIKMMK----- 369
           NF++   D ++K R  +++ E  E       G   +  + +     +VYA+K++      
Sbjct: 49  NFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI 108
Query: 370 --------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHEN 421
                   W   EE  I+   N   +V+L  F    +D   Y++ EY+  G L + L  N
Sbjct: 109 KRSDSAFFW---EERDIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVN-LMSN 162
Query: 422 KNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFG---- 477
            +    W  R   A +V   L  IH       +H+D+K  N+LLD +   K+A+FG    
Sbjct: 163 YDVPEKW-ARFYTA-EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK 217
Query: 478 LAKSG---CNAITMHIVGTQGYIAPEYL----ADGVVSTKMDVFSFGVVLLELISG 526
           + K G   C+      VGT  YI+PE L     DG    + D +S GV L E++ G
Sbjct: 218 MNKEGMVRCDT----AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 82/160 (51%), Gaps = 20/160 (12%)
Query: 375 ELKILQKVNHGNLVK-LEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           E+ ++++  + N+V  L+ + +  E    +++ EY+  GSL   + E   +        R
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDE---LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR 123
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT------ 487
              +    L+++H +   +V+H+DIKS NILL  +   K+ +FG     C  IT      
Sbjct: 124 ---ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF----CAQITPEQSKR 173
Query: 488 MHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
             +VGT  ++APE +       K+D++S G++ +E+I G+
Sbjct: 174 SEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 86/167 (51%), Gaps = 19/167 (11%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLN------- 427
           E  ++++ N  ++V+L G  +  +     +I E +  G L S+L   + E  N       
Sbjct: 100 EASVMKEFNCHHVVRLLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 157
Query: 428 -WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI 486
                +++A ++A+G+ Y++ +   + VH+D+ + N ++  +   KI +FG+ +      
Sbjct: 158 SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD-IYET 213
Query: 487 TMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELISGKE 528
             +  G +G     +++PE L DGV +T  DV+SFGVVL E+ +  E
Sbjct: 214 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 260

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 82/160 (51%), Gaps = 20/160 (12%)
Query: 375 ELKILQKVNHGNLVK-LEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           E+ ++++  + N+V  L+ + +  E    +++ EY+  GSL   + E   +        R
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDE---LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR 123
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH---- 489
              +    L+++H +   +V+H+DIKS NILL  +   K+ +FG     C  IT      
Sbjct: 124 ---ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF----CAQITPEQSKR 173
Query: 490 --IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
             +VGT  ++APE +       K+D++S G++ +E+I G+
Sbjct: 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 104/236 (44%), Gaps = 40/236 (16%)
Query: 316 NFMADVSDCLDKYRIFKIE-ELREATDNFSEGCLIQGSVYKGNIHGEVYAIKMMK----- 369
           NF++   D ++K R  +++ E  E       G   +  + +     +VYA+K++      
Sbjct: 54  NFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI 113
Query: 370 --------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHEN 421
                   W   EE  I+   N   +V+L  F    +D   Y++ EY+  G L + L  N
Sbjct: 114 KRSDSAFFW---EERDIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVN-LMSN 167
Query: 422 KNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFG---- 477
            +    W  R   A +V   L  IH       +H+D+K  N+LLD +   K+A+FG    
Sbjct: 168 YDVPEKW-ARFYTA-EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK 222
Query: 478 LAKSG---CNAITMHIVGTQGYIAPEYL----ADGVVSTKMDVFSFGVVLLELISG 526
           + K G   C+      VGT  YI+PE L     DG    + D +S GV L E++ G
Sbjct: 223 MNKEGMVRCDT----AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 82/160 (51%), Gaps = 20/160 (12%)
Query: 375 ELKILQKVNHGNLVK-LEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           E+ ++++  + N+V  L+ + +  E    +++ EY+  GSL   + E   +        R
Sbjct: 68  EILVMRENKNPNIVNYLDSYLVGDE---LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR 124
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH---- 489
              +    L+++H +   +V+H+DIKS NILL  +   K+ +FG     C  IT      
Sbjct: 125 ---ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF----CAQITPEQSKR 174
Query: 490 --IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
             +VGT  ++APE +       K+D++S G++ +E+I G+
Sbjct: 175 SXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 85/167 (50%), Gaps = 19/167 (11%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLN------- 427
           E  ++++ N  ++V+L G  +  +     +I E +  G L S+L   + E  N       
Sbjct: 63  EASVMKEFNCHHVVRLLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 120
Query: 428 -WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI 486
                +++A ++A+G+ Y++ +   + VH+D+ + N ++  +   KI +FG+ +      
Sbjct: 121 SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD-IXET 176
Query: 487 TMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELISGKE 528
                G +G     +++PE L DGV +T  DV+SFGVVL E+ +  E
Sbjct: 177 DXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 223

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 82/160 (51%), Gaps = 20/160 (12%)
Query: 375 ELKILQKVNHGNLVK-LEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           E+ ++++  + N+V  L+ + +  E    +++ EY+  GSL   + E   +        R
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDE---LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR 123
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH---- 489
              +    L+++H +   +V+H+DIKS NILL  +   K+ +FG     C  IT      
Sbjct: 124 ---ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF----CAQITPEQSKR 173
Query: 490 --IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
             +VGT  ++APE +       K+D++S G++ +E+I G+
Sbjct: 174 SXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 86/179 (48%), Gaps = 22/179 (12%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDP---EDANCYLIYEYIENGSLHSWLHENKNENLNWKTR 431
           E+KIL +  H N++ +      P   +  + Y++ + +E   L+  L   K ++L+    
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHI 130
Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG-----CNAI 486
                 +  GL+YIH      V+H+D+K SN+LL++    KI +FGLA+           
Sbjct: 131 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187
Query: 487 TMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELIS------GKEAIDEEGKFCG 538
               V T+ Y APE + +    TK +D++S G +L E++S      GK  +D+     G
Sbjct: 188 LXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 246

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 79/157 (50%), Gaps = 12/157 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+ IL+++ H N++ L     +  D    LI E +  G L  +L E   E+L  +     
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTD--VILIGELVAGGELFDFLAEK--ESLTEEEATEF 119
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNI-LLDSNM---RAKIANFGLA-KSGCNAITMH 489
              + NG+ Y+H     ++ H D+K  NI LLD N+   R KI +FGLA K        +
Sbjct: 120 LKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           I GT  ++APE +    +  + D++S GV+   L+SG
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 86/179 (48%), Gaps = 22/179 (12%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDP---EDANCYLIYEYIENGSLHSWLHENKNENLNWKTR 431
           E+KIL +  H N++ +      P   +  + Y++ + +E   L+  L   K ++L+    
Sbjct: 76  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHI 131
Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG-----CNAI 486
                 +  GL+YIH      V+H+D+K SN+LL++    KI +FGLA+           
Sbjct: 132 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 188
Query: 487 TMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELIS------GKEAIDEEGKFCG 538
               V T+ Y APE + +    TK +D++S G +L E++S      GK  +D+     G
Sbjct: 189 LXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 247

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 79/157 (50%), Gaps = 12/157 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+ IL+++ H N++ L     +  D    LI E +  G L  +L E   E+L  +     
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTD--VILILELVAGGELFDFLAEK--ESLTEEEATEF 119
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNI-LLDSNM---RAKIANFGLA-KSGCNAITMH 489
              + NG+ Y+H     ++ H D+K  NI LLD N+   R KI +FGLA K        +
Sbjct: 120 LKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           I GT  ++APE +    +  + D++S GV+   L+SG
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 7/152 (4%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E++I   ++H N+++L  +  D      YLI EY   G L+  L   K+   + +    I
Sbjct: 73  EIEIQAHLHHPNILRLYNYFYD--RRRIYLILEYAPRGELYKEL--QKSCTFDEQRTATI 128
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
             ++A+ L Y H     +V+H+DIK  N+LL      KIA+FG +    +     + GT 
Sbjct: 129 MEELADALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMCGTL 185
Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            Y+ PE +   + + K+D++  GV+  EL+ G
Sbjct: 186 DYLPPEMIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 86/179 (48%), Gaps = 22/179 (12%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDP---EDANCYLIYEYIENGSLHSWLHENKNENLNWKTR 431
           E+KIL +  H N++ +      P   +  + Y++ + +E   L+  L   K ++L+    
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHI 130
Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG-----CNAI 486
                 +  GL+YIH      V+H+D+K SN+LL++    KI +FGLA+           
Sbjct: 131 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187
Query: 487 TMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELIS------GKEAIDEEGKFCG 538
               V T+ Y APE + +    TK +D++S G +L E++S      GK  +D+     G
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 246

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 86/179 (48%), Gaps = 22/179 (12%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDP---EDANCYLIYEYIENGSLHSWLHENKNENLNWKTR 431
           E+KIL +  H N++ +      P   +  + Y++ + +E   L+  L   K ++L+    
Sbjct: 73  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHI 128
Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG-----CNAI 486
                 +  GL+YIH      V+H+D+K SN+LL++    KI +FGLA+           
Sbjct: 129 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 185
Query: 487 TMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELIS------GKEAIDEEGKFCG 538
               V T+ Y APE + +    TK +D++S G +L E++S      GK  +D+     G
Sbjct: 186 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 244

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 74/156 (47%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   L KLE    D  ++N Y++ EY   G + S  H  +        
Sbjct: 88  HTLNEKRILQAVNFPFLTKLEFSFKD--NSNLYMVMEYAPGGEMFS--HLRRIGRFXEPH 143
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+++D     K+ +FG AK      T  +
Sbjct: 144 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKR-VKGRTWXL 199
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  Y+APE +     +  +D ++ GV++ E+ +G
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 98/230 (42%), Gaps = 47/230 (20%)
Query: 336 LREATDNFSEGCLIQGSV-----YKGNIHGEVYAIKMMKWNA------CEELKILQKVNH 384
           LR A+D      L QG+       +  +    YAIK ++           E+ +L  +NH
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNH 61
Query: 385 GNLVKLEGFCIDPED-----------ANCYLIYEYIENGSLHSWLHENKNENLNWKTR-- 431
             +V+     ++  +           +  ++  EY EN +L+  +H   +ENLN +    
Sbjct: 62  QYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIH---SENLNQQRDEY 118
Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS---------- 481
            R+   +   L YIH      ++H+++K  NI +D +   KI +FGLAK+          
Sbjct: 119 WRLFRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 482 ------GCNAITMHIVGTQGYIAPEYL-ADGVVSTKMDVFSFGVVLLELI 524
                 G +      +GT  Y+A E L   G  + K+D +S G++  E I
Sbjct: 176 DSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 86/179 (48%), Gaps = 22/179 (12%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDP---EDANCYLIYEYIENGSLHSWLHENKNENLNWKTR 431
           E+KIL +  H N++ +      P   +  + Y++ + +E   L+  L   K ++L+    
Sbjct: 76  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHI 131
Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG-----CNAI 486
                 +  GL+YIH      V+H+D+K SN+LL++    KI +FGLA+           
Sbjct: 132 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 188
Query: 487 TMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELIS------GKEAIDEEGKFCG 538
               V T+ Y APE + +    TK +D++S G +L E++S      GK  +D+     G
Sbjct: 189 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 247

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 86/179 (48%), Gaps = 22/179 (12%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDP---EDANCYLIYEYIENGSLHSWLHENKNENLNWKTR 431
           E+KIL +  H N++ +      P   +  + Y++ + +E   L+  L   K ++L+    
Sbjct: 77  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHI 132
Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG-----CNAI 486
                 +  GL+YIH      V+H+D+K SN+LL++    KI +FGLA+           
Sbjct: 133 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 189
Query: 487 TMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELIS------GKEAIDEEGKFCG 538
               V T+ Y APE + +    TK +D++S G +L E++S      GK  +D+     G
Sbjct: 190 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 248

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 86/179 (48%), Gaps = 22/179 (12%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDP---EDANCYLIYEYIENGSLHSWLHENKNENLNWKTR 431
           E+KIL +  H N++ +      P   +  + Y++ + +E   L+  L   K ++L+    
Sbjct: 68  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHI 123
Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG-----CNAI 486
                 +  GL+YIH      V+H+D+K SN+LL++    KI +FGLA+           
Sbjct: 124 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 180
Query: 487 TMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELIS------GKEAIDEEGKFCG 538
               V T+ Y APE + +    TK +D++S G +L E++S      GK  +D+     G
Sbjct: 181 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 239

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 86/179 (48%), Gaps = 22/179 (12%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDP---EDANCYLIYEYIENGSLHSWLHENKNENLNWKTR 431
           E+KIL +  H N++ +      P   +  + Y++ + +E   L+  L   K ++L+    
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHI 130
Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG-----CNAI 486
                 +  GL+YIH      V+H+D+K SN+LL++    KI +FGLA+           
Sbjct: 131 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187
Query: 487 TMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELIS------GKEAIDEEGKFCG 538
               V T+ Y APE + +    TK +D++S G +L E++S      GK  +D+     G
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 246

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 87/163 (53%), Gaps = 15/163 (9%)
Query: 371 NACEELKILQKVNHGNLVKL-EGFCIDP---EDANCYLIYEYIENGSLHSWLHENKNENL 426
            A  EL++L+ + H N++ L + F  D    +  + YL+  ++         HE   E+ 
Sbjct: 70  RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGED- 128
Query: 427 NWKTRLRIAI-DVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA 485
               R++  +  +  GL+YIH      ++H+D+K  N+ ++ +   KI +FGLA+   + 
Sbjct: 129 ----RIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181
Query: 486 ITMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELISGK 527
           +   +V T+ Y APE + + +  T+ +D++S G ++ E+I+GK
Sbjct: 182 MXGXVV-TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 86/179 (48%), Gaps = 22/179 (12%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDP---EDANCYLIYEYIENGSLHSWLHENKNENLNWKTR 431
           E+KIL +  H N++ +      P   +  + Y++ + +E   L+  L   K ++L+    
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHI 126
Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG-----CNAI 486
                 +  GL+YIH      V+H+D+K SN+LL++    KI +FGLA+           
Sbjct: 127 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 183
Query: 487 TMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELIS------GKEAIDEEGKFCG 538
               V T+ Y APE + +    TK +D++S G +L E++S      GK  +D+     G
Sbjct: 184 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 242

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 86/179 (48%), Gaps = 22/179 (12%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDP---EDANCYLIYEYIENGSLHSWLHENKNENLNWKTR 431
           E+KIL +  H N++ +      P   +  + Y++ + +E   L+  L   K ++L+    
Sbjct: 69  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHI 124
Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG-----CNAI 486
                 +  GL+YIH      V+H+D+K SN+LL++    KI +FGLA+           
Sbjct: 125 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 181
Query: 487 TMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELIS------GKEAIDEEGKFCG 538
               V T+ Y APE + +    TK +D++S G +L E++S      GK  +D+     G
Sbjct: 182 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 240

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 86/179 (48%), Gaps = 22/179 (12%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDP---EDANCYLIYEYIENGSLHSWLHENKNENLNWKTR 431
           E+KIL +  H N++ +      P   +  + Y++ + +E   L+  L   K ++L+    
Sbjct: 69  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHI 124
Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG-----CNAI 486
                 +  GL+YIH      V+H+D+K SN+LL++    KI +FGLA+           
Sbjct: 125 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 181
Query: 487 TMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELIS------GKEAIDEEGKFCG 538
               V T+ Y APE + +    TK +D++S G +L E++S      GK  +D+     G
Sbjct: 182 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 240

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 76/156 (48%), Gaps = 8/156 (5%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           +   E +ILQ VN   LVKLE    D  ++N Y++ EY+  G + S  H  +    +   
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGGEMFS--HLRRIGRFSEPH 142
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
               A  +    +Y+H      ++++D+K  N+L+D     ++ +FG AK      T  +
Sbjct: 143 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWXL 198
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT   +APE +     +  +D ++ GV++ E+ +G
Sbjct: 199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 30/201 (14%)
Query: 349 IQGSVYKGNIHGEVYAIKMMKWNACEEL-KILQKVN-----HGNLVKLEGFCIDPEDANC 402
           +QG+V   N  G+ YA+K+++  A     ++ ++V       GN   LE      +D   
Sbjct: 29  VQGAVSLQN--GKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRF 86
Query: 403 YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSN 462
           YL++E ++ GS+ +  H  K ++ N +   R+  DVA  L ++H      + H+D+K  N
Sbjct: 87  YLVFEKLQGGSILA--HIQKQKHFNEREASRVVRDVAAALDFLHTKG---IAHRDLKPEN 141
Query: 463 ILLDSNMR---AKIANFGLAK-----SGCNAITMHIV----GTQGYIAPEYL-----ADG 505
           IL +S  +    KI +F L       + C  IT   +    G+  Y+APE +        
Sbjct: 142 ILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQAT 201
Query: 506 VVSTKMDVFSFGVVLLELISG 526
               + D++S GVVL  ++SG
Sbjct: 202 FYDKRCDLWSLGVVLYIMLSG 222

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 86/179 (48%), Gaps = 22/179 (12%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDP---EDANCYLIYEYIENGSLHSWLHENKNENLNWKTR 431
           E+KIL +  H N++ +      P   +  + Y++ + +E   L+  L   K ++L+    
Sbjct: 91  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHI 146
Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG-----CNAI 486
                 +  GL+YIH      V+H+D+K SN+LL++    KI +FGLA+           
Sbjct: 147 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 203
Query: 487 TMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELIS------GKEAIDEEGKFCG 538
               V T+ Y APE + +    TK +D++S G +L E++S      GK  +D+     G
Sbjct: 204 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 262

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 86/179 (48%), Gaps = 22/179 (12%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDP---EDANCYLIYEYIENGSLHSWLHENKNENLNWKTR 431
           E+KIL +  H N++ +      P   +  + Y++ + +E   L+  L   K ++L+    
Sbjct: 79  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHI 134
Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG-----CNAI 486
                 +  GL+YIH      V+H+D+K SN+LL++    KI +FGLA+           
Sbjct: 135 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 191
Query: 487 TMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELIS------GKEAIDEEGKFCG 538
               V T+ Y APE + +    TK +D++S G +L E++S      GK  +D+     G
Sbjct: 192 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 250

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 86/179 (48%), Gaps = 22/179 (12%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDP---EDANCYLIYEYIENGSLHSWLHENKNENLNWKTR 431
           E+KIL +  H N++ +      P   +  + Y++ + +E   L+  L   K ++L+    
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHI 126
Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG-----CNAI 486
                 +  GL+YIH      V+H+D+K SN+LL++    KI +FGLA+           
Sbjct: 127 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 183
Query: 487 TMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELIS------GKEAIDEEGKFCG 538
               V T+ Y APE + +    TK +D++S G +L E++S      GK  +D+     G
Sbjct: 184 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 242

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 85/179 (47%), Gaps = 22/179 (12%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDP---EDANCYLIYEYIENGSLHSWLHENKNENLNWKTR 431
           E+KIL +  H N++ +      P   +  + YL+  ++    L+  L   K ++L+    
Sbjct: 91  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV-THLMGADLYKLL---KTQHLSNDHI 146
Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG-----CNAI 486
                 +  GL+YIH      V+H+D+K SN+LL++    KI +FGLA+           
Sbjct: 147 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGF 203
Query: 487 TMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELIS------GKEAIDEEGKFCG 538
               V T+ Y APE + +    TK +D++S G +L E++S      GK  +D+     G
Sbjct: 204 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 262

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 58/126 (46%), Gaps = 6/126 (4%)
Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI 463
           +I E +E G L S + E  ++    +    I  D+   +Q++H H    + H+D+K  N+
Sbjct: 84  IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENL 140
Query: 464 LLDSNMR---AKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVL 520
           L  S  +    K+ +FG AK            T  Y+APE L         D++S GV++
Sbjct: 141 LYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 200
Query: 521 LELISG 526
             L+ G
Sbjct: 201 YILLCG 206

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 58/126 (46%), Gaps = 6/126 (4%)
Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI 463
           +I E +E G L S + E  ++    +    I  D+   +Q++H H    + H+D+K  N+
Sbjct: 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENL 159
Query: 464 LLDSNMR---AKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVL 520
           L  S  +    K+ +FG AK            T  Y+APE L         D++S GV++
Sbjct: 160 LYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
Query: 521 LELISG 526
             L+ G
Sbjct: 220 YILLCG 225

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/209 (22%), Positives = 101/209 (48%), Gaps = 32/209 (15%)
Query: 336 LREATDNFSEGCLIQGSV--YKGNIHGEVYAIKMMKWNACEELKILQKVNHGNLVKLEGF 393
           +REA     +G  ++ +V   K +I       + ++  AC     +++ +H ++ KL G 
Sbjct: 39  VREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAAC-----MKEFDHPHVAKLVGV 93
Query: 394 CIDPEDAN----CYLIYEYIENGSLHSWLHENK----NENLNWKTRLRIAIDVANGLQYI 445
            +            +I  ++++G LH++L  ++      NL  +T +R  +D+A G++Y+
Sbjct: 94  SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL 153
Query: 446 HEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLA---------KSGCNAITMHIVGTQGY 496
                   +H+D+ + N +L  +M   +A+FGL+         + GC +          +
Sbjct: 154 SSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL-----PVKW 205
Query: 497 IAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           +A E LAD + +   DV++FGV + E+++
Sbjct: 206 LALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 88/180 (48%), Gaps = 21/180 (11%)
Query: 372 ACEELKILQKVNHGNLVKLEGFCIDPEDA-----NCYLIYEYIENGSLHSWLHENKNENL 426
           A  EL +++ VNH N++ L      P+       + YL+ E ++         E  +E +
Sbjct: 70  AYRELVLMKXVNHKNIISLLN-VFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERM 128
Query: 427 NWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI 486
           ++     +   +  G++++H      ++H+D+K SNI++ S+   KI +FGLA++   + 
Sbjct: 129 SY-----LLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSF 180
Query: 487 TM-HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELI------SGKEAIDEEGKFCGQ 539
            M   V T+ Y APE +        +D++S G ++ E++       G++ ID+  K   Q
Sbjct: 181 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 84/158 (53%), Gaps = 12/158 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL--HENKNENLNWKTRL 432
           E+++L+ ++H N++K+  F +  +  N Y++ E  E G L   +   + + + L+     
Sbjct: 70  EIEVLKSLDHPNIIKI--FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA 127
Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL-DSNMRA--KIANFGLAK-SGCNAITM 488
            +   + N L Y H      VVHKD+K  NIL  D++  +  KI +FGLA+    +  + 
Sbjct: 128 ELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHST 184
Query: 489 HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           +  GT  Y+APE      V+ K D++S GVV+  L++G
Sbjct: 185 NAAGTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTG 221

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 83/156 (53%), Gaps = 11/156 (7%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E  ++  V++ ++ +L G C+    +   LI + +  G L  ++ E+K+ N+  +  L 
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKD-NIGSQYLLN 123
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK-SGCNAITMHIVG 492
             + +A G+ Y+ +    R+VH+D+ + N+L+ +    KI +FG AK  G      H  G
Sbjct: 124 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG 180
Query: 493 TQ---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
            +    ++A E +   + + + DV+S+GV + EL++
Sbjct: 181 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 85/167 (50%), Gaps = 19/167 (11%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLN------- 427
           E  ++++ N  ++V+L G  +  +     +I E +  G L S+L   + E  N       
Sbjct: 65  EASVMKEFNCHHVVRLLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 122
Query: 428 -WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI 486
                +++A ++A+G+ Y++ +   + VH+D+ + N  +  +   KI +FG+ +      
Sbjct: 123 SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRD-IYET 178
Query: 487 TMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELISGKE 528
             +  G +G     +++PE L DGV +T  DV+SFGVVL E+ +  E
Sbjct: 179 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 225

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 83/156 (53%), Gaps = 11/156 (7%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E  ++  V++ ++ +L G C+    +   LI + +  G L  ++ E+K+ N+  +  L 
Sbjct: 70  DEAYVMASVDNPHVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKD-NIGSQYLLN 125
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK-SGCNAITMHIVG 492
             + +A G+ Y+ +    R+VH+D+ + N+L+ +    KI +FG AK  G      H  G
Sbjct: 126 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG 182
Query: 493 TQ---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
            +    ++A E +   + + + DV+S+GV + EL++
Sbjct: 183 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 83/156 (53%), Gaps = 11/156 (7%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E  ++  V++ ++ +L G C+    +   LI + +  G L  ++ E+K+ N+  +  L 
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKD-NIGSQYLLN 123
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK-SGCNAITMHIVG 492
             + +A G+ Y+ +    R+VH+D+ + N+L+ +    KI +FG AK  G      H  G
Sbjct: 124 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG 180
Query: 493 TQ---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
            +    ++A E +   + + + DV+S+GV + EL++
Sbjct: 181 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 85/167 (50%), Gaps = 19/167 (11%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLN------- 427
           E  ++++ N  ++V+L G  +  +     +I E +  G L S+L   +    N       
Sbjct: 78  EASVMKEFNCHHVVRLLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 135
Query: 428 -WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI 486
                +++A ++A+G+ Y++ +   + VH+D+ + N ++  +   KI +FG+ +      
Sbjct: 136 SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD-IYET 191
Query: 487 TMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELISGKE 528
             +  G +G     +++PE L DGV +T  DV+SFGVVL E+ +  E
Sbjct: 192 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 238

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 83/156 (53%), Gaps = 11/156 (7%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E  ++  V++ ++ +L G C+    +   LI + +  G L  ++ E+K+ N+  +  L 
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKD-NIGSQYLLN 123
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK-SGCNAITMHIVG 492
             + +A G+ Y+ +    R+VH+D+ + N+L+ +    KI +FG AK  G      H  G
Sbjct: 124 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG 180
Query: 493 TQ---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
            +    ++A E +   + + + DV+S+GV + EL++
Sbjct: 181 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 85/167 (50%), Gaps = 19/167 (11%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLN------- 427
           E  ++++ N  ++V+L G  +  +     +I E +  G L S+L   +    N       
Sbjct: 68  EASVMKEFNCHHVVRLLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 125
Query: 428 -WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI 486
                +++A ++A+G+ Y++ +   + VH+D+ + N ++  +   KI +FG+ +      
Sbjct: 126 SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD-IYET 181
Query: 487 TMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLELISGKE 528
             +  G +G     +++PE L DGV +T  DV+SFGVVL E+ +  E
Sbjct: 182 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 228

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 80/156 (51%), Gaps = 12/156 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E +I+ ++++  +V+L G C   +     L+ E    G LH +L   K E +       +
Sbjct: 60  EAQIMHQLDNPYIVRLIGVC---QAEALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAEL 115
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
              V+ G++Y+ E      VH+D+ + N+LL +   AKI++FGL+K+     + +   + 
Sbjct: 116 LHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 172
Query: 495 G-----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           G     + APE +     S++ DV+S+GV + E +S
Sbjct: 173 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 208

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 83/156 (53%), Gaps = 11/156 (7%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E  ++  V++ ++ +L G C+    +   LI + +  G L  ++ E+K+ N+  +  L 
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKD-NIGSQYLLN 121
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK-SGCNAITMHIVG 492
             + +A G+ Y+ +    R+VH+D+ + N+L+ +    KI +FG AK  G      H  G
Sbjct: 122 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG 178
Query: 493 TQ---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
            +    ++A E +   + + + DV+S+GV + EL++
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 86/179 (48%), Gaps = 22/179 (12%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDP---EDANCYLIYEYIENGSLHSWLHENKNENLNWKTR 431
           E+KIL +  H N++ +      P   +  + Y++ + +E   L+  L   K ++L+    
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KCQHLSNDHI 130
Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG-----CNAI 486
                 +  GL+YIH      V+H+D+K SN+LL++    KI +FGLA+           
Sbjct: 131 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187
Query: 487 TMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELIS------GKEAIDEEGKFCG 538
               V T+ Y APE + +    TK +D++S G +L E++S      GK  +D+     G
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 246

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 85/179 (47%), Gaps = 22/179 (12%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDP---EDANCYLIYEYIENGSLHSWLHENKNENLNWKTR 431
           E+KIL    H N++ +      P   +  + Y++ + +E   L+  L   K ++L+    
Sbjct: 73  EIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHI 128
Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG-----CNAI 486
                 +  GL+YIH      V+H+D+K SN+LL++    KI +FGLA+           
Sbjct: 129 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGF 185
Query: 487 TMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELIS------GKEAIDEEGKFCG 538
               V T+ Y APE + +    TK +D++S G +L E++S      GK  +D+     G
Sbjct: 186 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 244

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 85/179 (47%), Gaps = 22/179 (12%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDP---EDANCYLIYEYIENGSLHSWLHENKNENLNWKTR 431
           E+KIL    H N++ +      P   +  + Y++ + +E   L+  L   K ++L+    
Sbjct: 73  EIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHI 128
Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG-----CNAI 486
                 +  GL+YIH      V+H+D+K SN+LL++    KI +FGLA+           
Sbjct: 129 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 185
Query: 487 TMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELIS------GKEAIDEEGKFCG 538
               V T+ Y APE + +    TK +D++S G +L E++S      GK  +D+     G
Sbjct: 186 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 244

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 83/156 (53%), Gaps = 11/156 (7%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E  ++  V++ ++ +L G C+    +   LI + +  G L  ++ E+K+ N+  +  L 
Sbjct: 73  DEAYVMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKD-NIGSQYLLN 128
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK-SGCNAITMHIVG 492
             + +A G+ Y+ +    R+VH+D+ + N+L+ +    KI +FG AK  G      H  G
Sbjct: 129 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG 185
Query: 493 TQ---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
            +    ++A E +   + + + DV+S+GV + EL++
Sbjct: 186 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 83/161 (51%), Gaps = 15/161 (9%)
Query: 372 ACEELKILQKVNHGNLVKLEGFCIDPEDA-----NCYLIYEYIENGSLHSWLHENKNENL 426
           A  EL +++ VNH N++ L      P+ +     + Y++ E ++         E  +E +
Sbjct: 70  AYRELVLMKVVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERM 128
Query: 427 NWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI 486
           ++     +   +  G++++H      ++H+D+K SNI++ S+   KI +FGLA++   + 
Sbjct: 129 SY-----LLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSF 180
Query: 487 TM-HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            M   V T+ Y APE +        +D++S GV++ E+I G
Sbjct: 181 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 83/161 (51%), Gaps = 15/161 (9%)
Query: 372 ACEELKILQKVNHGNLVKLEGFCIDPEDA-----NCYLIYEYIENGSLHSWLHENKNENL 426
           A  EL +++ VNH N++ L      P+ +     + Y++ E ++         E  +E +
Sbjct: 70  AYRELVLMKVVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERM 128
Query: 427 NWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI 486
           ++     +   +  G++++H      ++H+D+K SNI++ S+   KI +FGLA++   + 
Sbjct: 129 SY-----LLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSF 180
Query: 487 TM-HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            M   V T+ Y APE +        +D++S GV++ E+I G
Sbjct: 181 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 88/180 (48%), Gaps = 21/180 (11%)
Query: 372 ACEELKILQKVNHGNLVKLEGFCIDPEDA-----NCYLIYEYIENGSLHSWLHENKNENL 426
           A  EL +++ VNH N++ L      P+       + YL+ E ++         E  +E +
Sbjct: 70  AYRELVLMKXVNHKNIISLLN-VFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERM 128
Query: 427 NWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI 486
           ++     +   +  G++++H      ++H+D+K SNI++ S+   KI +FGLA++   + 
Sbjct: 129 SY-----LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSF 180
Query: 487 TM-HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELI------SGKEAIDEEGKFCGQ 539
            M   V T+ Y APE +        +D++S G ++ E++       G++ ID+  K   Q
Sbjct: 181 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 85/185 (45%), Gaps = 16/185 (8%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANC-YLIYEYIENGSLHSWLHENKNENLNWK 429
           N  +E+ I + +NH N+VK  G      + N  YL  EY   G L   +  +    +   
Sbjct: 50  NIKKEIXINKMLNHENVVKFYGHR---REGNIQYLFLEYCSGGELFDRIEPDIG--MPEP 104
Query: 430 TRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNA 485
              R    +  G+ Y+H      + H+DIK  N+LLD     KI++FGLA     +    
Sbjct: 105 DAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 161
Query: 486 ITMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGY 544
           +   + GT  Y+APE L       + +DV+S G+VL  +++G+   D+    C +     
Sbjct: 162 LLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSD 219
Query: 545 WREMK 549
           W+E K
Sbjct: 220 WKEKK 224

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 85/185 (45%), Gaps = 16/185 (8%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANC-YLIYEYIENGSLHSWLHENKNENLNWK 429
           N  +E+ I + +NH N+VK  G      + N  YL  EY   G L   +  +    +   
Sbjct: 50  NIKKEIXINKMLNHENVVKFYGHR---REGNIQYLFLEYCSGGELFDRIEPDIG--MPEP 104
Query: 430 TRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNA 485
              R    +  G+ Y+H      + H+DIK  N+LLD     KI++FGLA     +    
Sbjct: 105 DAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 161
Query: 486 ITMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGY 544
           +   + GT  Y+APE L       + +DV+S G+VL  +++G+   D+    C +     
Sbjct: 162 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSD 219
Query: 545 WREMK 549
           W+E K
Sbjct: 220 WKEKK 224

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 88/180 (48%), Gaps = 21/180 (11%)
Query: 372 ACEELKILQKVNHGNLVKLEGFCIDPEDA-----NCYLIYEYIENGSLHSWLHENKNENL 426
           A  EL +++ VNH N++ L      P+       + YL+ E ++         E  +E +
Sbjct: 70  AYRELVLMKCVNHKNIISLLN-VFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERM 128
Query: 427 NWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI 486
           ++     +   +  G++++H      ++H+D+K SNI++ S+   KI +FGLA++   + 
Sbjct: 129 SY-----LLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSF 180
Query: 487 TM-HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELI------SGKEAIDEEGKFCGQ 539
            M   V T+ Y APE +        +D++S G ++ E++       G++ ID+  K   Q
Sbjct: 181 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 85/185 (45%), Gaps = 16/185 (8%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANC-YLIYEYIENGSLHSWLHENKNENLNWK 429
           N  +E+ I + +NH N+VK  G      + N  YL  EY   G L   +  +    +   
Sbjct: 51  NIKKEIXINKMLNHENVVKFYGHR---REGNIQYLFLEYCSGGELFDRIEPDIG--MPEP 105
Query: 430 TRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNA 485
              R    +  G+ Y+H      + H+DIK  N+LLD     KI++FGLA     +    
Sbjct: 106 DAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162
Query: 486 ITMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGY 544
           +   + GT  Y+APE L       + +DV+S G+VL  +++G+   D+    C +     
Sbjct: 163 LLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSD 220
Query: 545 WREMK 549
           W+E K
Sbjct: 221 WKEKK 225

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 87/179 (48%), Gaps = 19/179 (10%)
Query: 372 ACEELKILQKVNHGNLVKLEGFCID----PEDANCYLIYEYIENGSLHSWLHENKNENLN 427
           A  EL +++ VNH N++ L           E  + YL+ E ++         E  +E ++
Sbjct: 63  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMS 122
Query: 428 WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT 487
           +     +   +  G++++H      ++H+D+K SNI++ S+   KI +FGLA++   +  
Sbjct: 123 Y-----LLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFM 174
Query: 488 M-HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELI------SGKEAIDEEGKFCGQ 539
           M   V T+ Y APE +        +D++S G ++ E++       G++ ID+  K   Q
Sbjct: 175 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 80/157 (50%), Gaps = 12/157 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+ IL++V H N++ L     +  D    LI E +  G L  +L   + E+L+ +     
Sbjct: 65  EVSILRQVLHPNIITLHDVYENRTD--VVLILELVSGGELFDFL--AQKESLSEEEATSF 120
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNI-LLDSNM---RAKIANFGLAKSGCNAITM-H 489
              + +G+ Y+H     ++ H D+K  NI LLD N+     K+ +FGLA    + +   +
Sbjct: 121 IKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177
Query: 490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           I GT  ++APE +    +  + D++S GV+   L+SG
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 76/160 (47%), Gaps = 13/160 (8%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+  +  ++H NL++L G  + P      ++ E    GSL   L +++   L   T  R 
Sbjct: 71  EVNAMHSLDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFL-LGTLSRY 126
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
           A+ VA G+ Y+      R +H+D+ + N+LL +    KI +FGL ++       +++   
Sbjct: 127 AVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 183
Query: 495 -----GYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKE 528
                 + APE L     S   D + FGV L E+ + G+E
Sbjct: 184 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 106/225 (47%), Gaps = 38/225 (16%)
Query: 319 ADVSDCLDKYRIFKIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKW------ 370
           A  +  +D+YR  +I +L E T          G VYK    +  E  AIK ++       
Sbjct: 27  APSATSIDRYR--RITKLGEGT---------YGEVYKAIDTVTNETVAIKRIRLEHEEEG 75
Query: 371 ---NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLN 427
               A  E+ +L+++ H N+++L+   +   +   +LI+EY EN  L  ++  +KN +++
Sbjct: 76  VPGTAIREVSLLKELQHRNIIELK--SVIHHNHRLHLIFEYAEN-DLKKYM--DKNPDVS 130
Query: 428 WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRA-----KIANFGLAKSG 482
            +        + NG+ + H     R +H+D+K  N+LL  +  +     KI +FGLA++ 
Sbjct: 131 MRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187
Query: 483 CNAITM--HIVGTQGYIAPE-YLADGVVSTKMDVFSFGVVLLELI 524
              I    H + T  Y  PE  L     ST +D++S   +  E++
Sbjct: 188 GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 116/240 (48%), Gaps = 50/240 (20%)
Query: 329 RIFKIEELREATDNF--SEGCLIQGS----VYKGNIHGEVYAIKMMKWNACE----ELKI 378
           RI  I    ++  N   SE  L  GS    V++G+  G   A+K M  + C+    E+K+
Sbjct: 2   RIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKL 61
Query: 379 L-QKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKN---ENLNWKTR--- 431
           L +  +H N+++   +C +  D   Y+  E + N +L   L E+KN   ENL  +     
Sbjct: 62  LTESDDHPNVIRY--YCSETTDRFLYIALE-LCNLNLQD-LVESKNVSDENLKLQKEYNP 117
Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS-------------NMRAKIANFGL 478
           + +   +A+G+ ++H     +++H+D+K  NIL+ +             N+R  I++FGL
Sbjct: 118 ISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174
Query: 479 AK---SGCNAITMHI---VGTQGYIAPEYLADG-------VVSTKMDVFSFGVVLLELIS 525
            K   SG ++   ++    GT G+ APE L +         ++  +D+FS G V   ++S
Sbjct: 175 CKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 76/160 (47%), Gaps = 13/160 (8%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+  +  ++H NL++L G  + P      ++ E    GSL   L +++   L   T  R 
Sbjct: 65  EVNAMHSLDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFL-LGTLSRY 120
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
           A+ VA G+ Y+      R +H+D+ + N+LL +    KI +FGL ++       +++   
Sbjct: 121 AVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 177
Query: 495 -----GYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKE 528
                 + APE L     S   D + FGV L E+ + G+E
Sbjct: 178 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 217

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 88/180 (48%), Gaps = 21/180 (11%)
Query: 372 ACEELKILQKVNHGNLVKLEGFCIDPEDA-----NCYLIYEYIENGSLHSWLHENKNENL 426
           A  EL +++ VNH N++ L      P+       + YL+ E ++         E  +E +
Sbjct: 70  AYRELVLMKXVNHKNIISLLN-VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 128
Query: 427 NWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI 486
           ++     +   +  G++++H      ++H+D+K SNI++ S+   KI +FGLA++   + 
Sbjct: 129 SY-----LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSF 180
Query: 487 TM-HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELI------SGKEAIDEEGKFCGQ 539
            M   V T+ Y APE +        +D++S G ++ E++       G++ ID+  K   Q
Sbjct: 181 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 80/157 (50%), Gaps = 12/157 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+ IL++V H N++ L     +  D    LI E +  G L  +L   + E+L+ +     
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTD--VVLILELVSGGELFDFL--AQKESLSEEEATSF 120
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNI-LLDSNM---RAKIANFGLAKSGCNAITM-H 489
              + +G+ Y+H     ++ H D+K  NI LLD N+     K+ +FGLA    + +   +
Sbjct: 121 IKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177
Query: 490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           I GT  ++APE +    +  + D++S GV+   L+SG
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 82/160 (51%), Gaps = 20/160 (12%)
Query: 375 ELKILQKVNHGNLVK-LEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           E+ ++++  + N+V  L+ + +  E    +++ EY+  GSL   + E   +        R
Sbjct: 68  EILVMRENKNPNIVNYLDSYLVGDE---LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR 124
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH---- 489
              +    L+++H +   +V+H++IKS NILL  +   K+ +FG     C  IT      
Sbjct: 125 ---ECLQALEFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGF----CAQITPEQSKR 174
Query: 490 --IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
             +VGT  ++APE +       K+D++S G++ +E+I G+
Sbjct: 175 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 76/160 (47%), Gaps = 13/160 (8%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+  +  ++H NL++L G  + P      ++ E    GSL   L +++   L   T  R 
Sbjct: 61  EVNAMHSLDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFL-LGTLSRY 116
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
           A+ VA G+ Y+      R +H+D+ + N+LL +    KI +FGL ++       +++   
Sbjct: 117 AVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 173
Query: 495 -----GYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKE 528
                 + APE L     S   D + FGV L E+ + G+E
Sbjct: 174 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 213

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 80/157 (50%), Gaps = 12/157 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+ IL++V H N++ L     +  D    LI E +  G L  +L   + E+L+ +     
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTD--VVLILELVSGGELFDFL--AQKESLSEEEATSF 120
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNI-LLDSNM---RAKIANFGLAKSGCNAITM-H 489
              + +G+ Y+H     ++ H D+K  NI LLD N+     K+ +FGLA    + +   +
Sbjct: 121 IKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177
Query: 490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           I GT  ++APE +    +  + D++S GV+   L+SG
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 80/156 (51%), Gaps = 12/156 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E +I+ ++++  +V+L G C   +     L+ E    G LH +L   K E +       +
Sbjct: 386 EAQIMHQLDNPYIVRLIGVC---QAEALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAEL 441
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
              V+ G++Y+ E      VH+++ + N+LL +   AKI++FGL+K+     + +   + 
Sbjct: 442 LHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 498
Query: 495 G-----YIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           G     + APE +     S++ DV+S+GV + E +S
Sbjct: 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 76/160 (47%), Gaps = 13/160 (8%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+  +  ++H NL++L G  + P      ++ E    GSL   L +++   L   T  R 
Sbjct: 65  EVNAMHSLDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFL-LGTLSRY 120
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
           A+ VA G+ Y+      R +H+D+ + N+LL +    KI +FGL ++       +++   
Sbjct: 121 AVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 177
Query: 495 -----GYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKE 528
                 + APE L     S   D + FGV L E+ + G+E
Sbjct: 178 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 217

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 80/157 (50%), Gaps = 12/157 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+ IL++V H N++ L     +  D    LI E +  G L  +L   + E+L+ +     
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTD--VVLILELVSGGELFDFL--AQKESLSEEEATSF 120
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNI-LLDSNM---RAKIANFGLAKSGCNAITM-H 489
              + +G+ Y+H     ++ H D+K  NI LLD N+     K+ +FGLA    + +   +
Sbjct: 121 IKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177
Query: 490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           I GT  ++APE +    +  + D++S GV+   L+SG
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 80/157 (50%), Gaps = 12/157 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+ IL++V H N++ L     +  D    LI E +  G L  +L   + E+L+ +     
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTD--VVLILELVSGGELFDFL--AQKESLSEEEATSF 120
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNI-LLDSNM---RAKIANFGLAKSGCNAITM-H 489
              + +G+ Y+H     ++ H D+K  NI LLD N+     K+ +FGLA    + +   +
Sbjct: 121 IKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177
Query: 490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           I GT  ++APE +    +  + D++S GV+   L+SG
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 76/160 (47%), Gaps = 13/160 (8%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+  +  ++H NL++L G  + P      ++ E    GSL   L +++   L   T  R 
Sbjct: 61  EVNAMHSLDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFL-LGTLSRY 116
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
           A+ VA G+ Y+      R +H+D+ + N+LL +    KI +FGL ++       +++   
Sbjct: 117 AVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 173
Query: 495 -----GYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKE 528
                 + APE L     S   D + FGV L E+ + G+E
Sbjct: 174 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 213

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 75/160 (46%), Gaps = 13/160 (8%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+  +  ++H NL++L G  + P      ++ E    GSL   L +++   L   T  R 
Sbjct: 71  EVNAMHSLDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFL-LGTLSRY 126
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-----GCNAITMH 489
           A+ VA G+ Y+      R +H+D+ + N+LL +    KI +FGL ++         +  H
Sbjct: 127 AVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEH 183
Query: 490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKE 528
                 + APE L     S   D + FGV L E+ + G+E
Sbjct: 184 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 80/157 (50%), Gaps = 12/157 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+ IL++V H N++ L     +  D    LI E +  G L  +L   + E+L+ +     
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTD--VVLILELVSGGELFDFL--AQKESLSEEEATSF 120
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNI-LLDSNM---RAKIANFGLAKSGCNAITM-H 489
              + +G+ Y+H     ++ H D+K  NI LLD N+     K+ +FGLA    + +   +
Sbjct: 121 IKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177
Query: 490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           I GT  ++APE +    +  + D++S GV+   L+SG
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 75/160 (46%), Gaps = 13/160 (8%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+  +  ++H NL++L G  + P      ++ E    GSL   L +++   L   T  R 
Sbjct: 61  EVNAMHSLDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFL-LGTLSRY 116
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-----GCNAITMH 489
           A+ VA G+ Y+      R +H+D+ + N+LL +    KI +FGL ++         +  H
Sbjct: 117 AVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEH 173
Query: 490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKE 528
                 + APE L     S   D + FGV L E+ + G+E
Sbjct: 174 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 213

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 85/185 (45%), Gaps = 16/185 (8%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANC-YLIYEYIENGSLHSWLHENKNENLNWK 429
           N  +E+ I + +NH N+VK  G      + N  YL  EY   G L   +  +    +   
Sbjct: 50  NIKKEICINKMLNHENVVKFYGHR---REGNIQYLFLEYCSGGELFDRIEPDIG--MPEP 104
Query: 430 TRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNA 485
              R    +  G+ Y+H      + H+DIK  N+LLD     KI++FGLA     +    
Sbjct: 105 DAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 161
Query: 486 ITMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGY 544
           +   + GT  Y+APE L       + +DV+S G+VL  +++G+   D+    C +     
Sbjct: 162 LLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSD 219
Query: 545 WREMK 549
           W+E K
Sbjct: 220 WKEKK 224

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 84/184 (45%), Gaps = 14/184 (7%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           N  +E+ I + +NH N+VK  G     E    YL  EY   G L   +  +    +    
Sbjct: 49  NIKKEICINKMLNHENVVKFYGH--RREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPD 104
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAI 486
             R    +  G+ Y+H      + H+DIK  N+LLD     KI++FGLA     +    +
Sbjct: 105 AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 161
Query: 487 TMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYW 545
              + GT  Y+APE L       + +DV+S G+VL  +++G+   D+    C +     W
Sbjct: 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDW 219
Query: 546 REMK 549
           +E K
Sbjct: 220 KEKK 223

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 84/184 (45%), Gaps = 14/184 (7%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           N  +E+ I + +NH N+VK  G     E    YL  EY   G L   +  +    +    
Sbjct: 50  NIKKEICINKMLNHENVVKFYGH--RREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPD 105
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAI 486
             R    +  G+ Y+H      + H+DIK  N+LLD     KI++FGLA     +    +
Sbjct: 106 AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 162
Query: 487 TMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYW 545
              + GT  Y+APE L       + +DV+S G+VL  +++G+   D+    C +     W
Sbjct: 163 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDW 220
Query: 546 REMK 549
           +E K
Sbjct: 221 KEKK 224

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 85/196 (43%), Gaps = 39/196 (19%)
Query: 364 AIKMMKWNA--------CEELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K  A          ELKI+  +  H N+V L G C         +I EY   G L
Sbjct: 65  AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT--HGGPVLVITEYCCYGDL 122
Query: 415 HSWLH---------------------ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRV 453
            ++L                      +     L  +  L  +  VA G+ ++        
Sbjct: 123 LNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNC 179
Query: 454 VHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ----GYIAPEYLADGVVST 509
           +H+D+ + N+LL +   AKI +FGLA+   N     + G       ++APE + D V + 
Sbjct: 180 IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTV 239
Query: 510 KMDVFSFGVVLLELIS 525
           + DV+S+G++L E+ S
Sbjct: 240 QSDVWSYGILLWEIFS 255

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 84/184 (45%), Gaps = 14/184 (7%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           N  +E+ I + +NH N+VK  G     E    YL  EY   G L   +  +    +    
Sbjct: 50  NIKKEICINKMLNHENVVKFYGH--RREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPD 105
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAI 486
             R    +  G+ Y+H      + H+DIK  N+LLD     KI++FGLA     +    +
Sbjct: 106 AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 162
Query: 487 TMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYW 545
              + GT  Y+APE L       + +DV+S G+VL  +++G+   D+    C +     W
Sbjct: 163 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDW 220
Query: 546 REMK 549
           +E K
Sbjct: 221 KEKK 224

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 85/185 (45%), Gaps = 16/185 (8%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANC-YLIYEYIENGSLHSWLHENKNENLNWK 429
           N  +E+ I + +NH N+VK  G      + N  YL  EY   G L   +  +    +   
Sbjct: 51  NIKKEICINKMLNHENVVKFYGHR---REGNIQYLFLEYCSGGELFDRIEPDIG--MPEP 105
Query: 430 TRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNA 485
              R    +  G+ Y+H      + H+DIK  N+LLD     KI++FGLA     +    
Sbjct: 106 DAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162
Query: 486 ITMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGY 544
           +   + GT  Y+APE L       + +DV+S G+VL  +++G+   D+    C +     
Sbjct: 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSD 220
Query: 545 WREMK 549
           W+E K
Sbjct: 221 WKEKK 225

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 85/185 (45%), Gaps = 16/185 (8%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANC-YLIYEYIENGSLHSWLHENKNENLNWK 429
           N  +E+ I + +NH N+VK  G      + N  YL  EY   G L   +  +    +   
Sbjct: 51  NIKKEICINKMLNHENVVKFYGHR---REGNIQYLFLEYCSGGELFDRIEPDIG--MPEP 105
Query: 430 TRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNA 485
              R    +  G+ Y+H      + H+DIK  N+LLD     KI++FGLA     +    
Sbjct: 106 DAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162
Query: 486 ITMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGY 544
           +   + GT  Y+APE L       + +DV+S G+VL  +++G+   D+    C +     
Sbjct: 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSD 220
Query: 545 WREMK 549
           W+E K
Sbjct: 221 WKEKK 225

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 85/185 (45%), Gaps = 16/185 (8%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANC-YLIYEYIENGSLHSWLHENKNENLNWK 429
           N  +E+ I + +NH N+VK  G      + N  YL  EY   G L   +  +    +   
Sbjct: 51  NIKKEICINKMLNHENVVKFYGHR---REGNIQYLFLEYCSGGELFDRIEPDIG--MPEP 105
Query: 430 TRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNA 485
              R    +  G+ Y+H      + H+DIK  N+LLD     KI++FGLA     +    
Sbjct: 106 DAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162
Query: 486 ITMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGY 544
           +   + GT  Y+APE L       + +DV+S G+VL  +++G+   D+    C +     
Sbjct: 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSD 220
Query: 545 WREMK 549
           W+E K
Sbjct: 221 WKEKK 225

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 85/185 (45%), Gaps = 16/185 (8%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANC-YLIYEYIENGSLHSWLHENKNENLNWK 429
           N  +E+ I + +NH N+VK  G      + N  YL  EY   G L   +  +    +   
Sbjct: 51  NIKKEICINKMLNHENVVKFYGHR---REGNIQYLFLEYCSGGELFDRIEPDIG--MPEP 105
Query: 430 TRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNA 485
              R    +  G+ Y+H      + H+DIK  N+LLD     KI++FGLA     +    
Sbjct: 106 DAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162
Query: 486 ITMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGY 544
           +   + GT  Y+APE L       + +DV+S G+VL  +++G+   D+    C +     
Sbjct: 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSD 220
Query: 545 WREMK 549
           W+E K
Sbjct: 221 WKEKK 225

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 85/185 (45%), Gaps = 16/185 (8%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANC-YLIYEYIENGSLHSWLHENKNENLNWK 429
           N  +E+ I + +NH N+VK  G      + N  YL  EY   G L   +  +    +   
Sbjct: 50  NIKKEICINKMLNHENVVKFYGHR---REGNIQYLFLEYCSGGELFDRIEPDIG--MPEP 104
Query: 430 TRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNA 485
              R    +  G+ Y+H      + H+DIK  N+LLD     KI++FGLA     +    
Sbjct: 105 DAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 161
Query: 486 ITMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGY 544
           +   + GT  Y+APE L       + +DV+S G+VL  +++G+   D+    C +     
Sbjct: 162 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSD 219
Query: 545 WREMK 549
           W+E K
Sbjct: 220 WKEKK 224

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 42/226 (18%)
Query: 332 KIEELREATDNF------SEGCLIQGSVYKGNIHGEVYAIKMM-KW-------NAC--EE 375
           K++++R   ++F        G   + +V K     +V+A+K++ KW        AC  EE
Sbjct: 65  KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE 124
Query: 376 LKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTR---- 431
             +L   +   +  L     D  D N YL+ +Y   G L + L + ++       R    
Sbjct: 125 RDVLVNGDSKWITTLHYAFQD--DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLA 182
Query: 432 -LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFG----LAKSGCNAI 486
            + IAID  + L Y         VH+DIK  NIL+D N   ++A+FG    L + G    
Sbjct: 183 EMVIAIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 233
Query: 487 TMHIVGTQGYIAPEYL-----ADGVVSTKMDVFSFGVVLLELISGK 527
           ++  VGT  YI+PE L       G    + D +S GV + E++ G+
Sbjct: 234 SV-AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 84/184 (45%), Gaps = 14/184 (7%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           N  +E+ I + +NH N+VK  G     E    YL  EY   G L   +  +    +    
Sbjct: 51  NIKKEICINKMLNHENVVKFYGH--RREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPD 106
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAI 486
             R    +  G+ Y+H      + H+DIK  N+LLD     KI++FGLA     +    +
Sbjct: 107 AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163
Query: 487 TMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYW 545
              + GT  Y+APE L       + +DV+S G+VL  +++G+   D+    C +     W
Sbjct: 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDW 221
Query: 546 REMK 549
           +E K
Sbjct: 222 KEKK 225

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 84/184 (45%), Gaps = 14/184 (7%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           N  +E+ I + +NH N+VK  G     E    YL  EY   G L   +  +    +    
Sbjct: 50  NIKKEICINKMLNHENVVKFYGH--RREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPD 105
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAI 486
             R    +  G+ Y+H      + H+DIK  N+LLD     KI++FGLA     +    +
Sbjct: 106 AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 162
Query: 487 TMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYW 545
              + GT  Y+APE L       + +DV+S G+VL  +++G+   D+    C +     W
Sbjct: 163 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDW 220
Query: 546 REMK 549
           +E K
Sbjct: 221 KEKK 224

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 90/178 (50%), Gaps = 10/178 (5%)
Query: 358 IHGEVYAIKMMKWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSW 417
           I+ +V A   M+     E+  L+ + H +++KL  + +        ++ EY  N      
Sbjct: 37  INKKVLAKSDMQGRIEREISYLRLLRHPHIIKL--YDVIKSKDEIIMVIEYAGNELFDYI 94
Query: 418 LHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFG 477
           +  +K   ++ +   R    + + ++Y H H   ++VH+D+K  N+LLD ++  KIA+FG
Sbjct: 95  VQRDK---MSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFG 148
Query: 478 LAKSGCNAITMHI-VGTQGYIAPEYLADGVVS-TKMDVFSFGVVLLELISGKEAIDEE 533
           L+    +   +    G+  Y APE ++  + +  ++DV+S GV+L  ++  +   D+E
Sbjct: 149 LSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE 206

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 84/184 (45%), Gaps = 14/184 (7%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           N  +E+ I + +NH N+VK  G     E    YL  EY   G L   +  +    +    
Sbjct: 50  NIKKEICINKMLNHENVVKFYGH--RREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPD 105
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAI 486
             R    +  G+ Y+H      + H+DIK  N+LLD     KI++FGLA     +    +
Sbjct: 106 AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 162
Query: 487 TMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYW 545
              + GT  Y+APE L       + +DV+S G+VL  +++G+   D+    C +     W
Sbjct: 163 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDW 220
Query: 546 REMK 549
           +E K
Sbjct: 221 KEKK 224

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 104/215 (48%), Gaps = 28/215 (13%)
Query: 329 RIFKIEELREATDNFSEGCLIQGSVYKGNIHGEVYAIKM-------------MKWNAC-E 374
           RIFK  ELR+       G  + G+V+KG    E  +IK+               + A  +
Sbjct: 26  RIFKETELRKLK---VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTD 82
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
            +  +  ++H ++V+L G C     ++  L+ +Y+  GSL   + +++   L  +  L  
Sbjct: 83  HMLAIGSLDHAHIVRLLGLC---PGSSLQLVTQYLPLGSLLDHVRQHRG-ALGPQLLLNW 138
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLA----KSGCNAITMHI 490
            + +A G+ Y+ EH    +VH+++ + N+LL S  + ++A+FG+A          +    
Sbjct: 139 GVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEA 195
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
                ++A E +  G  + + DV+S+GV + EL++
Sbjct: 196 KTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 84/184 (45%), Gaps = 14/184 (7%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           N  +E+ I + +NH N+VK  G     E    YL  EY   G L   +  +    +    
Sbjct: 51  NIKKEICINKMLNHENVVKFYGH--RREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPD 106
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAI 486
             R    +  G+ Y+H      + H+DIK  N+LLD     KI++FGLA     +    +
Sbjct: 107 AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163
Query: 487 TMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYW 545
              + GT  Y+APE L       + +DV+S G+VL  +++G+   D+    C +     W
Sbjct: 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDW 221
Query: 546 REMK 549
           +E K
Sbjct: 222 KEKK 225

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 84/184 (45%), Gaps = 14/184 (7%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           N  +E+ I + +NH N+VK  G     E    YL  EY   G L   +  +    +    
Sbjct: 50  NIKKEICINKMLNHENVVKFYGH--RREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPD 105
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAI 486
             R    +  G+ Y+H      + H+DIK  N+LLD     KI++FGLA     +    +
Sbjct: 106 AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 162
Query: 487 TMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYW 545
              + GT  Y+APE L       + +DV+S G+VL  +++G+   D+    C +     W
Sbjct: 163 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDW 220
Query: 546 REMK 549
           +E K
Sbjct: 221 KEKK 224

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 85/185 (45%), Gaps = 16/185 (8%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANC-YLIYEYIENGSLHSWLHENKNENLNWK 429
           N  +E+ I + +NH N+VK  G      + N  YL  EY   G L   +  +    +   
Sbjct: 50  NIKKEICINKMLNHENVVKFYGHR---REGNIQYLFLEYCSGGELFDRIEPDIG--MPEP 104
Query: 430 TRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNA 485
              R    +  G+ Y+H      + H+DIK  N+LLD     KI++FGLA     +    
Sbjct: 105 DAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 161
Query: 486 ITMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGY 544
           +   + GT  Y+APE L       + +DV+S G+VL  +++G+   D+    C +     
Sbjct: 162 LLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSD 219
Query: 545 WREMK 549
           W+E K
Sbjct: 220 WKEKK 224

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 104/215 (48%), Gaps = 28/215 (13%)
Query: 329 RIFKIEELREATDNFSEGCLIQGSVYKGNIHGEVYAIKM-------------MKWNAC-E 374
           RIFK  ELR+       G  + G+V+KG    E  +IK+               + A  +
Sbjct: 8   RIFKETELRKLK---VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTD 64
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
            +  +  ++H ++V+L G C     ++  L+ +Y+  GSL   + +++   L  +  L  
Sbjct: 65  HMLAIGSLDHAHIVRLLGLC---PGSSLQLVTQYLPLGSLLDHVRQHRG-ALGPQLLLNW 120
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLA----KSGCNAITMHI 490
            + +A G+ Y+ EH    +VH+++ + N+LL S  + ++A+FG+A          +    
Sbjct: 121 GVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEA 177
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
                ++A E +  G  + + DV+S+GV + EL++
Sbjct: 178 KTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 84/184 (45%), Gaps = 14/184 (7%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           N  +E+ I + +NH N+VK  G     E    YL  EY   G L   +  +    +    
Sbjct: 50  NIKKEICINKMLNHENVVKFYGH--RREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPD 105
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAI 486
             R    +  G+ Y+H      + H+DIK  N+LLD     KI++FGLA     +    +
Sbjct: 106 AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 162
Query: 487 TMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYW 545
              + GT  Y+APE L       + +DV+S G+VL  +++G+   D+    C +     W
Sbjct: 163 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDW 220
Query: 546 REMK 549
           +E K
Sbjct: 221 KEKK 224

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 50/240 (20%)
Query: 329 RIFKIEELREATDNF--SEGCLIQGS----VYKGNIHGEVYAIKMMKWNACE----ELKI 378
           RI  I    ++  N   SE  L  GS    V++G+  G   A+K M  + C+    E+K+
Sbjct: 2   RIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKL 61
Query: 379 L-QKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKN---ENLNWKTR--- 431
           L +  +H N+++   +C +  D   Y+  E + N +L   L E+KN   ENL  +     
Sbjct: 62  LTESDDHPNVIRY--YCSETTDRFLYIALE-LCNLNLQD-LVESKNVSDENLKLQKEYNP 117
Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS-------------NMRAKIANFGL 478
           + +   +A+G+ ++H     +++H+D+K  NIL+ +             N+R  I++FGL
Sbjct: 118 ISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174
Query: 479 AK---SGCNAITMHI---VGTQGYIAPEYLADG-------VVSTKMDVFSFGVVLLELIS 525
            K   SG      ++    GT G+ APE L +         ++  +D+FS G V   ++S
Sbjct: 175 CKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 104/228 (45%), Gaps = 36/228 (15%)
Query: 332 KIEELREATDNF--SEGCLIQGSVYKGNIHGEV---------YAIKMMK-----WNACEE 375
           K+   RE  ++    EGC +    Y G+++            YA+K ++      +AC E
Sbjct: 10  KLSSERERVEDLFEYEGCKVGRGTY-GHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE 68
Query: 376 LKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSW-LHENKNENLNWKTRLR- 433
           + +L+++ H N++ L+   +   D   +L+++Y E+   H    H     N       R 
Sbjct: 69  IALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRG 128
Query: 434 ----IAIDVANGLQYIHEHTRPRVVHKDIKSSNILL----DSNMRAKIANFGLAKSGCNA 485
               +   + +G+ Y+H +    V+H+D+K +NIL+        R KIA+ G A+   + 
Sbjct: 129 MVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 185
Query: 486 ITM-----HIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELISGK 527
           +        +V T  Y APE L      TK +D+++ G +  EL++ +
Sbjct: 186 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 89/178 (50%), Gaps = 10/178 (5%)
Query: 358 IHGEVYAIKMMKWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSW 417
           I+ +V A   M+     E+  L+ + H +++KL  + +        ++ EY  N      
Sbjct: 46  INKKVLAKSDMQGRIEREISYLRLLRHPHIIKL--YDVIKSKDEIIMVIEYAGNELFDYI 103
Query: 418 LHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFG 477
           +  +K   ++ +   R    + + ++Y H H   ++VH+D+K  N+LLD ++  KIA+FG
Sbjct: 104 VQRDK---MSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFG 157
Query: 478 LAKSGCNAITMHI-VGTQGYIAPEYLADGV-VSTKMDVFSFGVVLLELISGKEAIDEE 533
           L+    +   +    G+  Y APE ++  +    ++DV+S GV+L  ++  +   D+E
Sbjct: 158 LSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE 215

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 89/178 (50%), Gaps = 10/178 (5%)
Query: 358 IHGEVYAIKMMKWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSW 417
           I+ +V A   M+     E+  L+ + H +++KL  + +        ++ EY  N      
Sbjct: 47  INKKVLAKSDMQGRIEREISYLRLLRHPHIIKL--YDVIKSKDEIIMVIEYAGNELFDYI 104
Query: 418 LHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFG 477
           +  +K   ++ +   R    + + ++Y H H   ++VH+D+K  N+LLD ++  KIA+FG
Sbjct: 105 VQRDK---MSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFG 158
Query: 478 LAKSGCNAITMHI-VGTQGYIAPEYLADGV-VSTKMDVFSFGVVLLELISGKEAIDEE 533
           L+    +   +    G+  Y APE ++  +    ++DV+S GV+L  ++  +   D+E
Sbjct: 159 LSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE 216

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 89/178 (50%), Gaps = 10/178 (5%)
Query: 358 IHGEVYAIKMMKWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSW 417
           I+ +V A   M+     E+  L+ + H +++KL  + +        ++ EY  N      
Sbjct: 41  INKKVLAKSDMQGRIEREISYLRLLRHPHIIKL--YDVIKSKDEIIMVIEYAGNELFDYI 98
Query: 418 LHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFG 477
           +  +K   ++ +   R    + + ++Y H H   ++VH+D+K  N+LLD ++  KIA+FG
Sbjct: 99  VQRDK---MSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFG 152
Query: 478 LAKSGCNAITMHI-VGTQGYIAPEYLADGV-VSTKMDVFSFGVVLLELISGKEAIDEE 533
           L+    +   +    G+  Y APE ++  +    ++DV+S GV+L  ++  +   D+E
Sbjct: 153 LSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE 210

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 92/174 (52%), Gaps = 23/174 (13%)
Query: 365 IKMMKWNACEELKILQKVN-HGNLVKLEGFCIDPEDANCY--LIYEYIENGSLHSWLHEN 421
           ++ ++    +E+ IL+KV+ H N+++L+    D  + N +  L+++ ++ G L  +L E 
Sbjct: 50  VQELREATLKEVDILRKVSGHPNIIQLK----DTYETNTFFFLVFDLMKKGELFDYLTEK 105
Query: 422 KNENLNWKTR--LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLA 479
              +   +TR  +R  ++V   L  ++      +VH+D+K  NILLD +M  K+ +FG +
Sbjct: 106 VTLSEK-ETRKIMRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFS 158
Query: 480 -KSGCNAITMHIVGTQGYIAPEYLADGV------VSTKMDVFSFGVVLLELISG 526
            +         + GT  Y+APE +   +         ++D++S GV++  L++G
Sbjct: 159 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 92/174 (52%), Gaps = 23/174 (13%)
Query: 365 IKMMKWNACEELKILQKVN-HGNLVKLEGFCIDPEDANCY--LIYEYIENGSLHSWLHEN 421
           ++ ++    +E+ IL+KV+ H N+++L+    D  + N +  L+++ ++ G L  +L E 
Sbjct: 63  VQELREATLKEVDILRKVSGHPNIIQLK----DTYETNTFFFLVFDLMKKGELFDYLTEK 118
Query: 422 KNENLNWKTR--LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLA 479
              +   +TR  +R  ++V   L  ++      +VH+D+K  NILLD +M  K+ +FG +
Sbjct: 119 VTLS-EKETRKIMRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFS 171
Query: 480 -KSGCNAITMHIVGTQGYIAPEYLADGV------VSTKMDVFSFGVVLLELISG 526
            +         + GT  Y+APE +   +         ++D++S GV++  L++G
Sbjct: 172 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 94/200 (47%), Gaps = 22/200 (11%)
Query: 341 DNFSEGCLIQGSVYKGN--IHGEVYAIKMMKW--------NACEELKILQKVNHGNLVKL 390
           D   EG     +VYKG   +   + A+K ++          A  E+ +L+ + H N+V L
Sbjct: 8   DKLGEGTY--ATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL 65
Query: 391 EGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTR 450
               I   + +  L++EY++   L  +L +  N  +N          +  GL Y H   R
Sbjct: 66  HD--IIHTEKSLTLVFEYLDK-DLKQYLDDCGN-IINMHNVKLFLFQLLRGLAYCH---R 118
Query: 451 PRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI--VGTQGYIAPEYLADGV-V 507
            +V+H+D+K  N+L++     K+A+FGLA++       +   V T  Y  P+ L      
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDY 178
Query: 508 STKMDVFSFGVVLLELISGK 527
           ST++D++  G +  E+ +G+
Sbjct: 179 STQIDMWGVGCIFYEMATGR 198

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 87/179 (48%), Gaps = 19/179 (10%)
Query: 372 ACEELKILQKVNHGNLVKLEGFCID----PEDANCYLIYEYIENGSLHSWLHENKNENLN 427
           A  EL +++ VNH N++ L           E  + YL+ E ++         E  +E ++
Sbjct: 64  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS 123
Query: 428 WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT 487
           +     +   +  G++++H      ++H+D+K SNI++ S+   KI +FGLA++   +  
Sbjct: 124 Y-----LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 175
Query: 488 M-HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELI------SGKEAIDEEGKFCGQ 539
           M   V T+ Y APE +        +D++S G ++ E++       G++ ID+  K   Q
Sbjct: 176 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 234

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 87/179 (48%), Gaps = 19/179 (10%)
Query: 372 ACEELKILQKVNHGNLVKLEGFCID----PEDANCYLIYEYIENGSLHSWLHENKNENLN 427
           A  EL +++ VNH N++ L           E  + YL+ E ++         E  +E ++
Sbjct: 63  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS 122
Query: 428 WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT 487
           +     +   +  G++++H      ++H+D+K SNI++ S+   KI +FGLA++   +  
Sbjct: 123 Y-----LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 174
Query: 488 M-HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELI------SGKEAIDEEGKFCGQ 539
           M   V T+ Y APE +        +D++S G ++ E++       G++ ID+  K   Q
Sbjct: 175 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 87/179 (48%), Gaps = 19/179 (10%)
Query: 372 ACEELKILQKVNHGNLVKLEGFCID----PEDANCYLIYEYIENGSLHSWLHENKNENLN 427
           A  EL +++ VNH N++ L           E  + YL+ E ++         E  +E ++
Sbjct: 69  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS 128
Query: 428 WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT 487
           +     +   +  G++++H      ++H+D+K SNI++ S+   KI +FGLA++   +  
Sbjct: 129 Y-----LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 180
Query: 488 M-HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELI------SGKEAIDEEGKFCGQ 539
           M   V T+ Y APE +        +D++S G ++ E++       G++ ID+  K   Q
Sbjct: 181 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 239

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 87/179 (48%), Gaps = 19/179 (10%)
Query: 372 ACEELKILQKVNHGNLVKLEGFCID----PEDANCYLIYEYIENGSLHSWLHENKNENLN 427
           A  EL +++ VNH N++ L           E  + YL+ E ++         E  +E ++
Sbjct: 64  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS 123
Query: 428 WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT 487
           +     +   +  G++++H      ++H+D+K SNI++ S+   KI +FGLA++   +  
Sbjct: 124 Y-----LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 175
Query: 488 M-HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELI------SGKEAIDEEGKFCGQ 539
           M   V T+ Y APE +        +D++S G ++ E++       G++ ID+  K   Q
Sbjct: 176 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 234

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 87/179 (48%), Gaps = 19/179 (10%)
Query: 372 ACEELKILQKVNHGNLVKLEGFCID----PEDANCYLIYEYIENGSLHSWLHENKNENLN 427
           A  EL +++ VNH N++ L           E  + YL+ E ++         E  +E ++
Sbjct: 70  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS 129
Query: 428 WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT 487
           +     +   +  G++++H      ++H+D+K SNI++ S+   KI +FGLA++   +  
Sbjct: 130 Y-----LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 181
Query: 488 M-HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELI------SGKEAIDEEGKFCGQ 539
           M   V T+ Y APE +        +D++S G ++ E++       G++ ID+  K   Q
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 87/179 (48%), Gaps = 19/179 (10%)
Query: 372 ACEELKILQKVNHGNLVKLEGFCID----PEDANCYLIYEYIENGSLHSWLHENKNENLN 427
           A  EL +++ VNH N++ L           E  + YL+ E ++         E  +E ++
Sbjct: 70  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS 129
Query: 428 WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT 487
           +     +   +  G++++H      ++H+D+K SNI++ S+   KI +FGLA++   +  
Sbjct: 130 Y-----LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 181
Query: 488 M-HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELI------SGKEAIDEEGKFCGQ 539
           M   V T+ Y APE +        +D++S G ++ E++       G++ ID+  K   Q
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 11/156 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E +I +K+ H N+V+L       E++  YL+++ +  G L   +     E  +       
Sbjct: 54  EARICRKLQHPNIVRLHDSI--QEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHC 109
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRA---KIANFGLAKSGCNAITMH-I 490
              +   + Y H +    +VH+++K  N+LL S  +    K+A+FGLA    ++   H  
Sbjct: 110 IQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF 166
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT GY++PE L     S  +D+++ GV+L  L+ G
Sbjct: 167 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 81/157 (51%), Gaps = 15/157 (9%)
Query: 375 ELKILQKVNHGNLVKL-EGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           E+ IL   +H N+VKL + F  +    N +++ E+   G++ + + E +      + ++ 
Sbjct: 84  EIDILASCDHPNIVKLLDAFYYE---NNLWILIEFCAGGAVDAVMLELERPLTESQIQV- 139
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH--IV 491
           +     + L Y+H++   +++H+D+K+ NIL   +   K+A+FG++      I      +
Sbjct: 140 VCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 196
Query: 492 GTQGYIAPEYLA-----DGVVSTKMDVFSFGVVLLEL 523
           GT  ++APE +      D     K DV+S G+ L+E+
Sbjct: 197 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 81/175 (46%), Gaps = 13/175 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E +I + + H N+V+L       E+   YL+++ +  G L   +     E  +       
Sbjct: 80  EARICRLLKHPNIVRLHDSI--SEEGFHYLVFDLVTGGELFEDI--VAREYYSEADASHC 135
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRA---KIANFGLA--KSGCNAITMH 489
              +   + +IH+H    +VH+D+K  N+LL S  +    K+A+FGLA    G       
Sbjct: 136 IHQILESVNHIHQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFG 192
Query: 490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAI-DEEGKFCGQKLKG 543
             GT GY++PE L        +D+++ GV+L  L+ G     DE+     Q++K 
Sbjct: 193 FAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKA 247

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 87/179 (48%), Gaps = 19/179 (10%)
Query: 372 ACEELKILQKVNHGNLVKLEGFCID----PEDANCYLIYEYIENGSLHSWLHENKNENLN 427
           A  EL +++ VNH N++ L           E  + YL+ E ++         E  +E ++
Sbjct: 71  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS 130
Query: 428 WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT 487
           +     +   +  G++++H      ++H+D+K SNI++ S+   KI +FGLA++   +  
Sbjct: 131 Y-----LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 182
Query: 488 M-HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELI------SGKEAIDEEGKFCGQ 539
           M   V T+ Y APE +        +D++S G ++ E++       G++ ID+  K   Q
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 241

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 87/179 (48%), Gaps = 19/179 (10%)
Query: 372 ACEELKILQKVNHGNLVKLEGFCID----PEDANCYLIYEYIENGSLHSWLHENKNENLN 427
           A  EL +++ VNH N++ L           E  + YL+ E ++         E  +E ++
Sbjct: 71  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS 130
Query: 428 WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT 487
           +     +   +  G++++H      ++H+D+K SNI++ S+   KI +FGLA++   +  
Sbjct: 131 Y-----LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 182
Query: 488 M-HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELI------SGKEAIDEEGKFCGQ 539
           M   V T+ Y APE +        +D++S G ++ E++       G++ ID+  K   Q
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 241

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 84/161 (52%), Gaps = 15/161 (9%)
Query: 372 ACEELKILQKVNHGNLVKLEGFCIDPEDA-----NCYLIYEYIENGSLHSWLHENKNENL 426
           A  EL +++ VNH N++ L      P+ +     + Y++ E ++         E  +E +
Sbjct: 72  AYRELVLMKCVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 130
Query: 427 NWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNA 485
           ++     +   +  G++++H      ++H+D+K SNI++ S+   KI +FGLA++ G + 
Sbjct: 131 SY-----LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 182
Query: 486 ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           + +  V T+ Y APE +        +D++S G ++ E+I G
Sbjct: 183 MMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 92/174 (52%), Gaps = 23/174 (13%)
Query: 365 IKMMKWNACEELKILQKVN-HGNLVKLEGFCIDPEDANCY--LIYEYIENGSLHSWLHEN 421
           ++ ++    +E+ IL+KV+ H N+++L+    D  + N +  L+++ ++ G L  +L E 
Sbjct: 63  VQELREATLKEVDILRKVSGHPNIIQLK----DTYETNTFFFLVFDLMKKGELFDYLTEK 118
Query: 422 KNENLNWKTR--LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLA 479
              +   +TR  +R  ++V   L  ++      +VH+D+K  NILLD +M  K+ +FG +
Sbjct: 119 VTLS-EKETRKIMRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFS 171
Query: 480 -KSGCNAITMHIVGTQGYIAPEYLADGV------VSTKMDVFSFGVVLLELISG 526
            +         + GT  Y+APE +   +         ++D++S GV++  L++G
Sbjct: 172 CQLDPGEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 87/197 (44%), Gaps = 40/197 (20%)
Query: 363 YAIKMMKW--------NACEELKILQKVNHGNLVK-----LEGFCIDPEDANCYLIYEYI 409
           YAIK ++             E+K L K+ H  +V+     LE    +    +   +Y YI
Sbjct: 33  YAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYI 92
Query: 410 E-----NGSLHSWLHENKNENLNWKTR---LRIAIDVANGLQYIHEHTRPRVVHKDIKSS 461
           +       +L  W+  N    +  + R   L I + +A  ++++H      ++H+D+K S
Sbjct: 93  QMQLCRKENLKDWM--NGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPS 147
Query: 462 NILLDSNMRAKIANFGLAK------------SGCNAITMHI--VGTQGYIAPEYLADGVV 507
           NI    +   K+ +FGL              +   A   H   VGT+ Y++PE +     
Sbjct: 148 NIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSY 207
Query: 508 STKMDVFSFGVVLLELI 524
           S K+D+FS G++L EL+
Sbjct: 208 SHKVDIFSLGLILFELL 224

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 11/156 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E +I +K+ H N+V+L       E++  YL+++ +  G L   +     E  +       
Sbjct: 55  EARICRKLQHPNIVRLHDSI--QEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHC 110
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRA---KIANFGLAKSGCNAITMH-I 490
              +   + Y H +    +VH+++K  N+LL S  +    K+A+FGLA    ++   H  
Sbjct: 111 IQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF 167
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT GY++PE L     S  +D+++ GV+L  L+ G
Sbjct: 168 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 80/160 (50%), Gaps = 13/160 (8%)
Query: 372 ACEELKILQKVNHGNLVKLEGFCID----PEDANCYLIYEYIENGSLHSWLHENKNENLN 427
           A  EL +L+ VNH N++ L           E  + YL+ E ++         E  +E ++
Sbjct: 68  AYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMS 127
Query: 428 WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG-CNAI 486
           +     +   +  G++++H      ++H+D+K SNI++ S+   KI +FGLA++   N +
Sbjct: 128 Y-----LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFM 179
Query: 487 TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
               V T+ Y APE +        +D++S G ++ EL+ G
Sbjct: 180 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 11/156 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E +I +K+ H N+V+L       E++  YL+++ +  G L   +     E  +       
Sbjct: 55  EARICRKLQHPNIVRLHDSI--QEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHC 110
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRA---KIANFGLAKSGCNAITMH-I 490
              +   + Y H +    +VH+++K  N+LL S  +    K+A+FGLA    ++   H  
Sbjct: 111 IQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF 167
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT GY++PE L     S  +D+++ GV+L  L+ G
Sbjct: 168 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 87/179 (48%), Gaps = 19/179 (10%)
Query: 372 ACEELKILQKVNHGNLVKLEGFCID----PEDANCYLIYEYIENGSLHSWLHENKNENLN 427
           A  EL +++ VNH N++ L           E  + YL+ E ++         E  +E ++
Sbjct: 108 AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS 167
Query: 428 WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT 487
           +     +   +  G++++H      ++H+D+K SNI++ S+   KI +FGLA++   +  
Sbjct: 168 Y-----LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 219
Query: 488 M-HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELI------SGKEAIDEEGKFCGQ 539
           M   V T+ Y APE +        +D++S G ++ E++       G++ ID+  K   Q
Sbjct: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 278

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 81/157 (51%), Gaps = 15/157 (9%)
Query: 375 ELKILQKVNHGNLVKL-EGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           E+ IL   +H N+VKL + F  +    N +++ E+   G++ + + E +      + ++ 
Sbjct: 84  EIDILASCDHPNIVKLLDAFYYE---NNLWILIEFCAGGAVDAVMLELERPLTESQIQV- 139
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH--IV 491
           +     + L Y+H++   +++H+D+K+ NIL   +   K+A+FG++      I      +
Sbjct: 140 VCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFI 196
Query: 492 GTQGYIAPEYL-----ADGVVSTKMDVFSFGVVLLEL 523
           GT  ++APE +      D     K DV+S G+ L+E+
Sbjct: 197 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 81/157 (51%), Gaps = 15/157 (9%)
Query: 375 ELKILQKVNHGNLVKL-EGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           E+ IL   +H N+VKL + F  +    N +++ E+   G++ + + E +      + ++ 
Sbjct: 84  EIDILASCDHPNIVKLLDAFYYE---NNLWILIEFCAGGAVDAVMLELERPLTESQIQV- 139
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH--IV 491
           +     + L Y+H++   +++H+D+K+ NIL   +   K+A+FG++      I      +
Sbjct: 140 VCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFI 196
Query: 492 GTQGYIAPEYLA-----DGVVSTKMDVFSFGVVLLEL 523
           GT  ++APE +      D     K DV+S G+ L+E+
Sbjct: 197 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 141 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY-VATRWYR 196
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 141 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY-VATRWYR 196
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 82/161 (50%), Gaps = 15/161 (9%)
Query: 372 ACEELKILQKVNHGNLVKLEGFCIDPEDA-----NCYLIYEYIENGSLHSWLHENKNENL 426
           A  EL +++ VNH N++ L      P+ +     + Y++ E ++         E  +E +
Sbjct: 70  AYRELVLMKVVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERM 128
Query: 427 NWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI 486
           ++     +   +  G++++H      ++H+D+K SNI++ S+   KI +FGLA++   + 
Sbjct: 129 SY-----LLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSF 180
Query: 487 TM-HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            M   V T+ Y APE +        +D++S G ++ E+I G
Sbjct: 181 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 141 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY-VATRWYR 196
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 83/184 (45%), Gaps = 14/184 (7%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           N  +E+ I   +NH N+VK  G     E    YL  EY   G L   +  +    +    
Sbjct: 51  NIKKEICINAMLNHENVVKFYGH--RREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPD 106
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAI 486
             R    +  G+ Y+H      + H+DIK  N+LLD     KI++FGLA     +    +
Sbjct: 107 AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163
Query: 487 TMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYW 545
              + GT  Y+APE L       + +DV+S G+VL  +++G+   D+    C +     W
Sbjct: 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDW 221
Query: 546 REMK 549
           +E K
Sbjct: 222 KEKK 225

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 11/156 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E +I +K+ H N+V+L       E++  YL+++ +  G L   +     E  +       
Sbjct: 78  EARICRKLQHPNIVRLHDSI--QEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHC 133
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRA---KIANFGLAKSGCNAITMH-I 490
              +   + Y H +    +VH+++K  N+LL S  +    K+A+FGLA    ++   H  
Sbjct: 134 IQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF 190
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT GY++PE L     S  +D+++ GV+L  L+ G
Sbjct: 191 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 87/179 (48%), Gaps = 19/179 (10%)
Query: 372 ACEELKILQKVNHGNLVKLEGFCID----PEDANCYLIYEYIENGSLHSWLHENKNENLN 427
           A  EL +++ VNH N++ L           E  + YL+ E ++         E  +E ++
Sbjct: 108 AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS 167
Query: 428 WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT 487
           +     +   +  G++++H      ++H+D+K SNI++ S+   KI +FGLA++   +  
Sbjct: 168 Y-----LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 219
Query: 488 M-HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELI------SGKEAIDEEGKFCGQ 539
           M   V T+ Y APE +        +D++S G ++ E++       G++ ID+  K   Q
Sbjct: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 278

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 82/161 (50%), Gaps = 15/161 (9%)
Query: 372 ACEELKILQKVNHGNLVKLEGFCIDPEDA-----NCYLIYEYIENGSLHSWLHENKNENL 426
           A  EL +++ VNH N++ L      P+ +     + Y++ E ++         E  +E +
Sbjct: 70  AYRELVLMKVVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERM 128
Query: 427 NWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI 486
           ++     +   +  G++++H      ++H+D+K SNI++ S+   KI +FGLA++   + 
Sbjct: 129 SY-----LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSF 180
Query: 487 TM-HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            M   V T+ Y APE +        +D++S G ++ E+I G
Sbjct: 181 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 134 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY-VATRWYR 189
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 190 APEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 25/220 (11%)
Query: 351 GSVYKGNI--HGEVYAIKMM---KWNACEELKILQKVNHGNLVKLEGFCIDP----EDAN 401
           G VY+  +   GE+ AIK +   K     EL+I++K++H N+V+L  F        ++  
Sbjct: 42  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 101
Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAI-DVANGLQYIHEHTRPRVVHKDIKS 460
             L+ +Y+         H ++ +       +++ +  +   L YIH      + H+DIK 
Sbjct: 102 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKP 158
Query: 461 SNILLDSNMRA-KIANFGLAKSGCNA-ITMHIVGTQGYIAPEYLADGV-VSTKMDVFSFG 517
            N+LLD +    K+ +FG AK        +  + ++ Y APE +      ++ +DV+S G
Sbjct: 159 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAG 218
Query: 518 VVLLELI---------SGKEAIDEEGKFCGQKLKGYWREM 548
            VL EL+         SG + + E  K  G   +   REM
Sbjct: 219 CVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 258

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 25/220 (11%)
Query: 351 GSVYKGNI--HGEVYAIKMM---KWNACEELKILQKVNHGNLVKLEGFCIDP----EDAN 401
           G VY+  +   GE+ AIK +   K     EL+I++K++H N+V+L  F        ++  
Sbjct: 34  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93
Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAI-DVANGLQYIHEHTRPRVVHKDIKS 460
             L+ +Y+         H ++ +       +++ +  +   L YIH      + H+DIK 
Sbjct: 94  LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKP 150
Query: 461 SNILLDSNMRA-KIANFGLAKSGCNA-ITMHIVGTQGYIAPEYLADGV-VSTKMDVFSFG 517
            N+LLD +    K+ +FG AK        +  + ++ Y APE +      ++ +DV+S G
Sbjct: 151 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAG 210
Query: 518 VVLLELI---------SGKEAIDEEGKFCGQKLKGYWREM 548
            VL EL+         SG + + E  K  G   +   REM
Sbjct: 211 CVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 81/162 (50%), Gaps = 16/162 (9%)
Query: 372 ACEELKILQKVNHGNLVKLEGFCIDPEDA-----NCYLIYEYIENGSLHSWLHENKNENL 426
           A  EL +L+ + H N++ L      P  +     + YL+  +++         E   E +
Sbjct: 88  AYRELLLLKHMQHENVIGLLD-VFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKI 146
Query: 427 NWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI 486
            +     +   +  GL+YIH      VVH+D+K  N+ ++ +   KI +FGLA+     +
Sbjct: 147 QY-----LVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEM 198
Query: 487 TMHIVGTQGYIAPEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           T ++V T+ Y APE +   +  +  +D++S G ++ E+++GK
Sbjct: 199 TGYVV-TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 83/184 (45%), Gaps = 32/184 (17%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNEN--------- 425
           E ++L  + H ++V+  G C   E     +++EY+ +G L+ +L  +  +          
Sbjct: 70  EAELLTMLQHQHIVRFFGVCT--EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDV 127
Query: 426 ----LNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS 481
               L     L +A  VA G+ Y+        VH+D+ + N L+   +  KI +FG+++ 
Sbjct: 128 APGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD 184
Query: 482 GCNAITMHIVGTQ----GYIAPEYLADGVVSTKMDVFSFGVVLLEL----------ISGK 527
             +     + G       ++ PE +     +T+ DV+SFGVVL E+          +S  
Sbjct: 185 IYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT 244
Query: 528 EAID 531
           EAID
Sbjct: 245 EAID 248

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 83/184 (45%), Gaps = 32/184 (17%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNEN--------- 425
           E ++L  + H ++V+  G C   E     +++EY+ +G L+ +L  +  +          
Sbjct: 64  EAELLTMLQHQHIVRFFGVCT--EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDV 121
Query: 426 ----LNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS 481
               L     L +A  VA G+ Y+        VH+D+ + N L+   +  KI +FG+++ 
Sbjct: 122 APGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD 178
Query: 482 GCNAITMHIVGTQ----GYIAPEYLADGVVSTKMDVFSFGVVLLEL----------ISGK 527
             +     + G       ++ PE +     +T+ DV+SFGVVL E+          +S  
Sbjct: 179 IYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT 238
Query: 528 EAID 531
           EAID
Sbjct: 239 EAID 242

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 90/195 (46%), Gaps = 45/195 (23%)
Query: 360 GEVYAIK--------MMKWNACEELKILQKVNHGNLVKLEGFCIDPEDA-----NCYLIY 406
           GE+ AIK        +       E+KIL+   H N++ +  F I   D+       Y+I 
Sbjct: 36  GEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITI--FNIQRPDSFENFNEVYIIQ 93
Query: 407 EYIENGSLH-----SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSS 461
           E ++   LH       L ++  +   ++T LR A+ V +G           V+H+D+K S
Sbjct: 94  ELMQT-DLHRVISTQMLSDDHIQYFIYQT-LR-AVKVLHGSN---------VIHRDLKPS 141
Query: 462 NILLDSNMRAKIANFGLAK------------SGCNAITMHIVGTQGYIAPE-YLADGVVS 508
           N+L++SN   K+ +FGLA+            +G  +  +  V T+ Y APE  L     S
Sbjct: 142 NLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYS 201
Query: 509 TKMDVFSFGVVLLEL 523
             MDV+S G +L EL
Sbjct: 202 RAMDVWSCGCILAEL 216

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 25/220 (11%)
Query: 351 GSVYKGNI--HGEVYAIKMM---KWNACEELKILQKVNHGNLVKLEGFCIDP----EDAN 401
           G VY+  +   GE+ AIK +   K     EL+I++K++H N+V+L  F        ++  
Sbjct: 35  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 94
Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAI-DVANGLQYIHEHTRPRVVHKDIKS 460
             L+ +Y+         H ++ +       +++ +  +   L YIH      + H+DIK 
Sbjct: 95  LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKP 151
Query: 461 SNILLDSNMRA-KIANFGLAKSGCNA-ITMHIVGTQGYIAPEYLADGV-VSTKMDVFSFG 517
            N+LLD +    K+ +FG AK        +  + ++ Y APE +      ++ +DV+S G
Sbjct: 152 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAG 211
Query: 518 VVLLELI---------SGKEAIDEEGKFCGQKLKGYWREM 548
            VL EL+         SG + + E  K  G   +   REM
Sbjct: 212 CVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 251

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 25/220 (11%)
Query: 351 GSVYKGNI--HGEVYAIKMM---KWNACEELKILQKVNHGNLVKLEGFCIDP----EDAN 401
           G VY+  +   GE+ AIK +   K     EL+I++K++H N+V+L  F        ++  
Sbjct: 34  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93
Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAI-DVANGLQYIHEHTRPRVVHKDIKS 460
             L+ +Y+         H ++ +       +++ +  +   L YIH      + H+DIK 
Sbjct: 94  LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKP 150
Query: 461 SNILLDSNMRA-KIANFGLAKSGCNA-ITMHIVGTQGYIAPEYLADGV-VSTKMDVFSFG 517
            N+LLD +    K+ +FG AK        +  + ++ Y APE +      ++ +DV+S G
Sbjct: 151 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAG 210
Query: 518 VVLLELI---------SGKEAIDEEGKFCGQKLKGYWREM 548
            VL EL+         SG + + E  K  G   +   REM
Sbjct: 211 CVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 139 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY-VATRWYR 194
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 25/220 (11%)
Query: 351 GSVYKGNI--HGEVYAIKMM---KWNACEELKILQKVNHGNLVKLEGFCIDP----EDAN 401
           G VY+  +   GE+ AIK +   K     EL+I++K++H N+V+L  F        ++  
Sbjct: 53  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 112
Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAI-DVANGLQYIHEHTRPRVVHKDIKS 460
             L+ +Y+         H ++ +       +++ +  +   L YIH      + H+DIK 
Sbjct: 113 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKP 169
Query: 461 SNILLDSNMRA-KIANFGLAKSGCNA-ITMHIVGTQGYIAPEYLADGV-VSTKMDVFSFG 517
            N+LLD +    K+ +FG AK        +  + ++ Y APE +      ++ +DV+S G
Sbjct: 170 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAG 229
Query: 518 VVLLELI---------SGKEAIDEEGKFCGQKLKGYWREM 548
            VL EL+         SG + + E  K  G   +   REM
Sbjct: 230 CVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 269

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 25/220 (11%)
Query: 351 GSVYKGNI--HGEVYAIKMM---KWNACEELKILQKVNHGNLVKLEGFCIDP----EDAN 401
           G VY+  +   GE+ AIK +   K     EL+I++K++H N+V+L  F        ++  
Sbjct: 34  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93
Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAI-DVANGLQYIHEHTRPRVVHKDIKS 460
             L+ +Y+         H ++ +       +++ +  +   L YIH      + H+DIK 
Sbjct: 94  LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKP 150
Query: 461 SNILLDSNMRA-KIANFGLAKSGCNA-ITMHIVGTQGYIAPEYLADGV-VSTKMDVFSFG 517
            N+LLD +    K+ +FG AK        +  + ++ Y APE +      ++ +DV+S G
Sbjct: 151 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAG 210
Query: 518 VVLLELI---------SGKEAIDEEGKFCGQKLKGYWREM 548
            VL EL+         SG + + E  K  G   +   REM
Sbjct: 211 CVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 139 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY-VATRWYR 194
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 82/161 (50%), Gaps = 15/161 (9%)
Query: 372 ACEELKILQKVNHGNLVKLEGFCIDPEDA-----NCYLIYEYIENGSLHSWLHENKNENL 426
           A  EL +++ VNH N++ L      P+ +     + Y++ E ++         E  +E +
Sbjct: 70  AYRELVLMKCVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 128
Query: 427 NWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI 486
           ++     +   +  G++++H      ++H+D+K SNI++ S+   KI +FGLA++   + 
Sbjct: 129 SY-----LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 180
Query: 487 TM-HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            M   V T+ Y APE +        +D++S G ++ E+I G
Sbjct: 181 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 134 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY-VATRWYR 189
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 25/220 (11%)
Query: 351 GSVYKGNI--HGEVYAIKMM---KWNACEELKILQKVNHGNLVKLEGFCIDP----EDAN 401
           G VY+  +   GE+ AIK +   K     EL+I++K++H N+V+L  F        ++  
Sbjct: 34  GVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93
Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAI-DVANGLQYIHEHTRPRVVHKDIKS 460
             L+ +Y+         H ++ +       +++ +  +   L YIH      + H+DIK 
Sbjct: 94  LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKP 150
Query: 461 SNILLDSNMRA-KIANFGLAKSGCNA-ITMHIVGTQGYIAPEYLADGV-VSTKMDVFSFG 517
            N+LLD +    K+ +FG AK        +  + ++ Y APE +      ++ +DV+S G
Sbjct: 151 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAG 210
Query: 518 VVLLELI---------SGKEAIDEEGKFCGQKLKGYWREM 548
            VL EL+         SG + + E  K  G   +   REM
Sbjct: 211 CVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 25/220 (11%)
Query: 351 GSVYKGNI--HGEVYAIKMM---KWNACEELKILQKVNHGNLVKLEGFCIDP----EDAN 401
           G VY+  +   GE+ AIK +   K     EL+I++K++H N+V+L  F        ++  
Sbjct: 68  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127
Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAI-DVANGLQYIHEHTRPRVVHKDIKS 460
             L+ +Y+         H ++ +       +++ +  +   L YIH      + H+DIK 
Sbjct: 128 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKP 184
Query: 461 SNILLDSNMRA-KIANFGLAKSGCNA-ITMHIVGTQGYIAPEYLADGV-VSTKMDVFSFG 517
            N+LLD +    K+ +FG AK        +  + ++ Y APE +      ++ +DV+S G
Sbjct: 185 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAG 244
Query: 518 VVLLELI---------SGKEAIDEEGKFCGQKLKGYWREM 548
            VL EL+         SG + + E  K  G   +   REM
Sbjct: 245 CVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 284

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 85/185 (45%), Gaps = 34/185 (18%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNEN--------- 425
           E ++L  + H ++V+  G C   E     +++EY+ +G L+ +L  +  +          
Sbjct: 93  EAELLTMLQHQHIVRFFGVCT--EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDV 150
Query: 426 ----LNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS 481
               L     L +A  VA G+ Y+        VH+D+ + N L+   +  KI +FG+++ 
Sbjct: 151 APGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD 207
Query: 482 GCNAITMHIVGTQG-----YIAPEYLADGVVSTKMDVFSFGVVLLEL----------ISG 526
              +   + VG +      ++ PE +     +T+ DV+SFGVVL E+          +S 
Sbjct: 208 -IYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN 266
Query: 527 KEAID 531
            EAID
Sbjct: 267 TEAID 271

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 25/220 (11%)
Query: 351 GSVYKGNI--HGEVYAIKMM---KWNACEELKILQKVNHGNLVKLEGFCIDP----EDAN 401
           G VY+  +   GE+ AIK +   K     EL+I++K++H N+V+L  F        ++  
Sbjct: 46  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 105
Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAI-DVANGLQYIHEHTRPRVVHKDIKS 460
             L+ +Y+         H ++ +       +++ +  +   L YIH      + H+DIK 
Sbjct: 106 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKP 162
Query: 461 SNILLDSNMRA-KIANFGLAKSGCNA-ITMHIVGTQGYIAPEYLADGV-VSTKMDVFSFG 517
            N+LLD +    K+ +FG AK        +  + ++ Y APE +      ++ +DV+S G
Sbjct: 163 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAG 222
Query: 518 VVLLELI---------SGKEAIDEEGKFCGQKLKGYWREM 548
            VL EL+         SG + + E  K  G   +   REM
Sbjct: 223 CVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 262

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 25/220 (11%)
Query: 351 GSVYKGNI--HGEVYAIKMM---KWNACEELKILQKVNHGNLVKLEGFCIDP----EDAN 401
           G VY+  +   GE+ AIK +   K     EL+I++K++H N+V+L  F        ++  
Sbjct: 46  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 105
Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAI-DVANGLQYIHEHTRPRVVHKDIKS 460
             L+ +Y+         H ++ +       +++ +  +   L YIH      + H+DIK 
Sbjct: 106 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKP 162
Query: 461 SNILLDSNMRA-KIANFGLAKSGCNA-ITMHIVGTQGYIAPEYLADGV-VSTKMDVFSFG 517
            N+LLD +    K+ +FG AK        +  + ++ Y APE +      ++ +DV+S G
Sbjct: 163 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAG 222
Query: 518 VVLLELI---------SGKEAIDEEGKFCGQKLKGYWREM 548
            VL EL+         SG + + E  K  G   +   REM
Sbjct: 223 CVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 262

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 86/191 (45%), Gaps = 34/191 (17%)
Query: 364 AIKMMKWNA--------CEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K +A          ELK+L  + NH N+V L G C         +I EY   G L
Sbjct: 57  AVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDL 114
Query: 415 HSWLHENKNENLNWKTRLRI----------------AIDVANGLQYIHEHTRPRVVHKDI 458
            ++L   ++  +  KT   I                +  VA G+ ++        +H+D+
Sbjct: 115 LNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDL 171
Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ----GYIAPEYLADGVVSTKMDVF 514
            + NILL      KI +FGLA+   N     + G       ++APE + + V + + DV+
Sbjct: 172 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 231
Query: 515 SFGVVLLELIS 525
           S+G+ L EL S
Sbjct: 232 SYGIFLWELFS 242

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 25/220 (11%)
Query: 351 GSVYKGNI--HGEVYAIKMM---KWNACEELKILQKVNHGNLVKLEGFCIDP----EDAN 401
           G VY+  +   GE+ AIK +   K     EL+I++K++H N+V+L  F        ++  
Sbjct: 68  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127
Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAI-DVANGLQYIHEHTRPRVVHKDIKS 460
             L+ +Y+         H ++ +       +++ +  +   L YIH      + H+DIK 
Sbjct: 128 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKP 184
Query: 461 SNILLDSNMRA-KIANFGLAKSGCNA-ITMHIVGTQGYIAPEYLADGV-VSTKMDVFSFG 517
            N+LLD +    K+ +FG AK        +  + ++ Y APE +      ++ +DV+S G
Sbjct: 185 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAG 244
Query: 518 VVLLELI---------SGKEAIDEEGKFCGQKLKGYWREM 548
            VL EL+         SG + + E  K  G   +   REM
Sbjct: 245 CVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 284

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 88/189 (46%), Gaps = 20/189 (10%)
Query: 360 GEVYAIKMMK-----WNACE------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEY 408
           G+++A+K++K      NA +      E  IL++V H  +V L            YLI EY
Sbjct: 45  GKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDL--IYAFQTGGKLYLILEY 102
Query: 409 IENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN 468
           +  G L  ++   +       T      +++  L ++H+     ++++D+K  NI+L+  
Sbjct: 103 LSGGEL--FMQLEREGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQ 157
Query: 469 MRAKIANFGLAKSGCN--AITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
              K+ +FGL K   +   +T    GT  Y+APE L     +  +D +S G ++ ++++G
Sbjct: 158 GHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217
Query: 527 KEAIDEEGK 535
                 E +
Sbjct: 218 APPFTGENR 226

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 86/191 (45%), Gaps = 34/191 (17%)
Query: 364 AIKMMKWNA--------CEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K +A          ELK+L  + NH N+V L G C         +I EY   G L
Sbjct: 80  AVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDL 137
Query: 415 HSWLHENKNENLNWKTRLRI----------------AIDVANGLQYIHEHTRPRVVHKDI 458
            ++L   ++  +  KT   I                +  VA G+ ++        +H+D+
Sbjct: 138 LNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDL 194
Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ----GYIAPEYLADGVVSTKMDVF 514
            + NILL      KI +FGLA+   N     + G       ++APE + + V + + DV+
Sbjct: 195 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 254
Query: 515 SFGVVLLELIS 525
           S+G+ L EL S
Sbjct: 255 SYGIFLWELFS 265

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 145 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY-VATRWYR 200
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 201 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 163 ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY-VATRWYR 218
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 219 APEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 25/220 (11%)
Query: 351 GSVYKGNI--HGEVYAIKMM---KWNACEELKILQKVNHGNLVKLEGFCIDP----EDAN 401
           G VY+  +   GE+ AIK +   K     EL+I++K++H N+V+L  F        ++  
Sbjct: 34  GVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93
Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAI-DVANGLQYIHEHTRPRVVHKDIKS 460
             L+ +Y+         H ++ +       +++ +  +   L YIH      + H+DIK 
Sbjct: 94  LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKP 150
Query: 461 SNILLDSNMRA-KIANFGLAKSGCNA-ITMHIVGTQGYIAPEYLADGV-VSTKMDVFSFG 517
            N+LLD +    K+ +FG AK        +  + ++ Y APE +      ++ +DV+S G
Sbjct: 151 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAG 210
Query: 518 VVLLELI---------SGKEAIDEEGKFCGQKLKGYWREM 548
            VL EL+         SG + + E  K  G   +   REM
Sbjct: 211 CVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 82/161 (50%), Gaps = 15/161 (9%)
Query: 372 ACEELKILQKVNHGNLVKLEGFCIDPEDA-----NCYLIYEYIENGSLHSWLHENKNENL 426
           A  EL +++ VNH N++ L      P+ +     + Y++ E ++         E  +E +
Sbjct: 70  AYRELVLMKCVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 128
Query: 427 NWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI 486
           ++     +   +  G++++H      ++H+D+K SNI++ S+   KI +FGLA++   + 
Sbjct: 129 SY-----LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 180
Query: 487 TM-HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            M   V T+ Y APE +        +D++S G ++ E+I G
Sbjct: 181 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 25/220 (11%)
Query: 351 GSVYKGNI--HGEVYAIKMM---KWNACEELKILQKVNHGNLVKLEGFCIDP----EDAN 401
           G VY+  +   GE+ AIK +   K     EL+I++K++H N+V+L  F        ++  
Sbjct: 62  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 121
Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAI-DVANGLQYIHEHTRPRVVHKDIKS 460
             L+ +Y+         H ++ +       +++ +  +   L YIH      + H+DIK 
Sbjct: 122 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKP 178
Query: 461 SNILLDSNMRA-KIANFGLAKSGCNA-ITMHIVGTQGYIAPEYLADGV-VSTKMDVFSFG 517
            N+LLD +    K+ +FG AK        +  + ++ Y APE +      ++ +DV+S G
Sbjct: 179 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAG 238
Query: 518 VVLLELI---------SGKEAIDEEGKFCGQKLKGYWREM 548
            VL EL+         SG + + E  K  G   +   REM
Sbjct: 239 CVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 278

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 25/220 (11%)
Query: 351 GSVYKGNI--HGEVYAIKMM---KWNACEELKILQKVNHGNLVKLEGFCIDP----EDAN 401
           G VY+  +   GE+ AIK +   K     EL+I++K++H N+V+L  F        ++  
Sbjct: 34  GVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93
Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAI-DVANGLQYIHEHTRPRVVHKDIKS 460
             L+ +Y+         H ++ +       +++ +  +   L YIH      + H+DIK 
Sbjct: 94  LNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKP 150
Query: 461 SNILLDSNMRA-KIANFGLAKSGCNA-ITMHIVGTQGYIAPEYLADGV-VSTKMDVFSFG 517
            N+LLD +    K+ +FG AK        +  + ++ Y APE +      ++ +DV+S G
Sbjct: 151 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAG 210
Query: 518 VVLLELI---------SGKEAIDEEGKFCGQKLKGYWREM 548
            VL EL+         SG + + E  K  G   +   REM
Sbjct: 211 CVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 25/220 (11%)
Query: 351 GSVYKGNI--HGEVYAIKMM---KWNACEELKILQKVNHGNLVKLEGFCIDP----EDAN 401
           G VY+  +   GE+ AIK +   K     EL+I++K++H N+V+L  F        ++  
Sbjct: 47  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 106
Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAI-DVANGLQYIHEHTRPRVVHKDIKS 460
             L+ +Y+         H ++ +       +++ +  +   L YIH      + H+DIK 
Sbjct: 107 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKP 163
Query: 461 SNILLDSNMRA-KIANFGLAKSGCNA-ITMHIVGTQGYIAPEYLADGV-VSTKMDVFSFG 517
            N+LLD +    K+ +FG AK        +  + ++ Y APE +      ++ +DV+S G
Sbjct: 164 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAG 223
Query: 518 VVLLELI---------SGKEAIDEEGKFCGQKLKGYWREM 548
            VL EL+         SG + + E  K  G   +   REM
Sbjct: 224 CVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 263

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 25/220 (11%)
Query: 351 GSVYKGNI--HGEVYAIKMM---KWNACEELKILQKVNHGNLVKLEGFCIDP----EDAN 401
           G VY+  +   GE+ AIK +   K     EL+I++K++H N+V+L  F        ++  
Sbjct: 70  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 129
Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAI-DVANGLQYIHEHTRPRVVHKDIKS 460
             L+ +Y+         H ++ +       +++ +  +   L YIH      + H+DIK 
Sbjct: 130 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKP 186
Query: 461 SNILLDSNMRA-KIANFGLAKSGCNA-ITMHIVGTQGYIAPEYLADGV-VSTKMDVFSFG 517
            N+LLD +    K+ +FG AK        +  + ++ Y APE +      ++ +DV+S G
Sbjct: 187 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAG 246
Query: 518 VVLLELI---------SGKEAIDEEGKFCGQKLKGYWREM 548
            VL EL+         SG + + E  K  G   +   REM
Sbjct: 247 CVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 286

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 82/161 (50%), Gaps = 15/161 (9%)
Query: 372 ACEELKILQKVNHGNLVKLEGFCIDPEDA-----NCYLIYEYIENGSLHSWLHENKNENL 426
           A  EL +++ VNH N++ L      P+ +     + Y++ E ++         E  +E +
Sbjct: 71  AYRELVLMKCVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 129
Query: 427 NWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI 486
           ++     +   +  G++++H      ++H+D+K SNI++ S+   KI +FGLA++   + 
Sbjct: 130 SY-----LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181
Query: 487 TM-HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            M   V T+ Y APE +        +D++S G ++ E+I G
Sbjct: 182 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 82/161 (50%), Gaps = 15/161 (9%)
Query: 372 ACEELKILQKVNHGNLVKLEGFCIDPEDA-----NCYLIYEYIENGSLHSWLHENKNENL 426
           A  EL +++ VNH N++ L      P+ +     + Y++ E ++         E  +E +
Sbjct: 70  AYRELVLMKCVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 128
Query: 427 NWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI 486
           ++     +   +  G++++H      ++H+D+K SNI++ S+   KI +FGLA++   + 
Sbjct: 129 SY-----LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 180
Query: 487 TMHI-VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            M   V T+ Y APE +        +D++S G ++ E+I G
Sbjct: 181 MMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 82/161 (50%), Gaps = 15/161 (9%)
Query: 372 ACEELKILQKVNHGNLVKLEGFCIDPEDA-----NCYLIYEYIENGSLHSWLHENKNENL 426
           A  EL +++ VNH N++ L      P+ +     + Y++ E ++         E  +E +
Sbjct: 70  AYRELVLMKCVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERM 128
Query: 427 NWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI 486
           ++     +   +  G++++H      ++H+D+K SNI++ S+   KI +FGLA++   + 
Sbjct: 129 SY-----LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSF 180
Query: 487 TM-HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            M   V T+ Y APE +        +D++S G ++ E+I G
Sbjct: 181 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 25/220 (11%)
Query: 351 GSVYKGNI--HGEVYAIKMM---KWNACEELKILQKVNHGNLVKLEGFCIDP----EDAN 401
           G VY+  +   GE+ AIK +   K     EL+I++K++H N+V+L  F        ++  
Sbjct: 38  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 97
Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAI-DVANGLQYIHEHTRPRVVHKDIKS 460
             L+ +Y+         H ++ +       +++ +  +   L YIH      + H+DIK 
Sbjct: 98  LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKP 154
Query: 461 SNILLDSNMRA-KIANFGLAKSGCNA-ITMHIVGTQGYIAPEYLADGV-VSTKMDVFSFG 517
            N+LLD +    K+ +FG AK        +  + ++ Y APE +      ++ +DV+S G
Sbjct: 155 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAG 214
Query: 518 VVLLELI---------SGKEAIDEEGKFCGQKLKGYWREM 548
            VL EL+         SG + + E  K  G   +   REM
Sbjct: 215 CVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 254

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 89/180 (49%), Gaps = 21/180 (11%)
Query: 372 ACEELKILQKVNHGNLVKLEGFCIDPEDA-----NCYLIYEYIENGSLHSWLHENKNENL 426
           A  EL +++ VNH N++ L      P+ +     + Y++ E ++         E  +E +
Sbjct: 70  AYRELVLMKCVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 128
Query: 427 NWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI 486
           ++     +   +  G++++H      ++H+D+K SNI++ S+   KI +FGLA++   + 
Sbjct: 129 SY-----LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 180
Query: 487 TMHI-VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELI------SGKEAIDEEGKFCGQ 539
            M   V T+ Y APE +        +D++S G ++ E++       G++ ID+  K   Q
Sbjct: 181 MMEPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQ 240

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 86/191 (45%), Gaps = 34/191 (17%)
Query: 364 AIKMMKWNA--------CEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K +A          ELK+L  + NH N+V L G C         +I EY   G L
Sbjct: 73  AVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDL 130
Query: 415 HSWLHENKNENLNWKTRLRI----------------AIDVANGLQYIHEHTRPRVVHKDI 458
            ++L   ++  +  KT   I                +  VA G+ ++        +H+D+
Sbjct: 131 LNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDL 187
Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ----GYIAPEYLADGVVSTKMDVF 514
            + NILL      KI +FGLA+   N     + G       ++APE + + V + + DV+
Sbjct: 188 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 247
Query: 515 SFGVVLLELIS 525
           S+G+ L EL S
Sbjct: 248 SYGIFLWELFS 258

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 86/191 (45%), Gaps = 34/191 (17%)
Query: 364 AIKMMKWNA--------CEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K +A          ELK+L  + NH N+V L G C         +I EY   G L
Sbjct: 75  AVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDL 132
Query: 415 HSWLHENKNENLNWKTRLRI----------------AIDVANGLQYIHEHTRPRVVHKDI 458
            ++L   ++  +  KT   I                +  VA G+ ++        +H+D+
Sbjct: 133 LNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDL 189
Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ----GYIAPEYLADGVVSTKMDVF 514
            + NILL      KI +FGLA+   N     + G       ++APE + + V + + DV+
Sbjct: 190 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 249
Query: 515 SFGVVLLELIS 525
           S+G+ L EL S
Sbjct: 250 SYGIFLWELFS 260

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 25/220 (11%)
Query: 351 GSVYKGNI--HGEVYAIKMM---KWNACEELKILQKVNHGNLVKLEGFCIDP----EDAN 401
           G VY+  +   GE+ AIK +   K     EL+I++K++H N+V+L  F        ++  
Sbjct: 39  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 98
Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAI-DVANGLQYIHEHTRPRVVHKDIKS 460
             L+ +Y+         H ++ +       +++ +  +   L YIH      + H+DIK 
Sbjct: 99  LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKP 155
Query: 461 SNILLDSNMRA-KIANFGLAKSGCNA-ITMHIVGTQGYIAPEYLADGV-VSTKMDVFSFG 517
            N+LLD +    K+ +FG AK        +  + ++ Y APE +      ++ +DV+S G
Sbjct: 156 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAG 215
Query: 518 VVLLELI---------SGKEAIDEEGKFCGQKLKGYWREM 548
            VL EL+         SG + + E  K  G   +   REM
Sbjct: 216 CVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 255

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 88/189 (46%), Gaps = 20/189 (10%)
Query: 360 GEVYAIKMMK-----WNACE------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEY 408
           G+++A+K++K      NA +      E  IL++V H  +V L            YLI EY
Sbjct: 45  GKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDL--IYAFQTGGKLYLILEY 102
Query: 409 IENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN 468
           +  G L  ++   +       T      +++  L ++H+     ++++D+K  NI+L+  
Sbjct: 103 LSGGEL--FMQLEREGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQ 157
Query: 469 MRAKIANFGLAKSGCN--AITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
              K+ +FGL K   +   +T    GT  Y+APE L     +  +D +S G ++ ++++G
Sbjct: 158 GHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217
Query: 527 KEAIDEEGK 535
                 E +
Sbjct: 218 APPFTGENR 226

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 25/220 (11%)
Query: 351 GSVYKGNI--HGEVYAIKMM---KWNACEELKILQKVNHGNLVKLEGFCIDP----EDAN 401
           G VY+  +   GE+ AIK +   K     EL+I++K++H N+V+L  F        ++  
Sbjct: 72  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 131
Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAI-DVANGLQYIHEHTRPRVVHKDIKS 460
             L+ +Y+         H ++ +       +++ +  +   L YIH      + H+DIK 
Sbjct: 132 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKP 188
Query: 461 SNILLDSNMRA-KIANFGLAKSGCNA-ITMHIVGTQGYIAPEYLADGV-VSTKMDVFSFG 517
            N+LLD +    K+ +FG AK        +  + ++ Y APE +      ++ +DV+S G
Sbjct: 189 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAG 248
Query: 518 VVLLELI---------SGKEAIDEEGKFCGQKLKGYWREM 548
            VL EL+         SG + + E  K  G   +   REM
Sbjct: 249 CVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 288

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 329 RIFKIEELREATDNFSEGCLIQGSVYKG-------NIHGEVYAIKMMKWNAC-------- 373
           RI K  ELR+       G    G+VYKG       N+   V AIK+++ N          
Sbjct: 12  RILKETELRKVK-VLGSGAF--GTVYKGIWIPDGENVKIPV-AIKVLRENTSPKANKEIL 67
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E  ++  V    + +L G C+    +   L+ + +  G L   + EN+   L  +  L 
Sbjct: 68  DEAYVMAGVGSPYVSRLLGICLT---STVQLVTQLMPYGCLLDHVRENRG-RLGSQDLLN 123
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK-SGCNAITMHIVG 492
             + +A G+ Y+ +    R+VH+D+ + N+L+ S    KI +FGLA+    +    H  G
Sbjct: 124 WCMQIAKGMSYLEDV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADG 180
Query: 493 TQ---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
            +    ++A E +     + + DV+S+GV + EL++
Sbjct: 181 GKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 134 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY-VATRWYR 189
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 139 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY-VATRWYR 194
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 140 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGY-VATRWYR 195
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 133 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY-VATRWYR 188
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 189 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 86/191 (45%), Gaps = 34/191 (17%)
Query: 364 AIKMMKWNA--------CEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
           A+KM+K +A          ELK+L  + NH N+V L G C         +I EY   G L
Sbjct: 80  AVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDL 137
Query: 415 HSWLHENKNENLNWKTRLRI----------------AIDVANGLQYIHEHTRPRVVHKDI 458
            ++L   ++  +  KT   I                +  VA G+ ++        +H+D+
Sbjct: 138 LNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDL 194
Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ----GYIAPEYLADGVVSTKMDVF 514
            + NILL      KI +FGLA+   N     + G       ++APE + + V + + DV+
Sbjct: 195 AARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 254
Query: 515 SFGVVLLELIS 525
           S+G+ L EL S
Sbjct: 255 SYGIFLWELFS 265

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 134 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY-VATRWYR 189
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 134 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY-VATRWYR 189
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 134 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY-VATRWYR 189
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 134 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY-VATRWYR 189
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 136 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGY-VATRWYR 191
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 134 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY-VATRWYR 189
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 144 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY-VATRWYR 199
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 200 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 134 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY-VATRWYR 189
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 141 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY-VATRWYR 196
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 136 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY-VATRWYR 191
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 136 ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY-VATRWYR 191
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 82/161 (50%), Gaps = 15/161 (9%)
Query: 372 ACEELKILQKVNHGNLVKLEGFCIDPEDA-----NCYLIYEYIENGSLHSWLHENKNENL 426
           A  EL +++ VNH N++ L      P+ +     + Y++ E ++         E  +E +
Sbjct: 70  AYRELVLMKCVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERM 128
Query: 427 NWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI 486
           ++     +   +  G++++H      ++H+D+K SNI++ S+   KI +FGLA++   + 
Sbjct: 129 SY-----LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 180
Query: 487 TM-HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            M   V T+ Y APE +        +D++S G ++ E+I G
Sbjct: 181 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 131 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY-VATRWYR 186
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 187 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 136 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY-VATRWYR 191
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 134 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY-VATRWYR 189
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 131 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY-VATRWYR 186
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 187 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 79/161 (49%), Gaps = 20/161 (12%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E +I + + H N+V+L       E+ + YLI++ +  G L         E++  +     
Sbjct: 71  EARICRLLKHPNIVRLHDSI--SEEGHHYLIFDLVTGGELF--------EDIVAREYYSE 120
Query: 435 AIDVANGLQYIHEHT----RPRVVHKDIKSSNILLDSNMRA---KIANFGLA--KSGCNA 485
           A D ++ +Q I E      +  VVH+D+K  N+LL S ++    K+A+FGLA    G   
Sbjct: 121 A-DASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 179
Query: 486 ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
                 GT GY++PE L        +D+++ GV+L  L+ G
Sbjct: 180 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 134 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY-VATRWYR 189
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 130 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY-VATRWYR 185
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 140 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY-VATRWYR 195
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 146 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY-VATRWYR 201
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 139 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY-VATRWYR 194
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 146 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY-VATRWYR 201
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 145 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY-VATRWYR 200
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 201 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 89/195 (45%), Gaps = 45/195 (23%)
Query: 360 GEVYAIK--------MMKWNACEELKILQKVNHGNLVKLEGFCIDPEDA-----NCYLIY 406
           GE+ AIK        +       E+KIL+   H N++ +  F I   D+       Y+I 
Sbjct: 36  GEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITI--FNIQRPDSFENFNEVYIIQ 93
Query: 407 EYIENGSLH-----SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSS 461
           E ++   LH       L ++  +   ++T LR A+ V +G           V+H+D+K S
Sbjct: 94  ELMQT-DLHRVISTQMLSDDHIQYFIYQT-LR-AVKVLHGSN---------VIHRDLKPS 141
Query: 462 NILLDSNMRAKIANFGLAK------------SGCNAITMHIVGTQGYIAPE-YLADGVVS 508
           N+L++SN   K+ +FGLA+            +G  +     V T+ Y APE  L     S
Sbjct: 142 NLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYS 201
Query: 509 TKMDVFSFGVVLLEL 523
             MDV+S G +L EL
Sbjct: 202 RAMDVWSCGCILAEL 216

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 130 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY-VATRWYR 185
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 140 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY-VATRWYR 195
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 146 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY-VATRWYR 201
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 132 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY-VATRWYR 187
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 188 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 100/220 (45%), Gaps = 25/220 (11%)
Query: 351 GSVYKGNI--HGEVYAIKMM---KWNACEELKILQKVNHGNLVKLEGFCIDPEDAN---- 401
           G VY+  +   GE+ AIK +   K     EL+I++K++H N+V+L  F     +      
Sbjct: 34  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDVVY 93
Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAI-DVANGLQYIHEHTRPRVVHKDIKS 460
             L+ +Y+         H ++ +       +++ +  +   L YIH      + H+DIK 
Sbjct: 94  LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKP 150
Query: 461 SNILLDSNMRA-KIANFGLAKSGCNA-ITMHIVGTQGYIAPEYLADGV-VSTKMDVFSFG 517
            N+LLD +    K+ +FG AK        +  + ++ Y APE +      ++ +DV+S G
Sbjct: 151 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAG 210
Query: 518 VVLLELI---------SGKEAIDEEGKFCGQKLKGYWREM 548
            VL EL+         SG + + E  K  G   +   REM
Sbjct: 211 CVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 157 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY-VATRWYR 212
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 213 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 140 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY-VATRWYR 195
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 89/180 (49%), Gaps = 21/180 (11%)
Query: 372 ACEELKILQKVNHGNLVKLEGFCIDPEDA-----NCYLIYEYIENGSLHSWLHENKNENL 426
           A  EL +++ VNH N++ L      P+ +     + Y++ E ++         E  +E +
Sbjct: 70  AYRELVLMKCVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 128
Query: 427 NWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI 486
           ++     +   +  G++++H      ++H+D+K SNI++ S+   KI +FGLA++   + 
Sbjct: 129 SY-----LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 180
Query: 487 TMHI-VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELI------SGKEAIDEEGKFCGQ 539
            M   V T+ Y APE +        +D++S G ++ E++       G++ ID+  K   Q
Sbjct: 181 MMEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQ 240

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 25/220 (11%)
Query: 351 GSVYKGNI--HGEVYAIKMM---KWNACEELKILQKVNHGNLVKLEGFCIDP----EDAN 401
           G VY+  +   GE+ AIK +   K     EL+I++K++H N+V+L  F        ++  
Sbjct: 113 GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 172
Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAI-DVANGLQYIHEHTRPRVVHKDIKS 460
             L+ +Y+         H ++ +       +++ +  +   L YIH      + H+DIK 
Sbjct: 173 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKP 229
Query: 461 SNILLDSNMRA-KIANFGLAKSGCNA-ITMHIVGTQGYIAPEYLADGV-VSTKMDVFSFG 517
            N+LLD +    K+ +FG AK        +  + ++ Y APE +      ++ +DV+S G
Sbjct: 230 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAG 289
Query: 518 VVLLELI---------SGKEAIDEEGKFCGQKLKGYWREM 548
            VL EL+         SG + + E  K  G   +   REM
Sbjct: 290 CVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 329

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 153 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY-VATRWYR 208
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 209 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 154 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY-VATRWYR 209
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 130 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY-VATRWYR 185
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 54/88 (61%), Gaps = 5/88 (5%)
Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPE 500
           GL+YIH      ++H+D+K SN+ ++ +   +I +FGLA+     +T + V T+ Y APE
Sbjct: 135 GLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGY-VATRWYRAPE 190
Query: 501 YLADGV-VSTKMDVFSFGVVLLELISGK 527
            + + +  +  +D++S G ++ EL+ GK
Sbjct: 191 IMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 89/195 (45%), Gaps = 45/195 (23%)
Query: 360 GEVYAIK--------MMKWNACEELKILQKVNHGNLVKLEGFCIDPEDA-----NCYLIY 406
           GE+ AIK        +       E+KIL+   H N++ +  F I   D+       Y+I 
Sbjct: 36  GEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITI--FNIQRPDSFENFNEVYIIQ 93
Query: 407 EYIENGSLH-----SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSS 461
           E ++   LH       L ++  +   ++T LR A+ V +G           V+H+D+K S
Sbjct: 94  ELMQT-DLHRVISTQMLSDDHIQYFIYQT-LR-AVKVLHGSN---------VIHRDLKPS 141
Query: 462 NILLDSNMRAKIANFGLAK------------SGCNAITMHIVGTQGYIAPE-YLADGVVS 508
           N+L++SN   K+ +FGLA+            +G  +     V T+ Y APE  L     S
Sbjct: 142 NLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYS 201
Query: 509 TKMDVFSFGVVLLEL 523
             MDV+S G +L EL
Sbjct: 202 RAMDVWSCGCILAEL 216

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 154 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY-VATRWYR 209
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T + V T+ Y 
Sbjct: 153 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY-VATRWYR 208
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 209 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 89/180 (49%), Gaps = 21/180 (11%)
Query: 372 ACEELKILQKVNHGNLVKLEGFCIDPEDA-----NCYLIYEYIENGSLHSWLHENKNENL 426
           A  EL +++ VNH N++ L      P+ +     + Y++ E ++         E  +E +
Sbjct: 75  AYRELVLMKCVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 133
Query: 427 NWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI 486
           ++     +   +  G++++H      ++H+D+K SNI++ S+   KI +FGLA++   + 
Sbjct: 134 SY-----LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 185
Query: 487 TM-HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELI------SGKEAIDEEGKFCGQ 539
            M   V T+ Y APE +        +D++S G ++ E++       G++ ID+  K   Q
Sbjct: 186 MMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQ 245

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 56/107 (52%), Gaps = 7/107 (6%)
Query: 423 NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG 482
            E +  +  +  +  VA G++++      + +H+D+ + NILL  N   KI +FGLA+  
Sbjct: 193 KEPITMEDLISYSFQVARGMEFLSSR---KCIHRDLAARNILLSENNVVKICDFGLARDI 249
Query: 483 CNAITMHIVGTQ----GYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
                    G       ++APE + D + STK DV+S+GV+L E+ S
Sbjct: 250 YKNPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 74/152 (48%), Gaps = 7/152 (4%)
Query: 374 EELKILQKVNHGNLVKL-EGFCIDPEDANC-YLIYEYIENGSLHSWLHENKNENLNWKTR 431
           EE + L+ + H N+V+  + +    +   C  L+ E   +G+L ++L   K   +  K  
Sbjct: 74  EEAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKI--KVL 131
Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRA-KIANFGLAKSGCNAITMHI 490
                 +  GLQ++H  T P ++H+D+K  NI +     + KI + GLA     +    +
Sbjct: 132 RSWCRQILKGLQFLHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV 190
Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLE 522
           +GT  + APE   +    + +DV++FG   LE
Sbjct: 191 IGTPEFXAPEXYEEKYDES-VDVYAFGXCXLE 221

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 54/88 (61%), Gaps = 5/88 (5%)
Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPE 500
           GL+YIH      ++H+D+K SN+ ++ +   +I +FGLA+     +T + V T+ Y APE
Sbjct: 143 GLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGY-VATRWYRAPE 198
Query: 501 YLADGV-VSTKMDVFSFGVVLLELISGK 527
            + + +  +  +D++S G ++ EL+ GK
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 79/168 (47%), Gaps = 14/168 (8%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANC-YLIYEYIENGSLHSWLHENKNENLNWK 429
           N  +E+ I + +NH N+VK  G      + N  YL  EY   G L   +  +    +   
Sbjct: 50  NIKKEICINKMLNHENVVKFYGHR---REGNIQYLFLEYCSGGELFDRIEPDIG--MPEP 104
Query: 430 TRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNA 485
              R    +  G+ Y+H      + H+DIK  N+LLD     KI++FGLA     +    
Sbjct: 105 DAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 161
Query: 486 ITMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELISGKEAIDE 532
           +   + GT  Y+APE L       + +DV+S G+VL  +++G+   D+
Sbjct: 162 LLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 58/96 (60%), Gaps = 7/96 (7%)
Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI-V 491
           +IA+ +   L+  H H++  V+H+D+K SN+L+++  + K+ +FG++    +++   I  
Sbjct: 157 KIAVSIVKALE--HLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDA 214
Query: 492 GTQGYIAPEYLADGV----VSTKMDVFSFGVVLLEL 523
           G + Y+APE +   +     S K D++S G+ ++EL
Sbjct: 215 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 250

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 66/126 (52%), Gaps = 7/126 (5%)
Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI 463
           LI EY   G + S       E ++    +R+   +  G+ Y+H++    +VH D+K  NI
Sbjct: 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNI 162
Query: 464 LLDSNM---RAKIANFGLAKSGCNAITM-HIVGTQGYIAPEYLADGVVSTKMDVFSFGVV 519
           LL S       KI +FG+++   +A  +  I+GT  Y+APE L    ++T  D+++ G++
Sbjct: 163 LLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGII 222
Query: 520 LLELIS 525
              L++
Sbjct: 223 AYMLLT 228

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 54/88 (61%), Gaps = 5/88 (5%)
Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPE 500
           GL+YIH      ++H+D+K SN+ ++ +   +I +FGLA+     +T + V T+ Y APE
Sbjct: 143 GLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGY-VATRWYRAPE 198
Query: 501 YLADGV-VSTKMDVFSFGVVLLELISGK 527
            + + +  +  +D++S G ++ EL+ GK
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 89/180 (49%), Gaps = 21/180 (11%)
Query: 372 ACEELKILQKVNHGNLVKLEGFCIDPEDA-----NCYLIYEYIENGSLHSWLHENKNENL 426
           A  EL +++ VNH N++ L      P+ +     + Y++ E ++         E  +E +
Sbjct: 64  AYRELVLMKCVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM 122
Query: 427 NWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI 486
           ++     +   +  G++++H      ++H+D+K SNI++ S+   KI +FGLA++   + 
Sbjct: 123 SY-----LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 174
Query: 487 TM-HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELI------SGKEAIDEEGKFCGQ 539
            M   V T+ Y APE +        +D++S G ++ E++       G++ ID+  K   Q
Sbjct: 175 MMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQ 234

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/113 (31%), Positives = 58/113 (51%), Gaps = 15/113 (13%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK-----SGCNAITMHIVG 492
           +  GL+YIH      V+H+D+K SN+L+++    KI +FGLA+               V 
Sbjct: 153 ILRGLKYIHSAN---VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVA 209
Query: 493 TQGYIAPEYLADGVVSTK-MDVFSFGVVLLELIS------GKEAIDEEGKFCG 538
           T+ Y APE + +    TK +D++S G +L E++S      GK  +D+     G
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 262

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 56/91 (61%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI  FGLA+   + +T + V T+ Y 
Sbjct: 134 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGY-VATRWYR 189
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 56/91 (61%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +T   V T+ Y 
Sbjct: 134 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GXVATRWYR 189
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 81/168 (48%), Gaps = 21/168 (12%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCY--LIYEYIENGSLHSWLHENKNE-NLNWKTR 431
           E ++L+K+NH N+VKL  F I+ E    +  LI E+   GSL++ L E  N   L     
Sbjct: 57  EFEVLKKLNHKNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF 114
Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL----DSNMRAKIANFGLAKS-GCNAI 486
           L +  DV  G+ ++ E+    +VH++IK  NI+     D     K+ +FG A+    +  
Sbjct: 115 LIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171
Query: 487 TMHIVGTQGYIAPEYLADGVV--------STKMDVFSFGVVLLELISG 526
            + + GT+ Y+ P+     V+           +D++S GV      +G
Sbjct: 172 FVXLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 54/107 (50%), Gaps = 17/107 (15%)
Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----------- 480
           L I I +A  ++++H      ++H+D+K SNI    +   K+ +FGL             
Sbjct: 167 LHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 481 -SGCNAITMHI--VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELI 524
            +   A   H   VGT+ Y++PE +     S K+D+FS G++L EL+
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 93/205 (45%), Gaps = 24/205 (11%)
Query: 335 ELREATDNFSEGCLIQGSVYKGNIH--GEVYAIKMMKWNACEELK-------ILQKVNHG 385
           E+ E      +G    G VYK      G + A K+++  + EEL+       IL   +H 
Sbjct: 19  EVWEIVGELGDGAF--GKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHP 76
Query: 386 NLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYI 445
            +VKL G      D   +++ E+   G++ + + E  +  L       +   +   L ++
Sbjct: 77  YIVKLLGAYY--HDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQVVCRQMLEALNFL 133
Query: 446 HEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH--IVGTQGYIAPEY-- 501
           H     R++H+D+K+ N+L+      ++A+FG++      +      +GT  ++APE   
Sbjct: 134 HSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVM 190
Query: 502 ---LADGVVSTKMDVFSFGVVLLEL 523
              + D     K D++S G+ L+E+
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEM 215

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 81/168 (48%), Gaps = 21/168 (12%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCY--LIYEYIENGSLHSWLHENKNE-NLNWKTR 431
           E ++L+K+NH N+VKL  F I+ E    +  LI E+   GSL++ L E  N   L     
Sbjct: 57  EFEVLKKLNHKNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF 114
Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL----DSNMRAKIANFGLAKS-GCNAI 486
           L +  DV  G+ ++ E+    +VH++IK  NI+     D     K+ +FG A+    +  
Sbjct: 115 LIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171
Query: 487 TMHIVGTQGYIAPEYLADGVV--------STKMDVFSFGVVLLELISG 526
            + + GT+ Y+ P+     V+           +D++S GV      +G
Sbjct: 172 FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 89/192 (46%), Gaps = 25/192 (13%)
Query: 330 IFKIEELREATDNF------SEGCLIQGSVYKGNIHGEVYAIKMM-KWN-------AC-- 373
           + +++E+R   D+F        G   + +V K    G+VYA+K+M KW+       +C  
Sbjct: 50  VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFR 109
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           EE  +L   +   + +L  F    E+   YL+ EY   G L + L +          R  
Sbjct: 110 EERDVLVNGDRRWITQLH-FAFQDEN-YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFY 167
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLA---KSGCNAITMHI 490
           +A ++   +  +H   R   VH+DIK  NILLD     ++A+FG     ++     ++  
Sbjct: 168 LA-EIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVA 223
Query: 491 VGTQGYIAPEYL 502
           VGT  Y++PE L
Sbjct: 224 VGTPDYLSPEIL 235

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/91 (30%), Positives = 57/91 (62%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI ++GLA+   + +T + V T+ Y 
Sbjct: 134 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGY-VATRWYR 189
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 54/89 (60%), Gaps = 5/89 (5%)
Query: 440 NGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAP 499
            GL+YIH      VVH+D+K  N+ ++ +   KI +FGLA+     +T ++V T+ Y AP
Sbjct: 137 KGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV-TRWYRAP 192
Query: 500 EYLADGV-VSTKMDVFSFGVVLLELISGK 527
           E +   +  +  +D++S G ++ E+++GK
Sbjct: 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 98/207 (47%), Gaps = 23/207 (11%)
Query: 338 EATDNFSEGCLIQGSVYKGNIH--GEVYAIKMMKWN---------ACEELKILQKVNHGN 386
           E  +   EG    G+V+K       E+ A+K ++ +         A  E+ +L+++ H N
Sbjct: 5   EKLEKIGEG--TYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 387 LVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIH 446
           +V+L    +   D    L++E+ +   L  +  ++ N +L+ +        +  GL + H
Sbjct: 63  IVRLHD--VLHSDKKLTLVFEFCDQ-DLKKYF-DSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 447 EHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI--VGTQGYIAPEYL-A 503
                 V+H+D+K  N+L++ N   K+ANFGLA++    +  +   V T  Y  P+ L  
Sbjct: 119 SRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 504 DGVVSTKMDVFSFGVVLLELISGKEAI 530
             + ST +D++S G +  EL +    +
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPL 202

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 93/205 (45%), Gaps = 24/205 (11%)
Query: 335 ELREATDNFSEGCLIQGSVYKGNIH--GEVYAIKMMKWNACEELK-------ILQKVNHG 385
           E+ E      +G    G VYK      G + A K+++  + EEL+       IL   +H 
Sbjct: 11  EVWEIVGELGDGAF--GKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHP 68
Query: 386 NLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYI 445
            +VKL G      D   +++ E+   G++ + + E  +  L       +   +   L ++
Sbjct: 69  YIVKLLGAYY--HDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQVVCRQMLEALNFL 125
Query: 446 HEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH--IVGTQGYIAPEY-- 501
           H     R++H+D+K+ N+L+      ++A+FG++      +      +GT  ++APE   
Sbjct: 126 HSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVM 182
Query: 502 ---LADGVVSTKMDVFSFGVVLLEL 523
              + D     K D++S G+ L+E+
Sbjct: 183 CETMKDTPYDYKADIWSLGITLIEM 207

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 54/100 (54%), Gaps = 7/100 (7%)
Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT-MHIV 491
           +I +     L ++ E+ +  ++H+DIK SNILLD +   K+ +FG++    ++I      
Sbjct: 129 KITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA 186
Query: 492 GTQGYIAPEYLADGV----VSTKMDVFSFGVVLLELISGK 527
           G + Y+APE +           + DV+S G+ L EL +G+
Sbjct: 187 GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 57/96 (59%), Gaps = 7/96 (7%)
Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI-V 491
           +IA+ +   L+  H H++  V+H+D+K SN+L+++  + K+ +FG++    + +   I  
Sbjct: 113 KIAVSIVKALE--HLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA 170
Query: 492 GTQGYIAPEYLADGV----VSTKMDVFSFGVVLLEL 523
           G + Y+APE +   +     S K D++S G+ ++EL
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 82/166 (49%), Gaps = 20/166 (12%)
Query: 372 ACEELKILQKVNHGNLVKLEGFC---IDPED---ANCYLIYEYIENGSLHSWLHENKNEN 425
           A  E+KILQ + H N+V L   C     P +   A+ YL++++ E+    + L  N    
Sbjct: 64  ALREIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDL--AGLLSNVLVK 121
Query: 426 LNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----- 480
                  R+   + NGL YIH   R +++H+D+K++N+L+  +   K+A+FGLA+     
Sbjct: 122 FTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLA 178
Query: 481 --SGCNAITMHIVGTQGYIAPE-YLADGVVSTKMDVFSFGVVLLEL 523
             S  N     +V T  Y  PE  L +      +D++  G ++ E+
Sbjct: 179 KNSQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 86/179 (48%), Gaps = 21/179 (11%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E +I + + H N+V+L       E+ + YLI++ +  G L         E++  +     
Sbjct: 60  EARICRLLKHPNIVRLHDSI--SEEGHHYLIFDLVTGGELF--------EDIVAREYYSE 109
Query: 435 AIDVANGLQYIHEHT----RPRVVHKDIKSSNILLDSNMRA---KIANFGLA--KSGCNA 485
           A D ++ +Q I E      +  VVH+++K  N+LL S ++    K+A+FGLA    G   
Sbjct: 110 A-DASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168
Query: 486 ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAI-DEEGKFCGQKLKG 543
                 GT GY++PE L        +D+++ GV+L  L+ G     DE+     Q++K 
Sbjct: 169 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA 227

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 90/196 (45%), Gaps = 22/196 (11%)
Query: 356 GNIHGEVYAIKMMK-----------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYL 404
           G+  G++YA+K++K            +   E ++L+ +     +    +    E    +L
Sbjct: 78  GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-TKLHL 136
Query: 405 IYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNIL 464
           I +YI  G L  + H ++ E            ++   L+++H   +  ++++DIK  NIL
Sbjct: 137 ILDYINGGEL--FTHLSQRERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENIL 191
Query: 465 LDSNMRAKIANFGLAKSGCNAITMH---IVGTQGYIAPEYL--ADGVVSTKMDVFSFGVV 519
           LDSN    + +FGL+K      T       GT  Y+AP+ +   D      +D +S GV+
Sbjct: 192 LDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVL 251
Query: 520 LLELISGKEAIDEEGK 535
           + EL++G      +G+
Sbjct: 252 MYELLTGASPFTVDGE 267

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 77/161 (47%), Gaps = 20/161 (12%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E +I + + H N+V+L       E+   YL+++ +  G L         E++  +     
Sbjct: 53  EARICRLLKHSNIVRLHDSI--SEEGFHYLVFDLVTGGELF--------EDIVAREYYSE 102
Query: 435 AIDVANGLQYIHEHT----RPRVVHKDIKSSNILLDSNMRA---KIANFGLA--KSGCNA 485
           A D ++ +Q I E      +  VVH+D+K  N+LL S  +    K+A+FGLA    G   
Sbjct: 103 A-DASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQ 161
Query: 486 ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
                 GT GY++PE L        +D+++ GV+L  L+ G
Sbjct: 162 AWFGFAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 68/141 (48%), Gaps = 22/141 (15%)
Query: 403 YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSN 462
           YL++E +  GS+ S +H  K  + N      +  DVA+ L ++H      + H+D+K  N
Sbjct: 87  YLVFEKMRGGSILSHIH--KRRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPEN 141
Query: 463 ILLDSNMR---AKIANFGLAK-----SGCNAIT----MHIVGTQGYIAPEYL-----ADG 505
           IL +   +    KI +FGL         C+ I+    +   G+  Y+APE +        
Sbjct: 142 ILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEAS 201
Query: 506 VVSTKMDVFSFGVVLLELISG 526
           +   + D++S GV+L  L+SG
Sbjct: 202 IYDKRCDLWSLGVILYILLSG 222

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 83/157 (52%), Gaps = 11/157 (7%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDP---EDANCYLIYEYIENGSLHSWLHENKNENLNWKTR 431
           EL++L+ + H N++ L          E+ N   +  ++    L++ +   K++ L     
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KSQKLTDDHV 127
Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIV 491
             +   +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGL +   + +T + V
Sbjct: 128 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGY-V 183
Query: 492 GTQGYIAPEYLADGV-VSTKMDVFSFGVVLLELISGK 527
            T+ Y APE + + +  +  +D++S G ++ EL++G+
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 78/163 (47%), Gaps = 12/163 (7%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
           N  +E+++L+++ H N+++L     + E    Y++ EY   G +   L     +      
Sbjct: 52  NVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQ 110
Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS----GCNAI 486
                  + +GL+Y+H      +VHKDIK  N+LL +    KI+  G+A++      +  
Sbjct: 111 AHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDT 167
Query: 487 TMHIVGTQGYIAPEYLADGV---VSTKMDVFSFGVVLLELISG 526
                G+  +  PE +A+G+      K+D++S GV L  + +G
Sbjct: 168 CRTSQGSPAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 28/91 (30%), Positives = 56/91 (61%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +  + V T+ Y 
Sbjct: 157 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGY-VATRWYR 212
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 213 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 28/91 (30%), Positives = 55/91 (60%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +    V T+ Y 
Sbjct: 134 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA-GFVATRWYR 189
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 28/91 (30%), Positives = 55/91 (60%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +    V T+ Y 
Sbjct: 134 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA-GFVATRWYR 189
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 98/207 (47%), Gaps = 23/207 (11%)
Query: 338 EATDNFSEGCLIQGSVYKGNIH--GEVYAIKMMKWN---------ACEELKILQKVNHGN 386
           E  +   EG    G+V+K       E+ A+K ++ +         A  E+ +L+++ H N
Sbjct: 5   EKLEKIGEG--TYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 387 LVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIH 446
           +V+L    +   D    L++E+ +   L  +  ++ N +L+ +        +  GL + H
Sbjct: 63  IVRLHD--VLHSDKKLTLVFEFCDQ-DLKKYF-DSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 447 EHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI--VGTQGYIAPEYL-A 503
                 V+H+D+K  N+L++ N   K+A+FGLA++    +  +   V T  Y  P+ L  
Sbjct: 119 SRN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 504 DGVVSTKMDVFSFGVVLLELISGKEAI 530
             + ST +D++S G +  EL +    +
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAARPL 202

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 28/91 (30%), Positives = 55/91 (60%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +    V T+ Y 
Sbjct: 130 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA-GFVATRWYR 185
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 81/166 (48%), Gaps = 20/166 (12%)
Query: 372 ACEELKILQKVNHGNLVKLEGFC---IDPED---ANCYLIYEYIENGSLHSWLHENKNEN 425
           A  E+KILQ + H N+V L   C     P +    + YL++++ E+    + L  N    
Sbjct: 64  ALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDL--AGLLSNVLVK 121
Query: 426 LNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----- 480
                  R+   + NGL YIH   R +++H+D+K++N+L+  +   K+A+FGLA+     
Sbjct: 122 FTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLA 178
Query: 481 --SGCNAITMHIVGTQGYIAPE-YLADGVVSTKMDVFSFGVVLLEL 523
             S  N     +V T  Y  PE  L +      +D++  G ++ E+
Sbjct: 179 KNSQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 81/166 (48%), Gaps = 20/166 (12%)
Query: 372 ACEELKILQKVNHGNLVKLEGFC---IDPED---ANCYLIYEYIENGSLHSWLHENKNEN 425
           A  E+KILQ + H N+V L   C     P +    + YL++++ E+    + L  N    
Sbjct: 63  ALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDL--AGLLSNVLVK 120
Query: 426 LNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----- 480
                  R+   + NGL YIH   R +++H+D+K++N+L+  +   K+A+FGLA+     
Sbjct: 121 FTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLA 177
Query: 481 --SGCNAITMHIVGTQGYIAPE-YLADGVVSTKMDVFSFGVVLLEL 523
             S  N     +V T  Y  PE  L +      +D++  G ++ E+
Sbjct: 178 KNSQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 222

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 88/175 (50%), Gaps = 19/175 (10%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKN-ENLNWKTRL 432
           E   ++ K++H +LV   G C+  ++    L+ E+++ GSL ++L +NKN  N+ WK  L
Sbjct: 61  EAASMMSKLSHKHLVLNYGVCVCGDEN--ILVQEFVKFGSLDTYLKKNKNCINILWK--L 116
Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVG 492
            +A  +A  + ++ E+T   ++H ++ + NILL      K  N    K     I++ ++ 
Sbjct: 117 EVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP 173
Query: 493 TQ------GYIAPEYLADGV-VSTKMDVFSFGVVLLELISGKE----AIDEEGKF 536
                    ++ PE + +   ++   D +SFG  L E+ SG +    A+D + K 
Sbjct: 174 KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL 228

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 81/166 (48%), Gaps = 20/166 (12%)
Query: 372 ACEELKILQKVNHGNLVKLEGFC---IDPED---ANCYLIYEYIENGSLHSWLHENKNEN 425
           A  E+KILQ + H N+V L   C     P +    + YL++++ E+    + L  N    
Sbjct: 64  ALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDL--AGLLSNVLVK 121
Query: 426 LNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----- 480
                  R+   + NGL YIH   R +++H+D+K++N+L+  +   K+A+FGLA+     
Sbjct: 122 FTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLA 178
Query: 481 --SGCNAITMHIVGTQGYIAPE-YLADGVVSTKMDVFSFGVVLLEL 523
             S  N     +V T  Y  PE  L +      +D++  G ++ E+
Sbjct: 179 KNSQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 80/156 (51%), Gaps = 14/156 (8%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E   +++ +H ++VKL G   +      ++I E    G L S+L   K  +L+  + + 
Sbjct: 88  QEALTMRQFDHPHIVKLIGVITE---NPVWIIMELCTLGELRSFLQVRKY-SLDLASLIL 143
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT 493
            A  ++  L Y+      R VH+DI + N+L+ SN   K+ +FGL++   ++   +   +
Sbjct: 144 YAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST--YYKAS 198
Query: 494 QG-----YIAPEYLADGVVSTKMDVFSFGVVLLELI 524
           +G     ++APE +     ++  DV+ FGV + E++
Sbjct: 199 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 80/156 (51%), Gaps = 14/156 (8%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E   +++ +H ++VKL G   +      ++I E    G L S+L   K  +L+  + + 
Sbjct: 57  QEALTMRQFDHPHIVKLIGVITE---NPVWIIMELCTLGELRSFLQVRKY-SLDLASLIL 112
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT 493
            A  ++  L Y+      R VH+DI + N+L+ SN   K+ +FGL++   +  + +   +
Sbjct: 113 YAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED--STYYKAS 167
Query: 494 QG-----YIAPEYLADGVVSTKMDVFSFGVVLLELI 524
           +G     ++APE +     ++  DV+ FGV + E++
Sbjct: 168 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 203

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 28/91 (30%), Positives = 55/91 (60%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +    V T+ Y 
Sbjct: 154 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMX-GXVATRWYR 209
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 80/156 (51%), Gaps = 14/156 (8%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E   +++ +H ++VKL G   +      ++I E    G L S+L   K  +L+  + + 
Sbjct: 62  QEALTMRQFDHPHIVKLIGVITE---NPVWIIMELCTLGELRSFLQVRKY-SLDLASLIL 117
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT 493
            A  ++  L Y+      R VH+DI + N+L+ SN   K+ +FGL++   +  + +   +
Sbjct: 118 YAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED--STYYKAS 172
Query: 494 QG-----YIAPEYLADGVVSTKMDVFSFGVVLLELI 524
           +G     ++APE +     ++  DV+ FGV + E++
Sbjct: 173 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 80/156 (51%), Gaps = 14/156 (8%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E   +++ +H ++VKL G   +      ++I E    G L S+L   K  +L+  + + 
Sbjct: 60  QEALTMRQFDHPHIVKLIGVITE---NPVWIIMELCTLGELRSFLQVRKY-SLDLASLIL 115
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT 493
            A  ++  L Y+      R VH+DI + N+L+ SN   K+ +FGL++   ++   +   +
Sbjct: 116 YAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST--YYKAS 170
Query: 494 QG-----YIAPEYLADGVVSTKMDVFSFGVVLLELI 524
           +G     ++APE +     ++  DV+ FGV + E++
Sbjct: 171 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 79/156 (50%), Gaps = 14/156 (8%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E   +++ +H ++VKL G   +      ++I E    G L S+L   K  +L+  + + 
Sbjct: 60  QEALTMRQFDHPHIVKLIGVITE---NPVWIIMELCTLGELRSFLQVRKF-SLDLASLIL 115
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT 493
            A  ++  L Y+      R VH+DI + N+L+ SN   K+ +FGL++   ++       +
Sbjct: 116 YAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXK--AS 170
Query: 494 QG-----YIAPEYLADGVVSTKMDVFSFGVVLLELI 524
           +G     ++APE +     ++  DV+ FGV + E++
Sbjct: 171 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 80/156 (51%), Gaps = 14/156 (8%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E   +++ +H ++VKL G   +      ++I E    G L S+L   K  +L+  + + 
Sbjct: 60  QEALTMRQFDHPHIVKLIGVITE---NPVWIIMELCTLGELRSFLQVRKY-SLDLASLIL 115
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT 493
            A  ++  L Y+      R VH+DI + N+L+ SN   K+ +FGL++   +  + +   +
Sbjct: 116 YAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED--STYYKAS 170
Query: 494 QG-----YIAPEYLADGVVSTKMDVFSFGVVLLELI 524
           +G     ++APE +     ++  DV+ FGV + E++
Sbjct: 171 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 28/91 (30%), Positives = 56/91 (61%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI + GLA+   + +T + V T+ Y 
Sbjct: 134 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGY-VATRWYR 189
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 80/156 (51%), Gaps = 14/156 (8%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E   +++ +H ++VKL G   +      ++I E    G L S+L   K  +L+  + + 
Sbjct: 65  QEALTMRQFDHPHIVKLIGVITE---NPVWIIMELCTLGELRSFLQVRKY-SLDLASLIL 120
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT 493
            A  ++  L Y+      R VH+DI + N+L+ SN   K+ +FGL++   +  + +   +
Sbjct: 121 YAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED--STYYKAS 175
Query: 494 QG-----YIAPEYLADGVVSTKMDVFSFGVVLLELI 524
           +G     ++APE +     ++  DV+ FGV + E++
Sbjct: 176 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 97/204 (47%), Gaps = 27/204 (13%)
Query: 343 FSEGCLIQGSVYKGN-------IHGEV---YAIKMM---KWNACEELKILQKVN-HGNLV 388
           FS+G +++ ++  G+       +H      YA+K++   K +  EE++IL +   H N++
Sbjct: 25  FSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNII 84
Query: 389 KLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEH 448
            L+    D    + YL+ E +  G L   +   K    + +    +   +   ++Y+H  
Sbjct: 85  TLKDVYDD--GKHVYLVTELMRGGELLDKILRQKF--FSEREASFVLHTIGKTVEYLHSQ 140
Query: 449 TRPRVVHKDIKSSNIL-LDSNMRA---KIANFGLAKS--GCNAITMHIVGTQGYIAPEYL 502
               VVH+D+K SNIL +D +      +I +FG AK     N + M    T  ++APE L
Sbjct: 141 G---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL 197
Query: 503 ADGVVSTKMDVFSFGVVLLELISG 526
                    D++S G++L  +++G
Sbjct: 198 KRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 80/156 (51%), Gaps = 14/156 (8%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E   +++ +H ++VKL G   +      ++I E    G L S+L   K  +L+  + + 
Sbjct: 63  QEALTMRQFDHPHIVKLIGVITE---NPVWIIMELCTLGELRSFLQVRKY-SLDLASLIL 118
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT 493
            A  ++  L Y+      R VH+DI + N+L+ SN   K+ +FGL++   +  + +   +
Sbjct: 119 YAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED--STYYKAS 173
Query: 494 QG-----YIAPEYLADGVVSTKMDVFSFGVVLLELI 524
           +G     ++APE +     ++  DV+ FGV + E++
Sbjct: 174 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 93/201 (46%), Gaps = 28/201 (13%)
Query: 339 ATDNFSEGCLIQGSVYKGNIHGEVYAIKMMKWNACEELKILQKV------NHGNLVKLEG 392
            + NF    L++  + K     E+ A+K ++  A  +  + +++       H N+V+ + 
Sbjct: 29  GSGNFGVARLMRDKLTK-----ELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKE 83
Query: 393 FCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPR 452
             + P   +  +I EY   G L+  +  N       + R      + +G+ Y H     +
Sbjct: 84  VILTP--THLAIIMEYASGGELYERIC-NAGRFSEDEARFFFQ-QLLSGVSYCHSM---Q 136
Query: 453 VVHKDIKSSNILLDSN--MRAKIANFGLAKSGC-NAITMHIVGTQGYIAPEYLA----DG 505
           + H+D+K  N LLD +   R KI +FG +KS   ++     VGT  YIAPE L     DG
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDG 196
Query: 506 VVSTKMDVFSFGVVLLELISG 526
            ++   DV+S GV L  ++ G
Sbjct: 197 KIA---DVWSCGVTLYVMLVG 214

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 76/161 (47%), Gaps = 9/161 (5%)
Query: 369 KWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNW 428
           K+    E+ I+ +++H  L+ L     D       LI E++  G L   +   ++  ++ 
Sbjct: 92  KYTVKNEISIMNQLHHPKLINLHDAFED--KYEMVLILEFLSGGELFDRI-AAEDYKMSE 148
Query: 429 KTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRA--KIANFGLA-KSGCNA 485
              +        GL+++HEH+   +VH DIK  NI+ ++   +  KI +FGLA K   + 
Sbjct: 149 AEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205
Query: 486 ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           I      T  + APE +    V    D+++ GV+   L+SG
Sbjct: 206 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 28/91 (30%), Positives = 56/91 (61%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI +F LA+   + +T + V T+ Y 
Sbjct: 134 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGY-VATRWYR 189
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 28/91 (30%), Positives = 56/91 (61%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI + GLA+   + +T + V T+ Y 
Sbjct: 134 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGY-VATRWYR 189
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 97/204 (47%), Gaps = 27/204 (13%)
Query: 343 FSEGCLIQGSVYKGN-------IHGEV---YAIKMM---KWNACEELKILQKVN-HGNLV 388
           FS+G +++ ++  G+       +H      YA+K++   K +  EE++IL +   H N++
Sbjct: 25  FSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNII 84
Query: 389 KLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEH 448
            L+    D    + YL+ E +  G L   +   K    + +    +   +   ++Y+H  
Sbjct: 85  TLKDVYDD--GKHVYLVTELMRGGELLDKILRQKF--FSEREASFVLHTIGKTVEYLHSQ 140
Query: 449 TRPRVVHKDIKSSNIL-LDSNMRA---KIANFGLAKS--GCNAITMHIVGTQGYIAPEYL 502
               VVH+D+K SNIL +D +      +I +FG AK     N + M    T  ++APE L
Sbjct: 141 G---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL 197
Query: 503 ADGVVSTKMDVFSFGVVLLELISG 526
                    D++S G++L  +++G
Sbjct: 198 KRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 83/179 (46%), Gaps = 21/179 (11%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E +I + + H N+V+L       E+   YL+++ +  G L         E++  +     
Sbjct: 53  EARICRLLKHPNIVRLHDSI--SEEGFHYLVFDLVTGGELF--------EDIVAREYYSE 102
Query: 435 AIDVANGLQYIHEHTRP----RVVHKDIKSSNILLDSNMRA---KIANFGLA--KSGCNA 485
           A D ++ +Q I E         +VH+D+K  N+LL S  +    K+A+FGLA    G   
Sbjct: 103 A-DASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQ 161
Query: 486 ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAI-DEEGKFCGQKLKG 543
                 GT GY++PE L        +D+++ GV+L  L+ G     DE+     Q++K 
Sbjct: 162 AWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKA 220

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 28/91 (30%), Positives = 56/91 (61%), Gaps = 5/91 (5%)
Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI 497
           +  GL+YIH      ++H+D+K SN+ ++ +   KI + GLA+   + +T + V T+ Y 
Sbjct: 134 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGY-VATRWYR 189
Query: 498 APEYLADGV-VSTKMDVFSFGVVLLELISGK 527
           APE + + +  +  +D++S G ++ EL++G+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 83/179 (46%), Gaps = 21/179 (11%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E +I + + H N+V+L       E+   YL+++ +  G L         E++  +     
Sbjct: 53  EARICRLLKHPNIVRLHDSI--SEEGFHYLVFDLVTGGELF--------EDIVAREYYSE 102
Query: 435 AIDVANGLQYIHEHTRP----RVVHKDIKSSNILLDSNMRA---KIANFGLA--KSGCNA 485
           A D ++ +Q I E         +VH+D+K  N+LL S  +    K+A+FGLA    G   
Sbjct: 103 A-DASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQ 161
Query: 486 ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAI-DEEGKFCGQKLKG 543
                 GT GY++PE L        +D+++ GV+L  L+ G     DE+     Q++K 
Sbjct: 162 AWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKA 220

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 78/155 (50%), Gaps = 9/155 (5%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+ ++ +++H NL++L        D    L+ EY++ G L   +  +++ NL     +  
Sbjct: 136 EISVMNQLDHANLIQLYDAFESKND--IVLVMEYVDGGELFDRII-DESYNLTELDTILF 192
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILL--DSNMRAKIANFGLAKSGCNAITMHI-V 491
              +  G++++H+     ++H D+K  NIL       + KI +FGLA+       + +  
Sbjct: 193 MKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF 249
Query: 492 GTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           GT  ++APE +    VS   D++S GV+   L+SG
Sbjct: 250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 80/156 (51%), Gaps = 14/156 (8%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E   +++ +H ++VKL G   +      ++I E    G L S+L   K  +L+  + + 
Sbjct: 440 QEALTMRQFDHPHIVKLIGVITE---NPVWIIMELCTLGELRSFLQVRKF-SLDLASLIL 495
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT 493
            A  ++  L Y+      R VH+DI + N+L+ SN   K+ +FGL++   +  + +   +
Sbjct: 496 YAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED--STYYKAS 550
Query: 494 QG-----YIAPEYLADGVVSTKMDVFSFGVVLLELI 524
           +G     ++APE +     ++  DV+ FGV + E++
Sbjct: 551 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 79/167 (47%), Gaps = 25/167 (14%)
Query: 371 NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL----HENKNENL 426
           N   E+   + + H N+V+ +   + P   +  ++ EY   G L   +      +++E  
Sbjct: 61  NVKREIINHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERICNAGRFSEDEAR 118
Query: 427 NWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN--MRAKIANFGLAKSGC- 483
            +  +L   +  A+ +Q         V H+D+K  N LLD +   R KIA+FG +K+   
Sbjct: 119 FFFQQLISGVSYAHAMQ---------VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVL 169
Query: 484 NAITMHIVGTQGYIAPEYLA----DGVVSTKMDVFSFGVVLLELISG 526
           ++     VGT  YIAPE L     DG V+   DV+S GV L  ++ G
Sbjct: 170 HSQPKSAVGTPAYIAPEVLLKKEYDGKVA---DVWSCGVTLYVMLVG 213

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 28/214 (13%)
Query: 343 FSEGCLIQGSVYKGNIHGEVYAIKMM-------KWNACEELKILQKVNHGNLVKLEGFCI 395
             EG      + +G   G  YA+K +       +  A  E  + +  NH N+++L  +C+
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 396 DPEDA--NCYLIYEYIENGSLHSWLHENKNEN--LNWKTRLRIAIDVANGLQYIHEHTRP 451
               A    +L+  + + G+L + +   K++   L     L + + +  GL+ IH     
Sbjct: 97  RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG-- 154
Query: 452 RVVHKDIKSSNILLDSNMRAKIANFGLAKSGC-------NAITMHIVGTQ----GYIAPE 500
              H+D+K +NILL    +  + + G     C        A+T+     Q     Y APE
Sbjct: 155 -YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE 213
Query: 501 YL---ADGVVSTKMDVFSFGVVLLELISGKEAID 531
                +  V+  + DV+S G VL  ++ G+   D
Sbjct: 214 LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 62/131 (47%), Gaps = 10/131 (7%)
Query: 402 CYLI-YEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
           C LI  E ++ G L S + +  ++    +    I   +   +QY+H      + H+D+K 
Sbjct: 93  CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKP 149
Query: 461 SNILLDS---NMRAKIANFGLAK--SGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFS 515
            N+L  S   N   K+ +FG AK  +  N++T     T  Y+APE L         D++S
Sbjct: 150 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMWS 208
Query: 516 FGVVLLELISG 526
            GV++  L+ G
Sbjct: 209 LGVIMYILLCG 219

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 62/131 (47%), Gaps = 10/131 (7%)
Query: 402 CYLI-YEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
           C LI  E ++ G L S + +  ++    +    I   +   +QY+H      + H+D+K 
Sbjct: 95  CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKP 151
Query: 461 SNILLDS---NMRAKIANFGLAK--SGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFS 515
            N+L  S   N   K+ +FG AK  +  N++T     T  Y+APE L         D++S
Sbjct: 152 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMWS 210
Query: 516 FGVVLLELISG 526
            GV++  L+ G
Sbjct: 211 LGVIMYILLCG 221

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 54/96 (56%), Gaps = 7/96 (7%)
Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI-V 491
           +IA+ +   L+  H H++  V+H+D+K SN+L+++  + K  +FG++    + +   I  
Sbjct: 140 KIAVSIVKALE--HLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDA 197
Query: 492 GTQGYIAPEYLADGV----VSTKMDVFSFGVVLLEL 523
           G + Y APE +   +     S K D++S G+  +EL
Sbjct: 198 GCKPYXAPERINPELNQKGYSVKSDIWSLGITXIEL 233

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 62/131 (47%), Gaps = 10/131 (7%)
Query: 402 CYLI-YEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
           C LI  E ++ G L S + +  ++    +    I   +   +QY+H      + H+D+K 
Sbjct: 94  CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKP 150
Query: 461 SNILLDS---NMRAKIANFGLAK--SGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFS 515
            N+L  S   N   K+ +FG AK  +  N++T     T  Y+APE L         D++S
Sbjct: 151 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMWS 209
Query: 516 FGVVLLELISG 526
            GV++  L+ G
Sbjct: 210 LGVIMYILLCG 220

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 62/131 (47%), Gaps = 10/131 (7%)
Query: 402 CYLI-YEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
           C LI  E ++ G L S + +  ++    +    I   +   +QY+H      + H+D+K 
Sbjct: 103 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKP 159
Query: 461 SNILLDS---NMRAKIANFGLAK--SGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFS 515
            N+L  S   N   K+ +FG AK  +  N++T     T  Y+APE L         D++S
Sbjct: 160 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMWS 218
Query: 516 FGVVLLELISG 526
            GV++  L+ G
Sbjct: 219 LGVIMYILLCG 229

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 101/214 (47%), Gaps = 27/214 (12%)
Query: 333 IEELREATDNFSEGCLIQGSVYKGN-------IHGEV---YAIKMM---KWNACEELKIL 379
           +++L   +  F++G  ++  +  G+       IH      +A+K++   K +  EE++IL
Sbjct: 10  VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEIL 69
Query: 380 QKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDV 438
            +   H N++ L+    D +    Y++ E ++ G L   +   K    + +    +   +
Sbjct: 70  LRYGQHPNIITLKDVYDDGK--YVYVVTELMKGGELLDKILRQKF--FSEREASAVLFTI 125
Query: 439 ANGLQYIHEHTRPRVVHKDIKSSNIL-LDSNMRA---KIANFGLAKS--GCNAITMHIVG 492
              ++Y+H      VVH+D+K SNIL +D +      +I +FG AK     N + M    
Sbjct: 126 TKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCY 182
Query: 493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           T  ++APE L         D++S GV+L  +++G
Sbjct: 183 TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 62/131 (47%), Gaps = 10/131 (7%)
Query: 402 CYLI-YEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
           C LI  E ++ G L S + +  ++    +    I   +   +QY+H      + H+D+K 
Sbjct: 89  CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKP 145
Query: 461 SNILLDS---NMRAKIANFGLAK--SGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFS 515
            N+L  S   N   K+ +FG AK  +  N++T     T  Y+APE L         D++S
Sbjct: 146 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMWS 204
Query: 516 FGVVLLELISG 526
            GV++  L+ G
Sbjct: 205 LGVIMYILLCG 215

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 67/141 (47%), Gaps = 22/141 (15%)
Query: 403 YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSN 462
           YL++E +  GS+ S +H  K  + N      +  DVA+ L ++H      + H+D+K  N
Sbjct: 87  YLVFEKMRGGSILSHIH--KRRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPEN 141
Query: 463 ILLDSNMR---AKIANFGLAK-----SGCNAIT----MHIVGTQGYIAPEYL-----ADG 505
           IL +   +    KI +F L         C+ I+    +   G+  Y+APE +        
Sbjct: 142 ILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEAS 201
Query: 506 VVSTKMDVFSFGVVLLELISG 526
           +   + D++S GV+L  L+SG
Sbjct: 202 IYDKRCDLWSLGVILYILLSG 222

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 87/175 (49%), Gaps = 19/175 (10%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKN-ENLNWKTRL 432
           E   ++ K++H +LV   G C   ++    L+ E+++ GSL ++L +NKN  N+ WK  L
Sbjct: 61  EAASMMSKLSHKHLVLNYGVCFCGDEN--ILVQEFVKFGSLDTYLKKNKNCINILWK--L 116
Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVG 492
            +A  +A  + ++ E+T   ++H ++ + NILL      K  N    K     I++ ++ 
Sbjct: 117 EVAKQLAWAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP 173
Query: 493 TQ------GYIAPEYLADGV-VSTKMDVFSFGVVLLELISGKE----AIDEEGKF 536
                    ++ PE + +   ++   D +SFG  L E+ SG +    A+D + K 
Sbjct: 174 KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL 228

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 62/131 (47%), Gaps = 10/131 (7%)
Query: 402 CYLI-YEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
           C LI  E ++ G L S + +  ++    +    I   +   +QY+H      + H+D+K 
Sbjct: 87  CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKP 143
Query: 461 SNILLDS---NMRAKIANFGLAK--SGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFS 515
            N+L  S   N   K+ +FG AK  +  N++T     T  Y+APE L         D++S
Sbjct: 144 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMWS 202
Query: 516 FGVVLLELISG 526
            GV++  L+ G
Sbjct: 203 LGVIMYILLCG 213

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 62/131 (47%), Gaps = 10/131 (7%)
Query: 402 CYLI-YEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
           C LI  E ++ G L S + +  ++    +    I   +   +QY+H      + H+D+K 
Sbjct: 88  CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKP 144
Query: 461 SNILLDS---NMRAKIANFGLAK--SGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFS 515
            N+L  S   N   K+ +FG AK  +  N++T     T  Y+APE L         D++S
Sbjct: 145 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMWS 203
Query: 516 FGVVLLELISG 526
            GV++  L+ G
Sbjct: 204 LGVIMYILLCG 214

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 62/131 (47%), Gaps = 10/131 (7%)
Query: 402 CYLI-YEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
           C LI  E ++ G L S + +  ++    +    I   +   +QY+H      + H+D+K 
Sbjct: 133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKP 189
Query: 461 SNILLDS---NMRAKIANFGLAK--SGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFS 515
            N+L  S   N   K+ +FG AK  +  N++T     T  Y+APE L         D++S
Sbjct: 190 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMWS 248
Query: 516 FGVVLLELISG 526
            GV++  L+ G
Sbjct: 249 LGVIMYILLCG 259

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 62/131 (47%), Gaps = 10/131 (7%)
Query: 402 CYLI-YEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
           C LI  E ++ G L S + +  ++    +    I   +   +QY+H      + H+D+K 
Sbjct: 89  CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKP 145
Query: 461 SNILLDS---NMRAKIANFGLAK--SGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFS 515
            N+L  S   N   K+ +FG AK  +  N++T     T  Y+APE L         D++S
Sbjct: 146 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMWS 204
Query: 516 FGVVLLELISG 526
            GV++  L+ G
Sbjct: 205 LGVIMYILLCG 215

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 62/131 (47%), Gaps = 10/131 (7%)
Query: 402 CYLI-YEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
           C LI  E ++ G L S + +  ++    +    I   +   +QY+H      + H+D+K 
Sbjct: 139 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKP 195
Query: 461 SNILLDS---NMRAKIANFGLAK--SGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFS 515
            N+L  S   N   K+ +FG AK  +  N++T     T  Y+APE L         D++S
Sbjct: 196 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMWS 254
Query: 516 FGVVLLELISG 526
            GV++  L+ G
Sbjct: 255 LGVIMYILLCG 265

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 69/143 (48%), Gaps = 22/143 (15%)
Query: 398 EDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI-----AIDVANGLQYIHEHTRPR 452
           ++ + YL+ +Y   G L + L + +++      R  I     AID  + L Y        
Sbjct: 145 DENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHY-------- 196
Query: 453 VVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH---IVGTQGYIAPEYL---ADGV 506
            VH+DIK  N+LLD N   ++A+FG      +  T+     VGT  YI+PE L    DG+
Sbjct: 197 -VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGM 255
Query: 507 --VSTKMDVFSFGVVLLELISGK 527
                + D +S GV + E++ G+
Sbjct: 256 GKYGPECDWWSLGVCMYEMLYGE 278

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 62/131 (47%), Gaps = 10/131 (7%)
Query: 402 CYLI-YEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
           C LI  E ++ G L S + +  ++    +    I   +   +QY+H      + H+D+K 
Sbjct: 87  CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKP 143
Query: 461 SNILLDS---NMRAKIANFGLAK--SGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFS 515
            N+L  S   N   K+ +FG AK  +  N++T     T  Y+APE L         D++S
Sbjct: 144 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLT-EPCYTPYYVAPEVLGPEKYDKSCDMWS 202
Query: 516 FGVVLLELISG 526
            GV++  L+ G
Sbjct: 203 LGVIMYILLCG 213

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 69/143 (48%), Gaps = 22/143 (15%)
Query: 398 EDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI-----AIDVANGLQYIHEHTRPR 452
           ++ + YL+ +Y   G L + L + +++      R  I     AID  + L Y        
Sbjct: 161 DENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHY-------- 212
Query: 453 VVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH---IVGTQGYIAPEYL---ADGV 506
            VH+DIK  N+LLD N   ++A+FG      +  T+     VGT  YI+PE L    DG+
Sbjct: 213 -VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGM 271
Query: 507 --VSTKMDVFSFGVVLLELISGK 527
                + D +S GV + E++ G+
Sbjct: 272 GKYGPECDWWSLGVCMYEMLYGE 294

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 22/152 (14%)
Query: 408 YIENGSLHSWLHENKNENLNWKTRLRI------AIDVANGLQYIHEHTRPRVVHKDIKSS 461
           ++E  SL     E   E+L +K  L +      +  VA G++++      + +H+D+ + 
Sbjct: 172 FVEEKSLSDVEEEEAPEDL-YKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAAR 227
Query: 462 NILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ----GYIAPEYLADGVVSTKMDVFSFG 517
           NILL      KI +FGLA+           G       ++APE + D V + + DV+SFG
Sbjct: 228 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 287
Query: 518 VVLLELISGKEA------IDEEGKFCGQKLKG 543
           V+L E+ S   +      IDEE  FC +  +G
Sbjct: 288 VLLWEIFSLGASPYPGVKIDEE--FCRRLKEG 317

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 22/152 (14%)
Query: 408 YIENGSLHSWLHENKNENLNWKTRLRI------AIDVANGLQYIHEHTRPRVVHKDIKSS 461
           ++E  SL     E   E+L +K  L +      +  VA G++++      + +H+D+ + 
Sbjct: 174 FVEEKSLSDVEEEEAPEDL-YKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAAR 229
Query: 462 NILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ----GYIAPEYLADGVVSTKMDVFSFG 517
           NILL      KI +FGLA+           G       ++APE + D V + + DV+SFG
Sbjct: 230 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 289
Query: 518 VVLLELISGKEA------IDEEGKFCGQKLKG 543
           V+L E+ S   +      IDEE  FC +  +G
Sbjct: 290 VLLWEIFSLGASPYPGVKIDEE--FCRRLKEG 319

>pdb|4EBY|A Chain A, Crystal Structure Of The Ectodomain Of A Receptor Like Kinase Length = 212

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 57/113 (50%), Gaps = 6/113 (5%)
Query: 96  FVPITCSCNTLNASYTISFANLSYTIKSGDTFYLVSTNKYQNLTTYQSVEVVNPTFVPTK 155
            VP  C C   +        N SY+++  DT+  V+ + Y NLTT +S++  NP F  T 
Sbjct: 62  LVPFPCECQPGD----FLGHNFSYSVRQEDTYERVAISNYANLTTMESLQARNP-FPATN 116
Query: 156 LEVGDVIIFPVFCKCPNQTQLRNRVNYLVSYVLQPSENLSSVASRFGIETQAI 208
           + +   +   V C C +++  ++     V+Y L+P ++LSS+A   G+    +
Sbjct: 117 IPLSATLNVLVNCSCGDESVSKD-FGLFVTYPLRPEDSLSSIARSSGVSADIL 168

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 22/152 (14%)
Query: 408 YIENGSLHSWLHENKNENLNWKTRLRI------AIDVANGLQYIHEHTRPRVVHKDIKSS 461
           ++E  SL     E   E+L +K  L +      +  VA G++++      + +H+D+ + 
Sbjct: 167 FVEEKSLSDVEEEEAPEDL-YKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAAR 222
Query: 462 NILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ----GYIAPEYLADGVVSTKMDVFSFG 517
           NILL      KI +FGLA+           G       ++APE + D V + + DV+SFG
Sbjct: 223 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 282
Query: 518 VVLLELISGKEA------IDEEGKFCGQKLKG 543
           V+L E+ S   +      IDEE  FC +  +G
Sbjct: 283 VLLWEIFSLGASPYPGVKIDEE--FCRRLKEG 312

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 22/152 (14%)
Query: 408 YIENGSLHSWLHENKNENLNWKTRLRI------AIDVANGLQYIHEHTRPRVVHKDIKSS 461
           ++E  SL     E   E+L +K  L +      +  VA G++++      + +H+D+ + 
Sbjct: 165 FVEEKSLSDVEEEEAPEDL-YKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAAR 220
Query: 462 NILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ----GYIAPEYLADGVVSTKMDVFSFG 517
           NILL      KI +FGLA+           G       ++APE + D V + + DV+SFG
Sbjct: 221 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 280
Query: 518 VVLLELISGKEA------IDEEGKFCGQKLKG 543
           V+L E+ S   +      IDEE  FC +  +G
Sbjct: 281 VLLWEIFSLGASPYPGVKIDEE--FCRRLKEG 310

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 78/159 (49%), Gaps = 11/159 (6%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  I++ ++H ++VKL G     E+   ++I E    G L  +L  NKN +L   T +  
Sbjct: 75  EAVIMKNLDHPHIVKLIGII---EEEPTWIIMELYPYGELGHYLERNKN-SLKVLTLVLY 130
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
           ++ +   + Y+        VH+DI   NIL+ S    K+ +FGL++   +        T+
Sbjct: 131 SLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTR 187
Query: 495 ---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEA 529
               +++PE +     +T  DV+ F V + E++S GK+ 
Sbjct: 188 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 226

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 78/159 (49%), Gaps = 11/159 (6%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  I++ ++H ++VKL G     E+   ++I E    G L  +L  NKN +L   T +  
Sbjct: 59  EAVIMKNLDHPHIVKLIGII---EEEPTWIIMELYPYGELGHYLERNKN-SLKVLTLVLY 114
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
           ++ +   + Y+        VH+DI   NIL+ S    K+ +FGL++   +        T+
Sbjct: 115 SLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTR 171
Query: 495 ---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEA 529
               +++PE +     +T  DV+ F V + E++S GK+ 
Sbjct: 172 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 210

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 93/193 (48%), Gaps = 29/193 (15%)
Query: 353 VYKGNIHGEVYAIKMMKWN----ACEELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYE 407
           VY+G       A+K +       A  E+++L++ + H N+++   FC + +    Y+  E
Sbjct: 41  VYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRY--FCTEKDRQFQYIAIE 98
Query: 408 YIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLD- 466
                +L  ++ +    +L  +  + +     +GL ++H      +VH+D+K  NIL+  
Sbjct: 99  LC-AATLQEYVEQKDFAHLGLEP-ITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISM 153
Query: 467 ----SNMRAKIANFGLAKSGCNAITMH-------IVGTQGYIAPEYLADGV---VSTKMD 512
                 ++A I++FGL K    A+  H       + GT+G+IAPE L++      +  +D
Sbjct: 154 PNAHGKIKAMISDFGLCKK--LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVD 211
Query: 513 VFSFGVVLLELIS 525
           +FS G V   +IS
Sbjct: 212 IFSAGCVFYYVIS 224

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 78/159 (49%), Gaps = 11/159 (6%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E  I++ ++H ++VKL G     E+   ++I E    G L  +L  NKN +L   T +  
Sbjct: 63  EAVIMKNLDHPHIVKLIGII---EEEPTWIIMELYPYGELGHYLERNKN-SLKVLTLVLY 118
Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ 494
           ++ +   + Y+        VH+DI   NIL+ S    K+ +FGL++   +        T+
Sbjct: 119 SLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTR 175
Query: 495 ---GYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEA 529
               +++PE +     +T  DV+ F V + E++S GK+ 
Sbjct: 176 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 35/199 (17%)
Query: 351 GSVYKGNIHGEVYAIKMM--KWNACEELKILQK-------VNHGNLVKLEGFCIDPEDAN 401
           G VY G  HGEV AI+++  + +  ++LK  ++         H N+V   G C+ P   +
Sbjct: 47  GQVYHGRWHGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP--PH 103
Query: 402 CYLIYEYIENGSLHSWLHENK-NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             +I    +  +L+S + + K   ++N KTR +IA ++  G+ Y+H      ++HKD+KS
Sbjct: 104 LAIITSLCKGRTLYSVVRDAKIVLDVN-KTR-QIAQEIVKGMGYLHAKG---ILHKDLKS 158
Query: 461 SNILLDSNMRAKIANFGL------AKSGCNAITMHIV-GTQGYIAPEYLADGVVSTK--- 510
            N+  D N +  I +FGL       ++G     + I  G   ++APE +      T+   
Sbjct: 159 KNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDK 217
Query: 511 ------MDVFSFGVVLLEL 523
                  DVF+ G +  EL
Sbjct: 218 LPFSKHSDVFALGTIWYEL 236

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 55/95 (57%), Gaps = 11/95 (11%)
Query: 440 NGLQYIHEHTRPRVVHKDIKSSNILLDSN-MRAKIANFG----LAKSGCNAITM---HIV 491
            GL+Y+H  TR R++H D+K+ N+LL S+  RA + +FG    L   G     +   +I 
Sbjct: 177 EGLEYLH--TR-RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 233
Query: 492 GTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           GT+ ++APE +       K+D++S   ++L +++G
Sbjct: 234 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 55/95 (57%), Gaps = 11/95 (11%)
Query: 440 NGLQYIHEHTRPRVVHKDIKSSNILLDSN-MRAKIANFG----LAKSGCNAITM---HIV 491
            GL+Y+H  TR R++H D+K+ N+LL S+  RA + +FG    L   G     +   +I 
Sbjct: 175 EGLEYLH--TR-RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 231
Query: 492 GTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           GT+ ++APE +       K+D++S   ++L +++G
Sbjct: 232 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 55/95 (57%), Gaps = 11/95 (11%)
Query: 440 NGLQYIHEHTRPRVVHKDIKSSNILLDSN-MRAKIANFG----LAKSGCNAITM---HIV 491
            GL+Y+H  TR R++H D+K+ N+LL S+  RA + +FG    L   G     +   +I 
Sbjct: 161 EGLEYLH--TR-RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 492 GTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           GT+ ++APE +       K+D++S   ++L +++G
Sbjct: 218 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 73/154 (47%), Gaps = 17/154 (11%)
Query: 380 QKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVA 439
           + + H N+V+ +   + P   +  ++ EY   G L   +  N       + R      + 
Sbjct: 70  RSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQ-QLI 125
Query: 440 NGLQYIHEHTRPRVVHKDIKSSNILLDSN--MRAKIANFGLAKSGC-NAITMHIVGTQGY 496
           +G+ Y H     +V H+D+K  N LLD +   R KI +FG +KS   ++     VGT  Y
Sbjct: 126 SGVSYCHAM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 182
Query: 497 IAPEYLA----DGVVSTKMDVFSFGVVLLELISG 526
           IAPE L     DG V+   DV+S GV L  ++ G
Sbjct: 183 IAPEVLLKKEYDGKVA---DVWSCGVTLYVMLVG 213

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 73/154 (47%), Gaps = 17/154 (11%)
Query: 380 QKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVA 439
           + + H N+V+ +   + P   +  ++ EY   G L   +  N       + R      + 
Sbjct: 69  RSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQ-QLI 124
Query: 440 NGLQYIHEHTRPRVVHKDIKSSNILLDSN--MRAKIANFGLAKSGC-NAITMHIVGTQGY 496
           +G+ Y H     +V H+D+K  N LLD +   R KI +FG +KS   ++     VGT  Y
Sbjct: 125 SGVSYCHAM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 181
Query: 497 IAPEYLA----DGVVSTKMDVFSFGVVLLELISG 526
           IAPE L     DG V+   DV+S GV L  ++ G
Sbjct: 182 IAPEVLLKKEYDGKVA---DVWSCGVTLYVMLVG 212

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 51/104 (49%), Gaps = 4/104 (3%)
Query: 442 LQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFG-LAKSGCNAITMHIVGTQGYIAPE 500
           L   H H++  +VH D+K +NI L    R K+ +FG L + G         G   Y+APE
Sbjct: 168 LALAHLHSQ-GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPE 226
Query: 501 YLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGY 544
            L  G   T  DVFS G+ +LE+    E +   G+   Q  +GY
Sbjct: 227 LL-QGSYGTAADVFSLGLTILEVACNME-LPHGGEGWQQLRQGY 268

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 79/156 (50%), Gaps = 14/156 (8%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E   +++ +H ++VKL G   +      ++I E    G L S+L   K  +L+  + + 
Sbjct: 60  QEALTMRQFDHPHIVKLIGVITE---NPVWIIMELCTLGELRSFLQVRKF-SLDLASLIL 115
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT 493
            A  ++  L Y+      R VH+DI + N+L+ +    K+ +FGL++   ++   +   +
Sbjct: 116 YAYQLSTALAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDST--YYKAS 170
Query: 494 QG-----YIAPEYLADGVVSTKMDVFSFGVVLLELI 524
           +G     ++APE +     ++  DV+ FGV + E++
Sbjct: 171 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 60/131 (45%), Gaps = 10/131 (7%)
Query: 402 CYLI-YEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
           C LI  E ++ G L S + +  ++    +    I   +   +QY+H      + H+D+K 
Sbjct: 133 CLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSIN---IAHRDVKP 189
Query: 461 SNILLDS---NMRAKIANFGLAK--SGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFS 515
            N+L  S   N   K+ +FG AK  +  N++T     T  Y+APE L         D +S
Sbjct: 190 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDXWS 248
Query: 516 FGVVLLELISG 526
            GV+   L+ G
Sbjct: 249 LGVIXYILLCG 259

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 78/162 (48%), Gaps = 18/162 (11%)
Query: 375 ELKILQKVNHGNLVKL-EGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRL- 432
           E  I   + H ++V+L E +     D   Y+++E+++   L   + +  +    +   + 
Sbjct: 76  EASICHMLKHPHIVELLETYS---SDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132
Query: 433 -RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS---NMRAKIANFGLA----KSGCN 484
                 +   L+Y H++    ++H+D+K  N+LL S   +   K+ +FG+A    +SG  
Sbjct: 133 SHYMRQILEALRYCHDNN---IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLV 189
Query: 485 AITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           A     VGT  ++APE +        +DV+  GV+L  L+SG
Sbjct: 190 AGGR--VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 82/177 (46%), Gaps = 17/177 (9%)
Query: 361 EVYAIKM----MKWNACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH 415
           + +A+K+    M+ N  +E+  L+    H N+VKL     D    + +L+ E +  G L 
Sbjct: 37  QAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHD--QLHTFLVMELLNGGELF 94
Query: 416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL---DSNMRAK 472
             +   K ++ +      I   + + + ++H+     VVH+D+K  N+L    + N+  K
Sbjct: 95  ERI--KKKKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIK 149
Query: 473 IANFGLA--KSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
           I +FG A  K   N        T  Y APE L         D++S GV+L  ++SG+
Sbjct: 150 IIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQ 206

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 76/161 (47%), Gaps = 15/161 (9%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           EEL     +    +V L G   +    N ++  E +E GSL   + E     L     L 
Sbjct: 115 EELMACAGLTSPRIVPLYGAVREGPWVNIFM--ELLEGGSLGQLVKEQGC--LPEDRALY 170
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN-MRAKIANFGLAKS------GCNAI 486
                  GL+Y+H     R++H D+K+ N+LL S+   A + +FG A        G + +
Sbjct: 171 YLGQALEGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLL 227
Query: 487 TM-HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           T  +I GT+ ++APE +       K+DV+S   ++L +++G
Sbjct: 228 TGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 74/161 (45%), Gaps = 15/161 (9%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           EEL     +    +V L G   +    N ++  E +E GSL   + E     L     L 
Sbjct: 134 EELMACAGLTSPRIVPLYGAVREGPWVNIFM--ELLEGGSLGQLVKEQGC--LPEDRALY 189
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN-MRAKIANFG----LAKSGCNAITM 488
                  GL+Y+H     R++H D+K+ N+LL S+   A + +FG    L   G     +
Sbjct: 190 YLGQALEGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLL 246
Query: 489 ---HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
              +I GT+ ++APE +       K+DV+S   ++L +++G
Sbjct: 247 TGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 54/102 (52%), Gaps = 10/102 (9%)
Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC-NAITMHIV 491
           ++ + +   L Y+ E  +  V+H+D+K SNILLD   + K+ +FG++     +       
Sbjct: 128 KMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA 185
Query: 492 GTQGYIAPEYLADGVVSTK------MDVFSFGVVLLELISGK 527
           G   Y+APE + D    TK       DV+S G+ L+EL +G+
Sbjct: 186 GCAAYMAPERI-DPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 72/154 (46%), Gaps = 17/154 (11%)
Query: 380 QKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVA 439
           + + H N+V+ +   + P   +  ++ EY   G L   +  N       + R      + 
Sbjct: 70  RSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQ-QLI 125
Query: 440 NGLQYIHEHTRPRVVHKDIKSSNILLDSN--MRAKIANFGLAKSGC-NAITMHIVGTQGY 496
           +G+ Y H     +V H+D+K  N LLD +   R KI  FG +KS   ++     VGT  Y
Sbjct: 126 SGVSYCHAM---QVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAY 182
Query: 497 IAPEYLA----DGVVSTKMDVFSFGVVLLELISG 526
           IAPE L     DG V+   DV+S GV L  ++ G
Sbjct: 183 IAPEVLLKKEYDGKVA---DVWSCGVTLYVMLVG 213

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 72/154 (46%), Gaps = 17/154 (11%)
Query: 380 QKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVA 439
           + + H N+V+ +   + P   +  ++ EY   G L   +  N       + R      + 
Sbjct: 70  RSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQ-QLI 125
Query: 440 NGLQYIHEHTRPRVVHKDIKSSNILLDSN--MRAKIANFGLAKSGC-NAITMHIVGTQGY 496
           +G+ Y H     +V H+D+K  N LLD +   R KI  FG +KS   ++     VGT  Y
Sbjct: 126 SGVSYCHAM---QVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAY 182
Query: 497 IAPEYLA----DGVVSTKMDVFSFGVVLLELISG 526
           IAPE L     DG V+   DV+S GV L  ++ G
Sbjct: 183 IAPEVLLKKEYDGKVA---DVWSCGVTLYVMLVG 213

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 79/156 (50%), Gaps = 14/156 (8%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E   +++ +H ++VKL G   +      ++I E    G L S+L   K  +L+  + + 
Sbjct: 440 QEALTMRQFDHPHIVKLIGVITE---NPVWIIMELCTLGELRSFLQVRKF-SLDLASLIL 495
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT 493
            A  ++  L Y+      R VH+DI + N+L+ +    K+ +FGL++   +  + +   +
Sbjct: 496 YAYQLSTALAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMED--STYYKAS 550
Query: 494 QG-----YIAPEYLADGVVSTKMDVFSFGVVLLELI 524
           +G     ++APE +     ++  DV+ FGV + E++
Sbjct: 551 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 79/169 (46%), Gaps = 15/169 (8%)
Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDAN----CYLIYEYIENGSLHSWLHENKNENLNWKT 430
           EL+I++ V H N+V L+ F     D        L+ EY+      +  H  K +      
Sbjct: 82  ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPML 141
Query: 431 RLRIAI-DVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRA-KIANFGLAK---SGCNA 485
            +++ +  +   L YIH      + H+DIK  N+LLD      K+ +FG AK   +G   
Sbjct: 142 LIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN 198
Query: 486 ITMHIVGTQGYIAPEYLADGV-VSTKMDVFSFGVVLLELISGKEAIDEE 533
           ++   + ++ Y APE +      +T +D++S G V+ EL+ G+     E
Sbjct: 199 VSX--ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGE 245

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 72/156 (46%), Gaps = 9/156 (5%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E+ IL    H N++ L       E+    +I+E+I    +   ++ +  E LN +  + 
Sbjct: 50  KEISILNIARHRNILHLHESFESMEE--LVMIFEFISGLDIFERINTSAFE-LNEREIVS 106
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRA--KIANFGLAKSGCNAITMHIV 491
               V   LQ++H H    + H DI+  NI+  +   +  KI  FG A+         ++
Sbjct: 107 YVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL 163
Query: 492 GTQ-GYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            T   Y APE     VVST  D++S G ++  L+SG
Sbjct: 164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 71/156 (45%), Gaps = 9/156 (5%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E++ +  + H  LV L     D  D    +IYE++  G L   + +  N+ ++    + 
Sbjct: 97  KEIQTMSVLRHPTLVNLHDAFED--DNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVE 153
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM--RAKIANFGLAKSGCNAITMHIV 491
               V  GL ++HE+     VH D+K  NI+  +      K+ +FGL        ++ + 
Sbjct: 154 YMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT 210
Query: 492 -GTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  + APE      V    D++S GV+   L+SG
Sbjct: 211 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 246

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 71/156 (45%), Gaps = 9/156 (5%)
Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           +E++ +  + H  LV L     D  D    +IYE++  G L   + +  N+ ++    + 
Sbjct: 203 KEIQTMSVLRHPTLVNLHDAFED--DNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVE 259
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM--RAKIANFGLAKSGCNAITMHIV 491
               V  GL ++HE+     VH D+K  NI+  +      K+ +FGL        ++ + 
Sbjct: 260 YMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT 316
Query: 492 -GTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            GT  + APE      V    D++S GV+   L+SG
Sbjct: 317 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 75/162 (46%), Gaps = 18/162 (11%)
Query: 375 ELKILQKVNHGNLVKLEGFCI---DPEDANCYLIYEYIENGSLHSWLHENK----NENLN 427
           E+++L   +H N++ L    +   +P     YL+ E +    L   +H+ +     +++ 
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQ 137
Query: 428 WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG-CNAI 486
           +         +  GL  +HE     VVH+D+   NILL  N    I +F LA+    +A 
Sbjct: 138 Y-----FMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN 189
Query: 487 TMHIVGTQGYIAPEYLADGVVSTKM-DVFSFGVVLLELISGK 527
             H V  + Y APE +      TK+ D++S G V+ E+ + K
Sbjct: 190 KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 75/162 (46%), Gaps = 18/162 (11%)
Query: 375 ELKILQKVNHGNLVKLEGFCI---DPEDANCYLIYEYIENGSLHSWLHENK----NENLN 427
           E+++L   +H N++ L    +   +P     YL+ E +    L   +H+ +     +++ 
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQ 137
Query: 428 WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG-CNAI 486
           +         +  GL  +HE     VVH+D+   NILL  N    I +F LA+    +A 
Sbjct: 138 Y-----FMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN 189
Query: 487 TMHIVGTQGYIAPEYLADGVVSTKM-DVFSFGVVLLELISGK 527
             H V  + Y APE +      TK+ D++S G V+ E+ + K
Sbjct: 190 KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 92/191 (48%), Gaps = 28/191 (14%)
Query: 353 VYKGNIHGEVYAIKMMK------WNACEELKILQ------KVNHGNLVK-LEGFCIDPED 399
            Y   +H  V A+KM++        A EE++IL+      K N  N++  LE F     +
Sbjct: 116 AYDHKVHQHV-ALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF--RN 172
Query: 400 ANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIK 459
             C + +E + + +L+  + +NK +  +     + A  +   L  +H++   R++H D+K
Sbjct: 173 HIC-MTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLK 227
Query: 460 SSNILLDSNMRA--KIANFGLAKSGC--NAITMHIVGTQGYIAPEYLADGVVSTKMDVFS 515
             NILL    R+  K+ +FG   S C  +      + ++ Y APE +        +D++S
Sbjct: 228 PENILLKQQGRSGIKVIDFG---SSCYEHQRVYXXIQSRFYRAPEVILGARYGMPIDMWS 284
Query: 516 FGVVLLELISG 526
            G +L EL++G
Sbjct: 285 LGCILAELLTG 295

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 98/214 (45%), Gaps = 27/214 (12%)
Query: 333 IEELREATDNFSEGCLIQGSVYKGN-------IHGEV---YAIKMM---KWNACEELKIL 379
           +++L   +  F++G  ++  +  G+       IH      +A+K++   K +  EE++IL
Sbjct: 10  VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEIL 69
Query: 380 QKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDV 438
            +   H N++ L+    D +    Y++ E  + G L   +   K    + +    +   +
Sbjct: 70  LRYGQHPNIITLKDVYDDGK--YVYVVTELXKGGELLDKILRQKF--FSEREASAVLFTI 125
Query: 439 ANGLQYIHEHTRPRVVHKDIKSSNIL-LDSNMRA---KIANFGLAKS--GCNAITMHIVG 492
              ++Y+H      VVH+D+K SNIL +D +      +I +FG AK     N +      
Sbjct: 126 TKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCY 182
Query: 493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           T  ++APE L         D++S GV+L   ++G
Sbjct: 183 TANFVAPEVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 92/191 (48%), Gaps = 28/191 (14%)
Query: 353 VYKGNIHGEVYAIKMMK------WNACEELKILQ------KVNHGNLVK-LEGFCIDPED 399
            Y   +H  V A+KM++        A EE++IL+      K N  N++  LE F     +
Sbjct: 116 AYDHKVHQHV-ALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF--RN 172
Query: 400 ANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIK 459
             C + +E + + +L+  + +NK +  +     + A  +   L  +H++   R++H D+K
Sbjct: 173 HIC-MTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLK 227
Query: 460 SSNILLDSNMRA--KIANFGLAKSGC--NAITMHIVGTQGYIAPEYLADGVVSTKMDVFS 515
             NILL    R+  K+ +FG   S C  +      + ++ Y APE +        +D++S
Sbjct: 228 PENILLKQQGRSGIKVIDFG---SSCYEHQRVYTXIQSRFYRAPEVILGARYGMPIDMWS 284
Query: 516 FGVVLLELISG 526
            G +L EL++G
Sbjct: 285 LGCILAELLTG 295

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 92/191 (48%), Gaps = 28/191 (14%)
Query: 353 VYKGNIHGEVYAIKMMK------WNACEELKILQ------KVNHGNLVK-LEGFCIDPED 399
            Y   +H  V A+KM++        A EE++IL+      K N  N++  LE F     +
Sbjct: 116 AYDHKVHQHV-ALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF--RN 172
Query: 400 ANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIK 459
             C + +E + + +L+  + +NK +  +     + A  +   L  +H++   R++H D+K
Sbjct: 173 HIC-MTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLK 227
Query: 460 SSNILLDSNMRA--KIANFGLAKSGC--NAITMHIVGTQGYIAPEYLADGVVSTKMDVFS 515
             NILL    R+  K+ +FG   S C  +      + ++ Y APE +        +D++S
Sbjct: 228 PENILLKQQGRSGIKVIDFG---SSCYEHQRVYTXIQSRFYRAPEVILGARYGMPIDMWS 284
Query: 516 FGVVLLELISG 526
            G +L EL++G
Sbjct: 285 LGCILAELLTG 295

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 90/177 (50%), Gaps = 28/177 (15%)
Query: 371 NACEELKILQKVNHGNLVKL------------EGFCIDPEDANCYLIYEYIENGSLHSWL 418
           +A  E+KI+++++H N+VK+            +      E  + Y++ EY+E   L + L
Sbjct: 54  HALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVL 112
Query: 419 HENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS-NMRAKIANFG 477
            +     L    RL     +  GL+YIH      V+H+D+K +N+ +++ ++  KI +FG
Sbjct: 113 EQGP--LLEEHARL-FMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFG 166
Query: 478 LAK------SGCNAITMHIVGTQGYIAPEYLADGVVSTK-MDVFSFGVVLLELISGK 527
           LA+      S    ++  +V T+ Y +P  L      TK +D+++ G +  E+++GK
Sbjct: 167 LARIMDPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 36/160 (22%), Positives = 74/160 (46%), Gaps = 12/160 (7%)
Query: 375 ELKILQKVNHG-NLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
           E+KIL+ +  G N++ L     DP      L++E++ N           + ++ +     
Sbjct: 81  EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF----- 135
Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRA-KIANFGLAKSGCNAITMHI-V 491
              ++   L Y H      ++H+D+K  N+++D   R  ++ ++GLA+        ++ V
Sbjct: 136 YMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV 192
Query: 492 GTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAI 530
            ++ +  PE L D  +    +D++S G +L  +I  KE  
Sbjct: 193 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 76/162 (46%), Gaps = 18/162 (11%)
Query: 375 ELKILQKVNHGNLVKL-EGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRL- 432
           E  I   + H ++V+L E +     D   Y+++E+++   L   + +  +    +   + 
Sbjct: 76  EASICHMLKHPHIVELLETYS---SDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132
Query: 433 -RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS---NMRAKIANFGLA----KSGCN 484
                 +   L+Y H++    ++H+D+K   +LL S   +   K+  FG+A    +SG  
Sbjct: 133 SHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV 189
Query: 485 AITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           A     VGT  ++APE +        +DV+  GV+L  L+SG
Sbjct: 190 AGGR--VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 76/162 (46%), Gaps = 18/162 (11%)
Query: 375 ELKILQKVNHGNLVKL-EGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRL- 432
           E  I   + H ++V+L E +     D   Y+++E+++   L   + +  +    +   + 
Sbjct: 78  EASICHMLKHPHIVELLETYS---SDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 134
Query: 433 -RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS---NMRAKIANFGLA----KSGCN 484
                 +   L+Y H++    ++H+D+K   +LL S   +   K+  FG+A    +SG  
Sbjct: 135 SHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV 191
Query: 485 AITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           A     VGT  ++APE +        +DV+  GV+L  L+SG
Sbjct: 192 AGGR--VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 22/75 (29%), Positives = 42/75 (56%), Gaps = 3/75 (4%)
Query: 455 HKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI---VGTQGYIAPEYLADGVVSTKM 511
           H+D+K  NIL+ ++  A + +FG+A +  +     +   VGT  Y APE  ++   + + 
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRA 216
Query: 512 DVFSFGVVLLELISG 526
           D+++   VL E ++G
Sbjct: 217 DIYALTCVLYECLTG 231

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 66/140 (47%), Gaps = 23/140 (16%)
Query: 405 IYEYIENGS--LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSN 462
           IY  +E G+  L+SWL + K+ +  W+ R     ++   +  IH+H    +VH D+K +N
Sbjct: 131 IYMVMECGNIDLNSWLKKKKSID-PWE-RKSYWKNMLEAVHTIHQHG---IVHSDLKPAN 185
Query: 463 ILLDSNMRAKIANFGLAK----SGCNAITMHIVGTQGYIAPEYLADGVVSTK-------- 510
            L+   M  K+ +FG+A        + +    VGT  Y+ PE + D   S +        
Sbjct: 186 FLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI 244
Query: 511 ---MDVFSFGVVLLELISGK 527
               DV+S G +L  +  GK
Sbjct: 245 SPKSDVWSLGCILYYMTYGK 264

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 66/144 (45%), Gaps = 22/144 (15%)
Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
           D   Y++ E   N  L+SWL + K+ +  W+ R     ++   +  IH+H    +VH D+
Sbjct: 100 DQYIYMVME-CGNIDLNSWLKKKKSID-PWE-RKSYWKNMLEAVHTIHQHG---IVHSDL 153
Query: 459 KSSNILLDSNMRAKIANFGLAK----SGCNAITMHIVGTQGYIAPEYLADGVVSTK---- 510
           K +N L+   M  K+ +FG+A        + +    VGT  Y+ PE + D   S +    
Sbjct: 154 KPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKS 212
Query: 511 -------MDVFSFGVVLLELISGK 527
                   DV+S G +L  +  GK
Sbjct: 213 KSKISPKSDVWSLGCILYYMTYGK 236

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 66/140 (47%), Gaps = 23/140 (16%)
Query: 405 IYEYIENGS--LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSN 462
           IY  +E G+  L+SWL + K+ +  W+ R     ++   +  IH+H    +VH D+K +N
Sbjct: 83  IYMVMECGNIDLNSWLKKKKSID-PWE-RKSYWKNMLEAVHTIHQHG---IVHSDLKPAN 137
Query: 463 ILLDSNMRAKIANFGLAKSGCNAITMHI----VGTQGYIAPEYLADGVVSTK-------- 510
            L+   M  K+ +FG+A       T  +    VGT  Y+ PE + D   S +        
Sbjct: 138 FLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI 196
Query: 511 ---MDVFSFGVVLLELISGK 527
               DV+S G +L  +  GK
Sbjct: 197 SPKSDVWSLGCILYYMTYGK 216

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 66/140 (47%), Gaps = 23/140 (16%)
Query: 405 IYEYIENGS--LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSN 462
           IY  +E G+  L+SWL + K+ +  W+ R     ++   +  IH+H    +VH D+K +N
Sbjct: 87  IYMVMECGNIDLNSWLKKKKSID-PWE-RKSYWKNMLEAVHTIHQHG---IVHSDLKPAN 141
Query: 463 ILLDSNMRAKIANFGLAKSGCNAITMHI----VGTQGYIAPEYLADGVVSTK-------- 510
            L+   M  K+ +FG+A       T  +    VGT  Y+ PE + D   S +        
Sbjct: 142 FLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI 200
Query: 511 ---MDVFSFGVVLLELISGK 527
               DV+S G +L  +  GK
Sbjct: 201 SPKSDVWSLGCILYYMTYGK 220

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	552
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	4e-86
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-80
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	9e-80
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-66
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-54
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-54
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-54
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	7e-53
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	7e-53
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-50
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-48
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-48
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-48
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-48
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-47
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-47
3q4u_A	301	Activin receptor type-1; structural genomics conso	6e-47
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-46
4eby_A	212	Chitin elicitor receptor kinase 1; pathogen-associ	2e-38
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-37
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-36
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-36
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	7e-36
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-35
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-35
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-35
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-35
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	8e-35
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-34
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-34
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-34
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-34
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-34
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	7e-34
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	7e-34
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-33
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-33
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-33
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-33
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	5e-33
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	6e-33
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	6e-33
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	9e-33
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-32
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-32
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-32
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-32
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-32
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-32
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-32
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-32
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	6e-32
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-32
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	8e-32
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	9e-32
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-31
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-31
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-31
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-31
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-31
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-31
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-31
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-31
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	7e-31
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	9e-31
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-30
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-30
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-30
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	8e-30
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-29
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-29
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-29
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-29
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-29
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-29
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-29
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-29
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	5e-29
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-29
4aoj_A	329	High affinity nerve growth factor receptor; transf	8e-29
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	9e-29
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-28
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-28
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-28
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-28
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-28
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-28
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-28
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	5e-28
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	9e-28
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-27
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-27
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	6e-27
3ork_A	311	Serine/threonine protein kinase; structural genomi	6e-27
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	7e-27
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	8e-27
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	8e-27
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	9e-27
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-26
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-26
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-26
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	7e-26
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-25
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-25
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	8e-25
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-24
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-24
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-24
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	5e-24
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-23
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-23
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-23
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-23
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	7e-23
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	7e-23
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	8e-23
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	9e-23
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	9e-23
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	9e-23
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	9e-23
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-22
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-22
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-22
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-22
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-22
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-22
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-22
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-22
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-22
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-22
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-22
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-22
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-22
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-22
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	5e-22
3aln_A	327	Dual specificity mitogen-activated protein kinase;	6e-22
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	6e-22
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	6e-22
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	6e-22
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	8e-22
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	8e-22
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	8e-22
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-21
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-21
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-21
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-21
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-21
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-21
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-21
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-21
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-21
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-21
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-21
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-21
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-21
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-21
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	5e-21
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	6e-21
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	7e-21
2dyl_A	318	Dual specificity mitogen-activated protein kinase	8e-21
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	8e-21
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-20
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-20
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-20
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-20
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-20
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-20
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	6e-20
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	6e-20
3an0_A	340	Dual specificity mitogen-activated protein kinase;	7e-20
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	9e-20
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-19
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-19
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-19
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-19
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	6e-19
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	8e-19
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	8e-19
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-18
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-18
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-18
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-18
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-18
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	6e-18
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-17
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-17
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-17
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-17
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-17
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-17
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-17
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-17
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-17
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-17
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	5e-17
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-17
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-16
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-16
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	8e-16
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	9e-16
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-15
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-15
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-15
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-15
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-08
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-15
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	5e-15
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	6e-15
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-14
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-14
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-14
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-14
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-14
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	7e-14
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-13
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-13
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-13
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-12
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-12
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-12
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	9e-06
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-09
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-08
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-08
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	6e-08
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	6e-08
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-07
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-07
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-07
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-07
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-07
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-06
2djp_A	77	Hypothetical protein SB145; LYSM, structural genom	8e-06
2l9y_A	167	CVNH-LYSM lectin; carbohydrate, sugar binding prot	2e-04
2l9y_A	167	CVNH-LYSM lectin; carbohydrate, sugar binding prot	8e-04
1e0g_A	48	Membrane-bound lytic murein transglycosylase D; ce	7e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  268 bits (688), Expect = 4e-86
 Identities = 88/222 (39%), Positives = 128/222 (57%), Gaps = 22/222 (9%)

Query: 329 RIFKIEELREATDNFSEGCLIQ----GSVYKGNIH-GEVYAIKMMKWNA--------CEE 375
           + F + EL+ A+DNFS   ++     G VYKG +  G + A+K +K             E
Sbjct: 18  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTE 77

Query: 376 LKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNE--NLNWKTRLR 433
           ++++    H NL++L GFC+        L+Y Y+ NGS+ S L E       L+W  R R
Sbjct: 78  VEMISMAVHRNLLRLRGFCM--TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135

Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI--- 490
           IA+  A GL Y+H+H  P+++H+D+K++NILLD    A + +FGLAK      T H+   
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTA 194

Query: 491 -VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
             GT G+IAPEYL+ G  S K DVF +GV+LLELI+G+ A D
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  254 bits (650), Expect = 1e-80
 Identities = 84/230 (36%), Positives = 121/230 (52%), Gaps = 32/230 (13%)

Query: 329 RIFKIEELREATDNFSEGCLIQ----------GSVYKGNIHGEVYAIKMMKWNACE---- 374
             F   EL+  T+NF E  +            G VYKG ++    A+K +          
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEE 72

Query: 375 -------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHE-NKNENL 426
                  E+K++ K  H NLV+L GF    +  +  L+Y Y+ NGSL   L   +    L
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSS--DGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 130

Query: 427 NWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI 486
           +W  R +IA   ANG+ ++HE+     +H+DIKS+NILLD    AKI++FGLA++     
Sbjct: 131 SWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187

Query: 487 TMH----IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDE 532
                  IVGT  Y+APE L  G ++ K D++SFGVVLLE+I+G  A+DE
Sbjct: 188 QTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 236

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  252 bits (645), Expect = 9e-80
 Identities = 82/223 (36%), Positives = 117/223 (52%), Gaps = 27/223 (12%)

Query: 329 RIFKIEELREATDNFSEGCLIQ----GSVYKGNIH-GEVYAIKMMK---------WNACE 374
               + +L EAT+NF    LI     G VYKG +  G   A+K            +    
Sbjct: 27  YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFET-- 84

Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLH--ENKNENLNWKTRL 432
           E++ L    H +LV L GFC   E     LIY+Y+ENG+L   L+  +    +++W+ RL
Sbjct: 85  EIETLSFCRHPHLVSLIGFCD--ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142

Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA----ITM 488
            I I  A GL Y+H      ++H+D+KS NILLD N   KI +FG++K G       ++ 
Sbjct: 143 EICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST 199

Query: 489 HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID 531
            + GT GYI PEY   G ++ K DV+SFGVVL E++  + AI 
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV 242

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  218 bits (557), Expect = 1e-66
 Identities = 66/231 (28%), Positives = 101/231 (43%), Gaps = 31/231 (13%)

Query: 331 FKIEELREATDNFSEGCLIQ----GSVYKGNIHGEVYAIKMMK------WNACEELKILQ 380
              E L   +       +      G V+K  +  E  A+K+        W    E+  L 
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLP 73

Query: 381 KVNHGNLVKLEGFCIDPEDAN--CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDV 438
            + H N+++  G        +   +LI  + E GSL  +L  N    ++W     IA  +
Sbjct: 74  GMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNELCHIAETM 130

Query: 439 ANGLQYIHEHT-------RPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAIT 487
           A GL Y+HE         +P + H+DIKS N+LL +N+ A IA+FGLA           T
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDT 190

Query: 488 MHIVGTQGYIAPEYLADGV-----VSTKMDVFSFGVVLLELISGKEAIDEE 533
              VGT+ Y+APE L   +        ++D+++ G+VL EL S   A D  
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  183 bits (468), Expect = 2e-54
 Identities = 45/190 (23%), Positives = 89/190 (46%), Gaps = 16/190 (8%)

Query: 351 GSVYKGNIHGEVYAIKMMKWNAC---------EELKILQKVNHGNLVKLEGFCIDPEDAN 401
           G ++KG   G    +K++K             EE   L+  +H N++ + G C  P   +
Sbjct: 24  GELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83

Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSS 461
             LI  ++  GSL++ LHE  N  ++    ++ A+D+A G+ ++H      +    + S 
Sbjct: 84  PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPL-IPRHALNSR 142

Query: 462 NILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLAD---GVVSTKMDVFSFGV 518
           ++++D +M A+I+   +  S     +   +    ++APE L            D++SF V
Sbjct: 143 SVMIDEDMTARISMADVKFS---FQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAV 199

Query: 519 VLLELISGKE 528
           +L EL++ + 
Sbjct: 200 LLWELVTREV 209

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  184 bits (470), Expect = 4e-54
 Identities = 57/186 (30%), Positives = 93/186 (50%), Gaps = 12/186 (6%)

Query: 350 QGSVYKGNIHGEVYAIKMMKW-----NACEELKILQKVNHGNLVKLEGFCIDPEDANCYL 404
            G V K     +  AIK ++          EL+ L +VNH N+VKL G C++P      L
Sbjct: 21  FGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNP----VCL 76

Query: 405 IYEYIENGSLHSWLHENKN-ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI 463
           + EY E GSL++ LH  +          +   +  + G+ Y+H      ++H+D+K  N+
Sbjct: 77  VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNL 136

Query: 464 LLDSNMR-AKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLE 522
           LL +     KI +FG A      +T +  G+  ++APE       S K DVFS+G++L E
Sbjct: 137 LLVAGGTVLKICDFGTACDIQTHMTNN-KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWE 195

Query: 523 LISGKE 528
           +I+ ++
Sbjct: 196 VITRRK 201

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  184 bits (470), Expect = 4e-54
 Identities = 62/191 (32%), Positives = 104/191 (54%), Gaps = 15/191 (7%)

Query: 350 QGSVYKGNIHGEVYAIKMMKWNA---------CEELKILQKVNHGNLVKLEGFCIDPEDA 400
            G+V++   HG   A+K++               E+ I++++ H N+V   G    P   
Sbjct: 50  FGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP-- 107

Query: 401 NCYLIYEYIENGSLHSWLHENKN-ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIK 459
           N  ++ EY+  GSL+  LH++   E L+ + RL +A DVA G+ Y+H    P +VH+++K
Sbjct: 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLK 166

Query: 460 SSNILLDSNMRAKIANFGLA--KSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFG 517
           S N+L+D     K+ +FGL+  K+     +    GT  ++APE L D   + K DV+SFG
Sbjct: 167 SPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFG 226

Query: 518 VVLLELISGKE 528
           V+L EL + ++
Sbjct: 227 VILWELATLQQ 237

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  182 bits (463), Expect = 7e-53
 Identities = 55/240 (22%), Positives = 95/240 (39%), Gaps = 39/240 (16%)

Query: 331 FKIEELREATDNFSEGCLI-QGS---VYKGNIHGEVYAIKMMKWNA----CEELKI--LQ 380
               E     DN     LI +G    VYKG++     A+K+  +        E  I  + 
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVP 62

Query: 381 KVNHGNLVKLEGFCIDPEDA---NCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAID 437
            + H N+ +                 L+ EY  NGSL  +L  +     +W +  R+A  
Sbjct: 63  LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHS 119

Query: 438 VANGLQYIHE------HTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----------S 481
           V  GL Y+H       H +P + H+D+ S N+L+ ++    I++FGL+            
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179

Query: 482 GCNAITMHIVGTQGYIAPEYLADGV-------VSTKMDVFSFGVVLLELISGKEAIDEEG 534
             +   +  VGT  Y+APE L   V          ++D+++ G++  E+      +    
Sbjct: 180 EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  180 bits (458), Expect = 7e-53
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 24/198 (12%)

Query: 350 QGSVYKGNIHGEVYAIKMMKWNACE-----------ELKILQKVNHGNLVKLEGFCIDPE 398
            G VY+    G+  A+K  + +  E           E K+   + H N++ L G C+   
Sbjct: 20  FGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP 79

Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
             N  L+ E+   G L+  L   +   +     +  A+ +A G+ Y+H+     ++H+D+
Sbjct: 80  --NLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDL 134

Query: 459 KSSNILLD--------SNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTK 510
           KSSNIL+         SN   KI +FGLA+       M   G   ++APE +   + S  
Sbjct: 135 KSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKG 194

Query: 511 MDVFSFGVVLLELISGKE 528
            DV+S+GV+L EL++G+ 
Sbjct: 195 SDVWSYGVLLWELLTGEV 212

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  174 bits (442), Expect = 2e-50
 Identities = 56/201 (27%), Positives = 102/201 (50%), Gaps = 30/201 (14%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNACE--------------ELKILQKVNHGNLVKLEGFC 394
           G V+KG       V AIK +     E              E+ I+  +NH N+VKL G  
Sbjct: 33  GLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM 92

Query: 395 IDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVV 454
            +P      ++ E++  G L+  L  +K   + W  +LR+ +D+A G++Y+     P +V
Sbjct: 93  HNP----PRMVMEFVPCGDLYHRLL-DKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIV 146

Query: 455 HKDIKSSNILLDS-----NMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLA--DGVV 507
           H+D++S NI L S      + AK+A+FGL++   ++    ++G   ++APE +   +   
Sbjct: 147 HRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-VSGLLGNFQWMAPETIGAEEESY 205

Query: 508 STKMDVFSFGVVLLELISGKE 528
           + K D +SF ++L  +++G+ 
Sbjct: 206 TEKADTYSFAMILYTILTGEG 226

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  169 bits (431), Expect = 1e-48
 Identities = 58/195 (29%), Positives = 96/195 (49%), Gaps = 24/195 (12%)

Query: 350 QGSVYKGNIHGEVYAIKMMKWNA---------CEELKILQKVNHGNLVKLEGFCIDPEDA 400
            G+VYKG  HG+V A+KM+   A           E+ +L+K  H N++   G+   P   
Sbjct: 37  FGTVYKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP--- 92

Query: 401 NCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
              ++ ++ E  SL+  LH         K  + IA   A G+ Y+H  +   ++H+D+KS
Sbjct: 93  QLAIVTQWCEGSSLYHHLH-ASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKS 148

Query: 461 SNILLDSNMRAKIANFGLAK----SGCNAITMHIVGTQGYIAPE---YLADGVVSTKMDV 513
           +NI L  +   KI +FGLA        +     + G+  ++APE          S + DV
Sbjct: 149 NNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDV 208

Query: 514 FSFGVVLLELISGKE 528
           ++FG+VL EL++G+ 
Sbjct: 209 YAFGIVLYELMTGQL 223

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  169 bits (429), Expect = 3e-48
 Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 31/204 (15%)

Query: 351 GSVYKG--NIHGEVYAIK-------MMKWNACEELKILQKVNHGNLVKLEGFCIDPEDAN 401
           G   K      GEV  +K         +    +E+K+++ + H N++K  G     +   
Sbjct: 24  GQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK--R 81

Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSS 461
              I EYI+ G+L   +  + +    W  R+  A D+A+G+ Y+H      ++H+D+ S 
Sbjct: 82  LNFITEYIKGGTLRGIIK-SMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSH 137

Query: 462 NILLDSNMRAKIANFGLA----------------KSGCNAITMHIVGTQGYIAPEYLADG 505
           N L+  N    +A+FGLA                K         +VG   ++APE +   
Sbjct: 138 NCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR 197

Query: 506 VVSTKMDVFSFGVVLLELISGKEA 529
               K+DVFSFG+VL E+I    A
Sbjct: 198 SYDEKVDVFSFGIVLCEIIGRVNA 221

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  169 bits (430), Expect = 4e-48
 Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 28/204 (13%)

Query: 351 GSVYKGNIHGEVYAIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPEDA--NC 402
           G V+ G   GE  A+K+             E+     + H N++      I    +    
Sbjct: 51  GEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110

Query: 403 YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHE-----HTRPRVVHKD 457
           YLI +Y ENGSL+ +L       L+ K+ L++A    +GL ++H        +P + H+D
Sbjct: 111 YLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRD 167

Query: 458 IKSSNILLDSNMRAKIANFGLA------KSGCNAITMHIVGTQGYIAPEYLADGV----- 506
           +KS NIL+  N    IA+ GLA       +  +      VGT+ Y+ PE L + +     
Sbjct: 168 LKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHF 227

Query: 507 -VSTKMDVFSFGVVLLELISGKEA 529
                 D++SFG++L E+     +
Sbjct: 228 QSYIMADMYSFGLILWEVARRCVS 251

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  165 bits (421), Expect = 5e-47
 Identities = 49/203 (24%), Positives = 83/203 (40%), Gaps = 33/203 (16%)

Query: 351 GSVYKGNIHGEVYAIKMMKWNA---------CEELKILQKVNHGNLVKLEGFCIDPEDAN 401
           G VY G  HGEV AI+++               E+   ++  H N+V   G C+ P   +
Sbjct: 47  GQVYHGRWHGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP--H 103

Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSS 461
             +I    +  +L+S +  +    L+     +IA ++  G+ Y+H      ++HKD+KS 
Sbjct: 104 LAIITSLCKGRTLYSVVR-DAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSK 159

Query: 462 NILLDSNMRAKIANFGLAK-------SGCNAITMHIVGTQGYIAPEYL---------ADG 505
           N+  D N +  I +FGL                    G   ++APE +            
Sbjct: 160 NVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKL 218

Query: 506 VVSTKMDVFSFGVVLLELISGKE 528
             S   DVF+ G +  EL + + 
Sbjct: 219 PFSKHSDVFALGTIWYELHAREW 241

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  165 bits (419), Expect = 6e-47
 Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 28/207 (13%)

Query: 351 GSVYKGNIHGEVYAIKMMK------WNACEELKILQKVNHGNLVKLEGFCIDPEDA--NC 402
           G V++G+  GE  A+K+        W    EL     + H N++      +    +    
Sbjct: 22  GEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81

Query: 403 YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHE-----HTRPRVVHKD 457
           +LI  Y E GSL+ +L       L+  + LRI + +A+GL ++H        +P + H+D
Sbjct: 82  WLITHYHEMGSLYDYLQLTT---LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRD 138

Query: 458 IKSSNILLDSNMRAKIANFGLAK------SGCNAITMHIVGTQGYIAPE------YLADG 505
           +KS NIL+  N +  IA+ GLA       +  +      VGT+ Y+APE       +   
Sbjct: 139 LKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCF 198

Query: 506 VVSTKMDVFSFGVVLLELISGKEAIDE 532
               ++D+++FG+VL E+     +   
Sbjct: 199 DSYKRVDIWAFGLVLWEVARRMVSNGI 225

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  165 bits (419), Expect = 2e-46
 Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 28/211 (13%)

Query: 351 GSVYKGNIHGEVYAIKMMK------WNACEELKILQKVNHGNLVKLEGFCIDPEDA--NC 402
           G V++G   GE  A+K+        W    E+     + H N++                
Sbjct: 56  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115

Query: 403 YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHT-----RPRVVHKD 457
           +L+ +Y E+GSL  +L+      +  +  +++A+  A+GL ++H        +P + H+D
Sbjct: 116 WLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRD 172

Query: 458 IKSSNILLDSNMRAKIANFGLAKSGCNAITM------HIVGTQGYIAPEYLADGV----- 506
           +KS NIL+  N    IA+ GLA    +A         H VGT+ Y+APE L D +     
Sbjct: 173 LKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHF 232

Query: 507 -VSTKMDVFSFGVVLLELISGKEAIDEEGKF 536
               + D+++ G+V  E+            +
Sbjct: 233 ESFKRADIYAMGLVFWEIARRCSIGGIHEDY 263

>4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A* Length = 212

 Score =  139 bits (351), Expect = 2e-38
 Identities = 45/208 (21%), Positives = 79/208 (37%), Gaps = 11/208 (5%)

Query: 36  TCSANQTTYPCRTYAFYRASAPDFLDLASIADLFSVSRLMISEPSNISSPSSPLIQNQPL 95
           +C     +Y             +    +SIA    ++   I   ++       +     +
Sbjct: 4   SCPLALASYYLENGTTLSVINQNLN--SSIAPYDQINFDPILRYNSNIKDKDRIQMGSRV 61

Query: 96  FVPITCSCNTLNASYTISFANLSYTIKSGDTFYLVSTNKYQNLTTYQSVEVVNPTFVPTK 155
            VP  C C            N SY+++  DT+  V+ + Y NLTT +S++  NP    T 
Sbjct: 62  LVPFPCEC----QPGDFLGHNFSYSVRQEDTYERVAISNYANLTTMESLQARNPF-PATN 116

Query: 156 LEVGDVIIFPVFCKCPNQTQLRNRVNYLVSYVLQPSENLSSVASRFGIETQAIIDVNG-- 213
           + +   +   V C C +++         V+Y L+P ++LSS+A   G+    +   N   
Sbjct: 117 IPLSATLNVLVNCSCGDESV-SKDFGLFVTYPLRPEDSLSSIARSSGVSADILQRYNPGV 175

Query: 214 NNIRPFDTLFVPVARLPELKQPAVAPST 241
           N       ++VP  R P    P    S 
Sbjct: 176 NFNSGNGIVYVPG-RDPNGAFPPFKSSK 202

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  142 bits (361), Expect = 2e-37
 Identities = 54/183 (29%), Positives = 93/183 (50%), Gaps = 16/183 (8%)

Query: 351 GSVYKGNIHGEVYAIKMMKWNA-----CEELKILQKVNHGNLVKLEGFCIDPEDANCYLI 405
           G V  G+  G   A+K +K +A       E  ++ ++ H NLV+L G  ++ E    Y++
Sbjct: 207 GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE-EKGGLYIV 265

Query: 406 YEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL 465
            EY+  GSL  +L       L     L+ ++DV   ++Y+  +     VH+D+ + N+L+
Sbjct: 266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLV 322

Query: 466 DSNMRAKIANFGLAKSGCNAITMHIVGTQGYI---APEYLADGVVSTKMDVFSFGVVLLE 522
             +  AK+++FGL K   +         +  +   APE L +   STK DV+SFG++L E
Sbjct: 323 SEDNVAKVSDFGLTKEASSTQD----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWE 378

Query: 523 LIS 525
           + S
Sbjct: 379 IYS 381

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  137 bits (347), Expect = 1e-36
 Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 24/215 (11%)

Query: 351 GSVYKG------NIHGEVYAIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCID 396
           G V         +  GE  A+K +K  +          E++IL+ + H N+VK +G C +
Sbjct: 35  GKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE 94

Query: 397 PEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHK 456
                  LI E++ +GSL  +L +NK   +N K +L+ A+ +  G+ Y+      + VH+
Sbjct: 95  DGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSR---QYVHR 150

Query: 457 DIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI-----APEYLADGVVSTKM 511
           D+ + N+L++S  + KI +FGL K+       + V           APE L         
Sbjct: 151 DLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIAS 210

Query: 512 DVFSFGVVLLELIS-GKEAIDEEGKFCGQKLKGYW 545
           DV+SFGV L EL++           F       + 
Sbjct: 211 DVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHG 245

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  136 bits (344), Expect = 1e-36
 Identities = 51/196 (26%), Positives = 93/196 (47%), Gaps = 23/196 (11%)

Query: 351 GSVYKG--NIHGEVYAIKMMKW---NACEELKILQKVNHGNLVKLEGFCIDPEDANC--- 402
           G V+K    I G+ Y IK +K+    A  E+K L K++H N+V   G     +       
Sbjct: 25  GQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84

Query: 403 -----------YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRP 451
                      ++  E+ + G+L  W+ + + E L+    L +   +  G+ YIH     
Sbjct: 85  KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK--- 141

Query: 452 RVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAITMHIVGTQGYIAPEYLADGVVSTK 510
           +++++D+K SNI L    + KI +FGL  S   +       GT  Y++PE ++      +
Sbjct: 142 KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKE 201

Query: 511 MDVFSFGVVLLELISG 526
           +D+++ G++L EL+  
Sbjct: 202 VDLYALGLILAELLHV 217

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  134 bits (339), Expect = 7e-36
 Identities = 55/185 (29%), Positives = 92/185 (49%), Gaps = 20/185 (10%)

Query: 351 GSVYKGNIHGEVYAIKMMKWNACE-----ELKILQKVNHGNLVKLEGFCIDPEDANCYLI 405
           G V  G+  G   A+K +K +A       E  ++ ++ H NLV+L G  ++ E    Y++
Sbjct: 35  GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE-EKGGLYIV 93

Query: 406 YEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL 465
            EY+  GSL  +L       L     L+ ++DV   ++Y+  +     VH+D+ + N+L+
Sbjct: 94  TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLV 150

Query: 466 DSNMRAKIANFGLAKSGCNAITMHIVGTQGYI-----APEYLADGVVSTKMDVFSFGVVL 520
             +  AK+++FGL K              G +     APE L +   STK DV+SFG++L
Sbjct: 151 SEDNVAKVSDFGLTKE------ASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILL 204

Query: 521 LELIS 525
            E+ S
Sbjct: 205 WEIYS 209

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  135 bits (341), Expect = 1e-35
 Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 26/215 (12%)

Query: 351 GSVYKG------NIHGEVYAIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCID 396
           G V         +  GE+ A+K +K +A          E+ IL+ + H +++K +G C D
Sbjct: 45  GKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCED 104

Query: 397 PEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHK 456
              A+  L+ EY+  GSL  +L  +    +     L  A  +  G+ Y+H       +H+
Sbjct: 105 AGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQ---HYIHR 158

Query: 457 DIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI-----APEYLADGVVSTKM 511
           D+ + N+LLD++   KI +FGLAK+       + V   G       APE L +       
Sbjct: 159 DLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYAS 218

Query: 512 DVFSFGVVLLELIS-GKEAIDEEGKFCGQKLKGYW 545
           DV+SFGV L EL++    +     KF         
Sbjct: 219 DVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQG 253

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  134 bits (339), Expect = 1e-35
 Identities = 62/193 (32%), Positives = 95/193 (49%), Gaps = 22/193 (11%)

Query: 351 GSVYKG------NIHGEVYAIKMMKWNACE-------ELKILQKVNHGNLVKLEGFCIDP 397
           GSV         +  GEV A+K ++ +  E       E++IL+ + H N+VK +G C   
Sbjct: 24  GSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83

Query: 398 EDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKD 457
              N  LI EY+  GSL  +L ++K E ++    L+    +  G++Y+      R +H+D
Sbjct: 84  GRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRD 139

Query: 458 IKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI-----APEYLADGVVSTKMD 512
           + + NIL+++  R KI +FGL K          V   G       APE L +   S   D
Sbjct: 140 LATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASD 199

Query: 513 VFSFGVVLLELIS 525
           V+SFGVVL EL +
Sbjct: 200 VWSFGVVLYELFT 212

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  135 bits (341), Expect = 1e-35
 Identities = 56/193 (29%), Positives = 93/193 (48%), Gaps = 22/193 (11%)

Query: 351 GSVYKGNIHGEVY------AIKMMKWNACE-------ELKILQKVNHGNLVKLEGFCIDP 397
           GSV                A+K ++ +  +       E++IL+ ++   +VK  G    P
Sbjct: 37  GSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96

Query: 398 EDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKD 457
              +  L+ EY+ +G L  +L  ++   L+    L  +  +  G++Y+      R VH+D
Sbjct: 97  GRQSLRLVMEYLPSGCLRDFLQRHRAR-LDASRLLLYSSQICKGMEYLGSR---RCVHRD 152

Query: 458 IKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI-----APEYLADGVVSTKMD 512
           + + NIL++S    KIA+FGLAK        ++V   G       APE L+D + S + D
Sbjct: 153 LAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSD 212

Query: 513 VFSFGVVLLELIS 525
           V+SFGVVL EL +
Sbjct: 213 VWSFGVVLYELFT 225

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  133 bits (337), Expect = 4e-35
 Identities = 62/193 (32%), Positives = 96/193 (49%), Gaps = 22/193 (11%)

Query: 351 GSVYKG------NIHGEVYAIKMMKWNACE-------ELKILQKVNHGNLVKLEGFCIDP 397
           GSV         +  GEV A+K ++ +  E       E++IL+ + H N+VK +G C   
Sbjct: 55  GSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114

Query: 398 EDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKD 457
              N  LI EY+  GSL  +L ++K E ++    L+    +  G++Y+      R +H+D
Sbjct: 115 GRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRD 170

Query: 458 IKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI-----APEYLADGVVSTKMD 512
           + + NIL+++  R KI +FGL K        + V   G       APE L +   S   D
Sbjct: 171 LATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASD 230

Query: 513 VFSFGVVLLELIS 525
           V+SFGVVL EL +
Sbjct: 231 VWSFGVVLYELFT 243

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  133 bits (338), Expect = 8e-35
 Identities = 49/190 (25%), Positives = 91/190 (47%), Gaps = 22/190 (11%)

Query: 351 GSVYKGNIHGEVY--AIKMMKWNA--------CEELKILQKVNHGNLVKLEGFCIDPEDA 400
           G V+ G +  +    A+K  +            +E +IL++ +H N+V+L G C   +  
Sbjct: 128 GEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 187

Query: 401 NCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             Y++ E ++ G   ++L       L  KT L++  D A G++Y+        +H+D+ +
Sbjct: 188 --YIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAA 241

Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI-----APEYLADGVVSTKMDVFS 515
            N L+      KI++FG+++   + +     G    +     APE L  G  S++ DV+S
Sbjct: 242 RNCLVTEKNVLKISDFGMSREEADGVYAASGGL-RQVPVKWTAPEALNYGRYSSESDVWS 300

Query: 516 FGVVLLELIS 525
           FG++L E  S
Sbjct: 301 FGILLWETFS 310

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  135 bits (341), Expect = 2e-34
 Identities = 51/186 (27%), Positives = 94/186 (50%), Gaps = 16/186 (8%)

Query: 351 GSVYKGNIHGEVY--AIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPEDANC 402
           G VY+G         A+K +K +  E      E  +++++ H NLV+L G C    +   
Sbjct: 234 GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--REPPF 291

Query: 403 YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSN 462
           Y+I E++  G+L  +L E   + ++    L +A  +++ ++Y+ +      +H+++ + N
Sbjct: 292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARN 348

Query: 463 ILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI---APEYLADGVVSTKMDVFSFGVV 519
            L+  N   K+A+FGL++           G +  I   APE LA    S K DV++FGV+
Sbjct: 349 CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 408

Query: 520 LLELIS 525
           L E+ +
Sbjct: 409 LWEIAT 414

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  131 bits (331), Expect = 3e-34
 Identities = 51/194 (26%), Positives = 94/194 (48%), Gaps = 27/194 (13%)

Query: 351 GSVYKG-------NIHGEVYAIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCI 395
           G+VYKG        +   V AIK ++             E  ++  V++ ++ +L G C+
Sbjct: 29  GTVYKGLWIPEGEKVKIPV-AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL 87

Query: 396 DPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVH 455
                   LI + +  G L  ++ E+K +N+  +  L   + +A G+ Y+ +    R+VH
Sbjct: 88  TST---VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVH 140

Query: 456 KDIKSSNILLDSNMRAKIANFGLAKS-GCNAITMHIVGTQGYI---APEYLADGVVSTKM 511
           +D+ + N+L+ +    KI +FGLAK  G      H  G +  I   A E +   + + + 
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 200

Query: 512 DVFSFGVVLLELIS 525
           DV+S+GV + EL++
Sbjct: 201 DVWSYGVTVWELMT 214

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  131 bits (332), Expect = 3e-34
 Identities = 43/190 (22%), Positives = 85/190 (44%), Gaps = 18/190 (9%)

Query: 351 GSVYKG--NIHGEVYAIKMMKW---------NACEELKILQKVNHGNLVKLEGFCIDPED 399
           G          G  Y IK +            +  E+ +L  + H N+V+      +  +
Sbjct: 38  GKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE--N 95

Query: 400 ANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIK 459
            + Y++ +Y E G L   ++  K         L   + +   L+++H+    +++H+DIK
Sbjct: 96  GSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIK 152

Query: 460 SSNILLDSNMRAKIANFGLAK--SGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFG 517
           S NI L  +   ++ +FG+A+  +    +    +GT  Y++PE   +   + K D+++ G
Sbjct: 153 SQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALG 212

Query: 518 VVLLELISGK 527
            VL EL + K
Sbjct: 213 CVLYELCTLK 222

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  130 bits (328), Expect = 3e-34
 Identities = 51/195 (26%), Positives = 93/195 (47%), Gaps = 34/195 (17%)

Query: 351 GSVYKGNIHGEVY--AIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPEDANC 402
           G VY+G         A+K +K +  E      E  +++++ H NLV+L G C        
Sbjct: 27  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF-- 84

Query: 403 YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSN 462
           Y+I E++  G+L  +L E   + ++    L +A  +++ ++Y+ +      +H+D+ + N
Sbjct: 85  YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARN 141

Query: 463 ILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI------------APEYLADGVVSTK 510
            L+  N   K+A+FGL++         ++    Y             APE LA    S K
Sbjct: 142 CLVGENHLVKVADFGLSR---------LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192

Query: 511 MDVFSFGVVLLELIS 525
            DV++FGV+L E+ +
Sbjct: 193 SDVWAFGVLLWEIAT 207

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  130 bits (328), Expect = 4e-34
 Identities = 57/237 (24%), Positives = 103/237 (43%), Gaps = 36/237 (15%)

Query: 311 KDMEVNFMADVSDCL---DKYRIFKIEELREATDNFSEGCLIQGSVYKGNIHGEVY---- 363
           +D++   +A+V D L   ++        +        +G    G VY G    +      
Sbjct: 1   RDLDSALLAEVKDVLIPHERVVTHSDRVI-------GKGHF--GVVYHGEYIDQAQNRIQ 51

Query: 364 -AIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
            AIK +              E  +++ +NH N++ L G  + PE    +++  Y+ +G L
Sbjct: 52  CAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGL-PHVLLPYMCHGDL 110

Query: 415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIA 474
             ++   +  N   K  +   + VA G++Y+ E    + VH+D+ + N +LD +   K+A
Sbjct: 111 LQFIRSPQR-NPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVA 166

Query: 475 NFGLAKS-GCNAITMHIVGTQGYI-----APEYLADGVVSTKMDVFSFGVVLLELIS 525
           +FGLA+                 +     A E L     +TK DV+SFGV+L EL++
Sbjct: 167 DFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  132 bits (335), Expect = 7e-34
 Identities = 49/186 (26%), Positives = 93/186 (50%), Gaps = 18/186 (9%)

Query: 351 GSVYKGNIHGEVY-AIKMMKWNACE------ELKILQKVNHGNLVKLEGFCI-DPEDANC 402
           G V+    +     A+K MK  +        E  +++ + H  LVKL      +P     
Sbjct: 202 GEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEP----I 257

Query: 403 YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSN 462
           Y+I E++  GSL  +L  ++         +  +  +A G+ +I +      +H+D++++N
Sbjct: 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAAN 314

Query: 463 ILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI---APEYLADGVVSTKMDVFSFGVV 519
           IL+ +++  KIA+FGLA+   +       G +  I   APE +  G  + K DV+SFG++
Sbjct: 315 ILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGIL 374

Query: 520 LLELIS 525
           L+E+++
Sbjct: 375 LMEIVT 380

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  129 bits (326), Expect = 7e-34
 Identities = 50/195 (25%), Positives = 91/195 (46%), Gaps = 26/195 (13%)

Query: 351 GSVYKGNIHG------EVYAIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCID 396
           G VY G +           A+K +              E  I++  +H N++ L G C+ 
Sbjct: 39  GCVYHGTLLDNDGKKIHC-AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 97

Query: 397 PEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHK 456
            E +   ++  Y+++G L +++    + N   K  +   + VA G++Y+      + VH+
Sbjct: 98  SEGSP-LVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKYLASK---KFVHR 152

Query: 457 DIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG------YIAPEYLADGVVSTK 510
           D+ + N +LD     K+A+FGLA+   +     +    G      ++A E L     +TK
Sbjct: 153 DLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTK 212

Query: 511 MDVFSFGVVLLELIS 525
            DV+SFGV+L EL++
Sbjct: 213 SDVWSFGVLLWELMT 227

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  128 bits (324), Expect = 1e-33
 Identities = 56/186 (30%), Positives = 95/186 (51%), Gaps = 18/186 (9%)

Query: 351 GSVYKGNIHGEVY-AIKMMKWNACE------ELKILQKVNHGNLVKLEGFCI-DPEDANC 402
           G V+ G  +G    A+K +K  +        E  +++++ H  LV+L      +P     
Sbjct: 27  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP----I 82

Query: 403 YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSN 462
           Y+I EY+ENGSL  +L       L     L +A  +A G+ +I E      +H+D++++N
Sbjct: 83  YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAAN 139

Query: 463 ILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI---APEYLADGVVSTKMDVFSFGVV 519
           IL+   +  KIA+FGLA+   +       G +  I   APE +  G  + K DV+SFG++
Sbjct: 140 ILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 199

Query: 520 LLELIS 525
           L E+++
Sbjct: 200 LTEIVT 205

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  131 bits (331), Expect = 2e-33
 Identities = 55/186 (29%), Positives = 94/186 (50%), Gaps = 18/186 (9%)

Query: 351 GSVYKGNIHGEVY-AIKMMKWNA------CEELKILQKVNHGNLVKLEGFCI-DPEDANC 402
           G V+ G  +G    AIK +K          +E ++++K+ H  LV+L      +P     
Sbjct: 198 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP----I 253

Query: 403 YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSN 462
           Y++ EY+  GSL  +L     + L     + +A  +A+G+ Y+        VH+D++++N
Sbjct: 254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAAN 310

Query: 463 ILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI---APEYLADGVVSTKMDVFSFGVV 519
           IL+  N+  K+A+FGLA+   +       G +  I   APE    G  + K DV+SFG++
Sbjct: 311 ILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 370

Query: 520 LLELIS 525
           L EL +
Sbjct: 371 LTELTT 376

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  129 bits (326), Expect = 3e-33
 Identities = 49/195 (25%), Positives = 91/195 (46%), Gaps = 26/195 (13%)

Query: 351 GSVYKGNIHG------EVYAIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCID 396
           G VY G +           A+K +              E  I++  +H N++ L G C+ 
Sbjct: 103 GCVYHGTLLDNDGKKIHC-AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 161

Query: 397 PEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHK 456
            E +   ++  Y+++G L +++    + N   K  +   + VA G++++      + VH+
Sbjct: 162 SEGS-PLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASK---KFVHR 216

Query: 457 DIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG------YIAPEYLADGVVSTK 510
           D+ + N +LD     K+A+FGLA+   +     +    G      ++A E L     +TK
Sbjct: 217 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTK 276

Query: 511 MDVFSFGVVLLELIS 525
            DV+SFGV+L EL++
Sbjct: 277 SDVWSFGVLLWELMT 291

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  127 bits (322), Expect = 4e-33
 Identities = 54/202 (26%), Positives = 100/202 (49%), Gaps = 32/202 (15%)

Query: 351 GSVYKGNIHGE------VYAIKMMKWNAC---------EELKILQKVNHGNLVKLEGFCI 395
           GSV +GN+  E      V A+K MK +            E   ++  +H N+++L G CI
Sbjct: 48  GSVMEGNLKQEDGTSLKV-AVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106

Query: 396 DPEDANC---YLIYEYIENGSLHSWL----HENKNENLNWKTRLRIAIDVANGLQYIHEH 448
           +          +I  +++ G LH++L     E   +++  +T L+  +D+A G++Y+   
Sbjct: 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR 166

Query: 449 TRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI-----APEYLA 503
                +H+D+ + N +L  +M   +A+FGL+K    +   +  G    +     A E LA
Sbjct: 167 ---NFLHRDLAARNCMLRDDMTVCVADFGLSKK-IYSGDYYRQGRIAKMPVKWIAIESLA 222

Query: 504 DGVVSTKMDVFSFGVVLLELIS 525
           D V ++K DV++FGV + E+ +
Sbjct: 223 DRVYTSKSDVWAFGVTMWEIAT 244

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  127 bits (322), Expect = 5e-33
 Identities = 48/203 (23%), Positives = 95/203 (46%), Gaps = 33/203 (16%)

Query: 351 GSVYKGNIHGE------VYAIKMMKWNAC---------EELKILQKVNHGNLVKLEGFCI 395
           GSV +  +  E      V A+KM+K +            E   +++ +H ++ KL G  +
Sbjct: 37  GSVREAQLKQEDGSFVKV-AVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL 95

Query: 396 DPEDANC----YLIYEYIENGSLHSWL----HENKNENLNWKTRLRIAIDVANGLQYIHE 447
                       +I  ++++G LH++L          NL  +T +R  +D+A G++Y+  
Sbjct: 96  RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS 155

Query: 448 HTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI-----APEYL 502
                 +H+D+ + N +L  +M   +A+FGL++    +   +  G    +     A E L
Sbjct: 156 R---NFIHRDLAARNCMLAEDMTVCVADFGLSRK-IYSGDYYRQGCASKLPVKWLALESL 211

Query: 503 ADGVVSTKMDVFSFGVVLLELIS 525
           AD + +   DV++FGV + E+++
Sbjct: 212 ADNLYTVHSDVWAFGVTMWEIMT 234

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  131 bits (331), Expect = 6e-33
 Identities = 55/186 (29%), Positives = 94/186 (50%), Gaps = 18/186 (9%)

Query: 351 GSVYKGNIHGEVY-AIKMMKWNA------CEELKILQKVNHGNLVKLEGFCI-DPEDANC 402
           G V+ G  +G    AIK +K          +E ++++K+ H  LV+L      +P     
Sbjct: 281 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP----I 336

Query: 403 YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSN 462
           Y++ EY+  GSL  +L     + L     + +A  +A+G+ Y+        VH+D++++N
Sbjct: 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAAN 393

Query: 463 ILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI---APEYLADGVVSTKMDVFSFGVV 519
           IL+  N+  K+A+FGLA+   +       G +  I   APE    G  + K DV+SFG++
Sbjct: 394 ILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 453

Query: 520 LLELIS 525
           L EL +
Sbjct: 454 LTELTT 459

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  125 bits (317), Expect = 6e-33
 Identities = 51/185 (27%), Positives = 94/185 (50%), Gaps = 16/185 (8%)

Query: 351 GSVYKGNIHGEVY-AIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPEDANCY 403
           G V+ G    +   AIK ++  A        E +++ K++H  LV+L G C++       
Sbjct: 22  GLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI--C 79

Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI 463
           L+ E++E+G L  +L   +      +T L + +DV  G+ Y+ E     V+H+D+ + N 
Sbjct: 80  LVTEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNC 135

Query: 464 LLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI---APEYLADGVVSTKMDVFSFGVVL 520
           L+  N   K+++FG+ +   +       GT+  +   +PE  +    S+K DV+SFGV++
Sbjct: 136 LVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLM 195

Query: 521 LELIS 525
            E+ S
Sbjct: 196 WEVFS 200

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  125 bits (317), Expect = 9e-33
 Identities = 43/191 (22%), Positives = 83/191 (43%), Gaps = 18/191 (9%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNAC---------EELKILQKVNHGNLVKLEGFCIDPED 399
            +VYKG         A   ++             EE ++L+ + H N+V+          
Sbjct: 40  KTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 99

Query: 400 ANCYL--IYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKD 457
               +  + E + +G+L ++L   K   +  K        +  GLQ++H    P ++H+D
Sbjct: 100 GKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTR-TPPIIHRD 156

Query: 458 IKSSNILLDSNM-RAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSF 516
           +K  NI +       KI + GLA     +    ++GT  ++APE   +      +DV++F
Sbjct: 157 LKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEK-YDESVDVYAF 215

Query: 517 GVVLLELISGK 527
           G+ +LE+ + +
Sbjct: 216 GMCMLEMATSE 226

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  125 bits (316), Expect = 1e-32
 Identities = 52/185 (28%), Positives = 93/185 (50%), Gaps = 16/185 (8%)

Query: 351 GSVYKGNIHGEVY-AIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPEDANCY 403
           G V  G   G+   A+KM+K  +        E + + K++H  LVK  G C        Y
Sbjct: 22  GVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI--Y 79

Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI 463
           ++ EYI NG L ++L  +    L     L +  DV  G+ ++  H   + +H+D+ + N 
Sbjct: 80  IVTEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNC 135

Query: 464 LLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI---APEYLADGVVSTKMDVFSFGVVL 520
           L+D ++  K+++FG+ +   +   +  VGT+  +   APE       S+K DV++FG+++
Sbjct: 136 LVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILM 195

Query: 521 LELIS 525
            E+ S
Sbjct: 196 WEVFS 200

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  125 bits (317), Expect = 1e-32
 Identities = 50/185 (27%), Positives = 93/185 (50%), Gaps = 16/185 (8%)

Query: 351 GSVYKGNIHGEVY-AIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPEDANCY 403
           G V  G   G+   AIKM+K  +        E K++  ++H  LV+L G C        +
Sbjct: 38  GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI--F 95

Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI 463
           +I EY+ NG L ++L E ++     +  L +  DV   ++Y+      + +H+D+ + N 
Sbjct: 96  IITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNC 151

Query: 464 LLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI---APEYLADGVVSTKMDVFSFGVVL 520
           L++     K+++FGL++   +      VG++  +    PE L     S+K D+++FGV++
Sbjct: 152 LVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLM 211

Query: 521 LELIS 525
            E+ S
Sbjct: 212 WEIYS 216

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  126 bits (318), Expect = 2e-32
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 41/207 (19%)

Query: 351 GSVYKGNIHGEVY----AIKMMKWNACE--------ELKILQKV-NHGNLVKLEGFCIDP 397
           G V K  I  +      AIK MK  A +        EL++L K+ +H N++ L G C   
Sbjct: 39  GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 98

Query: 398 EDANCYLIYEYIENGSLHSWLHENK--------------NENLNWKTRLRIAIDVANGLQ 443
                YL  EY  +G+L  +L +++                 L+ +  L  A DVA G+ 
Sbjct: 99  GYL--YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMD 156

Query: 444 YIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI-----A 498
           Y+ +    + +H+D+ + NIL+  N  AKIA+FGL++       +++  T G +     A
Sbjct: 157 YLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQ----EVYVKKTMGRLPVRWMA 209

Query: 499 PEYLADGVVSTKMDVFSFGVVLLELIS 525
            E L   V +T  DV+S+GV+L E++S
Sbjct: 210 IESLNYSVYTTNSDVWSYGVLLWEIVS 236

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  126 bits (318), Expect = 2e-32
 Identities = 49/195 (25%), Positives = 92/195 (47%), Gaps = 29/195 (14%)

Query: 351 GSVYKG-------NIHGEVYAIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCI 395
           G+VYKG        +   V AIK ++             E  ++  V++ ++ +L G C+
Sbjct: 29  GTVYKGLWIPEGEKVKIPV-AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL 87

Query: 396 DPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVH 455
                   LI + +  G L  ++ E+K +N+  +  L   + +A G+ Y+ +    R+VH
Sbjct: 88  TST---VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVH 140

Query: 456 KDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI-----APEYLADGVVSTK 510
           +D+ + N+L+ +    KI +FGLAK    A         G +     A E +   + + +
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGLAKL-LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 199

Query: 511 MDVFSFGVVLLELIS 525
            DV+S+GV + EL++
Sbjct: 200 SDVWSYGVTVWELMT 214

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  124 bits (314), Expect = 2e-32
 Identities = 48/194 (24%), Positives = 88/194 (45%), Gaps = 17/194 (8%)

Query: 351 GSVYKG--NIHGEVYAIKMMKW---------NACEELKILQKVNHGNLVKLEGFCIDPED 399
           G   K      G++   K + +             E+ +L+++ H N+V+     ID  +
Sbjct: 20  GRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN 79

Query: 400 ANCYLIYEYIENGSLHSWL--HENKNENLNWKTRLRIAIDVANGLQYIHE--HTRPRVVH 455
              Y++ EY E G L S +     + + L+ +  LR+   +   L+  H        V+H
Sbjct: 80  TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLH 139

Query: 456 KDIKSSNILLDSNMRAKIANFGLAK--SGCNAITMHIVGTQGYIAPEYLADGVVSTKMDV 513
           +D+K +N+ LD     K+ +FGLA+  +   +     VGT  Y++PE +     + K D+
Sbjct: 140 RDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDI 199

Query: 514 FSFGVVLLELISGK 527
           +S G +L EL +  
Sbjct: 200 WSLGCLLYELCALM 213

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  125 bits (316), Expect = 3e-32
 Identities = 52/202 (25%), Positives = 91/202 (45%), Gaps = 29/202 (14%)

Query: 351 GSVYKGNIH---GEVYAIKMMK--------WNACEELKILQKVNHGNLVKLEGFCIDPED 399
            +V++G  H   G+++AIK+               E ++L+K+NH N+VKL     +   
Sbjct: 23  ANVFRG-RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT 81

Query: 400 ANCYLIYEYIENGSLHSWLHENKNEN-LNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
            +  LI E+   GSL++ L E  N   L     L +  DV  G+ ++ E+    +VH++I
Sbjct: 82  RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNI 138

Query: 459 KSSNILL----DSNMRAKIANFGLAKSGCNAITMH-IVGTQGYIAPEYLADGVVST---- 509
           K  NI+     D     K+ +FG A+   +      + GT+ Y+ P+     V+      
Sbjct: 139 KPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQK 198

Query: 510 ----KMDVFSFGVVLLELISGK 527
                +D++S GV      +G 
Sbjct: 199 KYGATVDLWSIGVTFYHAATGS 220

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  125 bits (316), Expect = 3e-32
 Identities = 45/202 (22%), Positives = 93/202 (46%), Gaps = 43/202 (21%)

Query: 351 GSVYKG-------NIHGEVYAIKMMKWNAC--------EELKILQKVNHGNLVKLEGFCI 395
           G+V+KG       +I   V  IK+++  +         + +  +  ++H ++V+L G C 
Sbjct: 27  GTVHKGVWIPEGESIKIPV-CIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP 85

Query: 396 DPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVH 455
                   L+ +Y+  GSL   + +++   L  +  L   + +A G+ Y+ EH    +VH
Sbjct: 86  GSS---LQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEH---GMVH 138

Query: 456 KDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGY------------IAPEYLA 503
           +++ + N+LL S  + ++A+FG+A          +                  +A E + 
Sbjct: 139 RNLAARNVLLKSPSQVQVADFGVADL--------LPPDDKQLLYSEAKTPIKWMALESIH 190

Query: 504 DGVVSTKMDVFSFGVVLLELIS 525
            G  + + DV+S+GV + EL++
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMT 212

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  124 bits (313), Expect = 4e-32
 Identities = 46/209 (22%), Positives = 83/209 (39%), Gaps = 38/209 (18%)

Query: 351 GSVYKGN--IHGEVYAIK-----MMKW---NACEELKILQKVNHGNLVKLEGFCID---- 396
           G V++    +    YAIK       +        E+K L K+ H  +V+     ++    
Sbjct: 19  GVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTT 78

Query: 397 ------PEDANCYLIYEYIENGSLHSWLHENK-NENLNWKTRLRIAIDVANGLQYIHEHT 449
                       Y+  +     +L  W++     E       L I + +A  ++++H   
Sbjct: 79  EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK- 137

Query: 450 RPRVVHKDIKSSNILLDSNMRAKIANFGLAK--------------SGCNAITMHIVGTQG 495
              ++H+D+K SNI    +   K+ +FGL                    A     VGT+ 
Sbjct: 138 --GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKL 195

Query: 496 YIAPEYLADGVVSTKMDVFSFGVVLLELI 524
           Y++PE +     S K+D+FS G++L EL+
Sbjct: 196 YMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  124 bits (314), Expect = 6e-32
 Identities = 56/193 (29%), Positives = 96/193 (49%), Gaps = 24/193 (12%)

Query: 351 GSVYKG----NIHGEVY-AIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCIDP 397
           G V  G        +V  AIK +K    E        E  I+ + +H N+++LEG     
Sbjct: 63  GEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122

Query: 398 EDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKD 457
             A   ++ EY+ENGSL ++L  +  +       + +   V  G++Y+ +      VH+D
Sbjct: 123 RLA--MIVTEYMENGSLDTFLRTHDGQ-FTIMQLVGMLRGVGAGMRYLSDL---GYVHRD 176

Query: 458 IKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI-----APEYLADGVVSTKMD 512
           + + N+L+DSN+  K+++FGL++   +        T G I     APE +A    S+  D
Sbjct: 177 LAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASD 236

Query: 513 VFSFGVVLLELIS 525
           V+SFGVV+ E+++
Sbjct: 237 VWSFGVVMWEVLA 249

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  123 bits (311), Expect = 7e-32
 Identities = 50/193 (25%), Positives = 92/193 (47%), Gaps = 26/193 (13%)

Query: 351 GSVYKG---NIHGEVY-AIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCIDPE 398
           GSV +G       ++  AIK++K    +        E +I+ ++++  +V+L G C    
Sbjct: 24  GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE- 82

Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
                L+ E    G LH +L   + E +       +   V+ G++Y+ E      VH+D+
Sbjct: 83  --ALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEK---NFVHRDL 136

Query: 459 KSSNILLDSNMRAKIANFGLAK---SGCNAITMHIVGTQGYI---APEYLADGVVSTKMD 512
            + N+LL +   AKI++FGL+K   +  +  T      +  +   APE +     S++ D
Sbjct: 137 AARNVLLVNRHYAKISDFGLSKALGADDSYYTAR-SAGKWPLKWYAPECINFRKFSSRSD 195

Query: 513 VFSFGVVLLELIS 525
           V+S+GV + E +S
Sbjct: 196 VWSYGVTMWEALS 208

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  124 bits (313), Expect = 8e-32
 Identities = 54/194 (27%), Positives = 97/194 (50%), Gaps = 25/194 (12%)

Query: 351 GSVYKGNIHGEVY------AIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCID 396
           G VYKG +           AIK +K    E        E  I+ + +H N+++LEG    
Sbjct: 58  GEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117

Query: 397 PEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHK 456
            +     +I EY+ENG+L  +L E   E  +    + +   +A G++Y+        VH+
Sbjct: 118 YKPM--MIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAAGMKYLANM---NYVHR 171

Query: 457 DIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI-----APEYLADGVVSTKM 511
           D+ + NIL++SN+  K+++FGL++   +        + G I     APE ++    ++  
Sbjct: 172 DLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSAS 231

Query: 512 DVFSFGVVLLELIS 525
           DV+SFG+V+ E+++
Sbjct: 232 DVWSFGIVMWEVMT 245

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  123 bits (310), Expect = 9e-32
 Identities = 53/193 (27%), Positives = 97/193 (50%), Gaps = 26/193 (13%)

Query: 351 GSVYKGNIHGEVY----AIKMMKWNACE---------ELKILQKVNHGNLVKLEGFCIDP 397
           G+V KG    +      A+K++K  A +         E  ++Q++++  +V++ G C   
Sbjct: 31  GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE 90

Query: 398 EDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKD 457
              +  L+ E  E G L+ +L +N++  +  K  + +   V+ G++Y+ E      VH+D
Sbjct: 91  ---SWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEES---NFVHRD 142

Query: 458 IKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI-----APEYLADGVVSTKMD 512
           + + N+LL +   AKI++FGL+K+       +   T G       APE +     S+K D
Sbjct: 143 LAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSD 202

Query: 513 VFSFGVVLLELIS 525
           V+SFGV++ E  S
Sbjct: 203 VWSFGVLMWEAFS 215

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  122 bits (308), Expect = 1e-31
 Identities = 49/192 (25%), Positives = 86/192 (44%), Gaps = 25/192 (13%)

Query: 351 GSVYKG------NIHGEVYAIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCID 396
           G V++G      N    V AIK  K    +        E   +++ +H ++VKL G   +
Sbjct: 29  GDVHQGIYMSPENPALAV-AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE 87

Query: 397 PEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHK 456
                 ++I E    G L S+L   K   L+  + +  A  ++  L Y+      R VH+
Sbjct: 88  N---PVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLESK---RFVHR 140

Query: 457 DIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI---APEYLADGVVSTKMDV 513
           DI + N+L+ SN   K+ +FGL++   ++        +  I   APE +     ++  DV
Sbjct: 141 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDV 200

Query: 514 FSFGVVLLELIS 525
           + FGV + E++ 
Sbjct: 201 WMFGVCMWEILM 212

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  123 bits (310), Expect = 2e-31
 Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 34/203 (16%)

Query: 351 GSVYKGNIHGEVY-------AIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCI 395
           G VY+G   G V        AIK +   A          E  ++++ N  ++V+L G   
Sbjct: 39  GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98

Query: 396 DPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTR--------LRIAIDVANGLQYIHE 447
             +     +I E +  G L S+L   +    N            +++A ++A+G+ Y++ 
Sbjct: 99  QGQPT--LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA 156

Query: 448 HTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI-----APEYL 502
           +   + VH+D+ + N ++  +   KI +FG+ +        +  G +G +     +PE L
Sbjct: 157 N---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD-IYETDYYRKGGKGLLPVRWMSPESL 212

Query: 503 ADGVVSTKMDVFSFGVVLLELIS 525
            DGV +T  DV+SFGVVL E+ +
Sbjct: 213 KDGVFTTYSDVWSFGVVLWEIAT 235

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  122 bits (309), Expect = 2e-31
 Identities = 44/195 (22%), Positives = 92/195 (47%), Gaps = 25/195 (12%)

Query: 351 GSVYKG--NIHGEVYAIKMM----------KWNACEELKILQKVNHGNLVKLEGFCIDPE 398
             VY+    + G   A+K +          + +  +E+ +L+++NH N++K     I  E
Sbjct: 46  SEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI--E 103

Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTR--LRIAIDVANGLQYIHEHTRPRVVHK 456
           D    ++ E  + G L   +   K +      R   +  + + + L+++H     RV+H+
Sbjct: 104 DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHR 160

Query: 457 DIKSSNILLDSNMRAKIANFGLAK----SGCNAITMHIVGTQGYIAPEYLADGVVSTKMD 512
           DIK +N+ + +    K+ + GL +        A ++  VGT  Y++PE + +   + K D
Sbjct: 161 DIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTPYYMSPERIHENGYNFKSD 218

Query: 513 VFSFGVVLLELISGK 527
           ++S G +L E+ + +
Sbjct: 219 IWSLGCLLYEMAALQ 233

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  122 bits (308), Expect = 3e-31
 Identities = 49/204 (24%), Positives = 89/204 (43%), Gaps = 36/204 (17%)

Query: 351 GSVYKG-NIHGEVYAIKMMK---------WNACEELKILQKVNHGNL--VKLEGFCIDPE 398
             V++  N   ++YAIK +           +   E+  L K+   +   ++L  + I  +
Sbjct: 42  SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101

Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
               Y++ E   N  L+SWL + K+  ++   R     ++   +  IH+H    +VH D+
Sbjct: 102 --YIYMVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQH---GIVHSDL 153

Query: 459 KSSNILLDSNMRAKIANFGLAKS----GCNAITMHIVGTQGYIAPEYLAD---------- 504
           K +N L+  +   K+ +FG+A        + +    VGT  Y+ PE + D          
Sbjct: 154 KPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKS 212

Query: 505 -GVVSTKMDVFSFGVVLLELISGK 527
              +S K DV+S G +L  +  GK
Sbjct: 213 KSKISPKSDVWSLGCILYYMTYGK 236

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  121 bits (307), Expect = 3e-31
 Identities = 47/195 (24%), Positives = 83/195 (42%), Gaps = 27/195 (13%)

Query: 351 GSVYKGNIHGEVY-----AIKMMKWNAC----------EELKILQKVNHGNLVKLEGFCI 395
           G V +G            A+K +K +             E+  +  ++H NL++L G  +
Sbjct: 32  GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 91

Query: 396 DPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVH 455
            P      ++ E    GSL   L +++  +    T  R A+ VA G+ Y+      R +H
Sbjct: 92  TP---PMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESK---RFIH 144

Query: 456 KDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI-----APEYLADGVVSTK 510
           +D+ + N+LL +    KI +FGL ++       +++     +     APE L     S  
Sbjct: 145 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHA 204

Query: 511 MDVFSFGVVLLELIS 525
            D + FGV L E+ +
Sbjct: 205 SDTWMFGVTLWEMFT 219

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  124 bits (312), Expect = 3e-31
 Identities = 52/202 (25%), Positives = 91/202 (45%), Gaps = 29/202 (14%)

Query: 351 GSVYKGNIH---GEVYAIKMMK--------WNACEELKILQKVNHGNLVKLEGFCIDPED 399
            +V++G  H   G+++AIK+               E ++L+K+NH N+VKL     +   
Sbjct: 23  ANVFRG-RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT 81

Query: 400 ANCYLIYEYIENGSLHSWLHENKNEN-LNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
            +  LI E+   GSL++ L E  N   L     L +  DV  G+ ++ E+    +VH++I
Sbjct: 82  RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNI 138

Query: 459 KSSNILL----DSNMRAKIANFGLAKSGCNAITMH-IVGTQGYIAPEYLADGVVST---- 509
           K  NI+     D     K+ +FG A+   +      + GT+ Y+ P+     V+      
Sbjct: 139 KPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQK 198

Query: 510 ----KMDVFSFGVVLLELISGK 527
                +D++S GV      +G 
Sbjct: 199 KYGATVDLWSIGVTFYHAATGS 220

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  122 bits (307), Expect = 4e-31
 Identities = 55/206 (26%), Positives = 75/206 (36%), Gaps = 27/206 (13%)

Query: 341 DNFSEGCLI-QGS---VYKGNIH---GEVYAIKMMKW---------NACEELKILQKV-N 383
            +F     +  GS   V+K       G +YA+K                 E+   +KV  
Sbjct: 57  QSFQRLSRLGHGSYGEVFKV-RSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115

Query: 384 HGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQ 443
           H   V+LE      E    YL  E     SL     E    +L          D    L 
Sbjct: 116 HPCCVRLEQAWE--EGGILYLQTELCG-PSLQQHC-EAWGASLPEAQVWGYLRDTLLALA 171

Query: 444 YIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH-IVGTQGYIAPEYL 502
           ++H      +VH D+K +NI L    R K+ +FGL      A       G   Y+APE L
Sbjct: 172 HLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL 228

Query: 503 ADGVVSTKMDVFSFGVVLLELISGKE 528
                 T  DVFS G+ +LE+    E
Sbjct: 229 QGS-YGTAADVFSLGLTILEVACNME 253

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  122 bits (307), Expect = 6e-31
 Identities = 49/204 (24%), Positives = 89/204 (43%), Gaps = 36/204 (17%)

Query: 351 GSVYKG-NIHGEVYAIKMMK---------WNACEELKILQKVNHGNL--VKLEGFCIDPE 398
             V++  N   ++YAIK +           +   E+  L K+   +   ++L  + I  +
Sbjct: 23  SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 82

Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
               Y++ E   N  L+SWL + K+  ++   R     ++   +  IH+H    +VH D+
Sbjct: 83  --YIYMVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQH---GIVHSDL 134

Query: 459 KSSNILLDSNMRAKIANFGLAKS----GCNAITMHIVGTQGYIAPEYLAD---------- 504
           K +N L+  +   K+ +FG+A        + +    VGT  Y+ PE + D          
Sbjct: 135 KPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKS 193

Query: 505 -GVVSTKMDVFSFGVVLLELISGK 527
              +S K DV+S G +L  +  GK
Sbjct: 194 KSKISPKSDVWSLGCILYYMTYGK 217

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  121 bits (306), Expect = 7e-31
 Identities = 56/203 (27%), Positives = 90/203 (44%), Gaps = 34/203 (16%)

Query: 351 GSVYKGNIHGEVY-------AIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCI 395
           G VY+G + G          A+K +     E        E  I+ K NH N+V+  G  +
Sbjct: 44  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 103

Query: 396 DPEDANCYLIYEYIENGSLHSWL-----HENKNENLNWKTRLRIAIDVANGLQYIHEHTR 450
                  +++ E +  G L S+L       ++  +L     L +A D+A G QY+ E+  
Sbjct: 104 QSLP--RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-- 159

Query: 451 PRVVHKDIKSSNILLD---SNMRAKIANFGLAKSGCNAITMHIVGTQGYI-----APEYL 502
              +H+DI + N LL        AKI +FG+A+    A      G    +      PE  
Sbjct: 160 -HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR-KGGCAMLPVKWMPPEAF 217

Query: 503 ADGVVSTKMDVFSFGVVLLELIS 525
            +G+ ++K D +SFGV+L E+ S
Sbjct: 218 MEGIFTSKTDTWSFGVLLWEIFS 240

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  123 bits (309), Expect = 9e-31
 Identities = 48/204 (23%), Positives = 88/204 (43%), Gaps = 36/204 (17%)

Query: 351 GSVYKG-NIHGEVYAIKMMK---------WNACEELKILQKVNHGNL--VKLEGFCIDPE 398
             V++  N   ++YAIK +           +   E+  L K+   +   ++L  + I  +
Sbjct: 70  SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 129

Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
               Y++ E   N  L+SWL + K+  ++   R     ++   +  IH+H    +VH D+
Sbjct: 130 --YIYMVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQH---GIVHSDL 181

Query: 459 KSSNILLDSNMRAKIANFGLAKS----GCNAITMHIVGTQGYIAPEYLAD---------- 504
           K +N L+  +   K+ +FG+A        + +    VG   Y+ PE + D          
Sbjct: 182 KPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKS 240

Query: 505 -GVVSTKMDVFSFGVVLLELISGK 527
              +S K DV+S G +L  +  GK
Sbjct: 241 KSKISPKSDVWSLGCILYYMTYGK 264

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  119 bits (300), Expect = 2e-30
 Identities = 52/192 (27%), Positives = 86/192 (44%), Gaps = 25/192 (13%)

Query: 351 GSVYKG---NIHGEVY--AIKMMKWNAC--------EELKILQKVNHGNLVKLEGFCI-D 396
           G VY+G   N  GE    A+K  K +           E  I++ ++H ++VKL G    +
Sbjct: 26  GEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE 85

Query: 397 PEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHK 456
           P     ++I E    G L  +L  NKN  L   T +  ++ +   + Y+        VH+
Sbjct: 86  P----TWIIMELYPYGELGHYLERNKNS-LKVLTLVLYSLQICKAMAYLESI---NCVHR 137

Query: 457 DIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI---APEYLADGVVSTKMDV 513
           DI   NIL+ S    K+ +FGL++   +        T+  I   +PE +     +T  DV
Sbjct: 138 DIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDV 197

Query: 514 FSFGVVLLELIS 525
           + F V + E++S
Sbjct: 198 WMFAVCMWEILS 209

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  121 bits (305), Expect = 3e-30
 Identities = 52/193 (26%), Positives = 97/193 (50%), Gaps = 24/193 (12%)

Query: 351 GSVYKG--NIHGEVY---AIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCIDP 397
           G V  G   +  +     AIK +K    E        E  I+ + +H N+++LEG     
Sbjct: 59  GEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS 118

Query: 398 EDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKD 457
           +     ++ EY+ENGSL S+L ++  +       + +   +A+G++Y+ +      VH+D
Sbjct: 119 KPV--MIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYLSDM---GYVHRD 172

Query: 458 IKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI-----APEYLADGVVSTKMD 512
           + + NIL++SN+  K+++FGL +   +          G I     +PE +A    ++  D
Sbjct: 173 LAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASD 232

Query: 513 VFSFGVVLLELIS 525
           V+S+G+VL E++S
Sbjct: 233 VWSYGIVLWEVMS 245

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  120 bits (302), Expect = 5e-30
 Identities = 56/203 (27%), Positives = 90/203 (44%), Gaps = 34/203 (16%)

Query: 351 GSVYKGNIHGEVY-------AIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCI 395
           G VY+G + G          A+K +     E        E  I+ K NH N+V+  G  +
Sbjct: 85  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 144

Query: 396 DPEDANCYLIYEYIENGSLHSWL-----HENKNENLNWKTRLRIAIDVANGLQYIHEHTR 450
                  +++ E +  G L S+L       ++  +L     L +A D+A G QY+ E+  
Sbjct: 145 QSLP--RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-- 200

Query: 451 PRVVHKDIKSSNILLD---SNMRAKIANFGLAKSGCNAITMHIVGTQGYI-----APEYL 502
              +H+DI + N LL        AKI +FG+A+    A      G    +      PE  
Sbjct: 201 -HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR-KGGCAMLPVKWMPPEAF 258

Query: 503 ADGVVSTKMDVFSFGVVLLELIS 525
            +G+ ++K D +SFGV+L E+ S
Sbjct: 259 MEGIFTSKTDTWSFGVLLWEIFS 281

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  118 bits (298), Expect = 8e-30
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 40/210 (19%)

Query: 351 GSVYKGNIHGEVY-------AIKMMKWNACE--------ELKILQKV-NHGNLVKLEGFC 394
           G V + +  G          A+KM+K  A          ELKIL  + +H N+V L G C
Sbjct: 41  GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 100

Query: 395 IDPEDANCYLIYEYIENGSLHSWLHENKNEN--------------LNWKTRLRIAIDVAN 440
                    +I E+ + G+L ++L   +NE               L  +  +  +  VA 
Sbjct: 101 TK-PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAK 159

Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI--- 497
           G++++      + +H+D+ + NILL      KI +FGLA+        ++      +   
Sbjct: 160 GMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARD-IYKDPDYVRKGDARLPLK 215

Query: 498 --APEYLADGVVSTKMDVFSFGVVLLELIS 525
             APE + D V + + DV+SFGV+L E+ S
Sbjct: 216 WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  117 bits (295), Expect = 1e-29
 Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 40/209 (19%)

Query: 351 GSVYKGNIHGEVY-------AIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCI 395
           G VYKG++ G          AIK +K  A          E  +  ++ H N+V L G   
Sbjct: 23  GKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT 82

Query: 396 DPEDANCYLIYEYIENGSLHSWLHEN--------------KNENLNWKTRLRIAIDVANG 441
             +     +I+ Y  +G LH +L                     L     + +   +A G
Sbjct: 83  KDQPL--SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAG 140

Query: 442 LQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI---- 497
           ++Y+  H    VVHKD+ + N+L+   +  KI++ GL +    A   + +     +    
Sbjct: 141 MEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFRE-VYAADYYKLLGNSLLPIRW 196

Query: 498 -APEYLADGVVSTKMDVFSFGVVLLELIS 525
            APE +  G  S   D++S+GVVL E+ S
Sbjct: 197 MAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  122 bits (308), Expect = 1e-29
 Identities = 49/192 (25%), Positives = 86/192 (44%), Gaps = 25/192 (13%)

Query: 351 GSVYKG------NIHGEVYAIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCID 396
           G V++G      N    V AIK  K    +        E   +++ +H ++VKL G   +
Sbjct: 404 GDVHQGIYMSPENPAMAV-AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE 462

Query: 397 PEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHK 456
                 ++I E    G L S+L   K   L+  + +  A  ++  L Y+      R VH+
Sbjct: 463 N---PVWIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAYLESK---RFVHR 515

Query: 457 DIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI---APEYLADGVVSTKMDV 513
           DI + N+L+ SN   K+ +FGL++   ++        +  I   APE +     ++  DV
Sbjct: 516 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDV 575

Query: 514 FSFGVVLLELIS 525
           + FGV + E++ 
Sbjct: 576 WMFGVCMWEILM 587

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  121 bits (306), Expect = 1e-29
 Identities = 50/194 (25%), Positives = 92/194 (47%), Gaps = 28/194 (14%)

Query: 351 GSVYKG-----NIHGEVYAIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCIDP 397
           GSV +G         +V AIK++K    +        E +I+ ++++  +V+L G C   
Sbjct: 350 GSVRQGVYRMRKKQIDV-AIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE 408

Query: 398 EDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKD 457
                 L+ E    G LH +L   + E +       +   V+ G++Y+ E      VH++
Sbjct: 409 A---LMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEK---NFVHRN 461

Query: 458 IKSSNILLDSNMRAKIANFGLAK---SGCNAITMHIVGTQGYI---APEYLADGVVSTKM 511
           + + N+LL +   AKI++FGL+K   +  +  T      +  +   APE +     S++ 
Sbjct: 462 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR-SAGKWPLKWYAPECINFRKFSSRS 520

Query: 512 DVFSFGVVLLELIS 525
           DV+S+GV + E +S
Sbjct: 521 DVWSYGVTMWEALS 534

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  118 bits (298), Expect = 2e-29
 Identities = 54/217 (24%), Positives = 95/217 (43%), Gaps = 53/217 (24%)

Query: 351 GSVYKGNIHGEVY---------AIKMMKWNACE--------ELKILQKV-NHGNLVKLEG 392
           G V      G            A+KM+K +A E        E+++++ +  H N++ L G
Sbjct: 95  GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 154

Query: 393 FCIDPEDANCYLIYEYIENGSLHSWLHENK--------------NENLNWKTRLRIAIDV 438
            C        Y+I EY   G+L  +L   +               E + +K  +     +
Sbjct: 155 ACTQDGPL--YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQL 212

Query: 439 ANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH-----IVGT 493
           A G++Y+      + +H+D+ + N+L+  N   KIA+FGLA+       ++        T
Sbjct: 213 ARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARD------INNIDYYKKTT 263

Query: 494 QGYI-----APEYLADGVVSTKMDVFSFGVVLLELIS 525
            G +     APE L D V + + DV+SFGV++ E+ +
Sbjct: 264 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  117 bits (294), Expect = 2e-29
 Identities = 52/212 (24%), Positives = 92/212 (43%), Gaps = 40/212 (18%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPEDANC 402
           G V K    +    YAIK ++    +      E+ +L  +NH  +V+     ++  +   
Sbjct: 20  GQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79

Query: 403 -----------YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRP 451
                      ++  EY ENG+L+  +H  +N N       R+   +   L YIH     
Sbjct: 80  PMTAVKKKSTLFIQMEYCENGTLYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQ--- 135

Query: 452 RVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI----------------VGTQG 495
            ++H+D+K  NI +D +   KI +FGLAK+   ++ +                  +GT  
Sbjct: 136 GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAM 195

Query: 496 YIAPEYLAD-GVVSTKMDVFSFGVVLLELISG 526
           Y+A E L   G  + K+D++S G++  E+I  
Sbjct: 196 YVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  117 bits (296), Expect = 2e-29
 Identities = 54/222 (24%), Positives = 93/222 (41%), Gaps = 58/222 (26%)

Query: 351 GSVYKGNIHGEVY-------AIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCI 395
           G V++    G +        A+KM+K  A          E  ++ + ++ N+VKL G C 
Sbjct: 61  GRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120

Query: 396 DPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTR----------------------LR 433
             +     L++EY+  G L+ +L       +   +                       L 
Sbjct: 121 VGKPM--CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLC 178

Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH---- 489
           IA  VA G+ Y+ E    + VH+D+ + N L+  NM  KIA+FGL+++      ++    
Sbjct: 179 IARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN------IYSADY 229

Query: 490 -IVGTQGYI-----APEYLADGVVSTKMDVFSFGVVLLELIS 525
                   I      PE +     +T+ DV+++GVVL E+ S
Sbjct: 230 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  116 bits (294), Expect = 3e-29
 Identities = 59/222 (26%), Positives = 97/222 (43%), Gaps = 58/222 (26%)

Query: 351 GSVYKGNIHGEVY-------AIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCI 395
           G V K               A+KM+K NA          E  +L++VNH +++KL G C 
Sbjct: 37  GKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS 96

Query: 396 DPEDANCYLIYEYIENGSLHSWL----------------------HENKNENLNWKTRLR 433
                   LI EY + GSL  +L                             L     + 
Sbjct: 97  QDGPL--LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLIS 154

Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH---- 489
            A  ++ G+QY+ E    ++VH+D+ + NIL+    + KI++FGL++       ++    
Sbjct: 155 FAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRD------VYEEDS 205

Query: 490 -IVGTQGYI-----APEYLADGVVSTKMDVFSFGVVLLELIS 525
            +  +QG I     A E L D + +T+ DV+SFGV+L E+++
Sbjct: 206 YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  117 bits (295), Expect = 3e-29
 Identities = 54/217 (24%), Positives = 95/217 (43%), Gaps = 53/217 (24%)

Query: 351 GSVYKGNIHGEVY---------AIKMMKWNACE--------ELKILQKV-NHGNLVKLEG 392
           G V      G            A+KM+K +A E        E+++++ +  H N++ L G
Sbjct: 49  GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 108

Query: 393 FCIDPEDANCYLIYEYIENGSLHSWL--------------HENKNENLNWKTRLRIAIDV 438
            C        Y+I EY   G+L  +L              +    E + +K  +     +
Sbjct: 109 ACTQDGPL--YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQL 166

Query: 439 ANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH-----IVGT 493
           A G++Y+      + +H+D+ + N+L+  N   KIA+FGLA+       ++        T
Sbjct: 167 ARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARD------INNIDYYKKTT 217

Query: 494 QGYI-----APEYLADGVVSTKMDVFSFGVVLLELIS 525
            G +     APE L D V + + DV+SFGV++ E+ +
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  120 bits (303), Expect = 5e-29
 Identities = 59/197 (29%), Positives = 93/197 (47%), Gaps = 24/197 (12%)

Query: 351 GSVYKGNIH---GEVYAIKM--------MKWNACEELKILQKVNHGNLVKL----EGFCI 395
           G V +  IH   GE  AIK          +   C E++I++K+NH N+V      +G   
Sbjct: 28  GYVLRW-IHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQK 86

Query: 396 DPEDANCYLIYEYIENGSLHSWLHENKNEN-LNWKTRLRIAIDVANGLQYIHEHTRPRVV 454
              +    L  EY E G L  +L++ +N   L       +  D+++ L+Y+HE+   R++
Sbjct: 87  LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RII 143

Query: 455 HKDIKSSNILLDSN---MRAKIANFGLAKSGCNAITMH-IVGTQGYIAPEYLADGVVSTK 510
           H+D+K  NI+L      +  KI + G AK           VGT  Y+APE L     +  
Sbjct: 144 HRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVT 203

Query: 511 MDVFSFGVVLLELISGK 527
           +D +SFG +  E I+G 
Sbjct: 204 VDYWSFGTLAFECITGF 220

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  115 bits (289), Expect = 5e-29
 Identities = 54/189 (28%), Positives = 90/189 (47%), Gaps = 19/189 (10%)

Query: 351 GSVYKG-NIH-GEVYAIKMM------KWNACE----ELKILQKVNHGNLVKLEGFCIDPE 398
           G+VY         + A+K++      K         E++I   + H N+++L G+  D  
Sbjct: 23  GNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-- 80

Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
               YLI EY   G+++  L +    +   +T      ++AN L Y H     RV+H+DI
Sbjct: 81  ATRVYLILEYAPLGTVYRELQKLSKFD-EQRTA-TYITELANALSYCHSK---RVIHRDI 135

Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGV 518
           K  N+LL S    KIA+FG +    ++    + GT  Y+ PE +   +   K+D++S GV
Sbjct: 136 KPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGV 195

Query: 519 VLLELISGK 527
           +  E + GK
Sbjct: 196 LCYEFLVGK 204

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  115 bits (291), Expect = 8e-29
 Identities = 48/208 (23%), Positives = 90/208 (43%), Gaps = 40/208 (19%)

Query: 351 GSVYKGNIHGEVY-------AIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCI 395
           G V+    H  +        A+K +K  A E        E ++L  + H ++V+  G C 
Sbjct: 55  GKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQREAELLTMLQHQHIVRFFGVCT 113

Query: 396 DPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTR-------------LRIAIDVANGL 442
           +       +++EY+ +G L+ +L  +  +                    L +A  VA G+
Sbjct: 114 EGRPL--LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGM 171

Query: 443 QYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI----- 497
            Y+        VH+D+ + N L+   +  KI +FG+++    +   + VG +  +     
Sbjct: 172 VYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRD-IYSTDYYRVGGRTMLPIRWM 227

Query: 498 APEYLADGVVSTKMDVFSFGVVLLELIS 525
            PE +     +T+ DV+SFGVVL E+ +
Sbjct: 228 PPESILYRKFTTESDVWSFGVVLWEIFT 255

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  115 bits (291), Expect = 9e-29
 Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 39/208 (18%)

Query: 351 GSVYKGNIHGEVY-------AIKMMKWNACE--------ELKILQKV-NHGNLVKLEGFC 394
           G V +    G          A+KM+K  A          ELKI+  +  H N+V L G C
Sbjct: 60  GKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119

Query: 395 IDPEDANCYLIYEYIENGSLHSWLHENK------------NENLNWKTRLRIAIDVANGL 442
                    +I EY   G L ++L                N   + +  L  +  VA G+
Sbjct: 120 THGGPV--LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGM 177

Query: 443 QYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI----- 497
            ++        +H+D+ + N+LL +   AKI +FGLA+      + +IV     +     
Sbjct: 178 AFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARD-IMNDSNYIVKGNARLPVKWM 233

Query: 498 APEYLADGVVSTKMDVFSFGVVLLELIS 525
           APE + D V + + DV+S+G++L E+ S
Sbjct: 234 APESIFDCVYTVQSDVWSYGILLWEIFS 261

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  114 bits (288), Expect = 1e-28
 Identities = 40/206 (19%), Positives = 87/206 (42%), Gaps = 45/206 (21%)

Query: 351 GSVYKGNIHGEVY---------AIKMMKWNAC-------EELKILQKVNHGNLVKLEGFC 394
             ++KG                 +K++            E   ++ K++H +LV   G C
Sbjct: 22  TKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVC 81

Query: 395 IDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVV 454
           +  ++    L+ E+++ GSL ++L +NKN  +N   +L +A  +A  + ++ E+    ++
Sbjct: 82  VCGDEN--ILVQEFVKFGSLDTYLKKNKNC-INILWKLEVAKQLAAAMHFLEEN---TLI 135

Query: 455 HKDIKSSNILLDS--------NMRAKIANFGLAKSGCNAITMHIVGTQGY------IAPE 500
           H ++ + NILL              K+++ G++ +        ++           + PE
Sbjct: 136 HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT--------VLPKDILQERIPWVPPE 187

Query: 501 YLADGVV-STKMDVFSFGVVLLELIS 525
            + +    +   D +SFG  L E+ S
Sbjct: 188 CIENPKNLNLATDKWSFGTTLWEICS 213

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  114 bits (288), Expect = 1e-28
 Identities = 48/209 (22%), Positives = 92/209 (44%), Gaps = 41/209 (19%)

Query: 351 GSVYKGNIHGEVY-------AIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCI 395
           G V+    +           A+K +K +           E ++L  + H ++VK  G C 
Sbjct: 29  GKVFLAECYNLSPTKDKMLVAVKALK-DPTLAARKDFQREAELLTNLQHEHIVKFYGVCG 87

Query: 396 DPEDANCYLIYEYIENGSLHSWLHEN--------------KNENLNWKTRLRIAIDVANG 441
           D +     +++EY+++G L+ +L  +                  L     L IA  +A+G
Sbjct: 88  DGDPL--IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASG 145

Query: 442 LQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI---- 497
           + Y+        VH+D+ + N L+ +N+  KI +FG+++    +   + VG    +    
Sbjct: 146 MVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRD-VYSTDYYRVGGHTMLPIRW 201

Query: 498 -APEYLADGVVSTKMDVFSFGVVLLELIS 525
             PE +     +T+ DV+SFGV+L E+ +
Sbjct: 202 MPPESIMYRKFTTESDVWSFGVILWEIFT 230

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  117 bits (294), Expect = 2e-28
 Identities = 46/192 (23%), Positives = 87/192 (45%), Gaps = 25/192 (13%)

Query: 353 VYKGNIHGEVYAIKMMKWNACE----ELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYE 407
           VY+G       A+K +          E+++L++ + H N+++      D +    Y+  E
Sbjct: 41  VYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQ--FQYIAIE 98

Query: 408 YIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL-- 465
                +L  ++ E K+        + +     +GL ++H      +VH+D+K  NIL+  
Sbjct: 99  LCA-ATLQEYV-EQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISM 153

Query: 466 ---DSNMRAKIANFGLAK-----SGCNAITMHIVGTQGYIAPEYLADGVV---STKMDVF 514
                 ++A I++FGL K         +    + GT+G+IAPE L++      +  +D+F
Sbjct: 154 PNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIF 213

Query: 515 SFGVVLLELISG 526
           S G V   +IS 
Sbjct: 214 SAGCVFYYVISE 225

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  113 bits (286), Expect = 2e-28
 Identities = 52/229 (22%), Positives = 80/229 (34%), Gaps = 47/229 (20%)

Query: 340 TDNFSEGCLI----QGSVYKGNIH---GEVYAIKMMKW---------NACEELKILQKV- 382
           T  F E   I     GSV+K  +    G +YAIK  K          NA  E+     + 
Sbjct: 10  TTEFHELEKIGSGEFGSVFKC-VKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG 68

Query: 383 NHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNEN--LNWKTRLRIAIDVAN 440
            H ++V+        ED +  +  EY   GSL   + EN              + + V  
Sbjct: 69  QHSHVVRYFS--AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126

Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSN-------------------MRAKIANFGLAKS 481
           GL+YIH      +VH DIK SNI +                      +  KI + G    
Sbjct: 127 GLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183

Query: 482 GCNAITMHIVGTQGYIAPEYLADGVV-STKMDVFSFGVVLLELISGKEA 529
             +       G   ++A E L +      K D+F+  + ++     +  
Sbjct: 184 ISSPQVE--EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  115 bits (291), Expect = 2e-28
 Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 43/212 (20%)

Query: 351 GSVYKGNIHGEVY---------AIKMMKWNACE--------ELKILQKV-NHGNLVKLEG 392
           G V      G            A+KM+K +A E        E+++++ +  H N++ L G
Sbjct: 83  GQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG 142

Query: 393 FCIDPEDANCYLIYEYIENGSLHSWL--------------HENKNENLNWKTRLRIAIDV 438
            C        Y+I EY   G+L  +L                N  E L+ K  +  A  V
Sbjct: 143 ACTQDGPL--YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQV 200

Query: 439 ANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI- 497
           A G++Y+      + +H+D+ + N+L+  +   KIA+FGLA+   + I  +   T G + 
Sbjct: 201 ARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR-DIHHIDYYKKTTNGRLP 256

Query: 498 ----APEYLADGVVSTKMDVFSFGVVLLELIS 525
               APE L D + + + DV+SFGV+L E+ +
Sbjct: 257 VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  114 bits (287), Expect = 2e-28
 Identities = 47/227 (20%), Positives = 90/227 (39%), Gaps = 35/227 (15%)

Query: 351 GSVY--KGNIHGEVYAIKMM-------KWNACEELKILQKVNHGNLVKLEGFCIDPEDAN 401
             V   +G   G  YA+K +       +  A  E  + +  NH N+++L  +C+    A 
Sbjct: 43  SYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102

Query: 402 C--YLIYEYIENGSLHSWLHENKNENLNWKTR--LRIAIDVANGLQYIHEHTRPRVVHKD 457
              +L+  + + G+L + +   K++         L + + +  GL+ IH        H+D
Sbjct: 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRD 159

Query: 458 IKSSNILLDSNMRAKIANFGLAKSGCNAITMH-----------IVGTQGYIAPEYLADG- 505
           +K +NILL    +  + + G     C  +                 T  Y APE L    
Sbjct: 160 LKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE-LFSVQ 218

Query: 506 ---VVSTKMDVFSFGVVLLELISGK---EAIDEEGKFCGQKLKGYWR 546
              V+  + DV+S G VL  ++ G+   + + ++G      ++    
Sbjct: 219 SHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS 265

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  113 bits (285), Expect = 4e-28
 Identities = 56/212 (26%), Positives = 92/212 (43%), Gaps = 43/212 (20%)

Query: 351 GSVYKGNIHGEVY-------AIKMMKWNACE--------ELKILQKV-NHGNLVKLEGFC 394
           G V +   +G +        A+KM+K +A          ELK+L  + NH N+V L G C
Sbjct: 37  GKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96

Query: 395 IDPEDANCYLIYEYIENGSLHSWL----------------HENKNENLNWKTRLRIAIDV 438
                    +I EY   G L ++L                 E+    L+ +  L  +  V
Sbjct: 97  TIGGPT--LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQV 154

Query: 439 ANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI- 497
           A G+ ++        +H+D+ + NILL      KI +FGLA+      + ++V     + 
Sbjct: 155 AKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARD-IKNDSNYVVKGNARLP 210

Query: 498 ----APEYLADGVVSTKMDVFSFGVVLLELIS 525
               APE + + V + + DV+S+G+ L EL S
Sbjct: 211 VKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  112 bits (283), Expect = 5e-28
 Identities = 57/192 (29%), Positives = 94/192 (48%), Gaps = 22/192 (11%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNACE----------ELKILQKVNHGNLVKLEGFCIDPE 398
            +VY     I     AIK +     E          E+    +++H N+V +    +D E
Sbjct: 25  STVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM--IDVDEE 82

Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
           D   YL+ EYIE  +L  ++  +    L+  T +     + +G+++ H+    R+VH+DI
Sbjct: 83  DDCYYLVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAHDM---RIVHRDI 137

Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNA---ITMHIVGTQGYIAPEYLADGVVSTKMDVFS 515
           K  NIL+DSN   KI +FG+AK+        T H++GT  Y +PE           D++S
Sbjct: 138 KPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYS 197

Query: 516 FGVVLLELISGK 527
            G+VL E++ G+
Sbjct: 198 IGIVLYEMLVGE 209

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  113 bits (283), Expect = 9e-28
 Identities = 46/248 (18%), Positives = 88/248 (35%), Gaps = 24/248 (9%)

Query: 300 KLQFNKGGRDLKDMEVNFMADVSDCLDKYRIFKIEELREATDNFSEGCLIQGSVYKGNIH 359
           +L   +  R+    EV  +A     L+   I +       T        +     K    
Sbjct: 40  RLPNRELAREKVMREVKALAK----LEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDEST 95

Query: 360 GEVYAIKMMKWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLH 419
               +          +++ +   +  N V              Y+  +     +L  W++
Sbjct: 96  DWPLSSPSPMDAPSVKIRRMDPFSTKNTVG--QLQPSSPKVYLYIQMQLCRKENLKDWMN 153

Query: 420 ENKN-ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGL 478
              + E+      L I I +A  ++++H      ++H+D+K SNI    +   K+ +FGL
Sbjct: 154 RRCSLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGL 210

Query: 479 AKSGCNAITMH--------------IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELI 524
             +                       VGT+ Y++PE +     S K+D+FS G++L EL+
Sbjct: 211 VTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

Query: 525 SGKEAIDE 532
                  E
Sbjct: 271 YSFSTQME 278

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  112 bits (283), Expect = 1e-27
 Identities = 55/217 (25%), Positives = 94/217 (43%), Gaps = 48/217 (22%)

Query: 351 GSVYKGNIHGEVY-------AIKMMKWNACE--------ELKILQKV-NHGNLVKLEGFC 394
           G V     +G          A+KM+K  A          ELK++ ++ +H N+V L G C
Sbjct: 59  GKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118

Query: 395 IDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTR---------------------LR 433
                   YLI+EY   G L ++L   + +    +                       L 
Sbjct: 119 TLSG--PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLC 176

Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT 493
            A  VA G++++        VH+D+ + N+L+      KI +FGLA+    + + ++V  
Sbjct: 177 FAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD-IMSDSNYVVRG 232

Query: 494 QGYI-----APEYLADGVVSTKMDVFSFGVVLLELIS 525
              +     APE L +G+ + K DV+S+G++L E+ S
Sbjct: 233 NARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  112 bits (281), Expect = 2e-27
 Identities = 48/199 (24%), Positives = 86/199 (43%), Gaps = 39/199 (19%)

Query: 351 GSVYKG-NIH-GEVYAIKMMKWNAC--EELKILQKVNHGNLVKLEGFCIDPEDANCYLIY 406
           G V++  +   G   A+K ++      EEL     ++   +V L G   +    N ++  
Sbjct: 72  GEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFM-- 129

Query: 407 EYIENGSLHSWLHENK--NENLNWKTRLRIAI---DVANGLQYIHEHTRPRVVHKDIKSS 461
           E +E GSL   + +     E+                  GL+Y+H     R++H D+K+ 
Sbjct: 130 ELLEGGSLGQLIKQMGCLPEDR-------ALYYLGQALEGLEYLHTR---RILHGDVKAD 179

Query: 462 NILLDSN-MRAKIANFGLAK-------SGCNAITMHIVGTQGYIAPEYLADGVV-----S 508
           N+LL S+  RA + +FG A                +I GT+ ++APE     VV      
Sbjct: 180 NVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE-----VVMGKPCD 234

Query: 509 TKMDVFSFGVVLLELISGK 527
            K+D++S   ++L +++G 
Sbjct: 235 AKVDIWSSCCMMLHMLNGC 253

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  110 bits (278), Expect = 6e-27
 Identities = 46/214 (21%), Positives = 82/214 (38%), Gaps = 46/214 (21%)

Query: 351 GSVYKGNIHGEVYAIKMMKWNACE------------------------ELKILQKVNHGN 386
             +       + YA+K  + +  E                        EL+I+  + +  
Sbjct: 45  NKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY 104

Query: 387 LVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRL------RIAIDVAN 440
            +  EG   + +    Y+IYEY+EN S+  +       + N+   +       I   V N
Sbjct: 105 CLTCEGIITNYD--EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLN 162

Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPE 500
              YIH      + H+D+K SNIL+D N R K+++FG ++   +       GT  ++ PE
Sbjct: 163 SFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPE 220

Query: 501 YLADGVVSTKM-------DVFSFGVVLLELISGK 527
                  S +        D++S G+ L  +    
Sbjct: 221 -----FFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  110 bits (276), Expect = 6e-27
 Identities = 42/196 (21%), Positives = 89/196 (45%), Gaps = 24/196 (12%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNACEELKILQK----------VNHGNLVKL--EGFCID 396
             V+           A+K+++ +   +     +          +NH  +V +   G    
Sbjct: 26  SEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 85

Query: 397 PEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHK 456
           P     Y++ EY++  +L   +H      +  K  + +  D    L + H++    ++H+
Sbjct: 86  PAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQN---GIIHR 140

Query: 457 DIKSSNILLDSNMRAKIANFGLAK---SGCNAITM--HIVGTQGYIAPEYLADGVVSTKM 511
           D+K +NI++ +    K+ +FG+A+      N++T    ++GT  Y++PE      V  + 
Sbjct: 141 DVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARS 200

Query: 512 DVFSFGVVLLELISGK 527
           DV+S G VL E+++G+
Sbjct: 201 DVYSLGCVLYEVLTGE 216

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  109 bits (275), Expect = 7e-27
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 35/198 (17%)

Query: 351 GSVYKG-NIH-GEVYAIKMM------KWNACE----ELKILQKVNHGNLVKLEGFCIDPE 398
              ++  +    EV+A K++      K +  E    E+ I + + H ++V   GF  D +
Sbjct: 29  AKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND 88

Query: 399 DANCYLIYEYIENGSLHSWLHENK--NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHK 456
               +++ E     SL       K   E    + R      +  G QY+H +   RV+H+
Sbjct: 89  --FVFVVLELCRRRSLLELHKRRKALTEP---EAR-YYLRQIVLGCQYLHRN---RVIHR 139

Query: 457 DIKSSNILLDSNMRAKIANFGLAKSGCNAITMH-------IVGTQGYIAPEYLADGVVST 509
           D+K  N+ L+ ++  KI +FGLA         +       + GT  YIAPE L+    S 
Sbjct: 140 DLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF 194

Query: 510 KMDVFSFGVVLLELISGK 527
           ++DV+S G ++  L+ GK
Sbjct: 195 EVDVWSIGCIMYTLLVGK 212

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  108 bits (273), Expect = 8e-27
 Identities = 54/196 (27%), Positives = 87/196 (44%), Gaps = 30/196 (15%)

Query: 351 GSVYKG-NIH-GEVYAIKMM------KWNACE----ELKILQKVNHGNLVKLEGFCIDPE 398
             VY+  +IH G   AIKM+      K    +    E+KI  ++ H ++++L  +  D  
Sbjct: 25  AGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN 84

Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
               YL+ E   NG ++ +L          + R      +  G+ Y+H H    ++H+D+
Sbjct: 85  --YVYLVLEMCHNGEMNRYLKNRVKPFSENEAR-HFMHQIITGMLYLHSH---GILHRDL 138

Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAITMH-------IVGTQGYIAPEYLADGVVSTKM 511
             SN+LL  NM  KIA+FGLA                 + GT  YI+PE         + 
Sbjct: 139 TLSNLLLTRNMNIKIADFGLA-----TQLKMPHEKHYTLCGTPNYISPEIATRSAHGLES 193

Query: 512 DVFSFGVVLLELISGK 527
           DV+S G +   L+ G+
Sbjct: 194 DVWSLGCMFYTLLIGR 209

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  112 bits (281), Expect = 8e-27
 Identities = 47/210 (22%), Positives = 90/210 (42%), Gaps = 42/210 (20%)

Query: 353 VYKGNIHGEVYAIKMMKWNACE----ELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYE 407
           V++G+  G   A+K M  + C+    E+K+L +  +H N+++             Y+  E
Sbjct: 32  VFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDR--FLYIALE 89

Query: 408 YIENGSLHSWLHENKNENLNWKTR-----LRIAIDVANGLQYIHEHTRPRVVHKDIKSSN 462
                +L   +      + N K +     + +   +A+G+ ++H     +++H+D+K  N
Sbjct: 90  LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQN 145

Query: 463 ILLDS-------------NMRAKIANFGLAK------SGCNAITMHIVGTQGYIAPEYLA 503
           IL+ +             N+R  I++FGL K      S       +  GT G+ APE L 
Sbjct: 146 ILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLE 205

Query: 504 DGVV-------STKMDVFSFGVVLLELISG 526
           +          +  +D+FS G V   ++S 
Sbjct: 206 ESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  109 bits (274), Expect = 9e-27
 Identities = 48/197 (24%), Positives = 91/197 (46%), Gaps = 30/197 (15%)

Query: 351 GSVYKG-NIH-GEVYAIKMMKWNACE-------ELKILQKVNHGNLVKLEGFCIDPEDAN 401
           G VY G ++      AIK +             E+ + + + H N+V+  G   +     
Sbjct: 36  GIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIK 95

Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLR-IAIDVANGLQYIHEHTRPRVVHKDIKS 460
            ++  E +  GSL + L        + +  +      +  GL+Y+H++   ++VH+DIK 
Sbjct: 96  IFM--EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKG 150

Query: 461 SNILLDS-NMRAKIANFGLAK--SGCNAITMHIVGTQGYIAPEYLADGVV-------STK 510
            N+L+++ +   KI++FG +K  +G N  T    GT  Y+APE     ++          
Sbjct: 151 DNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPE-----IIDKGPRGYGKA 205

Query: 511 MDVFSFGVVLLELISGK 527
            D++S G  ++E+ +GK
Sbjct: 206 ADIWSLGCTIIEMATGK 222

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  110 bits (277), Expect = 1e-26
 Identities = 51/188 (27%), Positives = 94/188 (50%), Gaps = 18/188 (9%)

Query: 351 GSVYKGNIH---GEVYAIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCIDPED 399
           G V+K   H   G V A K++              EL++L + N   +V   G      D
Sbjct: 47  GVVFKV-SHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--D 103

Query: 400 ANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIK 459
               +  E+++ GSL   L +     +  +   +++I V  GL Y+ E  + +++H+D+K
Sbjct: 104 GEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVK 159

Query: 460 SSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVV 519
            SNIL++S    K+ +FG++    +++    VGT+ Y++PE L     S + D++S G+ 
Sbjct: 160 PSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLS 219

Query: 520 LLELISGK 527
           L+E+  G+
Sbjct: 220 LVEMAVGR 227

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  110 bits (276), Expect = 1e-26
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 35/198 (17%)

Query: 351 GSVYKG-NIH-GEVYAIKMM------KWNACE----ELKILQKVNHGNLVKLEGFCIDPE 398
              ++  +    EV+A K++      K +  E    E+ I + + H ++V   GF  D +
Sbjct: 55  AKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND 114

Query: 399 DANCYLIYEYIENGSLHSWLHENK--NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHK 456
               +++ E     SL       K   E    + R      +  G QY+H +   RV+H+
Sbjct: 115 --FVFVVLELCRRRSLLELHKRRKALTE---PEAR-YYLRQIVLGCQYLHRN---RVIHR 165

Query: 457 DIKSSNILLDSNMRAKIANFGLAKSGCNAITMH-------IVGTQGYIAPEYLADGVVST 509
           D+K  N+ L+ ++  KI +FGLA         +       + GT  YIAPE L+    S 
Sbjct: 166 DLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF 220

Query: 510 KMDVFSFGVVLLELISGK 527
           ++DV+S G ++  L+ GK
Sbjct: 221 EVDVWSIGCIMYTLLVGK 238

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  108 bits (273), Expect = 1e-26
 Identities = 45/189 (23%), Positives = 88/189 (46%), Gaps = 19/189 (10%)

Query: 351 GSVY--KGNIHGEVYAIKMM------KWNACE----ELKILQKVNHGNLVKLEGFCIDPE 398
           G+VY  +   +  + A+K++      K         E++I   + H N++++  +  D +
Sbjct: 28  GNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK 87

Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
               YL+ E+   G L+  L ++   +   ++      ++A+ L Y HE    +V+H+DI
Sbjct: 88  --RIYLMLEFAPRGELYKELQKHGRFD-EQRSA-TFMEELADALHYCHER---KVIHRDI 140

Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGV 518
           K  N+L+      KIA+FG +    +     + GT  Y+ PE +       K+D++  GV
Sbjct: 141 KPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGV 200

Query: 519 VLLELISGK 527
           +  E + G 
Sbjct: 201 LCYEFLVGM 209

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  108 bits (271), Expect = 7e-26
 Identities = 45/247 (18%), Positives = 92/247 (37%), Gaps = 44/247 (17%)

Query: 307 GRDLKDMEVNFMADVSDCLDKYRIFKIEELREATDNFSEGCLIQGSVYKGNIH---GEVY 363
              ++++    M+        Y +  +  + +  ++         +V     +   GE  
Sbjct: 6   HHHMENLYFQGMSSFLPEGGCYEL--LTVIGKGFEDL-------MTVNLA-RYKPTGEYV 55

Query: 364 AIKMMKWNACE---------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL 414
            ++ +   AC          EL + +  NH N+V      I   D   +++  ++  GS 
Sbjct: 56  TVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFI--ADNELWVVTSFMAYGSA 113

Query: 415 HSWLHENKNENLNWKTRLRIAI---DVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRA 471
              +  +  + +N    L IA     V   L YIH       VH+ +K+S+IL+  + + 
Sbjct: 114 KDLICTHFMDGMN---ELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKV 167

Query: 472 KIANFG----LAKSGCNAITMHI-----VGTQGYIAPEYLADGVV--STKMDVFSFGVVL 520
            ++       +   G     +H      V    +++PE L   +     K D++S G+  
Sbjct: 168 YLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITA 227

Query: 521 LELISGK 527
            EL +G 
Sbjct: 228 CELANGH 234

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  109 bits (273), Expect = 3e-25
 Identities = 40/193 (20%), Positives = 77/193 (39%), Gaps = 29/193 (15%)

Query: 351 GSVYKG---NIHGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPED 399
           G +Y     N++G    +K +  +        A  E + L +V H ++V++  F    + 
Sbjct: 94  GWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDR 153

Query: 400 ANC---YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHK 456
                 Y++ EY+   SL     +     L     +   +++   L Y+H      +V+ 
Sbjct: 154 HGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSYLHSI---GLVYN 206

Query: 457 DIKSSNILLDSNMRAKIANFGLAKSGCNAITM--HIVGTQGYIAPEYLADGVVSTKMDVF 514
           D+K  NI+L    + K+ + G        I    ++ GT G+ APE +     +   D++
Sbjct: 207 DLKPENIMLTEE-QLKLIDLGAVS----RINSFGYLYGTPGFQAPE-IVRTGPTVATDIY 260

Query: 515 SFGVVLLELISGK 527
           + G  L  L    
Sbjct: 261 TVGRTLAALTLDL 273

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  105 bits (264), Expect = 4e-25
 Identities = 37/258 (14%), Positives = 87/258 (33%), Gaps = 44/258 (17%)

Query: 329 RIFKIEELREATDNFSEGCLI-QGS---VYKG-------NIHGEVYAIKMMK----WNA- 372
            I    E +  +       L+ +G+   VY+          + + + +K+ K    W   
Sbjct: 53  AIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFY 112

Query: 373 --CEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNEN---LN 427
              + ++ L+       +K     +        L+ E    G+L + ++  KN     + 
Sbjct: 113 IGTQLMERLKPSMQHMFMKFYSAHLFQN--GSVLVGELYSYGTLLNAINLYKNTPEKVMP 170

Query: 428 WKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL-----------DSNMRAKIANF 476
               +  A+ +   ++ +H+     ++H DIK  N +L           D +    + + 
Sbjct: 171 QGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDL 227

Query: 477 GLAK----SGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK--EAI 530
           G +          I      T G+   E L++   + ++D F     +  ++ G   +  
Sbjct: 228 GQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287

Query: 531 DEEGKFC-GQKLKGYWRE 547
           +E G+       +     
Sbjct: 288 NEGGECKPEGLFRRLPHL 305

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  103 bits (260), Expect = 8e-25
 Identities = 40/192 (20%), Positives = 78/192 (40%), Gaps = 22/192 (11%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNACE----------ELKILQKVNHGNLVKLEGFCIDPE 398
           G VY+    +   + A+K+M                E +   ++   ++V +        
Sbjct: 48  GDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI--HDFGEI 105

Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
           D   Y+    I    L + L       L     + I   + + L   H        H+D+
Sbjct: 106 DGQLYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDV 160

Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNA-ITM--HIVGTQGYIAPEYLADGVVSTKMDVFS 515
           K  NIL+ ++  A + +FG+A +  +  +T   + VGT  Y+APE  ++   + + D+++
Sbjct: 161 KPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYA 220

Query: 516 FGVVLLELISGK 527
              VL E ++G 
Sbjct: 221 LTCVLYECLTGS 232

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  105 bits (263), Expect = 1e-24
 Identities = 52/201 (25%), Positives = 91/201 (45%), Gaps = 34/201 (16%)

Query: 351 GSVYKGNIH---GEVYAIKMMKWNACE---------------ELKILQKVNHGNLVKLEG 392
           G V          +  AI+++                     E++IL+K+NH  ++K++ 
Sbjct: 149 GEVKLA-FERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKN 207

Query: 393 FCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPR 452
           F    +  + Y++ E +E G L   +  NK   L   T       +   +QY+HE+    
Sbjct: 208 FF---DAEDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHEN---G 259

Query: 453 VVHKDIKSSNILLDS---NMRAKIANFGLAKS-GCNAITMHIVGTQGYIAPEYLADGVV- 507
           ++H+D+K  N+LL S   +   KI +FG +K  G  ++   + GT  Y+APE L      
Sbjct: 260 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTA 319

Query: 508 --STKMDVFSFGVVLLELISG 526
             +  +D +S GV+L   +SG
Sbjct: 320 GYNRAVDCWSLGVILFICLSG 340

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  103 bits (258), Expect = 4e-24
 Identities = 22/168 (13%), Positives = 60/168 (35%), Gaps = 20/168 (11%)

Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYE--YIENGSLHSWLHE--NKNENLNWKT 430
              +++      ++++     D    + + +Y        +    L    + +++L    
Sbjct: 148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHA 207

Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
           RL++ + V   L  +H +    +VH  ++  +I+LD      +  F         +    
Sbjct: 208 RLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVS-- 262

Query: 491 VGTQGYIAPEYLAD-----------GVVSTKMDVFSFGVVLLELISGK 527
             ++G+  PE  A             +++   D ++ G+V+  +    
Sbjct: 263 SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  101 bits (254), Expect = 4e-24
 Identities = 54/195 (27%), Positives = 92/195 (47%), Gaps = 32/195 (16%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCIDPEDA 400
           G V+KG  N   +V AIK++     E        E+ +L + +   + K  G  +  +D 
Sbjct: 36  GEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL--KDT 93

Query: 401 NCYLIYEYIENGSLHSWLHENK-NENLNWKTRLRIAI---DVANGLQYIHEHTRPRVVHK 456
             ++I EY+  GS    L     +E         IA    ++  GL Y+H     + +H+
Sbjct: 94  KLWIIMEYLGGGSALDLLEPGPLDETQ-------IATILREILKGLDYLHSE---KKIHR 143

Query: 457 DIKSSNILLDSNMRAKIANFGLAKSGCNAITMH----IVGTQGYIAPEYLADGVVSTKMD 512
           DIK++N+LL  +   K+A+FG+  +G    T       VGT  ++APE +      +K D
Sbjct: 144 DIKAANVLLSEHGEVKLADFGV--AGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKAD 201

Query: 513 VFSFGVVLLELISGK 527
           ++S G+  +EL  G+
Sbjct: 202 IWSLGITAIELARGE 216

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  104 bits (261), Expect = 5e-24
 Identities = 64/218 (29%), Positives = 100/218 (45%), Gaps = 31/218 (14%)

Query: 351 GSVYKGNIH---GEVYAIKMMKWNACE---------ELKILQKVNHGNLVKLEGFCIDPE 398
           G V             AIK+++  +           E+ +L+ ++H N++KL  F  D  
Sbjct: 51  GEVLLC-RDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKR 109

Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
             N YL+ E  + G L   +        N      I   V +G+ Y+H+H    +VH+D+
Sbjct: 110 --NYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDL 162

Query: 459 KSSNILLDS---NMRAKIANFGLAKSGCNAITMH-IVGTQGYIAPEYLADGVVSTKMDVF 514
           K  N+LL+S   +   KI +FGL+    N   M   +GT  YIAPE L       K DV+
Sbjct: 163 KPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL-RKKYDEKCDVW 221

Query: 515 SFGVVLLELISGKEAIDEEGKFCGQKLKGYWREMKRGK 552
           S GV+L  L++G         F GQ  +   R++++GK
Sbjct: 222 SIGVILFILLAGYPP------FGGQTDQEILRKVEKGK 253

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 99.6 bits (249), Expect = 2e-23
 Identities = 51/208 (24%), Positives = 96/208 (46%), Gaps = 21/208 (10%)

Query: 325 LDKYRIFKIEELREATDNFSEGCLIQGSVYKGNIHGEVYAIKMMKWNACEELKILQKVNH 384
           L K ++ +                  G +       +VY          +E+ IL+K++H
Sbjct: 46  LSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVY----------QEIAILKKLDH 95

Query: 385 GNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQY 444
            N+VKL     DP + + Y+++E +  G +           L+         D+  G++Y
Sbjct: 96  PNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP---LSEDQARFYFQDLIKGIEY 152

Query: 445 IHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK--SGCNAITMHIVGTQGYIAPEYL 502
           +H     +++H+DIK SN+L+  +   KIA+FG++    G +A+  + VGT  ++APE L
Sbjct: 153 LHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESL 209

Query: 503 AD---GVVSTKMDVFSFGVVLLELISGK 527
           ++         +DV++ GV L   + G+
Sbjct: 210 SETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  101 bits (252), Expect = 3e-23
 Identities = 23/168 (13%), Positives = 63/168 (37%), Gaps = 21/168 (12%)

Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE--NGSLHSWLHENKNEN--LNWKT 430
              +++      ++++     D    + + +Y  ++    +    L  + + +  L    
Sbjct: 153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHA 212

Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAITMH 489
           RL++ + V   L  +H +    +VH  ++  +I+LD      +  F      G +A++  
Sbjct: 213 RLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSP- 268

Query: 490 IVGTQGYIAPEYLA----------DGVVSTKMDVFSFGVVLLELISGK 527
               +G+  PE  A            +++   D ++ G+ +  +    
Sbjct: 269 --IGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  100 bits (251), Expect = 3e-23
 Identities = 51/214 (23%), Positives = 94/214 (43%), Gaps = 29/214 (13%)

Query: 326 DKYRIFKIEELREATDNFSEGCLIQGSVYKGNIH---GEVYAIKMMKWNACE-------E 375
             Y + K E L              G V+K       G   A K++K    +       E
Sbjct: 87  SFYTVSKTEILGGGR---------FGQVHKC-EETATGLKLAAKIIKTRGMKDKEEVKNE 136

Query: 376 LKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIA 435
           + ++ +++H NL++L          +  L+ EY++ G L   + + ++ NL     +   
Sbjct: 137 ISVMNQLDHANLIQLYDAFESKN--DIVLVMEYVDGGELFDRIID-ESYNLTELDTILFM 193

Query: 436 IDVANGLQYIHEHTRPRVVHKDIKSSNILLDS--NMRAKIANFGLAKSGCNAITMH-IVG 492
             +  G++++H+     ++H D+K  NIL  +    + KI +FGLA+       +    G
Sbjct: 194 KQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFG 250

Query: 493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           T  ++APE +    VS   D++S GV+   L+SG
Sbjct: 251 TPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  100 bits (249), Expect = 4e-23
 Identities = 14/157 (8%), Positives = 36/157 (22%), Gaps = 12/157 (7%)

Query: 378 ILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHE-----NKNENLNWKTRL 432
            +   +     +L     D   AN  L+        L               +       
Sbjct: 139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALH 197

Query: 433 RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVG 492
            +   +      +       +VH      N+ +  + R  + +                 
Sbjct: 198 ILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWK-VGTRGPASSV 253

Query: 493 TQGYIAPEYLADG--VVSTKMDVFSFGVVLLELISGK 527
              Y   E+L       +  ++ +  G+ +  +    
Sbjct: 254 PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 97.7 bits (244), Expect = 7e-23
 Identities = 52/192 (27%), Positives = 85/192 (44%), Gaps = 22/192 (11%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCIDPEDA 400
           G V+       G    IK +  +  +        E+++L+ ++H N++K+     D    
Sbjct: 36  GDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH-- 93

Query: 401 NCYLIYEYIENGSLHSWLHE--NKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
           N Y++ E  E G L   +     + + L+      +   + N L Y H      VVHKD+
Sbjct: 94  NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDL 150

Query: 459 KSSNILLDS---NMRAKIANFGLAKSGCNAITMH-IVGTQGYIAPEYLADGVVSTKMDVF 514
           K  NIL      +   KI +FGLA+   +        GT  Y+APE      V+ K D++
Sbjct: 151 KPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF-KRDVTFKCDIW 209

Query: 515 SFGVVLLELISG 526
           S GVV+  L++G
Sbjct: 210 SAGVVMYFLLTG 221

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 98.0 bits (245), Expect = 7e-23
 Identities = 53/191 (27%), Positives = 89/191 (46%), Gaps = 25/191 (13%)

Query: 351 GSVYKGNIH---GEVYAIKMMKWNACE-------ELKILQKVNHGNLVKLEGFCIDPEDA 400
             V+        G+++A+K +K +          E+ +L+K+ H N+V LE         
Sbjct: 23  SEVFLV-KQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTT-- 79

Query: 401 NCYLIYEYIENGSLHSWLHENKN--ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
           + YL+ + +  G L   + E     E         +   V + ++Y+HE+    +VH+D+
Sbjct: 80  HYYLVMQLVSGGELFDRILERGVYTEK---DAS-LVIQQVLSAVKYLHEN---GIVHRDL 132

Query: 459 KSSNILLDS---NMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFS 515
           K  N+L  +   N +  I +FGL+K   N I     GT GY+APE LA    S  +D +S
Sbjct: 133 KPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWS 192

Query: 516 FGVVLLELISG 526
            GV+   L+ G
Sbjct: 193 IGVITYILLCG 203

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  100 bits (252), Expect = 8e-23
 Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 32/219 (14%)

Query: 351 GSVYKGNIH---GEVYAIKMMKWNACE----------ELKILQKVNHGNLVKLEGFCIDP 397
           G V         G+  A+K++     +          E+++L++++H N++KL  F  D 
Sbjct: 40  GEVILC-KDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDK 98

Query: 398 EDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKD 457
                YL+ E    G L   +   K    +     RI   V +G+ Y+H++   ++VH+D
Sbjct: 99  G--YFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKN---KIVHRD 151

Query: 458 IKSSNILLDS---NMRAKIANFGLAKSGCNAITMH-IVGTQGYIAPEYLADGVVSTKMDV 513
           +K  N+LL+S   +   +I +FGL+     +  M   +GT  YIAPE L  G    K DV
Sbjct: 152 LKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTYDEKCDV 210

Query: 514 FSFGVVLLELISGKEAIDEEGKFCGQKLKGYWREMKRGK 552
           +S GV+L  L+SG         F G       +++++GK
Sbjct: 211 WSTGVILYILLSGCPP------FNGANEYDILKKVEKGK 243

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  101 bits (252), Expect = 9e-23
 Identities = 52/257 (20%), Positives = 96/257 (37%), Gaps = 27/257 (10%)

Query: 287 KKKREREIDEQKQKLQFNKGGRDLKDMEVNFMADVSDCLDKYRIFKIEELREATDNFSEG 346
           ++KR R  D  +Q       G    + +            +    K + +    D++   
Sbjct: 106 ERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVL---DHYDIH 162

Query: 347 CLI----QGSVYKGNIH---GEVYAIKMMKWNACE-------ELKILQKVNHGNLVKLEG 392
             +     G V++       G  +A K +             E++ +  + H  LV L  
Sbjct: 163 EELGTGAFGVVHRV-TERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHD 221

Query: 393 FCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPR 452
              D       +IYE++  G L   + + ++  ++    +     V  GL ++HE+    
Sbjct: 222 AFEDDN--EMVMIYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHEN---N 275

Query: 453 VVHKDIKSSNILLDSNMRA--KIANFGLAKSGCNAITMH-IVGTQGYIAPEYLADGVVST 509
            VH D+K  NI+  +      K+ +FGL        ++    GT  + APE      V  
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGY 335

Query: 510 KMDVFSFGVVLLELISG 526
             D++S GV+   L+SG
Sbjct: 336 YTDMWSVGVLSYILLSG 352

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 97.7 bits (244), Expect = 9e-23
 Identities = 49/205 (23%), Positives = 95/205 (46%), Gaps = 39/205 (19%)

Query: 351 GSVYKGNIH---GEVYAIKM----------------MKWNACEELKILQKVN-HGNLVKL 390
             V +  IH    + YA+K+                ++    +E+ IL+KV+ H N+++L
Sbjct: 31  SVVRRC-IHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQL 89

Query: 391 EGFCIDPEDANCYLIYEYIENGSLHSWLHENKN--ENLNWKTRLRIAIDVANGLQYIHEH 448
           +           +L+++ ++ G L  +L E     E    +TR +I   +   +  +H+ 
Sbjct: 90  KDTYETNT--FFFLVFDLMKKGELFDYLTEKVTLSEK---ETR-KIMRALLEVICALHKL 143

Query: 449 TRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAITMHIVGTQGYIAPEYLADGVV 507
               +VH+D+K  NILLD +M  K+ +FG +           + GT  Y+APE +   + 
Sbjct: 144 ---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMN 200

Query: 508 ST------KMDVFSFGVVLLELISG 526
                   ++D++S GV++  L++G
Sbjct: 201 DNHPGYGKEVDMWSTGVIMYTLLAG 225

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 98.4 bits (246), Expect = 9e-23
 Identities = 53/196 (27%), Positives = 93/196 (47%), Gaps = 23/196 (11%)

Query: 351 GSVYKG---NIHGEVYAIKMMKWNACEE------------LKILQKVNHGNLVKLEGFCI 395
           G V+K       G   A+K ++    EE            L+ L+   H N+V+L   C 
Sbjct: 25  GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 84

Query: 396 DP---EDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPR 452
                 +    L++E+++   L ++L +     +  +T   +   +  GL ++H H   R
Sbjct: 85  VSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---R 140

Query: 453 VVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM-HIVGTQGYIAPEYLADGVVSTKM 511
           VVH+D+K  NIL+ S+ + K+A+FGLA+     + +  +V T  Y APE L     +T +
Sbjct: 141 VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPV 200

Query: 512 DVFSFGVVLLELISGK 527
           D++S G +  E+   K
Sbjct: 201 DLWSVGCIFAEMFRRK 216

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 98.4 bits (246), Expect = 9e-23
 Identities = 52/221 (23%), Positives = 99/221 (44%), Gaps = 34/221 (15%)

Query: 322 SDCLDKYRIFKIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWNACE----- 374
              ++KY    +  + E +          G V K      G + AIK    +  +     
Sbjct: 21  FQSMEKYE--NLGLVGEGS---------YGMVMKCRNKDTGRIVAIKKFLESDDDKMVKK 69

Query: 375 ----ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
               E+K+L+++ H NLV L    +  +    YL++E++++ ++   L E     L+++ 
Sbjct: 70  IAMREIKLLKQLRHENLVNL--LEVCKKKKRWYLVFEFVDH-TILDDL-ELFPNGLDYQV 125

Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK---SGCNAIT 487
             +    + NG+ + H H    ++H+DIK  NIL+  +   K+ +FG A+   +      
Sbjct: 126 VQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYD 182

Query: 488 MHIVGTQGYIAPEYL-ADGVVSTKMDVFSFGVVLLELISGK 527
              V T+ Y APE L  D      +DV++ G ++ E+  G+
Sbjct: 183 -DEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 98.1 bits (245), Expect = 1e-22
 Identities = 46/193 (23%), Positives = 84/193 (43%), Gaps = 23/193 (11%)

Query: 351 GSVYKGNIH---GEVYAIKMMKWNACE---------ELKILQKVNHG-NLVKLEGFCIDP 397
             V +  I    G+ YA K +K              E+ +L+       ++ L     + 
Sbjct: 43  AVVRQC-ISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101

Query: 398 EDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKD 457
                 LI EY   G + S       E ++    +R+   +  G+ Y+H++    +VH D
Sbjct: 102 S--EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLD 156

Query: 458 IKSSNILL---DSNMRAKIANFGLAKSGCNAITMH-IVGTQGYIAPEYLADGVVSTKMDV 513
           +K  NILL         KI +FG+++   +A  +  I+GT  Y+APE L    ++T  D+
Sbjct: 157 LKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDM 216

Query: 514 FSFGVVLLELISG 526
           ++ G++   L++ 
Sbjct: 217 WNIGIIAYMLLTH 229

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 98.0 bits (245), Expect = 1e-22
 Identities = 59/219 (26%), Positives = 110/219 (50%), Gaps = 31/219 (14%)

Query: 322 SDCLDKYRIFKIEELREATDNFSEGCLIQGSVYKG-NIHGEVYAIKMMKWNACE------ 374
              ++KY+  K+E++ E T          G VYK  +  G + A+K ++ +A +      
Sbjct: 17  QGLMEKYQ--KLEKVGEGT---------YGVVYKAKDSQGRIVALKRIRLDAEDEGIPST 65

Query: 375 ---ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTR 431
              E+ +L++++H N+V L    +   +    L++E++E   L   L +     L     
Sbjct: 66  AIREISLLKELHHPNIVSL--IDVIHSERCLTLVFEFMEK-DLKKVL-DENKTGLQDSQI 121

Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAITM-H 489
                 +  G+ + H+H   R++H+D+K  N+L++S+   K+A+FGLA++ G    +  H
Sbjct: 122 KIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH 178

Query: 490 IVGTQGYIAPEYL-ADGVVSTKMDVFSFGVVLLELISGK 527
            V T  Y AP+ L      ST +D++S G +  E+I+GK
Sbjct: 179 EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 97.4 bits (243), Expect = 1e-22
 Identities = 49/194 (25%), Positives = 89/194 (45%), Gaps = 31/194 (15%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNACE-------ELKILQKVNHGNLVKLEGFCIDPEDAN 401
           G+VY       G+  AI+ M             E+ ++++  + N+V      +      
Sbjct: 34  GTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL--VGDE 91

Query: 402 CYLIYEYIENGSLHSWLHENK-NENLNWKTRLRIAI---DVANGLQYIHEHTRPRVVHKD 457
            +++ EY+  GSL   + E   +E        +IA    +    L+++H +   +V+H+D
Sbjct: 92  LWVVMEYLAGGSLTDVVTETCMDEG-------QIAAVCRECLQALEFLHSN---QVIHRD 141

Query: 458 IKSSNILLDSNMRAKIANFGLAKSGCNAI----TMHIVGTQGYIAPEYLADGVVSTKMDV 513
           IKS NILL  +   K+ +FG             TM  VGT  ++APE +       K+D+
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGTPYWMAPEVVTRKAYGPKVDI 199

Query: 514 FSFGVVLLELISGK 527
           +S G++ +E+I G+
Sbjct: 200 WSLGIMAIEMIEGE 213

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 98.1 bits (245), Expect = 1e-22
 Identities = 46/188 (24%), Positives = 77/188 (40%), Gaps = 19/188 (10%)

Query: 351 GSVYKGNIH---GEVYAIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPEDAN 401
           G V++  +     + Y  K +K    +      E+ IL    H N++ L       E   
Sbjct: 19  GIVHRC-VETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESME--E 75

Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSS 461
             +I+E+I    +   ++      LN +  +     V   LQ++H H    + H DI+  
Sbjct: 76  LVMIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPE 131

Query: 462 NILLDS--NMRAKIANFGLAKSGCNAITMH-IVGTQGYIAPEYLADGVVSTKMDVFSFGV 518
           NI+  +  +   KI  FG A+          +     Y APE     VVST  D++S G 
Sbjct: 132 NIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGT 191

Query: 519 VLLELISG 526
           ++  L+SG
Sbjct: 192 LVYVLLSG 199

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 97.5 bits (243), Expect = 2e-22
 Identities = 46/221 (20%), Positives = 92/221 (41%), Gaps = 38/221 (17%)

Query: 351 GSVY--KGNIHGEVYAIKMMKWNACEELKILQK--------VNHGNLVKL-EGFCIDPED 399
             VY  +    G  YA+K +  N  E+ + + +          H N+V+      I  E+
Sbjct: 42  AFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101

Query: 400 ANC----YLIYEYIENGSLHSWLHENKNEN-LNWKTRLRIAIDVANGLQYIHEHTRPRVV 454
           ++     +L+   +  G L  +L + ++   L+  T L+I       +Q++H   +P ++
Sbjct: 102 SDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPII 160

Query: 455 HKDIKSSNILLDSNMRAKIANFGLAKSGCN----------------AITMHIVGTQGYIA 498
           H+D+K  N+LL +    K+ +FG A +  +                 IT +   T  Y  
Sbjct: 161 HRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN--TTPMYRT 218

Query: 499 PE---YLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGKF 536
           PE     ++  +  K D+++ G +L  L   +   ++  K 
Sbjct: 219 PEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 96.1 bits (240), Expect = 2e-22
 Identities = 60/192 (31%), Positives = 95/192 (49%), Gaps = 25/192 (13%)

Query: 351 GSVYKGNIH---GEVYAIKMMKWNACE---------ELKILQKVNHGNLVKLEGFCIDPE 398
           G V K        + YA+K++   + +         E+++L+K++H N++KL     D  
Sbjct: 36  GEVLKC-KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS 94

Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
             + Y++ E    G L   + + K    +     RI   V +G+ Y+H+H    +VH+D+
Sbjct: 95  --SFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKH---NIVHRDL 147

Query: 459 KSSNILLDS---NMRAKIANFGLAKSGCNAITMH-IVGTQGYIAPEYLADGVVSTKMDVF 514
           K  NILL+S   +   KI +FGL+        M   +GT  YIAPE L  G    K DV+
Sbjct: 148 KPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYDEKCDVW 206

Query: 515 SFGVVLLELISG 526
           S GV+L  L+SG
Sbjct: 207 SAGVILYILLSG 218

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 99.4 bits (248), Expect = 2e-22
 Identities = 64/218 (29%), Positives = 103/218 (47%), Gaps = 31/218 (14%)

Query: 351 GSVYKGNIH---GEVYAIKMMKWNACE---------ELKILQKVNHGNLVKLEGFCIDPE 398
           G V K        + YA+K++   + +         E+++L+K++H N++KL     D  
Sbjct: 36  GEVLKC-KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS 94

Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
             + Y++ E    G L   + + K    +     RI   V +G+ Y+H+H    +VH+D+
Sbjct: 95  --SFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKH---NIVHRDL 147

Query: 459 KSSNILLDS---NMRAKIANFGLAKSGCNAITMH-IVGTQGYIAPEYLADGVVSTKMDVF 514
           K  NILL+S   +   KI +FGL+        M   +GT  YIAPE L  G    K DV+
Sbjct: 148 KPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYDEKCDVW 206

Query: 515 SFGVVLLELISGKEAIDEEGKFCGQKLKGYWREMKRGK 552
           S GV+L  L+SG         F G+      + ++ GK
Sbjct: 207 SAGVILYILLSGTPP------FYGKNEYDILKRVETGK 238

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 97.9 bits (244), Expect = 3e-22
 Identities = 45/189 (23%), Positives = 81/189 (42%), Gaps = 20/189 (10%)

Query: 351 GSVYKGNIH---GEVYAIKMMKWNACE-------ELKILQKVNHGNLVKLEGFCIDPEDA 400
           G V++  +    G V+  K +             E+ I+ +++H  L+ L     D    
Sbjct: 65  GVVHRC-VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY-- 121

Query: 401 NCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
              LI E++  G L   +   ++  ++    +        GL+++HEH    +VH DIK 
Sbjct: 122 EMVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKP 177

Query: 461 SNILLDSNMRA--KIANFGLAKSGCNAITMH-IVGTQGYIAPEYLADGVVSTKMDVFSFG 517
            NI+ ++   +  KI +FGLA        +     T  + APE +    V    D+++ G
Sbjct: 178 ENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIG 237

Query: 518 VVLLELISG 526
           V+   L+SG
Sbjct: 238 VLGYVLLSG 246

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 96.5 bits (241), Expect = 3e-22
 Identities = 47/184 (25%), Positives = 85/184 (46%), Gaps = 25/184 (13%)

Query: 360 GEVYAIKMMKWNACEELK----------ILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI 409
              YAIK+++     +            ++ +++H   VKL     D E    Y    Y 
Sbjct: 55  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE--KLYFGLSYA 112

Query: 410 ENGSLHSWLHENK--NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS 467
           +NG L  ++ +    +E     TR   A ++ + L+Y+H      ++H+D+K  NILL+ 
Sbjct: 113 KNGELLKYIRKIGSFDETC---TRFYTA-EIVSALEYLHGKG---IIHRDLKPENILLNE 165

Query: 468 NMRAKIANFGLAK----SGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLEL 523
           +M  +I +FG AK        A     VGT  Y++PE L +       D+++ G ++ +L
Sbjct: 166 DMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 225

Query: 524 ISGK 527
           ++G 
Sbjct: 226 VAGL 229

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 98.2 bits (245), Expect = 3e-22
 Identities = 49/197 (24%), Positives = 89/197 (45%), Gaps = 30/197 (15%)

Query: 351 GSVYKGNIH--GEVYAIKMMKWNACE---ELKILQKVNHGNLVKLEGFCIDPEDANC--- 402
           G VY+  +   GE+ AIK +  +      EL+I++K++H N+V+L  F     +      
Sbjct: 68  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127

Query: 403 -YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAID--------VANGLQYIHEHTRPRV 453
             L+ +Y+   +++             + +  + +         +   L YIH      +
Sbjct: 128 LNLVLDYVPE-TVYRVARHY------SRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GI 177

Query: 454 VHKDIKSSNILLDSNMRA-KIANFGLAKSGCNAITM-HIVGTQGYIAPEYLADGVV-STK 510
            H+DIK  N+LLD +    K+ +FG AK           + ++ Y APE +      ++ 
Sbjct: 178 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSS 237

Query: 511 MDVFSFGVVLLELISGK 527
           +DV+S G VL EL+ G+
Sbjct: 238 IDVWSAGCVLAELLLGQ 254

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 98.6 bits (246), Expect = 4e-22
 Identities = 53/182 (29%), Positives = 90/182 (49%), Gaps = 18/182 (9%)

Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+ +L+ ++H N++KL     D +    YL+ E+ E G L   +        +      I
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKK--YFYLVTEFYEGGELFEQIINRH--KFDECDAANI 151

Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS---NMRAKIANFGLAKSGCNAITMH-I 490
              + +G+ Y+H+H    +VH+DIK  NILL++    +  KI +FGL+        +   
Sbjct: 152 MKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR 208

Query: 491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYWREMKR 550
           +GT  YIAPE L     + K DV+S GV++  L+ G         F GQ  +   +++++
Sbjct: 209 LGTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYPP------FGGQNDQDIIKKVEK 261

Query: 551 GK 552
           GK
Sbjct: 262 GK 263

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 96.1 bits (240), Expect = 4e-22
 Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 25/198 (12%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNACEE---------------LKILQKVNHGNLVKLEGF 393
           G+VYK      G   A+K ++                     L+ L+   H N+V+L   
Sbjct: 23  GTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDV 82

Query: 394 CIDPE---DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTR 450
           C       +    L++E+++   L ++L +     L  +T   +      GL ++H +  
Sbjct: 83  CATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN-- 139

Query: 451 PRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM-HIVGTQGYIAPEYLADGVVST 509
             +VH+D+K  NIL+ S    K+A+FGLA+     + +  +V T  Y APE L     +T
Sbjct: 140 -CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYAT 198

Query: 510 KMDVFSFGVVLLELISGK 527
            +D++S G +  E+   K
Sbjct: 199 PVDMWSVGCIFAEMFRRK 216

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 95.3 bits (238), Expect = 4e-22
 Identities = 51/197 (25%), Positives = 84/197 (42%), Gaps = 29/197 (14%)

Query: 351 GSVYKGNIH---GEVYAIKMMKWNACE-------------ELKILQKVNHGNLVKLEGFC 394
             V K       G+ YA K +K                  E+ IL+++ H N++ L    
Sbjct: 19  AIVRKC-RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIF 77

Query: 395 IDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVV 454
            +    +  LI E +  G L  +L E   E+L      +    + +G+ Y+H     R+ 
Sbjct: 78  ENKT--DVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSK---RIA 130

Query: 455 HKDIKSSNILLDS----NMRAKIANFGLAKSGCNAITMH-IVGTQGYIAPEYLADGVVST 509
           H D+K  NI+L      N R K+ +FG+A           I GT  ++APE +    +  
Sbjct: 131 HFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGL 190

Query: 510 KMDVFSFGVVLLELISG 526
           + D++S GV+   L+SG
Sbjct: 191 EADMWSIGVITYILLSG 207

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 95.7 bits (239), Expect = 5e-22
 Identities = 51/217 (23%), Positives = 95/217 (43%), Gaps = 32/217 (14%)

Query: 325 LDKYRIFKIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWNACE-------- 374
           ++KY   KI ++ E +          G V+K      G++ AIK    +  +        
Sbjct: 2   MEKYE--KIGKIGEGS---------YGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL 50

Query: 375 -ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
            E+++L+++ H NLV L    +       +L++EY ++ ++   L +     +       
Sbjct: 51  REIRMLKQLKHPNLVNL--LEVFRRKRRLHLVFEYCDH-TVLHEL-DRYQRGVPEHLVKS 106

Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAITM-HIV 491
           I       + + H+H     +H+D+K  NIL+  +   K+ +FG A+     +      V
Sbjct: 107 ITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV 163

Query: 492 GTQGYIAPEYL-ADGVVSTKMDVFSFGVVLLELISGK 527
            T+ Y +PE L  D      +DV++ G V  EL+SG 
Sbjct: 164 ATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 95.9 bits (239), Expect = 6e-22
 Identities = 46/202 (22%), Positives = 91/202 (45%), Gaps = 36/202 (17%)

Query: 351 GSVYKGNIH---GEVYAIKMMKWNACE--------ELKILQK-VNHGNLVKLEGFCIDPE 398
           GSV K  +H   G++ A+K ++    E        +L ++ +  +   +V+  G      
Sbjct: 36  GSVNKM-VHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR-- 92

Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRL------RIAIDVANGLQYIHEHTRPR 452
           + +C++  E + + S   +     +        +      +I +     L ++ E+ +  
Sbjct: 93  EGDCWICMELM-STSFDKFYKYVYSVL---DDVIPEEILGKITLATVKALNHLKENLK-- 146

Query: 453 VVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM---HIVGTQGYIAPEYLADGVV-- 507
           ++H+DIK SNILLD +   K+ +FG+  SG    ++      G + Y+APE +       
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGI--SGQLVDSIAKTRDAGCRPYMAPERIDPSASRQ 204

Query: 508 --STKMDVFSFGVVLLELISGK 527
               + DV+S G+ L EL +G+
Sbjct: 205 GYDVRSDVWSLGITLYELATGR 226

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 97.0 bits (242), Expect = 6e-22
 Identities = 50/197 (25%), Positives = 84/197 (42%), Gaps = 31/197 (15%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNACE---ELKILQKVNHGNLVKLEGFCIDPEDANC--- 402
           G V++       EV AIK +  +      EL+I++ V H N+V L+ F     D      
Sbjct: 54  GVVFQAKLVESDEV-AIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112

Query: 403 -YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAID--------VANGLQYIHEHTRPRV 453
             L+ EY+   +++             K +  + +         +   L YIH      +
Sbjct: 113 LNLVLEYVPE-TVYRASRHY------AKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GI 162

Query: 454 VHKDIKSSNILLDSNMRA-KIANFGLAKSGCNAITM-HIVGTQGYIAPEYLADGVV-STK 510
            H+DIK  N+LLD      K+ +FG AK           + ++ Y APE +      +T 
Sbjct: 163 CHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTN 222

Query: 511 MDVFSFGVVLLELISGK 527
           +D++S G V+ EL+ G+
Sbjct: 223 IDIWSTGCVMAELMQGQ 239

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 95.3 bits (238), Expect = 6e-22
 Identities = 60/216 (27%), Positives = 106/216 (49%), Gaps = 31/216 (14%)

Query: 325 LDKYRIFKIEELREATDNFSEGCLIQGSVYKG-NIHGEVYAIKMMKWNACE--------- 374
           ++KY    +E++ E T          G VYK  N +GE +A+K ++    +         
Sbjct: 1   MEKYH--GLEKIGEGT---------YGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR 49

Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+ IL+++ H N+VKL  + +        L++E+++   L   L +     L   T    
Sbjct: 50  EISILKELKHSNIVKL--YDVIHTKKRLVLVFEHLDQ-DLKKLL-DVCEGGLESVTAKSF 105

Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAITM-HIVG 492
            + + NG+ Y H+    RV+H+D+K  N+L++     KIA+FGLA++ G       H + 
Sbjct: 106 LLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV 162

Query: 493 TQGYIAPEYL-ADGVVSTKMDVFSFGVVLLELISGK 527
           T  Y AP+ L      ST +D++S G +  E+++G 
Sbjct: 163 TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 95.5 bits (238), Expect = 6e-22
 Identities = 51/207 (24%), Positives = 87/207 (42%), Gaps = 41/207 (19%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNACE--------ELKILQKVNHGNLVKLEG-FCIDPED 399
             V         E  AIK +    C+        E++ + + +H N+V     F      
Sbjct: 29  AVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFV---VK 85

Query: 400 ANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR---IAI---DVANGLQYIHEHTRPRV 453
              +L+ + +  GS+   +     +  +    L    IA    +V  GL+Y+H++     
Sbjct: 86  DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQ 142

Query: 454 VHKDIKSSNILLDSNMRAKIANFG----LAKSGCNAITMH---IVGTQGYIAPEYLADGV 506
           +H+D+K+ NILL  +   +IA+FG    LA  G           VGT  ++APE     V
Sbjct: 143 IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE-----V 197

Query: 507 VS------TKMDVFSFGVVLLELISGK 527
           +        K D++SFG+  +EL +G 
Sbjct: 198 MEQVRGYDFKADIWSFGITAIELATGA 224

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 95.4 bits (238), Expect = 8e-22
 Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 34/201 (16%)

Query: 351 GSVYKGNIH---GEVYAIKMMKWNACE---------------ELKILQKVNHGNLVKLEG 392
           G V          +  AIK++                     E++IL+K+NH  ++K++ 
Sbjct: 24  GEVKLA-FERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKN 82

Query: 393 FCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPR 452
           F    +  + Y++ E +E G L   +  NK   L   T       +   +QY+HE+    
Sbjct: 83  FF---DAEDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHEN---G 134

Query: 453 VVHKDIKSSNILLDS---NMRAKIANFGLAKS-GCNAITMHIVGTQGYIAPEYLADGVV- 507
           ++H+D+K  N+LL S   +   KI +FG +K  G  ++   + GT  Y+APE L      
Sbjct: 135 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTA 194

Query: 508 --STKMDVFSFGVVLLELISG 526
             +  +D +S GV+L   +SG
Sbjct: 195 GYNRAVDCWSLGVILFICLSG 215

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 96.1 bits (240), Expect = 8e-22
 Identities = 58/232 (25%), Positives = 98/232 (42%), Gaps = 46/232 (19%)

Query: 323 DCLDKYRIFKIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWN--------- 371
           D + KY   K+ ++ + T          G V+K      G+  A+K +            
Sbjct: 14  DEVSKYE--KLAKIGQGT---------FGEVFKARHRKTGQKVALKKVLMENEKEGFPIT 62

Query: 372 ACEELKILQKVNHGNLVKLEGFCIDPEDANC------YLIYEYIENGSLH--SWLHENKN 423
           A  E+KILQ + H N+V L   C              YL++++ E    H  + L  N  
Sbjct: 63  ALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE----HDLAGLLSNVL 118

Query: 424 ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLA---- 479
                    R+   + NGL YIH +   +++H+D+K++N+L+  +   K+A+FGLA    
Sbjct: 119 VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFS 175

Query: 480 ---KSGCNAITMHIVGTQGYIAPEYLADGVV-STKMDVFSFGVVLLELISGK 527
               S  N  T + V T  Y  PE L         +D++  G ++ E+ +  
Sbjct: 176 LAKNSQPNRYT-NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 94.6 bits (236), Expect = 8e-22
 Identities = 47/189 (24%), Positives = 80/189 (42%), Gaps = 21/189 (11%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNACE-------ELKILQKVNHGNLVKLEGFCIDPEDAN 401
           G V            A K +     E       E++I++ ++H N+++L     D    +
Sbjct: 23  GEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNT--D 80

Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSS 461
            YL+ E    G L   +   +          RI  DV + + Y H+     V H+D+K  
Sbjct: 81  IYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPE 135

Query: 462 NILLDS---NMRAKIANFGLAKSGCNAITMH-IVGTQGYIAPEYLADGVVSTKMDVFSFG 517
           N L  +   +   K+ +FGLA        M   VGT  Y++P+ L +G+   + D +S G
Sbjct: 136 NFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL-EGLYGPECDEWSAG 194

Query: 518 VVLLELISG 526
           V++  L+ G
Sbjct: 195 VMMYVLLCG 203

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 95.1 bits (237), Expect = 1e-21
 Identities = 50/195 (25%), Positives = 100/195 (51%), Gaps = 33/195 (16%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNACE-------ELKILQKVNHGNLVKLEG-FCIDPEDA 400
           G V        G   A+KMM     +       E+ I++   H N+V++   + +  E  
Sbjct: 59  GIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEE-- 116

Query: 401 NCYLIYEYIENGSLHSWLHENK-NENLNWKTRLRIAI---DVANGLQYIHEHTRPRVVHK 456
             +++ E+++ G+L   + + + NE        +IA     V   L Y+H      V+H+
Sbjct: 117 -LWVLMEFLQGGALTDIVSQVRLNEE-------QIATVCEAVLQALAYLHAQ---GVIHR 165

Query: 457 DIKSSNILLDSNMRAKIANFG----LAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMD 512
           DIKS +ILL  + R K+++FG    ++K      ++  VGT  ++APE ++  + +T++D
Sbjct: 166 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL--VGTPYWMAPEVISRSLYATEVD 223

Query: 513 VFSFGVVLLELISGK 527
           ++S G++++E++ G+
Sbjct: 224 IWSLGIMVIEMVDGE 238

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 95.2 bits (237), Expect = 2e-21
 Identities = 50/204 (24%), Positives = 93/204 (45%), Gaps = 38/204 (18%)

Query: 351 GSVYKGNIH---GEVYAIKMMKWNACE---------------ELKILQKV-NHGNLVKLE 391
             V +  +H   G  +A+K+M+  A                 E  IL++V  H +++ L 
Sbjct: 108 SVVRRC-VHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166

Query: 392 GFCIDPEDANCYLIYEYIENGSLHSWLHENKN--ENLNWKTRLRIAIDVANGLQYIHEHT 449
                      +L+++ +  G L  +L E     E    +TR  I   +   + ++H + 
Sbjct: 167 DSYESSS--FMFLVFDLMRKGELFDYLTEKVALSEK---ETR-SIMRSLLEAVSFLHAN- 219

Query: 450 RPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAITMHIVGTQGYIAPEYLADGVV- 507
              +VH+D+K  NILLD NM+ ++++FG +           + GT GY+APE L   +  
Sbjct: 220 --NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDE 277

Query: 508 -----STKMDVFSFGVVLLELISG 526
                  ++D+++ GV+L  L++G
Sbjct: 278 THPGYGKEVDLWACGVILFTLLAG 301

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 94.4 bits (235), Expect = 2e-21
 Identities = 55/191 (28%), Positives = 98/191 (51%), Gaps = 25/191 (13%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNA-----CEELKILQKVNHGNLVKLEGFCIDPEDANCY 403
           GSVYK      G++ AIK +   +      +E+ I+Q+ +  ++VK  G     ++ + +
Sbjct: 43  GSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYF--KNTDLW 100

Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAI---DVANGLQYIHEHTRPRVVHKDIKS 460
           ++ EY   GS+   +   +N+ L   T   IA        GL+Y+H     R +H+DIK+
Sbjct: 101 IVMEYCGAGSVSD-IIRLRNKTL---TEDEIATILQSTLKGLEYLHFM---RKIHRDIKA 153

Query: 461 SNILLDSNMRAKIANFG----LAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSF 516
            NILL++   AK+A+FG    L  +     T+  +GT  ++APE + +   +   D++S 
Sbjct: 154 GNILLNTEGHAKLADFGVAGQLTDTMAKRNTV--IGTPFWMAPEVIQEIGYNCVADIWSL 211

Query: 517 GVVLLELISGK 527
           G+  +E+  GK
Sbjct: 212 GITAIEMAEGK 222

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 95.5 bits (238), Expect = 2e-21
 Identities = 49/184 (26%), Positives = 83/184 (45%), Gaps = 25/184 (13%)

Query: 360 GEVYAIKMMKWNAC----------EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI 409
            ++YA+K M    C          +EL+I+Q + H  LV L     D E  + +++ + +
Sbjct: 40  KKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE--DMFMVVDLL 97

Query: 410 ENGSLHSWLHENK--NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS 467
             G L   L +N    E      +L I  ++   L Y+      R++H+D+K  NILLD 
Sbjct: 98  LGGDLRYHLQQNVHFKEE---TVKLFIC-ELVMALDYLQNQ---RIIHRDMKPDNILLDE 150

Query: 468 NMRAKIANFGLAKSGC-NAITMHIVGTQGYIAPEYLADGVVS--TKM-DVFSFGVVLLEL 523
           +    I +F +A           + GT+ Y+APE  +    +  +   D +S GV   EL
Sbjct: 151 HGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYEL 210

Query: 524 ISGK 527
           + G+
Sbjct: 211 LRGR 214

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 93.7 bits (234), Expect = 2e-21
 Identities = 56/229 (24%), Positives = 105/229 (45%), Gaps = 37/229 (16%)

Query: 325 LDKYRIFKIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWNACE-------- 374
           + KY   K+E++ E T          G+V+K       E+ A+K ++ +  +        
Sbjct: 1   MQKYE--KLEKIGEGT---------YGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL 49

Query: 375 -ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
            E+ +L+++ H N+V+L    +   D    L++E+ +   L  +  ++ N +L+ +    
Sbjct: 50  REICLLKELKHKNIVRL--HDVLHSDKKLTLVFEFCDQ-DLKKYF-DSCNGDLDPEIVKS 105

Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAITM-HIV 491
               +  GL + H      V+H+D+K  N+L++ N   K+ANFGLA++ G         V
Sbjct: 106 FLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEV 162

Query: 492 GTQGYIAPEYLADGVV-STKMDVFSFGVVLLELISGKEAIDEEGKFCGQ 539
            T  Y  P+ L    + ST +D++S G +  EL +    +     F G 
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL-----FPGN 206

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 95.1 bits (237), Expect = 2e-21
 Identities = 49/197 (24%), Positives = 84/197 (42%), Gaps = 29/197 (14%)

Query: 351 GSVYKGNIH---GEVYAIKMMKWNACE-------------ELKILQKVNHGNLVKLEGFC 394
             V K       G  YA K +K                  E+ IL++V H N++ L    
Sbjct: 26  AIVKKC-REKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY 84

Query: 395 IDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVV 454
            +    +  LI E +  G L  +L +   E+L+ +        + +G+ Y+H     ++ 
Sbjct: 85  ENRT--DVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTK---KIA 137

Query: 455 HKDIKSSNILLDS----NMRAKIANFGLAKSGCNAITMH-IVGTQGYIAPEYLADGVVST 509
           H D+K  NI+L          K+ +FGLA    + +    I GT  ++APE +    +  
Sbjct: 138 HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGL 197

Query: 510 KMDVFSFGVVLLELISG 526
           + D++S GV+   L+SG
Sbjct: 198 EADMWSIGVITYILLSG 214

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 94.7 bits (236), Expect = 2e-21
 Identities = 48/192 (25%), Positives = 85/192 (44%), Gaps = 27/192 (14%)

Query: 351 GSVYKGNIH---GEVYAIKMM---KWNACEELKILQK-VNHGNLVKLEGFCIDPEDANC- 402
               +  IH      +A+K++   K +  EE++IL +   H N++ L+      +D    
Sbjct: 36  SVCKRC-IHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVY---DDGKYV 91

Query: 403 YLIYEYIENGSLHSWLHENKN--ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
           Y++ E ++ G L   +   K   E    +    +   +   ++Y+H      VVH+D+K 
Sbjct: 92  YVVTELMKGGELLDKILRQKFFSER---EAS-AVLFTITKTVEYLHAQ---GVVHRDLKP 144

Query: 461 SNILLDSN----MRAKIANFGLAK--SGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVF 514
           SNIL           +I +FG AK     N + M    T  ++APE L         D++
Sbjct: 145 SNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIW 204

Query: 515 SFGVVLLELISG 526
           S GV+L  +++G
Sbjct: 205 SLGVLLYTMLTG 216

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 97.3 bits (242), Expect = 2e-21
 Identities = 52/182 (28%), Positives = 84/182 (46%), Gaps = 21/182 (11%)

Query: 360 GEVYAIKMMK----------WNACEELKILQKVNHGN---LVKLEGFCIDPEDANCYLIY 406
           G++YA+K +             A  E  +L  V+ G+   +V +  +     D     I 
Sbjct: 214 GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS-YAFHTPD-KLSFIL 271

Query: 407 EYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLD 466
           + +  G LH  L ++   +     R   A ++  GL+++H      VV++D+K +NILLD
Sbjct: 272 DLMNGGDLHYHLSQHGVFSEA-DMRFYAA-EIILGLEHMHNR---FVVYRDLKPANILLD 326

Query: 467 SNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKM-DVFSFGVVLLELIS 525
            +   +I++ GLA           VGT GY+APE L  GV      D FS G +L +L+ 
Sbjct: 327 EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 386

Query: 526 GK 527
           G 
Sbjct: 387 GH 388

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 94.3 bits (235), Expect = 3e-21
 Identities = 42/187 (22%), Positives = 79/187 (42%), Gaps = 15/187 (8%)

Query: 351 GSVYKGNIH---GEVYAIKMMKWNAC--EELKILQKV-NHGNLVKLEGFCIDP--EDANC 402
           G V +   H   G+  A+K++  +    +E+    +     ++V +     +        
Sbjct: 43  GKVLEC-FHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101

Query: 403 YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSN 462
            +I E +E G L S + E  ++    +    I  D+   +Q++H H    + H+D+K  N
Sbjct: 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPEN 158

Query: 463 ILL---DSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVV 519
           +L    + +   K+ +FG AK            T  Y+APE L         D++S GV+
Sbjct: 159 LLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 218

Query: 520 LLELISG 526
           +  L+ G
Sbjct: 219 MYILLCG 225

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 93.9 bits (234), Expect = 3e-21
 Identities = 49/197 (24%), Positives = 84/197 (42%), Gaps = 29/197 (14%)

Query: 351 GSVYKGNIH---GEVYAIKMMKWNACE-------------ELKILQKVNHGNLVKLEGFC 394
             V K       G  YA K +K                  E+ IL++V H N++ L    
Sbjct: 26  AIVKKC-REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY 84

Query: 395 IDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVV 454
            +    +  LI E +  G L  +L +   E+L+ +        + +G+ Y+H     ++ 
Sbjct: 85  ENRT--DVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTK---KIA 137

Query: 455 HKDIKSSNILLDS----NMRAKIANFGLAKSGCNAITMH-IVGTQGYIAPEYLADGVVST 509
           H D+K  NI+L          K+ +FGLA    + +    I GT  ++APE +    +  
Sbjct: 138 HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGL 197

Query: 510 KMDVFSFGVVLLELISG 526
           + D++S GV+   L+SG
Sbjct: 198 EADMWSIGVITYILLSG 214

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 93.8 bits (234), Expect = 3e-21
 Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 31/216 (14%)

Query: 325 LDKYRIFKIEELREATDNFSEGCLIQGSVYKGNIH--GEVYAIKMMKWNACE-------- 374
           ++ Y   K+++L E T           +VYKG       + A+K ++    E        
Sbjct: 1   METYI--KLDKLGEGT---------YATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR 49

Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+ +L+ + H N+V L    I   + +  L++EY++   L  +L ++    +N       
Sbjct: 50  EVSLLKDLKHANIVTL--HDIIHTEKSLTLVFEYLDK-DLKQYL-DDCGNIINMHNVKLF 105

Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS-GCNAITM-HIVG 492
              +  GL Y H     +V+H+D+K  N+L++     K+A+FGLA++      T  + V 
Sbjct: 106 LFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV 162

Query: 493 TQGYIAPEYL-ADGVVSTKMDVFSFGVVLLELISGK 527
           T  Y  P+ L      ST++D++  G +  E+ +G+
Sbjct: 163 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 93.0 bits (232), Expect = 3e-21
 Identities = 47/192 (24%), Positives = 84/192 (43%), Gaps = 24/192 (12%)

Query: 351 GSVYKGNIH---GEVYAIKMMKWNACE---------ELKILQKVNHGNLVKLEGFCIDPE 398
             V +  +H   G  +A K++               E +I +K+ H N+V+L     +  
Sbjct: 20  SVVRRC-VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES 78

Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
               YL+++ +  G L   +     E  +          +   + Y H +    +VH+++
Sbjct: 79  --FHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSN---GIVHRNL 131

Query: 459 KSSNILLDS---NMRAKIANFGLAKSGCNAITMH-IVGTQGYIAPEYLADGVVSTKMDVF 514
           K  N+LL S       K+A+FGLA    ++   H   GT GY++PE L     S  +D++
Sbjct: 132 KPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIW 191

Query: 515 SFGVVLLELISG 526
           + GV+L  L+ G
Sbjct: 192 ACGVILYILLVG 203

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 96.0 bits (239), Expect = 4e-21
 Identities = 50/205 (24%), Positives = 93/205 (45%), Gaps = 25/205 (12%)

Query: 360 GEVYAIKMMK----------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI 409
           G++YA K +             A  E KIL KV+   +V L  +  + +     L+   +
Sbjct: 210 GKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTD-LCLVMTIM 267

Query: 410 ENGSLHSWLHENKNENLNWK-TRLRI-AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS 467
             G +   ++    +N  ++  R       + +GL+++H+     ++++D+K  N+LLD 
Sbjct: 268 NGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDD 324

Query: 468 NMRAKIANFGLAKSGC--NAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           +   +I++ GLA         T    GT G++APE L        +D F+ GV L E+I+
Sbjct: 325 DGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIA 384

Query: 526 GKEAIDEEGKFCGQKLKGYWREMKR 550
            +      G F  +  K   +E+K+
Sbjct: 385 AR------GPFRARGEKVENKELKQ 403

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 92.7 bits (231), Expect = 4e-21
 Identities = 44/196 (22%), Positives = 91/196 (46%), Gaps = 25/196 (12%)

Query: 351 GSVYKGNIH---GEVYAIKMMKWNACE--------ELKI-LQKVNHGNLVKLEGFCIDPE 398
           G V K   H   G++ A+K ++             +L I ++ V+    V   G      
Sbjct: 21  GVVEKM-RHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG 79

Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRL--RIAIDVANGLQYIHEHTRPRVVHK 456
           D   ++  E + + SL  +  +  ++       +  +IA+ +   L+++H   +  V+H+
Sbjct: 80  D--VWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLSVIHR 134

Query: 457 DIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI-VGTQGYIAPE----YLADGVVSTKM 511
           D+K SN+L+++  + K+ +FG++    + +   I  G + Y+APE     L     S K 
Sbjct: 135 DVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKS 194

Query: 512 DVFSFGVVLLELISGK 527
           D++S G+ ++EL   +
Sbjct: 195 DIWSLGITMIELAILR 210

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 93.0 bits (232), Expect = 5e-21
 Identities = 52/193 (26%), Positives = 97/193 (50%), Gaps = 21/193 (10%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCIDPEDA 400
            +VYKG     G   A+K +K ++ E        E+ +++++ H N+V+L  + +   + 
Sbjct: 19  ATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRL--YDVIHTEN 76

Query: 401 NCYLIYEYIEN---GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKD 457
              L++E+++N     + S    N    L           +  GL + HE+   +++H+D
Sbjct: 77  KLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRD 133

Query: 458 IKSSNILLDSNMRAKIANFGLAKS-GCNAITM-HIVGTQGYIAPEYL-ADGVVSTKMDVF 514
           +K  N+L++   + K+ +FGLA++ G    T    V T  Y AP+ L      ST +D++
Sbjct: 134 LKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIW 193

Query: 515 SFGVVLLELISGK 527
           S G +L E+I+GK
Sbjct: 194 SCGCILAEMITGK 206

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 93.4 bits (233), Expect = 6e-21
 Identities = 63/235 (26%), Positives = 106/235 (45%), Gaps = 50/235 (21%)

Query: 318 MA-DVSDCLDKYRIFKIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWNACE 374
           MA DV     +Y   K++ L E             +VYK       ++ AIK +K     
Sbjct: 1   MALDVKSRAKRYE--KLDFLGEGQ---------FATVYKARDKNTNQIVAIKKIKLGHRS 49

Query: 375 ------------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENK 422
                       E+K+LQ+++H N++ L         +N  L+++++E   L   + ++ 
Sbjct: 50  EAKDGINRTALREIKLLQELSHPNIIGLLD--AFGHKSNISLVFDFMET-DLEVII-KDN 105

Query: 423 NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK-- 480
           +  L         +    GL+Y+H+H    ++H+D+K +N+LLD N   K+A+FGLAK  
Sbjct: 106 SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF 162

Query: 481 -SGCNAITMHIVGTQGYIAPE-------YLADGVVSTKMDVFSFGVVLLELISGK 527
            S   A T H V T+ Y APE       Y         +D+++ G +L EL+   
Sbjct: 163 GSPNRAYT-HQVVTRWYRAPELLFGARMY------GVGVDMWAVGCILAELLLRV 210

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 92.8 bits (231), Expect = 7e-21
 Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 35/203 (17%)

Query: 351 GSVYKGNIH---GEVYAIKMMKWNACE------ELKILQKV-NHGNLVKLEG----FCID 396
           G VYKG  H   G++ AIK+M     E      E+ +L+K  +H N+    G        
Sbjct: 38  GQVYKG-RHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96

Query: 397 PEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAI---DVANGLQYIHEHTRPRV 453
             D   +L+ E+   GS+   +   K   L       IA    ++  GL ++H+H   +V
Sbjct: 97  GMDDQLWLVMEFCGAGSVTDLIKNTKGNTL---KEEWIAYICREILRGLSHLHQH---KV 150

Query: 454 VHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI----TMHIVGTQGYIAPEYLADGVVS- 508
           +H+DIK  N+LL  N   K+ +FG++      +    T   +GT  ++APE +A      
Sbjct: 151 IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF--IGTPYWMAPEVIACDENPD 208

Query: 509 ----TKMDVFSFGVVLLELISGK 527
                K D++S G+  +E+  G 
Sbjct: 209 ATYDFKSDLWSLGITAIEMAEGA 231

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 92.4 bits (230), Expect = 8e-21
 Identities = 47/199 (23%), Positives = 84/199 (42%), Gaps = 33/199 (16%)

Query: 351 GSVYKGNIH---GEVYAIKMMKWNACE--------ELKILQK-VNHGNLVKLEGFCIDPE 398
           G V+K       G V A+K M+ +  +        +L ++ K  +   +V+  G  I   
Sbjct: 39  GQVWKM-RFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT-- 95

Query: 399 DANCYLIYEYIENGSLHSWLHENK--NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHK 456
           + + ++  E +   +            E +  K    + + +   L Y+ E  +  V+H+
Sbjct: 96  NTDVFIAMELMGTCAEKLKKRMQGPIPERILGK----MTVAIVKALYYLKE--KHGVIHR 149

Query: 457 DIKSSNILLDSNMRAKIANFGLAKSGCNAITM---HIVGTQGYIAPE-----YLADGVVS 508
           D+K SNILLD   + K+ +FG+  SG            G   Y+APE             
Sbjct: 150 DVKPSNILLDERGQIKLCDFGI--SGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYD 207

Query: 509 TKMDVFSFGVVLLELISGK 527
            + DV+S G+ L+EL +G+
Sbjct: 208 IRADVWSLGISLVELATGQ 226

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 92.0 bits (229), Expect = 8e-21
 Identities = 45/199 (22%), Positives = 92/199 (46%), Gaps = 34/199 (17%)

Query: 351 GSVYKGNIH---GEVYAIKMMKWNACE-------ELKILQKVNHGNLVKLEGFCIDPEDA 400
           G VYK   +   G + A K+++  + E       E++IL   +H  +VKL G      D 
Sbjct: 33  GKVYKA-KNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY--HDG 89

Query: 401 NCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAI---DVANGLQYIHEHTRPRVVHKD 457
             +++ E+   G++ + +    +  L   T  +I +    +   L ++H     R++H+D
Sbjct: 90  KLWIMIEFCPGGAVDA-IMLELDRGL---TEPQIQVVCRQMLEALNFLHSK---RIIHRD 142

Query: 458 IKSSNILLDSNMRAKIANFG----LAKSGCNAITMHIVGTQGYIAPEYLADGVVS----- 508
           +K+ N+L+      ++A+FG      K+     +   +GT  ++APE +    +      
Sbjct: 143 LKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF--IGTPYWMAPEVVMCETMKDTPYD 200

Query: 509 TKMDVFSFGVVLLELISGK 527
            K D++S G+ L+E+   +
Sbjct: 201 YKADIWSLGITLIEMAQIE 219

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 92.3 bits (230), Expect = 1e-20
 Identities = 53/198 (26%), Positives = 83/198 (41%), Gaps = 31/198 (15%)

Query: 351 GSVYKGNIH---GEVYAIKMMKWNACE-------------ELKILQKVNHGNLVKLEGFC 394
             V K       G  YA K +K    +             E+ IL+++ H N++ L    
Sbjct: 25  AVVKKC-REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY 83

Query: 395 IDPEDANC-YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRV 453
              E+     LI E +  G L  +L E   E+L  +        + NG+ Y+H     ++
Sbjct: 84  ---ENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSL---QI 135

Query: 454 VHKDIKSSNILLDS----NMRAKIANFGLAKSGCNAITMH-IVGTQGYIAPEYLADGVVS 508
            H D+K  NI+L        R KI +FGLA           I GT  ++APE +    + 
Sbjct: 136 AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLG 195

Query: 509 TKMDVFSFGVVLLELISG 526
            + D++S GV+   L+SG
Sbjct: 196 LEADMWSIGVITYILLSG 213

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 93.3 bits (232), Expect = 1e-20
 Identities = 55/250 (22%), Positives = 104/250 (41%), Gaps = 56/250 (22%)

Query: 312 DMEVNFMADVSDCLDKYRI--FKIEELREATDNFSEGCLIQGSVYKG----NIHGEVYAI 365
           D +V   ++     D +     K+            G    G VYK         + YA+
Sbjct: 6   DFKVKLSSERERVEDLFEYEGCKV----------GRGTY--GHVYKAKRKDGKDDKDYAL 53

Query: 366 KMMKW-----NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHE 420
           K ++      +AC E+ +L+++ H N++ L+   +   D   +L+++Y E+  L   +  
Sbjct: 54  KQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKF 112

Query: 421 NKNENLNWKTRLRIAIDVA-------NGLQYIHEHTRPRVVHKDIKSSNILLDS----NM 469
           ++    N K        V        +G+ Y+H +    V+H+D+K +NIL+        
Sbjct: 113 HRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERG 169

Query: 470 RAKIANFGLAK---SGCNAIT--MHIVGTQGYIAPE-------YLADGVVSTKMDVFSFG 517
           R KIA+ G A+   S    +     +V T  Y APE       Y      +  +D+++ G
Sbjct: 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHY------TKAIDIWAIG 223

Query: 518 VVLLELISGK 527
            +  EL++ +
Sbjct: 224 CIFAELLTSE 233

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 91.5 bits (228), Expect = 2e-20
 Identities = 58/225 (25%), Positives = 105/225 (46%), Gaps = 38/225 (16%)

Query: 322 SDCLDKYRIFKIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWN-------- 371
           +  +D+YR  +I +L E T          G VYK    +  E  AIK ++          
Sbjct: 30  ATSIDRYR--RITKLGEGT---------YGEVYKAIDTVTNETVAIKRIRLEHEEEGVPG 78

Query: 372 -ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
            A  E+ +L+++ H N+++L+   +   +   +LI+EY EN  L  ++  +KN +++ + 
Sbjct: 79  TAIREVSLLKELQHRNIIELK--SVIHHNHRLHLIFEYAEN-DLKKYM--DKNPDVSMRV 133

Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRA-----KIANFGLAKS-GCN 484
                  + NG+ + H     R +H+D+K  N+LL  +  +     KI +FGLA++ G  
Sbjct: 134 IKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190

Query: 485 AITM-HIVGTQGYIAPEYL-ADGVVSTKMDVFSFGVVLLELISGK 527
                H + T  Y  PE L      ST +D++S   +  E++   
Sbjct: 191 IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 91.6 bits (228), Expect = 2e-20
 Identities = 42/201 (20%), Positives = 84/201 (41%), Gaps = 27/201 (13%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNACE----ELKILQKV-NHGNLVKLEGFCIDPEDANCY 403
             V++     + E   +K++K    +    E+KIL+ +    N++ L     DP      
Sbjct: 50  SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109

Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTR--LRIAIDVANGLQYIHEHTRPRVVHKDIKSS 461
           L++E++ N           + ++ +     L+        L Y H      ++H+D+K  
Sbjct: 110 LVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK-------ALDYCHSM---GIMHRDVKPH 159

Query: 462 NILLDSNMRA-KIANFGLAKSGCNAITM-HIVGTQGYIAPEYLADGVV-STKMDVFSFGV 518
           N+++D   R  ++ ++GLA+           V ++ +  PE L D  +    +D++S G 
Sbjct: 160 NVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGC 219

Query: 519 VLLELISGKEAIDEEGKFCGQ 539
           +L  +I  KE       F G 
Sbjct: 220 MLASMIFRKEPF-----FHGH 235

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 93.7 bits (233), Expect = 2e-20
 Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 24/203 (11%)

Query: 360 GEVYAIKMMK----------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI 409
           G++YA K ++            A  E +IL+KVN   +V L  +  + +DA   L+   +
Sbjct: 209 GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA-YAYETKDA-LCLVLTLM 266

Query: 410 ENGSLHSWLHENKNENLNWKTRLRI-AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN 468
             G L   ++         + R    A ++  GL+ +H     R+V++D+K  NILLD +
Sbjct: 267 NGGDLKFHIYHMGQAGFP-EARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDH 322

Query: 469 MRAKIANFGLAKSGCNAITMH-IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
              +I++ GLA       T+   VGT GY+APE + +   +   D ++ G +L E+I+G+
Sbjct: 323 GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

Query: 528 EAIDEEGKFCGQKLKGYWREMKR 550
                   F  +K K    E++R
Sbjct: 383 ------SPFQQRKKKIKREEVER 399

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 90.7 bits (225), Expect = 4e-20
 Identities = 50/241 (20%), Positives = 82/241 (34%), Gaps = 71/241 (29%)

Query: 351 GSVYKGNIH---GEVYAIKMMKWNACE------------ELKILQKVNHGNLVKLEGFCI 395
           G V    I      + AIK+M  N               E+++++K++H N+ +L     
Sbjct: 40  GVVRVA-IENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY- 97

Query: 396 DPEDANC-YLIYEYIENGSLHSWLHENKNENLNWKTRL---------------------- 432
             ED     L+ E    G L   L+   +++                             
Sbjct: 98  --EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIH 155

Query: 433 ----------------RIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS--NMRAKIA 474
                            I   + + L Y+H      + H+DIK  N L  +  +   K+ 
Sbjct: 156 GFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLV 212

Query: 475 NFGLAK------SGCNAITMHIVGTQGYIAPEYLADGV--VSTKMDVFSFGVVLLELISG 526
           +FGL+K      +G         GT  ++APE L         K D +S GV+L  L+ G
Sbjct: 213 DFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMG 272

Query: 527 K 527
            
Sbjct: 273 A 273

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 90.4 bits (225), Expect = 6e-20
 Identities = 41/198 (20%), Positives = 84/198 (42%), Gaps = 28/198 (14%)

Query: 351 GSVYKGNIH---GEVYAIKMMKWNACE------------ELKILQKVNHGNLVKLEGFCI 395
             V +  I+   G+ +A+K++                  E  I   + H ++V+L     
Sbjct: 38  SVVRRC-INRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYS 96

Query: 396 DPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRL--RIAIDVANGLQYIHEHTRPRV 453
                  Y+++E+++   L   + +  +    +   +       +   L+Y H++    +
Sbjct: 97  SDG--MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NI 151

Query: 454 VHKDIKSSNILLDS---NMRAKIANFGLAKS-GCNAITMH-IVGTQGYIAPEYLADGVVS 508
           +H+D+K   +LL S   +   K+  FG+A   G + +     VGT  ++APE +      
Sbjct: 152 IHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYG 211

Query: 509 TKMDVFSFGVVLLELISG 526
             +DV+  GV+L  L+SG
Sbjct: 212 KPVDVWGCGVILFILLSG 229

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 89.6 bits (223), Expect = 6e-20
 Identities = 46/196 (23%), Positives = 78/196 (39%), Gaps = 43/196 (21%)

Query: 360 GEVYAIK-----------MMKWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEY 408
               A+K             + N  +E+++L+++ H N+++L     + E    Y++ EY
Sbjct: 30  LCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEY 89

Query: 409 IENGSLHSWLHENKNENLNWKTRLRIAIDVA--------NGLQYIHEHTRPRVVHKDIKS 460
              G           E L+     R  +  A        +GL+Y+H      +VHKDIK 
Sbjct: 90  CVCGM---------QEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKP 137

Query: 461 SNILLDSNMRAKIANFGLA---KSGCNAITMHIV-GTQGYIAPEYLA-----DGVVSTKM 511
            N+LL +    KI+  G+A          T     G+  +  PE         G    K+
Sbjct: 138 GNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSG---FKV 194

Query: 512 DVFSFGVVLLELISGK 527
           D++S GV L  + +G 
Sbjct: 195 DIWSAGVTLYNITTGL 210

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 89.8 bits (223), Expect = 9e-20
 Identities = 56/195 (28%), Positives = 90/195 (46%), Gaps = 30/195 (15%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNACE----------ELKILQKVNHGNLVKLEGFCIDPE 398
           G+VY      + EV AIK M ++  +          E++ LQK+ H N ++  G  +   
Sbjct: 68  GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL--R 125

Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAI---DVANGLQYIHEHTRPRVVH 455
           +   +L+ EY    +    L E   + L     + IA        GL Y+H H    ++H
Sbjct: 126 EHTAWLVMEYCLGSASD--LLEVHKKPL---QEVEIAAVTHGALQGLAYLHSH---NMIH 177

Query: 456 KDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPE---YLADGVVSTKMD 512
           +D+K+ NILL      K+ +FG A     A +   VGT  ++APE    + +G    K+D
Sbjct: 178 RDVKAGNILLSEPGLVKLGDFGSASIMAPANSF--VGTPYWMAPEVILAMDEGQYDGKVD 235

Query: 513 VFSFGVVLLELISGK 527
           V+S G+  +EL   K
Sbjct: 236 VWSLGITCIELAERK 250

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 89.7 bits (223), Expect = 1e-19
 Identities = 49/189 (25%), Positives = 89/189 (47%), Gaps = 22/189 (11%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNACE-----ELKILQKVNHGNLVKLEGFCIDPEDANCY 403
             VY+       + YA+K++K    +     E+ +L +++H N++KL+     P      
Sbjct: 67  SIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPT--EIS 124

Query: 404 LIYEYIENGSLHSWLHENK--NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSS 461
           L+ E +  G L   + E    +E    +        +   + Y+HE+    +VH+D+K  
Sbjct: 125 LVLELVTGGELFDRIVEKGYYSE----RDAADAVKQILEAVAYLHEN---GIVHRDLKPE 177

Query: 462 NILL---DSNMRAKIANFGLAKSGCNAITMH-IVGTQGYIAPEYLADGVVSTKMDVFSFG 517
           N+L      +   KIA+FGL+K   + + M  + GT GY APE L       ++D++S G
Sbjct: 178 NLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVG 237

Query: 518 VVLLELISG 526
           ++   L+ G
Sbjct: 238 IITYILLCG 246

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 89.3 bits (222), Expect = 1e-19
 Identities = 49/192 (25%), Positives = 83/192 (43%), Gaps = 27/192 (14%)

Query: 351 GSVYKGNIH---GEVYAIKM----MKWNACEELKILQKV-NHGNLVKLEGFCIDPEDANC 402
               K  +H    + +A+K+    M+ N  +E+  L+    H N+VKL        D   
Sbjct: 25  SICRKC-VHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVF---HDQLH 80

Query: 403 -YLIYEYIENGSLHSWLHENKN--ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIK 459
            +L+ E +  G L   + + K+  E         I   + + + ++H+     VVH+D+K
Sbjct: 81  TFLVMELLNGGELFERIKKKKHFSE----TEASYIMRKLVSAVSHMHDV---GVVHRDLK 133

Query: 460 SSNILL---DSNMRAKIANFGLAK--SGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVF 514
             N+L    + N+  KI +FG A+     N        T  Y APE L         D++
Sbjct: 134 PENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLW 193

Query: 515 SFGVVLLELISG 526
           S GV+L  ++SG
Sbjct: 194 SLGVILYTMLSG 205

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 89.7 bits (223), Expect = 1e-19
 Identities = 47/192 (24%), Positives = 84/192 (43%), Gaps = 24/192 (12%)

Query: 351 GSVYKGNIH---GEVYAIKMMKWNACE---------ELKILQKVNHGNLVKLEGFCIDPE 398
             V +  +H   G  +A K++               E +I +K+ H N+V+L     +  
Sbjct: 43  SVVRRC-VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES 101

Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
               YL+++ +  G L   +     E  +          +   + Y H +    +VH+++
Sbjct: 102 --FHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSN---GIVHRNL 154

Query: 459 KSSNILLDS---NMRAKIANFGLAKSGCNAITMH-IVGTQGYIAPEYLADGVVSTKMDVF 514
           K  N+LL S       K+A+FGLA    ++   H   GT GY++PE L     S  +D++
Sbjct: 155 KPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIW 214

Query: 515 SFGVVLLELISG 526
           + GV+L  L+ G
Sbjct: 215 ACGVILYILLVG 226

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 89.4 bits (222), Expect = 2e-19
 Identities = 40/188 (21%), Positives = 82/188 (43%), Gaps = 16/188 (8%)

Query: 351 GSVYKGNIH---GEVYAIKMMKWNAC--EELKILQKV-NHGNLVKLEGFCIDP--EDANC 402
           G V +   +    E +A+KM++       E+++  +     ++V++     +        
Sbjct: 76  GKVLQI-FNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134

Query: 403 YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSN 462
            ++ E ++ G L S + +  ++    +    I   +   +QY+H      + H+D+K  N
Sbjct: 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPEN 191

Query: 463 ILLDS---NMRAKIANFGLAKSGCNAITMH-IVGTQGYIAPEYLADGVVSTKMDVFSFGV 518
           +L  S   N   K+ +FG AK   +  ++     T  Y+APE L         D++S GV
Sbjct: 192 LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 251

Query: 519 VLLELISG 526
           ++  L+ G
Sbjct: 252 IMYILLCG 259

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 88.7 bits (220), Expect = 6e-19
 Identities = 58/235 (24%), Positives = 103/235 (43%), Gaps = 36/235 (15%)

Query: 320 DVSDCLDKYRIF--KIEELREATDNFSEGCLI-QGS---VY----KGNIHGEVYAIKMM- 368
           ++ + L+  + F  K++++R   ++F    +I +G+   V     K     +V+A+K++ 
Sbjct: 51  NILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNA--DKVFAMKILN 108

Query: 369 KWN-------AC--EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLH 419
           KW        AC  EE  +L   +   +  L     D    N YL+ +Y   G L + L 
Sbjct: 109 KWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN--NLYLVMDYYVGGDLLTLLS 166

Query: 420 ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLA 479
           + ++       R  +A ++   +  +H+      VH+DIK  NIL+D N   ++A+FG  
Sbjct: 167 KFEDRLPEEMARFYLA-EMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSC 222

Query: 480 KSGC---NAITMHIVGTQGYIAPEYLADGVVSTKM-----DVFSFGVVLLELISG 526
                     +   VGT  YI+PE L              D +S GV + E++ G
Sbjct: 223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 87.0 bits (216), Expect = 8e-19
 Identities = 49/179 (27%), Positives = 82/179 (45%), Gaps = 22/179 (12%)

Query: 360 GEVYAIKMMKWNACEELK----------ILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI 409
           G  YA+K++      +LK          ILQ VN   LVKLE    D    N Y++ EY+
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS--NLYMVMEYV 123

Query: 410 ENGSLHSWLHENK--NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS 467
             G + S L      +E      R   A  +    +Y+H      ++++D+K  N+L+D 
Sbjct: 124 AGGEMFSHLRRIGRFSEP---HARFYAA-QIVLTFEYLHSLD---LIYRDLKPENLLIDQ 176

Query: 468 NMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
               ++ +FG AK      T  + GT   +APE +     +  +D ++ GV++ E+ +G
Sbjct: 177 QGYIQVTDFGFAKR-VKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 86.6 bits (215), Expect = 8e-19
 Identities = 59/185 (31%), Positives = 91/185 (49%), Gaps = 30/185 (16%)

Query: 360 GEVYAIKMM---KWNACE------ELKILQKVNHGNLVKL-EGFCIDPEDANCYLIYEYI 409
           G   AIK++   + N         E++I++ +NH N+VKL E   I+ E    YLI EY 
Sbjct: 40  GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE--VIETEK-TLYLIMEYA 96

Query: 410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM 469
             G +  +L  +    +  K        + + +QY H+    R+VH+D+K+ N+LLD++M
Sbjct: 97  SGGEVFDYLVAHGR--MKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADM 151

Query: 470 RAKIANFGLA---KSGCNAITMHIVGTQGYIAPEYLA----DGVVSTKMDVFSFGVVLLE 522
             KIA+FG +     G         G   Y APE       DG    ++DV+S GV+L  
Sbjct: 152 NIKIADFGFSNEFTVGGKLDAF--CGAPPYAAPELFQGKKYDG---PEVDVWSLGVILYT 206

Query: 523 LISGK 527
           L+SG 
Sbjct: 207 LVSGS 211

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 87.4 bits (217), Expect = 1e-18
 Identities = 65/246 (26%), Positives = 104/246 (42%), Gaps = 39/246 (15%)

Query: 309 DLKDMEVNFMADVSDCLDKYRIF--KIEELREATDNFSEGCLI-QGS---VY----KGNI 358
           DL    +    ++ + L +Y+    KI +LR   +++    +I +G+   V     K   
Sbjct: 35  DLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKST- 93

Query: 359 HGEVYAIKMM-KWN-------AC--EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEY 408
             +VYA+K++ K+        A   EE  I+   N   +V+L     D      Y++ EY
Sbjct: 94  -RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR--YLYMVMEY 150

Query: 409 IENGSLHSWLHENK-NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS 467
           +  G L + +      E      R   A +V   L  IH       +H+D+K  N+LLD 
Sbjct: 151 MPGGDLVNLMSNYDVPEKW---ARFYTA-EVVLALDAIHSM---GFIHRDVKPDNMLLDK 203

Query: 468 NMRAKIANFGLAK---SGCNAITMHIVGTQGYIAPEYL----ADGVVSTKMDVFSFGVVL 520
           +   K+A+FG                VGT  YI+PE L     DG    + D +S GV L
Sbjct: 204 SGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 263

Query: 521 LELISG 526
            E++ G
Sbjct: 264 YEMLVG 269

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 87.4 bits (217), Expect = 1e-18
 Identities = 45/193 (23%), Positives = 80/193 (41%), Gaps = 25/193 (12%)

Query: 351 GSVYKGNIH---GEVYAIKMMKWNACE---------ELKILQKVNHGNLVKLEGFCIDPE 398
             V +  +    G+ YA  ++               E +I + + H N+V+L     +  
Sbjct: 25  SVVRRC-VKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEG 83

Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
             + YLI++ +  G L   +     E  +          +   + + H+     VVH+++
Sbjct: 84  --HHYLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQM---GVVHRNL 136

Query: 459 KSSNILLDS---NMRAKIANFGLAK--SGCNAITMHIVGTQGYIAPEYLADGVVSTKMDV 513
           K  N+LL S       K+A+FGLA    G         GT GY++PE L        +D+
Sbjct: 137 KPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDL 196

Query: 514 FSFGVVLLELISG 526
           ++ GV+L  L+ G
Sbjct: 197 WACGVILYILLVG 209

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 86.3 bits (214), Expect = 2e-18
 Identities = 39/159 (24%), Positives = 80/159 (50%), Gaps = 15/159 (9%)

Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANC----YLIYEYIENGSLHSWLHEN-KNENLNWK 429
           EL +++ VNH N++ L       +        Y++ E ++  +L   +     +E +++ 
Sbjct: 74  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSY- 131

Query: 430 TRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM- 488
               +   +  G++++H      ++H+D+K SNI++ S+   KI +FGLA++   +  M 
Sbjct: 132 ----LLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 184

Query: 489 HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
             V T+ Y APE +        +D++S G ++ E+I G 
Sbjct: 185 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 84.2 bits (209), Expect = 3e-18
 Identities = 50/191 (26%), Positives = 80/191 (41%), Gaps = 42/191 (21%)

Query: 360 GEVYAIKMM----KWNACE----ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN 411
            E  A+K++      +  E    E+ I + +NH N+VK  G   +      YL  EY   
Sbjct: 32  EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNI--QYLFLEYCSG 89

Query: 412 GSLHSWLHENKNENLNWKTRLRIAIDVA--------NGLQYIHEHTRPRVVHKDIKSSNI 463
           G L   +  +            +    A         G+ Y+H      + H+DIK  N+
Sbjct: 90  GELFDRIEPDI----------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENL 136

Query: 464 LLDSNMRAKIANFGLA---KSGCNAITMH-IVGTQGYIAPEYLA----DGVVSTKMDVFS 515
           LLD     KI++FGLA   +       ++ + GT  Y+APE L            +DV+S
Sbjct: 137 LLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA---EPVDVWS 193

Query: 516 FGVVLLELISG 526
            G+VL  +++G
Sbjct: 194 CGIVLTAMLAG 204

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 84.6 bits (210), Expect = 3e-18
 Identities = 49/207 (23%), Positives = 89/207 (42%), Gaps = 42/207 (20%)

Query: 351 GSVYKGNIH---GEVYAIKMMKWNACE-------ELKILQKV-NHGNLVKLEGFCIDPED 399
             V    I+    + YA+K+++            E+++L +   H N+++L  F    E+
Sbjct: 27  ARVQTC-INLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF---EE 82

Query: 400 ANC-YLIYEYIENGSLHSWLHENK--NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHK 456
            +  YL++E +  GS+ S +H+ +  NE         +  DVA+ L ++H      + H+
Sbjct: 83  EDRFYLVFEKMRGGSILSHIHKRRHFNE----LEASVVVQDVASALDFLHNK---GIAHR 135

Query: 457 DIKSSNILL---DSNMRAKIANFGLAK---------SGCNAITMHIVGTQGYIAPEYLAD 504
           D+K  NIL    +     KI +F L                  +   G+  Y+APE +  
Sbjct: 136 DLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEA 195

Query: 505 GVVSTKM-----DVFSFGVVLLELISG 526
                 +     D++S GV+L  L+SG
Sbjct: 196 FSEEASIYDKRCDLWSLGVILYILLSG 222

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 83.7 bits (208), Expect = 6e-18
 Identities = 53/179 (29%), Positives = 91/179 (50%), Gaps = 22/179 (12%)

Query: 360 GEVYAIKMMKWNACEELK----------ILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI 409
           G  YA+K++K      LK          +L  V H  ++++ G   D +    ++I +YI
Sbjct: 31  GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ--QIFMIMDYI 88

Query: 410 ENGSLHSWLHENK--NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS 467
           E G L S L +++          +   A +V   L+Y+H      ++++D+K  NILLD 
Sbjct: 89  EGGELFSLLRKSQRFPNP---VAKFYAA-EVCLALEYLHSKD---IIYRDLKPENILLDK 141

Query: 468 NMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
           N   KI +FG AK     +T  + GT  YIAPE ++    +  +D +SFG+++ E+++G
Sbjct: 142 NGHIKITDFGFAKY-VPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 83.1 bits (206), Expect = 1e-17
 Identities = 50/191 (26%), Positives = 80/191 (41%), Gaps = 42/191 (21%)

Query: 360 GEVYAIKMM----KWNACE----ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN 411
            E  A+K++      +  E    E+ I + +NH N+VK  G   +      YL  EY   
Sbjct: 32  EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNI--QYLFLEYCSG 89

Query: 412 GSLHSWLHENKNENLNWKTRLRIAIDVA--------NGLQYIHEHTRPRVVHKDIKSSNI 463
           G L   +  +            +    A         G+ Y+H      + H+DIK  N+
Sbjct: 90  GELFDRIEPDI----------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENL 136

Query: 464 LLDSNMRAKIANFGLA---KSGCNAITMH-IVGTQGYIAPEYLA----DGVVSTKMDVFS 515
           LLD     KI++FGLA   +       ++ + GT  Y+APE L            +DV+S
Sbjct: 137 LLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA---EPVDVWS 193

Query: 516 FGVVLLELISG 526
            G+VL  +++G
Sbjct: 194 CGIVLTAMLAG 204

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 83.9 bits (208), Expect = 1e-17
 Identities = 43/158 (27%), Positives = 80/158 (50%), Gaps = 13/158 (8%)

Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANC----YLIYEYIENGSLHSWLHENKNENLNWKT 430
           EL++L+ + H N++ L       E  +     YL+  ++    L   +   K+E L    
Sbjct: 74  ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLM---KHEKLGEDR 129

Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI 490
              +   +  GL+YIH      ++H+D+K  N+ ++ +   KI +FGLA+   + +T + 
Sbjct: 130 IQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY- 185

Query: 491 VGTQGYIAPEY-LADGVVSTKMDVFSFGVVLLELISGK 527
           V T+ Y APE  L     +  +D++S G ++ E+I+GK
Sbjct: 186 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 84.4 bits (209), Expect = 1e-17
 Identities = 52/183 (28%), Positives = 82/183 (44%), Gaps = 24/183 (13%)

Query: 360 GEVYAIKMMK-----------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEY 408
           G  YA+K++K               E  ++LQ   H  L  L+ +     D     + EY
Sbjct: 173 GRYYAMKILKKEVIVAKDEVAHTLTEN-RVLQNSRHPFLTALK-YSFQTHD-RLCFVMEY 229

Query: 409 IENGSLHSWLHENK--NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLD 466
              G L   L   +  +E+   + R   A ++ + L Y+H      VV++D+K  N++LD
Sbjct: 230 ANGGELFFHLSRERVFSED---RARFYGA-EIVSALDYLHSEKN--VVYRDLKLENLMLD 283

Query: 467 SNMRAKIANFGLAKSGC--NAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELI 524
            +   KI +FGL K G    A      GT  Y+APE L D      +D +  GVV+ E++
Sbjct: 284 KDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 343

Query: 525 SGK 527
            G+
Sbjct: 344 CGR 346

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 83.6 bits (207), Expect = 1e-17
 Identities = 52/188 (27%), Positives = 78/188 (41%), Gaps = 39/188 (20%)

Query: 360 GEVYAIK------MMKWNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS 413
            E+ A+K       +  N   E+   + + H N+V+ +   + P      +I EY   G 
Sbjct: 45  KELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTH--LAIIMEYASGGE 102

Query: 414 LHSWLHENKNENLNWKTRLRIAIDVA--------NGLQYIHEHTRPRVVHKDIKSSNILL 465
           L+  +              R + D A        +G+ Y H     ++ H+D+K  N LL
Sbjct: 103 LYERICNAG----------RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLL 149

Query: 466 DSN--MRAKIANFGLAKSGCNAITMH-IVGTQGYIAPEYLA----DGVVSTKMDVFSFGV 518
           D +   R KI +FG +KS          VGT  YIAPE L     DG      DV+S GV
Sbjct: 150 DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDG---KIADVWSCGV 206

Query: 519 VLLELISG 526
            L  ++ G
Sbjct: 207 TLYVMLVG 214

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 83.1 bits (206), Expect = 2e-17
 Identities = 41/208 (19%), Positives = 84/208 (40%), Gaps = 46/208 (22%)

Query: 351 GSVYKGNIH--GEVYAIK------MMKWNACEELKILQKVNHGNLVKLEGFCIDPEDAN- 401
           G+V  G     G   AIK        +    + ++ L  ++H N+V+L+ +     + + 
Sbjct: 37  GTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96

Query: 402 ----CYLIYEYIENGSLHSWLHENKNENLNWKTR---------LRIAIDVANGLQYIHEH 448
                 ++ EY+ + +LH          +              +R        +  +H  
Sbjct: 97  RDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIR-------SIGCLHLP 148

Query: 449 TRPRVVHKDIKSSNILLD-SNMRAKIANFGLAKSGCNAITM-HIVGTQGYIAPE------ 500
           +   V H+DIK  N+L++ ++   K+ +FG AK    +      + ++ Y APE      
Sbjct: 149 SV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQ 207

Query: 501 -YLADGVVSTKMDVFSFGVVLLELISGK 527
            Y      +T +D++S G +  E++ G+
Sbjct: 208 HY------TTAVDIWSVGCIFAEMMLGE 229

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 84.1 bits (208), Expect = 2e-17
 Identities = 40/158 (25%), Positives = 78/158 (49%), Gaps = 13/158 (8%)

Query: 375 ELKILQKVNHGNLVKLEG-FCIDPEDAN---CYLIYEYIENGSLHSWLHENKNENLNWKT 430
           EL +++ VNH N++ L   F            YL+ E ++     + L +     L+ + 
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-----ANLCQVIQMELDHER 165

Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM-H 489
              +   +  G++++H      ++H+D+K SNI++ S+   KI +FGLA++   +  M  
Sbjct: 166 MSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 222

Query: 490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
            V T+ Y APE +        +D++S G ++ E++  K
Sbjct: 223 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 83.2 bits (206), Expect = 2e-17
 Identities = 42/162 (25%), Positives = 80/162 (49%), Gaps = 21/162 (12%)

Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANC----YLIYEYIENGSLHSWLHENKNENLNWKT 430
           EL++L+ + H N++ L                YL+   +    L++ +   K  + + + 
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQF 136

Query: 431 ----RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI 486
                LR       GL+YIH      ++H+D+K SN+ ++ +   KI +FGLA+   + +
Sbjct: 137 LIYQILR-------GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM 186

Query: 487 TMHIVGTQGYIAPE-YLADGVVSTKMDVFSFGVVLLELISGK 527
           T + V T+ Y APE  L     +  +D++S G ++ EL++G+
Sbjct: 187 TGY-VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 82.5 bits (204), Expect = 3e-17
 Identities = 37/158 (23%), Positives = 71/158 (44%), Gaps = 16/158 (10%)

Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS-LHSWLHENKNENLNWKTRLR 433
           E+ IL +V H N++K+     +       L+ E   +G  L +++  +++  L+      
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGF--FQLVMEKHGSGLDLFAFI--DRHPRLDEPLASY 134

Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH-IVG 492
           I   + + + Y+       ++H+DIK  NI++  +   K+ +FG A         +   G
Sbjct: 135 IFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCG 191

Query: 493 TQGYIAPEYLA----DGVVSTKMDVFSFGVVLLELISG 526
           T  Y APE L      G    +++++S GV L  L+  
Sbjct: 192 TIEYCAPEVLMGNPYRG---PELEMWSLGVTLYTLVFE 226

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 82.3 bits (204), Expect = 3e-17
 Identities = 41/159 (25%), Positives = 77/159 (48%), Gaps = 16/159 (10%)

Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANC----YLIYEYIENGSLHSWLHEN-KNENLNWK 429
           EL +L+ + H N++ L                YL+  +++   L   +      E + + 
Sbjct: 73  ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQY- 130

Query: 430 TRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH 489
               +   +  GL+YIH      VVH+D+K  N+ ++ +   KI +FGLA+     +T +
Sbjct: 131 ----LVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY 183

Query: 490 IVGTQGYIAPE-YLADGVVSTKMDVFSFGVVLLELISGK 527
            V T+ Y APE  L+    +  +D++S G ++ E+++GK
Sbjct: 184 -VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 82.8 bits (205), Expect = 3e-17
 Identities = 63/248 (25%), Positives = 104/248 (41%), Gaps = 38/248 (15%)

Query: 309 DLKDMEVNFMADVSDCLDKYR--IFKIEELREATDNFSEGCLI-QGS---VY----KGNI 358
           +L   E+     V+D L      + +++E+R   D+F    +I +G+   V     K   
Sbjct: 27  ELGASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQT- 85

Query: 359 HGEVYAIKMM-KWN-------AC--EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEY 408
            G+VYA+K+M KW+       +C  EE  +L   +   + +L  F    E+   YL+ EY
Sbjct: 86  -GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDEN-YLYLVMEY 142

Query: 409 IENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN 468
              G L + L +          R  +A ++   +  +H       VH+DIK  NILLD  
Sbjct: 143 YVGGDLLTLLSKFGERIPAEMARFYLA-EIVMAIDSVHRL---GYVHRDIKPDNILLDRC 198

Query: 469 MRAKIANFGLAKSGC---NAITMHIVGTQGYIAPEYLADGVVSTKM-------DVFSFGV 518
              ++A+FG            ++  VGT  Y++PE L                D ++ GV
Sbjct: 199 GHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGV 258

Query: 519 VLLELISG 526
              E+  G
Sbjct: 259 FAYEMFYG 266

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 82.0 bits (203), Expect = 5e-17
 Identities = 41/164 (25%), Positives = 69/164 (42%), Gaps = 22/164 (13%)

Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDAN---CYLIYEYIENGSLHSWLHENKNENLNWKTR 431
           E+++L   +H N++ L    +  E+      YL+ E +    L   +H+ +        +
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQ 137

Query: 432 ------LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA 485
                 L        GL  +HE     VVH+D+   NILL  N    I +F LA+     
Sbjct: 138 YFMYHILL-------GLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTAD 187

Query: 486 ITM-HIVGTQGYIAPEY-LADGVVSTKMDVFSFGVVLLELISGK 527
               H V  + Y APE  +     +  +D++S G V+ E+ + K
Sbjct: 188 ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 80.8 bits (200), Expect = 6e-17
 Identities = 50/201 (24%), Positives = 82/201 (40%), Gaps = 35/201 (17%)

Query: 351 GSVYKGNIH---GEVYAIK------MMKWNACE-------ELKILQKVNHG--NLVKLEG 392
           GSVY G I        AIK      +  W           E+ +L+KV+ G   +++L  
Sbjct: 57  GSVYSG-IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115

Query: 393 FCIDPEDANCYLIYEYIEN-GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRP 451
           +   P+     LI E  E    L  ++ E     L  +        V   +++ H     
Sbjct: 116 WFERPDS--FVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCHNC--- 168

Query: 452 RVVHKDIKSSNILLDSN-MRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLA----DGV 506
            V+H+DIK  NIL+D N    K+ +FG      + +     GT+ Y  PE++      G 
Sbjct: 169 GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHG- 227

Query: 507 VSTKMDVFSFGVVLLELISGK 527
                 V+S G++L +++ G 
Sbjct: 228 --RSAAVWSLGILLYDMVCGD 246

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 79.2 bits (196), Expect = 1e-16
 Identities = 52/211 (24%), Positives = 94/211 (44%), Gaps = 61/211 (28%)

Query: 351 GSVYKGNIH---GEVYAIKMM------KWNACE----ELKILQKVNHGNLVKLEGFCIDP 397
           G V  G  H   G   A+K++        +       E++ L+   H +++KL  + +  
Sbjct: 25  GKVKIG-EHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL--YQVIS 81

Query: 398 EDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVA--------NGLQYIHEHT 449
              + +++ EY+  G L  ++ ++           R+    A        + + Y H H 
Sbjct: 82  TPTDFFMVMEYVSGGELFDYICKHG----------RVEEMEARRLFQQILSAVDYCHRH- 130

Query: 450 RPRVVHKDIKSSNILLDSNMRAKIANFGLA---------KSGCNAITMHIVGTQGYIAPE 500
              VVH+D+K  N+LLD++M AKIA+FGL+         ++ C        G+  Y APE
Sbjct: 131 --MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC--------GSPNYAAPE 180

Query: 501 YLA----DGVVSTKMDVFSFGVVLLELISGK 527
            ++     G    ++D++S GV+L  L+ G 
Sbjct: 181 VISGRLYAG---PEVDIWSCGVILYALLCGT 208

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 52/182 (28%), Positives = 82/182 (45%), Gaps = 23/182 (12%)

Query: 360 GEVYAIKMMK----------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI 409
           G  YA+K+++           +   E ++LQ   H  L  L+ +     D     + EY 
Sbjct: 30  GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK-YAFQTHD-RLCFVMEYA 87

Query: 410 ENGSLHSWLHENK--NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS 467
             G L   L   +   E    + R   A ++ + L+Y+H      VV++DIK  N++LD 
Sbjct: 88  NGGELFFHLSRERVFTEE---RARFYGA-EIVSALEYLHSR---DVVYRDIKLENLMLDK 140

Query: 468 NMRAKIANFGLAKSGC--NAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
           +   KI +FGL K G    A      GT  Y+APE L D      +D +  GVV+ E++ 
Sbjct: 141 DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 200

Query: 526 GK 527
           G+
Sbjct: 201 GR 202

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 77.3 bits (191), Expect = 8e-16
 Identities = 46/202 (22%), Positives = 77/202 (38%), Gaps = 37/202 (18%)

Query: 351 GSVYKGNIH---GEVYAIK------MMKWNACE-------ELKILQKVN----HGNLVKL 390
           G+V+ G          AIK      ++ W+          E+ +L KV     H  +++L
Sbjct: 45  GTVFAG-HRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103

Query: 391 EGFCIDPEDANCYLIYEYIENGS-LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHT 449
             +    E     L+ E       L  ++ E     L           V   +Q+ H   
Sbjct: 104 LDWFETQEG--FMLVLERPLPAQDLFDYITEKGP--LGEGPSRCFFGQVVAAIQHCHSR- 158

Query: 450 RPRVVHKDIKSSNILLDSNM-RAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLA----D 504
              VVH+DIK  NIL+D     AK+ +FG      +       GT+ Y  PE+++     
Sbjct: 159 --GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYH 216

Query: 505 GVVSTKMDVFSFGVVLLELISG 526
                   V+S G++L +++ G
Sbjct: 217 A---LPATVWSLGILLYDMVCG 235

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 77.6 bits (192), Expect = 9e-16
 Identities = 50/181 (27%), Positives = 87/181 (48%), Gaps = 22/181 (12%)

Query: 360 GEVYAIKMMKWNACE---------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE 410
            ++YA+K++K    +         E  IL +VNH  +VKL  +    E    YLI +++ 
Sbjct: 52  RQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLH-YAFQTEG-KLYLILDFLR 109

Query: 411 NGSLHSWLHENK--NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN 468
            G L + L +     E      +  +A ++A  L ++H      ++++D+K  NILLD  
Sbjct: 110 GGDLFTRLSKEVMFTEE---DVKFYLA-ELALALDHLHSL---GIIYRDLKPENILLDEE 162

Query: 469 MRAKIANFGLAKSGC--NAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
              K+ +FGL+K             GT  Y+APE +     +   D +SFGV++ E+++G
Sbjct: 163 GHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

Query: 527 K 527
            
Sbjct: 223 T 223

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 77.6 bits (192), Expect = 1e-15
 Identities = 45/183 (24%), Positives = 84/183 (45%), Gaps = 24/183 (13%)

Query: 360 GEVYAIKMMK-------WNACE----ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEY 408
           G+++A+K++K                E  IL++V H  +V L  +         YLI EY
Sbjct: 45  GKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLI-YAFQTGG-KLYLILEY 102

Query: 409 IENGSLHSWLHENK--NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLD 466
           +  G L   L       E+        +A +++  L ++H+     ++++D+K  NI+L+
Sbjct: 103 LSGGELFMQLEREGIFMED---TACFYLA-EISMALGHLHQK---GIIYRDLKPENIMLN 155

Query: 467 SNMRAKIANFGLAKSGC--NAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELI 524
                K+ +FGL K       +T    GT  Y+APE L     +  +D +S G ++ +++
Sbjct: 156 HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDML 215

Query: 525 SGK 527
           +G 
Sbjct: 216 TGA 218

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 78.7 bits (194), Expect = 1e-15
 Identities = 46/174 (26%), Positives = 85/174 (48%), Gaps = 47/174 (27%)

Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E++ L+   H +++KL  + +    ++ +++ EY+  G L  ++ +N           R+
Sbjct: 66  EIQNLKLFRHPHIIKL--YQVISTPSDIFMVMEYVSGGELFDYICKNG----------RL 113

Query: 435 AIDVA--------NGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLA------- 479
               +        +G+ Y H H    VVH+D+K  N+LLD++M AKIA+FGL+       
Sbjct: 114 DEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170

Query: 480 --KSGCNAITMHIVGTQGYIAPEYLA----DGVVSTKMDVFSFGVVLLELISGK 527
             ++ C        G+  Y APE ++     G    ++D++S GV+L  L+ G 
Sbjct: 171 FLRTSC--------GSPNYAAPEVISGRLYAG---PEVDIWSSGVILYALLCGT 213

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 50/183 (27%), Positives = 84/183 (45%), Gaps = 26/183 (14%)

Query: 360 GEVYAIKMMK-----------WNACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYE 407
            + +AIK +K               E+ ++L     H  L  +       ++ N + + E
Sbjct: 42  NQFFAIKALKKDVVLMDDDVECTMVEK-RVLSLAWEHPFLTHMF-CTFQTKE-NLFFVME 98

Query: 408 YIENGSLHSWLHENK--NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL 465
           Y+  G L   +      + +   +     A ++  GLQ++H      +V++D+K  NILL
Sbjct: 99  YLNGGDLMYHIQSCHKFDLS---RATFYAA-EIILGLQFLHSK---GIVYRDLKLDNILL 151

Query: 466 DSNMRAKIANFGLAKSGC--NAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLEL 523
           D +   KIA+FG+ K     +A T    GT  YIAPE L     +  +D +SFGV+L E+
Sbjct: 152 DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEM 211

Query: 524 ISG 526
           + G
Sbjct: 212 LIG 214

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 78.5 bits (193), Expect = 2e-15
 Identities = 49/184 (26%), Positives = 83/184 (45%), Gaps = 26/184 (14%)

Query: 360 GEVYAIKMMK-----------WNACEELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYE 407
            E+YA+K++K               E+ ++L        L +L   C    D   Y + E
Sbjct: 366 DELYAVKILKKDVVIQDDDVECTMVEK-RVLALPGKPPFLTQLH-SCFQTMD-RLYFVME 422

Query: 408 YIENGSLHSWLHENK--NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL 465
           Y+  G L   + +     E          A ++A GL ++       ++++D+K  N++L
Sbjct: 423 YVNGGDLMYHIQQVGRFKEP---HAVFYAA-EIAIGLFFLQSK---GIIYRDLKLDNVML 475

Query: 466 DSNMRAKIANFGLAKSGC--NAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLEL 523
           DS    KIA+FG+ K        T    GT  YIAPE +A       +D ++FGV+L E+
Sbjct: 476 DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 535

Query: 524 ISGK 527
           ++G+
Sbjct: 536 LAGQ 539

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 76.5 bits (189), Expect = 2e-15
 Identities = 49/184 (26%), Positives = 85/184 (46%), Gaps = 26/184 (14%)

Query: 360 GEVYAIKMMK-----------WNACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYE 407
             +YA+K++K           W   E+  + ++  NH  LV L   C   E    + + E
Sbjct: 34  DRIYAMKVVKKELVNDDEDIDWVQTEK-HVFEQASNHPFLVGLH-SCFQTES-RLFFVIE 90

Query: 408 YIENGSLHSWLHENK--NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL 465
           Y+  G L   +   +   E      R   A +++  L Y+HE     ++++D+K  N+LL
Sbjct: 91  YVNGGDLMFHMQRQRKLPEE---HARFYSA-EISLALNYLHER---GIIYRDLKLDNVLL 143

Query: 466 DSNMRAKIANFGLAKSGC--NAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLEL 523
           DS    K+ ++G+ K G      T    GT  YIAPE L        +D ++ GV++ E+
Sbjct: 144 DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEM 203

Query: 524 ISGK 527
           ++G+
Sbjct: 204 MAGR 207

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 76.6 bits (189), Expect = 3e-15
 Identities = 51/191 (26%), Positives = 81/191 (42%), Gaps = 36/191 (18%)

Query: 360 GEVYAIKMMKWNACE----------ELKILQKVNHGNLVKLEGFCIDPEDAN---CYLIY 406
               AIK  K +  E          E+KIL +  H N++ +      P        Y++ 
Sbjct: 52  KVRVAIK--KISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQ 109

Query: 407 EYIENGSLHSWLHENKNENLNWKT----RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSN 462
           + +E   L+  L      N +        LR       GL+YIH      V+H+D+K SN
Sbjct: 110 DLMET-DLYKLLKTQHLSNDHICYFLYQILR-------GLKYIHS---ANVLHRDLKPSN 158

Query: 463 ILLDSNMRAKIANFGLAKSGCNAITMHI-----VGTQGYIAPEY-LADGVVSTKMDVFSF 516
           +LL++    KI +FGLA+               V T+ Y APE  L     +  +D++S 
Sbjct: 159 LLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 218

Query: 517 GVVLLELISGK 527
           G +L E++S +
Sbjct: 219 GCILAEMLSNR 229

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 76.5 bits (188), Expect = 3e-15
 Identities = 30/130 (23%), Positives = 61/130 (46%), Gaps = 9/130 (6%)

Query: 401 NCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
           + ++  + + +        +   + L  +  +  +  VA G++++      + +H+D+ +
Sbjct: 165 SGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 221

Query: 461 SNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYI-----APEYLADGVVSTKMDVFS 515
            NILL      KI +FGLA+        ++      +     APE + D V + + DV+S
Sbjct: 222 RNILLSEKNVVKICDFGLARD-IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 280

Query: 516 FGVVLLELIS 525
           FGV+L E+ S
Sbjct: 281 FGVLLWEIFS 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 31/119 (26%), Positives = 52/119 (43%), Gaps = 17/119 (14%)

Query: 351 GSVYKGNIHG-------EVYAIKMMKWNAC--------EELKILQKV-NHGNLVKLEGFC 394
           G V + +  G          A+KM+K  A          ELKIL  + +H N+V L G C
Sbjct: 36  GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 95

Query: 395 IDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRV 453
             P      +I E+ + G+L ++L   +NE + +KT+        + +  I    + R+
Sbjct: 96  TKPGGP-LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRL 153

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 76.1 bits (188), Expect = 4e-15
 Identities = 49/184 (26%), Positives = 90/184 (48%), Gaps = 26/184 (14%)

Query: 360 GEVYAIKMMK-----------WNACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYE 407
           G++YA+K++K               E+ +IL    NH  L +L   C    D   + + E
Sbjct: 48  GDLYAVKVLKKDVILQDDDVECTMTEK-RILSLARNHPFLTQLF-CCFQTPD-RLFFVME 104

Query: 408 YIENGSLHSWLHENK--NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL 465
           ++  G L   + +++  +E    + R   A ++ + L ++H+     ++++D+K  N+LL
Sbjct: 105 FVNGGDLMFHIQKSRRFDEA---RARFYAA-EIISALMFLHDK---GIIYRDLKLDNVLL 157

Query: 466 DSNMRAKIANFGLAKSGC--NAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLEL 523
           D     K+A+FG+ K G      T    GT  YIAPE L + +    +D ++ GV+L E+
Sbjct: 158 DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEM 217

Query: 524 ISGK 527
           + G 
Sbjct: 218 LCGH 221

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 75.7 bits (187), Expect = 5e-15
 Identities = 51/198 (25%), Positives = 83/198 (41%), Gaps = 43/198 (21%)

Query: 360 GEVYAIKMMKWNACE----------ELKILQKVNHGNLVKLEGFCIDPEDAN---CYLIY 406
           GE+ AIK  K    +          E+KIL+   H N++ +          N    Y+I 
Sbjct: 36  GEIVAIK--KIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQ 93

Query: 407 EYIENGSLHSWLHENKNENLNWKT----RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSN 462
           E ++   LH  +      + + +      LR        ++ +H      V+H+D+K SN
Sbjct: 94  ELMQT-DLHRVISTQMLSDDHIQYFIYQTLR-------AVKVLHG---SNVIHRDLKPSN 142

Query: 463 ILLDSNMRAKIANFGLAKSGCNAITMHI------------VGTQGYIAPEY-LADGVVST 509
           +L++SN   K+ +FGLA+    +   +             V T+ Y APE  L     S 
Sbjct: 143 LLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSR 202

Query: 510 KMDVFSFGVVLLELISGK 527
            MDV+S G +L EL   +
Sbjct: 203 AMDVWSCGCILAELFLRR 220

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 75.8 bits (187), Expect = 6e-15
 Identities = 48/184 (26%), Positives = 85/184 (46%), Gaps = 26/184 (14%)

Query: 360 GEVYAIKMMK-----------WNACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYE 407
             +YA++++K           W   E+  + ++  NH  LV L   C   E    + + E
Sbjct: 77  DRIYAMRVVKKELVNDDEDIDWVQTEK-HVFEQASNHPFLVGLH-SCFQTES-RLFFVIE 133

Query: 408 YIENGSLHSWLHENK--NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL 465
           Y+  G L   +   +   E      R   A +++  L Y+HE     ++++D+K  N+LL
Sbjct: 134 YVNGGDLMFHMQRQRKLPEE---HARFYSA-EISLALNYLHER---GIIYRDLKLDNVLL 186

Query: 466 DSNMRAKIANFGLAKSGC--NAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLEL 523
           DS    K+ ++G+ K G      T    GT  YIAPE L        +D ++ GV++ E+
Sbjct: 187 DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEM 246

Query: 524 ISGK 527
           ++G+
Sbjct: 247 MAGR 250

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 74.8 bits (184), Expect = 1e-14
 Identities = 47/229 (20%), Positives = 87/229 (37%), Gaps = 62/229 (27%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNA---CEELKILQKVNHGNLVKLEGFCIDPEDANC--- 402
           G V +      G+ +A+K +  +      EL I++ ++H N++KL  +     D      
Sbjct: 21  GIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP 80

Query: 403 ---------------------------------YLIYEYIENGSLHSWLHENKNENLNWK 429
                                             +I EY+ + +LH  L          +
Sbjct: 81  QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSF------IR 133

Query: 430 TRLRIAID--------VANGLQYIHEHTRPRVVHKDIKSSNILLDSNM-RAKIANFGLAK 480
           +   I ++        +   + +IH      + H+DIK  N+L++S     K+ +FG AK
Sbjct: 134 SGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAK 190

Query: 481 SGCNAITM-HIVGTQGYIAPEYLADGVV-STKMDVFSFGVVLLELISGK 527
               +      + ++ Y APE +      +  +D++S G V  ELI GK
Sbjct: 191 KLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 74.2 bits (183), Expect = 2e-14
 Identities = 49/184 (26%), Positives = 83/184 (45%), Gaps = 26/184 (14%)

Query: 360 GEVYAIKMMK-----------WNACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYE 407
            E+YA+K++K               E+ ++L        L +L   C    D   Y + E
Sbjct: 45  DELYAVKILKKDVVIQDDDVECTMVEK-RVLALPGKPPFLTQLH-SCFQTMD-RLYFVME 101

Query: 408 YIENGSLHSWLHENK--NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL 465
           Y+  G L   + +     E          A ++A GL ++       ++++D+K  N++L
Sbjct: 102 YVNGGDLMYHIQQVGRFKEP---HAVFYAA-EIAIGLFFLQSK---GIIYRDLKLDNVML 154

Query: 466 DSNMRAKIANFGLAKSGC--NAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLEL 523
           DS    KIA+FG+ K        T    GT  YIAPE +A       +D ++FGV+L E+
Sbjct: 155 DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 214

Query: 524 ISGK 527
           ++G+
Sbjct: 215 LAGQ 218

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 73.4 bits (181), Expect = 3e-14
 Identities = 53/183 (28%), Positives = 79/183 (43%), Gaps = 24/183 (13%)

Query: 360 GEVYAIKMMK-----------WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEY 408
              YA+K+++               E   +L+ V H  LV L  F     D   Y + +Y
Sbjct: 63  EVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTAD-KLYFVLDY 120

Query: 409 IENGSLHSWLHENK--NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLD 466
           I  G L   L   +   E    + R   A ++A+ L Y+H      +V++D+K  NILLD
Sbjct: 121 INGGELFYHLQRERCFLEP---RARFYAA-EIASALGYLHSLN---IVYRDLKPENILLD 173

Query: 467 SNMRAKIANFGLAKSGC--NAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELI 524
           S     + +FGL K     N+ T    GT  Y+APE L        +D +  G VL E++
Sbjct: 174 SQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 233

Query: 525 SGK 527
            G 
Sbjct: 234 YGL 236

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 45/166 (27%), Positives = 79/166 (47%), Gaps = 32/166 (19%)

Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+  L+ + H +++KL      P D    ++ EY   G L  ++   + + +      R 
Sbjct: 59  EISYLKLLRHPHIIKLYDVITTPTD--IVMVIEYA-GGELFDYI--VEKKRMTEDEGRRF 113

Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLA---------KSGCNA 485
              +   ++Y H H   ++VH+D+K  N+LLD N+  KIA+FGL+         K+ C  
Sbjct: 114 FQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC-- 168

Query: 486 ITMHIVGTQGYIAPEYLA----DGVVSTKMDVFSFGVVLLELISGK 527
                 G+  Y APE +      G    ++DV+S G+VL  ++ G+
Sbjct: 169 ------GSPNYAAPEVINGKLYAG---PEVDVWSCGIVLYVMLVGR 205

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 71.6 bits (176), Expect = 7e-14
 Identities = 35/187 (18%), Positives = 74/187 (39%), Gaps = 35/187 (18%)

Query: 351 GSVYKGNIH---GEVYAIKMMKWNAC--EELKILQKV-NHGNLVKLEGFCIDP--EDANC 402
           G V +   +    E +A+KM++       E+++  +     ++V++     +        
Sbjct: 32  GKVLQI-FNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90

Query: 403 YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSN 462
            ++ E ++ G L S + +  ++    +    I   +   +QY+H      + H+D+K  N
Sbjct: 91  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPEN 147

Query: 463 ILLDS---NMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVV 519
           +L  S   N   K+ +FG AK             + Y               D++S GV+
Sbjct: 148 LLYTSKRPNAILKLTDFGFAK---------ETTGEKY-----------DKSCDMWSLGVI 187

Query: 520 LLELISG 526
           +  L+ G
Sbjct: 188 MYILLCG 194

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 71.6 bits (176), Expect = 1e-13
 Identities = 49/187 (26%), Positives = 90/187 (48%), Gaps = 28/187 (14%)

Query: 360 GEVYAIKMMK-------WNACE----ELKILQKVNHGN-LVKLEGFCIDPEDANCYLIYE 407
           G++YA+K++K           E    E ++L+ +     LV L  +    E    +LI +
Sbjct: 82  GKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH-YAFQTET-KLHLILD 139

Query: 408 YIENGSLHSWLHENK--NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL 465
           YI  G L + L + +   E+   + ++ +  ++   L+++H+     ++++DIK  NILL
Sbjct: 140 YINGGELFTHLSQRERFTEH---EVQIYVG-EIVLALEHLHKL---GIIYRDIKLENILL 192

Query: 466 DSNMRAKIANFGLAKSGC---NAITMHIVGTQGYIAPEYLADGVVSTKMDV--FSFGVVL 520
           DSN    + +FGL+K              GT  Y+AP+ +  G       V  +S GV++
Sbjct: 193 DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLM 252

Query: 521 LELISGK 527
            EL++G 
Sbjct: 253 YELLTGA 259

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 70.8 bits (174), Expect = 2e-13
 Identities = 39/172 (22%), Positives = 83/172 (48%), Gaps = 26/172 (15%)

Query: 375 ELKILQKVNHGNLVKL-----------EGFCIDPEDAN-CYLIYEYIENGSLHSWLHENK 422
           E+KI+++++H N+VK+                   + N  Y++ EY+E   L + L +  
Sbjct: 58  EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGP 116

Query: 423 NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS-NMRAKIANFGLAKS 481
               + +        +  GL+YIH      V+H+D+K +N+ +++ ++  KI +FGLA+ 
Sbjct: 117 LLEEHARL---FMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARI 170

Query: 482 GCNAITMHI-----VGTQGYIAPE-YLADGVVSTKMDVFSFGVVLLELISGK 527
                +        + T+ Y +P   L+    +  +D+++ G +  E+++GK
Sbjct: 171 MDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 70.1 bits (172), Expect = 4e-13
 Identities = 47/182 (25%), Positives = 86/182 (47%), Gaps = 40/182 (21%)

Query: 375 ELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT--- 430
           E+ IL +++ H N+V L        D + YL+++Y+E   LH+ +  N  E ++ +    
Sbjct: 58  EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQYVVY 116

Query: 431 -RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH 489
             ++        ++Y+H      ++H+D+K SNILL++    K+A+FGL++S  N   + 
Sbjct: 117 QLIK-------VIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT 166

Query: 490 I-----------------------VGTQGYIAPEY-LADGVVSTKMDVFSFGVVLLELIS 525
                                   V T+ Y APE  L     +  +D++S G +L E++ 
Sbjct: 167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC 226

Query: 526 GK 527
           GK
Sbjct: 227 GK 228

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 69.9 bits (171), Expect = 7e-13
 Identities = 47/225 (20%), Positives = 88/225 (39%), Gaps = 54/225 (24%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNACE----------ELKILQKVNHGNLVKLEGFCIDPE 398
           G V +    +   V AIK +     E          E+ IL ++NH ++VK+    I  +
Sbjct: 67  GHVCEAYDKLEKRVVAIKKIL-RVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKD 125

Query: 399 DAN---CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVH 455
                  Y++ E  ++              L       +  ++  G++Y+H      ++H
Sbjct: 126 VEKFDELYVVLEIADS-DFKKLFR--TPVYLTELHIKTLLYNLLVGVKYVHSA---GILH 179

Query: 456 KDIKSSNILLDSNMRAKIANFGLA------------------------------KSGCNA 485
           +D+K +N L++ +   K+ +FGLA                              K+    
Sbjct: 180 RDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQ 239

Query: 486 ITMHIVGTQGYIAPE-YLADGVVSTKMDVFSFGVVLLELISGKEA 529
           +T H+V T+ Y APE  L     +  +DV+S G +  EL++  + 
Sbjct: 240 LTGHVV-TRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 67.5 bits (165), Expect = 1e-12
 Identities = 16/147 (10%), Positives = 40/147 (27%), Gaps = 34/147 (23%)

Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
           +++   + ++    +    A   ++ E+I  GSL      +     +    +R    +A 
Sbjct: 87  RIDKPGVARV--LDVVHTRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAA 140

Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPE 500
                H      V       S + +  +    +A                      +   
Sbjct: 141 AADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYP------------------ATMPD- 178

Query: 501 YLADGVVSTKMDVFSFGVVLLELISGK 527
                  + + D+   G  L  L+  +
Sbjct: 179 ------ANPQDDIRGIGASLYALLVNR 199

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 67.9 bits (166), Expect = 3e-12
 Identities = 41/186 (22%), Positives = 79/186 (42%), Gaps = 40/186 (21%)

Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANC----YLIYEYIENGSLHSWLHE--NKNENLNW 428
           E+ IL ++    +++L    I P+D       Y++ E  +     S L +       L  
Sbjct: 75  EITILNRLKSDYIIRLYD-LIIPDDLLKFDELYIVLEIAD-----SDLKKLFKTPIFLTE 128

Query: 429 KTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM 488
           +    I  ++  G  +IHE     ++H+D+K +N LL+ +   K+ +FGLA++  +    
Sbjct: 129 EHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185

Query: 489 HI------------------------VGTQGYIAPEY-LADGVVSTKMDVFSFGVVLLEL 523
           +I                        V T+ Y APE  L     +  +D++S G +  EL
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245

Query: 524 ISGKEA 529
           ++  ++
Sbjct: 246 LNMLQS 251

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 67.1 bits (164), Expect = 4e-12
 Identities = 45/200 (22%), Positives = 86/200 (43%), Gaps = 37/200 (18%)

Query: 351 GSVYKGNIH--GEVYAIKMMKWN------ACEELKILQKVNHGNLVKLEGFCIDPEDA-N 401
           G V K   H   +  A+KM++        A EE++IL+ +             D ++  N
Sbjct: 111 GQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRK----------QDKDNTMN 160

Query: 402 CYLIYEYIE------------NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHT 449
              + E               + +L+  + +NK +  +     + A  +   L  +H++ 
Sbjct: 161 VIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN- 219

Query: 450 RPRVVHKDIKSSNILLDSNMRA--KIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVV 507
             R++H D+K  NILL    R+  K+ +FG +      +  +I  ++ Y APE +     
Sbjct: 220 --RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQ-SRFYRAPEVILGARY 276

Query: 508 STKMDVFSFGVVLLELISGK 527
              +D++S G +L EL++G 
Sbjct: 277 GMPIDMWSLGCILAELLTGY 296

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 46/215 (21%), Positives = 92/215 (42%), Gaps = 37/215 (17%)

Query: 359 HGEVYAIKMMKWN------ACEELKILQKVNHG-----------NLVKL-EGFCIDPEDA 400
           +    A+K+++ +      A +E+K+LQ+VN             +++KL + F     + 
Sbjct: 43  NNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNG 102

Query: 401 N--CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
                +++E +   +L + + + ++  +      +I+  +  GL Y+H   R  ++H DI
Sbjct: 103 VHVV-MVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH--RRCGIIHTDI 158

Query: 459 KSSNILLDSNMRA------KIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMD 512
           K  N+L++           KIA+ G A       T  I  T+ Y +PE L         D
Sbjct: 159 KPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ-TREYRSPEVLLGAPWGCGAD 217

Query: 513 VFSFGVVLLELISGKEAIDEEGKFCGQKLKGYWRE 547
           ++S   ++ ELI+G         F   +   Y ++
Sbjct: 218 IWSTACLIFELITGDFL------FEPDEGHSYTKD 246

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 62.6 bits (151), Expect = 2e-10
 Identities = 73/502 (14%), Positives = 146/502 (29%), Gaps = 157/502 (31%)

Query: 80  SNISSPSSPLIQNQPLFVPITCSCNTLNASYTISFANLSYTIKSGDTF--YLVSTNKYQN 137
            N +SP + L   Q L   I  +  + +       +N+   I S       L+ +  Y+N
Sbjct: 190 KNCNSPETVLEMLQKLLYQIDPNWTSRSDHS----SNIKLRIHSIQAELRRLLKSKPYEN 245

Query: 138 ----LTTYQSVEVVNPTFVPTKLEVGDVIIFPVFCKCPNQTQLRNRVNYLVSYVLQPSEN 193
               L   Q+ +  N               F + CK                 +L  +  
Sbjct: 246 CLLVLLNVQNAKAWNA--------------FNLSCK-----------------ILLTTRF 274

Query: 194 LSSVASRFGIETQAIIDVNGNNIRPFD-----TLFVPVARLPELKQPAVAPSTPPSAETP 248
              V       T   I ++ ++          +L +          P    +T P     
Sbjct: 275 -KQVTDFLSAATTTHISLD-HHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRR--- 329

Query: 249 SRKTERKGVIIGLSIGLGICGASLVLVAGMWIYREALLKKKREREIDEQKQKLQFNKGGR 308
                           L I   S+      W   + +   K    I+     L+      
Sbjct: 330 ----------------LSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPA---- 369

Query: 309 DLKDMEVNFMADVSDCLDKYRIFKIEELREATDNFSEGCLIQGSVYKGNIHGEVYAIKMM 368
           + + M              +    +         F     I   +        +      
Sbjct: 370 EYRKM--------------FDRLSV---------FPPSAHIPTILL------SLI----- 395

Query: 369 KWNACEE---LKILQKVNHGNLVKLEGFCIDPEDANCYL--IY----EYIEN-GSLHSWL 418
            W    +   + ++ K++  +LV+       P+++   +  IY      +EN  +LH  +
Sbjct: 396 -WFDVIKSDVMVVVNKLHKYSLVEK-----QPKESTISIPSIYLELKVKLENEYALHRSI 449

Query: 419 --HENKNENLNWKTRLRIAIDVANGLQYIHEH-----TRPRVVHKDIKSSNILLDSN-MR 470
             H N  +  +    +   +D     QY + H            +      + LD   + 
Sbjct: 450 VDHYNIPKTFDSDDLIPPYLD-----QYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLE 504

Query: 471 AKIANFGLAKSGCNAITMHIVGT----QGYIA---PEYLADGVVSTKMDVFSFG------ 517
            KI +   A +   +I ++ +      + YI    P+Y  + +V+  +D F         
Sbjct: 505 QKIRHDSTAWNASGSI-LNTLQQLKFYKPYICDNDPKY--ERLVNAILD-FLPKIEENLI 560

Query: 518 ------VVLLELISGKEAIDEE 533
                 ++ + L++  EAI EE
Sbjct: 561 CSKYTDLLRIALMAEDEAIFEE 582

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.5 bits (112), Expect = 9e-06
 Identities = 31/215 (14%), Positives = 69/215 (32%), Gaps = 59/215 (27%)

Query: 279 WIYREALLKKKREREIDEQKQKLQFNKGGRDLKDMEVNFMADVSDCLDKY---RIFKIEE 335
           ++    +  ++R+  +  +    Q ++   D            +    KY   R+    +
Sbjct: 93  FLM-SPIKTEQRQPSMMTRMYIEQRDRLYND------------NQVFAKYNVSRLQPYLK 139

Query: 336 LREATDNFSEGCLIQGSVYKG-NIHGEVYAIKMM----KW----NACEELKILQKVNHG- 385
           LR+A        L++    K   I G       +    K     + C   K+  K++   
Sbjct: 140 LRQA--------LLELRPAKNVLIDG-------VLGSGKTWVALDVCLSYKVQCKMDFKI 184

Query: 386 ---NLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANG- 441
              NL      C  PE      + E ++   L   +  N     +  + +++ I      
Sbjct: 185 FWLNL----KNCNSPET-----VLEMLQK--LLYQIDPNWTSRSDHSSNIKLRIHSIQAE 233

Query: 442 ---LQYIHEHTRPRVVHKDIKSSNILLDSNMRAKI 473
              L     +    +V  +++++      N+  KI
Sbjct: 234 LRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKI 268

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 61.3 bits (149), Expect = 3e-10
 Identities = 42/200 (21%), Positives = 79/200 (39%), Gaps = 35/200 (17%)

Query: 351 GSVYKGNIH--GEVYAIKMMKWN------ACEELKILQKVNHGNLVKLEGFCIDPEDA-N 401
           G V K       E  AIK++K        A  E+++L+ +N            D E    
Sbjct: 68  GQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNK----------HDTEMKYY 117

Query: 402 CYLIYEYIE------------NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHT 449
              +  +              + +L+  L       ++     + A  +   L ++    
Sbjct: 118 IVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP- 176

Query: 450 RPRVVHKDIKSSNILLDSNMRA--KIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVV 507
              ++H D+K  NILL +  R+  KI +FG +      I  +I  ++ Y +PE L     
Sbjct: 177 ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQ-SRFYRSPEVLLGMPY 235

Query: 508 STKMDVFSFGVVLLELISGK 527
              +D++S G +L+E+ +G+
Sbjct: 236 DLAIDMWSLGCILVEMHTGE 255

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 57.4 bits (139), Expect = 4e-09
 Identities = 28/156 (17%), Positives = 61/156 (39%), Gaps = 26/156 (16%)

Query: 345 EGCLIQGSVYKGNIHGEVYAIKM-----------------MKWNACEELKILQKVNHGNL 387
           E               + +++K+                  K     + K L       +
Sbjct: 60  EAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAI 119

Query: 388 VKLEGFCIDPEDANCYLIYEYIENG-SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIH 446
               GF +  +D   +L+   +  G SL S L  +    L+ ++ L++A  + + L+++H
Sbjct: 120 PTCMGFGVH-QDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH 176

Query: 447 EHTRPRVVHKDIKSSNILLDSNMRAKI--ANFGLAK 480
           E+     VH ++ + NI +D   ++++  A +G A 
Sbjct: 177 EN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 54.3 bits (131), Expect = 3e-08
 Identities = 41/153 (26%), Positives = 65/153 (42%), Gaps = 21/153 (13%)

Query: 351 GSVYKG-NIH-GEVYAIKMMKWNA-----CEELKILQKVNHGNLV-KLEGFCIDPEDANC 402
           G +Y G +I  GE  AIK+            E KI + +  G  +  +       E    
Sbjct: 23  GDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG--AEGDYN 80

Query: 403 YLIYEYIENG-SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSS 461
            ++ E +  G SL   L    +   + KT L +A  + + ++YIH       +H+D+K  
Sbjct: 81  VMVMELL--GPSL-EDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPD 134

Query: 462 NILLDSNMRAK---IANFGLAKSGCNAIT-MHI 490
           N L+    +     I +FGLAK   +A T  HI
Sbjct: 135 NFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 167

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 54.3 bits (131), Expect = 4e-08
 Identities = 36/158 (22%), Positives = 63/158 (39%), Gaps = 35/158 (22%)

Query: 351 GSVYKG-NIH-GEVYAIKMMKWNACE------ELKILQKVNHGNLVKLE----------- 391
           G +Y     +  E  A  ++K    E      ELK  Q+V   + +K             
Sbjct: 51  GLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGI 110

Query: 392 ------GFCIDPEDANCYLIYEYIENG-SLHSWLHENKNENLNWKTRLRIAIDVANGLQY 444
                 G       +  +++ E +  G  L       +N      T L++ I + + L+Y
Sbjct: 111 PLFYGSGLTEFKGRSYRFMVMERL--GIDLQKIS--GQNGTFKKSTVLQLGIRMLDVLEY 166

Query: 445 IHEHTRPRVVHKDIKSSNILLDSNMRAKI--ANFGLAK 480
           IHE+     VH DIK++N+LL      ++  A++GL+ 
Sbjct: 167 IHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 53.5 bits (129), Expect = 6e-08
 Identities = 39/160 (24%), Positives = 72/160 (45%), Gaps = 23/160 (14%)

Query: 346 GCLIQGSVYKG-NIH-GEVYAIKMMKWNA-----CEELKILQKVNHGNLV-KLEGFCIDP 397
           GC   G +  G N++  E  AIK+    +       E +  +++  G+ + ++  F   P
Sbjct: 18  GCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFG--P 75

Query: 398 EDANCYLIYEYIENG-SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHK 456
                 ++ E +  G SL   L +  +   + KT L IAI + + ++Y+H      ++++
Sbjct: 76  CGKYNAMVLELL--GPSLED-LFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYR 129

Query: 457 DIKSSNILL--DSNMRAK---IANFGLAKSGCNAIT-MHI 490
           D+K  N L+    N   +   I +F LAK   +  T  HI
Sbjct: 130 DVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHI 169

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 53.7 bits (128), Expect = 6e-08
 Identities = 34/236 (14%), Positives = 62/236 (26%), Gaps = 66/236 (27%)

Query: 322 SDCLDKYRIFKIEELREATDNFSEGCLIQGSVYKGNIHGEVYAIKMMKWNA--------- 372
           S CL   ++ + E++ E    F E       V++        AIK++             
Sbjct: 14  SHCLPTEKLQRCEKIGEGV--FGE-------VFQTIADHTPVAIKIIAIEGPDLVNGSHQ 64

Query: 373 ------CEELKILQKV---------NHGNLVKLEGFCI---------------------- 395
                   E+ I +++              + L                           
Sbjct: 65  KTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGS 124

Query: 396 ------DPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHT 449
                   +D   +++ E+   G     L + + +  +  T   I   +   L       
Sbjct: 125 ANDRPDFFKDDQLFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVAEA-- 179

Query: 450 RPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADG 505
             R  H+D+   N+LL      K+      KS         V    Y       DG
Sbjct: 180 SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG 235

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 34/171 (19%), Positives = 66/171 (38%), Gaps = 37/171 (21%)

Query: 351 GSVYKGNIH-------GEVYAIKMMKWNA---CEELKILQKVNHGNLVKLE--------- 391
           G +Y  +++            +K+   +      ELK  Q+      ++           
Sbjct: 49  GCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYL 108

Query: 392 --------GFCIDPEDANCYLIYEYIENG-SLHSWLHENKNENLNWKTRLRIAIDVANGL 442
                   G       +  ++I +    G  L   ++E   +  + KT L++++ + + L
Sbjct: 109 GVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQK-IYEANAKRFSRKTVLQLSLRILDIL 165

Query: 443 QYIHEHTRPRVVHKDIKSSNILLDSNMRAKI--ANFGLAKSGCNAIT-MHI 490
           +YIHEH     VH DIK+SN+LL+     ++   ++GLA   C        
Sbjct: 166 EYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAY 213

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 33/155 (21%), Positives = 63/155 (40%), Gaps = 23/155 (14%)

Query: 351 GSVYKG-NIH-GEVYAIKMMKWNA-----CEELKILQKVNHGNLV-KLEGFCIDPEDANC 402
           G +++G N+   +  AIK     +      +E +  + +     +  +  F    E  + 
Sbjct: 24  GVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG--QEGLHN 81

Query: 403 YLIYEYIENG-SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSS 461
            L+ + +  G SL   L +      + KT    A  +   +Q IHE +   +V++DIK  
Sbjct: 82  VLVIDLL--GPSLED-LLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPD 135

Query: 462 NILLDSNMRAK-----IANFGLAKSGCNAIT-MHI 490
           N L+            + +FG+ K   + +T  HI
Sbjct: 136 NFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 170

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 46/229 (20%), Positives = 74/229 (32%), Gaps = 73/229 (31%)

Query: 351 GSVYKGNIH--GEVYAIKMMKWN------ACEELKILQKVNHGNLVKLEGFCIDPEDANC 402
           G V         + YA+K+++        A  E  IL+K+ +           D  + N 
Sbjct: 49  GRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQND----------DINNNNI 98

Query: 403 YLIYEYIE------------NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTR 450
              +                  SL+  +  N     + +      I++   L Y+ +   
Sbjct: 99  VKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM-- 156

Query: 451 PRVVHKDIKSSNILLDSNMRA-------------------------KIANFGLAKSGCNA 485
             + H D+K  NILLD                              K+ +FG        
Sbjct: 157 -SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG---CATFK 212

Query: 486 ITMH--IVGTQGYIAPEYLADGVV-----STKMDVFSFGVVLLELISGK 527
              H  I+ T+ Y APE     V+         D++SFG VL EL +G 
Sbjct: 213 SDYHGSIINTRQYRAPE-----VILNLGWDVSSDMWSFGCVLAELYTGS 256

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 42/214 (19%), Positives = 77/214 (35%), Gaps = 66/214 (30%)

Query: 359 HGEVYAIKMMKWN------ACEELKILQKVNHGNLVKLEGFCIDPEDA-NCYLIYEYIE- 410
                A+K+++        A  E+ +L+K+             D E+   C L+ ++   
Sbjct: 44  GKSQVALKIIRNVGKYREAARLEINVLKKIKEK----------DKENKFLCVLMSDWFNF 93

Query: 411 -----------NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIK 459
                        +   +L EN  +         +A  + + L+++HE+   ++ H D+K
Sbjct: 94  HGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLK 150

Query: 460 SSNILLDSNMRA-------------------KIANFGLAKSGCNAITMH--IVGTQGYIA 498
             NIL  ++                      ++A+FG   S       H  IV T+ Y  
Sbjct: 151 PENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG---SATFDHEHHTTIVATRHYRP 207

Query: 499 PEYLADGVV-----STKMDVFSFGVVLLELISGK 527
           PE     V+     +   DV+S G +L E   G 
Sbjct: 208 PE-----VILELGWAQPCDVWSIGCILFEYYRGF 236

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 44/153 (28%), Positives = 67/153 (43%), Gaps = 21/153 (13%)

Query: 351 GSVYKG-NIH-GEVYAIKMMKWNA-----CEELKILQKVNHGNLV-KLEGFCIDPEDANC 402
           G +Y G NI   E  AIK+            E KI + +  G  +  +  F    E    
Sbjct: 21  GEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFG--VEGDYN 78

Query: 403 YLIYEYIENG-SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSS 461
            L+ + +  G SL   L    +  L+ KT L +A  + N ++++H  +    +H+DIK  
Sbjct: 79  VLVMDLL--GPSL-EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPD 132

Query: 462 NILLDSNMRAK---IANFGLAKSGCNAIT-MHI 490
           N L+    RA    I +FGLAK   +  T  HI
Sbjct: 133 NFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 51.8 bits (124), Expect = 3e-07
 Identities = 45/224 (20%), Positives = 76/224 (33%), Gaps = 81/224 (36%)

Query: 372 ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE-------NG------------ 412
           A +E+++L+ V +           DP D N  ++ + ++       NG            
Sbjct: 80  ALDEIRLLKSVRNS----------DPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGH 129

Query: 413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL------- 465
            L  W+ ++  + L      +I   V  GL Y+H  T+ R++H DIK  NILL       
Sbjct: 130 HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYI 187

Query: 466 ------------------------------------------DSNMRAKIANFGLAKSGC 483
                                                        ++ KIA+ G A    
Sbjct: 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH 247

Query: 484 NAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
              T   + T+ Y + E L     +T  D++S   +  EL +G 
Sbjct: 248 KHFT-EDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGD 290

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 42/211 (19%), Positives = 74/211 (35%), Gaps = 60/211 (28%)

Query: 359 HGEVYAIKMMKWN------ACEELKILQKVNHGNLVKLEGFCIDPEDA-NCYLIYEYIE- 410
            G   A+K++K        A  E+++L+ +N            DP     C  + E+ E 
Sbjct: 39  GGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTT----------DPNSTFRCVQMLEWFEH 88

Query: 411 -----------NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIK 459
                        S + ++ EN           ++A  +   + ++H +   ++ H D+K
Sbjct: 89  HGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLK 145

Query: 460 SSNILLDSNMRAKIANFGLAKSGCNAITMHI------------------VGTQGYIAPEY 501
             NIL   +   +  N  + +     I   I                  V T+ Y APE 
Sbjct: 146 PENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPE- 204

Query: 502 LADGVV-----STKMDVFSFGVVLLELISGK 527
               V+     S   DV+S G +L+E   G 
Sbjct: 205 ----VILALGWSQPCDVWSIGCILIEYYLGF 231

>2djp_A Hypothetical protein SB145; LYSM, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 77

 Score = 42.9 bits (101), Expect = 8e-06
 Identities = 15/66 (22%), Positives = 31/66 (46%), Gaps = 8/66 (12%)

Query: 184 VSYVLQPSENLSSVASRFGIETQAIIDVNG----NNIRPFDTLFVPVARLPELKQPAVAP 239
           + + L+P + L+ +A ++G+  + I   N     ++I    TL++P+   P      +  
Sbjct: 16  LEHQLEPGDTLAGLALKYGVTMEQIKRANRLYTNDSIFLKKTLYIPILTEP----RDLFN 71

Query: 240 STPPSA 245
           S P S 
Sbjct: 72  SGPSSG 77

>2l9y_A CVNH-LYSM lectin; carbohydrate, sugar binding protein; NMR {Magnaporthe oryzae 70-15} Length = 167

 Score = 41.2 bits (96), Expect = 2e-04
 Identities = 13/100 (13%), Positives = 28/100 (28%), Gaps = 5/100 (5%)

Query: 118 SYTIKSGDTFYLVSTNKYQNLTTYQSVEVVNPTFVPTKLEVGDVIIFPVFCKCPNQTQLR 177
           + T++ GDT   +   ++     +  +   N       +  G V+  P   K  +     
Sbjct: 64  TVTVQQGDTLRDIG-RRFD--CDFHEIARRNNIQNEDLIYPGQVLQVPT--KGGSGGGAG 118

Query: 178 NRVNYLVSYVLQPSENLSSVASRFGIETQAIIDVNGNNIR 217
           N  +      L     +     R+             +I 
Sbjct: 119 NFWDSARDVRLVDGGKVLEAELRYSGGWNRSRIYLDEHIG 158

>2l9y_A CVNH-LYSM lectin; carbohydrate, sugar binding protein; NMR {Magnaporthe oryzae 70-15} Length = 167

 Score = 39.6 bits (92), Expect = 8e-04
 Identities = 12/77 (15%), Positives = 21/77 (27%), Gaps = 11/77 (14%)

Query: 184 VSYVLQPSENLSSVASRFGIETQAIIDVNG----NNIRPFDTLFVPVARLPELKQPAVAP 239
            +  +Q  + L  +  RF  +   I   N     + I P   L VP        +     
Sbjct: 63  ATVTVQQGDTLRDIGRRFDCDFHEIARRNNIQNEDLIYPGQVLQVP-------TKGGSGG 115

Query: 240 STPPSAETPSRKTERKG 256
                 ++        G
Sbjct: 116 GAGNFWDSARDVRLVDG 132

>1e0g_A Membrane-bound lytic murein transglycosylase D; cell WALL, hydrolase, glycosidase, lipoprotein, outer membrane, multigene family; NMR {Escherichia coli} SCOP: d.7.1.1 Length = 48

 Score = 36.7 bits (86), Expect = 7e-04
 Identities = 13/45 (28%), Positives = 27/45 (60%), Gaps = 2/45 (4%)

Query: 184 VSYVLQPSENLSSVASRFGIETQAIIDVNG--NNIRPFDTLFVPV 226
           ++Y ++  ++LSS+A R G+  + ++  N    N++P D L + V
Sbjct: 3   ITYRVRKGDSLSSIAKRHGVNIKDVMRWNSDTANLQPGDKLTLFV 47

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	552
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4eby_A	212	Chitin elicitor receptor kinase 1; pathogen-associ	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.98
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.98
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.98
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.98
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.98
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.98
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.98
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.98
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.98
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.98
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.98
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.98
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.98
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.98
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.98
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.98
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.98
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.98
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.98
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.98
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.98
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.98
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.98
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.98
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.98
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.98
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.98
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.98
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.98
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.98
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.98
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.98
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.98
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.98
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.98
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.98
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.98
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.98
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.98
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.98
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.97
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.97
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.97
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.97
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.97
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.97
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.97
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.97
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.97
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.97
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.97
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.97
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.97
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.97
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.97
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.97
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.97
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.97
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.97
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.97
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.97
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.97
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.97
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.97
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.97
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.97
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.97
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.97
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.97
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.97
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.97
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.97
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.97
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.97
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.97
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.97
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.97
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.97
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.97
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.97
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.97
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.97
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.97
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.97
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.97
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.97
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.97
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.97
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.97
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.97
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.97
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.97
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.97
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.97
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.97
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.97
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.97
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.97
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.97
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.97
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.97
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.97
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.97
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.97
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.97
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.97
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.97
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.97
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.97
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.97
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.97
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.97
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.97
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.97
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.97
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.97
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.97
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.97
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.97
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.96
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.96
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.96
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.96
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.96
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.96
3uqc_A	286	Probable conserved transmembrane protein; structur	99.96
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.94
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.9
4eby_A	212	Chitin elicitor receptor kinase 1; pathogen-associ	99.82
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.8
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.68
2l9y_A	167	CVNH-LYSM lectin; carbohydrate, sugar binding prot	99.54
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.5
2l9y_A	167	CVNH-LYSM lectin; carbohydrate, sugar binding prot	99.3
2gu1_A	361	Zinc peptidase; alpha/beta, beta barrel, structura	99.24
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.17
2gu1_A	361	Zinc peptidase; alpha/beta, beta barrel, structura	99.17
2djp_A	77	Hypothetical protein SB145; LYSM, structural genom	99.17
2djp_A	77	Hypothetical protein SB145; LYSM, structural genom	99.14
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.99
1e0g_A	48	Membrane-bound lytic murein transglycosylase D; ce	98.97
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.92
1e0g_A	48	Membrane-bound lytic murein transglycosylase D; ce	98.92
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.86
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.32
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.25
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.24
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.22
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.16
4a1k_A	165	Putative L, D-transpeptidase YKUD; transferase, pe	98.07
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.04
4a1k_A	165	Putative L, D-transpeptidase YKUD; transferase, pe	97.98
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.77
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.53
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.44
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.41
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.24
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.24
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.19
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	96.96
3slu_A	371	M23 peptidase domain protein; outer membrane, hydr	96.9
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.9
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.86
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.85
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.77
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.69
3slu_A	371	M23 peptidase domain protein; outer membrane, hydr	96.39
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.26
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.21
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.33
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	95.28
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	93.29
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.1
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	93.03
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	92.38
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	92.24
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	88.57
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	82.43

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.9e-44  Score=361.32  Aligned_cols=185  Identities=24%  Similarity=0.421  Sum_probs=162.2

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      .|.|+||.||+++.  +|+.||||+++..         +.+|+.++++++||||+++++++.+  ++.+|+||||+++|+
T Consensus        32 lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~--~~~~yiVmEy~~gg~  109 (350)
T 4b9d_A           32 IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE--NGSLYIVMDYCEGGD  109 (350)
T ss_dssp             C------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEEECCTTCB
T ss_pred             EecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE--CCEEEEEEeCCCCCc
Confidence            48888899999987  6999999998532         3479999999999999999999987  778999999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--cccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIV  491 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~  491 (552)
                      |.+++...+...+++.+++.|+.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+.....  .....+
T Consensus       110 L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~  186 (350)
T 4b9d_A          110 LFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI  186 (350)
T ss_dssp             HHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHHHHHH
T ss_pred             HHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCcccccccC
Confidence            999998766666899999999999999999999999   999999999999999999999999999865433  233468


Q ss_pred             ccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          492 GTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       492 gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ||+.|||||++.+..++.++|||||||++|||+||+.||.+.+
T Consensus       187 GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~  229 (350)
T 4b9d_A          187 GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS  229 (350)
T ss_dssp             SCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence            9999999999999999999999999999999999999998654

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=6.7e-44  Score=354.49  Aligned_cols=183  Identities=25%  Similarity=0.435  Sum_probs=165.0

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|.|+||.||+++.  +|+.||||++++.          ..+|++++++++||||+++++++.+  ++.+|+||||+++|
T Consensus        40 lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~yivmEy~~gG  117 (311)
T 4aw0_A           40 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD--DEKLYFGLSYAKNG  117 (311)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEEECCCTTE
T ss_pred             EecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEEEEecCCCC
Confidence            38888899999987  7899999998532          3479999999999999999999987  77899999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC----Cccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN----AITM  488 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~----~~~~  488 (552)
                      +|.+++....  .+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+....    ....
T Consensus       118 ~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~  192 (311)
T 4aw0_A          118 ELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN  192 (311)
T ss_dssp             EHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBC
T ss_pred             CHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCccccc
Confidence            9999998654  4999999999999999999999999   99999999999999999999999999985432    2234


Q ss_pred             cccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          489 HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       489 ~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..+||+.|||||++.+..++.++||||+||++|||+||+.||.+.+
T Consensus       193 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~  238 (311)
T 4aw0_A          193 SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN  238 (311)
T ss_dssp             CCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            5689999999999999999999999999999999999999998655

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.9e-43  Score=356.38  Aligned_cols=182  Identities=25%  Similarity=0.448  Sum_probs=165.0

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEecc-------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKW-------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~-------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      .|.|+||.||+|+.  +|+.||||+++.       ...+|+.+|++++||||+++++++.+  ++.+|+||||+++|+|.
T Consensus        82 iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~--~~~~~ivmEy~~gg~L~  159 (346)
T 4fih_A           82 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVVMEFLEGGALT  159 (346)
T ss_dssp             EEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEECCCTTEEHH
T ss_pred             eecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEEEeCCCCCcHH
Confidence            37788899999988  689999999843       24689999999999999999999988  77899999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC--Ccccccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN--AITMHIVGT  493 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~--~~~~~~~gt  493 (552)
                      +++...   .+++.++..++.||+.||+|||+++   |+||||||+|||++.+|.+||+|||+|+....  ......+||
T Consensus       160 ~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT  233 (346)
T 4fih_A          160 DIVTHT---RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGT  233 (346)
T ss_dssp             HHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSC
T ss_pred             HHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccccccC
Confidence            998764   3999999999999999999999999   99999999999999999999999999985433  234457899


Q ss_pred             ccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       494 ~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +.|||||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus       234 p~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~  274 (346)
T 4fih_A          234 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP  274 (346)
T ss_dssp             GGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             cCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence            99999999999999999999999999999999999998654

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.9e-43  Score=346.40  Aligned_cols=185  Identities=25%  Similarity=0.398  Sum_probs=162.7

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecC--CCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDP--EDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~~~lv~e~~~~  411 (552)
                      .|.|+||.||+|.+  ++..||+|++...         +.+|++++++++||||++++++|.+.  .+..+|+||||+++
T Consensus        34 iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~g  113 (290)
T 3fpq_A           34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTS  113 (290)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred             EecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCC
Confidence            48888899999988  6889999998532         45799999999999999999998652  23568999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECC-CCcEEEeeccCCccCCCCccccc
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS-NMRAKIANFGLAKSGCNAITMHI  490 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kL~Dfg~a~~~~~~~~~~~  490 (552)
                      |+|.+++....  .+++..++.|+.|++.||+|||+++ ++|+||||||+|||++. ++.+||+|||+|+..........
T Consensus       114 g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~~~~~~  190 (290)
T 3fpq_A          114 GTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV  190 (290)
T ss_dssp             CBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEES
T ss_pred             CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCCCccCCc
Confidence            99999998654  4999999999999999999999985 35999999999999974 79999999999987666666678


Q ss_pred             cccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       491 ~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      +||+.|||||++.+ .++.++|||||||++|||+||+.||.+.
T Consensus       191 ~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~  232 (290)
T 3fpq_A          191 IGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC  232 (290)
T ss_dssp             CSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             ccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            99999999998864 6999999999999999999999999754

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.8e-43  Score=354.17  Aligned_cols=183  Identities=25%  Similarity=0.304  Sum_probs=162.6

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC--hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhhhhh
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN--ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHE  420 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~--~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~  420 (552)
                      .|.|+||.||+++.  +|+.||||+++.+  ..+|+.++++++||||+++++++.+  ++.+|+||||+++|+|.+++..
T Consensus        66 lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~~l~HpnIV~l~~~~~~--~~~~~ivmEy~~gg~L~~~l~~  143 (336)
T 4g3f_A           66 VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVRE--GPWVNIFMELLEGGSLGQLIKQ  143 (336)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTTTCCCTTBCCEEEEEEE--TTEEEEEECCCTTCBHHHHHHH
T ss_pred             eccCCCeEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEEEeccCCCcHHHHHHH
Confidence            48888899999987  6899999999754  3489999999999999999999987  6789999999999999999986


Q ss_pred             cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCC-cEEEeeccCCccCCCCc-------cccccc
Q 037224          421 NKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM-RAKIANFGLAKSGCNAI-------TMHIVG  492 (552)
Q Consensus       421 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~~~~~~-------~~~~~g  492 (552)
                      ..  .+++.+++.++.|++.||+|||+++   |+||||||+|||++.+| ++||+|||+|+......       ....+|
T Consensus       144 ~~--~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~G  218 (336)
T 4g3f_A          144 MG--CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG  218 (336)
T ss_dssp             HS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCC
T ss_pred             cC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCcccc
Confidence            54  4999999999999999999999999   99999999999999987 69999999998543211       123579


Q ss_pred             cccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       493 t~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      |+.|||||++.+..++.++|||||||++|||+||+.||.+..
T Consensus       219 T~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~  260 (336)
T 4g3f_A          219 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF  260 (336)
T ss_dssp             CGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC
T ss_pred             CccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence            999999999999999999999999999999999999998654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.1e-43  Score=350.14  Aligned_cols=185  Identities=26%  Similarity=0.468  Sum_probs=160.9

Q ss_pred             CCceEEEEEEEEee-------cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          345 EGCLIQGSVYKGNI-------HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-------~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      .|.|+||.||+|++       ++..||||+++..       +.+|++++++++||||++++|+|.+  ++..++||||++
T Consensus        21 lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~--~~~~~lV~Ey~~   98 (299)
T 4asz_A           21 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE--GDPLIMVFEYMK   98 (299)
T ss_dssp             EEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSSEEEEEECCT
T ss_pred             EeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEee--CCEEEEEEEcCC
Confidence            48888899999986       3678999999643       4579999999999999999999987  667899999999


Q ss_pred             CCCchhhhhhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCC
Q 037224          411 NGSLHSWLHENK-----------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLA  479 (552)
Q Consensus       411 ~gsL~~~l~~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  479 (552)
                      +|+|.++++...           ...++|.+++.|+.|+++||+|||+++   |+||||||+|||+++++.+||+|||+|
T Consensus        99 ~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki~DFGla  175 (299)
T 4asz_A           99 HGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMS  175 (299)
T ss_dssp             TCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCH
T ss_pred             CCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEECCcccc
Confidence            999999997642           246999999999999999999999998   999999999999999999999999999


Q ss_pred             ccCCCCc----cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          480 KSGCNAI----TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       480 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      +......    .....||+.|||||.+.+..++.++|||||||++|||+| |+.||.+.+
T Consensus       176 ~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~  235 (299)
T 4asz_A          176 RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS  235 (299)
T ss_dssp             HHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             eecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            7433221    223468999999999999999999999999999999999 999998754

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=8.3e-43  Score=348.56  Aligned_cols=185  Identities=29%  Similarity=0.455  Sum_probs=161.9

Q ss_pred             CCceEEEEEEEEee-------cCcEEEEEEecc--------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeec
Q 037224          345 EGCLIQGSVYKGNI-------HGEVYAIKMMKW--------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI  409 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-------~g~~vAvK~~~~--------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~  409 (552)
                      .|.|+||.||+|++       +++.||||+++.        ++.+|+.++++++||||++++|+|.+  +...++||||+
T Consensus        34 lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~--~~~~~lV~Ey~  111 (308)
T 4gt4_A           34 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK--DQPLSMIFSYC  111 (308)
T ss_dssp             EEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEEECC
T ss_pred             eccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE--CCEEEEEEEcC
Confidence            37788899999986       457899999853        25689999999999999999999987  66789999999


Q ss_pred             cCCCchhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEee
Q 037224          410 ENGSLHSWLHENK--------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIAN  475 (552)
Q Consensus       410 ~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~D  475 (552)
                      ++|+|.++|....              ...++|.+++.|+.|+++||+|||+++   |+||||||+|||+++++.+||+|
T Consensus       112 ~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~~Ki~D  188 (308)
T 4gt4_A          112 SHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISD  188 (308)
T ss_dssp             SSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECC
T ss_pred             CCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCCEEECC
Confidence            9999999996532              135899999999999999999999998   99999999999999999999999


Q ss_pred             ccCCccCCCC----ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          476 FGLAKSGCNA----ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       476 fg~a~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      ||+++.....    ......||+.|||||++.++.++.++|||||||+||||+| |+.||.+.+
T Consensus       189 FGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~  252 (308)
T 4gt4_A          189 LGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS  252 (308)
T ss_dssp             SCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC
T ss_pred             cccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Confidence            9999753221    2234578999999999999999999999999999999998 899998754

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.7e-42  Score=357.93  Aligned_cols=182  Identities=25%  Similarity=0.448  Sum_probs=164.7

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEecc-------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKW-------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~-------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      .|.|+||.||+|+.  +|+.||||+++.       ...+|+.+|++++||||++++++|.+  ++.+|+|||||++|+|.
T Consensus       159 iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~--~~~~~iVmEy~~gG~L~  236 (423)
T 4fie_A          159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVVMEFLEGGALT  236 (423)
T ss_dssp             EEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEEECCTTEEHH
T ss_pred             eccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEE--CCEEEEEEeCCCCCcHH
Confidence            37788899999998  689999999843       24589999999999999999999988  67899999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC--Ccccccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN--AITMHIVGT  493 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~--~~~~~~~gt  493 (552)
                      +++...   .+++.++..++.||+.||+|||+++   |+||||||+|||++.+|.+||+|||+|+....  ......+||
T Consensus       237 ~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT  310 (423)
T 4fie_A          237 DIVTHT---RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGT  310 (423)
T ss_dssp             HHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCCEEC
T ss_pred             HHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCccccccccC
Confidence            998764   3999999999999999999999999   99999999999999999999999999985433  234457899


Q ss_pred             ccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       494 ~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +.|||||++.+..|+.++|||||||++|||++|+.||.+.+
T Consensus       311 p~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~  351 (423)
T 4fie_A          311 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP  351 (423)
T ss_dssp             TTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             cCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence            99999999999999999999999999999999999998654

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.8e-42  Score=349.38  Aligned_cols=185  Identities=25%  Similarity=0.442  Sum_probs=157.2

Q ss_pred             CCceEEEEEEEEee-------cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          345 EGCLIQGSVYKGNI-------HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-------~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      .|.|+||.||+|++       +++.||||+++..       +.+|+++|++++||||++++|+|.+  +..+++||||++
T Consensus        49 LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~--~~~~~lV~Ey~~  126 (329)
T 4aoj_A           49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE--GRPLLMVFEYMR  126 (329)
T ss_dssp             EEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSSEEEEEECCT
T ss_pred             EccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEEEEcCC
Confidence            47888899999986       3678999999643       4589999999999999999999987  667899999999


Q ss_pred             CCCchhhhhhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeecc
Q 037224          411 NGSLHSWLHENKN-------------ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFG  477 (552)
Q Consensus       411 ~gsL~~~l~~~~~-------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg  477 (552)
                      +|+|.++++....             .+++|.+++.|+.|+++||+|||+++   |+||||||+|||+++++.+||+|||
T Consensus       127 ~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~Ki~DFG  203 (329)
T 4aoj_A          127 HGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFG  203 (329)
T ss_dssp             TCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC
T ss_pred             CCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcEEEcccc
Confidence            9999999976431             35999999999999999999999998   9999999999999999999999999


Q ss_pred             CCccCCCC----ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          478 LAKSGCNA----ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       478 ~a~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      +++.....    ......||+.|||||++.+..++.++|||||||+||||+| |+.||.+.+
T Consensus       204 la~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~  265 (329)
T 4aoj_A          204 MSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS  265 (329)
T ss_dssp             ----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC
T ss_pred             cceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC
Confidence            99854322    2234578999999999999999999999999999999999 999998654

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.4e-42  Score=337.53  Aligned_cols=182  Identities=25%  Similarity=0.446  Sum_probs=150.8

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|.|++|.||+++.  +|+.||+|+++..          ..+|+.++++++||||+++++++.+  ++.+|+||||+ +|
T Consensus        21 lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~ivmEy~-~g   97 (275)
T 3hyh_A           21 LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS--KDEIIMVIEYA-GN   97 (275)
T ss_dssp             EEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEEEECC-CE
T ss_pred             EecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEEEEEEeCC-CC
Confidence            38888899999987  7899999998532          3479999999999999999999987  67899999999 57


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC-Ccccccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN-AITMHIV  491 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~-~~~~~~~  491 (552)
                      +|.+++....  .+++.++..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+.... ......+
T Consensus        98 ~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~  172 (275)
T 3hyh_A           98 ELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC  172 (275)
T ss_dssp             EHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-------------
T ss_pred             CHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCCCccCCee
Confidence            9999987654  4999999999999999999999999   99999999999999999999999999985443 2334578


Q ss_pred             ccccccCccccCCCCC-CChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          492 GTQGYIAPEYLADGVV-STKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       492 gt~~y~aPE~~~~~~~-s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ||+.|||||++.+..+ +.++||||+||++|||+||+.||.+.+
T Consensus       173 GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~  216 (275)
T 3hyh_A          173 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES  216 (275)
T ss_dssp             --CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC
Confidence            9999999999988776 579999999999999999999998654

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.5e-42  Score=343.85  Aligned_cols=182  Identities=31%  Similarity=0.516  Sum_probs=155.5

Q ss_pred             CCceEEEEEEEEeecCcEEEEEEecc---------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          345 EGCLIQGSVYKGNIHGEVYAIKMMKW---------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~g~~vAvK~~~~---------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      .|.|+||+||+|++.+ .||||+++.         .+.+|+.++++++||||++++++|.+   +.+++||||+++|+|.
T Consensus        44 iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~---~~~~iVmEy~~gGsL~  119 (307)
T 3omv_A           44 IGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK---DNLAIVTQWCEGSSLY  119 (307)
T ss_dssp             CCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEEEEECCSSCBHH
T ss_pred             EeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC---CeEEEEEEcCCCCCHH
Confidence            4888889999999866 589999863         24579999999999999999998854   4579999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC----Ccccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN----AITMHIV  491 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~----~~~~~~~  491 (552)
                      +++.... ..+++.+++.|+.|+++||+|||+++   |+||||||+|||+++++.+||+|||+|+....    .......
T Consensus       120 ~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~  195 (307)
T 3omv_A          120 KHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPT  195 (307)
T ss_dssp             HHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------------CC
T ss_pred             HHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccc
Confidence            9997654 35999999999999999999999998   99999999999999999999999999975432    2233468


Q ss_pred             ccccccCccccCC---CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          492 GTQGYIAPEYLAD---GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       492 gt~~y~aPE~~~~---~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ||+.|||||++.+   +.++.++|||||||+||||+||+.||.+.+
T Consensus       196 GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~  241 (307)
T 3omv_A          196 GSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN  241 (307)
T ss_dssp             CCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             cCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC
Confidence            9999999999853   458999999999999999999999998643

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=6.4e-43  Score=347.35  Aligned_cols=184  Identities=27%  Similarity=0.417  Sum_probs=159.4

Q ss_pred             CCceEEEEEEEEee-----cCcEEEEEEecc---------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          345 EGCLIQGSVYKGNI-----HGEVYAIKMMKW---------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-----~g~~vAvK~~~~---------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      .|.|++|.||+++.     .++.||+|+++.         .+.+|++++++++||||+++++++.+  ++.+|+||||++
T Consensus        32 lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~ivmEy~~  109 (304)
T 3ubd_A           32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT--EGKLYLILDFLR  109 (304)
T ss_dssp             EECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE--TTEEEEEECCCT
T ss_pred             EecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEEEEEEEcCC
Confidence            37778899999975     467999999853         24579999999999999999999988  778999999999


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC--CCccc
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC--NAITM  488 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~--~~~~~  488 (552)
                      +|+|.+++....  .+++.++..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+...  .....
T Consensus       110 gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~  184 (304)
T 3ubd_A          110 GGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY  184 (304)
T ss_dssp             TCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-----CCCC
T ss_pred             CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCCCcccc
Confidence            999999998754  4999999999999999999999999   9999999999999999999999999997532  22334


Q ss_pred             cccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          489 HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       489 ~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      ..+||+.|||||++.+..++.++|||||||++|||+||+.||.+.+.
T Consensus       185 ~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~  231 (304)
T 3ubd_A          185 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR  231 (304)
T ss_dssp             SCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH
Confidence            57899999999999999999999999999999999999999987653

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.3e-41  Score=337.36  Aligned_cols=185  Identities=28%  Similarity=0.432  Sum_probs=153.0

Q ss_pred             CCceEEEEEEEEeecCcEEEEEEeccChH------HHHHHHHHcCCCCccceeeeeecCCC--CeeEEEEeeccCCCchh
Q 037224          345 EGCLIQGSVYKGNIHGEVYAIKMMKWNAC------EELKILQKVNHGNLVKLEGFCIDPED--ANCYLIYEYIENGSLHS  416 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~g~~vAvK~~~~~~~------~E~~~l~~l~h~niv~l~~~~~~~~~--~~~~lv~e~~~~gsL~~  416 (552)
                      .|.|+||.||+|+++|+.||||+++....      .|+..+.+++||||++++++|.+...  ..+++||||+++|+|.+
T Consensus        11 iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~   90 (303)
T 3hmm_A           11 IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFD   90 (303)
T ss_dssp             EEECSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHH
T ss_pred             EeeCCCeEEEEEEECCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHH
Confidence            37888899999999999999999975432      35555677899999999999986432  25799999999999999


Q ss_pred             hhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC------
Q 037224          417 WLHENKNENLNWKTRLRIAIDVANGLQYIHEH-----TRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA------  485 (552)
Q Consensus       417 ~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-----~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~------  485 (552)
                      +++...   ++|+++++++.|+++||+|||++     ..++|+||||||+|||++.++.+||+|||+++.....      
T Consensus        91 ~l~~~~---l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~  167 (303)
T 3hmm_A           91 YLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI  167 (303)
T ss_dssp             HHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESC
T ss_pred             HHHhCC---CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceee
Confidence            998654   99999999999999999999987     1234999999999999999999999999999743221      


Q ss_pred             ccccccccccccCccccCCC------CCCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          486 ITMHIVGTQGYIAPEYLADG------VVSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       486 ~~~~~~gt~~y~aPE~~~~~------~~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                      ......||+.|||||++.+.      .++.++|||||||+||||+||+.||..
T Consensus       168 ~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~  220 (303)
T 3hmm_A          168 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI  220 (303)
T ss_dssp             C-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred             ecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCc
Confidence            12235799999999998654      467799999999999999999887753

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.9e-40  Score=335.96  Aligned_cols=186  Identities=30%  Similarity=0.479  Sum_probs=160.1

Q ss_pred             CCceEEEEEEEEeecC-------cEEEEEEeccC--------hHHHHHHHHHcCC-CCccceeeeeecCCCCeeEEEEee
Q 037224          345 EGCLIQGSVYKGNIHG-------EVYAIKMMKWN--------ACEELKILQKVNH-GNLVKLEGFCIDPEDANCYLIYEY  408 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~g-------~~vAvK~~~~~--------~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~~~lv~e~  408 (552)
                      .|.|+||.||+|++.+       +.||||+++..        +.+|+.+|.+++| |||++++|+|.+. +..+++||||
T Consensus        72 LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~-~~~~~iV~Ey  150 (353)
T 4ase_A           72 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-GGPLMVIVEF  150 (353)
T ss_dssp             EEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-TSCCEEEEEC
T ss_pred             EecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec-CCEEEEEEEc
Confidence            3888889999998733       58999998643        4579999999965 8999999999753 3467999999


Q ss_pred             ccCCCchhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEe
Q 037224          409 IENGSLHSWLHENK--------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIA  474 (552)
Q Consensus       409 ~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~  474 (552)
                      |++|+|.++|+...              ...+++.+++.++.|+++||+|||+++   |+||||||+|||+++++.+||+
T Consensus       151 ~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~vKi~  227 (353)
T 4ase_A          151 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKIC  227 (353)
T ss_dssp             CTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEEC
T ss_pred             CCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceeeCCCCCEEEC
Confidence            99999999997543              234899999999999999999999999   9999999999999999999999


Q ss_pred             eccCCccCCCC----ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          475 NFGLAKSGCNA----ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       475 Dfg~a~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      |||+|+.....    ......||+.|||||++.+..++.++|||||||+||||+| |+.||.+..
T Consensus       228 DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~  292 (353)
T 4ase_A          228 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  292 (353)
T ss_dssp             CCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             cchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence            99999854322    2234578999999999999999999999999999999998 999998654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.1e-39  Score=325.14  Aligned_cols=183  Identities=25%  Similarity=0.445  Sum_probs=149.4

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCC----------CeeEE
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPED----------ANCYL  404 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~----------~~~~l  404 (552)
                      .|.|+||.||+++.  +|+.||||+++..        +.+|+.++++++||||+++++++.+.+.          ..+|+
T Consensus        13 lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~i   92 (299)
T 4g31_A           13 LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYI   92 (299)
T ss_dssp             EEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEE
T ss_pred             EecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEE
Confidence            37888899999987  6899999998532        3479999999999999999999875332          24789


Q ss_pred             EEeeccCCCchhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC
Q 037224          405 IYEYIENGSLHSWLHENKN-ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC  483 (552)
Q Consensus       405 v~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  483 (552)
                      ||||+++|+|.+++..... ...++..++.++.|+++||+|||+++   |+||||||+|||++.++.+||+|||+|+...
T Consensus        93 vmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DFGla~~~~  169 (299)
T 4g31_A           93 QMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD  169 (299)
T ss_dssp             EEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCCCC----
T ss_pred             EEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccCccceecC
Confidence            9999999999999976543 33567778999999999999999999   9999999999999999999999999997543


Q ss_pred             CCc--------------cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          484 NAI--------------TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       484 ~~~--------------~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      ...              ....+||+.|||||++.+..++.++|||||||++|||++   ||...
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~  230 (299)
T 4g31_A          170 QDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ  230 (299)
T ss_dssp             ----------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred             CCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc
Confidence            211              123479999999999999999999999999999999996   78643

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=4.4e-39  Score=347.17  Aligned_cols=182  Identities=27%  Similarity=0.387  Sum_probs=162.0

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccCh----------HHH---HHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWNA----------CEE---LKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~~----------~~E---~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      |.|+||.||+++.  +|+.||+|++++..          .+|   +.+++.++||||++++++|.+  ...+|+||||++
T Consensus       198 G~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~--~~~lylVmEy~~  275 (689)
T 3v5w_A          198 GRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDKLSFILDLMN  275 (689)
T ss_dssp             EECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC--SSEEEEEECCCC
T ss_pred             ecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE--CCEEEEEEecCC
Confidence            8888899999988  78999999995431          123   556666799999999999988  778999999999


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccccc
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI  490 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  490 (552)
                      ||+|.+++....  .+++..++.++.||+.||+|||+++   |+||||||+|||++.+|.+||+|||+|+..........
T Consensus       276 GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~~~t~  350 (689)
T 3v5w_A          276 GGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS  350 (689)
T ss_dssp             SCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCCCCSC
T ss_pred             CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecCCCCCCCc
Confidence            999999998754  4999999999999999999999999   99999999999999999999999999987666666678


Q ss_pred             cccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          491 VGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       491 ~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +||+.|||||++.. ..++.++|+|||||++|||++|+.||.+.+
T Consensus       351 ~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~  395 (689)
T 3v5w_A          351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK  395 (689)
T ss_dssp             CSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGG
T ss_pred             cCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999965 579999999999999999999999998654

>4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A*

Probab=100.00  E-value=3.2e-38  Score=294.28  Aligned_cols=177  Identities=25%  Similarity=0.385  Sum_probs=154.6

Q ss_pred             CCcc-ceeEeeccCCCCCCHHHHHHHhCCCh--------hhhcCcC-CCCCCCCCccCCCcEEEeeecccccCCCCCcee
Q 037224           44 YPCR-TYAFYRASAPDFLDLASIADLFSVSR--------LMISEPS-NISSPSSPLIQNQPLFVPITCSCNTLNASYTIS  113 (552)
Q Consensus        44 ~~c~-~~~~y~v~~~~g~tl~~Ia~~~~~~~--------~~l~~~N-~~~~~~~~~~~g~~l~iP~~~~~~~~~~~~~~~  113 (552)
                      .+|+ +++.|+|++  ||||+.||++||+++        ++|+++| ++.+ ++.|.+||.|+||.+|.|..    +...
T Consensus         3 ~~C~~a~~~Y~V~~--GDTL~~IA~~~~vsv~~~~~~~~~~I~~~Np~l~~-~~~l~~Gq~L~IP~~~~~~~----~~~~   75 (212)
T 4eby_A            3 TSCPLALASYYLEN--GTTLSVINQNLNSSIAPYDQINFDPILRYNSNIKD-KDRIQMGSRVLVPFPCECQP----GDFL   75 (212)
T ss_dssp             CCCSCEEEEEECCT--TCCHHHHHHHTCCSSSCCCSSCCHHHHTTCTTCSC-TTSCCTTCEEEEEECCEEET----TTEE
T ss_pred             CCCccceEEEEeCC--CCCHHHHHHHHCCCchhccccCHHHHHHhccCCCC-cCccCCCCEEEEeccccccC----Cccc
Confidence            3799 999999999  999999999999999        9999999 8865 67899999999999999972    3455


Q ss_pred             eeeeEEEEecCCchhhhHHhhcCCcchHHHHHHhCCCCCCCCCCCCcEEEEeeeecCCCCccccCceeEEEEEecCCCCC
Q 037224          114 FANLSYTIKSGDTFYLVSTNKYQNLTTYQSVEVVNPTFVPTKLEVGDVIIFPVFCKCPNQTQLRNRVNYLVSYVLQPSEN  193 (552)
Q Consensus       114 ~~~~~y~v~~gdtl~~Ia~~~~~~~~~~~~l~~~N~~~~~~~l~~gq~l~ip~~~~~~~~~~~~~~~~~~~~y~v~~Gdt  193 (552)
                      ....+|+|++|||||.||+++|++++++++|+++|++ +++.|++||+|.||..|+|++.. ........++|+|++|||
T Consensus        76 ~~~~~Y~V~~GDTL~~IA~~~y~~lvt~~~L~~~N~~-~~~~l~~Gq~L~IP~~~~~~~~~-~~~~~~~~~~Y~V~~GDT  153 (212)
T 4eby_A           76 GHNFSYSVRQEDTYERVAISNYANLTTMESLQARNPF-PATNIPLSATLNVLVNCSCGDES-VSKDFGLFVTYPLRPEDS  153 (212)
T ss_dssp             EEEEEEECCTTCCHHHHHHTTTTTSSCHHHHHHHCCS-CTTCCCTTCEEEEEEECCCCCTT-TCSSCCCEEEEECCTTCC
T ss_pred             cCceEEEecCCCcHHHHHHHhcCCCCCHHHHHHhcCC-CcccCCCCCEEEEcCCCcCCCcc-cccCCCCeEEEEECCCCc
Confidence            6677899999999999997799999999999999995 44899999999999999997653 334445567999999999


Q ss_pred             HHHHHhHhCCChhhHhhhcCC---cccCCceeeccccCCC
Q 037224          194 LSSVASRFGIETQAIIDVNGN---NIRPFDTLFVPVARLP  230 (552)
Q Consensus       194 l~~ia~~~~~s~~~l~~~N~~---~~~~g~~l~ip~~~~P  230 (552)
                      ||+||++||+++++|++||++   .+.+|. |+||....+
T Consensus       154 L~~IA~~fgvsv~~L~~~N~~~~~~~~~g~-l~IP~~~~~  192 (212)
T 4eby_A          154 LSSIARSSGVSADILQRYNPGVNFNSGNGI-VYVPGRDPN  192 (212)
T ss_dssp             HHHHHHHHTSCHHHHHHHSTTCCTTSCSSE-EEEECCCTT
T ss_pred             HHHHHHHHCcCHHHHHHhcCCCccCCCCCE-EEecCCCCC
Confidence            999999999999999999998   455555 999988753

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=329.33  Aligned_cols=185  Identities=26%  Similarity=0.456  Sum_probs=159.7

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecC----CCCeeEEEEeec
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDP----EDANCYLIYEYI  409 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~----~~~~~~lv~e~~  409 (552)
                      .|.|+||.||+|+.  +|+.||||+++..         ..+|+.+|++++||||+++++++...    +.+.+|+||||+
T Consensus        62 lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~  141 (398)
T 4b99_A           62 IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLM  141 (398)
T ss_dssp             EEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECC
T ss_pred             EecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCC
Confidence            37777899999987  7999999999643         34799999999999999999988642    246789999999


Q ss_pred             cCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC-----
Q 037224          410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN-----  484 (552)
Q Consensus       410 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~-----  484 (552)
                      + |+|.+++....  .+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++....     
T Consensus       142 ~-g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~  215 (398)
T 4b99_A          142 E-SDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEH  215 (398)
T ss_dssp             S-EEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC-------
T ss_pred             C-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeecccCcccc
Confidence            6 58999887654  5999999999999999999999999   99999999999999999999999999975422     


Q ss_pred             -CccccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          485 -AITMHIVGTQGYIAPEYLADG-VVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       485 -~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                       ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+.
T Consensus       216 ~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~  268 (398)
T 4b99_A          216 QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY  268 (398)
T ss_dssp             CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH
T ss_pred             ccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH
Confidence             223346899999999998765 569999999999999999999999987654

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.2e-37  Score=318.61  Aligned_cols=179  Identities=26%  Similarity=0.401  Sum_probs=154.0

Q ss_pred             CceEEEEEEEEee-----cCcEEEEEEeccC-----hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI-----HGEVYAIKMMKWN-----ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~-----~g~~vAvK~~~~~-----~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|+||.||+|+.     .++.||+|.+...     ..+|+++++.+ +||||+++++++.+  ++.+|+||||+++|+|
T Consensus        30 G~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~--~~~~~lvmE~~~g~~L  107 (361)
T 4f9c_A           30 GEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRK--NDHVVIAMPYLEHESF  107 (361)
T ss_dssp             EECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEE--TTEEEEEEECCCCCCH
T ss_pred             ecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEE--CCEEEEEEeCCCcccH
Confidence            7788899999975     3678999988543     34799999998 69999999999987  7789999999999999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCC-CcEEEeeccCCccCCCC--------
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN-MRAKIANFGLAKSGCNA--------  485 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kL~Dfg~a~~~~~~--------  485 (552)
                      .+++.     .+++.++..++.|++.||+|||++|   |+||||||+|||++.+ +.+||+|||+|+.....        
T Consensus       108 ~~~~~-----~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~  179 (361)
T 4f9c_A          108 LDILN-----SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFV  179 (361)
T ss_dssp             HHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC
T ss_pred             HHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccc
Confidence            99884     3899999999999999999999999   9999999999999876 79999999999743221        


Q ss_pred             ----------------------ccccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          486 ----------------------ITMHIVGTQGYIAPEYLADG-VVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       486 ----------------------~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                                            .....+||+.|+|||++.+. .++.++||||+||++|||+||+.||....
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~  251 (361)
T 4f9c_A          180 QSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS  251 (361)
T ss_dssp             --------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             cccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence                                  11234799999999998775 58999999999999999999999996543

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2e-37  Score=335.73  Aligned_cols=185  Identities=25%  Similarity=0.367  Sum_probs=164.1

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      .|.|.||.||+++.  +|+.||+|+++..       ..+|+.+|++++||||+++++++.+  +..+|+||||+++|+|.
T Consensus       165 lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~iv~E~~~gg~L~  242 (573)
T 3uto_A          165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED--DNEMVMIYEFMSGGELF  242 (573)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC--SSEEEEEEECCCCCBHH
T ss_pred             EeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEEEEeecCCCcHH
Confidence            37888899999987  7899999998543       3479999999999999999999987  77899999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCC--CcEEEeeccCCccCCC-Cccccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN--MRAKIANFGLAKSGCN-AITMHIVG  492 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~--~~~kL~Dfg~a~~~~~-~~~~~~~g  492 (552)
                      +++.... ..+++.++..++.||+.||+|||+++   |+||||||+|||++.+  +.+||+|||+++.... ......+|
T Consensus       243 ~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~G  318 (573)
T 3uto_A          243 EKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTG  318 (573)
T ss_dssp             HHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEECS
T ss_pred             HHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCCceeeeEE
Confidence            9886543 34999999999999999999999999   9999999999999854  8999999999986543 33445689


Q ss_pred             cccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       493 t~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      |+.|||||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus       319 T~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~  361 (573)
T 3uto_A          319 TAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND  361 (573)
T ss_dssp             SGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred             CccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH
Confidence            9999999999999999999999999999999999999986553

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.5e-35  Score=310.96  Aligned_cols=183  Identities=27%  Similarity=0.382  Sum_probs=161.5

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEecc----------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKW----------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~----------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|++|.||+++.  +++.||+|+++.          ...+|..++..++||||++++++|.+  +...++||||+++|+
T Consensus        83 G~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~--~~~~~lV~Ey~~gg~  160 (437)
T 4aw2_A           83 GRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD--DNNLYLVMDYYVGGD  160 (437)
T ss_dssp             EECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC--SSEEEEEECCCTTCB
T ss_pred             EeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--CCEEEEEEecCCCCc
Confidence            7888899999998  578999999853          14579999999999999999999987  678999999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc---cccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI---TMHI  490 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~---~~~~  490 (552)
                      |.+++.... ..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++......   ....
T Consensus       161 L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~  236 (437)
T 4aw2_A          161 LLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA  236 (437)
T ss_dssp             HHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECCSC
T ss_pred             HHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcccccc
Confidence            999997632 34999999999999999999999999   9999999999999999999999999997543221   2235


Q ss_pred             cccccccCccccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          491 VGTQGYIAPEYLA-----DGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       491 ~gt~~y~aPE~~~-----~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .||+.|+|||++.     ...++.++|||||||++|||++|+.||.+.+
T Consensus       237 ~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~  285 (437)
T 4aw2_A          237 VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES  285 (437)
T ss_dssp             CSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             cCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC
Confidence            8999999999986     5678999999999999999999999998654

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=5.3e-35  Score=297.16  Aligned_cols=182  Identities=28%  Similarity=0.445  Sum_probs=162.5

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|++|.||+++.  +|+.||+|+++..          ..+|+.+++.++||||+++++++.+  ....++||||+++|+
T Consensus        14 G~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--~~~~~lv~E~~~gg~   91 (337)
T 1o6l_A           14 GKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLCFVMEYANGGE   91 (337)
T ss_dssp             EECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC--SSEEEEEEECCTTCB
T ss_pred             ecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe--CCEEEEEEeCCCCCc
Confidence            7777899999987  6899999998643          3469999999999999999999987  678899999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC--CCcccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC--NAITMHIV  491 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~--~~~~~~~~  491 (552)
                      |.+++....  .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++...  ........
T Consensus        92 L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~  166 (337)
T 1o6l_A           92 LFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC  166 (337)
T ss_dssp             HHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCE
T ss_pred             HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcccccc
Confidence            999987654  4899999999999999999999999   9999999999999999999999999997532  22344568


Q ss_pred             ccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          492 GTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       492 gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ||+.|+|||.+.+..++.++||||||+++|||++|+.||.+.+
T Consensus       167 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~  209 (337)
T 1o6l_A          167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD  209 (337)
T ss_dssp             ECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC
Confidence            9999999999999999999999999999999999999998654

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.9e-35  Score=302.35  Aligned_cols=184  Identities=27%  Similarity=0.490  Sum_probs=159.3

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|++|.||+++.  +|+.||+|+++..          ..+|..++..+ +||||+++++++.+  ....++||||+++
T Consensus        31 lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~~~lv~E~~~g  108 (353)
T 3txo_A           31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT--PDRLFFVMEFVNG  108 (353)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEEEEECCCS
T ss_pred             EeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe--CCEEEEEEeCCCC
Confidence            37888899999987  6899999999643          23688899988 79999999999987  6788999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC--CCcccc
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC--NAITMH  489 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~--~~~~~~  489 (552)
                      |+|.+++....  .+++.+++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++...  ......
T Consensus       109 g~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~  183 (353)
T 3txo_A          109 GDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT  183 (353)
T ss_dssp             CBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-------
T ss_pred             CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecccCCccccc
Confidence            99999997654  4999999999999999999999999   9999999999999999999999999997532  223345


Q ss_pred             ccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      .+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus       184 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~  229 (353)
T 3txo_A          184 FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE  229 (353)
T ss_dssp             --CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             cCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH
Confidence            6899999999999888899999999999999999999999987653

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=5.2e-35  Score=296.24  Aligned_cols=182  Identities=30%  Similarity=0.461  Sum_probs=161.6

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|++|.||++..  +|+.||+|+++..         ..+|+.++++++||||+++++++.+  ....++||||+++++|
T Consensus        24 G~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~e~~~~~~L  101 (328)
T 3fe3_A           24 GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET--EKTLYLIMEYASGGEV  101 (328)
T ss_dssp             EECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEEECCCTTCBH
T ss_pred             eeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCEEEEEEECCCCCcH
Confidence            7777899999987  7899999998543         3479999999999999999999987  6788999999999999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC-Ccccccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN-AITMHIVGT  493 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~-~~~~~~~gt  493 (552)
                      .+++....  .+++.+++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++..... .......||
T Consensus       102 ~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt  176 (328)
T 3fe3_A          102 FDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGA  176 (328)
T ss_dssp             HHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGTTSSS
T ss_pred             HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCCccccccCC
Confidence            99997654  4999999999999999999999999   99999999999999999999999999975432 233456899


Q ss_pred             ccccCccccCCCCCC-ChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          494 QGYIAPEYLADGVVS-TKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       494 ~~y~aPE~~~~~~~s-~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +.|+|||.+.+..+. .++||||||+++|||++|+.||.+.+
T Consensus       177 ~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  218 (328)
T 3fe3_A          177 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN  218 (328)
T ss_dssp             GGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC
Confidence            999999999887765 79999999999999999999998764

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4.4e-35  Score=305.07  Aligned_cols=181  Identities=28%  Similarity=0.355  Sum_probs=161.0

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|++|.||+++.  +++.||+|+++..          ..+|+.+++.++||||+++++++.+  +...++||||+++|+
T Consensus        78 G~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~lV~E~~~gg~  155 (410)
T 3v8s_A           78 GRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD--DRYLYMVMEYMPGGD  155 (410)
T ss_dssp             EECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEEECCCTTEE
T ss_pred             EcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEEEEeCCCCCc
Confidence            7888899999988  6889999998542          4479999999999999999999987  678999999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC---ccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA---ITMHI  490 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~---~~~~~  490 (552)
                      |.+++...   .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....   .....
T Consensus       156 L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~  229 (410)
T 3v8s_A          156 LVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA  229 (410)
T ss_dssp             HHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSC
T ss_pred             HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccccCC
Confidence            99998764   3899999999999999999999999   999999999999999999999999999754432   22356


Q ss_pred             cccccccCccccCCCC----CCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          491 VGTQGYIAPEYLADGV----VSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       491 ~gt~~y~aPE~~~~~~----~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .||+.|+|||++.+..    ++.++|||||||++|||++|+.||...+
T Consensus       230 ~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~  277 (410)
T 3v8s_A          230 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS  277 (410)
T ss_dssp             CSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             cCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC
Confidence            8999999999987655    7899999999999999999999998655

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=7.9e-35  Score=296.73  Aligned_cols=182  Identities=29%  Similarity=0.475  Sum_probs=162.0

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      |.|++|.||+++.  +|+.||+|+++..          ..+|..++..+ +||||+++++++.+  ....++||||+++|
T Consensus        26 G~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~--~~~~~lv~E~~~gg  103 (345)
T 1xjd_A           26 GKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KENLFFVMEYLNGG  103 (345)
T ss_dssp             EECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEEEEEEECCTTC
T ss_pred             eeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe--CCEEEEEEeCCCCC
Confidence            7777899999998  6899999999643          23688888887 99999999999987  67889999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC--CCccccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC--NAITMHI  490 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~--~~~~~~~  490 (552)
                      +|.+++....  .+++.+++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++...  .......
T Consensus       104 ~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~  178 (345)
T 1xjd_A          104 DLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF  178 (345)
T ss_dssp             BHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCC
T ss_pred             cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCcccCC
Confidence            9999997654  4999999999999999999999999   9999999999999999999999999997532  2334457


Q ss_pred             cccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       491 ~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .||+.|+|||.+.+..++.++||||||+++|||++|+.||.+.+
T Consensus       179 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~  222 (345)
T 1xjd_A          179 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD  222 (345)
T ss_dssp             CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC
Confidence            89999999999999999999999999999999999999998654

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=9.3e-35  Score=293.08  Aligned_cols=181  Identities=30%  Similarity=0.500  Sum_probs=162.4

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|++|.||+++.  +|+.||+|+++..          ..+|..+++.++||||+++++++.+  ....++||||+++|+
T Consensus        15 G~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~~lv~e~~~gg~   92 (318)
T 1fot_A           15 GTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQIFMIMDYIEGGE   92 (318)
T ss_dssp             EECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--SSEEEEEECCCCSCB
T ss_pred             eeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe--CCEEEEEEeCCCCCC
Confidence            6777799999987  6899999998643          2368999999999999999999987  678899999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcccccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT  493 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~gt  493 (552)
                      |.+++....  .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.... ......||
T Consensus        93 L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-~~~~~~gt  166 (318)
T 1fot_A           93 LFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-VTYTLCGT  166 (318)
T ss_dssp             HHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS-CBCCCCSC
T ss_pred             HHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC-ccccccCC
Confidence            999997654  4999999999999999999999999   99999999999999999999999999986543 23456899


Q ss_pred             ccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       494 ~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +.|+|||.+.+..++.++|+||||+++|||++|+.||.+.+
T Consensus       167 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  207 (318)
T 1fot_A          167 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN  207 (318)
T ss_dssp             TTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             ccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999999999999999999997654

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.5e-34  Score=299.51  Aligned_cols=181  Identities=25%  Similarity=0.464  Sum_probs=161.5

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|++|.||+++.  +++.||+|+++..          ..+|..++.++ +||||+++++++.+  ....++||||+++
T Consensus        60 LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~~~lV~E~~~g  137 (396)
T 4dc2_A           60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFFVIEYVNG  137 (396)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEEEEEEECCTT
T ss_pred             EeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE--CCEEEEEEEcCCC
Confidence            37778899999987  6889999998643          34688899887 89999999999987  6788999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccC--CCCcccc
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG--CNAITMH  489 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~--~~~~~~~  489 (552)
                      |+|.+++....  .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++..  .......
T Consensus       138 g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~  212 (396)
T 4dc2_A          138 GDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST  212 (396)
T ss_dssp             CBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCC
T ss_pred             CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccCCCcccc
Confidence            99999987654  4999999999999999999999999   999999999999999999999999999742  2233445


Q ss_pred             ccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                      .+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       213 ~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~  255 (396)
T 4dc2_A          213 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  255 (396)
T ss_dssp             CCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred             ccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence            7899999999999999999999999999999999999999964

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.7e-34  Score=288.49  Aligned_cols=182  Identities=25%  Similarity=0.439  Sum_probs=162.1

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      .|.|++|.||++..  +|+.||+|++...       ..+|+.++++++||||+++++++.+  .+..++||||+++++|.
T Consensus        28 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~  105 (297)
T 3fxz_A           28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVVMEYLAGGSLT  105 (297)
T ss_dssp             EEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEEECCTTCBHH
T ss_pred             eccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE--CCEEEEEEECCCCCCHH
Confidence            37788899999976  7899999998432       3579999999999999999999987  67889999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--cccccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIVGT  493 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~gt  493 (552)
                      +++....   +++.+++.++.|++.||+|||+++   ++||||||+|||++.++.+||+|||++......  ......||
T Consensus       106 ~~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  179 (297)
T 3fxz_A          106 DVVTETC---MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT  179 (297)
T ss_dssp             HHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSC
T ss_pred             HHHhhcC---CCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCccCC
Confidence            9997653   899999999999999999999999   999999999999999999999999998754322  23346799


Q ss_pred             ccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       494 ~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +.|+|||.+.+..++.++||||||+++|||++|+.||.+.+
T Consensus       180 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  220 (297)
T 3fxz_A          180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN  220 (297)
T ss_dssp             GGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             cCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999999999999999999997654

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.5e-34  Score=294.82  Aligned_cols=183  Identities=27%  Similarity=0.408  Sum_probs=162.4

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC-------------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeec
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN-------------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI  409 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~  409 (552)
                      .|.|.+|.||++..  +|+.||+|+++..             ..+|+.++++++||||+++++++.+  ....++||||+
T Consensus        20 LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~lv~e~~   97 (361)
T 2yab_A           20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN--RTDVVLILELV   97 (361)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEEEECC
T ss_pred             EeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe--CCEEEEEEEcC
Confidence            37788899999988  6899999998532             3579999999999999999999987  67889999999


Q ss_pred             cCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCC----cEEEeeccCCccCCCC
Q 037224          410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM----RAKIANFGLAKSGCNA  485 (552)
Q Consensus       410 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~----~~kL~Dfg~a~~~~~~  485 (552)
                      ++++|.+++....  .+++.++..++.|++.||.|||+++   |+||||||+|||++.++    .+||+|||++......
T Consensus        98 ~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~  172 (361)
T 2yab_A           98 SGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG  172 (361)
T ss_dssp             CSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTT
T ss_pred             CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCC
Confidence            9999999997643  4999999999999999999999999   99999999999998877    7999999999754432


Q ss_pred             -ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          486 -ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       486 -~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                       ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+
T Consensus       173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~  222 (361)
T 2yab_A          173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT  222 (361)
T ss_dssp             CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred             CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence             2345679999999999999899999999999999999999999998654

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.5e-34  Score=295.54  Aligned_cols=181  Identities=27%  Similarity=0.405  Sum_probs=162.7

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|.+|.||+++.  +|+.||+|+++..          ..+|+.+++.++||||+++++++.+  ....++||||+++|+
T Consensus        50 G~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~gg~  127 (350)
T 1rdq_E           50 GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGGE  127 (350)
T ss_dssp             EECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEEEECCTTCB
T ss_pred             ecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--CCEEEEEEcCCCCCc
Confidence            7777799999988  6899999998532          2369999999999999999999987  678899999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcccccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT  493 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~gt  493 (552)
                      |.+++....  .+++.+++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++..... .....||
T Consensus       128 L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-~~~~~gt  201 (350)
T 1rdq_E          128 MFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-TWTLCGT  201 (350)
T ss_dssp             HHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-BCCCEEC
T ss_pred             HHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC-cccccCC
Confidence            999998654  4999999999999999999999999   999999999999999999999999999865432 3456899


Q ss_pred             ccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       494 ~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       202 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~  242 (350)
T 1rdq_E          202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ  242 (350)
T ss_dssp             GGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC
Confidence            99999999999999999999999999999999999998654

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.4e-34  Score=295.80  Aligned_cols=183  Identities=27%  Similarity=0.444  Sum_probs=161.9

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|++|.||+++.  +|+.||+|+++..          ..+|..++..+ +||||+++++++.+  ....|+||||+++
T Consensus        28 lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~~~lv~E~~~g  105 (353)
T 2i0e_A           28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRLYFVMEYVNG  105 (353)
T ss_dssp             EEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC--SSEEEEEEECCCS
T ss_pred             EeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc--CCEEEEEEeCCCC
Confidence            37888899999998  5789999998643          23688888887 89999999999987  6788999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC--CCcccc
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC--NAITMH  489 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~--~~~~~~  489 (552)
                      |+|.+++....  .+++.+++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++...  ......
T Consensus       106 g~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~  180 (353)
T 2i0e_A          106 GDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT  180 (353)
T ss_dssp             CBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCC
T ss_pred             CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccccCCccccc
Confidence            99999997654  4999999999999999999999999   9999999999999999999999999997532  223445


Q ss_pred             ccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       181 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~  225 (353)
T 2i0e_A          181 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED  225 (353)
T ss_dssp             CCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC
Confidence            689999999999999999999999999999999999999998654

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=5.2e-34  Score=288.19  Aligned_cols=198  Identities=25%  Similarity=0.430  Sum_probs=170.5

Q ss_pred             ccccHHHHHHHhhcc--------------CCCceEEEEEEEEee--cCcEEEEEEeccC-------hHHHHHHHHHcCCC
Q 037224          329 RIFKIEELREATDNF--------------SEGCLIQGSVYKGNI--HGEVYAIKMMKWN-------ACEELKILQKVNHG  385 (552)
Q Consensus       329 ~~~~~~~l~~~t~~~--------------~~G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------~~~E~~~l~~l~h~  385 (552)
                      ..|+.+++..+++..              ..|.|++|.||+|+.  +|+.||||+++..       +.+|+.++++++|+
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            346777777766532              137888899999987  6899999998532       34799999999999


Q ss_pred             CccceeeeeecCCCCeeEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE
Q 037224          386 NLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL  465 (552)
Q Consensus       386 niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll  465 (552)
                      ||+++++++..  ....++||||+++++|.+++...   .+++.++..++.|++.||+|||+.+   ++||||||+||++
T Consensus       103 niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll  174 (321)
T 2c30_A          103 NVVEMYKSYLV--GEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILL  174 (321)
T ss_dssp             TBCCEEEEEEE--TTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred             CcceEEEEEEE--CCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEE
Confidence            99999999987  66889999999999999988654   4999999999999999999999999   9999999999999


Q ss_pred             CCCCcEEEeeccCCccCCCC--ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          466 DSNMRAKIANFGLAKSGCNA--ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       466 ~~~~~~kL~Dfg~a~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +.++.+||+|||++......  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       175 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~  245 (321)
T 2c30_A          175 TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS  245 (321)
T ss_dssp             CTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             CCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999998754332  2334679999999999999999999999999999999999999997654

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.3e-34  Score=292.44  Aligned_cols=180  Identities=26%  Similarity=0.475  Sum_probs=160.7

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      |.|++|.||+++.  +++.||+|+++..          ..+|..++.++ +||||+++++++.+  ....++||||+++|
T Consensus        18 G~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~~~lv~e~~~gg   95 (345)
T 3a8x_A           18 GRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFFVIEYVNGG   95 (345)
T ss_dssp             EECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEEEECCCCSC
T ss_pred             EecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe--CCEEEEEEeCCCCC
Confidence            7777899999998  6889999999643          23688999988 89999999999987  67889999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC--CCccccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC--NAITMHI  490 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~--~~~~~~~  490 (552)
                      +|.+++....  .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++...  .......
T Consensus        96 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~~~~  170 (345)
T 3a8x_A           96 DLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF  170 (345)
T ss_dssp             BHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCCBCCC
T ss_pred             cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCCCCccccc
Confidence            9999997654  4999999999999999999999999   9999999999999999999999999997532  2334456


Q ss_pred             cccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       491 ~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                      .||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       171 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  212 (345)
T 3a8x_A          171 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  212 (345)
T ss_dssp             CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence            899999999999999999999999999999999999999975

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.7e-35  Score=302.69  Aligned_cols=183  Identities=26%  Similarity=0.361  Sum_probs=161.6

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEecc----------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKW----------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~----------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|++|.||+++.  +|+.||+|++++          ...+|..++.+++|+||+++++++.+  +...|+||||+++|+
T Consensus        70 G~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~--~~~~~lVmE~~~gg~  147 (412)
T 2vd5_A           70 GRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD--ENYLYLVMEYYVGGD  147 (412)
T ss_dssp             EECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC--SSEEEEEECCCCSCB
T ss_pred             eeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee--CCEEEEEEcCCCCCc
Confidence            7888899999998  689999999853          23579999999999999999999987  678999999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc---cccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI---TMHI  490 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~---~~~~  490 (552)
                      |.+++.... ..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++......   ....
T Consensus       148 L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~  223 (412)
T 2vd5_A          148 LLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVA  223 (412)
T ss_dssp             HHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECSSC
T ss_pred             HHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccCCCcccccee
Confidence            999997643 25999999999999999999999999   9999999999999999999999999997543322   2235


Q ss_pred             cccccccCccccC-------CCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          491 VGTQGYIAPEYLA-------DGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       491 ~gt~~y~aPE~~~-------~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .||+.|+|||++.       ...++.++|||||||++|||++|+.||...+
T Consensus       224 ~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~  274 (412)
T 2vd5_A          224 VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS  274 (412)
T ss_dssp             CSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             ccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC
Confidence            8999999999986       4568999999999999999999999998765

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.9e-34  Score=283.52  Aligned_cols=183  Identities=28%  Similarity=0.467  Sum_probs=157.9

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------------------------------hHHHHHHHHHcCCCCccce
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------------------------------ACEELKILQKVNHGNLVKL  390 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------------------------------~~~E~~~l~~l~h~niv~l  390 (552)
                      |.|++|.||++..  +++.||+|+++..                                 +.+|+.++++++||||+++
T Consensus        22 G~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~  101 (298)
T 2zv2_A           22 GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKL  101 (298)
T ss_dssp             EC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTTBCCE
T ss_pred             eecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCCCCeE
Confidence            7788899999987  7899999998432                                 3579999999999999999


Q ss_pred             eeeeecCCCCeeEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCc
Q 037224          391 EGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR  470 (552)
Q Consensus       391 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~  470 (552)
                      ++++.+......++||||+++++|.+++..   ..+++.+++.++.|++.||+|||+++   ++||||||+|||++.++.
T Consensus       102 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~  175 (298)
T 2zv2_A          102 VEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGH  175 (298)
T ss_dssp             EEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSC
T ss_pred             EEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCC
Confidence            999987667789999999999999987643   34999999999999999999999999   999999999999999999


Q ss_pred             EEEeeccCCccCCCC--ccccccccccccCccccCCCC---CCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          471 AKIANFGLAKSGCNA--ITMHIVGTQGYIAPEYLADGV---VSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       471 ~kL~Dfg~a~~~~~~--~~~~~~gt~~y~aPE~~~~~~---~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +||+|||++......  ......||+.|+|||.+.+..   .+.++||||||+++|||++|+.||.+..
T Consensus       176 ~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  244 (298)
T 2zv2_A          176 IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER  244 (298)
T ss_dssp             EEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence            999999999754322  233467899999999987655   3778999999999999999999997643

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-34  Score=288.29  Aligned_cols=183  Identities=26%  Similarity=0.348  Sum_probs=162.1

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhh
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSW  417 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~  417 (552)
                      |.|.+|.||++..  +++.+|+|.++..      ..+|+.+++.++||||+++++++.+  ....++||||+++++|.++
T Consensus        14 G~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~e~~~g~~L~~~   91 (321)
T 1tki_A           14 GRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES--MEELVMIFEFISGLDIFER   91 (321)
T ss_dssp             EECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEE--TTEEEEEECCCCCCBHHHH
T ss_pred             ecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEec--CCEEEEEEEeCCCCCHHHH
Confidence            7777899999988  6889999998643      3479999999999999999999987  6788999999999999999


Q ss_pred             hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECC--CCcEEEeeccCCccCCCC-ccccccccc
Q 037224          418 LHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS--NMRAKIANFGLAKSGCNA-ITMHIVGTQ  494 (552)
Q Consensus       418 l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~--~~~~kL~Dfg~a~~~~~~-~~~~~~gt~  494 (552)
                      +.... ..+++.+++.++.|++.||.|||+++   ++||||||+|||++.  ++.+||+|||++...... ......+|+
T Consensus        92 l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~  167 (321)
T 1tki_A           92 INTSA-FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAP  167 (321)
T ss_dssp             HTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCG
T ss_pred             HHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccccCCh
Confidence            87543 35999999999999999999999999   999999999999987  789999999999865432 333467899


Q ss_pred             cccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       495 ~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       168 ~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  207 (321)
T 1tki_A          168 EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET  207 (321)
T ss_dssp             GGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             hhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC
Confidence            9999999998889999999999999999999999998654

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=6.1e-34  Score=292.46  Aligned_cols=182  Identities=25%  Similarity=0.403  Sum_probs=160.4

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|.+|.||++..  +|+.||+|+++..         ..+|+.++++++||||+++++++.+  +...++||||+++++|
T Consensus        38 G~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~lv~e~~~gg~L  115 (362)
T 2bdw_A           38 GKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYLVFDLVTGGEL  115 (362)
T ss_dssp             EEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEEECCCCSCBH
T ss_pred             ecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEEEEecCCCCCH
Confidence            7777899999987  6899999998532         3479999999999999999999987  6788999999999999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCC---cEEEeeccCCccCCCC-ccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM---RAKIANFGLAKSGCNA-ITMHI  490 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~---~~kL~Dfg~a~~~~~~-~~~~~  490 (552)
                      .+++....  .+++.+++.++.|++.||.|||+++   |+||||||+|||++.++   .+||+|||++...... .....
T Consensus       116 ~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~  190 (362)
T 2bdw_A          116 FEDIVARE--FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF  190 (362)
T ss_dssp             HHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCS
T ss_pred             HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccccC
Confidence            99887654  4899999999999999999999999   99999999999997654   5999999999755432 22346


Q ss_pred             cccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       491 ~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus       191 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~  234 (362)
T 2bdw_A          191 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED  234 (362)
T ss_dssp             CSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence            79999999999999899999999999999999999999997654

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=4.5e-34  Score=289.42  Aligned_cols=182  Identities=26%  Similarity=0.426  Sum_probs=157.1

Q ss_pred             CceEEEEEEEEee-----cCcEEEEEEeccC-----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeec
Q 037224          346 GCLIQGSVYKGNI-----HGEVYAIKMMKWN-----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI  409 (552)
Q Consensus       346 G~g~~G~Vy~~~~-----~g~~vAvK~~~~~-----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~  409 (552)
                      |.|++|.||+++.     +|+.||+|+++..           ..+|+.++++++||||+++++++.+  ++..++||||+
T Consensus        26 G~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~  103 (327)
T 3a62_A           26 GKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT--GGKLYLILEYL  103 (327)
T ss_dssp             EEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC--SSCEEEEEECC
T ss_pred             EeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc--CCEEEEEEeCC
Confidence            7788899999986     6889999998643           2369999999999999999999987  67889999999


Q ss_pred             cCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC--CCcc
Q 037224          410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC--NAIT  487 (552)
Q Consensus       410 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~--~~~~  487 (552)
                      ++++|.+++....  .+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++...  ....
T Consensus       104 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  178 (327)
T 3a62_A          104 SGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT  178 (327)
T ss_dssp             TTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC----------
T ss_pred             CCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccccccCCccc
Confidence            9999999997654  4899999999999999999999999   9999999999999999999999999987432  2223


Q ss_pred             ccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          488 MHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       488 ~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       179 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  225 (327)
T 3a62_A          179 HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN  225 (327)
T ss_dssp             CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC
Confidence            34678999999999999999999999999999999999999998654

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-33  Score=286.05  Aligned_cols=182  Identities=29%  Similarity=0.416  Sum_probs=161.2

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC-------------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN-------------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      |.|.+|.||++..  +|+.||+|+++..             ..+|+.++++++||||+++++++.+  ....++||||++
T Consensus        20 G~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~   97 (326)
T 2y0a_A           20 GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN--KTDVILILELVA   97 (326)
T ss_dssp             ECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEEEECCC
T ss_pred             eeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCEEEEEEEcCC
Confidence            6667799999988  6899999998532             3479999999999999999999987  678899999999


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCC----cEEEeeccCCccCCC-C
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM----RAKIANFGLAKSGCN-A  485 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~----~~kL~Dfg~a~~~~~-~  485 (552)
                      +++|.+++....  .+++.+++.++.|++.||.|||+++   ++||||||+|||++.++    .+||+|||++..... .
T Consensus        98 ~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~  172 (326)
T 2y0a_A           98 GGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN  172 (326)
T ss_dssp             SCBHHHHHTTSS--CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTS
T ss_pred             CCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCC
Confidence            999999997643  4999999999999999999999999   99999999999998887    899999999975432 2


Q ss_pred             ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          486 ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       486 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       173 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  221 (326)
T 2y0a_A          173 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT  221 (326)
T ss_dssp             CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred             ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence            3334679999999999998999999999999999999999999997654

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=6.3e-34  Score=288.06  Aligned_cols=183  Identities=24%  Similarity=0.360  Sum_probs=143.9

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----hHHHHHHHHHcC-CCCccceeeeeecCCCCeeEEEEeeccCCCchhh
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----ACEELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSW  417 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~  417 (552)
                      .|.|++|.||++..  +++.||||+++..    ..+|+.+++.+. ||||+++++++.+  +...++||||+++++|.++
T Consensus        19 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~   96 (325)
T 3kn6_A           19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHD--QLHTFLVMELLNGGELFER   96 (325)
T ss_dssp             SEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEEEECCCCSCBHHHH
T ss_pred             cccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEc--CCEEEEEEEccCCCcHHHH
Confidence            58888899999998  6899999999754    347999999996 9999999999987  6788999999999999999


Q ss_pred             hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCC---cEEEeeccCCccCCC--Cccccccc
Q 037224          418 LHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM---RAKIANFGLAKSGCN--AITMHIVG  492 (552)
Q Consensus       418 l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~---~~kL~Dfg~a~~~~~--~~~~~~~g  492 (552)
                      +....  .+++.+++.++.|++.||+|||+++   |+||||||+|||++.++   .+||+|||+++....  .......+
T Consensus        97 l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  171 (325)
T 3kn6_A           97 IKKKK--HFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF  171 (325)
T ss_dssp             HHHCS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------
T ss_pred             HHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCC
Confidence            98754  4999999999999999999999999   99999999999997765   899999999975432  22234578


Q ss_pred             cccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       493 t~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      |+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       172 t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  213 (325)
T 3kn6_A          172 TLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD  213 (325)
T ss_dssp             ------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred             CcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence            999999999999999999999999999999999999998644

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=9.6e-34  Score=298.19  Aligned_cols=183  Identities=24%  Similarity=0.365  Sum_probs=160.3

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      .|.|++|.||++..  +|+.+|+|+++..         ..+|+.++++++||||+++++++.+  ++..++||||+++|+
T Consensus        19 LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~lv~E~~~gg~   96 (444)
T 3soa_A           19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE--EGHHYLIFDLVTGGE   96 (444)
T ss_dssp             EEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC--SSEEEEEECCCBCCB
T ss_pred             eccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE--CCEEEEEEEeCCCCC
Confidence            37788899999987  7899999998543         3479999999999999999999987  778899999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEC---CCCcEEEeeccCCccCCCC--ccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLD---SNMRAKIANFGLAKSGCNA--ITM  488 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~---~~~~~kL~Dfg~a~~~~~~--~~~  488 (552)
                      |.+++....  .+++.++..++.|++.||.|||+++   |+||||||+|||++   .++.+||+|||++......  ...
T Consensus        97 L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~  171 (444)
T 3soa_A           97 LFEDIVARE--YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF  171 (444)
T ss_dssp             HHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCC
T ss_pred             HHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceee
Confidence            999987754  4999999999999999999999999   99999999999998   4678999999999754432  223


Q ss_pred             cccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          489 HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       489 ~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ...||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+
T Consensus       172 ~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~  217 (444)
T 3soa_A          172 GFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED  217 (444)
T ss_dssp             CSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc
Confidence            4679999999999999999999999999999999999999997654

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=5.2e-34  Score=294.39  Aligned_cols=182  Identities=26%  Similarity=0.408  Sum_probs=160.4

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|++|.||++..  +++.||+|+++..          ..+|+.++++++||||+++++++.+  ....++||||+++|+
T Consensus        24 G~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~lv~e~~~gg~  101 (384)
T 4fr4_A           24 GKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD--EEDMFMVVDLLLGGD  101 (384)
T ss_dssp             ECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEEECCCTTEE
T ss_pred             eeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCEEEEEEecCCCCc
Confidence            6777799999987  6789999998532          3479999999999999999999987  678899999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC-CCccccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC-NAITMHIVG  492 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~-~~~~~~~~g  492 (552)
                      |.+++....  .+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++.... ........|
T Consensus       102 L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~g  176 (384)
T 4fr4_A          102 LRYHLQQNV--HFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAG  176 (384)
T ss_dssp             HHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCCCCS
T ss_pred             HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCCCceeccCC
Confidence            999997654  4999999999999999999999999   9999999999999999999999999998543 233445789


Q ss_pred             cccccCccccCC---CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          493 TQGYIAPEYLAD---GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       493 t~~y~aPE~~~~---~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      |+.|+|||++..   ..++.++|||||||++|||++|+.||....
T Consensus       177 t~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~  221 (384)
T 4fr4_A          177 TKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS  221 (384)
T ss_dssp             CGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCT
T ss_pred             CccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCC
Confidence            999999999864   458899999999999999999999997543

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.1e-34  Score=295.10  Aligned_cols=184  Identities=15%  Similarity=0.207  Sum_probs=159.1

Q ss_pred             CCceEEEEEEEEe-------ecCcEEEEEEeccC----hHHHHHHHHHcC---CCCccceeeeeecCCCCeeEEEEeecc
Q 037224          345 EGCLIQGSVYKGN-------IHGEVYAIKMMKWN----ACEELKILQKVN---HGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       345 ~G~g~~G~Vy~~~-------~~g~~vAvK~~~~~----~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      .|.|++|.||+|.       ..++.||+|+++..    +.+|+.++..++   |+||+++++++..  ++..++||||++
T Consensus        73 lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~--~~~~~lv~e~~~  150 (365)
T 3e7e_A           73 LGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF--QNGSVLVGELYS  150 (365)
T ss_dssp             EEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC--SSCEEEEECCCC
T ss_pred             eeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeec--CCCcEEEEeccC
Confidence            3777889999993       27889999999764    346788888886   9999999999987  667899999999


Q ss_pred             CCCchhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECC-----------CCcEEEeec
Q 037224          411 NGSLHSWLHEN---KNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS-----------NMRAKIANF  476 (552)
Q Consensus       411 ~gsL~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~-----------~~~~kL~Df  476 (552)
                      +|+|.+++...   ....+++.+++.++.|++.||+|||+++   |+||||||+|||++.           ++.+||+||
T Consensus       151 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DF  227 (365)
T 3e7e_A          151 YGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDL  227 (365)
T ss_dssp             SCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC------CTTEEECCC
T ss_pred             CCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccccccCCEEEeeC
Confidence            99999999753   2345999999999999999999999998   999999999999998           899999999


Q ss_pred             cCCccCC----CCccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          477 GLAKSGC----NAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       477 g~a~~~~----~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      |+++...    ........||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus       228 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~  288 (365)
T 3e7e_A          228 GQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKN  288 (365)
T ss_dssp             TTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred             chhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccC
Confidence            9996322    22334467999999999999999999999999999999999999999754

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=8e-34  Score=286.38  Aligned_cols=185  Identities=28%  Similarity=0.428  Sum_probs=161.6

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      |.|++|.||+++.  +++.||||+++..        ..+|++++++++||||+++++++........++||||+++++|.
T Consensus        18 g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~   97 (319)
T 4euu_A           18 GQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLY   97 (319)
T ss_dssp             EECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHH
T ss_pred             cCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHH
Confidence            7777899999998  5899999998642        34799999999999999999999876666889999999999999


Q ss_pred             hhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE----CCCCcEEEeeccCCccCCCC-cccc
Q 037224          416 SWLHENKN-ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL----DSNMRAKIANFGLAKSGCNA-ITMH  489 (552)
Q Consensus       416 ~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll----~~~~~~kL~Dfg~a~~~~~~-~~~~  489 (552)
                      +++..... ..+++.+++.++.|++.||+|||+++   |+||||||+|||+    +.++.+||+|||+++..... ....
T Consensus        98 ~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~  174 (319)
T 4euu_A           98 TVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS  174 (319)
T ss_dssp             HHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCCBCC
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCceee
Confidence            99976543 34999999999999999999999999   9999999999999    78888999999999754332 2334


Q ss_pred             ccccccccCccccC--------CCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          490 IVGTQGYIAPEYLA--------DGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       490 ~~gt~~y~aPE~~~--------~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      ..||+.|+|||.+.        +..++.++||||||+++|||++|+.||...
T Consensus       175 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  226 (319)
T 4euu_A          175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF  226 (319)
T ss_dssp             CCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECT
T ss_pred             cccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            67899999999875        577899999999999999999999999754

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.1e-33  Score=291.53  Aligned_cols=185  Identities=29%  Similarity=0.496  Sum_probs=159.5

Q ss_pred             CCceEEEEEEEEee---------cCcEEEEEEeccC--------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEE
Q 037224          345 EGCLIQGSVYKGNI---------HGEVYAIKMMKWN--------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIY  406 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~---------~g~~vAvK~~~~~--------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~  406 (552)
                      .|.|++|.||++++         .+..||+|+++..        +.+|+.+++++ +||||++++++|.+  ++..++||
T Consensus        89 LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~--~~~~~lv~  166 (370)
T 2psq_A           89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ--DGPLYVIV  166 (370)
T ss_dssp             ESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS--SSSCEEEE
T ss_pred             EeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc--CCCEEEEE
Confidence            37777799999985         2357999999643        34799999999 89999999999977  66789999


Q ss_pred             eeccCCCchhhhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEE
Q 037224          407 EYIENGSLHSWLHENKN--------------ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAK  472 (552)
Q Consensus       407 e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~k  472 (552)
                      ||+++|+|.+++.....              ..+++.+++.++.|++.||+|||+++   |+||||||+|||++.++.+|
T Consensus       167 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~k  243 (370)
T 2psq_A          167 EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMK  243 (370)
T ss_dssp             ECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEE
T ss_pred             EcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEECCCCCEE
Confidence            99999999999976532              34899999999999999999999999   99999999999999999999


Q ss_pred             EeeccCCccCCCC----ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          473 IANFGLAKSGCNA----ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       473 L~Dfg~a~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      |+|||+++.....    ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.+..
T Consensus       244 l~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~  310 (370)
T 2psq_A          244 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  310 (370)
T ss_dssp             ECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             EccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            9999999744322    1223456789999999999999999999999999999999 999998654

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3.7e-34  Score=294.79  Aligned_cols=182  Identities=29%  Similarity=0.426  Sum_probs=156.2

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccCh----------HHHHHH-HHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWNA----------CEELKI-LQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~~----------~~E~~~-l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      |.|++|.||+++.  +++.||+|+++...          .+|..+ ++.++||||+++++++.+  ....|+||||+++|
T Consensus        47 G~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~--~~~~~lv~E~~~gg  124 (373)
T 2r5t_A           47 GKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADKLYFVLDYINGG  124 (373)
T ss_dssp             ECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC--SSEEEEEEECCCSC
T ss_pred             eeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe--CCEEEEEEeCCCCC
Confidence            6677799999998  67899999985432          234444 456799999999999987  67889999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccC--CCCccccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG--CNAITMHI  490 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~--~~~~~~~~  490 (552)
                      +|.+++....  .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++..  ........
T Consensus       125 ~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~~~~~  199 (373)
T 2r5t_A          125 ELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTF  199 (373)
T ss_dssp             BHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCCCCSB
T ss_pred             cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccCCCccccc
Confidence            9999997654  4899999999999999999999999   999999999999999999999999999742  22334456


Q ss_pred             cccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       491 ~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .||+.|+|||++.+..++.++|+||||+++|||++|+.||...+
T Consensus       200 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~  243 (373)
T 2r5t_A          200 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN  243 (373)
T ss_dssp             SCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB
T ss_pred             cCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence            89999999999999999999999999999999999999998654

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=5.5e-34  Score=284.28  Aligned_cols=182  Identities=30%  Similarity=0.460  Sum_probs=157.3

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEecc----------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKW----------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~----------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|++|.||+++.  .++.||+|.+..          .+.+|+.++++++||||+++++++.+  ++..++||||+++++
T Consensus        20 g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~g~~   97 (294)
T 4eqm_A           20 GGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE--DDCYYLVMEYIEGPT   97 (294)
T ss_dssp             EEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC--SSEEEEEEECCCSCB
T ss_pred             ccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee--CCeEEEEEeCCCCCC
Confidence            7777899999987  688999999732          23479999999999999999999977  678899999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC---ccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA---ITMHI  490 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~---~~~~~  490 (552)
                      |.+++....  .+++.+++.++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++......   .....
T Consensus        98 L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  172 (294)
T 4eqm_A           98 LSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHV  172 (294)
T ss_dssp             HHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-----------
T ss_pred             HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccccccccCcc
Confidence            999997654  4999999999999999999999999   999999999999999999999999999754322   22335


Q ss_pred             cccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       491 ~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .||+.|+|||.+.+..++.++||||||+++|||++|+.||.+..
T Consensus       173 ~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  216 (294)
T 4eqm_A          173 LGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET  216 (294)
T ss_dssp             --CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred             ccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            68999999999999999999999999999999999999998654

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=4.8e-34  Score=286.81  Aligned_cols=187  Identities=33%  Similarity=0.556  Sum_probs=155.4

Q ss_pred             CCceEEEEEEEEeecCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          345 EGCLIQGSVYKGNIHGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      .|.|++|.||+++..|+.||+|++...         +.+|+.++++++||||+++++++.+  ....++||||+++++|.
T Consensus        45 lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~  122 (309)
T 3p86_A           45 IGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ--PPNLSIVTEYLSRGSLY  122 (309)
T ss_dssp             EEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--TTCCEEEEECCTTCBHH
T ss_pred             eecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCceEEEEecCCCCcHH
Confidence            377778999999999999999998532         3479999999999999999999977  56789999999999999


Q ss_pred             hhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--ccccccc
Q 037224          416 SWLHENKN-ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIVG  492 (552)
Q Consensus       416 ~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~g  492 (552)
                      +++..... ..+++..++.++.|++.||+|||+++ ++++||||||+||+++.++.+||+|||+++.....  ......|
T Consensus       123 ~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~g  201 (309)
T 3p86_A          123 RLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAG  201 (309)
T ss_dssp             HHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-----------------
T ss_pred             HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccccccccccCCC
Confidence            99976432 24899999999999999999999986 34999999999999999999999999999754332  2234678


Q ss_pred             cccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       493 t~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      |+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       202 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~  243 (309)
T 3p86_A          202 TPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN  243 (309)
T ss_dssp             CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred             CccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999999999999999999998654

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.5e-33  Score=283.11  Aligned_cols=183  Identities=31%  Similarity=0.510  Sum_probs=160.4

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      .|.|++|.||++..  +++.||+|.+...       +.+|++++++++||||+++++++.+  +...++||||+++++|.
T Consensus        18 lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~   95 (310)
T 3s95_A           18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK--DKRLNFITEYIKGGTLR   95 (310)
T ss_dssp             EECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEEEECCTTCBHH
T ss_pred             ecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec--CCeeEEEEEecCCCcHH
Confidence            36777799999998  6899999988432       3479999999999999999999987  67889999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcc--------
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT--------  487 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~--------  487 (552)
                      +++.... ..+++.+++.++.|+++||+|||+++   ++||||||+||+++.++.+||+|||++........        
T Consensus        96 ~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  171 (310)
T 3s95_A           96 GIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSL  171 (310)
T ss_dssp             HHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC------------
T ss_pred             HHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccc
Confidence            9998743 34999999999999999999999999   99999999999999999999999999975432211        


Q ss_pred             --------ccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          488 --------MHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       488 --------~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                              ....||+.|+|||.+.+..++.++||||||+++|||++|..||...
T Consensus       172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~  225 (310)
T 3s95_A          172 KKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY  225 (310)
T ss_dssp             --------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred             cccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcch
Confidence                    1357899999999999999999999999999999999999998753

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=8.8e-34  Score=295.16  Aligned_cols=187  Identities=23%  Similarity=0.366  Sum_probs=155.0

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC--hHHHHHHHHHc-CCCCccceeeeeec--CCCCeeEEEEeeccCCCchhh
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN--ACEELKILQKV-NHGNLVKLEGFCID--PEDANCYLIYEYIENGSLHSW  417 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~--~~~E~~~l~~l-~h~niv~l~~~~~~--~~~~~~~lv~e~~~~gsL~~~  417 (552)
                      .|.|.+|.||++..  +|+.||||+++..  ..+|+.++.++ +|+||+++++++..  .+....++||||+++|+|.++
T Consensus        70 LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~  149 (400)
T 1nxk_A           70 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSR  149 (400)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHH
T ss_pred             eeeccCeEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHH
Confidence            37888899999988  6889999999654  45788887554 89999999998864  224568999999999999999


Q ss_pred             hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECC---CCcEEEeeccCCccCCCC-cccccccc
Q 037224          418 LHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS---NMRAKIANFGLAKSGCNA-ITMHIVGT  493 (552)
Q Consensus       418 l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kL~Dfg~a~~~~~~-~~~~~~gt  493 (552)
                      +.......+++.+++.++.|++.||.|||+.+   |+||||||+|||++.   ++.+||+|||+++..... ......||
T Consensus       150 l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt  226 (400)
T 1nxk_A          150 IQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT  226 (400)
T ss_dssp             HHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------
T ss_pred             HHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccccCCCCccccCCCC
Confidence            98765556999999999999999999999999   999999999999987   789999999999854422 23346789


Q ss_pred             ccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       494 ~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       227 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  267 (400)
T 1nxk_A          227 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH  267 (400)
T ss_dssp             CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCT
T ss_pred             CCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence            99999999999999999999999999999999999997654

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=9.8e-34  Score=289.77  Aligned_cols=184  Identities=22%  Similarity=0.342  Sum_probs=159.8

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEecc------------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKW------------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~------------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      |.|.+|.||++..  +|+.||+|+++.            ...+|+.++++++||||+++++++.+  ++..++||||+++
T Consensus        33 G~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~e~~~g  110 (351)
T 3c0i_A           33 GKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS--DGMLYMVFEFMDG  110 (351)
T ss_dssp             EECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEEECCSS
T ss_pred             eeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCEEEEEEeCCCC
Confidence            6677799999987  689999999842            23579999999999999999999987  6788999999999


Q ss_pred             CCchhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCc---EEEeeccCCccCCCC-
Q 037224          412 GSLHSWLHENK--NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR---AKIANFGLAKSGCNA-  485 (552)
Q Consensus       412 gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~---~kL~Dfg~a~~~~~~-  485 (552)
                      ++|.+++....  ...+++..++.++.|++.||+|||+++   |+||||||+|||++.++.   +||+|||++...... 
T Consensus       111 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~  187 (351)
T 3c0i_A          111 ADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG  187 (351)
T ss_dssp             CBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTS
T ss_pred             CCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcceeEecCCC
Confidence            99988876532  235899999999999999999999999   999999999999987654   999999999754432 


Q ss_pred             -ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          486 -ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       486 -~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                       ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.+..
T Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  237 (351)
T 3c0i_A          188 LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK  237 (351)
T ss_dssp             CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH
T ss_pred             eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH
Confidence             2234679999999999999999999999999999999999999997643

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.2e-33  Score=298.80  Aligned_cols=184  Identities=29%  Similarity=0.485  Sum_probs=161.6

Q ss_pred             CceEEEEEEEEeecCcEEEEEEeccC-----hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhhhhh
Q 037224          346 GCLIQGSVYKGNIHGEVYAIKMMKWN-----ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHE  420 (552)
Q Consensus       346 G~g~~G~Vy~~~~~g~~vAvK~~~~~-----~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~  420 (552)
                      |.|.+|.||+|.+.|+.||||+++..     +.+|+.++++++||||+++++++.+. +...++||||+++|+|.+++..
T Consensus       202 G~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~iv~e~~~~g~L~~~l~~  280 (450)
T 1k9a_A          202 GKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVTEYMAKGSLVDYLRS  280 (450)
T ss_dssp             EECSSEEEEEEEETTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECT-TSCEEEEEECCTTCBHHHHHHH
T ss_pred             cCcCCeeEEEEEecCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcC-CCceEEEEEecCCCcHHHHHHh
Confidence            77778999999999999999999754     45899999999999999999998763 3468999999999999999987


Q ss_pred             cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccccccccccccCcc
Q 037224          421 NKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPE  500 (552)
Q Consensus       421 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~gt~~y~aPE  500 (552)
                      .....+++..++.++.|++.||+|||+++   ++||||||+|||++.++.+||+|||+++...... ....++..|+|||
T Consensus       281 ~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~y~aPE  356 (450)
T 1k9a_A          281 RGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPVKWTAPE  356 (450)
T ss_dssp             HCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-------CCCTTTSCHH
T ss_pred             cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-cCCCCCcceeCHH
Confidence            66555899999999999999999999999   9999999999999999999999999998543322 2236688999999


Q ss_pred             ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          501 YLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       501 ~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      .+.+..++.++||||||+++|||+| |+.||....
T Consensus       357 ~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~  391 (450)
T 1k9a_A          357 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP  391 (450)
T ss_dssp             HHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC
T ss_pred             HhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999999998 999998643

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.2e-33  Score=286.49  Aligned_cols=183  Identities=20%  Similarity=0.284  Sum_probs=160.8

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEecc-----ChHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccCCCchh
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKW-----NACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHS  416 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~-----~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~  416 (552)
                      .|.|++|.||+++.  +|+.||||+++.     ...+|+.+++++ +|+||+++++++.+  +...++||||+ +++|.+
T Consensus        17 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~lv~e~~-~~~L~~   93 (330)
T 2izr_A           17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC--GKYNAMVLELL-GPSLED   93 (330)
T ss_dssp             CCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEE--TTEEEEEEECC-CCBHHH
T ss_pred             eeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEec--CCccEEEEEeC-CCCHHH
Confidence            37777899999996  789999999853     356899999999 99999999999987  67889999999 889999


Q ss_pred             hhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCc-----EEEeeccCCccCCCCc-----
Q 037224          417 WLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR-----AKIANFGLAKSGCNAI-----  486 (552)
Q Consensus       417 ~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~-----~kL~Dfg~a~~~~~~~-----  486 (552)
                      ++... ...+++.+++.++.|++.||+|||+++   |+||||||+|||++.++.     +||+|||+++......     
T Consensus        94 ~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~  169 (330)
T 2izr_A           94 LFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHI  169 (330)
T ss_dssp             HHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBC
T ss_pred             HHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccc
Confidence            99764 235999999999999999999999999   999999999999998887     9999999997432211     


Q ss_pred             ----cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          487 ----TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       487 ----~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                          .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.+..
T Consensus       170 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~  221 (330)
T 2izr_A          170 PYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK  221 (330)
T ss_dssp             CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             cccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccc
Confidence                234679999999999999999999999999999999999999998754

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.4e-33  Score=303.40  Aligned_cols=184  Identities=27%  Similarity=0.380  Sum_probs=165.4

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|++|.||+++.  +|+.||+|+++..          ..+|+.++++++||||+++++++.+  ....++||||+++|+
T Consensus       193 G~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~l~lVmEy~~gg~  270 (576)
T 2acx_A          193 GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KDALCLVLTLMNGGD  270 (576)
T ss_dssp             EEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEEECCCCSCB
T ss_pred             eeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee--CCEEEEEEEcCCCCc
Confidence            7888899999988  6899999998532          3479999999999999999999987  678899999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-ccccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-ITMHIVG  492 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-~~~~~~g  492 (552)
                      |.+++.......+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++...... ......|
T Consensus       271 L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~G  347 (576)
T 2acx_A          271 LKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVG  347 (576)
T ss_dssp             HHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCEECCCS
T ss_pred             HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccCccccccCC
Confidence            999998766556999999999999999999999999   999999999999999999999999999865432 2344689


Q ss_pred             cccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       493 t~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      |+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       348 T~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~  389 (576)
T 2acx_A          348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK  389 (576)
T ss_dssp             CGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred             CccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence            999999999999899999999999999999999999998754

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3.4e-34  Score=289.35  Aligned_cols=185  Identities=40%  Similarity=0.696  Sum_probs=161.9

Q ss_pred             CCceEEEEEEEEee-cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchh
Q 037224          345 EGCLIQGSVYKGNI-HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHS  416 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~  416 (552)
                      .|.|++|.||+|++ +++.||+|++...       +.+|+.++++++||||+++++++.+  .+..++||||+++++|.+
T Consensus        47 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~  124 (321)
T 2qkw_B           47 IGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE--RNEMILIYKYMENGNLKR  124 (321)
T ss_dssp             SCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC--TTCCEEEEECCTTCBTGG
T ss_pred             eecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CCeEEEEEEcCCCCcHHH
Confidence            48888899999998 6899999998532       3579999999999999999999876  667899999999999999


Q ss_pred             hhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC----ccccc
Q 037224          417 WLHENKN--ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA----ITMHI  490 (552)
Q Consensus       417 ~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~----~~~~~  490 (552)
                      ++.....  ..+++.+++.++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++......    .....
T Consensus       125 ~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  201 (321)
T 2qkw_B          125 HLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVV  201 (321)
T ss_dssp             GSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCC
T ss_pred             HHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccccccccccccccccc
Confidence            9976542  35899999999999999999999999   999999999999999999999999999743221    22234


Q ss_pred             cccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       491 ~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       202 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~  245 (321)
T 2qkw_B          202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL  245 (321)
T ss_dssp             EEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSS
T ss_pred             CCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccC
Confidence            68999999999988899999999999999999999999997654

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.7e-33  Score=290.19  Aligned_cols=184  Identities=26%  Similarity=0.379  Sum_probs=157.8

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      .|.|.+|.||++..  +|+.||+|+++..       +.+|+.++++++||||+++++++.+  ....++||||+++++|.
T Consensus        97 lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~E~~~~~~L~  174 (373)
T 2x4f_A           97 LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFES--KNDIVLVMEYVDGGELF  174 (373)
T ss_dssp             CC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEEEECCTTCEEH
T ss_pred             EecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEEEEeCCCCCcHH
Confidence            48888899999987  6899999998653       3479999999999999999999987  67889999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE--CCCCcEEEeeccCCccCCCC-ccccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL--DSNMRAKIANFGLAKSGCNA-ITMHIVG  492 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll--~~~~~~kL~Dfg~a~~~~~~-~~~~~~g  492 (552)
                      +++.... ..+++.+++.++.|++.||+|||+.+   |+||||||+|||+  +.++.+||+|||+++..... ......|
T Consensus       175 ~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~g  250 (373)
T 2x4f_A          175 DRIIDES-YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFG  250 (373)
T ss_dssp             HHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCS
T ss_pred             HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccC
Confidence            9887543 24899999999999999999999999   9999999999999  67789999999999854332 2334579


Q ss_pred             cccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       493 t~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      |+.|+|||.+.+..++.++||||||+++|||++|+.||.+.+
T Consensus       251 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~  292 (373)
T 2x4f_A          251 TPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN  292 (373)
T ss_dssp             SCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             CCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999998999999999999999999999999998654

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.9e-34  Score=290.11  Aligned_cols=183  Identities=34%  Similarity=0.488  Sum_probs=157.3

Q ss_pred             CceEEEEEEEEeecCcEEEEEEeccCh------HHHHHHHHHcCCCCccceeeeeecCC--CCeeEEEEeeccCCCchhh
Q 037224          346 GCLIQGSVYKGNIHGEVYAIKMMKWNA------CEELKILQKVNHGNLVKLEGFCIDPE--DANCYLIYEYIENGSLHSW  417 (552)
Q Consensus       346 G~g~~G~Vy~~~~~g~~vAvK~~~~~~------~~E~~~l~~l~h~niv~l~~~~~~~~--~~~~~lv~e~~~~gsL~~~  417 (552)
                      |.|++|.||+|++.++.||||+++...      .+|+.++++++||||+++++++.+..  ...+++||||+++|+|.++
T Consensus        33 g~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~  112 (322)
T 3soc_A           33 ARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDF  112 (322)
T ss_dssp             ECSTTCEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHH
T ss_pred             cccCceEEEEEEECCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHH
Confidence            677779999999999999999996442      35788899999999999999998643  2357999999999999999


Q ss_pred             hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--
Q 037224          418 LHENKNENLNWKTRLRIAIDVANGLQYIHEH----------TRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--  485 (552)
Q Consensus       418 l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----------~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--  485 (552)
                      +....   +++.+++.++.|++.||+|||+.          +   |+||||||+|||++.++.+||+|||+++.....  
T Consensus       113 l~~~~---~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~  186 (322)
T 3soc_A          113 LKANV---VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS  186 (322)
T ss_dssp             HHHCC---BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECCCTTCEEECTTSC
T ss_pred             HHhcC---CCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEccCCcccccccccC
Confidence            97653   99999999999999999999998          7   999999999999999999999999999643221  


Q ss_pred             --ccccccccccccCccccCC-----CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          486 --ITMHIVGTQGYIAPEYLAD-----GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       486 --~~~~~~gt~~y~aPE~~~~-----~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                        ......||+.|+|||.+.+     ..++.++||||||+++|||+||+.||.+..
T Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~  242 (322)
T 3soc_A          187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV  242 (322)
T ss_dssp             CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred             ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence              2233578999999999876     345678899999999999999999998643

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=4e-34  Score=289.39  Aligned_cols=204  Identities=43%  Similarity=0.754  Sum_probs=174.7

Q ss_pred             CccccccHHHHHHHhhccCC----CceEEEEEEEEee-cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceee
Q 037224          326 DKYRIFKIEELREATDNFSE----GCLIQGSVYKGNI-HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEG  392 (552)
Q Consensus       326 ~~~~~~~~~~l~~~t~~~~~----G~g~~G~Vy~~~~-~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~  392 (552)
                      ...+.|++.++....++|..    |.|++|.||+++. +|+.||+|+++..        +.+|+.++++++||||+++++
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence            34566788888888887765    7888899999987 6889999998543        357999999999999999999


Q ss_pred             eeecCCCCeeEEEEeeccCCCchhhhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCc
Q 037224          393 FCIDPEDANCYLIYEYIENGSLHSWLHENKN--ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR  470 (552)
Q Consensus       393 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~  470 (552)
                      ++.+  ....++||||+++++|.+++.....  ..+++..++.++.|++.||+|||++..++++||||||+|||++.++.
T Consensus        95 ~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~  172 (326)
T 3uim_A           95 FCMT--PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE  172 (326)
T ss_dssp             EECC--SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC
T ss_pred             EEec--CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC
Confidence            9987  5667999999999999999986543  34999999999999999999999991112999999999999999999


Q ss_pred             EEEeeccCCccCCC---CccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCC
Q 037224          471 AKIANFGLAKSGCN---AITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID  531 (552)
Q Consensus       471 ~kL~Dfg~a~~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~  531 (552)
                      +||+|||++.....   .......||+.|+|||.+.+..++.++||||||+++|||++|+.||+
T Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  236 (326)
T 3uim_A          173 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD  236 (326)
T ss_dssp             EEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred             EEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence            99999999975432   22233568999999999988889999999999999999999999996

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.2e-33  Score=301.10  Aligned_cols=185  Identities=26%  Similarity=0.405  Sum_probs=163.9

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|.|++|.||+++.  +|+.||+|+++..          ..+|+.++++++||||+++++++.+  ....++||||+++|
T Consensus       193 LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~l~lVmE~~~gg  270 (543)
T 3c4z_A          193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET--KTDLCLVMTIMNGG  270 (543)
T ss_dssp             EEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEEECCCTTC
T ss_pred             EeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee--CCEEEEEEEeccCC
Confidence            37788899999988  6899999998532          3469999999999999999999987  67889999999999


Q ss_pred             CchhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--ccc
Q 037224          413 SLHSWLHENK--NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITM  488 (552)
Q Consensus       413 sL~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~  488 (552)
                      +|.+++....  ...+++..++.++.|++.||+|||+++   |+||||||+|||++.+|.+||+|||+++.....  ...
T Consensus       271 ~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~  347 (543)
T 3c4z_A          271 DIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK  347 (543)
T ss_dssp             BHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCCBC
T ss_pred             CHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccCCCcccc
Confidence            9999987654  345999999999999999999999999   999999999999999999999999999754332  223


Q ss_pred             cccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          489 HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       489 ~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       348 ~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~  393 (543)
T 3c4z_A          348 GYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG  393 (543)
T ss_dssp             CCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred             cccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence            4589999999999999999999999999999999999999998654

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=4.4e-33  Score=279.14  Aligned_cols=201  Identities=43%  Similarity=0.692  Sum_probs=174.2

Q ss_pred             cccccHHHHHHHhhccCC----------CceEEEEEEEEeecCcEEEEEEeccC-----------hHHHHHHHHHcCCCC
Q 037224          328 YRIFKIEELREATDNFSE----------GCLIQGSVYKGNIHGEVYAIKMMKWN-----------ACEELKILQKVNHGN  386 (552)
Q Consensus       328 ~~~~~~~~l~~~t~~~~~----------G~g~~G~Vy~~~~~g~~vAvK~~~~~-----------~~~E~~~l~~l~h~n  386 (552)
                      ...|++.++..++++|..          |.|++|.||+|..+++.||+|++...           +.+|+.++++++|||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   91 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN   91 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence            456889999999988764          68888999999999999999998532           347999999999999


Q ss_pred             ccceeeeeecCCCCeeEEEEeeccCCCchhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE
Q 037224          387 LVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENK-NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL  465 (552)
Q Consensus       387 iv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll  465 (552)
                      |+++++++.+  ....+++|||+++++|.+++.... ...+++..++.++.|++.||.|||+++   ++||||||+||++
T Consensus        92 i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili  166 (307)
T 2nru_A           92 LVELLGFSSD--GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL  166 (307)
T ss_dssp             BCCEEEEECS--SSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             eEEEEEEEec--CCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence            9999999977  567899999999999999987543 345999999999999999999999999   9999999999999


Q ss_pred             CCCCcEEEeeccCCccCCCC----ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          466 DSNMRAKIANFGLAKSGCNA----ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       466 ~~~~~~kL~Dfg~a~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +.++.+||+|||++......    ......|++.|+|||.+.+ .++.++||||||+++|||++|+.||....
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~  238 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHR  238 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTB
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCc
Confidence            99999999999998754322    1223578999999998864 57899999999999999999999998654

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.3e-33  Score=285.51  Aligned_cols=182  Identities=30%  Similarity=0.431  Sum_probs=159.8

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEecc--------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKW--------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~--------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      |.|++|.||++..  +++.||+|+++.        ...+|+.+++.++|+||+++++++.+  +...++||||+++++|.
T Consensus        16 G~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~e~~~~~~L~   93 (323)
T 3tki_A           16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYLFLEYCSGGELF   93 (323)
T ss_dssp             EEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEEEECCTTEEGG
T ss_pred             ecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec--CCeEEEEEEcCCCCcHH
Confidence            7788899999987  689999999842        34589999999999999999999987  67889999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC----Ccccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN----AITMHIV  491 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~----~~~~~~~  491 (552)
                      +++....  .+++.+++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++.....    .......
T Consensus        94 ~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  168 (323)
T 3tki_A           94 DRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC  168 (323)
T ss_dssp             GGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCC
T ss_pred             HHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCc
Confidence            9987654  3999999999999999999999999   99999999999999999999999999974321    1223467


Q ss_pred             ccccccCccccCCCCC-CChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          492 GTQGYIAPEYLADGVV-STKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       492 gt~~y~aPE~~~~~~~-s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ||+.|+|||.+.+..+ +.++||||||+++|||++|+.||....
T Consensus       169 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  212 (323)
T 3tki_A          169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS  212 (323)
T ss_dssp             SCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSC
T ss_pred             cCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence            8999999999987765 778999999999999999999998654

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.9e-33  Score=286.40  Aligned_cols=181  Identities=24%  Similarity=0.403  Sum_probs=158.0

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccCCCchhhhh
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLH  419 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~  419 (552)
                      |.|.+|.||++..  +|+.||+|+++..   ..+|++++.++ +||||+++++++.+  +...++||||+++|+|.+++.
T Consensus        31 G~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~~~gg~L~~~i~  108 (342)
T 2qr7_A           31 GVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDD--GKYVYVVTELMKGGELLDKIL  108 (342)
T ss_dssp             EECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEEEEECCCCSCBHHHHHH
T ss_pred             eeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEc--CCEEEEEEeCCCCCcHHHHHH
Confidence            6777799999988  6889999999643   46899999998 79999999999987  678899999999999999987


Q ss_pred             hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCC----CcEEEeeccCCccCCC--Ccccccccc
Q 037224          420 ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN----MRAKIANFGLAKSGCN--AITMHIVGT  493 (552)
Q Consensus       420 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~----~~~kL~Dfg~a~~~~~--~~~~~~~gt  493 (552)
                      ...  .+++.++..++.|++.||+|||+++   |+||||||+|||+.++    +.+||+|||++.....  .......+|
T Consensus       109 ~~~--~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt  183 (342)
T 2qr7_A          109 RQK--FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYT  183 (342)
T ss_dssp             TCT--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCC
T ss_pred             HcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCC
Confidence            654  4999999999999999999999999   9999999999998443    3599999999975332  233446789


Q ss_pred             ccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       494 ~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      +.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       184 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~  223 (342)
T 2qr7_A          184 ANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG  223 (342)
T ss_dssp             SSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred             ccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCC
Confidence            9999999998888899999999999999999999999864

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-33  Score=288.84  Aligned_cols=183  Identities=26%  Similarity=0.396  Sum_probs=161.5

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchh
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHS  416 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~  416 (552)
                      |.|++|.||++..  +|+.||+|++...       ..+|+.++++++||||+++++++.+  ....++||||+++++|.+
T Consensus        60 G~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~lv~E~~~gg~L~~  137 (387)
T 1kob_A           60 GSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED--KYEMVLILEFLSGGELFD  137 (387)
T ss_dssp             EEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC--SSEEEEEEECCCCCBHHH
T ss_pred             ecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe--CCEEEEEEEcCCCCcHHH
Confidence            7788899999988  6889999998643       3479999999999999999999987  678899999999999999


Q ss_pred             hhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECC--CCcEEEeeccCCccCCCC-cccccccc
Q 037224          417 WLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS--NMRAKIANFGLAKSGCNA-ITMHIVGT  493 (552)
Q Consensus       417 ~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~--~~~~kL~Dfg~a~~~~~~-~~~~~~gt  493 (552)
                      ++.... ..+++.+++.++.|++.||+|||+++   |+||||||+|||++.  ++.+||+|||++...... ......||
T Consensus       138 ~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt  213 (387)
T 1kob_A          138 RIAAED-YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTAT  213 (387)
T ss_dssp             HTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSS
T ss_pred             HHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCcceeeeccC
Confidence            887543 35999999999999999999999999   999999999999974  577999999999854432 23345799


Q ss_pred             ccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       494 ~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus       214 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~  254 (387)
T 1kob_A          214 AEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED  254 (387)
T ss_dssp             GGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred             CCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999999999999999999998654

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=8e-34  Score=299.97  Aligned_cols=183  Identities=28%  Similarity=0.429  Sum_probs=157.0

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|.|++|.||+++.  +|+.||+|+++..          ..+|+.++++++||||+++++++.+  .+..++||||++++
T Consensus       156 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--~~~~~lv~e~~~~~  233 (446)
T 4ejn_A          156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRLCFVMEYANGG  233 (446)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE--TTEEEEEECCCSSC
T ss_pred             EeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee--CCEEEEEEeeCCCC
Confidence            37788899999987  7899999998642          2368888999999999999999987  67889999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC--CCcccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHE-HTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC--NAITMH  489 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~--~~~~~~  489 (552)
                      +|.+++....  .+++..+..++.|++.||+|||+ .+   |+||||||+|||++.++.+||+|||+++...  ......
T Consensus       234 ~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~  308 (446)
T 4ejn_A          234 ELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT  308 (446)
T ss_dssp             BHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----CC
T ss_pred             cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCCCccccc
Confidence            9999987654  49999999999999999999998 88   9999999999999999999999999997532  223344


Q ss_pred             ccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..||+.|+|||++.+..++.++||||||+++|||++|+.||.+.+
T Consensus       309 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~  353 (446)
T 4ejn_A          309 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD  353 (446)
T ss_dssp             SSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence            689999999999999999999999999999999999999997654

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.6e-33  Score=285.93  Aligned_cols=181  Identities=27%  Similarity=0.471  Sum_probs=159.5

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|.|++|.||++..  +++.||+|+++..          ..+|+.+++.++||||+++++++.+  ....++||||+ +|
T Consensus        17 lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~E~~-~g   93 (336)
T 3h4j_B           17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT--PTDIVMVIEYA-GG   93 (336)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEEECCC-CE
T ss_pred             EecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEEEEECC-CC
Confidence            37788899999997  7899999998532          3479999999999999999999987  66889999999 67


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-cccccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-ITMHIV  491 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-~~~~~~  491 (552)
                      +|.+++....  .+++.+++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++...... ......
T Consensus        94 ~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~~~  168 (336)
T 3h4j_B           94 ELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC  168 (336)
T ss_dssp             EHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTCCCT
T ss_pred             cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCccccccc
Confidence            9998887654  4999999999999999999999999   999999999999999999999999999754432 234467


Q ss_pred             ccccccCccccCCCCC-CChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          492 GTQGYIAPEYLADGVV-STKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       492 gt~~y~aPE~~~~~~~-s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      ||+.|+|||.+.+..+ ++++||||||+++|||++|+.||.+.
T Consensus       169 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~  211 (336)
T 3h4j_B          169 GSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE  211 (336)
T ss_dssp             TSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred             CCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCc
Confidence            9999999999988776 68999999999999999999999864

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.7e-33  Score=276.94  Aligned_cols=184  Identities=30%  Similarity=0.530  Sum_probs=152.5

Q ss_pred             CceEEEEEEEEeecCcEEEEEEeccC-----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNIHGEVYAIKMMKWN-----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~~g~~vAvK~~~~~-----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|++|.||++.+.++.||+|+++..           ..+|+++++.++||||+++++++.+  +...++||||+++++|
T Consensus        16 g~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L   93 (271)
T 3dtc_A           16 GIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK--EPNLCLVMEFARGGPL   93 (271)
T ss_dssp             EEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC--C--CEEEEECCTTEEH
T ss_pred             ccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec--CCceEEEEEcCCCCCH
Confidence            77888999999999999999998532           3479999999999999999999987  5678999999999999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECC--------CCcEEEeeccCCccCCCCc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS--------NMRAKIANFGLAKSGCNAI  486 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~--------~~~~kL~Dfg~a~~~~~~~  486 (552)
                      .+++...   .+++..++.++.|++.||.|||+++..+++||||||+||+++.        ++.+||+|||++.......
T Consensus        94 ~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~  170 (271)
T 3dtc_A           94 NRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT  170 (271)
T ss_dssp             HHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--------
T ss_pred             HHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccccccc
Confidence            9988643   4999999999999999999999997555889999999999986        7789999999998655544


Q ss_pred             cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          487 TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       487 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .....|++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       171 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  218 (271)
T 3dtc_A          171 KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID  218 (271)
T ss_dssp             -----CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred             ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            455688999999999988889999999999999999999999998654

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.8e-33  Score=284.76  Aligned_cols=183  Identities=29%  Similarity=0.448  Sum_probs=156.5

Q ss_pred             CceEEEEEEEEee-----cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          346 GCLIQGSVYKGNI-----HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       346 G~g~~G~Vy~~~~-----~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      |.|++|.||+|.+     .+..||||+++..        +.+|+.++++++||||+++++++.+  ....++||||++++
T Consensus        58 G~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~  135 (325)
T 3kul_A           58 GSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR--GRLAMIVTEYMENG  135 (325)
T ss_dssp             EETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG--GGCCEEEEECCTTC
T ss_pred             EeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCccEEEeeCCCCC
Confidence            7777899999987     3446999999643        3479999999999999999999976  56779999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc-----c
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI-----T  487 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-----~  487 (552)
                      +|.+++.... ..+++.+++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......     .
T Consensus       136 ~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  211 (325)
T 3kul_A          136 SLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT  211 (325)
T ss_dssp             BHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEEC
T ss_pred             cHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccccCccceeec
Confidence            9999996543 35999999999999999999999999   9999999999999999999999999997543221     1


Q ss_pred             ccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          488 MHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       488 ~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      ....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.+..
T Consensus       212 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~  259 (325)
T 3kul_A          212 TGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT  259 (325)
T ss_dssp             C---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred             cCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC
Confidence            12345678999999988899999999999999999999 999997654

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.4e-33  Score=280.24  Aligned_cols=186  Identities=27%  Similarity=0.460  Sum_probs=161.1

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEecc------------ChHHHHHHHHHcC---CCCccceeeeeecCCCC---eeEEE
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKW------------NACEELKILQKVN---HGNLVKLEGFCIDPEDA---NCYLI  405 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~------------~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~---~~~lv  405 (552)
                      |.|++|.||+++.  +++.||+|+++.            ...+|+.++++++   ||||+++++++......   ..+++
T Consensus        18 g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv   97 (308)
T 3g33_A           18 GVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLV   97 (308)
T ss_dssp             CCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEE
T ss_pred             ecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEE
Confidence            7777899999996  789999999852            2347887777764   99999999999764322   57899


Q ss_pred             EeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC-
Q 037224          406 YEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN-  484 (552)
Q Consensus       406 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~-  484 (552)
                      |||++ ++|.+++.......+++.+++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.... 
T Consensus        98 ~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  173 (308)
T 3g33_A           98 FEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ  173 (308)
T ss_dssp             EECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECSCSCTTTSTTC
T ss_pred             ehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEeeCccccccCCC
Confidence            99997 59999998876666999999999999999999999999   99999999999999999999999999975442 


Q ss_pred             CccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          485 AITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       485 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      .......+|+.|+|||.+.+..++.++||||||+++|||++|+.||....+
T Consensus       174 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~  224 (308)
T 3g33_A          174 MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE  224 (308)
T ss_dssp             CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH
T ss_pred             cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            233456789999999999999999999999999999999999999987654

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.6e-33  Score=276.91  Aligned_cols=182  Identities=29%  Similarity=0.466  Sum_probs=158.4

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|++|.||++..  +++.||+|++...          ..+|+.++++++||||+++++++.+  ....++||||+++++
T Consensus        18 g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~   95 (279)
T 3fdn_A           18 GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGT   95 (279)
T ss_dssp             EECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEEECCCTTEE
T ss_pred             ecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec--CCEEEEEEecCCCCc
Confidence            6777799999987  5779999998432          3469999999999999999999987  678899999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcccccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT  493 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~gt  493 (552)
                      |.+++....  .+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++............++
T Consensus        96 l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  170 (279)
T 3fdn_A           96 VYRELQKLS--KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGT  170 (279)
T ss_dssp             HHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--------CCC
T ss_pred             HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCcccccccCCC
Confidence            999987654  3999999999999999999999998   99999999999999999999999999876555555567889


Q ss_pred             ccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       494 ~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       171 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  211 (279)
T 3fdn_A          171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT  211 (279)
T ss_dssp             CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             CCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc
Confidence            99999999999999999999999999999999999998654

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.6e-33  Score=289.52  Aligned_cols=184  Identities=31%  Similarity=0.483  Sum_probs=152.3

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcC-CCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|.|++|.||++..  +|+.||+|++...         ..+|+.++.++. |+||+++++++...+....++||||++ +
T Consensus        17 lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~   95 (388)
T 3oz6_A           17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-T   95 (388)
T ss_dssp             -------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-E
T ss_pred             eeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-c
Confidence            48888899999987  7899999998532         237999999997 999999999998755667899999998 5


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC--------
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN--------  484 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~--------  484 (552)
                      +|.+++...   .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....        
T Consensus        96 ~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~  169 (388)
T 3oz6_A           96 DLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI  169 (388)
T ss_dssp             EHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCG
T ss_pred             CHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccc
Confidence            899888764   4999999999999999999999999   99999999999999999999999999974321        


Q ss_pred             ---------------CccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          485 ---------------AITMHIVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       485 ---------------~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                                     .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  236 (388)
T 3oz6_A          170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST  236 (388)
T ss_dssp             GGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             cccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence                           11223579999999999876 6789999999999999999999999987653

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.7e-33  Score=280.60  Aligned_cols=182  Identities=30%  Similarity=0.456  Sum_probs=156.8

Q ss_pred             CceEEEEEEEEee-cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          346 GCLIQGSVYKGNI-HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       346 G~g~~G~Vy~~~~-~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      |.|++|.||+++. +|+.||+|+++..         ..+|+.++++++||||+++++++.+  +...++||||+++ +|.
T Consensus        30 G~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~-~l~  106 (311)
T 3niz_A           30 GEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS--ERCLTLVFEFMEK-DLK  106 (311)
T ss_dssp             EECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC--SSCEEEEEECCSE-EHH
T ss_pred             cCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc--CCEEEEEEcCCCC-CHH
Confidence            7777799999998 7899999998632         3479999999999999999999976  6678999999985 888


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC--Ccccccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN--AITMHIVGT  493 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~--~~~~~~~gt  493 (552)
                      +++.... ..+++.+++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++.....  .......+|
T Consensus       107 ~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t  182 (311)
T 3niz_A          107 KVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVT  182 (311)
T ss_dssp             HHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---CCCCC
T ss_pred             HHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCcccccCCccc
Confidence            8876644 35999999999999999999999999   99999999999999999999999999975432  223345789


Q ss_pred             ccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          494 QGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       494 ~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +.|+|||.+.+ ..++.++||||||+++|||++|+.||.+..
T Consensus       183 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  224 (311)
T 3niz_A          183 LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVT  224 (311)
T ss_dssp             CTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999876 568999999999999999999999997654

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=8.2e-33  Score=279.28  Aligned_cols=182  Identities=27%  Similarity=0.414  Sum_probs=161.1

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC-------------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN-------------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      |.|.+|.||+++.  +|+.||+|+++..             ..+|+.++++++||||+++++++.+  ....++||||++
T Consensus        21 g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~   98 (321)
T 2a2a_A           21 GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN--RTDVVLILELVS   98 (321)
T ss_dssp             EECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEEECCCC
T ss_pred             eecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec--CCEEEEEEEcCC
Confidence            6667799999988  6899999998532             3579999999999999999999987  678899999999


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCC----cEEEeeccCCccCCCC-
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM----RAKIANFGLAKSGCNA-  485 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~----~~kL~Dfg~a~~~~~~-  485 (552)
                      +++|.+++....  .+++.+++.++.|++.||+|||+++   ++||||||+||+++.++    .+||+|||++...... 
T Consensus        99 ~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~  173 (321)
T 2a2a_A           99 GGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV  173 (321)
T ss_dssp             SCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTC
T ss_pred             CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccceecCccc
Confidence            999999997643  4899999999999999999999999   99999999999999888    7999999999754432 


Q ss_pred             ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          486 ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       486 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       174 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  222 (321)
T 2a2a_A          174 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT  222 (321)
T ss_dssp             CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred             cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC
Confidence            2334578999999999999999999999999999999999999997654

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.5e-33  Score=285.39  Aligned_cols=182  Identities=27%  Similarity=0.460  Sum_probs=149.8

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC-----hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhhh
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN-----ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL  418 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~-----~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l  418 (552)
                      |.|++|.||+++.  +++.||+|+++..     ..+|+.++++++||||+++++++.+  ....++||||+++++|.+++
T Consensus        62 G~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l  139 (349)
T 2w4o_A           62 GRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFET--PTEISLVLELVTGGELFDRI  139 (349)
T ss_dssp             EECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEEC--SSEEEEEECCCCSCBHHHHH
T ss_pred             eeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEec--CCeEEEEEEeCCCCCHHHHH
Confidence            6777799999998  5789999998643     3479999999999999999999987  67889999999999999998


Q ss_pred             hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECC---CCcEEEeeccCCccCCCC-ccccccccc
Q 037224          419 HENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS---NMRAKIANFGLAKSGCNA-ITMHIVGTQ  494 (552)
Q Consensus       419 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kL~Dfg~a~~~~~~-~~~~~~gt~  494 (552)
                      ....  .+++.+++.++.|++.||.|||+.+   |+||||||+|||++.   ++.+||+|||+++..... ......||+
T Consensus       140 ~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~  214 (349)
T 2w4o_A          140 VEKG--YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTP  214 (349)
T ss_dssp             TTCS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC----------------CG
T ss_pred             HhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCcccccccccCCC
Confidence            7654  4899999999999999999999999   999999999999975   889999999999754332 233467899


Q ss_pred             cccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       495 ~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .|+|||.+.+..++.++||||||+++|||++|+.||.+..
T Consensus       215 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  254 (349)
T 2w4o_A          215 GYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER  254 (349)
T ss_dssp             GGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT
T ss_pred             CccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCc
Confidence            9999999999999999999999999999999999997543

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=3.1e-33  Score=309.16  Aligned_cols=184  Identities=27%  Similarity=0.440  Sum_probs=162.4

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|++|.||+++.  +++.||||+++..          ...|..++..+ +|++|+++++++.+  ...+|+||||+++
T Consensus       349 LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~--~~~~~lV~E~~~g  426 (674)
T 3pfq_A          349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRLYFVMEYVNG  426 (674)
T ss_dssp             SSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC--SSEEEEEEECCCS
T ss_pred             EccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe--CCEEEEEEeCcCC
Confidence            47777899999988  6789999998643          23688888877 79999999998876  6788999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccC--CCCcccc
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG--CNAITMH  489 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~--~~~~~~~  489 (552)
                      |+|.+++....  .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++..  .......
T Consensus       427 g~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~  501 (674)
T 3pfq_A          427 GDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT  501 (674)
T ss_dssp             CBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCCBCC
T ss_pred             CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccccCCccccc
Confidence            99999998754  4999999999999999999999999   999999999999999999999999999742  2233445


Q ss_pred             ccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      ..||+.|+|||++.+..++.++||||||+++|||++|+.||.+.+.
T Consensus       502 ~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~  547 (674)
T 3pfq_A          502 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE  547 (674)
T ss_dssp             CCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH
Confidence            7899999999999999999999999999999999999999987653

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4.6e-33  Score=288.87  Aligned_cols=184  Identities=21%  Similarity=0.291  Sum_probs=161.0

Q ss_pred             Cce--EEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          346 GCL--IQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       346 G~g--~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      |.|  ++|.||+++.  +|+.||||+++..         ..+|+.++++++||||+++++++.+  ++..++||||++++
T Consensus        34 G~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~  111 (389)
T 3gni_B           34 GKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DNELWVVTSFMAYG  111 (389)
T ss_dssp             EEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEEECCTTC
T ss_pred             cCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE--CCEEEEEEEccCCC
Confidence            555  7899999998  6899999998643         2369999999999999999999987  67889999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC---------
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC---------  483 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~---------  483 (552)
                      +|.+++.......+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||.+....         
T Consensus       112 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~  188 (389)
T 3gni_B          112 SAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVV  188 (389)
T ss_dssp             BHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCB
T ss_pred             CHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeecccccccccc
Confidence            9999998775566999999999999999999999999   9999999999999999999999999875321         


Q ss_pred             CCccccccccccccCccccCC--CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          484 NAITMHIVGTQGYIAPEYLAD--GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       484 ~~~~~~~~gt~~y~aPE~~~~--~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ........||+.|+|||.+.+  ..++.++|||||||++|||++|+.||.+.+
T Consensus       189 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  241 (389)
T 3gni_B          189 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP  241 (389)
T ss_dssp             CCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             ccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence            111223478899999999987  678999999999999999999999998654

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=6.3e-33  Score=277.77  Aligned_cols=182  Identities=31%  Similarity=0.506  Sum_probs=162.7

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchh
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHS  416 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~  416 (552)
                      |.|.+|.||+++.  +|+.||+|+++..       ..+|+.++++++||||+++++++.+  ....++||||+++++|.+
T Consensus        18 g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~   95 (304)
T 2jam_A           18 GSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYES--TTHYYLVMQLVSGGELFD   95 (304)
T ss_dssp             EECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEEECCCCSCBHHH
T ss_pred             cCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhccc--CCEEEEEEEcCCCccHHH
Confidence            6677799999987  6899999998643       3479999999999999999999987  678899999999999999


Q ss_pred             hhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE---CCCCcEEEeeccCCccCCCCcccccccc
Q 037224          417 WLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL---DSNMRAKIANFGLAKSGCNAITMHIVGT  493 (552)
Q Consensus       417 ~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~~~~~~~~~~~~gt  493 (552)
                      ++....  .+++.+++.++.|++.||.|||+.+   ++||||||+||++   +.++.+||+|||++............|+
T Consensus        96 ~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  170 (304)
T 2jam_A           96 RILERG--VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGT  170 (304)
T ss_dssp             HHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTTHHHHSC
T ss_pred             HHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCccccccCC
Confidence            987654  4899999999999999999999999   9999999999999   7889999999999986555444456789


Q ss_pred             ccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       494 ~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       171 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  211 (304)
T 2jam_A          171 PGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET  211 (304)
T ss_dssp             CCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             CCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence            99999999999999999999999999999999999997654

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=6.9e-33  Score=279.42  Aligned_cols=185  Identities=26%  Similarity=0.446  Sum_probs=155.3

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      .|.|++|.||++..  +|+.||+|+++..        ..+|+.++++++||||+++++++.+  ++..++||||++ ++|
T Consensus        13 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~-~~L   89 (317)
T 2pmi_A           13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT--ENKLTLVFEFMD-NDL   89 (317)
T ss_dssp             ------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC--TTEEEEEEECCC-CBH
T ss_pred             ECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE--CCeEEEEEEecC-CCH
Confidence            37788899999987  6899999998532        3579999999999999999999977  678899999998 599


Q ss_pred             hhhhhhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC--Cccc
Q 037224          415 HSWLHENK----NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN--AITM  488 (552)
Q Consensus       415 ~~~l~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~--~~~~  488 (552)
                      .+++....    ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++.....  ....
T Consensus        90 ~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~  166 (317)
T 2pmi_A           90 KKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFS  166 (317)
T ss_dssp             HHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCCCC
T ss_pred             HHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecCCCcccCC
Confidence            99886542    135899999999999999999999999   99999999999999999999999999975432  2223


Q ss_pred             cccccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          489 HIVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       489 ~~~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      ...+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||.+.+.
T Consensus       167 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~  214 (317)
T 2pmi_A          167 SEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND  214 (317)
T ss_dssp             CCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             CCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence            4578999999999876 4689999999999999999999999987654

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=6.7e-33  Score=274.74  Aligned_cols=182  Identities=25%  Similarity=0.430  Sum_probs=162.8

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEecc----------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKW----------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~----------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|.+|.||+++.  +++.||+|++..          ...+|++++++++|+||+++++++.+  ....+++|||+++++
T Consensus        23 g~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~  100 (284)
T 2vgo_A           23 GKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD--RKRIYLMLEFAPRGE  100 (284)
T ss_dssp             EECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEEECCCTTEE
T ss_pred             cCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc--CCEEEEEEEeCCCCc
Confidence            6677799999988  578999999843          23479999999999999999999987  678899999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcccccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT  493 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~gt  493 (552)
                      |.+++....  .+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++............++
T Consensus       101 L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  175 (284)
T 2vgo_A          101 LYKELQKHG--RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGT  175 (284)
T ss_dssp             HHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSSCBCCCCSC
T ss_pred             HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcccccccccCC
Confidence            999997654  4899999999999999999999999   99999999999999999999999999976554444556789


Q ss_pred             ccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       494 ~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       176 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  216 (284)
T 2vgo_A          176 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS  216 (284)
T ss_dssp             GGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             CCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC
Confidence            99999999999999999999999999999999999998654

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.1e-33  Score=290.24  Aligned_cols=184  Identities=27%  Similarity=0.481  Sum_probs=160.0

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      .|.|.+|.||+|++  +++.||||.++..        +.+|+.++++++||||+++++++.+  +...++||||+++|+|
T Consensus       122 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e~~~~g~L  199 (377)
T 3cbl_A          122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPIYIVMELVQGGDF  199 (377)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS--SSSCEEEEECCTTCBH
T ss_pred             eccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec--CCCcEEEEEcCCCCCH
Confidence            37788899999998  6899999998643        4579999999999999999999976  5678999999999999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcccc----c
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH----I  490 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~----~  490 (552)
                      .+++.... ..+++.+++.++.|++.||+|||+++   ++||||||+|||++.++.+||+|||+++.........    .
T Consensus       200 ~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~  275 (377)
T 3cbl_A          200 LTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLR  275 (377)
T ss_dssp             HHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCC
T ss_pred             HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCC
Confidence            99997643 24899999999999999999999999   9999999999999999999999999997543322211    2


Q ss_pred             cccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       491 ~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      .++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus       276 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~  320 (377)
T 3cbl_A          276 QVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS  320 (377)
T ss_dssp             EEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred             CCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            34678999999988889999999999999999998 999998654

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3.6e-33  Score=295.86  Aligned_cols=182  Identities=30%  Similarity=0.544  Sum_probs=161.0

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|++|.||+|+.  +|+.||||+++..          ..+|+.+++.++||||+++++++.+  ....++||||+++++
T Consensus        25 G~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~~~~lv~E~~~gg~  102 (476)
T 2y94_A           25 GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST--PSDIFMVMEYVSGGE  102 (476)
T ss_dssp             ECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEEEECCSSEE
T ss_pred             eeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEEEeCCCCCc
Confidence            6777799999987  6899999998532          3479999999999999999999987  678899999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC-Cccccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN-AITMHIVG  492 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~-~~~~~~~g  492 (552)
                      |.+++....  .+++.+++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++..... .......|
T Consensus       103 L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~g  177 (476)
T 2y94_A          103 LFDYICKNG--RLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCG  177 (476)
T ss_dssp             HHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCBCCCCS
T ss_pred             HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccccccccccCC
Confidence            999997643  4999999999999999999999999   99999999999999999999999999985443 23344679


Q ss_pred             cccccCccccCCCCC-CChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          493 TQGYIAPEYLADGVV-STKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       493 t~~y~aPE~~~~~~~-s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      |+.|+|||.+.+..+ +.++||||||+++|||++|+.||.+..
T Consensus       178 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~  220 (476)
T 2y94_A          178 SPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH  220 (476)
T ss_dssp             CSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC
Confidence            999999999987765 689999999999999999999998654

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=7e-33  Score=272.09  Aligned_cols=183  Identities=28%  Similarity=0.453  Sum_probs=159.6

Q ss_pred             CceEEEEEEEEee-cCcEEEEEEeccC------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhhh
Q 037224          346 GCLIQGSVYKGNI-HGEVYAIKMMKWN------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL  418 (552)
Q Consensus       346 G~g~~G~Vy~~~~-~g~~vAvK~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l  418 (552)
                      |.|++|.||++.. ++..||+|+++..      ..+|+.++++++||||+++++++.+  +...++||||+++++|.+++
T Consensus        17 g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l   94 (268)
T 3sxs_A           17 GSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK--EYPIYIVTEYISNGCLLNYL   94 (268)
T ss_dssp             EEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSEEEEEECCTTCBHHHHH
T ss_pred             ccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEcc--CCceEEEEEccCCCcHHHHH
Confidence            7788899999988 5568999998653      3579999999999999999999976  66789999999999999999


Q ss_pred             hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccc---ccccccc
Q 037224          419 HENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM---HIVGTQG  495 (552)
Q Consensus       419 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~---~~~gt~~  495 (552)
                      .... ..+++.+++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.........   ...+++.
T Consensus        95 ~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~  170 (268)
T 3sxs_A           95 RSHG-KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK  170 (268)
T ss_dssp             HHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGG
T ss_pred             HHcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCCCcCcc
Confidence            7653 24899999999999999999999999   999999999999999999999999999754433222   2345667


Q ss_pred             ccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          496 YIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       496 y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      |+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       171 y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~  210 (268)
T 3sxs_A          171 WSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT  210 (268)
T ss_dssp             GCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             cCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC
Confidence            999999988889999999999999999999 999997544

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.7e-33  Score=274.36  Aligned_cols=183  Identities=29%  Similarity=0.494  Sum_probs=160.7

Q ss_pred             CceEEEEEEEEee-cCcEEEEEEeccC------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhhh
Q 037224          346 GCLIQGSVYKGNI-HGEVYAIKMMKWN------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL  418 (552)
Q Consensus       346 G~g~~G~Vy~~~~-~g~~vAvK~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l  418 (552)
                      |.|++|.||++.. +++.||+|+++..      +.+|+.++++++||||+++++++.+  +...++||||+++++|.+++
T Consensus        19 g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l   96 (269)
T 4hcu_A           19 GSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPICLVFEFMEHGCLSDYL   96 (269)
T ss_dssp             EECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSEEEEEECCTTCBHHHHH
T ss_pred             cCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCceEEEEEeCCCCcHHHHH
Confidence            7777799999998 7889999998643      4589999999999999999999977  66789999999999999999


Q ss_pred             hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc---ccccccccc
Q 037224          419 HENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI---TMHIVGTQG  495 (552)
Q Consensus       419 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~---~~~~~gt~~  495 (552)
                      .... ..+++..++.++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++.......   .....+++.
T Consensus        97 ~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~  172 (269)
T 4hcu_A           97 RTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK  172 (269)
T ss_dssp             HTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGG
T ss_pred             HhcC-cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccccccCcccccc
Confidence            7644 35899999999999999999999999   9999999999999999999999999997544322   122455678


Q ss_pred             ccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          496 YIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       496 y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      |+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       173 y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~  212 (269)
T 4hcu_A          173 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS  212 (269)
T ss_dssp             GCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             cCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC
Confidence            999999988899999999999999999999 999998654

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.3e-33  Score=283.80  Aligned_cols=184  Identities=23%  Similarity=0.411  Sum_probs=154.2

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCC--eeEEEEeeccC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDA--NCYLIYEYIEN  411 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~--~~~lv~e~~~~  411 (552)
                      |.|++|.||+++.  +++.||+|+++..          +.+|+.++++++||||+++++++......  ..++||||+++
T Consensus        21 g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g  100 (311)
T 3ork_A           21 GFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDG  100 (311)
T ss_dssp             EECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCE
T ss_pred             ccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCC
Confidence            6777799999996  7899999999643          34788889999999999999998753322  45899999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-----c
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-----I  486 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-----~  486 (552)
                      ++|.+++....  .+++.+++.++.|++.||+|||+++   ++||||||+|||++.++.+||+|||++......     .
T Consensus       101 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  175 (311)
T 3ork_A          101 VTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ  175 (311)
T ss_dssp             EEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC------------
T ss_pred             CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCccccccccccccc
Confidence            99999997654  4999999999999999999999999   999999999999999999999999999743321     1


Q ss_pred             cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          487 TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       487 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       176 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  223 (311)
T 3ork_A          176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS  223 (311)
T ss_dssp             ------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            223568999999999999999999999999999999999999998654

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=4.2e-33  Score=286.11  Aligned_cols=182  Identities=26%  Similarity=0.373  Sum_probs=150.2

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhh
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSW  417 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~  417 (552)
                      |.|++|.||+++.  +++.||+|+++..      ..+|+.++++++||||+++++++.+  ....++||||+++++|.++
T Consensus        29 G~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e~~~~~~L~~~  106 (361)
T 3uc3_A           29 GSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIIMEYASGGELYER  106 (361)
T ss_dssp             SSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEEEECCCSCBHHHH
T ss_pred             ccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEee--CCEEEEEEEeCCCCCHHHH
Confidence            6677799999988  7899999998643      4589999999999999999999987  6788999999999999999


Q ss_pred             hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCc--EEEeeccCCccCC-CCccccccccc
Q 037224          418 LHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR--AKIANFGLAKSGC-NAITMHIVGTQ  494 (552)
Q Consensus       418 l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a~~~~-~~~~~~~~gt~  494 (552)
                      +....  .+++.+++.++.|++.||+|||+++   |+||||||+|||++.++.  +||+|||+++... ........||+
T Consensus       107 l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~  181 (361)
T 3uc3_A          107 ICNAG--RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP  181 (361)
T ss_dssp             HHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC---------------C
T ss_pred             HHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCCCcCCC
Confidence            87654  4999999999999999999999999   999999999999987765  9999999987432 22233467999


Q ss_pred             cccCccccCCCCCCCh-hhHHHHHHHHHHHHcCCCCCCccC
Q 037224          495 GYIAPEYLADGVVSTK-MDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       495 ~y~aPE~~~~~~~s~~-~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .|+|||.+.+..++.+ +||||||+++|||++|+.||....
T Consensus       182 ~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~  222 (361)
T 3uc3_A          182 AYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPE  222 (361)
T ss_dssp             TTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC---
T ss_pred             CcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCc
Confidence            9999999988777655 899999999999999999998643

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.2e-32  Score=282.53  Aligned_cols=183  Identities=28%  Similarity=0.388  Sum_probs=162.9

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC------hHHHHHHHHHcC-----CCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN------ACEELKILQKVN-----HGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~------~~~E~~~l~~l~-----h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      |.|++|.||+++.  +++.||||+++..      ..+|+.+++++.     |+||+++++++..  ....++||||+ ++
T Consensus        44 G~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~--~~~~~lv~e~~-~~  120 (360)
T 3llt_A           44 GDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY--YDHMCLIFEPL-GP  120 (360)
T ss_dssp             EECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE--TTEEEEEECCC-CC
T ss_pred             cccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE--CCeeEEEEcCC-CC
Confidence            7777899999998  7899999999743      346899999996     9999999999987  67889999999 88


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECC-------------------------
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS-------------------------  467 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~-------------------------  467 (552)
                      +|.+++.......+++.+++.++.|++.||+|||+++   |+||||||+|||++.                         
T Consensus       121 ~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (360)
T 3llt_A          121 SLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK  197 (360)
T ss_dssp             BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEES
T ss_pred             CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhcccccccccccccC
Confidence            9999998876667999999999999999999999999   999999999999975                         


Q ss_pred             CCcEEEeeccCCccCCCCccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          468 NMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       468 ~~~~kL~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      ++.+||+|||++...... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.
T Consensus       198 ~~~~kl~DFG~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  264 (360)
T 3llt_A          198 STGIKLIDFGCATFKSDY-HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEH  264 (360)
T ss_dssp             CCCEEECCCTTCEETTSC-CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             CCCEEEEeccCceecCCC-CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcH
Confidence            789999999999864432 3346789999999999999999999999999999999999999987653

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-32  Score=285.21  Aligned_cols=185  Identities=30%  Similarity=0.479  Sum_probs=160.3

Q ss_pred             CCceEEEEEEEEeec---------CcEEEEEEeccC--------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEE
Q 037224          345 EGCLIQGSVYKGNIH---------GEVYAIKMMKWN--------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIY  406 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~---------g~~vAvK~~~~~--------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~  406 (552)
                      .|.|++|.||+++..         +..||+|+++..        ..+|+++++++ +||||+++++++.+  ++..++||
T Consensus        77 LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~--~~~~~lv~  154 (382)
T 3tt0_A           77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ--DGPLYVIV  154 (382)
T ss_dssp             EEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEE
T ss_pred             EecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc--CCceEEEE
Confidence            377778999999862         257999998643        34799999999 99999999999977  66789999


Q ss_pred             eeccCCCchhhhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEE
Q 037224          407 EYIENGSLHSWLHENKN--------------ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAK  472 (552)
Q Consensus       407 e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~k  472 (552)
                      ||+++++|.+++.....              ..+++.+++.++.|++.||+|||+++   |+||||||+|||++.++.+|
T Consensus       155 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~k  231 (382)
T 3tt0_A          155 EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMK  231 (382)
T ss_dssp             ECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEE
T ss_pred             EecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEEcCCCcEE
Confidence            99999999999976542              35999999999999999999999999   99999999999999999999


Q ss_pred             EeeccCCccCCCC----ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          473 IANFGLAKSGCNA----ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       473 L~Dfg~a~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      |+|||+++.....    ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       232 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~  298 (382)
T 3tt0_A          232 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  298 (382)
T ss_dssp             ECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             EcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999754321    2233466789999999999999999999999999999999 999998654

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2e-32  Score=270.21  Aligned_cols=181  Identities=25%  Similarity=0.346  Sum_probs=158.8

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchh
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHS  416 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~  416 (552)
                      |.|++|.||++..  ++..+|+|++...       +.+|+.++++++||||+++++++.+  ....++||||+++++|.+
T Consensus        18 g~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~   95 (277)
T 3f3z_A           18 GRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFED--NTDIYLVMELCTGGELFE   95 (277)
T ss_dssp             EEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEEEECCCSCBHHH
T ss_pred             eecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCeEEEEEeccCCCcHHH
Confidence            7777899999988  5678999998542       4579999999999999999999987  678899999999999999


Q ss_pred             hhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE---CCCCcEEEeeccCCccCCC-Cccccccc
Q 037224          417 WLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL---DSNMRAKIANFGLAKSGCN-AITMHIVG  492 (552)
Q Consensus       417 ~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~~~~~-~~~~~~~g  492 (552)
                      ++....  .+++.+++.++.|++.||+|||+++   ++||||||+||++   +.++.+||+|||++..... .......+
T Consensus        96 ~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  170 (277)
T 3f3z_A           96 RVVHKR--VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVG  170 (277)
T ss_dssp             HHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCCCS
T ss_pred             HHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhccCC
Confidence            887654  3899999999999999999999999   9999999999999   7889999999999975432 23344678


Q ss_pred             cccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       493 t~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      |+.|+|||.+.+. ++.++||||||+++|||++|+.||....
T Consensus       171 t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~  211 (277)
T 3f3z_A          171 TPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT  211 (277)
T ss_dssp             CTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC
Confidence            9999999988654 8999999999999999999999998654

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4.5e-33  Score=283.51  Aligned_cols=184  Identities=30%  Similarity=0.475  Sum_probs=159.1

Q ss_pred             CceEEEEEEEEeecC-------cEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          346 GCLIQGSVYKGNIHG-------EVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       346 G~g~~G~Vy~~~~~g-------~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      |.|.+|.||+++..+       +.||+|+++..        +.+|+.++++++||||+++++++.+  +...++||||++
T Consensus        56 g~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~  133 (343)
T 1luf_A           56 GEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV--GKPMCLLFEYMA  133 (343)
T ss_dssp             EECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSCEEEEECCT
T ss_pred             eecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc--CCceEEEEecCC
Confidence            777789999999854       78999998643        3479999999999999999999977  667899999999


Q ss_pred             CCCchhhhhhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCC
Q 037224          411 NGSLHSWLHENKN----------------------ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN  468 (552)
Q Consensus       411 ~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~  468 (552)
                      +++|.+++.....                      ..+++.+++.++.|+++||.|||+++   ++||||||+|||++.+
T Consensus       134 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~  210 (343)
T 1luf_A          134 YGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGEN  210 (343)
T ss_dssp             TCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGG
T ss_pred             CCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEECCC
Confidence            9999999976421                      45999999999999999999999999   9999999999999999


Q ss_pred             CcEEEeeccCCccCCCC----ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          469 MRAKIANFGLAKSGCNA----ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       469 ~~~kL~Dfg~a~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      +.+||+|||++......    ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.+..
T Consensus       211 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  281 (343)
T 1luf_A          211 MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA  281 (343)
T ss_dssp             GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             CeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence            99999999998643221    1223567889999999988889999999999999999999 999997654

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=5.5e-33  Score=281.17  Aligned_cols=184  Identities=26%  Similarity=0.444  Sum_probs=156.2

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEecc--------ChHHHHHHHHHcCCCCccceeeeeecCCC----------------
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKW--------NACEELKILQKVNHGNLVKLEGFCIDPED----------------  399 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~--------~~~~E~~~l~~l~h~niv~l~~~~~~~~~----------------  399 (552)
                      |.|++|.||+++.  +|+.||||+++.        .+.+|+.++++++||||+++++++.+...                
T Consensus        15 G~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~   94 (332)
T 3qd2_B           15 GRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDES   94 (332)
T ss_dssp             ECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC-------
T ss_pred             cCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhcccc
Confidence            7778899999988  689999999852        23579999999999999999999865322                


Q ss_pred             ---------------------------------------CeeEEEEeeccCCCchhhhhhcCC-CCCCHHHHHHHHHHHH
Q 037224          400 ---------------------------------------ANCYLIYEYIENGSLHSWLHENKN-ENLNWKTRLRIAIDVA  439 (552)
Q Consensus       400 ---------------------------------------~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~  439 (552)
                                                             ...+++|||+++++|.+++..... ...++..++.++.|++
T Consensus        95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~  174 (332)
T 3qd2_B           95 TDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIA  174 (332)
T ss_dssp             -------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHH
T ss_pred             ccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHH
Confidence                                                   237999999999999999987543 3467778999999999


Q ss_pred             HHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--------------ccccccccccccCccccCCC
Q 037224          440 NGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--------------ITMHIVGTQGYIAPEYLADG  505 (552)
Q Consensus       440 ~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--------------~~~~~~gt~~y~aPE~~~~~  505 (552)
                      .||+|||+++   ++||||||+|||++.++.+||+|||+++.....              ......||+.|+|||.+.+.
T Consensus       175 ~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  251 (332)
T 3qd2_B          175 EAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGN  251 (332)
T ss_dssp             HHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCC
T ss_pred             HHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCC
Confidence            9999999999   999999999999999999999999999754332              12234689999999999999


Q ss_pred             CCCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          506 VVSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       506 ~~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                      .++.++||||||+++|||++|..|+..
T Consensus       252 ~~~~~~Di~slG~il~el~~~~~~~~~  278 (332)
T 3qd2_B          252 NYSHKVDIFSLGLILFELLYSFSTQME  278 (332)
T ss_dssp             CCCTHHHHHHHHHHHHHHHSCCCCHHH
T ss_pred             CCcchhhHHHHHHHHHHHHHcCCChhH
Confidence            999999999999999999999888753

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.8e-33  Score=291.19  Aligned_cols=186  Identities=27%  Similarity=0.423  Sum_probs=160.9

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      |.|++|.||+++.  +|+.||||+++..        ..+|++++++++||||+++++++.+......++||||+++++|.
T Consensus        18 G~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~   97 (396)
T 4eut_A           18 GQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLY   97 (396)
T ss_dssp             EECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHH
T ss_pred             EcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHH
Confidence            7777899999998  5899999998642        34799999999999999999999876666789999999999999


Q ss_pred             hhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE----CCCCcEEEeeccCCccCCCC-cccc
Q 037224          416 SWLHENKN-ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL----DSNMRAKIANFGLAKSGCNA-ITMH  489 (552)
Q Consensus       416 ~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll----~~~~~~kL~Dfg~a~~~~~~-~~~~  489 (552)
                      +++..... ..+++.+++.++.|++.||+|||+++   |+||||||+|||+    +.++.+||+|||+++..... ....
T Consensus        98 ~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~~~~  174 (396)
T 4eut_A           98 TVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS  174 (396)
T ss_dssp             HHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGGSSC
T ss_pred             HHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCcccc
Confidence            99976543 34999999999999999999999999   9999999999999    77888999999999754432 2334


Q ss_pred             ccccccccCccccCC--------CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          490 IVGTQGYIAPEYLAD--------GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~--------~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..||+.|+|||.+.+        ..++.++||||||+++|||++|+.||....
T Consensus       175 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~  227 (396)
T 4eut_A          175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE  227 (396)
T ss_dssp             SSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred             ccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            678999999998764        567789999999999999999999997543

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.3e-32  Score=272.34  Aligned_cols=184  Identities=28%  Similarity=0.435  Sum_probs=158.0

Q ss_pred             CCceEEEEEEEEee-cCcEEEEEEeccC------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhh
Q 037224          345 EGCLIQGSVYKGNI-HGEVYAIKMMKWN------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSW  417 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-~g~~vAvK~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~  417 (552)
                      .|.|++|.||++.+ ++..||+|+++..      +.+|++++.+++|+||+++++++.+  +...++||||+++++|.++
T Consensus        32 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~  109 (283)
T 3gen_A           32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK--QRPIFIITEYMANGCLLNY  109 (283)
T ss_dssp             CC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSEEEEECCCTTCBHHHH
T ss_pred             cCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEec--CCCeEEEEeccCCCcHHHH
Confidence            47888899999998 5668999999643      4579999999999999999999976  6678999999999999999


Q ss_pred             hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcc---ccccccc
Q 037224          418 LHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT---MHIVGTQ  494 (552)
Q Consensus       418 l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~---~~~~gt~  494 (552)
                      +.... ..+++.+++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++........   ....+++
T Consensus       110 l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~  185 (283)
T 3gen_A          110 LREMR-HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV  185 (283)
T ss_dssp             HHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCG
T ss_pred             HHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccccccccCCccCc
Confidence            97643 34999999999999999999999999   99999999999999999999999999975433221   1234567


Q ss_pred             cccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          495 GYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       495 ~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      .|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       186 ~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~  226 (283)
T 3gen_A          186 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT  226 (283)
T ss_dssp             GGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             ccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC
Confidence            8999999988889999999999999999998 999998644

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=6.6e-33  Score=276.85  Aligned_cols=182  Identities=30%  Similarity=0.485  Sum_probs=153.9

Q ss_pred             CceEEEEEEEEeecCcEEEEEEeccCh----HHHHHHHHH--cCCCCccceeeeeecCC--CCeeEEEEeeccCCCchhh
Q 037224          346 GCLIQGSVYKGNIHGEVYAIKMMKWNA----CEELKILQK--VNHGNLVKLEGFCIDPE--DANCYLIYEYIENGSLHSW  417 (552)
Q Consensus       346 G~g~~G~Vy~~~~~g~~vAvK~~~~~~----~~E~~~l~~--l~h~niv~l~~~~~~~~--~~~~~lv~e~~~~gsL~~~  417 (552)
                      |.|++|.||+|+.+++.||||+++...    .+|.+++..  ++||||+++++++.+..  ....++||||+++|+|.++
T Consensus        17 g~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~   96 (301)
T 3q4u_A           17 GKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDY   96 (301)
T ss_dssp             EECSSEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHH
T ss_pred             ccCCCcEEEEEEECCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHH
Confidence            777789999999999999999997543    357777777  79999999999876532  3467999999999999999


Q ss_pred             hhhcCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc---
Q 037224          418 LHENKNENLNWKTRLRIAIDVANGLQYIH--------EHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI---  486 (552)
Q Consensus       418 l~~~~~~~l~~~~~~~i~~qi~~aL~~LH--------~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~---  486 (552)
                      +...   .+++..++.++.|++.||+|||        +.+   ++||||||+|||++.++.+||+|||+++......   
T Consensus        97 l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  170 (301)
T 3q4u_A           97 LQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQL  170 (301)
T ss_dssp             HTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEE
T ss_pred             Hhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeCCCeeecccccccc
Confidence            9654   4999999999999999999999        777   9999999999999999999999999986432211   


Q ss_pred             ---cccccccccccCccccCCC------CCCChhhHHHHHHHHHHHHcC----------CCCCCcc
Q 037224          487 ---TMHIVGTQGYIAPEYLADG------VVSTKMDVFSFGVVLLELISG----------KEAIDEE  533 (552)
Q Consensus       487 ---~~~~~gt~~y~aPE~~~~~------~~s~~~Dv~slG~il~elltG----------~~pf~~~  533 (552)
                         .....||+.|+|||.+.+.      .++.++||||||+++|||++|          +.||.+.
T Consensus       171 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~  236 (301)
T 3q4u_A          171 DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV  236 (301)
T ss_dssp             ECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             cccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence               1224789999999998776      455799999999999999999          8888653

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.6e-33  Score=286.56  Aligned_cols=185  Identities=30%  Similarity=0.457  Sum_probs=158.0

Q ss_pred             CCceEEEEEEEEee-------cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeec
Q 037224          345 EGCLIQGSVYKGNI-------HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI  409 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-------~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~  409 (552)
                      .|.|++|.||+|++       .++.||||+++..        +.+|+.++++++||||+++++++.+  ....++||||+
T Consensus        79 LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~e~~  156 (367)
T 3l9p_A           79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ--SLPRFILLELM  156 (367)
T ss_dssp             CCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEEECC
T ss_pred             eeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec--CCCCEEEEEeC
Confidence            47778899999985       4568999998542        3479999999999999999999977  56679999999


Q ss_pred             cCCCchhhhhhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCC---cEEEeeccCCcc
Q 037224          410 ENGSLHSWLHENKN-----ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM---RAKIANFGLAKS  481 (552)
Q Consensus       410 ~~gsL~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~---~~kL~Dfg~a~~  481 (552)
                      ++|+|.+++.....     ..+++.+++.++.|++.||+|||+++   |+||||||+|||++.++   .+||+|||+++.
T Consensus       157 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~  233 (367)
T 3l9p_A          157 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD  233 (367)
T ss_dssp             TTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHHHH
T ss_pred             CCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEECCCccccc
Confidence            99999999976542     35899999999999999999999999   99999999999999555   599999999863


Q ss_pred             C----CCCccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          482 G----CNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       482 ~----~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      .    .........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus       234 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~  291 (367)
T 3l9p_A          234 IYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS  291 (367)
T ss_dssp             HHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             cccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            2    1122233567889999999988999999999999999999998 999998654

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.8e-32  Score=269.87  Aligned_cols=182  Identities=27%  Similarity=0.440  Sum_probs=158.3

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC-------------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN-------------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      |.|.+|.||++..  +|+.||+|+++..             +.+|+.++++++||||+++++++.+  ....++||||++
T Consensus        14 g~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~   91 (283)
T 3bhy_A           14 GSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN--KTDVVLILELVS   91 (283)
T ss_dssp             EECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEEEECCC
T ss_pred             cccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC--CCeEEEEEeecC
Confidence            6677799999998  5889999998532             3579999999999999999999987  678899999999


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCC----cEEEeeccCCccCCCC-
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM----RAKIANFGLAKSGCNA-  485 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~----~~kL~Dfg~a~~~~~~-  485 (552)
                      +++|.+++....  .+++.+++.++.|++.||.|||+++   ++||||||+||+++.++    .+||+|||++...... 
T Consensus        92 ~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~  166 (283)
T 3bhy_A           92 GGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN  166 (283)
T ss_dssp             SCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC---
T ss_pred             CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccceeccCCC
Confidence            999999997654  4999999999999999999999999   99999999999998877    8999999999754322 


Q ss_pred             ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          486 ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       486 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ......+++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       167 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  215 (283)
T 3bhy_A          167 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET  215 (283)
T ss_dssp             -----CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc
Confidence            2234578999999999998999999999999999999999999998654

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.8e-32  Score=270.05  Aligned_cols=182  Identities=25%  Similarity=0.405  Sum_probs=159.9

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|++|.||++..  +++.||+|+++..         ..+|+.++++++|+||+++++++.+  +...+++|||+++++|
T Consensus        15 g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~~l   92 (284)
T 3kk8_A           15 GKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYLVFDLVTGGEL   92 (284)
T ss_dssp             EEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEEECCCCSCBH
T ss_pred             cCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc--CCEEEEEEecCCCCCH
Confidence            7778899999987  6889999998542         2479999999999999999999976  6778999999999999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCc---EEEeeccCCccCCCCc-cccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR---AKIANFGLAKSGCNAI-TMHI  490 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~---~kL~Dfg~a~~~~~~~-~~~~  490 (552)
                      .+++....  .+++.++..++.|++.||.|||+++   ++||||||+||+++.++.   +||+|||++....... ....
T Consensus        93 ~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~  167 (284)
T 3kk8_A           93 FEDIVARE--FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF  167 (284)
T ss_dssp             HHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCS
T ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCC
Confidence            98887654  4999999999999999999999999   999999999999987655   9999999997544332 2346


Q ss_pred             cccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       491 ~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .+++.|+|||.+.+..++.++||||||+++|+|++|+.||.+..
T Consensus       168 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  211 (284)
T 3kk8_A          168 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED  211 (284)
T ss_dssp             CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc
Confidence            78999999999999999999999999999999999999997654

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=8e-33  Score=281.11  Aligned_cols=183  Identities=23%  Similarity=0.359  Sum_probs=160.4

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC---------------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEe
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN---------------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYE  407 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  407 (552)
                      .|.|++|.||++..  +++.||+|+++..               +.+|+.++++++||||+++++++.+  ....++|||
T Consensus        32 lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--~~~~~lv~e  109 (335)
T 3dls_A           32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN--QGFFQLVME  109 (335)
T ss_dssp             CSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEEEE
T ss_pred             EEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee--CCEEEEEEE
Confidence            37777899999976  7899999998543               2369999999999999999999987  678899999


Q ss_pred             eccCC-CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-
Q 037224          408 YIENG-SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-  485 (552)
Q Consensus       408 ~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-  485 (552)
                      |+.+| +|.+++....  .+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++...... 
T Consensus       110 ~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  184 (335)
T 3dls_A          110 KHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK  184 (335)
T ss_dssp             CCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             eCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccceECCCCC
Confidence            99776 9999887654  4999999999999999999999999   999999999999999999999999999754432 


Q ss_pred             ccccccccccccCccccCCCCC-CChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          486 ITMHIVGTQGYIAPEYLADGVV-STKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       486 ~~~~~~gt~~y~aPE~~~~~~~-s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||....
T Consensus       185 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  234 (335)
T 3dls_A          185 LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE  234 (335)
T ss_dssp             CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG
T ss_pred             ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH
Confidence            2334678999999999988776 789999999999999999999997543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=7.8e-33  Score=293.31  Aligned_cols=183  Identities=25%  Similarity=0.366  Sum_probs=153.0

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCC----CCeeEEEEeec
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPE----DANCYLIYEYI  409 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~~~lv~e~~  409 (552)
                      .|.|++|.||++..  +|+.||||++...         ..+|+.+++.++||||+++++++....    ....++||||+
T Consensus        70 lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~  149 (464)
T 3ttj_A           70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM  149 (464)
T ss_dssp             EEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECC
T ss_pred             eecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCC
Confidence            37778899999987  7899999998542         347999999999999999999997532    24679999999


Q ss_pred             cCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-ccc
Q 037224          410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-ITM  488 (552)
Q Consensus       410 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-~~~  488 (552)
                      ++ +|.+.+..    .+++.++..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++..... ...
T Consensus       150 ~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~  221 (464)
T 3ttj_A          150 DA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT  221 (464)
T ss_dssp             SE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-----CCCC-
T ss_pred             CC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeecCCCcccC
Confidence            86 56665543    3899999999999999999999999   999999999999999999999999999865432 234


Q ss_pred             cccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          489 HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       489 ~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus       222 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~  268 (464)
T 3ttj_A          222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY  268 (464)
T ss_dssp             ---CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             CCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            46899999999999999999999999999999999999999987653

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=4.5e-33  Score=294.76  Aligned_cols=183  Identities=26%  Similarity=0.454  Sum_probs=159.7

Q ss_pred             CceEEEEEEEEee-cCcEEEEEEeccC------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhhh
Q 037224          346 GCLIQGSVYKGNI-HGEVYAIKMMKWN------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL  418 (552)
Q Consensus       346 G~g~~G~Vy~~~~-~g~~vAvK~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l  418 (552)
                      |.|.+|.||+|.+ .+..||||+++..      +.+|+.++++++||||+++++++.   +...++||||+++|+|.+++
T Consensus       197 G~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~---~~~~~lv~e~~~~g~L~~~l  273 (454)
T 1qcf_A          197 GAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT---KEPIYIITEFMAKGSLLDFL  273 (454)
T ss_dssp             ECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSCEEEECCCTTCBHHHHH
T ss_pred             ccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe---CCccEEEEeecCCCcHHHHH
Confidence            6777799999998 5788999999743      458999999999999999999885   34679999999999999999


Q ss_pred             hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcc---cccccccc
Q 037224          419 HENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT---MHIVGTQG  495 (552)
Q Consensus       419 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~---~~~~gt~~  495 (552)
                      .......+++.+++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.......   ....++..
T Consensus       274 ~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~  350 (454)
T 1qcf_A          274 KSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK  350 (454)
T ss_dssp             HSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGG
T ss_pred             HhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCccccc
Confidence            8654445899999999999999999999999   99999999999999999999999999986543221   12345678


Q ss_pred             ccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          496 YIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       496 y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      |+|||.+....++.++||||||+++|||+| |+.||.+..
T Consensus       351 y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~  390 (454)
T 1qcf_A          351 WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS  390 (454)
T ss_dssp             GSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC
Confidence            999999988899999999999999999999 999998654

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=6.6e-33  Score=272.25  Aligned_cols=185  Identities=25%  Similarity=0.399  Sum_probs=161.3

Q ss_pred             CceEEEEEEEEeecCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchh
Q 037224          346 GCLIQGSVYKGNIHGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHS  416 (552)
Q Consensus       346 G~g~~G~Vy~~~~~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~  416 (552)
                      |.|++|.||+++++++.||+|+++..         +.+|+.++++++||||+++++++.+......++||||+++++|.+
T Consensus        19 g~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~   98 (271)
T 3kmu_A           19 NENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYN   98 (271)
T ss_dssp             EEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHH
T ss_pred             cCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHH
Confidence            77788999999999999999998643         347899999999999999999998765578899999999999999


Q ss_pred             hhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccccccccccc
Q 037224          417 WLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGY  496 (552)
Q Consensus       417 ~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~gt~~y  496 (552)
                      ++.......+++.+++.++.|++.||.|||+++ ++++||||||+||+++.++.++|+|||++.....   ....+|+.|
T Consensus        99 ~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~---~~~~~t~~y  174 (271)
T 3kmu_A           99 VLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS---PGRMYAPAW  174 (271)
T ss_dssp             HHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC---TTCBSCGGG
T ss_pred             HHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc---cCccCCccc
Confidence            998766556999999999999999999999875 3499999999999999999999999998764322   235789999


Q ss_pred             cCccccCCCCCCC---hhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          497 IAPEYLADGVVST---KMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       497 ~aPE~~~~~~~s~---~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +|||.+.+...+.   ++||||||+++|||++|+.||.+..
T Consensus       175 ~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~  215 (271)
T 3kmu_A          175 VAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS  215 (271)
T ss_dssp             SCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC
T ss_pred             cChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence            9999988765544   7999999999999999999998644

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.4e-32  Score=280.70  Aligned_cols=181  Identities=31%  Similarity=0.487  Sum_probs=157.9

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|.|++|.||+++.  +|+.||||+++..          +.+|+.++++++||||+++++++.+  +...++||||++ |
T Consensus        62 lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e~~~-g  138 (348)
T 1u5q_A           62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWLVMEYCL-G  138 (348)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEEECCS-E
T ss_pred             EccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCeEEEEEecCC-C
Confidence            37777899999986  7899999998532          3479999999999999999999987  678899999997 5


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccccccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVG  492 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~g  492 (552)
                      +|.+++.... ..+++.+++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++......  ....|
T Consensus       139 ~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--~~~~g  212 (348)
T 1u5q_A          139 SASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--NSFVG  212 (348)
T ss_dssp             EHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--CCCCS
T ss_pred             CHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC--CcccC
Confidence            8888776433 35999999999999999999999999   999999999999999999999999999765432  34678


Q ss_pred             cccccCccccC---CCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          493 TQGYIAPEYLA---DGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       493 t~~y~aPE~~~---~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      |+.|+|||.+.   ...++.++||||||+++|||++|+.||.+.+
T Consensus       213 t~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~  257 (348)
T 1u5q_A          213 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN  257 (348)
T ss_dssp             CGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             CcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999874   5678999999999999999999999997644

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.8e-32  Score=277.10  Aligned_cols=183  Identities=27%  Similarity=0.397  Sum_probs=161.7

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|.|++|.||++..  +++.||+|++...          +.+|+.++++++|+||+++++++.+  .+..++||||++++
T Consensus        49 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~  126 (335)
T 2owb_A           49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--NDFVFVVLELCRRR  126 (335)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEEECCCTTC
T ss_pred             EeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--CCeEEEEEecCCCC
Confidence            37788899999998  5789999998543          3469999999999999999999987  67889999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC--Cccccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN--AITMHI  490 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~--~~~~~~  490 (552)
                      +|.+++....  .+++.+++.++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++.....  ......
T Consensus       127 ~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  201 (335)
T 2owb_A          127 SLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL  201 (335)
T ss_dssp             BHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCC
T ss_pred             CHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCccccccc
Confidence            9999887654  4999999999999999999999999   99999999999999999999999999975432  223345


Q ss_pred             cccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       491 ~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .|++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       202 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  245 (335)
T 2owb_A          202 CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC  245 (335)
T ss_dssp             CSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             CCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC
Confidence            78999999999998889999999999999999999999998653

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=4.2e-32  Score=270.38  Aligned_cols=183  Identities=27%  Similarity=0.397  Sum_probs=161.4

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|.|++|.||++..  .++.+|+|++...          ..+|+.++++++|+||+++++++.+  ++..+++|||++++
T Consensus        23 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~  100 (294)
T 2rku_A           23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--NDFVFVVLELCRRR  100 (294)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEEEECCTTC
T ss_pred             EeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc--CCEEEEEEecCCCC
Confidence            37788899999998  5789999998532          2469999999999999999999987  67889999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC--Cccccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN--AITMHI  490 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~--~~~~~~  490 (552)
                      +|.+++....  .+++.+++.++.|+++||+|||+++   ++||||||+||+++.++.+||+|||++.....  ......
T Consensus       101 ~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  175 (294)
T 2rku_A          101 SLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL  175 (294)
T ss_dssp             BHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCC
T ss_pred             CHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCccccccc
Confidence            9999887654  4999999999999999999999999   99999999999999999999999999975432  223345


Q ss_pred             cccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       491 ~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .+++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  219 (294)
T 2rku_A          176 CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC  219 (294)
T ss_dssp             CSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             cCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            78999999999998889999999999999999999999998654

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=6.4e-33  Score=296.62  Aligned_cols=185  Identities=27%  Similarity=0.442  Sum_probs=162.7

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchh
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHS  416 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~  416 (552)
                      .|.|.+|.||+|.+  .+..||||+++..      +.+|+.++++++||||++++++|.+  +...++||||+++|+|.+
T Consensus       228 lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lv~E~~~~g~L~~  305 (495)
T 1opk_A          228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYIITEFMTYGNLLD  305 (495)
T ss_dssp             SGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEEECCTTCBHHH
T ss_pred             ecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEec--CCcEEEEEEccCCCCHHH
Confidence            47777899999998  4789999999643      4589999999999999999999977  567899999999999999


Q ss_pred             hhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcc---cccccc
Q 037224          417 WLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT---MHIVGT  493 (552)
Q Consensus       417 ~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~---~~~~gt  493 (552)
                      ++.......+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.......   ....++
T Consensus       306 ~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~  382 (495)
T 1opk_A          306 YLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP  382 (495)
T ss_dssp             HHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCC
T ss_pred             HHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCCcCC
Confidence            998766566999999999999999999999999   99999999999999999999999999986543221   123456


Q ss_pred             ccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       494 ~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      ..|+|||.+....++.++||||||+++|||+| |+.||.+.+
T Consensus       383 ~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~  424 (495)
T 1opk_A          383 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID  424 (495)
T ss_dssp             GGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             cceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC
Confidence            78999999988899999999999999999999 999998654

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=9.2e-33  Score=274.95  Aligned_cols=180  Identities=27%  Similarity=0.424  Sum_probs=154.4

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|.+|.||+++.  +++.||+|+++..         ..+|+.++++++||||+++++++.+  +...++||||+++ +|
T Consensus        11 g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~-~l   87 (292)
T 3o0g_A           11 GEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLVFEFCDQ-DL   87 (292)
T ss_dssp             EECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEEEECCSE-EH
T ss_pred             cCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe--CCEEEEEEecCCC-CH
Confidence            6777799999998  6899999998532         3479999999999999999999987  6788999999986 66


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC--Cccccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN--AITMHIVG  492 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~--~~~~~~~g  492 (552)
                      .+.+.... ..+++.+++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++.....  .......+
T Consensus        88 ~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  163 (292)
T 3o0g_A           88 KKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV  163 (292)
T ss_dssp             HHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCSCCS
T ss_pred             HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCccccccCCcc
Confidence            66555432 35999999999999999999999999   99999999999999999999999999975432  22334578


Q ss_pred             cccccCccccCCCC-CCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          493 TQGYIAPEYLADGV-VSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       493 t~~y~aPE~~~~~~-~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                      |+.|+|||.+.+.. ++.++||||||+++|||++|..||..
T Consensus       164 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~  204 (292)
T 3o0g_A          164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  204 (292)
T ss_dssp             CGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred             ccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcC
Confidence            99999999987765 79999999999999999999888643

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-32  Score=282.55  Aligned_cols=183  Identities=26%  Similarity=0.431  Sum_probs=154.5

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCC----CeeEEEEeec
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPED----ANCYLIYEYI  409 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~~~lv~e~~  409 (552)
                      .|.|++|.||++..  +|+.||||++...         ..+|+.++++++||||+++++++.....    ..+++||||+
T Consensus        33 lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~  112 (367)
T 1cm8_A           33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM  112 (367)
T ss_dssp             C------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC
T ss_pred             eeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC
Confidence            47888899999987  6899999998432         3479999999999999999999876321    3569999999


Q ss_pred             cCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcccc
Q 037224          410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH  489 (552)
Q Consensus       410 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  489 (552)
                       +++|.+++...   .+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+||+|||+++..... ...
T Consensus       113 -~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-~~~  184 (367)
T 1cm8_A          113 -GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-MTG  184 (367)
T ss_dssp             -SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSS-CCS
T ss_pred             -CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecccccccc-cCc
Confidence             77999998763   4999999999999999999999999   999999999999999999999999999865433 334


Q ss_pred             ccccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          490 IVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      ..+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+.
T Consensus       185 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  231 (367)
T 1cm8_A          185 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH  231 (367)
T ss_dssp             SCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             CcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            678999999999876 6799999999999999999999999987653

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.4e-32  Score=280.42  Aligned_cols=185  Identities=25%  Similarity=0.400  Sum_probs=163.8

Q ss_pred             CceEEEEEEEEeecCcEEEEEEec------------------------cChHHHHHHHHHcCCCCccceeeeeecCCCCe
Q 037224          346 GCLIQGSVYKGNIHGEVYAIKMMK------------------------WNACEELKILQKVNHGNLVKLEGFCIDPEDAN  401 (552)
Q Consensus       346 G~g~~G~Vy~~~~~g~~vAvK~~~------------------------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  401 (552)
                      |.|.+|.||++..+|+.||+|++.                        ..+.+|+.++++++||||+++++++.+  .+.
T Consensus        40 g~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~  117 (348)
T 2pml_X           40 NQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITN--YDE  117 (348)
T ss_dssp             ECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEES--SSE
T ss_pred             cCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEee--CCe
Confidence            667779999999999999999984                        334589999999999999999999987  678


Q ss_pred             eEEEEeeccCCCchhh------hhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEECCCCcEEEe
Q 037224          402 CYLIYEYIENGSLHSW------LHENKNENLNWKTRLRIAIDVANGLQYIHE-HTRPRVVHKDIKSSNILLDSNMRAKIA  474 (552)
Q Consensus       402 ~~lv~e~~~~gsL~~~------l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kL~  474 (552)
                      .++||||+++++|.++      +.......+++..++.++.|++.||.|||+ .+   ++||||||+||+++.++.+||+
T Consensus       118 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~~~~~~kl~  194 (348)
T 2pml_X          118 VYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDKNGRVKLS  194 (348)
T ss_dssp             EEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEECTTSCEEEC
T ss_pred             EEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEcCCCcEEEe
Confidence            8999999999999998      665445569999999999999999999999 88   9999999999999999999999


Q ss_pred             eccCCccCCCCccccccccccccCccccCCC-CCCC-hhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          475 NFGLAKSGCNAITMHIVGTQGYIAPEYLADG-VVST-KMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       475 Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      |||++............++..|+|||.+.+. .++. ++||||||+++|||++|+.||.....
T Consensus       195 dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  257 (348)
T 2pml_X          195 DFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS  257 (348)
T ss_dssp             CCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred             ccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence            9999986544445557889999999999877 5666 99999999999999999999986543

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5e-33  Score=286.80  Aligned_cols=183  Identities=29%  Similarity=0.462  Sum_probs=148.5

Q ss_pred             CceEEEEEEEEeec-----CcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          346 GCLIQGSVYKGNIH-----GEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       346 G~g~~G~Vy~~~~~-----g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      |.|++|.||+|+..     +..||||+++..        +.+|+.++++++||||+++++++.+  ....++||||++++
T Consensus        54 G~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~  131 (373)
T 2qol_A           54 GAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK--SKPVMIVTEYMENG  131 (373)
T ss_dssp             EECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSSCEEEEECCTTC
T ss_pred             eeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCceEEEEeCCCCC
Confidence            77888999999863     667999998642        4479999999999999999999976  56789999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc-----c
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI-----T  487 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-----~  487 (552)
                      +|.+++.... ..+++.+++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++......     .
T Consensus       132 sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  207 (373)
T 2qol_A          132 SLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTT  207 (373)
T ss_dssp             BHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----------------
T ss_pred             cHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccccCCccceec
Confidence            9999997643 35999999999999999999999999   9999999999999999999999999997543221     1


Q ss_pred             ccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          488 MHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       488 ~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      ....++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       208 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~  255 (373)
T 2qol_A          208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS  255 (373)
T ss_dssp             ------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC
T ss_pred             cCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence            11234678999999998999999999999999999998 999997543

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=3.5e-32  Score=271.15  Aligned_cols=182  Identities=20%  Similarity=0.246  Sum_probs=159.4

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEecc-----ChHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccCCCchhh
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKW-----NACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSW  417 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~-----~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~  417 (552)
                      |.|.+|.||++..  +|+.||+|+++.     ...+|+.+++++ +|+|++++++++.+  ....++||||+ +++|.++
T Consensus        19 g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~lv~e~~-~~~L~~~   95 (298)
T 1csn_A           19 GEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVLVIDLL-GPSLEDL   95 (298)
T ss_dssp             EECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEEEEECC-CCBHHHH
T ss_pred             eecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCC--CceeEEEEEec-CCCHHHH
Confidence            6777799999995  789999999853     356899999999 89999999999876  67889999999 8899999


Q ss_pred             hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCc-----EEEeeccCCccCCCC-------
Q 037224          418 LHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR-----AKIANFGLAKSGCNA-------  485 (552)
Q Consensus       418 l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~-----~kL~Dfg~a~~~~~~-------  485 (552)
                      +.... ..+++.+++.++.|++.||+|||+++   ++||||||+||+++.++.     +||+|||++......       
T Consensus        96 l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  171 (298)
T 1csn_A           96 LDLCG-RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP  171 (298)
T ss_dssp             HHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCC
T ss_pred             HHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccccccccc
Confidence            97653 34999999999999999999999999   999999999999987776     999999999743322       


Q ss_pred             --ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          486 --ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       486 --~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                        ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  222 (298)
T 1csn_A          172 YREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK  222 (298)
T ss_dssp             CCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             ccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhh
Confidence              1234578999999999999999999999999999999999999998743

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=7.2e-33  Score=275.20  Aligned_cols=182  Identities=29%  Similarity=0.465  Sum_probs=154.9

Q ss_pred             CceEEEEEEEEee-cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          346 GCLIQGSVYKGNI-HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       346 G~g~~G~Vy~~~~-~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      |.|.+|.||+++. .|+.||+|+++..         ..+|+.++++++||||+++++++.+  ....++||||+++ +|.
T Consensus        11 g~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~-~l~   87 (288)
T 1ob3_A           11 GEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT--KKRLVLVFEHLDQ-DLK   87 (288)
T ss_dssp             EEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--SSCEEEEEECCSE-EHH
T ss_pred             ccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc--CCeEEEEEEecCC-CHH
Confidence            7778899999998 5899999998532         3479999999999999999999987  6678999999986 898


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC--Ccccccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN--AITMHIVGT  493 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~--~~~~~~~gt  493 (552)
                      +++.... ..+++.+++.++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++.....  .......+|
T Consensus        88 ~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t  163 (288)
T 1ob3_A           88 KLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVT  163 (288)
T ss_dssp             HHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CC
T ss_pred             HHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccccccccccc
Confidence            8887543 35899999999999999999999999   99999999999999999999999999874322  122345789


Q ss_pred             ccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          494 QGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       494 ~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +.|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus       164 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  205 (288)
T 1ob3_A          164 LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS  205 (288)
T ss_dssp             CTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999875 458999999999999999999999998654

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.9e-33  Score=277.99  Aligned_cols=184  Identities=32%  Similarity=0.482  Sum_probs=157.3

Q ss_pred             CceEEEEEEEEee------cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          346 GCLIQGSVYKGNI------HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       346 G~g~~G~Vy~~~~------~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      |.|++|.||++++      +++.||+|+++..       +.+|+.++++++||||+++++++...+....++||||++++
T Consensus        19 g~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~   98 (295)
T 3ugc_A           19 GKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG   98 (295)
T ss_dssp             EECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTC
T ss_pred             eccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCC
Confidence            6777799999984      6789999998643       34799999999999999999998764456689999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc-----c
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI-----T  487 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-----~  487 (552)
                      +|.+++..... .+++.+++.++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++.......     .
T Consensus        99 ~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  174 (295)
T 3ugc_A           99 SLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK  174 (295)
T ss_dssp             BHHHHHHHCGG-GCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC------------
T ss_pred             CHHHHHHhccc-ccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeec
Confidence            99999977543 4899999999999999999999999   9999999999999999999999999997543221     2


Q ss_pred             ccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          488 MHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       488 ~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      ....++..|+|||.+.+..++.++||||||+++|||+||..||...
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~  220 (295)
T 3ugc_A          175 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP  220 (295)
T ss_dssp             -CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred             cCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCC
Confidence            2245677899999999899999999999999999999999998754

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3e-32  Score=276.00  Aligned_cols=185  Identities=26%  Similarity=0.393  Sum_probs=159.4

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEecc---------ChHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKW---------NACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~---------~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|.|++|.||++..  +++.||+|+++.         ...+|+.+++++ +||||+++++++.+  ....++||||++++
T Consensus        37 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~--~~~~~lv~e~~~~~  114 (327)
T 3lm5_A           37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN--TSEIILILEYAAGG  114 (327)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEEEEECCTTE
T ss_pred             eCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe--CCeEEEEEEecCCC
Confidence            47788899999988  689999999853         234799999999 56999999999987  67889999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECC---CCcEEEeeccCCccCCCC-ccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS---NMRAKIANFGLAKSGCNA-ITM  488 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kL~Dfg~a~~~~~~-~~~  488 (552)
                      +|.+++.......+++.+++.++.|++.||+|||+++   ++||||||+|||++.   ++.+||+|||++...... ...
T Consensus       115 ~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~  191 (327)
T 3lm5_A          115 EIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELR  191 (327)
T ss_dssp             EGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-------
T ss_pred             cHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCccccccCCccccc
Confidence            9999987665567999999999999999999999999   999999999999988   789999999999754432 223


Q ss_pred             cccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          489 HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       489 ~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ...||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       192 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  237 (327)
T 3lm5_A          192 EIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED  237 (327)
T ss_dssp             --CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            4678999999999999999999999999999999999999997654

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2e-32  Score=275.49  Aligned_cols=183  Identities=26%  Similarity=0.438  Sum_probs=154.9

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC-------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN-------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      .|.|.+|.||++..  +++.||||+++..       ..+|+.++.++ +||||+++++++.+  ++..++||||+++++|
T Consensus        21 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L   98 (316)
T 2ac3_A           21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE--EDRFYLVFEKMRGGSI   98 (316)
T ss_dssp             CCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEEEECCTTCBH
T ss_pred             ecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee--CCEEEEEEEcCCCCcH
Confidence            47788899999986  7899999998532       35799999995 79999999999987  6788999999999999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCc---EEEeeccCCccCCC-------
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR---AKIANFGLAKSGCN-------  484 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~---~kL~Dfg~a~~~~~-------  484 (552)
                      .+++....  .+++.+++.++.|++.||+|||+++   ++||||||+|||++.++.   +||+|||++.....       
T Consensus        99 ~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~  173 (316)
T 2ac3_A           99 LSHIHKRR--HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPI  173 (316)
T ss_dssp             HHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----------
T ss_pred             HHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccc
Confidence            99997754  4899999999999999999999999   999999999999988776   99999999874321       


Q ss_pred             --CccccccccccccCccccCC-----CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          485 --AITMHIVGTQGYIAPEYLAD-----GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       485 --~~~~~~~gt~~y~aPE~~~~-----~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                        .......||+.|+|||.+..     ..++.++||||||+++|||++|+.||....
T Consensus       174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  230 (316)
T 2ac3_A          174 STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC  230 (316)
T ss_dssp             --------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred             cccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence              11123468999999999865     557889999999999999999999998653

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.1e-32  Score=272.77  Aligned_cols=184  Identities=29%  Similarity=0.519  Sum_probs=161.4

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEecc---ChHHHHHHHHHcCCCCccceeeeeec--------------CCCCeeEEEE
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKW---NACEELKILQKVNHGNLVKLEGFCID--------------PEDANCYLIY  406 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~---~~~~E~~~l~~l~h~niv~l~~~~~~--------------~~~~~~~lv~  406 (552)
                      |.|.+|.||++..  +++.||+|+++.   ...+|++++++++||||+++++++..              ......++||
T Consensus        20 g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~   99 (284)
T 2a19_B           20 GSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQM   99 (284)
T ss_dssp             ECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEE
T ss_pred             ccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEE
Confidence            6677799999998  589999999854   46689999999999999999998753              1234579999


Q ss_pred             eeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-
Q 037224          407 EYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-  485 (552)
Q Consensus       407 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-  485 (552)
                      ||+++++|.+++.......+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++...... 
T Consensus       100 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  176 (284)
T 2a19_B          100 EFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG  176 (284)
T ss_dssp             CCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEESSCCS
T ss_pred             eccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEEECcchhheeccccc
Confidence            9999999999998765566999999999999999999999999   999999999999999999999999998754332 


Q ss_pred             ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          486 ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       486 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                      ......+++.|+|||.+.+..++.++||||||+++|||++|..|+..
T Consensus       177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~  223 (284)
T 2a19_B          177 KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE  223 (284)
T ss_dssp             CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH
T ss_pred             cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh
Confidence            23345789999999999999999999999999999999999999864

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.7e-32  Score=270.83  Aligned_cols=183  Identities=28%  Similarity=0.483  Sum_probs=141.3

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|.+|.||+++.  +|+.||+|+++..          ..+|+.++++++||||+++++++.+  ....++||||+++++
T Consensus        20 g~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~   97 (278)
T 3cok_A           20 GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED--SNYVYLVLEMCHNGE   97 (278)
T ss_dssp             EECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC--SSEEEEEEECCTTEE
T ss_pred             cCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc--CCeEEEEEecCCCCc
Confidence            6677799999987  7899999998532          3479999999999999999999987  678899999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--cccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIV  491 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~  491 (552)
                      |.+++.... ..+++.+++.++.|+++||+|||+++   ++||||||+||+++.++.+||+|||++......  ......
T Consensus        98 L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~  173 (278)
T 3cok_A           98 MNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC  173 (278)
T ss_dssp             HHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC----------
T ss_pred             HHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcceecc
Confidence            999987643 35899999999999999999999999   999999999999999999999999999754322  223457


Q ss_pred             ccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          492 GTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       492 gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       174 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  216 (278)
T 3cok_A          174 GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDT  216 (278)
T ss_dssp             ------------------CTHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred             CCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChh
Confidence            8999999999998889999999999999999999999998643

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=9.1e-33  Score=283.13  Aligned_cols=185  Identities=30%  Similarity=0.478  Sum_probs=158.3

Q ss_pred             CceEEEEEEEEee-------cCcEEEEEEeccC--------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeec
Q 037224          346 GCLIQGSVYKGNI-------HGEVYAIKMMKWN--------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYI  409 (552)
Q Consensus       346 G~g~~G~Vy~~~~-------~g~~vAvK~~~~~--------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~  409 (552)
                      |.|++|.||++++       +++.||||+++..        +.+|++++.++ +||||+++++++.+. +...++||||+
T Consensus        31 G~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~-~~~~~iv~e~~  109 (359)
T 3vhe_A           31 GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-GGPLMVIVEFC  109 (359)
T ss_dssp             EECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-TSCCEEEEECC
T ss_pred             cCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC-CCceEEEEEec
Confidence            7778899999974       4578999999643        45799999999 899999999998763 34579999999


Q ss_pred             cCCCchhhhhhcCC----------------------------------------------------------------CC
Q 037224          410 ENGSLHSWLHENKN----------------------------------------------------------------EN  425 (552)
Q Consensus       410 ~~gsL~~~l~~~~~----------------------------------------------------------------~~  425 (552)
                      ++|+|.+++.....                                                                ..
T Consensus       110 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (359)
T 3vhe_A          110 KFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDF  189 (359)
T ss_dssp             TTEEHHHHHHTTTTSBCSCC------------------------------------------------------CTTTTC
T ss_pred             CCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchhccc
Confidence            99999999976532                                                                12


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC----ccccccccccccCccc
Q 037224          426 LNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA----ITMHIVGTQGYIAPEY  501 (552)
Q Consensus       426 l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~----~~~~~~gt~~y~aPE~  501 (552)
                      +++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++......    ......+|+.|+|||.
T Consensus       190 l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~  266 (359)
T 3vhe_A          190 LTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET  266 (359)
T ss_dssp             BCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHH
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhh
Confidence            899999999999999999999999   999999999999999999999999999754322    2223567889999999


Q ss_pred             cCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          502 LADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       502 ~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      +.+..++.++||||||+++|||+| |+.||.+..
T Consensus       267 ~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  300 (359)
T 3vhe_A          267 IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  300 (359)
T ss_dssp             HHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccc
Confidence            998999999999999999999998 999998654

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3.5e-32  Score=279.74  Aligned_cols=182  Identities=26%  Similarity=0.481  Sum_probs=159.0

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEe
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYE  407 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e  407 (552)
                      |.|.+|.||++..  +|+.||||+++..               ..+|+.+++++ +||||+++++++..  ....++|||
T Consensus       103 g~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~~lv~e  180 (365)
T 2y7j_A          103 GRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES--SSFMFLVFD  180 (365)
T ss_dssp             EECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB--SSEEEEEEC
T ss_pred             ecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee--CCEEEEEEE
Confidence            7777799999988  5899999998532               24699999999 89999999999987  678899999


Q ss_pred             eccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC-Cc
Q 037224          408 YIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN-AI  486 (552)
Q Consensus       408 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~-~~  486 (552)
                      |+++++|.+++....  .+++..++.++.|++.||.|||+.|   ++|+||||+|||++.++.+||+|||++..... ..
T Consensus       181 ~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~  255 (365)
T 2y7j_A          181 LMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK  255 (365)
T ss_dssp             CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC
T ss_pred             eCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCcccccCCCcc
Confidence            999999999997654  4999999999999999999999999   99999999999999999999999999875432 23


Q ss_pred             cccccccccccCccccC------CCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          487 TMHIVGTQGYIAPEYLA------DGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       487 ~~~~~gt~~y~aPE~~~------~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .....||+.|+|||++.      ...++.++||||||+++|||++|+.||....
T Consensus       256 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~  309 (365)
T 2y7j_A          256 LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR  309 (365)
T ss_dssp             BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC
Confidence            34467999999999875      3358889999999999999999999997654

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.4e-32  Score=274.82  Aligned_cols=183  Identities=31%  Similarity=0.482  Sum_probs=157.4

Q ss_pred             CceEEEEEEEEee------cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          346 GCLIQGSVYKGNI------HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       346 G~g~~G~Vy~~~~------~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      |.|++|.||++++      +++.||+|+++..        ..+|+.++++++|+||+++++++.+......++||||+++
T Consensus        30 g~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~  109 (302)
T 4e5w_A           30 GEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS  109 (302)
T ss_dssp             EECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTT
T ss_pred             CCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCC
Confidence            7777799999983      6889999998643        3579999999999999999999987655778999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc-----
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI-----  486 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-----  486 (552)
                      ++|.+++.... ..+++.+++.++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++.......     
T Consensus       110 ~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  185 (302)
T 4e5w_A          110 GSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTV  185 (302)
T ss_dssp             CBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEEC
T ss_pred             CcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccccccCCCcceec
Confidence            99999996544 34999999999999999999999999   9999999999999999999999999997543321     


Q ss_pred             cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          487 TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       487 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                      .....+|..|+|||.+.+..++.++||||||+++|||++|+.|+..
T Consensus       186 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  231 (302)
T 4e5w_A          186 KDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS  231 (302)
T ss_dssp             CCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred             cCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcc
Confidence            2234677889999999888999999999999999999999998753

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.2e-32  Score=286.42  Aligned_cols=181  Identities=29%  Similarity=0.440  Sum_probs=150.4

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC---------------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEe
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN---------------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYE  407 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  407 (552)
                      .|.|++|.||++..  +++.||+|+++..               +.+|+.++++++||||+++++++..   ...++|||
T Consensus       143 LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~---~~~~lv~e  219 (419)
T 3i6u_A          143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA---EDYYIVLE  219 (419)
T ss_dssp             EEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES---SEEEEEEE
T ss_pred             EeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec---CceEEEEE
Confidence            37777899999987  6789999998532               4579999999999999999999753   45799999


Q ss_pred             eccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCC---cEEEeeccCCccCCC
Q 037224          408 YIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM---RAKIANFGLAKSGCN  484 (552)
Q Consensus       408 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~---~~kL~Dfg~a~~~~~  484 (552)
                      |+++++|.+++....  .+++.+++.++.|++.||+|||+++   |+||||||+|||++.++   .+||+|||+++....
T Consensus       220 ~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  294 (419)
T 3i6u_A          220 LMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE  294 (419)
T ss_dssp             CCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-
T ss_pred             cCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeecccceecCC
Confidence            999999999887654  4999999999999999999999999   99999999999997544   599999999986543


Q ss_pred             C-ccccccccccccCccccCC---CCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          485 A-ITMHIVGTQGYIAPEYLAD---GVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       485 ~-~~~~~~gt~~y~aPE~~~~---~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      . ......||+.|+|||++.+   ..++.++||||||+++|||++|+.||...
T Consensus       295 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~  347 (419)
T 3i6u_A          295 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH  347 (419)
T ss_dssp             ----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred             CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence            2 2334679999999999853   66788999999999999999999999764

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.9e-32  Score=273.14  Aligned_cols=180  Identities=29%  Similarity=0.320  Sum_probs=151.0

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|.|++|+||+|+.  +|+.||||++...         ...|+..+.++ +|+||++++++|.+  ++..++||||+ ++
T Consensus        65 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~--~~~~~lv~e~~-~~  141 (311)
T 3p1a_A           65 LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE--GGILYLQTELC-GP  141 (311)
T ss_dssp             EEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEEECC-CC
T ss_pred             eccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe--CCEEEEEEecc-CC
Confidence            47888899999998  6899999998542         12355555555 89999999999987  77889999999 56


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-cccccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-ITMHIV  491 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-~~~~~~  491 (552)
                      +|.+++.... ..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++...... ......
T Consensus       142 ~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~  217 (311)
T 3p1a_A          142 SLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE  217 (311)
T ss_dssp             BHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC------CCC
T ss_pred             CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccCCCCcccC
Confidence            9998887654 35999999999999999999999999   999999999999999999999999998754332 233456


Q ss_pred             ccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          492 GTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       492 gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                      ||+.|+|||++.+ .++.++||||||+++|||++|..|+..
T Consensus       218 gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~  257 (311)
T 3p1a_A          218 GDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG  257 (311)
T ss_dssp             CCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred             CCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            8999999998875 789999999999999999999777654

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=5.2e-32  Score=269.16  Aligned_cols=185  Identities=25%  Similarity=0.392  Sum_probs=160.4

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecC--CCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDP--EDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~~~lv~e~~~~  411 (552)
                      .|.|++|.||+|..  ++..||+|.++..         +.+|+.++++++||||+++++++...  .....++||||+++
T Consensus        34 lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~  113 (290)
T 1t4h_A           34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTS  113 (290)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCS
T ss_pred             ccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCC
Confidence            37777899999988  6789999998532         34799999999999999999988642  24568999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEC-CCCcEEEeeccCCccCCCCccccc
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLD-SNMRAKIANFGLAKSGCNAITMHI  490 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~-~~~~~kL~Dfg~a~~~~~~~~~~~  490 (552)
                      ++|.+++....  .+++..++.++.|++.||.|||+.+ ++++||||||+||+++ .++.+||+|||++...........
T Consensus       114 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~  190 (290)
T 1t4h_A          114 GTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV  190 (290)
T ss_dssp             CBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEES
T ss_pred             CCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccccccc
Confidence            99999997654  4899999999999999999999885 3499999999999997 789999999999986665555567


Q ss_pred             cccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       491 ~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      .|++.|+|||.+. +.++.++||||||+++|+|++|+.||...
T Consensus       191 ~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~  232 (290)
T 1t4h_A          191 IGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSEC  232 (290)
T ss_dssp             CSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             cCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCc
Confidence            8999999999876 45899999999999999999999999763

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-32  Score=280.68  Aligned_cols=182  Identities=27%  Similarity=0.425  Sum_probs=156.8

Q ss_pred             CceEEEEEEEEee-----cCcEEEEEEeccC-----------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEee
Q 037224          346 GCLIQGSVYKGNI-----HGEVYAIKMMKWN-----------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEY  408 (552)
Q Consensus       346 G~g~~G~Vy~~~~-----~g~~vAvK~~~~~-----------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~  408 (552)
                      |.|++|.||+++.     +++.||||+++..           ..+|+.+++++ +|+||+++++++.+  +...++||||
T Consensus        63 G~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~  140 (355)
T 1vzo_A           63 GTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--ETKLHLILDY  140 (355)
T ss_dssp             EETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--TTEEEEEECC
T ss_pred             ccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee--CceEEEEeec
Confidence            6777799999987     6889999998532           34699999999 69999999999987  6788999999


Q ss_pred             ccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC---
Q 037224          409 IENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA---  485 (552)
Q Consensus       409 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~---  485 (552)
                      +++++|.+++....  .+++.+++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.....   
T Consensus       141 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  215 (355)
T 1vzo_A          141 INGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE  215 (355)
T ss_dssp             CCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGG
T ss_pred             CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCC
Confidence            99999999997654  4999999999999999999999999   999999999999999999999999999754322   


Q ss_pred             ccccccccccccCccccCC--CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          486 ITMHIVGTQGYIAPEYLAD--GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       486 ~~~~~~gt~~y~aPE~~~~--~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ......||+.|+|||.+.+  ..++.++||||||+++|||++|+.||...+
T Consensus       216 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~  266 (355)
T 1vzo_A          216 RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG  266 (355)
T ss_dssp             GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred             cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCC
Confidence            2233578999999999875  447889999999999999999999997543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.98  E-value=4.2e-32  Score=290.49  Aligned_cols=182  Identities=32%  Similarity=0.456  Sum_probs=155.6

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      .|.|++|.||+++.  .+..||+|+++..         ..+|+.+++.++||||+++++++.+  ....++||||+++|+
T Consensus        45 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e~~~~g~  122 (494)
T 3lij_A           45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED--KRNYYLVMECYKGGE  122 (494)
T ss_dssp             EECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEEEECCCSCB
T ss_pred             EecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEEEEecCCCCc
Confidence            37777899999988  6889999998532         3479999999999999999999987  678899999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCC---CcEEEeeccCCccCCCC-cccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN---MRAKIANFGLAKSGCNA-ITMH  489 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~---~~~kL~Dfg~a~~~~~~-~~~~  489 (552)
                      |.+++....  .+++.+++.++.|++.||.|||+++   |+||||||+|||++..   +.+||+|||++...... ....
T Consensus       123 L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~  197 (494)
T 3lij_A          123 LFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKE  197 (494)
T ss_dssp             HHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCC
T ss_pred             HHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccc
Confidence            999887654  3999999999999999999999999   9999999999999764   45999999999754332 3344


Q ss_pred             ccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..||+.|+|||++. ..++.++|||||||++|+|++|+.||.+..
T Consensus       198 ~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~  241 (494)
T 3lij_A          198 RLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT  241 (494)
T ss_dssp             CCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC
Confidence            67999999999886 568999999999999999999999998654

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.98  E-value=1.8e-32  Score=279.41  Aligned_cols=184  Identities=27%  Similarity=0.341  Sum_probs=153.2

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC------------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN------------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~------------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      |.|++|.||++..  +++.||+|+++..            +.+|+.++++++||||+++++++.+  ....++||||+++
T Consensus        35 G~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e~~~g  112 (345)
T 3hko_A           35 GQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED--EQYICLVMELCHG  112 (345)
T ss_dssp             EECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEEEECCCS
T ss_pred             eecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc--CCeEEEEEeCCCC
Confidence            6777799999987  6789999998532            3469999999999999999999987  6788999999999


Q ss_pred             CCchhhhhhcC--------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 037224          412 GSLHSWLHENK--------------------------------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRV  453 (552)
Q Consensus       412 gsL~~~l~~~~--------------------------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~i  453 (552)
                      ++|.+++....                                      ...+++..++.++.|++.||+|||+++   +
T Consensus       113 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i  189 (345)
T 3hko_A          113 GHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---I  189 (345)
T ss_dssp             CBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             CcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---c
Confidence            99999885211                                      112467788899999999999999999   9


Q ss_pred             EecCCCCCcEEECCCC--cEEEeeccCCccCCC------CccccccccccccCccccCC--CCCCChhhHHHHHHHHHHH
Q 037224          454 VHKDIKSSNILLDSNM--RAKIANFGLAKSGCN------AITMHIVGTQGYIAPEYLAD--GVVSTKMDVFSFGVVLLEL  523 (552)
Q Consensus       454 vH~Dikp~NIll~~~~--~~kL~Dfg~a~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~s~~~Dv~slG~il~el  523 (552)
                      +||||||+||+++.++  .+||+|||++.....      .......||+.|+|||.+.+  ..++.++||||||+++|||
T Consensus       190 vH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el  269 (345)
T 3hko_A          190 CHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL  269 (345)
T ss_dssp             ECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHH
T ss_pred             cccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHH
Confidence            9999999999998776  899999999974321      11234578999999999865  6789999999999999999


Q ss_pred             HcCCCCCCccC
Q 037224          524 ISGKEAIDEEG  534 (552)
Q Consensus       524 ltG~~pf~~~~  534 (552)
                      ++|+.||.+..
T Consensus       270 ~~g~~pf~~~~  280 (345)
T 3hko_A          270 LMGAVPFPGVN  280 (345)
T ss_dssp             HHSSCSSCCSS
T ss_pred             HHCCCCCCCCC
Confidence            99999997654

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.98  E-value=1.3e-32  Score=286.91  Aligned_cols=186  Identities=26%  Similarity=0.452  Sum_probs=149.4

Q ss_pred             CCceEEEEEEEEee----cCcEEEEEEeccC-----hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          345 EGCLIQGSVYKGNI----HGEVYAIKMMKWN-----ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~----~g~~vAvK~~~~~-----~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      .|.|++|.||+++.    +++.||+|+++..     ..+|+.++++++||||+++++++....+...++||||+++ +|.
T Consensus        29 lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~-~l~  107 (405)
T 3rgf_A           29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLW  107 (405)
T ss_dssp             CC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE-EHH
T ss_pred             eeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC-CHH
Confidence            58889999999985    4788999998643     4589999999999999999999977667889999999975 888


Q ss_pred             hhhhhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE----CCCCcEEEeeccCCccCCC
Q 037224          416 SWLHENK-------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL----DSNMRAKIANFGLAKSGCN  484 (552)
Q Consensus       416 ~~l~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll----~~~~~~kL~Dfg~a~~~~~  484 (552)
                      +++....       ...+++..++.++.|++.||+|||+++   |+||||||+|||+    +.++.+||+|||+++....
T Consensus       108 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~  184 (405)
T 3rgf_A          108 HIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS  184 (405)
T ss_dssp             HHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----
T ss_pred             HHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCC
Confidence            7775322       124999999999999999999999999   9999999999999    7788999999999975432


Q ss_pred             C-----ccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          485 A-----ITMHIVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       485 ~-----~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .     ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus       185 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  240 (405)
T 3rgf_A          185 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  240 (405)
T ss_dssp             ------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             CCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence            1     2234678999999999877 458999999999999999999999997654

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.98  E-value=3.6e-32  Score=290.50  Aligned_cols=181  Identities=32%  Similarity=0.482  Sum_probs=156.6

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|++|.||+++.  +++.||+|+++..         ..+|+.++++++||||+++++++.+  ....++||||+++++|
T Consensus        31 G~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e~~~~~~L  108 (486)
T 3mwu_A           31 GKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED--SSSFYIVGELYTGGEL  108 (486)
T ss_dssp             ECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEEECCCCSCBH
T ss_pred             eecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc--CCEEEEEEEcCCCCcH
Confidence            6667799999987  6899999998432         3479999999999999999999987  6788999999999999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEC---CCCcEEEeeccCCccCCC-Cccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLD---SNMRAKIANFGLAKSGCN-AITMHI  490 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~---~~~~~kL~Dfg~a~~~~~-~~~~~~  490 (552)
                      .+++....  .+++.+++.++.|++.||.|||+++   |+||||||+|||++   .++.+||+|||++..... ......
T Consensus       109 ~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~  183 (486)
T 3mwu_A          109 FDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR  183 (486)
T ss_dssp             HHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CC
T ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCC
Confidence            99887654  4999999999999999999999999   99999999999995   456799999999975432 233346


Q ss_pred             cccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       491 ~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+
T Consensus       184 ~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~  226 (486)
T 3mwu_A          184 IGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN  226 (486)
T ss_dssp             TTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            79999999999865 58999999999999999999999997654

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.98  E-value=2.9e-32  Score=285.65  Aligned_cols=187  Identities=27%  Similarity=0.420  Sum_probs=155.1

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC---hHHHHHHHHHcCCCCccceeeeeecCC----CCeeEEEEeeccCCCch
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN---ACEELKILQKVNHGNLVKLEGFCIDPE----DANCYLIYEYIENGSLH  415 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~~~lv~e~~~~gsL~  415 (552)
                      .|.|.+|.||++++  +|+.||||++..+   ..+|++++++++|+||+++++++....    ....++||||+++ +|.
T Consensus        62 lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~  140 (420)
T 1j1b_A           62 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVY  140 (420)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHH
T ss_pred             EeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHH
Confidence            37777899999998  6899999998543   347999999999999999999886421    2246799999986 666


Q ss_pred             hhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCC-CcEEEeeccCCccCC-CCcccccc
Q 037224          416 SWLHE--NKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN-MRAKIANFGLAKSGC-NAITMHIV  491 (552)
Q Consensus       416 ~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kL~Dfg~a~~~~-~~~~~~~~  491 (552)
                      +.+..  .....+++..++.++.|+++||+|||+++   |+||||||+|||++.+ +.+||+|||+++... ........
T Consensus       141 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~  217 (420)
T 1j1b_A          141 RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI  217 (420)
T ss_dssp             HHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCC
T ss_pred             HHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhhcccCCCceeee
Confidence            65543  22345999999999999999999999999   9999999999999965 578999999998543 22233467


Q ss_pred             ccccccCccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          492 GTQGYIAPEYLADG-VVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       492 gt~~y~aPE~~~~~-~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      +|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.
T Consensus       218 ~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~  262 (420)
T 1j1b_A          218 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG  262 (420)
T ss_dssp             SCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             eCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence            89999999998764 789999999999999999999999987653

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.98  E-value=1.1e-32  Score=291.56  Aligned_cols=184  Identities=29%  Similarity=0.441  Sum_probs=156.1

Q ss_pred             CCceEEEEEEEEeec-CcEEEEEEeccC------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhh
Q 037224          345 EGCLIQGSVYKGNIH-GEVYAIKMMKWN------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSW  417 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~-g~~vAvK~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~  417 (552)
                      .|.|.+|.||+|.+. +..||||+++..      +.+|+.++++++||||+++++++.+   ...++||||+++|+|.++
T Consensus       192 lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~~iv~e~~~~gsL~~~  268 (452)
T 1fmk_A          192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVTEYMSKGSLLDF  268 (452)
T ss_dssp             EEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEECCCTTCBHHHH
T ss_pred             ecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC---CceEEEehhhcCCCHHHH
Confidence            377777999999994 467999999643      4689999999999999999999864   457999999999999999


Q ss_pred             hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc---cccccccc
Q 037224          418 LHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI---TMHIVGTQ  494 (552)
Q Consensus       418 l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~---~~~~~gt~  494 (552)
                      +.......+++.+++.++.|++.||+|||+++   ++||||||+|||++.++.+||+|||+++......   .....++.
T Consensus       269 l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~  345 (452)
T 1fmk_A          269 LKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI  345 (452)
T ss_dssp             HSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCG
T ss_pred             HHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCCcccc
Confidence            97654456999999999999999999999999   9999999999999999999999999998543221   12245677


Q ss_pred             cccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          495 GYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       495 ~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      .|+|||.+.+..++.++||||||+++|||++ |+.||.+..
T Consensus       346 ~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~  386 (452)
T 1fmk_A          346 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV  386 (452)
T ss_dssp             GGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             cccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC
Confidence            8999999988899999999999999999999 999997654

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.98  E-value=1.5e-32  Score=275.87  Aligned_cols=184  Identities=32%  Similarity=0.487  Sum_probs=158.8

Q ss_pred             CceEEEEEEEEee-------cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          346 GCLIQGSVYKGNI-------HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       346 G~g~~G~Vy~~~~-------~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      |.|++|.||++..       +++.||+|+++..        ..+|+.++++++||||+++++++.+  +...++||||++
T Consensus        32 g~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~  109 (314)
T 2ivs_A           32 GEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ--DGPLLLIVEYAK  109 (314)
T ss_dssp             EECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSSCEEEEECCT
T ss_pred             cccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec--CCceEEEEeecC
Confidence            7777799999975       3478999998643        3479999999999999999999976  567899999999


Q ss_pred             CCCchhhhhhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCC
Q 037224          411 NGSLHSWLHENKN----------------------ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN  468 (552)
Q Consensus       411 ~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~  468 (552)
                      +++|.+++.....                      ..+++.+++.++.|+++||+|||+++   ++||||||+||+++.+
T Consensus       110 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp~NIli~~~  186 (314)
T 2ivs_A          110 YGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEG  186 (314)
T ss_dssp             TCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETT
T ss_pred             CCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---CcccccchheEEEcCC
Confidence            9999999976542                      23899999999999999999999999   9999999999999999


Q ss_pred             CcEEEeeccCCccCCCCc----cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          469 MRAKIANFGLAKSGCNAI----TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       469 ~~~kL~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      +.+||+|||++.......    .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       187 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  257 (314)
T 2ivs_A          187 RKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP  257 (314)
T ss_dssp             TEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             CCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            999999999997543221    223456788999999988889999999999999999999 999998654

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.98  E-value=2.6e-32  Score=278.12  Aligned_cols=184  Identities=30%  Similarity=0.500  Sum_probs=158.0

Q ss_pred             CceEEEEEEEEee-------cCcEEEEEEeccC--------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeec
Q 037224          346 GCLIQGSVYKGNI-------HGEVYAIKMMKWN--------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYI  409 (552)
Q Consensus       346 G~g~~G~Vy~~~~-------~g~~vAvK~~~~~--------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~  409 (552)
                      |.|++|.||++..       .+..||+|+++..        ..+|+.+++++ +||||+++++++.+  .+..++||||+
T Consensus        54 G~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~~lv~e~~  131 (344)
T 1rjb_A           54 GSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL--SGPIYLIFEYC  131 (344)
T ss_dssp             EECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEEECC
T ss_pred             cCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee--CCccEEEEecC
Confidence            7777899999986       3568999998642        34799999999 99999999999987  56789999999


Q ss_pred             cCCCchhhhhhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCC
Q 037224          410 ENGSLHSWLHENKN---------------------ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN  468 (552)
Q Consensus       410 ~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~  468 (552)
                      ++|+|.+++.....                     ..+++.+++.++.|++.||+|||+++   |+||||||+|||++.+
T Consensus       132 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~  208 (344)
T 1rjb_A          132 CYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHG  208 (344)
T ss_dssp             TTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEETT
T ss_pred             CCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEEcCC
Confidence            99999999976542                     23799999999999999999999999   9999999999999999


Q ss_pred             CcEEEeeccCCccCCCC----ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          469 MRAKIANFGLAKSGCNA----ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       469 ~~~kL~Dfg~a~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      +.+||+|||++......    ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.+..
T Consensus       209 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          209 KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             CcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            99999999999743222    1223456788999999988899999999999999999998 999998654

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.98  E-value=7.3e-32  Score=289.36  Aligned_cols=182  Identities=30%  Similarity=0.450  Sum_probs=157.7

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC--------------------hHHHHHHHHHcCCCCccceeeeeecCCCCee
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN--------------------ACEELKILQKVNHGNLVKLEGFCIDPEDANC  402 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------------------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  402 (552)
                      .|.|++|.||+++.  .++.||+|+++..                    ..+|+.++++++||||+++++++.+  ....
T Consensus        44 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~  121 (504)
T 3q5i_A           44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFED--KKYF  121 (504)
T ss_dssp             EEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEE
T ss_pred             ecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--CCEE
Confidence            37778899999987  6789999998532                    2369999999999999999999987  6788


Q ss_pred             EEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCC---cEEEeeccCC
Q 037224          403 YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM---RAKIANFGLA  479 (552)
Q Consensus       403 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~---~~kL~Dfg~a  479 (552)
                      ++||||+++|+|.+++....  .+++..++.++.|++.||+|||+++   |+||||||+|||++.++   .+||+|||++
T Consensus       122 ~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a  196 (504)
T 3q5i_A          122 YLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLS  196 (504)
T ss_dssp             EEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEECCCTTC
T ss_pred             EEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEEEECCCC
Confidence            99999999999999887654  4999999999999999999999999   99999999999998776   6999999999


Q ss_pred             ccCCCC-ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          480 KSGCNA-ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       480 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ...... ......||+.|+|||.+. +.++.++||||||+++|+|++|+.||.+.+
T Consensus       197 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~  251 (504)
T 3q5i_A          197 SFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN  251 (504)
T ss_dssp             EECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            754432 334567999999999986 568999999999999999999999998754

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.98  E-value=4.4e-32  Score=280.90  Aligned_cols=186  Identities=25%  Similarity=0.386  Sum_probs=156.6

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---hHHHHHHHHHcCCCCccceeeeeecC-----------------------
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---ACEELKILQKVNHGNLVKLEGFCIDP-----------------------  397 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---~~~E~~~l~~l~h~niv~l~~~~~~~-----------------------  397 (552)
                      |.|++|.||++..  +|+.||+|++..+   ..+|+.+++.++|+||+++++++...                       
T Consensus        16 G~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   95 (383)
T 3eb0_A           16 GTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNG   95 (383)
T ss_dssp             ECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC-----------------------
T ss_pred             EeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccc
Confidence            7788899999987  7899999998544   34899999999999999999998642                       


Q ss_pred             -------------CCCeeEEEEeeccCCCchhhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCc
Q 037224          398 -------------EDANCYLIYEYIENGSLHSWLHE--NKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSN  462 (552)
Q Consensus       398 -------------~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~N  462 (552)
                                   .....++||||+++ +|.+.+..  .....+++..++.++.|+++||+|||+++   |+||||||+|
T Consensus        96 ~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---i~H~Dikp~N  171 (383)
T 3eb0_A           96 VNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQN  171 (383)
T ss_dssp             --------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGG
T ss_pred             cccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc---CccCccCHHH
Confidence                         23347899999985 88777754  22345999999999999999999999999   9999999999


Q ss_pred             EEEC-CCCcEEEeeccCCccCC-CCccccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          463 ILLD-SNMRAKIANFGLAKSGC-NAITMHIVGTQGYIAPEYLADG-VVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       463 Ill~-~~~~~kL~Dfg~a~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      ||++ .++.+||+|||+++... ........+|+.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+.
T Consensus       172 il~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  247 (383)
T 3eb0_A          172 LLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETS  247 (383)
T ss_dssp             EEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             EEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCh
Confidence            9997 68899999999997543 2333446789999999988764 489999999999999999999999987653

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.98  E-value=2.5e-32  Score=275.38  Aligned_cols=183  Identities=30%  Similarity=0.445  Sum_probs=160.2

Q ss_pred             CCceEEEEEEEEee------cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          345 EGCLIQGSVYKGNI------HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~------~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      .|.|++|.||++.+      +++.||||+++..        +.+|++++++++||||+++++++.+......++||||++
T Consensus        39 lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~  118 (318)
T 3lxp_A           39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVP  118 (318)
T ss_dssp             EEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCT
T ss_pred             ecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEeccc
Confidence            37777799988764      6789999999753        357999999999999999999998866678899999999


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc----
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI----  486 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~----  486 (552)
                      +++|.+++....   +++.+++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......    
T Consensus       119 ~~~L~~~l~~~~---~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~  192 (318)
T 3lxp_A          119 LGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR  192 (318)
T ss_dssp             TCBHHHHGGGSC---CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEE
T ss_pred             CCcHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccccccccccc
Confidence            999999997654   999999999999999999999999   9999999999999999999999999997544321    


Q ss_pred             -cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          487 -TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       487 -~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                       .....++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       193 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~  240 (318)
T 3lxp_A          193 VREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP  240 (318)
T ss_dssp             C---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred             cccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence             22345778899999999888999999999999999999999999754

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.98  E-value=1.6e-32  Score=282.11  Aligned_cols=184  Identities=21%  Similarity=0.315  Sum_probs=152.8

Q ss_pred             CCceEEEEEEEEeec-------CcEEEEEEeccCh---HHH---------------HHHHHHcCCCCccceeeeeecCCC
Q 037224          345 EGCLIQGSVYKGNIH-------GEVYAIKMMKWNA---CEE---------------LKILQKVNHGNLVKLEGFCIDPED  399 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~-------g~~vAvK~~~~~~---~~E---------------~~~l~~l~h~niv~l~~~~~~~~~  399 (552)
                      .|.|++|.||++.+.       ++.||||++....   .+|               +..+..++|+||+++++++.....
T Consensus        43 lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~  122 (364)
T 3op5_A           43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKN  122 (364)
T ss_dssp             CCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEEET
T ss_pred             EecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeeccC
Confidence            478888999999872       4789999986442   233               344455679999999999876322


Q ss_pred             --CeeEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEC--CCCcEEEee
Q 037224          400 --ANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLD--SNMRAKIAN  475 (552)
Q Consensus       400 --~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~--~~~~~kL~D  475 (552)
                        ...++||||+ +++|.+++.... ..+++.+++.++.|++.||+|||+++   |+||||||+|||++  .++.+||+|
T Consensus       123 ~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~~~~~~kl~D  197 (364)
T 3op5_A          123 GKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVD  197 (364)
T ss_dssp             TEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESSCTTCEEECC
T ss_pred             CcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecCCCCeEEEEE
Confidence              4579999999 899999997643 35999999999999999999999999   99999999999998  889999999


Q ss_pred             ccCCccCCCC---------ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          476 FGLAKSGCNA---------ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       476 fg~a~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      ||+++.....         ......||+.|+|||.+.+..++.++||||||+++|||+||+.||.+.
T Consensus       198 FG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~  264 (364)
T 3op5_A          198 YGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN  264 (364)
T ss_dssp             CTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             CCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence            9999643221         112345999999999999999999999999999999999999999864

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.98  E-value=1.9e-32  Score=277.13  Aligned_cols=182  Identities=26%  Similarity=0.458  Sum_probs=154.2

Q ss_pred             CceEEEEEEEEee--cCcE----EEEEEecc--------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          346 GCLIQGSVYKGNI--HGEV----YAIKMMKW--------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~----vAvK~~~~--------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      |.|++|.||+|.+  +++.    ||+|.+..        ...+|+.++++++||||+++++++.+   ...++||||+++
T Consensus        22 G~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~~~~   98 (325)
T 3kex_A           22 GSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG---SSLQLVTQYLPL   98 (325)
T ss_dssp             ECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB---SSEEEEEECCTT
T ss_pred             eecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC---CccEEEEEeCCC
Confidence            7777799999987  4443    78887742        23479999999999999999998853   457899999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC----cc
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA----IT  487 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~----~~  487 (552)
                      ++|.+++.... ..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....    ..
T Consensus        99 ~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  174 (325)
T 3kex_A           99 GSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY  174 (325)
T ss_dssp             CBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-
T ss_pred             CCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCcccccccc
Confidence            99999997653 34899999999999999999999999   999999999999999999999999999854322    22


Q ss_pred             ccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          488 MHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       488 ~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      ....++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  222 (325)
T 3kex_A          175 SEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR  222 (325)
T ss_dssp             ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred             cCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC
Confidence            33567889999999998999999999999999999999 999998654

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.98  E-value=7.9e-33  Score=283.92  Aligned_cols=182  Identities=29%  Similarity=0.471  Sum_probs=160.1

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      |.|.+|.||++..  +++.||+|+++..        ..+|+.++++++|+||+++++++.+  ++..++||||+++++|.
T Consensus        42 g~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~  119 (360)
T 3eqc_A           42 GAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLD  119 (360)
T ss_dssp             EECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE--TTEEEEEECCCTTCBHH
T ss_pred             cCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE--CCEEEEEEECCCCCCHH
Confidence            7777799999998  5899999998643        3479999999999999999999987  67889999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccccccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEH-TRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ  494 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~gt~  494 (552)
                      +++....  .+++..+..++.|++.||.|||+. +   ++||||||+|||++.++.+||+|||++............||+
T Consensus       120 ~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~gt~  194 (360)
T 3eqc_A          120 QVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR  194 (360)
T ss_dssp             HHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC----CCCC
T ss_pred             HHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccccccCCCCCC
Confidence            9997654  389999999999999999999996 8   999999999999999999999999998644333334467899


Q ss_pred             cccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       495 ~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       195 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  234 (360)
T 3eqc_A          195 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD  234 (360)
T ss_dssp             TTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred             CeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999999999999999999998654

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.98  E-value=2e-32  Score=271.66  Aligned_cols=185  Identities=28%  Similarity=0.450  Sum_probs=163.2

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchh
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHS  416 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~  416 (552)
                      .|.|++|.||++..  .+..||+|.++.+      +.+|+.++++++|+||+++++++.+  +...++||||+++++|.+
T Consensus        21 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~   98 (288)
T 3kfa_A           21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYIITEFMTYGNLLD   98 (288)
T ss_dssp             SGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSEEEEEECCTTEEHHH
T ss_pred             cCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc--CCCEEEEEEcCCCCcHHH
Confidence            47777899999998  4889999998643      3479999999999999999999976  667899999999999999


Q ss_pred             hhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc---ccccccc
Q 037224          417 WLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI---TMHIVGT  493 (552)
Q Consensus       417 ~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~---~~~~~gt  493 (552)
                      ++.......+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++.......   .....++
T Consensus        99 ~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~  175 (288)
T 3kfa_A           99 YLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP  175 (288)
T ss_dssp             HHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEEC
T ss_pred             HHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccCCccc
Confidence            998766667999999999999999999999999   9999999999999999999999999997544322   2224567


Q ss_pred             ccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       494 ~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      +.|+|||.+.+..++.++||||||+++|+|++ |+.||...+
T Consensus       176 ~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~  217 (288)
T 3kfa_A          176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID  217 (288)
T ss_dssp             GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             cCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            78999999988899999999999999999999 999998644

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.98  E-value=2.7e-32  Score=273.97  Aligned_cols=183  Identities=26%  Similarity=0.393  Sum_probs=155.0

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|++|.||++..  +|+.||+|++...         ..+|+.++++++||||+++++++.+  ....++||||+++++|
T Consensus        12 g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~l   89 (311)
T 4agu_A           12 GEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR--KRRLHLVFEYCDHTVL   89 (311)
T ss_dssp             EECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEEECCSEEHH
T ss_pred             eecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec--CCeEEEEEEeCCCchH
Confidence            6777799999998  5899999988432         3479999999999999999999987  6788999999999999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--ccccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIVG  492 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~g  492 (552)
                      .+++....  .+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++......  ......+
T Consensus        90 ~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  164 (311)
T 4agu_A           90 HELDRYQR--GVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA  164 (311)
T ss_dssp             HHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-----------
T ss_pred             HHHHhhhc--CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCCCcC
Confidence            88876543  4999999999999999999999999   999999999999999999999999999754322  2234578


Q ss_pred             cccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          493 TQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       493 t~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      |+.|+|||.+.+ ..++.++||||||+++|||++|+.||.+...
T Consensus       165 ~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~  208 (311)
T 4agu_A          165 TRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD  208 (311)
T ss_dssp             -GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             CccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence            999999999875 6689999999999999999999999987653

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.98  E-value=9.4e-32  Score=272.30  Aligned_cols=179  Identities=22%  Similarity=0.346  Sum_probs=157.8

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----hHHHHHHHHHcC-CCCccceeeeeecCCCCeeEEEEeeccCCCchhhh
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----ACEELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL  418 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l  418 (552)
                      |.|.+|.||++..  +++.||+|+++..    ..+|+.++++++ |+||+++++++.+......+++|||+++++|.+++
T Consensus        45 g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~  124 (330)
T 3nsz_A           45 GRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY  124 (330)
T ss_dssp             EECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHG
T ss_pred             cccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHH
Confidence            7777799999976  7899999999743    457999999997 99999999999886677889999999999999887


Q ss_pred             hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCC-cEEEeeccCCccCCC-Cccccccccccc
Q 037224          419 HENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM-RAKIANFGLAKSGCN-AITMHIVGTQGY  496 (552)
Q Consensus       419 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~~~~-~~~~~~~gt~~y  496 (552)
                      ..     +++.+++.++.|++.||+|||+++   ++||||||+|||++.++ .+||+|||+++.... .......++..|
T Consensus       125 ~~-----~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y  196 (330)
T 3nsz_A          125 QT-----LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYF  196 (330)
T ss_dssp             GG-----CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCGGG
T ss_pred             Hh-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccccccccccc
Confidence            53     899999999999999999999999   99999999999999776 899999999975432 223346789999


Q ss_pred             cCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          497 IAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       497 ~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                      +|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       197 ~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~  233 (330)
T 3nsz_A          197 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH  233 (330)
T ss_dssp             CCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             cChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            99999877 6789999999999999999999999954

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.98  E-value=2.3e-32  Score=276.44  Aligned_cols=183  Identities=26%  Similarity=0.460  Sum_probs=154.3

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      |.|++|.||+++.  +++.||+|+++..        ..+|+.++++++||||+++++++.+  +...++||||+++ +|.
T Consensus        11 G~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~-~l~   87 (324)
T 3mtl_A           11 GEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT--EKSLTLVFEYLDK-DLK   87 (324)
T ss_dssp             EECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEEC--SSCEEEEEECCSE-EHH
T ss_pred             cCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEee--CCEEEEEeccccc-CHH
Confidence            7777899999988  6889999998643        2369999999999999999999987  6678999999985 898


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--cccccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIVGT  493 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~gt  493 (552)
                      +++.... ..+++.+++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++......  ......+|
T Consensus        88 ~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t  163 (324)
T 3mtl_A           88 QYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVT  163 (324)
T ss_dssp             HHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC------------C
T ss_pred             HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCccccccccCc
Confidence            8887653 35899999999999999999999999   999999999999999999999999998754322  22335789


Q ss_pred             ccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          494 QGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       494 ~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      +.|+|||.+.+ ..++.++||||||+++|||++|+.||.+.+.
T Consensus       164 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~  206 (324)
T 3mtl_A          164 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV  206 (324)
T ss_dssp             GGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            99999999876 5689999999999999999999999987653

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.98  E-value=2.6e-32  Score=273.91  Aligned_cols=183  Identities=32%  Similarity=0.485  Sum_probs=152.0

Q ss_pred             CceEEEEEEEEeecCcEEEEEEeccC-----hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhhhhh
Q 037224          346 GCLIQGSVYKGNIHGEVYAIKMMKWN-----ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHE  420 (552)
Q Consensus       346 G~g~~G~Vy~~~~~g~~vAvK~~~~~-----~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~  420 (552)
                      |.|++|.||++++.++.||+|.++..     +.+|+.++++++||||+++++++.+    ..++||||+++++|.+++..
T Consensus        17 g~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~lv~e~~~~~~L~~~l~~   92 (307)
T 2eva_A           17 GRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN----PVCLVMEYAEGGSLYNVLHG   92 (307)
T ss_dssp             ECCSSSEEEEEEETTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT----TTEEEEECCTTCBHHHHHHC
T ss_pred             ecCCCceEEEEEECCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC----CcEEEEEcCCCCCHHHHHhc
Confidence            67777999999999999999999654     4579999999999999999998863    36899999999999999976


Q ss_pred             cCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCc-EEEeeccCCccCCCCccccccccccccC
Q 037224          421 NKN-ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR-AKIANFGLAKSGCNAITMHIVGTQGYIA  498 (552)
Q Consensus       421 ~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~-~kL~Dfg~a~~~~~~~~~~~~gt~~y~a  498 (552)
                      ... ..+++..++.++.|+++||+|||+.+..+++||||||+||+++.++. +||+|||++...... .....||+.|+|
T Consensus        93 ~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-~~~~~gt~~y~a  171 (307)
T 2eva_A           93 AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-MTNNKGSAAWMA  171 (307)
T ss_dssp             SSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------------CCTTSSC
T ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-cccCCCCCceEC
Confidence            543 34789999999999999999999932122999999999999988886 799999999754332 233568999999


Q ss_pred             ccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          499 PEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       499 PE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      ||.+.+..++.++||||||+++|||++|+.||...
T Consensus       172 PE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  206 (307)
T 2eva_A          172 PEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI  206 (307)
T ss_dssp             HHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred             hhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence            99999999999999999999999999999999854

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.98  E-value=8.9e-33  Score=272.95  Aligned_cols=184  Identities=29%  Similarity=0.485  Sum_probs=154.7

Q ss_pred             CceEEEEEEEEeecCcEEEEEEeccC-----hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhhhhh
Q 037224          346 GCLIQGSVYKGNIHGEVYAIKMMKWN-----ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHE  420 (552)
Q Consensus       346 G~g~~G~Vy~~~~~g~~vAvK~~~~~-----~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~  420 (552)
                      |.|++|.||+++..|+.||+|+++..     +.+|+.++++++|+||+++++++.+. ....++||||+++++|.+++..
T Consensus        30 g~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~  108 (278)
T 1byg_A           30 GKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVTEYMAKGSLVDYLRS  108 (278)
T ss_dssp             EECSSCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEEEECCCTTEEHHHHHHH
T ss_pred             ecCCCceEEEEEEcCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CCceEEEEecCCCCCHHHHHHh
Confidence            67777999999999999999999754     35799999999999999999987653 3467999999999999999976


Q ss_pred             cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccccccccccccCcc
Q 037224          421 NKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPE  500 (552)
Q Consensus       421 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~gt~~y~aPE  500 (552)
                      .....+++..++.++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++....... ....+++.|+|||
T Consensus       109 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~y~aPE  184 (278)
T 1byg_A          109 RGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPVKWTAPE  184 (278)
T ss_dssp             HHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------------CCTTTSCHH
T ss_pred             cccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc-cCCCccccccCHH
Confidence            54444899999999999999999999999   9999999999999999999999999987543322 2346788999999


Q ss_pred             ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          501 YLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       501 ~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      .+.+..++.++||||||+++|||++ |+.||....
T Consensus       185 ~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~  219 (278)
T 1byg_A          185 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP  219 (278)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred             HhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9988899999999999999999998 999997643

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.98  E-value=2.7e-32  Score=291.33  Aligned_cols=182  Identities=30%  Similarity=0.445  Sum_probs=159.6

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|.|++|.||+++.  +|+.||||++...          ..+|+.++++++||||+++++++.+  ....++||||+.++
T Consensus        34 lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e~~~~~  111 (484)
T 3nyv_A           34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED--KGYFYLVGEVYTGG  111 (484)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEEECCCCSC
T ss_pred             EecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCEEEEEEecCCCC
Confidence            37777899999988  7899999998422          3479999999999999999999987  67889999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE---CCCCcEEEeeccCCccCCC-Cccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL---DSNMRAKIANFGLAKSGCN-AITM  488 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~~~~~-~~~~  488 (552)
                      +|.+++....  .+++.+++.++.|++.||.|||+++   |+||||||+|||+   +.++.+||+|||++..... ....
T Consensus       112 ~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~  186 (484)
T 3nyv_A          112 ELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK  186 (484)
T ss_dssp             BHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSHH
T ss_pred             CHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccccc
Confidence            9999887654  4999999999999999999999999   9999999999999   5678999999999875432 2334


Q ss_pred             cccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          489 HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       489 ~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ...||+.|+|||.+.+ .++.++||||||+++|+|++|+.||.+.+
T Consensus       187 ~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~  231 (484)
T 3nyv_A          187 DKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN  231 (484)
T ss_dssp             HHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC
Confidence            4679999999999865 68999999999999999999999998654

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.98  E-value=4e-32  Score=268.28  Aligned_cols=183  Identities=30%  Similarity=0.473  Sum_probs=158.5

Q ss_pred             CceEEEEEEEEee-cCcEEEEEEeccC------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhhh
Q 037224          346 GCLIQGSVYKGNI-HGEVYAIKMMKWN------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL  418 (552)
Q Consensus       346 G~g~~G~Vy~~~~-~g~~vAvK~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l  418 (552)
                      |.|++|.||++.. ++..||+|.++..      +.+|++++++++|+||+++++++.+   +..++||||+++++|.+++
T Consensus        22 g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v~e~~~~~~L~~~l   98 (279)
T 1qpc_A           22 GAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIYIITEYMENGSLVDFL   98 (279)
T ss_dssp             EEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEEECCTTCBHHHHT
T ss_pred             cCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC---CCcEEEEecCCCCCHHHHH
Confidence            7777899999998 4568999998643      3579999999999999999998863   4579999999999999999


Q ss_pred             hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcc---cccccccc
Q 037224          419 HENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT---MHIVGTQG  495 (552)
Q Consensus       419 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~---~~~~gt~~  495 (552)
                      .......+++.+++.++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++........   ....++..
T Consensus        99 ~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~  175 (279)
T 1qpc_A           99 KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK  175 (279)
T ss_dssp             TSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTT
T ss_pred             hcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCccC
Confidence            7654345999999999999999999999999   99999999999999999999999999975443221   22456778


Q ss_pred             ccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          496 YIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       496 y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      |+|||.+.+..++.++||||||+++|||++ |+.||.+..
T Consensus       176 y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  215 (279)
T 1qpc_A          176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT  215 (279)
T ss_dssp             TSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             ccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC
Confidence            999999988889999999999999999999 999997644

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.98  E-value=2.2e-32  Score=276.94  Aligned_cols=183  Identities=27%  Similarity=0.462  Sum_probs=152.8

Q ss_pred             CCceEEEEEEEEee--cCc----EEEEEEecc--------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          345 EGCLIQGSVYKGNI--HGE----VYAIKMMKW--------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~----~vAvK~~~~--------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      .|.|++|.||+|++  +++    .||+|.++.        .+.+|+.++++++||||++++++|.+  . ..++++||++
T Consensus        23 lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~-~~~~v~e~~~   99 (327)
T 3poz_A           23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--S-TVQLITQLMP   99 (327)
T ss_dssp             EEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES--S-SEEEEEECCT
T ss_pred             EeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec--C-CeEEEEEecC
Confidence            37788899999987  444    368887743        24579999999999999999999986  2 3689999999


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC----c
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA----I  486 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~----~  486 (552)
                      +|+|.+++.... ..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....    .
T Consensus       100 ~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  175 (327)
T 3poz_A          100 FGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH  175 (327)
T ss_dssp             TCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC---
T ss_pred             CCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccCCccccc
Confidence            999999997754 34999999999999999999999999   999999999999999999999999998743221    1


Q ss_pred             cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          487 TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       487 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      .....+|..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       176 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  224 (327)
T 3poz_A          176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP  224 (327)
T ss_dssp             ----CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             ccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCC
Confidence            223456789999999999999999999999999999999 999998654

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.98  E-value=4e-32  Score=266.31  Aligned_cols=183  Identities=29%  Similarity=0.482  Sum_probs=160.3

Q ss_pred             CceEEEEEEEEee-cCcEEEEEEeccC------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhhh
Q 037224          346 GCLIQGSVYKGNI-HGEVYAIKMMKWN------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL  418 (552)
Q Consensus       346 G~g~~G~Vy~~~~-~g~~vAvK~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l  418 (552)
                      |.|.+|.||++.. +++.||+|+++..      ..+|+.++++++||||+++++++.+  +...+++|||+++++|.+++
T Consensus        17 g~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~   94 (267)
T 3t9t_A           17 GSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPICLVTEFMEHGCLSDYL   94 (267)
T ss_dssp             EEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSCEEEECCCTTCBHHHHH
T ss_pred             cCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcc--CCCeEEEEeCCCCCcHHHHH
Confidence            7777899999998 7789999999643      4579999999999999999999977  56789999999999999999


Q ss_pred             hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc---ccccccccc
Q 037224          419 HENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI---TMHIVGTQG  495 (552)
Q Consensus       419 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~---~~~~~gt~~  495 (552)
                      .... ..+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++.......   .....++..
T Consensus        95 ~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~  170 (267)
T 3t9t_A           95 RTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK  170 (267)
T ss_dssp             HHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGG
T ss_pred             hhCc-ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccccccccccccccc
Confidence            7653 35899999999999999999999999   9999999999999999999999999997543321   122456778


Q ss_pred             ccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          496 YIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       496 y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      |+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       171 y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~  210 (267)
T 3t9t_A          171 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS  210 (267)
T ss_dssp             GCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             ccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC
Confidence            999999988889999999999999999999 899998654

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.98  E-value=4.4e-32  Score=287.67  Aligned_cols=184  Identities=23%  Similarity=0.352  Sum_probs=144.5

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCC---CCeeEEEEeecc
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPE---DANCYLIYEYIE  410 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~---~~~~~lv~e~~~  410 (552)
                      .|.|++|.||++..  +++.||||++...         ..+|+.++++++|+||+++++++....   ....|+||||++
T Consensus        61 lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~  140 (458)
T 3rp9_A           61 IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD  140 (458)
T ss_dssp             -------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCCS
T ss_pred             eeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEeccc
Confidence            48888899999976  7899999998542         347999999999999999999986532   256899999985


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-----
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-----  485 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-----  485 (552)
                       ++|.+++....  .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....     
T Consensus       141 -~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  214 (458)
T 3rp9_A          141 -SDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNS  214 (458)
T ss_dssp             -EEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCC
T ss_pred             -cchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhccCcccccc
Confidence             58998887543  4999999999999999999999999   999999999999999999999999999754311     


Q ss_pred             ------------------------ccccccccccccCcccc-CCCCCCChhhHHHHHHHHHHHHc-----------CCCC
Q 037224          486 ------------------------ITMHIVGTQGYIAPEYL-ADGVVSTKMDVFSFGVVLLELIS-----------GKEA  529 (552)
Q Consensus       486 ------------------------~~~~~~gt~~y~aPE~~-~~~~~s~~~Dv~slG~il~ellt-----------G~~p  529 (552)
                                              .....+||+.|+|||++ ....++.++|||||||++|||++           |+++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~  294 (458)
T 3rp9_A          215 QLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPL  294 (458)
T ss_dssp             CCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCS
T ss_pred             ccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccccccccc
Confidence                                    12235779999999976 56679999999999999999999           6667


Q ss_pred             CCccC
Q 037224          530 IDEEG  534 (552)
Q Consensus       530 f~~~~  534 (552)
                      |.+.+
T Consensus       295 f~g~~  299 (458)
T 3rp9_A          295 FPGSS  299 (458)
T ss_dssp             CC---
T ss_pred             CCCCc
Confidence            75543

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.98  E-value=1.5e-32  Score=271.30  Aligned_cols=189  Identities=26%  Similarity=0.423  Sum_probs=159.2

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|++|.||++..  +++.||+|.++..         +.+|+.++++++||||+++++++.+......++||||+++++|
T Consensus        15 g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L   94 (279)
T 2w5a_A           15 GTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDL   94 (279)
T ss_dssp             EECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEH
T ss_pred             cCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCH
Confidence            6777799999988  6899999998532         3479999999999999999998876556788999999999999


Q ss_pred             hhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc--cc
Q 037224          415 HSWLHENK--NENLNWKTRLRIAIDVANGLQYIHEHT--RPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI--TM  488 (552)
Q Consensus       415 ~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~--~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~--~~  488 (552)
                      .+++....  ...+++..++.++.|++.||+|||+.+  ..+++||||||+||+++.++.+||+|||++.......  ..
T Consensus        95 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~  174 (279)
T 2w5a_A           95 ASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK  174 (279)
T ss_dssp             HHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CHHHH
T ss_pred             HHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecccccccc
Confidence            99997643  234899999999999999999999976  2349999999999999999999999999987543322  22


Q ss_pred             cccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          489 HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       489 ~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ...+++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       175 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  220 (279)
T 2w5a_A          175 TFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS  220 (279)
T ss_dssp             HHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC
Confidence            3578999999999998899999999999999999999999998654

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.98  E-value=4.8e-32  Score=267.08  Aligned_cols=182  Identities=29%  Similarity=0.425  Sum_probs=158.5

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      |.|.+|.||++..  +++.||+|+++..        ..+|+.+++.++|+||+++++++.+  +...++||||+++++|.
T Consensus        16 g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~   93 (276)
T 2yex_A           16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYLFLEYCSGGELF   93 (276)
T ss_dssp             EECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEEEECCTTEEGG
T ss_pred             ecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc--CCEEEEEEEecCCCcHH
Confidence            6677799999987  6899999998532        3479999999999999999999987  67889999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC----Ccccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN----AITMHIV  491 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~----~~~~~~~  491 (552)
                      +++....  .+++.+++.++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++.....    .......
T Consensus        94 ~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  168 (276)
T 2yex_A           94 DRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC  168 (276)
T ss_dssp             GGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCC
T ss_pred             HHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCc
Confidence            9987543  4899999999999999999999999   99999999999999999999999999874321    1123457


Q ss_pred             ccccccCccccCCCCC-CChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          492 GTQGYIAPEYLADGVV-STKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       492 gt~~y~aPE~~~~~~~-s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +++.|+|||.+.+..+ +.++||||||+++|||++|+.||....
T Consensus       169 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  212 (276)
T 2yex_A          169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS  212 (276)
T ss_dssp             SCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSC
T ss_pred             cccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Confidence            8999999999987665 778999999999999999999998654

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.98  E-value=5e-32  Score=275.07  Aligned_cols=185  Identities=29%  Similarity=0.494  Sum_probs=158.3

Q ss_pred             CCceEEEEEEEEee---------cCcEEEEEEeccC--------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEE
Q 037224          345 EGCLIQGSVYKGNI---------HGEVYAIKMMKWN--------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIY  406 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~---------~g~~vAvK~~~~~--------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~  406 (552)
                      .|.|++|.||+++.         ++..||+|+++..        ..+|+.+++++ +||||+++++++.+  ++..++||
T Consensus        43 lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~~lv~  120 (334)
T 2pvf_A           43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ--DGPLYVIV  120 (334)
T ss_dssp             EEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCCEEEE
T ss_pred             EeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc--CCceEEEE
Confidence            37777899999985         3568999999643        34799999999 99999999999977  66789999


Q ss_pred             eeccCCCchhhhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEE
Q 037224          407 EYIENGSLHSWLHENKN--------------ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAK  472 (552)
Q Consensus       407 e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~k  472 (552)
                      ||+++++|.+++.....              ..+++.+++.++.|++.||.|||+++   ++||||||+||+++.++.+|
T Consensus       121 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~k  197 (334)
T 2pvf_A          121 EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMK  197 (334)
T ss_dssp             ECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred             ECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEEcCCCCEE
Confidence            99999999999976542              24899999999999999999999999   99999999999999999999


Q ss_pred             EeeccCCccCCCCc----cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          473 IANFGLAKSGCNAI----TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       473 L~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      |+|||++.......    .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.+..
T Consensus       198 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  264 (334)
T 2pvf_A          198 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  264 (334)
T ss_dssp             ECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             EccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence            99999997543321    223456788999999988889999999999999999999 999997654

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.98  E-value=9.1e-32  Score=282.55  Aligned_cols=184  Identities=24%  Similarity=0.346  Sum_probs=161.7

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC------hHHHHHHHHHc------CCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN------ACEELKILQKV------NHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~------~~~E~~~l~~l------~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      .|.|++|.||++..  .++.||||+++..      ..+|+.+++.+      +|+||+++++++..  ....++||||+.
T Consensus       105 LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~--~~~~~lv~e~~~  182 (429)
T 3kvw_A          105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF--RNHICMTFELLS  182 (429)
T ss_dssp             EEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE--TTEEEEEECCCC
T ss_pred             cccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc--CCeEEEEEeccC
Confidence            37777899999987  6789999999754      33688888887      56799999999987  678899999996


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCc--EEEeeccCCccCCCCccc
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR--AKIANFGLAKSGCNAITM  488 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a~~~~~~~~~  488 (552)
                       ++|.+++.......+++..++.++.|++.||+|||+++   |+||||||+|||++.++.  +||+|||++...... ..
T Consensus       183 -~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~-~~  257 (429)
T 3kvw_A          183 -MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR-VY  257 (429)
T ss_dssp             -CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC-CC
T ss_pred             -CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccceecCCc-cc
Confidence             59999998877667999999999999999999999999   999999999999999887  999999999754432 33


Q ss_pred             cccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          489 HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       489 ~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      ...+|+.|+|||++.+..++.++|||||||++|||++|+.||.+.++
T Consensus       258 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~  304 (429)
T 3kvw_A          258 TYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE  304 (429)
T ss_dssp             SSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            46789999999999999999999999999999999999999987654

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.98  E-value=3.9e-32  Score=272.80  Aligned_cols=184  Identities=30%  Similarity=0.444  Sum_probs=159.6

Q ss_pred             CceEEEEEEEEee-------cCcEEEEEEeccC--------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeec
Q 037224          346 GCLIQGSVYKGNI-------HGEVYAIKMMKWN--------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYI  409 (552)
Q Consensus       346 G~g~~G~Vy~~~~-------~g~~vAvK~~~~~--------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~  409 (552)
                      |.|++|.||++++       .++.||+|+++..        +.+|+.+++++ +||||+++++++.+  ++..++||||+
T Consensus        32 g~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~lv~e~~  109 (313)
T 1t46_A           32 GAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI--GGPTLVITEYC  109 (313)
T ss_dssp             EECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEEECC
T ss_pred             CccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec--CCCcEEEEecC
Confidence            7777899999985       4578999998643        34799999999 99999999999977  56779999999


Q ss_pred             cCCCchhhhhhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEE
Q 037224          410 ENGSLHSWLHENKN----------------ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKI  473 (552)
Q Consensus       410 ~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL  473 (552)
                      ++++|.+++.....                ..+++.+++.++.|++.||.|||+++   ++||||||+||+++.++.+||
T Consensus       110 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl  186 (313)
T 1t46_A          110 CYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKI  186 (313)
T ss_dssp             TTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEEEE
T ss_pred             CCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEcCCCCEEE
Confidence            99999999976542                24899999999999999999999999   999999999999999999999


Q ss_pred             eeccCCccCCCCc----cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          474 ANFGLAKSGCNAI----TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       474 ~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      +|||++.......    .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       187 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  252 (313)
T 1t46_A          187 CDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (313)
T ss_dssp             CCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             ccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence            9999997544322    123456788999999988899999999999999999999 999998654

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.98  E-value=2.6e-32  Score=270.18  Aligned_cols=182  Identities=26%  Similarity=0.365  Sum_probs=147.5

Q ss_pred             CceEEEEEEEEeec-----CcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          346 GCLIQGSVYKGNIH-----GEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       346 G~g~~G~Vy~~~~~-----g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      |.|++|.||+|...     +..||+|..+..        +.+|+.++++++||||+++++++.   ++..++||||++++
T Consensus        24 g~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---~~~~~lv~e~~~~~  100 (281)
T 1mp8_A           24 GEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT---ENPVWIIMELCTLG  100 (281)
T ss_dssp             EECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC---SSSCEEEEECCTTE
T ss_pred             eecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc---cCccEEEEecCCCC
Confidence            77777999999872     457999998642        347999999999999999999874   34678999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc---ccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI---TMH  489 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~---~~~  489 (552)
                      +|.+++.... ..+++.+++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++......   ...
T Consensus       101 ~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  176 (281)
T 1mp8_A          101 ELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK  176 (281)
T ss_dssp             EHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----------------
T ss_pred             CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCccccccccc
Confidence            9999997653 34899999999999999999999999   9999999999999999999999999997543221   223


Q ss_pred             ccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      ..+++.|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~  222 (281)
T 1mp8_A          177 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK  222 (281)
T ss_dssp             --CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             CCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCC
Confidence            456778999999988899999999999999999996 999998643

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.98  E-value=4.8e-32  Score=278.79  Aligned_cols=183  Identities=25%  Similarity=0.414  Sum_probs=142.2

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCC----CCeeEEEEeec
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPE----DANCYLIYEYI  409 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~~~lv~e~~  409 (552)
                      .|.|++|.||++..  +|+.||||+++..         ..+|+.++++++||||+++++++....    ....++++|++
T Consensus        37 lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~  116 (367)
T 2fst_X           37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM  116 (367)
T ss_dssp             CC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC
T ss_pred             EeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc
Confidence            47888899999986  7899999998542         237999999999999999999986531    25679999999


Q ss_pred             cCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcccc
Q 037224          410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH  489 (552)
Q Consensus       410 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  489 (552)
                       +++|.+++...   .+++..++.++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++..... ...
T Consensus       117 -~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-~~~  188 (367)
T 2fst_X          117 -GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE-MTG  188 (367)
T ss_dssp             -CEECC-----C---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC--------------
T ss_pred             -CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccccccccc-CCC
Confidence             67999988653   4999999999999999999999999   999999999999999999999999999765432 334


Q ss_pred             ccccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          490 IVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      ..+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+.
T Consensus       189 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  235 (367)
T 2fst_X          189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH  235 (367)
T ss_dssp             --CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             cCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            678999999999876 6789999999999999999999999987653

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.98  E-value=6.8e-32  Score=267.80  Aligned_cols=183  Identities=31%  Similarity=0.561  Sum_probs=156.2

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEecc--------------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEee
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKW--------------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEY  408 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~--------------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~  408 (552)
                      .|.|++|.||+++.  +++.||+|++..              .+.+|+.++++++|+||+++++++.+  ..  ++||||
T Consensus        27 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~--~lv~e~  102 (287)
T 4f0f_A           27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN--PP--RMVMEF  102 (287)
T ss_dssp             CCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT--TT--EEEEEC
T ss_pred             cccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC--CC--eEEEEe
Confidence            47777799999998  789999999842              24579999999999999999999865  22  799999


Q ss_pred             ccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCc-----EEEeeccCCccCC
Q 037224          409 IENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR-----AKIANFGLAKSGC  483 (552)
Q Consensus       409 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~-----~kL~Dfg~a~~~~  483 (552)
                      +++++|.+++.... ..+++..++.++.|++.||+|||+++ ++++||||||+||+++.++.     +||+|||+++...
T Consensus       103 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~  180 (287)
T 4f0f_A          103 VPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV  180 (287)
T ss_dssp             CTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCS
T ss_pred             cCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCCcccccc
Confidence            99999998886543 35999999999999999999999986 34999999999999988776     9999999997544


Q ss_pred             CCccccccccccccCcccc--CCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          484 NAITMHIVGTQGYIAPEYL--ADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       484 ~~~~~~~~gt~~y~aPE~~--~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      . ......||+.|+|||.+  ....++.++||||||+++|||++|+.||....
T Consensus       181 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  232 (287)
T 4f0f_A          181 H-SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS  232 (287)
T ss_dssp             S-CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             c-cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence            3 23446789999999998  44567889999999999999999999997644

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.98  E-value=6.8e-32  Score=267.96  Aligned_cols=183  Identities=28%  Similarity=0.431  Sum_probs=157.3

Q ss_pred             CCceEEEEEEEEee----cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI----HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~----~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|.|++|.||++.+    .+..||+|+++..        ..+|+.++++++||||+++++++.   .+..++||||++++
T Consensus        18 lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~~lv~e~~~~~   94 (287)
T 1u59_A           18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ---AEALMLVMEMAGGG   94 (287)
T ss_dssp             EECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE---SSSEEEEEECCTTE
T ss_pred             ccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec---CCCcEEEEEeCCCC
Confidence            36777799999975    5778999999652        347999999999999999999984   34579999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc-----c
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI-----T  487 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-----~  487 (552)
                      +|.+++.... ..+++.+++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......     .
T Consensus        95 ~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~  170 (287)
T 1u59_A           95 PLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR  170 (287)
T ss_dssp             EHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCC
T ss_pred             CHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccCcceeecc
Confidence            9999986543 35999999999999999999999999   9999999999999999999999999997543221     1


Q ss_pred             ccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          488 MHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       488 ~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       171 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  218 (287)
T 1u59_A          171 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK  218 (287)
T ss_dssp             CSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             ccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence            22345788999999988889999999999999999998 999997644

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.98  E-value=1e-31  Score=268.84  Aligned_cols=181  Identities=29%  Similarity=0.471  Sum_probs=160.2

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      |.|++|.||+|..  +++.||+|+++..        +.+|+.++++++|+||+++++++.+  +...++||||+++++|.
T Consensus        31 g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~  108 (303)
T 3a7i_A           31 GKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DTKLWIIMEYLGGGSAL  108 (303)
T ss_dssp             EECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEEECCTTEEHH
T ss_pred             cccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CCeEEEEEEeCCCCcHH
Confidence            6677799999987  6889999998532        3579999999999999999999987  67889999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--cccccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIVGT  493 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~gt  493 (552)
                      +++...   .+++.+++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++......  ......++
T Consensus       109 ~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  182 (303)
T 3a7i_A          109 DLLEPG---PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGT  182 (303)
T ss_dssp             HHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCCCCSC
T ss_pred             HHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccccccCccCCC
Confidence            998653   4999999999999999999999999   999999999999999999999999999754322  22345789


Q ss_pred             ccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       494 ~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       183 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  223 (303)
T 3a7i_A          183 PFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH  223 (303)
T ss_dssp             GGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             cCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC
Confidence            99999999999999999999999999999999999997643

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.98  E-value=6.7e-32  Score=283.94  Aligned_cols=180  Identities=24%  Similarity=0.348  Sum_probs=152.0

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCC---CeeEEEEeeccC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPED---ANCYLIYEYIEN  411 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~~~lv~e~~~~  411 (552)
                      |.|++|.||++..  +++.||||+++..         ..+|+.++++++|+||+++++++.....   ...|+||||+++
T Consensus        35 G~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~  114 (432)
T 3n9x_A           35 GRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS  114 (432)
T ss_dssp             EEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCSE
T ss_pred             eecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCCc
Confidence            7778899999987  6889999999642         3479999999999999999999876422   568999999974


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC------
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA------  485 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~------  485 (552)
                       +|.+++....  .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....      
T Consensus       115 -~L~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  188 (432)
T 3n9x_A          115 -DLKKLFKTPI--FLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIV  188 (432)
T ss_dssp             -EHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC---------
T ss_pred             -CHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccccccccccccc
Confidence             9999887643  4999999999999999999999999   999999999999999999999999999754321      


Q ss_pred             ------------------ccccccccccccCcccc-CCCCCCChhhHHHHHHHHHHHHcCCCCCC
Q 037224          486 ------------------ITMHIVGTQGYIAPEYL-ADGVVSTKMDVFSFGVVLLELISGKEAID  531 (552)
Q Consensus       486 ------------------~~~~~~gt~~y~aPE~~-~~~~~s~~~Dv~slG~il~elltG~~pf~  531 (552)
                                        ......||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             ----------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             ccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence                              12446789999999985 56679999999999999999998655554

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.98  E-value=3.3e-32  Score=274.88  Aligned_cols=187  Identities=25%  Similarity=0.423  Sum_probs=149.1

Q ss_pred             CCceEEEEEEEEeec--Cc---EEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCC----eeEEEE
Q 037224          345 EGCLIQGSVYKGNIH--GE---VYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDA----NCYLIY  406 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~--g~---~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~----~~~lv~  406 (552)
                      .|.|++|.||+++..  ++   .||+|+++..         +.+|+.++++++||||+++++++......    ..+++|
T Consensus        31 lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~  110 (323)
T 3qup_A           31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVIL  110 (323)
T ss_dssp             EEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEE
T ss_pred             ecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEE
Confidence            377888999999873  32   7999998643         34799999999999999999999763222    238999


Q ss_pred             eeccCCCchhhhhhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccC
Q 037224          407 EYIENGSLHSWLHENKN----ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG  482 (552)
Q Consensus       407 e~~~~gsL~~~l~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  482 (552)
                      ||+++++|.+++.....    ..+++.+++.++.|++.||+|||+++   ++||||||+|||++.++.+||+|||+++..
T Consensus       111 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~  187 (323)
T 3qup_A          111 PFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKI  187 (323)
T ss_dssp             ECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred             EeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEEeeccccccc
Confidence            99999999999865432    24899999999999999999999999   999999999999999999999999999754


Q ss_pred             CCCc----cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          483 CNAI----TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       483 ~~~~----~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      ....    .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.+..
T Consensus       188 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~  244 (323)
T 3qup_A          188 YSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE  244 (323)
T ss_dssp             -------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             cccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC
Confidence            3221    122456778999999999999999999999999999999 999998654

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.98  E-value=2.1e-32  Score=295.25  Aligned_cols=184  Identities=29%  Similarity=0.438  Sum_probs=159.9

Q ss_pred             CCceEEEEEEEEeec-CcEEEEEEeccC------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhh
Q 037224          345 EGCLIQGSVYKGNIH-GEVYAIKMMKWN------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSW  417 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~-g~~vAvK~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~  417 (552)
                      .|.|.+|.||+|.+. +..||||+++..      +.+|+.++++++|+||+++++++.+   ...++||||+++|+|.++
T Consensus       275 lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~lv~e~~~~gsL~~~  351 (535)
T 2h8h_A          275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVTEYMSKGSLLDF  351 (535)
T ss_dssp             EEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEECCCTTEEHHHH
T ss_pred             cccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee---ccceEeeehhcCCcHHHH
Confidence            377778999999994 468999999643      4689999999999999999999864   457999999999999999


Q ss_pred             hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcc---ccccccc
Q 037224          418 LHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT---MHIVGTQ  494 (552)
Q Consensus       418 l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~---~~~~gt~  494 (552)
                      +.......+++.+++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.......   ....++.
T Consensus       352 l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~  428 (535)
T 2h8h_A          352 LKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI  428 (535)
T ss_dssp             HSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCG
T ss_pred             HhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcc
Confidence            97654455999999999999999999999999   99999999999999999999999999986543221   1234577


Q ss_pred             cccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          495 GYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       495 ~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      .|+|||.+....++.++||||||+++|||++ |+.||.+..
T Consensus       429 ~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~  469 (535)
T 2h8h_A          429 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV  469 (535)
T ss_dssp             GGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC
T ss_pred             cccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            8999999988899999999999999999999 999998653

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.98  E-value=4.4e-33  Score=287.76  Aligned_cols=184  Identities=17%  Similarity=0.317  Sum_probs=148.0

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHH---HHHHHcCCCCcccee-------eeeecCCC---
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEEL---KILQKVNHGNLVKLE-------GFCIDPED---  399 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~---~~l~~l~h~niv~l~-------~~~~~~~~---  399 (552)
                      .|.|++|.||+|+.  +|+.||||+++..          +.+|+   .++++++||||++++       +++.+.+.   
T Consensus        81 lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~  160 (377)
T 3byv_A           81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKM  160 (377)
T ss_dssp             EEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSE
T ss_pred             eecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccc
Confidence            37788899999996  6899999998522          34788   455566899999998       55544211   


Q ss_pred             -------C-----eeEEEEeeccCCCchhhhhhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCc
Q 037224          400 -------A-----NCYLIYEYIENGSLHSWLHENKN-----ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSN  462 (552)
Q Consensus       400 -------~-----~~~lv~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~N  462 (552)
                             .     ..+++|||+ +|+|.+++.....     ..+++..++.++.|++.||+|||+++   |+||||||+|
T Consensus       161 ~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDikp~N  236 (377)
T 3byv_A          161 IRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVD  236 (377)
T ss_dssp             EEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred             cccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHH
Confidence                   1     368999999 5799999976432     12335888899999999999999999   9999999999


Q ss_pred             EEECCCCcEEEeeccCCccCCCCccccccccccccCccccCCC-----------CCCChhhHHHHHHHHHHHHcCCCCCC
Q 037224          463 ILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADG-----------VVSTKMDVFSFGVVLLELISGKEAID  531 (552)
Q Consensus       463 Ill~~~~~~kL~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~~Dv~slG~il~elltG~~pf~  531 (552)
                      ||++.++.+||+|||+++.... ......| +.|+|||.+.+.           .++.++||||||+++|||++|+.||.
T Consensus       237 Ill~~~~~~kL~DFG~a~~~~~-~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~  314 (377)
T 3byv_A          237 IVLDQRGGVFLTGFEHLVRDGA-RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPIT  314 (377)
T ss_dssp             EEECTTCCEEECCGGGCEETTC-EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred             EEEcCCCCEEEEechhheecCC-cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCc
Confidence            9999999999999999986443 3334567 999999999877           89999999999999999999999997


Q ss_pred             ccC
Q 037224          532 EEG  534 (552)
Q Consensus       532 ~~~  534 (552)
                      ...
T Consensus       315 ~~~  317 (377)
T 3byv_A          315 KDA  317 (377)
T ss_dssp             ---
T ss_pred             ccc
Confidence            654

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.98  E-value=8.3e-32  Score=265.52  Aligned_cols=182  Identities=28%  Similarity=0.516  Sum_probs=152.2

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|.+|.||++..  +|+.||+|+++..          ..+|+.++++++|+||+++++++.+  ....++||||+++++
T Consensus        20 g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~   97 (276)
T 2h6d_A           20 GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST--PTDFFMVMEYVSGGE   97 (276)
T ss_dssp             EECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEEEECCCSCB
T ss_pred             cCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec--CCeEEEEEeccCCCc
Confidence            6677799999987  6899999998532          3479999999999999999999987  678899999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-ccccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-ITMHIVG  492 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-~~~~~~g  492 (552)
                      |.+++....  .+++.+++.++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||++...... ......+
T Consensus        98 L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  172 (276)
T 2h6d_A           98 LFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCG  172 (276)
T ss_dssp             HHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---------
T ss_pred             HHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCcceecccC
Confidence            999997654  3899999999999999999999999   999999999999999999999999999754432 2234578


Q ss_pred             cccccCccccCCCCC-CChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          493 TQGYIAPEYLADGVV-STKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       493 t~~y~aPE~~~~~~~-s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ++.|+|||.+.+..+ +.++||||||+++|||++|+.||....
T Consensus       173 ~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  215 (276)
T 2h6d_A          173 SPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH  215 (276)
T ss_dssp             ----CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence            999999999987765 689999999999999999999997653

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.97  E-value=8e-32  Score=269.62  Aligned_cols=185  Identities=24%  Similarity=0.356  Sum_probs=157.3

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC-----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN-----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~-----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      |.|++|.||++..  +++.||+|+++..           ..+|+.++++++|+||+++++++.+.+....++||||++++
T Consensus        14 g~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~   93 (305)
T 2wtk_C           14 GEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG   93 (305)
T ss_dssp             EECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE
T ss_pred             ecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC
Confidence            6777799999988  6789999998532           34799999999999999999999765567889999999875


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC----Cccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN----AITM  488 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~----~~~~  488 (552)
                       |.+++.......+++.+++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++.....    ....
T Consensus        94 -l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~  169 (305)
T 2wtk_C           94 -MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR  169 (305)
T ss_dssp             -HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEEC
T ss_pred             -HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccccCccccccccc
Confidence             777777665667999999999999999999999999   99999999999999999999999999975431    2223


Q ss_pred             cccccccccCccccCCCC--CCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          489 HIVGTQGYIAPEYLADGV--VSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       489 ~~~gt~~y~aPE~~~~~~--~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ...+++.|+|||.+.+..  .+.++||||||+++|||++|+.||....
T Consensus       170 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  217 (305)
T 2wtk_C          170 TSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN  217 (305)
T ss_dssp             CCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch
Confidence            456899999999987644  3779999999999999999999998654

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.97  E-value=3.3e-32  Score=275.91  Aligned_cols=182  Identities=27%  Similarity=0.425  Sum_probs=151.8

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      .|.|.+|.||++..  +++.||+|+++..         ..+|+.++++++||||+++++++.+  +...++||||+++ +
T Consensus        42 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~-~  118 (329)
T 3gbz_A           42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH--NHRLHLIFEYAEN-D  118 (329)
T ss_dssp             EEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE--TTEEEEEEECCSE-E
T ss_pred             EEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec--CCEEEEEEecCCC-C
Confidence            37777799999976  7899999998532         3479999999999999999999987  6788999999985 9


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE-----CCCCcEEEeeccCCccCCC--Cc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL-----DSNMRAKIANFGLAKSGCN--AI  486 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll-----~~~~~~kL~Dfg~a~~~~~--~~  486 (552)
                      |.+++....  .+++.+++.++.|++.||+|||+++   |+||||||+|||+     +.++.+||+|||++.....  ..
T Consensus       119 L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~  193 (329)
T 3gbz_A          119 LKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ  193 (329)
T ss_dssp             HHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----
T ss_pred             HHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccc
Confidence            999987765  3999999999999999999999999   9999999999999     4555699999999874321  22


Q ss_pred             cccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          487 TMHIVGTQGYIAPEYLADG-VVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       487 ~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .....+|+.|+|||.+.+. .++.++||||||+++|||++|+.||....
T Consensus       194 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  242 (329)
T 3gbz_A          194 FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS  242 (329)
T ss_dssp             ------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC
Confidence            2345679999999998774 48999999999999999999999997654

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.97  E-value=3.8e-32  Score=277.10  Aligned_cols=179  Identities=28%  Similarity=0.454  Sum_probs=150.7

Q ss_pred             CceEEEEEEEEee-cCcEEEEEEeccC---------hHHHHHHHHHcCC--CCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI-HGEVYAIKMMKWN---------ACEELKILQKVNH--GNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~-~g~~vAvK~~~~~---------~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|++|.||++.. +++.||+|+++..         +.+|+.++.+++|  +||+++++++.+  +...++||| +.+++
T Consensus        18 G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--~~~~~lv~e-~~~~~   94 (343)
T 3dbq_A           18 GSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYIYMVME-CGNID   94 (343)
T ss_dssp             SCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEEEEC-CCSEE
T ss_pred             ecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee--CCEEEEEEe-CCCCC
Confidence            7777899999987 7889999998532         3479999999976  999999999987  678899999 45779


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc----ccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI----TMH  489 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~----~~~  489 (552)
                      |.+++....  .+++.++..++.|++.||+|||+++   |+||||||+|||++ ++.+||+|||+++......    ...
T Consensus        95 L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~  168 (343)
T 3dbq_A           95 LNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDS  168 (343)
T ss_dssp             HHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----------
T ss_pred             HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCC
Confidence            999998754  4999999999999999999999999   99999999999997 6789999999997543222    224


Q ss_pred             ccccccccCccccCC-----------CCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          490 IVGTQGYIAPEYLAD-----------GVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~-----------~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      ..||+.|+|||.+.+           ..++.++||||||+++|||++|+.||.+.
T Consensus       169 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  223 (343)
T 3dbq_A          169 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI  223 (343)
T ss_dssp             -CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             CcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh
Confidence            579999999999854           67889999999999999999999999753

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=8.2e-32  Score=273.34  Aligned_cols=181  Identities=32%  Similarity=0.485  Sum_probs=152.1

Q ss_pred             CceEEEEEEEEeecCcEEEEEEeccCh----HHHHHHHHHc--CCCCccceeeeeecCCC--CeeEEEEeeccCCCchhh
Q 037224          346 GCLIQGSVYKGNIHGEVYAIKMMKWNA----CEELKILQKV--NHGNLVKLEGFCIDPED--ANCYLIYEYIENGSLHSW  417 (552)
Q Consensus       346 G~g~~G~Vy~~~~~g~~vAvK~~~~~~----~~E~~~l~~l--~h~niv~l~~~~~~~~~--~~~~lv~e~~~~gsL~~~  417 (552)
                      |.|++|.||+++..++.||||++....    .+|.+++..+  +|+||+++++++.....  ...++||||+++++|.++
T Consensus        46 g~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~  125 (337)
T 3mdy_A           46 GKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDY  125 (337)
T ss_dssp             EEETTEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHH
T ss_pred             ecCCCeEEEEEEECCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHH
Confidence            777889999999999999999986442    2455555554  89999999999987432  678999999999999999


Q ss_pred             hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcc--
Q 037224          418 LHENKNENLNWKTRLRIAIDVANGLQYIHEH--------TRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT--  487 (552)
Q Consensus       418 l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~--  487 (552)
                      +...   .+++.+++.++.|++.||+|||++        +   ++||||||+|||++.++.+||+|||++........  
T Consensus       126 l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  199 (337)
T 3mdy_A          126 LKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV  199 (337)
T ss_dssp             HHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             hhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCEEEEeCCCceeeccccccc
Confidence            9765   399999999999999999999988        7   99999999999999999999999999964332211  


Q ss_pred             ----ccccccccccCccccCCCCCCCh------hhHHHHHHHHHHHHcC----------CCCCCc
Q 037224          488 ----MHIVGTQGYIAPEYLADGVVSTK------MDVFSFGVVLLELISG----------KEAIDE  532 (552)
Q Consensus       488 ----~~~~gt~~y~aPE~~~~~~~s~~------~Dv~slG~il~elltG----------~~pf~~  532 (552)
                          ....||+.|+|||.+.+...+..      +||||||+++|||+||          +.||..
T Consensus       200 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~  264 (337)
T 3mdy_A          200 DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD  264 (337)
T ss_dssp             ---CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             cCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence                23578999999999987766654      9999999999999999          677754

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.97  E-value=5.7e-32  Score=268.38  Aligned_cols=183  Identities=29%  Similarity=0.392  Sum_probs=154.3

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      |.|++|.||++..  ++..+|+|++...        ..+|++++++++||||+++++++.+  ....++||||+++++|.
T Consensus        31 g~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~  108 (285)
T 3is5_A           31 GSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED--YHNMYIVMETCEGGELL  108 (285)
T ss_dssp             EECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEEECCCSCCBHH
T ss_pred             ccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheec--CCeEEEEEEeCCCCcHH
Confidence            6666799999987  6889999998543        3579999999999999999999987  67889999999999999


Q ss_pred             hhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE---CCCCcEEEeeccCCccCCC-Ccccc
Q 037224          416 SWLHENK--NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL---DSNMRAKIANFGLAKSGCN-AITMH  489 (552)
Q Consensus       416 ~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~~~~~-~~~~~  489 (552)
                      +++....  ...+++..++.++.|++.||+|||+++   ++||||||+||++   +.++.+||+|||++..... .....
T Consensus       109 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~  185 (285)
T 3is5_A          109 ERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN  185 (285)
T ss_dssp             HHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---------
T ss_pred             HHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcC
Confidence            9886532  345999999999999999999999999   9999999999999   4567899999999975432 22344


Q ss_pred             ccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..+++.|+|||.+. ..++.++||||||+++|||++|+.||.+..
T Consensus       186 ~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~  229 (285)
T 3is5_A          186 AAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS  229 (285)
T ss_dssp             -CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC
Confidence            67899999999875 568899999999999999999999998654

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.97  E-value=4.8e-32  Score=275.53  Aligned_cols=187  Identities=24%  Similarity=0.363  Sum_probs=139.5

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccChH--HHH-HHHHHcCCCCccceeeeeecCC--CCeeEEEEeeccCCCchhh
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWNAC--EEL-KILQKVNHGNLVKLEGFCIDPE--DANCYLIYEYIENGSLHSW  417 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~~~--~E~-~~l~~l~h~niv~l~~~~~~~~--~~~~~lv~e~~~~gsL~~~  417 (552)
                      .|.|++|.||++..  +|+.||+|++.....  +|+ ..++.++|+||+++++++....  ....++||||+++|+|.++
T Consensus        37 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~  116 (336)
T 3fhr_A           37 LGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSR  116 (336)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHH
T ss_pred             eeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHH
Confidence            37788899999988  589999999965532  333 3456679999999999986522  3457999999999999999


Q ss_pred             hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECC---CCcEEEeeccCCccCCCCccccccccc
Q 037224          418 LHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS---NMRAKIANFGLAKSGCNAITMHIVGTQ  494 (552)
Q Consensus       418 l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kL~Dfg~a~~~~~~~~~~~~gt~  494 (552)
                      +.......+++.+++.++.|++.||.|||+++   ++||||||+||+++.   ++.+||+|||++............+|+
T Consensus       117 l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~  193 (336)
T 3fhr_A          117 IQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTP  193 (336)
T ss_dssp             HHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC------------
T ss_pred             HHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccceeccccccccCCCCc
Confidence            98776667999999999999999999999999   999999999999976   455999999999866555555567899


Q ss_pred             cccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       495 ~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       194 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  233 (336)
T 3fhr_A          194 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNT  233 (336)
T ss_dssp             ----------CHHHHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             CccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence            9999999988889999999999999999999999997543

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.97  E-value=1.8e-31  Score=266.08  Aligned_cols=182  Identities=26%  Similarity=0.452  Sum_probs=158.6

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------------hHHHHHHHHHcC-CCCccceeeeeecCCCCeeEEEE
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------------ACEELKILQKVN-HGNLVKLEGFCIDPEDANCYLIY  406 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------------~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~lv~  406 (552)
                      |.|.+|.||++..  +|+.||+|+++..                ..+|+.+++++. ||||+++++++.+  +...++||
T Consensus        26 g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~--~~~~~lv~  103 (298)
T 1phk_A           26 GRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET--NTFFFLVF  103 (298)
T ss_dssp             EECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEEEEEE
T ss_pred             cCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc--CCeEEEEE
Confidence            6777799999988  6889999998532                236999999995 9999999999977  67889999


Q ss_pred             eeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC-C
Q 037224          407 EYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN-A  485 (552)
Q Consensus       407 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~-~  485 (552)
                      ||+++++|.+++....  .+++.+++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++..... .
T Consensus       104 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  178 (298)
T 1phk_A          104 DLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE  178 (298)
T ss_dssp             ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred             eccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccchhhcCCCc
Confidence            9999999999997654  4999999999999999999999999   99999999999999999999999999975432 2


Q ss_pred             ccccccccccccCccccC------CCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          486 ITMHIVGTQGYIAPEYLA------DGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       486 ~~~~~~gt~~y~aPE~~~------~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ......+++.|+|||.+.      ...++.++||||||+++|||++|+.||....
T Consensus       179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  233 (298)
T 1phk_A          179 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK  233 (298)
T ss_dssp             CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc
Confidence            233457899999999874      4568899999999999999999999997544

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.97  E-value=1.3e-31  Score=273.91  Aligned_cols=186  Identities=27%  Similarity=0.423  Sum_probs=157.0

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCC------CCeeEEEEe
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPE------DANCYLIYE  407 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~~~lv~e  407 (552)
                      .|.|++|.||+++.  +|+.||+|++...         ..+|+.++++++|+||+++++++.+..      .+..++|||
T Consensus        25 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e  104 (351)
T 3mi9_A           25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFD  104 (351)
T ss_dssp             CSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEE
T ss_pred             EecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEe
Confidence            47777799999998  7899999988432         347999999999999999999997643      346899999


Q ss_pred             eccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC----
Q 037224          408 YIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC----  483 (552)
Q Consensus       408 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~----  483 (552)
                      |+++ +|.+.+.... ..+++.+++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++...    
T Consensus       105 ~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  179 (351)
T 3mi9_A          105 FCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN  179 (351)
T ss_dssp             CCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCCCSS
T ss_pred             ccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhccccccccc
Confidence            9986 7777776543 34999999999999999999999999   9999999999999999999999999997432    


Q ss_pred             --CCccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          484 --NAITMHIVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       484 --~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                        ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.+...
T Consensus       180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  234 (351)
T 3mi9_A          180 SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE  234 (351)
T ss_dssp             SSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh
Confidence              112234578999999998876 5589999999999999999999999987654

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.97  E-value=8.6e-32  Score=277.48  Aligned_cols=183  Identities=25%  Similarity=0.374  Sum_probs=150.0

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCC----CCeeEEEEeec
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPE----DANCYLIYEYI  409 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~~~lv~e~~  409 (552)
                      .|.|++|.||++..  +++.||||+++..         ..+|+.+++.++||||+++++++....    ....++||||+
T Consensus        33 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~  112 (371)
T 2xrw_A           33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM  112 (371)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECC
T ss_pred             eEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcC
Confidence            37777899999987  6899999998542         347999999999999999999987632    23789999999


Q ss_pred             cCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-ccc
Q 037224          410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-ITM  488 (552)
Q Consensus       410 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-~~~  488 (552)
                      ++ +|.+++..    .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++..... ...
T Consensus       113 ~~-~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~  184 (371)
T 2xrw_A          113 DA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT  184 (371)
T ss_dssp             SE-EHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-----------
T ss_pred             CC-CHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecccccccccccC
Confidence            85 78887753    3899999999999999999999999   999999999999999999999999999754432 233


Q ss_pred             cccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          489 HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       489 ~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      ...||+.|+|||.+.+..++.++||||||+++|||++|+.||.+.+.
T Consensus       185 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~  231 (371)
T 2xrw_A          185 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH  231 (371)
T ss_dssp             -----CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             CceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            46789999999999999999999999999999999999999987653

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.97  E-value=7.6e-32  Score=275.06  Aligned_cols=182  Identities=20%  Similarity=0.256  Sum_probs=151.1

Q ss_pred             CCceEEEEEEEEee-----cCcEEEEEEeccC------------------hHHHHHHHHHcCCCCccceeeeeecC--CC
Q 037224          345 EGCLIQGSVYKGNI-----HGEVYAIKMMKWN------------------ACEELKILQKVNHGNLVKLEGFCIDP--ED  399 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-----~g~~vAvK~~~~~------------------~~~E~~~l~~l~h~niv~l~~~~~~~--~~  399 (552)
                      .|.|++|.||++..     .+..+|+|+....                  ..+|+..++.++|+||+++++++.+.  ..
T Consensus        45 lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~  124 (345)
T 2v62_A           45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGR  124 (345)
T ss_dssp             C------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESSSC
T ss_pred             EeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccCCC
Confidence            47788899999998     5678999998543                  22466777788999999999998762  24


Q ss_pred             CeeEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCC--cEEEeecc
Q 037224          400 ANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM--RAKIANFG  477 (552)
Q Consensus       400 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~--~~kL~Dfg  477 (552)
                      ...++||||+ +++|.+++....  .+++.+++.++.|++.||+|||+++   |+||||||+|||++.++  .+||+|||
T Consensus       125 ~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kL~Dfg  198 (345)
T 2v62_A          125 SYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYG  198 (345)
T ss_dssp             EEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTTSEEECCCT
T ss_pred             cEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCCcEEEEeCC
Confidence            5789999999 889999997655  5999999999999999999999999   99999999999998877  99999999


Q ss_pred             CCccCCC---------CccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          478 LAKSGCN---------AITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       478 ~a~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                      +++....         .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       199 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~  262 (345)
T 2v62_A          199 LSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ  262 (345)
T ss_dssp             TCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred             CceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            9974321         112345789999999999999999999999999999999999999965

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.97  E-value=1.7e-31  Score=268.50  Aligned_cols=184  Identities=28%  Similarity=0.439  Sum_probs=158.8

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC-----hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhh
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN-----ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSW  417 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~-----~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~  417 (552)
                      .|.|.+|.||++..  +|+.||+|.++..     ..+|+.++++++||||+++++++.+  +...++||||+++++|.++
T Consensus        37 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~  114 (314)
T 3com_A           37 LGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFK--NTDLWIVMEYCGAGSVSDI  114 (314)
T ss_dssp             CC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEEEECCTTEEHHHH
T ss_pred             eccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe--CCEEEEEeecCCCCCHHHH
Confidence            47788899999988  5899999998543     4589999999999999999999987  6788999999999999999


Q ss_pred             hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--cccccccccc
Q 037224          418 LHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIVGTQG  495 (552)
Q Consensus       418 l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~gt~~  495 (552)
                      +.... ..+++.+++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++......  ......+++.
T Consensus       115 ~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  190 (314)
T 3com_A          115 IRLRN-KTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPF  190 (314)
T ss_dssp             HHHHT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCCCSCGG
T ss_pred             HHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCccCCCCC
Confidence            86432 35999999999999999999999999   999999999999999999999999999754322  2234578999


Q ss_pred             ccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          496 YIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       496 y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      |+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       191 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  229 (314)
T 3com_A          191 WMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH  229 (314)
T ss_dssp             GCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             ccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999899999999999999999999999997643

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.97  E-value=1.2e-31  Score=275.57  Aligned_cols=182  Identities=27%  Similarity=0.420  Sum_probs=156.2

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEecc--------ChHHHHHHHHHcCCCCccceeeeeecCC---CCeeEEEEeeccCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKW--------NACEELKILQKVNHGNLVKLEGFCIDPE---DANCYLIYEYIENG  412 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~--------~~~~E~~~l~~l~h~niv~l~~~~~~~~---~~~~~lv~e~~~~g  412 (552)
                      |.|++|.||++..  +++.||+|+++.        .+.+|+.++++++||||+++++++....   ....++||||+++ 
T Consensus        36 G~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~-  114 (364)
T 3qyz_A           36 GEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-  114 (364)
T ss_dssp             EECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCSE-
T ss_pred             ecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccCc-
Confidence            7777899999987  688999999863        2347999999999999999999986532   2468999999985 


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc-----c
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI-----T  487 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-----~  487 (552)
                      +|.+++...   .+++.+++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++.......     .
T Consensus       115 ~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  188 (364)
T 3qyz_A          115 DLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL  188 (364)
T ss_dssp             EHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTT
T ss_pred             CHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccc
Confidence            999988764   3999999999999999999999999   9999999999999999999999999997543221     2


Q ss_pred             ccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          488 MHIVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       488 ~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.+..
T Consensus       189 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  236 (364)
T 3qyz_A          189 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH  236 (364)
T ss_dssp             CCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC
Confidence            33578999999998654 558999999999999999999999998654

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.97  E-value=8.6e-32  Score=279.44  Aligned_cols=185  Identities=24%  Similarity=0.334  Sum_probs=158.2

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC------hHHHHHHHHHcC--------CCCccceeeeeecC--CCCeeEEEEe
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN------ACEELKILQKVN--------HGNLVKLEGFCIDP--EDANCYLIYE  407 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~------~~~E~~~l~~l~--------h~niv~l~~~~~~~--~~~~~~lv~e  407 (552)
                      |.|++|.||+++.  +++.||||+++..      ..+|+.++++++        |+||+++++++...  .....++|||
T Consensus        46 g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e  125 (397)
T 1wak_A           46 GWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFE  125 (397)
T ss_dssp             EECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEEC
T ss_pred             eecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEe
Confidence            7777899999987  6889999999753      347999999985        78899999988732  2557899999


Q ss_pred             eccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEECCCC-----------------
Q 037224          408 YIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEH-TRPRVVHKDIKSSNILLDSNM-----------------  469 (552)
Q Consensus       408 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~ivH~Dikp~NIll~~~~-----------------  469 (552)
                      |+ +++|.+++.......+++.+++.++.|++.||+|||++ +   |+||||||+|||++.++                 
T Consensus       126 ~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~  201 (397)
T 1wak_A          126 VL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSG  201 (397)
T ss_dssp             CC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHHHHHHC------
T ss_pred             cc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhhhhhhHHHhhcC
Confidence            99 55777777665555699999999999999999999998 8   99999999999998775                 


Q ss_pred             --------------------------------cEEEeeccCCccCCCCccccccccccccCccccCCCCCCChhhHHHHH
Q 037224          470 --------------------------------RAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFG  517 (552)
Q Consensus       470 --------------------------------~~kL~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG  517 (552)
                                                      .+||+|||++...... .....||+.|+|||++.+..++.++||||||
T Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG  280 (397)
T 1wak_A          202 APPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-FTEDIQTRQYRSLEVLIGSGYNTPADIWSTA  280 (397)
T ss_dssp             ---------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHH
T ss_pred             CCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-CccCCCCCcccCChhhcCCCCCcHHHHHHHH
Confidence                                            7999999999765433 3345789999999999999999999999999


Q ss_pred             HHHHHHHcCCCCCCccCc
Q 037224          518 VVLLELISGKEAIDEEGK  535 (552)
Q Consensus       518 ~il~elltG~~pf~~~~~  535 (552)
                      |++|||++|+.||.....
T Consensus       281 ~il~elltg~~pf~~~~~  298 (397)
T 1wak_A          281 CMAFELATGDYLFEPHSG  298 (397)
T ss_dssp             HHHHHHHHSSCSCCCCCC
T ss_pred             HHHHHHhhCCCCCCCCcc
Confidence            999999999999986543

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=8.4e-32  Score=273.37  Aligned_cols=183  Identities=30%  Similarity=0.454  Sum_probs=153.0

Q ss_pred             CceEEEEEEEEeec------CcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          346 GCLIQGSVYKGNIH------GEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       346 G~g~~G~Vy~~~~~------g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      |.|++|.||+|...      +..||+|+++..        +.+|+.++++++||||+++++++.+  ....++||||+++
T Consensus        53 G~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~  130 (333)
T 1mqb_A           53 GAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK--YKPMMIITEYMEN  130 (333)
T ss_dssp             EECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSEEEEEECCTT
T ss_pred             ecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec--CCCcEEEEeCCCC
Confidence            77888999999873      235999998643        3479999999999999999999976  6678999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc-----
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI-----  486 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-----  486 (552)
                      ++|.+++.... ..+++.+++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++.......     
T Consensus       131 ~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~  206 (333)
T 1mqb_A          131 GALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT  206 (333)
T ss_dssp             EEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-------------
T ss_pred             CcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhccccccccc
Confidence            99999997643 35999999999999999999999999   9999999999999999999999999997543221     


Q ss_pred             cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          487 TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       487 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.+..
T Consensus       207 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~  255 (333)
T 1mqb_A          207 TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS  255 (333)
T ss_dssp             ----CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             cCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC
Confidence            112345778999999998999999999999999999999 999997543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.97  E-value=4.3e-32  Score=272.56  Aligned_cols=182  Identities=23%  Similarity=0.352  Sum_probs=151.4

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|.+|.||++..  +++.||+|+++..          +.+|+.++++++||||+++++++.+  ++..+++|||+++++
T Consensus        43 g~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~~~  120 (309)
T 2h34_A           43 GRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI--DGQLYVDMRLINGVD  120 (309)
T ss_dssp             EECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEEEECCCCEE
T ss_pred             cCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee--CCeEEEEEEecCCCC
Confidence            6677799999987  6889999998532          3479999999999999999999987  678899999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC---ccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA---ITMHI  490 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~---~~~~~  490 (552)
                      |.+++....  .+++.+++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++......   .....
T Consensus       121 L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  195 (309)
T 2h34_A          121 LAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNT  195 (309)
T ss_dssp             HHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC---------------
T ss_pred             HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccccccccccccc
Confidence            999997654  4999999999999999999999999   999999999999999999999999998754322   12235


Q ss_pred             cccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       491 ~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .+++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       196 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  239 (309)
T 2h34_A          196 VGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ  239 (309)
T ss_dssp             -CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH
T ss_pred             CCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch
Confidence            78999999999999999999999999999999999999997653

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.97  E-value=5.6e-32  Score=273.82  Aligned_cols=186  Identities=30%  Similarity=0.421  Sum_probs=162.1

Q ss_pred             CCceEEEEEEEEee------cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI------HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~------~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|.+|.||++++      .++.||+|+++..       +.+|+.++++++|+||+++++++...+....++||||+++
T Consensus        31 lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~  110 (327)
T 3lxl_A           31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPS  110 (327)
T ss_dssp             EEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTT
T ss_pred             ccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCC
Confidence            37777899999984      6789999998643       4579999999999999999999987667788999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc-----
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI-----  486 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-----  486 (552)
                      ++|.+++..... .+++.+++.++.|++.||+|||+++   ++||||||+|||++.++.+||+|||++.......     
T Consensus       111 ~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~  186 (327)
T 3lxl_A          111 GCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV  186 (327)
T ss_dssp             CBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEEC
T ss_pred             CCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceecccCCcccee
Confidence            999999976433 4999999999999999999999999   9999999999999999999999999997543222     


Q ss_pred             cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          487 TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       487 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .....++..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       187 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~  234 (327)
T 3lxl_A          187 REPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS  234 (327)
T ss_dssp             SSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred             eccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcccc
Confidence            123457788999999988889999999999999999999999987543

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.97  E-value=8.4e-32  Score=272.20  Aligned_cols=186  Identities=30%  Similarity=0.500  Sum_probs=156.0

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC------hHHHHHHHHHc-CCCCccceeeeeecCC----CCeeEEEEeeccCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN------ACEELKILQKV-NHGNLVKLEGFCIDPE----DANCYLIYEYIENG  412 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~------~~~E~~~l~~l-~h~niv~l~~~~~~~~----~~~~~lv~e~~~~g  412 (552)
                      |.|.+|.||+++.  +|+.||+|+++..      ..+|+.+++++ +|+||+++++++....    ....++||||++++
T Consensus        33 g~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~  112 (326)
T 2x7f_A           33 GNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAG  112 (326)
T ss_dssp             EEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTE
T ss_pred             ccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCC
Confidence            7777899999998  7899999998532      45799999999 8999999999997643    46789999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--ccccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHI  490 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~  490 (552)
                      +|.+++.......+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++......  .....
T Consensus       113 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  189 (326)
T 2x7f_A          113 SVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF  189 (326)
T ss_dssp             EHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTTTC------------
T ss_pred             cHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcCceecCcCccccccc
Confidence            9999998765556999999999999999999999999   999999999999999999999999998754322  22345


Q ss_pred             cccccccCccccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          491 VGTQGYIAPEYLA-----DGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       491 ~gt~~y~aPE~~~-----~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .+++.|+|||.+.     +..++.++||||||+++|||++|+.||.+..
T Consensus       190 ~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  238 (326)
T 2x7f_A          190 IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH  238 (326)
T ss_dssp             -CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             cCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence            7899999999986     5668899999999999999999999997644

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.97  E-value=4.6e-32  Score=269.56  Aligned_cols=180  Identities=31%  Similarity=0.543  Sum_probs=146.3

Q ss_pred             CceEEEEEEEEeecCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchh
Q 037224          346 GCLIQGSVYKGNIHGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHS  416 (552)
Q Consensus       346 G~g~~G~Vy~~~~~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~  416 (552)
                      |.|++|.||+++..+ .+|+|+++..         +.+|+.++++++|+||+++++++.   ....++||||+++++|.+
T Consensus        33 G~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---~~~~~lv~e~~~~~~L~~  108 (289)
T 3og7_A           33 GSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST---APQLAIVTQWCEGSSLYH  108 (289)
T ss_dssp             EECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSCEEEEECCCEEEHHH
T ss_pred             cCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc---CCccEEEEEecCCCcHHH
Confidence            777789999998765 4999998532         347999999999999999999764   345799999999999999


Q ss_pred             hhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC----Cccccccc
Q 037224          417 WLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN----AITMHIVG  492 (552)
Q Consensus       417 ~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~----~~~~~~~g  492 (552)
                      ++.... ..+++.+++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++.....    .......|
T Consensus       109 ~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g  184 (289)
T 3og7_A          109 HLHASE-TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSG  184 (289)
T ss_dssp             HHTTC----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------------------C
T ss_pred             HHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccccccccccccCC
Confidence            986543 35999999999999999999999999   99999999999999999999999999874332    22233578


Q ss_pred             cccccCccccC---CCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          493 TQGYIAPEYLA---DGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       493 t~~y~aPE~~~---~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      |+.|+|||.+.   ...++.++||||||+++|||++|+.||.+.
T Consensus       185 t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  228 (289)
T 3og7_A          185 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI  228 (289)
T ss_dssp             CCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred             CccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcccc
Confidence            99999999986   566888999999999999999999999764

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.97  E-value=2e-31  Score=265.44  Aligned_cols=183  Identities=26%  Similarity=0.307  Sum_probs=157.0

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEecc-----ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhhh
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKW-----NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL  418 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~-----~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l  418 (552)
                      |.|.+|.||+++.  +|+.||+|++..     ...+|+.+++.++|++++..+..+.. .....++||||+ +++|.+++
T Consensus        18 g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~-~~~~~~lv~e~~-~~~L~~~~   95 (296)
T 3uzp_A           18 GSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA-EGDYNVMVMELL-GPSLEDLF   95 (296)
T ss_dssp             EEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEE-ETTEEEEEEECC-CCBHHHHH
T ss_pred             ccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccC-CCCceEEEEEec-CCCHHHHH
Confidence            6777899999995  789999999753     35689999999999988877776644 256789999999 88999999


Q ss_pred             hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE---CCCCcEEEeeccCCccCCCCc---------
Q 037224          419 HENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL---DSNMRAKIANFGLAKSGCNAI---------  486 (552)
Q Consensus       419 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~~~~~~~---------  486 (552)
                      .... ..+++.+++.++.|++.||+|||+++   ++||||||+|||+   +.++.+||+|||++.......         
T Consensus        96 ~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  171 (296)
T 3uzp_A           96 NFCS-RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRE  171 (296)
T ss_dssp             HHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCC
T ss_pred             Hhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccccccccc
Confidence            7543 35999999999999999999999999   9999999999999   488899999999997433221         


Q ss_pred             cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          487 TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       487 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       172 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  219 (296)
T 3uzp_A          172 NKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK  219 (296)
T ss_dssp             SCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             ccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcC
Confidence            234578999999999999999999999999999999999999998643

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=5.6e-32  Score=276.15  Aligned_cols=183  Identities=31%  Similarity=0.440  Sum_probs=157.2

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEecc------------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKW------------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~------------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      .|.|++|.||+++.  +|+.||+|+++.            ...+|+.++++++||||+++++++.+  ....++||||++
T Consensus        18 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~   95 (346)
T 1ua2_A           18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--KSNISLVFDFME   95 (346)
T ss_dssp             EEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--TTCCEEEEECCS
T ss_pred             EeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee--CCceEEEEEcCC
Confidence            37778899999988  589999999853            23479999999999999999999976  667899999998


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC--Cccc
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN--AITM  488 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~--~~~~  488 (552)
                      + +|.+++.... ..+++.+++.++.|++.||+|||+++   ++||||||+|||++.++.+||+|||+++....  ....
T Consensus        96 ~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~  170 (346)
T 1ua2_A           96 T-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT  170 (346)
T ss_dssp             E-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCC
T ss_pred             C-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceeccCCcccCC
Confidence            6 8888886543 35899999999999999999999999   99999999999999999999999999975432  2233


Q ss_pred             cccccccccCccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          489 HIVGTQGYIAPEYLADG-VVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       489 ~~~gt~~y~aPE~~~~~-~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ...+|+.|+|||.+.+. .++.++||||||+++|||++|..||.+..
T Consensus       171 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~  217 (346)
T 1ua2_A          171 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS  217 (346)
T ss_dssp             CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence            46789999999998654 58899999999999999999999998654

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.97  E-value=1.2e-31  Score=270.82  Aligned_cols=181  Identities=30%  Similarity=0.444  Sum_probs=155.5

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEee
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEY  408 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~  408 (552)
                      |.|++|.||++..  +++.||||+++..               +.+|+.++++++||||+++++++..  + ..++||||
T Consensus        19 g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~-~~~lv~e~   95 (322)
T 2ycf_A           19 GSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA--E-DYYIVLEL   95 (322)
T ss_dssp             EECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES--S-SEEEEEEC
T ss_pred             ecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC--C-ceEEEEec
Confidence            6777799999987  6789999998532               4579999999999999999999865  2 37999999


Q ss_pred             ccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCc---EEEeeccCCccCCCC
Q 037224          409 IENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR---AKIANFGLAKSGCNA  485 (552)
Q Consensus       409 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~---~kL~Dfg~a~~~~~~  485 (552)
                      +++++|.+++....  .+++.+++.++.|++.||.|||+++   ++||||||+||+++.++.   +||+|||++......
T Consensus        96 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  170 (322)
T 2ycf_A           96 MEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET  170 (322)
T ss_dssp             CTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCC
T ss_pred             CCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCccceecccc
Confidence            99999999887543  4999999999999999999999999   999999999999987664   999999999865433


Q ss_pred             c-cccccccccccCccccC---CCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          486 I-TMHIVGTQGYIAPEYLA---DGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       486 ~-~~~~~gt~~y~aPE~~~---~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      . .....||+.|+|||.+.   ...++.++||||||+++|||++|+.||....
T Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  223 (322)
T 2ycf_A          171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR  223 (322)
T ss_dssp             HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT
T ss_pred             cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence            2 23457899999999863   5678899999999999999999999997643

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.97  E-value=2.7e-32  Score=279.21  Aligned_cols=184  Identities=21%  Similarity=0.305  Sum_probs=158.0

Q ss_pred             CceEEEEEEEEeec----------CcEEEEEEeccC--hHHHHHHHHHcCCCCccc---------------eeeeeecCC
Q 037224          346 GCLIQGSVYKGNIH----------GEVYAIKMMKWN--ACEELKILQKVNHGNLVK---------------LEGFCIDPE  398 (552)
Q Consensus       346 G~g~~G~Vy~~~~~----------g~~vAvK~~~~~--~~~E~~~l~~l~h~niv~---------------l~~~~~~~~  398 (552)
                      |.|++|.||+++..          ++.||+|+++..  ..+|++++++++||||++               +++++.. +
T Consensus        51 g~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~-~  129 (352)
T 2jii_A           51 TRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVH-Q  129 (352)
T ss_dssp             EEETTEEEEEEEECC-----------CEEEEEEETTSTHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEE-T
T ss_pred             cCCCCeEEEEEeecCCccccccccCceEEEEEecccchHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhcccc-C
Confidence            77778999999873          689999999654  678999999999999887               5556554 2


Q ss_pred             CCeeEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCC--cEEEeec
Q 037224          399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM--RAKIANF  476 (552)
Q Consensus       399 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~--~~kL~Df  476 (552)
                      +...++||||+ +++|.+++.......+++.+++.++.|++.||.|||+++   |+||||||+|||++.++  .+||+||
T Consensus       130 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~~~~~~~~~kl~Df  205 (352)
T 2jii_A          130 DKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGY  205 (352)
T ss_dssp             TTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEEETTEEEEEEECCG
T ss_pred             CcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEEcCCCCceEEEecC
Confidence            56789999999 899999998764456999999999999999999999999   99999999999999998  8999999


Q ss_pred             cCCccCCCC---------ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          477 GLAKSGCNA---------ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       477 g~a~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      |+++.....         ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       206 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          206 GFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             GGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             cceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            999744321         1123478999999999999999999999999999999999999998754

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.97  E-value=3.1e-32  Score=299.10  Aligned_cols=182  Identities=29%  Similarity=0.444  Sum_probs=155.5

Q ss_pred             CCceEEEEEEEEee----cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI----HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~----~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|.+|.||+|.+    .++.||||+++..         +.+|+.++++++||||+++++++.+   ...++||||+++
T Consensus       377 LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---~~~~lv~E~~~~  453 (635)
T 4fl3_A          377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMAEL  453 (635)
T ss_dssp             EEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEEEEEECCTT
T ss_pred             eccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCEEEEEEccCC
Confidence            47888899999965    4578999999642         3479999999999999999999864   347899999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc-----
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI-----  486 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-----  486 (552)
                      |+|.+++....  .+++.+++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++......     
T Consensus       454 g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  528 (635)
T 4fl3_A          454 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  528 (635)
T ss_dssp             EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred             CCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence            99999997654  4999999999999999999999999   9999999999999999999999999997543221     


Q ss_pred             cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          487 TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       487 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||.+..
T Consensus       529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~  577 (635)
T 4fl3_A          529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK  577 (635)
T ss_dssp             ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            122346788999999999999999999999999999998 999998754

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.97  E-value=2.8e-32  Score=276.87  Aligned_cols=181  Identities=27%  Similarity=0.463  Sum_probs=149.2

Q ss_pred             CceEEEEEEEEeecCcEEEEEEeccCh----HHHHHH--HHHcCCCCccceeeeeec---CCCCeeEEEEeeccCCCchh
Q 037224          346 GCLIQGSVYKGNIHGEVYAIKMMKWNA----CEELKI--LQKVNHGNLVKLEGFCID---PEDANCYLIYEYIENGSLHS  416 (552)
Q Consensus       346 G~g~~G~Vy~~~~~g~~vAvK~~~~~~----~~E~~~--l~~l~h~niv~l~~~~~~---~~~~~~~lv~e~~~~gsL~~  416 (552)
                      |.|++|.||+|+.+++.||||+++...    ..|.++  +..++|+||+++++.+..   .....+++||||+++|+|.+
T Consensus        22 g~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~  101 (336)
T 3g2f_A           22 GRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXK  101 (336)
T ss_dssp             EECSSEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHH
T ss_pred             ccCCCeEEEEEEECCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHH
Confidence            777789999999999999999996443    233333  445799999999976542   22346789999999999999


Q ss_pred             hhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--
Q 037224          417 WLHENKNENLNWKTRLRIAIDVANGLQYIHEH---------TRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--  485 (552)
Q Consensus       417 ~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---------~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--  485 (552)
                      ++....   .++..++.++.|++.||+|||+.         +   |+||||||+|||++.++.+||+|||++......  
T Consensus       102 ~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~  175 (336)
T 3g2f_A          102 YLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL  175 (336)
T ss_dssp             HHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEECCCTTCEECSSSSC
T ss_pred             HHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEeeccceeecccccc
Confidence            997654   68999999999999999999998         7   999999999999999999999999999743321  


Q ss_pred             --------ccccccccccccCccccCC-------CCCCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          486 --------ITMHIVGTQGYIAPEYLAD-------GVVSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       486 --------~~~~~~gt~~y~aPE~~~~-------~~~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                              ......||+.|+|||.+.+       ..++.++||||||+++|||++|..||..
T Consensus       176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~  237 (336)
T 3g2f_A          176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP  237 (336)
T ss_dssp             C---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred             cCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence                    1223468999999999876       4566789999999999999999877654

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.97  E-value=5.3e-32  Score=274.53  Aligned_cols=183  Identities=27%  Similarity=0.476  Sum_probs=155.3

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|++|.||+++.  +|+.||+|++...         ..+|+.++++++||||+++++++.+  ....++||||+++++|
T Consensus        34 g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~l  111 (331)
T 4aaa_A           34 GEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK--KKRWYLVFEFVDHTIL  111 (331)
T ss_dssp             GGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEEECCSEEHH
T ss_pred             eecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec--CCEEEEEEecCCcchH
Confidence            7777799999998  5899999998432         3479999999999999999999987  6788999999999888


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC--Cccccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN--AITMHIVG  492 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~--~~~~~~~g  492 (552)
                      .+++....  .+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++.....  .......+
T Consensus       112 ~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  186 (331)
T 4aaa_A          112 DDLELFPN--GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA  186 (331)
T ss_dssp             HHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------------CCC
T ss_pred             HHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCccccCCCcC
Confidence            88765443  4999999999999999999999999   99999999999999999999999999975332  22234578


Q ss_pred             cccccCccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          493 TQGYIAPEYLADG-VVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       493 t~~y~aPE~~~~~-~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      ++.|+|||.+.+. .++.++||||||+++|||++|+.||.....
T Consensus       187 t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  230 (331)
T 4aaa_A          187 TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD  230 (331)
T ss_dssp             CCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             CccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence            9999999998765 789999999999999999999999987653

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.97  E-value=1.3e-31  Score=275.00  Aligned_cols=196  Identities=25%  Similarity=0.354  Sum_probs=156.6

Q ss_pred             HHHHHHhhccCC----CceEEEEEEEEee-cCcEEEEEEecc------------------ChHHHHHHHHHcCCCCccce
Q 037224          334 EELREATDNFSE----GCLIQGSVYKGNI-HGEVYAIKMMKW------------------NACEELKILQKVNHGNLVKL  390 (552)
Q Consensus       334 ~~l~~~t~~~~~----G~g~~G~Vy~~~~-~g~~vAvK~~~~------------------~~~~E~~~l~~l~h~niv~l  390 (552)
                      .++....+.|..    |.|++|.||++.. +|+.||||++..                  .+.+|+.++++++||||+++
T Consensus        15 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   94 (362)
T 3pg1_A           15 AELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGL   94 (362)
T ss_dssp             HHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred             HHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccce
Confidence            344444444432    7888899999987 789999999842                  24579999999999999999


Q ss_pred             eeeeecC---CCCeeEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECC
Q 037224          391 EGFCIDP---EDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS  467 (552)
Q Consensus       391 ~~~~~~~---~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~  467 (552)
                      ++++...   .....++||||++ ++|.+++.... ..+++..++.++.|++.||.|||+++   ++||||||+||+++.
T Consensus        95 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~  169 (362)
T 3pg1_A           95 RDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLAD  169 (362)
T ss_dssp             SEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECT
T ss_pred             eeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcC
Confidence            9998652   2346899999998 58888887543 35999999999999999999999999   999999999999999


Q ss_pred             CCcEEEeeccCCccCCC-CccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          468 NMRAKIANFGLAKSGCN-AITMHIVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       468 ~~~~kL~Dfg~a~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ++.+||+|||++..... .......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||.+..
T Consensus       170 ~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  238 (362)
T 3pg1_A          170 NNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST  238 (362)
T ss_dssp             TCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence            99999999999974332 22334678999999999876 678999999999999999999999998765

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.97  E-value=5.9e-32  Score=296.05  Aligned_cols=183  Identities=28%  Similarity=0.426  Sum_probs=155.8

Q ss_pred             CCceEEEEEEEEee----cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI----HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~----~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|.|.||.||+|.+    ++..||||+++..        +.+|+.++++++||||++++++|.+   +..++||||+++|
T Consensus       344 LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---~~~~lv~E~~~~g  420 (613)
T 2ozo_A          344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EALMLVMEMAGGG  420 (613)
T ss_dssp             EEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES---SSEEEEEECCTTC
T ss_pred             EecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc---CCeEEEEEeCCCC
Confidence            47888899999977    3567999998642        3579999999999999999999875   3579999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc-----c
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI-----T  487 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-----~  487 (552)
                      +|.+++.... ..+++.+++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++......     .
T Consensus       421 ~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~  496 (613)
T 2ozo_A          421 PLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR  496 (613)
T ss_dssp             BHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred             cHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence            9999997543 35999999999999999999999999   9999999999999999999999999998543221     1


Q ss_pred             ccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          488 MHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       488 ~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      ....+++.|+|||++.+..++.++||||||+++|||++ |+.||.+..
T Consensus       497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~  544 (613)
T 2ozo_A          497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK  544 (613)
T ss_dssp             -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence            12345678999999998999999999999999999998 999998654

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.97  E-value=2.3e-31  Score=264.91  Aligned_cols=183  Identities=25%  Similarity=0.294  Sum_probs=157.3

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEec-----cChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhhh
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMK-----WNACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL  418 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l  418 (552)
                      |.|.+|.||+++.  +++.||+|++.     ....+|+.+++.++|++++..+..+... ....+++|||+ +++|.+++
T Consensus        18 g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~lv~e~~-~~~L~~~~   95 (296)
T 4hgt_A           18 GSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVMVMELL-GPSLEDLF   95 (296)
T ss_dssp             EECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEE-TTEEEEEEECC-CCBHHHHH
T ss_pred             cCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCC-CCceEEEEEcc-CCCHHHHH
Confidence            6777799999995  78999999863     3456899999999999888887776542 56789999999 88999998


Q ss_pred             hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE---CCCCcEEEeeccCCccCCCC---------c
Q 037224          419 HENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL---DSNMRAKIANFGLAKSGCNA---------I  486 (552)
Q Consensus       419 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~~~~~~---------~  486 (552)
                      .... ..+++.+++.++.|++.||.|||+++   ++||||||+|||+   +.++.+||+|||+++.....         .
T Consensus        96 ~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~  171 (296)
T 4hgt_A           96 NFCS-RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRE  171 (296)
T ss_dssp             HHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCC
T ss_pred             HHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCc
Confidence            7543 34999999999999999999999999   9999999999999   78899999999999743322         1


Q ss_pred             cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          487 TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       487 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       172 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  219 (296)
T 4hgt_A          172 NKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK  219 (296)
T ss_dssp             SCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             ccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence            224578999999999999999999999999999999999999998643

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.97  E-value=1.7e-31  Score=264.45  Aligned_cols=181  Identities=26%  Similarity=0.350  Sum_probs=154.9

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|.+|.||++..  +++.||+|+++..         ..+|+..+.++ +||||+++++++.+  ++..++||||+++++
T Consensus        20 g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~   97 (289)
T 1x8b_A           20 GSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE--DDHMLIQNEYCNGGS   97 (289)
T ss_dssp             EEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE--TTEEEEEEECCTTCB
T ss_pred             cCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeEEEEEEecCCCc
Confidence            7777899999998  6899999998642         34688888888 99999999999987  678899999999999


Q ss_pred             chhhhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCC-------------------CcEE
Q 037224          414 LHSWLHENKN--ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN-------------------MRAK  472 (552)
Q Consensus       414 L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~-------------------~~~k  472 (552)
                      |.+++.....  ..+++.+++.++.|++.||+|||+++   |+||||||+||+++.+                   ..+|
T Consensus        98 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~k  174 (289)
T 1x8b_A           98 LADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK  174 (289)
T ss_dssp             HHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC--------------------CCCEE
T ss_pred             HHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccccCCceEEE
Confidence            9999976432  45899999999999999999999999   9999999999999844                   4799


Q ss_pred             EeeccCCccCCCCccccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          473 IANFGLAKSGCNAITMHIVGTQGYIAPEYLADG-VVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       473 L~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      |+|||.+.......  ...+|+.|+|||.+.+. .+++++||||||+++|||++|..|+...
T Consensus       175 l~Dfg~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~  234 (289)
T 1x8b_A          175 IGDLGHVTRISSPQ--VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG  234 (289)
T ss_dssp             ECCCTTCEETTCSC--CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred             EcccccccccCCcc--ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence            99999997654332  34689999999998765 5678999999999999999999877543

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.97  E-value=5.9e-32  Score=268.44  Aligned_cols=180  Identities=24%  Similarity=0.404  Sum_probs=154.0

Q ss_pred             CCceEEEEEEEEee--cC-------cEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEee
Q 037224          345 EGCLIQGSVYKGNI--HG-------EVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEY  408 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g-------~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~  408 (552)
                      .|.|.+|.||++..  .+       ..||+|+++..       +.+|+.++++++||||+++++++.+  +...++||||
T Consensus        16 lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~   93 (289)
T 4fvq_A           16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC--GDENILVQEF   93 (289)
T ss_dssp             EEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC--TTCCEEEEEC
T ss_pred             eccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe--CCCCEEEEEC
Confidence            37788899999987  33       57999998542       3479999999999999999999987  5677999999


Q ss_pred             ccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCc--------EEEeeccCCc
Q 037224          409 IENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR--------AKIANFGLAK  480 (552)
Q Consensus       409 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~--------~kL~Dfg~a~  480 (552)
                      +++++|.+++..... .+++..++.++.|++.||.|||+++   ++||||||+|||++.++.        +||+|||++.
T Consensus        94 ~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~  169 (289)
T 4fvq_A           94 VKFGSLDTYLKKNKN-CINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI  169 (289)
T ss_dssp             CTTCBHHHHHHHTGG-GCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCT
T ss_pred             CCCCCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeeeccCcccc
Confidence            999999999976543 3899999999999999999999999   999999999999988887        9999999987


Q ss_pred             cCCCCccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCC-CCCCc
Q 037224          481 SGCNAITMHIVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGK-EAIDE  532 (552)
Q Consensus       481 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~-~pf~~  532 (552)
                      .....  ....+++.|+|||.+.+ ..++.++||||||+++|||++|. .||..
T Consensus       170 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~  221 (289)
T 4fvq_A          170 TVLPK--DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA  221 (289)
T ss_dssp             TTSCH--HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             cccCc--cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccc
Confidence            54332  23567899999999987 77899999999999999999955 44543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.97  E-value=2.7e-32  Score=281.21  Aligned_cols=183  Identities=10%  Similarity=0.048  Sum_probs=141.1

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccCh----------HHHHHHHHHc--CCCCcccee-------eeeecCCC----
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWNA----------CEELKILQKV--NHGNLVKLE-------GFCIDPED----  399 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~~----------~~E~~~l~~l--~h~niv~l~-------~~~~~~~~----  399 (552)
                      .|.|++|.||++++  +|+.||+|+++...          .+|+.+++.+  +||||++++       +++.....    
T Consensus        70 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~  149 (371)
T 3q60_A           70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFA  149 (371)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSS
T ss_pred             ccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCee
Confidence            37777899999987  78999999997532          2565545555  699988754       44433211    


Q ss_pred             -----------CeeEEEEeeccCCCchhhhhhcCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCceEecCCCCCc
Q 037224          400 -----------ANCYLIYEYIENGSLHSWLHENKNENLNWKTR------LRIAIDVANGLQYIHEHTRPRVVHKDIKSSN  462 (552)
Q Consensus       400 -----------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~N  462 (552)
                                 ...++||||++ ++|.+++..... .+++..+      +.++.|++.||+|||+++   |+||||||+|
T Consensus       150 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---ivHrDikp~N  224 (371)
T 3q60_A          150 QLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDN  224 (371)
T ss_dssp             BCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGG
T ss_pred             eccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---CccCcCCHHH
Confidence                       34799999999 799999986432 2455566      778899999999999999   9999999999


Q ss_pred             EEECCCCcEEEeeccCCccCCCCccccccccccccCccccCC--CCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          463 ILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLAD--GVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       463 Ill~~~~~~kL~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      ||++.++.+||+|||+++...... ....+++.|+|||.+.+  ..++.++||||||+++|||++|+.||...
T Consensus       225 Ill~~~~~~kL~DFG~a~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~  296 (371)
T 3q60_A          225 LFIMPDGRLMLGDVSALWKVGTRG-PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV  296 (371)
T ss_dssp             EEECTTSCEEECCGGGEEETTCEE-EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred             EEECCCCCEEEEecceeeecCCCc-cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence            999999999999999998654332 24566799999999987  77999999999999999999999999876

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.97  E-value=6.1e-32  Score=272.73  Aligned_cols=184  Identities=26%  Similarity=0.422  Sum_probs=157.7

Q ss_pred             CceEEEEEEEEeec-------CcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          346 GCLIQGSVYKGNIH-------GEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       346 G~g~~G~Vy~~~~~-------g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      |.|++|.||+|...       ++.||+|.++..        +.+|+.++++++|+||+++++++.+  ....++||||++
T Consensus        34 g~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~  111 (322)
T 1p4o_A           34 GQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--GQPTLVIMELMT  111 (322)
T ss_dssp             EECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS--SSSCEEEEECCT
T ss_pred             ccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc--CCccEEEEEeCC
Confidence            77777999999763       578999998643        3479999999999999999999976  567799999999


Q ss_pred             CCCchhhhhhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccC
Q 037224          411 NGSLHSWLHENKN--------ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG  482 (552)
Q Consensus       411 ~gsL~~~l~~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  482 (552)
                      +++|.+++.....        ..+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++...
T Consensus       112 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl~Dfg~~~~~  188 (322)
T 1p4o_A          112 RGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDI  188 (322)
T ss_dssp             TCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCCCGG
T ss_pred             CCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEECcCcccccc
Confidence            9999999875321        34799999999999999999999999   999999999999999999999999999743


Q ss_pred             CCCc----cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          483 CNAI----TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       483 ~~~~----~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      ....    .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       189 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  245 (322)
T 1p4o_A          189 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS  245 (322)
T ss_dssp             GGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred             ccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC
Confidence            3221    122356788999999988889999999999999999999 899997643

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.97  E-value=2.3e-31  Score=267.05  Aligned_cols=184  Identities=22%  Similarity=0.398  Sum_probs=150.0

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEecc----------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKW----------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~----------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|.|.+|.||++..  +|+.||+|+++.          .+.+|+.++++++|+||+++++++.+  ++..++||||++++
T Consensus        40 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~  117 (310)
T 2wqm_A           40 IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--DNELNIVLELADAG  117 (310)
T ss_dssp             EECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEEEECCCSC
T ss_pred             ecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCcEEEEEecCCCC
Confidence            37778899999986  789999999863          13479999999999999999999987  67889999999999


Q ss_pred             Cchhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--ccc
Q 037224          413 SLHSWLHEN--KNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITM  488 (552)
Q Consensus       413 sL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~  488 (552)
                      +|.+++...  ....+++.+++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++......  ...
T Consensus       118 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~  194 (310)
T 2wqm_A          118 DLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH  194 (310)
T ss_dssp             BHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------------
T ss_pred             CHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCcccc
Confidence            999998652  2345899999999999999999999999   999999999999999999999999998754322  222


Q ss_pred             cccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          489 HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       489 ~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      ...+++.|+|||.+.+..++.++||||||+++|||++|+.||.+.
T Consensus       195 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  239 (310)
T 2wqm_A          195 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  239 (310)
T ss_dssp             ----CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred             ccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            356899999999999999999999999999999999999999754

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.97  E-value=9.8e-32  Score=272.06  Aligned_cols=185  Identities=34%  Similarity=0.460  Sum_probs=157.1

Q ss_pred             CCceEEEEEEEEee--cCcE--EEEEEeccC--------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI--HGEV--YAIKMMKWN--------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~--vAvK~~~~~--------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|++|.||+++.  ++..  +|+|.++..        +.+|+.+++++ +||||+++++++.+  .+..++||||+++
T Consensus        33 lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~~lv~e~~~~  110 (327)
T 1fvr_A           33 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLYLAIEYAPH  110 (327)
T ss_dssp             EECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--TTEEEEEECCCTT
T ss_pred             eecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee--CCceEEEEecCCC
Confidence            36777799999987  5554  499988542        34799999999 99999999999987  6788999999999


Q ss_pred             CCchhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeecc
Q 037224          412 GSLHSWLHENK--------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFG  477 (552)
Q Consensus       412 gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg  477 (552)
                      ++|.+++....              ...+++.+++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||
T Consensus       111 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kL~Dfg  187 (327)
T 1fvr_A          111 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  187 (327)
T ss_dssp             CBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTT
T ss_pred             CCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeEEEcccC
Confidence            99999997653              245999999999999999999999999   9999999999999999999999999


Q ss_pred             CCccCCCC-ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          478 LAKSGCNA-ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       478 ~a~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      +++..... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       188 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~  246 (327)
T 1fvr_A          188 LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT  246 (327)
T ss_dssp             CEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             cCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc
Confidence            98743322 1223456789999999988889999999999999999998 999997654

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.97  E-value=1.6e-31  Score=268.61  Aligned_cols=186  Identities=28%  Similarity=0.470  Sum_probs=149.8

Q ss_pred             CceEEEEEEEEeec-----CcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCC---eeEEEEee
Q 037224          346 GCLIQGSVYKGNIH-----GEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDA---NCYLIYEY  408 (552)
Q Consensus       346 G~g~~G~Vy~~~~~-----g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~---~~~lv~e~  408 (552)
                      |.|++|.||++...     +..||+|+++..         +.+|+.++++++||||+++++++.+....   ..+++|||
T Consensus        43 g~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~  122 (313)
T 3brb_A           43 GEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPF  122 (313)
T ss_dssp             EC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEEC
T ss_pred             eecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEec
Confidence            77778999999772     348999998632         34799999999999999999999864332   45999999


Q ss_pred             ccCCCchhhhhhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC
Q 037224          409 IENGSLHSWLHEN----KNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN  484 (552)
Q Consensus       409 ~~~gsL~~~l~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  484 (552)
                      +++++|.+++...    ....+++.+++.++.|+++||.|||+++   ++||||||+||+++.++.+||+|||++.....
T Consensus       123 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~  199 (313)
T 3brb_A          123 MKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYS  199 (313)
T ss_dssp             CTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEECSCSCC-----
T ss_pred             ccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEEeecCcceeccc
Confidence            9999999998532    2345999999999999999999999998   99999999999999999999999999975432


Q ss_pred             C----ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          485 A----ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       485 ~----~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      .    ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       200 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  254 (313)
T 3brb_A          200 GDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ  254 (313)
T ss_dssp             -----------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence            2    1223456789999999999999999999999999999999 999997654

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.97  E-value=1.4e-31  Score=278.12  Aligned_cols=188  Identities=26%  Similarity=0.374  Sum_probs=153.9

Q ss_pred             CCceEEEEEEEEee-cCcEEEEEEeccC---hHHHHHHHHHcCCCCccceeeeeecCC----CCeeEEEEeeccCCCchh
Q 037224          345 EGCLIQGSVYKGNI-HGEVYAIKMMKWN---ACEELKILQKVNHGNLVKLEGFCIDPE----DANCYLIYEYIENGSLHS  416 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-~g~~vAvK~~~~~---~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~~~lv~e~~~~gsL~~  416 (552)
                      .|.|++|.||+++. .+..+|+|++...   ..+|+.+++.++|+||+++++++....    ....++||||++++.+..
T Consensus        48 lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~  127 (394)
T 4e7w_A           48 IGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRA  127 (394)
T ss_dssp             EEEETTEEEEEEEETTTEEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHH
T ss_pred             EeeCCCeEEEEEEECCCCeEEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHH
Confidence            37888899999998 5666899887433   347999999999999999999986532    223789999998744333


Q ss_pred             hhhh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEC-CCCcEEEeeccCCccCC-CCcccccccc
Q 037224          417 WLHE-NKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLD-SNMRAKIANFGLAKSGC-NAITMHIVGT  493 (552)
Q Consensus       417 ~l~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~-~~~~~kL~Dfg~a~~~~-~~~~~~~~gt  493 (552)
                      .... .....+++..++.++.|+++||+|||+++   |+||||||+|||++ .++.+||+|||+++... ........+|
T Consensus       128 ~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t  204 (394)
T 4e7w_A          128 SRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICS  204 (394)
T ss_dssp             HHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSSCSC
T ss_pred             HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCCcccccC
Confidence            2221 12345999999999999999999999999   99999999999998 79999999999997543 2233346789


Q ss_pred             ccccCccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          494 QGYIAPEYLADG-VVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       494 ~~y~aPE~~~~~-~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      +.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+.
T Consensus       205 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  247 (394)
T 4e7w_A          205 RYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG  247 (394)
T ss_dssp             GGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             cCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            999999998664 589999999999999999999999987653

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.97  E-value=1.1e-31  Score=267.13  Aligned_cols=182  Identities=29%  Similarity=0.445  Sum_probs=155.3

Q ss_pred             CCceEEEEEEEEee----cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI----HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~----~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|++|.||++.+    .++.||+|+++..         +.+|+.++++++||||+++++++.   ....++||||+++
T Consensus        25 lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---~~~~~lv~e~~~~  101 (291)
T 1xbb_A           25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE---AESWMLVMEMAEL  101 (291)
T ss_dssp             EEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE---SSSEEEEEECCTT
T ss_pred             cccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC---CCCcEEEEEeCCC
Confidence            37777899999965    4678999998643         347999999999999999999983   4567999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcc----
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT----  487 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~----  487 (552)
                      ++|.+++....  .+++.+++.++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++........    
T Consensus       102 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  176 (291)
T 1xbb_A          102 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  176 (291)
T ss_dssp             EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred             CCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccc
Confidence            99999998754  4999999999999999999999999   99999999999999999999999999975432211    


Q ss_pred             -ccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          488 -MHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       488 -~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                       ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       177 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~  225 (291)
T 1xbb_A          177 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK  225 (291)
T ss_dssp             ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             cccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence             12345688999999988889999999999999999999 999998654

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.97  E-value=3.1e-31  Score=267.90  Aligned_cols=186  Identities=27%  Similarity=0.449  Sum_probs=160.4

Q ss_pred             CceEEEEEEEEee---cCcEEEEEEecc---------ChHHHHHHHHHc---CCCCccceeeeeec---CCCCeeEEEEe
Q 037224          346 GCLIQGSVYKGNI---HGEVYAIKMMKW---------NACEELKILQKV---NHGNLVKLEGFCID---PEDANCYLIYE  407 (552)
Q Consensus       346 G~g~~G~Vy~~~~---~g~~vAvK~~~~---------~~~~E~~~l~~l---~h~niv~l~~~~~~---~~~~~~~lv~e  407 (552)
                      |.|.+|.||++..   +|+.||+|+++.         ...+|+.+++.+   +||||+++++++..   ......++|||
T Consensus        20 g~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e   99 (326)
T 1blx_A           20 GEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFE   99 (326)
T ss_dssp             EEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEE
T ss_pred             cccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEe
Confidence            7777899999987   578999999842         245788887777   89999999999862   12567899999


Q ss_pred             eccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-c
Q 037224          408 YIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-I  486 (552)
Q Consensus       408 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-~  486 (552)
                      |++ ++|.+++.......+++.+++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++...... .
T Consensus       100 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~  175 (326)
T 1blx_A          100 HVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA  175 (326)
T ss_dssp             CCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGG
T ss_pred             cCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecCcccccccCCCC
Confidence            998 59999998776666999999999999999999999999   999999999999999999999999999754422 2


Q ss_pred             cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          487 TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       487 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      .....+++.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus       176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  224 (326)
T 1blx_A          176 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD  224 (326)
T ss_dssp             GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence            3346789999999999999999999999999999999999999987653

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.97  E-value=1.4e-31  Score=277.65  Aligned_cols=179  Identities=27%  Similarity=0.448  Sum_probs=151.5

Q ss_pred             CceEEEEEEEEee-cCcEEEEEEeccC---------hHHHHHHHHHcC--CCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI-HGEVYAIKMMKWN---------ACEELKILQKVN--HGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~-~g~~vAvK~~~~~---------~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|++|.||++.. .++.||||+++..         +.+|+.++++++  |+||+++++++..  +...++||| +.+++
T Consensus        65 G~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~--~~~~~lv~E-~~~~~  141 (390)
T 2zmd_A           65 GSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYIYMVME-CGNID  141 (390)
T ss_dssp             ECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEEEEE-CCSEE
T ss_pred             ccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec--CCEEEEEEe-cCCCC
Confidence            7777799999987 6889999998532         347999999996  5999999999987  667899999 56789


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc----ccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI----TMH  489 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~----~~~  489 (552)
                      |.+++....  .+++.+++.++.|++.||+|||+++   |+||||||+|||++ ++.+||+|||+++......    ...
T Consensus       142 L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~  215 (390)
T 2zmd_A          142 LNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDS  215 (390)
T ss_dssp             HHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CC
T ss_pred             HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCC
Confidence            999998754  4899999999999999999999999   99999999999995 5789999999998543221    234


Q ss_pred             ccccccccCccccCC-----------CCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          490 IVGTQGYIAPEYLAD-----------GVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~-----------~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      ..||+.|+|||++.+           ..++.++|||||||++|||++|+.||...
T Consensus       216 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~  270 (390)
T 2zmd_A          216 QVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI  270 (390)
T ss_dssp             SCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             CCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhh
Confidence            579999999999864           46888999999999999999999999754

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=4.7e-32  Score=279.36  Aligned_cols=185  Identities=26%  Similarity=0.464  Sum_probs=148.5

Q ss_pred             CCceEEEEEEEEee--c---CcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI--H---GEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~---g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|++|.||+|++  +   +..||+|.++..        +.+|+.++++++||||+++++++... ++..++||||+++
T Consensus        97 LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~~~lv~e~~~~  175 (373)
T 3c1x_A           97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLVVLPYMKH  175 (373)
T ss_dssp             EECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC-SSCCEEEEECCTT
T ss_pred             eeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC-CCCeEEEEECCCC
Confidence            37777899999987  2   236899998532        34799999999999999999987653 3567899999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC------
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA------  485 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~------  485 (552)
                      ++|.+++.... ..+++.+++.++.|+++||+|||+++   |+||||||+|||++.++.+||+|||+++.....      
T Consensus       176 g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~  251 (373)
T 3c1x_A          176 GDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH  251 (373)
T ss_dssp             CBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------------
T ss_pred             CCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccccccccccc
Confidence            99999997543 34899999999999999999999999   999999999999999999999999999743221      


Q ss_pred             ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          486 ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       486 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      ......+++.|+|||.+.+..++.++||||||+++|||+| |..||...+
T Consensus       252 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~  301 (373)
T 3c1x_A          252 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN  301 (373)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred             ccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC
Confidence            1123456788999999999999999999999999999999 777887543

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.97  E-value=1e-31  Score=265.77  Aligned_cols=181  Identities=27%  Similarity=0.370  Sum_probs=153.6

Q ss_pred             CceEEEEEEEEeec-----CcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          346 GCLIQGSVYKGNIH-----GEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       346 G~g~~G~Vy~~~~~-----g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      |.|++|.||++.+.     +..||+|.++..        +.+|+.++++++||||+++++++.+   ...+++|||++++
T Consensus        21 g~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v~e~~~~~   97 (281)
T 3cc6_A           21 GEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE---EPTWIIMELYPYG   97 (281)
T ss_dssp             EECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS---SSCEEEEECCTTC
T ss_pred             EecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCCEEEEecCCCC
Confidence            67777999999862     236999998653        3469999999999999999999764   3458999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc---ccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI---TMH  489 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~---~~~  489 (552)
                      +|.+++.... ..+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++.......   ...
T Consensus        98 ~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  173 (281)
T 3cc6_A           98 ELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV  173 (281)
T ss_dssp             BHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC---------C
T ss_pred             CHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccccccccccccc
Confidence            9999997643 34899999999999999999999999   9999999999999999999999999987543321   223


Q ss_pred             ccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCcc
Q 037224          490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEE  533 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~  533 (552)
                      ..+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       174 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~  218 (281)
T 3cc6_A          174 TRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL  218 (281)
T ss_dssp             CCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             CCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccC
Confidence            456788999999988889999999999999999998 99999743

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.97  E-value=2e-31  Score=265.84  Aligned_cols=184  Identities=27%  Similarity=0.465  Sum_probs=154.1

Q ss_pred             CCceEEEEEEEEeec-----CcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNIH-----GEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~-----g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|++|.||+|...     ...+|+|.++..        +.+|+.++++++||||+++++++... ++..+++|||+++
T Consensus        33 lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~~v~e~~~~  111 (298)
T 3f66_A           33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLVVLPYMKH  111 (298)
T ss_dssp             EEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS-SSCCEEEEECCTT
T ss_pred             eeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC-CCceEEEEeCCCC
Confidence            377888999999862     235899998642        34799999999999999999987653 4567899999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc-----
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI-----  486 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-----  486 (552)
                      ++|.+++.... ..+++.+++.++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++.......     
T Consensus       112 ~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  187 (298)
T 3f66_A          112 GDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVH  187 (298)
T ss_dssp             CBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-
T ss_pred             CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccccchhccc
Confidence            99999997543 35899999999999999999999999   9999999999999999999999999997543221     


Q ss_pred             -cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCcc
Q 037224          487 -TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEE  533 (552)
Q Consensus       487 -~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~  533 (552)
                       .....+|+.|+|||.+.+..++.++||||||+++|||++ |.+||...
T Consensus       188 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~  236 (298)
T 3f66_A          188 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV  236 (298)
T ss_dssp             ----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred             cccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccC
Confidence             223456788999999998899999999999999999999 56666544

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=4e-31  Score=263.49  Aligned_cols=182  Identities=29%  Similarity=0.419  Sum_probs=154.0

Q ss_pred             CCceEEEEEEEEee--cC---cEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI--HG---EVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g---~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|++|.||+|.+  ++   ..+|+|.++..        +.+|+.++++++||||+++++++.+. +...+++|||+.+
T Consensus        29 lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~~v~e~~~~  107 (298)
T 3pls_A           29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP-EGLPHVLLPYMCH  107 (298)
T ss_dssp             EEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS-SSCCEEEECCCTT
T ss_pred             eccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC-CCCcEEEEecccC
Confidence            37888899999986  22   27999998642        34799999999999999999999763 3345899999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC------
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA------  485 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~------  485 (552)
                      ++|.+++.... ..+++.+++.++.|++.||+|||+++   ++||||||+||+++.++.+||+|||+++.....      
T Consensus       108 ~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  183 (298)
T 3pls_A          108 GDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQ  183 (298)
T ss_dssp             CBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSC
T ss_pred             CCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccc
Confidence            99999997633 45899999999999999999999999   999999999999999999999999999744321      


Q ss_pred             ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCC
Q 037224          486 ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID  531 (552)
Q Consensus       486 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~  531 (552)
                      ......+++.|+|||.+.+..++.++||||||+++|||++|..|+.
T Consensus       184 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~  229 (298)
T 3pls_A          184 QHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY  229 (298)
T ss_dssp             CSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred             cCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCC
Confidence            2223567889999999999999999999999999999999655543

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.97  E-value=2.8e-31  Score=270.15  Aligned_cols=182  Identities=29%  Similarity=0.464  Sum_probs=155.6

Q ss_pred             CceEEEEEEEEeecCcEEEEEEeccC----hHHHHHHHHH--cCCCCccceeeeeecCCC--CeeEEEEeeccCCCchhh
Q 037224          346 GCLIQGSVYKGNIHGEVYAIKMMKWN----ACEELKILQK--VNHGNLVKLEGFCIDPED--ANCYLIYEYIENGSLHSW  417 (552)
Q Consensus       346 G~g~~G~Vy~~~~~g~~vAvK~~~~~----~~~E~~~l~~--l~h~niv~l~~~~~~~~~--~~~~lv~e~~~~gsL~~~  417 (552)
                      |.|.+|.||+++.+|+.||+|+++..    ..+|.+++..  ++||||+++++++.....  ...++||||+++++|.++
T Consensus        51 g~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~  130 (342)
T 1b6c_B           51 GKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDY  130 (342)
T ss_dssp             EEETTEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHH
T ss_pred             cCCCCcEEEEEEEcCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHH
Confidence            77788999999999999999999654    3468888888  799999999999987432  278999999999999999


Q ss_pred             hhhcCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc---
Q 037224          418 LHENKNENLNWKTRLRIAIDVANGLQYIH--------EHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI---  486 (552)
Q Consensus       418 l~~~~~~~l~~~~~~~i~~qi~~aL~~LH--------~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~---  486 (552)
                      +...   .+++.+++.++.|++.||+|||        +.+   ++||||||+|||++.++.+||+|||++.......   
T Consensus       131 l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~  204 (342)
T 1b6c_B          131 LNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI  204 (342)
T ss_dssp             HHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEE
T ss_pred             Hhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEEEECCCceecccccccc
Confidence            9764   3999999999999999999999        777   9999999999999999999999999997433221   


Q ss_pred             ---cccccccccccCccccCCC------CCCChhhHHHHHHHHHHHHcC----------CCCCCcc
Q 037224          487 ---TMHIVGTQGYIAPEYLADG------VVSTKMDVFSFGVVLLELISG----------KEAIDEE  533 (552)
Q Consensus       487 ---~~~~~gt~~y~aPE~~~~~------~~s~~~Dv~slG~il~elltG----------~~pf~~~  533 (552)
                         .....||+.|+|||.+.+.      .++.++||||||+++|||+||          +.||...
T Consensus       205 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~  270 (342)
T 1b6c_B          205 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL  270 (342)
T ss_dssp             EECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             ccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence               2335789999999998765      234689999999999999999          7888654

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.97  E-value=7.1e-32  Score=273.65  Aligned_cols=184  Identities=30%  Similarity=0.466  Sum_probs=157.5

Q ss_pred             CceEEEEEEEEeec--C-----cEEEEEEeccC--------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeec
Q 037224          346 GCLIQGSVYKGNIH--G-----EVYAIKMMKWN--------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYI  409 (552)
Q Consensus       346 G~g~~G~Vy~~~~~--g-----~~vAvK~~~~~--------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~  409 (552)
                      |.|++|.||++...  +     ..||+|.++..        ..+|+.+++++ +||||+++++++.+  ++..++||||+
T Consensus        55 G~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~~  132 (333)
T 2i1m_A           55 GAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH--GGPVLVITEYC  132 (333)
T ss_dssp             EECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEEECC
T ss_pred             ccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec--CCceEEEEecC
Confidence            77778999999872  2     47999998643        34799999999 89999999999977  56789999999


Q ss_pred             cCCCchhhhhhcC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeecc
Q 037224          410 ENGSLHSWLHENK------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFG  477 (552)
Q Consensus       410 ~~gsL~~~l~~~~------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg  477 (552)
                      ++|+|.+++....            ...+++.+++.++.|++.||+|||+++   ++||||||+|||++.++.+||+|||
T Consensus       133 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg  209 (333)
T 2i1m_A          133 CYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFG  209 (333)
T ss_dssp             TTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGGEEEBCCCG
T ss_pred             CCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCCeEEECccc
Confidence            9999999987542            235899999999999999999999999   9999999999999999999999999


Q ss_pred             CCccCCCCc----cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          478 LAKSGCNAI----TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       478 ~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      ++.......    .....+++.|+|||.+.+..++.++||||||+++|||+| |..||.+..
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  271 (333)
T 2i1m_A          210 LARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL  271 (333)
T ss_dssp             GGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             cccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence            997432211    123456788999999988899999999999999999998 999997643

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.97  E-value=3.6e-31  Score=268.43  Aligned_cols=182  Identities=24%  Similarity=0.342  Sum_probs=159.6

Q ss_pred             CceEEEEEEEEee---cCcEEEEEEeccC------hHHHHHHHHHcCCCC------ccceeeeeecCCCCeeEEEEeecc
Q 037224          346 GCLIQGSVYKGNI---HGEVYAIKMMKWN------ACEELKILQKVNHGN------LVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       346 G~g~~G~Vy~~~~---~g~~vAvK~~~~~------~~~E~~~l~~l~h~n------iv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      |.|.+|.||++..   +++.||+|+++..      ..+|+.+++.++|++      ++++++++.+  .+..++||||+ 
T Consensus        23 g~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~-   99 (339)
T 1z57_A           23 GEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH--HGHICIVFELL-   99 (339)
T ss_dssp             EEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE--TTEEEEEEECC-
T ss_pred             ecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc--CCcEEEEEcCC-
Confidence            7777899999976   6889999999743      347899999987654      8999999987  67889999999 


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECC-------------------CCcE
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS-------------------NMRA  471 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~-------------------~~~~  471 (552)
                      +++|.+++.......+++.+++.++.|++.||+|||+++   ++||||||+|||++.                   ++.+
T Consensus       100 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (339)
T 1z57_A          100 GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI  176 (339)
T ss_dssp             CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCE
T ss_pred             CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccccccccccCCCc
Confidence            789999998776566999999999999999999999999   999999999999987                   6689


Q ss_pred             EEeeccCCccCCCCccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          472 KIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       472 kL~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ||+|||++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       177 kl~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  238 (339)
T 1z57_A          177 KVVDFGSATYDDEH-HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD  238 (339)
T ss_dssp             EECCCSSCEETTSC-CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred             eEeeCcccccCccc-cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999764432 334678999999999999999999999999999999999999998654

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.97  E-value=1.2e-31  Score=269.74  Aligned_cols=185  Identities=31%  Similarity=0.479  Sum_probs=158.3

Q ss_pred             CceEEEEEEEEee-------cCcEEEEEEeccC--------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeec
Q 037224          346 GCLIQGSVYKGNI-------HGEVYAIKMMKWN--------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYI  409 (552)
Q Consensus       346 G~g~~G~Vy~~~~-------~g~~vAvK~~~~~--------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~  409 (552)
                      |.|++|.||++.+       +++.||+|+++..        ..+|+.++.++ +||||+++++++... +...+++|||+
T Consensus        36 g~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-~~~~~lv~e~~  114 (316)
T 2xir_A           36 GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-GGPLMVIVEFC  114 (316)
T ss_dssp             EECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-TSCCEEEEECC
T ss_pred             cCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC-CCceEEEEEcC
Confidence            7777899999974       4578999998643        34799999999 799999999998763 34579999999


Q ss_pred             cCCCchhhhhhcCCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEee
Q 037224          410 ENGSLHSWLHENKNE--------------NLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIAN  475 (552)
Q Consensus       410 ~~gsL~~~l~~~~~~--------------~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~D  475 (552)
                      ++++|.+++......              .+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|
T Consensus       115 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~D  191 (316)
T 2xir_A          115 KFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICD  191 (316)
T ss_dssp             TTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECC
T ss_pred             CCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEECC
Confidence            999999999765431              2889999999999999999999999   99999999999999999999999


Q ss_pred             ccCCccCCCCc----cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          476 FGLAKSGCNAI----TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       476 fg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      ||+++......    .....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus       192 fg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~  255 (316)
T 2xir_A          192 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  255 (316)
T ss_dssp             CGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             CccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence            99997543221    223467889999999988899999999999999999998 999997643

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.97  E-value=1.7e-31  Score=270.49  Aligned_cols=182  Identities=27%  Similarity=0.469  Sum_probs=150.6

Q ss_pred             CceEEEEEEEEee--cCcE----EEEEEecc--------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          346 GCLIQGSVYKGNI--HGEV----YAIKMMKW--------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~----vAvK~~~~--------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      |.|++|.||++.+  +++.    ||+|.++.        .+.+|+.++++++||||+++++++.+  + ..++++||+.+
T Consensus        24 G~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~-~~~~v~~~~~~  100 (327)
T 3lzb_A           24 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--S-TVQLITQLMPF  100 (327)
T ss_dssp             EECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES--S-SEEEEECCCSS
T ss_pred             eeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec--C-CceEEEEecCC
Confidence            7777899999987  4543    57777642        23579999999999999999999986  2 36899999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC----cc
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA----IT  487 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~----~~  487 (552)
                      ++|.+++..... .+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.....    ..
T Consensus       101 g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~  176 (327)
T 3lzb_A          101 GCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA  176 (327)
T ss_dssp             CBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-------------
T ss_pred             CcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccc
Confidence            999999976543 4999999999999999999999999   999999999999999999999999999754321    12


Q ss_pred             ccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          488 MHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       488 ~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       177 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~  224 (327)
T 3lzb_A          177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP  224 (327)
T ss_dssp             ---CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             cCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence            22456778999999999999999999999999999999 999998654

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.97  E-value=1.9e-31  Score=265.48  Aligned_cols=184  Identities=28%  Similarity=0.414  Sum_probs=158.2

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      .|.|.+|.||+|..  +++.||+|.++..       +.+|+.++++++||||+++++++.+  .+..++||||+++++|.
T Consensus        30 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~  107 (295)
T 2clq_A           30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE--NGFIKIFMEQVPGGSLS  107 (295)
T ss_dssp             EEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEEEECCSEEEHH
T ss_pred             EeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe--CCcEEEEEEeCCCCCHH
Confidence            47778899999997  6889999998532       3479999999999999999999987  67889999999999999


Q ss_pred             hhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECC-CCcEEEeeccCCccCCCC--cccccc
Q 037224          416 SWLHENKN-ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS-NMRAKIANFGLAKSGCNA--ITMHIV  491 (552)
Q Consensus       416 ~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kL~Dfg~a~~~~~~--~~~~~~  491 (552)
                      +++..... ..+++..+..++.|++.||.|||+++   ++||||||+||+++. ++.+||+|||++......  ......
T Consensus       108 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  184 (295)
T 2clq_A          108 ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT  184 (295)
T ss_dssp             HHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCC
T ss_pred             HHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccccC
Confidence            99976532 34778999999999999999999999   999999999999987 899999999999754322  223457


Q ss_pred             ccccccCccccCCCC--CCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          492 GTQGYIAPEYLADGV--VSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       492 gt~~y~aPE~~~~~~--~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      |++.|+|||.+.+..  ++.++||||||+++|||++|+.||...
T Consensus       185 ~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  228 (295)
T 2clq_A          185 GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL  228 (295)
T ss_dssp             CCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGG
T ss_pred             CCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCC
Confidence            899999999986643  788999999999999999999999754

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.97  E-value=2.3e-31  Score=269.32  Aligned_cols=185  Identities=30%  Similarity=0.465  Sum_probs=154.6

Q ss_pred             CCceEEEEEEEEee-------cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeec
Q 037224          345 EGCLIQGSVYKGNI-------HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI  409 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-------~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~  409 (552)
                      .|.|++|.||++++       +++.||+|++...        +.+|+.++++++||||+++++++.+  ....++||||+
T Consensus        38 lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~  115 (327)
T 2yfx_A           38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ--SLPRFILMELM  115 (327)
T ss_dssp             CC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEEECC
T ss_pred             EcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC--CCCcEEEEecC
Confidence            47777899999984       4668999998532        3479999999999999999999987  56679999999


Q ss_pred             cCCCchhhhhhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECC---CCcEEEeeccCCcc
Q 037224          410 ENGSLHSWLHENKN-----ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS---NMRAKIANFGLAKS  481 (552)
Q Consensus       410 ~~gsL~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kL~Dfg~a~~  481 (552)
                      ++++|.+++.....     ..+++.+++.++.|++.||.|||+++   ++||||||+|||++.   +..+||+|||++..
T Consensus       116 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~  192 (327)
T 2yfx_A          116 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD  192 (327)
T ss_dssp             TTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHHHH
T ss_pred             CCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEECccccccc
Confidence            99999999987542     34899999999999999999999999   999999999999984   44699999999863


Q ss_pred             CCC----CccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          482 GCN----AITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       482 ~~~----~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      ...    .......+++.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus       193 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  250 (327)
T 2yfx_A          193 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS  250 (327)
T ss_dssp             HHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             cccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC
Confidence            211    11223467889999999988899999999999999999998 999998654

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.97  E-value=4.1e-31  Score=272.42  Aligned_cols=181  Identities=27%  Similarity=0.422  Sum_probs=152.2

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCC----eeEEEEeec
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDA----NCYLIYEYI  409 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~----~~~lv~e~~  409 (552)
                      .|.|++|.||++..  +|+.||+|+++..         ..+|+.++++++||||+++++++......    ..++||||+
T Consensus        50 lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~  129 (371)
T 4exu_A           50 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM  129 (371)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECC
T ss_pred             EecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEccc
Confidence            37777899999987  6899999998642         34799999999999999999999763221    249999999


Q ss_pred             cCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcccc
Q 037224          410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH  489 (552)
Q Consensus       410 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  489 (552)
                      + ++|.+++..    .+++.+++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++..... ...
T Consensus       130 ~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-~~~  200 (371)
T 4exu_A          130 Q-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE-MTG  200 (371)
T ss_dssp             C-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC---------C
T ss_pred             c-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcccccccC-cCC
Confidence            8 588777632    3999999999999999999999999   999999999999999999999999999755432 334


Q ss_pred             ccccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          490 IVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||.+.+
T Consensus       201 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  246 (371)
T 4exu_A          201 YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD  246 (371)
T ss_dssp             TTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            678999999999877 778999999999999999999999998654

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.97  E-value=5.6e-31  Score=265.08  Aligned_cols=184  Identities=24%  Similarity=0.396  Sum_probs=154.7

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecC--CCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDP--EDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~~~lv~e~~~~gsL  414 (552)
                      |.|++|.||+++.  +|+.||+|++...       +.+|+.++++++||||+++++++...  .....++||||+++++|
T Consensus        38 g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L  117 (317)
T 2buj_A           38 GEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTL  117 (317)
T ss_dssp             EC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBH
T ss_pred             cCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcH
Confidence            7778899999986  7899999988432       34799999999999999999998742  23478999999999999


Q ss_pred             hhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc------
Q 037224          415 HSWLHEN--KNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI------  486 (552)
Q Consensus       415 ~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~------  486 (552)
                      .+++...  ....+++.+++.++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++.......      
T Consensus       118 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~  194 (317)
T 2buj_A          118 WNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQA  194 (317)
T ss_dssp             HHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHH
T ss_pred             HHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhccccccccccc
Confidence            9998763  2345999999999999999999999999   9999999999999999999999999987543211      


Q ss_pred             -----cccccccccccCccccCCCC---CCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          487 -----TMHIVGTQGYIAPEYLADGV---VSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       487 -----~~~~~gt~~y~aPE~~~~~~---~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                           .....||+.|+|||.+....   ++.++||||||+++|||++|+.||..
T Consensus       195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  248 (317)
T 2buj_A          195 LTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM  248 (317)
T ss_dssp             HHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred             ccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence                 11235689999999987544   68899999999999999999999964

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.97  E-value=2.5e-31  Score=269.02  Aligned_cols=184  Identities=33%  Similarity=0.487  Sum_probs=157.2

Q ss_pred             CceEEEEEEEEee------cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          346 GCLIQGSVYKGNI------HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       346 G~g~~G~Vy~~~~------~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      |.|++|.||++++      +++.||+|+++..       +.+|+.++++++|+||+++++++........++||||++++
T Consensus        50 g~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~  129 (326)
T 2w1i_A           50 GKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG  129 (326)
T ss_dssp             ECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTC
T ss_pred             ccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCC
Confidence            6677799999984      6889999998642       34799999999999999999998775555789999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc-----c
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI-----T  487 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-----~  487 (552)
                      +|.+++.... ..+++.+++.++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++.......     .
T Consensus       130 ~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~  205 (326)
T 2w1i_A          130 SLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK  205 (326)
T ss_dssp             BHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECS
T ss_pred             CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhccccccccccc
Confidence            9999997754 34899999999999999999999999   9999999999999999999999999997544322     1


Q ss_pred             ccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          488 MHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       488 ~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      ....++..|+|||.+.+..++.++||||||+++|||+||+.||...
T Consensus       206 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~  251 (326)
T 2w1i_A          206 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP  251 (326)
T ss_dssp             SCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSH
T ss_pred             cCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCC
Confidence            2235677899999998888999999999999999999999998743

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.97  E-value=7.3e-31  Score=260.53  Aligned_cols=181  Identities=33%  Similarity=0.482  Sum_probs=156.3

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|.+|.||+++.  +++.||+|+++..         ..+|+.++++++||||+++++++.+  ....+++|||+++++|
T Consensus        31 g~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L  108 (287)
T 2wei_A           31 GKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED--SSSFYIVGELYTGGEL  108 (287)
T ss_dssp             EEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEEECCCCSCBH
T ss_pred             cCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC--CCeEEEEEEccCCCCH
Confidence            6777799999988  6899999998432         3479999999999999999999987  6788999999999999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCC---CcEEEeeccCCccCCCC-ccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN---MRAKIANFGLAKSGCNA-ITMHI  490 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~---~~~kL~Dfg~a~~~~~~-~~~~~  490 (552)
                      .+++....  .+++.+++.++.|++.||.|||+++   ++||||||+||+++.+   +.+||+|||++...... .....
T Consensus       109 ~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~  183 (287)
T 2wei_A          109 FDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR  183 (287)
T ss_dssp             HHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCH
T ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeecCCCccccc
Confidence            99887654  4999999999999999999999999   9999999999999764   46999999998754322 22334


Q ss_pred             cccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       491 ~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .+++.|+|||.+.+ .++.++||||||+++|+|++|+.||.+.+
T Consensus       184 ~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~  226 (287)
T 2wei_A          184 IGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN  226 (287)
T ss_dssp             HHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC
Confidence            68899999998865 48899999999999999999999997654

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.97  E-value=9.4e-31  Score=277.83  Aligned_cols=183  Identities=25%  Similarity=0.322  Sum_probs=154.7

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEecc-----ChHHHHHHHHHcCCCCccc-eeeeeecCCCCeeEEEEeeccCCCchh
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKW-----NACEELKILQKVNHGNLVK-LEGFCIDPEDANCYLIYEYIENGSLHS  416 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~-----~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~~~lv~e~~~~gsL~~  416 (552)
                      .|.|.+|.||+++.  +++.||||+++.     ...+|+++++.++|.+.+. +..++..  ....++||||+ +++|.+
T Consensus        15 LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~--~~~~~lvme~~-g~sL~~   91 (483)
T 3sv0_A           15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVE--GDYNVLVMDLL-GPSLED   91 (483)
T ss_dssp             CEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEE--TTEEEEEEECC-CCBHHH
T ss_pred             EeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEee--CCEEEEEEECC-CCCHHH
Confidence            47788899999987  689999998743     4568999999998755554 4444444  66789999999 889999


Q ss_pred             hhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE---CCCCcEEEeeccCCccCCCCc-------
Q 037224          417 WLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL---DSNMRAKIANFGLAKSGCNAI-------  486 (552)
Q Consensus       417 ~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~~~~~~~-------  486 (552)
                      ++.... ..+++.+++.|+.||+.||+|||+++   |+||||||+|||+   +.++.+||+|||+++......       
T Consensus        92 ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~  167 (483)
T 3sv0_A           92 LFNFCS-RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPY  167 (483)
T ss_dssp             HHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCC
T ss_pred             HHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcccccccc
Confidence            997533 35999999999999999999999999   9999999999999   688999999999997433221       


Q ss_pred             --cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          487 --TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       487 --~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                        .....||+.|+|||.+.+..++.++||||||++||||++|+.||.+..
T Consensus       168 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~  217 (483)
T 3sv0_A          168 RENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK  217 (483)
T ss_dssp             CCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             ccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence              124678999999999999999999999999999999999999998744

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.97  E-value=3.3e-31  Score=272.87  Aligned_cols=184  Identities=23%  Similarity=0.368  Sum_probs=156.3

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC------hHHHHHHHHHcC-----------CCCccceeeeeecCC--CCeeEE
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN------ACEELKILQKVN-----------HGNLVKLEGFCIDPE--DANCYL  404 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~------~~~E~~~l~~l~-----------h~niv~l~~~~~~~~--~~~~~l  404 (552)
                      |.|++|.||+++.  +++.||+|+++..      ..+|+.++++++           |+||+++++++....  ....++
T Consensus        28 g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l  107 (373)
T 1q8y_A           28 GWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVM  107 (373)
T ss_dssp             EECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEE
T ss_pred             eecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEE
Confidence            6777799999986  7899999999744      347899988886           899999999987532  237899


Q ss_pred             EEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEC------CCCcEEEeecc
Q 037224          405 IYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEH-TRPRVVHKDIKSSNILLD------SNMRAKIANFG  477 (552)
Q Consensus       405 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~ivH~Dikp~NIll~------~~~~~kL~Dfg  477 (552)
                      +|||+ +++|.+++.......+++..++.++.|++.||+|||++ +   |+||||||+|||++      ..+.+||+|||
T Consensus       108 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg  183 (373)
T 1q8y_A          108 VFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLG  183 (373)
T ss_dssp             EECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEEECCCT
T ss_pred             EEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCcCcceEEEcccc
Confidence            99999 78999999876666699999999999999999999998 8   99999999999994      44589999999


Q ss_pred             CCccCCCCccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          478 LAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       478 ~a~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ++...... .....+|+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       184 ~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  239 (373)
T 1q8y_A          184 NACWYDEH-YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE  239 (373)
T ss_dssp             TCEETTBC-CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             cccccCCC-CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence            99765432 234578999999999999999999999999999999999999998655

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.97  E-value=3.1e-31  Score=267.67  Aligned_cols=182  Identities=25%  Similarity=0.350  Sum_probs=159.4

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC-------------hHHHHHHHHHcC--CCCccceeeeeecCCCCeeEEEEe
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN-------------ACEELKILQKVN--HGNLVKLEGFCIDPEDANCYLIYE  407 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------------~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~~~lv~e  407 (552)
                      .|.|++|.||++..  +++.||||+++..             ..+|+.++++++  |+||+++++++.+  ....++++|
T Consensus        51 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~--~~~~~lv~e  128 (320)
T 3a99_A           51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER--PDSFVLILE  128 (320)
T ss_dssp             CSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--SSEEEEEEE
T ss_pred             EeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec--CCcEEEEEE
Confidence            37777899999987  7899999998532             337999999996  5999999999987  678899999


Q ss_pred             eccC-CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEC-CCCcEEEeeccCCccCCCC
Q 037224          408 YIEN-GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLD-SNMRAKIANFGLAKSGCNA  485 (552)
Q Consensus       408 ~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~-~~~~~kL~Dfg~a~~~~~~  485 (552)
                      ++.+ ++|.+++....  .+++..++.++.|++.||+|||+.+   |+||||||+|||++ +++.+||+|||++......
T Consensus       129 ~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~  203 (320)
T 3a99_A          129 RPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT  203 (320)
T ss_dssp             CCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCSS
T ss_pred             cCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCccccccccc
Confidence            9986 89999987654  4899999999999999999999999   99999999999998 7899999999999876655


Q ss_pred             ccccccccccccCccccCCCCC-CChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          486 ITMHIVGTQGYIAPEYLADGVV-STKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       486 ~~~~~~gt~~y~aPE~~~~~~~-s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||...
T Consensus       204 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  252 (320)
T 3a99_A          204 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD  252 (320)
T ss_dssp             CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred             cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence            5555679999999999876665 67899999999999999999999754

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.97  E-value=3e-31  Score=263.33  Aligned_cols=181  Identities=23%  Similarity=0.365  Sum_probs=143.1

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccCh---------HHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWNA---------CEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~~---------~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|++|.||+++.  +|+.||+|+++...         .++...++.++||||+++++++.+  ++..++||||+++ +|
T Consensus        16 g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~--~~~~~lv~e~~~~-~l   92 (290)
T 3fme_A           16 GRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR--EGDVWICMELMDT-SL   92 (290)
T ss_dssp             EECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSSEEEEEECCSE-EH
T ss_pred             CCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec--cCCEEEEEehhcc-ch
Confidence            6777799999998  78999999986431         133444677799999999999987  6678999999985 88


Q ss_pred             hhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-ccccc
Q 037224          415 HSWLHEN--KNENLNWKTRLRIAIDVANGLQYIHEH-TRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-ITMHI  490 (552)
Q Consensus       415 ~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-~~~~~  490 (552)
                      .+++...  ....+++..++.++.|++.||+|||++ +   ++||||||+||+++.++.+||+|||++...... .....
T Consensus        93 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  169 (290)
T 3fme_A           93 DKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID  169 (290)
T ss_dssp             HHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC---------------
T ss_pred             HHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccccccccccc
Confidence            8877542  234599999999999999999999998 8   999999999999999999999999999754332 22334


Q ss_pred             cccccccCcccc----CCCCCCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          491 VGTQGYIAPEYL----ADGVVSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       491 ~gt~~y~aPE~~----~~~~~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                      .||+.|+|||.+    .+..++.++||||||+++|||++|+.||..
T Consensus       170 ~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  215 (290)
T 3fme_A          170 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS  215 (290)
T ss_dssp             CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred             CCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence            789999999995    566789999999999999999999999975

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.97  E-value=2.1e-31  Score=266.21  Aligned_cols=183  Identities=24%  Similarity=0.416  Sum_probs=153.9

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchh
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHS  416 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~  416 (552)
                      |.|++|.||+++.  +++.||+|+++..       +.+|+.++++++||||+++++++.+  +...++||||+++++|.+
T Consensus        28 g~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~l~~  105 (302)
T 2j7t_A           28 GDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH--DGKLWIMIEFCPGGAVDA  105 (302)
T ss_dssp             ECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--C-CEEEEEECCTTEEHHH
T ss_pred             ccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee--CCeEEEEEEeCCCCcHHH
Confidence            6666799999998  5889999998532       3479999999999999999999987  667899999999999999


Q ss_pred             hhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC--Cccccccccc
Q 037224          417 WLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN--AITMHIVGTQ  494 (552)
Q Consensus       417 ~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~--~~~~~~~gt~  494 (552)
                      ++.... ..+++.+++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.....  .......+++
T Consensus       106 ~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~  181 (302)
T 2j7t_A          106 IMLELD-RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTP  181 (302)
T ss_dssp             HHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-----CCG
T ss_pred             HHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccccccccccCCh
Confidence            887543 34999999999999999999999999   99999999999999999999999998752211  1122356899


Q ss_pred             cccCcccc-----CCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          495 GYIAPEYL-----ADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       495 ~y~aPE~~-----~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .|+|||.+     ....++.++||||||+++|||++|+.||...+
T Consensus       182 ~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  226 (302)
T 2j7t_A          182 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN  226 (302)
T ss_dssp             GGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             hhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence            99999987     46778999999999999999999999998644

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.97  E-value=1.3e-30  Score=267.17  Aligned_cols=187  Identities=21%  Similarity=0.337  Sum_probs=147.1

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC------hHHHHHHHHHcCCCCccceeeeeecCCC-----CeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN------ACEELKILQKVNHGNLVKLEGFCIDPED-----ANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~~~~lv~e~~~~  411 (552)
                      .|.|++|.||+++.  +|+.||||++..+      ..+|+..+..++||||+++++++.....     ...++||||+++
T Consensus        31 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~  110 (360)
T 3e3p_A           31 AGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD  110 (360)
T ss_dssp             --------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC
T ss_pred             EecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccc
Confidence            48888999999997  5899999988433      3467778888999999999999865222     237899999987


Q ss_pred             CCchhhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCceEecCCCCCcEEECC-CCcEEEeeccCCccCCCC-
Q 037224          412 GSLHSWLHE--NKNENLNWKTRLRIAIDVANGLQYIH--EHTRPRVVHKDIKSSNILLDS-NMRAKIANFGLAKSGCNA-  485 (552)
Q Consensus       412 gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~~~~ivH~Dikp~NIll~~-~~~~kL~Dfg~a~~~~~~-  485 (552)
                       +|.+.+..  .....+++..+..++.|++.||.|||  +.+   |+||||||+|||++. ++.+||+|||+++..... 
T Consensus       111 -~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~  186 (360)
T 3e3p_A          111 -TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE  186 (360)
T ss_dssp             -BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTS
T ss_pred             -cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCC
Confidence             55544432  22345899999999999999999999  888   999999999999986 899999999999854432 


Q ss_pred             ccccccccccccCccccCCCC-CCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          486 ITMHIVGTQGYIAPEYLADGV-VSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       486 ~~~~~~gt~~y~aPE~~~~~~-~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||...+.
T Consensus       187 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~  237 (360)
T 3e3p_A          187 PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS  237 (360)
T ss_dssp             CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh
Confidence            233457899999999986544 89999999999999999999999987653

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.97  E-value=1.1e-30  Score=270.16  Aligned_cols=184  Identities=23%  Similarity=0.332  Sum_probs=158.0

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccCh------HHHHHHHHHcC-CC-----CccceeeeeecCCCCeeEEEEeecc
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWNA------CEELKILQKVN-HG-----NLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~~------~~E~~~l~~l~-h~-----niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      .|.|++|.||++..  +++.||||+++...      .+|+.+++.++ |+     +++++++++..  ....++||||++
T Consensus        62 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~--~~~~~lv~e~~~  139 (382)
T 2vx3_A           62 IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF--RNHLCLVFEMLS  139 (382)
T ss_dssp             EEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE--TTEEEEEEECCC
T ss_pred             EeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc--CCceEEEEecCC
Confidence            37788899999987  68899999997542      35888888885 44     38999999887  678899999996


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCCCceEecCCCCCcEEEC--CCCcEEEeeccCCccCCCCc
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHE--HTRPRVVHKDIKSSNILLD--SNMRAKIANFGLAKSGCNAI  486 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~~~~ivH~Dikp~NIll~--~~~~~kL~Dfg~a~~~~~~~  486 (552)
                      + +|.+++.......+++..++.++.|++.||.|||+  .+   |+||||||+|||++  .++.+||+|||+++..... 
T Consensus       140 ~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~-  214 (382)
T 2vx3_A          140 Y-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-  214 (382)
T ss_dssp             C-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC-
T ss_pred             C-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEeccCceecccc-
Confidence            5 99999987765669999999999999999999994  56   99999999999994  5778999999999865432 


Q ss_pred             cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          487 TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       487 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      .....+|+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus       215 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~  263 (382)
T 2vx3_A          215 IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE  263 (382)
T ss_dssp             CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            3346789999999999999999999999999999999999999987654

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.97  E-value=7.1e-31  Score=268.42  Aligned_cols=182  Identities=27%  Similarity=0.388  Sum_probs=154.9

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCC---CCeeEEEEeeccCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPE---DANCYLIYEYIENG  412 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~---~~~~~lv~e~~~~g  412 (552)
                      |.|++|.||++..  +|+.||||+++..        ..+|+.++++++|+||+++++++....   ....+++|||++ +
T Consensus        20 g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~   98 (353)
T 2b9h_A           20 GEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-T   98 (353)
T ss_dssp             EECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-E
T ss_pred             cCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-c
Confidence            6777799999998  5899999998532        247999999999999999999886521   357899999997 5


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc------
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI------  486 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~------  486 (552)
                      +|.+++...   .+++..++.++.|++.||+|||+++   ++||||||+|||++.++.+||+|||++.......      
T Consensus        99 ~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  172 (353)
T 2b9h_A           99 DLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP  172 (353)
T ss_dssp             EHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC---------
T ss_pred             cHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccccccccccccCc
Confidence            899988764   4999999999999999999999999   9999999999999999999999999997543211      


Q ss_pred             ------cccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          487 ------TMHIVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       487 ------~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                            .....||+.|+|||.+.. ..++.++||||||+++|||++|+.||.+.+
T Consensus       173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  227 (353)
T 2b9h_A          173 TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD  227 (353)
T ss_dssp             -------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                  112468999999998754 778999999999999999999999998654

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.97  E-value=8.1e-31  Score=268.24  Aligned_cols=181  Identities=27%  Similarity=0.419  Sum_probs=152.7

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCC----CeeEEEEeec
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPED----ANCYLIYEYI  409 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~~~lv~e~~  409 (552)
                      .|.|++|.||++..  +|+.||||+++..         ..+|+.++++++||||+++++++.....    ..++++|||+
T Consensus        32 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~  111 (353)
T 3coi_A           32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM  111 (353)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC
T ss_pred             EecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEeccc
Confidence            37777899999987  6899999998542         3479999999999999999999876322    2359999999


Q ss_pred             cCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcccc
Q 037224          410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH  489 (552)
Q Consensus       410 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  489 (552)
                      + ++|.+++..    .+++.+++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++...... ...
T Consensus       112 ~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-~~~  182 (353)
T 3coi_A          112 Q-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE-MTG  182 (353)
T ss_dssp             S-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC--------
T ss_pred             c-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCCCCC-ccc
Confidence            8 588887743    3899999999999999999999999   999999999999999999999999999764432 334


Q ss_pred             ccccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          490 IVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||.+.+
T Consensus       183 ~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  228 (353)
T 3coi_A          183 YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD  228 (353)
T ss_dssp             -CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred             cccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            578999999999876 678999999999999999999999998765

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.97  E-value=1.2e-31  Score=267.72  Aligned_cols=185  Identities=25%  Similarity=0.401  Sum_probs=147.0

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      .|.|++|.||++..  +++.||+|++...        ..+|+.++++++||||+++++++..  .+..++||||+++++|
T Consensus        23 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L  100 (303)
T 2vwi_A           23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV--KDELWLVMKLLSGGSV  100 (303)
T ss_dssp             CC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEES--SSCEEEEEECCTTCBH
T ss_pred             eccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee--cCCcEEEehhccCCch
Confidence            47778899999987  7899999988532        3478889999999999999999987  5678999999999999


Q ss_pred             hhhhhhc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC---
Q 037224          415 HSWLHEN------KNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA---  485 (552)
Q Consensus       415 ~~~l~~~------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~---  485 (552)
                      .+++...      ....+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++......   
T Consensus       101 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  177 (303)
T 2vwi_A          101 LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDI  177 (303)
T ss_dssp             HHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHHCC-----
T ss_pred             HHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchheeccCCCc
Confidence            9998641      2345899999999999999999999999   999999999999999999999999988643211   


Q ss_pred             ----ccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          486 ----ITMHIVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       486 ----~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                          ......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus       178 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  231 (303)
T 2vwi_A          178 TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP  231 (303)
T ss_dssp             ----------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             cchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCc
Confidence                1223568999999999865 568999999999999999999999998643

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.97  E-value=5.6e-31  Score=266.92  Aligned_cols=186  Identities=24%  Similarity=0.356  Sum_probs=141.4

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC-------hHHHHHHHHHcC-CCCccceeeeeec------CCCCeeEEEEeec
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN-------ACEELKILQKVN-HGNLVKLEGFCID------PEDANCYLIYEYI  409 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------~~~E~~~l~~l~-h~niv~l~~~~~~------~~~~~~~lv~e~~  409 (552)
                      |.|.+|.||+++.  +++.||+|++...       ..+|+.++.++. ||||+++++++..      .....++++|||+
T Consensus        37 g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~  116 (337)
T 3ll6_A           37 AEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELC  116 (337)
T ss_dssp             ECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECC
T ss_pred             ccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEec
Confidence            6777799999998  7899999988432       347999999995 9999999999852      2244679999999


Q ss_pred             cCCCchhhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcc-
Q 037224          410 ENGSLHSWLHEN-KNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT-  487 (552)
Q Consensus       410 ~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~-  487 (552)
                      + |+|.+++... ....+++.+++.++.|++.||.|||+++ ++++||||||+|||++.++.+||+|||++........ 
T Consensus       117 ~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  194 (337)
T 3ll6_A          117 K-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDY  194 (337)
T ss_dssp             S-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC--
T ss_pred             C-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCccceeccccCcc
Confidence            6 6999888652 2245999999999999999999999875 3499999999999999999999999999975432211 


Q ss_pred             -------------ccccccccccCcccc---CCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          488 -------------MHIVGTQGYIAPEYL---ADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       488 -------------~~~~gt~~y~aPE~~---~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                                   ....+|+.|+|||.+   .+..++.++||||||+++|||++|+.||.+.
T Consensus       195 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~  256 (337)
T 3ll6_A          195 SWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG  256 (337)
T ss_dssp             -----------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             cccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence                         134589999999998   5677889999999999999999999999754

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.97  E-value=1.9e-30  Score=265.04  Aligned_cols=183  Identities=23%  Similarity=0.359  Sum_probs=157.5

Q ss_pred             CceEEEEEEEEee--cC-cEEEEEEeccC------hHHHHHHHHHcCCCC------ccceeeeeecCCCCeeEEEEeecc
Q 037224          346 GCLIQGSVYKGNI--HG-EVYAIKMMKWN------ACEELKILQKVNHGN------LVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g-~~vAvK~~~~~------~~~E~~~l~~l~h~n------iv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      |.|.+|.||++..  .+ +.||+|+++..      ..+|+.++++++|++      ++.+.+++..  .+..++||||+ 
T Consensus        28 g~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~--~~~~~lv~e~~-  104 (355)
T 2eu9_A           28 GEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF--HGHMCIAFELL-  104 (355)
T ss_dssp             EEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE--TTEEEEEEECC-
T ss_pred             eccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee--CCeEEEEEecc-
Confidence            7777899999987  34 78999999753      346899999997766      8888888877  67889999999 


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE-------------------CCCCcE
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL-------------------DSNMRA  471 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll-------------------~~~~~~  471 (552)
                      +++|.+++.......+++.+++.++.|++.||+|||+++   |+||||||+|||+                   +.++.+
T Consensus       105 ~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~  181 (355)
T 2eu9_A          105 GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSI  181 (355)
T ss_dssp             CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCE
T ss_pred             CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccccccccCCCcE
Confidence            567878777665556999999999999999999999998   9999999999999                   567899


Q ss_pred             EEeeccCCccCCCCccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          472 KIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       472 kL~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      ||+|||++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+.
T Consensus       182 kl~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  244 (355)
T 2eu9_A          182 RVADFGSATFDHEH-HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN  244 (355)
T ss_dssp             EECCCTTCEETTSC-CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             EEeecCcccccccc-ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence            99999999764432 2346789999999999999999999999999999999999999987653

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.97  E-value=7.1e-31  Score=260.75  Aligned_cols=183  Identities=28%  Similarity=0.409  Sum_probs=148.7

Q ss_pred             CCceEEEEEEEEee---cCc--EEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeec
Q 037224          345 EGCLIQGSVYKGNI---HGE--VYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI  409 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~---~g~--~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~  409 (552)
                      .|.|.+|.||++++   +++  .||+|+++..          +.+|+.++++++||||+++++++.+.   ..++++||+
T Consensus        26 lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~v~e~~  102 (291)
T 1u46_A           26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---PMKMVTELA  102 (291)
T ss_dssp             CC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---SCEEEEECC
T ss_pred             ecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC---CceeeEecc
Confidence            47788899999986   223  6899988532          24799999999999999999998762   368999999


Q ss_pred             cCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc---
Q 037224          410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI---  486 (552)
Q Consensus       410 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~---  486 (552)
                      ++++|.+++.... ..+++.+++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++.......   
T Consensus       103 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  178 (291)
T 1u46_A          103 PLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY  178 (291)
T ss_dssp             TTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEE
T ss_pred             cCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccccccccch
Confidence            9999999997653 24899999999999999999999999   9999999999999999999999999997543221   


Q ss_pred             --cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          487 --TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       487 --~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                        .....++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~  229 (291)
T 1u46_A          179 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN  229 (291)
T ss_dssp             EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             hhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC
Confidence              123456778999999988889999999999999999999 999997643

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.97  E-value=1.4e-30  Score=262.05  Aligned_cols=184  Identities=26%  Similarity=0.414  Sum_probs=150.6

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecC------------CCCeeE
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDP------------EDANCY  403 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~------------~~~~~~  403 (552)
                      .|.|++|.||++..  +++.||+|++...       ..+|+.++++++||||+++++++...            .....+
T Consensus        19 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~   98 (320)
T 2i6l_A           19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVY   98 (320)
T ss_dssp             CC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEE
T ss_pred             eccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCcee
Confidence            47888899999998  4899999988532       34799999999999999999987432            246789


Q ss_pred             EEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEC-CCCcEEEeeccCCccC
Q 037224          404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLD-SNMRAKIANFGLAKSG  482 (552)
Q Consensus       404 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~-~~~~~kL~Dfg~a~~~  482 (552)
                      +||||++ ++|.+++...   .+++..++.++.|++.||+|||+++   ++||||||+||+++ +++.+||+|||+++..
T Consensus        99 lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~  171 (320)
T 2i6l_A           99 IVQEYME-TDLANVLEQG---PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIM  171 (320)
T ss_dssp             EEEECCS-EEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEECCCTTCBCC
T ss_pred             EEeeccC-CCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEccCcccccc
Confidence            9999998 5999988653   4899999999999999999999999   99999999999997 5679999999999754


Q ss_pred             CCC-----ccccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          483 CNA-----ITMHIVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       483 ~~~-----~~~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      ...     ......++..|+|||.+.. ..++.++||||||+++|||++|+.||.....
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  230 (320)
T 2i6l_A          172 DPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE  230 (320)
T ss_dssp             --------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             CCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH
Confidence            321     1223467889999998765 6789999999999999999999999987653

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.97  E-value=5.6e-31  Score=264.54  Aligned_cols=181  Identities=25%  Similarity=0.366  Sum_probs=155.5

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC-------------hHHHHHHHHHc----CCCCccceeeeeecCCCCeeEEEE
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN-------------ACEELKILQKV----NHGNLVKLEGFCIDPEDANCYLIY  406 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------------~~~E~~~l~~l----~h~niv~l~~~~~~~~~~~~~lv~  406 (552)
                      |.|++|.||++..  +++.||+|+++..             ..+|+.++.++    +|+||+++++++.+  .+..++++
T Consensus        40 g~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~--~~~~~~v~  117 (312)
T 2iwi_A           40 GKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET--QEGFMLVL  117 (312)
T ss_dssp             EEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-------CEEEE
T ss_pred             EcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec--CCeEEEEE
Confidence            7777899999987  7889999998532             23699999999    89999999999876  56779999


Q ss_pred             ee-ccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEC-CCCcEEEeeccCCccCCC
Q 037224          407 EY-IENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLD-SNMRAKIANFGLAKSGCN  484 (552)
Q Consensus       407 e~-~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~-~~~~~kL~Dfg~a~~~~~  484 (552)
                      |+ +.+++|.+++....  .+++..++.++.|++.||+|||+++   ++||||||+||+++ .++.+||+|||++.....
T Consensus       118 e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~  192 (312)
T 2iwi_A          118 ERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHD  192 (312)
T ss_dssp             ECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEECCCSSCEECCS
T ss_pred             EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEEEcchhhhccc
Confidence            99 78899999997654  4999999999999999999999999   99999999999998 889999999999986665


Q ss_pred             CccccccccccccCccccCCCCC-CChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          485 AITMHIVGTQGYIAPEYLADGVV-STKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       485 ~~~~~~~gt~~y~aPE~~~~~~~-s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      .......++..|+|||.+.+..+ +.++||||||+++|||++|+.||...
T Consensus       193 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  242 (312)
T 2iwi_A          193 EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD  242 (312)
T ss_dssp             SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred             CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh
Confidence            55556778999999999876665 45899999999999999999999754

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.97  E-value=5.1e-31  Score=265.49  Aligned_cols=182  Identities=27%  Similarity=0.397  Sum_probs=152.5

Q ss_pred             CCceEEEEEEEEeecCcEEEEEEecc---------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          345 EGCLIQGSVYKGNIHGEVYAIKMMKW---------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~g~~vAvK~~~~---------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      .|.|++|.||+++..+. +|+|+++.         .+.+|+.++++++|+||+++++++.+  ....+++|||+++++|.
T Consensus        41 lg~G~~g~V~~~~~~~~-~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~iv~e~~~~~~L~  117 (319)
T 2y4i_B           41 IGKGRFGQVYHGRWHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS--PPHLAIITSLCKGRTLY  117 (319)
T ss_dssp             CCCSSSSEEEEEEESSS-EEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC--SSCEEEECBCCCSEEHH
T ss_pred             eccCCceEEEEEEEcCe-EEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec--CCceEEEeecccCCcHH
Confidence            37777899999998664 89999853         23479999999999999999999987  56789999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC-------CCccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC-------NAITM  488 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~-------~~~~~  488 (552)
                      +++.... ..+++.+++.++.|++.||+|||+++   ++||||||+||+++ ++.+||+|||++....       .....
T Consensus       118 ~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  192 (319)
T 2y4i_B          118 SVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLR  192 (319)
T ss_dssp             HHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCB
T ss_pred             HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccc
Confidence            9997643 35899999999999999999999999   99999999999998 6799999999976432       11222


Q ss_pred             cccccccccCccccCC---------CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          489 HIVGTQGYIAPEYLAD---------GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       489 ~~~gt~~y~aPE~~~~---------~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ...|++.|+|||.+..         ..++.++||||||+++|||++|+.||....
T Consensus       193 ~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~  247 (319)
T 2y4i_B          193 IQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP  247 (319)
T ss_dssp             CCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC
T ss_pred             cCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            3468899999999864         457889999999999999999999998654

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.97  E-value=2.1e-30  Score=258.46  Aligned_cols=176  Identities=29%  Similarity=0.493  Sum_probs=147.0

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC------hHHHHHHHHHcCCCCccceeeeeecCC-----------CCeeEEEE
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN------ACEELKILQKVNHGNLVKLEGFCIDPE-----------DANCYLIY  406 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~~-----------~~~~~lv~  406 (552)
                      |.|.+|.||+++.  +++.||+|+++..      ..+|+.++++++||||+++++++.+..           ....++||
T Consensus        15 g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~   94 (303)
T 1zy4_A           15 GQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQM   94 (303)
T ss_dssp             EECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEE
T ss_pred             ccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEE
Confidence            6777799999987  7899999998643      347999999999999999999886532           35679999


Q ss_pred             eeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC--
Q 037224          407 EYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN--  484 (552)
Q Consensus       407 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~--  484 (552)
                      ||+++++|.+++.... ..+++.+++.++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++.....  
T Consensus        95 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  170 (303)
T 1zy4_A           95 EYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSL  170 (303)
T ss_dssp             ECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCCCSCTTC--
T ss_pred             ecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEeeCcchhhccccc
Confidence            9999999999997643 34788999999999999999999999   99999999999999999999999999875431  


Q ss_pred             --------------CccccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHc
Q 037224          485 --------------AITMHIVGTQGYIAPEYLADG-VVSTKMDVFSFGVVLLELIS  525 (552)
Q Consensus       485 --------------~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slG~il~ellt  525 (552)
                                    .......+++.|+|||.+.+. .++.++||||||+++|||++
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~  226 (303)
T 1zy4_A          171 DILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY  226 (303)
T ss_dssp             -----------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred             chhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence                          112235689999999998754 68999999999999999998

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.97  E-value=2.6e-30  Score=261.46  Aligned_cols=183  Identities=24%  Similarity=0.413  Sum_probs=136.6

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccCh--------HHHHH-HHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWNA--------CEELK-ILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~~--------~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      .|.|++|.||++..  +|+.||+|+++...        .+|+. +++.++||||+++++++.+  ++..++||||+++ +
T Consensus        30 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~--~~~~~lv~e~~~~-~  106 (327)
T 3aln_A           30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR--EGDCWICMELMST-S  106 (327)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC--SSEEEEEECCCSE-E
T ss_pred             eccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe--CCceEEEEeecCC-C
Confidence            37777899999998  58999999986431        23444 5666799999999999987  6788999999986 8


Q ss_pred             chhhhhh---cCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc-cc
Q 037224          414 LHSWLHE---NKNENLNWKTRLRIAIDVANGLQYIHEH-TRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI-TM  488 (552)
Q Consensus       414 L~~~l~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-~~  488 (552)
                      |.+++..   .....+++..+..++.|++.||.|||+. +   ++||||||+||+++.++.+||+|||+++...... ..
T Consensus       107 l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  183 (327)
T 3aln_A          107 FDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKT  183 (327)
T ss_dssp             HHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC--------
T ss_pred             hHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecccccccc
Confidence            8777653   2234599999999999999999999998 8   9999999999999999999999999997543322 22


Q ss_pred             cccccccccCcccc----CCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          489 HIVGTQGYIAPEYL----ADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       489 ~~~gt~~y~aPE~~----~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      ...|++.|+|||.+    .+..++.++||||||+++|||++|+.||...
T Consensus       184 ~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  232 (327)
T 3aln_A          184 RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW  232 (327)
T ss_dssp             ----------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC
T ss_pred             cCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence            34789999999998    4567899999999999999999999999753

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.97  E-value=2.2e-30  Score=285.51  Aligned_cols=182  Identities=26%  Similarity=0.364  Sum_probs=154.5

Q ss_pred             CceEEEEEEEEeec-----CcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          346 GCLIQGSVYKGNIH-----GEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       346 G~g~~G~Vy~~~~~-----g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      |.|++|.||+|.+.     +..||+|.++..        +.+|+.++++++||||+++++++.   ++..++||||+++|
T Consensus       399 G~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~---~~~~~lv~E~~~~g  475 (656)
T 2j0j_A          399 GEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT---ENPVWIIMELCTLG  475 (656)
T ss_dssp             ECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC---SSSCEEEEECCTTC
T ss_pred             eeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe---cCceEEEEEcCCCC
Confidence            77778999999872     457999998642        347999999999999999999984   34579999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc---ccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI---TMH  489 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~---~~~  489 (552)
                      +|.+++.... ..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++......   ...
T Consensus       476 ~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~  551 (656)
T 2j0j_A          476 ELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK  551 (656)
T ss_dssp             BHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC--------
T ss_pred             cHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecCCCcceeccC
Confidence            9999997653 34899999999999999999999999   9999999999999999999999999998543322   122


Q ss_pred             ccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      ..+++.|+|||.+.+..++.++||||||+++|||++ |+.||.+..
T Consensus       552 ~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~  597 (656)
T 2j0j_A          552 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK  597 (656)
T ss_dssp             --CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             CCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC
Confidence            456789999999988899999999999999999997 999998654

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.97  E-value=6.7e-30  Score=257.09  Aligned_cols=182  Identities=24%  Similarity=0.392  Sum_probs=137.5

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccCh---------HHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWNA---------CEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~~---------~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      .|.|.+|.||++..  +|+.||+|+++...         .++..+++.++||||+++++++.+  +...++||||+ ++.
T Consensus        33 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~--~~~~~lv~e~~-~~~  109 (318)
T 2dyl_A           33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT--NTDVFIAMELM-GTC  109 (318)
T ss_dssp             C------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEEEECCC-SEE
T ss_pred             eeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec--CCcEEEEEecc-CCc
Confidence            47888899999998  68999999986431         133446777899999999999987  66889999999 434


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC-Ccccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEH-TRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN-AITMHIV  491 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~-~~~~~~~  491 (552)
                      +..+. ......+++..++.++.|++.||.|||++ +   ++||||||+||+++.++.+||+|||++..... .......
T Consensus       110 ~~~l~-~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  185 (318)
T 2dyl_A          110 AEKLK-KRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA  185 (318)
T ss_dssp             HHHHH-HHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-------------
T ss_pred             HHHHH-HHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCCccccccC
Confidence            44443 33334599999999999999999999995 8   99999999999999999999999999864432 2223457


Q ss_pred             ccccccCccccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          492 GTQGYIAPEYLA-----DGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       492 gt~~y~aPE~~~-----~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      +++.|+|||.+.     ...++.++||||||+++|||++|+.||...
T Consensus       186 ~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  232 (318)
T 2dyl_A          186 GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC  232 (318)
T ss_dssp             -CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             CCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCC
Confidence            899999999984     566889999999999999999999999863

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.97  E-value=1.7e-30  Score=273.42  Aligned_cols=182  Identities=26%  Similarity=0.440  Sum_probs=144.5

Q ss_pred             CceEEEEEEE-EeecCcEEEEEEeccC----hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccCCCchhhhh
Q 037224          346 GCLIQGSVYK-GNIHGEVYAIKMMKWN----ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLH  419 (552)
Q Consensus       346 G~g~~G~Vy~-~~~~g~~vAvK~~~~~----~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~  419 (552)
                      |.|++|+||. +..+|+.||||++..+    ..+|+.+++++ +||||+++++++.+  +...++||||++ |+|.+++.
T Consensus        24 G~G~~g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~~~lv~E~~~-gsL~~~l~  100 (434)
T 2rio_A           24 GYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETT--DRFLYIALELCN-LNLQDLVE  100 (434)
T ss_dssp             EECSTTCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEEEEECCCS-EEHHHHHH
T ss_pred             eeCCCeEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEec--CCeEEEEEecCC-CCHHHHHh
Confidence            7777799864 4558999999998654    34799999987 89999999999876  678899999996 59999997


Q ss_pred             hcCCCC-----CCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCC-------------CcEEEeeccCCcc
Q 037224          420 ENKNEN-----LNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN-------------MRAKIANFGLAKS  481 (552)
Q Consensus       420 ~~~~~~-----l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~-------------~~~kL~Dfg~a~~  481 (552)
                      ......     .++..++.++.|++.||+|||+++   |+||||||+|||++.+             +.+||+|||++..
T Consensus       101 ~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~  177 (434)
T 2rio_A          101 SKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK  177 (434)
T ss_dssp             TC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEE
T ss_pred             ccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEEccccccee
Confidence            654311     133456789999999999999999   9999999999999654             4899999999975


Q ss_pred             CCCCc------cccccccccccCccccCC-------CCCCChhhHHHHHHHHHHHHc-CCCCCCcc
Q 037224          482 GCNAI------TMHIVGTQGYIAPEYLAD-------GVVSTKMDVFSFGVVLLELIS-GKEAIDEE  533 (552)
Q Consensus       482 ~~~~~------~~~~~gt~~y~aPE~~~~-------~~~s~~~Dv~slG~il~ellt-G~~pf~~~  533 (552)
                      .....      .....||+.|+|||++.+       ..++.++|||||||++|||++ |+.||.+.
T Consensus       178 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~  243 (434)
T 2rio_A          178 LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK  243 (434)
T ss_dssp             CCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred             cCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence            43321      123579999999999865       668999999999999999999 99999754

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.97  E-value=2.8e-30  Score=271.15  Aligned_cols=181  Identities=27%  Similarity=0.423  Sum_probs=147.6

Q ss_pred             CceEEEE-EEEEeecCcEEEEEEeccC----hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccCCCchhhhh
Q 037224          346 GCLIQGS-VYKGNIHGEVYAIKMMKWN----ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLH  419 (552)
Q Consensus       346 G~g~~G~-Vy~~~~~g~~vAvK~~~~~----~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~  419 (552)
                      |.|++|+ ||++..+|+.||||++..+    ..+|+.+++++ +||||+++++++.+  ....++||||++ |+|.+++.
T Consensus        33 G~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~--~~~~~lv~E~~~-g~L~~~l~  109 (432)
T 3p23_A           33 GHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKD--RQFQYIAIELCA-ATLQEYVE  109 (432)
T ss_dssp             EECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEE--TTEEEEEEECCS-EEHHHHHH
T ss_pred             ecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEec--CCEEEEEEECCC-CCHHHHHH
Confidence            6777787 5666779999999998643    46899999999 89999999999887  678899999997 59999987


Q ss_pred             hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECC-----CCcEEEeeccCCccCCCC-----cccc
Q 037224          420 ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS-----NMRAKIANFGLAKSGCNA-----ITMH  489 (552)
Q Consensus       420 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~-----~~~~kL~Dfg~a~~~~~~-----~~~~  489 (552)
                      .... .+.+.+++.++.|++.||+|||+++   |+||||||+|||++.     ...+||+|||+++.....     ....
T Consensus       110 ~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~  185 (432)
T 3p23_A          110 QKDF-AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG  185 (432)
T ss_dssp             SSSC-CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------
T ss_pred             hcCC-CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccc
Confidence            6543 3555567899999999999999999   999999999999953     335889999999754322     2234


Q ss_pred             ccccccccCccccC---CCCCCChhhHHHHHHHHHHHHc-CCCCCCcc
Q 037224          490 IVGTQGYIAPEYLA---DGVVSTKMDVFSFGVVLLELIS-GKEAIDEE  533 (552)
Q Consensus       490 ~~gt~~y~aPE~~~---~~~~s~~~Dv~slG~il~ellt-G~~pf~~~  533 (552)
                      ..||+.|+|||++.   ...++.++|||||||++|||++ |+.||...
T Consensus       186 ~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~  233 (432)
T 3p23_A          186 VPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS  233 (432)
T ss_dssp             CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST
T ss_pred             cCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh
Confidence            57999999999987   4567889999999999999999 99999654

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.96  E-value=7.5e-30  Score=256.49  Aligned_cols=179  Identities=28%  Similarity=0.448  Sum_probs=149.2

Q ss_pred             CceEEEEEEEEee-cCcEEEEEEeccC---------hHHHHHHHHHcC--CCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI-HGEVYAIKMMKWN---------ACEELKILQKVN--HGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~-~g~~vAvK~~~~~---------~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|.+|.||++.. +++.||+|+++..         +.+|+.++.+++  |+||+++++++.+  +...+++|| +.+++
T Consensus        37 g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--~~~~~lv~e-~~~~~  113 (313)
T 3cek_A           37 GSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYIYMVME-CGNID  113 (313)
T ss_dssp             ECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC--SSEEEEEEC-CCSEE
T ss_pred             cCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec--CCEEEEEEe-cCCCc
Confidence            6777799999988 6889999998532         347999999997  5999999999987  668899999 56779


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc----ccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI----TMH  489 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~----~~~  489 (552)
                      |.+++....  .+++.+++.++.|+++||.|||+++   ++||||||+||++++ +.+||+|||++.......    ...
T Consensus       114 L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~  187 (313)
T 3cek_A          114 LNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDS  187 (313)
T ss_dssp             HHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC------------
T ss_pred             HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccccCccccccccC
Confidence            999998654  4899999999999999999999999   999999999999964 899999999997543221    223


Q ss_pred             ccccccccCccccCC-----------CCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          490 IVGTQGYIAPEYLAD-----------GVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~-----------~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      ..|++.|+|||.+.+           ..++.++||||||+++|||++|+.||...
T Consensus       188 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  242 (313)
T 3cek_A          188 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI  242 (313)
T ss_dssp             --CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             CCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence            568999999999865           46888999999999999999999999754

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.96  E-value=2.2e-30  Score=263.15  Aligned_cols=178  Identities=13%  Similarity=0.169  Sum_probs=149.0

Q ss_pred             CCceEEEEEEEEeecCcEEEEEEeccC---------------hHHHHHHHHHcC---------CCCccceeeeeecC---
Q 037224          345 EGCLIQGSVYKGNIHGEVYAIKMMKWN---------------ACEELKILQKVN---------HGNLVKLEGFCIDP---  397 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~g~~vAvK~~~~~---------------~~~E~~~l~~l~---------h~niv~l~~~~~~~---  397 (552)
                      .|.|++|.||+++.+|+.||||+++..               ..+|+.+++.++         |+||+++.+.+...   
T Consensus        28 lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~  107 (336)
T 2vuw_A           28 IGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSY  107 (336)
T ss_dssp             EEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSC
T ss_pred             ecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCC
Confidence            377778999999999999999998633               357999999886         77777776654310   


Q ss_pred             -------------------------CCCeeEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCC
Q 037224          398 -------------------------EDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIH-EHTRP  451 (552)
Q Consensus       398 -------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~~~  451 (552)
                                               .....++||||+++|++.+.+..   ..+++.+++.++.|++.||+||| +++  
T Consensus       108 hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~~--  182 (336)
T 2vuw_A          108 PPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASLAVAEASLR--  182 (336)
T ss_dssp             CHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHHHHHHHHHC--
T ss_pred             cHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHhCC--
Confidence                                     15678999999999987776644   34899999999999999999999 898  


Q ss_pred             ceEecCCCCCcEEECCCC--------------------cEEEeeccCCccCCCCccccccccccccCccccCCCCCCChh
Q 037224          452 RVVHKDIKSSNILLDSNM--------------------RAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKM  511 (552)
Q Consensus       452 ~ivH~Dikp~NIll~~~~--------------------~~kL~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~  511 (552)
                       |+||||||+|||++.++                    .+||+|||+++.....   ...||+.|+|||++.+.. +.++
T Consensus       183 -ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~---~~~gt~~y~aPE~~~g~~-~~~~  257 (336)
T 2vuw_A          183 -FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG---IVVFCDVSMDEDLFTGDG-DYQF  257 (336)
T ss_dssp             -CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT---EEECCCCTTCSGGGCCCS-SHHH
T ss_pred             -EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC---cEEEeecccChhhhcCCC-ccce
Confidence             99999999999999887                    8999999999854432   357999999999998666 8899


Q ss_pred             hHHHHHHH-HHHHHcCCCCCCc
Q 037224          512 DVFSFGVV-LLELISGKEAIDE  532 (552)
Q Consensus       512 Dv~slG~i-l~elltG~~pf~~  532 (552)
                      ||||++++ .+++++|..||.+
T Consensus       258 Diwsl~~~~~~~~~~g~~p~~~  279 (336)
T 2vuw_A          258 DIYRLMKKENNNRWGEYHPYSN  279 (336)
T ss_dssp             HHHHHHHHHHTTCTTSCCTHHH
T ss_pred             ehhhhhCCCCcccccccCCCcc
Confidence            99998777 7788999999964

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.96  E-value=4.5e-30  Score=279.02  Aligned_cols=185  Identities=30%  Similarity=0.438  Sum_probs=160.1

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeec----CCCCeeEEEEeecc
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCID----PEDANCYLIYEYIE  410 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~~~lv~e~~~  410 (552)
                      .|.|++|.||++..  +|+.||||+++..        +.+|+.++++++||||+++++++..    ......++||||++
T Consensus        22 LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~  101 (676)
T 3qa8_A           22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCE  101 (676)
T ss_dssp             CCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCS
T ss_pred             EeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCC
Confidence            47788899999987  6899999998643        3469999999999999999998754    22456799999999


Q ss_pred             CCCchhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCc---EEEeeccCCccCCCC-
Q 037224          411 NGSLHSWLHENKN-ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR---AKIANFGLAKSGCNA-  485 (552)
Q Consensus       411 ~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~---~kL~Dfg~a~~~~~~-  485 (552)
                      +++|.+++..... ..+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.   +||+|||++...... 
T Consensus       102 ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~  178 (676)
T 3qa8_A          102 GGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE  178 (676)
T ss_dssp             SCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCC
T ss_pred             CCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccccccccccc
Confidence            9999999976442 35899999999999999999999999   999999999999987765   999999999864432 


Q ss_pred             ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          486 ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       486 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                      ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       179 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~  225 (676)
T 3qa8_A          179 LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP  225 (676)
T ss_dssp             CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence            23346789999999999999999999999999999999999999964

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.96  E-value=7.1e-30  Score=283.60  Aligned_cols=178  Identities=22%  Similarity=0.326  Sum_probs=150.6

Q ss_pred             CCceEEEEEEEEee---cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCC---eeEEEEeecc
Q 037224          345 EGCLIQGSVYKGNI---HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDA---NCYLIYEYIE  410 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~---~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~---~~~lv~e~~~  410 (552)
                      .|.|++|.||++.+   +|+.||||++...        +.+|+.++++++||||+++++++......   ..|+||||++
T Consensus        88 lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~  167 (681)
T 2pzi_A           88 IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVG  167 (681)
T ss_dssp             EEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCC
T ss_pred             EeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCC
Confidence            37788899999987   4789999998532        34799999999999999999999863321   2699999999


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccccc
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI  490 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  490 (552)
                      +++|.+++..    .+++.+++.++.|++.||.|||+++   |+||||||+|||++.+ .+||+|||+++.....  ...
T Consensus       168 g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~--~~~  237 (681)
T 2pzi_A          168 GQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF--GYL  237 (681)
T ss_dssp             CEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEETTCC--SCC
T ss_pred             CCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhcccC--Ccc
Confidence            9999987754    4999999999999999999999999   9999999999999886 8999999999865433  346


Q ss_pred             cccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       491 ~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      .||+.|+|||++.+.. +.++||||||+++|||++|..||.+.
T Consensus       238 ~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~  279 (681)
T 2pzi_A          238 YGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGR  279 (681)
T ss_dssp             CCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTE
T ss_pred             CCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccc
Confidence            7999999999986654 88999999999999999999998753

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.96  E-value=5.6e-29  Score=248.54  Aligned_cols=166  Identities=22%  Similarity=0.385  Sum_probs=143.6

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC--hHHHHHHH-HHcCCCCccceeeeeec--CCCCeeEEEEeeccCCCchhh
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN--ACEELKIL-QKVNHGNLVKLEGFCID--PEDANCYLIYEYIENGSLHSW  417 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~--~~~E~~~l-~~l~h~niv~l~~~~~~--~~~~~~~lv~e~~~~gsL~~~  417 (552)
                      .|.|++|.||++..  +++.||+|+++..  ..+|+.++ +.++||||+++++++..  ..+...++||||+++++|.++
T Consensus        26 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~  105 (299)
T 3m2w_A           26 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSR  105 (299)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHH
T ss_pred             cccCCCeEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHH
Confidence            37788899999987  7899999999754  45788888 55599999999998864  234568999999999999999


Q ss_pred             hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECC---CCcEEEeeccCCccCCCCccccccccc
Q 037224          418 LHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS---NMRAKIANFGLAKSGCNAITMHIVGTQ  494 (552)
Q Consensus       418 l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kL~Dfg~a~~~~~~~~~~~~gt~  494 (552)
                      +.......+++.+++.++.|++.||.|||+++   ++||||||+||+++.   ++.+||+|||++....           
T Consensus       106 l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-----------  171 (299)
T 3m2w_A          106 IQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-----------  171 (299)
T ss_dssp             HHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-----------
T ss_pred             HHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccccccc-----------
Confidence            98876667999999999999999999999999   999999999999998   7889999999985432           


Q ss_pred             cccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       495 ~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                               +..++.++||||||+++|||++|+.||...
T Consensus       172 ---------~~~~~~~~DiwslG~il~el~tg~~pf~~~  201 (299)
T 3m2w_A          172 ---------GEKYDKSCDMWSLGVIMYILLCGYPPFYSN  201 (299)
T ss_dssp             ---------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-
T ss_pred             ---------cccCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence                     244678999999999999999999999654

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.96  E-value=1.8e-29  Score=263.75  Aligned_cols=184  Identities=15%  Similarity=0.265  Sum_probs=142.6

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCC-CCccc---------eeee---------
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNH-GNLVK---------LEGF---------  393 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h-~niv~---------l~~~---------  393 (552)
                      .|.|++|.||++++  +|+.||||+++..          +.+|+.+++.++| +|...         ..+.         
T Consensus        86 LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (413)
T 3dzo_A           86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKM  165 (413)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC----
T ss_pred             cccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCcc
Confidence            48888899999997  5999999998621          3478888888876 22111         1111         


Q ss_pred             ---eecCC---CCeeEEEEeeccCCCchhhhh-----hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCc
Q 037224          394 ---CIDPE---DANCYLIYEYIENGSLHSWLH-----ENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSN  462 (552)
Q Consensus       394 ---~~~~~---~~~~~lv~e~~~~gsL~~~l~-----~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~N  462 (552)
                         +....   ....+++|+++ +++|.+++.     ......+++..++.++.|+++||+|||+++   |+||||||+|
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiHrDiKp~N  241 (413)
T 3dzo_A          166 IRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVD  241 (413)
T ss_dssp             -----------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred             ccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcccce
Confidence               11111   22356777765 569998885     222334888899999999999999999999   9999999999


Q ss_pred             EEECCCCcEEEeeccCCccCCCCccccccccccccCcccc----------CCCCCCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          463 ILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYL----------ADGVVSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       463 Ill~~~~~~kL~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                      ||++.++.+||+|||+++..... .....| +.|+|||++          ....++.++|||||||++|||++|+.||..
T Consensus       242 ILl~~~~~~kL~DFG~a~~~~~~-~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~  319 (413)
T 3dzo_A          242 IVLDQRGGVFLTGFEHLVRDGAS-AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD  319 (413)
T ss_dssp             EEECTTCCEEECCGGGCEETTEE-ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCT
T ss_pred             EEEecCCeEEEEeccceeecCCc-cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            99999999999999998765433 334567 999999998          566688899999999999999999999986


Q ss_pred             cC
Q 037224          533 EG  534 (552)
Q Consensus       533 ~~  534 (552)
                      ..
T Consensus       320 ~~  321 (413)
T 3dzo_A          320 DA  321 (413)
T ss_dssp             TG
T ss_pred             cc
Confidence            54

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.96  E-value=8.2e-29  Score=245.78  Aligned_cols=155  Identities=14%  Similarity=0.138  Sum_probs=135.7

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|++|.||++..  .++.||||+++..          +.+|+.++.+++|+||+++++++.+  ++..|+||||+++++
T Consensus        40 g~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~g~~  117 (286)
T 3uqc_A           40 GGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT--RAGGLVVAEWIRGGS  117 (286)
T ss_dssp             EBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEEEECCCEEE
T ss_pred             cccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE--CCcEEEEEEecCCCC
Confidence            6677799999998  4899999998642          3579999999999999999999987  678899999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcccccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT  493 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~gt  493 (552)
                      |.+++...    ....++..++.|++.||+|||+++   |+||||||+|||++.++.+||++++                
T Consensus       118 L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~----------------  174 (286)
T 3uqc_A          118 LQEVADTS----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA----------------  174 (286)
T ss_dssp             HHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC----------------
T ss_pred             HHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc----------------
Confidence            99998543    466678999999999999999999   9999999999999999999998543                


Q ss_pred             ccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       494 ~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                        |++|       ++.++||||||+++|||+||+.||.+.+
T Consensus       175 --~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~  206 (286)
T 3uqc_A          175 --TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAG  206 (286)
T ss_dssp             --CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCS
T ss_pred             --ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence              3333       6789999999999999999999998654

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.94  E-value=1.3e-28  Score=266.62  Aligned_cols=173  Identities=16%  Similarity=0.149  Sum_probs=124.2

Q ss_pred             ceEEEEEEEEee--cCcEEEEEEeccC-----------------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEE
Q 037224          347 CLIQGSVYKGNI--HGEVYAIKMMKWN-----------------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIY  406 (552)
Q Consensus       347 ~g~~G~Vy~~~~--~g~~vAvK~~~~~-----------------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~  406 (552)
                      .+..|.+..++.  .|+.+++|++..+                 +.+|+++|+++ .|+||+++++++.+  ++..||||
T Consensus       244 ~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed--~~~~yLVM  321 (569)
T 4azs_A          244 AGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN--AQSGWLVM  321 (569)
T ss_dssp             --------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC--SSEEEEEE
T ss_pred             cCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE--CCEEEEEE
Confidence            334455555443  7999999999543                 44799999999 79999999999987  78899999


Q ss_pred             eeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-
Q 037224          407 EYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-  485 (552)
Q Consensus       407 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-  485 (552)
                      ||++|++|.+++....  +++..   +|+.||+.||+|+|++|   |+||||||+|||++++|++||+|||+++..... 
T Consensus       322 Eyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~  393 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC  393 (569)
T ss_dssp             ECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred             ecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence            9999999999998654  36654   47899999999999999   999999999999999999999999999854332 


Q ss_pred             -ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCC
Q 037224          486 -ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAI  530 (552)
Q Consensus       486 -~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf  530 (552)
                       .....+||+.|+|||++.+ .+..++|+|++|+++++|.++..++
T Consensus       394 ~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          394 SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence             2345689999999999865 4667899999999988876655443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.90  E-value=1.2e-24  Score=234.09  Aligned_cols=170  Identities=18%  Similarity=0.177  Sum_probs=141.4

Q ss_pred             CCceEEEEEEEEeecCcEEEEEEeccC---------------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeec
Q 037224          345 EGCLIQGSVYKGNIHGEVYAIKMMKWN---------------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI  409 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~g~~vAvK~~~~~---------------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~  409 (552)
                      .|.|.+|.||++...++.+++|+....               +.+|++++++++||||+++..++.+  ....++||||+
T Consensus       344 LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--~~~~~lVmE~~  421 (540)
T 3en9_A          344 IGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD--LDNKRIMMSYI  421 (540)
T ss_dssp             ----CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE--TTTTEEEEECC
T ss_pred             EeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe--CCccEEEEECC
Confidence            488888999999889999999986321               3579999999999999966555555  44569999999


Q ss_pred             cCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc---
Q 037224          410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI---  486 (552)
Q Consensus       410 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~---  486 (552)
                      ++++|.+++..          ++.++.|+++||+|||+++   |+||||||+|||++.  .+||+|||+++......   
T Consensus       422 ~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~  486 (540)
T 3en9_A          422 NGKLAKDVIED----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA  486 (540)
T ss_dssp             CSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred             CCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence            99999999875          4579999999999999999   999999999999998  99999999998665432   


Q ss_pred             ------cccccccccccCccccCC--CCCCChhhHHHHHHHHHHHHcCCCCCC
Q 037224          487 ------TMHIVGTQGYIAPEYLAD--GVVSTKMDVFSFGVVLLELISGKEAID  531 (552)
Q Consensus       487 ------~~~~~gt~~y~aPE~~~~--~~~s~~~Dv~slG~il~elltG~~pf~  531 (552)
                            .....||+.|+|||++..  ..|+...|+|+..+-.++-+.++.+|.
T Consensus       487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence                  124679999999999876  557778899999999999988888774

>4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A*

Probab=99.82  E-value=3e-20  Score=173.03  Aligned_cols=105  Identities=20%  Similarity=0.321  Sum_probs=92.4

Q ss_pred             eEEEEecCCchhhhHHhhcCCcchH--------HHHHHhC-CCCCCCCCCCCcEEEEeeeecCCCCccccCceeEEEEEe
Q 037224          117 LSYTIKSGDTFYLVSTNKYQNLTTY--------QSVEVVN-PTFVPTKLEVGDVIIFPVFCKCPNQTQLRNRVNYLVSYV  187 (552)
Q Consensus       117 ~~y~v~~gdtl~~Ia~~~~~~~~~~--------~~l~~~N-~~~~~~~l~~gq~l~ip~~~~~~~~~~~~~~~~~~~~y~  187 (552)
                      .+|+|++|||||.|| ++|+  +++        ++|+++| ++.+++.|.+||+|.||.+|.|.+..    ......+|+
T Consensus        10 ~~Y~V~~GDTL~~IA-~~~~--vsv~~~~~~~~~~I~~~Np~l~~~~~l~~Gq~L~IP~~~~~~~~~----~~~~~~~Y~   82 (212)
T 4eby_A           10 ASYYLENGTTLSVIN-QNLN--SSIAPYDQINFDPILRYNSNIKDKDRIQMGSRVLVPFPCECQPGD----FLGHNFSYS   82 (212)
T ss_dssp             EEEECCTTCCHHHHH-HHTC--CSSSCCCSSCCHHHHTTCTTCSCTTSCCTTCEEEEEECCEEETTT----EEEEEEEEE
T ss_pred             EEEEeCCCCCHHHHH-HHHC--CCchhccccCHHHHHHhccCCCCcCccCCCCEEEEeccccccCCc----cccCceEEE
Confidence            469999999999999 7899  888        9999999 88767899999999999998885321    223346899


Q ss_pred             cCCCCCHHHHH-hHhC--CChhhHhhhcCC---cccCCceeeccccC
Q 037224          188 LQPSENLSSVA-SRFG--IETQAIIDVNGN---NIRPFDTLFVPVAR  228 (552)
Q Consensus       188 v~~Gdtl~~ia-~~~~--~s~~~l~~~N~~---~~~~g~~l~ip~~~  228 (552)
                      |++|||||+|| ++|+  +++++|+++|++   .|++||.|.||...
T Consensus        83 V~~GDTL~~IA~~~y~~lvt~~~L~~~N~~~~~~l~~Gq~L~IP~~~  129 (212)
T 4eby_A           83 VRQEDTYERVAISNYANLTTMESLQARNPFPATNIPLSATLNVLVNC  129 (212)
T ss_dssp             CCTTCCHHHHHHTTTTTSSCHHHHHHHCCSCTTCCCTTCEEEEEEEC
T ss_pred             ecCCCcHHHHHHHhcCCCCCHHHHHHhcCCCcccCCCCCEEEEcCCC
Confidence            99999999999 8999  999999999998   79999999999764

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.80  E-value=2.1e-20  Score=184.58  Aligned_cols=127  Identities=17%  Similarity=0.139  Sum_probs=104.5

Q ss_pred             CceEEEEEEEEee-cCcEEEEEEecc-------------------------ChHHHHHHHHHcCCCCccceeeeeecCCC
Q 037224          346 GCLIQGSVYKGNI-HGEVYAIKMMKW-------------------------NACEELKILQKVNHGNLVKLEGFCIDPED  399 (552)
Q Consensus       346 G~g~~G~Vy~~~~-~g~~vAvK~~~~-------------------------~~~~E~~~l~~l~h~niv~l~~~~~~~~~  399 (552)
                      |.|.+|.||++.. +|+.||+|+++.                         .+.+|+.++++++  | +++.+++..   
T Consensus        99 G~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~~---  172 (282)
T 1zar_A           99 GEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYAW---  172 (282)
T ss_dssp             EECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEEE---
T ss_pred             ccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEec---
Confidence            7777899999998 688999999852                         1347999999999  5 666665533   


Q ss_pred             CeeEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCC
Q 037224          400 ANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLA  479 (552)
Q Consensus       400 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  479 (552)
                      +..++||||+++++|.+ +..        .+...++.|++.||.|||+.+   |+||||||+|||++ ++.+||+|||++
T Consensus       173 ~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~DFG~a  239 (282)
T 1zar_A          173 EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQS  239 (282)
T ss_dssp             ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECCCTTC
T ss_pred             cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEECCCC
Confidence            34599999999999988 421        234579999999999999999   99999999999999 999999999998


Q ss_pred             ccCCCCccccccccccccCcccc
Q 037224          480 KSGCNAITMHIVGTQGYIAPEYL  502 (552)
Q Consensus       480 ~~~~~~~~~~~~gt~~y~aPE~~  502 (552)
                      +.           +..++|||.+
T Consensus       240 ~~-----------~~~~~a~e~l  251 (282)
T 1zar_A          240 VE-----------VGEEGWREIL  251 (282)
T ss_dssp             EE-----------TTSTTHHHHH
T ss_pred             eE-----------CCCCCHHHHH
Confidence            63           3356888876

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.68  E-value=1e-16  Score=156.12  Aligned_cols=121  Identities=19%  Similarity=0.241  Sum_probs=95.1

Q ss_pred             CceEEEEEEEEee--cCcE--EEEEEecc-------------------------------ChHHHHHHHHHcCCCCc--c
Q 037224          346 GCLIQGSVYKGNI--HGEV--YAIKMMKW-------------------------------NACEELKILQKVNHGNL--V  388 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~--vAvK~~~~-------------------------------~~~~E~~~l~~l~h~ni--v  388 (552)
                      |.|.+|.||+|..  +|+.  ||||+++.                               ...+|+.++.++.|+++  +
T Consensus        56 g~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p  135 (258)
T 1zth_A           56 STGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGVSVP  135 (258)
T ss_dssp             EECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             eecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCCCCCC
Confidence            7778899999998  7888  99998632                               23579999999988864  3


Q ss_pred             ceeeeeecCCCCeeEEEEeeccC-C----CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCceEecCCCCCc
Q 037224          389 KLEGFCIDPEDANCYLIYEYIEN-G----SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIH-EHTRPRVVHKDIKSSN  462 (552)
Q Consensus       389 ~l~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~~~~ivH~Dikp~N  462 (552)
                      .++++      ...++||||+.+ |    +|.++...     .++.++..++.|++.+|.||| +.+   |+||||||+|
T Consensus       136 ~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDlkp~N  201 (258)
T 1zth_A          136 QPYTY------MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAE---LVHADLSEYN  201 (258)
T ss_dssp             CEEEE------ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSC---EECSSCSTTS
T ss_pred             eEEEc------CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHH
Confidence            33332      234899999942 4    55554322     235567889999999999999 888   9999999999


Q ss_pred             EEECCCCcEEEeeccCCccC
Q 037224          463 ILLDSNMRAKIANFGLAKSG  482 (552)
Q Consensus       463 Ill~~~~~~kL~Dfg~a~~~  482 (552)
                      ||++.  .++|+|||++...
T Consensus       202 ILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          202 IMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             EEESS--SEEECCCTTCEET
T ss_pred             EEEcC--cEEEEECcccccC
Confidence            99988  8999999999654

>2l9y_A CVNH-LYSM lectin; carbohydrate, sugar binding protein; NMR {Magnaporthe oryzae 70-15}

Probab=99.54  E-value=8.8e-16  Score=137.17  Aligned_cols=96  Identities=11%  Similarity=0.082  Sum_probs=76.9

Q ss_pred             eeeEEEEecCCchhhhHHhhcCCcchHHHHHHhCCCCCCCCCCCCcEEEEeeeecCCCCccccCceeEEEEEecCCCCCH
Q 037224          115 ANLSYTIKSGDTFYLVSTNKYQNLTTYQSVEVVNPTFVPTKLEVGDVIIFPVFCKCPNQTQLRNRVNYLVSYVLQPSENL  194 (552)
Q Consensus       115 ~~~~y~v~~gdtl~~Ia~~~~~~~~~~~~l~~~N~~~~~~~l~~gq~l~ip~~~~~~~~~~~~~~~~~~~~y~v~~Gdtl  194 (552)
                      ...+|+|++|||||.|| ++|+  +++.+|+++|++.+|+.|++||+|.||....-+..... ........|.|++||||
T Consensus        61 ~~~~y~V~~GDTL~~IA-~~~~--~~~~~l~~~N~~~~~~~i~~Gq~L~ip~~~~~~~~~~~-~~~~~~~~~~v~~GdtL  136 (167)
T 2l9y_A           61 GTATVTVQQGDTLRDIG-RRFD--CDFHEIARRNNIQNEDLIYPGQVLQVPTKGGSGGGAGN-FWDSARDVRLVDGGKVL  136 (167)
T ss_dssp             SCEEEEECTTCCHHHHH-HHTT--CCHHHHHHHHTCCGGGCCCTTEEEEESCCCCCSSSSCC-GGGGEEEEEEETTTTEE
T ss_pred             CCceEEECCCCcHHHHH-HHcC--CCHHHHHHHcCCCCcccccCCCEEEEcCCCCccccccc-cccccceEEEeCCcCCh
Confidence            34569999999999999 6788  99999999999999999999999999975432110110 01112357999999999


Q ss_pred             HHHHhHhCCChhhHhhhcCC
Q 037224          195 SSVASRFGIETQAIIDVNGN  214 (552)
Q Consensus       195 ~~ia~~~~~s~~~l~~~N~~  214 (552)
                      ++||++||.++...+.+|..
T Consensus       137 ~aIA~r~G~~v~s~i~Ln~~  156 (167)
T 2l9y_A          137 EAELRYSGGWNRSRIYLDEH  156 (167)
T ss_dssp             EEEEEETTEEEEEEECGGGT
T ss_pred             HHHHHHcCCceEEEEEcccc
Confidence            99999999999998888864

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.50  E-value=3.1e-14  Score=144.61  Aligned_cols=121  Identities=13%  Similarity=0.169  Sum_probs=89.4

Q ss_pred             CceEEEEEEEEee-cCcEEEEEEeccC-----------------------------hHHHHHHHHHcCCCCccceeeeee
Q 037224          346 GCLIQGSVYKGNI-HGEVYAIKMMKWN-----------------------------ACEELKILQKVNHGNLVKLEGFCI  395 (552)
Q Consensus       346 G~g~~G~Vy~~~~-~g~~vAvK~~~~~-----------------------------~~~E~~~l~~l~h~niv~l~~~~~  395 (552)
                      |.|.+|.||+|.. +|+.||||+++..                             ..+|...|.++.+.++.....+..
T Consensus       104 G~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~p~~~  183 (397)
T 4gyi_A          104 GVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPEPIAQ  183 (397)
T ss_dssp             EECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCCEEEE
T ss_pred             eeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCeeeec
Confidence            7888899999987 7999999987421                             013566666665444432222222


Q ss_pred             cCCCCeeEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCC------
Q 037224          396 DPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM------  469 (552)
Q Consensus       396 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~------  469 (552)
                      .    ..++||||+++++|.++...        .+...++.|++.+|.+||+.|   ||||||||.|||+++++      
T Consensus       184 ~----~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd~~d~~  248 (397)
T 4gyi_A          184 S----RHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKDAEDPS  248 (397)
T ss_dssp             E----TTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEECSSCTT
T ss_pred             c----CceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCCccccc
Confidence            2    12799999999888765321        234568899999999999999   99999999999998776      


Q ss_pred             ----cEEEeeccCCcc
Q 037224          470 ----RAKIANFGLAKS  481 (552)
Q Consensus       470 ----~~kL~Dfg~a~~  481 (552)
                          .+.|+||+.+..
T Consensus       249 ~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          249 SITLTPIIIXFPQMVS  264 (397)
T ss_dssp             SEEEEEEECCCTTCEE
T ss_pred             ccccceEEEEeCCccc
Confidence                389999998753

>2l9y_A CVNH-LYSM lectin; carbohydrate, sugar binding protein; NMR {Magnaporthe oryzae 70-15}

Probab=99.30  E-value=1.5e-13  Score=122.69  Aligned_cols=94  Identities=15%  Similarity=-0.005  Sum_probs=70.6

Q ss_pred             ceeEeeccCCCCCCHHHHHHHhCCChhhhcCcCCCCCCCCCccCCCcEEEeeecccccCCCCCceeeeeeEEEEecCCch
Q 037224           48 TYAFYRASAPDFLDLASIADLFSVSRLMISEPSNISSPSSPLIQNQPLFVPITCSCNTLNASYTISFANLSYTIKSGDTF  127 (552)
Q Consensus        48 ~~~~y~v~~~~g~tl~~Ia~~~~~~~~~l~~~N~~~~~~~~~~~g~~l~iP~~~~~~~~~~~~~~~~~~~~y~v~~gdtl  127 (552)
                      +...|+|++  ||||+.||++||+++.+|+++|++.+ ++.|.+||.|.||....-.... ..........|+|++||||
T Consensus        61 ~~~~y~V~~--GDTL~~IA~~~~~~~~~l~~~N~~~~-~~~i~~Gq~L~ip~~~~~~~~~-~~~~~~~~~~~~v~~GdtL  136 (167)
T 2l9y_A           61 GTATVTVQQ--GDTLRDIGRRFDCDFHEIARRNNIQN-EDLIYPGQVLQVPTKGGSGGGA-GNFWDSARDVRLVDGGKVL  136 (167)
T ss_dssp             SCEEEEECT--TCCHHHHHHHTTCCHHHHHHHHTCCG-GGCCCTTEEEEESCCCCCSSSS-CCGGGGEEEEEEETTTTEE
T ss_pred             CCceEEECC--CCcHHHHHHHcCCCHHHHHHHcCCCC-cccccCCCEEEEcCCCCccccc-cccccccceEEEeCCcCCh
Confidence            456899999  99999999999999999999999987 6899999999999754321000 0111122456999999999


Q ss_pred             hhhHHhhcCCcchHHHHHHhC
Q 037224          128 YLVSTNKYQNLTTYQSVEVVN  148 (552)
Q Consensus       128 ~~Ia~~~~~~~~~~~~l~~~N  148 (552)
                      +.||+ +++  .+++....+|
T Consensus       137 ~aIA~-r~G--~~v~s~i~Ln  154 (167)
T 2l9y_A          137 EAELR-YSG--GWNRSRIYLD  154 (167)
T ss_dssp             EEEEE-ETT--EEEEEEECGG
T ss_pred             HHHHH-HcC--CceEEEEEcc
Confidence            99995 477  5544544444

>2gu1_A Zinc peptidase; alpha/beta, beta barrel, structural genomics, PSI, protein structure initiative; 1.90A {Vibrio cholerae}

Probab=99.24  E-value=3.3e-12  Score=129.40  Aligned_cols=109  Identities=13%  Similarity=0.146  Sum_probs=84.1

Q ss_pred             eEEEEecCCchhhhHHhhcCCcchHHHHHHhCCCCC----CCCCCCCcEEEEeeeecCCC---------Cc------ccc
Q 037224          117 LSYTIKSGDTFYLVSTNKYQNLTTYQSVEVVNPTFV----PTKLEVGDVIIFPVFCKCPN---------QT------QLR  177 (552)
Q Consensus       117 ~~y~v~~gdtl~~Ia~~~~~~~~~~~~l~~~N~~~~----~~~l~~gq~l~ip~~~~~~~---------~~------~~~  177 (552)
                      .+|+|++||||+.|| ++|+  ++.++|.++|++..    .+.|++||+|.||....-.-         ..      ...
T Consensus         8 ~~~~Vk~GDTL~~Ia-~r~g--vs~~~l~~~n~~~~~~~~~~~L~~Gq~L~i~~~~~~~l~~l~~~~~~~~~~~~~~~~~   84 (361)
T 2gu1_A            8 IHYMVKVGDTLSGIF-AQLG--VPYSILQKILSVDLDHLQLDMIQPGEELELMMDDMGQLSRLIYHMSIVEKAIYTREND   84 (361)
T ss_dssp             EEEECCTTCCHHHHH-HHTT--CCHHHHHHHHHHGGGTCCGGGCCTTCEEEEEECTTSCEEEEEEEEETTEEEEEEECTT
T ss_pred             eEEEECCCCcHHHHH-HHcC--CCHHHHHHHHhhcccccchhcCCCCCEEEEEECCCCcceEEEEEcCccceEEEEecCC
Confidence            459999999999999 8898  99999999998753    36899999999997421100         00      000


Q ss_pred             C----------ceeEEEEEecCCCCCHHHHHhHhCCChhhHhhhcCC---------cccCCceeeccccC
Q 037224          178 N----------RVNYLVSYVLQPSENLSSVASRFGIETQAIIDVNGN---------NIRPFDTLFVPVAR  228 (552)
Q Consensus       178 ~----------~~~~~~~y~v~~Gdtl~~ia~~~~~s~~~l~~~N~~---------~~~~g~~l~ip~~~  228 (552)
                      +          .......|.|+.||||+.||++||++..+|++||++         .|++||.+.|+...
T Consensus        85 g~f~~~~~~~~~~~~~~~~~v~igdSL~~iA~~~Gvs~~~i~~ln~i~~~~idf~~~Lr~GD~l~V~~~~  154 (361)
T 2gu1_A           85 GSFSYDFQEISGEWREILFSGEINGSFSVSARRVGLTSSQVANITQVMKDKIDFSRSLRAGDRFDILVKQ  154 (361)
T ss_dssp             SCEEEEEEECCCEEEEEEEEEESSSCHHHHHHHTTCCHHHHHHHHHHHTTTCCTTTCCCC-CEEEEEEEE
T ss_pred             CcceeeecccCceEEEEEEEEEECCcHHHHHHHcCCCHHHHHHHHHhhcccccccccCCCCCEEEEEEEE
Confidence            0          111235799999999999999999999999999986         38999999887653

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.17  E-value=8.4e-11  Score=114.12  Aligned_cols=124  Identities=16%  Similarity=0.120  Sum_probs=97.7

Q ss_pred             eEEEEEEEEeecCcEEEEEEecc-------ChHHHHHHHHHcC-CCCccceeeeeecCCCCeeEEEEeeccCCCchhhhh
Q 037224          348 LIQGSVYKGNIHGEVYAIKMMKW-------NACEELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLH  419 (552)
Q Consensus       348 g~~G~Vy~~~~~g~~vAvK~~~~-------~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~  419 (552)
                      +..+.||+....++.+++|+...       ...+|+.+++.+. +..+.++++++.+  .+..|+||||++|.+|.+.+.
T Consensus        25 ~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~lv~e~i~G~~l~~~~~  102 (263)
T 3tm0_A           25 MSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNLLMSEADGVLCSEEYE  102 (263)
T ss_dssp             CSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEEEECCSSEEHHHHCC
T ss_pred             CCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec--CCceEEEEEecCCeehhhccC
Confidence            33478999988889999999864       3568999999994 6678889888876  567899999999999877532


Q ss_pred             hcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------------
Q 037224          420 ENKNENLNWKTRLRIAIDVANGLQYIHEHT--------------------------------------------------  449 (552)
Q Consensus       420 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--------------------------------------------------  449 (552)
                             +..+...++.+++++|..||+..                                                  
T Consensus       103 -------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~  175 (263)
T 3tm0_A          103 -------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLK  175 (263)
T ss_dssp             -------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHH
T ss_pred             -------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHH
Confidence                   11223468889999999999811                                                  


Q ss_pred             ------CCceEecCCCCCcEEECCCCcEEEeeccCCc
Q 037224          450 ------RPRVVHKDIKSSNILLDSNMRAKIANFGLAK  480 (552)
Q Consensus       450 ------~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  480 (552)
                            .+.++|+|+++.||++++++.+.|+||+.+.
T Consensus       176 ~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          176 TEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                  1348999999999999876556799999874

>2gu1_A Zinc peptidase; alpha/beta, beta barrel, structural genomics, PSI, protein structure initiative; 1.90A {Vibrio cholerae}

Probab=99.17  E-value=1e-11  Score=125.76  Aligned_cols=115  Identities=11%  Similarity=0.084  Sum_probs=87.7

Q ss_pred             ceeEeeccCCCCCCHHHHHHHhCCChhhhcCcCCCCC---CCCCccCCCcEEEeeeccccc----------------CCC
Q 037224           48 TYAFYRASAPDFLDLASIADLFSVSRLMISEPSNISS---PSSPLIQNQPLFVPITCSCNT----------------LNA  108 (552)
Q Consensus        48 ~~~~y~v~~~~g~tl~~Ia~~~~~~~~~l~~~N~~~~---~~~~~~~g~~l~iP~~~~~~~----------------~~~  108 (552)
                      .+..|+|++  ||||++||++||+++++|.++|++..   +...|.+||.|.||....-..                ...
T Consensus         6 ~~~~~~Vk~--GDTL~~Ia~r~gvs~~~l~~~n~~~~~~~~~~~L~~Gq~L~i~~~~~~~l~~l~~~~~~~~~~~~~~~~   83 (361)
T 2gu1_A            6 KRIHYMVKV--GDTLSGIFAQLGVPYSILQKILSVDLDHLQLDMIQPGEELELMMDDMGQLSRLIYHMSIVEKAIYTREN   83 (361)
T ss_dssp             -CEEEECCT--TCCHHHHHHHTTCCHHHHHHHHHHGGGTCCGGGCCTTCEEEEEECTTSCEEEEEEEEETTEEEEEEECT
T ss_pred             CceEEEECC--CCcHHHHHHHcCCCHHHHHHHHhhcccccchhcCCCCCEEEEEECCCCcceEEEEEcCccceEEEEecC
Confidence            467899999  99999999999999999999997642   136799999999997432100                000


Q ss_pred             CCcee---------eeeeEEEEecCCchhhhHHhhcCCcchHHHHHHhCCCCCC-----CCCCCCcEEEEeee
Q 037224          109 SYTIS---------FANLSYTIKSGDTFYLVSTNKYQNLTTYQSVEVVNPTFVP-----TKLEVGDVIIFPVF  167 (552)
Q Consensus       109 ~~~~~---------~~~~~y~v~~gdtl~~Ia~~~~~~~~~~~~l~~~N~~~~~-----~~l~~gq~l~ip~~  167 (552)
                      .+.+.         .....|+|+.|||||.|| +.++  ++.++|+++|++...     ..|++||+|.|+..
T Consensus        84 ~g~f~~~~~~~~~~~~~~~~~v~igdSL~~iA-~~~G--vs~~~i~~ln~i~~~~idf~~~Lr~GD~l~V~~~  153 (361)
T 2gu1_A           84 DGSFSYDFQEISGEWREILFSGEINGSFSVSA-RRVG--LTSSQVANITQVMKDKIDFSRSLRAGDRFDILVK  153 (361)
T ss_dssp             TSCEEEEEEECCCEEEEEEEEEESSSCHHHHH-HHTT--CCHHHHHHHHHHHTTTCCTTTCCCC-CEEEEEEE
T ss_pred             CCcceeeecccCceEEEEEEEEEECCcHHHHH-HHcC--CCHHHHHHHHHhhcccccccccCCCCCEEEEEEE
Confidence            11111         122469999999999999 7888  999999999988653     46999999999975

>2djp_A Hypothetical protein SB145; LYSM, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens}

Probab=99.17  E-value=2.3e-11  Score=94.38  Aligned_cols=58  Identities=24%  Similarity=0.372  Sum_probs=50.9

Q ss_pred             CCcEEEEeeeecCCCCccccCceeEEEEEecCCCCCHHHHHhHhCCChhhHhhhcCC----cccCCceeeccccC
Q 037224          158 VGDVIIFPVFCKCPNQTQLRNRVNYLVSYVLQPSENLSSVASRFGIETQAIIDVNGN----NIRPFDTLFVPVAR  228 (552)
Q Consensus       158 ~gq~l~ip~~~~~~~~~~~~~~~~~~~~y~v~~Gdtl~~ia~~~~~s~~~l~~~N~~----~~~~g~~l~ip~~~  228 (552)
                      .||.|.||..             ....+|+|++|||||+||++|++++++|+++|++    .|++||.|.||...
T Consensus         3 ~Gq~l~ip~~-------------~~~~~y~V~~GDTL~~IA~~~~~~~~~l~~~N~l~~~~~l~~Gq~l~iP~~~   64 (77)
T 2djp_A            3 SGSSGCSPVR-------------ERRLEHQLEPGDTLAGLALKYGVTMEQIKRANRLYTNDSIFLKKTLYIPILT   64 (77)
T ss_dssp             CCCCCCCCCC-------------EEEEEECCCTTCCHHHHHHHHTCCHHHHHHHHTCCCSSCGGGSSCEEEEEEC
T ss_pred             CCcEeeccCC-------------CCcEEEEECCCCcHHHHHHHHCcCHHHHHHHcCCCCccccCCCCEEEECCCC
Confidence            5888888843             2345899999999999999999999999999998    69999999999765

>2djp_A Hypothetical protein SB145; LYSM, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens}

Probab=99.14  E-value=1.9e-11  Score=94.83  Aligned_cols=62  Identities=16%  Similarity=0.300  Sum_probs=53.3

Q ss_pred             CCCcEEEeeecccccCCCCCceeeeeeEEEEecCCchhhhHHhhcCCcchHHHHHHhCCCCCCCCCCCCcEEEEeeee
Q 037224           91 QNQPLFVPITCSCNTLNASYTISFANLSYTIKSGDTFYLVSTNKYQNLTTYQSVEVVNPTFVPTKLEVGDVIIFPVFC  168 (552)
Q Consensus        91 ~g~~l~iP~~~~~~~~~~~~~~~~~~~~y~v~~gdtl~~Ia~~~~~~~~~~~~l~~~N~~~~~~~l~~gq~l~ip~~~  168 (552)
                      .||.+.||...             ...+|+|++|||||.|| ++|+  +++++|+++|++.+++.|.+||+|.||...
T Consensus         3 ~Gq~l~ip~~~-------------~~~~y~V~~GDTL~~IA-~~~~--~~~~~l~~~N~l~~~~~l~~Gq~l~iP~~~   64 (77)
T 2djp_A            3 SGSSGCSPVRE-------------RRLEHQLEPGDTLAGLA-LKYG--VTMEQIKRANRLYTNDSIFLKKTLYIPILT   64 (77)
T ss_dssp             CCCCCCCCCCE-------------EEEEECCCTTCCHHHHH-HHHT--CCHHHHHHHHTCCCSSCGGGSSCEEEEEEC
T ss_pred             CCcEeeccCCC-------------CcEEEEECCCCcHHHHH-HHHC--cCHHHHHHHcCCCCccccCCCCEEEECCCC
Confidence            58888888432             23459999999999999 7888  999999999999877899999999999863

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.99  E-value=2.2e-09  Score=109.16  Aligned_cols=133  Identities=14%  Similarity=0.239  Sum_probs=102.2

Q ss_pred             CceEEEEEEEEeecCcEEEEEEec--c--------ChHHHHHHHHHcC--CCCccceeeeeecCCC-CeeEEEEeeccCC
Q 037224          346 GCLIQGSVYKGNIHGEVYAIKMMK--W--------NACEELKILQKVN--HGNLVKLEGFCIDPED-ANCYLIYEYIENG  412 (552)
Q Consensus       346 G~g~~G~Vy~~~~~g~~vAvK~~~--~--------~~~~E~~~l~~l~--h~niv~l~~~~~~~~~-~~~~lv~e~~~~g  412 (552)
                      +.|..+.||+....+..+++|+..  .        ...+|..+++.+.  +..+++++.++.+... +..|+||||++|.
T Consensus        47 ~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~  126 (359)
T 3dxp_A           47 KGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGR  126 (359)
T ss_dssp             CC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCB
T ss_pred             CCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCe
Confidence            445557899998888889999876  2        3457999999996  4557888888765321 4578999999998


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHT-------------------------------------------  449 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-------------------------------------------  449 (552)
                      .+.+...    ..++..+...++.++++.|..||+..                                           
T Consensus       127 ~l~~~~~----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  202 (359)
T 3dxp_A          127 VLWDQSL----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMD  202 (359)
T ss_dssp             CCCCTTC----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHH
T ss_pred             ecCCCcc----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHH
Confidence            8754221    23788889999999999999999731                                           


Q ss_pred             ------------CCceEecCCCCCcEEECCCCc--EEEeeccCCccC
Q 037224          450 ------------RPRVVHKDIKSSNILLDSNMR--AKIANFGLAKSG  482 (552)
Q Consensus       450 ------------~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a~~~  482 (552)
                                  .+.++|||+++.||+++.++.  +.|+||+.+...
T Consensus       203 ~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          203 WLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                        245999999999999987753  689999998643

>1e0g_A Membrane-bound lytic murein transglycosylase D; cell WALL, hydrolase, glycosidase, lipoprotein, outer membrane, multigene family; NMR {Escherichia coli} SCOP: d.7.1.1

Probab=98.97  E-value=2.5e-10  Score=79.66  Aligned_cols=45  Identities=20%  Similarity=0.385  Sum_probs=41.0

Q ss_pred             eEEEEecCCchhhhHHhhcCCcchHHHHHHhCCCCCCCCCCCCcEEEEee
Q 037224          117 LSYTIKSGDTFYLVSTNKYQNLTTYQSVEVVNPTFVPTKLEVGDVIIFPV  166 (552)
Q Consensus       117 ~~y~v~~gdtl~~Ia~~~~~~~~~~~~l~~~N~~~~~~~l~~gq~l~ip~  166 (552)
                      .+|+|++|||||+|| ++|+  +++++|+++|+  +++.|.+||+|.||+
T Consensus         3 ~~y~V~~GDtl~~Ia-~~~~--~~~~~l~~~N~--~~~~l~~G~~l~ip~   47 (48)
T 1e0g_A            3 ITYRVRKGDSLSSIA-KRHG--VNIKDVMRWNS--DTANLQPGDKLTLFV   47 (48)
T ss_dssp             CEEEECTTCCHHHHH-HHHT--CCHHHHHHHCS--CGGGCCTTEEEECCC
T ss_pred             EEEEEcCCCcHHHHH-HHHC--cCHHHHHHhCC--CCCcCCcCCEEEEec
Confidence            359999999999999 7888  89999999999  558999999999995

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.92  E-value=2.7e-09  Score=102.97  Aligned_cols=122  Identities=13%  Similarity=0.102  Sum_probs=89.8

Q ss_pred             eEEEEEEEEee-cCcEEEEEEeccC----hHHHHHHHHHcCCCC--ccceeeeeecCCCCeeEEEEeeccCCCchhhhhh
Q 037224          348 LIQGSVYKGNI-HGEVYAIKMMKWN----ACEELKILQKVNHGN--LVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHE  420 (552)
Q Consensus       348 g~~G~Vy~~~~-~g~~vAvK~~~~~----~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~  420 (552)
                      |..+.||+... +|+.+++|+....    ..+|+.+++.+.+.+  +.+++++..+  ++..++||||++|.+|.  ...
T Consensus        31 g~~~~v~~~~~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~--~~~~~~v~e~i~G~~l~--~~~  106 (264)
T 1nd4_A           31 CSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDWLLLGEVPGQDLL--SSH  106 (264)
T ss_dssp             TSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEEEEEECCSSEETT--TSC
T ss_pred             CCCceEEEEecCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccC--CCCCEEEEEecCCcccC--cCc
Confidence            33478999876 4678999998643    458999999996544  4567777665  45679999999998884  211


Q ss_pred             cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------------------
Q 037224          421 NKNENLNWKTRLRIAIDVANGLQYIHEHT---------------------------------------------------  449 (552)
Q Consensus       421 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---------------------------------------------------  449 (552)
                           .+   ...++.++++.|..||+..                                                   
T Consensus       107 -----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  178 (264)
T 1nd4_A          107 -----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARM  178 (264)
T ss_dssp             -----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTC
T ss_pred             -----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhc
Confidence                 12   1256777888888888643                                                   


Q ss_pred             ----CCceEecCCCCCcEEECCCCcEEEeeccCCcc
Q 037224          450 ----RPRVVHKDIKSSNILLDSNMRAKIANFGLAKS  481 (552)
Q Consensus       450 ----~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  481 (552)
                          ...++|+|++|.||++++++.+.|+||+.+..
T Consensus       179 ~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          179 PDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                12399999999999998776677999998753

>1e0g_A Membrane-bound lytic murein transglycosylase D; cell WALL, hydrolase, glycosidase, lipoprotein, outer membrane, multigene family; NMR {Escherichia coli} SCOP: d.7.1.1

Probab=98.92  E-value=9.3e-10  Score=76.73  Aligned_cols=42  Identities=31%  Similarity=0.567  Sum_probs=39.6

Q ss_pred             EEecCCCCCHHHHHhHhCCChhhHhhhcCC--cccCCceeeccc
Q 037224          185 SYVLQPSENLSSVASRFGIETQAIIDVNGN--NIRPFDTLFVPV  226 (552)
Q Consensus       185 ~y~v~~Gdtl~~ia~~~~~s~~~l~~~N~~--~~~~g~~l~ip~  226 (552)
                      +|+|++||||++||++||++..+|+++|+.  .|++|+.|.||+
T Consensus         4 ~y~V~~GDtl~~Ia~~~~~~~~~l~~~N~~~~~l~~G~~l~ip~   47 (48)
T 1e0g_A            4 TYRVRKGDSLSSIAKRHGVNIKDVMRWNSDTANLQPGDKLTLFV   47 (48)
T ss_dssp             EEEECTTCCHHHHHHHHTCCHHHHHHHCSCGGGCCTTEEEECCC
T ss_pred             EEEEcCCCcHHHHHHHHCcCHHHHHHhCCCCCcCCcCCEEEEec
Confidence            799999999999999999999999999964  799999999985

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.86  E-value=4.4e-09  Score=104.38  Aligned_cols=179  Identities=21%  Similarity=0.217  Sum_probs=116.2

Q ss_pred             ceEEEEEEEEeecCcEEEEEEeccC-----hHHHHHHHHHcC-CCC--ccceeeeeecCCC-CeeEEEEeeccCCCchhh
Q 037224          347 CLIQGSVYKGNIHGEVYAIKMMKWN-----ACEELKILQKVN-HGN--LVKLEGFCIDPED-ANCYLIYEYIENGSLHSW  417 (552)
Q Consensus       347 ~g~~G~Vy~~~~~g~~vAvK~~~~~-----~~~E~~~l~~l~-h~n--iv~l~~~~~~~~~-~~~~lv~e~~~~gsL~~~  417 (552)
                      .|....||+..   +.+++|+....     ..+|..+++.+. +..  +.+++........ ...|+|||+++|.+|.+.
T Consensus        30 ~G~~n~v~~v~---~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~  106 (304)
T 3sg8_A           30 EGNDCIAYEIN---RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPL  106 (304)
T ss_dssp             ECSSEEEEEST---TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHH
T ss_pred             CCCcceEEEEC---CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcc
Confidence            34446788764   56889987543     357999999883 333  3344433322111 234889999999888754


Q ss_pred             hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------------
Q 037224          418 LHENKNENLNWKTRLRIAIDVANGLQYIHEHT------------------------------------------------  449 (552)
Q Consensus       418 l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~------------------------------------------------  449 (552)
                      ...    .++..++..++.++++.|..||+..                                                
T Consensus       107 ~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~  182 (304)
T 3sg8_A          107 LLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILE  182 (304)
T ss_dssp             HHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHT
T ss_pred             ccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHh
Confidence            332    2778888889999999999999621                                                


Q ss_pred             -------CCceEecCCCCCcEEECC--CCcEEEeeccCCccCCCCccccccccccc---cCccccCC-----CCC-----
Q 037224          450 -------RPRVVHKDIKSSNILLDS--NMRAKIANFGLAKSGCNAITMHIVGTQGY---IAPEYLAD-----GVV-----  507 (552)
Q Consensus       450 -------~~~ivH~Dikp~NIll~~--~~~~kL~Dfg~a~~~~~~~~~~~~gt~~y---~aPE~~~~-----~~~-----  507 (552)
                             .+.++|+|+++.||++++  ...+.|+||+.+..........  ....+   ..|+....     +..     
T Consensus       183 ~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~--~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~  260 (304)
T 3sg8_A          183 NEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFI--SLMEDDEEYGMEFVSKILNHYKHKDIPTV  260 (304)
T ss_dssp             CGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHH--TTCCTTTSCCHHHHHHHHHHHTCSCHHHH
T ss_pred             ccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHH--HHHhhccccCHHHHHHHHHHcCCCCcHHH
Confidence                   135899999999999988  4568899999886433211110  00111   22221100     111     


Q ss_pred             ----CChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          508 ----STKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       508 ----s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                          ....+.|+++.++|.+.+|+.+|...+
T Consensus       261 ~~r~~~~~~~~~l~~~~~~~~~g~~~~~~~g  291 (304)
T 3sg8_A          261 LEKYRMKEKYWSFEKIIYGKEYGYMDWYEEG  291 (304)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHTTCHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHHHcCCHHHHHHH
Confidence                112589999999999999999886554

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.25  E-value=7.4e-06  Score=81.05  Aligned_cols=126  Identities=17%  Similarity=0.182  Sum_probs=86.7

Q ss_pred             EEEEEEEeecCcEEEEEEeccC-----hHHHHHHHHHcCCC---CccceeeeeecCCCCeeEEEEeeccCCCchhhhhhc
Q 037224          350 QGSVYKGNIHGEVYAIKMMKWN-----ACEELKILQKVNHG---NLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHEN  421 (552)
Q Consensus       350 ~G~Vy~~~~~g~~vAvK~~~~~-----~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~  421 (552)
                      ...||+.   |+.+++|+-+..     ..+|..+|+.+.+.   .+.+++.++.. ..+..+++|||++|.++.+.... 
T Consensus        32 ~n~v~~v---g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~-~~g~~~~v~e~i~G~~l~~~~~~-  106 (306)
T 3tdw_A           32 RNYAILV---NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR-SDGNPFVGYRKVQGQILGEDGMA-  106 (306)
T ss_dssp             SEEEEEE---TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC-TTSCEEEEEECCCSEECHHHHHT-
T ss_pred             ceeEEEE---CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc-CCCceEEEEeccCCeECchhhhh-
Confidence            3577876   677888986532     34799999999653   35566666542 24567899999999888763211 


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------------------
Q 037224          422 KNENLNWKTRLRIAIDVANGLQYIHEH-----------------------------------------------------  448 (552)
Q Consensus       422 ~~~~l~~~~~~~i~~qi~~aL~~LH~~-----------------------------------------------------  448 (552)
                         .++..+...++.++.+.|..||+.                                                     
T Consensus       107 ---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~  183 (306)
T 3tdw_A          107 ---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHP  183 (306)
T ss_dssp             ---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCH
T ss_pred             ---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCc
Confidence               145555566666666666666643                                                     


Q ss_pred             ----CCCceEecCCCCCcEEECC---CCc-EEEeeccCCccCC
Q 037224          449 ----TRPRVVHKDIKSSNILLDS---NMR-AKIANFGLAKSGC  483 (552)
Q Consensus       449 ----~~~~ivH~Dikp~NIll~~---~~~-~kL~Dfg~a~~~~  483 (552)
                          ..+.++|+|+++.||+++.   ++. ..|+||+.+....
T Consensus       184 ~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd  226 (306)
T 3tdw_A          184 VYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD  226 (306)
T ss_dssp             HHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred             ccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence                2234799999999999987   455 4899999886443

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.22  E-value=4.8e-06  Score=80.59  Aligned_cols=123  Identities=17%  Similarity=0.153  Sum_probs=89.0

Q ss_pred             EEEEEEee--cCcEEEEEEeccC----hHHHHHHHHHcC-CCCccceeeeeecCCCCeeEEEEeeccCCCchhhhhhcCC
Q 037224          351 GSVYKGNI--HGEVYAIKMMKWN----ACEELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKN  423 (552)
Q Consensus       351 G~Vy~~~~--~g~~vAvK~~~~~----~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~  423 (552)
                      ..||+...  .+..+.+|+....    ..+|...|+.+. +--+.+++.++.+  .+..++|||+++|.++.+.....  
T Consensus        39 ~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~--~~~~~lvme~l~G~~~~~~~~~~--  114 (272)
T 4gkh_A           39 ATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRT--PDDAWLLTTAIPGKTAFQVLEEY--  114 (272)
T ss_dssp             CEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEEEECCCSEEHHHHHHHC--
T ss_pred             CeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEE--CCeEEEEEEeeCCccccccccCC--
Confidence            46888655  4668999987543    457999998884 3346778888776  56779999999998877654332  


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------------------
Q 037224          424 ENLNWKTRLRIAIDVANGLQYIHEHT------------------------------------------------------  449 (552)
Q Consensus       424 ~~l~~~~~~~i~~qi~~aL~~LH~~~------------------------------------------------------  449 (552)
                          ..+...+..+++..|..||...                                                      
T Consensus       115 ----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  190 (272)
T 4gkh_A          115 ----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFS  190 (272)
T ss_dssp             ----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCC
T ss_pred             ----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhccccc
Confidence                1233456677777777777321                                                      


Q ss_pred             -CCceEecCCCCCcEEECCCCcEEEeeccCCcc
Q 037224          450 -RPRVVHKDIKSSNILLDSNMRAKIANFGLAKS  481 (552)
Q Consensus       450 -~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  481 (552)
                       .+.++|+|+++.|||+++++.+-|+||+.+..
T Consensus       191 ~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          191 PDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             CCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             CCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence             12379999999999999877778999998753

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.16  E-value=1e-05  Score=81.70  Aligned_cols=70  Identities=4%  Similarity=0.046  Sum_probs=48.9

Q ss_pred             ceEEEEEEEEeec--------CcEEEEEEecc----------ChHHHHHHHHHcCC---CCccceeeeeecCC-CCeeEE
Q 037224          347 CLIQGSVYKGNIH--------GEVYAIKMMKW----------NACEELKILQKVNH---GNLVKLEGFCIDPE-DANCYL  404 (552)
Q Consensus       347 ~g~~G~Vy~~~~~--------g~~vAvK~~~~----------~~~~E~~~l~~l~h---~niv~l~~~~~~~~-~~~~~l  404 (552)
                      .|....+|+....        ++.+++|+...          ...+|..+++.+..   -.+.+++.++.+.. .+..++
T Consensus        31 ~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~  110 (357)
T 3ats_A           31 TGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFF  110 (357)
T ss_dssp             TSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEE
T ss_pred             CCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceE
Confidence            4445789988765        77899998643          24579999998843   35677877765421 134689


Q ss_pred             EEeeccCCCchh
Q 037224          405 IYEYIENGSLHS  416 (552)
Q Consensus       405 v~e~~~~gsL~~  416 (552)
                      +|||++|.++.+
T Consensus       111 v~e~l~G~~l~~  122 (357)
T 3ats_A          111 LMDYVEGVVPPD  122 (357)
T ss_dssp             EEECCCCBCCCB
T ss_pred             EEEecCCCChhh
Confidence            999999877654

>4a1k_A Putative L, D-transpeptidase YKUD; transferase, peptidoglycan synthesis; HET: CME; 1.75A {Bacillus subtilis} PDB: 4a1j_A 4a1i_A* 1y7m_A 3zqd_A 4a52_A*

Probab=98.07  E-value=2.3e-06  Score=76.19  Aligned_cols=43  Identities=23%  Similarity=0.505  Sum_probs=39.9

Q ss_pred             EEEecCCCCCHHHHHhHhCCChhhHhhhcCC---cccCCceeeccc
Q 037224          184 VSYVLQPSENLSSVASRFGIETQAIIDVNGN---NIRPFDTLFVPV  226 (552)
Q Consensus       184 ~~y~v~~Gdtl~~ia~~~~~s~~~l~~~N~~---~~~~g~~l~ip~  226 (552)
                      ++|+|++||||++||++|+++..+|+++|+.   .+.+|+.+.||.
T Consensus         3 ~~y~V~~GdtL~~IA~~f~~g~~~l~~aNp~vd~~l~~g~~i~ip~   48 (165)
T 4a1k_A            3 LTYQVKQGDTLNSIAADFRISTAALLQANPSLQAGLTAGQSIVIPG   48 (165)
T ss_dssp             EEEECCTTCCHHHHHHHTTCCHHHHHHHCGGGGGCCCTTCEEEETT
T ss_pred             EEEEECCCCCHHHHHHHhCCCHHHHHHhCccCCCccCCCccccCcc
Confidence            5899999999999999999999999999986   678999999983

>4a1k_A Putative L, D-transpeptidase YKUD; transferase, peptidoglycan synthesis; HET: CME; 1.75A {Bacillus subtilis} PDB: 4a1j_A 4a1i_A* 1y7m_A 3zqd_A 4a52_A*

Probab=97.98  E-value=3e-06  Score=75.36  Aligned_cols=46  Identities=26%  Similarity=0.554  Sum_probs=41.4

Q ss_pred             eEEEEecCCchhhhHHhhcCCcchHHHHHHhCCCCCCCCCCCCcEEEEee
Q 037224          117 LSYTIKSGDTFYLVSTNKYQNLTTYQSVEVVNPTFVPTKLEVGDVIIFPV  166 (552)
Q Consensus       117 ~~y~v~~gdtl~~Ia~~~~~~~~~~~~l~~~N~~~~~~~l~~gq~l~ip~  166 (552)
                      .+|+|++||||+.|| ++|+  +..++|+++|+..+ ..|.+||+|.||.
T Consensus         3 ~~y~V~~GdtL~~IA-~~f~--~g~~~l~~aNp~vd-~~l~~g~~i~ip~   48 (165)
T 4a1k_A            3 LTYQVKQGDTLNSIA-ADFR--ISTAALLQANPSLQ-AGLTAGQSIVIPG   48 (165)
T ss_dssp             EEEECCTTCCHHHHH-HHTT--CCHHHHHHHCGGGG-GCCCTTCEEEETT
T ss_pred             EEEEECCCCCHHHHH-HHhC--CCHHHHHHhCccCC-CccCCCccccCcc
Confidence            469999999999999 7888  99999999999887 4689999999983

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.77  E-value=0.0002  Score=71.40  Aligned_cols=133  Identities=13%  Similarity=0.128  Sum_probs=78.3

Q ss_pred             eEEEEEEEEeecCcEEEEEEeccCh---HHHHHHHHHcCC--CCccceeee-----e-ecCCCCeeEEEEeeccCCCchh
Q 037224          348 LIQGSVYKGNIHGEVYAIKMMKWNA---CEELKILQKVNH--GNLVKLEGF-----C-IDPEDANCYLIYEYIENGSLHS  416 (552)
Q Consensus       348 g~~G~Vy~~~~~g~~vAvK~~~~~~---~~E~~~l~~l~h--~niv~l~~~-----~-~~~~~~~~~lv~e~~~~gsL~~  416 (552)
                      |..+.||+...++..+++|+.....   ..|..+++.+..  -.+++++..     + ..  .+..+++|||++|.++..
T Consensus        43 G~~n~~~~v~~~~~~~vlk~~~~~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~--~~~~~~l~~~i~G~~~~~  120 (346)
T 2q83_A           43 NQMALVWKVHTDSGAVCLKRIHRPEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKH--GSFLFVVYDWIEGRPFEL  120 (346)
T ss_dssp             ---CEEEEEEETTEEEEEEEECSCHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEE--TTEEEEEEECCCCBCCCT
T ss_pred             cccCcEEEEEeCCCCEEEEecCCCHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEE--CCEEEEEEEeecCccCCC
Confidence            3457899988877779999987532   246666666632  133444431     1 12  456789999999865530


Q ss_pred             --------------hhhhcCC----C--------CCCHHHH-------------------------------HHHHHHHH
Q 037224          417 --------------WLHENKN----E--------NLNWKTR-------------------------------LRIAIDVA  439 (552)
Q Consensus       417 --------------~l~~~~~----~--------~l~~~~~-------------------------------~~i~~qi~  439 (552)
                                    .++....    .        ...|...                               ..+..++.
T Consensus       121 ~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (346)
T 2q83_A          121 TVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDGFIEDGL  200 (346)
T ss_dssp             TSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHHHHHHHH
Confidence                          1111100    0        0122211                               01112234


Q ss_pred             HHHHHHHh----------CCCCceEecCCCCCcEEECCCCcEEEeeccCCccC
Q 037224          440 NGLQYIHE----------HTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSG  482 (552)
Q Consensus       440 ~aL~~LH~----------~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  482 (552)
                      .++++|++          .....++|+|+++.||+++.++.+.|+||+.+...
T Consensus       201 ~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~g  253 (346)
T 2q83_A          201 RIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSFD  253 (346)
T ss_dssp             HHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEEC
T ss_pred             HHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcccC
Confidence            45666653          12345999999999999988889999999988543

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.53  E-value=0.00056  Score=67.51  Aligned_cols=129  Identities=13%  Similarity=0.163  Sum_probs=82.8

Q ss_pred             CceEEEEEEEEeecCcEEEEEEeccC----hHHHHHHHHHcC---CCCccceeeeeecCCCCeeEEEEeeccCCCchh--
Q 037224          346 GCLIQGSVYKGNIHGEVYAIKMMKWN----ACEELKILQKVN---HGNLVKLEGFCIDPEDANCYLIYEYIENGSLHS--  416 (552)
Q Consensus       346 G~g~~G~Vy~~~~~g~~vAvK~~~~~----~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~--  416 (552)
                      +.|....+|+...+++.+++|+....    +.+|...|+.+.   ...+++++.++..  .+..++||||+++.++..  
T Consensus        45 ~gG~~n~~y~v~~~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~--~g~~~lvme~l~G~~~~~~~  122 (312)
T 3jr1_A           45 YSGEMNEIWLINDEVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNS--QGHSFLLLEALNKSKNKQSS  122 (312)
T ss_dssp             CCSSSSEEEEEESSSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC--SSEEEEEEECCCCCCCCTTH
T ss_pred             CCccceeeeEEEECCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeec--CCceEEEEEeccCCCCCchh
Confidence            33444789998888889999987543    457888888883   3567788877765  467899999999876531  


Q ss_pred             ---------hhhhcCC-C-------------------CCCHHHHH---HHH----------------HHHHHHH-HHHHh
Q 037224          417 ---------WLHENKN-E-------------------NLNWKTRL---RIA----------------IDVANGL-QYIHE  447 (552)
Q Consensus       417 ---------~l~~~~~-~-------------------~l~~~~~~---~i~----------------~qi~~aL-~~LH~  447 (552)
                               .++.... .                   .-+|.+..   ++.                .++++.+ ..|..
T Consensus       123 ~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~~L~~  202 (312)
T 3jr1_A          123 FTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVADTLSK  202 (312)
T ss_dssp             HHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHHHhcc
Confidence                     1222111 0                   01344322   111                1122222 23321


Q ss_pred             -CCCCceEecCCCCCcEEECCCCcEEEeecc
Q 037224          448 -HTRPRVVHKDIKSSNILLDSNMRAKIANFG  477 (552)
Q Consensus       448 -~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg  477 (552)
                       ...+.++|+|+.+.|++++.++ ..|+|+.
T Consensus       203 ~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          203 HNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             CCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             CCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence             2346799999999999999887 8999984

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.44  E-value=0.00081  Score=66.50  Aligned_cols=150  Identities=14%  Similarity=0.170  Sum_probs=83.9

Q ss_pred             ccHHHHHHHhhccCCC---------ceEEEEEEEEeecCcEEEEEEecc-----ChHHHHHHHHHcCCCC--ccceeeee
Q 037224          331 FKIEELREATDNFSEG---------CLIQGSVYKGNIHGEVYAIKMMKW-----NACEELKILQKVNHGN--LVKLEGFC  394 (552)
Q Consensus       331 ~~~~~l~~~t~~~~~G---------~g~~G~Vy~~~~~g~~vAvK~~~~-----~~~~E~~~l~~l~h~n--iv~l~~~~  394 (552)
                      ++.+++......++.|         .|....+|+...++..+++|+...     ....|..++..+....  +.+++...
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~   86 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRK   86 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBT
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCC
Confidence            4455555555555543         243467898887666789998865     2346888888874323  33443211


Q ss_pred             ec----CCCCeeEEEEeeccCCCchhh--------------hhhcC-C---C---CC---CHHHHHH------------H
Q 037224          395 ID----PEDANCYLIYEYIENGSLHSW--------------LHENK-N---E---NL---NWKTRLR------------I  434 (552)
Q Consensus       395 ~~----~~~~~~~lv~e~~~~gsL~~~--------------l~~~~-~---~---~l---~~~~~~~------------i  434 (552)
                      ..    ...+..+++++|++|..+...              ++... .   .   ..   .|.....            +
T Consensus        87 ~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l  166 (322)
T 2ppq_A           87 DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGL  166 (322)
T ss_dssp             TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTH
T ss_pred             CCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhh
Confidence            00    012456899999998654220              11110 0   0   01   1221100            0


Q ss_pred             HHHHHHHHHHHHhC----CCCceEecCCCCCcEEECCCCcEEEeeccCCc
Q 037224          435 AIDVANGLQYIHEH----TRPRVVHKDIKSSNILLDSNMRAKIANFGLAK  480 (552)
Q Consensus       435 ~~qi~~aL~~LH~~----~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  480 (552)
                      ...+.+.++++++.    .+..++|+|+++.||+++.++.+.|+||+.+.
T Consensus       167 ~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          167 REEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             HHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            11234455566532    12358999999999999887666899999875

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.41  E-value=0.00053  Score=70.16  Aligned_cols=63  Identities=16%  Similarity=-0.034  Sum_probs=40.3

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEecc--------------ChHHHHHHHHHcCC--C-CccceeeeeecCCCCeeEEEE
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKW--------------NACEELKILQKVNH--G-NLVKLEGFCIDPEDANCYLIY  406 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~--------------~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~~~~~lv~  406 (552)
                      |.|..+.||++..  .++.++||....              ....|.++++.+..  + .+.+++.+  +  ....++||
T Consensus        39 g~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d--~~~~~lvm  114 (397)
T 2olc_A           39 GDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D--TEMAVTVM  114 (397)
T ss_dssp             CSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E--TTTTEEEE
T ss_pred             CCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--c--CCccEEEE
Confidence            4555689999965  568899997531              12468889888742  3 34455543  3  23348999


Q ss_pred             eeccCC
Q 037224          407 EYIENG  412 (552)
Q Consensus       407 e~~~~g  412 (552)
                      ||+++.
T Consensus       115 E~l~g~  120 (397)
T 2olc_A          115 EDLSHL  120 (397)
T ss_dssp             CCCTTS
T ss_pred             EeCCCc
Confidence            999764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.24  E-value=0.00091  Score=69.03  Aligned_cols=77  Identities=9%  Similarity=0.115  Sum_probs=47.6

Q ss_pred             CCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccccc-c--ccccccCccccCCC---CCCChhhHHHHHHHHHHH
Q 037224          450 RPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI-V--GTQGYIAPEYLADG---VVSTKMDVFSFGVVLLEL  523 (552)
Q Consensus       450 ~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~-~--gt~~y~aPE~~~~~---~~s~~~Dv~slG~il~el  523 (552)
                      .+.++|||+++.|||++.++ ++|+||+.+.......+-.. .  -...|++|+.....   ......++......+|+.
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            44599999999999998876 99999998875432211110 0  11345666544311   112234556777777777


Q ss_pred             HcCC
Q 037224          524 ISGK  527 (552)
Q Consensus       524 ltG~  527 (552)
                      ++++
T Consensus       310 y~~~  313 (420)
T 2pyw_A          310 FNKR  313 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            6653

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.24  E-value=0.0017  Score=64.49  Aligned_cols=127  Identities=13%  Similarity=0.084  Sum_probs=73.3

Q ss_pred             EEEEeec-CcEEEEEEec----cChHHHHHHHHHcCCCC--ccceeeeeecCCCCeeEEEEeeccCCCchhhhhhcC---
Q 037224          353 VYKGNIH-GEVYAIKMMK----WNACEELKILQKVNHGN--LVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENK---  422 (552)
Q Consensus       353 Vy~~~~~-g~~vAvK~~~----~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---  422 (552)
                      +|+.... |+.+++|...    .....|+.+++.+....  +.+++.+..  +.+  +++||++.+..+.+++....   
T Consensus        35 ~~r~~~~~~~~~vlk~~~~~~~~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g--~ll~e~l~~~~l~~~l~~~~~~~  110 (333)
T 3csv_A           35 YQRLRSPTGAKAVLMDWSPEEGGDTQPFVDLAQYLRNLDISAPEIYAEEH--ARG--LLLIEDLGDALFTEVINNDPAQE  110 (333)
T ss_dssp             CEEEECTTCCEEEEEECCTTTTCCSHHHHHHHHHHHHTTCBCCCEEEEET--TTT--EEEECCCCSCBHHHHHHHCGGGH
T ss_pred             EEEEEcCCCCeEEEEECCCCCCccccHHHHHHHHHHhCCCCCCceeeecC--CCC--EEEEeeCCCcchHHHhcCCCccH
Confidence            5676663 7778888764    34567899888884333  455665532  233  78999997766654332110   


Q ss_pred             ------------------C---CCCCHHHHH-------HH-------------HHHHHHHHHHHH---hCCCCceEecCC
Q 037224          423 ------------------N---ENLNWKTRL-------RI-------------AIDVANGLQYIH---EHTRPRVVHKDI  458 (552)
Q Consensus       423 ------------------~---~~l~~~~~~-------~i-------------~~qi~~aL~~LH---~~~~~~ivH~Di  458 (552)
                                        .   ..++.....       .+             ...+...++.+.   ......++|||+
T Consensus       111 ~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~~~~~lvHgD~  190 (333)
T 3csv_A          111 MPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLEGDMVFVHRDF  190 (333)
T ss_dssp             HHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCCSCCEEECSCC
T ss_pred             HHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcccCCCeeEeCCc
Confidence                              0   012211110       00             001112222221   122345999999


Q ss_pred             CCCcEEECCC----CcEEEeeccCCccCC
Q 037224          459 KSSNILLDSN----MRAKIANFGLAKSGC  483 (552)
Q Consensus       459 kp~NIll~~~----~~~kL~Dfg~a~~~~  483 (552)
                      ++.||+++.+    +.+.|+||+.+....
T Consensus       191 ~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          191 HAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             SGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             CcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence            9999999874    689999999886443

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.19  E-value=0.0032  Score=65.53  Aligned_cols=63  Identities=22%  Similarity=0.138  Sum_probs=43.4

Q ss_pred             CceEEEEEEEEeecC--cEEEEEEecc------ChHHHHHHHHHcCCCCc-cceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNIHG--EVYAIKMMKW------NACEELKILQKVNHGNL-VKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~~g--~~vAvK~~~~------~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      +.|....+|+....+  +.+.+|+...      +..+|..+++.+...++ .++++.+.    +  .+||||++|.+|
T Consensus       117 sgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~----~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          117 NGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT----N--GRIEEFMDGYAL  188 (458)
T ss_dssp             CC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET----T--EEEEECCCSEEC
T ss_pred             CCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC----C--eEEEEeeCCccC
Confidence            344557899998865  7899998742      12589999999965555 55666552    2  369999998555

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=96.96  E-value=0.003  Score=61.37  Aligned_cols=63  Identities=17%  Similarity=0.258  Sum_probs=43.6

Q ss_pred             CceEEEEEEEEee-cCcEEEEEEeccC-------hHHHHHHHHHcCCC---CccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI-HGEVYAIKMMKWN-------ACEELKILQKVNHG---NLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~-~g~~vAvK~~~~~-------~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|..+.||+.+. +|+.+.+|+....       +.+|...|+.|...   .+++++++  +  +.  +++|||++++..
T Consensus        24 g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~--~lv~e~l~~~~~   97 (288)
T 3f7w_A           24 GHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DR--TLAMEWVDERPP   97 (288)
T ss_dssp             EEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TT--EEEEECCCCCCC
T ss_pred             CCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--Cc--eEEEEeecccCC
Confidence            4444589999998 7899999986421       45799999988422   24444443  2  22  799999987654

>3slu_A M23 peptidase domain protein; outer membrane, hydrolase; 2.41A {Neisseria meningitidis}

Probab=96.90  E-value=0.0026  Score=63.80  Aligned_cols=107  Identities=8%  Similarity=0.059  Sum_probs=73.7

Q ss_pred             eEEEEecCCchhhhHHhhcCCcchHHHHHHhCCCC----CCCCCCCCcEEEEeeeecCCCCc-----ccc-CceeEE---
Q 037224          117 LSYTIKSGDTFYLVSTNKYQNLTTYQSVEVVNPTF----VPTKLEVGDVIIFPVFCKCPNQT-----QLR-NRVNYL---  183 (552)
Q Consensus       117 ~~y~v~~gdtl~~Ia~~~~~~~~~~~~l~~~N~~~----~~~~l~~gq~l~ip~~~~~~~~~-----~~~-~~~~~~---  183 (552)
                      ..|+|++||||..|- ++++  ++.+++.+.+...    +...|++||.|.+.+...- .-.     ... ......   
T Consensus        15 ~~~~V~~GDTL~~IL-~r~G--ls~~di~~i~~~~~~~~~l~~LrpGq~l~i~~~~~~-~l~~l~~~~~~~~~~~~v~i~   90 (371)
T 3slu_A           15 VQEAVQPGDSLADVL-ARSG--MARDEIARITEKYGGEADLRHLRADQSVHVLVGGDG-GAREVQFFTDEDGERNLVALE   90 (371)
T ss_dssp             EEEECCTTCCHHHHH-HHTT--CCHHHHHHHHTTC------CCBCSSSEEEEEECTTS-CEEEEEEEECCTTEEEEEEEE
T ss_pred             EEEEECCCCcHHHHH-HHcC--CCHHHHHHHHHhccccCchhhCCCCCEEEEEECCCC-CeEEEEEEecCCCceeEEEEE
Confidence            469999999999999 7787  8878887775543    3368999999999864211 000     000 000000   


Q ss_pred             -------------------EEEecCCCCCHHHHHhHhCCChhhHhhhcCC--------cccCCceeecccc
Q 037224          184 -------------------VSYVLQPSENLSSVASRFGIETQAIIDVNGN--------NIRPFDTLFVPVA  227 (552)
Q Consensus       184 -------------------~~y~v~~Gdtl~~ia~~~~~s~~~l~~~N~~--------~~~~g~~l~ip~~  227 (552)
                                         ..+.+.-.++|+..|.+.|++...+++++.+        .|++|+.+.|...
T Consensus        91 ~~dg~f~~~~~~~~~~~~~~~~~g~I~~Sl~~a~~~agl~~~~~~~l~~i~~~~idf~~l~~GD~f~v~~~  161 (371)
T 3slu_A           91 KKGGIWRRSASEADMKVLPTLRSVVVKTSARGSLARAEVPVEIRESLSGIFAGRFSLDGLKEGDAVRLIYD  161 (371)
T ss_dssp             EETTEEEECCCGGGEEEEEEEEEEECSSCHHHHHHHTTCCHHHHHHHHHHHTTTCCTTCCCTTCEEEEEEE
T ss_pred             ecCCeeEEEeeecccceeeeEEEEEEeccHHHHHHHcCCCHHHHHHHHHHHccCcCHHHcCCCCEEEEEEE
Confidence                               0122334789999999999999999988875        4899999977654

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.90  E-value=0.0033  Score=61.57  Aligned_cols=31  Identities=23%  Similarity=0.246  Sum_probs=25.9

Q ss_pred             CceEecCCCCCcEEECCCCcEEEeeccCCccC
Q 037224          451 PRVVHKDIKSSNILLDSNMRAKIANFGLAKSG  482 (552)
Q Consensus       451 ~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  482 (552)
                      ..++|+|+.+.||+ ..++.+.|+||..+...
T Consensus       173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          173 LAACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             CEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             ceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence            44899999999999 56677899999988643

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.86  E-value=0.0026  Score=65.83  Aligned_cols=62  Identities=16%  Similarity=0.154  Sum_probs=41.8

Q ss_pred             ceEEEEEEEEeec---------CcEEEEEEecc-----ChHHHHHHHHHcCCCCc-cceeeeeecCCCCeeEEEEeeccC
Q 037224          347 CLIQGSVYKGNIH---------GEVYAIKMMKW-----NACEELKILQKVNHGNL-VKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       347 ~g~~G~Vy~~~~~---------g~~vAvK~~~~-----~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|....+|+....         ++.+.+|+...     ...+|..+++.+...++ +++++.+.+      .+|+||++|
T Consensus        83 gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~------g~v~e~l~G  156 (429)
T 1nw1_A           83 GGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG------GRLEEYIPS  156 (429)
T ss_dssp             CCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT------EEEECCCCE
T ss_pred             CCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC------CEEEEEeCC
Confidence            3344789998763         47899999843     23468888888854444 566665432      489999987


Q ss_pred             CCc
Q 037224          412 GSL  414 (552)
Q Consensus       412 gsL  414 (552)
                      .+|
T Consensus       157 ~~l  159 (429)
T 1nw1_A          157 RPL  159 (429)
T ss_dssp             EEC
T ss_pred             ccc
Confidence            554

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.85  E-value=0.0044  Score=61.84  Aligned_cols=69  Identities=13%  Similarity=0.105  Sum_probs=43.9

Q ss_pred             CceEEEEEEEEeecCcEEEEEEeccCh-HHHHHHHHHcCCC---Cccceeeeeec----CCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNIHGEVYAIKMMKWNA-CEELKILQKVNHG---NLVKLEGFCID----PEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~~g~~vAvK~~~~~~-~~E~~~l~~l~h~---niv~l~~~~~~----~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|....||+....+..+++|+..... .+|+.+++.|...   ++++++.....    ...+..+++|+|++|..+
T Consensus        32 G~g~~N~vy~v~~~~g~~vLK~~~~~~~~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~~~  108 (339)
T 3i1a_A           32 GADTNAFAYQADSESKSYFIKLKYGYHDEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAPNG  108 (339)
T ss_dssp             TSCSSCEEEEEECSSCEEEEEEEECSSCCHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCCBT
T ss_pred             cCccccceEEEEeCCCCEEEEEecCccchHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCCcC
Confidence            333346799988755599999876543 5788888877322   24454432110    114567899999998766

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.77  E-value=0.0057  Score=61.72  Aligned_cols=62  Identities=8%  Similarity=0.130  Sum_probs=40.0

Q ss_pred             ceEEEEEEEEeecC----------cEEEEEEeccC------hHHHHHHHHHcCCCC-ccceeeeeecCCCCeeEEEEeec
Q 037224          347 CLIQGSVYKGNIHG----------EVYAIKMMKWN------ACEELKILQKVNHGN-LVKLEGFCIDPEDANCYLIYEYI  409 (552)
Q Consensus       347 ~g~~G~Vy~~~~~g----------~~vAvK~~~~~------~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~~~lv~e~~  409 (552)
                      .|....+|+....+          +.+++|+....      ...|..+++.+...+ ..++++..    .+  +++|||+
T Consensus        43 ~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~--~~v~e~i  116 (369)
T 3c5i_A           43 SGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF----NG--GRIEEWL  116 (369)
T ss_dssp             ---CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE----TT--EEEEECC
T ss_pred             CcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec----CC--cEEEEEe
Confidence            34446788887643          68899987532      357888998885444 44666443    22  7899999


Q ss_pred             cCCCc
Q 037224          410 ENGSL  414 (552)
Q Consensus       410 ~~gsL  414 (552)
                      +|.++
T Consensus       117 ~G~~l  121 (369)
T 3c5i_A          117 YGDPL  121 (369)
T ss_dssp             CSEEC
T ss_pred             cCCcC
Confidence            98654

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.69  E-value=0.005  Score=62.37  Aligned_cols=127  Identities=14%  Similarity=0.176  Sum_probs=76.7

Q ss_pred             eEEEEEEEEeec---------CcEEEEEEecc------ChHHHHHHHHHcC-CCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          348 LIQGSVYKGNIH---------GEVYAIKMMKW------NACEELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       348 g~~G~Vy~~~~~---------g~~vAvK~~~~------~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      |....+|+....         ++.+.+|+...      ...+|..+++.+. +.-..++++++.+      .+||||++|
T Consensus        61 G~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~------g~v~e~i~G  134 (379)
T 3feg_A           61 GLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE------GRLEQYIPS  134 (379)
T ss_dssp             ---CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT------EEEEECCSE
T ss_pred             cccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC------ccEEEEecC
Confidence            334667887663         46889998632      2347999988884 3334566665532      389999998


Q ss_pred             CCchhh-----------------hhhcC---CCCC--CHHHHHHHHHHHHH-------------------HHHHHH----
Q 037224          412 GSLHSW-----------------LHENK---NENL--NWKTRLRIAIDVAN-------------------GLQYIH----  446 (552)
Q Consensus       412 gsL~~~-----------------l~~~~---~~~l--~~~~~~~i~~qi~~-------------------aL~~LH----  446 (552)
                      .+|..-                 ++...   ....  -+.++.++..++..                   .++.|.    
T Consensus       135 ~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~  214 (379)
T 3feg_A          135 RPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLE  214 (379)
T ss_dssp             EECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHH
T ss_pred             ccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHh
Confidence            665421                 11111   1112  24555556554422                   233332    


Q ss_pred             hC-CCCceEecCCCCCcEEECCC----CcEEEeeccCCc
Q 037224          447 EH-TRPRVVHKDIKSSNILLDSN----MRAKIANFGLAK  480 (552)
Q Consensus       447 ~~-~~~~ivH~Dikp~NIll~~~----~~~kL~Dfg~a~  480 (552)
                      .. ....++|+|+.+.||+++.+    +.+.|+||..+.
T Consensus       215 ~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          215 STPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             TSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             hcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            22 22358999999999999876    789999999885

>3slu_A M23 peptidase domain protein; outer membrane, hydrolase; 2.41A {Neisseria meningitidis}

Probab=96.39  E-value=0.0057  Score=61.34  Aligned_cols=118  Identities=10%  Similarity=-0.014  Sum_probs=76.4

Q ss_pred             ccceeEeeccCCCCCCHHHHHHHhCCChhhhcCcCCCCC---CCCCccCCCcEEEeeeccccc------CCCCCcee---
Q 037224           46 CRTYAFYRASAPDFLDLASIADLFSVSRLMISEPSNISS---PSSPLIQNQPLFVPITCSCNT------LNASYTIS---  113 (552)
Q Consensus        46 c~~~~~y~v~~~~g~tl~~Ia~~~~~~~~~l~~~N~~~~---~~~~~~~g~~l~iP~~~~~~~------~~~~~~~~---  113 (552)
                      -..|..|+|++  ||||++|-+++|++..++.+++....   +...|++||.|.+.....-..      ........   
T Consensus        11 ~~~W~~~~V~~--GDTL~~IL~r~Gls~~di~~i~~~~~~~~~l~~LrpGq~l~i~~~~~~~l~~l~~~~~~~~~~~~v~   88 (371)
T 3slu_A           11 TAYWVQEAVQP--GDSLADVLARSGMARDEIARITEKYGGEADLRHLRADQSVHVLVGGDGGAREVQFFTDEDGERNLVA   88 (371)
T ss_dssp             CCEEEEEECCT--TCCHHHHHHHTTCCHHHHHHHHTTC------CCBCSSSEEEEEECTTSCEEEEEEEECCTTEEEEEE
T ss_pred             CCceEEEEECC--CCcHHHHHHHcCCCHHHHHHHHHhccccCchhhCCCCCEEEEEECCCCCeEEEEEEecCCCceeEEE
Confidence            34688999999  99999999999999988877664321   256899999999976432100      00000000   


Q ss_pred             --eeeeEEE----------------EecCCchhhhHHhhcCCcchHHHHHHhCCCCCC----CCCCCCcEEEEeeee
Q 037224          114 --FANLSYT----------------IKSGDTFYLVSTNKYQNLTTYQSVEVVNPTFVP----TKLEVGDVIIFPVFC  168 (552)
Q Consensus       114 --~~~~~y~----------------v~~gdtl~~Ia~~~~~~~~~~~~l~~~N~~~~~----~~l~~gq~l~ip~~~  168 (552)
                        ...-.|+                +.=+++||..| ...+  ++.+.+++++.+-..    ..|++|+++.|....
T Consensus        89 i~~~dg~f~~~~~~~~~~~~~~~~~g~I~~Sl~~a~-~~ag--l~~~~~~~l~~i~~~~idf~~l~~GD~f~v~~~~  162 (371)
T 3slu_A           89 LEKKGGIWRRSASEADMKVLPTLRSVVVKTSARGSL-ARAE--VPVEIRESLSGIFAGRFSLDGLKEGDAVRLIYDS  162 (371)
T ss_dssp             EEEETTEEEECCCGGGEEEEEEEEEEECSSCHHHHH-HHTT--CCHHHHHHHHHHHTTTCCTTCCCTTCEEEEEEEE
T ss_pred             EEecCCeeEEEeeecccceeeeEEEEEEeccHHHHH-HHcC--CCHHHHHHHHHHHccCcCHHHcCCCCEEEEEEEE
Confidence              0001122                23378999988 6666  677777776654332    258999999998653

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.21  E-value=0.044  Score=53.91  Aligned_cols=128  Identities=12%  Similarity=0.207  Sum_probs=72.2

Q ss_pred             EEEEEEee-cCcEEEEEEeccC------hHHHHHHHHHcCCCC--ccceeeeeecC-----CCCeeEEEEeeccCCCchh
Q 037224          351 GSVYKGNI-HGEVYAIKMMKWN------ACEELKILQKVNHGN--LVKLEGFCIDP-----EDANCYLIYEYIENGSLHS  416 (552)
Q Consensus       351 G~Vy~~~~-~g~~vAvK~~~~~------~~~E~~~l~~l~h~n--iv~l~~~~~~~-----~~~~~~lv~e~~~~gsL~~  416 (552)
                      ..||+... +|+.+++|.....      ...|..+++.+....  +++++..  +.     .++..+++|+|++|.++..
T Consensus        39 n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~l~~~i~G~~~~~  116 (328)
T 1zyl_A           39 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFAVFPSVGGRQFEA  116 (328)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEEEEECCCCEECCS
T ss_pred             cceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEEEEEecCCCCCCC
Confidence            57898876 5668999998632      346888888874322  3444432  11     1345678999998855431


Q ss_pred             -----h---------hhhc----CC---CCCCHHHH----HHH---------------HHHHHHHHHHHHhC----CCCc
Q 037224          417 -----W---------LHEN----KN---ENLNWKTR----LRI---------------AIDVANGLQYIHEH----TRPR  452 (552)
Q Consensus       417 -----~---------l~~~----~~---~~l~~~~~----~~i---------------~~qi~~aL~~LH~~----~~~~  452 (552)
                           +         ++..    ..   ..+++...    ..+               ...+...++.+...    ....
T Consensus       117 ~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  196 (328)
T 1zyl_A          117 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL  196 (328)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred             CCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhhcCCee
Confidence                 0         1110    00   11222211    001               01111223333321    2345


Q ss_pred             eEecCCCCCcEEECCCCcEEEeeccCCccC
Q 037224          453 VVHKDIKSSNILLDSNMRAKIANFGLAKSG  482 (552)
Q Consensus       453 ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  482 (552)
                      ++|+|+++.||+++ + .+.|+||+.+...
T Consensus       197 l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          197 RLHGDCHAGNILWR-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             ECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred             eeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence            89999999999998 4 8999999987643

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.33  E-value=0.098  Score=53.63  Aligned_cols=125  Identities=14%  Similarity=0.190  Sum_probs=76.5

Q ss_pred             EEEEEEEEeec---------CcEEEEEEecc------ChHHHHHHHHHcCCCC-ccceeeeeecCCCCeeEEEEeeccCC
Q 037224          349 IQGSVYKGNIH---------GEVYAIKMMKW------NACEELKILQKVNHGN-LVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       349 ~~G~Vy~~~~~---------g~~vAvK~~~~------~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      ....+|+....         ++.+.+|+...      +..+|..+++.+.... ..++++.+    .+  ++|+||++|.
T Consensus        82 ~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~----~~--~~I~efI~G~  155 (424)
T 3mes_A           82 LTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF----PE--GRIEEFIDGE  155 (424)
T ss_dssp             SSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE----TT--EEEEECCCSE
T ss_pred             cccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc----CC--CEEEEEeCCc
Confidence            33678887765         68899998743      2357999999884333 45565533    22  7899999986


Q ss_pred             Cchhh-----------------hhhc-----------CCCCCCHHHHHHHHHHH-------------------HHHHHHH
Q 037224          413 SLHSW-----------------LHEN-----------KNENLNWKTRLRIAIDV-------------------ANGLQYI  445 (552)
Q Consensus       413 sL~~~-----------------l~~~-----------~~~~l~~~~~~~i~~qi-------------------~~aL~~L  445 (552)
                      +|..-                 ++..           ...+.-+.++.++..++                   ...+.+|
T Consensus       156 ~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~e~~~L  235 (424)
T 3mes_A          156 PLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILEEIDQL  235 (424)
T ss_dssp             ECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHHHHHHH
T ss_pred             cCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHHHHHHH
Confidence            64310                 0100           00111244444444332                   1223333


Q ss_pred             Hh---------------------CCCCceEecCCCCCcEEECCCCcEEEeeccCCc
Q 037224          446 HE---------------------HTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK  480 (552)
Q Consensus       446 H~---------------------~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  480 (552)
                      .+                     .....++|+|+.+.||+ +.++.+.|+||..+.
T Consensus       236 ~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~  290 (424)
T 3mes_A          236 EELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA  290 (424)
T ss_dssp             HHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred             HHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence            21                     11235899999999999 788899999999885

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=95.28  E-value=0.094  Score=48.11  Aligned_cols=122  Identities=13%  Similarity=0.082  Sum_probs=78.1

Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcccccc
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIV  491 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~  491 (552)
                      -+|.+.|.... .+++++++|.++.|.+.+|.-+-....  -..+=+.|..|++..+|.+...+ ..+.          .
T Consensus        33 vSL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------~   98 (229)
T 2yle_A           33 LSLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD----------A   98 (229)
T ss_dssp             EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             ccHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc----------c
Confidence            37888887654 469999999999999999877632111  11333457999999999987764 1110          1


Q ss_pred             ccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccCcccccchHHHHHHHh
Q 037224          492 GTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYWREMK  549 (552)
Q Consensus       492 gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  549 (552)
                      ....+.+||... ...+.+.=|||||+++|..+-=..|-+... ...+.+...+..|-
T Consensus        99 ~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~eE~-eLS~~LE~LL~~Mt  154 (229)
T 2yle_A           99 GEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENEER-ELSPPLEQLIDHMA  154 (229)
T ss_dssp             --------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTEEE-CCCHHHHHHHHHHT
T ss_pred             cccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcccch-hhCHHHHHHHHHHH
Confidence            123466888763 445678899999999999887665554433 34566677766663

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=93.29  E-value=0.024  Score=37.44  Aligned_cols=18  Identities=6%  Similarity=-0.228  Sum_probs=7.4

Q ss_pred             hhhHHHHHHHHHHHHHHH
Q 037224          263 IGLGICGASLVLVAGMWI  280 (552)
Q Consensus       263 i~~~~~~~~l~~~~~~~~  280 (552)
                      +..+++++++++++.+++
T Consensus        17 VVgGv~~~~ii~~~~~~~   34 (44)
T 2ks1_B           17 MVGALLLLLVVALGIGLF   34 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHHHHHH
Confidence            333444444444333333

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.10  E-value=0.46  Score=48.19  Aligned_cols=28  Identities=25%  Similarity=0.484  Sum_probs=24.6

Q ss_pred             eEecCCCCCcEEE------CCCCcEEEeeccCCc
Q 037224          453 VVHKDIKSSNILL------DSNMRAKIANFGLAK  480 (552)
Q Consensus       453 ivH~Dikp~NIll------~~~~~~kL~Dfg~a~  480 (552)
                      ++|+|+.+.|||+      +++..+.++||..|.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            6799999999999      456779999999985

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=93.03  E-value=0.018  Score=36.83  Aligned_cols=30  Identities=30%  Similarity=0.412  Sum_probs=16.6

Q ss_pred             CCCccEEEeeehhhHHHHHHHHHHHHHHHHh
Q 037224          252 TERKGVIIGLSIGLGICGASLVLVAGMWIYR  282 (552)
Q Consensus       252 ~~~~~~~i~i~i~~~~~~~~l~~~~~~~~~~  282 (552)
                      ....+.+.+++++. ++++++++.+++|++|
T Consensus         7 ~ls~GaIAGiVvG~-v~gv~li~~l~~~~~r   36 (38)
T 2k1k_A            7 GLTGGEIVAVIFGL-LLGAALLLGILVFRSR   36 (38)
T ss_dssp             TCCHHHHHHHHHHH-HHHHHHHHHHHHHHHC
T ss_pred             CCCCCceeeeehHH-HHHHHHHHHHHHHHee
Confidence            34466677766663 4444555555555554

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=92.38  E-value=0.031  Score=36.77  Aligned_cols=11  Identities=18%  Similarity=0.187  Sum_probs=4.8

Q ss_pred             HHHHHHHHHHH
Q 037224          266 GICGASLVLVA  276 (552)
Q Consensus       266 ~~~~~~l~~~~  276 (552)
                      +++++++++++
T Consensus        19 Gv~~v~ii~~~   29 (44)
T 2l2t_A           19 GLFILVIVGLT   29 (44)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHHH
Confidence            44444444433

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=92.24  E-value=0.022  Score=37.46  Aligned_cols=8  Identities=38%  Similarity=0.621  Sum_probs=3.4

Q ss_pred             EEEeeehh
Q 037224          257 VIIGLSIG  264 (552)
Q Consensus       257 ~~i~i~i~  264 (552)
                      .+++.+++
T Consensus        13 ~Ia~~vVG   20 (44)
T 2jwa_A           13 SIISAVVG   20 (44)
T ss_dssp             HHHHHHHH
T ss_pred             chHHHHHH
Confidence            34444444

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=88.57  E-value=1.5  Score=39.94  Aligned_cols=116  Identities=9%  Similarity=0.147  Sum_probs=76.7

Q ss_pred             CCCCccceeeeeecCCCCeeEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCc
Q 037224          383 NHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSN  462 (552)
Q Consensus       383 ~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~N  462 (552)
                      .||+++.. .+-.+  ++.+.+.++.-+  +...|-.-.   .++..++++++.+++....+++.     -+|--++|+|
T Consensus        43 ~~~~Fl~~-~I~e~--eD~v~~~y~~~~--~~~~f~~ik---~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N  109 (215)
T 4ann_A           43 HSPYFIDA-ELTEL--RDSFQIHYDIND--NHTPFDNIK---SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE  109 (215)
T ss_dssp             CCTTBCCE-EEEEC--SSEEEEEECCCT--TSEEGGGGG---GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred             cCCcccce-EEEEc--ccEEEEEEEcCc--ccCCHHHHH---hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence            67888766 33333  455555555433  333332221   27889999999999988865553     3678899999


Q ss_pred             EEECCCCcEEEeeccCCccCCCCccccccccccccCccccCCCCCCChhh-HHHHHHHHHHHHcCCCCCCc
Q 037224          463 ILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMD-VFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       463 Ill~~~~~~kL~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~D-v~slG~il~elltG~~pf~~  532 (552)
                      |+++.++.+++.-.|.-..               ++|.     ..+ ..| .-.+=+++..+++++..|++
T Consensus       110 L~f~~~~~p~i~~RGik~~---------------l~P~-----~~~-ee~fL~qyKAliiall~~K~~Fe~  159 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQNV---------------VDPL-----PVS-EAEFLTRYKALVICAFNEKQSFDA  159 (215)
T ss_dssp             EEECTTSCEEESCCEETTT---------------BSCC-----CCC-HHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred             EEEcCCCCEEEEEccCccC---------------CCCC-----CCC-HHHHHHHHHHHHHHHHcCCCCHHH
Confidence            9999999999987765321               2222     112 233 34778889999999999974

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=82.43  E-value=5.1  Score=36.59  Aligned_cols=115  Identities=10%  Similarity=0.160  Sum_probs=72.7

Q ss_pred             CCCCccceeeeeecCCCCeeEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCceEecCCCCC
Q 037224          383 NHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQ-YIHEHTRPRVVHKDIKSS  461 (552)
Q Consensus       383 ~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~-~LH~~~~~~ivH~Dikp~  461 (552)
                      .||++ .. .+-.+  ++.+.+.++.-+++.=...+.     .++..++++++.+++.... +++.     -+|--++|+
T Consensus        48 ~~~~f-~~-~I~~~--eD~~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~  113 (219)
T 4ano_A           48 VDPCI-VR-DIDVS--EDEVKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE  113 (219)
T ss_dssp             SCSSS-EE-EEEEC--SSEEEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred             cCCCC-Ce-EEEEe--CCEEEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence            67777 22 23333  555555555443322122222     2788999998888877666 4443     467889999


Q ss_pred             cEEECCCCcEEEeeccCCccCCCCccccccccccccCccccCCCCCCChhhHH-HHHHHHHHHHcCCCCCCc
Q 037224          462 NILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVF-SFGVVLLELISGKEAIDE  532 (552)
Q Consensus       462 NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~-slG~il~elltG~~pf~~  532 (552)
                      ||++|.++.+++.-.|.-.               -++|.-+      ...|.| ++=+++..++.++..|++
T Consensus       114 NL~f~~~~~p~i~hRGi~~---------------~lpP~e~------~ee~fl~qyKali~all~~K~~Fe~  164 (219)
T 4ano_A          114 NLMFNRALEPFFLHVGVKE---------------SLPPDEW------DDERLLREVKATVLALTEGEYRFDE  164 (219)
T ss_dssp             GEEECTTCCEEESCCEETT---------------TBSSCSC------CHHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred             eEEEeCCCcEEEEEcCCcc---------------cCCCCCC------CHHHHHHHHHHHHHHHHcCCCCHHH
Confidence            9999999999998776532               2333221      233433 677888888888888863

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	552
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-53
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-51
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-50
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-48
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-47
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-46
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	8e-46
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-45
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	9e-45
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-44
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-43
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-43
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-43
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-42
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-42
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	7e-42
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-41
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-41
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	9e-41
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-40
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-40
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	7e-39
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	9e-39
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-38
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-38
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-38
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-38
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-38
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	6e-38
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	7e-38
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-37
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	8e-37
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-36
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	6e-36
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	8e-36
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-35
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-35
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-34
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-34
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-34
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-33
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-33
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	5e-33
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-32
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-32
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	7e-32
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	7e-32
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	7e-32
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-31
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-31
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-30
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-29
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-29
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-29
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-29
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-28
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-27
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-26
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-24
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-24
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-23
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-22
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-13
d1e0ga_	48	d.7.1.1 (A:) Membrane-bound lytic murein transclyc	2e-05
d1y7ma2	48	d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-term	0.002

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 2e-53
 Identities = 51/203 (25%), Positives = 97/203 (47%), Gaps = 20/203 (9%)

Query: 339 ATDNFSEGCLI----QGSVYKG--NIHGEVYAIKMMKWNACE--------ELKILQKVNH 384
             D+F +   +     G V+K      G V A K++              EL++L + N 
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 385 GNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQY 444
             +V   G           +  E+++ GSL   L +     +  +   +++I V  GL Y
Sbjct: 64  PYIVGFYGAFYSDG--EISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTY 119

Query: 445 IHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLAD 504
           + E  + +++H+D+K SNIL++S    K+ +FG++    +++    VGT+ Y++PE L  
Sbjct: 120 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQG 177

Query: 505 GVVSTKMDVFSFGVVLLELISGK 527
              S + D++S G+ L+E+  G+
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGR 200

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (446), Expect = 1e-51
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 24/199 (12%)

Query: 351 GSVYKGNIHGEVYAIKMMKWNAC---------EELKILQKVNHGNLVKLEGFCIDPEDAN 401
           G+VYKG  HG+V A+KM+   A           E+ +L+K  H N++   G+   P    
Sbjct: 22  GTVYKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP---Q 77

Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSS 461
             ++ ++ E  SL+  LH  +         + IA   A G+ Y+H      ++H+D+KS+
Sbjct: 78  LAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSN 133

Query: 462 NILLDSNMRAKIANFGLAK----SGCNAITMHIVGTQGYIAPEYL---ADGVVSTKMDVF 514
           NI L  ++  KI +FGLA        +     + G+  ++APE +        S + DV+
Sbjct: 134 NIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVY 193

Query: 515 SFGVVLLELISGKEAIDEE 533
           +FG+VL EL++G+      
Sbjct: 194 AFGIVLYELMTGQLPYSNI 212

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 4e-50
 Identities = 54/183 (29%), Positives = 93/183 (50%), Gaps = 10/183 (5%)

Query: 351 GSVYKGNIHGEVYAIKMMKWNACE-----ELKILQKVNHGNLVKLEGFCIDPEDANCYLI 405
           G V  G+  G   A+K +K +A       E  ++ ++ H NLV+L G  ++ E    Y++
Sbjct: 21  GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE-EKGGLYIV 79

Query: 406 YEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILL 465
            EY+  GSL  +L       L     L+ ++DV   ++Y+  +     VH+D+ + N+L+
Sbjct: 80  TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLV 136

Query: 466 DSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS 525
             +  AK+++FGL K   ++          + APE L +   STK DV+SFG++L E+ S
Sbjct: 137 SEDNVAKVSDFGLTKE-ASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 195

Query: 526 GKE 528
              
Sbjct: 196 FGR 198

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 1e-48
 Identities = 50/208 (24%), Positives = 94/208 (45%), Gaps = 21/208 (10%)

Query: 341 DNFSEGCLI----QGSVYKG--NIHGEVYAIKMMKWNAC---------EELKILQKVNHG 385
           +++     I     G   K      G++   K + + +           E+ +L+++ H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 386 NLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNEN--LNWKTRLRIAIDVANGLQ 443
           N+V+     ID  +   Y++ EY E G L S + +   E   L+ +  LR+   +   L+
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 444 YIHEHTR--PRVVHKDIKSSNILLDSNMRAKIANFGLAK--SGCNAITMHIVGTQGYIAP 499
             H  +     V+H+D+K +N+ LD     K+ +FGLA+  +   +     VGT  Y++P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183

Query: 500 EYLADGVVSTKMDVFSFGVVLLELISGK 527
           E +     + K D++S G +L EL +  
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALM 211

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 1e-47
 Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 30/216 (13%)

Query: 324 CLDKYRIFKIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWNACE------- 374
            L+ + I     L +            G+VY         + A+K++     E       
Sbjct: 4   ALEDFEI--GRPLGKGK---------FGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ 52

Query: 375 ---ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTR 431
              E++I   + H N+++L G+  D      YLI EY   G+++  L +      + +  
Sbjct: 53  LRREVEIQSHLRHPNILRLYGYFHDAT--RVYLILEYAPLGTVYRELQKLSK--FDEQRT 108

Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIV 491
                ++AN L Y H     RV+H+DIK  N+LL S    KIA+FG +    ++    + 
Sbjct: 109 ATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC 165

Query: 492 GTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
           GT  Y+ PE +   +   K+D++S GV+  E + GK
Sbjct: 166 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 201

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 1e-46
 Identities = 52/193 (26%), Positives = 89/193 (46%), Gaps = 16/193 (8%)

Query: 351 GSVYKGNIH-GEVYAIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPEDANCY 403
           G V+ G  +     A+K +K  +        E  +++++ H  LV+L            Y
Sbjct: 27  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE---PIY 83

Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI 463
           +I EY+ENGSL  +L       L     L +A  +A G+ +I E      +H+D++++NI
Sbjct: 84  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANI 140

Query: 464 LLDSNMRAKIANFGLAK---SGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVL 520
           L+   +  KIA+FGLA+                  + APE +  G  + K DV+SFG++L
Sbjct: 141 LVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 200

Query: 521 LELISGKEAIDEE 533
            E+++        
Sbjct: 201 TEIVTHGRIPYPG 213

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 8e-46
 Identities = 44/191 (23%), Positives = 83/191 (43%), Gaps = 18/191 (9%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNAC---------EELKILQKVNHGNLVKLEGFCIDPED 399
            +VYKG         A   ++             EE ++L+ + H N+V+          
Sbjct: 23  KTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 82

Query: 400 AN--CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKD 457
                 L+ E + +G+L ++L   K   +  K        +  GLQ++H    P ++H+D
Sbjct: 83  GKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTR-TPPIIHRD 139

Query: 458 IKSSNILLDS-NMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSF 516
           +K  NI +       KI + GLA     +    ++GT  ++APE   +      +DV++F
Sbjct: 140 LKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMY-EEKYDESVDVYAF 198

Query: 517 GVVLLELISGK 527
           G+ +LE+ + +
Sbjct: 199 GMCMLEMATSE 209

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  160 bits (406), Expect = 2e-45
 Identities = 53/192 (27%), Positives = 85/192 (44%), Gaps = 24/192 (12%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNACE----------ELKILQKVNHGNLVKLEGFCIDPE 398
           G+VY      + EV AIK M ++  +          E++ LQK+ H N ++  G  +   
Sbjct: 29  GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 88

Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
               +L+ EY    +        K   L       +      GL Y+H H    ++H+D+
Sbjct: 89  --TAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLHSH---NMIHRDV 141

Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLA---DGVVSTKMDVFS 515
           K+ NILL      K+ +FG A     A +   VGT  ++APE +    +G    K+DV+S
Sbjct: 142 KAGNILLSEPGLVKLGDFGSASIMAPANSF--VGTPYWMAPEVILAMDEGQYDGKVDVWS 199

Query: 516 FGVVLLELISGK 527
            G+  +EL   K
Sbjct: 200 LGITCIELAERK 211

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (399), Expect = 9e-45
 Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 28/202 (13%)

Query: 351 GSVYKGNIHGEVYAIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPEDANC-- 402
           G V++G   GE  A+K+             E+     + H N++                
Sbjct: 17  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76

Query: 403 YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEH-----TRPRVVHKD 457
           +L+ +Y E+GSL  +L+      +  +  +++A+  A+GL ++H        +P + H+D
Sbjct: 77  WLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRD 133

Query: 458 IKSSNILLDSNMRAKIANFGL------AKSGCNAITMHIVGTQGYIAPEYLADGV----- 506
           +KS NIL+  N    IA+ GL      A    +    H VGT+ Y+APE L D +     
Sbjct: 134 LKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHF 193

Query: 507 -VSTKMDVFSFGVVLLELISGK 527
               + D+++ G+V  E+    
Sbjct: 194 ESFKRADIYAMGLVFWEIARRC 215

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 3e-44
 Identities = 47/193 (24%), Positives = 88/193 (45%), Gaps = 22/193 (11%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNACE-------ELKILQKVNHGNLVKLEGFCIDPEDAN 401
           G VYK        + A K++   + E       E+ IL   +H N+VKL          N
Sbjct: 26  GKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN--N 83

Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSS 461
            +++ E+   G++ + + E +   L       +     + L Y+H++   +++H+D+K+ 
Sbjct: 84  LWILIEFCAGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAG 139

Query: 462 NILLDSNMRAKIANFGLAKSGCNAITMH--IVGTQGYIAPEYLA-----DGVVSTKMDVF 514
           NIL   +   K+A+FG++      I      +GT  ++APE +      D     K DV+
Sbjct: 140 NILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVW 199

Query: 515 SFGVVLLELISGK 527
           S G+ L+E+   +
Sbjct: 200 SLGITLIEMAEIE 212

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 2e-43
 Identities = 53/198 (26%), Positives = 87/198 (43%), Gaps = 22/198 (11%)

Query: 351 GSVYKG--NIHGEVYAIKMMKW--------NACEELKILQKVNHGNLVKLEGFCIDPEDA 400
           G V      +  E  A+K++          N  +E+ I + +NH N+VK  G   +    
Sbjct: 19  GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN-- 76

Query: 401 NCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
             YL  EY   G L   +  +    +      R    +  G+ Y+H      + H+DIK 
Sbjct: 77  IQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKP 131

Query: 461 SNILLDSNMRAKIANFGLAK----SGCNAITMHIVGTQGYIAPEYLADG-VVSTKMDVFS 515
            N+LLD     KI++FGLA     +    +   + GT  Y+APE L      +  +DV+S
Sbjct: 132 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 191

Query: 516 FGVVLLELISGKEAIDEE 533
            G+VL  +++G+   D+ 
Sbjct: 192 CGIVLTAMLAGELPWDQP 209

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 3e-43
 Identities = 51/188 (27%), Positives = 87/188 (46%), Gaps = 16/188 (8%)

Query: 351 GSVYKG-NIHGEVYAIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPEDANCY 403
           G V+ G        AIK +K           E ++++K+ H  LV+L     +      Y
Sbjct: 31  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE---PIY 87

Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI 463
           ++ EY+  GSL  +L     + L     + +A  +A+G+ Y+        VH+D++++NI
Sbjct: 88  IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANI 144

Query: 464 LLDSNMRAKIANFGLAK---SGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVL 520
           L+  N+  K+A+FGLA+                  + APE    G  + K DV+SFG++L
Sbjct: 145 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 204

Query: 521 LELISGKE 528
            EL +   
Sbjct: 205 TELTTKGR 212

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 5e-43
 Identities = 49/188 (26%), Positives = 94/188 (50%), Gaps = 16/188 (8%)

Query: 351 GSVYKG-NIHGEVYAIKMMKWNA------CEELKILQKVNHGNLVKLEGFCIDPEDANCY 403
           G V+ G  ++ +  AIK ++  A       EE +++ K++H  LV+L G C++       
Sbjct: 19  GLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA--PIC 76

Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI 463
           L++E++E+G L       +      +T L + +DV  G+ Y+ E     V+H+D+ + N 
Sbjct: 77  LVFEFMEHGCLS-DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNC 132

Query: 464 LLDSNMRAKIANFGLAK---SGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVL 520
           L+  N   K+++FG+ +         +        + +PE  +    S+K DV+SFGV++
Sbjct: 133 LVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLM 192

Query: 521 LELISGKE 528
            E+ S  +
Sbjct: 193 WEVFSEGK 200

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 3e-42
 Identities = 49/218 (22%), Positives = 95/218 (43%), Gaps = 30/218 (13%)

Query: 321 VSDCLDKYRIFKIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWNACE---- 374
           V D   KY     E++ +            G+VY       G+  AI+ M          
Sbjct: 15  VGDPKKKYTR--FEKIGQGA---------SGTVYTAMDVATGQEVAIRQMNLQQQPKKEL 63

Query: 375 ---ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTR 431
              E+ ++++  + N+V      +  +    +++ EY+  GSL   + E      +    
Sbjct: 64  IINEILVMRENKNPNIVNYLDSYLVGD--ELWVVMEYLAGGSLTDVVTETCM---DEGQI 118

Query: 432 LRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS--GCNAITMH 489
             +  +    L+++H +   +V+H+DIKS NILL  +   K+ +FG         +    
Sbjct: 119 AAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175

Query: 490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
           +VGT  ++APE +       K+D++S G++ +E+I G+
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  151 bits (381), Expect = 4e-42
 Identities = 54/231 (23%), Positives = 97/231 (41%), Gaps = 39/231 (16%)

Query: 331 FKIEELREATDNFSEGCLIQ-------------GSVYKG-----NIHGEVYAIKMMKWNA 372
           F  E+  EA   F++   I              G V  G            AIK +K   
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 373 CE--------ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNE 424
            E        E  I+ + +H N++ LEG           +I E++ENGSL        + 
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST--PVMIITEFMENGSLD-SFLRQNDG 123

Query: 425 NLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN 484
                  + +   +A G++Y+ +      VH+D+ + NIL++SN+  K+++FGL++   +
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180

Query: 485 AITMH-------IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKE 528
             +               + APE +     ++  DV+S+G+V+ E++S  E
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 7e-42
 Identities = 52/196 (26%), Positives = 97/196 (49%), Gaps = 26/196 (13%)

Query: 351 GSVYKGNIH----GEVYAIKMMKWNACE---------ELKILQKVNHGNLVKLEGFCIDP 397
           G+V KG        +  A+K++K  A +         E  ++Q++++  +V++ G C   
Sbjct: 21  GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE 80

Query: 398 EDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKD 457
              +  L+ E  E G L+ +L +N++  +  K  + +   V+ G++Y+ E      VH+D
Sbjct: 81  ---SWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEES---NFVHRD 132

Query: 458 IKSSNILLDSNMRAKIANFGLAKS-----GCNAITMHIVGTQGYIAPEYLADGVVSTKMD 512
           + + N+LL +   AKI++FGL+K+            H      + APE +     S+K D
Sbjct: 133 LAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSD 192

Query: 513 VFSFGVVLLELISGKE 528
           V+SFGV++ E  S  +
Sbjct: 193 VWSFGVLMWEAFSYGQ 208

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 3e-41
 Identities = 50/195 (25%), Positives = 88/195 (45%), Gaps = 24/195 (12%)

Query: 351 GSVYKGNIH----GEVYAIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCIDPE 398
           GSV +G           AIK++K    +        E +I+ ++++  +V+L G C   +
Sbjct: 23  GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC---Q 79

Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
                L+ E    G LH +L   K E +       +   V+ G++Y+ E      VH+D+
Sbjct: 80  AEALMLVMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDL 135

Query: 459 KSSNILLDSNMRAKIANFGLAK-----SGCNAITMHIVGTQGYIAPEYLADGVVSTKMDV 513
            + N+LL +   AKI++FGL+K                    + APE +     S++ DV
Sbjct: 136 AARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDV 195

Query: 514 FSFGVVLLELISGKE 528
           +S+GV + E +S  +
Sbjct: 196 WSYGVTMWEALSYGQ 210

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  147 bits (373), Expect = 3e-41
 Identities = 51/189 (26%), Positives = 94/189 (49%), Gaps = 16/189 (8%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPEDANC 402
           G VY+G    +    A+K +K +  E      E  +++++ H NLV+L G C        
Sbjct: 31  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP--PF 88

Query: 403 YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSN 462
           Y+I E++  G+L  +L E   + ++    L +A  +++ ++Y+ +      +H+D+ + N
Sbjct: 89  YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARN 145

Query: 463 ILLDSNMRAKIANFGLAKSGCNAITMHIVGTQG---YIAPEYLADGVVSTKMDVFSFGVV 519
            L+  N   K+A+FGL++           G +    + APE LA    S K DV++FGV+
Sbjct: 146 CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 205

Query: 520 LLELISGKE 528
           L E+ +   
Sbjct: 206 LWEIATYGM 214

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (368), Expect = 9e-41
 Identities = 47/188 (25%), Positives = 88/188 (46%), Gaps = 16/188 (8%)

Query: 351 GSVYKGNIH-GEVYAIKMMKWNAC------EELKILQKVNHGNLVKLEGFCIDPEDANCY 403
           G V  G        AIKM+K  +       EE K++  ++H  LV+L G C        +
Sbjct: 18  GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR--PIF 75

Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI 463
           +I EY+ NG L ++L          +  L +  DV   ++Y+      + +H+D+ + N 
Sbjct: 76  IITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNC 131

Query: 464 LLDSNMRAKIANFGLAKSGCNA---ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVL 520
           L++     K+++FGL++   +     ++       +  PE L     S+K D+++FGV++
Sbjct: 132 LVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLM 191

Query: 521 LELISGKE 528
            E+ S  +
Sbjct: 192 WEIYSLGK 199

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (368), Expect = 2e-40
 Identities = 47/211 (22%), Positives = 92/211 (43%), Gaps = 27/211 (12%)

Query: 337 REATDNFSEGCLI----QGSVYKG--NIHGEVYAIKMMK----------WNACEELKILQ 380
           ++  ++F  G ++      +V           YAIK+++               E  ++ 
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63

Query: 381 KVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVAN 440
           +++H   VKL     D E    Y    Y +NG L  ++ +  +   +         ++ +
Sbjct: 64  RLDHPFFVKLYFTFQDDE--KLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVS 119

Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC----NAITMHIVGTQGY 496
            L+Y+H      ++H+D+K  NILL+ +M  +I +FG AK        A     VGT  Y
Sbjct: 120 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 176

Query: 497 IAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
           ++PE L +       D+++ G ++ +L++G 
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGL 207

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  146 bits (368), Expect = 2e-40
 Identities = 57/242 (23%), Positives = 99/242 (40%), Gaps = 50/242 (20%)

Query: 332 KIEELREATDNFSEGCLI----QGSVYKGNIH-------GEVYAIKMMKWNACE------ 374
           K+  L    +N      I     G V++             + A+KM+K  A        
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 375 --ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNEN------- 425
             E  ++ + ++ N+VKL G C   +     L++EY+  G L+ +L              
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGK--PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 121

Query: 426 ---------------LNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMR 470
                          L+   +L IA  VA G+ Y+ E    + VH+D+ + N L+  NM 
Sbjct: 122 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMV 178

Query: 471 AKIANFGLAK----SGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISG 526
            KIA+FGL++    +       +      ++ PE +     +T+ DV+++GVVL E+ S 
Sbjct: 179 VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238

Query: 527 KE 528
             
Sbjct: 239 GL 240

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 7e-39
 Identities = 49/197 (24%), Positives = 87/197 (44%), Gaps = 24/197 (12%)

Query: 351 GSVYKG-----NIHGEVYAIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCIDP 397
           G VY G     +      A+K +              E  I++  +H N++ L G C+  
Sbjct: 41  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 100

Query: 398 EDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKD 457
           E  +  ++  Y+++G L +    N+  N   K  +   + VA G++++      + VH+D
Sbjct: 101 EG-SPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRD 155

Query: 458 IKSSNILLDSNMRAKIANFGLAK------SGCNAITMHIVGTQGYIAPEYLADGVVSTKM 511
           + + N +LD     K+A+FGLA+                     ++A E L     +TK 
Sbjct: 156 LAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKS 215

Query: 512 DVFSFGVVLLELISGKE 528
           DV+SFGV+L EL++   
Sbjct: 216 DVWSFGVLLWELMTRGA 232

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  143 bits (362), Expect = 9e-39
 Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 27/213 (12%)

Query: 341 DNFSEGCLI----QGSVYKG--NIHGEVYAIKMMK-------------WNACEELKILQK 381
           ++FS   +I     G VY       G++YA+K +               N    L ++  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 382 VNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANG 441
            +   +V +      P+      I + +  G LH  L   ++   +       A ++  G
Sbjct: 64  GDCPFIVCMSYAFHTPD--KLSFILDLMNGGDLHYHLS--QHGVFSEADMRFYAAEIILG 119

Query: 442 LQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEY 501
           L+++H      VV++D+K +NILLD +   +I++ GLA           VGT GY+APE 
Sbjct: 120 LEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEV 176

Query: 502 LADGV-VSTKMDVFSFGVVLLELISGKEAIDEE 533
           L  GV   +  D FS G +L +L+ G     + 
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 209

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  142 bits (360), Expect = 1e-38
 Identities = 46/189 (24%), Positives = 81/189 (42%), Gaps = 18/189 (9%)

Query: 351 GSVYKG--NIHGEVYAIKMMK-------WNACEELKILQKVNHGNLVKLEGFCIDPEDAN 401
           G V++      G V+  K +        +    E+ I+ +++H  L+ L     D     
Sbjct: 43  GVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY--E 100

Query: 402 CYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSS 461
             LI E++  G L   +   ++  ++    +        GL+++HEH    +VH DIK  
Sbjct: 101 MVLILEFLSGGELFDRIA-AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPE 156

Query: 462 NILLDS--NMRAKIANFGLAKS-GCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGV 518
           NI+ ++      KI +FGLA     + I      T  + APE +    V    D+++ GV
Sbjct: 157 NIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGV 216

Query: 519 VLLELISGK 527
           +   L+SG 
Sbjct: 217 LGYVLLSGL 225

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 1e-38
 Identities = 63/230 (27%), Positives = 104/230 (45%), Gaps = 38/230 (16%)

Query: 351 GSVYKGNIHGE----VYAIKMMKWNACE--------ELKILQKV-NHGNLVKLEGFCIDP 397
           G V K  I  +      AIK MK  A +        EL++L K+ +H N++ L G C   
Sbjct: 24  GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 83

Query: 398 EDANCYLIYEYIENGSLHSWLHEN--------------KNENLNWKTRLRIAIDVANGLQ 443
                YL  EY  +G+L  +L ++                  L+ +  L  A DVA G+ 
Sbjct: 84  G--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMD 141

Query: 444 YIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH-IVGTQGYIAPEYL 502
           Y+ +    + +H+D+ + NIL+  N  AKIA+FGL++     +          ++A E L
Sbjct: 142 YLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESL 198

Query: 503 ADGVVSTKMDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYWREMKRGK 552
              V +T  DV+S+GV+L E++S          +CG      + ++ +G 
Sbjct: 199 NYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAELYEKLPQGY 243

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 1e-38
 Identities = 55/219 (25%), Positives = 94/219 (42%), Gaps = 46/219 (21%)

Query: 351 GSVYKGNIHG-------EVYAIKMMKWNACE--------ELKILQKV-NHGNLVKLEGFC 394
           G V     +G          A+KM+K  A          ELK++ ++ +H N+V L G C
Sbjct: 51  GKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 110

Query: 395 IDPEDANCYLIYEYIENGSLHSWLHENKNEN---------------------LNWKTRLR 433
                   YLI+EY   G L ++L   + +                      L ++  L 
Sbjct: 111 TLSG--PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLC 168

Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAITMH 489
            A  VA G++++        VH+D+ + N+L+      KI +FGLA+         +  +
Sbjct: 169 FAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGN 225

Query: 490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKE 528
                 ++APE L +G+ + K DV+S+G++L E+ S   
Sbjct: 226 ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 264

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  142 bits (359), Expect = 1e-38
 Identities = 52/215 (24%), Positives = 82/215 (38%), Gaps = 29/215 (13%)

Query: 325 LDKYRIFKIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMKWNACE-------E 375
           LD Y I   EEL              G V++      G  +A K +             E
Sbjct: 25  LDHYDI--HEELGTGA---------FGVVHRVTERATGNNFAAKFVMTPHESDKETVRKE 73

Query: 376 LKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIA 435
           ++ +  + H  LV L     D       +IYE++  G L   + +  N  ++    +   
Sbjct: 74  IQTMSVLRHPTLVNLHDAFEDDN--EMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYM 130

Query: 436 IDVANGLQYIHEHTRPRVVHKDIKSSNILLDS--NMRAKIANFGLAKS-GCNAITMHIVG 492
             V  GL ++HE+     VH D+K  NI+  +  +   K+ +FGL              G
Sbjct: 131 RQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTG 187

Query: 493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK 527
           T  + APE      V    D++S GV+   L+SG 
Sbjct: 188 TAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL 222

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 3e-38
 Identities = 53/218 (24%), Positives = 90/218 (41%), Gaps = 41/218 (18%)

Query: 351 GSVYKGNIH-------GEVYAIKMMKWNACE--------ELKILQKV-NHGNLVKLEGFC 394
           G V +   +           A+KM+K +A          ELK+L  + NH N+V L G C
Sbjct: 37  GKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96

Query: 395 IDPEDANCYLIYEYIENGSLHSWLHENKNEN----------------LNWKTRLRIAIDV 438
                    +I EY   G L ++L   ++                  L+ +  L  +  V
Sbjct: 97  TIGG--PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQV 154

Query: 439 ANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAITMHIVGTQ 494
           A G+ ++        +H+D+ + NILL      KI +FGLA+         +  +     
Sbjct: 155 AKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV 211

Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDE 532
            ++APE + + V + + DV+S+G+ L EL S   +   
Sbjct: 212 KWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 6e-38
 Identities = 47/198 (23%), Positives = 80/198 (40%), Gaps = 27/198 (13%)

Query: 351 GSVYKG-----NIHGEVYAIKMMKWNACE----------ELKILQKVNHGNLVKLEGFCI 395
           G V +G     +      A+K +K +             E+  +  ++H NL++L G  +
Sbjct: 22  GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 81

Query: 396 DPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVH 455
            P      ++ E    GSL          +    T  R A+ VA G+ Y+      R +H
Sbjct: 82  TP---PMKMVTELAPLGSLLDR-LRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIH 134

Query: 456 KDIKSSNILLDSNMRAKIANFGLAKSGCN-----AITMHIVGTQGYIAPEYLADGVVSTK 510
           +D+ + N+LL +    KI +FGL ++         +  H      + APE L     S  
Sbjct: 135 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHA 194

Query: 511 MDVFSFGVVLLELISGKE 528
            D + FGV L E+ +  +
Sbjct: 195 SDTWMFGVTLWEMFTYGQ 212

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 7e-38
 Identities = 47/188 (25%), Positives = 78/188 (41%), Gaps = 17/188 (9%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNACE------ELKILQKVNHGNLVKLEGFCIDPEDANC 402
           G V++       + Y  K +K    +      E+ IL    H N++ L       E    
Sbjct: 19  GIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESME--EL 76

Query: 403 YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSN 462
            +I+E+I    +   ++ +  E LN +  +     V   LQ++H H    + H DI+  N
Sbjct: 77  VMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPEN 132

Query: 463 ILLDS--NMRAKIANFGLAKS-GCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVV 519
           I+  +  +   KI  FG A+          +     Y APE     VVST  D++S G +
Sbjct: 133 IIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTL 192

Query: 520 LLELISGK 527
           +  L+SG 
Sbjct: 193 VYVLLSGI 200

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 1e-37
 Identities = 50/222 (22%), Positives = 95/222 (42%), Gaps = 36/222 (16%)

Query: 329 RIFKIEELREATDNFSEGCLI----QGSVYK------GNIHGEVYAIKMMKWNACE---- 374
           RI K  E       F +  ++     G+VYK      G       AIK ++         
Sbjct: 4   RILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK 56

Query: 375 ----ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKT 430
               E  ++  V++ ++ +L G C+        LI + +  G L  ++ E+K+     + 
Sbjct: 57  EILDEAYVMASVDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNI-GSQY 112

Query: 431 RLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAI 486
            L   + +A G+ Y+ +    R+VH+D+ + N+L+ +    KI +FGLAK          
Sbjct: 113 LLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 169

Query: 487 TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKE 528
                    ++A E +   + + + DV+S+GV + EL++   
Sbjct: 170 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 211

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  135 bits (341), Expect = 8e-37
 Identities = 41/196 (20%), Positives = 88/196 (44%), Gaps = 24/196 (12%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNACE----------ELKILQKVNHGNLVKLEGFCIDPE 398
             V+           A+K+++ +             E +    +NH  +V +        
Sbjct: 21  SEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 80

Query: 399 DANC--YLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHK 456
            A    Y++ EY++  +L   +H      +  K  + +  D    L + H++    ++H+
Sbjct: 81  PAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQN---GIIHR 135

Query: 457 DIKSSNILLDSNMRAKIANFGLAKSGCNAI-----TMHIVGTQGYIAPEYLADGVVSTKM 511
           D+K +NI++ +    K+ +FG+A++  ++      T  ++GT  Y++PE      V  + 
Sbjct: 136 DVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARS 195

Query: 512 DVFSFGVVLLELISGK 527
           DV+S G VL E+++G+
Sbjct: 196 DVYSLGCVLYEVLTGE 211

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 2e-36
 Identities = 53/216 (24%), Positives = 97/216 (44%), Gaps = 29/216 (13%)

Query: 341 DNFSEGCLI----QGSVYKGNIHGE------VYAIKMMKWNACE--------ELKILQKV 382
              +   +I     G VYKG +           AIK +K    E        E  I+ + 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 383 NHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGL 442
           +H N+++LEG     +     +I EY+ENG+        K+   +    + +   +A G+
Sbjct: 67  SHHNIIRLEGVISKYK--PMMIITEYMENGA-LDKFLREKDGEFSVLQLVGMLRGIAAGM 123

Query: 443 QYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK-----SGCNAITMHIVGTQGYI 497
           +Y+        VH+D+ + NIL++SN+  K+++FGL++           T        + 
Sbjct: 124 KYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180

Query: 498 APEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE 533
           APE ++    ++  DV+SFG+V+ E+++  E    E
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 216

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  134 bits (338), Expect = 6e-36
 Identities = 47/188 (25%), Positives = 78/188 (41%), Gaps = 15/188 (7%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCIDPEDA 400
             V         ++ AIK +   A E        E+ +L K+ H N+V L+         
Sbjct: 23  SEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGG-- 80

Query: 401 NCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKS 460
           + YLI + +  G L   + E        +   R+   V + ++Y+H+        K    
Sbjct: 81  HLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENL 138

Query: 461 SNILLDSNMRAKIANFGLAK-SGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVV 519
               LD + +  I++FGL+K     ++     GT GY+APE LA    S  +D +S GV+
Sbjct: 139 LYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 198

Query: 520 LLELISGK 527
              L+ G 
Sbjct: 199 AYILLCGY 206

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 8e-36
 Identities = 44/194 (22%), Positives = 83/194 (42%), Gaps = 23/194 (11%)

Query: 351 GSVYKG-----NIHGEVYAIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCIDP 397
           G V++G            AIK  K    +        E   +++ +H ++VKL G     
Sbjct: 21  GDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI--- 77

Query: 398 EDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKD 457
            +   ++I E    G L S+  + +  +L+  + +  A  ++  L Y+      R VH+D
Sbjct: 78  TENPVWIIMELCTLGELRSF-LQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRD 133

Query: 458 IKSSNILLDSNMRAKIANFGLAK---SGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVF 514
           I + N+L+ SN   K+ +FGL++                  ++APE +     ++  DV+
Sbjct: 134 IAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVW 193

Query: 515 SFGVVLLELISGKE 528
            FGV + E++    
Sbjct: 194 MFGVCMWEILMHGV 207

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  132 bits (332), Expect = 2e-35
 Identities = 47/217 (21%), Positives = 96/217 (44%), Gaps = 37/217 (17%)

Query: 341 DNFSEGCLI----QGSVYKG--NIHGEVYAIKMMKWNACE----------------ELKI 378
           +N+    ++       V +       + YA+K++                      E+ I
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 379 LQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAID 437
           L+KV+ H N+++L+           +L+++ ++ G L  +L E     L+ K   +I   
Sbjct: 63  LRKVSGHPNIIQLKDTYETNT--FFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRA 118

Query: 438 VANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITM-HIVGTQGY 496
           +   +  +H+     +VH+D+K  NILLD +M  K+ +FG +        +  + GT  Y
Sbjct: 119 LLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSY 175

Query: 497 IAPEYLADGVV------STKMDVFSFGVVLLELISGK 527
           +APE +   +         ++D++S GV++  L++G 
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 2e-35
 Identities = 51/206 (24%), Positives = 86/206 (41%), Gaps = 26/206 (12%)

Query: 341 DNFSEGCLI----QGSVYKG--NIHGEVYAIKMMKWNAC-----------EELKILQKVN 383
           ++F    ++     G V+        + +AIK +K +             E+  +     
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 384 HGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQ 443
           H  L  +       E  N + + EY+  G L   +        +       A ++  GLQ
Sbjct: 62  HPFLTHMFCTFQTKE--NLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQ 117

Query: 444 YIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH--IVGTQGYIAPEY 501
           ++H      +V++D+K  NILLD +   KIA+FG+ K             GT  YIAPE 
Sbjct: 118 FLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI 174

Query: 502 LADGVVSTKMDVFSFGVVLLELISGK 527
           L     +  +D +SFGV+L E++ G+
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQ 200

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 1e-34
 Identities = 48/205 (23%), Positives = 93/205 (45%), Gaps = 32/205 (15%)

Query: 351 GSVYKG-------NIHGEVYAIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCI 395
           G VY+G       +      AIK +   A          E  ++++ N  ++V+L G   
Sbjct: 34  GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93

Query: 396 DPEDANCYLIYEYIENGSLHSWLHENKNEN--------LNWKTRLRIAIDVANGLQYIHE 447
             +     +I E +  G L S+L   +            +    +++A ++A+G+ Y++ 
Sbjct: 94  QGQ--PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA 151

Query: 448 HTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAITMHIVGTQGYIAPEYLA 503
           +   + VH+D+ + N ++  +   KI +FG+ +    +         +    +++PE L 
Sbjct: 152 N---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK 208

Query: 504 DGVVSTKMDVFSFGVVLLELISGKE 528
           DGV +T  DV+SFGVVL E+ +  E
Sbjct: 209 DGVFTTYSDVWSFGVVLWEIATLAE 233

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 1e-34
 Identities = 41/188 (21%), Positives = 82/188 (43%), Gaps = 14/188 (7%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWN--ACEELKILQKV-NHGNLVKLEGFCIDP--EDANCY 403
           G V +       E +A+KM++    A  E+++  +     ++V++     +         
Sbjct: 26  GKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85

Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI 463
           ++ E ++ G L S + +  ++    +    I   +   +QY+H      + H+D+K  N+
Sbjct: 86  IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENL 142

Query: 464 LLDS---NMRAKIANFGLAKSGCNAITMHIV-GTQGYIAPEYLADGVVSTKMDVFSFGVV 519
           L  S   N   K+ +FG AK   +  ++     T  Y+APE L         D++S GV+
Sbjct: 143 LYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 202

Query: 520 LLELISGK 527
           +  L+ G 
Sbjct: 203 MYILLCGY 210

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 1e-34
 Identities = 52/217 (23%), Positives = 90/217 (41%), Gaps = 38/217 (17%)

Query: 351 GSVYKGNIH-------GEVYAIKMMKWNAC---------EELKILQKVNHGNLVKLEGFC 394
           G V + +             A+KM+K  A          E   ++   +H N+V L G C
Sbjct: 27  GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86

Query: 395 IDPEDANCYLIYEYIENGSLHSWLHENKNEN--------------LNWKTRLRIAIDVAN 440
             P      +I E+ + G+L ++L   +NE               L  +  +  +  VA 
Sbjct: 87  TKPGG-PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAK 145

Query: 441 GLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH----IVGTQGY 496
           G++++      + +H+D+ + NILL      KI +FGLA+                   +
Sbjct: 146 GMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 202

Query: 497 IAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE 533
           +APE + D V + + DV+SFGV+L E+ S   +    
Sbjct: 203 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 1e-33
 Identities = 58/238 (24%), Positives = 104/238 (43%), Gaps = 46/238 (19%)

Query: 351 GSVYKG---------NIHGEVYAIKMMKWNACE--------ELKILQKV-NHGNLVKLEG 392
           G V                   A+KM+K +A E        E+++++ +  H N++ L G
Sbjct: 27  GQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG 86

Query: 393 FCIDPEDANCYLIYEYIENGSLHSWLH--------------ENKNENLNWKTRLRIAIDV 438
            C        Y+I EY   G+L  +L                N  E L+ K  +  A  V
Sbjct: 87  ACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQV 144

Query: 439 ANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAK----SGCNAITMHIVGTQ 494
           A G++Y+      + +H+D+ + N+L+  +   KIA+FGLA+          T +     
Sbjct: 145 ARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV 201

Query: 495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGKFCGQKLKGYWREMKRGK 552
            ++APE L D + + + DV+SFGV+L E+ +   +      + G  ++  ++ +K G 
Sbjct: 202 KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP-----YPGVPVEELFKLLKEGH 254

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  127 bits (321), Expect = 1e-33
 Identities = 53/189 (28%), Positives = 93/189 (49%), Gaps = 20/189 (10%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNAC----------EELKILQKVNHGNLVKLEGFCIDPE 398
           G V+      +G  YA+K++K              +E  +L  V H  ++++ G   D +
Sbjct: 18  GRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ 77

Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
               ++I +YIE G L S L +++            A +V   L+Y+H      ++++D+
Sbjct: 78  --QIFMIMDYIEGGELFSLLRKSQRFP--NPVAKFYAAEVCLALEYLHSK---DIIYRDL 130

Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGV 518
           K  NILLD N   KI +FG AK   +     + GT  YIAPE ++    +  +D +SFG+
Sbjct: 131 KPENILLDKNGHIKITDFGFAKYVPDVTY-TLCGTPDYIAPEVVSTKPYNKSIDWWSFGI 189

Query: 519 VLLELISGK 527
           ++ E+++G 
Sbjct: 190 LIYEMLAGY 198

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (316), Expect = 5e-33
 Identities = 52/195 (26%), Positives = 88/195 (45%), Gaps = 21/195 (10%)

Query: 351 GSVYKGNIH---GEVYAIKMMKWNACEE------------LKILQKVNHGNLVKLEGFCI 395
           G V+K       G   A+K ++    EE            L+ L+   H N+V+L   C 
Sbjct: 21  GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 80

Query: 396 DPEDANCYLIYEYIE--NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRV 453
                    +    E  +  L ++L +     +  +T   +   +  GL ++H H   RV
Sbjct: 81  VSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RV 137

Query: 454 VHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH-IVGTQGYIAPEYLADGVVSTKMD 512
           VH+D+K  NIL+ S+ + K+A+FGLA+     + +  +V T  Y APE L     +T +D
Sbjct: 138 VHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVD 197

Query: 513 VFSFGVVLLELISGK 527
           ++S G +  E+   K
Sbjct: 198 LWSVGCIFAEMFRRK 212

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 1e-32
 Identities = 45/196 (22%), Positives = 79/196 (40%), Gaps = 25/196 (12%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNACE-------------ELKILQKVNHG--NLVKLEGF 393
           GSVY G         AIK ++ +                E+ +L+KV+ G   +++L  +
Sbjct: 18  GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 77

Query: 394 CIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRV 453
              P+  +  LI E  E           +   L  +        V   +++ H      V
Sbjct: 78  FERPD--SFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHNC---GV 131

Query: 454 VHKDIKSSNILLDSN-MRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLA-DGVVSTKM 511
           +H+DIK  NIL+D N    K+ +FG      + +     GT+ Y  PE++          
Sbjct: 132 LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSA 191

Query: 512 DVFSFGVVLLELISGK 527
            V+S G++L +++ G 
Sbjct: 192 AVWSLGILLYDMVCGD 207

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 5e-32
 Identities = 55/217 (25%), Positives = 103/217 (47%), Gaps = 31/217 (14%)

Query: 325 LDKYRIFKIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMK---------WNAC 373
           ++ ++   +E++ E T          G VYK    + GEV A+K ++           A 
Sbjct: 1   MENFQK--VEKIGEGT---------YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI 49

Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
            E+ +L+++NH N+VKL            YL++E++    L  ++  +    +       
Sbjct: 50  REISLLKELNHPNIVKLLDVIHTEN--KLYLVFEFLHQD-LKKFMDASALTGIPLPLIKS 106

Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH--IV 491
               +  GL + H H   RV+H+D+K  N+L+++    K+A+FGLA++    +  +   V
Sbjct: 107 YLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV 163

Query: 492 GTQGYIAPE-YLADGVVSTKMDVFSFGVVLLELISGK 527
            T  Y APE  L     ST +D++S G +  E+++ +
Sbjct: 164 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 7e-32
 Identities = 49/195 (25%), Positives = 83/195 (42%), Gaps = 24/195 (12%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNACE--------ELKILQKVNHGNLVKLEGFCIDP--E 398
           G V     N++    AIK +     +        E+KIL +  H N++ +      P  E
Sbjct: 22  GMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 81

Query: 399 DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDI 458
                 +  ++    L+  L       L+          +  GL+YIH      V+H+D+
Sbjct: 82  QMKDVYLVTHLMGADLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSA---NVLHRDL 135

Query: 459 KSSNILLDSNMRAKIANFGLAKSGCNAIT-----MHIVGTQGYIAPEYLADGVVST-KMD 512
           K SN+LL++    KI +FGLA+               V T+ Y APE + +    T  +D
Sbjct: 136 KPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSID 195

Query: 513 VFSFGVVLLELISGK 527
           ++S G +L E++S +
Sbjct: 196 IWSVGCILAEMLSNR 210

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 7e-32
 Identities = 53/194 (27%), Positives = 94/194 (48%), Gaps = 24/194 (12%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWN------------ACEELKILQKVNHGNLVKLEGFCID 396
            +VYK       ++ AIK +K              A  E+K+LQ+++H N++ L      
Sbjct: 12  ATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH 71

Query: 397 PEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHK 456
               N  L+++++E       + ++ +  L         +    GL+Y+H+H    ++H+
Sbjct: 72  KS--NISLVFDFMETDLEV--IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHR 124

Query: 457 DIKSSNILLDSNMRAKIANFGLAKSGCNAIT--MHIVGTQGYIAPEYLAD-GVVSTKMDV 513
           D+K +N+LLD N   K+A+FGLAKS  +      H V T+ Y APE L    +    +D+
Sbjct: 125 DLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDM 184

Query: 514 FSFGVVLLELISGK 527
           ++ G +L EL+   
Sbjct: 185 WAVGCILAELLLRV 198

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 7e-32
 Identities = 58/240 (24%), Positives = 101/240 (42%), Gaps = 29/240 (12%)

Query: 337 REATDNFSEGCLI----QGSVYKG--NIHGEVYAIKMMKWNACE---ELKILQKVNHGNL 387
           R    ++++  +I     G VY+      GE+ AIK +  +      EL+I++K++H N+
Sbjct: 16  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNI 75

Query: 388 VKLEGFCIDP----EDANCYLIYEYIENGSLHSWLHENK-NENLNWKTRLRIAIDVANGL 442
           V+L  F        ++    L+ +Y+         H ++  + L           +   L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 443 QYIHEHTRPRVVHKDIKSSNILLDSN-MRAKIANFGLAKSGCNAITMH-IVGTQGYIAP- 499
            YIH      + H+DIK  N+LLD +    K+ +FG AK           + ++ Y AP 
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 192

Query: 500 EYLADGVVSTKMDVFSFGVVLLELISGK---------EAIDEEGKFCGQKLKGYWREMKR 550
                   ++ +DV+S G VL EL+ G+         + + E  K  G   +   REM  
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 1e-31
 Identities = 51/197 (25%), Positives = 84/197 (42%), Gaps = 27/197 (13%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNACE-------------ELKILQKVNHGNLVKLEGFCI 395
             V K      G  YA K +K    +             E+ IL+++ H N++ L     
Sbjct: 24  AVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE 83

Query: 396 DPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVH 455
           +    +  LI E +  G L  +L E ++  L  +        + NG+ Y+H     ++ H
Sbjct: 84  NKT--DVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSL---QIAH 136

Query: 456 KDIKSSNILLDSN----MRAKIANFGLAKS-GCNAITMHIVGTQGYIAPEYLADGVVSTK 510
            D+K  NI+L        R KI +FGLA          +I GT  ++APE +    +  +
Sbjct: 137 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLE 196

Query: 511 MDVFSFGVVLLELISGK 527
            D++S GV+   L+SG 
Sbjct: 197 ADMWSIGVITYILLSGA 213

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 2e-31
 Identities = 52/205 (25%), Positives = 84/205 (40%), Gaps = 25/205 (12%)

Query: 341 DNFSEGCLI----QGSVYKG--NIHGEVYAIKMMKWNACE----------ELKILQKVNH 384
           ++F    L+     G V        G  YA+K+++               E ++LQ   H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 385 GNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQY 444
             L  L+      +      + EY   G L   L   +      +       ++ + L+Y
Sbjct: 65  PFLTALKYAFQTHD--RLCFVMEYANGGELFFHLS--RERVFTEERARFYGAEIVSALEY 120

Query: 445 IHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC--NAITMHIVGTQGYIAPEYL 502
           +H      VV++DIK  N++LD +   KI +FGL K G    A      GT  Y+APE L
Sbjct: 121 LHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177

Query: 503 ADGVVSTKMDVFSFGVVLLELISGK 527
            D      +D +  GVV+ E++ G+
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGR 202

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (295), Expect = 4e-30
 Identities = 47/201 (23%), Positives = 87/201 (43%), Gaps = 29/201 (14%)

Query: 351 GSVYKG--NIHGEVYAIKMMK---------WNACEELKILQKVNHGNLVKLEGFCIDPE- 398
           G V+K      G+  A+K +            A  E+KILQ + H N+V L   C     
Sbjct: 24  GEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS 83

Query: 399 -----DANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRV 453
                  + YL++++ E+       +             R+   + NGL YIH +   ++
Sbjct: 84  PYNRCKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRN---KI 138

Query: 454 VHKDIKSSNILLDSNMRAKIANFGLAK------SGCNAITMHIVGTQGYIAPEYLA-DGV 506
           +H+D+K++N+L+  +   K+A+FGLA+      +       + V T  Y  PE L  +  
Sbjct: 139 LHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERD 198

Query: 507 VSTKMDVFSFGVVLLELISGK 527
               +D++  G ++ E+ +  
Sbjct: 199 YGPPIDLWGAGCIMAEMWTRS 219

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  115 bits (289), Expect = 1e-29
 Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 31/216 (14%)

Query: 325 LDKYRIFKIEELREATDNFSEGCLIQGSVYKG-NIHGEVYAIKMMK---------WNACE 374
           ++KY    +E++ E T          G VYK  N +GE +A+K ++              
Sbjct: 1   MEKYHG--LEKIGEGT---------YGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR 49

Query: 375 ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRI 434
           E+ IL+++ H N+VKL       +     L++E+++       L +     L   T    
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKK--RLVLVFEHLDQDLK--KLLDVCEGGLESVTAKSF 105

Query: 435 AIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT--MHIVG 492
            + + NG+ Y H+    RV+H+D+K  N+L++     KIA+FGLA++    +    H + 
Sbjct: 106 LLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV 162

Query: 493 TQGYIAPEYLA-DGVVSTKMDVFSFGVVLLELISGK 527
           T  Y AP+ L      ST +D++S G +  E+++G 
Sbjct: 163 TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  114 bits (286), Expect = 4e-29
 Identities = 34/198 (17%), Positives = 71/198 (35%), Gaps = 27/198 (13%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNA-----CEELKILQKVNHGNLVKLEGFCIDPEDANCY 403
           G +++G   ++ +  AIK     +      +E +  + +     +    +    E  +  
Sbjct: 19  GVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-EGLHNV 77

Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI 463
           L+ + +  G     L +      + KT    A  +   +Q IHE     +V++DIK  N 
Sbjct: 78  LVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNF 132

Query: 464 LLDSNMR-----AKIANFGLAK---------SGCNAITMHIVGTQGYIAPEYLADGVVST 509
           L+            + +FG+ K                 ++ GT  Y++         S 
Sbjct: 133 LIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSR 192

Query: 510 KMDVFSFGVVLLELISGK 527
           + D+ + G V +  + G 
Sbjct: 193 RDDLEALGHVFMYFLRGS 210

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  114 bits (286), Expect = 4e-29
 Identities = 45/196 (22%), Positives = 74/196 (37%), Gaps = 25/196 (12%)

Query: 351 GSVYKG--NIHGEVYAIKMMK-----WNACEELKILQKVNHGNLVKLEGFCIDPEDANCY 403
           G +Y G     GE  AIK+            E KI + +  G  +    +C    D    
Sbjct: 21  GDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGD-YNV 79

Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI 463
           ++ E +       +   ++    + KT L +A  + + ++YIH       +H+D+K  N 
Sbjct: 80  MVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNF 134

Query: 464 L---LDSNMRAKIANFGLAKSGCNAITM---------HIVGTQGYIAPEYLADGVVSTKM 511
           L           I +FGLAK   +A T          ++ GT  Y +         S + 
Sbjct: 135 LMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRD 194

Query: 512 DVFSFGVVLLELISGK 527
           D+ S G VL+    G 
Sbjct: 195 DLESLGYVLMYFNLGS 210

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  115 bits (289), Expect = 5e-29
 Identities = 54/248 (21%), Positives = 101/248 (40%), Gaps = 31/248 (12%)

Query: 292 REIDEQKQKLQFNKGGRDLKDMEVNFMADVSDCLDKYRIFKIEELREATDNFSEGCLIQG 351
           ++  EQ+   +F    ++    +    +  +  LD++    I+ L   +          G
Sbjct: 7   KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDR--IKTLGTGS---------FG 55

Query: 352 SVYKG--NIHGEVYAIKMMK----------WNACEELKILQKVNHGNLVKLEGFCIDPED 399
            V        G  YA+K++            +   E +ILQ VN   LVKLE    D   
Sbjct: 56  RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS- 114

Query: 400 ANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIK 459
            N Y++ EY+  G + S L        +       A  +    +Y+H      ++++D+K
Sbjct: 115 -NLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLK 168

Query: 460 SSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVV 519
             N+L+D     ++ +FG AK         + GT   +APE +     +  +D ++ GV+
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRT-WTLCGTPEALAPEIILSKGYNKAVDWWALGVL 227

Query: 520 LLELISGK 527
           + E+ +G 
Sbjct: 228 IYEMAAGY 235

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 3e-28
 Identities = 44/192 (22%), Positives = 82/192 (42%), Gaps = 22/192 (11%)

Query: 351 GSVYKG--NIHGEVYAIKMMK---------WNACEELKILQKVNHGNLVKLEGFCIDPED 399
           G+V        G   AIK +            A  EL++L+ + H N++ L       E 
Sbjct: 32  GAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 91

Query: 400 ----ANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVH 455
                + YL+  ++            K+E L       +   +  GL+YIH      ++H
Sbjct: 92  LDDFTDFYLVMPFMGT----DLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA---GIIH 144

Query: 456 KDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFS 515
           +D+K  N+ ++ +   KI +FGLA+   + +T ++V          L     +  +D++S
Sbjct: 145 RDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWS 204

Query: 516 FGVVLLELISGK 527
            G ++ E+I+GK
Sbjct: 205 VGCIMAEMITGK 216

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  110 bits (276), Expect = 2e-27
 Identities = 38/187 (20%), Positives = 79/187 (42%), Gaps = 18/187 (9%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNACE----ELKILQKVN-HGNLVKLEGFCIDPEDANCY 403
             V++     + E   +K++K    +    E+KIL+ +    N++ L     DP      
Sbjct: 49  SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108

Query: 404 LIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNI 463
           L++E++ N              L          ++   L Y H      ++H+D+K  N+
Sbjct: 109 LVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNV 160

Query: 464 LLDS-NMRAKIANFGLAKS-GCNAITMHIVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVL 520
           ++D  + + ++ ++GLA+           V ++ +  PE L D  +    +D++S G +L
Sbjct: 161 MIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCML 220

Query: 521 LELISGK 527
             +I  K
Sbjct: 221 ASMIFRK 227

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (268), Expect = 1e-26
 Identities = 51/217 (23%), Positives = 97/217 (44%), Gaps = 32/217 (14%)

Query: 325 LDKYRIFKIEELREATDNFSEGCLIQGSVYKG--NIHGEVYAIKMMK---------WNAC 373
           + KY    +E++ E T          G+V+K       E+ A+K ++          +A 
Sbjct: 1   MQKYEK--LEKIGEGT---------YGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL 49

Query: 374 EELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLR 433
            E+ +L+++ H N+V+L        D    L++E+ +      +   N + +   +    
Sbjct: 50  REICLLKELKHKNIVRLHDVLHS--DKKLTLVFEFCDQDLKKYFDSCNGDLD--PEIVKS 105

Query: 434 IAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH--IV 491
               +  GL + H      V+H+D+K  N+L++ N   K+ANFGLA++    +  +   V
Sbjct: 106 FLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEV 162

Query: 492 GTQGYIAPEYLA-DGVVSTKMDVFSFGVVLLELISGK 527
            T  Y  P+ L    + ST +D++S G +  EL +  
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG 199

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (252), Expect = 4e-24
 Identities = 45/193 (23%), Positives = 83/193 (43%), Gaps = 24/193 (12%)

Query: 351 GSVYKG--NIHGEVYAIKMMKW---------NACEELKILQKVNHGNLVKLEGFCIDP-- 397
           G V      +     AIK +            A  EL +++ VNH N++ L         
Sbjct: 31  GIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT 90

Query: 398 --EDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVH 455
             E  + YL+ E ++         E      + +    +   +  G++++H       +H
Sbjct: 91  LEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSYLLYQMLCGIKHLHSAGI---IH 142

Query: 456 KDIKSSNILLDSNMRAKIANFGLAKSGCNAITM-HIVGTQGYIAPEYLADGVVSTKMDVF 514
           +D+K SNI++ S+   KI +FGLA++   +  M   V T+ Y APE +        +D++
Sbjct: 143 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 202

Query: 515 SFGVVLLELISGK 527
           S G ++ E++  K
Sbjct: 203 SVGCIMGEMVRHK 215

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (251), Expect = 5e-24
 Identities = 38/188 (20%), Positives = 77/188 (40%), Gaps = 14/188 (7%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWNACE---------ELKILQKVNHGNLVKLEGFCIDPED 399
           GSV        G   A+K +               EL++L+ + H N++ L         
Sbjct: 32  GSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 91

Query: 400 ANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIK 459
              +     + +       +  K + L       +   +  GL+YIH      ++H+D+K
Sbjct: 92  LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLK 148

Query: 460 SSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVV 519
            SN+ ++ +   KI +FGLA+   + +T ++           L     +  +D++S G +
Sbjct: 149 PSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCI 208

Query: 520 LLELISGK 527
           + EL++G+
Sbjct: 209 MAELLTGR 216

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.1 bits (246), Expect = 2e-23
 Identities = 48/199 (24%), Positives = 86/199 (43%), Gaps = 29/199 (14%)

Query: 351 GSVYKG-----NIHGEVYAIKMMKWNACE-----------ELKILQKVNHG-NLVKLEGF 393
           G V+       +  G++YA+K++K                E ++L+ +     LV L   
Sbjct: 38  GKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 97

Query: 394 CIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRV 453
                    +LI +YI  G L + L   + E            ++   L+++H+     +
Sbjct: 98  FQTET--KLHLILDYINGGELFTHLS--QRERFTEHEVQIYVGEIVLALEHLHKL---GI 150

Query: 454 VHKDIKSSNILLDSNMRAKIANFGLA---KSGCNAITMHIVGTQGYIAPEYLADGV--VS 508
           +++DIK  NILLDSN    + +FGL+    +          GT  Y+AP+ +  G     
Sbjct: 151 IYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHD 210

Query: 509 TKMDVFSFGVVLLELISGK 527
             +D +S GV++ EL++G 
Sbjct: 211 KAVDWWSLGVLMYELLTGA 229

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 97.0 bits (240), Expect = 1e-22
 Identities = 39/203 (19%), Positives = 87/203 (42%), Gaps = 29/203 (14%)

Query: 351 GSVYKG--NIHGEVYAIKMMKWN------ACEELKILQKVNHGNLVKLEGFCID------ 396
            +V+     ++    A+K+++ +      A +E+K+LQ+VN  +  K +    +      
Sbjct: 27  STVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 86

Query: 397 ------PEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTR 450
                   +    ++   +   +L + + + ++  +      +I+  +  GL Y+H    
Sbjct: 87  DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR-- 144

Query: 451 PRVVHKDIKSSNILLDSN------MRAKIANFGLAKSGCNAITMHIVGTQGYIAPEYLAD 504
             ++H DIK  N+L++        ++ KIA+ G A         + + T+ Y +PE L  
Sbjct: 145 CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-TNSIQTREYRSPEVLLG 203

Query: 505 GVVSTKMDVFSFGVVLLELISGK 527
                  D++S   ++ ELI+G 
Sbjct: 204 APWGCGADIWSTACLIFELITGD 226

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 67.5 bits (164), Expect = 1e-13
 Identities = 17/149 (11%), Positives = 40/149 (26%), Gaps = 29/149 (19%)

Query: 351 GSVYKG-NIHGEVYAIKMMKWNACE-----------------ELKILQKVNHGNLVKLEG 392
            +V+   +       +K  K                            +     L KL+G
Sbjct: 14  SAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG 73

Query: 393 FCIDPEDANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPR 452
             +         +Y +  N  L   +   +   +  +    +   +   +   +      
Sbjct: 74  LAVPK-------VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHR---G 123

Query: 453 VVHKDIKSSNILLDSNMRAKIANFGLAKS 481
           +VH D+   N+L+       I +F  +  
Sbjct: 124 IVHGDLSQYNVLVS-EEGIWIIDFPQSVE 151

>d1e0ga_ d.7.1.1 (A:) Membrane-bound lytic murein transclycosylase D, MltD {Escherichia coli [TaxId: 562]} Length = 48

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Membrane-bound lytic murein transclycosylase D, MltD
species: Escherichia coli [TaxId: 562]

 Score = 40.0 bits (94), Expect = 2e-05
 Identities = 13/45 (28%), Positives = 27/45 (60%), Gaps = 2/45 (4%)

Query: 184 VSYVLQPSENLSSVASRFGIETQAIIDVNG--NNIRPFDTLFVPV 226
           ++Y ++  ++LSS+A R G+  + ++  N    N++P D L + V
Sbjct: 3   ITYRVRKGDSLSSIAKRHGVNIKDVMRWNSDTANLQPGDKLTLFV 47

>d1y7ma2 d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-terminal domain {Bacillus subtilis [TaxId: 1423]} Length = 48

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Hypothetical protein YkuD, N-terminal domain
species: Bacillus subtilis [TaxId: 1423]

 Score = 34.4 bits (79), Expect = 0.002
 Identities = 10/46 (21%), Positives = 25/46 (54%), Gaps = 3/46 (6%)

Query: 183 LVSYVLQPSENLSSVASRFGIETQAIIDVNG---NNIRPFDTLFVP 225
           +++Y ++  + L+S+A+ F I T A++  N      +    ++ +P
Sbjct: 1   MLTYQVKQGDTLNSIAADFRISTAALLQANPSLQAGLTAGQSIVIP 46

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	552
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.96
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.83
d1e0ga_	48	Membrane-bound lytic murein transclycosylase D, Ml	99.38
d1y7ma2	48	Hypothetical protein YkuD, N-terminal domain {Baci	99.33
d1e0ga_	48	Membrane-bound lytic murein transclycosylase D, Ml	99.29
d1y7ma2	48	Hypothetical protein YkuD, N-terminal domain {Baci	99.22
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.24
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.81
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.15
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.57
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.28
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.18
d1ijwc_	47	HIN recombinase (DNA-binding domain) {Synthetic}	81.24

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-42  Score=337.15  Aligned_cols=183  Identities=28%  Similarity=0.457  Sum_probs=166.4

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|.|++|.||+++.  +|+.||+|++...          ..+|++++++++||||+++++++.+  ++..|+||||+++|
T Consensus        14 iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~ivmEy~~~g   91 (263)
T d2j4za1          14 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLG   91 (263)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEEEECCTTC
T ss_pred             EecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE--CCEEEEEEeecCCC
Confidence            37777899999988  6889999998532          3479999999999999999999987  67899999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccccccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVG  492 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~g  492 (552)
                      +|.+++....  .+++.+++.++.||++||+|||+++   |+||||||+|||++.++.+||+|||++............|
T Consensus        92 ~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~G  166 (263)
T d2j4za1          92 TVYRELQKLS--KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG  166 (263)
T ss_dssp             BHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCCEETTE
T ss_pred             cHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCCcccccCC
Confidence            9999997654  4999999999999999999999999   9999999999999999999999999998766666667789


Q ss_pred             cccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       493 t~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      |+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus       167 t~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~  208 (263)
T d2j4za1         167 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT  208 (263)
T ss_dssp             EGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             CCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC
Confidence            999999999999999999999999999999999999998654

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-41  Score=333.11  Aligned_cols=182  Identities=25%  Similarity=0.446  Sum_probs=163.3

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      .|.|++|.||+|..  +|+.||||+++..       ..+|+.++++++||||+++++++.+  ++..|+||||+++|+|.
T Consensus        28 iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~ivmEy~~gg~L~  105 (293)
T d1yhwa1          28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVVMEYLAGGSLT  105 (293)
T ss_dssp             CCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEEECCTTCBHH
T ss_pred             EecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE--CCEEEEEEEecCCCcHH
Confidence            47788899999986  6999999998532       3589999999999999999999988  67899999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC--CCcccccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC--NAITMHIVGT  493 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~--~~~~~~~~gt  493 (552)
                      +++...   .+++.+++.++.|++.||+|||++|   |+||||||+|||++.++.+||+|||+++...  ........||
T Consensus       106 ~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt  179 (293)
T d1yhwa1         106 DVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT  179 (293)
T ss_dssp             HHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSC
T ss_pred             HHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccccccccccC
Confidence            988664   3999999999999999999999999   9999999999999999999999999998543  2234456799


Q ss_pred             ccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       494 ~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +.|+|||++.+..++.++|||||||++|||+||+.||.+.+
T Consensus       180 ~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~  220 (293)
T d1yhwa1         180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN  220 (293)
T ss_dssp             GGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             CCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC
Confidence            99999999999999999999999999999999999997654

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-41  Score=331.46  Aligned_cols=183  Identities=30%  Similarity=0.424  Sum_probs=161.5

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEecc--------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKW--------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~--------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      .|.|++|+||+|+.  +|+.||||+++.        .+.+|+.++++++||||+++++++.+  ++..|+||||+++|+|
T Consensus        13 lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~--~~~~~ivmEy~~gg~L   90 (271)
T d1nvra_          13 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYLFLEYCSGGEL   90 (271)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEEEECCTTEEG
T ss_pred             EecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc--CceeEEEEeccCCCcH
Confidence            37888899999987  689999999843        24589999999999999999999988  6788999999999999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC----Cccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN----AITMHI  490 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~----~~~~~~  490 (552)
                      .+++....  .+++.+++.++.|+++||+|||+++   |+||||||+|||+++++.+||+|||+|+....    ......
T Consensus        91 ~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~  165 (271)
T d1nvra_          91 FDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM  165 (271)
T ss_dssp             GGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCC
T ss_pred             HHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCccccccce
Confidence            99997544  4999999999999999999999999   99999999999999999999999999985421    123346


Q ss_pred             cccccccCccccCCCCC-CChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          491 VGTQGYIAPEYLADGVV-STKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       491 ~gt~~y~aPE~~~~~~~-s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .||+.|+|||++.+..+ +.++|||||||++|||+||+.||....
T Consensus       166 ~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~  210 (271)
T d1nvra_         166 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS  210 (271)
T ss_dssp             CSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS
T ss_pred             eeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC
Confidence            89999999999988776 578999999999999999999997654

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-42  Score=333.43  Aligned_cols=189  Identities=26%  Similarity=0.426  Sum_probs=152.5

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|+||.||+++.  +|+.||+|+++..         +.+|++++++++||||+++++++.+..+..+|+||||+++|+|
T Consensus        13 G~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L   92 (269)
T d2java1          13 GTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDL   92 (269)
T ss_dssp             EECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEH
T ss_pred             ecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcH
Confidence            7777899999987  6899999998532         3479999999999999999999987666778999999999999


Q ss_pred             hhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCC--CceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--ccc
Q 037224          415 HSWLHENK--NENLNWKTRLRIAIDVANGLQYIHEHTR--PRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITM  488 (552)
Q Consensus       415 ~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~--~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~  488 (552)
                      .+++....  ...+++.+++.++.|++.||+|||+++.  .+|+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        93 ~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~  172 (269)
T d2java1          93 ASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK  172 (269)
T ss_dssp             HHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC--------
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCCccc
Confidence            99986532  3469999999999999999999998652  34999999999999999999999999999854332  234


Q ss_pred             cccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          489 HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       489 ~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ...||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+
T Consensus       173 ~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~  218 (269)
T d2java1         173 AFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS  218 (269)
T ss_dssp             ---CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC
Confidence            5689999999999999999999999999999999999999998654

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-41  Score=326.88  Aligned_cols=185  Identities=25%  Similarity=0.398  Sum_probs=161.9

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecC--CCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDP--EDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~~~lv~e~~~~  411 (552)
                      .|.|+||+||+|..  +++.||+|.++..         +.+|++++++++||||+++++++.+.  .+..+++||||+++
T Consensus        17 iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~   96 (270)
T d1t4ha_          17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTS   96 (270)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCS
T ss_pred             EecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCC
Confidence            48888899999988  6789999998532         34799999999999999999998652  24568999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEC-CCCcEEEeeccCCccCCCCccccc
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLD-SNMRAKIANFGLAKSGCNAITMHI  490 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~-~~~~~kL~Dfg~a~~~~~~~~~~~  490 (552)
                      |+|.+++....  .+++.+++.++.|+++||+|||+++ ++|+||||||+|||++ +++.+||+|||+++..........
T Consensus        97 g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~~~~~  173 (270)
T d1t4ha_          97 GTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV  173 (270)
T ss_dssp             CBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEES
T ss_pred             CcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCccCCc
Confidence            99999997654  4999999999999999999999885 4499999999999996 578999999999987666556667


Q ss_pred             cccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       491 ~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      .||+.|+|||++.+ .++.++|||||||++|||++|+.||.+.
T Consensus       174 ~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~  215 (270)
T d1t4ha_         174 IGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC  215 (270)
T ss_dssp             CSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             ccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc
Confidence            89999999998865 5999999999999999999999999754

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-41  Score=331.99  Aligned_cols=182  Identities=25%  Similarity=0.443  Sum_probs=161.2

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|++|.||+|+.  +|+.||||+++..          +.+|++++++++||||+++++++.+  ++..|+||||+++|+
T Consensus        17 G~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~ivmEy~~gg~   94 (288)
T d1uu3a_          17 GEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD--DEKLYFGLSYAKNGE   94 (288)
T ss_dssp             EECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC--SSEEEEEECCCTTEE
T ss_pred             eeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE--CCEEEEEEEccCCCC
Confidence            7777899999987  6899999998532          3479999999999999999999987  678899999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC----Ccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN----AITMH  489 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~----~~~~~  489 (552)
                      |.+++....  .+++.+++.++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++....    .....
T Consensus        95 L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~  169 (288)
T d1uu3a_          95 LLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS  169 (288)
T ss_dssp             HHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC----------
T ss_pred             HHHhhhccC--CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCccccccc
Confidence            999887654  4999999999999999999999999   99999999999999999999999999985432    12234


Q ss_pred             ccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          490 IVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       170 ~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~  214 (288)
T d1uu3a_         170 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN  214 (288)
T ss_dssp             CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC
Confidence            679999999999999999999999999999999999999998654

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-41  Score=329.57  Aligned_cols=184  Identities=26%  Similarity=0.403  Sum_probs=161.4

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEecc-------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKW-------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~-------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      .|.|++|.||+|+.  +|+.||+|+++.       .+.+|++++++++||||+++++++.+  ++..++||||+++|+|.
T Consensus        20 iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lvmEy~~~g~L~   97 (288)
T d2jfla1          20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWILIEFCAGGAVD   97 (288)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEEECCTTEEHH
T ss_pred             EeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCeEEEEEecCCCCcHH
Confidence            37888899999987  688999999853       24589999999999999999999987  67889999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--cccccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIVGT  493 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~gt  493 (552)
                      +++.... ..+++.++..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++......  ......||
T Consensus        98 ~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt  173 (288)
T d2jfla1          98 AVMLELE-RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGT  173 (288)
T ss_dssp             HHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCCCSC
T ss_pred             HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCcccccccccc
Confidence            9876543 35999999999999999999999999   999999999999999999999999999754322  22346899


Q ss_pred             ccccCccccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          494 QGYIAPEYLA-----DGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       494 ~~y~aPE~~~-----~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +.|+|||++.     +..++.++|||||||++|||+||+.||.+.+
T Consensus       174 ~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~  219 (288)
T d2jfla1         174 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN  219 (288)
T ss_dssp             CTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             cccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC
Confidence            9999999874     4567899999999999999999999998654

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-41  Score=340.57  Aligned_cols=182  Identities=29%  Similarity=0.471  Sum_probs=161.8

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      |.|+||+||+|+.  +|+.||+|+++..        ..+|+.+|++++||||++++++|.+  +...++||||+++|+|.
T Consensus        15 G~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~iVmEy~~gg~L~   92 (322)
T d1s9ja_          15 GAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLD   92 (322)
T ss_dssp             ECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC--SSEEEEEEECCTTEEHH
T ss_pred             ecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEEEEcCCCCcHH
Confidence            7777799999997  6899999998532        3479999999999999999999987  67899999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccccccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEH-TRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQ  494 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~gt~  494 (552)
                      +++.+..  .+++..+..++.|++.||.|||++ +   |+||||||+|||++.++.+||+|||+|+...........||+
T Consensus        93 ~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~GT~  167 (322)
T d1s9ja_          93 QVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR  167 (322)
T ss_dssp             HHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC---CCSS
T ss_pred             HHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCCccccccCCc
Confidence            9997654  499999999999999999999974 7   999999999999999999999999999854444445578999


Q ss_pred             cccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       495 ~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus       168 ~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~  207 (322)
T d1s9ja_         168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD  207 (322)
T ss_dssp             CCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred             cccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            9999999999999999999999999999999999997654

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.3e-41  Score=331.86  Aligned_cols=183  Identities=28%  Similarity=0.479  Sum_probs=150.1

Q ss_pred             CceEEEEEEEEee--cCc---EEEEEEecc--------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          346 GCLIQGSVYKGNI--HGE---VYAIKMMKW--------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~---~vAvK~~~~--------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      |.|+||+||+|++  +++   .||||.+..        .+.+|+.+|++++||||++++++|.+  ++..++||||+++|
T Consensus        35 G~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~~~~~iv~Ey~~~g  112 (299)
T d1jpaa_          35 GAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK--STPVMIITEFMENG  112 (299)
T ss_dssp             EECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSSCEEEEECCTTE
T ss_pred             eeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee--CCEEEEEEEecCCC
Confidence            8888899999987  332   689998753        24579999999999999999999977  56789999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc------
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI------  486 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~------  486 (552)
                      +|.+++.... ..+++.+++.++.|+++||+|||+++   |+||||||+|||++.++.+||+|||+++......      
T Consensus       113 ~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~  188 (299)
T d1jpaa_         113 SLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYT  188 (299)
T ss_dssp             EHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----------------
T ss_pred             cceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCCCCcceee
Confidence            9999887643 35999999999999999999999998   9999999999999999999999999997543221      


Q ss_pred             -cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          487 -TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       487 -~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                       .....+|+.|+|||.+.++.++.++|||||||++|||+| |+.||.+..
T Consensus       189 ~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~  238 (299)
T d1jpaa_         189 SALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT  238 (299)
T ss_dssp             -------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             ecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC
Confidence             112357889999999999999999999999999999998 899998654

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-40  Score=330.50  Aligned_cols=183  Identities=27%  Similarity=0.444  Sum_probs=151.2

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      .|.|++|+||+++.  +|+.||||+++..        +.+|+.++++++||||+++++++.+  ++.+|+||||+++|+|
T Consensus        17 lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lvmE~~~gg~L   94 (307)
T d1a06a_          17 LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES--GGHLYLIMQLVSGGEL   94 (307)
T ss_dssp             SBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEEECCCCSCBH
T ss_pred             EeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEEEeccCCCcH
Confidence            47788899999987  6899999998533        2379999999999999999999987  7789999999999999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEC---CCCcEEEeeccCCccCCCC-ccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLD---SNMRAKIANFGLAKSGCNA-ITMHI  490 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~---~~~~~kL~Dfg~a~~~~~~-~~~~~  490 (552)
                      .+++....  .+++.++..++.|++.||+|||+++   |+||||||+|||+.   +++.+||+|||+++..... .....
T Consensus        95 ~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~  169 (307)
T d1a06a_          95 FDRIVEKG--FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA  169 (307)
T ss_dssp             HHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC---------------
T ss_pred             HHhhhccc--CCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccCCCeeeee
Confidence            99997654  4999999999999999999999999   99999999999994   5789999999999854432 33456


Q ss_pred             cccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       491 ~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus       170 ~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~  213 (307)
T d1a06a_         170 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN  213 (307)
T ss_dssp             ---CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             eeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC
Confidence            79999999999999999999999999999999999999998654

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-40  Score=331.21  Aligned_cols=183  Identities=28%  Similarity=0.444  Sum_probs=165.0

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|++|.||+++.  +|+.||+|++++.          ..+|+.+|++++||||+++++++.+  +..+|+||||+++|+
T Consensus        14 G~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~iv~ey~~gg~   91 (337)
T d1o6la_          14 GKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLCFVMEYANGGE   91 (337)
T ss_dssp             EECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC--SSEEEEEEECCTTCB
T ss_pred             ecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc--ccccccceeccCCCc
Confidence            7778899999987  7899999998642          3479999999999999999999987  778999999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC--CCcccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC--NAITMHIV  491 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~--~~~~~~~~  491 (552)
                      |.+++....  .+++..++.++.|++.||+|||+++   |+||||||+|||++.+|.+||+|||+|+...  .......+
T Consensus        92 L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~~~  166 (337)
T d1o6la_          92 LFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC  166 (337)
T ss_dssp             HHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCE
T ss_pred             hhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCCcccccce
Confidence            999988755  4899999999999999999999999   9999999999999999999999999998543  23344578


Q ss_pred             ccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          492 GTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       492 gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      ||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus       167 GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~  210 (337)
T d1o6la_         167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH  210 (337)
T ss_dssp             ECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             eCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH
Confidence            99999999999999999999999999999999999999987653

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.1e-40  Score=328.67  Aligned_cols=181  Identities=30%  Similarity=0.495  Sum_probs=163.5

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGS  413 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  413 (552)
                      |.|++|.||+++.  +|+.||||+++..          +.+|+.++++++||||+++++++.+  ++..|+||||+++|+
T Consensus        13 G~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~ivmE~~~gg~   90 (316)
T d1fota_          13 GTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQIFMIMDYIEGGE   90 (316)
T ss_dssp             EECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--SSEEEEEECCCCSCB
T ss_pred             ecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee--CCeeeeEeeecCCcc
Confidence            7777899999987  6899999998532          3479999999999999999999987  778999999999999


Q ss_pred             chhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcccccccc
Q 037224          414 LHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGT  493 (552)
Q Consensus       414 L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~gt  493 (552)
                      |.+++.....  +++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++..... .....||
T Consensus        91 l~~~~~~~~~--~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-~~~~~Gt  164 (316)
T d1fota_          91 LFSLLRKSQR--FPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-TYTLCGT  164 (316)
T ss_dssp             HHHHHHHTSS--CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC-BCCCCSC
T ss_pred             cccccccccc--ccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc-cccccCc
Confidence            9998876553  889999999999999999999999   999999999999999999999999999865443 3457899


Q ss_pred             ccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       494 ~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +.|+|||++.+..++.++|||||||++|||+||+.||.+.+
T Consensus       165 ~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~  205 (316)
T d1fota_         165 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN  205 (316)
T ss_dssp             TTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             ccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC
Confidence            99999999999999999999999999999999999998654

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.2e-40  Score=325.23  Aligned_cols=183  Identities=27%  Similarity=0.429  Sum_probs=162.0

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchh
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHS  416 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~  416 (552)
                      .|.|+||+||+|.+  +|+.||||+++.+      +.+|+.++++++||||++++++|.+  ++..++||||+++|+|.+
T Consensus        25 iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~iv~E~~~~g~l~~  102 (287)
T d1opja_          25 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYIITEFMTYGNLLD  102 (287)
T ss_dssp             TTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEEECCTTCBHHH
T ss_pred             EeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEee--CCeeEEEeecccCcchHH
Confidence            47777799999998  6889999998643      4589999999999999999999987  667899999999999999


Q ss_pred             hhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcc---cccccc
Q 037224          417 WLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAIT---MHIVGT  493 (552)
Q Consensus       417 ~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~---~~~~gt  493 (552)
                      ++.......+++..++.++.|+++||+|||+++   |+||||||+|||++.++.+||+|||+++.......   ....|+
T Consensus       103 ~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~  179 (287)
T d1opja_         103 YLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP  179 (287)
T ss_dssp             HHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEEC
T ss_pred             HhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCceeecccccc
Confidence            998776667999999999999999999999999   99999999999999999999999999986543322   224578


Q ss_pred             ccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       494 ~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                      +.|+|||.+.+..++.++|||||||++|||++|..||..
T Consensus       180 ~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~  218 (287)
T d1opja_         180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP  218 (287)
T ss_dssp             GGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC
Confidence            899999999999999999999999999999997777653

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-40  Score=324.47  Aligned_cols=181  Identities=30%  Similarity=0.517  Sum_probs=154.0

Q ss_pred             CceEEEEEEEEeecCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchh
Q 037224          346 GCLIQGSVYKGNIHGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHS  416 (552)
Q Consensus       346 G~g~~G~Vy~~~~~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~  416 (552)
                      |.|+||+||+|++.+ .||||+++..         +.+|+.++++++||||+++++++.+   ...++||||+++|+|.+
T Consensus        17 G~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~---~~~~lv~Ey~~~g~L~~   92 (276)
T d1uwha_          17 GSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQLAIVTQWCEGSSLYH   92 (276)
T ss_dssp             EECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEEEEECCCEEEHHH
T ss_pred             eeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec---cEEEEEEecCCCCCHHH
Confidence            788889999998765 5999998532         3479999999999999999998754   45799999999999999


Q ss_pred             hhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC----ccccccc
Q 037224          417 WLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA----ITMHIVG  492 (552)
Q Consensus       417 ~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~----~~~~~~g  492 (552)
                      ++..... .+++.+++.++.|+++||+|||+++   |+||||||+|||++.++.+||+|||+|+.....    ......|
T Consensus        93 ~l~~~~~-~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~g  168 (276)
T d1uwha_          93 HLHIIET-KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSG  168 (276)
T ss_dssp             HHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCC
T ss_pred             HHhhccC-CCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCCccccccccc
Confidence            9976543 4999999999999999999999998   999999999999999999999999999754321    2234678


Q ss_pred             cccccCccccCC---CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          493 TQGYIAPEYLAD---GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       493 t~~y~aPE~~~~---~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      |+.|+|||++.+   ..++.++|||||||++|||+||+.||.+.+
T Consensus       169 t~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~  213 (276)
T d1uwha_         169 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN  213 (276)
T ss_dssp             CGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             CcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC
Confidence            999999999864   347899999999999999999999998644

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-40  Score=320.95  Aligned_cols=182  Identities=29%  Similarity=0.483  Sum_probs=151.1

Q ss_pred             CceEEEEEEEEee-cCcEEEEEEeccC------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhhh
Q 037224          346 GCLIQGSVYKGNI-HGEVYAIKMMKWN------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL  418 (552)
Q Consensus       346 G~g~~G~Vy~~~~-~g~~vAvK~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l  418 (552)
                      |.|+||.||+|++ +++.||||+++..      +.+|++++++++||||++++|+|.+  ++..++||||+++|+|.+++
T Consensus        14 G~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~--~~~~~lv~E~~~~g~L~~~l   91 (263)
T d1sm2a_          14 GSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPICLVFEFMEHGCLSDYL   91 (263)
T ss_dssp             ECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEEECCTTCBHHHHH
T ss_pred             eeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceecc--CCceEEEEEecCCCcHHHHh
Confidence            7777799999998 6788999998643      4589999999999999999999987  56789999999999999988


Q ss_pred             hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC---cccccccccc
Q 037224          419 HENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA---ITMHIVGTQG  495 (552)
Q Consensus       419 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~---~~~~~~gt~~  495 (552)
                      .... ..+++..++.++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++.....   ......||+.
T Consensus        92 ~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~  167 (263)
T d1sm2a_          92 RTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK  167 (263)
T ss_dssp             HTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------------CTT
T ss_pred             hccc-cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCceeecceecCcc
Confidence            7643 35899999999999999999999999   999999999999999999999999999754332   2223578999


Q ss_pred             ccCccccCCCCCCChhhHHHHHHHHHHHHcC-CCCCCcc
Q 037224          496 YIAPEYLADGVVSTKMDVFSFGVVLLELISG-KEAIDEE  533 (552)
Q Consensus       496 y~aPE~~~~~~~s~~~Dv~slG~il~elltG-~~pf~~~  533 (552)
                      |+|||.+.+..++.++|||||||++|||+|+ ++||...
T Consensus       168 y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~  206 (263)
T d1sm2a_         168 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR  206 (263)
T ss_dssp             SCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC
T ss_pred             cCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC
Confidence            9999999999999999999999999999995 5555543

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-40  Score=322.76  Aligned_cols=183  Identities=28%  Similarity=0.431  Sum_probs=158.2

Q ss_pred             CCceEEEEEEEEee----cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI----HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~----~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|.|+||.||+|.+    ++..||||+++..        +.+|++++++++||||++++++|.+   +.+++||||+++|
T Consensus        17 iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---~~~~lvmE~~~~g   93 (285)
T d1u59a_          17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EALMLVMEMAGGG   93 (285)
T ss_dssp             EECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEEEEEECCTTE
T ss_pred             EecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc---CeEEEEEEeCCCC
Confidence            47788899999976    3457999998642        3479999999999999999999864   3579999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc-----c
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI-----T  487 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-----~  487 (552)
                      +|.+++.... ..+++.+++.++.|+++||+|||+++   |+||||||+|||++.++.+||+|||+++......     .
T Consensus        94 ~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~  169 (285)
T d1u59a_          94 PLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR  169 (285)
T ss_dssp             EHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCC
T ss_pred             cHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccccccccccc
Confidence            9999876543 35999999999999999999999999   9999999999999999999999999998543221     1


Q ss_pred             ccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          488 MHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       488 ~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      ....||+.|+|||.+.++.++.++|||||||++|||+| |+.||.+..
T Consensus       170 ~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~  217 (285)
T d1u59a_         170 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK  217 (285)
T ss_dssp             CSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             cccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC
Confidence            23467899999999998999999999999999999998 999998654

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-40  Score=322.18  Aligned_cols=181  Identities=29%  Similarity=0.458  Sum_probs=158.1

Q ss_pred             CCceEEEEEEEEee-cCcEEEEEEeccC------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhh
Q 037224          345 EGCLIQGSVYKGNI-HGEVYAIKMMKWN------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSW  417 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-~g~~vAvK~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~  417 (552)
                      .|.|+||.||+|.+ +++.||||+++..      +.+|++++++++||||+++++++.+   +..++||||+++|+|.++
T Consensus        21 iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~---~~~~iv~Ey~~~g~L~~~   97 (272)
T d1qpca_          21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIYIITEYMENGSLVDF   97 (272)
T ss_dssp             EEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEEECCTTCBHHHH
T ss_pred             EecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc---CCeEEEEEeCCCCcHHHH
Confidence            38888899999999 5678999999643      4689999999999999999998854   456899999999999998


Q ss_pred             hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc---cccccccc
Q 037224          418 LHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI---TMHIVGTQ  494 (552)
Q Consensus       418 l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~---~~~~~gt~  494 (552)
                      +.......+++.+++.|+.|+++||.|||+++   |+||||||+|||+++++.+||+|||+++......   .....||+
T Consensus        98 ~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~  174 (272)
T d1qpca_          98 LKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI  174 (272)
T ss_dssp             TTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCT
T ss_pred             HhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccccccccCCcc
Confidence            87655556999999999999999999999998   9999999999999999999999999998654322   22357889


Q ss_pred             cccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCC
Q 037224          495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAID  531 (552)
Q Consensus       495 ~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~  531 (552)
                      .|+|||.+.+..++.++|||||||++|||+||..|+.
T Consensus       175 ~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~  211 (272)
T d1qpca_         175 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY  211 (272)
T ss_dssp             TTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             cccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCC
Confidence            9999999998899999999999999999999655554

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.5e-40  Score=327.18  Aligned_cols=181  Identities=30%  Similarity=0.448  Sum_probs=159.3

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|.|+||.||+|+.  +|+.||||+++..          +.+|+.++++++||||+++++++.+  +...|+||||+++|
T Consensus        23 lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~iv~E~~~~g  100 (309)
T d1u5ra_          23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWLVMEYCLGS  100 (309)
T ss_dssp             EEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEEEECCSEE
T ss_pred             EecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE--CCEEEEEEEecCCC
Confidence            37777899999987  7899999998532          3479999999999999999999987  67899999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccccccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVG  492 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~g  492 (552)
                      +|..++....  .+++.+++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++......  ....|
T Consensus       101 ~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~--~~~~G  173 (309)
T d1u5ra_         101 ASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--NSFVG  173 (309)
T ss_dssp             HHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--CCCCS
T ss_pred             chHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC--Ccccc
Confidence            9877665543  4999999999999999999999999   999999999999999999999999999865433  34689


Q ss_pred             cccccCccccCC---CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          493 TQGYIAPEYLAD---GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       493 t~~y~aPE~~~~---~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      |+.|+|||++.+   ..++.++|||||||++|||++|+.||.+..
T Consensus       174 T~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~  218 (309)
T d1u5ra_         174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN  218 (309)
T ss_dssp             CGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             CccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC
Confidence            999999999853   458999999999999999999999997654

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.1e-39  Score=329.86  Aligned_cols=184  Identities=26%  Similarity=0.365  Sum_probs=163.2

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      .|.|++|.||+++.  +|+.||||++...       ..+|+.++++++||||+++++++.+  ++.+|+||||+++|+|.
T Consensus        34 lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~ivmE~~~gg~L~  111 (350)
T d1koaa2          34 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED--DNEMVMIYEFMSGGELF  111 (350)
T ss_dssp             EEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE--TTEEEEEECCCCSCBHH
T ss_pred             EecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEEEEcCCCCCHH
Confidence            48888899999987  6899999998643       2479999999999999999999987  77899999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEC--CCCcEEEeeccCCccCCC-Cccccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLD--SNMRAKIANFGLAKSGCN-AITMHIVG  492 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~--~~~~~kL~Dfg~a~~~~~-~~~~~~~g  492 (552)
                      +++.... ..+++.+++.++.||+.||+|||+++   |+||||||+|||++  .++.+||+|||+++.... .......|
T Consensus       112 ~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~g  187 (350)
T d1koaa2         112 EKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTG  187 (350)
T ss_dssp             HHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEECS
T ss_pred             HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccccccceecC
Confidence            9886543 34999999999999999999999999   99999999999995  467899999999986443 33445789


Q ss_pred             cccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       493 t~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      |+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus       188 T~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~  229 (350)
T d1koaa2         188 TAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN  229 (350)
T ss_dssp             CTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999999999999999999998654

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-39  Score=321.51  Aligned_cols=183  Identities=29%  Similarity=0.419  Sum_probs=162.9

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC-------------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN-------------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      |.|+||.||+|+.  +|+.||||+++..             +.+|+.++++++||||+++++++.+  +...|+||||++
T Consensus        19 G~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~iv~E~~~   96 (293)
T d1jksa_          19 GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN--KTDVILILELVA   96 (293)
T ss_dssp             EECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEEEECCC
T ss_pred             ecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEEEEcCC
Confidence            7777899999987  6899999998421             3579999999999999999999987  778999999999


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCC----cEEEeeccCCccCCC-C
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM----RAKIANFGLAKSGCN-A  485 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~----~~kL~Dfg~a~~~~~-~  485 (552)
                      +|+|.+++....  .+++.+++.++.|++.||+|||+++   |+||||||+|||++.++    .+||+|||++..... .
T Consensus        97 gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~  171 (293)
T d1jksa_          97 GGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN  171 (293)
T ss_dssp             SCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSC
T ss_pred             Cccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhhhcCCCc
Confidence            999999997754  4999999999999999999999999   99999999999998776    599999999975543 3


Q ss_pred             ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          486 ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       486 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||.+.+.
T Consensus       172 ~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~  221 (293)
T d1jksa_         172 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK  221 (293)
T ss_dssp             BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH
Confidence            34456889999999999999999999999999999999999999987653

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-40  Score=322.14  Aligned_cols=182  Identities=29%  Similarity=0.444  Sum_probs=156.7

Q ss_pred             CCceEEEEEEEEee----cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI----HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~----~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|+||.||+|.+    .++.||||+++.+         +.+|++++++++||||++++++|.+   +..++||||+++
T Consensus        15 iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~---~~~~lvmE~~~~   91 (277)
T d1xbba_          15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMAEL   91 (277)
T ss_dssp             EEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---SSEEEEEECCTT
T ss_pred             cccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc---CCEEEEEEcCCC
Confidence            47788899999986    2468999998532         4479999999999999999999864   346899999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc-----
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI-----  486 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-----  486 (552)
                      |+|.+++....  .+++.+++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++......     
T Consensus        92 g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  166 (277)
T d1xbba_          92 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  166 (277)
T ss_dssp             EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred             CcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence            99999988654  4999999999999999999999998   9999999999999999999999999997543221     


Q ss_pred             cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          487 TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       487 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+.+
T Consensus       167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~  215 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK  215 (277)
T ss_dssp             ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC
Confidence            123468899999999999999999999999999999998 899998654

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.5e-39  Score=329.11  Aligned_cols=184  Identities=26%  Similarity=0.387  Sum_probs=163.5

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC-------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN-------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      .|.|++|.||+|+.  +|+.||||+++..       ..+|+.++++++||||+++++++.+  +..+|+||||+++|+|.
T Consensus        37 lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~ivmE~~~gg~L~  114 (352)
T d1koba_          37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED--KYEMVLILEFLSGGELF  114 (352)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC--SSEEEEEEECCCCCBHH
T ss_pred             EecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEEEEcCCCChHH
Confidence            37888899999987  7899999998643       2479999999999999999999987  77899999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEC--CCCcEEEeeccCCccCCC-Cccccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLD--SNMRAKIANFGLAKSGCN-AITMHIVG  492 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~--~~~~~kL~Dfg~a~~~~~-~~~~~~~g  492 (552)
                      +++.... ..+++.+++.|+.||+.||+|||++|   |+||||||+|||++  .++.+||+|||++..... .......|
T Consensus       115 ~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~g  190 (352)
T d1koba_         115 DRIAAED-YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA  190 (352)
T ss_dssp             HHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECS
T ss_pred             HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCCceeeccC
Confidence            8776543 35999999999999999999999999   99999999999997  678999999999986543 33445689


Q ss_pred             cccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       493 t~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      |+.|+|||++.+..++.++|||||||++|||+||+.||.+.+
T Consensus       191 t~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~  232 (352)
T d1koba_         191 TAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED  232 (352)
T ss_dssp             SGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred             cccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999999999999999999998654

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.9e-39  Score=326.96  Aligned_cols=182  Identities=27%  Similarity=0.398  Sum_probs=164.2

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      .|.|++|.||+++.  +|+.||||+++..          ..+|+.+++.++||||+++++++.+  ....++||||+.+|
T Consensus        49 lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~~v~e~~~~g  126 (350)
T d1rdqe_          49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGG  126 (350)
T ss_dssp             EEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEEEECCTTC
T ss_pred             eecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc--cccccccccccccc
Confidence            37778899999987  6999999998532          3479999999999999999999987  67889999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccccccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVG  492 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~g  492 (552)
                      +|.+++....  .+++.+++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..... .....|
T Consensus       127 ~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-~~~~~G  200 (350)
T d1rdqe_         127 EMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-TWTLCG  200 (350)
T ss_dssp             BHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-BCCCEE
T ss_pred             chhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc-cccccC
Confidence            9999987654  4999999999999999999999999   999999999999999999999999999865433 345789


Q ss_pred             cccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          493 TQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       493 t~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      |+.|+|||++.+..++.++|||||||++|||+||+.||.+.+
T Consensus       201 t~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~  242 (350)
T d1rdqe_         201 TPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ  242 (350)
T ss_dssp             CGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC
Confidence            999999999999999999999999999999999999998764

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.1e-39  Score=328.48  Aligned_cols=183  Identities=26%  Similarity=0.370  Sum_probs=161.0

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccCh----------HH---HHHHHHHcCCCCccceeeeeecCCCCeeEEEEeec
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWNA----------CE---ELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI  409 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~~----------~~---E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~  409 (552)
                      .|.|++|.||+|+.  +|+.||||+++...          .+   |+.+++.++||||+++++++.+  ++..|+||||+
T Consensus        12 lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~--~~~~~ivmE~~   89 (364)
T d1omwa3          12 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDKLSFILDLM   89 (364)
T ss_dssp             EEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC--SSEEEEEECCC
T ss_pred             EecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE--CCEEEEEEEec
Confidence            37788899999988  68999999985321          23   3566667789999999999987  67889999999


Q ss_pred             cCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcccc
Q 037224          410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH  489 (552)
Q Consensus       410 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  489 (552)
                      ++|+|.+++....  .+++.+++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+.........
T Consensus        90 ~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~~~~  164 (364)
T d1omwa3          90 NGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA  164 (364)
T ss_dssp             CSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSSSCCCS
T ss_pred             CCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCCCcccc
Confidence            9999999997654  4899999999999999999999999   9999999999999999999999999998766666666


Q ss_pred             ccccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          490 IVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ..||+.|+|||++.. ..++.++|||||||++|||+||+.||....
T Consensus       165 ~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~  210 (364)
T d1omwa3         165 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK  210 (364)
T ss_dssp             CCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred             cccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCC
Confidence            789999999999865 568999999999999999999999998654

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-39  Score=310.41  Aligned_cols=185  Identities=28%  Similarity=0.443  Sum_probs=162.5

Q ss_pred             CCceEEEEEEEEee-cCcEEEEEEeccC------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhh
Q 037224          345 EGCLIQGSVYKGNI-HGEVYAIKMMKWN------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSW  417 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-~g~~vAvK~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~  417 (552)
                      .|.|+||+||+|++ +++.||||+++..      +.+|+.++++++||||++++|+|.+  ++.+++||||+++|+|.++
T Consensus        12 iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~--~~~~~iv~Ey~~~g~l~~~   89 (258)
T d1k2pa_          12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK--QRPIFIITEYMANGCLLNY   89 (258)
T ss_dssp             CCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECC--SSSEEEEEECCTTEEHHHH
T ss_pred             EecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEee--CCceEEEEEccCCCcHHHh
Confidence            48888899999999 5678999998643      4589999999999999999999987  6778999999999999998


Q ss_pred             hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC---ccccccccc
Q 037224          418 LHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA---ITMHIVGTQ  494 (552)
Q Consensus       418 l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~---~~~~~~gt~  494 (552)
                      +..... .+++..+++++.|+++||+|||+++   |+||||||+||++++++.+||+|||+++.....   ......+|+
T Consensus        90 ~~~~~~-~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~  165 (258)
T d1k2pa_          90 LREMRH-RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV  165 (258)
T ss_dssp             HHSGGG-CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCG
T ss_pred             hhcccc-CCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCceeecccCCCC
Confidence            765443 4899999999999999999999999   999999999999999999999999999754322   222356889


Q ss_pred             cccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccCc
Q 037224          495 GYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEGK  535 (552)
Q Consensus       495 ~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~~  535 (552)
                      .|+|||.+.+..++.++||||||+++|||+| |+.||.....
T Consensus       166 ~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~  207 (258)
T d1k2pa_         166 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN  207 (258)
T ss_dssp             GGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH
T ss_pred             CcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH
Confidence            9999999999999999999999999999998 8999986653

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-39  Score=319.85  Aligned_cols=183  Identities=29%  Similarity=0.473  Sum_probs=161.2

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHH-HcCCCCccceeeeeecCCCCeeEEEEeeccCC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQ-KVNHGNLVKLEGFCIDPEDANCYLIYEYIENG  412 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  412 (552)
                      |.|++|+||+|+.  +|+.||||+++.+          ..+|..++. .++||||+++++++.+  ++..|+||||+++|
T Consensus        11 G~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~--~~~~yivmEy~~~g   88 (320)
T d1xjda_          11 GKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KENLFFVMEYLNGG   88 (320)
T ss_dssp             EECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEEEEEEECCTTC
T ss_pred             ecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc--CCceeEEEeecCCC
Confidence            7777899999988  7899999999532          234666655 6899999999999988  67899999999999


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC--CCccccc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC--NAITMHI  490 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~--~~~~~~~  490 (552)
                      +|.+++....  .+++.+++.++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++...  .......
T Consensus        89 ~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~~~  163 (320)
T d1xjda_          89 DLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF  163 (320)
T ss_dssp             BHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCC
T ss_pred             cHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccccccccccc
Confidence            9999997655  3899999999999999999999999   9999999999999999999999999997543  2233346


Q ss_pred             cccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          491 VGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       491 ~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      .||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+.
T Consensus       164 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~  208 (320)
T d1xjda_         164 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE  208 (320)
T ss_dssp             CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             CCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH
Confidence            899999999999999999999999999999999999999987653

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-39  Score=324.25  Aligned_cols=187  Identities=23%  Similarity=0.367  Sum_probs=163.1

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC--hHHHHHHHHHc-CCCCccceeeeeec--CCCCeeEEEEeeccCCCchhh
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN--ACEELKILQKV-NHGNLVKLEGFCID--PEDANCYLIYEYIENGSLHSW  417 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~--~~~E~~~l~~l-~h~niv~l~~~~~~--~~~~~~~lv~e~~~~gsL~~~  417 (552)
                      .|.|+||.||+|+.  +++.||||+++..  ..+|+.++.++ +||||+++++++.+  ..+..+|+||||+++|+|.++
T Consensus        20 lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~   99 (335)
T d2ozaa1          20 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSR   99 (335)
T ss_dssp             EEECSSCEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHH
T ss_pred             eeeccCeEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHH
Confidence            37788899999987  6899999999754  45799987665 89999999999865  234578999999999999999


Q ss_pred             hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECC---CCcEEEeeccCCccCC-CCcccccccc
Q 037224          418 LHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS---NMRAKIANFGLAKSGC-NAITMHIVGT  493 (552)
Q Consensus       418 l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kL~Dfg~a~~~~-~~~~~~~~gt  493 (552)
                      +.......+++.+++.++.|++.||+|||+++   |+||||||+|||++.   ++.+||+|||+++... ........||
T Consensus       100 i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt  176 (335)
T d2ozaa1         100 IQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT  176 (335)
T ss_dssp             HHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCC
T ss_pred             HHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---CccccccccccccccccccccccccccceeeeccCCCccccccCC
Confidence            98766567999999999999999999999999   999999999999975   5679999999997543 2334456899


Q ss_pred             ccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          494 QGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       494 ~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +.|+|||++.+..++.++|||||||++|||+||+.||.+.+
T Consensus       177 ~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~  217 (335)
T d2ozaa1         177 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH  217 (335)
T ss_dssp             CSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETT
T ss_pred             cccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCC
Confidence            99999999999999999999999999999999999997654

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.6e-38  Score=309.57  Aligned_cols=183  Identities=26%  Similarity=0.454  Sum_probs=161.6

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------------hHHHHHHHHHcC-CCCccceeeeeecCCCCeeEEEE
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------------ACEELKILQKVN-HGNLVKLEGFCIDPEDANCYLIY  406 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------------~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~lv~  406 (552)
                      |.|.+|+||+++.  +|+.||||+++..                ..+|+.++++++ ||||+++++++.+  ++..|+||
T Consensus        12 G~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~--~~~~~ivm   89 (277)
T d1phka_          12 GRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET--NTFFFLVF   89 (277)
T ss_dssp             EECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEEEEEE
T ss_pred             ecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc--CcceEEEE
Confidence            6777799999987  7899999998432                347999999997 9999999999987  77899999


Q ss_pred             eeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCC-CC
Q 037224          407 EYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGC-NA  485 (552)
Q Consensus       407 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~-~~  485 (552)
                      ||+++|+|.+++....  .+++.+++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++... ..
T Consensus        90 E~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~  164 (277)
T d1phka_          90 DLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE  164 (277)
T ss_dssp             ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred             EcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchheeEccCCC
Confidence            9999999999997654  4999999999999999999999999   9999999999999999999999999998544 23


Q ss_pred             ccccccccccccCccccC------CCCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          486 ITMHIVGTQGYIAPEYLA------DGVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       486 ~~~~~~gt~~y~aPE~~~------~~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      ......||+.|+|||.+.      ...++.++||||+||++|||++|+.||.+.++
T Consensus       165 ~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~  220 (277)
T d1phka_         165 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ  220 (277)
T ss_dssp             CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH
Confidence            344568999999999875      34578899999999999999999999987653

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-38  Score=317.06  Aligned_cols=184  Identities=26%  Similarity=0.345  Sum_probs=163.1

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhh
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSW  417 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~  417 (552)
                      |.|+||.||+|..  +|+.||+|+++..      ..+|+++|++++||||+++++++.+  ++.+|+||||+++|+|.++
T Consensus        14 G~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~lvmE~~~gg~L~~~   91 (321)
T d1tkia_          14 GRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES--MEELVMIFEFISGLDIFER   91 (321)
T ss_dssp             EECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEE--TTEEEEEECCCCCCBHHHH
T ss_pred             ecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEEEEecCCCCcHHHH
Confidence            7778899999987  6889999999654      3479999999999999999999987  6789999999999999999


Q ss_pred             hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCC--CcEEEeeccCCccCCC-Cccccccccc
Q 037224          418 LHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN--MRAKIANFGLAKSGCN-AITMHIVGTQ  494 (552)
Q Consensus       418 l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~--~~~kL~Dfg~a~~~~~-~~~~~~~gt~  494 (552)
                      +.... ..+++.+++.++.||+.||+|||+++   |+||||||+|||++.+  ..+||+|||+++.... .......+++
T Consensus        92 i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~  167 (321)
T d1tkia_          92 INTSA-FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAP  167 (321)
T ss_dssp             HTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCG
T ss_pred             HHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccCCccccccccc
Confidence            97653 24999999999999999999999999   9999999999999854  5899999999986543 3344567899


Q ss_pred             cccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       495 ~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      .|+|||.+.+..++.++|||||||++|||++|+.||...+.
T Consensus       168 ~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~  208 (321)
T d1tkia_         168 EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN  208 (321)
T ss_dssp             GGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred             ccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH
Confidence            99999999999999999999999999999999999987653

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-38  Score=318.84  Aligned_cols=184  Identities=30%  Similarity=0.502  Sum_probs=158.0

Q ss_pred             CceEEEEEEEEeecC-------cEEEEEEeccC--------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeec
Q 037224          346 GCLIQGSVYKGNIHG-------EVYAIKMMKWN--------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYI  409 (552)
Q Consensus       346 G~g~~G~Vy~~~~~g-------~~vAvK~~~~~--------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~  409 (552)
                      |.|+||+||+|++.+       ..||+|.+...        +.+|+.++.++ +||||++++++|.+  .+..++||||+
T Consensus        46 G~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~--~~~~~lv~Ey~  123 (325)
T d1rjba_          46 GSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL--SGPIYLIFEYC  123 (325)
T ss_dssp             EECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEEECC
T ss_pred             eeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee--CCeEEEEEEcC
Confidence            778889999998732       36999998432        34799999998 89999999999987  66789999999


Q ss_pred             cCCCchhhhhhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCC
Q 037224          410 ENGSLHSWLHENKN---------------------ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN  468 (552)
Q Consensus       410 ~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~  468 (552)
                      ++|+|.+++.....                     ..+++.+++.++.|+++||+|||+++   |+||||||+|||++.+
T Consensus       124 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~Nill~~~  200 (325)
T d1rjba_         124 CYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHG  200 (325)
T ss_dssp             TTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEETT
T ss_pred             CCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchhccccccC
Confidence            99999999976432                     34899999999999999999999999   9999999999999999


Q ss_pred             CcEEEeeccCCccCCCCc----cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          469 MRAKIANFGLAKSGCNAI----TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       469 ~~~kL~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      +.+||+|||+|+......    .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||.+.+
T Consensus       201 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~  271 (325)
T d1rjba_         201 KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  271 (325)
T ss_dssp             TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             CeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence            999999999997543221    223567999999999999999999999999999999998 899998654

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.8e-38  Score=310.17  Aligned_cols=184  Identities=22%  Similarity=0.403  Sum_probs=155.1

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCC--CeeEEEEeeccC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPED--ANCYLIYEYIEN  411 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~~~lv~e~~~~  411 (552)
                      |.|++|.||+|+.  +|+.||||+++.+          +.+|+.++++++||||+++++++.....  ...|+||||+++
T Consensus        16 G~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g   95 (277)
T d1o6ya_          16 GFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDG   95 (277)
T ss_dssp             EECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCE
T ss_pred             eeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCC
Confidence            7778899999987  6999999998542          3479999999999999999999876432  347899999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC-----Cc
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN-----AI  486 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~-----~~  486 (552)
                      ++|.+++....  .+++.+++.++.|++.||+|||+++   |+||||||+|||++.++..+|+|||.+.....     ..
T Consensus        96 ~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~  170 (277)
T d1o6ya_          96 VTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ  170 (277)
T ss_dssp             EEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEECC--------
T ss_pred             CEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhhccccccccc
Confidence            99999887654  4999999999999999999999999   99999999999999999999999998864321     12


Q ss_pred             cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          487 TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       487 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .....||+.|+|||++.+..+++++|||||||++|||+||+.||.+.+
T Consensus       171 ~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~  218 (277)
T d1o6ya_         171 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS  218 (277)
T ss_dssp             --------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC
Confidence            334579999999999999999999999999999999999999998654

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-38  Score=312.50  Aligned_cols=182  Identities=29%  Similarity=0.430  Sum_probs=154.5

Q ss_pred             CCceEEEEEEEEee-cCcEEEEEEeccC------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhh
Q 037224          345 EGCLIQGSVYKGNI-HGEVYAIKMMKWN------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSW  417 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-~g~~vAvK~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~  417 (552)
                      .|.|+||.||+|++ +++.||||+++..      +.+|+.++++++|+||++++++|.+   +..++||||+++|+|.++
T Consensus        25 iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~---~~~~lv~Ey~~~g~l~~~  101 (285)
T d1fmka3          25 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVTEYMSKGSLLDF  101 (285)
T ss_dssp             EEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEECCCTTCBHHHH
T ss_pred             EeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec---CCeEEEEEecCCCchhhh
Confidence            37778899999998 5678999999633      5689999999999999999999854   456899999999999998


Q ss_pred             hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC---ccccccccc
Q 037224          418 LHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA---ITMHIVGTQ  494 (552)
Q Consensus       418 l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~---~~~~~~gt~  494 (552)
                      +.......++|.+++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....   ......||+
T Consensus       102 ~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~  178 (285)
T d1fmka3         102 LKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI  178 (285)
T ss_dssp             HSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCG
T ss_pred             hhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCceeeccccccc
Confidence            87665556999999999999999999999999   999999999999999999999999999754322   222356899


Q ss_pred             cccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          495 GYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       495 ~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                      .|+|||.+.+..++.++||||||+++|||+||..|+..
T Consensus       179 ~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~  216 (285)
T d1fmka3         179 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP  216 (285)
T ss_dssp             GGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             cccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCC
Confidence            99999999999999999999999999999997666554

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-39  Score=311.04  Aligned_cols=184  Identities=29%  Similarity=0.489  Sum_probs=155.6

Q ss_pred             CceEEEEEEEEeecCcEEEEEEeccC-----hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhhhhh
Q 037224          346 GCLIQGSVYKGNIHGEVYAIKMMKWN-----ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHE  420 (552)
Q Consensus       346 G~g~~G~Vy~~~~~g~~vAvK~~~~~-----~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~  420 (552)
                      |.|++|.||+|++.|..||||+++.+     +.+|++++++++||||++++|+|.+. .+.+++||||+++|+|.+++..
T Consensus        16 G~G~fg~Vy~~~~~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~lv~ey~~~g~L~~~l~~   94 (262)
T d1byga_          16 GKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVTEYMAKGSLVDYLRS   94 (262)
T ss_dssp             EECSSCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEEEECCCTTEEHHHHHHH
T ss_pred             ecCCCeEEEEEEECCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEec-CCcEEEEEeccCCCCHHHHHHh
Confidence            77777999999999999999999654     45799999999999999999998753 3457999999999999999976


Q ss_pred             cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccccccccccccCcc
Q 037224          421 NKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHIVGTQGYIAPE  500 (552)
Q Consensus       421 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~gt~~y~aPE  500 (552)
                      .....+++..++.|+.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++..... .....++..|+|||
T Consensus        95 ~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-~~~~~~~~~y~aPE  170 (262)
T d1byga_          95 RGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-QDTGKLPVKWTAPE  170 (262)
T ss_dssp             HHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------------CCTTTSCHH
T ss_pred             cCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC-CccccccccCCChH
Confidence            55445899999999999999999999998   999999999999999999999999999865433 23456789999999


Q ss_pred             ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          501 YLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       501 ~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      .+.+..+++++||||||+++|||+| |+.||...+
T Consensus       171 ~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~  205 (262)
T d1byga_         171 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP  205 (262)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred             HHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC
Confidence            9999999999999999999999998 788887543

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-38  Score=310.31  Aligned_cols=182  Identities=29%  Similarity=0.426  Sum_probs=151.8

Q ss_pred             CCceEEEEEEEEeecC------cEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          345 EGCLIQGSVYKGNIHG------EVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~g------~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      .|.|+||.||+|.+.+      ..||||+++..        +.+|+.++++++||||++++|++.+  ....+++|||+.
T Consensus        15 iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~--~~~~~~v~e~~~   92 (283)
T d1mqba_          15 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK--YKPMMIITEYME   92 (283)
T ss_dssp             EEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSEEEEEECCT
T ss_pred             EeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec--CCceEEEEEecc
Confidence            4888889999998732      36999998532        4579999999999999999999987  667899999999


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-----
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-----  485 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-----  485 (552)
                      ++++.+++.... ..+++.+++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....     
T Consensus        93 ~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~  168 (283)
T d1mqba_          93 NGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY  168 (283)
T ss_dssp             TEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------------
T ss_pred             cCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccCCCccce
Confidence            999998776543 35999999999999999999999999   999999999999999999999999999854322     


Q ss_pred             ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          486 ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       486 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                      ......||+.|+|||.+.+..++.++|||||||++|||++|..|+..
T Consensus       169 ~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~  215 (283)
T d1mqba_         169 TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW  215 (283)
T ss_dssp             -----CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             EeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccc
Confidence            12234678999999999999999999999999999999997666543

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-38  Score=312.19  Aligned_cols=183  Identities=30%  Similarity=0.404  Sum_probs=156.7

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC------------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN------------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~------------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      |.|.||+||+|+.  +|+.||||+++..            +.+|+.++++++||||+++++++.+  ++..++||||+++
T Consensus         7 G~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~--~~~~~ivmE~~~~   84 (299)
T d1ua2a_           7 GEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--KSNISLVFDFMET   84 (299)
T ss_dssp             EEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--TTCCEEEEECCSE
T ss_pred             ccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc--CCceeehhhhhcc
Confidence            7788899999987  6899999998532            3479999999999999999999987  6678999999998


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--cccc
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMH  489 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~  489 (552)
                      +++..+....  ..+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        85 ~~~~~~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~  159 (299)
T d1ua2a_          85 DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH  159 (299)
T ss_dssp             EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCC
T ss_pred             hHHhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcccccc
Confidence            7776655433  34899999999999999999999999   999999999999999999999999999754432  2334


Q ss_pred             ccccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          490 IVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      ..||+.|+|||.+.. ..++.++|||||||++|||+||+.||....+
T Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~  206 (299)
T d1ua2a_         160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD  206 (299)
T ss_dssp             SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH
Confidence            579999999998865 4579999999999999999999999986543

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-38  Score=306.61  Aligned_cols=183  Identities=25%  Similarity=0.342  Sum_probs=159.2

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC-------------hHHHHHHHHHcC--CCCccceeeeeecCCCCeeEEEEe
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN-------------ACEELKILQKVN--HGNLVKLEGFCIDPEDANCYLIYE  407 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~-------------~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~~~lv~e  407 (552)
                      .|.|+||.||+|+.  +|+.||||+++..             ..+|+.++++++  ||||+++++++.+  ++..++|||
T Consensus        12 lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~--~~~~~lv~e   89 (273)
T d1xwsa_          12 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER--PDSFVLILE   89 (273)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--SSEEEEEEE
T ss_pred             EeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee--CCeEEEEEE
Confidence            37888899999997  6899999998532             347999999996  8999999999987  678899999


Q ss_pred             eccC-CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECC-CCcEEEeeccCCccCCCC
Q 037224          408 YIEN-GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS-NMRAKIANFGLAKSGCNA  485 (552)
Q Consensus       408 ~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kL~Dfg~a~~~~~~  485 (552)
                      |+.+ +++.+++....  .+++.+++.++.|+++||+|||+++   |+||||||+|||++. ++.+||+|||+++.....
T Consensus        90 ~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~  164 (273)
T d1xwsa_          90 RPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT  164 (273)
T ss_dssp             CCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCSS
T ss_pred             eccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccceecccc
Confidence            9986 56777776544  4999999999999999999999999   999999999999985 579999999999876665


Q ss_pred             ccccccccccccCccccCCCCC-CChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          486 ITMHIVGTQGYIAPEYLADGVV-STKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       486 ~~~~~~gt~~y~aPE~~~~~~~-s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ......||+.|+|||++.+..+ +.++|||||||++|||+||+.||...+
T Consensus       165 ~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~  214 (273)
T d1xwsa_         165 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE  214 (273)
T ss_dssp             CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH
T ss_pred             cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch
Confidence            5666789999999999877665 567899999999999999999998653

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-37  Score=309.85  Aligned_cols=182  Identities=27%  Similarity=0.469  Sum_probs=153.3

Q ss_pred             CceEEEEEEEEee--cCc----EEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          346 GCLIQGSVYKGNI--HGE----VYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~----~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      |.|+||+||+|.+  +|+    .||+|.++..        +.+|++++++++||||++++++|.+   +..++++||+.+
T Consensus        18 G~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~---~~~~~v~e~~~~   94 (317)
T d1xkka_          18 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---STVQLITQLMPF   94 (317)
T ss_dssp             EECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEEEEEECCTT
T ss_pred             ecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCeeEEEEeccC
Confidence            7788899999987  444    5899987532        4579999999999999999999976   345788999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC----cc
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA----IT  487 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~----~~  487 (552)
                      ++|.+++.... ..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....    ..
T Consensus        95 ~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  170 (317)
T d1xkka_          95 GCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA  170 (317)
T ss_dssp             CBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC----
T ss_pred             Ccccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecccccccccc
Confidence            99999887654 35999999999999999999999998   999999999999999999999999999854322    12


Q ss_pred             ccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          488 MHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       488 ~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      ....||+.|+|||.+.++.++.++|||||||++|||+| |+.||.+.+
T Consensus       171 ~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~  218 (317)
T d1xkka_         171 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP  218 (317)
T ss_dssp             ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred             cccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC
Confidence            23468999999999999999999999999999999998 899998654

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-37  Score=304.53  Aligned_cols=184  Identities=26%  Similarity=0.355  Sum_probs=149.1

Q ss_pred             CCceEEEEEEEEeec-----CcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNIH-----GEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~-----g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|+||.||+|++.     +..||||.++..        +.+|+.++++++||||+++++++.   ++..++||||+++
T Consensus        15 iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~---~~~~~iv~E~~~~   91 (273)
T d1mp8a_          15 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT---ENPVWIIMELCTL   91 (273)
T ss_dssp             EEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC---SSSCEEEEECCTT
T ss_pred             EeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe---cCeEEEEEEeccC
Confidence            377888999999872     346899988532        347999999999999999999985   3567999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC---ccc
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA---ITM  488 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~---~~~  488 (552)
                      |+|.+++.... ..+++.+++.++.|+++||+|||+++   ++||||||+||+++.++.+||+|||+++.....   ...
T Consensus        92 g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~  167 (273)
T d1mp8a_          92 GELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS  167 (273)
T ss_dssp             EEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC----------------
T ss_pred             CcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccCCcceecc
Confidence            99999876543 35899999999999999999999999   999999999999999999999999999754322   233


Q ss_pred             cccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccCc
Q 037224          489 HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEGK  535 (552)
Q Consensus       489 ~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~~  535 (552)
                      ...||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+...
T Consensus       168 ~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~  215 (273)
T d1mp8a_         168 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN  215 (273)
T ss_dssp             ---CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred             ceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH
Confidence            4568899999999999999999999999999999998 8999986543

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.4e-37  Score=306.00  Aligned_cols=185  Identities=29%  Similarity=0.435  Sum_probs=157.8

Q ss_pred             CceEEEEEEEEeec-------CcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeecc
Q 037224          346 GCLIQGSVYKGNIH-------GEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIE  410 (552)
Q Consensus       346 G~g~~G~Vy~~~~~-------g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  410 (552)
                      |.|+||+||+|++.       ++.||||+++..        +.+|+.++++++||||++++++|.+  ....+++|||++
T Consensus        22 G~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~~~~~v~e~~~   99 (301)
T d1lufa_          22 GEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV--GKPMCLLFEYMA   99 (301)
T ss_dssp             EECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSCEEEEECCT
T ss_pred             eeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc--CCceEEEEEecC
Confidence            78888999999874       368999998532        4589999999999999999999987  567899999999


Q ss_pred             CCCchhhhhhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCC
Q 037224          411 NGSLHSWLHENK----------------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSN  468 (552)
Q Consensus       411 ~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~  468 (552)
                      +|+|.+++....                      ...+++.+++.++.|++.||+|||+++   ++||||||+|||++.+
T Consensus       100 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp~NILld~~  176 (301)
T d1lufa_         100 YGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGEN  176 (301)
T ss_dssp             TCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGG
T ss_pred             CCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcccceEECCC
Confidence            999999986532                      124899999999999999999999999   9999999999999999


Q ss_pred             CcEEEeeccCCccCCCC----ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCC-CCCCccCc
Q 037224          469 MRAKIANFGLAKSGCNA----ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK-EAIDEEGK  535 (552)
Q Consensus       469 ~~~kL~Dfg~a~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~-~pf~~~~~  535 (552)
                      +.+||+|||+++.....    ......+++.|+|||.+.+..++.++|||||||++|||++|. +||.+.++
T Consensus       177 ~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~  248 (301)
T d1lufa_         177 MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH  248 (301)
T ss_dssp             GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             CcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence            99999999999743221    223456889999999999999999999999999999999996 56776543

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-37  Score=306.77  Aligned_cols=185  Identities=28%  Similarity=0.442  Sum_probs=152.4

Q ss_pred             CCceEEEEEEEEeecCcEEEEEEeccChH----H--HHHHHHHcCCCCccceeeeeecCCC--CeeEEEEeeccCCCchh
Q 037224          345 EGCLIQGSVYKGNIHGEVYAIKMMKWNAC----E--ELKILQKVNHGNLVKLEGFCIDPED--ANCYLIYEYIENGSLHS  416 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~g~~vAvK~~~~~~~----~--E~~~l~~l~h~niv~l~~~~~~~~~--~~~~lv~e~~~~gsL~~  416 (552)
                      .|.|+||.||+|+++|+.||||+++.+..    +  |+..+.+++||||++++++|.+...  ..+++||||+++|+|.+
T Consensus        11 iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~   90 (303)
T d1vjya_          11 IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFD   90 (303)
T ss_dssp             EECCSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHH
T ss_pred             EeeCCCeEEEEEEECCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHH
Confidence            37788899999999999999999965432    3  4444557799999999999986433  26799999999999999


Q ss_pred             hhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC------
Q 037224          417 WLHENKNENLNWKTRLRIAIDVANGLQYIHEHT-----RPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA------  485 (552)
Q Consensus       417 ~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-----~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~------  485 (552)
                      +++...   ++|.+++.++.|++.||+|||+..     .++|+||||||+|||++.++.+||+|||+++.....      
T Consensus        91 ~l~~~~---l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~  167 (303)
T d1vjya_          91 YLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI  167 (303)
T ss_dssp             HHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC
T ss_pred             HHhcCC---CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceec
Confidence            998753   999999999999999999999741     234999999999999999999999999999743221      


Q ss_pred             ccccccccccccCccccCCCC------CCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          486 ITMHIVGTQGYIAPEYLADGV------VSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       486 ~~~~~~gt~~y~aPE~~~~~~------~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                      ......||+.|+|||++.+..      ++.++|||||||+||||+||..||..
T Consensus       168 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~  220 (303)
T d1vjya_         168 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI  220 (303)
T ss_dssp             ----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred             cccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence            223467999999999986543      56789999999999999999988754

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-37  Score=300.05  Aligned_cols=183  Identities=27%  Similarity=0.394  Sum_probs=149.9

Q ss_pred             CCceEEEEEEEEeec---C--cEEEEEEeccC----------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeec
Q 037224          345 EGCLIQGSVYKGNIH---G--EVYAIKMMKWN----------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI  409 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~---g--~~vAvK~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~  409 (552)
                      .|.|+||.||+|++.   +  ..||||+++.+          +.+|+.++++++||||++++|+|.+   ...++||||+
T Consensus        16 iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~---~~~~lv~e~~   92 (273)
T d1u46a_          16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---PPMKMVTELA   92 (273)
T ss_dssp             CC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEEECC
T ss_pred             EecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee---cchheeeeee
Confidence            488888999999873   2  37899988532          3579999999999999999999965   3568999999


Q ss_pred             cCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCc---
Q 037224          410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAI---  486 (552)
Q Consensus       410 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~---  486 (552)
                      ++|++.+++..... .+++..++.++.|+++||.|||+++   |+||||||+||+++.++.+||+|||+++......   
T Consensus        93 ~~~~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~  168 (273)
T d1u46a_          93 PLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY  168 (273)
T ss_dssp             TTCBHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEE
T ss_pred             cCcchhhhhhcccC-CCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcccCCCcc
Confidence            99999988776443 4999999999999999999999998   9999999999999999999999999998543221   


Q ss_pred             --cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          487 --TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       487 --~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                        .....++..|+|||.+.+..++.++||||||+++|||+| |+.||.+.+
T Consensus       169 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~  219 (273)
T d1u46a_         169 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN  219 (273)
T ss_dssp             EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             eecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC
Confidence              223467889999999999999999999999999999998 899997654

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-37  Score=303.08  Aligned_cols=183  Identities=29%  Similarity=0.490  Sum_probs=157.2

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|.+|+||+|+.  +|+.||||+++..         ..+|++++++++||||+++++++.+  +...|+||||+.+ ++
T Consensus        11 G~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~--~~~~~iv~e~~~~-~~   87 (298)
T d1gz8a_          11 GEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYLVFEFLHQ-DL   87 (298)
T ss_dssp             EECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEEEECCSE-EH
T ss_pred             ecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc--ccceeEEEeecCC-ch
Confidence            6777899999987  6899999998532         3479999999999999999999988  7789999999976 55


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC--Cccccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN--AITMHIVG  492 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~--~~~~~~~g  492 (552)
                      .+++.......+++.+++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||.++....  .......|
T Consensus        88 ~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~g  164 (298)
T d1gz8a_          88 KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV  164 (298)
T ss_dssp             HHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTCCBC
T ss_pred             hhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCcccceeecc
Confidence            55565555556999999999999999999999999   99999999999999999999999999974432  23334689


Q ss_pred             cccccCccccCCCC-CCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          493 TQGYIAPEYLADGV-VSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       493 t~~y~aPE~~~~~~-~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      |+.|+|||.+.... ++.++|||||||++|||++|+.||.+.+
T Consensus       165 t~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~  207 (298)
T d1gz8a_         165 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS  207 (298)
T ss_dssp             CCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC
Confidence            99999999876655 5789999999999999999999998654

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-36  Score=301.96  Aligned_cols=184  Identities=27%  Similarity=0.461  Sum_probs=157.2

Q ss_pred             CCceEEEEEEEEeec---C--cEEEEEEecc--------ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNIH---G--EVYAIKMMKW--------NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~---g--~~vAvK~~~~--------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|.|+||+||+|++.   +  ..||||+++.        ++.+|++++++++||||++++|++.+. +...++||||+++
T Consensus        35 iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~lv~E~~~~  113 (311)
T d1r0pa_          35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLVVLPYMKH  113 (311)
T ss_dssp             EEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET-TTEEEEEEECCTT
T ss_pred             EeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec-CCceEEEEEEeec
Confidence            488899999999872   1  2689999853        245899999999999999999998753 4578999999999


Q ss_pred             CCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC------
Q 037224          412 GSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA------  485 (552)
Q Consensus       412 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~------  485 (552)
                      |+|.+++.... ..+++.+++.++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+++.....      
T Consensus       114 g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~  189 (311)
T d1r0pa_         114 GDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH  189 (311)
T ss_dssp             CBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTT
T ss_pred             Cchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccccce
Confidence            99999887543 35788999999999999999999999   999999999999999999999999999753322      


Q ss_pred             ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCcc
Q 037224          486 ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEE  533 (552)
Q Consensus       486 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~  533 (552)
                      ......||+.|+|||.+....++.++||||||+++|||+||+.||...
T Consensus       190 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~  237 (311)
T d1r0pa_         190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD  237 (311)
T ss_dssp             CTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-
T ss_pred             ecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCC
Confidence            122346889999999999999999999999999999999988887643

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-36  Score=298.53  Aligned_cols=185  Identities=30%  Similarity=0.500  Sum_probs=154.9

Q ss_pred             CCceEEEEEEEEeecC---------cEEEEEEeccC--------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEE
Q 037224          345 EGCLIQGSVYKGNIHG---------EVYAIKMMKWN--------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIY  406 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~g---------~~vAvK~~~~~--------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~  406 (552)
                      .|.|+||.||+|+..+         ..||||+++.+        +.+|...+.++ +||||++++++|.+  +...++||
T Consensus        21 iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~--~~~~~~v~   98 (299)
T d1fgka_          21 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ--DGPLYVIV   98 (299)
T ss_dssp             CC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEE
T ss_pred             EeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc--CCeEEEEE
Confidence            4888889999998622         37999998643        23588888888 89999999999987  66789999


Q ss_pred             eeccCCCchhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEE
Q 037224          407 EYIENGSLHSWLHENK--------------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAK  472 (552)
Q Consensus       407 e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~k  472 (552)
                      ||+++|+|.+++....              ...+++.+++.++.|++.||+|||+++   |+||||||+|||++.++.+|
T Consensus        99 e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~~~~~~k  175 (299)
T d1fgka_          99 EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMK  175 (299)
T ss_dssp             CCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEE
T ss_pred             EccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeecCCCCeE
Confidence            9999999999997553              235899999999999999999999999   99999999999999999999


Q ss_pred             EeeccCCccCCCC----ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCccC
Q 037224          473 IANFGLAKSGCNA----ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEEG  534 (552)
Q Consensus       473 L~Dfg~a~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~~  534 (552)
                      |+|||+++.....    ......+++.|+|||.+.++.+++++||||||+++|||++ |+.||.+.+
T Consensus       176 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~  242 (299)
T d1fgka_         176 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  242 (299)
T ss_dssp             ECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             eccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence            9999999854322    2334578899999999999999999999999999999998 788887654

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-36  Score=300.88  Aligned_cols=185  Identities=30%  Similarity=0.456  Sum_probs=147.9

Q ss_pred             CceEEEEEEEEee-------cCcEEEEEEeccC--------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeec
Q 037224          346 GCLIQGSVYKGNI-------HGEVYAIKMMKWN--------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYI  409 (552)
Q Consensus       346 G~g~~G~Vy~~~~-------~g~~vAvK~~~~~--------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~  409 (552)
                      |.|+||.||+|.+       +++.||||+++..        +.+|..++.++ +|+||+.+++++... +...++||||+
T Consensus        22 G~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-~~~~~iv~E~~  100 (299)
T d1ywna1          22 GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-GGPLMVIVEFC  100 (299)
T ss_dssp             EECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-TSCCEEEEECC
T ss_pred             eecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC-CCeEEEEEEec
Confidence            7788899999986       2368999998643        23567777777 688999999888653 45679999999


Q ss_pred             cCCCchhhhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEee
Q 037224          410 ENGSLHSWLHENKN--------------ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIAN  475 (552)
Q Consensus       410 ~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~D  475 (552)
                      ++|+|.+++.....              ..+++.+++.++.|+++||+|||+++   |+||||||+|||+++++.+||+|
T Consensus       101 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~~~~~~Kl~D  177 (299)
T d1ywna1         101 KFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICD  177 (299)
T ss_dssp             TTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECC
T ss_pred             CCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeECCCCcEEEcc
Confidence            99999999975431              34899999999999999999999999   99999999999999999999999


Q ss_pred             ccCCccCCCC----ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCC-CCCCccC
Q 037224          476 FGLAKSGCNA----ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK-EAIDEEG  534 (552)
Q Consensus       476 fg~a~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~-~pf~~~~  534 (552)
                      ||+|+.....    ......||+.|+|||.+.+..++.++|||||||++|||+||. .||....
T Consensus       178 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~  241 (299)
T d1ywna1         178 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  241 (299)
T ss_dssp             ------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             CcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence            9999743322    223457899999999999999999999999999999999975 5776543

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-36  Score=300.85  Aligned_cols=185  Identities=33%  Similarity=0.449  Sum_probs=157.1

Q ss_pred             CCceEEEEEEEEee--cCc--EEEEEEecc--------ChHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          345 EGCLIQGSVYKGNI--HGE--VYAIKMMKW--------NACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~--~vAvK~~~~--------~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|+|+||.||+|++  +|.  .||||.++.        .+.+|+++++++ +||||++++++|.+  .+..++||||+++
T Consensus        18 iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~~~iV~ey~~~   95 (309)
T d1fvra_          18 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLYLAIEYAPH   95 (309)
T ss_dssp             EECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--TTEEEEEECCCTT
T ss_pred             EeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec--CCeeEEEEEecCC
Confidence            47788899999988  444  578888742        245899999999 79999999999987  6788999999999


Q ss_pred             CCchhhhhhc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeecc
Q 037224          412 GSLHSWLHEN--------------KNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFG  477 (552)
Q Consensus       412 gsL~~~l~~~--------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg  477 (552)
                      |+|.++++..              ....+++.+++.++.|++.||.|||+++   ++||||||+|||++.++.+||+|||
T Consensus        96 g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~kl~DfG  172 (309)
T d1fvra_          96 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  172 (309)
T ss_dssp             CBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTT
T ss_pred             CcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCceEEcccc
Confidence            9999998754              2356999999999999999999999998   9999999999999999999999999


Q ss_pred             CCccCCCCcc-ccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCC-CCCCccC
Q 037224          478 LAKSGCNAIT-MHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK-EAIDEEG  534 (552)
Q Consensus       478 ~a~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~-~pf~~~~  534 (552)
                      +++....... ....||..|+|||.+.+..++.++||||||+++|||++|. .||.+.+
T Consensus       173 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~  231 (309)
T d1fvra_         173 LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT  231 (309)
T ss_dssp             CEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             ccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC
Confidence            9975443322 2356899999999999999999999999999999999976 4676544

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-36  Score=296.40  Aligned_cols=186  Identities=26%  Similarity=0.417  Sum_probs=156.7

Q ss_pred             CceEEEEEEEEee---cCcEEEEEEecc---------ChHHHHHHHHHc---CCCCccceeeeeecC---CCCeeEEEEe
Q 037224          346 GCLIQGSVYKGNI---HGEVYAIKMMKW---------NACEELKILQKV---NHGNLVKLEGFCIDP---EDANCYLIYE  407 (552)
Q Consensus       346 G~g~~G~Vy~~~~---~g~~vAvK~~~~---------~~~~E~~~l~~l---~h~niv~l~~~~~~~---~~~~~~lv~e  407 (552)
                      |.|+||+||+++.   .++.||||+++.         ...+|+.+++.+   +||||++++++|...   .+...+++||
T Consensus        16 G~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e   95 (305)
T d1blxa_          16 GEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFE   95 (305)
T ss_dssp             EEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEE
T ss_pred             ecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEE
Confidence            7888899999986   356899999842         234788887776   799999999998642   2357899999


Q ss_pred             eccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC-Cc
Q 037224          408 YIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN-AI  486 (552)
Q Consensus       408 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~-~~  486 (552)
                      |++++.+... .......+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.... ..
T Consensus        96 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~~  171 (305)
T d1blxa_          96 HVDQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA  171 (305)
T ss_dssp             CCSCBHHHHH-HHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGG
T ss_pred             eccCCchhhh-hhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhhhhhhccccc
Confidence            9988666543 3334456999999999999999999999999   99999999999999999999999999875443 23


Q ss_pred             cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          487 TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       487 ~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.++
T Consensus       172 ~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~  220 (305)
T d1blxa_         172 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD  220 (305)
T ss_dssp             GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             CCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH
Confidence            3457899999999999999999999999999999999999999987653

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-35  Score=300.71  Aligned_cols=188  Identities=28%  Similarity=0.416  Sum_probs=156.4

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC---hHHHHHHHHHcCCCCccceeeeeecC----CCCeeEEEEeeccCCCch
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN---ACEELKILQKVNHGNLVKLEGFCIDP----EDANCYLIYEYIENGSLH  415 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---~~~E~~~l~~l~h~niv~l~~~~~~~----~~~~~~lv~e~~~~gsL~  415 (552)
                      .|.|+||+||+|+.  +|+.||||+++.+   ..+|+++|++++|+||++++++|...    +....++||||++++.+.
T Consensus        28 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~  107 (350)
T d1q5ka_          28 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR  107 (350)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHH
T ss_pred             EeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHH
Confidence            48888899999998  6899999998643   45899999999999999999998642    234578999999875443


Q ss_pred             hhhhh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCC-cEEEeeccCCccCC-CCccccccc
Q 037224          416 SWLHE-NKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM-RAKIANFGLAKSGC-NAITMHIVG  492 (552)
Q Consensus       416 ~~l~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~~~-~~~~~~~~g  492 (552)
                      .+... .....+++.+++.++.|++.||+|||+++   |+||||||+|||++.++ .+||+|||++.... ........|
T Consensus       108 ~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~g  184 (350)
T d1q5ka_         108 VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC  184 (350)
T ss_dssp             HHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCCSCCS
T ss_pred             HHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhccCCcccccccc
Confidence            33321 22346999999999999999999999999   99999999999999775 89999999997543 233445689


Q ss_pred             cccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          493 TQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       493 t~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      +..|+|||.+.+ ..++.++||||+||++|||++|+.||...+.
T Consensus       185 t~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~  228 (350)
T d1q5ka_         185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG  228 (350)
T ss_dssp             CTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH
T ss_pred             cccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH
Confidence            999999998765 5689999999999999999999999986653

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=7e-36  Score=294.45  Aligned_cols=182  Identities=28%  Similarity=0.427  Sum_probs=154.1

Q ss_pred             CceEEEEEEEEee-cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCch
Q 037224          346 GCLIQGSVYKGNI-HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLH  415 (552)
Q Consensus       346 G~g~~G~Vy~~~~-~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~  415 (552)
                      |.|.+|+||+|+. +|+.||||+++..         +.+|+.++++++||||+++++++.+  ++..++++||+.++.+.
T Consensus        11 G~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~i~~e~~~~~~~~   88 (286)
T d1ob3a_          11 GEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT--KKRLVLVFEHLDQDLKK   88 (286)
T ss_dssp             EEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--SSCEEEEEECCSEEHHH
T ss_pred             ecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc--CCceeEEEEeehhhhHH
Confidence            7788899999988 7899999998532         3589999999999999999999987  67789999999886666


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC--Ccccccccc
Q 037224          416 SWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN--AITMHIVGT  493 (552)
Q Consensus       416 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~--~~~~~~~gt  493 (552)
                      .+....  ..+++.++..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||.+.....  .......++
T Consensus        89 ~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~  163 (286)
T d1ob3a_          89 LLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVT  163 (286)
T ss_dssp             HHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CC
T ss_pred             HHHhhc--CCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCccccceeccc
Confidence            555433  35999999999999999999999998   99999999999999999999999999875332  223345789


Q ss_pred             ccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          494 QGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       494 ~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +.|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+
T Consensus       164 ~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~  205 (286)
T d1ob3a_         164 LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS  205 (286)
T ss_dssp             CTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             chhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC
Confidence            99999999865 456899999999999999999999998654

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-36  Score=297.41  Aligned_cols=185  Identities=25%  Similarity=0.402  Sum_probs=158.3

Q ss_pred             CCceEEEEEEEEeec-------CcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeec
Q 037224          345 EGCLIQGSVYKGNIH-------GEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYI  409 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~~-------g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~  409 (552)
                      .|.|+||+||+|.+.       +..||||+++..        +.+|++++++++||||++++++|..  +...++||||+
T Consensus        28 lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--~~~~~lv~e~~  105 (308)
T d1p4oa_          28 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--GQPTLVIMELM  105 (308)
T ss_dssp             EEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS--SSSCEEEEECC
T ss_pred             EeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec--CCceeEEEeec
Confidence            377788999999873       468999999643        3589999999999999999999976  56779999999


Q ss_pred             cCCCchhhhhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCcc
Q 037224          410 ENGSLHSWLHENK--------NENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS  481 (552)
Q Consensus       410 ~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  481 (552)
                      ++|+|.+++....        ...+++..+..++.|+++||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       106 ~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~DFGla~~  182 (308)
T d1p4oa_         106 TRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRD  182 (308)
T ss_dssp             TTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCCCG
T ss_pred             CCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEeeccccee
Confidence            9999999886532        134789999999999999999999998   99999999999999999999999999975


Q ss_pred             CCCC----ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCC-CCCCccC
Q 037224          482 GCNA----ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGK-EAIDEEG  534 (552)
Q Consensus       482 ~~~~----~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~-~pf~~~~  534 (552)
                      ....    ......+|+.|+|||.+.+..++.++||||||+++|||+||. .||.+.+
T Consensus       183 ~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~  240 (308)
T d1p4oa_         183 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS  240 (308)
T ss_dssp             GGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred             ccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC
Confidence            4322    122346889999999999999999999999999999999985 6776544

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-35  Score=294.53  Aligned_cols=184  Identities=30%  Similarity=0.442  Sum_probs=157.8

Q ss_pred             CCceEEEEEEEEee-------cCcEEEEEEeccC--------hHHHHHHHHHc-CCCCccceeeeeecCCCCeeEEEEee
Q 037224          345 EGCLIQGSVYKGNI-------HGEVYAIKMMKWN--------ACEELKILQKV-NHGNLVKLEGFCIDPEDANCYLIYEY  408 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~-------~g~~vAvK~~~~~--------~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~  408 (552)
                      .|.|+||.||+|++       .++.||||+++..        +.+|+.+++++ +||||++++++|.+  ....+++|||
T Consensus        31 iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~--~~~~~lvmE~  108 (311)
T d1t46a_          31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI--GGPTLVITEY  108 (311)
T ss_dssp             EEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEEEC
T ss_pred             EeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee--CCEEEEEEEc
Confidence            38888899999985       3468999999643        34799999999 79999999999987  5678999999


Q ss_pred             ccCCCchhhhhhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEE
Q 037224          409 IENGSLHSWLHENKN----------------ENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAK  472 (552)
Q Consensus       409 ~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~k  472 (552)
                      +++|+|.+++.....                ..+++.+++.++.||++||+|||+++   ++||||||+||+++.++.+|
T Consensus       109 ~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~~~~~~k  185 (311)
T d1t46a_         109 CCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITK  185 (311)
T ss_dssp             CTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEEE
T ss_pred             CCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccccccCccc
Confidence            999999999876432                25899999999999999999999999   99999999999999999999


Q ss_pred             EeeccCCccCCCCc----cccccccccccCccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCcc
Q 037224          473 IANFGLAKSGCNAI----TMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELIS-GKEAIDEE  533 (552)
Q Consensus       473 L~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~ellt-G~~pf~~~  533 (552)
                      |+|||.++......    .....||+.|+|||.+.++.++.++||||||+++|||+| |++||...
T Consensus       186 i~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~  251 (311)
T d1t46a_         186 ICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM  251 (311)
T ss_dssp             ECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             ccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence            99999998544321    223578999999999999999999999999999999999 55556544

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=8e-35  Score=287.56  Aligned_cols=183  Identities=20%  Similarity=0.237  Sum_probs=157.1

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEecc-----ChHHHHHHHHHcCC-CCccceeeeeecCCCCeeEEEEeeccCCCchh
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKW-----NACEELKILQKVNH-GNLVKLEGFCIDPEDANCYLIYEYIENGSLHS  416 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~-----~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~  416 (552)
                      .|.|++|.||+|+.  +|+.||||+++.     ...+|++.++.++| +|++.+++++.+  +...++||||+ +++|.+
T Consensus        13 iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~~vme~~-~~~l~~   89 (293)
T d1csna_          13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVLVIDLL-GPSLED   89 (293)
T ss_dssp             EEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEEEEECC-CCBHHH
T ss_pred             EecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeec--CCccEEEEEec-CCCHHH
Confidence            37788899999987  689999999843     24689999999965 899999998876  77889999998 579999


Q ss_pred             hhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECC-----CCcEEEeeccCCccCCCC------
Q 037224          417 WLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS-----NMRAKIANFGLAKSGCNA------  485 (552)
Q Consensus       417 ~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~-----~~~~kL~Dfg~a~~~~~~------  485 (552)
                      ++.... ..+++.++..++.|++.||+|||+++   |+||||||+|||++.     ++.+||+|||+++.....      
T Consensus        90 ~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~  165 (293)
T d1csna_          90 LLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI  165 (293)
T ss_dssp             HHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBC
T ss_pred             HHHhhc-cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEcccCccccce
Confidence            886543 35999999999999999999999999   999999999999964     578999999999743211      


Q ss_pred             ---ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          486 ---ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       486 ---~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                         ......||+.|+|||.+.+..+++++||||||+++|||+||+.||....
T Consensus       166 ~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~  217 (293)
T d1csna_         166 PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK  217 (293)
T ss_dssp             CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             eecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCcc
Confidence               1223579999999999999999999999999999999999999998654

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-35  Score=294.50  Aligned_cols=184  Identities=26%  Similarity=0.361  Sum_probs=152.8

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC--------hHHHHHHHHHcCCCCccceeeeeecCCC--CeeEEEEeeccCC
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN--------ACEELKILQKVNHGNLVKLEGFCIDPED--ANCYLIYEYIENG  412 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~--------~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~~~lv~e~~~~g  412 (552)
                      .|.|++|+||+|..  +|+.||||+++..        +.+|+.+|++++||||+++++++.....  ...+++++|+.+|
T Consensus        16 LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g   95 (345)
T d1pmea_          16 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGA   95 (345)
T ss_dssp             CC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCE
T ss_pred             EeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCC
Confidence            47888899999987  6999999998632        3479999999999999999999865321  2234555667789


Q ss_pred             CchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC-----cc
Q 037224          413 SLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA-----IT  487 (552)
Q Consensus       413 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-----~~  487 (552)
                      +|.+++...   .+++.+++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++......     ..
T Consensus        96 ~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~  169 (345)
T d1pmea_          96 DLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL  169 (345)
T ss_dssp             EHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTT
T ss_pred             chhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceee
Confidence            999999764   3999999999999999999999999   999999999999999999999999999744322     22


Q ss_pred             ccccccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          488 MHIVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       488 ~~~~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ....||+.|+|||.+.. ..++.++||||+||++|||++|+.||...+
T Consensus       170 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~  217 (345)
T d1pmea_         170 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH  217 (345)
T ss_dssp             CCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC
Confidence            34578999999999854 557889999999999999999999998654

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.4e-34  Score=290.84  Aligned_cols=181  Identities=22%  Similarity=0.334  Sum_probs=157.1

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC----hHHHHHHHHHcC-CCCccceeeeeecCCCCeeEEEEeeccCCCchhhh
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN----ACEELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWL  418 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~----~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l  418 (552)
                      |.|+||+||+|+.  +|+.||||+++..    ..+|+++|++++ ||||+++++++........++||||+++++|.++.
T Consensus        44 G~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~  123 (328)
T d3bqca1          44 GRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY  123 (328)
T ss_dssp             EECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT
T ss_pred             ecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh
Confidence            7777799999997  6899999998754    347999999995 99999999999876677889999999999998764


Q ss_pred             hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCC-cEEEeeccCCccCCC-Cccccccccccc
Q 037224          419 HENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNM-RAKIANFGLAKSGCN-AITMHIVGTQGY  496 (552)
Q Consensus       419 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~~~~-~~~~~~~gt~~y  496 (552)
                      .     .+++.+++.++.||+.||+|||+++   |+||||||+|||++.++ .+||+|||+++.... .......+|+.|
T Consensus       124 ~-----~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y  195 (328)
T d3bqca1         124 Q-----TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYF  195 (328)
T ss_dssp             T-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSCGGG
T ss_pred             c-----CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCCCcccccccCccc
Confidence            2     4999999999999999999999999   99999999999998655 699999999975443 234456789999


Q ss_pred             cCccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          497 IAPEYLADG-VVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       497 ~aPE~~~~~-~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      +|||.+.+. .++.++||||+||++|||++|+.||....
T Consensus       196 ~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~  234 (328)
T d3bqca1         196 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH  234 (328)
T ss_dssp             CCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             cCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence            999998765 47999999999999999999999997654

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-34  Score=293.79  Aligned_cols=183  Identities=26%  Similarity=0.423  Sum_probs=152.6

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCC----CCeeEEEEeec
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPE----DANCYLIYEYI  409 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~~~lv~e~~  409 (552)
                      .|.|++|+||+|..  +|+.||||+++..         ..+|+.+|++++||||++++++|...+    ...+++||||+
T Consensus        26 lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~  105 (346)
T d1cm8a_          26 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM  105 (346)
T ss_dssp             C------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC
T ss_pred             EecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc
Confidence            48888899999987  6999999998642         347999999999999999999997632    23579999999


Q ss_pred             cCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCcccc
Q 037224          410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMH  489 (552)
Q Consensus       410 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  489 (552)
                       +.+|..++...   .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++..... ...
T Consensus       106 -~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~-~~~  177 (346)
T d1cm8a_         106 -GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-MTG  177 (346)
T ss_dssp             -SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSS-CCS
T ss_pred             -cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceeccCCc-ccc
Confidence             45777766543   4999999999999999999999999   999999999999999999999999999866543 345


Q ss_pred             ccccccccCccccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          490 IVGTQGYIAPEYLAD-GVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       490 ~~gt~~y~aPE~~~~-~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      ..||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.+.+.
T Consensus       178 ~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~  224 (346)
T d1cm8a_         178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH  224 (346)
T ss_dssp             SCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh
Confidence            689999999998865 4578999999999999999999999987653

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-34  Score=289.94  Aligned_cols=185  Identities=26%  Similarity=0.396  Sum_probs=152.6

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCC------CCeeEEEEee
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPE------DANCYLIYEY  408 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~~~lv~e~  408 (552)
                      |.|.+|+||+|+.  +|+.||||+++.+         ..+|+.+|++++|+|++++++++....      +...+++|||
T Consensus        19 G~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~   98 (318)
T d3blha1          19 GQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDF   98 (318)
T ss_dssp             EECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEEC
T ss_pred             ecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEec
Confidence            7777799999987  7899999997422         358999999999999999999886532      3467999999


Q ss_pred             ccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC----
Q 037224          409 IENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN----  484 (552)
Q Consensus       409 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~----  484 (552)
                      ++++.+..+...  ...+++.+++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++....    
T Consensus        99 ~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~  173 (318)
T d3blha1          99 CEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS  173 (318)
T ss_dssp             CCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCC----
T ss_pred             cCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceeeeccccccc
Confidence            988666544333  235899999999999999999999999   99999999999999999999999999964331    


Q ss_pred             --CccccccccccccCccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          485 --AITMHIVGTQGYIAPEYLADG-VVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       485 --~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                        .......||+.|+|||.+.+. .+++++|||||||++|||++|+.||.+.++
T Consensus       174 ~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~  227 (318)
T d3blha1         174 QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE  227 (318)
T ss_dssp             -CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH
Confidence              122235789999999998754 689999999999999999999999986553

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-34  Score=289.63  Aligned_cols=182  Identities=27%  Similarity=0.438  Sum_probs=156.5

Q ss_pred             CceEEEEEEEEee-----cCcEEEEEEeccC-----------hHHHHHHHHHcCC-CCccceeeeeecCCCCeeEEEEee
Q 037224          346 GCLIQGSVYKGNI-----HGEVYAIKMMKWN-----------ACEELKILQKVNH-GNLVKLEGFCIDPEDANCYLIYEY  408 (552)
Q Consensus       346 G~g~~G~Vy~~~~-----~g~~vAvK~~~~~-----------~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~~~lv~e~  408 (552)
                      |.|++|+||+++.     +|+.||||+++..           ..+|++++++++| |||+++++++.+  ....+++|||
T Consensus        33 G~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~--~~~~~~v~e~  110 (322)
T d1vzoa_          33 GTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--ETKLHLILDY  110 (322)
T ss_dssp             EETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--TTEEEEEECC
T ss_pred             ecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc--CCceeeeeec
Confidence            6777799999975     4789999998532           3479999999976 799999999988  6788999999


Q ss_pred             ccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC---
Q 037224          409 IENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA---  485 (552)
Q Consensus       409 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~---  485 (552)
                      +.+|+|.+++.....  +.+..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....   
T Consensus       111 ~~~~~L~~~i~~~~~--~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~  185 (322)
T d1vzoa_         111 INGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE  185 (322)
T ss_dssp             CCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGG
T ss_pred             ccccHHHHHHHhccc--ccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhhcccccc
Confidence            999999999977653  789999999999999999999999   999999999999999999999999999754322   


Q ss_pred             ccccccccccccCccccCCC--CCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          486 ITMHIVGTQGYIAPEYLADG--VVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       486 ~~~~~~gt~~y~aPE~~~~~--~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ......|++.|++||.+.+.  .++.++|||||||+||||++|+.||....
T Consensus       186 ~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~  236 (322)
T d1vzoa_         186 RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG  236 (322)
T ss_dssp             GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred             cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            23346789999999998654  46889999999999999999999997654

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.5e-34  Score=282.11  Aligned_cols=184  Identities=25%  Similarity=0.285  Sum_probs=152.0

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEecc-----ChHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCchhh
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKW-----NACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSW  417 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~-----~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~  417 (552)
                      .|.|+||.||+|++  +|+.||||+++.     ...+|++++++++|+|++..+..+... ....++||||+. ++|.+.
T Consensus        15 iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~-~~~~~ivme~~~-~~l~~~   92 (299)
T d1ckia_          15 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVMVMELLG-PSLEDL   92 (299)
T ss_dssp             EEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEE-TTEEEEEEECCC-CBHHHH
T ss_pred             EeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEec-CCEEEEEEEEcC-Cchhhh
Confidence            37788899999987  689999998753     356799999999888777666555432 567899999995 467666


Q ss_pred             hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECC---CCcEEEeeccCCccCCCC---------
Q 037224          418 LHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDS---NMRAKIANFGLAKSGCNA---------  485 (552)
Q Consensus       418 l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kL~Dfg~a~~~~~~---------  485 (552)
                      +.... ..+++..++.++.|++.||+|||+++   |+||||||+|||++.   +..+||+|||+++.....         
T Consensus        93 ~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~  168 (299)
T d1ckia_          93 FNFCS-RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYR  168 (299)
T ss_dssp             HHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCC
T ss_pred             hhhcc-CCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccccccccceecc
Confidence            55433 35999999999999999999999999   999999999999864   557999999999754321         


Q ss_pred             ccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          486 ITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       486 ~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      ......||+.|+|||.+.+..++.++|||||||++|||+||+.||....
T Consensus       169 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~  217 (299)
T d1ckia_         169 ENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK  217 (299)
T ss_dssp             BCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             ccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccc
Confidence            1234579999999999999999999999999999999999999997643

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-34  Score=280.26  Aligned_cols=180  Identities=27%  Similarity=0.396  Sum_probs=156.3

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecCCCCeeEEEEeeccCCCc
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDPEDANCYLIYEYIENGSL  414 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  414 (552)
                      |.|+||+||+|+.  +|+.||||+++..         ..+|+.++++++|+||+++++++.+  ....++++|++.+++|
T Consensus        11 G~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~~~~iv~~~~~~~~l   88 (292)
T d1unla_          11 GEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLVFEFCDQDLK   88 (292)
T ss_dssp             EECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEEEECCSEEHH
T ss_pred             ecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc--ccceeEEeeecccccc
Confidence            6777799999997  7889999998532         2489999999999999999999988  6788999999999888


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCC--ccccccc
Q 037224          415 HSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNA--ITMHIVG  492 (552)
Q Consensus       415 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~g  492 (552)
                      ..++....  .+++.+++.++.|+++||+|||+++   |+||||||+|||++.++.+||+|||.++.....  ......+
T Consensus        89 ~~~~~~~~--~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~~~  163 (292)
T d1unla_          89 KYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV  163 (292)
T ss_dssp             HHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSCCS
T ss_pred             cccccccc--ccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCccceeecc
Confidence            88776543  4899999999999999999999999   999999999999999999999999999854332  2233467


Q ss_pred             cccccCccccCCCC-CCChhhHHHHHHHHHHHHcCCCCCCc
Q 037224          493 TQGYIAPEYLADGV-VSTKMDVFSFGVVLLELISGKEAIDE  532 (552)
Q Consensus       493 t~~y~aPE~~~~~~-~s~~~Dv~slG~il~elltG~~pf~~  532 (552)
                      +..|+|||.+.... ++.++|||||||++|||++|+.||..
T Consensus       164 ~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~  204 (292)
T d1unla_         164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  204 (292)
T ss_dssp             CGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred             ccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC
Confidence            78899999887655 68999999999999999999999754

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-33  Score=286.33  Aligned_cols=183  Identities=25%  Similarity=0.352  Sum_probs=148.5

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecC----CCCeeEEEEeec
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDP----EDANCYLIYEYI  409 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~----~~~~~~lv~e~~  409 (552)
                      .|.|++|+||+|..  +|+.||||+++..         ..+|+.++++++||||++++++|...    ....+|+||||+
T Consensus        25 LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~  104 (355)
T d2b1pa1          25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM  104 (355)
T ss_dssp             CSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECC
T ss_pred             eecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEecc
Confidence            48888899999987  6999999998633         34799999999999999999998653    246889999999


Q ss_pred             cCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCC-Cccc
Q 037224          410 ENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCN-AITM  488 (552)
Q Consensus       410 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~-~~~~  488 (552)
                      .++.+ +.+.    ..+++..++.++.|++.||+|||++|   |+||||||+|||++.++.+|++|||+++.... ....
T Consensus       105 ~~~l~-~~~~----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~~~  176 (355)
T d2b1pa1         105 DANLC-QVIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT  176 (355)
T ss_dssp             SEEHH-HHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----------
T ss_pred             chHHH-Hhhh----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhccccccccc
Confidence            77544 4443    23899999999999999999999999   99999999999999999999999999875433 2333


Q ss_pred             cccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          489 HIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       489 ~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      ...+|+.|+|||.+.+..+++++||||+||++|||++|+.||.+.+.
T Consensus       177 ~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~  223 (355)
T d2b1pa1         177 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY  223 (355)
T ss_dssp             ----CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             cccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH
Confidence            45789999999999999999999999999999999999999986653

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-34  Score=287.39  Aligned_cols=183  Identities=25%  Similarity=0.382  Sum_probs=153.0

Q ss_pred             CCceEEEEEEEEee--cCcEEEEEEeccC---------hHHHHHHHHHcCCCCccceeeeeecC---CCCeeEEEEeecc
Q 037224          345 EGCLIQGSVYKGNI--HGEVYAIKMMKWN---------ACEELKILQKVNHGNLVKLEGFCIDP---EDANCYLIYEYIE  410 (552)
Q Consensus       345 ~G~g~~G~Vy~~~~--~g~~vAvK~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~---~~~~~~lv~e~~~  410 (552)
                      .|.|+||+||+|+.  +|+.||||+++..         ..+|+.+|++++|+|++++++++...   ++...+++++|+.
T Consensus        26 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~  105 (348)
T d2gfsa1          26 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM  105 (348)
T ss_dssp             CGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECC
T ss_pred             EecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeec
Confidence            47778899999986  7999999998643         34799999999999999999988642   2334466777888


Q ss_pred             CCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCCccCCCCccccc
Q 037224          411 NGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLAKSGCNAITMHI  490 (552)
Q Consensus       411 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  490 (552)
                      +|+|.+++...   .+++.+++.++.||+.||+|||+++   |+||||||+|||++.++.+|++|||++..... .....
T Consensus       106 gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-~~~~~  178 (348)
T d2gfsa1         106 GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-EMTGY  178 (348)
T ss_dssp             SEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCTG-GGSSS
T ss_pred             CCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccCc-ccccc
Confidence            99999998654   4999999999999999999999999   99999999999999999999999999975543 23446


Q ss_pred             cccccccCccccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCccC
Q 037224          491 VGTQGYIAPEYLADG-VVSTKMDVFSFGVVLLELISGKEAIDEEG  534 (552)
Q Consensus       491 ~gt~~y~aPE~~~~~-~~s~~~Dv~slG~il~elltG~~pf~~~~  534 (552)
                      .|++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+
T Consensus       179 ~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~  223 (348)
T d2gfsa1         179 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD  223 (348)
T ss_dssp             CHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC
Confidence            789999999986664 46889999999999999999999998654

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.96  E-value=7.5e-30  Score=259.58  Aligned_cols=186  Identities=22%  Similarity=0.302  Sum_probs=149.6

Q ss_pred             CceEEEEEEEEee--cCcEEEEEEeccCh------HHHHHHHHHcC-----------CCCccceeeeeecCCCCeeEEEE
Q 037224          346 GCLIQGSVYKGNI--HGEVYAIKMMKWNA------CEELKILQKVN-----------HGNLVKLEGFCIDPEDANCYLIY  406 (552)
Q Consensus       346 G~g~~G~Vy~~~~--~g~~vAvK~~~~~~------~~E~~~l~~l~-----------h~niv~l~~~~~~~~~~~~~lv~  406 (552)
                      |.|++|+||+|+.  +|+.||||+++.+.      .+|+.+++.++           |+||+++++++........++++
T Consensus        22 G~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~  101 (362)
T d1q8ya_          22 GWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVM  101 (362)
T ss_dssp             EECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEE
T ss_pred             eeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeee
Confidence            6677799999987  78999999997652      46888888875           57899999988765556667777


Q ss_pred             eeccCCCch-hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEECCCC------cEEEeeccC
Q 037224          407 EYIENGSLH-SWLHENKNENLNWKTRLRIAIDVANGLQYIHE-HTRPRVVHKDIKSSNILLDSNM------RAKIANFGL  478 (552)
Q Consensus       407 e~~~~gsL~-~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~Dikp~NIll~~~~------~~kL~Dfg~  478 (552)
                      +++..+... ..........+++..+..++.|++.||+|||+ .+   |+||||||+|||++.++      .++++|||.
T Consensus       102 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~  178 (362)
T d1q8ya_         102 VFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGN  178 (362)
T ss_dssp             EECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEEECCCTT
T ss_pred             eecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccceeeEeeccc
Confidence            777655433 33334444568999999999999999999998 77   99999999999997665      499999999


Q ss_pred             CccCCCCccccccccccccCccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCccCc
Q 037224          479 AKSGCNAITMHIVGTQGYIAPEYLADGVVSTKMDVFSFGVVLLELISGKEAIDEEGK  535 (552)
Q Consensus       479 a~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Dv~slG~il~elltG~~pf~~~~~  535 (552)
                      +..... ......||+.|+|||.+.+..++.++|+||+||+++||++|+.||...+.
T Consensus       179 s~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~  234 (362)
T d1q8ya_         179 ACWYDE-HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG  234 (362)
T ss_dssp             CEETTB-CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             cccccc-ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcc
Confidence            975443 23456799999999999999999999999999999999999999986543

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.83  E-value=1.7e-21  Score=178.81  Aligned_cols=149  Identities=16%  Similarity=0.110  Sum_probs=110.8

Q ss_pred             CceEEEEEEEEee-cCcEEEEEEeccC-------------------------hHHHHHHHHHcCCCCccceeeeeecCCC
Q 037224          346 GCLIQGSVYKGNI-HGEVYAIKMMKWN-------------------------ACEELKILQKVNHGNLVKLEGFCIDPED  399 (552)
Q Consensus       346 G~g~~G~Vy~~~~-~g~~vAvK~~~~~-------------------------~~~E~~~l~~l~h~niv~l~~~~~~~~~  399 (552)
                      |.|++|.||+|+. +|+.||||+++..                         ..+|...+.++.|.+++..+++..    
T Consensus         9 G~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~~----   84 (191)
T d1zara2           9 GEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEG----   84 (191)
T ss_dssp             EECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEET----
T ss_pred             eeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEecC----
Confidence            7788899999987 7899999986421                         124788899999999998876532    


Q ss_pred             CeeEEEEeeccCCCchhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEECCCCcEEEeeccCC
Q 037224          400 ANCYLIYEYIENGSLHSWLHENKNENLNWKTRLRIAIDVANGLQYIHEHTRPRVVHKDIKSSNILLDSNMRAKIANFGLA  479 (552)
Q Consensus       400 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  479 (552)
                      .  +++|||+++..+.+         +++.....++.|++++|+|||+++   |+||||||+|||++++ .++|+|||.+
T Consensus        85 ~--~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDFG~a  149 (191)
T d1zara2          85 N--AVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDFPQS  149 (191)
T ss_dssp             T--EEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCCTTC
T ss_pred             C--EEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEECCCc
Confidence            2  79999998865433         344556789999999999999999   9999999999999865 5899999998


Q ss_pred             ccCCCCccccccccccccCc------cccCCCCCCChhhHHHHHHHH
Q 037224          480 KSGCNAITMHIVGTQGYIAP------EYLADGVVSTKMDVFSFGVVL  520 (552)
Q Consensus       480 ~~~~~~~~~~~~gt~~y~aP------E~~~~~~~s~~~Dv~slG~il  520 (552)
                      .........      .|...      |. ..+.++.++|+||+.--+
T Consensus       150 ~~~~~~~~~------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         150 VEVGEEGWR------EILERDVRNIITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             EETTSTTHH------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred             ccCCCCCcH------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence            754322211      11111      11 135567888999986443

>d1e0ga_ d.7.1.1 (A:) Membrane-bound lytic murein transclycosylase D, MltD {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Membrane-bound lytic murein transclycosylase D, MltD
species: Escherichia coli [TaxId: 562]

Probab=99.38  E-value=1.3e-13  Score=93.32  Aligned_cols=44  Identities=30%  Similarity=0.562  Sum_probs=41.6

Q ss_pred             EEEecCCCCCHHHHHhHhCCChhhHhhhcCC--cccCCceeecccc
Q 037224          184 VSYVLQPSENLSSVASRFGIETQAIIDVNGN--NIRPFDTLFVPVA  227 (552)
Q Consensus       184 ~~y~v~~Gdtl~~ia~~~~~s~~~l~~~N~~--~~~~g~~l~ip~~  227 (552)
                      ++|+|++||||++||++||+++++|+++|++  .|+|||.|.||+.
T Consensus         3 v~y~V~~GDTl~~IA~~y~vs~~~i~~~N~l~~~l~~Gq~L~i~vk   48 (48)
T d1e0ga_           3 ITYRVRKGDSLSSIAKRHGVNIKDVMRWNSDTANLQPGDKLTLFVK   48 (48)
T ss_dssp             CEEEECTTCCHHHHHHHHTCCHHHHHHHCSCGGGCCTTEEEECCCC
T ss_pred             EEEEECCCCCHHHHHHHHCCCHHHHHHHcCCcccCcCCCEEEEEeC
Confidence            4899999999999999999999999999999  8999999999863

>d1y7ma2 d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-terminal domain {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Hypothetical protein YkuD, N-terminal domain
species: Bacillus subtilis [TaxId: 1423]

Probab=99.33  E-value=2.4e-13  Score=92.48  Aligned_cols=43  Identities=23%  Similarity=0.505  Sum_probs=41.1

Q ss_pred             EEEecCCCCCHHHHHhHhCCChhhHhhhcCC---cccCCceeeccc
Q 037224          184 VSYVLQPSENLSSVASRFGIETQAIIDVNGN---NIRPFDTLFVPV  226 (552)
Q Consensus       184 ~~y~v~~Gdtl~~ia~~~~~s~~~l~~~N~~---~~~~g~~l~ip~  226 (552)
                      ++|+|++|||||+||++||+++++|+++|++   .|++||.|.||.
T Consensus         2 i~y~V~~GDTL~~IA~~y~v~~~~i~~~N~~~~~~l~~Gq~L~IPg   47 (48)
T d1y7ma2           2 LTYQVKQGDTLNSIAADFRISTAALLQANPSLQAGLTAGQSIVIPG   47 (48)
T ss_dssp             EEEECCTTCCHHHHHHHTTSCCCCCCCTSCTTCSSCCTTCEEEETT
T ss_pred             EEEEECCCCCHHHHHHHhCCCHHHHHHHcCCCCCCCCCCCEEEeCC
Confidence            5899999999999999999999999999998   899999999983

>d1e0ga_ d.7.1.1 (A:) Membrane-bound lytic murein transclycosylase D, MltD {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Membrane-bound lytic murein transclycosylase D, MltD
species: Escherichia coli [TaxId: 562]

Probab=99.29  E-value=5.3e-13  Score=90.28  Aligned_cols=45  Identities=20%  Similarity=0.389  Sum_probs=41.2

Q ss_pred             eEEEEecCCchhhhHHhhcCCcchHHHHHHhCCCCCCCCCCCCcEEEEee
Q 037224          117 LSYTIKSGDTFYLVSTNKYQNLTTYQSVEVVNPTFVPTKLEVGDVIIFPV  166 (552)
Q Consensus       117 ~~y~v~~gdtl~~Ia~~~~~~~~~~~~l~~~N~~~~~~~l~~gq~l~ip~  166 (552)
                      .+|+|++|||||+|| ++|+  +++++|+++|++.  +.|++||+|.||+
T Consensus         3 v~y~V~~GDTl~~IA-~~y~--vs~~~i~~~N~l~--~~l~~Gq~L~i~v   47 (48)
T d1e0ga_           3 ITYRVRKGDSLSSIA-KRHG--VNIKDVMRWNSDT--ANLQPGDKLTLFV   47 (48)
T ss_dssp             CEEEECTTCCHHHHH-HHHT--CCHHHHHHHCSCG--GGCCTTEEEECCC
T ss_pred             EEEEECCCCCHHHHH-HHHC--CCHHHHHHHcCCc--ccCcCCCEEEEEe
Confidence            469999999999999 8899  9999999999985  4699999999986

>d1y7ma2 d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-terminal domain {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Hypothetical protein YkuD, N-terminal domain
species: Bacillus subtilis [TaxId: 1423]

Probab=99.22  E-value=4.7e-12  Score=85.96  Aligned_cols=46  Identities=22%  Similarity=0.212  Sum_probs=42.5

Q ss_pred             eEeeccCCCCCCHHHHHHHhCCChhhhcCcCCCCCCCCCccCCCcEEEee
Q 037224           50 AFYRASAPDFLDLASIADLFSVSRLMISEPSNISSPSSPLIQNQPLFVPI   99 (552)
Q Consensus        50 ~~y~v~~~~g~tl~~Ia~~~~~~~~~l~~~N~~~~~~~~~~~g~~l~iP~   99 (552)
                      .+|+|++  ||||++||++||+++++|+++|++.+  ..|.+||.|.||.
T Consensus         2 i~y~V~~--GDTL~~IA~~y~v~~~~i~~~N~~~~--~~l~~Gq~L~IPg   47 (48)
T d1y7ma2           2 LTYQVKQ--GDTLNSIAADFRISTAALLQANPSLQ--AGLTAGQSIVIPG   47 (48)
T ss_dssp             EEEECCT--TCCHHHHHHHTTSCCCCCCCTSCTTC--SSCCTTCEEEETT
T ss_pred             EEEEECC--CCCHHHHHHHhCCCHHHHHHHcCCCC--CCCCCCCEEEeCC
Confidence            5799999  99999999999999999999999874  4699999999993

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.24  E-value=3.7e-06  Score=78.67  Aligned_cols=122  Identities=16%  Similarity=0.129  Sum_probs=86.2

Q ss_pred             EEEEEEeecCcEEEEEEeccC-------hHHHHHHHHHcC-CCCccceeeeeecCCCCeeEEEEeeccCCCchhhhhhcC
Q 037224          351 GSVYKGNIHGEVYAIKMMKWN-------ACEELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENK  422 (552)
Q Consensus       351 G~Vy~~~~~g~~vAvK~~~~~-------~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~  422 (552)
                      ..||+...+++.+.+|+....       ..+|...+..+. +--+.+++.+..+  ++..++||+++++.++.+..... 
T Consensus        28 ~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~--~~~~~lv~~~l~G~~~~~~~~~~-  104 (263)
T d1j7la_          28 AKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNLLMSEADGVLCSEEYEDE-  104 (263)
T ss_dssp             SEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEEEECCSSEEHHHHTTTC-
T ss_pred             CcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEec--CCceEEEEEeccccccccccccc-
Confidence            579998888888999998532       457898888884 3345677776655  56789999999998775543211 


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------------------
Q 037224          423 NENLNWKTRLRIAIDVANGLQYIHEHT-----------------------------------------------------  449 (552)
Q Consensus       423 ~~~l~~~~~~~i~~qi~~aL~~LH~~~-----------------------------------------------------  449 (552)
                            .....++.++++.+..||+..                                                     
T Consensus       105 ------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  178 (263)
T d1j7la_         105 ------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEK  178 (263)
T ss_dssp             ------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSC
T ss_pred             ------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcC
Confidence                  112334556666666666321                                                     


Q ss_pred             ---CCceEecCCCCCcEEECCCCcEEEeeccCCcc
Q 037224          450 ---RPRVVHKDIKSSNILLDSNMRAKIANFGLAKS  481 (552)
Q Consensus       450 ---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  481 (552)
                         ...++|+|+.|.|||+++++...|+||+.+..
T Consensus       179 ~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         179 PEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             CcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence               12379999999999999876677999998753

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.81  E-value=2.8e-05  Score=72.04  Aligned_cols=119  Identities=14%  Similarity=0.109  Sum_probs=77.3

Q ss_pred             EEEEEEeec-CcEEEEEEeccC----hHHHHHHHHHcCCC--CccceeeeeecCCCCeeEEEEeeccCCCchhhhhhcCC
Q 037224          351 GSVYKGNIH-GEVYAIKMMKWN----ACEELKILQKVNHG--NLVKLEGFCIDPEDANCYLIYEYIENGSLHSWLHENKN  423 (552)
Q Consensus       351 G~Vy~~~~~-g~~vAvK~~~~~----~~~E~~~l~~l~h~--niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~  423 (552)
                      ..||+...+ +..+.+|.....    ..+|...++.+...  .+.+++.+..+  ++..+++|++++|.++.+..     
T Consensus        25 ~~v~r~~~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~--~~~~~~v~~~i~G~~~~~~~-----   97 (255)
T d1nd4a_          25 AAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDWLLLGEVPGQDLLSSH-----   97 (255)
T ss_dssp             CEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEEEEEECCSSEETTTSC-----
T ss_pred             CeEEEEEeCCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeeccc--ccceEEEEEeeecccccccc-----
Confidence            568998884 556888987543    45788888888433  35666766655  56779999999986654311     


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHH---------------------------------------------------hC----
Q 037224          424 ENLNWKTRLRIAIDVANGLQYIH---------------------------------------------------EH----  448 (552)
Q Consensus       424 ~~l~~~~~~~i~~qi~~aL~~LH---------------------------------------------------~~----  448 (552)
                        ....   ..+.++.+.|.-||                                                   ..    
T Consensus        98 --~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  172 (255)
T d1nd4a_          98 --LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDG  172 (255)
T ss_dssp             --CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSS
T ss_pred             --ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCcc
Confidence              1111   11222333333333                                                   21    


Q ss_pred             CCCceEecCCCCCcEEECCCCcEEEeeccCCcc
Q 037224          449 TRPRVVHKDIKSSNILLDSNMRAKIANFGLAKS  481 (552)
Q Consensus       449 ~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  481 (552)
                      ..+.++|+|+.|.|||++++...-|+||+.+..
T Consensus       173 ~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         173 EDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             CCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence            112379999999999998876678999998753

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.15  E-value=0.00095  Score=65.75  Aligned_cols=31  Identities=19%  Similarity=0.369  Sum_probs=26.3

Q ss_pred             CceEecCCCCCcEEECCCCcEEEeeccCCccC
Q 037224          451 PRVVHKDIKSSNILLDSNMRAKIANFGLAKSG  482 (552)
Q Consensus       451 ~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  482 (552)
                      ..++|||+++.|||+++++ ++|+||..+...
T Consensus       223 ~~LiHGDl~~gNIlv~~~~-~~vID~E~a~~G  253 (392)
T d2pula1         223 ETLIHGDLHTGSIFASEHE-TKVIDPEFAFYG  253 (392)
T ss_dssp             CEEECSCCCGGGEEECSSC-EEECCCTTCEEE
T ss_pred             cceeccCCcCCceeEcCCc-eEEechhhcccC
Confidence            3599999999999998764 899999988643

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.57  E-value=0.0049  Score=58.73  Aligned_cols=129  Identities=10%  Similarity=0.159  Sum_probs=71.1

Q ss_pred             EEEEEee-cCcEEEEEEeccC------hHHHHHHHHHcCCCCccceeeeeec-----CCCCeeEEEEeeccCCCchhh--
Q 037224          352 SVYKGNI-HGEVYAIKMMKWN------ACEELKILQKVNHGNLVKLEGFCID-----PEDANCYLIYEYIENGSLHSW--  417 (552)
Q Consensus       352 ~Vy~~~~-~g~~vAvK~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~-----~~~~~~~lv~e~~~~gsL~~~--  417 (552)
                      .||+.+. +|+.+++|+.+..      ..+|...+..|....+....-...+     ..++..+.++++++|..+...  
T Consensus        37 ~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~  116 (325)
T d1zyla1          37 RVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNI  116 (325)
T ss_dssp             EEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCH
T ss_pred             eeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCCH
Confidence            6999988 7888999998643      3468888888753333211111111     114567889999987443210  


Q ss_pred             ------------hhh----cCC---CCCCHH-------------------HHHHHHHHHHHHHHHHHh----CCCCceEe
Q 037224          418 ------------LHE----NKN---ENLNWK-------------------TRLRIAIDVANGLQYIHE----HTRPRVVH  455 (552)
Q Consensus       418 ------------l~~----~~~---~~l~~~-------------------~~~~i~~qi~~aL~~LH~----~~~~~ivH  455 (552)
                                  ++.    ...   ..+++.                   ....+...+...++.+..    ..+..++|
T Consensus       117 ~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~liH  196 (325)
T d1zyla1         117 DQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLH  196 (325)
T ss_dssp             HHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECC
T ss_pred             HHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceeec
Confidence                        010    000   011111                   111122222223333332    22345899


Q ss_pred             cCCCCCcEEECCCCcEEEeeccCCccC
Q 037224          456 KDIKSSNILLDSNMRAKIANFGLAKSG  482 (552)
Q Consensus       456 ~Dikp~NIll~~~~~~kL~Dfg~a~~~  482 (552)
                      +|+++.|||++++  ..++||+.+...
T Consensus       197 gDlh~~NvL~~~~--~~~IDFdd~~~g  221 (325)
T d1zyla1         197 GDCHAGNILWRDG--PMFVDLDDARNG  221 (325)
T ss_dssp             SSCSGGGEEESSS--EEECCCTTCCEE
T ss_pred             CCCCcccEEEeCC--ceEEechhcccC
Confidence            9999999999743  458999988643

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.28  E-value=0.0062  Score=59.68  Aligned_cols=63  Identities=14%  Similarity=0.083  Sum_probs=40.6

Q ss_pred             ceEEEEEEEEeec---------CcEEEEEEecc-----ChHHHHHHHHHcC-CCCccceeeeeecCCCCeeEEEEeeccC
Q 037224          347 CLIQGSVYKGNIH---------GEVYAIKMMKW-----NACEELKILQKVN-HGNLVKLEGFCIDPEDANCYLIYEYIEN  411 (552)
Q Consensus       347 ~g~~G~Vy~~~~~---------g~~vAvK~~~~-----~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~lv~e~~~~  411 (552)
                      .|..-.+|+....         .+.|.+++.-.     +..+|..+++.+. +.-..++++++.+      ++|+||+++
T Consensus        52 GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~------g~I~efi~g  125 (395)
T d1nw1a_          52 GGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG------GRLEEYIPS  125 (395)
T ss_dssp             CCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT------EEEECCCCE
T ss_pred             CccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC------ceEEEEecc
Confidence            3344678887652         34677777532     2347888888884 4334577776643      789999987


Q ss_pred             CCch
Q 037224          412 GSLH  415 (552)
Q Consensus       412 gsL~  415 (552)
                      .+|.
T Consensus       126 ~~l~  129 (395)
T d1nw1a_         126 RPLS  129 (395)
T ss_dssp             EECC
T ss_pred             ccCC
Confidence            5553

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.18  E-value=0.0076  Score=56.88  Aligned_cols=150  Identities=14%  Similarity=0.092  Sum_probs=79.0

Q ss_pred             ccHHHHHHHhhccCCCceE---------EEEEEEEeecCcEEEEEEeccC-----hHHHHHHHHHcCCCCccceeeeeec
Q 037224          331 FKIEELREATDNFSEGCLI---------QGSVYKGNIHGEVYAIKMMKWN-----ACEELKILQKVNHGNLVKLEGFCID  396 (552)
Q Consensus       331 ~~~~~l~~~t~~~~~G~g~---------~G~Vy~~~~~g~~vAvK~~~~~-----~~~E~~~l~~l~h~niv~l~~~~~~  396 (552)
                      .+.+|+......++.|.-.         .-+.|+.+.++..+++|+....     ...|++++..+...++.-..-.-..
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~   82 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRK   82 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBT
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCcEEEEEcCCCCCHHHHHHHHHHHHhhhhccccccccceec
Confidence            3556676767777665332         2457888887777999998542     2357777888754333221111000


Q ss_pred             ------CCCCeeEEEEeeccCCCchhh--------------hhhc----C---CCCCCH------------------HHH
Q 037224          397 ------PEDANCYLIYEYIENGSLHSW--------------LHEN----K---NENLNW------------------KTR  431 (552)
Q Consensus       397 ------~~~~~~~lv~e~~~~gsL~~~--------------l~~~----~---~~~l~~------------------~~~  431 (552)
                            .-......++.+..+......              ++..    .   ......                  ...
T Consensus        83 ~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (316)
T d2ppqa1          83 DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGL  162 (316)
T ss_dssp             TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTH
T ss_pred             CCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhH
Confidence                  012344566666665333211              0000    0   000000                  011


Q ss_pred             HHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEECCCCcEEEeeccCCc
Q 037224          432 LRIAIDVANGLQYIHEH-TRPRVVHKDIKSSNILLDSNMRAKIANFGLAK  480 (552)
Q Consensus       432 ~~i~~qi~~aL~~LH~~-~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  480 (552)
                      ...+......+...+.. -+..+||+|+.++||+++.+...-|+||+.+.
T Consensus       163 ~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         163 REEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             HHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            11222222222222221 12348999999999999988777899999885

>d1ijwc_ a.4.1.2 (C:) HIN recombinase (DNA-binding domain) {Synthetic}

class: All alpha proteins
fold: DNA/RNA-binding 3-helical bundle
superfamily: Homeodomain-like
family: Recombinase DNA-binding domain
domain: HIN recombinase (DNA-binding domain)
species: Synthetic

Probab=81.24  E-value=0.39  Score=30.61  Aligned_cols=24  Identities=21%  Similarity=0.300  Sum_probs=21.6

Q ss_pred             cCCCCCHHHHHhHhCCChhhHhhh
Q 037224          188 LQPSENLSSVASRFGIETQAIIDV  211 (552)
Q Consensus       188 v~~Gdtl~~ia~~~~~s~~~l~~~  211 (552)
                      +..|.+..+||+.||||..+|.++
T Consensus        18 ~~~G~s~~~iA~~~gVSr~TiYry   41 (47)
T d1ijwc_          18 LEKGHPRQQLAIIFGIGVSTLYRY   41 (47)
T ss_dssp             HHTTCCHHHHHHHHTCCHHHHHHH
T ss_pred             HHCCCCHHHHHHHHCcCHHHHHhh
Confidence            467999999999999999999765